mim_number,mim_name,prefix
100050,"AARSKOG SYNDROME, AUTOSOMAL DOMINANT",
100070,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1",Percent
100100,PRUNE BELLY SYNDROME; PBS,Number Sign
100200,ABDUCENS PALSY,
100300,ADAMS-OLIVER SYNDROME 1; AOS1,Number Sign
100500,MOVED TO 200150,Caret
100600,ACANTHOSIS NIGRICANS,Percent
100640,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A1; ALDH1A1",Asterisk
100650,ALDEHYDE DEHYDROGENASE 2 FAMILY; ALDH2,Plus
100660,"ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 1; ALDH3A1",Asterisk
100670,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER B1; ALDH1B1",Asterisk
100675,ACETAMINOPHEN METABOLISM,
100678,ACETYL-CoA ACETYLTRANSFERASE 2; ACAT2,Asterisk
100680,MOVED TO 100740,Caret
100690,"CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 1; CHRNA1",Asterisk
100700,ACHARD SYNDROME,
100710,"CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1; CHRNB1",Asterisk
100720,"CHOLINERGIC RECEPTOR, NICOTINIC, DELTA POLYPEPTIDE; CHRND",Asterisk
100725,"CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE; CHRNE",Asterisk
100730,"CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG",Asterisk
100735,MOVED TO 142445,Caret
100740,ACETYLCHOLINESTERASE; ACHE,Asterisk
100790,"ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 1; ASCL1",Asterisk
100800,ACHONDROPLASIA; ACH,Number Sign
100820,ACHOO SYNDROME,Percent
100850,"ACONITASE, MITOCHONDRIAL; ACO2",Asterisk
100880,"ACONITASE 1, SOLUBLE; ACO1",Asterisk
100900,MOVED TO 100880,Caret
101000,"NEUROFIBROMATOSIS, TYPE II; NF2",Number Sign
101120,ACROCEPHALOPOLYSYNDACTYLY TYPE III,
101200,APERT SYNDROME,Number Sign
101400,SAETHRE-CHOTZEN SYNDROME; SCS,Number Sign
101600,PFEIFFER SYNDROME,Number Sign
101800,ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1,Number Sign
101805,"ACROFACIAL DYSOSTOSIS, CATANIA TYPE",
101840,"ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT",
101850,"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE III; PPKP3",Percent
101900,ACROKERATOSIS VERRUCIFORMIS; AKV,Number Sign
102000,"ACROLEUKOPATHY, SYMMETRIC",
102100,"ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA",Percent
102150,ACROMEGALOID FACIAL APPEARANCE SYNDROME,Percent
102200,"PITUITARY ADENOMA 1, MULTIPLE TYPES; PITA1",Number Sign
102300,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1",Percent
102350,ACROMIAL DIMPLES,Percent
102370,ACROMICRIC DYSPLASIA; ACMICD,Number Sign
102400,ACROOSTEOLYSIS,
102480,ACROSIN; ACR,Asterisk
102490,MOVED TO 607323,Caret
102500,HAJDU-CHENEY SYNDROME; HJCYS,Number Sign
102510,ACROPECTOROVERTEBRAL DYSPLASIA; ACRPV,Percent
102520,ACRORENAL SYNDROME,
102525,ACROSOMAL VESICLE PROTEIN 1; ACRV1,Asterisk
102530,SPERMATOGENIC FAILURE 6; SPGF6,Number Sign
102540,"ACTIN, ALPHA, CARDIAC MUSCLE; ACTC1",Asterisk
102545,"ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC; ACTG2",Asterisk
102550,MOVED TO 102630,Caret
102560,"ACTIN, GAMMA-1; ACTG1",Asterisk
102565,FILAMIN C; FLNC,Asterisk
102570,REMOVED FROM DATABASE,Caret
102573,"ACTININ, ALPHA-2; ACTN2",Asterisk
102574,"ACTININ, ALPHA-3; ACTN3",Asterisk
102575,"ACTININ, ALPHA-1; ACTN1",Asterisk
102576,"ACTIVIN A RECEPTOR, TYPE I; ACVR1",Asterisk
102577,"REPLICATION FACTOR C, SUBUNIT 4; RFC4",Asterisk
102578,"ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML",Asterisk
102579,"REPLICATION FACTOR C, SUBUNIT 1; RFC1",Asterisk
102581,"ACTIVIN A RECEPTOR, TYPE IIA; ACVR2A",Asterisk
102582,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3,Asterisk
102590,"ACYLASE, COBALT-ACTIVATED",
102593,ACYLOXYACYL HYDROLASE; AOAH,Asterisk
102595,"ACYLPHOSPHATASE 2, MUSCLE TYPE; ACYP2",Asterisk
102600,ADENINE PHOSPHORIBOSYLTRANSFERASE; APRT,Asterisk
102610,"ACTIN, ALPHA, SKELETAL MUSCLE 1; ACTA1",Asterisk
102620,"ACTIN, ALPHA-2, SMOOTH MUSCLE, AORTA; ACTA2",Asterisk
102630,"ACTIN, BETA; ACTB",Asterisk
102640,MOVED TO 102630,Caret
102642,STEROL O-ACYLTRANSFERASE 1; SOAT1,Asterisk
102645,ACYLPEPTIDE HYDROLASE; APH,Asterisk
102650,"ADACTYLIA, UNILATERAL",
102660,ADAMANTINOMA OF LONG BONES,
102670,MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1; MADCAM1,Asterisk
102680,ADDUCIN 1; ADD1,Asterisk
102681,ADDUCIN 2; ADD2,Asterisk
102699,ADENO-ASSOCIATED VIRUS INTEGRATION SITE 1; AAVS1,
102700,"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY",Number Sign
102710,MOVED TO 102720,Caret
102720,DIPEPTIDYL PEPTIDASE IV; DPP4,Asterisk
102730,"ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO",
102750,ADENOSINE KINASE; ADK,Asterisk
102770,ADENOSINE MONOPHOSPHATE DEAMINASE 1; AMPD1,Asterisk
102771,ADENOSINE MONOPHOSPHATE DEAMINASE 2; AMPD2,Asterisk
102772,ADENOSINE MONOPHOSPHATE DEAMINASE 3; AMPD3,Asterisk
102775,ADENOSINE A1 RECEPTOR; ADORA1,Asterisk
102776,ADENOSINE A2A RECEPTOR; ADORA2A,Asterisk
102777,ADENOSINE A2 RECEPTOR-LIKE; ADORA2L1,Asterisk
102800,"ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO",Percent
102900,"ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES",Number Sign
102910,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, BETA SUBUNIT; ATP5F1B",Asterisk
102920,REMOVED FROM DATABASE,Caret
102930,REMOVED FROM DATABASE,Caret
102940,REMOVED FROM DATABASE,Caret
102970,REMOVED FROM DATABASE,Caret
102980,ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1; ADCYAP1,Asterisk
102981,"ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1, RECEPTOR FOR; ADCYAP1R1",Asterisk
102990,MOVED TO 145600,Caret
103000,ADENYLATE KINASE 1; AK1,Asterisk
103020,ADENYLATE KINASE 2; AK2,Asterisk
103030,ADENYLATE KINASE 3-LIKE 1; AK3L1,Asterisk
103050,ADENYLOSUCCINASE DEFICIENCY; ADSLD,Number Sign
103060,ADENYLOSUCCINATE SYNTHETASE; ADSS,Asterisk
103070,ADENYLATE CYCLASE 8; ADCY8,Asterisk
103071,ADENYLATE CYCLASE 2; ADCY2,Asterisk
103072,ADENYLATE CYCLASE 1; ADCY1,Asterisk
103100,ADIE PUPIL,Number Sign
103180,ADP-RIBOSYLATION FACTOR 1; ARF1,Asterisk
103188,ADP-RIBOSYLATION FACTOR 5; ARF5,Asterisk
103190,ADP-RIBOSYLATION FACTOR 3; ARF3,Asterisk
103195,PERILIPIN 2; PLIN2,Asterisk
103200,ADIPOSIS DOLOROSA,Percent
103220,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 4; SLC25A4",Asterisk
103230,"ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL",
103260,FERREDOXIN 1; FDX1,Asterisk
103270,FERREDOXIN REDUCTASE; FDXR,Asterisk
103275,ADRENOMEDULLIN; ADM,Asterisk
103280,"H19, IMPRINTED MATERNALLY EXPRESSED NONCODING TRANSCRIPT; H19",Asterisk
103285,ADULT SYNDROME,Number Sign
103300,HYPOGLOSSIA-HYPODACTYLIA,Percent
103320,AGRIN; AGRN,Asterisk
103321,MOVED TO 128239,Caret
103390,AHNAK NUCLEOPROTEIN; AHNAK,Asterisk
103400,AINHUM,
103420,"ALACRIMA, CONGENITAL, AUTOSOMAL DOMINANT",Percent
103470,"ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS",Number Sign
103500,TIETZ ALBINISM-DEAFNESS SYNDROME; TADS,Number Sign
103580,"PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A",Number Sign
103581,MOVED TO 103580,Caret
103600,ALBUMIN; ALB,Asterisk
103700,"ALCOHOL DEHYDROGENASE 1A, CLASS I, ALPHA POLYPEPTIDE; ADH1A",Asterisk
103710,"ALCOHOL DEHYDROGENASE 5, CHI POLYPEPTIDE; ADH5",Asterisk
103720,"ALCOHOL DEHYDROGENASE 1B, CLASS I, BETA POLYPEPTIDE; ADH1B",Asterisk
103730,"ALCOHOL DEHYDROGENASE 1C, GAMMA POLYPEPTIDE; ADH1C",Asterisk
103735,ALCOHOL DEHYDROGENASE 6; ADH6,Asterisk
103740,ALCOHOL DEHYDROGENASE 4; ADH4,Asterisk
103780,ALCOHOL DEPENDENCE,Number Sign
103800,MOVED TO 253200 AND 258870,Caret
103830,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER A1; AKR1A1",Asterisk
103850,"ALDOLASE A, FRUCTOSE-BISPHOSPHATE; ALDOA",Asterisk
103870,"ALDOLASE C, FRUCTOSE-BISPHOSPHATE; ALDOC",Asterisk
103880,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER B1; AKR1B1",Asterisk
103890,ALDOSE REDUCTASE M; ARM,Asterisk
103900,"HYPERALDOSTERONISM, FAMILIAL, TYPE I; HALD1",Number Sign
103920,"ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, FAMILIAL",
103950,ALPHA-2-MACROGLOBULIN; A2M,Asterisk
104000,ALOPECIA AREATA 1; AA1,Percent
104100,PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1,Number Sign
104110,"ALOPECIA, FAMILIAL FOCAL; ALPF",
104130,"ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY",Percent
104145,AFAMIN; AFM,Asterisk
104150,ALPHA-FETOPROTEIN; AFP,Asterisk
104155,ZINC FINGER HOMEOBOX 3; ZFHX3,Asterisk
104160,"GLUCOSIDASE, ALPHA, NEUTRAL AB; GANAB",Asterisk
104170,N-ACETYL-ALPHA-D-GALACTOSAMINIDASE; NAGA,Asterisk
104175,"GLYCOPROTEIN, ALPHA-GALACTOSYLTRANSFERASE 1 PSEUDOGENE; GGTA1P",Asterisk
104180,"GLUCOSIDASE, ALPHA, NEUTRAL C; GANC",Asterisk
104200,"ALPORT SYNDROME, AUTOSOMAL DOMINANT",Number Sign
104210,ALPHA-2A-ADRENERGIC RECEPTOR; ADRA2A,Asterisk
104219,ALPHA-1D-ADRENERGIC RECEPTOR; ADRA1D,Asterisk
104220,ALPHA-1B-ADRENERGIC RECEPTOR; ADRA1B,Asterisk
104221,ALPHA-1A-ADRENERGIC RECEPTOR; ADRA1A,Asterisk
104222,MOVED TO 104219,Caret
104225,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ASSOCIATED PROTEIN 1; LRPAP1,Asterisk
104230,FUCOSYLTRANSFERASE 4; FUT4,Asterisk
104240,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 4; ST3GAL4",Asterisk
104250,ALPHA-2C-ADRENERGIC RECEPTOR; ADRA2C,Plus
104260,ALPHA-2B-ADRENERGIC RECEPTOR; ADRA2B,Asterisk
104290,ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1,Number Sign
104300,ALZHEIMER DISEASE; AD,Number Sign
104310,ALZHEIMER DISEASE 2; AD2,Number Sign
104311,PRESENILIN 1; PSEN1,Asterisk
104350,"AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM",
104400,AMELIA AND TERMINAL TRANSVERSE HEMIMELIA,
104500,"AMELOGENESIS IMPERFECTA, TYPE IB; AI1B",Number Sign
104510,"AMELOGENESIS IMPERFECTA, TYPE IV; AI4",Number Sign
104530,"AMELOGENESIS IMPERFECTA, TYPE IA; AI1A",Number Sign
104570,AMELOONYCHOHYPOHIDROTIC SYNDROME,Percent
104600,AMENORRHEA-GALACTORRHEA SYNDROME,
104610,AMILORIDE-BINDING PROTEIN 1; ABP1,Asterisk
104613,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6A; CCT6A",Asterisk
104614,"SOLUTE CARRIER FAMILY 3 (CYSTINE, DIBASIC, AND NEUTRAL AMINO ACID TRANSPORTER), MEMBER 1; SLC3A1",Asterisk
104615,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 1; SLC7A1",Asterisk
104620,AMINOACYLASE 1; ACY1,Asterisk
104640,AMPHIREGULIN; AREG,Asterisk
104650,"AMYLASE, PANCREATIC, A; AMY2A",Asterisk
104660,"AMYLASE, PANCREATIC, B; AMY2B",Asterisk
104700,"AMYLASE, SALIVARY, A; AMY1A",Asterisk
104701,"AMYLASE, SALIVARY, B; AMY1B",Asterisk
104702,"AMYLASE, SALIVARY, C; AMY1C",Asterisk
104740,MOVED TO 602414,Caret
104750,SERUM AMYLOID A1; SAA1,Asterisk
104751,SERUM AMYLOID A2; SAA2,Asterisk
104752,SERUM AMYLOID A4; SAA4,Asterisk
104760,AMYLOID BETA A4 PRECURSOR PROTEIN; APP,Asterisk
104770,"AMYLOID P COMPONENT, SERUM; APCS",Asterisk
104775,AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 1; APLP1,Asterisk
104776,AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 2; APLP2,Asterisk
105120,"AMYLOIDOSIS, FINNISH TYPE",Number Sign
105150,"CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED",Number Sign
105200,"AMYLOIDOSIS, FAMILIAL VISCERAL",Number Sign
105210,"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",Number Sign
105250,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1",Number Sign
105300,AMYOTROPHIC DYSTONIC PARAPLEGIA,
105400,AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1,Number Sign
105500,AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1,Number Sign
105550,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1; FTDALS1,Number Sign
105563,ANAL SPHINCTER DYSPLASIA; ASDP,
105565,"ANAL SPHINCTER MYOPATHY, INTERNAL",
105570,"ANDROSTENONE, ABILITY TO SMELL",
105580,ANAL CANAL CARCINOMA,
105590,ANAPLASTIC LYMPHOMA KINASE; ALK,Asterisk
105600,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE III; CDAN3",Percent
105650,DIAMOND-BLACKFAN ANEMIA 1; DBA1,Number Sign
105800,"ANEURYSM, INTRACRANIAL BERRY, 1; ANIB1",Percent
105805,ANEURYSM OF INTERVENTRICULAR SEPTUM,
105830,ANGELMAN SYNDROME; AS,Number Sign
105835,ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED,
105850,ANGIOGENIN; ANG,Asterisk
106050,"ANGIOMA SERPIGINOSUM, AUTOSOMAL DOMINANT",
106070,"ANGIOMA, HEREDITARY NEUROCUTANEOUS",Percent
106100,"ANGIOEDEMA, HEREDITARY, TYPE I; HAE1",Number Sign
106150,ANGIOTENSINOGEN; AGT,Plus
106160,MOVED TO 106165,Caret
106165,ANGIOTENSIN RECEPTOR 1; AGTR1,Asterisk
106180,ANGIOTENSIN I-CONVERTING ENZYME; ACE,Plus
106190,"ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD",Number Sign
106195,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 3; SLC4A3",Asterisk
106200,MOVED TO 106210,Caret
106210,ANIRIDIA 1; AN1,Number Sign
106220,ANIRIDIA AND ABSENT PATELLA,
106230,"ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT",
106240,ANISOCORIA,
106250,ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE; AFA,
106260,ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE,Number Sign
106280,ANKYLOGLOSSIA,
106300,"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1",Number Sign
106400,ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS,
106410,ANKYRIN 2; ANK2,Asterisk
106490,ANNEXIN A3; ANXA3,Asterisk
106491,ANNEXIN A4; ANXA4,Asterisk
106500,ANNULAR ERYTHEMA,
106600,"TOOTH AGENESIS, SELECTIVE, 1; STHAG1",Number Sign
106700,TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1,Percent
106750,ANONYCHIA WITH FLEXURAL PIGMENTATION,
106900,ANONYCHIA-ECTRODACTYLY,
106990,ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY,
106995,ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES,Percent
107000,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6",Percent
107100,ANORECTAL ANOMALIES,Percent
107200,"ANOSMIA, ISOLATED CONGENITAL; ANIC",Percent
107240,MOVED TO 116930,Caret
107250,ANTERIOR SEGMENT DYSGENESIS 1; ASGD1,Number Sign
107253,REMOVED FROM DATABASE,Caret
107254,ANTIGEN IDENTIFIED BY MONOCLONAL ANTIBODY 30.2A8; MIC12,Asterisk
107257,ANTIGEN MSK3 IDENTIFIED BY MONOCLONAL ANTIBODY M68; MSK3,Asterisk
107260,ANTIGEN MSK41 IDENTIFIED BY MONOCLONAL ANTIBODY E3; MSK41,Asterisk
107265,CD19 ANTIGEN; CD19,Asterisk
107266,CD22 ANTIGEN; CD22,Asterisk
107269,CD44 ANTIGEN; CD44,Asterisk
107270,CD38 ANTIGEN; CD38,Asterisk
107271,CD59 ANTIGEN; CD59,Asterisk
107272,CD72 ANTIGEN; CD72,Asterisk
107273,CD69 ANTIGEN; CD69,Asterisk
107280,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 3; SERPINA3",Asterisk
107285,SECRETORY LEUKOCYTE PROTEASE INHIBITOR; SLPI,Asterisk
107290,ANTIPYRINE METABOLISM,Percent
107300,"SERPIN PEPTIDASE INHIBITOR, CLADE C (ANTITHROMBIN), MEMBER 1; SERPINC1",Asterisk
107310,"SOLUTE CARRIER FAMILY 9, MEMBER 1; SLC9A1",Asterisk
107320,"ANTIPHOSPHOLIPID SYNDROME, FAMILIAL",
107323,"ALDEHYDE DEHYDROGENASE 7 FAMILY, MEMBER A1; ALDH7A1",Asterisk
107325,CD3-EPSILON-ASSOCIATED PROTEIN; CD3EAP,Asterisk
107400,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 1; SERPINA1",Asterisk
107410,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE; SERPINA2P",
107440,"ANTIVIRAL STATE REPRESSOR, REGULATOR OF; AVRR",
107450,"INTERFERON-ALPHA, -BETA, AND -OMEGA RECEPTOR 1; IFNAR1",Asterisk
107460,MOVED TO 107450,Caret
107470,INTERFERON-GAMMA RECEPTOR 1; IFNGR1,Asterisk
107480,TOWNES-BROCKS SYNDROME 1; TBS1,Number Sign
107500,AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION,
107550,"AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA",
107580,TRANSCRIPTION FACTOR AP2-ALPHA; TFAP2A,Asterisk
107600,"APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC",Number Sign
107601,MOVED TO 100300,Caret
107640,"APNEA, CENTRAL SLEEP",
107650,"APNEA, OBSTRUCTIVE SLEEP",Percent
107670,APOLIPOPROTEIN A-II; APOA2,Plus
107680,APOLIPOPROTEIN A-I; APOA1,Plus
107690,APOLIPOPROTEIN A-IV; APOA4,Asterisk
107700,"APPENDICITIS, PRONENESS TO",
107710,APOLIPOPROTEIN C-I; APOC1,Asterisk
107720,APOLIPOPROTEIN C-III; APOC3,Asterisk
107730,APOLIPOPROTEIN B; APOB,Plus
107740,APOLIPOPROTEIN D; APOD,Asterisk
107741,APOLIPOPROTEIN E; APOE,Asterisk
107748,APEX NUCLEASE 1; APEX1,Asterisk
107750,ARBITRARY RESTRICTION POLYMORPHISM 1,Number Sign
107760,APOLIPOPROTEIN F; APOF,Asterisk
107770,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LRP1,Asterisk
107773,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 2; NR2F2",Asterisk
107776,AQUAPORIN 1; AQP1,Asterisk
107777,AQUAPORIN 2; AQP2,Asterisk
107800,ARCUS CORNEAE,
107820,ARGINYL-tRNA SYNTHETASE; RARS,Asterisk
107830,ARGINASE 2; ARG2,Asterisk
107840,MOVED TO 215700,Caret
107850,ARM FOLDING PREFERENCE,
107900,"ARMS, MALFORMATION OF",
107910,"CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1",Asterisk
107920,AROMATIC ALPHA-KETO ACID REDUCTASE,
107930,DOPA DECARBOXYLASE; DDC,Asterisk
107940,"ARRESTIN, BETA, 1; ARRB1",Asterisk
107941,"ARRESTIN, BETA, 2; ARRB2",Asterisk
107950,MOVED TO 138800,Caret
107970,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1",Number Sign
108000,"ARTERIES, ANOMALIES OF",
108010,ARTERIOVENOUS MALFORMATIONS OF THE BRAIN,Number Sign
108050,"ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS",
108100,"ARTHRITIS, SACROILIAC",
108110,MOVED TO 108120,Caret
108120,"ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A",Number Sign
108130,MOVED TO 601680,Caret
108140,MOVED TO 601680,Caret
108145,"ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5",Number Sign
108200,"ARTHROGRYPOSIS, DISTAL, TYPE 6; DA6",
108300,"STICKLER SYNDROME, TYPE I; STL1",Number Sign
108320,"ARTICHOKE, MODIFICATION OF TASTE BY",
108330,"CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1A1",Asterisk
108340,ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY,Percent
108345,N-ACETYLTRANSFERASE 1; NAT1,Asterisk
108355,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2; GRB2,Asterisk
108360,ASIALOGLYCOPROTEIN RECEPTOR 1; ASGR1,Asterisk
108361,ASIALOGLYCOPROTEIN RECEPTOR 2; ASGR2,Asterisk
108370,ASPARAGINE SYNTHETASE; ASNS,Asterisk
108390,"ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY",Percent
108400,REMOVED FROM DATABASE,Caret
108410,ASPARAGINYL-tRNA SYNTHETASE; NARS,Asterisk
108420,SPERMATOGENIC FAILURE 2; SPGF2,Percent
108450,ASYMMETRIC SHORT STATURE SYNDROME,
108500,"EPISODIC ATAXIA, TYPE 2; EA2",Number Sign
108600,"SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1",Number Sign
108650,"SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7",Percent
108700,ATAXIA WITH FASCICULATIONS,
108720,"ATELOSTEOGENESIS, TYPE I; AO1",Number Sign
108721,"ATELOSTEOGENESIS, TYPE III; AO3",Number Sign
108725,ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS,Percent
108728,ATP CITRATE LYASE; ACLY,Asterisk
108729,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, GAMMA SUBUNIT 1; ATP5F1C",Asterisk
108730,"ATPase, Ca(2+)-TRANSPORTING, FAST-TWITCH 1; ATP2A1",Asterisk
108731,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 1; ATP2B1",Asterisk
108732,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 4; ATP2B4",Asterisk
108733,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 2; ATP2B2",Asterisk
108740,"ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2",Asterisk
108745,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 16-KD, V0 SUBUNIT C; ATP6V0C",Asterisk
108746,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E, ISOFORM 1; ATP6V1E1",Asterisk
108760,ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS,Percent
108770,ATRIAL STANDSTILL 1; ATRST1,Number Sign
108780,NATRIURETIC PEPTIDE PRECURSOR A; NPPA,Asterisk
108800,ATRIAL SEPTAL DEFECT 1; ASD1,Percent
108900,ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7,Number Sign
108950,ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL,
108960,NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A; NPR1,Asterisk
108961,NATRIURETIC PEPTIDE RECEPTOR 2; NPR2,Asterisk
108962,NATRIURETIC PEPTIDE RECEPTOR C; NPR3,Asterisk
108970,MOVED TO 120520,Caret
108980,"PR INTERVAL, VARIATION IN",Percent
108985,SVEINSSON CHORIORETINAL ATROPHY; SCRA,Number Sign
108990,ATTACHED CELL ANTIGEN 28.3.7; MIC7,Asterisk
109000,AURICULOOSTEODYSPLASIA,Percent
109050,AUROCEPHALOSYNDACTYLY,
109090,SJOGREN SYNDROME ANTIGEN B; SSB,Asterisk
109091,CALRETICULIN; CALR,Asterisk
109092,TRIPARTITE MOTIF-CONTAINING PROTEIN 21; TRIM21,Asterisk
109100,AUTOIMMUNE DISEASE,Number Sign
109110,AUTONOMOUSLY REPLICATING SEQUENCE 1,Asterisk
109120,"AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES",
109130,AXIAL OSTEOMALACIA,
109135,AXL RECEPTOR TYROSINE KINASE; AXL,Asterisk
109150,MACHADO-JOSEPH DISEASE; MJD,Number Sign
109160,"AZOTEMIA, FAMILIAL",Percent
109170,LEUKOCYTE-SPECIFIC TRANSCRIPT 1; LST1,Asterisk
109180,BABOON M7 VIRUS INTEGRATION SITE; BEVI,
109190,"SOLUTE CARRIER FAMILY 1 (NEUTRAL AMINO ACID TRANSPORTER), MEMBER 5; SLC1A5",Asterisk
109195,BACTERICIDAL PERMEABILITY-INCREASING PROTEIN; BPI,Asterisk
109200,"ALOPECIA, ANDROGENETIC, 1; AGA1",Percent
109270,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1",Plus
109280,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 2; SLC4A2",Asterisk
109300,BANKI SYNDROME,
109350,GASTROESOPHAGEAL REFLUX; GER,Percent
109390,MOVED TO 301845,Caret
109400,BASAL CELL NEVUS SYNDROME; BCNS,Number Sign
109480,BASIGIN; BSG,Asterisk
109500,"BASILAR IMPRESSION, PRIMARY",Percent
109530,CD48 ANTIGEN; CD48,Asterisk
109535,CD40 ANTIGEN; CD40,Asterisk
109540,B-CELL GROWTH FACTOR; BCGF,
109543,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2",Percent
109545,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17; TNFRSF17",Asterisk
109560,B-CELL LEUKEMIA/LYMPHOMA 3; BCL3,Asterisk
109565,B-CELL LYMPHOMA 6; BCL6,Asterisk
109580,B-CELL TRANSLOCATION GENE 1; BTG1,Asterisk
109600,BEETURIA,
109610,"TRANSLOCATOR PROTEIN, 18-KD; TSPO",Asterisk
109630,BETA-1-ADRENERGIC RECEPTOR; ADRB1,Plus
109635,BETA-ADRENERGIC RECEPTOR KINASE 1; ADRBK1,Asterisk
109636,BETA-ADRENERGIC RECEPTOR KINASE 2; ADRBK2,Asterisk
109640,BETA-GLYCEROL PHOSPHATASE; GPB,Asterisk
109650,BEHCET SYNDROME,Percent
109660,"BETA-AMINO ACIDS, RENAL TRANSPORT OF; AABT",Percent
109670,"BETA-ADRENERGIC STIMULATION, RESPONSE TO; BAS",
109675,"ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 1; ST6GAL1",Asterisk
109684,17-BETA-HYDROXYSTEROID DEHYDROGENASE I; HSD17B1,Asterisk
109685,17-BETA-HYDROXYSTEROID DEHYDROGENASE II; HSD17B2,Asterisk
109690,BETA-2-ADRENERGIC RECEPTOR; ADRB2,Plus
109691,BETA-3-ADRENERGIC RECEPTOR; ADRB3,Asterisk
109700,BETA-2-MICROGLOBULIN; B2M,Asterisk
109710,BETA-2-MICROGLOBULIN REGULATOR; B2MR,Asterisk
109715,3-BETA-HYDROXYSTEROID DEHYDROGENASE 1; HSD3B1,Asterisk
109720,"BILIARY CIRRHOSIS, PRIMARY, 1; PBC1",Percent
109730,AORTIC VALVE DISEASE 1; AOVD1,Number Sign
109740,"BIFID NOSE, AUTOSOMAL DOMINANT",
109750,BILIVERDIN REDUCTASE A; BLVRA,Asterisk
109760,5-HYDROXYTRYPTAMINE RECEPTOR 1A; HTR1A,Asterisk
109770,CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1; CEACAM1,Asterisk
109780,BKM DNA,Asterisk
109800,BLADDER CANCER,Number Sign
109820,BLADDER DIVERTICULUM,
109900,BLEPHAROCHALASIS AND DOUBLE LIP,
110000,"BLEPHAROCHALASIS, SUPERIOR",
110050,BLEPHARONASOFACIAL MALFORMATION SYNDROME,
110100,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES",Number Sign
110150,"BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS",
110250,BLOOD GROUP--ABO SUPPRESSOR,
110300,ABO GLYCOSYLTRANSFERASE; ABO,Asterisk
110310,"BLOOD GROUP--ABH ANTIGEN, TYPE 2",
110350,BLOOD GROUP--AHONEN; AN,Percent
110450,"BLOOD GROUP, COLTON SYSTEM; CO",Number Sign
110500,"BLOOD GROUP, DIEGO SYSTEM; DI",Number Sign
110600,ADP-RIBOSYLTRANSFERASE 4; ART4,Asterisk
110700,"BLOOD GROUP, DUFFY SYSTEM; FY",Number Sign
110720,BLOOD GROUP--En,
110750,GLYCOPHORIN C; GYPC,Asterisk
110800,"BLOOD GROUP, I SYSTEM; Ii",Number Sign
110900,BLOOD GROUP--KELL SYSTEM; KEL,Number Sign
111000,"BLOOD GROUP, KIDD SYSTEM; JK",Number Sign
111100,FUCOSYLTRANSFERASE 3; FUT3,Plus
111130,BLOOD GROUP--LKE; LKE,Percent
111150,BLOOD GROUP--LUTHERAN INHIBITOR; INLU,Number Sign
111200,BLOOD GROUP--LUTHERAN SYSTEM; LU,Number Sign
111250,"BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW",Number Sign
111300,"BLOOD GROUP, MN; MN",Number Sign
111360,BLOOD GROUP--NEWFOUNDLAND; NFLD,
111380,BLOOD GROUP--OK; OK,Number Sign
111400,"BLOOD GROUP, P1PK SYSTEM",Number Sign
111410,MOVED TO 111400,Caret
111500,BLOOD GROUP--PRIVATE SYSTEMS,Number Sign
111600,"BLOOD GROUP, LANGEREIS SYSTEM; LAN",Number Sign
111620,RADIN BLOOD GROUP ANTIGEN; RD,Number Sign
111680,"RHESUS BLOOD GROUP, D ANTIGEN; RHD",Asterisk
111690,MOVED TO 111700,Caret
111700,"RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE",Asterisk
111730,"BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 2; B4GALNT2",Asterisk
111740,"BLOOD GROUP, Ss; Ss",Number Sign
111750,BLOOD GROUP--SCIANNA SYSTEM; SC,Number Sign
111800,BLOOD GROUP--STOLTZFUS SYSTEM; Sf,Percent
112000,BLOOD GROUP--Ul SYSTEM; UL,Percent
112010,BLOOD GROUP--WALDNER TYPE; WD,Number Sign
112050,BLOOD GROUP--WRIGHT ANTIGEN; WR,Number Sign
112100,YT BLOOD GROUP ANTIGEN,Number Sign
112200,BLUE RUBBER BLEB NEVUS,Percent
112203,CD80 ANTIGEN; CD80,Asterisk
112205,CD79A ANTIGEN; CD79A,Asterisk
112210,"MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 1; MS4A1",Asterisk
112240,COLE-CARPENTER SYNDROME 1; CLCRP1,Number Sign
112250,DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH,Number Sign
112260,"GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, BONE; BGLAP",Asterisk
112261,BONE MORPHOGENETIC PROTEIN 2; BMP2,Asterisk
112262,BONE MORPHOGENETIC PROTEIN 4; BMP4,Asterisk
112263,BONE MORPHOGENETIC PROTEIN 3; BMP3,Asterisk
112264,BONE MORPHOGENETIC PROTEIN 1; BMP1,Asterisk
112265,BONE MORPHOGENETIC PROTEIN 5; BMP5,Asterisk
112266,BONE MORPHOGENETIC PROTEIN 6; BMP6,Asterisk
112267,BONE MORPHOGENETIC PROTEIN 7; BMP7,Asterisk
112270,"BONE PAIN, PERIODIC",
112300,BOOK SYNDROME,Percent
112310,BOOMERANG DYSPLASIA,Number Sign
112350,WEISMANN-NETTER SYNDROME; WNS,Percent
112370,"BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS ADDUCTUS, AND DEVELOPMENTAL DELAY",
112410,HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB,Number Sign
112430,LONG-THUMB BRACHYDACTYLY SYNDROME,
112440,"BRACHYDACTYLY, COMBINED B AND E TYPES",Percent
112450,"BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION",
112500,"BRACHYDACTYLY, TYPE A1; BDA1",Number Sign
112600,"BRACHYDACTYLY, TYPE A2; BDA2",Number Sign
112700,"BRACHYDACTYLY, TYPE A3; BDA3",Percent
112800,"BRACHYDACTYLY, TYPE A4; BDA4",Percent
112900,MOVED TO 112800,Caret
112910,OSEBOLD-REMONDINI SYNDROME,
113000,"BRACHYDACTYLY, TYPE B1; BDB1",Number Sign
113100,"BRACHYDACTYLY, TYPE C; BDC",Number Sign
113200,"BRACHYDACTYLY, TYPE D; BDD",Number Sign
113300,"BRACHYDACTYLY, TYPE E1; BDE1",Number Sign
113301,"BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II",
113310,BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA,
113400,BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA,
113450,BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME,
113470,BRACHYMESOMELIA-RENAL SYNDROME,
113475,BRACHYMETATARSUS IV,
113477,BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME,
113480,BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME,
113500,BRACHYOLMIA TYPE 3; BCYM3,Number Sign
113503,BRADYKININ RECEPTOR B2; BDKRB2,Asterisk
113505,BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF,Asterisk
113508,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ETA ISOFORM; YWHAH",Asterisk
113510,BRAIN-SPECIFIC PROTEIN Pc-1,Asterisk
113520,BRANCHED-CHAIN AMINOTRANSFERASE 1; BCAT1,Asterisk
113530,BRANCHED-CHAIN AMINOTRANSFERASE 2; BCAT2,Asterisk
113600,BRANCHIAL CLEFT ANOMALIES,
113610,BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA,
113620,BRANCHIOOCULOFACIAL SYNDROME; BOFS,Number Sign
113630,MOVED TO 151410,Caret
113640,MOVED TO 151410,Caret
113650,BRANCHIOOTORENAL SYNDROME 1; BOR1,Number Sign
113660,MOVED TO 151410,Caret
113670,"HYPERTROPHY OF THE BREAST, JUVENILE; JHB",Percent
113700,"BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 1; BNAH1",Percent
113703,RIBOSOMAL PROTEIN L13; RPL13,Asterisk
113705,BREAST CANCER 1 GENE; BRCA1,Asterisk
113710,TREFOIL FACTOR 1; TFF1,Asterisk
113720,BREAST CANCER-ASSOCIATED DF3 ANTIGEN,Asterisk
113721,BREAST CANCER-RELATED REGULATOR OF TP53,
113725,"POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 2; POU4F2",Asterisk
113730,UNCOUPLING PROTEIN 1; UCP1,Asterisk
113750,"ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6",Number Sign
113800,EPIDERMOLYTIC HYPERKERATOSIS; EHK,Number Sign
113810,DYSTONIN; DST,Asterisk
113811,"COLLAGEN, TYPE XVII, ALPHA-1; COL17A1",Asterisk
113900,"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A",Number Sign
113950,"BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT",Percent
113955,"BUNGAROTOXIN, ALPHA, RECEPTOR FOR; BGTXR",Asterisk
113960,BUTYRYLESTERASE 1,
113970,BURKITT LYMPHOMA; BL,Number Sign
113995,COMPLEMENT COMPONENT 5a RECEPTOR 1; C5AR1,Asterisk
114000,CAFFEY DISEASE,Number Sign
114010,CARBAMOYL PHOSPHATE SYNTHETASE/ASPARTATE TRANSCARBAMOYLASE/DIHYDROOROTASE; CAD,Asterisk
114019,CADHERIN 15; CDH15,Asterisk
114020,CADHERIN 2; CDH2,Asterisk
114021,CADHERIN 3; CDH3,Asterisk
114025,"CATENIN, ALPHA-2; CTNNA2",Asterisk
114030,"CAFE-AU-LAIT SPOTS, MULTIPLE",
114050,CALBINDIN 1; CALB1,Asterisk
114051,CALBINDIN 2; CALB2,Asterisk
114065,"CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL",
114070,ANNEXIN A6; ANXA6,Asterisk
114078,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-ALPHA; CAMK2A,Asterisk
114080,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IV; CAMK4,Asterisk
114085,S100 CALCIUM-BINDING PROTEIN A10; S100A10,Asterisk
114090,CALPASTATIN; CAST,Asterisk
114100,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET",Percent
114105,"PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP3CA",Asterisk
114106,"PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, BETA ISOFORM; PPP3CB",Asterisk
114107,"PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP3CC",Asterisk
114110,S100 CALCIUM-BINDING PROTEIN A6; S100A6,Asterisk
114120,MOVED TO 211900,Caret
114130,"CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA; CALCA",Asterisk
114131,CALCITONIN RECEPTOR; CALCR,Asterisk
114140,"CALLOSITIES, HEREDITARY PAINFUL",Percent
114150,CAMPTOBRACHYDACTYLY,Percent
114160,"CALCITONIN-RELATED POLYPEPTIDE, BETA; CALCB",Asterisk
114170,"CALPAIN, SMALL SUBUNIT 1; CAPNS1",Asterisk
114180,CALMODULIN 1; CALM1,Asterisk
114181,MOVED TO 114180,Caret
114182,CALMODULIN 2; CALM2,Asterisk
114183,CALMODULIN 3; CALM3,Asterisk
114184,CALMODULIN-LIKE 3; CALML3,Asterisk
114190,CALCITONIN RECEPTOR-LIKE GENE; CALCRL,Asterisk
114200,CAMPTODACTYLY 1; CAMPD1,Percent
114204,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 1; CACNA2D1",Asterisk
114205,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1C SUBUNIT; CACNA1C",Asterisk
114206,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1D SUBUNIT; CACNA1D",Asterisk
114207,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT; CACNB1",Asterisk
114208,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT; CACNA1S",Asterisk
114209,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-1 SUBUNIT; CACNG1",Asterisk
114210,S100 CALCIUM-BINDING PROTEIN A4; S100A4,Asterisk
114212,CALCYPHOSINE; CAPS,Asterisk
114213,CALDESMON 1; CALD1,Asterisk
114217,CALNEXIN; CANX,Asterisk
114220,CALPAIN 1; CAPN1,Asterisk
114230,CALPAIN 2; CAPN2,Asterisk
114240,CALPAIN 3; CAPN3,Asterisk
114250,CALSEQUESTRIN 1; CASQ1,Asterisk
114251,CALSEQUESTRIN 2; CASQ2,Asterisk
114260,MOVED TO 300006,Caret
114280,CAMPATH-1 ANTIGEN; CDW52,Asterisk
114290,CAMPOMELIC DYSPLASIA,Number Sign
114300,"ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3",Number Sign
114350,"NUCLEOPORIN, 214-KD; NUP214",Asterisk
114400,MOVED TO 120435,Caret
114450,"CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE",
114480,BREAST CANCER,Number Sign
114500,COLORECTAL CANCER; CRC,Number Sign
114550,HEPATOCELLULAR CARCINOMA,Number Sign
114580,"CANDIDIASIS, FAMILIAL, 1; CANDF1",Percent
114600,"CANINE TEETH, ABSENCE OF UPPER PERMANENT",Percent
114610,CANNABINOID RECEPTOR 1; CNR1,Asterisk
114620,CRANIOFACIOFRONTODIGITAL SYNDROME,
114650,CAR FACTOR DEFICIENCY,
114700,CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH,
114750,CARBONIC ANHYDRASE III; CA3,Asterisk
114760,CARBONIC ANHYDRASE IV; CA4,Asterisk
114761,CARBONIC ANHYDRASE VA; CA5A,Asterisk
114770,CARBONIC ANHYDRASE VII; CA7,Asterisk
114780,CARBONIC ANHYDRASE VI; CA6,Asterisk
114800,CARBONIC ANHYDRASE I; CA1,Asterisk
114815,CARBONIC ANHYDRASE VIII; CA8,Asterisk
114830,CARBONYL REDUCTASE 1; CBR1,Asterisk
114835,CARBOXYLESTERASE 1; CES1,Asterisk
114836,MOVED TO 114835,Caret
114840,CARBOXYL-ESTER LIPASE; CEL,Asterisk
114841,MOVED TO 114840,Caret
114850,CARBOXYPEPTIDASE A1; CPA1,Asterisk
114851,"CARBOXYPEPTIDASE A3, MAST CELL; CPA3",Asterisk
114852,"CARBOXYPEPTIDASE B1, TISSUE; CPB1",Asterisk
114855,CARBOXYPEPTIDASE E; CPE,Asterisk
114860,CARBOXYPEPTIDASE M; CPM,Asterisk
114890,CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5; CEACAM5,Asterisk
114900,"CARCINOID TUMORS, INTESTINAL",Percent
115000,CARDIAC ARRHYTHMIA,
115080,CARDIAC CONDUCTION DEFECT,Number Sign
115150,CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1,Number Sign
115195,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2",Number Sign
115196,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3",Number Sign
115197,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4",Number Sign
115198,MOVED TO 192600 AND 115197,Caret
115200,"CARDIOMYOPATHY, DILATED, 1A; CMD1A",Number Sign
115210,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1",Number Sign
115250,"COLLAGENOMA, FAMILIAL CUTANEOUS",
115300,"HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT; HCVAD",Number Sign
115310,PARAGANGLIOMAS 4; PGL4,Number Sign
115400,CARPAL DISPLACEMENT,
115430,CARPAL TUNNEL SYNDROME; CTS1,Number Sign
115435,HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 1; HAPLN1,Asterisk
115437,MATRILIN 1; MATN1,Asterisk
115440,"CASEIN KINASE II, ALPHA-1; CSNK2A1",Asterisk
115441,"CASEIN KINASE II, BETA; CSNK2B",Asterisk
115442,"CASEIN KINASE II, ALPHA-2; CSNK2A2",Asterisk
115450,"CASEIN, ALPHA; CSN1",Asterisk
115460,"CASEIN, BETA; CSN2",Asterisk
115470,CAT EYE SYNDROME; CES,Number Sign
115500,CATALASE; CAT,Asterisk
115501,TYROSINASE-RELATED PROTEIN 1; TYRP1,Asterisk
115645,"CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION",
115650,"CATARACT 32, MULTIPLE TYPES; CTRCT32",Percent
115660,CATARACT 7; CTRCT7,Percent
115665,"CATARACT 8, MULTIPLE TYPES; CTRCT8",Percent
115700,"CATARACT 4, MULTIPLE TYPES; CTRCT4",Number Sign
115800,CATARACT 29; CTRCT29,Percent
115900,CATARACT 42; CTRCT42,Number Sign
116100,"CATARACT 20, MULTIPLE TYPES; CTRCT20",Number Sign
116150,MOVED TO 116200 AND 107250,Caret
116200,"CATARACT 1, MULTIPLE TYPES; CTRCT1",Number Sign
116300,"CATARACT 30, MULTIPLE TYPES; CTRCT30",Number Sign
116400,CATARACT 41; CTRCT41,Number Sign
116600,"CATARACT 6, MULTIPLE TYPES; CTRCT6",Number Sign
116700,CATARACT 13 WITH ADULT i PHENOTYPE; CTRCT13,Number Sign
116790,CATECHOL-O-METHYLTRANSFERASE; COMT,Plus
116800,"CATARACT 5, MULTIPLE TYPES; CTRCT5",Number Sign
116805,"CATENIN, ALPHA-1; CTNNA1",Asterisk
116806,"CATENIN, BETA-1; CTNNB1",Asterisk
116810,CATHEPSIN B; CTSB,Asterisk
116820,CATHEPSIN H; CTSH,Asterisk
116830,CATHEPSIN G; CTSG,Asterisk
116831,GRANZYME H; GZMH,Asterisk
116840,CATHEPSIN D; CTSD,Asterisk
116845,CATHEPSIN S; CTSS,Asterisk
116850,CATATRICHY,
116860,CEREBRAL CAVERNOUS MALFORMATIONS; CCM,Number Sign
116870,CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT OF DIAPHRAGM,
116880,CATHEPSIN L; CTSL,Asterisk
116890,CATHEPSIN E; CTSE,Asterisk
116896,CUT-LIKE 1; CUTL1,Asterisk
116897,"CCAAT/ENHANCER-BINDING PROTEIN, ALPHA; CEBPA",Asterisk
116898,"CCAAT/ENHANCER-BINDING PROTEIN, DELTA; CEBPD",Asterisk
116899,CYCLIN-DEPENDENT KINASE INHIBITOR 1A; CDKN1A,Asterisk
116900,CDC28 PROTEIN KINASE 1B; CKS1B,Asterisk
116901,CDC2-ASSOCIATED PROTEIN CKS2; CKS2,Asterisk
116920,"LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD",Number Sign
116930,"CELL ADHESION MOLECULE, NEURAL, 1; NCAM1",Asterisk
116935,MOVED TO 602783,Caret
116940,CYCLIN-DEPENDENT KINASE 1; CDK1,Asterisk
116945,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 2; MCM2,Asterisk
116946,CELL DIVISION CYCLE 27; CDC27,Asterisk
116947,CELL DIVISION CYCLE 25A; CDC25A,Asterisk
116948,"CELL DIVISION CYCLE 34, S. CEREVISIAE, HOMOLOG OF; CDC34",Asterisk
116949,CELL DIVISION CYCLE 25B; CDC25B,Asterisk
116950,TEMPERATURE-SENSITIVE AF8 COMPLEMENT; AF8T,
116951,CYCLIN-DEPENDENT KINASE 11A; CDK11A,Asterisk
116952,CELL DIVISION CYCLE 42; CDC42,Asterisk
116953,CYCLIN-DEPENDENT KINASE 2; CDK2,Asterisk
116954,MOVED TO 120920,Caret
116955,CCHC-TYPE ZINC FINGER NUCLEIC ACID-BINDING PROTEIN; CNBP,Asterisk
116957,RETINOBLASTOMA-LIKE 1; RBL1,Asterisk
116960,MORTALITY FACTOR 4; MORF4,Asterisk
117000,CENTRAL CORE DISEASE OF MUSCLE; CCD,Number Sign
117100,CENTRALOPATHIC EPILEPSY,Percent
117139,CENTROMERIC PROTEIN A; CENPA,Asterisk
117140,CENTROMERIC PROTEIN B; CENPB,Asterisk
117141,CENTROMERIC PROTEIN C1; CENPC1,Asterisk
117142,CENTROMERIC PROTEIN D; CENPD,Asterisk
117143,CENTROMERIC PROTEIN E; CENPE,Asterisk
117200,REMOVED FROM DATABASE,Caret
117210,SPINOCEREBELLAR ATAXIA 31; SCA31,Number Sign
117300,"CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2",Number Sign
117340,CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 2; CDR2,Asterisk
117350,MOVED TO 183090,Caret
117360,SPINOCEREBELLAR ATAXIA 29; SCA29,Number Sign
117400,MOVED TO 164400 AND 117210,Caret
117550,SOTOS SYNDROME 1; SOTOS1,Number Sign
117600,CEREBRAL SARCOMA,
117650,CEREBROCOSTOMANDIBULAR SYNDROME; CCMS,Number Sign
117700,CERULOPLASMIN; CP,Asterisk
117800,"APOCRINE GLAND SECRETION, VARIATION IN",Number Sign
117850,CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS,
117900,CERVICAL RIB,
118000,CERVICAL VERTEBRAL BRIDGE,
118005,CERVICAL VERTEBRAL DYSPLASIA,
118100,"KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1",Number Sign
118150,MOVED TO 107776,Caret
118190,HEAT-SHOCK 60-KD PROTEIN 1; HSPD1,Asterisk
118200,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B",Number Sign
118210,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1",Number Sign
118220,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A",Number Sign
118230,"CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE",
118300,CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS,Number Sign
118301,CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM,
118330,CHEILITIS GLANDULARIS,
118350,"CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS",
118400,CHERUBISM,Number Sign
118420,CHIARI MALFORMATION TYPE I,Percent
118423,CHIMERIN 1; CHN1,Asterisk
118425,"CHLORIDE CHANNEL 1, SKELETAL MUSCLE; CLCN1",Asterisk
118430,CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF,
118440,CHOLECYSTOKININ; CCK,Asterisk
118444,CHOLECYSTOKININ A RECEPTOR; CCKAR,Asterisk
118445,CHOLECYSTOKININ B RECEPTOR; CCKBR,Asterisk
118450,ALAGILLE SYNDROME 1; ALGS1,Number Sign
118455,"CYTOCHROME P450, SUBFAMILY VIIA, POLYPEPTIDE 1; CYP7A1",Asterisk
118457,CHOLESTEROL CRYSTALLIZATION INHIBITOR; CCI,Asterisk
118470,"CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA; CETP",Asterisk
118480,MOVED TO 134634,Caret
118485,"CYTOCHROME P450, SUBFAMILY XIA, POLYPEPTIDE 1; CYP11A1",Asterisk
118490,CHOLINE ACETYLTRANSFERASE; CHAT,Asterisk
118491,"CHOLINE KINASE, ALPHA; CHKA",Asterisk
118493,"CHOLINERGIC RECEPTOR, MUSCARINIC, 2; CHRM2",Asterisk
118494,"CHOLINERGIC RECEPTOR, MUSCARINIC, 3; CHRM3",Asterisk
118495,"CHOLINERGIC RECEPTOR, MUSCARINIC, 4; CHRM4",Asterisk
118496,"CHOLINERGIC RECEPTOR, MUSCARINIC, 5; CHRM5",Asterisk
118502,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2; CHRNA2",Asterisk
118503,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 3; CHRNA3",Asterisk
118504,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4",Asterisk
118505,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 5; CHRNA5",Asterisk
118507,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2",Asterisk
118508,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 3; CHRNB3",Asterisk
118509,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 4; CHRNB4",Asterisk
118510,"CHOLINERGIC RECEPTOR, MUSCARINIC, 1; CHRM1",Asterisk
118511,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 7; CHRNA7",Asterisk
118600,CHONDROCALCINOSIS 2; CCAL2,Number Sign
118610,CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION,
118650,"CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT",
118651,"CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE",Percent
118661,VERSICAN; VCAN,Asterisk
118670,CHONDRONECTIN,
118700,"CHOREA, BENIGN HEREDITARY; BHC",Number Sign
118750,"CHOREOATHETOSIS, FAMILIAL INVERTED",
118800,PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1,Number Sign
118820,CHORIONIC SOMATOMAMMOTROPIN HORMONE 2; CSH2,Asterisk
118825,CHM-LIKE; CHML,Asterisk
118830,"CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEIN LIPASE",Percent
118840,CHROMATE RESISTANCE; CHR,Percent
118850,"CHORIONIC GONADOTROPIN, ALPHA CHAIN; CGA",Asterisk
118860,"CHORIONIC GONADOTROPIN, BETA CHAIN; CGB",Asterisk
118865,"CHOROIDAL OSTEOMA, BILATERAL",
118870,"CHROMOSOMAL PROTEIN, NONHISTONE 1; NHCP1",Asterisk
118880,"CHROMOSOMAL PROTEIN, NONHISTONE 2; NHCP2",Asterisk
118888,CHYMOTRYPSIN-LIKE PROTEASE; CTRL,Asterisk
118890,CHYMOTRYPSINOGEN B1; CTRB1,Asterisk
118900,"CIRRHOSIS, FAMILIAL",
118910,CHROMOGRANIN A; CHGA,Asterisk
118920,CHROMOGRANIN B; CHGB,Asterisk
118930,SECRETOGRANIN II; SCG2,Asterisk
118938,CHYMASE 1; CMA1,Asterisk
118940,MOVED TO 118938,Caret
118943,CHYMOSIN PSEUDOGENE; CYMP,
118945,CILIARY NEUROTROPHIC FACTOR; CNTF,Asterisk
118946,CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR,Asterisk
118950,"CITRATE SYNTHASE, MITOCHONDRIAL; CS",Asterisk
118953,MOVED TO 192020,Caret
118955,"CLATHRIN, HEAVY POLYPEPTIDE; CLTC",Asterisk
118960,"CLATHRIN, LIGHT POLYPEPTIDE A; CLTA",Asterisk
118970,"CLATHRIN, LIGHT POLYPEPTIDE B; CLTB",Asterisk
118980,"CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL",
118990,SPERM-SPECIFIC ANTIGEN 2; SSFA2,Asterisk
119000,CLEFT CHIN,Percent
119100,SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1; SHFLD1,Percent
119300,VAN DER WOUDE SYNDROME 1; VWS1,Number Sign
119500,POPLITEAL PTERYGIUM SYNDROME; PPS,Number Sign
119530,OROFACIAL CLEFT 1; OFC1,Percent
119540,"CLEFT PALATE, ISOLATED; CPI",Percent
119550,SYNGNATHIA,Percent
119570,CLEFT SOFT PALATE,
119580,BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1,Number Sign
119600,CLEIDOCRANIAL DYSPLASIA; CCD,Number Sign
119650,CLEIDORHIZOMELIC SYNDROME,
119800,"CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF",Number Sign
119900,"DIGITAL CLUBBING, ISOLATED CONGENITAL",Number Sign
119915,"CLUSTER HEADACHE, FAMILIAL",Percent
120000,COARCTATION OF AORTA,
120040,COCHLEOSACCULAR DEGENERATION WITH PROGRESSIVE CATARACTS,
120050,COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S,Percent
120070,"COLLAGEN, TYPE IV, ALPHA-3; COL4A3",Asterisk
120080,COLCHICINE RESISTANCE,Number Sign
120090,"COLLAGEN, TYPE IV, ALPHA-2; COL4A2",Asterisk
120100,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1,Number Sign
120105,"COLIPASE, PANCREATIC; CLPS",Asterisk
120110,"COLLAGEN, TYPE X, ALPHA-1; COL10A1",Asterisk
120120,"COLLAGEN, TYPE VII, ALPHA-1; COL7A1",Asterisk
120130,"COLLAGEN, TYPE IV, ALPHA-1; COL4A1",Asterisk
120131,"COLLAGEN, TYPE IV, ALPHA-4; COL4A4",Asterisk
120140,"COLLAGEN, TYPE II, ALPHA-1; COL2A1",Plus
120150,"COLLAGEN, TYPE I, ALPHA-1; COL1A1",Plus
120160,"COLLAGEN, TYPE I, ALPHA-2; COL1A2",Asterisk
120165,"COLLAGEN, TYPE XIX, ALPHA-1; COL19A1",Asterisk
120170,"COLLAGEN, FETAL MEMBRANE, B POLYPEPTIDE",Asterisk
120180,"COLLAGEN, TYPE III, ALPHA-1; COL3A1",Asterisk
120190,"COLLAGEN, TYPE V, ALPHA-2; COL5A2",Asterisk
120200,"COLOBOMA, OCULAR, AUTOSOMAL DOMINANT",Number Sign
120210,"COLLAGEN, TYPE IX, ALPHA-1; COL9A1",Asterisk
120215,"COLLAGEN, TYPE V, ALPHA-1; COL5A1",Asterisk
120216,"COLLAGEN, TYPE V, ALPHA-3; COL5A3",Asterisk
120220,"COLLAGEN, TYPE VI, ALPHA-1; COL6A1",Asterisk
120240,"COLLAGEN, TYPE VI, ALPHA-2; COL6A2",Asterisk
120250,"COLLAGEN, TYPE VI, ALPHA-3; COL6A3",Asterisk
120251,"COLLAGEN, TYPE VIII, ALPHA-1; COL8A1",Asterisk
120252,"COLLAGEN, TYPE VIII, ALPHA-2; COL8A2",Asterisk
120260,"COLLAGEN, TYPE IX, ALPHA-2; COL9A2",Asterisk
120270,"COLLAGEN, TYPE IX, ALPHA-3; COL9A3",Asterisk
120280,"COLLAGEN, TYPE XI, ALPHA-1; COL11A1",Asterisk
120290,"COLLAGEN, TYPE XI, ALPHA-2; COL11A2",Asterisk
120300,COLOBOMA OF MACULA,Percent
120310,MOVED TO 120140,Caret
120320,"COLLAGEN, TYPE XII, ALPHA-1; COL12A1",Asterisk
120321,MOVED TO 120320,Caret
120324,"COLLAGEN, TYPE XIV, ALPHA-1; COL14A1",Asterisk
120325,"COLLAGEN, TYPE XV, ALPHA-1; COL15A1",Asterisk
120326,"COLLAGEN, TYPE XVI, ALPHA-1; COL16A1",Asterisk
120327,MOVED TO 113811,Caret
120328,"COLLAGEN, TYPE XVIII, ALPHA-1; COL18A1",Asterisk
120330,PAPILLORENAL SYNDROME; PAPRS,Number Sign
120340,"COLLAGEN, TYPE I, ALPHA, RECEPTOR; COL1AR",Asterisk
120350,"COLLAGEN, TYPE XIII, ALPHA-1; COL13A1",Asterisk
120353,MATRIX METALLOPROTEINASE 1; MMP1,Asterisk
120355,MATRIX METALLOPROTEINASE 8; MMP8,Asterisk
120360,MATRIX METALLOPROTEINASE 2; MMP2,Asterisk
120361,MATRIX METALLOPROTEINASE 9; MMP9,Asterisk
120400,COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY,
120420,COLONY-STIMULATING FACTOR 1; CSF1,Asterisk
120430,COLOBOMA OF OPTIC NERVE,Number Sign
120433,"COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1",Number Sign
120435,LYNCH SYNDROME I,Number Sign
120436,"MutL, E. COLI, HOMOLOG OF, 1; MLH1",Asterisk
120440,COLONIC VARICES WITHOUT PORTAL HYPERTENSION,
120450,"COMEDONES, FAMILIAL DYSKERATOTIC",Percent
120460,MOVED TO 191170,Caret
120470,DCC NETRIN 1 RECEPTOR; DCC,Asterisk
120500,COMMISSURAL LIP PITS,
120502,BRANCHIOOTIC SYNDROME 2,Percent
120520,MEMBRANE METALLOENDOPEPTIDASE; MME,Asterisk
120550,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT, A CHAIN; C1QA",Asterisk
120560,"COMPLEMENT COMPONENT C1q, FIBROBLAST TYPE",Asterisk
120570,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT, B CHAIN; C1QB",Asterisk
120575,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT, C CHAIN; C1QC",Asterisk
120577,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT, RECEPTOR 1; C1QR1",Asterisk
120580,"COMPLEMENT COMPONENT 1, s SUBCOMPONENT; C1S",Asterisk
120620,COMPLEMENT COMPONENT RECEPTOR 1; CR1,Asterisk
120650,COMPLEMENT COMPONENT RECEPTOR 2; CR2,Asterisk
120700,COMPLEMENT COMPONENT 3; C3,Asterisk
120790,"COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF",Number Sign
120810,COMPLEMENT COMPONENT 4A; C4A,Asterisk
120820,COMPLEMENT COMPONENT 4B; C4B,Asterisk
120830,"COMPLEMENT COMPONENT 4-BINDING PROTEIN, ALPHA; C4BPA",Asterisk
120831,"COMPLEMENT COMPONENT 4-BINDING PROTEIN, BETA CHAIN; C4BPB",Asterisk
120832,MOVED TO 120830,Caret
120900,COMPLEMENT COMPONENT 5; C5,Asterisk
120920,CD46 ANTIGEN; CD46,Asterisk
120930,"COMPLEMENT COMPONENT 8, GAMMA SUBUNIT; C8G",Asterisk
120940,COMPLEMENT COMPONENT 9; C9,Asterisk
120950,"COMPLEMENT COMPONENT 8, ALPHA SUBUNIT; C8A",Asterisk
120960,"COMPLEMENT COMPONENT 8, BETA SUBUNIT; C8B",Asterisk
120970,CONE-ROD DYSTROPHY 2; CORD2,Number Sign
120980,"INTEGRIN, ALPHA-M; ITGAM",Asterisk
121000,REMOVED FROM DATABASE,Caret
121009,CONNECTIVE TISSUE GROWTH FACTOR; CTGF,Asterisk
121010,PRO-PLATELET BASIC PROTEIN; PPBP,Asterisk
121011,"GAP JUNCTION PROTEIN, BETA-2; GJB2",Asterisk
121012,"GAP JUNCTION PROTEIN, ALPHA-4; GJA4",Asterisk
121013,"GAP JUNCTION PROTEIN, ALPHA-5; GJA5",Asterisk
121014,"GAP JUNCTION PROTEIN, ALPHA-1; GJA1",Asterisk
121015,"GAP JUNCTION PROTEIN, ALPHA-3; GJA3",Asterisk
121020,MOVED TO 160120,Caret
121050,"ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9",Number Sign
121070,"ARTHROGRYPOSIS, DISTAL, TYPE 2E",
121200,"SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1",Number Sign
121201,"SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2",Number Sign
121210,"FEBRILE SEIZURES, FAMILIAL, 1; FEB1",Percent
121250,MOVED TO 300088,Caret
121270,"COPPER DEFICIENCY, FAMILIAL BENIGN",
121300,"COPROPORPHYRIA, HEREDITARY; HCP",Number Sign
121350,"CORACOCLAVICULAR JOINT, ANOMALOUS",
121360,"CORE-BINDING FACTOR, BETA SUBUNIT; CBFB",Asterisk
121390,CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS,Percent
121400,"CORNEA PLANA 1, AUTOSOMAL DOMINANT; CNA1",Percent
121450,"CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS",
121700,MOVED TO 122000,Caret
121800,SCHNYDER CORNEAL DYSTROPHY; SCCD,Number Sign
121820,"CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD",Number Sign
121850,"CORNEAL DYSTROPHY, FLECK",Number Sign
121900,"CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1",Number Sign
122000,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1",Number Sign
122100,"CORNEAL DYSTROPHY, MEESMANN; MECD",Number Sign
122200,"CORNEAL DYSTROPHY, LATTICE TYPE I; LCD1",Number Sign
122400,EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED,Number Sign
122430,"CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS, UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION",
122440,CORNEODERMATOOSSEOUS SYNDROME,
122450,"CORNEAL HYPESTHESIA, FAMILIAL",Percent
122455,"CORONARY ARTERY DISSECTION, SPONTANEOUS",
122460,HUMAN CORONAVIRUS SENSITIVITY; HCVS,Percent
122470,CORNELIA DE LANGE SYNDROME 1; CDLS1,Number Sign
122480,MOVED TO 166740,Caret
122500,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 6; SERPINA6",Asterisk
122550,CORTICOSTERONE SIDE-CHAIN ISOMERASE; CSCI,
122559,CORTICOTROPIN-RELEASING HORMONE-BINDING PROTEIN; CRHBP,Asterisk
122560,CORTICOTROPIN-RELEASING HORMONE; CRH,Asterisk
122561,CORTICOTROPIN-RELEASING HORMONE RECEPTOR 1; CRHR1,Asterisk
122580,"COSTOCORACOID LIGAMENT, CONGENITALLY SHORT",
122600,SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5,Number Sign
122700,COUMARIN RESISTANCE,Number Sign
122720,"CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6",Plus
122750,COXA VARA,Percent
122780,COXOAURICULAR SYNDROME,
122850,CRANIOACROFACIAL SYNDROME,
122860,"CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD",Number Sign
122880,CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS,Number Sign
122900,CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA,
122920,MOVED TO 304110,Caret
123000,"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD",Number Sign
123050,CRANIORHINY,
123100,CRANIOSYNOSTOSIS 1; CRS1,Number Sign
123101,"MUSCLE SEGMENT HOMEOBOX, DROSOPHILA, HOMOLOG OF, 2; MSX2",Asterisk
123150,JACKSON-WEISS SYNDROME; JWS,Number Sign
123155,"HYDROCEPHALUS, AUTOSOMAL DOMINANT; HDCPH1",Percent
123260,"C-REACTIVE PROTEIN, PENTRAXIN-RELATED; CRP",Asterisk
123270,"CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF; CKBE",
123280,"CREATINE KINASE, BRAIN TYPE; CKB",Asterisk
123290,"CREATINE KINASE, MITOCHONDRIAL 1B; CKMT1B",Asterisk
123295,"CREATINE KINASE, MITOCHONDRIAL 2; CKMT2",Asterisk
123310,"CREATINE KINASE, MUSCLE TYPE; CKM",Asterisk
123320,"CREATINE PHOSPHOKINASE, ELEVATED SERUM",Number Sign
123400,CREUTZFELDT-JAKOB DISEASE; CJD,Number Sign
123450,CRI-DU-CHAT SYNDROME,Number Sign
123500,CROUZON SYNDROME,Number Sign
123540,"CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY",
123550,"CRYOGLOBULINEMIA, FAMILIAL MIXED",Percent
123555,MOVED TO 125220,Caret
123557,"CRYPTOTIA, FAMILIAL",
123560,CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME,
123570,"CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED",Percent
123580,"CRYSTALLIN, ALPHA-A; CRYAA",Asterisk
123590,"CRYSTALLIN, ALPHA-B; CRYAB",Asterisk
123610,"CRYSTALLIN, BETA-A1; CRYBA1",Asterisk
123620,"CRYSTALLIN, BETA-B2; CRYBB2",Asterisk
123630,"CRYSTALLIN, BETA-B3; CRYBB3",Asterisk
123631,"CRYSTALLIN, BETA-A4; CRYBA4",Asterisk
123660,"CRYSTALLIN, GAMMA-A; CRYGA",Asterisk
123670,"CRYSTALLIN, GAMMA-B; CRYGB",Asterisk
123680,"CRYSTALLIN, GAMMA-C; CRYGC",Asterisk
123690,"CRYSTALLIN, GAMMA-D; CRYGD",Asterisk
123691,"CRYSTALLIN, ZETA; CRYZ",Asterisk
123695,"PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, ALPHA ISOFORM; PCYT1A",Asterisk
123700,"CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1",Number Sign
123710,MOVED TO 123660,Caret
123720,MOVED TO 123660,Caret
123730,"CRYSTALLIN, GAMMA-S; CRYGS",Asterisk
123740,"CRYSTALLIN, MU; CRYM",Asterisk
123790,BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS,Number Sign
123803,ACTIVATING TRANSCRIPTION FACTOR 1; ATF1,Asterisk
123805,"PHOSPHODIESTERASE 3A, cGMP-INHIBITED; PDE3A",Asterisk
123810,cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1,Asterisk
123811,ACTIVATING TRANSCRIPTION FACTOR 2; ATF2,Asterisk
123812,cAMP RESPONSE ELEMENT MODULATOR; CREM,Asterisk
123825,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-1; CNGA1",Asterisk
123828,CYCLIN-DEPENDENT KINASE 3; CDK3,Asterisk
123829,CYCLIN-DEPENDENT KINASE 4; CDK4,Asterisk
123830,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CNP,Asterisk
123831,CYCLIN-DEPENDENT KINASE 5; CDK5,Asterisk
123832,CYCLIN-DEPENDENT KINASE INHIBITOR 3; CDKN3,Asterisk
123833,CYCLIN D2; CCND2,Asterisk
123834,CYCLIN D3; CCND3,Asterisk
123835,CYCLIN A2; CCNA2,Asterisk
123836,CYCLIN B1; CCNB1,Asterisk
123837,CYCLIN E1; CCNE1,Asterisk
123838,CYCLIN C; CCNC,Asterisk
123839,MOVED TO 600262,Caret
123840,PEPTIDYL-PROLYL ISOMERASE A; PPIA,Asterisk
123841,PEPTIDYL-PROLYL ISOMERASE B; PPIB,Asterisk
123842,PEPTIDYL-PROLYL ISOMERASE C; PPIC,Asterisk
123850,MOVED TO 132700,Caret
123853,CYPRUS FACIAL NEUROMUSCULOSKELETAL SYNDROME,
123855,CYSTATIN 1; CST1,Asterisk
123856,CYSTATIN 2; CST2,Asterisk
123857,CYSTATIN 4; CST4,Asterisk
123858,CYSTATIN 5; CST5,Asterisk
123859,CYSTEINYL-tRNA SYNTHETASE; CARS,Asterisk
123860,CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 1; CTPS1,Asterisk
123864,"CYTOCHROME c OXIDASE, SUBUNIT 4I1; COX4I1",Asterisk
123866,"CYTOCHROME c OXIDASE, SUBUNIT 5B; COX5B",Asterisk
123870,"CYTOCHROME c OXIDASE, SUBUNIT 8A; COX8A",Asterisk
123875,CYSTEINE-RICH INTESTINAL PROTEIN 1; CRIP1,Asterisk
123876,CYSTEINE- AND GLYCINE-RICH PROTEIN 1; CSRP1,Asterisk
123880,"CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE",
123885,S100 CALCIUM-BINDING PROTEIN A8; S100A8,Asterisk
123886,S100 CALCIUM-BINDING PROTEIN A9; S100A9,Asterisk
123889,"INTERLEUKIN 10 RECEPTOR, BETA; IL10RB",Asterisk
123890,CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4; CTLA4,Asterisk
123900,EZRIN; EZR,Asterisk
123910,GRANZYME B; GZMB,Asterisk
123920,CYTIDINE DEAMINASE; CDA,Asterisk
123930,"CYTOCHROME P450, SUBFAMILY IIB, POLYPEPTIDE 6; CYP2B6",Asterisk
123940,"KERATIN 4, TYPE II; KRT4",Asterisk
123950,MOVED TO 250790,Caret
123960,MOVED TO 122720,Caret
123970,"CYTOCHROME C, SOMATIC; CYCS",Asterisk
123980,CYTOCHROME C1; CYC1,Asterisk
123995,"CYTOCHROME c OXIDASE, SUBUNIT 7A1; COX7A1",Asterisk
123996,"CYTOCHROME c OXIDASE, SUBUNIT 7A2; COX7A2",Asterisk
123997,"CYTOCHROME c OXIDASE, SUBUNIT 7A2, PSEUDOGENE 2; COX7A2P2",
124000,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1",Number Sign
124010,"CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4",Asterisk
124015,CYTOCHROME P450 OXIDOREDUCTASE; POR,Asterisk
124020,"CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19",Asterisk
124030,"CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6",Asterisk
124040,"CYTOCHROME P450, SUBFAMILY IIE; CYP2E1",Asterisk
124050,D-AMINO ACID OXIDASE; DAO,Asterisk
124060,"CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2",Plus
124070,"CYTOCHROME P450, SUBFAMILY IIF, POLYPEPTIDE 1; CYP2F1",Asterisk
124075,"CYTOCHROME P450, SUBFAMILY IVB, MEMBER 1; CYP4B1",Asterisk
124080,"CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2",Asterisk
124089,"CYTOCHROME c OXIDASE, SUBUNIT 6B1; COX6B1",Asterisk
124090,"CYTOCHROME c OXIDASE, SUBUNIT 6C; COX6C",Asterisk
124092,INTERLEUKIN 10; IL10,Asterisk
124095,CYTOPLASMIC TYROSINE KINASE; CSK,Asterisk
124097,D SITE OF ALBUMIN PROMOTER-BINDING PROTEIN; DBP,Asterisk
124100,DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY,
124200,DARIER-WHITE DISEASE; DAR,Number Sign
124300,DARWINIAN TUBERCLE OF PINNA,Percent
124400,DARWINIAN TUBERCLE OF PINNA,
124450,D-ASPARTATE OXIDASE; DDO,Asterisk
124480,"DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD",Number Sign
124490,"DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY",
124500,VOHWINKEL SYNDROME; VOWNKL,Number Sign
124580,REMOVED FROM DATABASE,Caret
124700,"DEAFNESS, MID-TONE NEURAL",Percent
124800,MOVED TO 600994,Caret
124900,"DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1",Number Sign
124910,MOVED TO 124900,Caret
124950,"DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE",
125000,"DEAFNESS, UNILATERAL",
125050,DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA,
125100,MOVED TO 602588,Caret
125220,"DEFENSIN, ALPHA, 1; DEFA1",Asterisk
125230,DEAFNESS-CRANIOFACIAL SYNDROME,
125240,CD55 ANTIGEN; CD55,Asterisk
125250,"OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY",Number Sign
125255,DECORIN; DCN,Asterisk
125260,"DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF",Percent
125263,"SULFOTRANSFERASE FAMILY 2A, DEHYDROEPIANDROSTERONE-PREFERRING, MEMBER 1; SULT2A1",Asterisk
125264,DEK ONCOGENE; DEK,Asterisk
125265,RECEPTOR EXPRESSION-ENHANCING PROTEIN 5; REEP5,Asterisk
125270,DELTA-AMINOLEVULINATE DEHYDRATASE; ALAD,Asterisk
125280,DENS EVAGINATUS,
125290,DELTA-AMINOLEVULINATE SYNTHASE 1; ALAS1,Asterisk
125300,DENS IN DENTE AND PALATAL INVAGINATIONS,
125305,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.9; EPB49,Asterisk
125310,"CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1",Number Sign
125320,DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES,
125350,"FAILURE OF TOOTH ERUPTION, PRIMARY; PFE",Number Sign
125370,DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA,Number Sign
125400,"DENTIN DYSPLASIA, TYPE I; DTDP1",Number Sign
125420,"DENTIN DYSPLASIA, TYPE II; DTDP2",Number Sign
125440,DENTIN DYSPLASIA WITH SCLEROTIC BONES,Percent
125450,DEOXYCYTIDINE KINASE; DCK,Asterisk
125460,DEOXYRIBOSE-5-PHOSPHATE ALDOLASE DEFICIENCY,
125480,MAJOR AFFECTIVE DISORDER 1; MAFD1,Percent
125485,DENTIN SIALOPHOSPHOPROTEIN; DSPP,Asterisk
125490,DENTINOGENESIS IMPERFECTA 1; DGI1,Number Sign
125500,"DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III",Number Sign
125505,DEOXYRIBONUCLEASE I; DNASE1,Asterisk
125510,REMOVED FROM DATABASE,Caret
125520,CAYLER CARDIOFACIAL SYNDROME,Percent
125530,"DERMAL RIDGES, NELSON SYNDROME",
125540,"DERMAL RIDGES, PATTERNLESS",Percent
125550,DERMAL RIDGES-OFF-THE-END; ROES,Percent
125570,DERMATOGLYPHICS--ARCH ON ANY DIGIT,
125580,DERMATOGLYPHICS--FINGER RIDGE COUNT,
125590,DERMATOGLYPHICS--FINGERPRINT PATTERN,Percent
125595,DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR,Number Sign
125597,DERMATOPONTIN; DPT,Asterisk
125600,DERMATOSIS PAPULOSA NIGRA,
125630,VIBRATORY URTICARIA; VBU,Number Sign
125635,"DERMOGRAPHISM, FAMILIAL",
125640,DERMOODONTODYSPLASIA,Percent
125643,DESMOCOLLIN 1; DSC1,Asterisk
125645,DESMOCOLLIN 2; DSC2,Asterisk
125647,DESMOPLAKIN; DSP,Asterisk
125650,MOVED TO 606418,Caret
125660,DESMIN; DES,Asterisk
125670,DESMOGLEIN 1; DSG1,Asterisk
125671,DESMOGLEIN 2; DSG2,Asterisk
125700,"DIABETES INSIPIDUS, NEUROHYPOPHYSEAL",Number Sign
125800,"DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL",Number Sign
125850,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1",Number Sign
125851,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2",Number Sign
125852,"DIABETES MELLITUS, INSULIN-DEPENDENT, 2",Number Sign
125853,"DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM",Number Sign
125855,"DIACYLGLYCEROL KINASE, ALPHA, 80-KD; DGKA",Asterisk
125860,"NAD(P)H DEHYDROGENASE, QUINONE 1; NQO1",Plus
125870,MOVED TO 600941,Caret
125880,DIAPHORASE 3; DIA3,Asterisk
125890,"DIARRHEA, GLUCOSE-STIMULATED SECRETORY, WITH COMMON VARIABLE IMMUNODEFICIENCY",
125900,"DIASTEMA, DENTAL MEDIAL",
125950,DIAZEPAM BINDING INHIBITOR; DBI,Asterisk
126050,DIGITOTALAR DYSMORPHISM,Percent
126060,DIHYDROFOLATE REDUCTASE; DHFR,Asterisk
126061,MOVED TO 126060,Caret
126063,DIHYDROLIPOAMIDE S-SUCCINYLTRANSFERASE; DLST,Asterisk
126064,DIHYDROOROTATE DEHYDROGENASE; DHODH,Asterisk
126065,"CYTOCHROME P450, FAMILY 24, SUBFAMILY A, POLYPEPTIDE 1; CYP24A1",Asterisk
126070,"DILUTION, PIGMENTARY",Percent
126090,PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 1; PCBD1,Asterisk
126100,"DIMPLES, FACIAL",
126110,ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; ARNT,Asterisk
126140,MOVED TO 102720,Caret
126141,DIPEPTIDYL PEPTIDASE VI; DPP6,Asterisk
126150,HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HBEGF,Asterisk
126180,"DISCRIMINATION, TWO-POINT, REDUCTION IN",
126190,DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS,
126200,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS",Number Sign
126250,DISTAL OSTEOSCLEROSIS,
126255,DISTAL-LESS HOMEOBOX 2; DLX2,Asterisk
126300,DISTICHIASIS,Percent
126320,DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL VASCULATURE,
126330,"DNA, CYTOPLASMIC-MEMBRANE; DNCM",Asterisk
126335,"GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, ALPHA; GADD45A",Asterisk
126337,DNA DAMAGE-INDUCIBLE TRANSCRIPT 3; DDIT3,Asterisk
126340,"EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2",Asterisk
126350,"DEOXYRIBONUCLEASE II, LYSOSOMAL; DNASE2",Asterisk
126370,"DNA, SATELLITE, III; HS3; D1Z1",
126375,DNA METHYLTRANSFERASE 1; DNMT1,Asterisk
126380,"EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 1; ERCC1",Asterisk
126390,"DNA, LOW-REPETITIVE SEQUENCES OF",
126391,"LIGASE I, DNA, ATP-DEPENDENT; LIG1",Asterisk
126410,"DNA, SATELLITE, ALPHA TYPE",
126420,"TOPOISOMERASE, DNA, I; TOP1",Asterisk
126430,"TOPOISOMERASE, DNA, II, ALPHA; TOP2A",Asterisk
126431,"TOPOISOMERASE, DNA, II, BETA; TOP2B",Asterisk
126440,REMOVED FROM DATABASE,Caret
126448,MOVED TO 126453,Caret
126449,DOPAMINE RECEPTOR D1; DRD1,Asterisk
126450,DOPAMINE RECEPTOR D2; DRD2,Asterisk
126451,DOPAMINE RECEPTOR D3; DRD3,Asterisk
126452,DOPAMINE RECEPTOR D4; DRD4,Asterisk
126453,DOPAMINE RECEPTOR D5; DRD5,Asterisk
126455,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, DOPAMINE), MEMBER 3; SLC6A3",Asterisk
126500,DOUBLE NAIL FOR FIFTH TOE,
126550,"DOUGHNUT LESIONS OF SKULL, FAMILIAL",Percent
126600,DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD,Number Sign
126650,"SOLUTE CARRIER FAMILY 26, MEMBER 3; SLC26A3",Asterisk
126660,DREBRIN E; DBN1,Asterisk
126700,BASAL LAMINAR DRUSEN,Number Sign
126800,DUANE RETRACTION SYNDROME 1; DURS1,Percent
126830,MOVED TO 169100,Caret
126840,DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION,
126850,"DUODENAL ULCER, HYPERPEPSINOGENEMIC I",Percent
126900,DUPUYTREN CONTRACTURE,Percent
126950,DWARFISM WITH TALL VERTEBRAE,
127000,"KENNY-CAFFEY SYNDROME, TYPE 2; KCS2",Number Sign
127100,"DWARFISM, LEVI TYPE",
127200,DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES,
127300,LERI-WEILL DYSCHONDROSTEOSIS; LWD,Number Sign
127350,DYSCHONDROSTEOSIS AND NEPHRITIS,
127400,DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH,Number Sign
127500,DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1,Percent
127550,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1; DKCA1",Number Sign
127600,"DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID",Percent
127700,"DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1",Number Sign
127750,"DEMENTIA, LEWY BODY; DLB",Number Sign
127800,DYSPLASIA EPIPHYSEALIS HEMIMELICA,
127820,DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS,
128000,DYSTELEPHALANGY,Percent
128100,"DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1",Number Sign
128101,"DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4",Number Sign
128200,EPISODIC KINESIGENIC DYSKINESIA 1; EKD1,Number Sign
128230,"DYSTONIA, DOPA-RESPONSIVE; DRD",Number Sign
128235,DYSTONIA 12; DYT12,Number Sign
128239,DYSTROPHIN-ASSOCIATED GLYCOPROTEIN 1; DAG1,Asterisk
128240,UTROPHIN; UTRN,Asterisk
128260,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE E; SNRPE,Asterisk
128290,"EAR ANTITRAGUS, TAG AT BASE OF",
128300,EAR EXOSTOSES,
128400,EAR FLARE,
128500,EAR FOLDING,
128600,EAR MALFORMATION,Percent
128700,"PREAURICULAR FISTULAE, CONGENITAL",Percent
128710,"EAR PITS, POSTERIOR HELICAL",
128800,EAR WITHOUT HELIX,
128900,"EARLOBE ATTACHMENT, ATTACHED VS UNATTACHED",
128950,EARLOBE CREASE,
128980,"EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES",Percent
128990,EARLY GROWTH RESPONSE 1; EGR1,Asterisk
128992,EARLY GROWTH RESPONSE 4; EGR4,Asterisk
129000,"EARRING HOLES, NATURAL",
129010,EARLY GROWTH RESPONSE 2; EGR2,Asterisk
129100,"EARS, ABILITY TO MOVE",
129150,ECHO VIRUS 11 SENSITIVITY; E11S,Percent
129190,ECTO-5-PRIME NUCLEOTIDASE; NT5E,Asterisk
129200,BASAN SYNDROME,Number Sign
129400,RAPP-HODGKIN SYNDROME; RHS,Number Sign
129490,"ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTD10A",Number Sign
129500,CLOUSTON SYNDROME,Number Sign
129510,"ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE",
129540,ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND PREAXIAL POLYDACTYLY OF FEET,
129550,ECTODERMAL DYSPLASIA WITH ADRENAL CYST,
129600,"ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1",Number Sign
129750,ECTOPIA PUPILLAE,
129810,ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE,
129830,ECTRODACTYLY-CLEFT PALATE SYNDROME,
129840,"EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL",
129850,EDINBURGH MALFORMATION SYNDROME,Number Sign
129900,"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1",Percent
129905,EGASYN,
130000,"EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1; EDSCL1",Number Sign
130010,"EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2",Number Sign
130020,"EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE; EDSHMB",Percent
130050,"EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC",Number Sign
130060,"EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1",Number Sign
130070,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1",Number Sign
130080,"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1",Number Sign
130090,"EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED",
130100,ELASTOSIS PERFORANS SERPIGINOSA; EPS,
130120,"CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 1; CELA1",Asterisk
130130,"ELASTASE, NEUTROPHIL-EXPRESSED; ELANE",Asterisk
130135,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 1; SERPINB1",Asterisk
130160,ELASTIN; ELN,Asterisk
130180,"ELECTROENCEPHALOGRAM, LOW-VOLTAGE",Percent
130190,"ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT LOCUS; EEGBQTL",Percent
130200,ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKE PHENOMENON,
130300,ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS,
130400,ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES,
130410,"ELECTRON TRANSFER FLAVOPROTEIN, BETA POLYPEPTIDE; ETFB",Asterisk
130500,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1; EPB41,Asterisk
130590,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-1; EEF1A1",Asterisk
130591,MOVED TO 600655,Caret
130592,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, DELTA; EEF1D",Asterisk
130593,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, GAMMA; EEF1G",Asterisk
130600,ELLIPTOCYTOSIS 2; EL2,Number Sign
130610,EUKARYOTIC TRANSLATION ELONGATION FACTOR 2; EEF2,Asterisk
130620,RIBOSOMAL PROTEIN S14; RPS14,Asterisk
130650,BECKWITH-WIEDEMANN SYNDROME; BWS,Number Sign
130660,ELASTIN MICROFIBRIL INTERFACER 1; EMILIN1,Asterisk
130700,"EMPHYSEMA, HEREDITARY PULMONARY",
130710,"EMPHYSEMA, CONGENITAL LOBAR; CLE",
130720,LATERAL MENINGOCELE SYNDROME; LMNS,Number Sign
130900,"AMELOGENESIS IMPERFECTA, TYPE IIIA; AI3A",Number Sign
130950,"ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD",
131100,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1",Number Sign
131150,ENDOGENOUS RETROVIRAL SEQUENCE 1; ERV1,Asterisk
131170,ENDOGENOUS RETROVIRAL SEQUENCE 3; ERV3,Asterisk
131180,ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-2; ERPL2,Asterisk
131190,ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-1; ERPL1,Asterisk
131195,ENDOGLIN; ENG,Asterisk
131200,"ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1",Percent
131210,SELECTIN E; SELE,Asterisk
131220,FIBROBLAST GROWTH FACTOR 1; FGF1,Asterisk
131222,THYMIDINE PHOSPHORYLASE; TYMP,Asterisk
131230,ANNEXIN A5; ANXA5,Asterisk
131235,KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 1; KDELR1,Asterisk
131240,ENDOTHELIN 1; EDN1,Plus
131241,ENDOTHELIN 2; EDN2,Asterisk
131242,ENDOTHELIN 3; EDN3,Asterisk
131243,"ENDOTHELIN RECEPTOR, TYPE A; EDNRA",Asterisk
131244,"ENDOTHELIN RECEPTOR, TYPE B; EDNRB",Asterisk
131290,ENGRAILED 1; EN1,Asterisk
131300,CAMURATI-ENGELMANN DISEASE; CAEND,Number Sign
131310,ENGRAILED 2; EN2,Asterisk
131320,GATA-BINDING PROTEIN 3; GATA3,Asterisk
131330,PROENKEPHALIN; PENK,Asterisk
131340,PRODYNORPHIN; PDYN,Asterisk
131360,ENOLASE 2; ENO2,Asterisk
131370,ENOLASE 3; ENO3,Asterisk
131375,"ENOLASE, SPERM SPECIFIC; ENO4",
131390,NIDOGEN 1; NID1,Asterisk
131398,"RIBONUCLEASE, RNase A FAMILY, 3; RNASE3",Asterisk
131399,EOSINOPHIL PEROXIDASE; EPX,Asterisk
131400,"EOSINOPHILIA, FAMILIAL",Percent
131410,"RIBONUCLEASE, RNase A FAMILY, 2; RNASE2",Asterisk
131430,EOSINOPHILOPENIA,
131440,"MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA",Number Sign
131445,MOVED TO 137800,Caret
131450,EPIBLEPHARON OF LOWER LID,
131460,EPIBLEPHARON OF UPPER LID,
131500,EPICANTHUS,Percent
131530,EPIDERMAL GROWTH FACTOR; EGF,Asterisk
131550,EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR,Asterisk
131560,FLOTILLIN 2; FLOT2,Asterisk
131600,EPIDERMOID CYSTS,
131705,TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN,Number Sign
131750,"EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB",Number Sign
131760,"EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM",Number Sign
131800,"EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED",Number Sign
131850,"EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL",Number Sign
131880,EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE,
131900,"EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED",Number Sign
131950,"EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE; EBSOG",Number Sign
131960,EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBSMP,Number Sign
132000,EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS,Number Sign
132090,"EPILEPSY, BENIGN OCCIPITAL; BOE",
132100,PHOTOPAROXYSMAL RESPONSE 1; PPR1,Percent
132300,"EPILEPSY, READING",
132350,SYNTAXIN 2; STX2,Asterisk
132400,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1",Number Sign
132450,"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS; EDMMD",Number Sign
132500,"EPISTAXIS, HEREDITARY",
132600,PILOMATRIXOMA,Number Sign
132700,"CYLINDROMATOSIS, FAMILIAL",Number Sign
132800,"MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE",Number Sign
132810,"EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1",Asterisk
132811,"EPOXIDE HYDROLASE 2, CYTOSOLIC; EPHX2",Asterisk
132850,EPSTEIN-BARR VIRUS INSERTION SITE 1; EBVS1,
132860,REMOVED FROM DATABASE,Caret
132880,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 6; NR2F6",Asterisk
132890,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 1; NR2F1",Asterisk
132900,"AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4",Number Sign
132990,"ERYTHEMA NODOSUM, FAMILIAL",
133000,ERYTHEMA PALMARE HEREDITARIUM,Percent
133020,"ERYTHERMALGIA, PRIMARY",Number Sign
133090,STOMATIN; STOM,Asterisk
133100,"ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1",Number Sign
133170,ERYTHROPOIETIN; EPO,Asterisk
133171,ERYTHROPOIETIN RECEPTOR; EPOR,Asterisk
133180,"ERYTHROLEUKEMIA, FAMILIAL",
133190,SPINOCEREBELLAR ATAXIA 34; SCA34,Number Sign
133200,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1; EKVP1,Number Sign
133220,ESTERASE A4; ESA4,Asterisk
133230,ESTERASE A-5; ESA5,Asterisk
133239,ESOPHAGEAL CANCER,Number Sign
133240,"ESOPHAGEAL RING, LOWER",
133250,MOVED TO 172460,Caret
133260,ESTERASE B; ESB,
133270,ESTERASE C; ESC,
133280,ESTERASE D; ESD,Asterisk
133290,ESTERASE B3; ESB3,Asterisk
133300,"ESTERASE ES-2, REGULATOR FOR",
133420,MOVED TO 113710,Caret
133430,ESTROGEN RECEPTOR 1; ESR1,Plus
133435,"RUNT-RELATED TRANSCRIPTION FACTOR 1, TRANSLOCATED TO, 1; RUNX1T1",Asterisk
133440,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; EIF4E,Asterisk
133450,EWING SARCOMA BREAKPOINT REGION 1; EWSR1,Asterisk
133500,"EXCHONDROSIS OF PINNA, POSTERIOR",Percent
133510,"EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; ERCC3",Asterisk
133520,"EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 4; ERCC4",Asterisk
133530,"EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; ERCC5",Asterisk
133535,"EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN MOUSE CELLS; ERCM1",Asterisk
133540,COCKAYNE SYNDROME B; CSB,Number Sign
133550,"SOLUTE CARRIER FAMILY 1 (NEURONAL/EPITHELIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 1; SLC1A1",Asterisk
133600,EXOSTOSES OF HEEL,
133690,"EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E",
133700,"EXOSTOSES, MULTIPLE, TYPE I",Number Sign
133701,"EXOSTOSES, MULTIPLE, TYPE II",Number Sign
133705,"EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS",
133710,REMOVED FROM DATABASE,Caret
133730,REMOVED FROM DATABASE,Caret
133740,REMOVED FROM DATABASE,Caret
133750,"EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATION AND MICROCEPHALY",
133780,EXUDATIVE VITREORETINOPATHY 1; EVR1,Number Sign
133800,"EYEBROW, WHORL IN",
133900,HEMIFACIAL HYPERPLASIA,
134000,FACIAL HYPERTRICHOSIS,
134100,MOVED TO 601471,Caret
134200,"FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL",Percent
134300,FACIAL SPASM,
134350,COMPLEMENT FACTOR D; CFD,Asterisk
134370,COMPLEMENT FACTOR H; CFH,Asterisk
134371,COMPLEMENT FACTOR H-RELATED 1; CFHR1,Asterisk
134390,COAGULATION FACTOR III; F3,Asterisk
134400,FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS,
134430,"FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF",
134450,MOVED TO 613878,Caret
134500,FACTOR VIII DEFICIENCY,
134510,"FACTOR VIII AND FACTOR IX, COMBINED DEFICIENCY OF; F8F9D",
134520,"FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF",
134530,MOVED TO 227600,Caret
134540,"FACTOR IX AND FACTOR XI, COMBINED DEFICIENCY OF",
134570,"FACTOR XIII, A1 SUBUNIT; F13A1",Asterisk
134580,"FACTOR XIII, B SUBUNIT; F13B",Asterisk
134600,FANCONI RENOTUBULAR SYNDROME 1; FRTS1,Percent
134610,"FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT",Number Sign
134629,FARNESYL DIPHOSPHATE SYNTHASE; FDPS,Asterisk
134631,MOVED TO 134629,Caret
134632,MOVED TO 134629,Caret
134633,MOVED TO 134629,Caret
134634,MOVED TO 134629,Caret
134635,"FARNESYLTRANSFERASE, CAAX BOX, ALPHA; FNTA",Asterisk
134636,"FARNESYLTRANSFERASE, CAAX BOX, BETA; FNTB",Asterisk
134637,FAS CELL SURFACE DEATH RECEPTOR; FAS,Asterisk
134638,FAS LIGAND; FASLG,Asterisk
134640,FATTY ACID-BINDING PROTEIN 2; FABP2,Asterisk
134650,FATTY ACID-BINDING PROTEIN 1; FABP1,Asterisk
134651,FATTY ACID-BINDING PROTEIN 3; FABP3,Asterisk
134660,"GLUTATHIONE S-TRANSFERASE, PI; GSTP1",Asterisk
134690,FAU GENE; FAU,Asterisk
134700,MOVED TO 300908,Caret
134720,"FECUNDITY GENE, BOOROOLA, OF SHEEP, HOMOLOG OF",
134750,FELTY SYNDROME,
134770,FERRITIN HEAVY CHAIN 1; FTH1,Asterisk
134780,FEMORAL-FACIAL SYNDROME; FFS,
134790,FERRITIN LIGHT CHAIN; FTL,Asterisk
134795,FIBRILLARIN; FBL,Asterisk
134797,FIBRILLIN 1; FBN1,Asterisk
134820,"FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA",Asterisk
134830,"FIBRINOGEN, B BETA POLYPEPTIDE; FGB",Asterisk
134850,"FIBRINOGEN, G GAMMA POLYPEPTIDE; FGG",Asterisk
134900,FIBRINOLYTIC DEFECT,
134920,FIBROBLAST GROWTH FACTOR 2; FGF2,Asterisk
134921,FIBROBLAST GROWTH FACTOR 6; FGF6,Asterisk
134934,FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3,Asterisk
134935,FIBROBLAST GROWTH FACTOR RECEPTOR 4; FGFR4,Asterisk
135000,MOVED TO 178500,Caret
135100,FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP,Number Sign
135150,BIRT-HOGG-DUBE SYNDROME; BHD,Number Sign
135290,"DESMOID DISEASE, HEREDITARY",Number Sign
135300,"FIBROMATOSIS, GINGIVAL, 1; GINGF1",Number Sign
135400,"HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3",Number Sign
135500,ZIMMERMANN-LABAND SYNDROME 1; ZLS1,Number Sign
135550,"FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS",Percent
135580,FIBROMUSCULAR DYSPLASIA; FMDA,
135600,FIBRONECTIN 1; FN1,Asterisk
135610,FIBRONECTIN-LIKE 2; FNL2,
135620,"INTEGRIN, ALPHA-5; ITGA5",Asterisk
135630,"INTEGRIN, BETA-1; ITGB1",Asterisk
135631,MOVED TO 135630,Caret
135700,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1",Number Sign
135750,LAURIN-SANDROW SYNDROME; LSS,Number Sign
135800,"FIBULA, RECURRENT DISLOCATION OF HEAD OF",
135820,FIBULIN 1; FBLN1,Asterisk
135821,FIBULIN 2; FBLN2,Asterisk
135900,COFFIN-SIRIS SYNDROME 1; CSS1,Number Sign
135940,FILAGGRIN; FLG,Asterisk
135950,"FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND PROPORTIONATE SHORT STATURE",
136000,ADERMATOGLYPHIA; ADERM,Number Sign
136100,"FINGERS, RELATIVE LENGTH OF",
136120,FISH-EYE DISEASE; FED,Number Sign
136130,FLAVIN-CONTAINING MONOOXYGENASE 1; FMO1,Asterisk
136131,FLAVIN-CONTAINING MONOOXYGENASE 4; FMO4,Asterisk
136132,FLAVIN-CONTAINING MONOOXYGENASE 3; FMO3,Asterisk
136140,FLOATING-HARBOR SYNDROME; FLHS,Number Sign
136150,FLOOD FACTOR DEFICIENCY,
136200,FLUSHING OF EARS AND SOMNOLENCE,
136300,FLYNN-AIRD SYNDROME,Percent
136350,FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1,Asterisk
136351,FMS-RELATED TYROSINE KINASE 3; FLT3,Asterisk
136352,FMS-LIKE TYROSINE KINASE 4; FLT4,Asterisk
136400,FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA,
136425,"FOLATE RECEPTOR 2, FETAL; FOLR2",Asterisk
136430,"FOLATE RECEPTOR 1, ADULT; FOLR1",Asterisk
136435,FOLLICLE-STIMULATING HORMONE RECEPTOR; FSHR,Asterisk
136440,3-KETODIHYDROSPHINGOSINE REDUCTASE; KDSR,Asterisk
136470,FOLLISTATIN; FST,Asterisk
136480,"FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL",
136490,MOVED TO 103710,Caret
136500,"FOCAL FACIAL DERMAL DYSPLASIA 1, BRAUER TYPE; FFDD1",Percent
136510,FOLYLPOLYGLUTAMATE SYNTHETASE; FPGS,Asterisk
136515,FOS-LIKE ANTIGEN 1; FOSL1,Asterisk
136520,FOVEAL HYPOPLASIA 1; FVH1,Number Sign
136530,"FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE; FSHB",Asterisk
136533,FORKHEAD BOX O1A; FOXO1A,Asterisk
136535,FORMIN 1; FMN1,Asterisk
136537,FORMYL PEPTIDE RECEPTOR 1; FPR1,Asterisk
136538,FORMYL PEPTIDE RECEPTOR 2; FPR2,Asterisk
136539,FORMYL PEPTIDE RECEPTOR 3; FPR3,Asterisk
136540,FRAGILE SITE 10q23,Number Sign
136550,"MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1",Number Sign
136560,MOVED TO 616109,Caret
136570,"CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB",Number Sign
136580,"FRAGILE SITE, DISTAMYCIN A TYPE, RARE, FRA(16)(q22.1); FRA16B",Number Sign
136590,FRAGILE SITE 20p11,Number Sign
136600,"FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL DEAFNESS",
136610,MOVED TO 601464,Caret
136620,FRAGILE SITE 10q25; FRA10B,Number Sign
136630,"MENTAL RETARDATION, FRA12A TYPE",Number Sign
136640,FRAGILE SITE 9q32,Number Sign
136650,MOVED TO 601153,Caret
136660,FRAGILE SITE 17p12,Number Sign
136670,REMOVED FROM DATABASE,Caret
136680,FRASIER SYNDROME,Number Sign
136750,MOVED TO 164770,Caret
136760,FRONTONASAL DYSPLASIA 1; FND1,Number Sign
136770,MOVED TO 164770,Caret
136800,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1",Number Sign
136820,"FUCOSIDASE, ALPHA-L, 2; FUCA2",Asterisk
136830,FUCOSIDASE REGULATOR,
136835,FUCOSYLTRANSFERASE 5; FUT5,Asterisk
136836,FUCOSYLTRANSFERASE 6; FUT6,Asterisk
136840,FULL-LENGTH RETROVIRAL SEQUENCE 1; FRV1,Asterisk
136850,FUMARATE HYDRATASE; FH,Asterisk
136870,FULL-LENGTH RETROVIRAL SEQUENCE 2; FRV2,Asterisk
136880,FUNDUS ALBIPUNCTATUS,Number Sign
136890,FULL-LENGTH RETROVIRAL SEQUENCE 3; FRV3,Asterisk
136900,SORSBY FUNDUS DYSTROPHY; SFD,Number Sign
136950,"FURIN, PAIRED BASIC AMINO ACID CLEAVING ENZYME; FURIN",Asterisk
137000,FUTCHER LINE,
137010,F9 EMBRYONIC ANTIGEN; FEA,Asterisk
137020,TISSUE-SPECIFIC TRANSPLANTATION ANTIGEN 3; TSTA3,Asterisk
137025,"FYN ONCOGENE RELATED TO SRC, FGR, YES; FYN",Asterisk
137026,G PROTEIN-COUPLED RECEPTOR KINASE 4; GRK4,Asterisk
137028,GALACTOKINASE 2; GALK2,Asterisk
137030,GALACTOSE MUTAROTASE; GALM,Asterisk
137033,MOVED TO 153619,Caret
137035,GALANIN; GAL,Asterisk
137040,"GALLBLADDER, AGENESIS OF",
137050,"GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF",
137060,"BETA-1,4-GALACTOSYLTRANSFERASE 1; B4GALT1",Asterisk
137061,MOVED TO 137060,Caret
137070,FUSED IN SARCOMA; FUS,Asterisk
137100,IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1,Percent
137130,GASTRIC SNEEZING,
137140,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-2; GABRA2",Asterisk
137141,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-4; GABRA4",Asterisk
137142,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-5; GABRA5",Asterisk
137143,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-6; GABRA6",Asterisk
137150,4-AMINOBUTYRATE AMINOTRANSFERASE; ABAT,Asterisk
137160,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-1; GABRA1",Asterisk
137161,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-1; GABRR1",Asterisk
137162,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-2; GABRR2",Asterisk
137163,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, DELTA; GABRD",Asterisk
137164,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-2; GABRG2",Asterisk
137165,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 1; SLC6A1",Asterisk
137166,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-1; GABRG1",Asterisk
137167,GAMMA-GLUTAMYL CARBOXYLASE; GGCX,Asterisk
137168,GAMMA-GLUTAMYLTRANSFERASE 5; GGT5,Asterisk
137170,GAMMA-GLUTAMYL CYCLOTRANSFERASE; GGCT,Asterisk
137181,GAMMA-GLUTAMYLTRANSFERASE 2; GGT2,Asterisk
137190,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-1; GABRB1",Asterisk
137192,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3",Asterisk
137200,"NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN",Number Sign
137207,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 32; LRRC32,Asterisk
137210,"GASTRIC VOLVULUS, INTRATHORACIC",
137215,"GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC",Number Sign
137216,"ATPase, H+,K+ EXCHANGING, ALPHA SUBUNIT; ATP4A",Asterisk
137217,"ATPase, H+,K+ EXCHANGING, BETA POLYPEPTIDE; ATP4B",Asterisk
137220,GASTRIC JUICE PEPTIDES,
137240,GASTRIC INHIBITORY POLYPEPTIDE; GIP,Asterisk
137241,GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GIPR,Plus
137245,"LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TYPE",Number Sign
137250,GASTRIN; GAS,Asterisk
137260,GASTRIN-RELEASING PEPTIDE; GRP,Asterisk
137270,GASTROCUTANEOUS SYNDROME,
137280,"GASTRITIS, FAMILIAL GIANT HYPERTROPHIC",
137290,TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2; TACSTD2,Asterisk
137295,GATA-BINDING PROTEIN 2; GATA2,Asterisk
137350,GELSOLIN; GSN,Asterisk
137357,MOVED TO 194072,Caret
137360,GENOCHONDROMATOSIS,Percent
137370,"GENU VALGUM, ST. HELENA FAMILIAL",
137400,GEOGRAPHIC AND FISSURED TONGUE,
137440,GERSTMANN-STRAUSSLER DISEASE; GSD,Number Sign
137500,GIANT NEUTROPHIL LEUKOCYTES,Percent
137550,"MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS",Number Sign
137560,MOVED TO 155100,Caret
137570,"SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 1; SLC20A1",Asterisk
137575,"GIGANTIFORM CEMENTOMA, FAMILIAL",Percent
137580,GILLES DE LA TOURETTE SYNDROME; GTS,Number Sign
137600,ANTERIOR SEGMENT DYSGENESIS 4; ASGD4,Number Sign
137700,GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE,
137750,"GLAUCOMA 1, OPEN ANGLE, A; GLC1A",Number Sign
137760,"GLAUCOMA, PRIMARY OPEN ANGLE; POAG",Number Sign
137763,GLAUCOMA AND SLEEP APNEA,
137765,MOVED TO 608328,Caret
137780,GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP,Asterisk
137800,GLIOMA SUSCEPTIBILITY 1; GLM1,Number Sign
137900,GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN,
137920,RENAL CYSTS AND DIABETES SYNDROME; RCAD,Number Sign
137940,HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS,Number Sign
137950,GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1,Percent
137960,"MPV17, MOUSE, HOMOLOG OF; MPV17",Asterisk
138000,GLOMUVENOUS MALFORMATIONS; GVM,Number Sign
138030,GLUCAGON; GCG,Asterisk
138032,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR; GLP1R,Asterisk
138033,GLUCAGON RECEPTOR; GCGR,Asterisk
138035,MOVED TO 230800,Caret
138040,"NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 1; NR3C1",Asterisk
138060,GLUCOCORTICOID RECEPTOR-LIKE 1; GRLL1,
138070,GLUCOGLYCINURIA,
138079,GLUCOKINASE; GCK,Asterisk
138090,HEXOSE-6-PHOSPHATE DEHYDROGENASE; H6PD,Asterisk
138100,MOVED TO 138090,Caret
138110,GLUCOSE-6-PHOSPHATE DEHYDROGENASE-LIKE; G6PDL,
138120,HEAT-SHOCK 70-KD PROTEIN 5; HSPA5,Asterisk
138130,GLUTAMATE DEHYDROGENASE 1; GLUD1,Asterisk
138140,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1; SLC2A1",Asterisk
138150,"GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL; GOT2",Asterisk
138160,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 2; SLC2A2",Asterisk
138170,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 3; SLC2A3",Asterisk
138180,"GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE; GOT1",Asterisk
138190,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 4; SLC2A4",Asterisk
138200,GLUTAMATE PYRUVATE TRANSAMINASE; GPT,Asterisk
138210,GLUTAMATE PYRUVATE TRANSAMINASE 2; GPT2,Asterisk
138220,MOVED TO 138200,Caret
138230,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE/FRUCTOSE TRANSPORTER), MEMBER 5; SLC2A5",Asterisk
138240,MOVED TO 138170,Caret
138243,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 3; GRIK3",Asterisk
138244,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 2; GRIK2",Asterisk
138245,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 1; GRIK1",Asterisk
138246,"GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 4; GRIA4",Asterisk
138247,"GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 2; GRIA2",Asterisk
138248,"GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1; GRIA1",Asterisk
138249,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1; GRIN1",Asterisk
138250,"ALDEHYDE DEHYDROGENASE 18 FAMILY, MEMBER A1; ALDH18A1",Asterisk
138251,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, ASSOCIATED PROTEIN; GRINA",Asterisk
138252,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2B; GRIN2B",Asterisk
138253,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2A; GRIN2A",Asterisk
138254,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2C; GRIN2C",Asterisk
138270,MOVED TO 138385,Caret
138275,GLUTAMATE DECARBOXYLASE 2; GAD2,Asterisk
138276,MOVED TO 605363,Caret
138277,"GLUTAMIC ACID DECARBOXYLASE, BRAIN, MEMBRANE FORM",
138280,"GLUTAMINASE, PHOSPHATE-ACTIVATED; GLS",Asterisk
138290,GLUTAMATE-AMMONIA LIGASE; GLUL,Asterisk
138292,GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 1; GFPT1,Asterisk
138295,GLUTAMYL-PROLYL-tRNA SYNTHETASE; EPRS,Asterisk
138297,GLUTAMYL AMINOPEPTIDASE; ENPEP,Asterisk
138300,GLUTATHIONE REDUCTASE; GSR,Plus
138319,GLUTATHIONE PEROXIDASE 2; GPX2,Asterisk
138320,GLUTATHIONE PEROXIDASE 1; GPX1,Asterisk
138321,GLUTATHIONE PEROXIDASE 3; GPX3,Asterisk
138322,GLUTATHIONE PEROXIDASE 4; GPX4,Asterisk
138330,"GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 1; MGST1",Asterisk
138333,"GLUTATHIONE S-TRANSFERASE, MU-4; GSTM4",Asterisk
138335,MOVED TO 138370,Caret
138340,GLUTATHIONE TRANSFERASE ACTIVITY TOWARD TRANS-STILBENE OXIDE,
138350,"GLUTATHIONE S-TRANSFERASE, MU-1; GSTM1",Asterisk
138359,"GLUTATHIONE S-TRANSFERASE, ALPHA-1; GSTA1",Asterisk
138360,"GLUTATHIONE S-TRANSFERASE, ALPHA-2; GSTA2",Asterisk
138370,MOVED TO 134660,Caret
138380,"GLUTATHIONE S-TRANSFERASE, MU-2; GSTM2",Asterisk
138385,"GLUTATHIONE S-TRANSFERASE, MU-5; GSTM5",Asterisk
138390,"GLUTATHIONE S-TRANSFERASE, MU-3; GSTM3",Asterisk
138391,REMOVED FROM DATABASE,Caret
138400,GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPDH,Asterisk
138420,GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1; GPD1,Asterisk
138430,GLYCEROL-3-PHOSPHATE DEHYDROGENASE 2; GPD2,Asterisk
138440,PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE/PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE/PHOSPHORIBOSYLAMINOIMIDAZOLE SYNTHETASE; GART,Asterisk
138450,"SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL; SHMT2",Asterisk
138470,COMPLEMENT FACTOR B; CFB,Asterisk
138480,GLYCINE B COMPLEMENTING; GLYB,Asterisk
138491,"GLYCINE RECEPTOR, ALPHA-1 SUBUNIT; GLRA1",Asterisk
138492,"GLYCINE RECEPTOR, BETA SUBUNIT; GLRB",Asterisk
138500,HYPERGLYCINURIA,Number Sign
138550,"GLYCOGEN PHOSPHORYLASE, BRAIN TYPE; PYGB",Asterisk
138570,GLYCOGEN SYNTHASE 1; GYS1,Asterisk
138571,GLYCOGEN SYNTHASE 2; GYS2,Asterisk
138590,GLYCOPHORIN E; GYPE,Asterisk
138600,OROSOMUCOID 1; ORM1,Asterisk
138610,OROSOMUCOID 2; ORM2,Asterisk
138670,ALPHA-1-B-GLYCOPROTEIN; A1BG,Asterisk
138680,ALPHA-2-HS-GLYCOPROTEIN; AHSG,Asterisk
138700,APOLIPOPROTEIN H; APOH,Asterisk
138710,"GLYCOPROTEIN, RENAL",
138720,"GLYCOPROTEIN Ib, PLATELET, BETA POLYPEPTIDE; GP1BB",Asterisk
138750,GLYOXALASE I; GLO1,Asterisk
138760,HYDROXYACYL GLUTATHIONE HYDROLASE; HAGH,Asterisk
138770,GMS SYNDROME,
138790,"GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES",
138800,"GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1",Number Sign
138850,GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR,Asterisk
138890,GOOSECOID HOMEOBOX; GSC,Asterisk
138900,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1",Number Sign
138920,GRANDDAD SYNDROME,
138930,GRANT SYNDROME,
138945,GRANULIN PRECURSOR; GRN,Asterisk
138960,COLONY-STIMULATING FACTOR 2; CSF2,Asterisk
138965,"CHEMOKINE, CXC MOTIF, LIGAND 6; CXCL6",Asterisk
138970,COLONY-STIMULATING FACTOR 3; CSF3,Asterisk
138971,"COLONY-STIMULATING FACTOR 3 RECEPTOR, GRANULOCYTE; CSF3R",Asterisk
138972,"CCAAT/ENHANCER-BINDING PROTEIN, GAMMA; CEBPG",Asterisk
138981,"GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, BETA; CSF2RB",Asterisk
138990,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL DOMINANT TYPE",
139000,GRANULOSIS RUBRA NASI,
139080,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GRAVES DISEASE AUTOANTIGEN), MEMBER 16; SLC25A16",Asterisk
139090,GRAY PLATELET SYNDROME; GPS,Number Sign
139100,"GRAYING OF HAIR, PRECOCIOUS",Percent
139110,"CHEMOKINE, CXC MOTIF, LIGAND 2; CXCL2",Asterisk
139111,"CHEMOKINE, CXC MOTIF, LIGAND 3; CXCL3",Asterisk
139130,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-3; GNB3",Asterisk
139139,"NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NR4A1",Asterisk
139145,MOVED TO 139139,Caret
139150,RAS p21 PROTEIN ACTIVATOR 1; RASA1,Asterisk
139160,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA Z POLYPEPTIDE; GNAZ",Asterisk
139180,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING, POLYPEPTIDE 2 PSEUDOGENE 1; GNAI2P1",Asterisk
139185,GROWTH ARREST-SPECIFIC 1; GAS1,Asterisk
139190,GROWTH HORMONE-RELEASING HORMONE; GHRH,Asterisk
139191,GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR,Asterisk
139200,GROUP-SPECIFIC COMPONENT; GC,Asterisk
139210,MYHRE SYNDROME; MYHRS,Number Sign
139220,REMOVED FROM DATABASE,Caret
139230,REMOVED FROM DATABASE,Caret
139240,GROWTH HORMONE 2; GH2,Asterisk
139250,GROWTH HORMONE 1; GH1,Asterisk
139255,METALLOTHIONEIN 3; MT3,Asterisk
139259,G1- TO S-PHASE TRANSITION 1; GSPT1,Asterisk
139260,GUANINE DEAMINASE; GDA,Asterisk
139265,GUANOSINE MONOPHOSPHATE REDUCTASE; GMPR,Asterisk
139270,GUANYLATE KINASE 1; GUK1,Asterisk
139280,GUANYLATE KINASE 2; GUK2,
139290,GUANYLATE KINASE 3; GUK3,
139300,AROMATASE EXCESS SYNDROME; AEXS,Number Sign
139310,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 1; GNAI1",Asterisk
139311,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE O; GNAO1",Asterisk
139312,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE, OLFACTORY TYPE; GNAL",Asterisk
139313,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-11; GNA11",Asterisk
139314,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-15; GNA15",Asterisk
139320,GNAS COMPLEX LOCUS; GNAS,Asterisk
139330,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNAT1",Asterisk
139340,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNAT2",Asterisk
139350,"KERATIN 1, TYPE II; KRT1",Asterisk
139360,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 2; GNAI2",Asterisk
139370,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 3; GNAI3",Asterisk
139380,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1; GNB1",Asterisk
139390,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2; GNB2",Asterisk
139391,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNGT2",Asterisk
139392,GUANYLATE CYCLASE ACTIVATOR 2A; GUCA2A,Asterisk
139393,"GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS",Number Sign
139395,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 3; GNAT3",Asterisk
139396,"GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-3; GUCY1A3",Asterisk
139397,"GUANYLATE CYCLASE 1, SOLUBLE, BETA-3; GUCY1B3",Asterisk
139400,HAIR WHORL,
139450,HAIR MORPHOLOGY 2; HRM2,Percent
139500,HAIRY EARS,
139600,HAIRY ELBOWS,Percent
139605,"HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 1; HES1",Asterisk
139630,HAIRY NOSE TIP,
139650,HAIRY PALMS AND SOLES,Percent
139750,HAND AND FOOT DEFORMITY WITH FLAT FACIES,
139800,HAND CLASPING PATTERN,
139900,"HAND SKILL, RELATIVE; HSR",Percent
140000,HAND-FOOT-GENITAL SYNDROME; HFG,Number Sign
140050,GRANZYME A; GZMA,Asterisk
140090,MOVED TO 189903,Caret
140100,HAPTOGLOBIN; HP,Asterisk
140210,HAPTOGLOBIN-RELATED PROTEIN GENE; HPR,Asterisk
140300,HASHIMOTO THYROIDITIS,Percent
140340,MOVED TO 125370,Caret
140350,HAWKINSINURIA,Number Sign
140400,"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II; PFHB2",Percent
140450,"HEART-HAND SYNDROME, SPANISH TYPE",
140500,"HEART, MALFORMATION OF",
140550,HEAT-SHOCK 70-KD PROTEIN 1A; HSPA1A,Asterisk
140555,HEAT-SHOCK 70-KD PROTEIN 6; HSPA6,Asterisk
140556,HEAT-SHOCK 70-KD PROTEIN 7; HSPA7,Asterisk
140559,HEAT-SHOCK 70-KD PROTEIN-LIKE 1; HSPA1L,Asterisk
140560,HEAT-SHOCK 70-KD PROTEIN 2; HSPA2,Asterisk
140570,MOVED TO 140550,Caret
140571,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1; HSP90AA1",Asterisk
140572,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS B, MEMBER 1; HSP90AB1",Asterisk
140573,MOVED TO 140571,Caret
140574,MOVED TO 140571,Caret
140575,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 2; HSP90AA2",Asterisk
140576,MOVED TO 140571,Caret
140580,HEAT-SHOCK TRANSCRIPTION FACTOR 1; HSF1,Asterisk
140581,HEAT-SHOCK TRANSCRIPTION FACTOR 2; HSF2,Asterisk
140600,OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2,Number Sign
140700,HEINZ BODY ANEMIAS,Number Sign
140750,SUPPRESSOR OF TUMORIGENICITY 5; ST5,Asterisk
140850,"HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE",
140900,HEMANGIOMAS OF SMALL INTESTINE,
141000,HEMANGIOMA-THROMBOCYTOPENIA SYNDROME,
141180,HEMATOPOIETIC PROTEIN HEM-1; HEM1,Asterisk
141200,"HEMATURIA, BENIGN FAMILIAL; BFH",Number Sign
141250,HEME OXYGENASE 1; HMOX1,Asterisk
141251,HEME OXYGENASE 2; HMOX2,Asterisk
141300,"HEMIFACIAL ATROPHY, PROGRESSIVE; HFA",Percent
141350,HEMIFACIAL HYPERPLASIA WITH STRABISMUS,Percent
141400,HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS,Percent
141405,"HEMIFACIAL SPASM, FAMILIAL",
141500,"MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1",Number Sign
141700,HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES,
141749,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1,Number Sign
141750,"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED",Number Sign
141800,HEMOGLOBIN--ALPHA LOCUS 1; HBA1,Asterisk
141850,HEMOGLOBIN--ALPHA LOCUS 2; HBA2,Asterisk
141860,HEMOGLOBIN--ALPHA LOCUS 3,Asterisk
141900,HEMOGLOBIN--BETA LOCUS; HBB,Asterisk
141940,MOVED TO 141900,Caret
142000,HEMOGLOBIN--DELTA LOCUS; HBD,Asterisk
142100,HEMOGLOBIN--EPSILON LOCUS; HBE1,Asterisk
142200,"HEMOGLOBIN, GAMMA A; HBG1",Asterisk
142210,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER D; HIST1H1D",Asterisk
142220,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER E; HIST1H1E",Asterisk
142230,HEMATOPOIETIC PROGENITOR CELL ANTIGEN CD34; CD34,Asterisk
142240,HEMOGLOBIN--THETA-1 LOCUS; HBQ1,Asterisk
142250,"HEMOGLOBIN, GAMMA G; HBG2",Asterisk
142270,MOVED TO 142200,Caret
142290,HEMOPEXIN; HPX,Asterisk
142300,MOVED TO 142310,Caret
142309,HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS UNKNOWN OR UNCERTAIN,Number Sign
142310,HEMOGLOBIN--ZETA LOCUS; HBZ,Asterisk
142330,"HEPATIC ADENOMAS, FAMILIAL",Number Sign
142333,MOVED TO 114550,Caret
142335,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5,Percent
142340,"DIAPHRAGMATIC HERNIA, CONGENITAL",Percent
142350,"HERNIA, DOUBLE INGUINAL",
142360,HEPARIN COFACTOR II; HCF2,Asterisk
142370,HEMOPOIETIC CELL KINASE; HCK,Asterisk
142380,MOVED TO 114550,Caret
142385,HEPATIC LEUKEMIA FACTOR; HLF,Asterisk
142390,HEPATIC PROTEIN; HEP10,Asterisk
142395,"HEPATITIS B VACCINE, RESPONSE TO",Number Sign
142400,"HERNIA, HIATUS",Percent
142408,MACROPHAGE STIMULATING 1; MST1,Asterisk
142409,HEPATOCYTE GROWTH FACTOR; HGF,Asterisk
142410,HNF1 HOMEOBOX A; HNF1A,Asterisk
142420,REMOVED FROM DATABASE,Caret
142440,HEPSIN; HPN,Asterisk
142445,NEUREGULIN 1; NRG1,Asterisk
142450,MOVED TO 600644,Caret
142460,SYNDECAN 2; SDC2,Asterisk
142461,HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE; HSPG2,Asterisk
142470,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2,Percent
142500,HETEROCHROMIA IRIDIS,
142510,MOVED TO 300049,Caret
142550,MOVED TO 142600,Caret
142560,DEAD BOX POLYPEPTIDE 39B; DDX39B,Asterisk
142570,HEXOKINASE 3; HK3,Asterisk
142580,PROLINE-RICH COILED-COIL PROTEIN 2A; PRRC2A,Asterisk
142590,BCL2-ASSOCIATED ATHANOGENE 6; BAG6,Asterisk
142600,HEXOKINASE 1; HK1,Asterisk
142610,G-PATCH DOMAIN- AND ANKYRIN REPEATS-CONTAINING PROTEIN 1; GPANK1,Asterisk
142620,ABHYDROLASE DOMAIN-CONTAINING 16A; ABHD16A,Asterisk
142622,HIPPOCALCIN; HPCA,Asterisk
142623,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1",Number Sign
142625,"HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION",
142630,"HISTIOCYTOSIS, PROGRESSIVE MUCINOUS",
142640,HISTIDINE-RICH GLYCOPROTEIN; HRG,Asterisk
142660,HEXOSAMINIDASE C; HEXC,
142669,BEUKES HIP DYSPLASIA; BHD,Number Sign
142680,"PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT",Number Sign
142690,"ACNE INVERSA, FAMILIAL, 1; ACNINV1",Number Sign
142695,HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN; HDLBP,Asterisk
142700,DEVELOPMENTAL DYSPLASIA OF THE HIP 1; DDH1,Percent
142701,HISTATIN 1; HTN1,Asterisk
142702,HISTATIN 3; HTN3,Asterisk
142703,HISTAMINE RECEPTOR H2; HRH2,Asterisk
142704,HISTIDINE DECARBOXYLASE; HDC,Asterisk
142705,HISTIDINE-RICH CALCIUM-BINDING PROTEIN; HRC,Asterisk
142708,"H1 HISTONE FAMILY, MEMBER 0; H1F0",Asterisk
142709,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER A; HIST1H1A",Asterisk
142710,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER C; HIST1H1C",Asterisk
142711,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER B; HIST1H1B",Asterisk
142712,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER T; HIST1H1T",Asterisk
142720,"HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER A3; HIST2H2AA3",Asterisk
142730,HISTIOCYTIC DERMATOARTHRITIS,
142750,"HISTONE GENE CLUSTER 2, H4 HISTONE FAMILY, MEMBER A; HIST2H4A",Asterisk
142760,MOVED TO 142720,Caret
142763,"H2A HISTONE FAMILY, MEMBER Z; H2AFZ",Asterisk
142765,"REGULATORY FACTOR X, 2; RFX2",Asterisk
142770,HLA MODIFIER,
142780,"HISTONE GENE CLUSTER 2, H3 HISTONE FAMILY, MEMBER C; HIST2H3C",Asterisk
142790,CD74 ANTIGEN; CD74,Asterisk
142795,HLA-8 HISTOCOMPATIBILITY TYPE; HLA8,Asterisk
142800,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A",Asterisk
142810,HISTIDYL-tRNA SYNTHETASE; HARS,Asterisk
142830,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B",Plus
142840,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, C; HLA-C",Asterisk
142850,MOVED TO 142860,Caret
142855,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM ALPHA; HLA-DMA",Asterisk
142856,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM BETA; HLA-DMB",Asterisk
142857,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1; HLA-DRB1",Asterisk
142858,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1; HLA-DPB1",Asterisk
142860,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA; HLA-DRA",Asterisk
142870,REMOVED FROM DATABASE,Caret
142871,"HLA-G HISTOCOMPATIBILITY ANTIGEN, CLASS I; HLA-G",Asterisk
142880,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1",Asterisk
142890,HLA-MT HISTOCOMPATIBILITY TYPE; HLA-MT,Asterisk
142900,HOLT-ORAM SYNDROME; HOS,Number Sign
142910,3-HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE; HMGCR,Plus
142920,HLA-DO HISTOCOMPATIBILITY TYPE; HLA-DO,Asterisk
142925,MOVED TO 142800,Caret
142930,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DN ALPHA; HLA-DNA",Asterisk
142940,3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 1; HMGCS1,Asterisk
142945,HOLOPROSENCEPHALY 3; HPE3,Number Sign
142946,HOLOPROSENCEPHALY 4; HPE4,Number Sign
142950,HOMEOBOX A7; HOXA7,Asterisk
142951,HOMEOBOX A6; HOXA6,Asterisk
142952,HOMEOBOX A5; HOXA5,Asterisk
142953,HOMEOBOX A4; HOXA4,Asterisk
142954,HOMEOBOX A3; HOXA3,Asterisk
142955,HOMEOBOX A1; HOXA1,Asterisk
142956,HOMEOBOX A9; HOXA9,Asterisk
142957,HOMEOBOX A10; HOXA10,Asterisk
142958,HOMEOBOX A11; HOXA11,Asterisk
142959,HOMEOBOX A13; HOXA13,Asterisk
142960,HOMEOBOX B5; HOXB5,Asterisk
142961,HOMEOBOX B6; HOXB6,Asterisk
142962,HOMEOBOX B7; HOXB7,Asterisk
142963,HOMEOBOX B8; HOXB8,Asterisk
142964,HOMEOBOX B9; HOXB9,Asterisk
142965,HOMEOBOX B4; HOXB4,Asterisk
142966,HOMEOBOX B3; HOXB3,Asterisk
142967,HOMEOBOX B2; HOXB2,Asterisk
142968,HOMEOBOX B1; HOXB1,Asterisk
142970,HOMEOBOX C8; HOXC8,Asterisk
142971,HOMEOBOX C9; HOXC9,Asterisk
142972,HOMEOBOX C6; HOXC6,Asterisk
142973,HOMEOBOX C5; HOXC5,Asterisk
142974,HOMEOBOX C4; HOXC4,Asterisk
142975,HOMEOBOX C12; HOXC12,Asterisk
142976,HOMEOBOX C13; HOXC13,Asterisk
142980,HOMEOBOX D3; HOXD3,Asterisk
142981,HOMEOBOX D4; HOXD4,Asterisk
142982,HOMEOBOX D9; HOXD9,Asterisk
142983,"MUSCLE SEGMENT HOMEOBOX, DROSOPHILA, HOMOLOG OF, 1; MSX1",Asterisk
142984,HOMEOBOX D10; HOXD10,Asterisk
142985,HOMEOBOX D8; HOXD8,Asterisk
142986,HOMEOBOX D11; HOXD11,Asterisk
142987,HOMEOBOX D1; HOXD1,Asterisk
142988,HOMEOBOX D12; HOXD12,Asterisk
142989,HOMEOBOX D13; HOXD13,Asterisk
142990,MOVED TO 142981,Caret
142991,EVEN-SKIPPED HOMEOBOX 2; EVX2,Asterisk
142992,H6 FAMILY HOMEOBOX 1; HMX1,Asterisk
142993,VISUAL SYSTEM HOMEOBOX 2; VSX2,Asterisk
142994,MOTOR NEURON AND PANCREAS HOMEOBOX 1; MNX1,Asterisk
142995,H.20-LIKE HOMEOBOX 1; HLX1,Asterisk
142996,EVEN-SKIPPED HOMEOBOX 1; EVX1,Asterisk
143000,"HORNER SYNDROME, CONGENITAL",Percent
143010,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, E; HLA-E",Asterisk
143020,"HPA I RECOGNITION POLYMORPHISM, BETA-GLOBIN-RELATED; HPA1",
143023,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 7; RASSF7",Asterisk
143024,GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 1; GNL1,Asterisk
143025,HTLV-RELATED ENDOGENOUS SEQUENCE 1; HRES1,Asterisk
143030,CD9 ANTIGEN; CD9,Asterisk
143040,ANTIGEN DEFINED BY MONOCLONAL ANTIBODY F10.44.2,Asterisk
143050,HUMERORADIAL SYNOSTOSIS,
143054,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 2; HIVEP2,Asterisk
143055,CYCLIN T1; CCNT1,Asterisk
143060,HUMAN LEUKOCYTE ANTIGEN MIC6; MIC6,Asterisk
143065,MOVED TO 107271,Caret
143070,REMOVED FROM DATABASE,Caret
143080,REMOVED FROM DATABASE,Caret
143089,HUMAN T-CELL LEUKEMIA VIRUS ENHANCER FACTOR; HTLF,Asterisk
143090,MOVED TO 138140,Caret
143095,SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD,Number Sign
143100,HUNTINGTON DISEASE; HD,Number Sign
143110,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, F; HLA-F",Asterisk
143150,MOVED TO 426000,Caret
143170,MALE-ENHANCED ANTIGEN 1; MEA1,Asterisk
143200,WAGNER VITREORETINOPATHY; WGVRP,Number Sign
143400,CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2,Number Sign
143450,"HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT; HADHB",Asterisk
143460,5-HYDROXYTRYPTAMINE OXYGENASE REGULATOR; HTOR,
143465,ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD,Number Sign
143470,HYPERALPHALIPOPROTEINEMIA 1; HALP1,Number Sign
143500,GILBERT SYNDROME,Number Sign
143850,"ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE",Percent
143860,"HYPERCHLORHIDROSIS, ISOLATED; HYCHL",Number Sign
143870,"HYPERCALCIURIA, ABSORPTIVE, 2; HCA2",Number Sign
143880,"HYPERCALCEMIA, INFANTILE, 1; HCINF1",Number Sign
143890,"HYPERCHOLESTEROLEMIA, FAMILIAL",Number Sign
144010,"HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B",Number Sign
144020,HYPERCHOLESTEROLEMIA SUPPRESSOR,
144050,HYPERHEPARINEMIA,
144100,"HYPERHIDROSIS, GUSTATORY; HYPRG",
144110,HYPERHIDROSIS PALMARIS ET PLANTARIS; HYPRPP,Percent
144120,HYPERIMMUNOGLOBULIN G1(A1) SYNDROME,
144150,HYPERKERATOSIS LENTICULARIS PERSTANS; HLP,Percent
144190,HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME,
144200,"PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK",Number Sign
144250,"HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL",Number Sign
144300,"HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS",
144400,MOVED TO 143890,Caret
144600,"HYPERLIPOPROTEINEMIA, TYPE IV",
144650,"HYPERLIPOPROTEINEMIA, TYPE V",Number Sign
144700,"RENAL CELL CARCINOMA, NONPAPILLARY; RCC",Number Sign
144750,"ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT",Number Sign
144755,HYPEROSTOSIS CRANIALIS INTERNA; HCIN,Number Sign
144800,HYPEROSTOSIS FRONTALIS INTERNA,
145000,HYPERPARATHYROIDISM 1; HRPT1,Number Sign
145001,HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2,Number Sign
145100,HYPERPIGMENTATION OF EYELIDS,Percent
145200,HYPERPIGMENTATION OF FULDAUER AND KUIJPERS,
145250,"HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE; FPHH",Number Sign
145260,"PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A",Percent
145270,HYPERPROGLUCAGONEMIA,
145290,HYPERREFLEXIA; HRX,
145295,"HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL",
145300,"HYPERSENSITIVITY PNEUMONITIS, FAMILIAL",
145350,HYPERTAURINURIC CARDIOMYOPATHY,
145400,HYPERTELORISM,Percent
145410,"OPITZ GBBB SYNDROME, TYPE II; GBBB2",Number Sign
145420,"HYPERTELORISM, TEEBI TYPE",Percent
145500,"HYPERTENSION, ESSENTIAL",Number Sign
145505,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 3; ACSM3",Asterisk
145590,"HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA",
145600,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1",Number Sign
145650,"THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH",Number Sign
145680,"HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC; DTTRH",Number Sign
145700,HYPERTRICHOSIS LANUGINOSA CONGENITA,Percent
145701,"HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1",Percent
145750,"HYPERTRIGLYCERIDEMIA, FAMILIAL",Number Sign
145800,HYPERTROPHIA MUSCULORUM VERA,Percent
145900,HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS,Number Sign
145980,"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1",Number Sign
145981,"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2",Number Sign
146000,HYPOCHONDROPLASIA; HCH,Number Sign
146110,HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7,Number Sign
146150,MOVED TO 300337,Caret
146160,HYPOMELIA WITH MULLERIAN DUCT ANOMALIES,
146200,"HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH",Number Sign
146255,"HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR",Number Sign
146300,"HYPOPHOSPHATASIA, ADULT",Number Sign
146350,HYPOPHOSPHATEMIC BONE DISEASE; HBD,Percent
146390,CHROMOSOME 18p DELETION SYNDROME,Number Sign
146400,MOVED TO 125400,Caret
146450,"HYPOSPADIAS 3, AUTOSOMAL; HYSP3",Percent
146500,"MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1",Number Sign
146510,PALLISTER-HALL SYNDROME; PHS,Number Sign
146520,HYPOTRICHOSIS 2; HYPT2,Number Sign
146530,MOVED TO 301845,Caret
146550,HYPOTRICHOSIS 4; HYPT4,Number Sign
146580,HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE SUPPRESSOR,
146590,"ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM",Number Sign
146600,ICHTHYOSIS HYSTRIX GRAVIOR,
146630,INTERCELLULAR ADHESION MOLECULE 2; ICAM2,Asterisk
146631,INTERCELLULAR ADHESION MOLECULE 3; ICAM3,Asterisk
146640,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 2; ITIH2",Asterisk
146650,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 3; ITIH3",Asterisk
146660,INTERLEUKIN 7; IL7,Asterisk
146661,INTERLEUKIN 7 RECEPTOR; IL7R,Asterisk
146680,INSULIN-DEGRADING ENZYME; IDE,Asterisk
146690,IMP DEHYDROGENASE 1; IMPDH1,Asterisk
146691,IMP DEHYDROGENASE 2; IMPDH2,Asterisk
146692,MOVED TO 146690,Caret
146700,ICHTHYOSIS VULGARIS,Number Sign
146710,"INTERLEUKIN 2 RECEPTOR, BETA; IL2RB",Asterisk
146720,ICHTHYOSIS--CHEEK--EYEBROW SYNDROME,
146730,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1; IGFBP1,Asterisk
146731,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2; IGFBP2,Asterisk
146732,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3,Asterisk
146733,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 4; IGFBP4,Asterisk
146734,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5; IGFBP5,Asterisk
146735,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; IGFBP6,Asterisk
146738,INSULIN-LIKE 3; INSL3,Asterisk
146740,"Fc FRAGMENT OF IgG, LOW AFFINITY IIIa, RECEPTOR FOR; FCGR3A",Asterisk
146750,"ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT",
146760,"Fc FRAGMENT OF IgG, HIGH AFFINITY Ia, RECEPTOR FOR; FCGR1A",Asterisk
146770,IMMUNOGLOBULIN LAMBDA-LIKE POLYPEPTIDE 1; IGLL1,Asterisk
146771,MOVED TO 146770,Caret
146780,IMMUNOGLOBULIN KAPPA DELETING ELEMENT; IGKDEL,Asterisk
146790,"Fc FRAGMENT OF IgG, LOW AFFINITY IIa, RECEPTOR FOR; FCGR2A",Asterisk
146800,ICHTHYOSIS BULLOSA OF SIEMENS; IBS,Number Sign
146810,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRPHEGAL; IPHEG,
146820,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT; IGAT,
146830,"IMMUNE DEFICIENCY, FAMILIAL VARIABLE",
146840,IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST,
146850,IMMUNE SUPPRESSION; IS,
146880,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1; HLA-DQA1",Asterisk
146900,IgA CONSTANT HEAVY CHAIN 1; IGHA1,Asterisk
146910,IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE CLUSTER; IGHD@,Asterisk
146920,"ADENOSINE DEAMINASE, RNA-SPECIFIC; ADAR",Asterisk
146928,"CHEMOKINE, CXC MOTIF, RECEPTOR 2; CXCR2",Asterisk
146929,"CHEMOKINE, CXC MOTIF, RECEPTOR 1; CXCR1",Asterisk
146930,INTERLEUKIN 8; IL8,Asterisk
146931,INTERLEUKIN 9; IL9,Asterisk
146932,MOVED TO 300007,Caret
146933,"INTERLEUKIN 10 RECEPTOR, ALPHA; IL10RA",Asterisk
146940,MOVED TO 147220,Caret
146950,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRHGAL; IHG,
146960,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRTGAL; ITG,
146970,IMMUNOGLOBULIN KAPPA LIGHT CHAIN JOINING GENE CLUSTER; IGKJ@,Asterisk
146980,IMMUNOGLOBULIN KAPPA LIGHT CHAIN VARIABLE GENE CLUSTER; IGKV@,Asterisk
146990,IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY REGION 2; IGHDY2,
147000,IgA CONSTANT HEAVY CHAIN 2; IGHA2,Asterisk
147010,IMMUNOGLOBULIN HEAVY CHAIN JOINING GENE CLUSTER; IGHJ@,Asterisk
147020,IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION MU; IGHM,Asterisk
147040,INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 2; IFIT2,Asterisk
147045,"Fc FRAGMENT OF IgA, RECEPTOR FOR; FCAR",Asterisk
147050,"IgE RESPONSIVENESS, ATOPIC; IGER",Number Sign
147060,"HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT",Number Sign
147061,"IMMUNOGLOBULIN E CONCENTRATION, SERUM; IGES",Percent
147070,IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE CLUSTER; IGHV@,Asterisk
147080,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 1; IGLP1,
147090,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 2; IGLP2,
147100,IgG HEAVY CHAIN LOCUS; IGHG1,Asterisk
147110,IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION GAMMA-2; IGHG2,Asterisk
147120,IMMUNOGLOBULIN Gm3; IGHG3,Asterisk
147130,IMMUNOGLOBULIN Gm4; IGHG4,Asterisk
147138,"MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 2; MS4A2",Asterisk
147139,"Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, GAMMA SUBUNIT; FCER1G",Asterisk
147140,"Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, ALPHA SUBUNIT; FCER1A",Asterisk
147141,TRANSCRIPTION FACTOR 3; TCF3,Asterisk
147150,"MYXOVIRUS RESISTANCE 1, MOUSE, HOMOLOG OF; MX1",Asterisk
147160,MOVED TO 147180,Caret
147170,IMMUNOGLOBULIN: HEAVY DELTA CHAIN; IGHD,Asterisk
147180,IMMUNOGLOBULIN: HEAVY EPSILON CHAIN; IGHE,Asterisk
147183,RECOMBINATION SIGNAL-BINDING PROTEIN FOR IMMUNOGLOBULIN KAPPA J REGION; RBPJ,Asterisk
147185,IMMUNOGLOBULIN KAPPA VARIABLE 1/OR2-108; IGKV1OR2108,Asterisk
147200,IMMUNOGLOBULIN KAPPA LIGHT CHAIN CONSTANT REGION; IGKC,Asterisk
147210,MOVED TO 147180,Caret
147220,IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1; IGLC1,Asterisk
147230,IMMUNOGLOBULIN LAMBDA LIGHT CHAIN JOINING GENE CLUSTER; IGLJ@,Asterisk
147240,IMMUNOGLOBULIN LAMBDA LIGHT CHAIN VARIABLE GENE CLUSTER; IGLV@,Asterisk
147245,CD79B ANTIGEN; CD79B,Asterisk
147250,SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI,Number Sign
147251,"INCISORS, FUSED MANDIBULAR",
147260,IMMUNOGLOBULIN SWITCH SEQUENCES,
147263,INOSITOL POLYPHOSPHATE-1-PHOSPHATASE; INPP1,Asterisk
147264,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 75-KD; INPP5B",Asterisk
147265,"INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1",Asterisk
147267,"INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR, TYPE 3; ITPR3",Asterisk
147270,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1; ITIH1",Asterisk
147280,INSULIN-LIKE GROWTH FACTOR II RECEPTOR; IGF2R,Asterisk
147290,"INHIBIN, BETA A; INHBA",Asterisk
147300,"INCISORS, LONG UPPER CENTRAL",
147310,"CHEMOKINE, CXC MOTIF, LIGAND 10; CXCL10",Asterisk
147320,"INSULIN RECEPTORS, FAMILIAL INCREASE IN",
147330,"INCISORS, LOWER CENTRAL, ABSENCE OF",
147350,"INCISORS, ROTATION OF UPPER CENTRAL",
147360,INVOLUCRIN; IVL,Asterisk
147370,INSULIN-LIKE GROWTH FACTOR I RECEPTOR; IGF1R,Asterisk
147380,"INHIBIN, ALPHA; INHA",Asterisk
147390,"INHIBIN, BETA B; INHBB",Asterisk
147400,"INCISORS, SHOVEL-SHAPED",Percent
147410,REMOVED FROM DATABASE,Caret
147420,MOVED TO 601419,Caret
147421,INCLUSION BODY MYOSITIS,Percent
147430,MARSILI SYNDROME; MARSIS,Number Sign
147435,"INDOLEAMINE 2,3-DIOXYGENASE; IDO1",Asterisk
147440,INSULIN-LIKE GROWTH FACTOR I; IGF1,Asterisk
147450,SUPEROXIDE DISMUTASE 1; SOD1,Asterisk
147460,SUPEROXIDE DISMUTASE 2; SOD2,Asterisk
147470,INSULIN-LIKE GROWTH FACTOR II; IGF2,Asterisk
147480,"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1",Number Sign
147485,INTRACISTERNAL A PARTICLE-PROMOTED POLYPEPTIDE; IPP,Asterisk
147490,REMOVED FROM DATABASE,Caret
147510,INSULIN-RELATED DNA POLYMORPHISM; IRDN,Asterisk
147520,INOSINE TRIPHOSPHATASE; ITPA,Asterisk
147521,"INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE A; ITPKA",Asterisk
147522,"INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE B; ITPKB",Asterisk
147530,INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY,
147540,"INSECT STINGS, HYPERSENSITIVITY TO",
147545,INSULIN RECEPTOR SUBSTRATE 1; IRS1,Plus
147553,"INTERFERON, OMEGA-1; IFNW1",Asterisk
147554,MOVED TO 147553,Caret
147556,"INTEGRIN, ALPHA-6; ITGA6",Asterisk
147557,"INTEGRIN, BETA-4; ITGB4",Asterisk
147558,"INTEGRIN, BETA-6; ITGB6",Asterisk
147559,"INTEGRIN, BETA-7; ITGB7",Asterisk
147560,INTERFERON ANTIVIRAL DEPRESSOR,
147561,"INTEGRIN, BETA-5; ITGB5",Asterisk
147562,"INTERFERON, ALPHA-2; IFNA2",Asterisk
147563,INTEGRIN-BINDING SIALOPROTEIN; IBSP,Asterisk
147564,"INTERFERON, ALPHA-4; IFNA4",Asterisk
147565,"INTERFERON, ALPHA-5; IFNA5",Asterisk
147566,"INTERFERON, ALPHA-6; IFNA6",Asterisk
147567,"INTERFERON, ALPHA-7; IFNA7",Asterisk
147568,"INTERFERON, ALPHA-8; IFNA8",Asterisk
147569,INTERFERON-GAMMA RECEPTOR 2; IFNGR2,Asterisk
147570,"INTERFERON, GAMMA; IFNG",Asterisk
147571,UBIQUITIN-LIKE MODIFIER ISG15; ISG15,Asterisk
147572,INTERFERON-ALPHA-INDUCIBLE PROTEIN 6; IFI6,Asterisk
147573,INTERFERON PRODUCTION REGULATOR; IFNR,Asterisk
147574,INTERFERON REGULATORY FACTOR 9; IRF9,Asterisk
147575,INTERFERON REGULATORY FACTOR 1; IRF1,Asterisk
147576,INTERFERON REGULATORY FACTOR 2; IRF2,Asterisk
147577,"INTERFERON, ALPHA-10; IFNA10",Asterisk
147578,"INTERFERON, ALPHA-13; IFNA13",Asterisk
147579,"INTERFERON, ALPHA-14; IFNA14",Asterisk
147580,"INTERFERON, ALPHA-16; IFNA16",Asterisk
147581,MOVED TO 100880,Caret
147582,IRON-RESPONSIVE ELEMENT-BINDING PROTEIN 2; IREB2,Asterisk
147583,"INTERFERON, ALPHA-17; IFNA17",Asterisk
147584,"INTERFERON, ALPHA-21; IFNA21",Asterisk
147585,MOVED TO 147660,Caret
147586,INTERFERON-GAMMA-INDUCIBLE PROTEIN 16; IFI16,Asterisk
147590,MOVED TO 109120,Caret
147610,"IRIS PIGMENT LAYER, CLEAVAGE OF",
147620,INTERLEUKIN 6; IL6,Asterisk
147625,ISLET CELL AUTOANTIGEN 1; ICA1,Asterisk
147630,INSULINOMATOSIS AND DIABETES MELLITUS; INSDM,Number Sign
147640,"INTERFERON, BETA-1; IFNB1",Asterisk
147650,ISOCITRATE DEHYDROGENASE 2; IDH2,Asterisk
147660,"INTERFERON, ALPHA-1; IFNA1",Asterisk
147670,INSULIN RECEPTOR; INSR,Asterisk
147671,INSULIN RECEPTOR-RELATED RECEPTOR; INSRR,Asterisk
147678,"CASPASE 1, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP1",Asterisk
147679,INTERLEUKIN 1 RECEPTOR ANTAGONIST; IL1RN,Asterisk
147680,INTERLEUKIN 2; IL2,Asterisk
147681,INTERLEUKIN 11; IL11,Asterisk
147683,INTERLEUKIN 13; IL13,Asterisk
147684,REMOVED FROM DATABASE,Caret
147685,FORKHEAD BOX K2; FOXK2,Asterisk
147686,MOVED TO 300119,Caret
147690,INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; IFIT1,Asterisk
147700,ISOCITRATE DEHYDROGENASE 1; IDH1,Asterisk
147710,INTUSSUSCEPTION,
147720,INTERLEUKIN 1-BETA; IL1B,Asterisk
147730,"INTERLEUKIN 2 RECEPTOR, ALPHA; IL2RA",Asterisk
147740,INTERLEUKIN 3; IL3,Asterisk
147750,IVIC SYNDROME,Number Sign
147760,INTERLEUKIN 1-ALPHA; IL1A,Asterisk
147770,JOHNSON NEUROECTODERMAL SYNDROME,Percent
147780,INTERLEUKIN 4; IL4,Asterisk
147781,INTERLEUKIN 4 RECEPTOR; IL4R,Asterisk
147790,"IMMUNOGLOBULIN J POLYPEPTIDE, LINKER PROTEIN FOR IMMUNOGLOBULIN ALPHA AND MU POLYPEPTIDES; IGJ",Asterisk
147791,JACOBSEN SYNDROME; JBS,Number Sign
147795,JANUS KINASE 1; JAK1,Asterisk
147796,JANUS KINASE 2; JAK2,Asterisk
147800,AASE-SMITH SYNDROME I,Percent
147810,"INTERLEUKIN 1 RECEPTOR, TYPE I; IL1R1",Asterisk
147811,"INTERLEUKIN 1 RECEPTOR, TYPE II; IL1R2",Asterisk
147820,"INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF",
147830,T-CELL TUMOR INVASION AND METASTASIS 1; TTIM1,Asterisk
147840,INTERCELLULAR ADHESION MOLECULE 1; ICAM1,Asterisk
147850,INTERLEUKIN 5; IL5,Asterisk
147851,"INTERLEUKIN 5 RECEPTOR, ALPHA; IL5RA",Asterisk
147860,"INTERFERON, BETA-3; IFNB3",
147870,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2",Asterisk
147880,INTERLEUKIN 6 RECEPTOR; IL6R,Asterisk
147890,"MYXOVIRUS RESISTANCE 2, MOUSE, HOMOLOG OF; MX2",Asterisk
147891,ISCHIOCOXOPODOPATELLAR SYNDROME; ICPPS,Number Sign
147892,"DEIODINASE, IODOTHYRONINE, TYPE I; DIO1",Asterisk
147900,"JOINT LAXITY, FAMILIAL",Percent
147910,KALLIKREIN 1; KLK1,Asterisk
147920,KABUKI SYNDROME 1; KABUK1,Number Sign
147935,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 4; SERPINA4",Asterisk
147940,ISLET AMYLOID POLYPEPTIDE; IAPP,Asterisk
147950,HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2,Number Sign
147960,KALLIKREIN-RELATED PEPTIDASE 2; KLK2,Asterisk
148000,"KAPOSI SARCOMA, SUSCEPTIBILITY TO",Number Sign
148020,KERATIN 19; KRT19,Asterisk
148021,KERATIN ASSOCIATED PROTEIN 5-9; KRTAP5-9,Asterisk
148022,KERATIN-ASSOCIATED PROTEIN 5-1; KRTAP5-1,Asterisk
148030,"KERATIN 15, TYPE I; KRT15",Asterisk
148040,"KERATIN 5, TYPE II; KRT5",Asterisk
148041,"KERATIN 6A, TYPE II; KRT6A",Asterisk
148042,"KERATIN 6B, TYPE II; KRT6B",Asterisk
148043,"KERATIN 3, TYPE II; KRT3",Asterisk
148050,KBG SYNDROME; KBGS,Number Sign
148059,"KERATIN 7, TYPE II; KRT7",Asterisk
148060,"KERATIN 8, TYPE II; KRT8",Asterisk
148065,"KERATIN 13, TYPE I; KRT13",Asterisk
148066,"KERATIN 14, TYPE I; KRT14",Asterisk
148067,"KERATIN 16, TYPE I; KRT16",Asterisk
148069,"KERATIN 17, TYPE I; KRT17",Asterisk
148070,"KERATIN 18, TYPE I; KRT18",Asterisk
148080,"KERATIN 10, TYPE I; KRT10",Asterisk
148100,KELOID FORMATION,Percent
148180,FIBROBLAST GROWTH FACTOR 7; FGF7,Asterisk
148181,MOVED TO 176943,Caret
148190,"KERATITIS, HEREDITARY",Number Sign
148200,KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH,Number Sign
148210,"KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT",Number Sign
148300,KERATOCONUS 1; KTCN1,Number Sign
148350,"KERATODERMA, PALMOPLANTAR, WITH DEAFNESS",Number Sign
148360,"KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY NEUROPATHY",
148370,KERATOLYTIC WINTER ERYTHEMA; KWE,Number Sign
148390,"KERATOSIS, FAMILIAL ACTINIC",
148500,TYLOSIS WITH ESOPHAGEAL CANCER; TOC,Number Sign
148520,KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY,
148600,"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A",Number Sign
148700,"PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1",Number Sign
148730,"KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL",Percent
148750,KINASE-LIKE PROTEIN G7P1; G7P1,Asterisk
148760,KINESIN FAMILY MEMBER 11; KIF11,Asterisk
148800,KLEEBLATTSCHAEDEL,
148820,"WAARDENBURG SYNDROME, TYPE 3; WS3",Number Sign
148840,KLEINE-LEVIN HIBERNATION SYNDROME,Percent
148860,MOVED TO 601076,Caret
148870,MOVED TO 118100,Caret
148900,MOVED TO 118100,Caret
149000,KLIPPEL-TRENAUNAY-WEBER SYNDROME,Percent
149100,KNUCKLE PADS,Number Sign
149200,"KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS",Number Sign
149300,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2; NDNC2",Percent
149400,HYPEREKPLEXIA 1; HKPX1,Number Sign
149500,KYRLE DISEASE,
149600,"LABIA MINORA, INCOMPLETE ADHESION OF",
149700,LACRIMAL DUCT DEFECT; LCDD,Number Sign
149730,LACRIMOAURICULODENTODIGITAL SYNDROME; LADD,Number Sign
149750,"LACTALBUMIN, ALPHA; LALBA",Asterisk
150000,LACTATE DEHYDROGENASE A; LDHA,Asterisk
150100,LACTATE DEHYDROGENASE B; LDHB,Asterisk
150150,LACTATE DEHYDROGENASE C; LDHC,Asterisk
150160,MOVED TO 150000,Caret
150170,"LACTIC ACIDOSIS, CHRONIC ADULT FORM",
150200,CHORIONIC SOMATOMAMMOTROPIN HORMONE 1; CSH1,Asterisk
150205,LACTOPEROXIDASE; LPO,Asterisk
150210,LACTOTRANSFERRIN; LTF,Asterisk
150220,MOVED TO 223000,Caret
150230,"TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2",Number Sign
150240,"LAMININ, BETA-1; LAMB1",Asterisk
150250,LARSEN SYNDROME; LRS,Number Sign
150260,LARYNGEAL ABDUCTOR PARALYSIS,Percent
150270,LARYNGEAL ADDUCTOR PARALYSIS; LAP,Percent
150280,LARYNGOMALACIA,
150290,"LAMININ, GAMMA-1; LAMC1",Asterisk
150292,"LAMININ, GAMMA-2; LAMC2",Asterisk
150300,"LARYNX, CONGENITAL PARTIAL ATRESIA OF",
150310,"LAMININ, BETA-3; LAMB3",Asterisk
150320,"LAMININ, ALPHA-1; LAMA1",Asterisk
150325,"LAMININ, BETA-2; LAMB2",Asterisk
150330,LAMIN A/C; LMNA,Asterisk
150340,LAMIN B1; LMNB1,Asterisk
150341,LAMIN B2; LMNB2,Asterisk
150360,"LARYNGEAL WEB, FAMILIAL",
150370,RIBOSOMAL PROTEIN SA; RPSA,Asterisk
150390,LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 1; LTBP1,Asterisk
150400,"TOOTH AGENESIS, SELECTIVE, 4; STHAG4",Number Sign
150500,LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT,
150550,LAZY LEUKOCYTE SYNDROME,
150570,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 1; LGALS1",Asterisk
150571,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 2; LGALS2",Asterisk
150590,"LEG ULCERS, FAMILIAL, OF JUVENILE ONSET",
150600,LEGG-CALVE-PERTHES DISEASE; LCPD,Number Sign
150699,"LEIOMYOMA, UTERINE; UL",Number Sign
150700,LEIOMYOMA OF VULVA AND ESOPHAGUS,
150800,HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC,Number Sign
150900,LENTIGINES,
151000,"LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC",
151001,"LENTIGINOSIS, INHERITED PATTERNED",Percent
151020,LENTIL AGGLUTININ BINDING,Asterisk
151050,LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD,Number Sign
151100,LEOPARD SYNDROME 1; LPRD1,Number Sign
151200,CHROMOSOME 8q22.1 DUPLICATION SYNDROME,Number Sign
151210,"PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT",Number Sign
151250,LETHAL ANTIGEN--A1; AL-A1,Asterisk
151290,"BETA-1,3-GLUCURONYLTRANSFERASE 1; B3GAT1",Asterisk
151300,LEUCYL-CYSTINYL AMINOPEPTIDASE; LNPEP,Asterisk
151310,"LEUCINE TRANSPORT, HIGH; LEUT",Asterisk
151350,LEUCYL-tRNA SYNTHETASE; LARS,Asterisk
151380,"LEUKEMIA, ACUTE MONOCYTIC",
151385,RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1,Asterisk
151390,MOVED TO 180385,Caret
151400,"LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL",Number Sign
151410,BREAKPOINT CLUSTER REGION; BCR,Asterisk
151430,B-CELL CLL/LYMPHOMA 2; BCL2,Plus
151440,LYMPHOBLASTIC LEUKEMIA-DERIVED SEQUENCE 1; LYL1,Asterisk
151441,"LEUKEMIA/LYMPHOMA, CHRONIC B-CELL, 5; BCL5",Asterisk
151442,STATHMIN 1; STMN1,Asterisk
151443,LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIFR,Asterisk
151445,"Fc FRAGMENT OF IgE, LOW AFFINITY II, RECEPTOR FOR; FCER2",Asterisk
151450,LEUKOCYTE ANTIGEN GROUP FIVE; LAG5,Asterisk
151460,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C; PTPRC",Asterisk
151465,MOVED TO 162643,Caret
151500,"LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF",
151510,"INTEGRIN, ALPHA-X; ITGAX",Asterisk
151520,LEUKOCYTE TYROSINE KINASE; LTK,Asterisk
151523,LEUKOCYTE SURFACE ANTIGEN CD37; CD37,Asterisk
151525,LEUKOCYTE SURFACE ANTIGEN CD53; CD53,Asterisk
151530,ALANYL AMINOPEPTIDASE; ANPEP,Asterisk
151540,MOVED TO 600623,Caret
151550,REMOVED FROM DATABASE,Caret
151570,LEUKOTRIENE A4 HYDROLASE; LTA4H,Asterisk
151580,MOVED TO 142360,Caret
151590,LICHEN SCLEROSUS ET ATROPHICUS; LSA,
151600,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3",Number Sign
151610,LEVATOR-MEDIAL RECTUS SYNKINESIS,
151620,"LICHEN PLANUS, FAMILIAL",
151623,LI-FRAUMENI SYNDROME; LFS,Number Sign
151625,LIGATIN; LGTN,Asterisk
151626,LINE RETROTRANSPOSABLE ELEMENT 1; LRE1,Asterisk
151627,LINKIN,Asterisk
151628,LINE RETROTRANSPOSABLE ELEMENT 2; LRE2,Asterisk
151630,"LIP, MEDIAN NODULE OF UPPER",Percent
151640,"LIP, HAMARTOMATOUS",
151660,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2",Number Sign
151670,"LIPASE, HEPATIC; LIPC",Asterisk
151675,LIPOCALIN 1; LCN1,Asterisk
151680,MOVED TO 269880,Caret
151690,ANNEXIN A1; ANXA1,Asterisk
151700,LIPOMA OF THE CONJUNCTIVA,
151710,MOVED TO 151740,Caret
151720,MOVED TO 151740,Caret
151730,MOVED TO 151740,Caret
151740,ANNEXIN A2; ANXA2,Asterisk
151750,"LIPASE, HORMONE-SENSITIVE; LIPE",Asterisk
151800,"LIPOMATOSIS, MULTIPLE SYMMETRIC; MSL",
151900,"LIPOMATOSIS, MULTIPLE",Percent
151990,LIPOPOLYSACCHARIDE-BINDING PROTEIN; LBP,Asterisk
152100,LIPOPROTEIN TYPES--Ld SYSTEM,Percent
152200,APOLIPOPROTEIN(a); LPA,Plus
152300,LIPOPROTEIN TYPES--Lt SYSTEM,
152310,TISSUE FACTOR PATHWAY INHIBITOR; TFPI,Asterisk
152390,ARACHIDONATE 5-LIPOXYGENASE; ALOX5,Asterisk
152391,ARACHIDONATE 12-OXIDOREDUCTASE; ALOX12,Asterisk
152392,ARACHIDONATE 15-LIPOXYGENASE; ALOX15,Asterisk
152400,"LIPOPROTEIN, VARIANT OF BETA",
152420,LITHIUM TRANSPORT,
152422,"LOCUS CONTROL REGION, ALPHA",Asterisk
152423,MOVED TO 192090,Caret
152424,"LOCUS CONTROL REGION, BETA",Asterisk
152425,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 1; ACSL1",Asterisk
152426,MOVED TO 152425,Caret
152427,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 2; KCNH2",Asterisk
152430,LONGEVITY 1,Percent
152445,LORICRIN; LOR,Asterisk
152450,"LOW DENSITY LIPOPROTEIN, VARIATION IN MOLECULAR WEIGHT OF",
152460,MOVED TO 137950,Caret
152550,"LUMBAR STENOSIS, FAMILIAL",
152600,LUNULAE OF FINGERNAILS,
152690,"X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 6; XRCC6",Asterisk
152700,SYSTEMIC LUPUS ERYTHEMATOSUS; SLE,Number Sign
152760,GONADOTROPIN-RELEASING HORMONE 1; GNRH1,Asterisk
152761,MOVED TO 138850,Caret
152780,"LUTEINIZING HORMONE, BETA POLYPEPTIDE; LHB",Asterisk
152790,LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; LHCGR,Asterisk
152800,"LYMPHANGIECTASIA, INTESTINAL",Percent
152900,LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY,
152950,"MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR",Number Sign
153000,MOVED TO 153400,Caret
153100,"LYMPHEDEMA, HEREDITARY, IA; LMPH1A",Number Sign
153200,"LYMPHEDEMA, HEREDITARY, II; LMPH2",Percent
153240,SELECTIN L; SELL,Asterisk
153243,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 8; TNFRSF8",Asterisk
153245,LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1,Plus
153280,"LYMPHOCYTE CYTOSOL POLYPEPTIDE, 40-KD",
153290,"LYMPHOCYTE CYTOSOL POLYPEPTIDE, 49-KD",
153300,YELLOW NAIL SYNDROME,Percent
153310,CHARCOT-LEYDEN CRYSTAL PROTEIN; CLC,Asterisk
153330,LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1; LAMP1,Asterisk
153335,MOVED TO 182284,Caret
153337,LYMPHOCYTE ACTIVATION GENE 3; LAG3,Asterisk
153340,LYMPHOCYTE ANTIGEN CD5; CD5,Asterisk
153360,MOVED TO 300257,Caret
153370,"INTEGRIN, ALPHA-L; ITGAL",Asterisk
153380,"LYMPHOCYTE CYTOSOL POLYPEPTIDE, 20-KD",Asterisk
153390,LYMPHOCYTE-SPECIFIC PROTEIN-TYROSINE KINASE; LCK,Asterisk
153400,LYMPHEDEMA-DISTICHIASIS SYNDROME,Number Sign
153420,CD58 MOLECULE; CD58,Asterisk
153430,LYMPHOCYTE CYTOSOLIC PROTEIN 1; LCP1,Asterisk
153432,LYMPHOCYTE-SPECIFIC PROTEIN;  LSP1,Asterisk
153435,LYMPHOKINE-ACTIVATED KILLER CELL LIGAND; LAKL,Asterisk
153440,LYMPHOTOXIN-ALPHA; LTA,Asterisk
153450,LYSOZYME; LYZ,Asterisk
153454,"PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PLOD1",Asterisk
153455,LYSYL OXIDASE; LOX,Asterisk
153456,LYSYL OXIDASE-LIKE 1; LOXL1,Asterisk
153460,MOVED TO 232600,Caret
153470,"MACROCEPHALY, BENIGN FAMILIAL",
153480,MOVED TO 158350,Caret
153550,CHROMOSOME 5q DELETION SYNDROME,Number Sign
153600,"MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1",Percent
153615,"CAPPING PROTEIN, GELSOLIN-LIKE; CAPG",Asterisk
153618,"MANNOSE RECEPTOR, C-TYPE, 1; MRC1",Asterisk
153619,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3; LGALS3",Asterisk
153620,MACROPHAGE MIGRATION INHIBITORY FACTOR; MIF,Asterisk
153622,MACROPHAGE SCAVENGER RECEPTOR; MSR1,Asterisk
153630,MACROGLOSSIA,Percent
153634,MACROPHAGE ANTIGEN CD68; CD68,Asterisk
153640,MOVED TO 155100,Caret
153650,MOVED TO 155100,Caret
153670,"BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2",Number Sign
153700,"MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2",Number Sign
153800,"MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2",Number Sign
153840,"MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1",Percent
153860,MOVED TO 169150,Caret
153870,"MACULAR DYSTROPHY, CONCENTRIC ANNULAR",Percent
153880,"MACULAR DYSTROPHY, DOMINANT CYSTOID; DCMD",Percent
153890,"MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE",
153900,MOVED TO 600110,Caret
154000,MOVED TO 145250,Caret
154020,"HYPOMAGNESEMIA 2, RENAL; HOMG2",Number Sign
154030,NUCLEASE-SENSITIVE ELEMENT-BINDING PROTEIN 1; NSEP1,Asterisk
154040,RD RNA-BINDING PROTEIN; RDBP,Asterisk
154045,"LENS INTRINSIC MEMBRANE PROTEIN 2, 19-KD; LIM2",Asterisk
154050,MAJOR INTRINSIC PROTEIN OF LENS FIBER; MIP,Asterisk
154100,"MALATE DEHYDROGENASE, MITOCHONDRIAL; MDH2",Asterisk
154200,"MALATE DEHYDROGENASE, SOLUBLE; MDH1",Asterisk
154230,"46,XY SEX REVERSAL 4; SRXY4",Number Sign
154235,MALE GERM CELL-ASSOCIATED KINASE; MAK,Asterisk
154250,MALIC ENZYME 1; ME1,Asterisk
154270,MALIC ENZYME 2; ME2,Asterisk
154275,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2",Percent
154276,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3",Percent
154280,SUPPRESSOR OF ANCHORAGE INDEPENDENCE 1; SAI1,Asterisk
154300,MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH,
154360,MALTASE-GLUCOAMYLASE; MGAM,Asterisk
154365,"PROTEASOME 26S SUBUNIT, ATPase, 2; PSMC2",Asterisk
154370,MAMMASTATIN,
154400,"ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1",Number Sign
154500,TREACHER COLLINS SYNDROME 1; TCS1,Number Sign
154540,"MANNOSE 6-PHOSPHATE RECEPTOR, CATION-DEPENDENT; M6PR",Asterisk
154545,"LECTIN, MANNOSE-BINDING, SOLUBLE, 2; MBL2",Asterisk
154550,MANNOSEPHOSPHATE ISOMERASE; MPI,Asterisk
154570,"MANNOSE 6-PHOSPHATE RECEPTOR RECOGNITION DEFECT, LEBANESE TYPE",Percent
154580,"MANNOSIDASE, ALPHA, CLASS 2C, MEMBER 1; MAN2C1",Asterisk
154582,"MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 1; MAN2A1",Asterisk
154600,MARCUS GUNN PHENOMENON,
154700,MARFAN SYNDROME; MFS,Number Sign
154705,MOVED TO 610380,Caret
154750,MARFANOID HYPERMOBILITY SYNDROME,
154780,MARSHALL SYNDROME; MRSHS,Number Sign
154790,PROTEASE INHIBITOR 5; PI5,Asterisk
154800,"MASTOCYTOSIS, CUTANEOUS; MASTC",Number Sign
154850,"MASTICATORY MUSCLES, HYPERTROPHY OF",
154870,MATRIX GAMMA-CARBOXYGLUTAMIC ACID; MGP,Asterisk
154950,MAX PROTEIN; MAX,Asterisk
155000,MAXILLOFACIAL DYSOSTOSIS,Percent
155050,"MAXILLONASAL DYSPLASIA, BINDER TYPE",Percent
155100,MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS,Number Sign
155120,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 11; ADAM11,Asterisk
155140,MECKEL DIVERTICULUM,
155145,"CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA",Percent
155150,MEDIAN-ULNAR NERVE COMMUNICATIONS,
155200,MEDIOSTERNAL DEPIGMENTATION LINE,
155240,"THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC",Number Sign
155250,MOVED TO 130130,Caret
155255,MEDULLOBLASTOMA; MDB,Number Sign
155310,VISCERAL MYOPATHY; VSCM,Number Sign
155350,"MEGALENCEPHALY, AUTOSOMAL DOMINANT",Percent
155500,MEGALODACTYLY,
155540,MELANOCORTIN 3 RECEPTOR; MC3R,Asterisk
155541,MELANOCORTIN 4 RECEPTOR; MC4R,Asterisk
155550,"SILVER, MOUSE, HOMOLOG OF; SILV",Asterisk
155555,MELANOCORTIN 1 RECEPTOR; MC1R,Asterisk
155600,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1",Percent
155601,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2",Number Sign
155700,"MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR",
155720,"MELANOMA, UVEAL",Number Sign
155730,"CHEMOKINE, CXC MOTIF, LIGAND 1; CXCL1",Asterisk
155735,MELANOMA ADHESION MOLECULE; MCAM,Asterisk
155740,CD63 ANTIGEN; CD63,Asterisk
155741,MOVED TO 600186,Caret
155750,MELANOMA-ASSOCIATED ANTIGEN p97; MFI2,Asterisk
155755,MELANOMA-ASTROCYTOMA SYNDROME,Number Sign
155760,AGGRECAN; ACAN,Asterisk
155770,MELANOMA TUMOR ANTIGEN GP90,
155800,MOVED TO 145250,Caret
155900,MELKERSSON-ROSENTHAL SYNDROME,Percent
155950,"MELORHEOSTOSIS, ISOLATED",Percent
155960,REMOVED FROM DATABASE,Caret
155970,MEMBRANE GLYCOPROTEIN MRC OX-2; MOX2,Asterisk
155975,MOVED TO 112205,Caret
155980,"MEMBRANOUS CRANIAL OSSIFICATION, DELAYED",Percent
156000,MENIERE DISEASE,
156100,MN1 GENE; MN1,Asterisk
156190,MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA,
156200,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1",Number Sign
156220,"MERALGIA PARAESTHETICA, FAMILIAL",
156225,"LAMININ, ALPHA-2; LAMA2",Asterisk
156230,MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE,Percent
156232,"MESOMELIC DYSPLASIA, KANTAPUTRA TYPE; MMDK",Percent
156240,"MESOTHELIOMA, MALIGNANT; MESOM",Number Sign
156250,METACHONDROMATOSIS; METCDS,Number Sign
156300,METACHROMASIA OF FIBROBLASTS,
156310,"METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASE A",
156340,MOVED TO 156360,Caret
156349,METALLOTHIONEIN 1B; MT1B,Asterisk
156350,METALLOTHIONEIN 1A; MT1A,Asterisk
156351,METALLOTHIONEIN 1E; MT1E,Asterisk
156352,METALLOTHIONEIN 1F; MT1F,Asterisk
156353,METALLOTHIONEIN 1G; MT1G,Asterisk
156354,METALLOTHIONEIN 1H; MT1H,Asterisk
156355,METALLOTHIONEIN 1I; MT1I,Asterisk
156356,METALLOTHIONEIN 1J; MT1J,Asterisk
156357,METALLOTHIONEIN 1K; MT1K,Asterisk
156358,METALLOTHIONEIN 1L; MT1L,Asterisk
156359,METALLOTHIONEIN 1X; MT1X,Asterisk
156360,METALLOTHIONEIN 2A; MT2A,Asterisk
156400,"METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE",Number Sign
156490,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 1; NME1,Asterisk
156491,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 2; NME2,Asterisk
156500,"METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS",Number Sign
156510,METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB,Number Sign
156520,"METATARSUS VARUS, TYPE I",Percent
156530,METATROPIC DYSPLASIA,Number Sign
156535,METHYL-CpG-BINDING DOMAIN PROTEIN 1; MBD1,Asterisk
156536,MOVED TO 600113,Caret
156540,METHYLTHIOADENOSINE PHOSPHORYLASE; MTAP,Asterisk
156550,KNIEST DYSPLASIA,Number Sign
156560,METHIONYL-tRNA SYNTHETASE; MARS,Asterisk
156565,N-METHYLPURINE DNA GLYCOSYLASE; MPG,Asterisk
156569,METHYLGUANINE-DNA METHYLTRANSFERASE; MGMT,Asterisk
156570,5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; MTR,Asterisk
156575,MOVED TO 600682,Caret
156580,"MICROCEPHALY, AUTOSOMAL DOMINANT",Percent
156590,MOVED TO 152950,Caret
156600,"MICROCORIA, CONGENITAL",Number Sign
156610,"SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1",Number Sign
156620,MICROCEPHALY-DEAFNESS SYNDROME,
156700,"MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES",
156790,MICROFIBRILLAR-ASSOCIATED PROTEIN 2; MFAP2,Asterisk
156810,MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD,
156830,MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL,
156845,MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF,Asterisk
156850,"MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1",Percent
156900,"MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA; MCOPCR",
157100,MOVED TO 193220,Caret
157129,MICROTUBULE-ASSOCIATED PROTEIN 1B; MAP1B,Asterisk
157130,MICROTUBULE-ASSOCIATED PROTEIN 2; MAP2,Asterisk
157132,MICROTUBULE-ASSOCIATED PROTEIN 4; MAP4,Asterisk
157140,MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT,Asterisk
157145,"MICROSEMINOPROTEIN, BETA; MSMB",Asterisk
157147,MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MTTP,Asterisk
157150,MICROSPHEROPHAKIA WITH HERNIA,
157151,MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA,
157160,MOVED TO 157140,Caret
157170,HOLOPROSENCEPHALY 2; HPE2,Number Sign
157200,MIDPHALANGEAL HAIR,
157300,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1",Percent
157400,"MILIA, MULTIPLE ERUPTIVE; MEM",Percent
157500,MOVED TO 173310,Caret
157550,MOVED TO 117000,Caret
157560,MINISATELLITE 33.6,Asterisk
157570,MINISATELLITE 33.15,Asterisk
157600,MIRROR MOVEMENTS 1; MRMV1,Number Sign
157640,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1",Number Sign
157650,MOVED TO 500002,Caret
157655,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 1; NDUFS1,Asterisk
157660,"MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP",Asterisk
157670,MOVED TO 600438,Caret
157680,CELL DIVISION CYCLE 25C; CDC25C,Asterisk
157700,MITRAL VALVE PROLAPSE 1; MVP1,Percent
157800,CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF,Number Sign
157860,MOVED TO 142860,Caret
157900,MOEBIUS SYNDROME; MBS,Percent
157910,MOVED TO 157900,Caret
157920,MOVED TO 309845,Caret
157950,"PERMANENT MOLARS, SECONDARY RETENTION OF",Percent
157960,"MOLONEY LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF; MLVI2",
157970,"PROTEASOME 26S SUBUNIT, NON-ATPase, 7; PSMD7",Asterisk
157975,MOVED TO 172411,Caret
157980,MOMO SYNDROME,
158000,MONILETHRIX; MNLIX,Number Sign
158020,MOVED TO 600182,Caret
158030,ANTIGEN DEFINED BY MONOCLONAL ANTIBODY AJ9,
158040,ANTIGEN DEFINED BY MONOCLONAL ANTIBODY T87,
158050,MONKEY RED BLOOD CELL RECEPTOR; MRBC,
158070,"SOLUTE CARRIER FAMILY 3 (ACTIVATOR OF DIBASIC AND NEUTRAL AMINO ACID TRANSPORT), MEMBER 2; SLC3A2",Asterisk
158100,MONOPHALANGY OF GREAT TOE,
158105,"CHEMOKINE, CC MOTIF, LIGAND 2; CCL2",Plus
158106,"CHEMOKINE, CC MOTIF, LIGAND 7; CCL7",Asterisk
158120,MONOCYTE DIFFERENTIATION ANTIGEN CD14; CD14,Asterisk
158130,MOVED TO 158105,Caret
158150,MOVED TO 172250,Caret
158170,CHROMOSOME 9p DELETION SYNDROME,Number Sign
158250,NONDISJUNCTION,
158270,MOTILIN; MLN,Asterisk
158280,MOTION SICKNESS,
158300,"ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7",Number Sign
158310,"MUCOEPITHELIAL DYSPLASIA, HEREDITARY",Percent
158320,MUIR-TORRE SYNDROME; MRTES,Number Sign
158330,MULLERIAN APLASIA AND HYPERANDROGENISM,Number Sign
158340,"MUCIN 1, TRANSMEMBRANE; MUC1",Asterisk
158343,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 1; ABCC1",Asterisk
158345,MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS,
158350,COWDEN SYNDROME 1; CWS1,Number Sign
158370,"MUCIN 2, INTESTINAL; MUC2",Asterisk
158371,"MUCIN 3A, INTESTINAL; MUC3A",Asterisk
158372,"MUCIN 4, TRACHEOBRONCHIAL; MUC4",Asterisk
158373,"MUCIN 5, SUBTYPES A AND C, TRACHEOBRONCHIAL; MUC5AC",Asterisk
158374,"MUCIN 6, GASTRIC; MUC6",Asterisk
158375,"MUCIN 7, SALIVARY; MUC7",Asterisk
158378,"SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 2; SLC20A2",Asterisk
158380,ECOTROPIC VIRAL INTEGRATION SITE 2A; EVI2A,Asterisk
158381,ECOTROPIC VIRAL INTEGRATION SITE 2B; EVI2B,Asterisk
158400,"MUSCLE CRAMPS, FAMILIAL",Percent
158500,"MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS",Percent
158580,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A",Number Sign
158590,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A",Number Sign
158600,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1",Number Sign
158650,"MUSCULAR ATROPHY, MALIGNANT NEUROGENIC",
158700,MOVED TO 105400,Caret
158800,"MUSCULAR DYSTROPHY, BARNES TYPE",
158810,BETHLEM MYOPATHY 1; BTHLM1,Number Sign
158900,FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1,Number Sign
158901,FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2,Number Sign
159000,MOVED TO 609200,Caret
159001,MOVED TO 181350,Caret
159050,"MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES",Percent
159100,"MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE",
159300,MUSICAL PERFECT PITCH,Percent
159350,MUTATED IN COLORECTAL CANCERS; MCC,Asterisk
159400,"MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE",
159405,V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1; MYBL1,Asterisk
159410,MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS,
159420,"MYDRIASIS, CONGENITAL",
159430,MYELIN BASIC PROTEIN; MBP,Asterisk
159440,MYELIN PROTEIN ZERO; MPZ,Asterisk
159455,MOVED TO 170715,Caret
159460,MYELIN-ASSOCIATED GLYCOPROTEIN; MAG,Asterisk
159465,MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MOG,Asterisk
159500,MYELINATED OPTIC NERVE FIBERS,
159530,MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; MPL,Asterisk
159540,LEUKEMIA-INHIBITORY FACTOR; LIF,Asterisk
159550,ATAXIA-PANCYTOPENIA SYNDROME; ATXPC,Number Sign
159552,MYELOID CELL LEUKEMIA SEQUENCE 1; MCL1,Asterisk
159553,MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN; MNDA,Asterisk
159555,LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A,Plus
159556,"MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 1; MLLT1",Asterisk
159557,"AF4/FMR2 FAMILY, MEMBER 1; AFF1",Asterisk
159558,"MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 3; MLLT3",Asterisk
159559,AFADIN; AFDN,Asterisk
159580,"MYELOPATHY, HTLV-1-ASSOCIATED; HAM",
159590,CD33 ANTIGEN; CD33,Asterisk
159595,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",Percent
159600,"MYOCLONIC EPILEPSY, HARTUNG TYPE",Percent
159700,MYOCLONUS AND ATAXIA,
159800,"MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS",
159900,"DYSTONIA 11, MYOCLONIC; DYT11",Number Sign
159950,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME,Number Sign
159970,MYOGENIC DIFFERENTIATION ANTIGEN 1; MYOD1,Asterisk
159980,MYOGENIN; MYOG,Asterisk
159990,MYOGENIC FACTOR 5; MYF5,Asterisk
159991,MYOGENIC FACTOR 6; MYF6,Asterisk
160000,MYOGLOBIN; MB,Asterisk
160010,"MYOGLOBINURIA, AUTOSOMAL DOMINANT",Percent
160100,MOVED TO 160120,Caret
160120,"EPISODIC ATAXIA, TYPE 1; EA1",Number Sign
160150,"MYOPATHY, CENTRONUCLEAR, 1; CNM1",Number Sign
160200,MOVED TO 161800,Caret
160300,"MYOPATHY, DISTAL, INFANTILE-ONSET",Percent
160500,"MYOPATHY, DISTAL, 1; MPD1",Number Sign
160550,MOVED TO 157640,Caret
160565,"MYOPATHY, TUBULAR AGGREGATE, 1; TAM1",Number Sign
160570,MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS,
160700,"MYOPIA 2, AUTOSOMAL DOMINANT; MYP2",Percent
160710,"MYOSIN, HEAVY CHAIN 6, CARDIAC MUSCLE, ALPHA; MYH6",Asterisk
160720,"MYOSIN, HEAVY CHAIN 3, SKELETAL MUSCLE, EMBRYONIC; MYH3",Asterisk
160730,"MYOSIN, HEAVY CHAIN 1, SKELETAL MUSCLE, ADULT; MYH1",Asterisk
160740,"MYOSIN, HEAVY CHAIN 2, SKELETAL MUSCLE, ADULT; MYH2",Asterisk
160741,"MYOSIN, HEAVY CHAIN 8, SKELETAL MUSCLE, PERINATAL; MYH8",Asterisk
160742,"MYOSIN, HEAVY CHAIN 4, SKELETAL MUSCLE; MYH4",Asterisk
160745,"MYOSIN, HEAVY CHAIN 11, SMOOTH MUSCLE; MYH11",Asterisk
160750,MYOSITIS,Percent
160760,"MYOSIN, HEAVY CHAIN 7, CARDIAC MUSCLE, BETA; MYH7",Asterisk
160770,"MYOSIN, LIGHT CHAIN 4, ALKALI, ATRIAL, EMBRYONIC; MYL4",Asterisk
160775,"MYOSIN, HEAVY CHAIN 9, NONMUSCLE; MYH9",Asterisk
160776,"MYOSIN, HEAVY CHAIN 10, NONMUSCLE; MYH10",Asterisk
160777,MYOSIN VA; MYO5A,Asterisk
160780,"MYOSIN, LIGHT POLYPEPTIDE 1, ALKALI, SKELETAL, FAST; MYL1",Asterisk
160781,"MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW; MYL2",Asterisk
160782,"MYOSIN, LIGHT CHAIN 5, REGULATORY; MYL5",Asterisk
160790,"MYOSIN, LIGHT CHAIN 3, ALKALI, VENTRICULAR, SKELETAL, SLOW; MYL3",Asterisk
160793,"MYOSIN-BINDING PROTEIN C, FAST TYPE; MYBPC2",Asterisk
160794,"MYOSIN-BINDING PROTEIN C, SLOW TYPE; MYBPC1",Asterisk
160795,MYOSIN-BINDING PROTEIN H; MYBPH,Asterisk
160800,"MYOTONIA CONGENITA, AUTOSOMAL DOMINANT",Number Sign
160900,MYOTONIC DYSTROPHY 1; DM1,Number Sign
160980,"CARNEY COMPLEX, TYPE 1; CNC1",Number Sign
160990,MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS,
160993,N-MYRISTOYLTRANSFERASE 1; NMT1,Asterisk
160994,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; HNRNPM,Asterisk
160995,"ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT1",Asterisk
160998,"NAD(P)H DEHYDROGENASE, QUINONE 2; NQO2",Asterisk
161000,NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME; NFJS,Number Sign
161015,NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 1; NDUFV1,Asterisk
161050,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1",Percent
161070,NAIL HIGH-SULFUR PROTEIN,
161080,NAIL LOW-SULFUR PROTEIN,
161100,"NAILBEDS, PIGMENTATION OF",
161200,NAIL-PATELLA SYNDROME; NPS,Number Sign
161400,NARCOLEPSY 1; NRCLP1,Number Sign
161470,"NASAL ALAR COLLAPSE, BILATERAL",
161480,"NASAL BONES, ABSENCE OF",
161500,"NASAL GROOVE, FAMILIAL TRANSVERSE",Percent
161530,"NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE",
161550,"NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2; NPCA2",Percent
161555,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 1; KLRC1",Asterisk
161560,INTERLEUKIN 12A; IL12A,Asterisk
161561,INTERLEUKIN 12B; IL12B,Asterisk
161565,NATURAL KILLER CELL TRIGGERING RECEPTOR; NKTR,Asterisk
161600,"NAVICULAR BONE, ACCESSORY",
161650,NEBULIN; NEB,Asterisk
161700,"NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT",
161800,NEMALINE MYOPATHY 3; NEM3,Number Sign
161900,"RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1",Percent
161950,"IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1",Percent
162000,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1",Number Sign
162010,NERVE GROWTH FACTOR RECEPTOR; NGFR,Asterisk
162020,"NERVE GROWTH FACTOR, ALPHA SUBUNIT; NGFA",
162030,NERVE GROWTH FACTOR; NGF,Asterisk
162040,MOVED TO 147960,Caret
162060,GROWTH-ASSOCIATED PROTEIN 43; GAP43,Asterisk
162080,NEURAL RETINA LEUCINE ZIPPER; NRL,Asterisk
162091,SCHWANNOMATOSIS 1; SWNTS1,Number Sign
162095,PLEIOTROPHIN; PTN,Asterisk
162096,MIDKINE; MDK,Asterisk
162100,"AMYOTROPHY, HEREDITARY NEURALGIC; HNA",Number Sign
162150,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1; PCSK1",Asterisk
162151,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 2; PCSK2",Asterisk
162200,"NEUROFIBROMATOSIS, TYPE I; NF1",Number Sign
162210,"NEUROFIBROMATOSIS, FAMILIAL SPINAL",Number Sign
162220,MOVED TO 162200 AND 606764,Caret
162230,"NEUROFILAMENT PROTEIN, HEAVY POLYPEPTIDE; NEFH",Asterisk
162240,NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME,
162250,"NEUROFILAMENT PROTEIN, MEDIUM POLYPEPTIDE; NEFM",Asterisk
162260,"NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL; NF3A",
162270,"NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI; NF4",
162280,"NEUROFILAMENT PROTEIN, LIGHT POLYPEPTIDE; NEFL",Asterisk
162300,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B",Number Sign
162320,TACHYKININ 1; TAC1,Asterisk
162321,TACHYKININ RECEPTOR 2; TACR2,Asterisk
162323,TACHYKININ RECEPTOR 1; TACR1,Asterisk
162330,TACHYKININ 3; TAC3,Asterisk
162332,TACHYKININ RECEPTOR 3; TACR3,Asterisk
162340,NEUROMEDIN B; NMB,Asterisk
162341,NEUROMEDIN B RECEPTOR; NMBR,Asterisk
162350,"CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B",Number Sign
162360,NESCIENT HELIX LOOP HELIX 1; NHLH1,Asterisk
162361,NESCIENT HELIX LOOP HELIX 2; NHLH2,Asterisk
162370,"NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX",Percent
162375,MOVED TO 118200,Caret
162380,"NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE",
162400,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A",Number Sign
162500,"NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP",Number Sign
162600,"NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE",
162640,NEUROPEPTIDE Y; NPY,Asterisk
162641,NEUROPEPTIDE Y RECEPTOR Y1; NPY1R,Asterisk
162642,NEUROPEPTIDE Y RECEPTOR Y2; NPY2R,Asterisk
162643,"CHEMOKINE, CXC MOTIF, RECEPTOR 4; CXCR4",Asterisk
162650,NEUROTENSIN; NTS,Asterisk
162651,NEUROTENSIN RECEPTOR 1; NTSR1,Asterisk
162660,NEUROTROPHIN 3; NTF3,Asterisk
162661,MOVED TO 162662,Caret
162662,NEUROTROPHIN 4; NTF4,Asterisk
162700,"NEUTROPENIA, CHRONIC FAMILIAL",Percent
162800,CYCLIC NEUTROPENIA,Number Sign
162815,NEUTROPHIL AZUROCIDIN; NAZC,Asterisk
162820,NEUTROPHIL MIGRATION; NM,Percent
162830,"NEUTROPHILIA, HEREDITARY",Number Sign
162860,CD177 ANTIGEN; CD177,Asterisk
162870,MOVED TO 146740,Caret
162880,NEUTROPHIL-SPECIFIC ANTIGEN: ND1,Asterisk
162890,NEUTROPHIL-SPECIFIC ANTIGEN: NE1,Asterisk
162900,"NEVUS, EPIDERMAL",Number Sign
163000,"CAPILLARY MALFORMATIONS, CONGENITAL; CMC",Number Sign
163050,NEVUS ANEMICUS,
163100,NEVUS FLAMMEUS OF NAPE OF NECK,Percent
163200,SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM,Number Sign
163260,NUCLEAR FACTOR ERYTHROID 2-LIKE 1; NFE2L1,Asterisk
163400,NIEVERGELT SYNDROME,Percent
163500,"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2",Number Sign
163600,NIPPLES INVERTED,
163700,"NIPPLES, SUPERNUMERARY",Percent
163728,MOVED TO 163730,Caret
163729,NITRIC OXIDE SYNTHASE 3; NOS3,Plus
163730,NITRIC OXIDE SYNTHASE 2A; NOS2A,Asterisk
163731,NITRIC OXIDE SYNTHASE 1; NOS1,Asterisk
163800,SICK SINUS SYNDROME 2; SSS2,Number Sign
163850,"NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES",
163890,"SYNUCLEIN, ALPHA; SNCA",Asterisk
163900,REMOVED FROM DATABASE,Caret
163905,HIGH MOBILITY GROUP BOX 1; HMGB1,Asterisk
163906,HIGH MOBILITY GROUP BOX 2; HMGB2,Asterisk
163910,HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 2; HMGN2,Asterisk
163920,HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 1; HMGN1,Asterisk
163950,NOONAN SYNDROME 1; NS1,Number Sign
163955,MOVED TO 163950 AND 610733,Caret
163970,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, NORADRENALINE), MEMBER 2; SLC6A2",Asterisk
163980,CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 6; CEACAM6,Asterisk
164000,"NOSE, ANOMALOUS SHAPE OF",
164005,NUCLEAR FACTOR I/X; NFIX,Asterisk
164008,"NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, ALPHA; NFKBIA",Asterisk
164009,NUCLEAR MITOTIC APPARATUS PROTEIN 1; NUMA1,Asterisk
164010,"CHMP FAMILY, MEMBER 1A; CHMP1A",Asterisk
164011,"NUCLEAR FACTOR KAPPA-B, SUBUNIT 1; NFKB1",Asterisk
164012,"NUCLEAR FACTOR KAPPA-B, SUBUNIT 2; NFKB2",Asterisk
164013,NUCLEAR FACTOR RELATED TO KAPPA-B BINDING PROTEIN; NFRKB,Asterisk
164014,V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG A; RELA,Asterisk
164015,MATRIN 3; MATR3,Asterisk
164016,MOVED TO 600489,Caret
164017,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HNRNPA1,Asterisk
164018,MOVED TO 600124,Caret
164019,MOVED TO 600124,Caret
164020,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HNRNPC,Asterisk
164021,NUCLEAR RIBONUCLEOPROTEIN PARTICLE L PROTEIN,Asterisk
164022,MOVED TO 300199,Caret
164031,NUCLEOLAR PROTEIN 1; NOL1,Asterisk
164035,NUCLEOLIN; NCL,Asterisk
164040,"NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 1; NPM1",Asterisk
164050,PURINE NUCLEOSIDE PHOSPHORYLASE; PNP,Asterisk
164060,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 1; NAP1L1,Asterisk
164100,"NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2",Percent
164150,"NYSTAGMUS, HEREDITARY VERTICAL",Percent
164160,LEPTIN; LEP,Asterisk
164170,"NYSTAGMUS, VOLUNTARY",Percent
164175,"POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 1; POU2F1",Asterisk
164176,"POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 2; POU2F2",Asterisk
164177,"POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1; POU5F1",Asterisk
164180,OCULOCEREBROCUTANEOUS SYNDROME,
164185,OCULAR CICATRICIAL PEMPHIGOID; OCP,
164190,OCULAR DOMINANCE,
164200,OCULODENTODIGITAL DYSPLASIA; ODDD,Number Sign
164210,HEMIFACIAL MICROSOMIA; HFM,Percent
164220,SCHILBACH-ROTT SYNDROME,Percent
164230,OBSESSIVE-COMPULSIVE DISORDER; OCD,Number Sign
164280,FEINGOLD SYNDROME 1; FGLDS1,Number Sign
164300,OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD,Number Sign
164310,OCULOPHARYNGODISTAL MYOPATHY; OPDM,Percent
164320,ODORANT-BINDING PROTEIN 2A; OBP2A,Asterisk
164330,ODONTOMA-DYSPHAGIA SYNDROME,
164340,OLFACTORY MARKER PROTEIN; OMP,Asterisk
164342,"OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY D, MEMBER 2; OR1D2",Asterisk
164343,EARLY B-CELL FACTOR 1; EBF1,Asterisk
164345,OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; OMG,Asterisk
164350,"2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 1; OAS1",Asterisk
164360,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, ALPHA SUBUNIT 1; ATP5F1A",Asterisk
164400,SPINOCEREBELLAR ATAXIA 1; SCA1,Number Sign
164500,SPINOCEREBELLAR ATAXIA 7; SCA7,Number Sign
164600,MOVED TO 164400,Caret
164680,"ONYCHOGRYPOSIS, PEDAL, WITH KERATOSIS PLANTARIS AND COARSE HAIR",
164690,V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ABL2,Asterisk
164700,OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V,
164710,REMOVED FROM DATABASE,Caret
164720,V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 1; ETS1,Asterisk
164730,V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1,Asterisk
164731,V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 2; AKT2,Asterisk
164740,V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 2; ETS2,Asterisk
164745,OMODYSPLASIA 2; OMOD2,Percent
164750,"OMPHALOCELE, AUTOSOMAL",Number Sign
164755,VIRAL INTEGRATION SITE 1; VIS1,Asterisk
164756,MOVED TO 164755,Caret
164757,V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1; BRAF,Asterisk
164759,MOVED TO 167000,Caret
164760,V-RAF-1 MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; RAF1,Asterisk
164761,REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET,Asterisk
164762,V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG; CRK,Asterisk
164765,CORTACTIN; CTTN,Asterisk
164770,COLONY-STIMULATING FACTOR 1 RECEPTOR; CSF1R,Asterisk
164772,V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG B; FOSB,Asterisk
164780,V-SKI AVIAN SARCOMA VIRAL ONCOGENE HOMOLOG; SKI,Asterisk
164785,MOUSE DOUBLE MINUTE 2 HOMOLOG; MDM2,Asterisk
164790,NEUROBLASTOMA RAS VIRAL ONCOGENE HOMOLOG; NRAS,Asterisk
164795,ONCOMODULIN; OCM,Asterisk
164800,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5",Percent
164810,V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG; FOS,Asterisk
164820,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 1; WNT1",Asterisk
164830,REMOVED FROM DATABASE,Caret
164831,"LEUKEMIA VIRAL BMI-1 ONCOGENE, MOUSE, HOMOLOG OF; BMI1",Asterisk
164840,"V-MYC AVIAN MYELOCYTOMATOSIS VIRAL-RELATED ONCOGENE, NEUROBLASTOMA-DERIVED; MYCN",Asterisk
164850,"V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG, LUNG CARCINOMA-DERIVED; MYCL",Asterisk
164860,MET PROTOONCOGENE; MET,Asterisk
164865,V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1; MYCLK1,Asterisk
164870,V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ERBB2,Asterisk
164873,ETS VARIANT GENE 3; ETV3,Asterisk
164874,FORKHEAD BOX G1; FOXG1,Asterisk
164875,VAV1 ONCOGENE; VAV1,Asterisk
164880,V-YES-1 YAMAGUCHI SARCOMA VIRAL ONCOGENE; YES1,Asterisk
164891,MOVED TO 164757,Caret
164900,OPHTHALMOMANDIBULOMELIC DYSPLASIA,Percent
164905,MOVED TO 600326,Caret
164910,V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG; REL,Asterisk
164920,V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; KIT,Asterisk
164940,GARDNER-RASHEED FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; FGR,Asterisk
164950,FIBROBLAST GROWTH FACTOR 3; FGF3,Asterisk
164951,"NOTCH, DROSOPHILA, HOMOLOG OF, 4; NOTCH4",Asterisk
164953,ONCOGENE LIPOSARCOMA; LPSA,Asterisk
164958,NEPHROBLASTOMA OVEREXPRESSED GENE; NOV,Asterisk
164960,ONCOGENE PIM 1; PIM1,Asterisk
164970,MOVED TO 191315 AND 191030,Caret
164975,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5A; WNT5A",Asterisk
164980,FIBROBLAST GROWTH FACTOR 4; FGF4,Asterisk
165000,"OPHTHALMOPLEGIA, FAMILIAL STATIC",Percent
165010,MOVED TO 164710,Caret
165020,V-ROS AVIAN UR2 SARCOMA VIRUS ONCOGENE HOMOLOG 1; ROS1,Asterisk
165040,RAS-ASSOCIATED PROTEIN RAB8A; RAB8A,Asterisk
165060,TRANSFER RNA SELENOCYSTEINE 1; TRNAU1,Asterisk
165070,FMS-RELATED TYROSINE KINASE 1; FLT1,Asterisk
165080,V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG; ERG,Asterisk
165090,RELATED RAS VIRAL ONCOGENE HOMOLOG; RRAS,Asterisk
165095,ONCOSTATIN M; OSM,Asterisk
165098,"OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION",
165110,S13 AVIAN ERYTHROBLASTOSIS ONCOGENE HOMOLOG; SEA,Asterisk
165120,V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG; LYN,Asterisk
165140,ONCOGENE PVT1; PVT1,Asterisk
165150,"OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY",
165160,V-JUN AVIAN SARCOMA VIRUS 17 ONCOGENE HOMOLOG; JUN,Asterisk
165161,ONCOGENE JUN-B; JUNB,Asterisk
165162,ONCOGENE JUN-D; JUND,Asterisk
165170,SPLEEN FOCUS FORMING VIRUS PROVIRAL INTEGRATION ONCOGENE SPI1; SPI1,Asterisk
165180,MAS1 ONCOGENE; MAS1,Asterisk
165190,FIBROBLAST GROWTH FACTOR 5; FGF5,Asterisk
165195,"OPIOID RECEPTOR, DELTA-1; OPRD1",Asterisk
165196,"OPIOID RECEPTOR, KAPPA-1; OPRK1",Asterisk
165199,"OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL DOMINANT",
165200,OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS,
165210,ONCOGENE BMYC; BMYC,
165215,MDS1 AND EVI1 COMPLEX LOCUS; MECOM,Asterisk
165220,GLIOMA-ASSOCIATED ONCOGENE HOMOLOG; GLI1,Asterisk
165230,GLI-KRUPPEL FAMILY MEMBER 2; GLI2,Asterisk
165240,GLI-KRUPPEL FAMILY MEMBER 3; GLI3,Asterisk
165250,GLI-KRUPPEL FAMILY MEMBER HKR1; HKR1,Asterisk
165260,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 22; ZSCAN22,Asterisk
165270,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 48; ZBTB48,Asterisk
165280,GLI-KRUPPEL FAMILY MEMBER 4; GLI4,Asterisk
165290,ONCOGENE RMYC; RMYC,
165300,"OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3",Number Sign
165320,LIVER CANCER ONCOGENE; LCO,Asterisk
165330,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3; WNT3",Asterisk
165340,SKI-LIKE; SKIL,Asterisk
165350,MOVED TO 311040,Caret
165360,CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE HOMOLOG; CBL,Asterisk
165370,"RAS HOMOLOG GENE FAMILY, MEMBER B; RHOB",Asterisk
165380,"RAS HOMOLOG GENE FAMILY, MEMBER C; RHOC",Asterisk
165390,"RAS HOMOLOG GENE FAMILY, MEMBER A; RHOA",Asterisk
165490,MOVED TO 165500,Caret
165500,OPTIC ATROPHY 1; OPA1,Number Sign
165510,OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS,
165550,"OPTIC NERVE HYPOPLASIA, BILATERAL",Number Sign
165590,OROFACIODIGITAL SYNDROME X; OFD10,
165600,"ORBITAL MARGIN, HYPOPLASIA OF",
165630,MOVED TO 163200,Caret
165635,MOVED TO 258870,Caret
165640,ORNITHINE DECARBOXYLASE 1; ODC1,Asterisk
165650,MOVED TO 165640,Caret
165660,OSLAM SYNDROME,Percent
165670,OSSIFIED EAR CARTILAGES,
165680,"OSSICULAR MALFORMATIONS, FAMILIAL",
165700,THIEMANN DISEASE,Percent
165720,OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1,Number Sign
165800,"SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD",Number Sign
166000,"ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE",Percent
166200,"OSTEOGENESIS IMPERFECTA, TYPE I; OI1",Number Sign
166210,"OSTEOGENESIS IMPERFECTA, TYPE II; OI2",Number Sign
166220,"OSTEOGENESIS IMPERFECTA, TYPE IV; OI4",Number Sign
166230,"OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES",
166240,MOVED TO 166200,Caret
166250,OSTEOGLOPHONIC DYSPLASIA; OGD,Number Sign
166260,GNATHODIAPHYSEAL DYSPLASIA; GDD,Number Sign
166300,MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO,Number Sign
166350,"OSSEOUS HETEROPLASIA, PROGRESSIVE; POH",Number Sign
166400,OSTEOMAS OF MANDIBLE,
166450,OSTEOMESOPYKNOSIS,
166490,SECRETED PHOSPHOPROTEIN 1; SPP1,Asterisk
166500,MOVED TO 300373,Caret
166600,"OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2",Number Sign
166700,BUSCHKE-OLLENDORFF SYNDROME; BOS,Number Sign
166705,OSTEOPOIKILOSIS AND DACRYOCYSTITIS,
166710,OSTEOPOROSIS,Number Sign
166720,MOVED TO 130720,Caret
166740,OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES,
166750,OTODENTAL DYSPLASIA,Number Sign
166760,"OTITIS MEDIA, SUSCEPTIBILITY TO; OMS",Number Sign
166780,OTOFACIOCERVICAL SYNDROME 1; OTFCS,Number Sign
166800,OTOSCLEROSIS 1; OTSC1,Percent
166900,"OVALOCYTOSIS, SOUTHEAST ASIAN; SAO",Number Sign
166910,"OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS",
166945,NEIGHBOR OF BRCA1 GENE 1; NBR1,Asterisk
166950,"TERATOMA, OVARIAN",
166970,OVARIAN FIBROMATA,
166990,"OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA, HYDROCEPHALUS, AND HYPERTENSION",
167000,OVARIAN CANCER,Number Sign
167030,"NEPHROLITHIASIS, CALCIUM OXALATE; CAON",Number Sign
167040,OXYSTEROL-BINDING PROTEIN; OSBP,Asterisk
167050,OXYTOCIN; OXT,Asterisk
167055,OXYTOCIN RECEPTOR; OXTR,Asterisk
167100,"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD",Percent
167200,PACHYONYCHIA CONGENITA 1; PC1,Number Sign
167210,PACHYONYCHIA CONGENITA 2; PC2,Number Sign
167220,PACMAN DYSPLASIA,
167250,PAGET DISEASE OF BONE 3; PDB3,Number Sign
167300,"PAGET DISEASE, EXTRAMAMMARY",
167320,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1,Number Sign
167400,PAROXYSMAL EXTREME PAIN DISORDER,Number Sign
167405,PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 6; PCSK6,Asterisk
167409,PAIRED BOX GENE 2; PAX2,Asterisk
167410,PAIRED BOX GENE 7; PAX7,Asterisk
167411,PAIRED BOX GENE 1; PAX1,Asterisk
167413,PAIRED BOX GENE 4; PAX4,Asterisk
167414,PAIRED BOX GENE 5; PAX5,Asterisk
167415,PAIRED BOX GENE 8; PAX8,Asterisk
167416,PAIRED BOX GENE 9; PAX9,Asterisk
167420,PAIRED-RELATED HOMEOBOX GENE 1; PRRX1,Asterisk
167500,PALATOPHARYNGEAL INCOMPETENCE,Percent
167600,"PALMARIS LONGUS MUSCLE, ABSENCE OF",
167700,PALMOMENTAL REFLEX,
167730,NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS,Percent
167750,"PANCREAS, ANNULAR",
167755,"PANCREAS, DORSAL, AGENESIS OF",
167770,REGENERATING ISLET-DERIVED 1-ALPHA; REG1A,Asterisk
167771,REGENERATING ISLET-DERIVED 1-BETA; REG1B,Asterisk
167780,PANCREATIC POLYPEPTIDE/PANCREATIC ICOSAPEPTIDE; PPY,Asterisk
167790,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 1; SPINK1",Asterisk
167800,"PANCREATITIS, HEREDITARY; PCTT",Number Sign
167805,REGENERATING ISLET-DERIVED 3-ALPHA; REG3A,Asterisk
167850,PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE,
167870,PANIC DISORDER 1; PAND1,Percent
167900,"PAPILLOMATOSIS, CONFLUENT AND RETICULATED; CARP",Percent
167950,"PAPILLOMATOSIS, FLORID, OF NIPPLE",
167959,HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1; HPV18I1,
167960,HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2; HPV18I2,
168000,PARAGANGLIOMAS 1; PGL1,Number Sign
168100,"PARALYSIS AGITANS, JUVENILE, OF HUNT",
168200,PARAMOLAR TUBERCLE OF BOLK,
168300,PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC,Number Sign
168350,MOVED TO 168300,Caret
168360,"EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 4; ELAVL4",Asterisk
168400,PARASTREMMATIC DWARFISM,Number Sign
168440,PARATHYMOSIN; PTMS,Asterisk
168450,PARATHYROID HORMONE; PTH,Asterisk
168460,MOVED TO 145001,Caret
168461,CYCLIN D1; CCND1,Asterisk
168468,PARATHYROID HORMONE 1 RECEPTOR; PTH1R,Asterisk
168470,PARATHYROID HORMONE-LIKE HORMONE; PTHLH,Asterisk
168500,PARIETAL FORAMINA 1; PFM1,Number Sign
168550,PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD,Number Sign
168600,"PARKINSON DISEASE, LATE-ONSET; PD",Number Sign
168601,"PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1",Number Sign
168605,PERRY SYNDROME,Number Sign
168610,MOVED TO 600274,Caret
168710,PAROTID PROLINE-RICH SALIVARY PROTEIN Pc,
168730,"PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 1; PRH1",Asterisk
168790,"PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 2; PRH2",Asterisk
168800,"PAROTIDOMEGALY, HEREDITARY BILATERAL",
168810,"PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 2; PRB2",Asterisk
168820,PARAOXONASE 1; PON1,Plus
168830,PASSOVOY FACTOR DEFECT,
168840,"PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 3; PRB3",Asterisk
168850,MOVED TO 147891,Caret
168860,PATELLA APLASIA-HYPOPLASIA; PTLAH,Percent
168885,"PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA",
168890,PARVALBUMIN; PVALB,Asterisk
168900,"PATELLA, CHONDROMALACIA OF",Percent
169000,"PATELLA, FAMILIAL RECURRENT DISLOCATION OF",Percent
169100,CHAR SYNDROME; CHAR,Number Sign
169150,"MACULAR DYSTROPHY, PATTERNED, 1; MDPT1",Number Sign
169170,PATTERSON PSEUDOLEPRECHAUNISM SYNDROME,
169190,CYCLIN-DEPENDENT KINASE 18; CDK18,Asterisk
169200,PECHET FACTOR DEFICIENCY,
169300,PECTUS EXCAVATUM,
169400,PELGER-HUET ANOMALY; PHA,Number Sign
169500,"LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD",Number Sign
169545,PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA,Percent
169550,PELVIS-SHOULDER DYSPLASIA,
169600,BENIGN CHRONIC PEMPHIGUS; BCPM,Number Sign
169610,"PEMPHIGUS VULGARIS, FAMILIAL",
169615,DESMOGLEIN 3; DSG3,Asterisk
169700,PEPSINOGEN; PG,Asterisk
169710,"PEPSINOGEN 3, GROUP I; PGA3",
169720,"PEPSINOGEN 4, GROUP I; PGA4",Asterisk
169730,"PEPSINOGEN 5, GROUP I; PGA5",Asterisk
169740,PROGASTRICSIN; PGC,Asterisk
169800,PEPTIDASE A; PEPA,Asterisk
169900,PEPTIDASE B; PEPB,Asterisk
170000,PEPTIDASE C; PEPC,Asterisk
170100,PROLIDASE DEFICIENCY,Number Sign
170200,PEPTIDASE E; PEPE,Asterisk
170250,LEUCINE AMINOPEPTIDASE 3; LAP3,Asterisk
170260,"TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 1; TAP1",Asterisk
170261,"TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 2; TAP2",Asterisk
170270,PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE; PAM,Asterisk
170280,PERFORIN 1; PRF1,Asterisk
170285,"NUCLEOPORIN, 85-KD; NUP85",Asterisk
170290,PERILIPIN 1; PLIN1,Asterisk
170300,MOVED TO 142680,Caret
170390,ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS,Number Sign
170400,"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1",Number Sign
170500,HYPERKALEMIC PERIODIC PARALYSIS; HYPP,Number Sign
170600,NORMOKALEMIC PERIODIC PARALYSIS,
170650,"PERIODONTITIS, AGGRESSIVE, 1",Number Sign
170700,PERIPHERAL DYSOSTOSIS,
170710,PERIPHERIN; PRPH,Asterisk
170715,PERIPHERAL MYELIN PROTEIN 2; PMP2,Asterisk
170900,PERNICIOUS ANEMIA,
170950,REMOVED FROM DATABASE,Caret
170980,"PERONEAL NERVE, ACCESSORY DEEP",
170990,"PEROXIDASE, SALIVARY; SAPX",
170993,PEROXISOME BIOGENESIS FACTOR 2; PEX2,Asterisk
170995,"ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 3; ABCD3",Asterisk
170998,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA,Plus
171000,PEYRONIE DISEASE,Percent
171050,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1",Asterisk
171060,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 4; ABCB4",Asterisk
171100,"PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN",
171150,"SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 1; SULT1A1",Asterisk
171190,PHENYLETHANOLAMINE N-METHYLTRANSFERASE; PNMT,Asterisk
171200,THIOUREA TASTING; THIOT,Number Sign
171300,PHEOCHROMOCYTOMA,Number Sign
171350,MOVED TO 115310,Caret
171400,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A",Number Sign
171420,PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME,
171450,PHLEBECTASIA OF LIPS,
171480,"PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA",
171490,PHOSDUCIN; PDC,Asterisk
171500,"ACID PHOSPHATASE 1, SOLUBLE; ACP1",Asterisk
171640,"PHOSPHATASE, ACID, TYPE 5, TARTRATE-RESISTANT; ACP5",Asterisk
171650,"ACID PHOSPHATASE 2, LYSOSOMAL; ACP2",Asterisk
171660,"PHOSPHATASE, ACID, OF TISSUES",
171700,REMOVED FROM DATABASE,Caret
171720,"ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",Percent
171740,"ALKALINE PHOSPHATASE, INTESTINAL; ALPI",Asterisk
171750,"ALKALINE PHOSPHATASE, INTESTINAL, FETAL FORM",Asterisk
171760,"ALKALINE PHOSPHATASE, LIVER; ALPL",Asterisk
171790,"PHOSPHATASE, PROSTATE-SPECIFIC ACID; ACPP",Asterisk
171800,"ALKALINE PHOSPHATASE, PLACENTAL; ALPP",Asterisk
171810,"ALKALINE PHOSPHATASE, PLACENTAL-LIKE 2; ALPPL2",Asterisk
171820,"PHOSPHATASE, SALIVARY ACID, A; SACP; ACPS",Asterisk
171830,"PHOSPHATASE, SALIVARY ACID, B",Asterisk
171833,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 1; PIK3R1",Asterisk
171834,"PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA; PIK3CA",Asterisk
171835,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2; PFKFB2",Asterisk
171840,"PHOSPHOFRUCTOKINASE, PLATELET TYPE; PFKP",Asterisk
171850,MOVED TO 171860 AND 610681,Caret
171860,"PHOSPHOFRUCTOKINASE, LIVER TYPE; PFKL",Asterisk
171880,MOVED TO 610681,Caret
171885,"PHOSPHODIESTERASE 7A, cAMP-SPECIFIC, HIGH AFFINITY; PDE7A",Asterisk
171890,PHOSPHODIESTERASE 1A; PDE1A,Asterisk
171891,PHOSPHODIESTERASE 1B; PDE1B,Asterisk
171900,PHOSPHOGLUCOMUTASE 1; PGM1,Asterisk
172000,PHOSPHOGLUCOMUTASE 2; PGM2,Asterisk
172100,PHOSPHOGLUCOMUTASE 3; PGM3,Asterisk
172110,PHOSPHOGLUCOMUTASE 4,
172150,6-PHOSPHOGLUCONOLACTONASE DEFICIENCY,Percent
172200,"6-PHOSPHOGLUCONATE DEHYDROGENASE, ERYTHROCYTE; PGD",Asterisk
172250,PHOSPHOGLYCERATE MUTASE 1; PGAM1,Asterisk
172270,PHOSPHOGLYCERATE KINASE 2; PGK2,Asterisk
172280,PHOSPHOGLYCOLATE PHOSPHATASE; PGP,Asterisk
172290,PHOSPHOGLYCOPROTEIN 1; PGP1,
172300,MOVED TO 171860,Caret
172400,GLUCOSE-6-PHOSPHATE ISOMERASE; GPI,Asterisk
172405,PHOSPHOLAMBAN; PLN,Asterisk
172410,"PHOSPHOLIPASE A2, GROUP IB; PLA2G1B",Asterisk
172411,"PHOSPHOLIPASE A2, GROUP IIA; PLA2G2A",Asterisk
172420,"PHOSPHOLIPASE C, GAMMA-1; PLCG1",Asterisk
172425,PHOSPHOLIPID TRANSFER PROTEIN; PLTP,Plus
172430,ENOLASE 1; ENO1,Asterisk
172439,PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE; PAICS,Asterisk
172450,PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; PPAT,Asterisk
172460,METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1; MTHFD1,Asterisk
172470,"PHOSPHORYLASE KINASE, MUSCLE, GAMMA-1; PHKG1",Asterisk
172471,"PHOSPHORYLASE KINASE, TESTIS/LIVER, GAMMA-2; PHKG2",Asterisk
172480,PHOSPHOSERINE PHOSPHATASE; PSPH,Asterisk
172490,"PHOSPHORYLASE KINASE, BETA SUBUNIT; PHKB",Asterisk
172500,"PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRAL DYSFUNCTION",
172700,PICK DISEASE OF BRAIN,Number Sign
172800,PIEBALD TRAIT; PBT,Number Sign
172850,PIEBALD TRAIT WITH NEUROLOGIC DEFECTS,
172860,"SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 1; SERPINF1",Asterisk
172870,PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA,Number Sign
172880,PIERRE ROBIN SYNDROME AND OLIGODACTYLY,
172900,PIGMENTED PURPURIC ERUPTION,Percent
173000,PILONIDAL SINUS,
173100,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2",Number Sign
173110,"POU DOMAIN, CLASS 1, TRANSCRIPTION FACTOR 1; POU1F1",Asterisk
173120,SECRETORY GRANULE NEUROENDOCRINE PROTEIN 1; SGNE1,Asterisk
173200,PITYRIASIS RUBRA PILARIS; PRP,Number Sign
173310,PROGESTAGEN-ASSOCIATED ENDOMETRIAL PROTEIN; PAEP,Asterisk
173320,RIBONUCLEASE/ANGIOGENIN INHIBITOR 1; RNH1,Asterisk
173321,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 6; SERPINB6",Asterisk
173325,JUNCTION PLAKOGLOBIN; JUP,Asterisk
173335,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1; ENPP1,Asterisk
173340,PLASMINOGEN-LIKE B1; PLGLB1,Asterisk
173350,PLASMINOGEN; PLG,Asterisk
173360,"SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 1; SERPINE1",Asterisk
173370,"PLASMINOGEN ACTIVATOR, TISSUE; PLAT",Asterisk
173390,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 2; SERPINB2",Asterisk
173391,"PLASMINOGEN ACTIVATOR RECEPTOR, UROKINASE-TYPE; PLAUR",Asterisk
173393,PLATELET-ACTIVATING FACTOR RECEPTOR; PTAFR,Asterisk
173395,PLATELET ADENYLATE CYCLASE ACTIVITY,
173400,"PLATELET AGGREGATION, SPONTANEOUS",
173410,"PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA; PDGFRB",Asterisk
173420,"PLATELET DISORDER, UNDEFINED",
173430,"PLATELET-DERIVED GROWTH FACTOR, ALPHA POLYPEPTIDE; PDGFA",Asterisk
173445,PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE 1; PECAM1,Asterisk
173450,PLATELET FACTOR 3 DEFICIENCY,
173460,PLATELET FACTOR 4; PF4,Asterisk
173461,"PLATELET FACTOR 4, VARIANT 1; PF4V1",Asterisk
173470,"INTEGRIN, BETA-3; ITGB3",Asterisk
173490,"PLATELET-DERIVED GROWTH FACTOR RECEPTOR, ALPHA; PDGFRA",Asterisk
173500,PLATELET GROUPS--Ko SYSTEM; HPA-2,Percent
173510,CD36 ANTIGEN; CD36,Asterisk
173511,"GLYCOPROTEIN V, PLATELET; GP5",Asterisk
173515,"GLYCOPROTEIN IX, PLATELET; GP9",Asterisk
173540,PLATELET GROUPS--Pl(E) SYSTEM,Percent
173560,PLATELET MEMBRANE FLUIDITY; PMF,
173570,PLECKSTRIN; PLEK,Asterisk
173580,"PLATELET RESPONSIVENESS TO ADRENALINE, DEPRESSED",
173590,PLATELET SIGNAL PROCESSING DEFECT,
173600,"PNEUMOTHORAX, PRIMARY SPONTANEOUS",Number Sign
173610,SELECTIN P; SELP,Asterisk
173650,KINDLER SYNDROME; KNDLRS,Number Sign
173700,"POIKILODERMA, HEREDITARY SCLEROSING",
173750,MOVED TO 173800 AND 157900,Caret
173800,POLAND SYNDROME,Percent
173850,POLIOVIRUS RECEPTOR; PVR,Asterisk
173865,MOVED TO 604680,Caret
173870,POLY(ADP-RIBOSE) POLYMERASE 1; PARP1,Asterisk
173871,MOVED TO 173870,Caret
173880,POLYMERIC IMMUNOGLOBULIN RECEPTOR; PIGR,Asterisk
173900,POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD1,Number Sign
173910,POLYCYSTIN 2; PKD2,Asterisk
174000,MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1,Number Sign
174050,POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1,Number Sign
174100,MOVED TO 192350,Caret
174200,"POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1",Number Sign
174300,OROFACIODIGITAL SYNDROME V; OFD5,Number Sign
174310,"POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA",
174400,"POLYDACTYLY, PREAXIAL I",Percent
174500,"POLYDACTYLY, PREAXIAL II; PPD2",Number Sign
174600,"POLYDACTYLY, PREAXIAL III",Percent
174700,"POLYDACTYLY, PREAXIAL IV",Number Sign
174750,POLYKARYOCYTOSIS INDUCER; FUSE,
174760,"POLYMERASE, DNA, BETA; POLB",Asterisk
174761,"POLYMERASE (DNA-DIRECTED), DELTA 1, CATALYTIC SUBUNIT; POLD1",Asterisk
174762,"POLYMERASE, DNA, EPSILON; POLE",Asterisk
174763,"POLYMERASE, DNA, GAMMA; POLG",Asterisk
174770,ACTINIC PRURIGO,Percent
174800,MCCUNE-ALBRIGHT SYNDROME; MAS,Number Sign
174810,FAMILIAL EXPANSILE OSTEOLYSIS; FEO,Number Sign
174880,"LYMPHOCYTE CYTOSOL POLYPEPTIDE, 100-KD",Asterisk
174900,JUVENILE POLYPOSIS SYNDROME; JPS,Number Sign
175000,MOVED TO 174900,Caret
175020,"POLYPOSIS, GASTRIC",Percent
175050,JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT,Number Sign
175100,FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1,Number Sign
175200,PEUTZ-JEGHERS SYNDROME; PJS,Number Sign
175400,"POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE",
175450,"POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES",
175500,"POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES",
175505,POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI,
175510,"POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL",
175690,"POLYSYNDACTYLY, CROSSED",Percent
175700,GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS,Number Sign
175750,POPLITEAL CYST,
175780,PORENCEPHALY 1; POREN1,Number Sign
175800,"POROKERATOSIS 1, MULTIPLE TYPES; POROK1",Number Sign
175850,"POROKERATOSIS 2, PALMAR, PLANTAR, AND DISSEMINATED TYPE; POROK2",Percent
175860,"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE II; PPKP2",Percent
175900,"POROKERATOSIS 3, MULTIPLE TYPES; POROK3",Number Sign
176000,"PORPHYRIA, ACUTE INTERMITTENT; AIP",Number Sign
176010,MOVED TO 176000,Caret
176090,"PORPHYRIA CUTANEA TARDA, TYPE I",
176100,PORPHYRIA CUTANEA TARDA,Number Sign
176200,PORPHYRIA VARIEGATA,Number Sign
176240,"POSTAXIAL OLIGODACTYLY, TETRAMELIC",
176250,POSTERIOR COLUMN ATAXIA,
176256,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 2; KCNC2",Asterisk
176257,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 6; KCNA6",Asterisk
176258,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 1; KCNC1",Asterisk
176260,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 1; KCNA1",Asterisk
176261,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 1; KCNE1",Asterisk
176262,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 2; KCNA2",Asterisk
176263,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 3; KCNA3",Asterisk
176264,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 3; KCNC3",Asterisk
176265,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 4; KCNC4",Asterisk
176266,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 4; KCNA4",Asterisk
176267,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 5; KCNA5",Asterisk
176268,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 7; KCNA7",Asterisk
176269,MOVED TO 176266,Caret
176270,PRADER-WILLI SYNDROME; PWS,Number Sign
176290,"DELTA, DROSOPHILA, HOMOLOG-LIKE 1; DLK1",Asterisk
176300,TRANSTHYRETIN; TTR,Asterisk
176305,"PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS",Number Sign
176310,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 1; PBX1,Asterisk
176311,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 2; PBX2,Asterisk
176312,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 3; PBX3,Asterisk
176385,PREGNANCY-ASSOCIATED PLASMA PROTEIN A; PAPPA,Asterisk
176390,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1; PSG1,Asterisk
176391,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 2; PSG2,Asterisk
176392,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 3; PSG3,Asterisk
176393,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 4; PSG4,Asterisk
176394,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 5; PSG5,Asterisk
176395,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 6; PSG6,Asterisk
176396,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 7; PSG7,Asterisk
176397,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 8; PSG8,Asterisk
176398,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 9; PSG9,Asterisk
176399,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 10; PSG10,Asterisk
176400,"PRECOCIOUS PUBERTY, CENTRAL, 1; CPPB1",Number Sign
176401,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 11; PSG11,Asterisk
176410,"PRECOCIOUS PUBERTY, MALE-LIMITED",Number Sign
176420,PREGNANCY ZONE PROTEIN; PZP,Asterisk
176430,PREMATURE CHROMATID SEPARATION TRAIT; PCS,Number Sign
176440,MOVED TO 311360,Caret
176450,CURRARINO SYNDROME,Number Sign
176500,"CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1",Number Sign
176590,PROFILIN 2; PFN2,Asterisk
176600,"PRESENILE DEMENTIA, KRAEPELIN TYPE",
176610,PROFILIN 1; PFN1,Asterisk
176620,"PRIAPISM, FAMILIAL IDIOPATHIC",
176630,PRIMARY RELEASE DISORDER OF PLATELETS,
176635,PRIMASE POLYPEPTIDE 1; PRIM1,Asterisk
176636,PRIMASE POLYPEPTIDE 2A; PRIM2A,Asterisk
176640,PRION PROTEIN; PRNP,Asterisk
176670,HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS,Number Sign
176680,MOVED TO 142880,Caret
176690,PROGEROID SHORT STATURE WITH PIGMENTED NEVI,Percent
176700,"PROGNATHISM, MANDIBULAR",Percent
176705,PROHIBITIN; PHB,Asterisk
176710,"PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 1; P4HA1",Asterisk
176720,PROLACTIN-INDUCIBLE PROTEIN; PIP,Asterisk
176730,INSULIN; INS,Asterisk
176740,PROLIFERATING CELL NUCLEAR ANTIGEN; PCNA,Asterisk
176741,PROLIFERATION-RELATED Ki-67 ANTIGEN; MKI67,Asterisk
176760,PROLACTIN; PRL,Asterisk
176761,PROLACTIN RECEPTOR; PRLR,Asterisk
176763,PEROXIREDOXIN 1; PRDX1,Asterisk
176770,"PROLINE-NEGATIVE AUXOTROPH OF HAMSTER, COMPLEMENTATION OF; PROA",
176780,"PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO",Percent
176785,PROLYLCARBOXYPEPTIDASE; PRCP,Asterisk
176790,"PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, BETA SUBUNIT; P4HB",Asterisk
176793,"PRO-MELANIN-CONCENTRATING HORMONE-LIKE 1, PSEUDOGENE; PMCHL1",Asterisk
176794,"PRO-MELANIN-CONCENTRATING HORMONE-LIKE 2, PSEUDOGENE; PMCHL2",Asterisk
176795,PRO-MELANIN-CONCENTRATING HORMONE; PMCH,Asterisk
176797,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 16; ZBTB16,Asterisk
176800,"PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF",
176801,PROSAPOSIN; PSAP,Asterisk
176802,"PROSTAGLANDIN E RECEPTOR 1, EP1 SUBTYPE; PTGER1",Asterisk
176803,"PROSTAGLANDIN D2 SYNTHASE, BRAIN; PTGDS",Asterisk
176804,"PROSTAGLANDIN E RECEPTOR 2, EP2 SUBTYPE; PTGER2",Asterisk
176805,PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1; PTGS1,Asterisk
176806,"PROSTAGLANDIN E RECEPTOR 3, EP3 SUBTYPE; PTGER3",Asterisk
176807,PROSTATE CANCER,Number Sign
176820,KALLIKREIN-RELATED PEPTIDASE 3; KLK3,Asterisk
176830,PROOPIOMELANOCORTIN; POMC,Asterisk
176842,"PROTEASOME SUBUNIT, ALPHA-TYPE, 2; PSMA2",Asterisk
176843,"PROTEASOME SUBUNIT, ALPHA-TYPE, 3; PSMA3",Asterisk
176844,"PROTEASOME SUBUNIT, ALPHA-TYPE, 5; PSMA5",Asterisk
176845,PROTEASOME COMPONENT 8; PSC8,Asterisk
176846,"PROTEASOME SUBUNIT, ALPHA-TYPE, 4; PSMA4",Asterisk
176847,"PROTEASOME SUBUNIT, BETA-TYPE, 10; PSMB10",Asterisk
176851,PROTEIN CARBOXYL METHYLTRANSFERASE 1; PCMT1,Asterisk
176860,"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3",Number Sign
176870,ALPHA-1 MICROGLOBULIN/BIKUNIN PRECURSOR; AMBP,Asterisk
176871,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 2; EIF2AK2,Asterisk
176872,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; MAP2K1,Asterisk
176873,CYCLIN-DEPENDENT KINASE 11B; CDK11B,Asterisk
176874,MOVED TO 114085,Caret
176875,"PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP1CA",Asterisk
176876,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11; PTPN11",Asterisk
176877,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 3; PTPN3",Asterisk
176878,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 4; PTPN4",Asterisk
176879,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 5; PTPN5",Asterisk
176880,PROTEIN S; PROS1,Asterisk
176882,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, BETA; PTPRB",Asterisk
176883,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 6; PTPN6",Asterisk
176884,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ALPHA; PTPRA",Asterisk
176885,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 1; PTPN1",Asterisk
176886,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, GAMMA; PTPRG",Asterisk
176887,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 2; PTPN2",Asterisk
176888,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, MU; PTPRM",Asterisk
176889,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 7; PTPN7",Asterisk
176891,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-1; PTPRZ1",Asterisk
176892,"PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, BETA; PRKACB",Asterisk
176893,"PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, GAMMA; PRKACG",Asterisk
176894,"PROTEIN KINASE, cGMP-DEPENDENT, REGULATORY, TYPE I; PRKG1",Asterisk
176895,PROTEIN Z; PROZ,Asterisk
176900,PROTEOLYTIC CAPACITY OF PLASMA,
176910,"PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, ALPHA; PRKAR2A",Asterisk
176911,"PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, BETA; PRKAR1B",Asterisk
176912,"PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, BETA; PRKAR2B",Asterisk
176914,"PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP1CC",Asterisk
176915,"PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP2CA",Asterisk
176916,"PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, BETA ISOFORM; PPP2CB",Asterisk
176920,PROTEUS SYNDROME,Number Sign
176930,COAGULATION FACTOR II; F2,Asterisk
176940,S100 CALCIUM-BINDING PROTEIN A1; S100A1,Asterisk
176941,TYROSINE KINASE 2; TYK2,Asterisk
176942,FPS/FES-RELATED TYROSINE KINASE; FER,Asterisk
176943,FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2,Asterisk
176944,MOVED TO 134935,Caret
176945,EPHRIN RECEPTOR EphA8; EPHA8,Asterisk
176946,EPHRIN RECEPTOR EphA2; EPHA2,Asterisk
176947,ZETA-CHAIN-ASSOCIATED PROTEIN KINASE; ZAP70,Asterisk
176948,MITOGEN-ACTIVATED PROTEIN KINASE 1; MAPK1,Asterisk
176949,MITOGEN-ACTIVATED PROTEIN KINASE 4; MAPK4,Asterisk
176950,MOVED TO 262890,Caret
176960,"PROTEIN KINASE C, ALPHA; PRKCA",Asterisk
176970,"PROTEIN KINASE C, BETA; PRKCB",Asterisk
176975,"PROTEIN KINASE C, EPSILON; PRKCE",Asterisk
176977,"PROTEIN KINASE C, DELTA; PRKCD",Asterisk
176980,"PROTEIN KINASE C, GAMMA; PRKCG",Asterisk
176981,"RECEPTOR FOR ACTIVATED PROTEIN KINASE C, 1; RACK1",Asterisk
176982,"PROTEIN KINASE C, ZETA FORM; PRKCZ",Asterisk
176990,"S100 CALCIUM-BINDING PROTEIN, BETA; S100B",Asterisk
176991,S100 CALCIUM-BINDING PROTEIN A5; S100A5,Asterisk
176992,S100 CALCIUM-BINDING PROTEIN A3; S100A3,Asterisk
176993,S100 CALCIUM-BINDING PROTEIN A2; S100A2,Asterisk
177000,"PROTOPORPHYRIA, ERYTHROPOIETIC, 1; EPP1",Number Sign
177010,"SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 2; SERPINE2",Asterisk
177015,PROTEIN SERINE KINASE H1; PSKH1,Asterisk
177020,PROTEINASE 3; PRTN3,Asterisk
177030,MOVED TO 176880,Caret
177040,SERGLYCIN; SRGN,Asterisk
177045,"PROTEASOME SUBUNIT, BETA-TYPE, 9; PSMB9",Asterisk
177046,"PROTEASOME SUBUNIT, BETA-TYPE, 8; PSMB8",Asterisk
177050,PROTRUSIO ACETABULI,Percent
177060,"PROTEIN KINASE C SUBSTRATE, 80-KD, HEAVY CHAIN; PRKCSH",Asterisk
177061,MYRISTOYLATED ALANINE-RICH PROTEIN KINASE C SUBSTRATE; MARCKS,Asterisk
177070,"PROTEIN 4.2, ERYTHROCYTIC; EPB42",Asterisk
177075,V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE HOMOLOG; MAF,Asterisk
177100,"PRURITUS, HEREDITARY LOCALIZED",
177150,MOVED TO 177170,Caret
177170,PSEUDOACHONDROPLASIA; PSACH,Number Sign
177200,LIDDLE SYNDROME 1; LIDLS1,Number Sign
177300,PSEUDOARTHROGRYPOSIS,
177350,PSEUDOATROPHODERMA COLLI,
177400,BUTYRYLCHOLINESTERASE; BCHE,Asterisk
177500,MOVED TO 177400,Caret
177600,"PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF",
177650,EXFOLIATION SYNDROME; XFS,Number Sign
177700,"GLAUCOMA 1, OPEN ANGLE, P; GLC1P",Number Sign
177720,MOVED TO 194380,Caret
177735,"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A",Number Sign
177750,PSEUDOMONILETHRIX,Percent
177800,PSEUDOPAPILLEDEMA,
177820,PSEUDO-VON WILLEBRAND DISEASE; VWDP,Number Sign
177850,"PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE",Number Sign
177860,REMOVED FROM DATABASE,Caret
177900,"PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1",Number Sign
177980,"PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES",Number Sign
177990,"PTERYGIUM COLLI, ISOLATED",
178000,PTERYGIUM OF CONJUNCTIVA AND CORNEA,
178110,"ARTHROGRYPOSIS, DISTAL, TYPE 8; DA8",Number Sign
178200,"PTERYGIUM, ANTECUBITAL",Percent
178300,"PTOSIS, HEREDITARY CONGENITAL 1; PTOS1",Percent
178330,"PTOSIS, STRABISMUS, AND ECTOPIC PUPILS",
178350,PUBIC BONE DYSPLASIA,Percent
178370,PULMONARY ATRESIA WITH VENTRICULAR SEPTAL DEFECT,
178400,"PULMONARY EDEMA OF MOUNTAINEERS, SUSCEPTIBILITY TO",
178500,"PULMONARY FIBROSIS, IDIOPATHIC; IPF",Number Sign
178550,PULMONARY HEMOSIDEROSIS,
178600,"PULMONARY HYPERTENSION, PRIMARY, 1; PPH1",Number Sign
178610,"PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL",
178620,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN C; SFTPC",Asterisk
178630,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A1; SFTPA1",Asterisk
178635,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D; SFTPD",Asterisk
178640,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN B; SFTPB",Asterisk
178642,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A2; SFTPA2",Asterisk
178650,"PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHIC ABNORMALITIES",
178651,PULMONIC STENOSIS AND DEAFNESS,
178800,"PUPIL, EGG-SHAPED",
178900,"PUPILLARY MEMBRANE, PERSISTENCE OF",
178990,MATRIX METALLOPROTEINASE 7; MMP7,Asterisk
178995,PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY; PUPPP,
179000,PURPURA SIMPLEX,
179010,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1",Percent
179020,PYRIDOXAL KINASE; PDXK,Asterisk
179030,"PYROPHOSPHATASE, INORGANIC, 1; PPA1",Asterisk
179035,PYRROLINE-5-CARBOXYLATE REDUCTASE 1; PYCR1,Asterisk
179040,MOVED TO 179050,Caret
179050,"PYRUVATE KINASE, MUSCLE; PKM",Asterisk
179060,"PYRUVATE DEHYDROGENASE, BETA POLYPEPTIDE; PDHB",Asterisk
179061,"PYRUVATE DEHYDROGENASE, ALPHA-2; PDHA2",Asterisk
179080,"RAB GERANYLGERANYL TRANSFERASE, BETA SUBUNIT; RABGGTB",Asterisk
179090,MOVED TO 164730,Caret
179095,UBIQUITIN-CONJUGATING ENZYME E2B; UBE2B,Asterisk
179200,"RADIAL HEADS, POSTERIOR DISLOCATION OF",Percent
179250,"RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARY DIASTEMA",
179270,RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA,
179280,RADIAL-RENAL SYNDROME,
179300,RADIOULNAR SYNOSTOSIS,
179400,"RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE",
179410,RADIXIN; RDX,Asterisk
179450,RAGWEED SENSITIVITY,
179490,RAS-ASSOCIATED PROTEIN RAB3A; RAB3A,Asterisk
179500,RAINDROP HYPOPIGMENTATION,
179502,"RAP1, GTPase-GDP DISSOCIATION STIMULATOR 1; RAP1GDS1",Asterisk
179503,RAS-RELATED ASSOCIATED WITH DIABETES; RRAD,Asterisk
179505,"RAS HOMOLOG GENE FAMILY, MEMBER G; RHOG",Asterisk
179508,RAS-ASSOCIATED PROTEIN RAB1; RAB1,Asterisk
179509,RAS-ASSOCIATED PROTEIN RAB2; RAB2,Asterisk
179510,RAS-ASSOCIATED PROTEIN RAB3B; RAB3B,Asterisk
179511,RAS-ASSOCIATED PROTEIN RAB4A; RAB4A,Asterisk
179512,RAS-ASSOCIATED PROTEIN RAB5A; RAB5A,Asterisk
179513,RAS-ASSOCIATED PROTEIN RAB6A; RAB6A,Asterisk
179514,RAS-ASSOCIATED PROTEIN RAB5B; RAB5B,Asterisk
179520,RAS-RELATED PROTEIN 1A; RAP1A,Asterisk
179530,RAS-RELATED PROTEIN RAP1B; RAP1B,Asterisk
179540,RAS-RELATED PROTEIN 2A; RAP2A,Asterisk
179541,RAS-RELATED PROTEIN 2B; RAP2B,Asterisk
179550,V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG A; RALA,Asterisk
179551,V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG B; RALB,Asterisk
179555,RAS SUPPRESSOR PROTEIN 1; RSU1,Asterisk
179590,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F; PTPRF",Asterisk
179600,RAYNAUD DISEASE,Percent
179605,"PERIPHERIN 2, MOUSE, HOMOLOG OF; PRPH2",Asterisk
179610,EPHRIN RECEPTOR EphA1; EPHA1,Asterisk
179611,EPHRIN RECEPTOR EphA3; EPHA3,Asterisk
179613,RECOMBINANT CHROMOSOME 8 SYNDROME,Number Sign
179615,RECOMBINATION-ACTIVATING GENE 1; RAG1,Asterisk
179616,RECOMBINATION-ACTIVATING GENE 2; RAG2,Asterisk
179617,"RAD51, S. CEREVISIAE, HOMOLOG OF; RAD51",Asterisk
179618,RECOVERIN; RCV1,Asterisk
179620,RAPH BLOOD GROUP SYSTEM,Number Sign
179650,RED CELL PERMEABILITY DEFECT,Percent
179700,RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS,Percent
179710,REGULATOR OF CHROMOSOME CONDENSATION 1; RCC1,Asterisk
179715,REMOVED FROM DATABASE,Caret
179730,RELAXIN 1; RLN1,Asterisk
179740,RELAXIN 2; RLN2,Asterisk
179755,PAPILLARY RENAL CELL CARCINOMA TRANSLOCATION-ASSOCIATED GENE; PRCC,Asterisk
179760,MOVED TO 144700,Caret
179770,MOVED TO 144700,Caret
179780,DIPEPTIDASE 1; DPEP1,Asterisk
179800,"RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT",Number Sign
179820,RENIN; REN,Asterisk
179830,"RENAL TUBULAR ACIDOSIS, PROXIMAL",
179835,"REPLICATION PROTEIN A1, 70-KD; RPA1",Asterisk
179836,"REPLICATION PROTEIN A2, 32-KD; RPA2",Asterisk
179837,"REPLICATION PROTEIN A3, 14-KD; RPA3",Asterisk
179838,CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 1; CLIP1,Asterisk
179840,RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM,
179850,DOWLING-DEGOS DISEASE 1; DDD1,Number Sign
179900,RETINAL APLASIA,Percent
180000,"RETINAL ARTERIES, TORTUOSITY OF; RATOR",Number Sign
180020,RETINAL CONE DYSTROPHY 1; RCD1,Percent
180040,"RETINAL DEGENERATION 3, MOUSE, HOMOLOG OF; RD3",Asterisk
180050,RETINAL DETACHMENT,Percent
180060,MOVED TO 152950,Caret
180069,RETINOID ISOMEROHYDROLASE RPE65; RPE65,Asterisk
180070,MOVED TO 221900,Caret
180071,"PHOSPHODIESTERASE 6A, cGMP-SPECIFIC, ROD, ALPHA; PDE6A",Asterisk
180072,"PHOSPHODIESTERASE 6B, cGMP-SPECIFIC, ROD, BETA; PDE6B",Asterisk
180073,"PHOSPHODIESTERASE 6G, cGMP-SPECIFIC, ROD, GAMMA; PDE6G",Asterisk
180080,RETINAL VENOUS BEADING,
180090,RETINALDEHYDE-BINDING PROTEIN 1; RLBP1,Asterisk
180100,RETINITIS PIGMENTOSA 1; RP1,Number Sign
180102,MOVED TO 180380,Caret
180103,MOVED TO 500004,Caret
180104,RETINITIS PIGMENTOSA 9; RP9,Number Sign
180105,RETINITIS PIGMENTOSA 10; RP10,Number Sign
180190,"RETINOIC ACID RECEPTOR, GAMMA; RARG",Asterisk
180200,RETINOBLASTOMA; RB1,Number Sign
180201,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4A; ARID4A,Asterisk
180202,LYSINE-SPECIFIC DEMETHYLASE 5A; KDM5A,Asterisk
180203,RETINOBLASTOMA-LIKE 2; RBL2,Asterisk
180210,"RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT",
180220,"RETINOIC ACID RECEPTOR, BETA; RARB",Asterisk
180230,"RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE I; CRABP1",Asterisk
180231,"RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE II; CRABP2",Asterisk
180240,"RETINOIC ACID RECEPTOR, ALPHA; RARA",Asterisk
180245,"RETINOID X RECEPTOR, ALPHA; RXRA",Asterisk
180246,"RETINOID X RECEPTOR, BETA; RXRB",Asterisk
180247,"RETINOID X RECEPTOR, GAMMA; RXRG",Asterisk
180250,RETINOL-BINDING PROTEIN 4; RBP4,Asterisk
180260,RETINOL-BINDING PROTEIN 1; RBP1,Asterisk
180270,"RETINOSCHISIS, AUTOSOMAL DOMINANT",
180280,RETINOL-BINDING PROTEIN 2; RBP2,Asterisk
180290,RETINOL-BINDING PROTEIN 3; RBP3,Asterisk
180295,"RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2",Number Sign
180297,RHESUS BLOOD GROUP-ASSOCIATED GLYCOPROTEIN; RHAG,Asterisk
180300,RHEUMATOID ARTHRITIS; RA,Number Sign
180330,REMOVED FROM DATABASE,Caret
180350,RHEUMATOID NODULOSIS,
180360,RHINY,
180370,THIOSULFATE SULFURTRANSFERASE; TST,Asterisk
180380,RHODOPSIN; RHO,Asterisk
180381,G PROTEIN-COUPLED RECEPTOR KINASE 1; GRK1,Asterisk
180385,LIM DOMAIN ONLY 2; LMO2,Asterisk
180386,LIM DOMAIN ONLY 3; LMO3,Asterisk
180390,"RIBONUCLEOTIDE REDUCTASE, M2 SUBUNIT; RRM2",Asterisk
180410,"RIBONUCLEOTIDE REDUCTASE, M1 SUBUNIT; RRM1",Asterisk
180420,"RNA, 5S RIBOSOMAL, GENE CLUSTER 1; RN5S1@",Asterisk
180430,RIBOSE 5-PHOSPHATE ISOMERASE A; RPIA,Asterisk
180435,RIBONUCLEASE L; RNASEL,Asterisk
180440,"RIBONUCLEASE, RNase A FAMILY, 1; RNASE1",Asterisk
180450,RIBOSOMAL RNA 1; RNR1,Asterisk
180451,RIBOSOMAL RNA 2; RNR2,Asterisk
180452,RIBOSOMAL RNA 3; RNR3,Asterisk
180453,RIBOSOMAL RNA 4; RNR4,Asterisk
180454,RIBOSOMAL RNA 5; RNR5,Asterisk
180460,RIBOSOMAL PROTEIN S6; RPS6,Asterisk
180461,MOVED TO 180472,Caret
180462,MOVED TO 180472,Caret
180463,RIBOSOMAL PROTEIN S20A; RPS20A,Asterisk
180464,RIBOSOMAL PROTEIN S20B; RPS20B,Asterisk
180465,RIBOSOMAL PROTEIN S25; RPS25,Asterisk
180466,RIBOSOMAL PROTEIN L19; RPL19,Asterisk
180467,RIBOSOMAL PROTEIN L30; RPL30,Asterisk
180468,RIBOSOMAL PROTEIN L35A; RPL35A,Asterisk
180469,RIBOSOMAL PROTEIN L36A-LIKE; RPL36AL,Asterisk
180470,RIBOPHORIN I; RPN1,Asterisk
180471,RIBOSOMAL PROTEIN S11; RPS11,Asterisk
180472,RIBOSOMAL PROTEIN S17; RPS17,Asterisk
180473,RIBOSOMAL PROTEIN S18; RPS18,Asterisk
180474,RIBOSOMAL PROTEIN L22; RPL22,Asterisk
180475,RIBOSOMAL PROTEIN L12; RPL12,Asterisk
180476,RIBOSOMAL PROTEIN S13; RPS13,Asterisk
180477,RIBOSOMAL PROTEIN S21; RPS21,Asterisk
180478,RIBOSOMAL PROTEIN S3a; RPS3A,Asterisk
180479,RIBOSOMAL PROTEIN L4; RPL4,Asterisk
180480,RIBULOSE 5-PHOSPHATE 3-EPIMERASE; RPE,Asterisk
180490,RIBOPHORIN II; RPN2,Asterisk
180500,"AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1",Number Sign
180510,"RIBOSOMAL PHOSPHOPROTEIN, LARGE, P0; RPLP0",Asterisk
180520,"RIBOSOMAL PHOSPHOPROTEIN, LARGE, P1; RPLP1",Asterisk
180530,"RIBOSOMAL PHOSPHOPROTEIN, LARGE, P2; RPLP2",Asterisk
180535,RIBOSOMAL PROTEIN S15; RPS15,Asterisk
180540,MOVED TO 131410,Caret
180550,RING DERMOID OF CORNEA; RDC,Number Sign
180600,RINGED HAIR,Percent
180610,REARRANGED LMYC FUSION; RLF,Asterisk
180620,TRANSFER RNA METHIONINE 2; TRNAM2,Asterisk
180621,TRANSFER RNA METHIONINE 1; TRNAM1,Asterisk
180630,DEAD/H BOX 5; DDX5,Asterisk
180640,TRANSFER RNA GLUTAMIC ACID; TRNAE1,Asterisk
180645,"SMALL NUCLEOLAR RNA, H/ACA BOX, 73A; SNORA73A",Asterisk
180646,"SMALL NUCLEOLAR RNA, H/ACA BOX, 62; SNORA62",Asterisk
180647,"SMALL NUCLEOLAR RNA, H/ACA BOX, 63; SNORA63",Asterisk
180660,"POLYMERASE II, RNA, SUBUNIT A; POLR2A",Asterisk
180661,"POLYMERASE II, RNA, SUBUNIT B; POLR2B",Asterisk
180662,"POLYMERASE II, RNA, SUBUNIT I; POLR2I",Asterisk
180663,"POLYMERASE II, RNA, SUBUNIT C; POLR2C",Asterisk
180664,"POLYMERASE II, RNA, SUBUNIT E; POLR2E",Asterisk
180670,RNA POLYMERASE III TRANSCRIPTIONAL UNITS,Asterisk
180680,"RNA, U1A SMALL NUCLEAR; RNU1A",Asterisk
180690,"RNA, U2 SMALL NUCLEAR, 1; RNU2-1",Asterisk
180691,"RNA, U5A SMALL NUCLEAR; RNU5A",Asterisk
180692,"RNA, U6 SMALL NUCLEAR, 1; RNU6-1",Asterisk
180700,"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1",Number Sign
180710,"SMALL NUCLEOLAR RNA, C/D BOX, 3A; SNORD3A",Asterisk
180720,MOVED TO 180680,Caret
180721,ROD OUTER SEGMENT PROTEIN 1; ROM1,Asterisk
180730,ROMBO SYNDROME,
180740,"SMALL NUCLEAR RIBONUCLEOPROTEIN, U1 SUBUNIT, 70-KD; SNRNP70",Asterisk
180750,ROBINOW-SORAUF SYNDROME,Number Sign
180800,ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA,Number Sign
180840,MOVED TO 601625,Caret
180849,RUBINSTEIN-TAYBI SYNDROME 1; RSTS1,Number Sign
180850,MOVED TO 180849,Caret
180860,SILVER-RUSSELL SYNDROME; SRS,Number Sign
180870,RUVALCABA SYNDROME,
180900,RUTHERFURD SYNDROME,Percent
180901,RYANODINE RECEPTOR 1; RYR1,Asterisk
180902,RYANODINE RECEPTOR 2; RYR2,Asterisk
180903,RYANODINE RECEPTOR 3; RYR3,Asterisk
180910,SALIVARY ESTERASE,Asterisk
180920,APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG,Number Sign
180930,REMOVED FROM DATABASE,Caret
180940,REMOVED FROM DATABASE,Caret
180950,"SALIVARY SUBSTANCE, CLOSTRIDIUM BOTULINUM TYPE",Percent
180960,S-ADENOSYLHOMOCYSTEINE HYDROLASE; AHCY,Asterisk
180980,S-ADENOSYLMETHIONINE DECARBOXYLASE; AMD1,Asterisk
180989,"PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 1; PRB1",Asterisk
180990,"PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 4; PRB4",Asterisk
181000,"SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1",Number Sign
181010,SALIVARY DUCT CALCULI,
181030,"SALIVARY GLAND ADENOMA, PLEOMORPHIC",Number Sign
181031,S-ANTIGEN; SAG,Asterisk
181035,TETRASPANIN 31; TSPAN31,Asterisk
181180,SAY SYNDROME,
181200,SC(1) TRAIT OF SALIVA,
181250,SCALP DEFECTS AND POSTAXIAL POLYDACTYLY,
181270,SCALP-EAR-NIPPLE SYNDROME; SENS,Number Sign
181300,"SCAPULA, CONTOUR OF VERTEBRAL BORDER OF",
181350,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2",Number Sign
181400,"SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK",Number Sign
181405,SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA,Number Sign
181430,"SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM",Number Sign
181440,SCHEUERMANN DISEASE,Percent
181450,ULNAR-MAMMARY SYNDROME; UMS,Number Sign
181460,"SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO",Percent
181500,SCHIZOPHRENIA; SCZD,Number Sign
181510,SCHIZOPHRENIA 1; SCZD1,Percent
181515,MOVED TO 300977,Caret
181520,MOVED TO 104640,Caret
181590,SCL/TAL1-INTERRUPTING LOCUS; STIL,Asterisk
181600,HURIEZ SYNDROME; HRZ,Percent
181700,"SCLEROCORNEA, AUTOSOMAL DOMINANT",
181750,"SCLERODERMA, FAMILIAL PROGRESSIVE",Percent
181800,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 1; IS1",Percent
182000,"KERATOSIS, SEBORRHEIC",Number Sign
182090,SIMIAN SARCOMA-ASSOCIATED VIRUS-1/GIBBON APE LEUKEMIA VIRUS; SSAV1,Asterisk
182098,SECRETIN RECEPTOR; SCTR,Asterisk
182099,SECRETIN; SCT,Asterisk
182100,FUCOSYLTRANSFERASE 2; FUT2,Plus
182115,CYTOHESIN 1; CYTH1,Asterisk
182120,"SECRETED PROTEIN, ACIDIC, CYSTEINE-RICH; SPARC",Asterisk
182125,SEPIAPTERIN REDUCTASE; SPR,Asterisk
182128,SERINE DEHYDRATASE; SDS,Asterisk
182131,5-HYDROXYTRYPTAMINE RECEPTOR 1B; HTR1B,Asterisk
182132,5-HYDROXYTRYPTAMINE RECEPTOR 1E; HTR1E,Asterisk
182133,5-HYDROXYTRYPTAMINE RECEPTOR 1D; HTR1D,Asterisk
182134,5-HYDROXYTRYPTAMINE RECEPTOR 1F; HTR1F,Asterisk
182135,5-HYDROXYTRYPTAMINE RECEPTOR 2A; HTR2A,Asterisk
182137,5-HYDROXYTRYPTAMINE RECEPTOR 7; HTR7,Asterisk
182138,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, SEROTONIN), MEMBER 4; SLC6A4",Asterisk
182139,5-HYDROXYTRYPTAMINE RECEPTOR 3A; HTR3A,Asterisk
182140,SEMENOGELIN I; SEMG1,Asterisk
182141,SEMENOGELIN II; SEMG2,Asterisk
182143,MOVED TO 177040,Caret
182144,"SERINE HYDROXYMETHYLTRANSFERASE, CYTOSOLIC; SHMT1",Asterisk
182145,SERUM PROTEIN POLYMORPHISM M-158,Asterisk
182150,SIMOSA CRANIOFACIAL SYNDROME,
182160,SIALOPHORIN; SPN,Asterisk
182170,"ANEMIA, SIDEROBLASTIC, 4; SIDBA4",Number Sign
182175,"SIGNAL RECOGNITION PARTICLE, 19-KD; SRP19",Asterisk
182180,"SIGNAL RECOGNITION PARTICLE RECEPTOR, ALPHA SUBUNIT; SRPRA",Asterisk
182190,SINUS NODE DISEASE AND MYOPIA,
182200,"SELLA TURCICA, BRIDGED",
182203,MOVED TO 162643,Caret
182205,SEX HORMONE-BINDING GLOBULIN; SHBG,Asterisk
182210,SHPRINTZEN OMPHALOCELE SYNDROME,
182212,SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS,Number Sign
182220,"SISTER CHROMATID EXCHANGE, FREQUENCY OF",
182230,SEPTOOPTIC DYSPLASIA,Number Sign
182250,SINGLETON-MERTEN SYNDROME 1; SGMRT1,Number Sign
182255,SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION,
182257,PROTEINASE INHIBITOR 3; PI3,Asterisk
182260,SLIPPED FEMORAL CAPITAL EPIPHYSES,
182265,SMALL PROLINE-RICH PROTEIN 1A; SPRR1A,Asterisk
182266,SMALL PROLINE-RICH PROTEIN 1B; SPRR1B,Asterisk
182267,SMALL PROLINE-RICH PROTEIN 2A; SPRR2A,Asterisk
182268,SMALL PROLINE-RICH PROTEIN 2B; SPRR2B,Asterisk
182269,"SMALL PROLINE-RICH PROTEIN 2C, PSEUDOGENE; SPRR2C",
182270,"KETONE COMPOUNDS, ABILITY TO SMELL",
182271,SMALL PROLINE-RICH PROTEIN 3; SPRR3,Asterisk
182279,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N; SNRPN,Asterisk
182280,SMALL CELL CANCER OF THE LUNG,Percent
182281,"CHEMOKINE, CC MOTIF, LIGAND 1; CCL1",Asterisk
182282,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDES B AND B1; SNRPB,Asterisk
182283,"CHEMOKINE, CC MOTIF, LIGAND 3; CCL3",Asterisk
182284,"CHEMOKINE, CC MOTIF, LIGAND 4; CCL4",Asterisk
182285,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A; SNRPA,Asterisk
182290,SMITH-MAGENIS SYNDROME; SMS,Number Sign
182305,"SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A1; SLC8A1",Asterisk
182307,"SOLUTE CARRIER FAMILY 9, MEMBER 3; SLC9A3",Asterisk
182308,"SOLUTE CARRIER FAMILY 17 (ORGANIC ANION COTRANSPORTER), MEMBER 1; SLC17A1",Asterisk
182309,"SOLUTE CARRIER FAMILY 34 (TYPE II SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 1; SLC34A1",Asterisk
182310,"ATPase, Na+/K+ TRANSPORTING, ALPHA-1 POLYPEPTIDE; ATP1A1",Asterisk
182330,"ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE; ATP1B1",Asterisk
182331,"ATPase, Na+/K+ TRANSPORTING, BETA-2 POLYPEPTIDE; ATP1B2",Asterisk
182340,"ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2",Asterisk
182350,"ATPase, Na+/K+ TRANSPORTING, ALPHA-3 POLYPEPTIDE; ATP1A3",Asterisk
182360,"ATPase, H+/K+ TRANSPORTING, NONGASTRIC, ALPHA POLYPEPTIDE; ATP12A",Asterisk
182370,MOVED TO 182330,Caret
182380,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 1; SLC5A1",Asterisk
182381,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 2; SLC5A2",Asterisk
182389,"SODIUM CHANNEL, NEURONAL TYPE I, ALPHA SUBUNIT; SCN1A",Asterisk
182390,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, ALPHA SUBUNIT; SCN2A",Asterisk
182391,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, ALPHA SUBUNIT; SCN3A",Asterisk
182392,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE VII, ALPHA SUBUNIT; SCN7A",Asterisk
182396,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 1; SLC10A1",Asterisk
182400,"SOMATOMEDIN, EMBRYONIC",
182410,SNEDDON SYNDROME,Number Sign
182450,SOMATOSTATIN; SST,Asterisk
182451,SOMATOSTATIN RECEPTOR 1; SSTR1,Asterisk
182452,SOMATOSTATIN RECEPTOR 2; SSTR2,Asterisk
182453,SOMATOSTATIN RECEPTOR 3; SSTR3,Asterisk
182454,SOMATOSTATIN RECEPTOR 4; SSTR4,Asterisk
182455,SOMATOSTATIN RECEPTOR 5; SSTR5,Plus
182465,SON DNA-BINDING PROTEIN; SON,Asterisk
182500,SORBITOL DEHYDROGENASE; SORD,Asterisk
182520,SORCIN; SRI,Asterisk
182530,"SON OF SEVENLESS, DROSOPHILA, HOMOLOG 1; SOS1",Asterisk
182590,TREFOIL FACTOR 2; TFF2,Asterisk
182600,"SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A",Number Sign
182601,"SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4",Number Sign
182610,"SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR",
182690,"SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND PROGRESSIVE NEPHROPATHY",
182700,MOVED TO 270685,Caret
182790,"SPECTRIN, BETA, NONERYTHROCYTIC, 1; SPTBN1",Asterisk
182800,SPASTIC PARAPLEGIA WITH ASSOCIATED EXTRAPYRAMIDAL SIGNS,
182810,"SPECTRIN, ALPHA, NONERYTHROCYTIC 1; SPTAN1",Asterisk
182815,SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA,
182820,SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY,
182830,"SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA",
182860,"SPECTRIN, ALPHA, ERYTHROCYTIC 1; SPTA1",Asterisk
182870,"SPECTRIN, BETA, ERYTHROCYTIC; SPTB",Asterisk
182875,"SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, AND TRANSVERSE EARLOBE CREASE",
182878,OUTER DENSE FIBER OF SPERM TAILS 1; ODF1,Asterisk
182879,MOVED TO 104776,Caret
182880,SPERM PROTAMINE P1; PRM1,Asterisk
182882,SPERM PROTAMINE P4; PRM4,
182888,ZONA PELLUCIDA GLYCOPROTEIN 2; ZP2,Asterisk
182889,ZONA PELLUCIDA GLYCOPROTEIN 3; ZP3,Asterisk
182890,SPERM PROTAMINE P2; PRM2,Asterisk
182891,SPERMIDINE SYNTHASE; SRM,Asterisk
182892,MOVED TO 300105,Caret
182900,"SPHEROCYTOSIS, TYPE 1; SPH1",Number Sign
182920,"MYOPATHY, SPHEROID BODY",Number Sign
182930,MOVED TO 167800,Caret
182940,"NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD",Number Sign
182950,SPINAL ARACHNOIDITIS,Percent
182960,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I; HMN1",Percent
182970,"SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE",Percent
182980,"SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK",Number Sign
182990,SPINAL INTRADURAL ARACHNOID CYSTS,
183000,MOVED TO 137440,Caret
183020,"SPINAL MUSCULAR ATROPHY, SEGMENTAL",
183050,SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY,Percent
183085,MOVED TO 109150,Caret
183086,SPINOCEREBELLAR ATAXIA 6; SCA6,Number Sign
183090,SPINOCEREBELLAR ATAXIA 2; SCA2,Number Sign
183100,SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS,
183250,REMOVED FROM DATABASE,Caret
183300,SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA,
183350,SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA AND REDUCED CIRCULATING T HELPER CELLS,
183400,SPLIT LOWER LIP,
183500,SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA,
183600,SPLIT-HAND/FOOT MALFORMATION 1; SHFM1,Number Sign
183700,SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS,
183800,"SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS",
183802,"SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATIC DEFECTS",
183840,"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2; SPDA2",Percent
183849,SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS,
183850,SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY,
183900,SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC,Number Sign
184000,"SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS",
184095,"SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE",Number Sign
184100,"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT",Percent
184200,SPONDYLOLISTHESIS,Percent
184250,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK",Number Sign
184252,"SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK",Number Sign
184253,"SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE",
184255,"SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF",Number Sign
184260,SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA,
184300,"SPONDYLOSIS, CERVICAL",
184400,SPRENGEL DEFORMITY,Percent
184420,FARNESYLDIPHOSPHATE FARNESYLTRANSFERASE 1; FDFT1,Asterisk
184429,SRY-BOX 2; SOX2,Asterisk
184430,SRY-BOX 4; SOX4,Asterisk
184450,"STUTTERING, FAMILIAL PERSISTENT, 1; STUT1",Number Sign
184460,STAPES ANKYLOSIS WITH BROAD THUMBS AND TOES,Number Sign
184470,STATHERIN; STATH,Asterisk
184500,STEATOCYSTOMA MULTIPLEX,Number Sign
184510,STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH,
184600,CYSTATIN A; CSTA,Asterisk
184601,MOVED TO 601145,Caret
184700,POLYCYSTIC OVARY SYNDROME 1; PCOS1,Percent
184705,STEINFELD SYNDROME,
184745,KIT LIGAND; KITLG,Asterisk
184747,MOVED TO 136351,Caret
184753,STEROID 5-ALPHA-REDUCTASE 1; SRD5A1,Asterisk
184754,MOVED TO 201910,Caret
184755,STEROL CARRIER PROTEIN 2; SCP2,Asterisk
184756,STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 1; SREBF1,Asterisk
184757,"NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1; NR5A1",Asterisk
184800,"STERNUM, PREMATURE OBLITERATION OF SUTURES OF",
184840,"OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA",Number Sign
184850,STIFF-PERSON SYNDROME; SPS,Percent
184900,STIFF SKIN SYNDROME; SSKS,Number Sign
185000,OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHST,Number Sign
185010,MOVED TO 194380,Caret
185020,CRYOHYDROCYTOSIS; CHC,Number Sign
185050,STORAGE POOL PLATELET DISEASE,Percent
185069,STORM SYNDROME,
185070,STORMORKEN SYNDROME; STRMK,Number Sign
185100,"STRABISMUS, SUSCEPTIBILITY TO",Percent
185120,STRATTON-PARKER SYNDROME,
185200,"STRIAE DISTENSAE, FAMILIAL",Percent
185250,MATRIX METALLOPROTEINASE 3; MMP3,Asterisk
185260,MATRIX METALLOPROTEINASE 10; MMP10,Asterisk
185261,MATRIX METALLOPROTEINASE 11; MMP11,Asterisk
185300,STURGE-WEBER SYNDROME; SWS,Number Sign
185400,MOVED TO 150360,Caret
185430,CLUSTERIN; CLU,Asterisk
185440,SUPPRESSOR OF TUMORIGENICITY 2; ST2,Asterisk
185450,REMOVED FROM DATABASE,Caret
185460,"SULFHEMOGLOBINEMIA, CONGENITAL",
185470,"SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT B, IRON SULFUR PROTEIN; SDHB",Asterisk
185480,"SUPRABULBAR PARESIS, CONGENITAL",
185490,SUPEROXIDE DISMUTASE 3; SOD3,Asterisk
185500,SUPRAVALVULAR AORTIC STENOSIS; SVAS,Number Sign
185510,SURFACE ANTIGEN 5; S5,Asterisk
185520,SURFACE ANTIGEN 6; S6,Asterisk
185535,EPITHELIAL CELLULAR ADHESION MOLECULE; EPCAM,Asterisk
185540,"SURFACE ANTIGEN, GLYCOPROTEIN 75",
185560,SURFACE ANTIGEN 8; S8,Asterisk
185570,SURFACE ANTIGEN 17; SA17,Asterisk
185580,SURFACE ANTIGEN 22; S13,Asterisk
185590,SURFACE ANTIGEN 21; S14,Asterisk
185595,REMOVED FROM DATABASE,Caret
185600,SYMPHALANGISM OF TOES,
185605,SYNAPTOTAGMIN 1; SYT1,Asterisk
185610,"SURFACE POLYPEPTIDES, ANONYMOUS",
185620,SURFEIT 1; SURF1,Asterisk
185630,SURFEIT 2; SURF2,Asterisk
185640,RIBOSOMAL PROTEIN L7a; RPL7A,Asterisk
185641,MEDIATOR COMPLEX SUBUNIT 22; MED22,Asterisk
185642,SURFEIT 6; SURF6,Asterisk
185650,"SYMPHALANGISM, C. S. LEWIS TYPE",
185660,SURFEIT 4; SURF4,Asterisk
185700,"SYMPHALANGISM, DISTAL",Percent
185750,SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET,
185800,"SYMPHALANGISM, PROXIMAL, 1A; SYM1A",Number Sign
185860,SYNAPTIC VESICLE GLYCOPROTEIN 2A; SV2A,Asterisk
185861,SYNAPTIC VESICLE GLYCOPROTEIN 2B; SV2B,Asterisk
185880,VESICLE-ASSOCIATED MEMBRANE PROTEIN 1; VAMP1,Asterisk
185881,VESICLE-ASSOCIATED MEMBRANE PROTEIN 2; VAMP2,Asterisk
185900,CHROMOSOME 2q35 DUPLICATION SYNDROME,Number Sign
186000,SYNPOLYDACTYLY 1; SPD1,Number Sign
186100,"SYNDACTYLY, TYPE III",Number Sign
186200,"SYNDACTYLY, TYPE IV; SDTY4",Number Sign
186300,"SYNDACTYLY, TYPE V; SDTY5",Number Sign
186350,SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME,Percent
186355,SYNDECAN 1; SDC1,Asterisk
186357,SYNDECAN 3; SDC3,Asterisk
186360,ANNEXIN A7; ANXA7,Asterisk
186400,"SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL",Percent
186500,MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1,Number Sign
186550,LIEBENBERG SYNDROME; LBNBG,Number Sign
186570,TARSAL-CARPAL COALITION SYNDROME; TCC,Number Sign
186575,"SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM",
186580,BLAU SYNDROME; BLAUS,Number Sign
186590,SYNTAXIN 1A; STX1A,Asterisk
186591,SYNTAXIN 4; STX4,Asterisk
186600,"SYRINGOMAS, MULTIPLE",
186690,REMOVED FROM DATABASE,Caret
186700,"SYRINGOMYELIA, NONCOMMUNICATING ISOLATED",Percent
186710,T-CELL ACTIVATION ANTIGEN p250; TP250,Asterisk
186711,CD27 ANTIGEN; CD27,Asterisk
186720,CD6 ANTIGEN; CD6,Asterisk
186730,"CD8 ANTIGEN, BETA POLYPEPTIDE; CD8B",Asterisk
186740,"CD3 ANTIGEN, GAMMA SUBUNIT; CD3G",Asterisk
186745,TALIN 1; TLN1,Asterisk
186750,TALONAVICULAR COALITION,
186760,ANTIGEN CD28; CD28,Asterisk
186770,"T-CELL LEUKEMIA, HOMEOBOX 1; TLX1",Asterisk
186780,CD247 ANTIGEN; CD247,Asterisk
186790,"CD3 ANTIGEN, DELTA SUBUNIT; CD3D",Asterisk
186810,T-CELL RECEPTOR DELTA CHAIN CONSTANT REGION; TRDC,Asterisk
186820,T-CELL ANTIGEN CD7; CD7,Asterisk
186830,"CD3 ANTIGEN, EPSILON SUBUNIT; CD3E",Asterisk
186845,CD81 ANTIGEN; CD81,Asterisk
186850,TARSAL COALITION,Percent
186852,"PROTEASOME 26S SUBUNIT, ATPase, 3; PSMC3",Asterisk
186854,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, TAURINE), MEMBER 6; SLC6A6",Asterisk
186855,T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 2; TAL2,Asterisk
186860,T-CELL LEUKEMIA/LYMPHOMA 4; TCL4,Asterisk
186880,T-CELL RECEPTOR ALPHA CHAIN CONSTANT REGION; TRAC,Asterisk
186890,"TEAR PROTEIN, ANODAL",Percent
186910,"CD8 ANTIGEN, ALPHA POLYPEPTIDE; CD8A",Asterisk
186920,REMOVED FROM DATABASE,Caret
186921,LIM DOMAIN ONLY 1; LMO1,Asterisk
186930,T-CELL RECEPTOR BETA CHAIN CONSTANT REGION 1; TRBC1,Asterisk
186940,CD4 ANTIGEN; CD4,Asterisk
186945,FK506-BINDING PROTEIN 1A; FKBP1A,Asterisk
186946,FK506-BINDING PROTEIN 2; FKBP2,Asterisk
186947,FK506-BINDING PROTEIN 3; FKBP3,Asterisk
186950,"T-CELL SUBGROUPS, NON-HLA-LINKED",
186960,T-CELL LEUKEMIA/LYMPHOMA 1A; TCL1A,Asterisk
186970,T-CELL RECEPTOR GAMMA CHAIN CONSTANT REGION 1; TRGC1,Asterisk
186973,IL2-INDUCIBLE T-CELL KINASE; ITK,Asterisk
186975,T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 1; TCTE1,Asterisk
186977,T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 3; TCTE3,Asterisk
186980,T-COMPLEX 1; TCP1,Asterisk
186982,T-COMPLEX HOMOLOG TCP11; TCP11,Asterisk
186990,T-LYMPHOCYTE SURFACE CD2 ANTIGEN; CD2,Asterisk
187000,"TEETH, ODD SHAPES OF",Percent
187010,MOVED TO 187011,Caret
187011,"CHEMOKINE, CC MOTIF, LIGAND 5; CCL5",Asterisk
187020,T-COMPLEX 10; TCP10,Asterisk
187030,T-COMPLEX LOCUS TCP10B; TCP10B,
187040,T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 1; TAL1,Asterisk
187050,TEETH PRESENT AT BIRTH,
187100,"TEETH, SUPERNUMERARY",
187260,"TELANGIECTASIA, HEREDITARY BENIGN",Percent
187270,TELOMERASE REVERSE TRANSCRIPTASE; TERT,Asterisk
187280,"POLYMERASE III, RNA, SUBUNIT D; POLR3D",Asterisk
187290,"TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, H142; H142T",
187300,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1; HHT1",Number Sign
187310,"TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, K12",
187320,"TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts13; TS13",
187330,"TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts546; TS546",
187340,TEMPERATURE-SENSITIVE LETHAL MUTATION,
187350,TELECANTHUS,
187360,TEMPORAL ARTERITIS,
187370,"ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10",Percent
187380,TENASCIN C; TNC,Asterisk
187390,"TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF",
187395,TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1,Plus
187400,TESTICULAR TORSION,
187410,"DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL; DNTT",Asterisk
187430,CYSTEINE-RICH SECRETORY PROTEIN 2; CRISP2,Asterisk
187450,MOVED TO 182205,Caret
187500,TETRALOGY OF FALLOT; TOF,Number Sign
187501,TETRALOGY OF FALLOT AND GLAUCOMA,
187510,TETRAMELIC MONODACTYLY,
187520,TETRANECTIN; TNA,Asterisk
187550,"THALASSEMIA, BETA+, SILENT ALLELE",
187600,"THANATOPHORIC DYSPLASIA, TYPE I; TD1",Number Sign
187601,"THANATOPHORIC DYSPLASIA, TYPE II; TD2",Number Sign
187650,THEOPHYLLINE BIOTRANSFORMATION,Percent
187680,THIOPURINE S-METHYLTRANSFERASE; TPMT,Asterisk
187700,THIOREDOXIN; TXN,Asterisk
187750,"THORACIC DYSOSTOSIS, ISOLATED",
187760,THORACOLARYNGOPELVIC DYSPLASIA; TLPD,
187770,THORACOPELVIC DYSOSTOSIS,
187790,THREONYL-tRNA SYNTHETASE; TARS,Asterisk
187800,"BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16",Number Sign
187900,"BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17",Number Sign
187930,COAGULATION FACTOR II RECEPTOR; F2R,Asterisk
187940,THROMBOCYTE B; THB,
187950,THROMBOCYTHEMIA 1; THCYT1,Number Sign
188000,THROMBOCYTOPENIA 2; THC2,Number Sign
188020,"THROMBOCYTOPENIA, CYCLIC",
188025,"THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT",Number Sign
188030,"THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP",
188035,PRO-PLATELET BASIC PROTEIN-LIKE 1; PPBPL1,Asterisk
188040,THROMBOMODULIN; THBD,Asterisk
188050,THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1,Number Sign
188055,THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2,Number Sign
188060,THROMBOSPONDIN I; THBS1,Asterisk
188061,THROMBOSPONDIN II; THBS2,Asterisk
188062,THROMBOSPONDIN III; THBS3,Asterisk
188070,"THROMBOXANE A2 RECEPTOR, PLATELET; TBXA2R",Asterisk
188100,THUMB DEFORMITY,
188150,THUMB DEFORMITY AND ALOPECIA,
188200,MOVED TO 107000,Caret
188201,"THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY",
188230,THY-1 T-CELL ANTIGEN; THY1,Asterisk
188250,"THYMIDINE KINASE, MITOCHONDRIAL; TK2",Asterisk
188300,"THYMIDINE KINASE, SOLUBLE; TK1",Asterisk
188340,THYMOCYTE ANTIGEN CD1C; CD1C,Asterisk
188345,DEOXYTHYMIDYLATE KINASE; DTYMK,Asterisk
188350,THYMIDYLATE SYNTHETASE; TYMS,Asterisk
188360,THYMOCYTE ANTIGEN CD1B; CD1B,Asterisk
188370,THYMOCYTE ANTIGEN CD1A; CD1A,Asterisk
188380,THYMOPOIETIN; TMPO,Asterisk
188390,"PROTHYMOSIN, ALPHA; PTMA",Asterisk
188395,MOVED TO 300159,Caret
188399,"THYMOSIN, BETA-10; TMSB10",Asterisk
188400,DIGEORGE SYNDROME; DGS,Number Sign
188410,THYMOCYTE ANTIGEN CD1D; CD1D,Asterisk
188411,THYMOCYTE ANTIGEN CD1E; CD1E,Asterisk
188450,THYROGLOBULIN; TG,Asterisk
188455,"THYROGLOSSAL DUCT CYST, FAMILIAL",
188470,"THYROID CANCER, NONMEDULLARY, 2; NMTC2",Number Sign
188530,MOVED TO 118850,Caret
188540,"THYROID-STIMULATING HORMONE, BETA CHAIN; TSHB",Asterisk
188545,THYROTROPIN-RELEASING HORMONE RECEPTOR; TRHR,Plus
188550,"THYROID CANCER, NONMEDULLARY, 1; NMTC1",Number Sign
188555,MOVED TO 179050,Caret
188560,THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT,
188570,"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH",Number Sign
188580,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1",Number Sign
188590,MOVED TO 190120,Caret
188595,THYROTROPH EMBRYONIC FACTOR; TEF,Asterisk
188600,MOVED TO 314200,Caret
188700,"BLOUNT DISEASE, INFANTILE",
188740,"TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY; THYP",Number Sign
188770,MOVED TO 188740,Caret
188800,"TIBIAL TORSION, BILATERAL MEDIAL",Percent
188825,TISSUE INHIBITOR OF METALLOPROTEINASE 2; TIMP2,Asterisk
188826,TISSUE INHIBITOR OF METALLOPROTEINASE 3; TIMP3,Asterisk
188830,"PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A",Asterisk
188840,TITIN; TTN,Asterisk
188850,TL ANTIGEN,
188855,GRANULYSIN; GNLY,Asterisk
188860,MYELIN AND LYMPHOCYTE PROTEIN; MAL,Asterisk
188890,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",Number Sign
189000,"TOE, FIFTH, NUMBER OF PHALANGES IN",
189100,"TOE, MISSHAPEN",
189150,"TOE, ROTATED FIFTH",
189200,"TOES, RELATIVE LENGTH OF FIRST AND SECOND",
189230,"TOES, SPACE BETWEEN FIRST AND SECOND",
189300,"TONGUE CURLING, FOLDING, OR ROLLING",
189490,MALPOSITION OF TEETH WITH OR WITHOUT HYPODONTIA/OLIGODONTIA,
189500,WITKOP SYNDROME,Number Sign
189600,TORTICOLLIS,
189700,TORUS PALATINUS AND TORUS MANDIBULARIS,Percent
189800,PREECLAMPSIA/ECLAMPSIA 1; PEE1,Percent
189880,TRANSFER RNA ASPARAGINE 1; TRNAN1,Asterisk
189889,TRANSCRIPTION FACTOR CP2; TFCP2,Asterisk
189890,TRANSFER RNA ASPARAGINE-LIKE; TRNL,Asterisk
189901,TRANSCRIPTION FACTOR 9; TCF9,Asterisk
189902,TRANSCRIPTION FACTOR DP1; TFDP1,Asterisk
189903,"NUCLEAR TRANSCRIPTION FACTOR Y, ALPHA; NFYA",Asterisk
189904,"NUCLEAR TRANSCRIPTION FACTOR Y, BETA; NFYB",Asterisk
189905,TRANSCOBALAMIN I; TCN1,Asterisk
189906,TRANSCRIPTION FACTOR Sp1; SP1,Asterisk
189907,HNF1 HOMEOBOX B; HNF1B,Asterisk
189908,TRANSCRIPTION FACTOR 7; TCF7,Asterisk
189909,ZINC FINGER E BOX-BINDING HOMEOBOX 1; ZEB1,Asterisk
189910,TRANSFER RNA SERINE (AGA) 2-4; TRS-AGA2-4,Asterisk
189911,TRANSFER RNA GLYCINE 1; TRNAG1,Asterisk
189912,TRANSFER RNA PROLINE (TGG) 3-5; TRP-TGG3-5,Asterisk
189913,TRANSFER RNA THREONINE (TGT) 6-1; TRT-TGT6-1,Asterisk
189918,TRANSFER RNA LYSINE (TTT) 3-4; TRK-TTT3-4,Asterisk
189919,TRANSFER RNA GLUTAMINE 1; TRNAQ1,Asterisk
189920,TRANSFER RNA LEUCINE 2; TRNAL2,Asterisk
189921,TRANSFER RNA VALINE (AAC) 1-4; TRV-AAC1-4,Asterisk
189923,TRANSFER RNA GLUTAMINE 2; TRNAQ2,Asterisk
189930,TRANSFER RNA PROLINE 1; TRNAP1,Asterisk
189931,TRANSFER RNA PROLINE 2; TRNAP2,Asterisk
189932,TRANSFER RNA LEUCINE (AAG) 2-1; TRL-AAG2-1,Asterisk
189933,TRANSFER RNA THREONINE 2; TRNAT2,Asterisk
189940,TRANSLOCATED PROMOTER REGION; TPR,Asterisk
189960,TRACHEOESOPHAGEAL FISTULA WITH OR WITHOUT ESOPHAGEAL ATRESIA,
189961,TRACHEOPATHIA OSTEOPLASTICA,
189962,"GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 1; GTF2E1",Asterisk
189963,GENERAL TRANSCRIPTION FACTOR IIB; GTF2B,Asterisk
189964,"GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 2; GTF2E2",Asterisk
189965,"CCAAT/ENHANCER-BINDING PROTEIN, BETA; CEBPB",Asterisk
189967,TEA DOMAIN FAMILY MEMBER 1; TEAD1,Asterisk
189968,"GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 1, 74-KD; GTF2F1",Asterisk
189969,"GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 2, 30-KD; GTF2F2",Asterisk
189970,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNGT1",Asterisk
189971,E2F TRANSCRIPTION FACTOR 1; E2F1,Asterisk
189972,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 1; GTF2H1",Asterisk
189973,E74-LIKE FACTOR 1; ELF1,Asterisk
189974,MOVED TO 139380,Caret
189980,ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ABL1,Asterisk
189990,V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG; MYB,Asterisk
190000,TRANSFERRIN; TF,Asterisk
190010,TRANSFERRIN RECEPTOR; TFRC,Asterisk
190020,V-HA-RAS HARVEY RAT SARCOMA VIRAL ONCOGENE HOMOLOG; HRAS,Asterisk
190030,V-FES FELINE SARCOMA VIRAL/V-FPS FUJINAMI AVIAN SARCOMA VIRAL ONCOGENE HOMOLOG; FES,Asterisk
190040,"PLATELET-DERIVED GROWTH FACTOR, BETA POLYPEPTIDE; PDGFB",Asterisk
190060,V-MOS MOLONEY MURINE SARCOMA VIRAL ONCOGENE HOMOLOG; MOS,Asterisk
190070,V-KI-RAS2 KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG; KRAS,Asterisk
190080,V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG; MYC,Asterisk
190090,V-SRC AVIAN SARCOMA (SCHMIDT-RUPPIN A-2) VIRAL ONCOGENE; SRC,Asterisk
190100,GENIOSPASM 1; GSM1,Percent
190110,MOVED TO 190070,Caret
190120,"THYROID HORMONE RECEPTOR, ALPHA-1; THRA",Asterisk
190151,V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 3; ERBB3,Asterisk
190160,"THYROID HORMONE RECEPTOR, BETA; THRB",Asterisk
190170,"TRANSFORMING GROWTH FACTOR, ALPHA; TGFA",Asterisk
190180,"TRANSFORMING GROWTH FACTOR, BETA-1; TGFB1",Asterisk
190181,"TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I; TGFBR1",Asterisk
190182,"TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II; TGFBR2",Asterisk
190190,MOVED TO 154280,Caret
190195,TRANSGLUTAMINASE 1; TGM1,Asterisk
190196,TRANSGLUTAMINASE 2; TGM2,Asterisk
190197,CONTACTIN 2; CNTN2,Asterisk
190198,"NOTCH, DROSOPHILA, HOMOLOG OF, 1; NOTCH1",Asterisk
190200,"TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS",
190220,"TRANSFORMING GROWTH FACTOR, BETA-2; TGFB2",Asterisk
190230,"TRANSFORMING GROWTH FACTOR, BETA-3; TGFB3",Asterisk
190231,TRANSITION PROTEIN 1; TNP1,Asterisk
190232,TRANSITION PROTEIN 2; TNP2,Asterisk
190300,"TREMOR, HEREDITARY ESSENTIAL, 1; ETM1",Number Sign
190310,"TREMOR, NYSTAGMUS, AND DUODENAL ULCER",Percent
190315,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, CITRATE TRANSPORTER), MEMBER 1; SLC25A1",Asterisk
190320,TRICHODENTOOSSEOUS SYNDROME; TDO,Number Sign
190330,TRICHOMEGALY; TCMGLY,Number Sign
190340,"DISCOID FIBROMAS, FAMILIAL MULTIPLE; FMDF",Percent
190345,"TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC",
190350,"TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1",Number Sign
190351,"TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3",Number Sign
190360,TRICHODYSPLASIA-XERODERMA,
190370,TRICHOHYALIN; TCHH,Asterisk
190400,TRIGEMINAL NEURALGIA,
190410,TRIGGER THUMB,
190420,"TRIGLYCERIDE STORAGE DISEASE, TYPE I",
190430,"TRIGLYCERIDE STORAGE DISEASE, TYPE II",
190440,TRIGONOCEPHALY 1; TRIGNO1,Number Sign
190445,TRIIODOTHYRONINE RECEPTOR AUXILIARY PROTEIN; TRAP,
190450,TRIOSEPHOSPHATE ISOMERASE 1; TPI1,Asterisk
190470,TRIPEPTIDYL PEPTIDASE II; TPP2,Asterisk
190500,TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES,
190600,"TRIPHALANGEAL THUMB, NONOPPOSABLE",Percent
190605,MOVED TO 174500,Caret
190650,TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA,
190680,TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY,Percent
190685,DOWN SYNDROME,Number Sign
190700,"ZINC FINGER PROTEIN 36, MOUSE, HOMOLOG OF; ZFP36",Asterisk
190800,TRISTICHIASIS,
190900,TRITANOPIA,Number Sign
190920,TROPHOBLAST GLYCOPROTEIN; TPBG,Asterisk
190930,TROPOMODULIN; TMOD,Asterisk
190940,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 1; ERVT1",Asterisk
190950,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 2; ERVT2",Asterisk
190960,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 3; ERVT3",Asterisk
190970,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 4; ERVT4",Asterisk
190980,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 5; ERVT5",Asterisk
190990,TROPOMYOSIN 2; TPM2,Asterisk
191000,"TROCHLEA OF THE HUMERUS, APLASIA OF",
191010,TROPOMYOSIN 1; TPM1,Asterisk
191020,MOVED TO 120920,Caret
191030,TROPOMYOSIN 3; TPM3,Asterisk
191039,"TROPONIN C, FAST; TNNC2",Asterisk
191040,"TROPONIN C, SLOW; TNNC1",Asterisk
191041,"TROPONIN T1, SKELETAL, SLOW; TNNT1",Asterisk
191042,"TROPONIN I, SLOW-TWITCH SKELETAL MUSCLE ISOFORM; TNNI1",Asterisk
191043,"TROPONIN I, FAST-TWITCH SKELETAL MUSCLE ISOFORM; TNNI2",Asterisk
191044,"TROPONIN I, CARDIAC; TNNI3",Asterisk
191045,"TROPONIN T2, CARDIAC; TNNT2",Asterisk
191050,TRYPTOPHANYL-tRNA SYNTHETASE; WARS,Asterisk
191060,TRYPTOPHAN HYDROXYLASE 1; TPH1,Asterisk
191070,"TRYPTOPHAN 2,3-DIOXYGENASE; TDO2",Asterisk
191080,"TRYPTASE, ALPHA/BETA-1; TPSAB1",Asterisk
191081,"TRYPTASE, BETA-2; TPSB2",Asterisk
191090,MOVED TO 191100,Caret
191091,MOVED TO 191100,Caret
191092,TSC2 GENE; TSC2,Asterisk
191100,TUBEROUS SCLEROSIS 1; TSC1,Number Sign
191110,"TUBULIN, ALPHA-4A; TUBA4A",Asterisk
191120,"TUBULIN, ALPHA-LIKE 1; TUBAL1",Asterisk
191130,"TUBULIN, BETA; TUBB",Asterisk
191135,"TUBULIN, GAMMA-1; TUBG1",Asterisk
191150,TUFTSIN DEFICIENCY,
191155,"TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 1; TM4SF1",Asterisk
191160,TUMOR NECROSIS FACTOR; TNF,Asterisk
191161,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 1; TNFAIP1,Asterisk
191163,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 3; TNFAIP3,Asterisk
191164,EPHRIN A1; EFNA1,Asterisk
191170,TUMOR PROTEIN p53; TP53,Asterisk
191175,"HEAT-SHOCK PROTEIN, 90-KD, BETA, 1; HSP90B1",Asterisk
191181,SUPPRESSOR OF TUMORIGENICITY 3; ST3,Percent
191190,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A; TNFRSF1A",Asterisk
191191,"TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY, MEMBER 1B; TNFRSF1B",Asterisk
191195,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8; MAP3K8,Asterisk
191200,TUNE DEAFNESS,Percent
191250,TWINNING DUE TO SUPERFETATION,
191270,TYROSINASE-LIKE; TYRL,
191275,DOPACHROME TAUTOMERASE; DCT,Asterisk
191290,TYROSINE HYDROXYLASE; TH,Asterisk
191305,"TYROSINE KINASE, B-LYMPHOCYTE SPECIFIC; BLK",Asterisk
191306,KINASE INSERT DOMAIN RECEPTOR; KDR,Asterisk
191309,MOVED TO 190151,Caret
191311,"DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 2; DDR2",Asterisk
191315,"NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1; NTRK1",Asterisk
191316,"NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3; NTRK3",Asterisk
191317,U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1; U2AF1,Asterisk
191318,U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 2; U2AF2,Asterisk
191320,MOVED TO 191339,Caret
191321,UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT; UBA52,Asterisk
191325,UBIQUITIN-ACTIVATING ENZYME 7; UBE7,Asterisk
191327,"UBIQUINOL-CYTOCHROME c REDUCTASE, RIESKE IRON-SULFUR; UQCRFS1",Asterisk
191328,UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN I; UQCRC1,Asterisk
191329,UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN II; UQCRC2,Asterisk
191330,UBIQUINOL-CYTOCHROME c REDUCTASE-BINDING PROTEIN; UQCRB,Asterisk
191339,UBIQUITIN B; UBB,Asterisk
191340,UBIQUITIN C; UBC,Asterisk
191342,UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1; UCHL1,Asterisk
191343,RIBOSOMAL PROTEIN S27a; RPS27A,Asterisk
191344,MOVED TO 191321,Caret
191350,DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE; DPAGT1,Asterisk
191390,INFLAMMATORY BOWEL DISEASE 11; IBD11,Percent
191400,"ULNA AND FIBULA, HYPOPLASIA OF",
191420,ULNA METAPHYSEAL DYSPLASIA SYNDROME,
191440,ULNAR HYPOPLASIA,Percent
191480,UNCOMBABLE HAIR SYNDROME 1; UHS1,Number Sign
191482,"UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, AND BRACHYDACTYLY",
191500,UNDRITZ ANOMALY,Percent
191510,"COLD-SHOCK DOMAIN-CONTAINING E1, RNA-BINDING; CSDE1",Asterisk
191520,UPINGTON DISEASE,Percent
191523,UPSTREAM TRANSCRIPTION FACTOR 1; USF1,Asterisk
191525,URACIL-DNA GLYCOSYLASE; UNG,Asterisk
191530,"URATE-BINDING GLOBULIN, DECREASE IN",Percent
191540,"URATE OXIDASE, PSEUDOGENE; UOX",
191550,"URETER, BIFID OR DOUBLE",Percent
191600,"URETER, CANCER OF",
191650,URETEROCELE,
191700,"UROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT",
191710,"CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 1, CYTOSOLIC; CMPK1",Asterisk
191720,"5-PRIME,3-PRIME-NUCLEOTIDASE, CYTOSOLIC; NT5C",Asterisk
191730,URIDINE PHOSPHORYLASE 1; UPP1,Asterisk
191740,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1",Asterisk
191741,MOVED TO 191740,Caret
191742,MOVED TO 600067 AND 191740,Caret
191743,MOVED TO 191742,Caret
191750,MOVED TO 191760,Caret
191760,URIDYL DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE 2; UGP2,Asterisk
191800,"URINARY BLADDER, ATONY OF",
191810,MOVED TO 131530,Caret
191830,RENAL HYPODYSPLASIA/APLASIA 1; RHDA1,Number Sign
191840,"PLASMINOGEN ACTIVATOR, URINARY; PLAU",Asterisk
191845,UROMODULIN; UMOD,Asterisk
191850,"URTICARIA, AQUAGENIC",
191900,MUCKLE-WELLS SYNDROME; MWS,Number Sign
191950,"URTICARIA, FAMILIAL LOCALIZED HEAT",
192000,UTERINE ANOMALIES,
192020,"SECRETOGLOBIN, FAMILY 1A, MEMBER 1; SCGB1A1",Asterisk
192050,UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL HEMATOCOLPOS WITH IPSILATERAL RENAL AGENESIS,
192070,REMOVED FROM DATABASE,Caret
192090,CADHERIN 1; CDH1,Asterisk
192100,"UVULA, BIFID",
192130,"ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A1; ATP6V0A1",Asterisk
192132,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 1; ATP6V1B1",Asterisk
192150,VALYL-tRNA SYNTHETASE; VARS,Asterisk
192200,VARICOSE VEINS,
192225,VASCULAR CELL ADHESION MOLECULE 1; VCAM1,Asterisk
192240,VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEGFA,Asterisk
192300,VASCULAR HELIX OF UMBILICAL CORD,
192310,"VASCULITIS, LYMPHOCYTIC, NODULAR",
192315,"VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL",Number Sign
192320,VASOACTIVE INTESTINAL PEPTIDE; VIP,Asterisk
192321,VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1; VIPR1,Asterisk
192340,ARGININE VASOPRESSIN; AVP,Asterisk
192350,VATER/VACTERL ASSOCIATION,Percent
192400,"VEINS, PATTERN OF, ON ANTERIOR THORAX",
192430,VELOCARDIOFACIAL SYNDROME,Number Sign
192445,"VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE",
192450,MOVED TO 603829,Caret
192500,LONG QT SYNDROME 1; LQT1,Number Sign
192600,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1",Number Sign
192605,"VENTRICULAR TACHYCARDIA, FAMILIAL",Number Sign
192700,"VENULAR INSUFFICIENCY, SYSTEMIC",
192800,"VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS",
192900,VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS,Percent
192950,"VERTICAL TALUS, CONGENITAL; CVT",Number Sign
192968,"INTEGRIN, ALPHA-1; ITGA1",Asterisk
192972,MOVED TO 192975,Caret
192974,"INTEGRIN, ALPHA-2; ITGA2",Asterisk
192975,"INTEGRIN, ALPHA-4; ITGA4",Asterisk
192977,VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VLDLR,Asterisk
193000,VESICOURETERAL REFLUX 1; VUR1,Percent
193001,"SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 2; SLC18A2",Asterisk
193002,"SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 1; SLC18A1",Asterisk
193003,"NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4",Percent
193005,"VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE",
193007,"VERTIGO, BENIGN RECURRENT; BRV",Percent
193010,MOVED TO 112266,Caret
193040,VILLIN; VIL,Asterisk
193050,MOVED TO 125630,Caret
193060,VIMENTIN; VIM,Asterisk
193065,VINCULIN; VCL,Asterisk
193067,FRIEND LEUKEMIA VIRUS INTEGRATION 1; FLI1,Asterisk
193070,VIRUS RD114 RNA COMPLEMENTARITY,
193090,TRANSCOBALAMIN I DEFICIENCY,Percent
193100,"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR",Number Sign
193190,VITRONECTIN; VTN,Asterisk
193200,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6; VAMAS6,Percent
193210,"INTEGRIN, ALPHA-V; ITGAV",Asterisk
193220,VITREORETINOCHOROIDOPATHY; VRCP,Number Sign
193230,"VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD",Number Sign
193235,"VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI",Number Sign
193240,VOCAL CORD PARALYSIS AND PTOSIS,
193245,VOLTAGE-DEPENDENT ANION CHANNEL 2; VDAC2,Asterisk
193250,VOLVULUS OF MIDGUT,Percent
193290,MOVED TO 151675,Caret
193300,VON HIPPEL-LINDAU SYNDROME; VHL,Number Sign
193400,"VON WILLEBRAND DISEASE, TYPE 1; VWD1",Number Sign
193450,"VULVOVAGINITIS, ALLERGIC SEMINAL",
193500,"WAARDENBURG SYNDROME, TYPE 1; WS1",Number Sign
193510,"WAARDENBURG SYNDROME, TYPE 2A; WS2A",Number Sign
193520,WATSON SYNDROME; WTSN,Number Sign
193525,"WEE1, S. POMBE, HOMOLOG OF; WEE1",Asterisk
193530,WEYERS ACROFACIAL DYSOSTOSIS; WAD,Number Sign
193670,WHIM SYNDROME; WHIMS,Number Sign
193675,REMOVED FROM DATABASE,Caret
193680,MOVED TO 128101,Caret
193700,"ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A",Number Sign
193900,WHITE SPONGE NEVUS 1; WSN1,Number Sign
194000,WIDOW'S PEAK,
194050,WILLIAMS-BEUREN SYNDROME; WBS,Number Sign
194070,WILMS TUMOR 1; WT1,Number Sign
194071,WILMS TUMOR 2; WT2,Number Sign
194072,"WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR",Number Sign
194080,DENYS-DRASH SYNDROME; DDS,Number Sign
194090,WILMS TUMOR 3; WT3,Percent
194100,MOVED TO 106600,Caret
194190,WOLF-HIRSCHHORN SYNDROME; WHS,Number Sign
194200,WOLFF-PARKINSON-WHITE SYNDROME,Number Sign
194300,"WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH",Number Sign
194320,WORONETS TRAIT,
194350,WT LIMB-BLOOD SYNDROME,Percent
194355,X BOX-BINDING PROTEIN 1; XBP1,Asterisk
194360,"X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 1; XRCC1",Asterisk
194363,"X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 4; XRCC4",Asterisk
194364,"X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; XRCC5",Asterisk
194370,X-RAY SENSITIVITY; XRS,
194380,DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1,Number Sign
194400,"XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD",
194450,YEAST FACTOR,Asterisk
194460,"ALPHA-2-GLYCOPROTEIN, ZINC; AZGP1",Asterisk
194470,"ZINC, ELEVATED PLASMA",Percent
194480,"ZINC FINGER PROTEIN 3, MOUSE, HOMOLOG OF; ZFP3",Asterisk
194490,ZINC FINGER PROTEIN 1; ZNF1,Asterisk
194500,ZINC FINGER PROTEIN 2; ZNF2,Asterisk
194510,ZINC FINGER PROTEIN 3; ZNF3,Asterisk
194520,REMOVED FROM DATABASE,Caret
194521,ZINC FINGER PROTEIN 33A; ZNF33A,Asterisk
194522,ZINC FINGER PROTEIN 33B; ZNF33B,Asterisk
194524,ZINC FINGER PROTEIN 18; ZNF18,Asterisk
194525,ZINC FINGER PROTEIN 19; ZNF19,Asterisk
194526,ZINC FINGER PROTEIN 34; ZNF34,Asterisk
194527,ZINC FINGER PROTEIN 23; ZNF23,Asterisk
194528,ZINC FINGER PROTEIN 25; ZNF25,Asterisk
194529,ZINC FINGER PROTEIN 22; ZNF22,Asterisk
194530,REMOVED FROM DATABASE,Caret
194531,ZINC FINGER PROTEIN 7; ZNF7,Asterisk
194532,ZINC FINGER PROTEIN 8; ZNF8,Asterisk
194533,ZINC FINGER PROTEIN 35; ZNF35,Asterisk
194534,ZINC FINGER PROTEIN 24; ZNF24,Asterisk
194535,ZINC FINGER PROTEIN 29; ZNF29,Asterisk
194536,ZINC FINGER PROTEIN 12; ZNF12,Asterisk
194537,ZINC FINGER PROTEIN 26; ZNF26,Asterisk
194538,ZINC FINGER PROTEIN 10; ZNF10,Asterisk
194539,ZINC FINGER PROTEIN 32; ZNF32,Asterisk
194540,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 1; HIVEP1,Asterisk
194541,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 25; ZBTB25,Asterisk
194542,ZINC FINGER PROTEIN 44; ZNF44,Asterisk
194543,ZINC FINGER PROTEIN 69; ZNF69,Asterisk
194544,ZINC FINGER PROTEIN 70; ZNF70,Asterisk
194545,ZINC FINGER PROTEIN 71; ZNF71,Asterisk
194546,ZINC FINGER PROTEIN 72; ZNF72,Asterisk
194547,ZINC FINGER PROTEIN 73; ZNF73,Asterisk
194548,ZINC FINGER PROTEIN 74; ZNF74,Asterisk
194549,ZINC FINGER PROTEIN 76; ZNF76,Asterisk
194550,MYELOID ZINC FINGER GENE 1; MZF1,Asterisk
194551,ZINC FINGER PROTEIN 77; ZNF77,Asterisk
194552,ZINC FINGER PROTEIN 79; ZNF79,Asterisk
194553,ZINC FINGER PROTEIN 80; ZNF80,Asterisk
194554,ZINC FINGER PROTEIN 45; ZNF45,Asterisk
194555,ZINC FINGER PROTEIN 224; ZNF224,Asterisk
194556,ZINC FINGER PROTEIN 14; ZNF14,Asterisk
194557,ZINC FINGER PROTEIN 20; ZNF20,Asterisk
194558,ZINC FINGER PROTEIN 83; ZNF83,Asterisk
194624,ZINC FINGER PROTEIN 117; ZNF117,Asterisk
194628,ZINC FINGER PROTEIN 121; ZNF121,Asterisk
194630,ZINC FINGER PROTEIN 123; ZNF123,Asterisk
194631,ZINC FINGER PROTEIN 124; ZNF124,Asterisk
194632,ZINC FINGER PROTEIN 125; ZNF125,Asterisk
194633,ZINC FINGER PROTEIN 126; ZNF126,Asterisk
194648,ZINC FINGER PROTEIN 141; ZNF141,Asterisk
195000,ZONA PELLUCIDA GLYCOPROTEIN 1; ZP1,Asterisk
195002,MOVED TO 182889,Caret
200100,ABETALIPOPROTEINEMIA; ABL,Number Sign
200110,ABLEPHARON-MACROSTOMIA SYNDROME; AMS,Number Sign
200130,ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION,
200150,CHOREOACANTHOCYTOSIS; CHAC,Number Sign
200170,ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT,
200300,ACETOPHENETIDIN SENSITIVITY,
200350,ACETYL-CoA CARBOXYLASE-ALPHA; ACACA,Asterisk
200400,"ACHALASIA, FAMILIAL ESOPHAGEAL",Percent
200440,MOVED TO 231550,Caret
200450,ACHALASIA-MICROCEPHALY SYNDROME,
200500,ACHEIROPODY; ACHP,Number Sign
200600,"ACHONDROGENESIS, TYPE IA; ACG1A",Number Sign
200610,"ACHONDROGENESIS, TYPE II; ACG2",Number Sign
200700,"CHONDRODYSPLASIA, GREBE TYPE",Number Sign
200710,MOVED TO 200610,Caret
200720,MOVED TO 200610,Caret
200900,SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY,
200930,REMOVED FROM DATABASE,Caret
200950,ACID PHOSPHATASE DEFICIENCY,
200970,ACKERMAN SYNDROME,
200980,ACRORENAL-MANDIBULAR SYNDROME,
200990,ACROCALLOSAL SYNDROME; ACLS,Number Sign
200995,ACROCEPHALOPOLYDACTYLOUS DYSPLASIA,
201000,CARPENTER SYNDROME 1; CRPT1,Number Sign
201020,ACROCEPHALOPOLYSYNDACTYLY TYPE IV,
201050,ACROCRANIOFACIAL DYSOSTOSIS,
201100,"ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ",Number Sign
201170,ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ,Percent
201180,ACROFRONTOFACIONASAL DYSOSTOSIS 1,
201181,MOVED TO 239710,Caret
201200,"ACROGERIA, GOTTRON TYPE",
201250,"ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE; AMDH",Number Sign
201300,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A",Number Sign
201310,"ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE",
201400,"ACTH DEFICIENCY, ISOLATED; IAD",Number Sign
201450,"ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD",Number Sign
201460,MOVED TO 201475,Caret
201470,"ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD",Number Sign
201475,"ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD",Number Sign
201550,ADDUCTED THUMBS SYNDROME,Percent
201710,LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH,Number Sign
201750,ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1,Number Sign
201810,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY",Number Sign
201910,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY",Number Sign
202010,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY",Number Sign
202110,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY",Number Sign
202150,"ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZING HORMONE",
202155,"ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE",
202200,GLUCOCORTICOID DEFICIENCY 1; GCCD1,Number Sign
202300,"ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC",Number Sign
202355,ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT,
202370,PEROXISOME BIOGENESIS DISORDER 2B; PBD2B,Number Sign
202400,"AFIBRINOGENEMIA, CONGENITAL",Number Sign
202500,MOVED TO 600899 AND 601457,Caret
202550,"AGANGLIONOSIS, TOTAL INTESTINAL",
202600,AGENESIS OF CEREBRAL WHITE MATTER,
202650,AGNATHIA-OTOCEPHALY COMPLEX; AGOTC,Number Sign
202660,PAGOD SYNDROME,
202700,"NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1",Number Sign
202900,"ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS",
203000,FRONTONASAL DYSPLASIA WITH ALAR CLEFTS,
203100,"ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A",Number Sign
203200,"ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2",Number Sign
203280,MOVED TO 606952,Caret
203285,MOVED TO 608233,Caret
203290,"ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3",Number Sign
203300,HERMANSKY-PUDLAK SYNDROME 1; HPS1,Number Sign
203310,MOVED TO 203200,Caret
203330,"PSEUDOHYPOPARATHYROIDISM, TYPE II; PHP2",Percent
203340,ALBINISM-MICROCEPHALY-DIGITAL ANOMALIES SYNDROME,
203400,CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY,Number Sign
203450,ALEXANDER DISEASE; ALXDRD,Number Sign
203500,ALKAPTONURIA; AKU,Number Sign
203550,ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME,
203600,ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN,
203650,ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1,Number Sign
203655,ALOPECIA UNIVERSALIS CONGENITA; ALUNC,Number Sign
203700,MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A,Number Sign
203740,ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY,Percent
203750,ALPHA-METHYLACETOACETIC ACIDURIA,Number Sign
203760,ALPHA-2-DEFICIENT COLLAGEN DISEASE,
203780,"ALPORT SYNDROME, AUTOSOMAL RECESSIVE",Number Sign
203800,ALSTROM SYNDROME; ALMS,Number Sign
204000,LEBER CONGENITAL AMAUROSIS 1; LCA1,Number Sign
204100,LEBER CONGENITAL AMAUROSIS 2; LCA2,Number Sign
204110,"AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS",
204200,"CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3",Number Sign
204300,"CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A",Number Sign
204400,REMOVED FROM DATABASE,Caret
204500,"CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2",Number Sign
204600,MOVED TO 204500,Caret
204650,"AMELOGENESIS IMPERFECTA, TYPE IC; AI1C",Number Sign
204690,"AMELOGENESIS IMPERFECTA, TYPE IG; AI1G",Number Sign
204700,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1",Number Sign
204730,"AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY, OSTEOPOROSIS, AND ACIDOSIS",
204750,2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD,Number Sign
204800,"AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF",Percent
204850,"AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION",
204870,"CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD",Number Sign
204900,"AMYLOIDOSIS, CUTANEOUS BULLOUS",
205000,AMYOTONIA CONGENITA,
205100,"AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2",Number Sign
205200,"AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA",Percent
205250,AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES,
205400,TANGIER DISEASE; TGD,Number Sign
205600,MOVED TO 105650,Caret
205700,"ANEMIA, AUTOIMMUNE HEMOLYTIC",
205900,MOVED TO 105650,Caret
205950,"ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2",Number Sign
206000,"ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE",
206100,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1",Number Sign
206200,IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA,Number Sign
206300,"ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF RED CELL MEMBRANE",
206400,"ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRIN METABOLISM",
206500,ANENCEPHALY; ANPH,Number Sign
206550,"ANGIOLIPOMATOSIS, FAMILIAL",
206570,"ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT",Percent
206600,"ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS",
206700,GILLESPIE SYNDROME; GLSP,Number Sign
206750,"ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTOR RETARDATION",
206780,ANODONTIA OF PERMANENT DENTITION,Percent
206800,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4",Number Sign
206900,"MICROPHTHALMIA, SYNDROMIC 3; MCOPS3",Number Sign
206920,MICROPHTHALMIA WITH LIMB ANOMALIES; MLA,Number Sign
207000,ANOSMIA FOR ISOBUTYRIC ACID,
207300,"ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO",
207410,ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2,Number Sign
207500,"ANUS, IMPERFORATE",
207600,TAKAYASU ARTERITIS,
207620,APHALANGY WITH HEMIVERTEBRAE,
207700,MOVED TO 107600,Caret
207720,"APNEA, CENTRAL SLEEP",
207731,APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA,
207740,"APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZED POLYNEUROPATHY",
207750,APOLIPOPROTEIN C-II DEFICIENCY,Number Sign
207765,MOVED TO 218030,Caret
207770,APROSENCEPHALY SYNDROME,
207780,AREDYLD,
207790,"ARACHNOID CYSTS, INTRACRANIAL",
207800,ARGININEMIA,Number Sign
207900,ARGININOSUCCINIC ACIDURIA,Number Sign
207950,CHIARI MALFORMATION TYPE II,Percent
208000,"ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1",Number Sign
208050,ARTERIAL TORTUOSITY SYNDROME; ATS,Number Sign
208060,"ARTERIOSCLEROSIS, SEVERE JUVENILE",Percent
208080,"ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION, AND FACIAL ANOMALIES",
208081,"ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTIC FACIES",
208085,"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1",Number Sign
208100,"ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN",Number Sign
208110,MOVED TO 208155,Caret
208150,FETAL AKINESIA DEFORMATION SEQUENCE; FADS,Number Sign
208155,ILLUM SYNDROME,
208158,ARTHROGRYPOSIS WITH HYPERKERATOSIS,
208200,MOVED TO 259450,Caret
208230,"ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC",Number Sign
208250,CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP,Number Sign
208300,"ASCITES, CHYLOUS",
208400,ASPARTYLGLUCOSAMINURIA; AGU,Number Sign
208500,SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1,Percent
208530,RIGHT ATRIAL ISOMERISM; RAI,Number Sign
208540,RENAL-HEPATIC-PANCREATIC DYSPLASIA 1; RHPD1,Number Sign
208550,"ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE",Number Sign
208600,"ASTHMA, SHORT STATURE, AND ELEVATED IgA",
208700,ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA,
208750,"ATAXIA, DEAFNESS, AND CARDIOMYOPATHY",Percent
208800,MOVED TO 312170,Caret
208850,ATAXIA-DEAFNESS-RETARDATION SYNDROME,
208870,ATAXIA-MICROCEPHALY-CATARACT SYNDROME,
208900,ATAXIA-TELANGIECTASIA; AT,Number Sign
208905,MOVED TO 208900,Caret
208910,ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH,
208920,"ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH",Number Sign
209000,MOVED TO 613179,Caret
209010,"ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS, PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE",
209050,"ATHROMBIA, ESSENTIAL",
209100,ATONIC-ASTATIC SYNDROME OF FOERSTER,Percent
209300,ATRANSFERRINEMIA,Number Sign
209400,MOVED TO 600309,Caret
209500,ATRICHIA WITH PAPULAR LESIONS; APL,Number Sign
209600,ATRIOVENTRICULAR DISSOCIATION,
209700,ATROPHODERMA VERMICULATA; AVA,Percent
209750,MOVED TO 209950,Caret
209770,"AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION",
209800,AUSTRALIA ANTIGEN,
209850,AUTISM,Percent
209880,"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS",Number Sign
209885,BARBER-SAY SYNDROME; BBRSAY,Number Sign
209900,BARDET-BIEDL SYNDROME 1; BBS1,Number Sign
209901,BBS1 GENE; BBS1,Asterisk
209920,"BARE LYMPHOCYTE SYNDROME, TYPE II",Number Sign
209930,MOVED TO 241200,Caret
209950,IMMUNODEFICIENCY 27A; IMD27A,Number Sign
209970,BEEMER LETHAL MALFORMATION SYNDROME,
210000,BEHR SYNDROME; BEHRS,Number Sign
210050,"BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION",
210100,BETA-AMINOISOBUTYRIC ACIDURIA; BAIBA,Number Sign
210200,3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D,Number Sign
210210,3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D,Number Sign
210250,SITOSTEROLEMIA,Number Sign
210300,MOVED TO 201300,Caret
210350,BIEMOND SYNDROME II,
210370,BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD,Number Sign
210400,"BIFID NOSE, AUTOSOMAL RECESSIVE",
210450,MOVED TO 607765,Caret
210500,"BILIARY ATRESIA, EXTRAHEPATIC; EHBA",Percent
210550,BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY,
210600,SECKEL SYNDROME 1; SCKL1,Number Sign
210700,"MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE",
210710,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1",Number Sign
210720,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2",Number Sign
210730,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III",Percent
210740,BANGSTAD SYNDROME,
210745,"BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE",Percent
210750,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6",Number Sign
210900,BLOOM SYNDROME; BLM,Number Sign
211000,BLUE DIAPER SYNDROME,
211100,FUCOSYLTRANSFERASE 1; FUT1,Asterisk
211120,"BONE DYSPLASIA, LETHAL, HOLMGREN TYPE",
211170,MOVED TO 249420,Caret
211180,BOWEN-CONRADI SYNDROME; BWCNS,Number Sign
211200,BOWEN SYNDROME OF MULTIPLE MALFORMATIONS,
211350,KYPHOMELIC DYSPLASIA,Percent
211355,"BOWING OF LONG BONES, ASYMMETRIC AND SYMMETRIC",
211369,"BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY",
211370,BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM,
211380,ELSAHY-WATERS SYNDROME; ESWS,Number Sign
211390,SABINAS BRITTLE HAIR SYNDROME,Percent
211400,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1,Number Sign
211410,MOVED TO 114450,Caret
211420,REMOVED FROM DATABASE,Caret
211450,BRONCHOMALACIA,
211480,BUERGER DISEASE,
211500,FAZIO-LONDE DISEASE,Number Sign
211530,BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1,Number Sign
211550,MOVED TO 113900,Caret
211600,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1",Number Sign
211750,C SYNDROME,Number Sign
211770,CAHMR SYNDROME,
211800,CALCIFICATION OF JOINTS AND ARTERIES; CALJA,Number Sign
211890,"CAMPOMELIA, CUMMING TYPE",Percent
211900,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1",Number Sign
211910,"CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1",
211920,"CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II",
211930,CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA,
211960,"CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMAL PALMAR CREASES",Percent
211965,CAMPTODACTYLY-ICHTHYOSIS SYNDROME,
211970,MOVED TO 114290,Caret
211980,LUNG CANCER,Number Sign
211990,"CAMPTOMELIC SYNDROME, LONG-LIMB TYPE",
212050,"CANDIDIASIS, FAMILIAL, 2; CANDF2",Number Sign
212060,CARBIMAZOLE SENSITIVITY,
212065,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A",Number Sign
212066,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A",Number Sign
212067,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx",
212070,CARBOXYPEPTIDASE N DEFICIENCY,Number Sign
212080,"CARDIAC LIPIDOSIS, FAMILIAL",
212090,CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA,
212093,"CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD",Number Sign
212100,CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS,
212110,MOVED TO 611880,Caret
212112,"CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM",Number Sign
212120,MOVED TO 212112,Caret
212130,CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH,Percent
212135,"CARDIOSKELETAL SYNDROME, KUWAITI TYPE",
212138,CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD,Number Sign
212140,"CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP",Number Sign
212160,"CARNITINE DEFICIENCY, MYOPATHIC",Percent
212200,CARNOSINEMIA,Percent
212350,SENGERS SYNDROME,Number Sign
212360,PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2,
212400,CATARACT AND CONGENITAL ICHTHYOSIS,Percent
212500,"CATARACT 46, JUVENILE-ONSET; CTRCT46",Number Sign
212540,"CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME",
212550,OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD,Number Sign
212600,REMOVED FROM DATABASE,Caret
212700,REMOVED FROM DATABASE,Caret
212710,CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME,
212720,MARTSOLF SYNDROME,Number Sign
212750,"CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1",Number Sign
212780,CENANI-LENZ SYNDACTYLY SYNDROME; CLSS,Number Sign
212790,PREMATURE CENTROMERE DIVISION; PCD,Percent
212800,CEPHALIN LIPIDOSIS,
212835,CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA,
212840,GORDON HOLMES SYNDROME; GDHS,Number Sign
212850,CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS,
212890,"CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA",
212895,"CEREBELLAR ATAXIA, EARLY-ONSET, WITH RETAINED TENDON REFLEXES; EOCA",Percent
212900,MOVED TO 258450,Caret
212905,MOVED TO 606854,Caret
213000,CEREBELLAR HYPOPLASIA,Percent
213002,CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS,
213010,CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZ SYNDROME AND MECKEL SYNDROME,
213100,CEREBELLOPARENCHYMAL DISORDER II; CPD2,Percent
213200,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2",Number Sign
213300,JOUBERT SYNDROME 1; JBTS1,Number Sign
213400,CEREBELLOPARENCHYMAL DISORDER V; CPD5,
213500,"CEREBRAL ANGIOPATHY, DYSPHORIC",
213600,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1",Number Sign
213700,CEREBROTENDINOUS XANTHOMATOSIS; CTX,Number Sign
213820,"CEREBRAL MALFORMATION, SEIZURES, HYPERTRICHOSIS, AND OVERLAPPING FINGERS",
213900,CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE,
213950,CEREBROCORTICAL DEGENERATION OF INFANCY,
213980,"CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME; CFSMR",Number Sign
214100,PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A,Number Sign
214110,PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A,Number Sign
214150,CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1,Number Sign
214200,CEROID STORAGE DISEASE,
214290,"CERVICAL VERTEBRAE, AGENESIS OF",
214300,"KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2",Number Sign
214350,CHAND SYNDROME; CHANDS,
214370,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION, AND ABSENT SENSORY LARGE MYELINATED FIBERS",Percent
214380,MOVED TO 606002,Caret
214400,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A",Number Sign
214450,"GRISCELLI SYNDROME, TYPE 1; GS1",Number Sign
214500,CHEDIAK-HIGASHI SYNDROME; CHS,Number Sign
214700,"DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1",Number Sign
214800,CHARGE SYNDROME,Number Sign
214900,CHOLESTASIS-LYMPHEDEMA SYNDROME,Percent
214950,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4",Number Sign
214980,"CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE",
215030,CHOLESTEROL PNEUMONIA,
215045,"CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD",Number Sign
215050,CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS,
215100,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1",Number Sign
215105,CHONDRODYSPLASIA PUNCTATA SYNDROME,
215140,GREENBERG DYSPLASIA; GRBGD,Number Sign
215150,"OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB",Number Sign
215250,"CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME",
215300,CHONDROSARCOMA,Number Sign
215400,"CHORDOMA, SUSCEPTIBILITY TO; CHDM",Number Sign
215450,"CHOREA, BENIGN FAMILIAL",
215470,BOUCHER-NEUHAUSER SYNDROME; BNHS,Number Sign
215480,CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION,
215500,"CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1",Number Sign
215510,CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY,
215518,CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION,
215520,CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES,Percent
215550,CIRCUMVALLATE PLACENTA SYNDROME,
215600,"CIRRHOSIS, FAMILIAL",Number Sign
215700,"CITRULLINEMIA, CLASSIC",Number Sign
215720,CITRULLINE TRANSPORT DEFECT,
215800,"CLEFT LARYNX, POSTERIOR",
215850,CLEFT-LIMB-HEART MALFORMATION SYNDROME,
216100,CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY,
216300,"CLEFT PALATE, DEAFNESS, AND OLIGODONTIA",
216330,"CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM",
216340,YUNIS-VARON SYNDROME; YVS,Number Sign
216360,COACH SYNDROME,Number Sign
216400,COCKAYNE SYNDROME A; CSA,Number Sign
216411,MOVED TO 216400,Caret
216550,COHEN SYNDROME; COH1,Number Sign
216700,"COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING; RPC",Percent
216800,COLOBOMA OF MACULA AND SKELETAL ANOMALIES,
216820,"COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE",Number Sign
216900,ACHROMATOPSIA 2; ACHM2,Number Sign
216920,COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT,
216950,COMPLEMENT COMPONENT C1r/C1s DEFICIENCY,Percent
217000,COMPLEMENT COMPONENT 2 DEFICIENCY; C2D,Number Sign
217030,COMPLEMENT FACTOR I; CFI,Asterisk
217050,COMPLEMENT COMPONENT 6; C6,Asterisk
217070,COMPLEMENT COMPONENT 7; C7,Asterisk
217080,JALILI SYNDROME,Number Sign
217085,"CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP",Number Sign
217090,"PLASMINOGEN DEFICIENCY, TYPE I",Number Sign
217095,CONOTRUNCAL HEART MALFORMATIONS; CTHM,Number Sign
217100,"CONSTRICTING BANDS, CONGENITAL",Percent
217150,"CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA",
217200,"CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET",
217300,"CORNEA PLANA 2, AUTOSOMAL RECESSIVE; CNA2",Number Sign
217400,CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD,Number Sign
217500,"CORNEAL DYSTROPHY, BAND-SHAPED",Percent
217520,"CORNEAL DEGENERATION, BAND-SHAPED SPHEROID",
217600,CENTRAL CLOUDY DYSTROPHY OF FRANCOIS; CCDF,
217700,CORNEAL ENDOTHELIAL DYSTROPHY; CHED,Number Sign
217800,"MACULAR DYSTROPHY, CORNEAL; MCD",Number Sign
217980,"CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE",Percent
217990,"CORPUS CALLOSUM, AGENESIS OF",Percent
218000,AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN,Number Sign
218010,"CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY",
218030,APPARENT MINERALOCORTICOID EXCESS; AME,Number Sign
218040,COSTELLO SYNDROME; CSTLO,Number Sign
218050,"CRAMPS, FAMILIAL ADOLESCENT",
218090,CRANE-HEISE SYNDROME,
218100,"CRANIAL NERVES, CONGENITAL PARESIS OF",Percent
218200,"CRANIAL NERVES, RECURRENT PARESIS OF",
218300,CRANIODIAPHYSEAL DYSPLASIA; CDD,
218330,CRANIOECTODERMAL DYSPLASIA 1; CED1,Number Sign
218340,TEMTAMY SYNDROME; TEMTYS,Number Sign
218350,CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE,
218400,"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR",Number Sign
218450,"CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS",
218455,MOVED TO 251200,Caret
218500,MOVED TO 123100 AND 123150,Caret
218530,CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS,
218550,CRANIOSYNOSTOSIS WITH FIBULAR APLASIA,
218600,BALLER-GEROLD SYNDROME; BGS,Number Sign
218649,CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG,
218650,CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME,
218670,CRANIOTELENCEPHALIC DYSPLASIA,
218700,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2",Number Sign
218800,"CRIGLER-NAJJAR SYNDROME, TYPE I",Number Sign
218900,CROME SYNDROME,Percent
219000,FRASER SYNDROME 1; FRASRS1,Number Sign
219050,"CRYPTORCHIDISM, UNILATERAL OR BILATERAL",Number Sign
219070,CURVED NAIL OF FOURTH TOE,
219080,ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1,Number Sign
219090,"PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4",Number Sign
219095,"CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL",
219100,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A",Number Sign
219150,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A",Number Sign
219200,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A",Number Sign
219250,CUTIS MARMORATA TELANGIECTATICA CONGENITA; CMTC,
219300,CUTIS VERTICIS GYRATA AND MENTAL RETARDATION; CVG/MR,
219400,CYANOSIS AND HEPATIC DISEASE,
219500,CYSTATHIONINURIA,Number Sign
219550,CYSTEINE PEPTIDURIA,
219600,CYSTIC DISEASE OF LUNG,
219700,CYSTIC FIBROSIS; CF,Number Sign
219721,"CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION",
219730,VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD,Number Sign
219750,"CYSTINOSIS, ADULT NONNEPHROPATHIC",Number Sign
219800,"CYSTINOSIS, NEPHROPATHIC; CTNS",Number Sign
219900,"CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE",Number Sign
220100,CYSTINURIA,Number Sign
220110,MITOCHONDRIAL COMPLEX IV DEFICIENCY,Number Sign
220111,"LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC",Number Sign
220120,D-GLYCERIC ACIDURIA,Number Sign
220150,"HYPOURICEMIA, RENAL, 1; RHUC1",Number Sign
220200,DANDY-WALKER SYNDROME; DWS,Percent
220210,RITSCHER-SCHINZEL SYNDROME 1; RTSC1,Number Sign
220219,"DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY",
220220,DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY,
220290,"DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A",Number Sign
220300,"DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY",
220400,JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1,Number Sign
220500,"DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS",Number Sign
220600,"SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE; SHFM1D",Number Sign
220700,MOVED TO 220290,Caret
220800,MOVED TO 220700,Caret
220900,"DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM",
221000,REMOVED FROM DATABASE,Caret
221200,DEAFNESS AND MYOPIA; DFNMYP,Number Sign
221300,"DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR",Percent
221320,"DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES",
221350,"DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA",Percent
221400,"DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL AND PROGRESSIVE SENSORY NEUROPATHY",
221500,"DEAFNESS, NEURAL, CONGENITAL MODERATE",
221600,MOVED TO 220290,Caret
221650,MOVED TO 220290,Caret
221700,"DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS",
221740,DEAFNESS-OLIGODONTIA SYNDROME,
221745,"DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE",
221750,"PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3",Number Sign
221760,"DERMATOGLYPHICS--PALMAR TRIRADIUS d, ABSENCE OF",
221770,POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL,Number Sign
221780,DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH,
221790,DERMATOLEUKODYSTROPHY,
221800,DERMOCHONDROCORNEAL DYSTROPHY,Percent
221810,"DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE",
221820,"LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS; HDLS",Number Sign
221900,"PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR",Number Sign
221950,DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA,
221995,"DIABETES INSIPIDUS, NEPHROGENIC, WITH MENTAL RETARDATION AND INTRACEREBRAL CALCIFICATION",
222000,MOVED TO 125800,Caret
222100,"DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM",Percent
222300,WOLFRAM SYNDROME 1; WFS1,Number Sign
222350,DIAMINOPENTANURIA,
222400,DIAPHRAGMATIC HERNIA 2; DIH2,Percent
222448,DONNAI-BARROW SYNDROME,Number Sign
222470,TRICHOHEPATOENTERIC SYNDROME 1; THES1,Number Sign
222500,DIASTEMATOMYELIA,
222600,DIASTROPHIC DYSPLASIA; DTD,Number Sign
222690,DIBASIC AMINO ACIDURIA I,Percent
222700,LYSINURIC PROTEIN INTOLERANCE; LPI,Number Sign
222730,DICARBOXYLIC AMINOACIDURIA; DCBXA,Number Sign
222745,"2,4-DIENOYL-CoA REDUCTASE 1, MITOCHONDRIAL; DECR1",Asterisk
222748,DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD,Number Sign
222760,MOVED TO 220500,Caret
222765,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2",Number Sign
222800,BISPHOSPHOGLYCERATE MUTASE DEFICIENCY,Number Sign
222900,"SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID",Number Sign
223000,"LACTASE DEFICIENCY, CONGENITAL",Number Sign
223100,"LACTOSE INTOLERANCE, ADULT TYPE",Number Sign
223200,"DISORGANIZATION, MOUSE, HOMOLOG OF",Percent
223300,DISSEMINATED SCLEROSIS WITH NARCOLEPSY,
223320,"DIVERTICULOSIS, SMALL-INTESTINAL",
223330,"DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT",
223340,DK PHOCOMELIA SYNDROME,
223350,DOHLE BODIES AND LEUKEMIA,
223360,"DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL",Number Sign
223370,DUBOWITZ SYNDROME,Percent
223380,"DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF",
223400,DUODENAL ATRESIA,
223500,"DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE",
223540,"DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY",
223550,"DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION",
223600,MOVED TO 127100,Caret
223610,MOVED TO 228900,Caret
223800,DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC,Number Sign
223900,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3",Number Sign
224000,DYSAUTONOMIA-LIKE DISORDER,
224050,"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1",Number Sign
224100,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2",Number Sign
224120,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A",Number Sign
224200,MOVED TO 229200,Caret
224230,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1",Number Sign
224250,DYSMYELINATION WITH JAUNDICE,
224300,DYSOSTEOSCLEROSIS,Percent
224400,"DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE; DDRD",Percent
224410,"DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH",Number Sign
224500,"DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2",Number Sign
224550,DYSTONIA WITH RINGBINDEN,
224570,MOVED TO 500001,Caret
224600,MOVED TO 128200,Caret
224690,MEIER-GORLIN SYNDROME 1; MGORS1,Number Sign
224700,EBSTEIN ANOMALY,
224750,SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS,Number Sign
224800,ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS,
224900,"ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B",Number Sign
225000,ROSSELLI-GULIENETTI SYNDROME,Percent
225040,"ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESIS OF THE CORPUS CALLOSUM",
225050,"ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARY DYSKINESIA",
225060,CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1,Number Sign
225100,"ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2",Number Sign
225200,ECTOPIA LENTIS ET PUPILLAE,Number Sign
225250,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5",Number Sign
225280,"ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME; EEMS",Number Sign
225290,ECTRODACTYLY-POLYDACTYLY,
225300,SPLIT-HAND/FOOT MALFORMATION 6; SHFM6,Number Sign
225310,EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTIN ABNORMALITY,
225320,"EHLERS-DANLOS SYNDROME, CARDIAC VALVULAR TYPE; EDSCV",Number Sign
225350,MOVED TO 130050,Caret
225360,REMOVED FROM DATABASE,Caret
225400,"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1",Number Sign
225410,"EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS",Number Sign
225450,MOVED TO 182860,Caret
225500,ELLIS-VAN CREVELD SYNDROME; EVC,Number Sign
225700,"ENCEPHALOMALACIA, MULTILOCULAR",
225740,"ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS",
225750,AICARDI-GOUTIERES SYNDROME 1; AGS1,Number Sign
225753,"PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4",Number Sign
225755,"ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION",
225790,PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH,Number Sign
225795,MOVED TO 166000,Caret
226000,ENDOCARDIAL FIBROELASTOSIS; EFE,
226100,ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA,
226110,"ENDOTHELIAL DYSTROPHY, CONGENITAL HEREDITARY, WITH NAIL HYPOPLASIA",
226150,ENTEROCOLITIS,
226200,ENTEROKINASE DEFICIENCY,Number Sign
226300,"COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE",Number Sign
226350,EOSINOPHILIC FASCIITIS,
226400,EPIDERMODYSPLASIA VERRUCIFORMIS; EV,Number Sign
226440,"EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTAL RETARDATION",
226450,MOVED TO 226600 AND 226650,Caret
226500,EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA,Percent
226600,"EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB",Number Sign
226650,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE",Number Sign
226670,EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY; EBSMD,Number Sign
226700,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE",Number Sign
226730,EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA,Number Sign
226735,EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA,
226750,KOHLSCHUTTER-TONZ SYNDROME; KTZS,Number Sign
226800,"EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION",
226810,EPILEPSY WITH BILATERAL OCCIPITAL CALCIFICATIONS,
226850,EPILEPSY-TELANGIECTASIA,
226900,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4",Number Sign
226950,"EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS",
226960,"EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS",Percent
226980,"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS",Number Sign
226985,"EPITHELIAL SQUAMOUS DYSPLASIA, KERATINIZING DESQUAMATIVE, OF URINARY TRACT",
226990,IMMUNODEFICIENCY 32B; IMD32B,Number Sign
227000,ERYTHEMA OF ACRAL REGIONS,
227010,ERMINE PHENOTYPE,
227050,TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD; TEC,Percent
227090,"ERYTHRODERMA, LETHAL CONGENITAL",Percent
227100,MOVED TO 120900,Caret
227150,ETHANOLAMINOSIS,Percent
227200,MOVED TO 614841,Caret
227210,"EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY",
227220,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1",Number Sign
227240,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5",Number Sign
227250,"FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION",
227255,FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS,
227260,"FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD3",Number Sign
227270,"FACIOCARDIOMELIC DYSPLASIA, LETHAL",
227280,FACIOCARDIORENAL SYNDROME,
227290,MOVED TO 222448,Caret
227295,MOVED TO 211910,Caret
227300,"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1",Number Sign
227310,"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, WITH NORMAL PROTEIN C AND PROTEIN C INHIBITOR",
227320,FACIOTHORACOGENITAL SYNDROME,
227330,"FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE",Percent
227400,FACTOR V DEFICIENCY,Number Sign
227500,FACTOR VII DEFICIENCY,Number Sign
227600,FACTOR X DEFICIENCY,Number Sign
227645,"FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC",Number Sign
227646,"FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2",Number Sign
227650,"FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA",Number Sign
227660,MOVED TO 300514,Caret
227700,MOVED TO 134600,Caret
227800,MOVED TO 134600,Caret
227810,FANCONI-BICKEL SYNDROME; FBS,Number Sign
227850,FANCONI-LIKE SYNDROME,
228000,FARBER LIPOGRANULOMATOSIS; FRBRL,Number Sign
228020,"FASCIAL DYSTROPHY, CONGENITAL",
228100,"VISCERAL STEATOSIS, CONGENITAL",Percent
228200,FEMUR-FIBULA-ULNA SYNDROME,
228250,"FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY",Percent
228300,HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23,Number Sign
228355,FETAL IODINE DEFICIENCY DISORDER; FIDD,
228400,"FEVER, FAMILIAL LIFELONG PERSISTENT",
228520,FIBROCHONDROGENESIS 1; FBCG1,Number Sign
228550,"MYOFIBROMATOSIS, INFANTILE, 1; IMF1",Number Sign
228560,"FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES",
228600,HYALINE FIBROMATOSIS SYNDROME; HFS,Number Sign
228800,"FIBROSCLEROSIS, MULTIFOCAL",
228900,FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY,Number Sign
228930,"FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY",Number Sign
228940,FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES,
228960,HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY,Number Sign
228980,"FLECK RETINA, FAMILIAL BENIGN; FRFB",Number Sign
228990,FLECK RETINA OF KANDORI,
229000,"KALLIKREIN B, PLASMA, 1; KLKB1",Asterisk
229045,"FOCAL EPITHELIAL HYPERPLASIA, ORAL",
229050,"FOLATE MALABSORPTION, HEREDITARY",Number Sign
229070,HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24,Number Sign
229100,GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY,Number Sign
229120,FOUNTAIN SYNDROME,Percent
229150,MOVED TO 300624,Caret
229200,BRITTLE CORNEA SYNDROME 1; BCS1,Number Sign
229230,FRASER-LIKE SYNDROME,
229250,"FREESIA FLOWERS, INABILITY TO SMELL",
229300,FRIEDREICH ATAXIA 1; FRDA,Number Sign
229310,FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA,
229400,FRONTOFACIONASAL DYSPLASIA,Percent
229500,FRUCTOSE AND GALACTOSE INTOLERANCE,Percent
229600,"FRUCTOSE INTOLERANCE, HEREDITARY",Number Sign
229650,FRUCTOSE UTILIZATION,
229700,"FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D",Number Sign
229800,"FRUCTOSURIA, ESSENTIAL",Number Sign
229850,FRYNS SYNDROME; FRNS,Percent
229900,MOVED TO 258870,Caret
229950,MOVED TO 136820,Caret
230000,FUCOSIDOSIS,Number Sign
230200,GALACTOKINASE DEFICIENCY,Number Sign
230300,GALACTORRHEA,
230350,GALACTOSE EPIMERASE DEFICIENCY,Number Sign
230400,GALACTOSEMIA,Number Sign
230430,MOVED TO 300622,Caret
230450,"GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO",Number Sign
230500,"GM1-GANGLIOSIDOSIS, TYPE I",Number Sign
230600,"GM1-GANGLIOSIDOSIS, TYPE II",Number Sign
230650,"GM1-GANGLIOSIDOSIS, TYPE III",Number Sign
230700,MOVED TO 272800,Caret
230710,MOVED TO 272800,Caret
230740,GAPO SYNDROME,Number Sign
230750,GASTROSCHISIS,
230800,"GAUCHER DISEASE, TYPE I",Number Sign
230900,"GAUCHER DISEASE, TYPE II",Number Sign
231000,"GAUCHER DISEASE, TYPE III",Number Sign
231005,"GAUCHER DISEASE, TYPE IIIC",Number Sign
231050,GELEOPHYSIC DYSPLASIA 1; GPHYSD1,Number Sign
231060,GENITOPALATOCARDIAC SYNDROME,
231070,GERODERMA OSTEODYSPLASTICUM; GO,Number Sign
231080,GERMAN SYNDROME,
231090,"HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1",Number Sign
231095,GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD,Number Sign
231100,"HEMOCHROMATOSIS, NEONATAL",
231200,BERNARD-SOULIER SYNDROME; BSS,Number Sign
231300,"GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A",Number Sign
231400,REMOVED FROM DATABASE,Caret
231500,MOVED TO 231300,Caret
231520,MOVED TO 273750,Caret
231530,3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY,Number Sign
231550,ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS,Number Sign
231610,REMOVED FROM DATABASE,Caret
231630,MONOSODIUM GLUTAMATE SENSITIVITY,
231670,GLUTARIC ACIDEMIA I; GA1,Number Sign
231675,ELECTRON TRANSFER FLAVOPROTEIN DEHYDROGENASE; ETFDH,Asterisk
231680,MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD,Number Sign
231690,GLUTARIC ACIDURIA III; GA3,Number Sign
231900,"GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO; GSSDE",Number Sign
231950,GLUTATHIONURIA,Number Sign
231970,"GLUTEAL MUSCLES, ABSENCE OF",
232000,"PROPIONYL-CoA CARBOXYLASE, ALPHA SUBUNIT; PCCA",Asterisk
232050,"PROPIONYL-CoA CARBOXYLASE, BETA SUBUNIT; PCCB",Asterisk
232200,GLYCOGEN STORAGE DISEASE Ia; GSD1A,Number Sign
232210,MOVED TO 232200,Caret
232220,GLYCOGEN STORAGE DISEASE Ib; GSD1B,Number Sign
232240,GLYCOGEN STORAGE DISEASE Ic; GSD1C,Number Sign
232300,GLYCOGEN STORAGE DISEASE II; GSD2,Number Sign
232330,MOVED TO 300257,Caret
232400,GLYCOGEN STORAGE DISEASE III; GSD3,Number Sign
232500,GLYCOGEN STORAGE DISEASE IV; GSD4,Number Sign
232600,GLYCOGEN STORAGE DISEASE V; GSD5,Number Sign
232700,GLYCOGEN STORAGE DISEASE VI; GSD6,Number Sign
232800,GLYCOGEN STORAGE DISEASE VII; GSD7,Number Sign
232900,GLYCOPROTEIN STORAGE DISEASE,
233100,RENAL GLUCOSURIA; GLYS,Number Sign
233270,GOMBO SYNDROME,
233300,OVARIAN DYSGENESIS 1; ODG1,Number Sign
233400,PERRAULT SYNDROME 1; PRLTS1,Number Sign
233420,"46,XY SEX REVERSAL 7; SRXY7",Number Sign
233430,"GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES",
233450,GOODPASTURE SYNDROME,
233500,MOVED TO 612289,Caret
233600,GRANULOCYTOPENIA WITH IMMUNOGLOBULIN ABNORMALITY,
233650,COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG,Number Sign
233670,GRANULOMATOUS DISEASE WITH DEFECT IN NEUTROPHIL CHEMOTAXIS,
233690,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE",Number Sign
233700,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1",Number Sign
233710,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2",Number Sign
233800,GROUPED PIGMENTATION OF THE RETINA,
233805,"GROWTH FACTORS, COMBINED DEFECT OF",
233810,"GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA",
233910,"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B",Number Sign
234000,FACTOR XII DEFICIENCY,Number Sign
234030,HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION,
234050,"TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4",Number Sign
234100,HALLERMANN-STREIFF SYNDROME; HSS,Percent
234200,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1,Number Sign
234250,HALL-RIGGS MENTAL RETARDATION SYNDROME,
234280,HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY,
234300,HALO NEVI,
234350,HALOTHANE HEPATITIS,
234500,HARTNUP DISORDER; HND,Number Sign
234580,HEIMLER SYNDROME 1; HMLR1,Number Sign
234700,"HEART BLOCK, CONGENITAL",
234750,"HEART, MALFORMATION OF",
234800,"HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES",
234810,"PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2",Number Sign
234820,"HEMANGIOPERICYTOMA, MALIGNANT",
235000,"HEMIHYPERPLASIA, ISOLATED; IH",Percent
235200,"HEMOCHROMATOSIS, TYPE 1; HFE1",Number Sign
235255,"MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY",Percent
235360,MOVED TO 219100,Caret
235370,HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS,
235400,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1",Number Sign
235500,"HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN",
235510,HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1; HKLLS1,Number Sign
235550,HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI,Number Sign
235555,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2",Number Sign
235600,MOVED TO 400045,Caret
235700,"HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY",Number Sign
235730,MOWAT-WILSON SYNDROME; MOWS,Number Sign
235735,MOVED TO 277580,Caret
235740,"HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS",
235750,"HIRSCHSPRUNG DISEASE WITH ULNAR POLYDACTYLY, POLYSYNDACTYLY OF BIG TOES, AND VENTRICULAR SEPTAL DEFECT",
235760,HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIAL FEATURES,
235800,HISTIDINEMIA,Number Sign
235830,HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT,Percent
235900,"HISTIOCYTOSIS, FAMILIAL LIPOCHROME",Percent
236000,"LYMPHOMA, HODGKIN, CLASSIC; CHL",Number Sign
236100,HOLOPROSENCEPHALY 1; HPE1,Percent
236110,HOLZGREVE SYNDROME,
236130,HOMOCARNOSINOSIS,
236200,HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY,Number Sign
236250,"HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY",Number Sign
236270,"HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE",Number Sign
236300,HOOFT DISEASE,
236400,HUMERORADIAL SYNOSTOSIS,Percent
236410,HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES,
236450,HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME,
236490,MOVED TO 228600,Caret
236500,"MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH",Number Sign
236600,"HYDROCEPHALUS, CONGENITAL, 1; HYC1",Number Sign
236635,HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS,
236640,HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS,
236660,"HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS",
236670,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1",Number Sign
236680,HYDROLETHALUS SYNDROME 1; HLS1,Number Sign
236690,"HYDROCEPHALUS, NORMAL-PRESSURE",
236700,MCKUSICK-KAUFMAN SYNDROME; MKKS,Number Sign
236730,UROFACIAL SYNDROME 1; UFS1,Number Sign
236750,"HYDROPS FETALIS, NONIMMUNE; NIHF",Number Sign
236792,L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA,Number Sign
236795,3-HYDROXYISOBUTYRIC ACIDURIA,Percent
236800,HYDROXYKYNURENINURIA,Number Sign
236900,HYDROXYLYSINURIA,Percent
237000,HYDROXYPROLINEMIA,
237100,"HYMEN, IMPERFORATE",
237300,"CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO",Number Sign
237310,N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD,Number Sign
237400,HYPER-BETA-ALANINEMIA,
237450,"HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR",Number Sign
237500,DUBIN-JOHNSON SYNDROME; DJS,Number Sign
237550,"HYPERBILIRUBINEMIA, CONJUGATED, TYPE III",
237800,"HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB",Percent
237900,"HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN",Number Sign
238200,MOVED TO 220100,Caret
238300,GLYCINE DECARBOXYLASE; GLDC,Asterisk
238310,AMINOMETHYLTRANSFERASE; AMT,Asterisk
238320,"LEYDIG CELL HYPOPLASIA, TYPE I",Number Sign
238330,GLYCINE CLEAVAGE SYSTEM H PROTEIN; GCSH,Asterisk
238331,DIHYDROLIPOAMIDE DEHYDROGENASE; DLD,Asterisk
238340,HYPERLEUCINE-ISOLEUCINEMIA,
238350,HYPERLEXIA,
238400,MOVED TO 144650,Caret
238500,MOVED TO 144650,Caret
238600,"HYPERLIPOPROTEINEMIA, TYPE I",Number Sign
238700,"HYPERLYSINEMIA, TYPE I",Number Sign
238710,HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA,
238750,HYPERLYSINURIA WITH HYPERAMMONEMIA,
238800,HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA,
238950,"HYPEROPIA, HIGH",
238970,HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME,Number Sign
239000,"PAGET DISEASE OF BONE 5, JUVENILE-ONSET; PDB5",Number Sign
239100,VAN BUCHEM DISEASE; VBCH,Number Sign
239199,"HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA",
239200,"HYPERPARATHYROIDISM, NEONATAL SEVERE; NSHPT",Number Sign
239300,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1,Number Sign
239350,"HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES",
239400,REMOVED FROM DATABASE,Caret
239500,"HYPERPROLINEMIA, TYPE I; HYRPRO1",Number Sign
239510,"HYPERPROLINEMIA, TYPE II; HYRPRO2",Number Sign
239710,ACROFRONTOFACIONASAL DYSOSTOSIS 2,
239711,HYPERTELORISM AND TETRALOGY OF FALLOT,
239800,"HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME",Percent
239840,"HYPERTRICHOSIS, CONGENITAL ANTERIOR CERVICAL, WITH PERIPHERAL SENSORY AND MOTOR NEUROPATHY",
239850,CANTU SYNDROME,Number Sign
239900,HYPERTROPHIC NEUROPATHY AND CATARACT,
240000,"HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE",
240100,REMOVED FROM DATABASE,Caret
240150,"HYPERVITAMINOSIS A, SUSCEPTIBILITY TO",
240200,"HYPOADRENOCORTICISM, FAMILIAL",Percent
240300,"AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1",Number Sign
240400,HYPOASCORBEMIA,
240500,"IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2",Number Sign
240600,"GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A",Number Sign
240800,"HYPOGLYCEMIA, LEUCINE-INDUCED; LIH",Number Sign
240900,HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH,Number Sign
240950,HYPOGONADISM-CATARACT SYNDROME,
241000,HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY,
241080,WOODHOUSE-SAKATI SYNDROME,Number Sign
241090,HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA,Percent
241100,"HYPOGONADISM, MALE",
241120,HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES,
241150,"HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY",Percent
241200,"BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2",Number Sign
241310,HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS,Percent
241400,MOVED TO 146200,Caret
241410,HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS,Number Sign
241500,"HYPOPHOSPHATASIA, INFANTILE",Number Sign
241510,"HYPOPHOSPHATASIA, CHILDHOOD",Number Sign
241519,"HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS",
241520,"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1",Number Sign
241530,"HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH",Number Sign
241540,"HYPOPITUITARISM, CONGENITAL, WITH CENTRAL DIABETES INSIPIDUS",
241550,HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1,Number Sign
241600,IMMUNODEFICIENCY 43; IMD43,Number Sign
241750,MOVED TO 146450,Caret
241760,HYPOSPADIAS-MENTAL RETARDATION SYNDROME,
241800,HYPOTHALAMIC HAMARTOMAS,
241850,"HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE",Number Sign
241900,MOVED TO 203655,Caret
242050,"HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY",
242100,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2; ARCI2",Number Sign
242150,"ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS",
242170,MOVED TO 601675,Caret
242300,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1",Number Sign
242400,ICHTHYOSIS CONGENITA WITH BILIARY ATRESIA,
242500,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B",Number Sign
242510,"ICHTHYOSIS WITH ALOPECIA, ECLABIUM, ECTROPION, AND MENTAL RETARDATION",
242520,"ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION",
242530,"ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT",
242550,"ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA",
242600,IMINOGLYCINURIA,Number Sign
242650,MOVED TO 244400,Caret
242670,CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES,Percent
242680,CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA,
242700,IMMUNE DEFECT DUE TO ABSENCE OF THYMUS,Percent
242800,REMOVED FROM DATABASE,Caret
242840,VICI SYNDROME; VICIS,Number Sign
242850,IMMUNE DEFICIENCY DISEASE,
242860,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1,Number Sign
242870,"IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTS AND BETA-2-MICROGLOBULIN FROM LYMPHOCYTES",
242880,IMMUNOERYTHROMYELOID HYPOPLASIA,
242890,"IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW",
242900,SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD,Number Sign
243000,"INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP",Number Sign
243050,INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION,
243060,SPERMATOGENIC FAILURE 5; SPGF5,Number Sign
243080,"INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO",
243095,MOVED TO 270450,Caret
243100,"INTERNAL CAROTID ARTERIES, HYPOPLASIA OF",
243110,IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN 1,
243150,GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID,Number Sign
243180,"VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE",Percent
243185,INTESTINAL PSEUDOOBSTRUCTION WITH PATENT DUCTUS ARTERIOSUS AND NATAL TEETH,
243200,"INTRACRANIAL HYPERTENSION, IDIOPATHIC",
243300,"CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1",Number Sign
243305,INVERSIN; INVS,Asterisk
243310,BARAITSER-WINTER SYNDROME 1; BRWS1,Number Sign
243320,"INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF",
243340,MOVED TO 242860,Caret
243400,"ACETYLATION, SLOW",Number Sign
243440,ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME,
243450,"ISOVALERIC ACID, INABILITY TO SMELL",
243500,ISOVALERIC ACIDEMIA; IVA,Number Sign
243600,JEJUNAL ATRESIA,Percent
243605,STROMME SYNDROME; STROMS,Number Sign
243700,"HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE",Number Sign
243800,JOHANSON-BLIZZARD SYNDROME; JBS,Number Sign
243910,ARIMA SYNDROME,Percent
244100,JUMPING FRENCHMEN OF MAINE,
244200,HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3,Number Sign
244300,KAPUR-TORIELLO SYNDROME,Percent
244400,"CILIARY DYSKINESIA, PRIMARY, 1; CILD1",Number Sign
244450,KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS,Number Sign
244460,"KENNY-CAFFEY SYNDROME, TYPE 1; KCS1",Number Sign
244500,MOVED TO 148300,Caret
244510,KERATOCONUS AND CONGENITAL HIP DYSPLASIA,
244600,KERATOCONUS POSTICUS CIRCUMSCRIPTUS; KPC,
244850,"PALMOPLANTAR KERATODERMA, NORRBOTTEN RECESSIVE TYPE; PPKNR",
245000,PAPILLON-LEFEVRE SYNDROME; PALS,Number Sign
245010,HAIM-MUNK SYNDROME; HMS,Number Sign
245050,SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY; SCOTD,Number Sign
245100,RICHARDS-RUNDLE SYNDROME; RRNS,Percent
245130,KETOADIPICACIDURIA,
245150,KEUTEL SYNDROME; KTLS,Number Sign
245160,KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS,
245180,KIFAFA SEIZURE DISORDER,
245190,"KNIEST-LIKE DYSPLASIA, LETHAL",
245200,KRABBE DISEASE,Number Sign
245210,MOVED TO 192430 AND 188400,Caret
245300,"KURU, SUSCEPTIBILITY TO",Number Sign
245340,ERYTHROCYTE LACTATE TRANSPORTER DEFECT,Number Sign
245348,PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD,Number Sign
245349,PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD,Number Sign
245400,MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9,Number Sign
245450,LACTIC ACIDURIA DUE TO D-LACTIC ACID,
245480,SPECIFIC GRANULE DEFICIENCY 1; SGD1,Number Sign
245500,REMOVED FROM DATABASE,Caret
245550,LAMBERT SYNDROME,
245552,LAMBOTTE SYNDROME,
245570,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD",Number Sign
245590,GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY,Number Sign
245600,"MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD",Number Sign
245650,"LARSEN-LIKE SYNDROME, LETHAL TYPE",
245660,LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS,Number Sign
245800,LAURENCE-MOON SYNDROME; LNMS,Number Sign
245900,LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY,Number Sign
246000,"LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT",Percent
246200,DONOHUE SYNDROME,Number Sign
246300,"LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3",Number Sign
246400,LETTERER-SIWE DISEASE,Percent
246450,3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD,Number Sign
246470,"LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER",
246490,MOVED TO 266265,Caret
246500,"LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS",
246530,LEUKOTRIENE C4 SYNTHASE; LTC4S,Asterisk
246550,LICHTENSTEIN SYNDROME,
246555,"LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY",
246560,SPLIT-HAND/FOOT MALFORMATION 3; SHFM3,Number Sign
246570,"FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME",
246600,PANCREATIC LIPASE; PNLIP,Asterisk
246650,"LIPASE DEFICIENCY, COMBINED",Number Sign
246700,CHYLOMICRON RETENTION DISEASE; CMRD,Number Sign
246800,MOVED TO 257220,Caret
246900,DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD,Number Sign
247100,LIPOID PROTEINOSIS OF URBACH AND WIETHE,Number Sign
247150,LIP PRINTS,
247200,MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS,Number Sign
247400,MOVED TO 210710,Caret
247410,LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME,
247420,LUTHERAN NULL,Number Sign
247430,"LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF",
247440,"LYMPHEDEMA, CONGENITAL RECESSIVE",
247450,"LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN",
247610,LYMPHOID INTERSTITIAL PNEUMONIA; LIP,
247630,"LYMPHOID SYSTEM DETERIORATION, PROGRESSIVE",
247640,"LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES; LALL",
247650,LYMPHOKINE DEFICIENCY,
247800,"LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE HEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS",Percent
247900,MOVED TO 238700,Caret
247950,LYSINE MALABSORPTION SYNDROME,
247980,"LIPASE B, LYSOSOMAL ACID; LIPB",Asterisk
247990,MACDERMOT-WINTER SYNDROME,
248000,"MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH",Number Sign
248010,"MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE",
248100,MACROSOMIA ADIPOSA CONGENITA,
248110,"MACROSOMIA WITH MICROPHTHALMIA, LETHAL",
248190,"HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5",Number Sign
248200,STARGARDT DISEASE 1; STGD1,Number Sign
248250,"HYPOMAGNESEMIA 3, RENAL; HOMG3",Number Sign
248260,"MAGNESIUM, ELEVATED RED CELL",
248300,MAL DE MELEDA; MDM,Number Sign
248310,PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL,Percent
248340,3MC SYNDROME 3; 3MC3,Number Sign
248350,MALOCCLUSION AND SHORT STATURE,
248360,MALONYL-CoA DECARBOXYLASE DEFICIENCY,Number Sign
248370,MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA,Number Sign
248390,TREACHER COLLINS SYNDROME 3; TCS3,Number Sign
248400,MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION,
248450,MANITOBA OCULOTRICHOANAL SYNDROME; MOTA,Number Sign
248500,"MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA",Number Sign
248510,"MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB",Number Sign
248600,MAPLE SYRUP URINE DISEASE; MSUD,Number Sign
248610,DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT,Asterisk
248611,"BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB",Asterisk
248700,MARDEN-WALKER SYNDROME; MWKS,Number Sign
248750,MOVED TO 154700,Caret
248760,MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS,
248770,"MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL",
248800,MARINESCO-SJOGREN SYNDROME; MSS,Number Sign
248810,MOVED TO 248800,Caret
248900,MAST SYNDROME,Number Sign
248910,"CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA",
248950,MCDONOUGH SYNDROME,
249000,"MECKEL SYNDROME, TYPE 1; MKS1",Number Sign
249100,FAMILIAL MEDITERRANEAN FEVER; FMF,Number Sign
249210,MOVED TO 155310,Caret
249230,MEGAEPIPHYSEAL DWARFISM,
249240,MEGALENCEPHALY WITH DYSMYELINATION,
249270,THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA,Number Sign
249300,MEGALOCORNEA,
249310,MEGALOCORNEA-MENTAL RETARDATION SYNDROME,Percent
249400,"MELANOSIS, NEUROCUTANEOUS; NCMS",Number Sign
249420,FRANK-TER HAAR SYNDROME; FTHS,Number Sign
249500,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1",Number Sign
249599,"MENTAL RETARDATION SYNDROME, BELGIAN TYPE",
249600,"MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE",
249620,OHDO SYNDROME,Percent
249630,"MENTAL RETARDATION, BUENOS AIRES TYPE",
249650,MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU,Percent
249660,"MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES",
249670,MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION,
249700,LANGER MESOMELIC DYSPLASIA; LMD,Number Sign
249710,MESOMELIC LIMB SHORTENING AND BOWING,
249800,REMOVED FROM DATABASE,Caret
249900,METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY,Number Sign
250100,METACHROMATIC LEUKODYSTROPHY; MLD,Number Sign
250215,METAPHYSEAL ACROSCYPHODYSPLASIA,Percent
250220,"SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS",Number Sign
250230,"METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE",
250250,CARTILAGE-HAIR HYPOPLASIA; CHH,Number Sign
250300,"METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE",
250400,"METAPHYSEAL DYSPLASIA, SPAHR TYPE; MDST",Number Sign
250410,RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES; RPSKA,Number Sign
250420,"METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS",
250450,"METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY",
250460,METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH,Number Sign
250500,"METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA",
250600,MOVED TO 156530,Caret
250620,3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD,Number Sign
250650,METHANE PRODUCTION,
250700,METHEMOGLOBIN REDUCTASE DEFICIENCY,
250790,METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG,Number Sign
250800,METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE,Number Sign
250850,METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY,Number Sign
250900,METHIONINE MALABSORPTION SYNDROME,Percent
250940,"HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG",Number Sign
250950,"3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1",Number Sign
250951,"3-METHYLGLUTACONIC ACIDURIA, TYPE IV; MGCA4",
251000,METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY,Number Sign
251100,"METHYLMALONIC ACIDURIA, cblA TYPE",Number Sign
251110,"METHYLMALONIC ACIDURIA, cblB TYPE",Number Sign
251120,METHYLMALONYL-CoA EPIMERASE DEFICIENCY,Number Sign
251170,MEVALONATE KINASE; MVK,Asterisk
251190,"MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE",
251200,"MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1",Number Sign
251220,MICROCEPHALY-CARDIOMYOPATHY,
251230,MICROCEPHALY-MICROMELIA SYNDROME; MIMIS,Number Sign
251240,MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA,
251250,MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES,
251255,JAWAD SYNDROME; JWDS,Number Sign
251260,NIJMEGEN BREAKAGE SYNDROME; NBS,Number Sign
251270,"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1",Number Sign
251280,"MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC",Number Sign
251290,PSEUDO-TORCH SYNDROME 1; PTORCH1,Number Sign
251300,GALLOWAY-MOWAT SYNDROME 1; GAMOS1,Number Sign
251400,MICROCOLON,
251450,DESBUQUOIS DYSPLASIA 1; DBQD1,Number Sign
251455,MOVED TO 258315,Caret
251500,MOVED TO 600118,Caret
251505,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4; MCOPCB4",
251600,"MICROPHTHALMIA, ISOLATED 1; MCOP1",Percent
251700,"MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA, AND DENTAL ANOMALIES",
251750,"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA",Number Sign
251800,MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS,Percent
251850,"DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2",Number Sign
251880,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3,Number Sign
251890,MOVED TO 143450,Caret
251900,MITOCHONDRIAL MYOPATHY,
251945,MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT,
251950,MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA,Number Sign
252010,MITOCHONDRIAL COMPLEX I DEFICIENCY,Number Sign
252011,MITOCHONDRIAL COMPLEX II DEFICIENCY,Number Sign
252030,REMOVED FROM DATABASE,Caret
252100,MOHR SYNDROME,Percent
252150,"MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA",Number Sign
252160,"MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB",Number Sign
252200,MOVED TO 158000 AND 607903,Caret
252250,MONOCYTE CHEMOTACTIC DISORDER,
252270,MONOSOMY 7 OF BONE MARROW,Number Sign
252300,MORQUIO SYNDROME C,
252320,"MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA",
252350,MOYAMOYA DISEASE 1; MYMY1,Percent
252500,MUCOLIPIDOSIS II ALPHA/BETA,Number Sign
252600,MUCOLIPIDOSIS III ALPHA/BETA,Number Sign
252605,MUCOLIPIDOSIS III GAMMA,Number Sign
252650,MUCOLIPIDOSIS IV; ML4,Number Sign
252700,"MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES",Number Sign
252800,ALPHA-L-IDURONIDASE; IDUA,Asterisk
252900,"MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A",Number Sign
252920,"MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B",Number Sign
252930,"MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C",Number Sign
252940,"MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D",Number Sign
253000,"MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A",Number Sign
253010,"MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B",Number Sign
253200,"MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6",Number Sign
253220,"MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7",Number Sign
253230,MOVED TO 601492,Caret
253240,MUCUS INSPISSATION OF RESPIRATORY TRACT,Percent
253250,MULIBREY NANISM,Number Sign
253260,BIOTINIDASE DEFICIENCY,Number Sign
253270,HOLOCARBOXYLASE SYNTHETASE DEFICIENCY,Number Sign
253280,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3",Number Sign
253290,"MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS",Number Sign
253300,"SPINAL MUSCULAR ATROPHY, TYPE I; SMA1",Number Sign
253310,LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1,Number Sign
253320,"MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPIC HYPOGONADISM",
253400,"SPINAL MUSCULAR ATROPHY, TYPE III; SMA3",Number Sign
253500,REMOVED FROM DATABASE,Caret
253550,"SPINAL MUSCULAR ATROPHY, TYPE II; SMA2",Number Sign
253590,"MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY",
253600,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A",Number Sign
253601,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2; LGMDR2",Number Sign
253700,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5; LGMDR5",Number Sign
253800,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4",Number Sign
253850,MOVED TO 602771,Caret
253900,"MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS",Percent
254000,"MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM",
254090,ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1,Number Sign
254100,"MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION",
254110,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8; LGMDR8",Number Sign
254120,"MUSCULAR HYPERTONIA, LETHAL",
254130,MIYOSHI MUSCULAR DYSTROPHY 1; MMD1,Number Sign
254150,"MUSK, INABILITY TO SMELL",Percent
254190,"MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS",
254195,MOVED TO 608931,Caret
254200,MYASTHENIA GRAVIS; MG,
254210,"MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6",Number Sign
254300,"MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10",Number Sign
254400,MYCOSIS FUNGOIDES,
254450,MYELOFIBROSIS,Number Sign
254500,"MYELOMA, MULTIPLE",Number Sign
254600,MYELOPEROXIDASE DEFICIENCY; MPOD,Number Sign
254700,"MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE",
254770,"EPILEPSY, MYOCLONIC JUVENILE; EJM",Number Sign
254780,MYOCLONIC EPILEPSY OF LAFORA,Number Sign
254800,MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG,Number Sign
254900,"EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4",Number Sign
254940,CAREY-FINEMAN-ZITER SYNDROME; CFZS,Number Sign
254950,"MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA",
254960,MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT,
255100,LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD,Number Sign
255110,"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED",Number Sign
255120,CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY,Number Sign
255125,"MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML",Number Sign
255140,MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA,
255160,"MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB",Number Sign
255170,MOVED TO 603280,Caret
255200,"MYOPATHY, CENTRONUCLEAR, 2; CNM2",Number Sign
255300,"MYOPATHY, CONGENITAL",Percent
255310,"MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD",Number Sign
255320,MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA,Number Sign
255500,"MYOPIA 18, AUTOSOMAL RECESSIVE; MYP18",Percent
255600,"MYOSCLEROSIS, AUTOSOMAL RECESSIVE",Number Sign
255700,"MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE",Number Sign
255710,MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION,
255800,"SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1",Number Sign
255900,MYXEDEMA,
255960,"MYXOMA, INTRACARDIAC",Number Sign
255980,NASODIGITOACOUSTIC SYNDROME,Percent
255990,NATHALIE SYNDROME,
255995,"MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB",Number Sign
256000,LEIGH SYNDROME; LS,Number Sign
256020,NAIL-PATELLA-LIKE RENAL DISEASE,
256030,NEMALINE MYOPATHY 2; NEM2,Number Sign
256040,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1,Number Sign
256050,"ATELOSTEOGENESIS, TYPE II; AO2",Number Sign
256100,NEPHRONOPHTHISIS 1; NPHP1,Number Sign
256120,"NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM",
256150,NEPHROSIALIDOSIS,
256200,NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS,
256300,"NEPHROTIC SYNDROME, TYPE 1; NPHS1",Number Sign
256340,MOVED TO 146255,Caret
256350,MOVED TO 600995,Caret
256370,"NEPHROTIC SYNDROME, TYPE 4; NPHS4",Number Sign
256450,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1",Number Sign
256500,NETHERTON SYNDROME; NETH,Number Sign
256520,NEU-LAXOVA SYNDROME 1; NLS1,Number Sign
256540,GALACTOSIALIDOSIS; GSL,Number Sign
256550,NEURAMINIDASE DEFICIENCY,Number Sign
256600,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A,Number Sign
256690,NEUROFACIODIGITORENAL SYNDROME,
256700,"NEUROBLASTOMA, SUSCEPTIBILITY TO",Number Sign
256710,ELEJALDE DISEASE,Number Sign
256720,"NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY",
256730,"CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1",Number Sign
256731,"CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5",Number Sign
256800,"INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA",Number Sign
256810,MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6,Number Sign
256840,"NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE",Number Sign
256850,"GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1",Number Sign
256851,MOVED TO 256850,Caret
256855,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING COMPLEX, AUTOSOMAL RECESSIVE",Percent
256860,"NEUROPATHY, HEREDITARY SENSORY, ATYPICAL",
256870,"NEUROPATHY, PAINFUL",
257000,NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES,
257050,MOVED TO 257220,Caret
257100,"NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA",
257150,NEUTROPHIL ACTIN DYSFUNCTION; NAD,Percent
257200,"NIEMANN-PICK DISEASE, TYPE A",Number Sign
257220,"NIEMANN-PICK DISEASE, TYPE C1; NPC1",Number Sign
257250,MOVED TO 257220,Caret
257270,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B",Number Sign
257300,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1,Number Sign
257320,LISSENCEPHALY 2; LIS2,Number Sign
257350,"NUCHAL BLEB, FAMILIAL",
257400,"NYSTAGMUS, CONGENITAL, AUTOSOMAL RECESSIVE",
257500,OBESITY-HYPOVENTILATION SYNDROME,
257550,OCULAR MOTOR APRAXIA,Percent
257600,OCULAR MYOPATHY WITH CURARE SENSITIVITY,Percent
257790,OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS,
257800,OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION,Percent
257850,"OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE",Number Sign
257910,OCULOPALATOCEREBRAL SYNDROME,Percent
257920,3MC SYNDROME 1; 3MC1,Number Sign
257950,MOVED TO 164300,Caret
257960,OCULOTRICHODYSPLASIA; OTD,
257970,OCULORENOCEREBELLAR SYNDROME,Percent
257980,ODONTOONYCHODERMAL DYSPLASIA; OODD,Number Sign
258040,OEIS COMPLEX,
258100,OGUCHI DISEASE 1,Number Sign
258120,MOVED TO 271245,Caret
258150,SPERMATOGENIC FAILURE 1; SPGF1,Percent
258200,OLIVER SYNDROME,
258300,"OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE",Percent
258315,OMODYSPLASIA 1; OMOD1,Number Sign
258320,"OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL",
258360,ONYCHOTRICHODYSPLASIA AND NEUTROPENIA,Percent
258400,OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS,Percent
258450,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1",Number Sign
258470,OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA,
258480,OPSISMODYSPLASIA; OPSMD,Number Sign
258500,OPTIC ATROPHY 6; OPA6,Percent
258501,"3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3",Number Sign
258650,"OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE",
258660,"NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO",Number Sign
258700,OPTICOCOCHLEODENTATE DEGENERATION,Percent
258800,"ORAL SENSIBILITY, DISTURBANCE OF",
258840,ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS,
258850,OROFACIODIGITAL SYNDROME III; OFD3,Percent
258860,OROFACIODIGITAL SYNDROME IV; OFD4,Number Sign
258865,OROFACIODIGITAL SYNDROME IX; OFD9,Percent
258870,GYRATE ATROPHY OF CHOROID AND RETINA; GACR,Number Sign
258900,OROTIC ACIDURIA,Number Sign
258920,MOVED TO 258900,Caret
259050,PRIMROSE SYNDROME; PRIMS,Number Sign
259100,"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1",Number Sign
259200,"BLOUNT DISEASE, ADOLESCENT",
259250,"OSTEODYSPLASIA, FAMILIAL, ANDERSON TYPE",Percent
259270,"OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI",
259400,MOVED TO 166210,Caret
259410,"OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS",
259420,"OSTEOGENESIS IMPERFECTA, TYPE III; OI3",Number Sign
259440,"OSTEOGENESIS IMPERFECTA, TYPE IX; OI9",Number Sign
259450,BRUCK SYNDROME 1; BRKS1,Number Sign
259500,OSTEOGENIC SARCOMA,Number Sign
259550,OSTEOID OSTEOMA,
259600,"MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA",Number Sign
259610,"OSTEOLYSIS SYNDROME, RECESSIVE",
259650,OSTEOMA OF MIDDLE EAR,
259660,"OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION",
259680,CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CRMO,
259690,OSTEOPENIA AND SPARSE HAIR,
259700,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1",Number Sign
259710,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2",Number Sign
259720,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5",Number Sign
259730,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3",Number Sign
259750,"OSTEOPOROSIS, JUVENILE",
259770,OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG,Number Sign
259775,RAINE SYNDROME; RNS,Number Sign
259780,OTOONYCHOPERONEAL SYNDROME,Percent
259900,"HYPEROXALURIA, PRIMARY, TYPE I; HP1",Number Sign
260000,"HYPEROXALURIA, PRIMARY, TYPE II; HP2",Number Sign
260005,5-OXOPROLINASE DEFICIENCY; OPLAHD,Number Sign
260100,PA POLYMORPHISM OF ALPHA-2-GLOBULIN,
260130,"PACHYONYCHIA CONGENITA, AUTOSOMAL RECESSIVE",
260150,PALANT CLEFT PALATE SYNDROME,
260200,"PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA",
260300,"PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15",Number Sign
260350,PANCREATIC CANCER,Number Sign
260370,PANCREATIC AGENESIS 1; PAGEN1,Number Sign
260400,SHWACHMAN-DIAMOND SYNDROME 1; SDS1,Number Sign
260450,"PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE",
260470,"PANENCEPHALITIS, SUBACUTE SCLEROSING",
260480,"PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX",
260490,MOVED TO 174800,Caret
260500,PAPILLOMA OF CHOROID PLEXUS; CPP,Number Sign
260530,PARANA HARD-SKIN SYNDROME,
260540,PARKINSON-DEMENTIA SYNDROME,Number Sign
260555,PARTINGTON-ANDERSON SYNDROME,
260565,PEHO SYNDROME; PEHO,Number Sign
260570,PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN,
260600,"LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3",Number Sign
260650,PELLAGRA-LIKE SYNDROME,
260660,COUSIN SYNDROME,Number Sign
260800,PENTOSURIA; PNTSU,Number Sign
260900,"PERICARDIAL EFFUSION, CHRONIC",
260910,"PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL",
260920,HYPER-IgD SYNDROME; HIDS,Number Sign
260950,"PERIODONTITIS, CHRONIC",
260970,"PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND SPONGY DEGENERATION OF BRAIN",
260980,MOVED TO 300388,Caret
261000,INTRINSIC FACTOR DEFICIENCY; IFD,Number Sign
261100,MEGALOBLASTIC ANEMIA 1,Number Sign
261400,"PERONEUS TERTIUS MUSCLE, ABSENCE OF",
261500,EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD,Number Sign
261510,MOVED TO 261515,Caret
261515,D-BIFUNCTIONAL PROTEIN DEFICIENCY,Number Sign
261540,PETERS-PLUS SYNDROME,Number Sign
261550,"PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS",Number Sign
261560,PFEIFFER-PALM-TELLER SYNDROME,
261575,PHAVER SYNDROME,
261590,PHENFORMIN 4-HYDROXYLATION,
261600,PHENYLKETONURIA; PKU,Number Sign
261630,"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C",Number Sign
261640,"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A",Number Sign
261650,"PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL; PCKDM",Percent
261660,REMOVED FROM DATABASE,Caret
261670,GLYCOGEN STORAGE DISEASE X; GSD10,Number Sign
261680,"PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC",Number Sign
261740,"GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL",Number Sign
261750,GLYCOGEN STORAGE DISEASE IXb; GSD9B,Number Sign
261800,PIERRE ROBIN SYNDROME; PRBNS,Percent
261900,"PILI TORTI, EARLY-ONSET",Percent
261990,PILI TORTI AND DEVELOPMENTAL DELAY,
262000,BJORNSTAD SYNDROME; BJS,Number Sign
262020,PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS,
262190,"PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES",Number Sign
262300,ACHROMATOPSIA 3; ACHM3,Number Sign
262350,MOVED TO 194190,Caret
262400,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A",Number Sign
262500,LARON SYNDROME,Number Sign
262600,"PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2",Number Sign
262650,KOWARSKI SYNDROME,Number Sign
262700,"PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4",Number Sign
262710,PITUITARY DWARFISM WITH LARGE SELLA TURCICA,
262780,MOVED TO 107910,Caret
262800,"PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF",
262850,ALPHA-2-PLASMIN INHIBITOR DEFICIENCY,Number Sign
262875,PLATELET PROSTACYCLIN RECEPTOR DEFECT,
262890,SCOTT SYNDROME; SCTS,Number Sign
262900,PLEOCONIAL MYOPATHY WITH SALT CRAVING,
263000,"INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP",Percent
263100,"POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS",
263200,POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4,Number Sign
263210,GILLESSEN-KAESBACH-NISHIMURA SYNDROME; GIKANIS,Number Sign
263300,POLYCYTHEMIA VERA; PV,Number Sign
263400,"ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2",Number Sign
263450,"POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5",Percent
263510,MOVED TO 613091,Caret
263520,SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6,Number Sign
263530,MOVED TO 613091,Caret
263540,"POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES",
263550,"POLYMYOCLONUS, INFANTILE",
263560,MOVED TO 214400,Caret
263570,"POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN",Number Sign
263600,"POLYSACCHARIDE, STORAGE OF UNUSUAL",
263610,"POLYHYDRAMNIOS, CHRONIC IDIOPATHIC",
263620,MOVED TO 240300,Caret
263630,POLYSYNDACTYLY WITH CARDIAC MALFORMATION,Percent
263650,"POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE",Number Sign
263700,"PORPHYRIA, CONGENITAL ERYTHROPOIETIC",Number Sign
263750,POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS,Number Sign
263800,GITELMAN SYNDROME; GTLMNS,Number Sign
264010,"PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY",
264050,PRENATAL BOWING,
264060,PREPAPILLARY VASCULAR LOOPS,
264070,"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D",Number Sign
264080,PROGESTERONE RESISTANCE,
264090,"PROGEROID SYNDROME, NEONATAL",Percent
264110,"PROLACTIN DEFICIENCY, ISOLATED",
264120,PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES,
264140,"PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, AND DEAFNESS",
264150,MOVED TO 177170,Caret
264160,MOVED TO 177170,Caret
264180,PSEUDODIASTROPHIC DYSPLASIA,
264200,MOVED TO 221900,Caret
264270,"PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES",Percent
264300,17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY,Number Sign
264350,"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B",Number Sign
264420,"FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM",
264450,MOVED TO 190685,Caret
264470,PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY,Number Sign
264475,"PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HAND ANOMALIES",
264480,PSEUDOTRISOMY 13 SYNDROME,
264500,PSEUDOURIDINURIA AND MENTAL DEFECT,
264600,PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH,Number Sign
264700,"VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A",Number Sign
264800,PSEUDOXANTHOMA ELASTICUM; PXE,Number Sign
264810,REMOVED FROM DATABASE,Caret
264900,COAGULATION FACTOR XI; F11,Asterisk
265000,"MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS",Number Sign
265050,3MC SYNDROME 2; 3MC2,Number Sign
265100,PULMONARY ALVEOLAR MICROLITHIASIS,Number Sign
265120,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1",Number Sign
265140,PULMONARY ARTERIOVENOUS FISTULAS,
265150,PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM,
265200,PULMONARY BULLAE CAUSING PNEUMOTHORAX,
265300,"LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL",Percent
265380,ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV,Number Sign
265400,"PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE",
265430,LUNG AGENESIS,
265450,"PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1",Number Sign
265500,PULMONIC STENOSIS,
265600,PULMONIC STENOSIS AND CONGENITAL NEPHROSIS,
265800,PYCNODYSOSTOSIS,Number Sign
265850,PYGMY,Percent
265880,PYKNOACHONDROGENESIS,
265900,PYLE DISEASE; PYL,Number Sign
265950,PYLORIC ATRESIA,Percent
266100,"EPILEPSY, PYRIDOXINE-DEPENDENT; EPD",Number Sign
266120,"URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO",Number Sign
266130,GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD,Number Sign
266140,"PYROPOIKILOCYTOSIS, HEREDITARY; HPP",Number Sign
266150,PYRUVATE CARBOXYLASE DEFICIENCY,Number Sign
266200,PYRUVATE KINASE DEFICIENCY OF RED CELLS,Number Sign
266250,"RADICULONEUROPATHY, FATAL NEONATAL",Percent
266255,"RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATION AND HYPOTONIA",
266265,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C",Number Sign
266270,RAMON SYNDROME,
266280,RAPADILINO SYNDROME,Number Sign
266300,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2",Number Sign
266350,RED SKIN PIGMENT ANOMALY OF NEW GUINEA,Percent
266400,REESE RETINAL DYSPLASIA,
266500,"REFSUM DISEASE, CLASSIC",Number Sign
266510,PEROXISOME BIOGENESIS DISORDER 3B; PBD3B,Number Sign
266600,INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1; IBD1,Number Sign
266810,RENAL AND MULLERIAN DUCT HYPOPLASIA,
266900,SENIOR-LOKEN SYNDROME 1; SLSN1,Number Sign
266910,RENAL DYSPLASIA-LIMB DEFECTS SYNDROME,
266920,SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9,Number Sign
267000,PERLMAN SYNDROME; PRLMNS,Number Sign
267010,"MECKEL SYNDROME, TYPE 7; MKS7",Number Sign
267200,RENAL TUBULAR ACIDOSIS III,
267300,"RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS",Number Sign
267400,"RENAL, GENITAL, AND MIDDLE EAR ANOMALIES",
267430,RENAL TUBULAR DYSGENESIS; RTD,Number Sign
267450,RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS,
267480,RESPIRATORY UNDERRESPONSIVENESS TO HYPOXIA AND HYPERCAPNIA,
267500,RETICULAR DYSGENESIS,Number Sign
267700,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1",Percent
267730,RETICULUM CELL SARCOMA,
267740,RETINAL DEGENERATION AND EPILEPSY,
267750,KNOBLOCH SYNDROME 1; KNO1,Number Sign
267760,"RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION, AND ANGLE CLOSURE GLAUCOMA",
267800,"RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE",
267900,RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA,
268000,RETINITIS PIGMENTOSA; RP,Number Sign
268010,RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS,
268020,"RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM",
268025,"RETINITIS PIGMENTOSA, LATE-ADULT ONSET",
268030,MOVED TO 600105,Caret
268040,RETINOHEPATOENDOCRINOLOGIC SYNDROME,
268050,"RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION",
268060,"RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE",
268080,RETINOSCHISIS OF FOVEA,Percent
268100,ENHANCED S-CONE SYNDROME; ESCS,Number Sign
268130,REVESZ SYNDROME,Number Sign
268150,"RH-NULL, REGULATOR TYPE; RHNR",Number Sign
268200,"MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE",Number Sign
268210,"RHABDOMYOSARCOMA, EMBRYONAL, 1; RMSE1",Number Sign
268220,RHABDOMYOSARCOMA 2; RMS2,Number Sign
268240,RHEUMATIC FEVER-RELATED ANTIGEN,
268250,RHIZOMELIC SYNDROME,
268300,ROBERTS SYNDROME; RBS,Number Sign
268305,ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES,Number Sign
268310,"ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS",Number Sign
268315,"ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION",
268320,RODRIGUES BLINDNESS,
268400,ROTHMUND-THOMSON SYNDROME; RTS,Number Sign
268500,ROWLEY-ROSENBERG SYNDROME,
268650,RUDIGER SYNDROME,
268670,MOVED TO 270400,Caret
268700,SACCHAROPINURIA,Percent
268800,SANDHOFF DISEASE,Number Sign
268850,RICHIERI-COSTA/GUION-ALMEIDA SYNDROME,Percent
268900,SARCOSINEMIA; SARCOS,Number Sign
268950,MOVED TO 254110,Caret
269000,SC PHOCOMELIA SYNDROME,Number Sign
269150,SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME,Number Sign
269160,SCHIZENCEPHALY,Number Sign
269200,"AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2",Percent
269250,SCHNECKENBECKEN DYSPLASIA; SHNKND,Number Sign
269300,CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD,Percent
269400,ANTERIOR SEGMENT DYSGENESIS 7; ASGD7,Number Sign
269500,SCLEROSTEOSIS 1; SOST1,Number Sign
269600,SEA-BLUE HISTIOCYTE DISEASE,Number Sign
269630,SECOND METATARSAL-METACARPAL SYNDROME,
269650,SECRETORY COMPONENT DEFICIENCY,
269700,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2",Number Sign
269720,"SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE",
269800,SENILE PLAQUE FORMATION,
269840,IMMUNODEFICIENCY 48; IMD48,Number Sign
269860,SHORT-RIB THORACIC DYSPLASIA 12; SRTD12,Percent
269870,SHORT STATURE-OBESITY SYNDROME; SSOS,
269880,SHORT SYNDROME,Number Sign
269920,INFANTILE SIALIC ACID STORAGE DISEASE; ISSD,Number Sign
269921,SIALURIA,Number Sign
269950,MOVED TO 206000,Caret
270050,MOVED TO 180860,Caret
270100,"HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5",Number Sign
270150,SJOGREN SYNDROME,Percent
270200,SJOGREN-LARSSON SYNDROME; SLS,Number Sign
270220,SJOGREN-LARSSON-LIKE ICHTHYOSIS WITHOUT CNS OR EYE INVOLVEMENT,
270230,MOVED TO 187600,Caret
270240,MOVED TO 268400,Caret
270300,PEELING SKIN SYNDROME 1; PSS1,Number Sign
270350,ANOSMIA FOR BUTYL MERCAPTAN,
270400,SMITH-LEMLI-OPITZ SYNDROME; SLOS,Number Sign
270420,"DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES; DIAR3",Number Sign
270425,SODIUM-POTASSIUM-ATPase ACTIVITY OF RED CELL,
270450,"INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES",Number Sign
270460,SONODA SYNDROME,
270500,"ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION",
270550,"SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS",Number Sign
270600,SPASTIC DIPLEGIA AND MENTAL RETARDATION,Percent
270680,MOVED TO 270750,Caret
270685,"SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17",Number Sign
270700,"SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15",Number Sign
270710,"MOVED TO 270550, 190350, AND 616944",Caret
270750,SPASTIC PARAPLEGIA 23; SPG23,Number Sign
270800,"SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A",Number Sign
270805,SPASTIC PARAPLEGIA WITH MYOCLONIC EPILEPSY,
270850,"SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION",
270900,SPASTIC PSEUDOSCLEROSIS,
270950,"SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION",
270960,SPERMATOGENIC FAILURE 4; SPGF4,Number Sign
270970,"SPHEROCYTOSIS, TYPE 3; SPH3",Number Sign
271100,MOVED TO 153400,Caret
271109,SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION,
271110,SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY,
271120,MOVED TO 182960,Caret
271150,"SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4",Number Sign
271200,"SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE",
271220,"SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL",
271225,"SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES",
271245,MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7,Number Sign
271250,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3",Percent
271270,SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM,
271310,SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY,
271320,"SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITAL CATARACTS, AND MYOPIA",
271322,SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM,
271400,"ASPLENIA, ISOLATED CONGENITAL; ICAS",Number Sign
271500,SPLENOPORTAL VASCULAR ANOMALIES,
271510,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE",Percent
271520,SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES,
271530,"BRACHYOLMIA TYPE 1, HOBAEK TYPE; BCYM1A",Percent
271550,MOVED TO 607944,Caret
271600,"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE",Percent
271620,SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION,
271630,"BRACHYOLMIA TYPE 1, TOLEDO TYPE; BCYM1B",Percent
271640,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1",Number Sign
271650,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE; SEMDIT",Percent
271665,"SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE",Number Sign
271700,SPONDYLOPERIPHERAL DYSPLASIA,Number Sign
271900,CANAVAN DISEASE,Number Sign
271930,"STRIATONIGRAL DEGENERATION, INFANTILE; SNDI",Number Sign
271950,"SUBAORTIC STENOSIS, MEMBRANOUS",
271960,SUBAORTIC STENOSIS--SHORT STATURE SYNDROME,
271980,SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD,Number Sign
272000,"SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION",
272100,SUDANOPHILIC CEREBRAL SCLEROSIS,
272120,SUDDEN INFANT DEATH SYNDROME,Number Sign
272150,SUGARMAN BRACHYDACTYLY,
272200,MULTIPLE SULFATASE DEFICIENCY; MSD,Number Sign
272300,"SULFITE OXIDASE DEFICIENCY, ISOLATED; ISOD",Number Sign
272350,SUMMITT SYNDROME,
272370,SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS; EC1,Percent
272430,CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1,Number Sign
272440,FILIPPI SYNDROME; FLPIS,Number Sign
272450,SYNDESMODYSPLASIC DWARFISM,
272460,SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT,Number Sign
272480,MOVED TO 186700,Caret
272500,MOVED TO 269700,Caret
272550,MOVED TO 138500,Caret
272600,TAPETORETINAL DEGENERATION WITH ATAXIA,
272620,TARDIVE DYSKINESIA,
272650,TATSUMI FACTOR DEFICIENCY,Percent
272700,TAURODONTISM,
272750,"GM2-GANGLIOSIDOSIS, AB VARIANT",Number Sign
272800,TAY-SACHS DISEASE; TSD,Number Sign
272950,TEEBI-SHALTOUT SYNDROME; TBSH,
272980,"TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR",
273000,"TEETH, FUSED",
273050,"TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM",
273120,"TERATOMA, PINEAL",
273150,"TESTES, RUDIMENTARY",
273250,TESTICULAR REGRESSION SYNDROME; TRS,Percent
273300,TESTICULAR GERM CELL TUMOR; TGCT,Number Sign
273350,MOVED TO 154230,Caret
273390,TETRAAMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES,
273395,TETRAAMELIA SYNDROME 1; TETAMS1,Number Sign
273400,"TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES",
273490,"THALAMIC DEGENERATION, SYMMETRIC INFANTILE",
273600,THALIDOMIDE SUSCEPTIBILITY,
273680,"THANATOPHORIC DYSPLASIA, GLASGOW VARIANT",
273730,THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME,
273740,THORACOMELIC DYSPLASIA,
273750,THREE M SYNDROME 1; 3M1,Number Sign
273770,THREONINEMIA,
273800,GLANZMANN THROMBASTHENIA; GT,Number Sign
273900,THROMBOCYTOPENIA 3; THC3,Number Sign
274000,THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR,Number Sign
274150,"THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP",Number Sign
274180,THROMBOXANE A SYNTHASE 1; TBXAS1,Asterisk
274190,"THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY",Percent
274200,"THUMB, DISTAL HYPEREXTENSIBILITY OF",
274205,"THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX, AND DEAFNESS",
274210,THYMIC APLASIA WITH FETAL DEATH,
274230,"THYMOMA, FAMILIAL",
274240,THYROCEREBRORETINAL SYNDROME,
274260,MOVED TO 274230,Caret
274265,THYMIC-RENAL-ANAL-LUNG DYSPLASIA,
274270,DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY,Number Sign
274300,"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH",Number Sign
274400,THYROID DYSHORMONOGENESIS 1; TDH1,Number Sign
274500,THYROID DYSHORMONOGENESIS 2A; TDH2A,Number Sign
274600,PENDRED SYNDROME; PDS,Number Sign
274700,THYROID DYSHORMONOGENESIS 3; TDH3,Number Sign
274800,THYROID DYSHORMONOGENESIS 4; TDH4,Number Sign
274900,THYROID DYSHORMONOGENESIS 5; TDH5,Number Sign
275000,"GRAVES DISEASE, SUSCEPTIBILITY TO, 1; GRD1",Percent
275100,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4",Number Sign
275120,THYROTROPIN-RELEASING HORMONE DEFICIENCY,Percent
275190,TIGLIC ACIDEMIA,
275200,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1",Number Sign
275210,"RESTRICTIVE DERMOPATHY, LETHAL",Number Sign
275220,TIBIAL HEMIMELIA,
275230,"TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS",
275240,"TINEA IMBRICATA, SUSCEPTIBILITY TO",
275250,"TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF",Percent
275300,TRACHEOBRONCHOMEGALY,
275350,TRANSCOBALAMIN II DEFICIENCY,Number Sign
275355,"SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC",Number Sign
275360,TREHALASE; TREH,Asterisk
275370,"TRICARBOXYLIC ACID CYCLE, DEFECT OF",Percent
275400,OLIVER-MCFARLANE SYNDROME; OMCS,Number Sign
275450,TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY,
275500,MOVED TO 190350,Caret
275550,MOVED TO 234050,Caret
275595,"TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIES OF THE HANDS AND FEET",
275600,REMOVED FROM DATABASE,Caret
275630,CHANARIN-DORFMAN SYNDROME; CDS,Number Sign
275650,MOVED TO 214950,Caret
275900,"SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20",Number Sign
276000,"PROTEASE, SERINE, 1; PRSS1",Asterisk
276100,TRYPTOPHANURIA WITH DWARFISM,Percent
276200,T-SUBSTANCE ANOMALY,
276300,MISMATCH REPAIR CANCER SYNDROME; MMRCS,Number Sign
276400,"TWINNING, DIZYGOTIC",Percent
276410,"TWINNING, MONOZYGOTIC",
276500,MOVED TO 276710,Caret
276600,"TYROSINEMIA, TYPE II; TYRSN2",Number Sign
276700,"TYROSINEMIA, TYPE I; TYRSN1",Number Sign
276710,"TYROSINEMIA, TYPE III; TYRSN3",Number Sign
276800,TYROSINOSIS,
276820,"ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY",Number Sign
276821,ULNAR HYPOPLASIA WITH MENTAL RETARDATION,
276822,ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS,
276850,MOVED TO 274150,Caret
276880,UROCANASE DEFICIENCY; UROCD,Number Sign
276900,"USHER SYNDROME, TYPE I; USH1",Number Sign
276901,"USHER SYNDROME, TYPE IIA; USH2A",Number Sign
276902,"USHER SYNDROME, TYPE IIIA; USH3A",Number Sign
276903,MYOSIN VIIA; MYO7A,Asterisk
276904,"USHER SYNDROME, TYPE IC; USH1C",Number Sign
276905,MOVED TO 605472,Caret
276950,VACTERL ASSOCIATION WITH HYDROCEPHALUS,Percent
277000,MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME,Percent
277100,VALINEMIA,Percent
277150,VAN BOGAERT-HOZAY SYNDROME,Percent
277170,OROFACIODIGITAL SYNDROME VI; OFD6,Number Sign
277175,VASCULAR HYALINOSIS,
277180,"VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD",Number Sign
277200,"RIGHT VENTRICULAR HYPOPLASIA, ISOLATED",
277300,"SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1",Number Sign
277320,"VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA",Percent
277350,"HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE",Percent
277380,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF",Number Sign
277400,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC",Number Sign
277410,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD",Number Sign
277420,MOVED TO 277440,Caret
277440,"VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A",Number Sign
277450,"VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1",Number Sign
277460,"VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED",Number Sign
277465,"VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION",
277470,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A",Number Sign
277480,"VON WILLEBRAND DISEASE, TYPE 3; VWD3",Number Sign
277580,"WAARDENBURG SYNDROME, TYPE 4A; WS4A",Number Sign
277590,WEAVER SYNDROME; WVS,Number Sign
277600,WEILL-MARCHESANI SYNDROME 1; WMS1,Number Sign
277610,MOVED TO 184840,Caret
277700,WERNER SYNDROME; WRN,Number Sign
277720,"WHISTLING FACE SYNDROME, RECESSIVE FORM",Percent
277730,WERNICKE-KORSAKOFF SYNDROME,Percent
277740,WHITE FORELOCK WITH MALFORMATIONS,
277900,WILSON DISEASE,Number Sign
277950,WINCHESTER SYNDROME; WNCHRS,Number Sign
277970,MOVED TO 614493,Caret
277990,WOLFF MENTAL RETARDATION SYNDROME,
278000,LYSOSOMAL ACID LIPASE DEFICIENCY,Number Sign
278100,WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS,
278150,HYPOTRICHOSIS 8; HYPT8,Number Sign
278200,"WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS",
278205,MOVED TO 601214,Caret
278250,WRINKLY SKIN SYNDROME; WSS,Number Sign
278300,"XANTHINURIA, TYPE I; XAN1",Number Sign
278400,MOVED TO 203290,Caret
278600,MOVED TO 236800,Caret
278700,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA",Number Sign
278720,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC",Number Sign
278730,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD",Number Sign
278740,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E",Number Sign
278750,"XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV",Number Sign
278760,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF",Number Sign
278780,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG",Number Sign
278800,DE SANCTIS-CACCHIONE SYNDROME,Number Sign
278810,MOVED TO 278720,Caret
278850,"46,XX SEX REVERSAL 2; SRXX2",Number Sign
278900,XYLOSIDASE DEFICIENCY,
279000,YOUNG SYNDROME,Percent
280000,"COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME",Number Sign
300000,"OPITZ GBBB SYNDROME, TYPE I; GBBB1",Number Sign
300001,"ICHTHYOSIS, X-LINKED, WITHOUT STEROID SULFATASE DEFICIENCY",Percent
300002,ARYLSULFATASE D; ARSD,Asterisk
300003,ARYLSULFATASE F; ARSF,Asterisk
300004,"CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA",Number Sign
300005,METHYL-CpG-BINDING PROTEIN 2; MECP2,Asterisk
300006,CENTRIN 2; CETN2,Asterisk
300007,INTERLEUKIN 9 RECEPTOR; IL9R,Asterisk
300008,CHLORIDE CHANNEL 5; CLCN5,Asterisk
300009,DENT DISEASE 1,Number Sign
300010,A-11 GENE; A11,Asterisk
300011,"ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE; ATP7A",Asterisk
300012,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 1; SMARCA1",Asterisk
300013,"N-ALPHA-ACETYLTRANSFERASE 10, NatA CATALYTIC SUBUNIT; NAA10",Asterisk
300014,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 3; ATP2B3",Asterisk
300015,"ACETYLSEROTONIN METHYLTRANSFERASE, X-CHROMOSOMAL; ASMT",Asterisk
300016,"MELANOMA ANTIGEN, FAMILY A, 1; MAGEA1",Asterisk
300017,FILAMIN A; FLNA,Asterisk
300018,"46,XY SEX REVERSAL 2; SRXY2",Number Sign
300019,HOST CELL FACTOR C1; HCFC1,Asterisk
300020,MOVED TO 102610,Caret
300021,MOVED TO 301830,Caret
300022,PLEXIN A3; PLXNA3,Asterisk
300023,RHO GTPase-ACTIVATING PROTEIN 4; ARHGAP4,Asterisk
300024,ZINC FINGER PROTEIN 157; ZNF157,Asterisk
300025,CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 4; CDX4,Asterisk
300026,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 2; NAP1L2,Asterisk
300027,RNA-BINDING MOTIF PROTEIN 3; RBM3,Asterisk
300028,"ZINC FINGER-, CCCH DOMAIN-, AND RNA-BINDING MOTIF-CONTAINING SERINE/ARGININE-RICH PROTEIN 2; ZRSR2",Asterisk
300029,RETINITIS PIGMENTOSA 3; RP3,Number Sign
300030,"DEAFNESS, X-LINKED 3; DFNX3",Percent
300031,"FAMILY WITH SEQUENCE SIMILARITY 11, MEMBER A; FAM11A",Asterisk
300032,ATR-X GENE; ATRX,Asterisk
300033,FORKHEAD BOX O4; FOXO4,Asterisk
300034,"ANGIOTENSIN II RECEPTOR, TYPE 2; AGTR2",Asterisk
300035,EPHRIN B1; EFNB1,Asterisk
300036,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8; SLC6A8",Asterisk
300037,GLYPICAN 3; GPC3,Asterisk
300038,"PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 4; P2RY4",Asterisk
300039,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4",Asterisk
300040,STRUCTURAL MAINTENANCE OF CHROMOSOMES 1A; SMC1A,Asterisk
300041,"GUANYLATE CYCLASE 2F, RETINAL; GUCY2F",Asterisk
300042,"ALOPECIA, CONGENITAL; ALPC",
300043,MOVED TO 611663,Caret
300044,TRANSKETOLASE-LIKE 1; TKTL1,Asterisk
300045,MOVED TO 602081,Caret
300046,"MENTAL RETARDATION, X-LINKED 23; MRX23",Percent
300047,"MENTAL RETARDATION, X-LINKED 20; MRX20",Percent
300048,"INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED",Number Sign
300049,PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1,Number Sign
300050,UBIQUITIN-SPECIFIC PROTEASE 11; USP11,Asterisk
300051,GLYCOPROTEIN M6B; GPM6B,Asterisk
300052,DYSTROPHIN-RELATED PROTEIN 2; DRP2,Asterisk
300053,VESICLE-ASSOCIATED MEMBRANE PROTEIN 7: VAMP7,Asterisk
300054,"BODY LENGTH, MOUSE, HUMAN HOMOLOG",
300055,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13",Number Sign
300056,HOLOCYTOCHROME C SYNTHASE; HCCS,Asterisk
300057,MOVED TO 601324,Caret
300058,MOVED TO 300446,Caret
300059,TRANSMEMBRANE PROTEIN 187; TMEM187,Asterisk
300060,"L ANTIGEN FAMILY, MEMBER 3; LAGE3",Asterisk
300061,"ZINC FINGER, MYM-TYPE 3; ZMYM3",Asterisk
300062,"MENTAL RETARDATION, X-LINKED 14; MRX14",Percent
300063,MOVED TO 304930,Caret
300064,"MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM",
300065,CENTROMERIC PROTEIN I; CENPI,Asterisk
300066,"DEAFNESS, X-LINKED 4; DFNX4",Number Sign
300067,"LISSENCEPHALY, X-LINKED, 1; LISX1",Number Sign
300068,ANDROGEN INSENSITIVITY SYNDROME; AIS,Number Sign
300069,MOVED TO 302060,Caret
300070,FIBROBLAST GROWTH FACTOR 13; FGF13,Asterisk
300071,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A",Number Sign
300072,"UBIQUITIN-SPECIFIC PROTEASE 9, X-LINKED; USP9X",Asterisk
300073,"FETAL AKINESIA SYNDROME, X-LINKED",
300074,X CHROMOSOME-CONTROLLING ELEMENT; XCE,Asterisk
300075,"RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 3; RPS6KA3",Asterisk
300076,"IMMUNONEUROLOGIC DISORDER, X-LINKED",Percent
300077,MOVED TO 300419,Caret
300078,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 1; NDUFA1",Asterisk
300079,"INHIBITOR OF APOPTOSIS, X-LINKED; XIAP",Asterisk
300080,RNA-BINDING MOTIF PROTEIN 10; RBM10,Asterisk
300081,DEOXYRIBONUCLEASE I-LIKE 1; DNASE1L1,Asterisk
300082,"COGNITIVE FUNCTION 1, SOCIAL; CGF1",Percent
300083,"PROTEIN KINASE, X-LINKED; PRKX",Asterisk
300084,NON-POU DOMAIN-CONTAINING OCTAMER-BINDING PROTEIN; NONO,Asterisk
300085,"CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2",Percent
300086,LYSOPHOSPHATIDIC ACID RECEPTOR 4; LPAR4,Asterisk
300087,"X INACTIVATION, FAMILIAL SKEWED, 1; SXI1",Number Sign
300088,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9",Number Sign
300089,"ISOCITRATE DEHYDROGENASE 3, GAMMA SUBUNIT; IDH3G",Asterisk
300090,"SIGNAL SEQUENCE RECEPTOR, DELTA; SSR4",Asterisk
300091,FOS-INDUCED GROWTH FACTOR; FIGF,Asterisk
300092,TESTIS-EXPRESSED GENE 28; TEX28,Asterisk
300093,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, EPSILON; GABRE",Asterisk
300094,MOVED TO 600539,Caret
300095,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 2; SLC16A2",Asterisk
300096,TETRASPANIN 7; TSPAN7,Asterisk
300097,"MELANOMA ANTIGEN, FAMILY B, 1; MAGEB1",Asterisk
300098,"MELANOMA ANTIGEN, FAMILY B, 2; MAGEB2",Asterisk
300099,MOVED TO 300097,Caret
300100,ADRENOLEUKODYSTROPHY; ALD,Number Sign
300101,"BONE MARROW KINASE, X-LINKED; BMX",Asterisk
300102,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 4; PNPLA4,Asterisk
300103,SHROOM FAMILY MEMBER 2; SHROOM2,Asterisk
300104,GDP DISSOCIATION INHIBITOR 1; GDI1,Asterisk
300105,SPERMINE SYNTHASE; SMS,Asterisk
300106,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED; SEMDX",Number Sign
300107,BOMBESIN-LIKE RECEPTOR 3; BRS3,Asterisk
300108,"DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 2; DIAPH2",Asterisk
300109,"PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 1; PPEF1",Asterisk
300110,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1F SUBUNIT; CACNA1F",Asterisk
300111,"PRICKLE, DROSOPHILA, HOMOLOG OF, 3; PRICKLE3",Asterisk
300112,PROTEOLIPID PROTEIN 2; PLP2,Asterisk
300113,"X-LINKED B CELL SURFACE ANTIGEN, MOUSE, HOMOLOG-LIKE 1; XLRL",
300114,"MENTAL RETARDATION, X-LINKED 49; MRX49",Number Sign
300115,"MENTAL RETARDATION, X-LINKED 50; MRX50",Percent
300116,MATURE T-CELL PROLIFERATION 1; MTCP1,Asterisk
300117,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 3; NAP1L3,Asterisk
300118,RHO GTPase-ACTIVATING PROTEIN 6; ARHGAP6,Asterisk
300119,"INTERLEUKIN 13 RECEPTOR, ALPHA-1; IL13RA1",Asterisk
300120,MASTERMIND-LIKE DOMAIN-CONTAINING PROTEIN 1; MAMLD1,Asterisk
300121,DOUBLECORTIN; DCX,Asterisk
300122,MOVED TO 300000,Caret
300123,"MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM",Number Sign
300124,GTP-BINDING PROTEIN 6; GTPBP6,Asterisk
300125,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 2",Percent
300126,DYSKERIN; DKC1,Asterisk
300127,OLIGOPHRENIN 1; OPHN1,Asterisk
300128,LYSINE-SPECIFIC DEMETHYLASE 6A; KDM6A,Asterisk
300129,"HEMATOPOIETIC STEM CELL KINETICS, CONTROL OF",
300130,"INTERLEUKIN 13 RECEPTOR, ALPHA-2; IL13RA2",Asterisk
300131,PLASTIN 3; PLS3,Asterisk
300132,TROPHININ; TRO,Asterisk
300133,VON HIPPEL-LINDAU BINDING PROTEIN 1; VBP1,Asterisk
300134,DUAL-SPECIFICITY PHOSPHATASE 9; DUSP9,Asterisk
300135,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 7; ABCB7",Asterisk
300136,"DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO",Percent
300137,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 1; IGSF1",Asterisk
300138,CHLORIDE INTRACELLULAR CHANNEL 2; CLIC2,Asterisk
300139,IMMUNOGLOBULIN-BINDING PROTEIN 1; IGBP1,Asterisk
300140,MOVED TO 600655,Caret
300141,MOVED TO 612725,Caret
300142,p21 PROTEIN-ACTIVATED KINASE 3; PAK3,Asterisk
300143,"MENTAL RETARDATION, X-LINKED 21; MRX21",Number Sign
300144,GLUTAMATE DEHYDROGENASE 2; GLUD2,Asterisk
300145,X-PROLYL AMINOPEPTIDASE 2; XPNPEP2,Asterisk
300146,CALPAIN 6; CAPN6,Asterisk
300147,"PROSTATE CANCER, HEREDITARY, X-LINKED 1; HPCX1",Percent
300148,MEHMO SYNDROME; MEHMO,Number Sign
300149,"CBP/p300-INTERACTING TRANSACTIVATOR WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 1; CITED1",Asterisk
300150,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A5; SLC25A5",Asterisk
300151,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A6; SLC25A6",Asterisk
300152,"MELANOMA ANTIGEN, FAMILY B, 3; MAGEB3",Asterisk
300153,"MELANOMA ANTIGEN, FAMILY B, 4; MAGEB4",Asterisk
300154,ESX1-LIKE PROTEIN; ESX1L,Asterisk
300155,RETINITIS PIGMENTOSA 24; RP24,Percent
300156,CANCER/TESTIS ANTIGEN 1B; CTAG1B,Asterisk
300157,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 4; ACSL4",Asterisk
300158,"ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX",Percent
300159,"THYMOSIN, BETA-4, X CHROMOSOME; TMSB4X",Asterisk
300160,"DEAD/H BOX 3, X-LINKED; DDX3X",Asterisk
300161,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 3; EIF2S3",Asterisk
300162,ACETYLSEROTONIN METHYLTRANSFERASE-LIKE; ASMTL,Asterisk
300163,FOUR-AND-A-HALF LIM DOMAINS 1; FHL1,Asterisk
300164,INACTIVATION ESCAPE 1; INE1,Asterisk
300165,INACTIVATION ESCAPE 2; INE2,Asterisk
300166,"MICROPHTHALMIA, SYNDROMIC 2; MCOPS2",Number Sign
300167,HEPHAESTIN; HEPH,Asterisk
300168,GLYPICAN 4; GPC4,Asterisk
300169,"APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 1; AIFM1",Asterisk
300170,OFD1 GENE; OFD1,Asterisk
300171,MYOTUBULARIN-RELATED PROTEIN 1; MTMR1,Asterisk
300172,CALCIUM/CALMODULIN-DEPENDENT SERINE PROTEIN KINASE; CASK,Asterisk
300173,"MELANOMA ANTIGEN, FAMILY A, 2; MAGEA2",Asterisk
300174,"MELANOMA ANTIGEN, FAMILY A, 3; MAGEA3",Asterisk
300175,"MELANOMA ANTIGEN, FAMILY A, 4; MAGEA4",Asterisk
300176,"MELANOMA ANTIGEN, FAMILY A, 6; MAGEA6",Asterisk
300177,"MELANOMA ANTIGEN, FAMILY A, 12; MAGEA12",Asterisk
300178,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 1; ZBED1,Asterisk
300179,"X INACTIVATION, FAMILIAL SKEWED, 2; SXI2",Percent
300180,ARYLSULFATASE E; ARSE,Asterisk
300181,X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE; TSIX,Asterisk
300182,MEDIATOR COMPLEX SUBUNIT 14; MED14,Asterisk
300183,MOVED TO 302060,Caret
300184,"HYPOTONIA, CONGENITAL NYSTAGMUS, ATAXIA, AND ABNORMAL AUDITORY BRAINSTEM RESPONSES",
300185,A-KINASE ANCHOR PROTEIN 4; AKAP4,Asterisk
300186,"EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, X-LINKED; EIF1AX",Asterisk
300187,"SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED; SRPX",Asterisk
300188,MEDIATOR COMPLEX SUBUNIT 12; MED12,Asterisk
300189,"DISCS LARGE, DROSOPHILA, HOMOLOG OF, 3; DLG3",Asterisk
300190,SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN; SH3BGRL,Asterisk
300191,TETRASPANIN 6; TSPAN6,Asterisk
300192,"SARCOMA, SYNOVIAL, X BREAKPOINT 2; SSX2",Asterisk
300193,HIGH MOBILITY GROUP BOX 3; HMGB3,Asterisk
300194,AMME COMPLEX,Number Sign
300195,AMME CHROMOSOME REGION GENE 1; AMMECR1,Asterisk
300196,"TRANSDUCIN-BETA-LIKE 1, X-LINKED; TBL1X",Asterisk
300197,"ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 1; ATP6AP1",Asterisk
300198,GLYCOGENIN 2; GYG2,Asterisk
300199,"RNA-BINDING MOTIF PROTEIN, X CHROMOSOME; RBMX",Asterisk
300200,"ADRENAL HYPOPLASIA, CONGENITAL; AHC",Number Sign
300201,CYSTEINYL LEUKOTRIENE RECEPTOR 1; CYSLTR1,Asterisk
300202,"TRACKING PROTEIN PARTICLE COMPLEX, SUBUNIT 2; TRAPPC2",Asterisk
300203,CYCLIN-DEPENDENT KINASE-LIKE 5; CDKL5,Asterisk
300204,MIDLINE 2; MID2,Asterisk
300205,EMOPAMIL-BINDING PROTEIN; EBP,Asterisk
300206,INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 1; IL1RAPL1,Asterisk
300207,G PROTEIN-COUPLED RECEPTOR 50; GPR50,Asterisk
300208,"SEX COMB ON MIDLEG, DROSOPHILA, HOMOLOG-LIKE 2; SCML2",Asterisk
300209,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2",Number Sign
300210,"MENTAL RETARDATION, X-LINKED 58; MRX58",Number Sign
300211,"EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX",Percent
300212,REGUCALCIN; RGN,Asterisk
300213,CAAX BOX PROTEIN 1; CXX1,Asterisk
300214,PLEXIN B3; PLXNB3,Asterisk
300215,"LISSENCEPHALY, X-LINKED, 2; LISX2",Number Sign
300216,COATS DISEASE,
300217,RETINOIC ACID-INDUCED 2; RAI2,Asterisk
300218,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 7; MRXS7",Percent
300219,MYOTUBULAR MYOPATHY WITH ABNORMAL GENITAL DEVELOPMENT,Number Sign
300220,MOVED TO 300438,Caret
300221,"LYMPHOMA, HODGKIN, X-LINKED PSEUDOAUTOSOMAL",Percent
300222,INTEGRAL MEMBRANE PROTEIN 2A; ITM2A,Asterisk
300223,"MELANOMA ANTIGEN, FAMILY C, 1; MAGEC1",Asterisk
300224,"MELANOMA ANTIGEN, FAMILY D, 1; MAGED1",Asterisk
300225,NADPH OXIDASE 1; NOX1,Asterisk
300226,"SMALL MUSCLE PROTEIN, X-LINKED; SMPX",Asterisk
300227,"SEX COMB ON MIDLEG, DROSOPHILA, HOMOLOG-LIKE 1; SCML1",Asterisk
300228,TESTICULAR GERM CELL TUMOR 1; TGCT1,Percent
300229,"VARIABLY CHARGED, X CHROMOSOME; VCX",Asterisk
300230,"CARBONIC ANHYDRASE VB, MITOCHONDRIAL; CA5B",Asterisk
300231,"SOLUTE CARRIER FAMILY 9, MEMBER 6; SLC9A6",Asterisk
300232,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION",
300233,"RADIOULNAR SYNOSTOSIS, RADIAL RAY ABNORMALITIES, AND SEVERE MALFORMATIONS IN THE MALE",
300234,UBIQUITOUSLY EXPRESSED TRANSCRIPT; UXT,Asterisk
300235,"ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, A; ZXDA",Asterisk
300236,"ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, B; ZXDB",Asterisk
300237,TRANSCRIPTION ELONGATION FACTOR A-LIKE 1; TCEAL1,Asterisk
300238,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11",Number Sign
300239,EPIDERMAL GROWTH FACTOR-LIKE 6; EGFL6,Asterisk
300240,MOVED TO 305000,Caret
300241,G PROTEIN-COUPLED RECEPTOR 34; GPR34,Asterisk
300242,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, BRAIN), MEMBER 14; SLC25A14",Asterisk
300243,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH",Number Sign
300244,TERMINAL OSSEOUS DYSPLASIA; TOD,Number Sign
300245,"PTOSIS, HEREDITARY CONGENITAL 2",Percent
300246,"PROTOCADHERIN 11, X-LINKED; PCDH11X",Asterisk
300247,BONE MORPHOGENETIC PROTEIN 15; BMP15,Asterisk
300248,"INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE OF, GAMMA; IKBKG",Asterisk
300249,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17, YEAST, HOMOLOG OF, B; TIMM17B",Asterisk
300250,MOVED TO 202200,Caret
300251,MOVED TO 605875,Caret
300252,"PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 4; PIN4",Asterisk
300253,G PROTEIN-COUPLED RECEPTOR 173; GPR173,Asterisk
300254,"SUPPRESSOR OF VARIEGATION 3-9, DROSOPHILA, HOMOLOG OF, 1; SUV39H1",Asterisk
300255,O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; OGT,Asterisk
300256,17-BETA-HYDROXYSTEROID DEHYDROGENASE X; HSD17B10,Asterisk
300257,DANON DISEASE,Number Sign
300258,MOVED TO 616651,Caret
300259,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED",
300260,LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL,Number Sign
300261,ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA,Percent
300262,ABIDI X-LINKED MENTAL RETARDATION SYNDROME; MRXSAB,Percent
300263,SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD,Number Sign
300264,UBIQUILIN 2; UBQLN2,Asterisk
300265,"ZIC FAMILY, MEMBER 3; ZIC3",Asterisk
300266,"SPASTIC PARAPLEGIA 16, X-LINKED; SPG16",Percent
300267,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; ARHGEF6,Asterisk
300268,MOVED TO 610618,Caret
300269,HISTONE DEACETYLASE 8; HDAC8,Asterisk
300270,ADRENOMYODYSTROPHY,
300271,"MENTAL RETARDATION, X-LINKED 72; MRX72",Number Sign
300272,HISTONE DEACETYLASE 6; HDAC6,Asterisk
300273,"GOITER, MULTINODULAR 2; MNG2",Percent
300274,MOVED TO 300068,Caret
300275,NAD(P)H STEROID DEHYDROGENASE-LIKE PROTEIN; NSDHL,Asterisk
300276,ECTODYSPLASIN A2 RECEPTOR; EDA2R,Asterisk
300277,INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 2; IL1RAPL2,Asterisk
300278,NYCTALOPIN; NYX,Asterisk
300279,MOVED TO 300260,Caret
300280,URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU,Number Sign
300281,"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 1; KCND1",Asterisk
300282,ECTO-NOX DISULFIDE-THIOL EXCHANGER 2; ENOX2,Asterisk
300283,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1; IRAK1,Asterisk
300284,RAS-ASSOCIATED PROTEIN RAB9; RAB9,Asterisk
300285,RAS-ASSOCIATED PROTEIN 9B; RAB9B,Asterisk
300286,KRUPPEL-LIKE FACTOR 8; KLF8,Asterisk
300287,"P ANTIGEN FAMILY, MEMBER 4; PAGE4",Asterisk
300288,"P ANTIGEN FAMILY, MEMBER 1; PAGE1",Asterisk
300289,"X ANTIGEN FAMILY, MEMBER 1D; XAGE1D",Asterisk
300290,MOVED TO 614732,Caret
300291,"ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY",Number Sign
300292,FORKHEAD BOX P3; FOXP3,Asterisk
300293,MOVED TO 301410,Caret
300294,"MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 2; MBTPS2",Asterisk
300295,ONCOGENE PIM2; PIM2,Asterisk
300296,PLACENTA-SPECIFIC GENE 1; PLAC1,Asterisk
300297,APELIN; APLN,Asterisk
300298,"UPF3, YEAST, HOMOLOG OF, B; UPF3B",Asterisk
300299,"NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX",Number Sign
300300,BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK,Asterisk
300301,"ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA; OLEDAID",Number Sign
300302,"DYNEIN, LIGHT CHAIN, TCTEX TYPE, 3; DYNLT3",Asterisk
300303,"RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 6; RPS6KA6",Asterisk
300304,CULLIN 4B; CUL4B,Asterisk
300305,"SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A1; SPANXA1",Asterisk
300306,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11; BMIQ11,Percent
300307,T-BOX 22; TBX22,Asterisk
300308,FERRITIN HEAVY POLYPEPTIDE-LIKE 17; FTHL17,Asterisk
300309,UBIQUITIN-SPECIFIC PROTEASE 26; USP26,Asterisk
300310,"AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2",Percent
300311,TESTIS-EXPRESSED GENE 11; TEX11,Asterisk
300312,TESTIS-EXPRESSED GENE 13A; TEX13A,Asterisk
300313,TESTIS-EXPRESSED GENE 13B; TEX13B,Asterisk
300314,"TAF7-LIKE RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 50-KD; TAF7L",Asterisk
300315,NUCLEAR RNA EXPORT FACTOR 2; NXF2,Asterisk
300316,NUCLEAR RNA EXPORT FACTOR 3; NXF3,Asterisk
300317,RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 2; REPS2,Asterisk
300318,NUCLEAR RNA EXPORT FACTOR 4; NXF4,Asterisk
300319,NUCLEAR RNA EXPORT FACTOR 5; NXF5,Asterisk
300320,NTF2-LIKE EXPORT FACTOR 2; NXT2,Asterisk
300321,FG SYNDROME 2; FGS2,Number Sign
300322,LESCH-NYHAN SYNDROME; LNS,Number Sign
300323,KELLEY-SEEGMILLER SYNDROME,Number Sign
300324,"MENTAL RETARDATION, X-LINKED 53; MRX53",Percent
300325,"SYNOVIAL SARCOMA, X BREAKPOINT 3; SSX3",Asterisk
300326,"SYNOVIAL SARCOMA, X BREAKPOINT 4; SSX4",Asterisk
300327,"SYNOVIAL SARCOMA, X BREAKPOINT 5; SSX5",Asterisk
300328,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED FAMILY, MEMBER 1-LIKE; KCNE1L",Asterisk
300329,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 33; ZBTB33,Asterisk
300330,"SPANX FAMILY, MEMBER C; SPANXC",Asterisk
300331,"THROMBOCYTHEMIA, X-LINKED; THCYTX",Percent
300332,"INTEGRIN, BETA-1, BINDING PROTEIN OF, 2; ITGB1BP2",Asterisk
300333,RAS-ASSOCIATED PROTEIN RAB33A; RAB33A,Asterisk
300334,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5; TRPC5",Asterisk
300335,ANGIOTENSIN I-CONVERTING ENZYME 2; ACE2,Asterisk
300336,NEUROLIGIN 3; NLGN3,Asterisk
300337,HYPOMELANOSIS OF ITO; HMI,Number Sign
300338,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-2; CNGA2",Asterisk
300339,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, BETA; PPP2R3B",Asterisk
300340,"MELANOMA ANTIGEN, FAMILY A, 5; MAGEA5",Asterisk
300341,"MELANOMA ANTIGEN, FAMILY A, 8; MAGEA8",Asterisk
300342,"MELANOMA ANTIGEN, FAMILY A, 9; MAGEA9",Asterisk
300343,"MELANOMA ANTIGEN, FAMILY A, 10; MAGEA10",Asterisk
300344,"MELANOMA ANTIGEN, FAMILY A, 11; MAGEA11",Asterisk
300345,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 1; MCOPCB1",Percent
300346,HIV-1 TAT STIMULATORY FACTOR 1; HTATSF1,Asterisk
300347,EARLY LYMPHOID ACTIVATION GENE,Asterisk
300348,KELCH-LIKE 4; KLHL4,Asterisk
300349,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, THETA; GABRQ",Asterisk
300350,CHORDIN-LIKE 1; CHRDL1,Asterisk
300351,"GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1",Percent
300352,CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1,Number Sign
300353,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 4; VSIG4,Asterisk
300354,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC",Number Sign
300355,"MENTAL RETARDATION, X-LINKED 73; MRX73",Percent
300356,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8, YEAST, HOMOLOG OF, A; TIMM8A",Asterisk
300357,CYTOKINE RECEPTOR-LIKE FACTOR 2; CRLF2,Asterisk
300358,"PROTEIN KINASE, LYSINE-DEFICIENT 3; WNK3",Asterisk
300359,SARCOMA ANTIGEN 1; SAGE1,Asterisk
300360,MOVED TO 300354,Caret
300361,NERVE GROWTH FACTOR RECEPTOR-ASSOCIATED PROTEIN 1; NGFRAP1,Asterisk
300362,"ARMADILLO REPEAT CONTAINING, X-LINKED 1; ARMCX3",Asterisk
300363,"ARMADILLO REPEAT CONTAINING, X-LINKED 2; ARMCX2",Asterisk
300364,"ARMADILLO REPEAT CONTAINING, X-LINKED 3; ARMCX3",Asterisk
300365,TOLL-LIKE RECEPTOR 7; TLR7,Asterisk
300366,TOLL-LIKE RECEPTOR 8; TLR8,Asterisk
300367,"THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA",Number Sign
300368,"SOLUTE CARRIER FAMILY 9, MEMBER 7; SLC9A7",Asterisk
300369,ACIDIC REPEAT-CONTAINING GENE; ACRC,Asterisk
300370,3-PRIME REPAIR EXONUCLEASE 2; TREX2,Asterisk
300371,"ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1; ABCD1",Asterisk
300372,"MENTAL RETARDATION, X-LINKED 42; MRX42",Percent
300373,OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS,Number Sign
300374,SH3-DOMAIN KINASE-BINDING PROTEIN 1; SH3KBP1,Asterisk
300375,CARBOHYDRATE SULFOTRANSFERASE 7; CHST7,Asterisk
300376,"MUSCULAR DYSTROPHY, BECKER TYPE; BMD",Number Sign
300377,DYSTROPHIN; DMD,Asterisk
300378,"RADIAL RAY DEFICIENCY, X-LINKED",Percent
300379,"RING FINGER PROTEIN, LIM DOMAIN-INTERACTING; RLIM",Asterisk
300380,CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 2; CTPS2,Asterisk
300381,ZINC FINGER PROTEIN 185; ZNF185,Asterisk
300382,"ARISTALESS-RELATED HOMEOBOX, X-LINKED; ARX",Asterisk
300383,COMPLEMENT FACTOR PROPERDIN; CFP,Asterisk
300384,EMERIN; EMD,Asterisk
300385,NUCLEOSOMAL BINDING PROTEIN 1; NSBP1,Asterisk
300386,CD40 LIGAND; CD40LG,Asterisk
300387,"MENTAL RETARDATION, X-LINKED 63; MRX63",Number Sign
300388,"POLYMICROGYRIA, BILATERAL PERISYLVIAN, X-LINKED; BPPX",Percent
300389,MOVED TO 300029,Caret
300390,CHM GENE; CHM,Asterisk
300391,AMELOGENIN; AMELX,Asterisk
300392,WAS GENE; WAS,Asterisk
300393,G PROTEIN-COUPLED RECEPTOR 101; GPR101,Asterisk
300394,TAFAZZIN; TAZ,Asterisk
300395,"THO COMPLEX, SUBUNIT 2; THOC2",Asterisk
300396,CANCER/TESTIS ANTIGEN 2; CTAG2,Asterisk
300397,MOVED TO 300352,Caret
300398,B-CELL RECEPTOR-ASSOCIATED PROTEIN 31; BCAP31,Asterisk
300399,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1, INHIBITOR OF: PCSK1N",Asterisk
300400,"SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1",Number Sign
300401,PROTEOLIPID PROTEIN 1; PLP1,Asterisk
300402,"LEUCINE ZIPPER, DOWNREGULATED IN CANCER 1; LDOC1",Asterisk
300403,"NADH DEHYDROGENASE 1 BETA SUBCOMPLEX, 11; NDUFB11",Asterisk
300404,MOVED TO 308205,Caret
300405,RAS-ASSOCIATED PROTEIN RAB40A-LIKE; RAB40AL,Asterisk
300406,FG SYNDROME 3; FGS3,Percent
300407,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 5; PABPC5",Asterisk
300408,GRIP1-ASSOCIATED PROTEIN 1; GRIPAP1,Asterisk
300409,MORTALITY FACTOR 4-LIKE PROTEIN 2; MORF4L2,Asterisk
300410,ANGIOMOTIN; AMOT,Asterisk
300411,"TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, X-LINKED; TGIF2LX",Asterisk
300412,MOVED TO 300166,Caret
300413,MUSCLEBLIND-LIKE SPLICING REGULATOR 3; MBNL3,Asterisk
300414,PHD FINGER PROTEIN 6; PHF6,Asterisk
300415,MYOTUBULARIN; MTM1,Asterisk
300416,"X ANTIGEN FAMILY, MEMBER 2; XAGE2",Asterisk
300417,G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1; GPRASP1,Asterisk
300418,G1- TO S-PHASE TRANSITION 2; GSPT2,Asterisk
300419,"MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED; MRXARX",Number Sign
300420,PRAJA 1; PJA1,Asterisk
300421,MOVED TO 194190,Caret
300422,FG SYNDROME 4; FGS4,Number Sign
300423,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH",Number Sign
300424,RETINITIS PIGMENTOSA 23; RP23,Number Sign
300425,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1",Number Sign
300426,MOVED TO 300143,Caret
300427,NEUROLIGIN 4; NLGN4,Asterisk
300428,"MENTAL RETARDATION, X-LINKED 2; MRX2",Percent
300429,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 9; ARHGEF9,Asterisk
300430,MOVED TO 300419,Caret
300431,ATKIN-FLAITZ SYNDROME,
300432,MOVED TO 308350,Caret
300433,"MENTAL RETARDATION, X-LINKED 81; MRX81",Percent
300434,STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX,Number Sign
300435,PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PGRMC1,Asterisk
300436,"MENTAL RETARDATION, X-LINKED 46; MRX46",Number Sign
300437,EMBRYONIC STEM CELL-EXPRESSED RAS; ERAS,Asterisk
300438,HSD10 MITOCHONDRIAL DISEASE; HSD10MD,Number Sign
300439,RING FINGER PROTEIN 128; RNF128,Asterisk
300440,NFKB-REPRESSING FACTOR; NKRF,Asterisk
300441,SH3 PROTEIN EXPRESSED IN LYMPHOCYTES,Asterisk
300442,MOVED TO 311900,Caret
300443,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 3; SLC7A3",Asterisk
300444,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 14; SLC6A14",Asterisk
300445,"H2A HISTONE FAMILY, MEMBER B3; H2AFB3",Asterisk
300446,"RHOX HOMEOBOX FAMILY, MEMBER 1; RHOXF1",Asterisk
300447,"RHOX HOMEOBOX FAMILY, MEMBER 2; RHOXF2",Asterisk
300448,ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS,Number Sign
300449,MOVED TO 300448,Caret
300450,FETAL AND ADULT TESTIS-EXPRESSED GENE 1; FATE1,Asterisk
300451,ECTODYSPLASIN A; EDA,Asterisk
300452,"INHIBITOR OF GROWTH, X-LINKED; INGX",Asterisk
300453,"FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER A; FAM50A",Asterisk
300454,"MENTAL RETARDATION, X-LINKED 77; MRX77",Percent
300455,"RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS",Number Sign
300456,CYCLIN B3; CCNB3,Asterisk
300457,NHS GENE; NHS,Asterisk
300458,MOVED TO 300055,Caret
300459,TENOMODULIN; TNMD,Asterisk
300460,PROTOCADHERIN 19; PCDH19,Asterisk
300461,ORNITHINE CARBAMOYLTRANSFERASE; OTC,Asterisk
300462,A-KINASE ANCHOR PROTEIN 14; AKAP14,Asterisk
300463,POLYGLUTAMINE-BINDING PROTEIN 1; PQBP1,Asterisk
300464,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3",Percent
300465,MOVED TO 301040,Caret
300466,"MELANOMA ANTIGEN, FAMILY B, 5; MAGEB5",Asterisk
300467,"MELANOMA ANTIGEN, FAMILY B, 6; MAGEB6",Asterisk
300468,"MELANOMA ANTIGEN, FAMILY C, 2; MAGEC2",Asterisk
300469,"MELANOMA ANTIGEN, FAMILY C, 3; MAGEC3",Asterisk
300470,"MELANOMA ANTIGEN, FAMILY D, 2; MAGED2",Asterisk
300471,CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES,Percent
300472,"CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA",Number Sign
300473,"NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1; NR0B1",Asterisk
300474,GLYCEROL KINASE; GK,Asterisk
300475,"DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH",Number Sign
300476,"CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3",Number Sign
300477,"FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER A; FAM9A",Asterisk
300478,"FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER B; FAM9B",Asterisk
300479,"FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER C; FAM9C",Asterisk
300480,TAK1-BINDING PROTEIN 3; TAB3,Asterisk
300481,"CYTOCHROME b(-245), BETA SUBUNIT; CYBB",Asterisk
300482,GRB2-ASSOCIATED BINDING PROTEIN 3; GAB3,Asterisk
300483,MOVED TO 300031,Caret
300484,OROFACIODIGITAL SYNDROME VIII; OFD8,Percent
300485,BCL6 COREPRESSOR; BCOR,Asterisk
300486,"MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE",Number Sign
300487,ACTIN-RELATED PROTEIN T1; ACTRT1,Asterisk
300488,"MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENOQ1",Percent
300489,"SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3",Number Sign
300490,SH2 DOMAIN PROTEIN 1A; SH2D1A,Asterisk
300491,"EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS",Number Sign
300492,"FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER A; FAM3A",Asterisk
300493,"SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A2; SPANXA2",Asterisk
300494,"ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1",Number Sign
300495,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2",Number Sign
300496,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3",Number Sign
300497,"ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2",Number Sign
300498,"MENTAL RETARDATION, X-LINKED 45; MRX45",Percent
300499,FTSJ HOMOLOG 1; FTSJ1,Asterisk
300500,"ALBINISM, OCULAR, TYPE I; OA1",Number Sign
300501,MOVED TO 309549,Caret
300502,"PYRUVATE DEHYDROGENASE, ALPHA-1; PDHA1",Asterisk
300503,MOVED TO 300419,Caret
300504,"MENTAL RETARDATION, X-LINKED 52; MRX52",Percent
300505,"MENTAL RETARDATION, X-LINKED 84; MRX84",Percent
300506,"TSC22 DOMAIN FAMILY, MEMBER 3; TSC22D3",Asterisk
300507,"H2B HISTONE FAMILY, MEMBER W, TESTIS-SPECIFIC; H2BFWT",Asterisk
300508,"UTP14, S. CEREVISIAE, HOMOLOG OF, A; UTP14A",Asterisk
300509,"DYSLEXIA, SUSCEPTIBILITY TO, 9; DYX9",Percent
300510,OVARIAN DYSGENESIS 2; ODG2,Number Sign
300511,PREMATURE OVARIAN FAILURE 2A; POF2A,Number Sign
300512,WD REPEAT-CONTAINING PROTEIN 13; WDR13,Asterisk
300513,G PROTEIN-COUPLED RECEPTOR 119; GPR119,Asterisk
300514,"FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB",Number Sign
300515,FANCB GENE; FANCB,Asterisk
300516,"ATPase, CLASS VI, TYPE 11C; ATP11C",Asterisk
300517,"SPINDLIN FAMILY, MEMBER 2",Asterisk
300518,"MENTAL RETARDATION, X-LINKED 82; MRX82",Percent
300519,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE; MRXSMP",Percent
300520,CLAUDIN 2; CLDN2,Asterisk
300521,KINESIN FAMILY MEMBER 4A; KIF4A,Asterisk
300522,IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 2; IQSEC2,Asterisk
300523,ALLAN-HERNDON-DUDLEY SYNDROME; AHDS,Number Sign
300524,NEURITE EXTENSION AND MIGRATION FACTOR; NEXMIF,Asterisk
300525,"PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 8; P2RY8",Asterisk
300526,WD REPEAT-CONTAINING PROTEIN 45; WDR45,Asterisk
300527,NUDIX HYDROLASE 10; NUDT10,Asterisk
300528,NUDIX HYDROLASE 11; NUDT11,Asterisk
300529,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 10; P2RY10",Asterisk
300530,MOVED TO 611775,Caret
300531,"SPROUTY, DROSOPHILA, HOMOLOG OF, 3; SPRY3",Asterisk
300532,"VARIABLY CHARGED, X CHROMOSOME, 2; VCX2",Asterisk
300533,"VARIABLY CHARGED, X CHROMOSOME, 3A; VCX3A",Asterisk
300534,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ",Number Sign
300535,OCRL GENE; OCRL,Asterisk
300536,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 4; BMND4,Percent
300537,MOVED TO 300049,Caret
300538,ARGININE VASOPRESSIN RECEPTOR 2; AVPR2,Asterisk
300539,NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD,Number Sign
300540,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 7; HAUS7",Asterisk
300541,"SARCOMA, SYNOVIAL, X BREAKPOINT 6; SSX6",Asterisk
300542,"SARCOMA, SYNOVIAL, X BREAKPOINT 7; SSX7",Asterisk
300543,"SARCOMA, SYNOVIAL, X BREAKPOINT 8; SSX8",Asterisk
300544,"SARCOMA, SYNOVIAL, X BREAKPOINT 9; SSX9",Asterisk
300545,HEPARAN SULFATE 6-O-SULFOTRANSFERASE 2; HS6ST2,Asterisk
300546,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 1; FGD1",Asterisk
300547,MST3- AND SOK1-RELATED KINASE,Asterisk
300548,"MELANOMA ANTIGEN, FAMILY H, 1; MAGEH1",Asterisk
300549,"MELANOMA ANTIGEN, FAMILY A, 2B; MAGEA2B",Asterisk
300550,"PHOSPHATE-REGULATING ENDOPEPTIDASE HOMOLOG, X-LINKED; PHEX",Asterisk
300551,MOVED TO 309530,Caret
300552,MIDLINE 1; MID1,Asterisk
300553,BROMODOMAIN- AND WD REPEAT-CONTAINING PROTEIN 3; BRWD3,Asterisk
300554,"HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE",Number Sign
300555,DENT DISEASE 2,Number Sign
300556,"ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 2; ATP6AP2",Asterisk
300557,PARKINSON DISEASE 12; PARK12,Percent
300558,"MENTAL RETARDATION, X-LINKED 30; MRX30",Number Sign
300559,"GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D",Number Sign
300560,PHD FINGER PROTEIN 8; PHF8,Asterisk
300561,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 2; SLITRK2",Asterisk
300562,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 4; SLITRK4",Asterisk
300563,MOVED TO 311070,Caret
300564,TSPY-LIKE 2; TSPYL2,Asterisk
300565,MOVED TO 300561,Caret
300566,LHFP-LIKE PROTEIN 1; LHFPL1,Asterisk
300567,PHOSPHOGLYCERATE MUTASE FAMILY MEMBER 4; PGAM4,Asterisk
300568,MICRO RNA 221; MIR221,Asterisk
300569,MICRO RNA 222; MIR222,Asterisk
300570,TRANSCRIPTION FACTOR YY2; YY2,Asterisk
300571,MOVED TO 615465,Caret
300572,ADHESION G PROTEIN-COUPLED RECEPTOR G2; ADGRG2,Asterisk
300573,ZINC FINGER PROTEIN 674; ZNF674,Asterisk
300574,"CHEMOKINE, CXC MOTIF, RECEPTOR 3; CXCR3",Asterisk
300575,"RIPPLY1, ZEBRAFISH, HOMOLOG OF; RIPPLY1",Asterisk
300576,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 15; ZDHHC15,Asterisk
300577,"MENTAL RETARDATION, X-LINKED 91; MRX91",Number Sign
300578,CHROMOSOME Xp11.3 DELETION SYNDROME,Number Sign
300579,SHROOM FAMILY MEMBER 4; SHROOM4,Asterisk
300580,"MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX",Percent
300581,FG SYNDROME 5; FGS5,Percent
300582,"SHORT STATURE, IDIOPATHIC, X-LINKED; ISS",Number Sign
300583,VESTIGIAL-LIKE 1; VGLL1,Asterisk
300584,IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA,Number Sign
300585,ZINC FINGER PROTEIN 673; ZNF673,Asterisk
300586,ARYLSULFATASE H; ARSH,Asterisk
300587,MALIGNANT T-CELL AMPLIFIED SEQUENCE 1; MCTS1,Asterisk
300588,TENEURIN TRANSMEMBRANE PROTEIN 1; TENM1,Asterisk
300589,"NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5",Percent
300590,CORNELIA DE LANGE SYNDROME 2; CDLS2,Number Sign
300591,STATURE QUANTITATIVE TRAIT LOCUS 6; STQTL6,Percent
300592,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A11; CT47A11",Asterisk
300593,SPERM ACROSOME-ASSOCIATED PROTEIN 5; SPACA5,Asterisk
300594,G ANTIGEN 1; GAGE1,Asterisk
300595,G ANTIGEN 2C; GAGE2C,Asterisk
300596,G ANTIGEN 3; GAGE3,Asterisk
300597,G ANTIGEN 4; GAGE4,Asterisk
300598,G ANTIGEN 5; GAGE5,Asterisk
300599,G ANTIGEN 6; GAGE6,Asterisk
300600,ALAND ISLAND EYE DISEASE; AIED,Number Sign
300601,G ANTIGEN 7; GAGE7,Asterisk
300602,CLARK-BARAITSER SYNDROME,
300603,POF1B GENE; POF1B,Asterisk
300604,PREMATURE OVARIAN FAILURE 2B; POF2B,Number Sign
300605,RETINITIS PIGMENTOSA 34; RP34,Percent
300606,MOVED TO 313500,Caret
300607,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8",Number Sign
300608,"DACHSHUND, DROSOPHILA, HOMOLOG OF, 2; DACH2",Asterisk
300609,"MALE-SPECIFIC LETHAL 3, DROSOPHILA, HOMOLOG OF; MSL3",Asterisk
300610,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H2; HNRNPH2,Asterisk
300611,C1GALT1-SPECIFIC CHAPERONE 1; C1GALT1C1,Asterisk
300612,BROOKS-WISNIEWSKI-BROWN SYNDROME,Percent
300613,"MYOPIA 13, X-LINKED; MYP13",Percent
300614,"DEAFNESS, X-LINKED 5; DFNX5",Number Sign
300615,BRUNNER SYNDROME; BRNRS,Number Sign
300616,LEUCINE ZIPPER PROTEIN 4; LUZP4,Asterisk
300617,"BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3; BRCC3",Asterisk
300618,PHD FINGER PROTEIN 16; PHF16,Asterisk
300619,"CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION",Percent
300620,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 1; VSIG1,Asterisk
300621,DXF34 GENE,Asterisk
300622,TN POLYAGGLUTINATION SYNDROME; TNPS,Number Sign
300623,FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS,Number Sign
300624,FRAGILE X SYNDROME; FXS,Number Sign
300625,KITA-KYUSHU LUNG CANCER ANTIGEN 1,Asterisk
300626,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 11; ASB11,Asterisk
300627,ZINC FINGER PROTEIN 449; ZNF449,Asterisk
300628,FERM DOMAIN-CONTAINING PROTEIN 7; FRMD7,Asterisk
300629,"ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-2 SUBUNIT; AP1S2",Asterisk
300630,MOVED TO 304340,Caret
300631,TRANSMEMBRANE PROTEIN 27; TMEM27,Asterisk
300632,PDZ DOMAIN-CONTAINING 11; PDZD11,Asterisk
300633,"HYPOSPADIAS 1, X-LINKED; HYSP1",Number Sign
300634,PDZ DOMAIN-CONTAINING 4; PDZD4,Asterisk
300635,"LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2",Number Sign
300636,IMMUNODEFICIENCY 33; IMD33,Number Sign
300637,G ANTIGEN 12I; GAGE12I,Asterisk
300638,G ANTIGEN 8; GAGE8,Asterisk
300639,MOVED TO 300354,Caret
300640,"INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2",Number Sign
300641,"SOLUTE CARRIER FAMILY 25, MEMBER 43; SLC25A43",Asterisk
300642,"SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED, 2; SRPX2",Asterisk
300643,"ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED; RESDX",Number Sign
300644,"GALACTOSIDASE, ALPHA; GLA",Asterisk
300645,IMMUNODEFICIENCY 34; IMD34,Number Sign
300646,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 9; ZDHHC9,Asterisk
300647,APC MEMBRANE RECRUITMENT PROTEIN 1; AMER1,Asterisk
300648,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A1; CT45A1",Asterisk
300649,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 5; SLC38A5",Asterisk
300650,"ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS; OASD",
300651,"PORCUPINE, DROSOPHILA, HOMOLOG OF; PORCN",Asterisk
300652,"ANGIOMA SERPIGINOSUM, X-LINKED",Percent
300653,PHOSPHOGLYCERATE KINASE 1 DEFICIENCY,Number Sign
300654,FATTY ACID AMIDE HYDROLASE 2; FAAH2,Asterisk
300655,KELCH-LIKE 13; KLHL13,Asterisk
300656,"URACIL PHOSPHORIBOSYLTRANSFERASE, S. CEREVISIAE, HOMOLOG OF; UPRT",Asterisk
300657,CANCER/TESTIS ANTIGEN 1A; CTAG1A,Asterisk
300658,NDP GENE; NDP,Asterisk
300659,"MENTAL RETARDATION, X-LINKED 93; MRX93",Number Sign
300660,LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD,Percent
300661,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY,Number Sign
300662,"SMALL NUCLEOLAR RNA, H/ACA BOX, 11; SNORA11",Asterisk
300663,"AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, A; ATG4A",Asterisk
300664,"SPANX FAMILY, MEMBER N1; SPANXN1",Asterisk
300665,"SPANX FAMILY, MEMBER N2; SPANXN2",Asterisk
300666,"SPANX FAMILY, MEMBER N3; SPANXN3",Asterisk
300667,"SPANX FAMILY, MEMBER N4; SPANXN4",Asterisk
300668,"SPANX FAMILY, MEMBER N5; SPANXN5",Asterisk
300669,"SPANX FAMILY, MEMBER B1; SPANXB1",Asterisk
300670,"SPANX FAMILY, MEMBER D; SPANXD",Asterisk
300671,"SPANX FAMILY, MEMBER E; SPANXE",Asterisk
300672,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2",Number Sign
300673,"ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS",Number Sign
300674,MOTILE SPERM DOMAIN-CONTAINING PROTEIN 1; MOSPD1,Asterisk
300675,PARANEOPLASTIC MA ANTIGEN 3; PNMA3,Asterisk
300676,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14",Number Sign
300677,CHROMOSOME X OPEN READING FRAME 15; CXORF15,Asterisk
300678,DUAL-SPECIFICITY PHOSPHATASE 21; DUSP21,Asterisk
300679,CHROMOSOME Xp21 DELETION SYNDROME,Number Sign
300680,"PREGNANCY-UPREGULATED, NONUBIQUITOUS, CAM KINASE; PNCK",Asterisk
300681,DEDICATOR OF CYTOKINESIS 11; DOCK11,Asterisk
300682,MICRO RNA 424; MIR424,Asterisk
300683,SEPTIN 6; SEPT6,Asterisk
300684,"X KELL BLOOD GROUP PRECURSOR-RELATED, X-LINKED; XKRX",Asterisk
300685,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 3; PRRG3,Asterisk
300686,MICRO RNA 448; MIR448,Asterisk
300687,ERCC6-LIKE; ERCC6L,Asterisk
300688,BCL6 COREPRESSOR-LIKE 1; BCORL1,Asterisk
300689,START DOMAIN-CONTAINING PROTEIN 8; STARD8,Asterisk
300690,BRAIN-EXPRESSED X-LINKED GENE 1; BEX1,Asterisk
300691,BRAIN-EXPRESSED X-LINKED GENE 2; BEX2,Asterisk
300692,BEX FAMILY MEMBER 4; BEX4,Asterisk
300693,BEX FAMILY MEMBER 5; BEX5,Asterisk
300694,MICRO RNA 223; MIR223,Asterisk
300695,"SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM",Number Sign
300696,"MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA",Number Sign
300697,"HECT, UBA, AND WWE DOMAINS-CONTAINING PROTEIN 1; HUWE1",Asterisk
300698,TRANSMEMBRANE PROTEIN 47; TMEM47,Asterisk
300699,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW",Number Sign
300700,ALBINISM-DEAFNESS SYNDROME; ADFN,Percent
300701,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 12; ZCCHC12,Asterisk
300702,"MELANOMA ANTIGEN, FAMILY D, 4; MAGED4",Asterisk
300703,"SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5",Percent
300704,"PROSTATE CANCER, HEREDITARY, X-LINKED 2; HPCX2",Percent
300705,CHROMOSOME Xp11.22 DUPLICATION SYNDROME,Number Sign
300706,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST",Number Sign
300707,"TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR",Number Sign
300708,"FAMILY WITH SEQUENCE SIMILARITY 58, MEMBER A; FAM58A",Asterisk
300709,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 9; MRXS9",Percent
300710,"ALOPECIA, ANDROGENETIC, 2; AGA2",Percent
300711,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 4; IHPS4",Percent
300712,CRANIOFACIOSKELETAL SYNDROME,Percent
300713,OTU DOMAIN-CONTAINING PROTEIN 5; OTUD5,Asterisk
300714,OTU DOMAIN-CONTAINING PROTEIN 6A; OTUD6A,Asterisk
300715,MAGNESIUM TRANSPORTER 1; MAGT1,Asterisk
300716,"MENTAL RETARDATION, X-LINKED 95; MRX95",Percent
300717,"REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET; RBMX1A",Number Sign
300718,"REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET; RBMX1B",Number Sign
300719,"DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES",Percent
300720,G ANTIGEN 2A; GAGE2A,Asterisk
300721,MICRO RNA LET7F2; MIRLET7F2,Asterisk
300722,MICRO RNA 19B2; MIR19B2,Asterisk
300723,SYNAPTOTAGMIN-LIKE 4; SYTL4,Asterisk
300724,CONNECTOR ENHANCER OF KINASE SUPPRESSOR OF RAS 2; CNKSR2,Asterisk
300725,RAS-RELATED GTP-BINDING PROTEIN B; RRAGB,Asterisk
300726,G ANTIGEN 2B; GAGE2B,Asterisk
300727,G ANTIGEN 12C; GAGE12C,Asterisk
300728,G ANTIGEN 12D; GAGE12D,Asterisk
300729,G ANTIGEN 12E; GAGE12E,Asterisk
300730,G ANTIGEN 12F; GAGE12F,Asterisk
300731,G ANTIGEN 12G; GAGE12G,Asterisk
300732,G ANTIGEN 12H; GAGE12H,Asterisk
300733,G ANTIGEN 12J; GAGE12J,Asterisk
300734,G ANTIGEN 13; GAGE13,Asterisk
300735,G ANTIGEN 2D; GAGE2D,Asterisk
300736,G ANTIGEN 2E; GAGE2E,Asterisk
300737,G ANTIGEN 10; GAGE10,Asterisk
300738,"P ANTIGEN FAMILY, MEMBER 2; PAGE2",Asterisk
300739,"P ANTIGEN FAMILY, MEMBER 3; PAGE3",Asterisk
300740,"X ANTIGEN FAMILY, MEMBER 3; XAGE3",Asterisk
300741,"FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER C; FAM120C",Asterisk
300742,"X ANTIGEN FAMILY, MEMBER 1A; XAGE1A",Asterisk
300743,"X ANTIGEN FAMILY, MEMBER 1B; XAGE1B",Asterisk
300744,"X ANTIGEN FAMILY, MEMBER 1C; XAGE1C",Asterisk
300745,"X ANTIGEN FAMILY, MEMBER 1E; XAGE1E",Asterisk
300746,COAGULATION FACTOR IX; F9,Asterisk
300747,STEROID SULFATASE; STS,Asterisk
300748,G PROTEIN-COUPLED RECEPTOR 82; GPR82,Asterisk
300749,MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH,Number Sign
300750,"SPASTIC PARAPLEGIA 34, X-LINKED; SPG34",Percent
300751,"ANEMIA, SIDEROBLASTIC, 1; SIDBA1",Number Sign
300752,"PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP",Number Sign
300753,APOLIPOPROTEIN O; APOO,Asterisk
300754,"TAF9B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 31-KD; TAF9B",Asterisk
300755,"AGAMMAGLOBULINEMIA, X-LINKED; XLA",Number Sign
300756,ALZHEIMER DISEASE 16; AD16,Percent
300757,RP2 GENE; RP2,Asterisk
300758,"HYPOSPADIAS 2, X-LINKED; HYSP2",Number Sign
300759,"MELANOMA ANTIGEN, FAMILY E, 1; MAGEE1",Asterisk
300760,"MELANOMA ANTIGEN, FAMILY E, 2; MAGEE2",Asterisk
300761,"MELANOMA ANTIGEN, FAMILY B, 10; MAGEB10",Asterisk
300762,"MELANOMA ANTIGEN, FAMILY B, 16; MAGEB16",Asterisk
300763,"MELANOMA ANTIGEN, FAMILY B, 17; MAGEB17",Asterisk
300764,"MELANOMA ANTIGEN, FAMILY A, 9B; MAGEA9B",Asterisk
300765,"MELANOMA ANTIGEN, FAMILY D, 4B; MAGED4B",Asterisk
300766,NFKB-ACTIVATING PROTEIN; NKAP,Asterisk
300767,REPLICATION PROTEIN A4; RPA4,Asterisk
300768,CYLICIN 1; CYLC1,Asterisk
300769,MICRO RNA 224; MIR224,Asterisk
300770,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4",Number Sign
300771,TRANSCRIPTION ELONGATION FACTOR A-LIKE 7; TCEAL7,Asterisk
300772,"TRANSCRIPTION FACTOR DP FAMILY, MEMBER 3; TFDP3",Asterisk
300773,APEX NUCLEASE (APURINIC/APYRIMIDINIC ENDONUCLEASE) 2; APEX2,Asterisk
300774,RAS-ASSOCIATED PROTEIN RAB39B; RAB39B,Asterisk
300775,E74-LIKE FACTOR 4; ELF4,Asterisk
300776,"ALG13, S. CEREVISIAE, HOMOLOG OF; ALG13",Asterisk
300777,EPSILON-TRIMETHYLLYSINE HYDROXYLASE; TMLHE,Asterisk
300778,"CORNEAL DYSTROPHY, LISCH EPITHELIAL; LECD",Percent
300779,"CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED; XECD",Percent
300780,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A1; CT47A1",Asterisk
300781,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A2; CT47A2",Asterisk
300782,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A3; CT47A3",Asterisk
300783,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A4; CT47A4",Asterisk
300784,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A5; CT47A5",Asterisk
300785,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A6; CT47A6",Asterisk
300786,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A7; CT47A7",Asterisk
300787,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A8; CT47A8",Asterisk
300788,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A9; CT47A9",Asterisk
300789,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A10; CT47A10",Asterisk
300790,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER B1; CT47B1",Asterisk
300791,NIK-RELATED KINASE; NRK,Asterisk
300792,MICRO RNA 106A; MIR106A,Asterisk
300793,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A2; CT45A2",Asterisk
300794,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A3; CT45A3",Asterisk
300795,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A4; CT45A4",Asterisk
300796,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A5; CT45A5",Asterisk
300797,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A6; CT45A6",Asterisk
300798,"PHOSPHORYLASE KINASE, LIVER, ALPHA-2 SUBUNIT; PHKA2",Asterisk
300799,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR",Number Sign
300800,MOVED TO 103580,Caret
300801,CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME,Number Sign
300802,"MENTAL RETARDATION, X-LINKED 96; MRX96",Number Sign
300803,"MENTAL RETARDATION, X-LINKED 97; MRX97",Number Sign
300804,JOUBERT SYNDROME 10; JBTS10,Number Sign
300805,FMR1 ANTISENSE RNA 1; FMR1AS1,Asterisk
300806,"AF4/FMR2 FAMILY, MEMBER 2; AFF2",Asterisk
300807,"THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THPH8",Number Sign
300808,G PROTEIN-COUPLED RECEPTOR 143; GPR143,Asterisk
300809,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15; SLEB15",Percent
300810,MICRO RNA 98; MIR98,Asterisk
300811,MICRO RNA 105-1; MIR105-1,Asterisk
300812,MICRO RNA 105-2; MIR105-2,Asterisk
300813,"SARCOMA, SYNOVIAL",
300814,"NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6",Number Sign
300815,CHROMOSOME Xq28 DUPLICATION SYNDROME,Number Sign
300816,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6,Number Sign
300817,EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 2; EFHC2,Asterisk
300818,PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1,Number Sign
300819,ZINC FINGER PROTEIN 630; ZNF630,Asterisk
300820,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 15; MAP3K15,Asterisk
300821,"OPSIN 1, MEDIUM-WAVE-SENSITIVE; OPN1MW",Asterisk
300822,"OPSIN 1, LONG-WAVE-SENSITIVE; OPN1LW",Asterisk
300823,IDURONATE 2-SULFATASE; IDS,Asterisk
300824,"OPN1LW AND OPN1MW GENES, CONTROLLER OF",Asterisk
300825,RETINOBLASTOMA-BINDING PROTEIN 7; RBBP7,Asterisk
300826,STROMAL ANTIGEN 2; STAG2,Asterisk
300827,FIBROBLAST GROWTH FACTOR 16; FGF16,Asterisk
300828,PATCHED DOMAIN-CONTAINING PROTEIN 1; PTCHD1,Asterisk
300829,"CARDIOMYOPATHY, FATAL FETAL, DUE TO MYOCARDIAL CALCIFICATION",Percent
300830,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 4; AUTSX4",Number Sign
300831,CK SYNDROME,Number Sign
300832,JUST PROXIMAL TO XIST; JPX,Asterisk
300833,"46,XX SEX REVERSAL 3; SRXX3",Number Sign
300834,"MACULAR DEGENERATION, X-LINKED ATROPHIC",Number Sign
300835,"ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP",Number Sign
300836,KAL1 GENE; KAL1,Asterisk
300837,"DIACYLGLYCEROL KINASE, KAPPA, 142-KD; DGKK",Asterisk
300838,FERM AND PDZ DOMAINS-CONTAINING PROTEIN 4; FRMPD4,Asterisk
300839,RETINOSCHISIN; RS1,Asterisk
300840,"PRA1 DOMAIN FAMILY, MEMBER 2; PRAF2",Asterisk
300841,COAGULATION FACTOR VIII; F8,Asterisk
300842,MCLEOD SYNDROME; MCLDS,Number Sign
300843,BORNHOLM EYE DISEASE; BED,Percent
300844,"MENTAL RETARDATION, X-LINKED 19; MRX19",Number Sign
300845,"MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM; MYMY4",Number Sign
300846,CD99 ANTIGEN-LIKE 2; CD99L2,Asterisk
300847,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5",Number Sign
300848,"MENTAL RETARDATION, X-LINKED 89; MRX89",Percent
300849,"MENTAL RETARDATION, X-LINKED 41; MRX41",Number Sign
300850,"MENTAL RETARDATION, X-LINKED 90; MRX90",Number Sign
300851,"MENTAL RETARDATION, X-LINKED 92; MRX92",Percent
300852,"MENTAL RETARDATION, X-LINKED 88; MRX88",Percent
300853,"IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN",Number Sign
300854,"RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1",Number Sign
300855,OGDEN SYNDROME; OGDNS,Number Sign
300856,"HYPOSPADIAS 4, X-LINKED, SUSCEPTIBILITY TO; HYSP4",Percent
300857,AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15,Number Sign
300858,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17",Percent
300859,COILED-COIL DOMAIN-CONTAINING PROTEIN 22; CCDC22,Asterisk
300860,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN",Number Sign
300861,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS",Percent
300862,ACYL-CoA THIOESTERASE 9; ACOT9,Asterisk
300863,"CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA",Number Sign
300864,"CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED",
300865,MICRO RNA 503; MIR503,Asterisk
300866,MICRO RNA 510; MIR510,Asterisk
300867,KABUKI SYNDROME 2; KABUK2,Number Sign
300868,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2,Number Sign
300869,CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME,Number Sign
300870,"ANEURYSM, INTRACRANIAL BERRY, 5; ANIB5",Percent
300871,FUN14 DOMAIN-CONTAINING PROTEIN 1; FUNDC1,Asterisk
300872,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6",Number Sign
300873,GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3-LIKE PROTEIN; GNL3L,Asterisk
300874,MICRO RNA 508; MIR508,Asterisk
300875,MICRO RNA 509-1; MIR509-1,Asterisk
300876,MICRO RNA 509-3; MIR509-3,Asterisk
300877,MICRO RNA 506; MIR506,Asterisk
300878,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C1; DMRTC1,Asterisk
300879,XG GLYCOPROTEIN; XG,Asterisk
300880,"PROTEASOME 26S SUBUNIT, NON-ATPase, 10; PSMD10",Asterisk
300881,BARATELA-SCOTT SYNDROME,Percent
300882,CORNELIA DE LANGE SYNDROME 5; CDLS5,Number Sign
300883,SORTING NEXIN 12; SNX12,Asterisk
300884,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36",Number Sign
300885,"CYTOCHROME c OXIDASE, SUBUNIT 7B; COX7B",Asterisk
300886,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32",Number Sign
300887,LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2,Number Sign
300888,"HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT; CHTE",Number Sign
300889,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12B; ZC3H12B,Asterisk
300890,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 9; ASB9,Asterisk
300891,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 12; ASB12,Asterisk
300892,LONG INTERGENIC NONCODING RNA 850; LINC00850,Asterisk
300893,MICRO RNA 502; MIR502,Asterisk
300894,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5,Number Sign
300895,"OHDO SYNDROME, X-LINKED; OHDOX",Number Sign
300896,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M",Number Sign
300897,ZINC FINGER C4H2 DOMAIN-CONTAINING PROTEIN; ZC4H2,Asterisk
300898,"CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 1, ANTISENSE; CDR1AS",Asterisk
300899,RIBOSOMAL PROTEIN L39; RPL39,Asterisk
300900,REMOVED FROM DATABASE,Caret
300901,X-ACTIVE-SPECIFIC NONCODING TRANSCRIPT; XACT,Asterisk
300902,RIBOSOMAL PROTEIN L36A; RPL36A,Asterisk
300903,G PROTEIN-COUPLED RECEPTOR 174; GPR174,Asterisk
300904,INSULIN RECEPTOR SUBSTRATE 4; IRS4,Asterisk
300905,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6",Number Sign
300906,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 3; PDK3",Asterisk
300907,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD; CSTF2",Asterisk
300908,"ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY",Number Sign
300909,"ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO; AEACEI",Number Sign
300910,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18; BMND18,Number Sign
300911,"PARKINSONISM WITH SPASTICITY, X-LINKED; XPDS",Number Sign
300912,"MENTAL RETARDATION, X-LINKED 98; MRX98",Number Sign
300913,"VMA21, S. CEREVISIAE, HOMOLOG OF; VMA21",Asterisk
300914,"DEAFNESS, X-LINKED 6; DFNX6",Number Sign
300915,"MICROPHTHALMIA, SYNDROMIC 13; MCOPS13",Number Sign
300916,"PARANEOPLASTIC MA ANTIGEN FAMILY, MEMBER 5; PNMA5",Asterisk
300917,"PARANEOPLASTIC MA ANTIGEN FAMILY, MEMBER 6A; PNMA6A",Asterisk
300918,"PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED",Number Sign
300919,"MENTAL RETARDATION, X-LINKED 99; MRX99",Number Sign
300920,ATAXIN 3-LIKE; ATXN3L,Asterisk
300921,"BASIC HELIX-LOOP-HELIX DOMAIN-CONTAINING PROTEIN, CLASS B, 9; BHLHB9",Asterisk
300922,CYSTEINE-RICH HYDROPHOBIC DOMAIN PROTEIN 1; CHIC1,Asterisk
300923,"MENTAL RETARDATION, X-LINKED 100; MRX100",Number Sign
300924,ACYL-CoA WAX ALCOHOL ACYLTRANSFERASE 1; AWAT1,Asterisk
300925,ACYL-CoA WAX ALCOHOL ACYLTRANSFERASE 2; AWAT2,Asterisk
300926,DIACYLGLYCEROL O-ACYLTRANSFERASE 2-LIKE 6; DGAT2L6,Asterisk
300927,PEROXIREDOXIN 4; PRDX4,Asterisk
300928,"MENTAL RETARDATION, X-LINKED 101; MRX101",Number Sign
300929,MICRO RNA 718; MIR718,Asterisk
300930,MAP7 DOMAIN-CONTAINING PROTEIN 3; MAP7D3,Asterisk
300931,PIRIN; PIR,Asterisk
300932,THYROXINE-BINDING GLOBULIN QUANTITATIVE TRAIT LOCUS; TBGQTL,Number Sign
300933,PIH1 DOMAIN-CONTAINING PROTEIN 3; PIH1D3,Asterisk
300934,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y",Number Sign
300935,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 1; PRRG1,Asterisk
300936,"FTX TRANSCRIPT, XIST REGULATOR, NONCODING; FTX",Asterisk
300937,RHO GTPase-ACTIVATING PROTEIN 36; ARHGAP36,Asterisk
300938,MATRIX REMODELING-ASSOCIATED PROTEIN 5; MXRA5,Asterisk
300939,"THYMOSIN, BETA-15A; TMSB15A",Asterisk
300940,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 2; GDPD2,Asterisk
300941,"SOLUTE CARRIER FAMILY 25, MEMBER 53; SLC25A53",Asterisk
300942,CHROMOSOME Xq26.3 DUPLICATION SYNDROME,Number Sign
300943,"PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2",Number Sign
300944,"CSAG FAMILY, MEMBER 1; CSAG1",Asterisk
300945,"TSR2, 20S rRNA ACCUMULATION, S. CEREVISIAE, HOMOLOG OF; TSR2",Asterisk
300946,DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14,Number Sign
300947,COILED-COIL DOMAIN-CONTAINING PROTEIN 120; CCDC120,Asterisk
300948,"PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, BETA ISOFORM; PCYT1B",Asterisk
300949,FORKHEAD BOX R2; FOXR2,Asterisk
300950,MICRO RNA 20B; MIR20B,Asterisk
300951,RING FINGER PROTEIN 113A; RNF113A,Asterisk
300952,LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3,Number Sign
300953,"TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE; TTD5",Number Sign
300954,CHROMOSOME X OPEN READING FRAME 40A; CXORF40A,Asterisk
300955,APOLIPOPROTEIN O-LIKE; APOOL,Asterisk
300956,BRAF PSEUDOGENE 1; BRAFP1,Asterisk
300957,"MENTAL RETARDATION, X-LINKED 12; MRX12",Number Sign
300958,"MENTAL RETARDATION, X-LINKED 102; MRX102",Number Sign
300959,CHROMOSOME X OPEN READING FRAME 36; CXORF36,Asterisk
300960,MEND SYNDROME; MEND,Number Sign
300961,MID1-INTERACTING PROTEIN 1; MID1IP1,Asterisk
300962,GEM-ASSOCIATED PROTEIN 8; GEMIN8,Asterisk
300963,RITSCHER-SCHINZEL SYNDROME 2; RTSC2,Number Sign
300964,LAS1-LIKE RIBOSOME BIOGENESIS FACTOR; LAS1L,Asterisk
300965,RETROTRANSPOSON GAG DOMAIN-CONTAINING PROTEIN 1; RGAG1,Asterisk
300966,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 33; MRXS33",Number Sign
300967,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34",Number Sign
300968,"MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F",Number Sign
300969,G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 2; GPRASP2,Asterisk
300970,MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 4; MORC4,Asterisk
300971,"BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT; BARTS5",Number Sign
300972,IMMUNODEFICIENCY 47; IMD47,Number Sign
300973,"RHOX HOMEOBOX FAMILY MEMBER 1, PSEUDOGENE 1; RHOXF1P1",Asterisk
300974,"PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 1; PLCXD1",Asterisk
300975,"UBIQUITIN-SPECIFIC PROTEASE 27, X-LINKED; USP27X",Asterisk
300976,"FAMILY WITH SEQUENCE SIMILARITY 46, MEMBER D; FAM46D",Asterisk
300977,SCHOLTE SYNDROME; SHLTS,Percent
300978,"MENTAL RETARDATION, X-LINKED 61; MRX61",Number Sign
300979,Xq25 DUPLICATION SYNDROME,Number Sign
300980,KELCH-LIKE 15; KLHL15,Asterisk
300981,"VARIABLY CHARGED, X CHROMOSOME, 3B; VCX3B",Asterisk
300982,"MENTAL RETARDATION, X-LINKED 103; MRX103",Number Sign
300983,"MENTAL RETARDATION, X-LINKED 104; MRX104",Number Sign
300984,"MENTAL RETARDATION, X-LINKED 105; MRX105",Number Sign
300985,"VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED; CBAVDX",Number Sign
300986,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB",Number Sign
300987,MOVED TO 300148,Caret
300988,IMMUNODEFICIENCY 50; IMD50,Number Sign
300989,MEESTER-LOEYS SYNDROME; MRLS,Number Sign
300990,"MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN",Number Sign
300991,"CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36",Number Sign
300992,NEGATIVE REGULATOR OF P-BODY ASSOCIATION; NBDY,Asterisk
300993,PAS DOMAIN-CONTAINING REPRESSOR 1; PASD1,Asterisk
300994,HIGHLY DIVERGENT HOMEOBOX; HDX,Asterisk
300995,KIAA1210 GENE; KIAA1210,Asterisk
300996,"YIP1 DOMAIN FAMILY, MEMBER 6; YIPF6",Asterisk
300997,"MENTAL RETARDATION, X-LINKED 106; MRX106",Number Sign
300998,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35",Number Sign
300999,FUNCTIONAL INTERGENIC REPEATING RNA ELEMENT; FIRRE,Asterisk
301000,WISKOTT-ALDRICH SYNDROME; WAS,Number Sign
301001,"DXZ4-ASSOCIATED NONCODING TRANSCRIPT 1, PROXIMAL; DANT1",Asterisk
301002,"PROTEIN KINASE, SERINE/ARGININE-SPECIFIC, 3; SRPK3",Asterisk
301003,G-PATCH DOMAIN AND KOW MOTIFS; GPKOW,Asterisk
301004,"DXZ4-ASSOCIATED NONCODING TRANSCRIPT 2, DISTAL; DANT2",Asterisk
301005,FERM- AND PDZ DOMAIN-CONTAINING PROTEIN 3; FRMPD3,Asterisk
301006,"GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2",Number Sign
301007,"ZINC FINGER, MATRIN-TYPE 1; ZMAT1",Asterisk
301008,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG",Number Sign
301009,"P ANTIGEN FAMILY, MEMBER 5; PAGE5",Asterisk
301010,"MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26",Number Sign
301011,"THYMOSIN, BETA-15B; TMSB15B",Asterisk
301012,CHROMOSOME X OPEN READING FRAME 56; CXORF56,Asterisk
301013,"MENTAL RETARDATION, X-LINKED 107; MRX107",Number Sign
301014,"OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19",Number Sign
301015,"HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED",Number Sign
301016,RAS-RELATED PROTEIN 2C; RAP2C,Asterisk
301017,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2C; PPP1R2C",Asterisk
301040,"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX",Number Sign
301050,"ALPORT SYNDROME, X-LINKED; ATS",Number Sign
301090,MOVED TO 273395,Caret
301100,MOVED TO 301200,Caret
301200,"AMELOGENESIS IMPERFECTA, TYPE IE; AI1E",Number Sign
301201,"AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2",Percent
301220,"PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR",Number Sign
301300,DELTA-AMINOLEVULINATE SYNTHASE 2; ALAS2,Asterisk
301310,"ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT",Number Sign
301410,"NEURAL TUBE DEFECTS, X-LINKED",
301500,FABRY DISEASE,Number Sign
301590,"MICROPHTHALMIA, SYNDROMIC 4; MCOPS4",Percent
301700,ANOSMIA,
301770,"ARRESTIN 3, RETINAL; ARR3",Asterisk
301780,"ARYLSULFATASE C, ISOZYME F; ARSC2",Asterisk
301790,"SPINOCEREBELLAR ATAXIA, X-LINKED 3",
301800,"ANUS, IMPERFORATE",
301810,MOVED TO 215700,Caret
301815,"ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY",
301820,MOVED TO 208085,Caret
301830,"SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2",Number Sign
301835,ARTS SYNDROME; ARTS,Number Sign
301840,"SPINOCEREBELLAR ATAXIA, X-LINKED 4",
301845,BAZEX SYNDROME; BZX,Percent
301850,"TUBULIN, BETA",
301870,BIGLYCAN; BGN,Asterisk
301880,REMOVED FROM DATABASE,Caret
301900,BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS,Number Sign
301940,"BRACHYDACTYLY, MONONEN TYPE",
301950,"BRANCHIAL ARCH SYNDROME, X-LINKED",
302000,"BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE",Percent
302020,S100 CALCIUM-BINDING PROTEIN G; S100G,Asterisk
302030,CALVARIAL HYPEROSTOSIS,Percent
302045,"CARDIOMYOPATHY, DILATED, 3B; CMD3B",Number Sign
302060,BARTH SYNDROME; BTHS,Number Sign
302200,CATARACT 40; CTRCT40,Number Sign
302300,MOVED TO 302200,Caret
302350,NANCE-HORAN SYNDROME; NHS,Number Sign
302380,MOVED TO 616145,Caret
302400,"CENTRAL INCISORS, ABSENCE OF",
302500,"SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1",Number Sign
302600,"SPINOCEREBELLAR ATAXIA, X-LINKED 2",
302650,CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 1; CDR1,Asterisk
302700,"CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE",
302800,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1",Number Sign
302801,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2",Percent
302802,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3",Percent
302803,"CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED, WITH APLASIA CUTIS CONGENITA",
302900,"CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA, COMBINED",
302905,ABRUZZO-ERICKSON SYNDROME; ABERS,Number Sign
302910,CHLORIDE CHANNEL 4; CLCN4,Asterisk
302920,MOVED TO 305425,Caret
302940,MOVED TO 302950,Caret
302950,"CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1",Number Sign
302960,"CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2",Number Sign
303100,CHOROIDEREMIA; CHM,Number Sign
303110,"CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION",Number Sign
303350,MASA SYNDROME,Number Sign
303400,"CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX",Number Sign
303600,COFFIN-LOWRY SYNDROME; CLS,Number Sign
303630,"COLLAGEN, TYPE IV, ALPHA-5; COL4A5",Asterisk
303631,"COLLAGEN, TYPE IV, ALPHA-6; COL4A6",Asterisk
303650,COLONIC ATRESIA,
303700,BLUE CONE MONOCHROMACY; BCM,Number Sign
303800,"COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD",Number Sign
303900,"COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP",Number Sign
304000,MOVED TO 613522,Caret
304020,"CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1",Number Sign
304030,"CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN",
304040,"GAP JUNCTION PROTEIN, BETA-1; GJB1",Asterisk
304050,AICARDI SYNDROME; AIC,Percent
304100,"CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED",Number Sign
304110,CRANIOFRONTONASAL SYNDROME; CFNS,Number Sign
304120,"OTOPALATODIGITAL SYNDROME, TYPE II; OPD2",Number Sign
304150,OCCIPITAL HORN SYNDROME; OHS,Number Sign
304200,"CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION",
304300,"CYANIDE, INABILITY TO SMELL",
304340,PETTIGREW SYNDROME; PGS,Number Sign
304350,DEAFNESS-HYPOGONADISM SYNDROME,
304400,"DEAFNESS, X-LINKED 2; DFNX2",Number Sign
304500,"DEAFNESS, X-LINKED 1; DFNX1",Number Sign
304590,MOVED TO 304500,Caret
304600,MOVED TO 304590,Caret
304700,MOHR-TRANEBJAERG SYNDROME; MTS,Number Sign
304730,DERMOIDS OF CORNEA; CND,Percent
304750,MOVED TO 306955,Caret
304790,"IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX",Number Sign
304800,"DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED",Number Sign
304900,"DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE",
304930,MOVED TO 304790,Caret
304950,"DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED",
304990,REMOVED FROM DATABASE,Caret
305000,"DYSKERATOSIS CONGENITA, X-LINKED; DKCX",Number Sign
305050,MOVED TO 304700,Caret
305100,"ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED",Number Sign
305200,"EHLERS-DANLOS SYNDROME, TYPE V",Percent
305300,MOVED TO 302060,Caret
305350,"EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2",
305360,"MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1",Asterisk
305370,TISSUE INHIBITOR OF METALLOPROTEINASE 1; TIMP1,Asterisk
305371,GATA-BINDING PROTEIN 1; GATA1,Asterisk
305390,"EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2",Number Sign
305400,AARSKOG-SCOTT SYNDROME; AAS,Number Sign
305423,FACTOR VIII-ASSOCIATED GENE 1; F8A,Asterisk
305424,FACTOR VIII-ASSOCIATED GENE 2,Asterisk
305425,MOVED TO 134629,Caret
305435,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HBFQTL3,Percent
305450,OPITZ-KAVEGGIA SYNDROME; OKS,Number Sign
305550,FINGERPRINT BODY MYOPATHY,
305600,FOCAL DERMAL HYPOPLASIA; FDH,Number Sign
305620,FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1,Number Sign
305645,MOVED TO 136760,Caret
305650,REMOVED FROM DATABASE,Caret
305660,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-3; GABRA3",Asterisk
305670,GASTRIN-RELEASING PEPTIDE RECEPTOR; GRPR,Asterisk
305690,GENITOURINARY TRACT ANOMALIES,
305700,"SPERMATOGENIC FAILURE, X-LINKED, 1; SPGFX1",
305800,"MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED",
305900,GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD,Asterisk
305910,MOVED TO 138130,Caret
305915,"GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 3; GRIA3",Asterisk
305920,GLUTAMYL RIBOSE-5-PHOSPHATE STORAGE DISEASE,
305980,MOVED TO 138140,Caret
305990,"GLYCINE RECEPTOR, ALPHA-2 SUBUNIT; GLRA2",Asterisk
306000,GLYCOGEN STORAGE DISEASE IXa1; GSD9A1,Number Sign
306100,MOVED TO 400044,Caret
306190,MOVED TO 300200,Caret
306250,"COLONY-STIMULATING FACTOR 2 RECEPTOR, ALPHA; CSF2RA",Asterisk
306300,"GRANULOMAS, CONGENITAL CEREBRAL",
306400,"GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX",Number Sign
306480,HALOACID DEHALOGENASE-LIKE HYDROLASE DOMAIN-CONTAINING 1A; HDHD1A,Asterisk
306500,MOVED TO 312300,Caret
306600,REMOVED FROM DATABASE,Caret
306700,HEMOPHILIA A; HEMA,Number Sign
306800,HEMOPHILIA A WITH VASCULAR ABNORMALITY,
306900,HEMOPHILIA B; HEMB,Number Sign
306930,HEMOPOIETIC PROLIFERATION,
306950,"HERNIA, ANTERIOR DIAPHRAGMATIC",
306955,"HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1",Number Sign
306960,HHHH SYNDROME,Percent
306970,MOVED TO 426000,Caret
306980,HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY,
306990,HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE,
306995,HOMOSEXUALITY 1; HMS1,
307000,HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS,Number Sign
307010,HYDROCEPHALUS WITH CEREBELLAR AGENESIS,
307030,GLYCEROL KINASE DEFICIENCY; GKD,Number Sign
307150,"HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2",Number Sign
307200,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3",Number Sign
307300,MOVED TO 312300,Caret
307500,"HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES",
307600,MOVED TO 602014,Caret
307700,"HYPOPARATHYROIDISM, X-LINKED; HYPX",Percent
307800,"HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR",Number Sign
307810,MOVED TO 307800 AND 300550,Caret
307830,"HYPOURICEMIA, FAMILIAL RENAL, DUE TO TUBULAR HYPERSECRETION",
308000,HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1,Asterisk
308050,CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS,Number Sign
308100,"ICHTHYOSIS, X-LINKED; XLI",Number Sign
308200,ICHTHYOSIS AND MALE HYPOGONADISM,
308205,IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME,Number Sign
308210,REMOVED FROM DATABASE,Caret
308220,"IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACE GLYCOPROTEIN",
308230,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1",Number Sign
308240,"LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1",Number Sign
308250,"IMMUNOGLOBULIN M, LEVEL OF",Percent
308280,"IMPACTED TEETH, MULTIPLE",Percent
308290,IMPRINTING GENE RELATED TO RETINOBLASTOMA,
308300,INCONTINENTIA PIGMENTI; IP,Number Sign
308310,MOVED TO 308300,Caret
308350,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1",Number Sign
308370,MOVED TO 312300,Caret
308380,"INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG",Asterisk
308385,"INTERLEUKIN 3 RECEPTOR, ALPHA; IL3RA",Asterisk
308400,REMOVED FROM DATABASE,Caret
308500,IRIS HYPOPLASIA WITH GLAUCOMA; IHG,
308600,"JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY",
308700,HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1,Number Sign
308750,KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA,
308800,"KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX",Number Sign
308830,"KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY",
308840,L1 CELL ADHESION MOLECULE; L1CAM,Asterisk
308850,LARYNGEAL ABDUCTOR PARALYSIS,
308905,"LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO",Percent
308930,MOVED TO 312170,Caret
308940,"LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS",Number Sign
308950,LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT,
308960,"LEUKEMIA, ACUTE, ?X-LINKED",
308980,MOVED TO 151660,Caret
308990,"PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS",Number Sign
309000,LOWE OCULOCEREBRORENAL SYNDROME; OCRL,Number Sign
309050,"LUTHERAN SUPPRESSOR, X-LINKED; XS",
309060,LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2; LAMP2,Asterisk
309100,"MACULAR DYSTROPHY, X-LINKED",Percent
309120,"SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2",Number Sign
309150,MOVED TO 614279,Caret
309200,MAJOR AFFECTIVE DISORDER 2; MAFD2,Percent
309300,MEGALOCORNEA; MGC1,Number Sign
309350,MELNICK-NEEDLES SYNDROME; MNS,Number Sign
309400,MENKES DISEASE,Number Sign
309470,MOVED TO 309500,Caret
309480,MENTAL RETARDATION AND PSORIASIS,
309490,MOVED TO 309580,Caret
309500,RENPENNING SYNDROME 1; RENS1,Number Sign
309510,PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS,Number Sign
309520,LUJAN-FRYNS SYNDROME,Number Sign
309530,"MENTAL RETARDATION, X-LINKED 1; MRX1",Number Sign
309540,MOVED TO 309548,Caret
309541,"METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE",Number Sign
309545,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12",Percent
309548,"MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE",Number Sign
309549,"MENTAL RETARDATION, X-LINKED 9; MRX9",Number Sign
309550,FMR1 GENE; FMR1,Asterisk
309555,"MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES",Percent
309560,MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS,Percent
309580,"MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1",Number Sign
309583,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR",Number Sign
309585,WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS,Number Sign
309590,MOVED TO 309580,Caret
309600,MOVED TO 300523,Caret
309605,MOVED TO 314580,Caret
309610,PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS,Percent
309620,"MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD",Percent
309630,METACARPAL 4-5 FUSION; MF4,Number Sign
309640,MENTAL RETARDATION WITH SPASTIC PARAPLEGIA,
309645,MOVED TO 602111,Caret
309660,MOVED TO 300257,Caret
309700,MOVED TO 310600,Caret
309800,"MICROPHTHALMIA, SYNDROMIC 1; MCOPS1",Number Sign
309801,LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1,Number Sign
309840,"MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS",
309845,MOESIN; MSN,Asterisk
309850,MONOAMINE OXIDASE A; MAOA,Asterisk
309860,MONOAMINE OXIDASE B; MAOB,Asterisk
309900,"MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2",Number Sign
309930,"MUSCULAR DYSTROPHY, CARDIAC TYPE",
309950,"MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE",
310000,"MUSCULAR DYSTROPHY, MABRY TYPE",
310095,"MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL",
310200,"MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD",Number Sign
310300,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1",Number Sign
310305,MOVED TO 601415,Caret
310310,MYCL-RELATED PROCESSED GENE; MYCL2,Asterisk
310350,MYELOLYMPHATIC INSUFFICIENCY,
310370,"MYOCLONIC EPILEPSY, PROGRESSIVE",
310400,"MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX",Number Sign
310440,"MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX",Number Sign
310450,MOVED TO 159000,Caret
310460,"MYOPIA 1, X-LINKED; MYP1",Percent
310465,N SYNDROME; NSX,
310468,"NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN",Number Sign
310470,"NEUROPATHY, HEREDITARY SENSORY, X-LINKED",
310490,COWCHOCK SYNDROME; COWCK,Number Sign
310500,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A",Number Sign
310600,NORRIE DISEASE; ND,Number Sign
310650,NUCLEAR RIBONUCLEIC ACID; nRNA,
310700,"NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1",Number Sign
310800,"NYSTAGMUS, MYOCLONIC",
310900,"OCCIPITAL HAIR, WHITE LOCK OF",
310980,"OMPHALOCELE, X-LINKED",
310990,MOVED TO 190020,Caret
311000,"OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM",Percent
311010,V-RAF MURINE SARCOMA 3611 VIRAL ONCOGENE HOMOLOG 1; ARAF1,Asterisk
311020,MOVED TO 311010,Caret
311030,MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE; MCF2,Asterisk
311040,"ELK1, MEMBER OF ETS ONCOGENE FAMILY; ELK1",Asterisk
311050,OPTIC ATROPHY 2; OPA2,Percent
311070,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5",Number Sign
311100,OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME,
311150,MOVED TO 304700,Caret
311200,OROFACIODIGITAL SYNDROME I; OFD1,Number Sign
311240,"TBC1 DOMAIN FAMILY, MEMBER 25; TBC1D25",Asterisk
311241,MOVED TO 258870,Caret
311250,"ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO",Number Sign
311280,MOVED TO 300373,Caret
311300,"OTOPALATODIGITAL SYNDROME, TYPE I; OPD1",Number Sign
311350,OUABAIN RESISTANCE; OUBR,
311360,PREMATURE OVARIAN FAILURE 1; POF1,Number Sign
311400,PAINE SYNDROME,
311450,PALLISTER W SYNDROME,
311510,WAISMAN SYNDROME; WSMN,Number Sign
311550,CYCLIN-DEPENDENT KINASE 16; CDK16,Asterisk
311601,MOVED TO 312080,Caret
311700,REMOVED FROM DATABASE,Caret
311750,MOVED TO 170650,Caret
311770,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS A PROTEIN; PIGA,Asterisk
311790,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1; PFKFB1",Asterisk
311800,PHOSPHOGLYCERATE KINASE 1; PGK1,Asterisk
311810,MOVED TO 311800,Caret
311850,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE I; PRPS1,Asterisk
311860,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE II; PRPS2,Asterisk
311870,"PHOSPHORYLASE KINASE, MUSCLE, ALPHA-1 SUBUNIT; PHKA1",Asterisk
311895,PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES,
311900,TARP SYNDROME; TARPS,Number Sign
312000,"PANHYPOPITUITARISM, X-LINKED; PHPX",Number Sign
312030,REMOVED FROM DATABASE,Caret
312040,"POLYMERASE, DNA, ALPHA-1; POLA1",Asterisk
312060,"PROPERDIN DEFICIENCY, X-LINKED; CFPD",Number Sign
312070,UBIQUITIN-LIKE 4A; UBL4A,Asterisk
312080,PELIZAEUS-MERZBACHER DISEASE; PMD,Number Sign
312090,SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY) MEMBER 3; SLC10A3,Asterisk
312095,A-KINASE ANCHOR PROTEIN 17A; AKAP17A,Asterisk
312100,MOVED TO 312300,Caret
312150,"MULTIPLE PTERYGIUM SYNDROME, X-LINKED",Percent
312170,PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD,Number Sign
312173,RIBOSOMAL PROTEIN L10; RPL10,Asterisk
312180,UBIQUITIN-CONJUGATING ENZYME E2A; UBE2A,Asterisk
312190,"RADIAL APLASIA, X-LINKED",
312200,"RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER",
312210,RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY,
312300,"ANDROGEN INSENSITIVITY, PARTIAL; PAIS",Number Sign
312390,MOVED TO 314310,Caret
312400,MOVED TO 604278,Caret
312420,RENIN-BINDING PROTEIN; RENBP,Asterisk
312450,MOVED TO 252010,Caret
312500,"RETICULOENDOTHELIOSIS, X-LINKED",Percent
312530,REMOVED FROM DATABASE,Caret
312550,"RETINAL DYSPLASIA, PRIMARY; PRD",
312600,RETINITIS PIGMENTOSA 2; RP2,Number Sign
312610,RETINITIS PIGMENTOSA GTPase REGULATOR; RPGR,Asterisk
312612,RETINITIS PIGMENTOSA 6; RP6,Percent
312700,"RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1",Number Sign
312750,RETT SYNDROME; RTT,Number Sign
312760,"RIBOSOMAL PROTEIN S4, X-LINKED; RPS4X",Asterisk
312780,"RUSSELL-SILVER SYNDROME, X-LINKED",
312800,MOVED TO 600145,Caret
312820,"SARCOMA, SYNOVIAL, X BREAKPOINT 1; SSX1",Asterisk
312830,SCARF SYNDROME,
312840,SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME,
312860,MOVED TO 272440,Caret
312861,5-HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C,Asterisk
312863,"COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX",Number Sign
312865,SHORT STATURE HOMEOBOX; SHOX,Asterisk
312870,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1",Number Sign
312890,MOVED TO 312920,Caret
312900,MOVED TO 303350,Caret
312910,SPASTIC PARAPARESIS AND DEAFNESS,
312920,"SPASTIC PARAPLEGIA 2, X-LINKED; SPG2",Number Sign
313000,"SPATIAL VISUALIZATION, APTITUDE FOR",Percent
313020,SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE 1; SAT1,Asterisk
313100,MOVED TO 605041,Caret
313200,"SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1",Number Sign
313350,SPLIT-HAND/FOOT MALFORMATION 2; SHFM2,Percent
313400,"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT",Number Sign
313420,"SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED",Percent
313430,SRY-BOX 3; SOX3,Asterisk
313440,SYNAPSIN I; SYN1,Asterisk
313450,REMOVED FROM DATABASE,Caret
313460,REMOVED FROM DATABASE,Caret
313470,"CD99 ANTIGEN, X CHROMOSOME; CD99",Asterisk
313475,SYNAPTOPHYSIN; SYP,Asterisk
313480,TaqI POLYMORPHISM; TAQ1,
313490,"TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS",
313500,"TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1",Number Sign
313550,REMOVED FROM DATABASE,Caret
313650,"TAF1 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 250-KD; TAF1",Asterisk
313680,MOVED TO 187395,Caret
313700,ANDROGEN RECEPTOR; AR,Asterisk
313850,THORACOABDOMINAL SYNDROME; THAS,Percent
313900,THROMBOCYTOPENIA 1; THC1,Number Sign
314000,THROMBOCYTOPENIA WITH ELEVATED SERUM IgA AND RENAL DISEASE,
314050,"THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT",Number Sign
314100,"THUMBS, CONGENITAL CLASPED",
314200,THYROXINE-BINDING GLOBULIN OF SERUM; TBG,Asterisk
314240,TOOTH SIZE,
314250,"DYSTONIA 3, TORSION, X-LINKED; DYT3",Number Sign
314300,"TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR",Percent
314310,TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER 3; TFE3,Asterisk
314320,TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY,
314350,REMOVED FROM DATABASE,Caret
314360,ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET,
314370,UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 1; UBA1,Asterisk
314375,"SOLUTE CARRIER FAMILY 35 (UDP-GALACTOSE TRANSPORTER), MEMBER 2; SLC35A2",Asterisk
314380,UNIQUE GREEN PHENOMENON,Percent
314390,"VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX",Number Sign
314400,"CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1",Number Sign
314500,VAN DEN BOSCH SYNDROME,Percent
314550,"VESICOURETERAL REFLUX, X-LINKED; VURX",
314555,MOVED TO 604492,Caret
314560,"VON WILLEBRAND DISEASE, X-LINKED FORM",
314570,WIDOW'S PEAK SYNDROME,
314580,WIEACKER-WOLFF SYNDROME; WRWF,Number Sign
314600,WILDERVANCK SYNDROME,Percent
314670,X INACTIVATION-SPECIFIC TRANSCRIPT; XIST,Asterisk
314690,LYSINE-SPECIFIC DEMETHYLASE 5C; KDM5C,Asterisk
314700,"BLOOD GROUP, XG SYSTEM; XG",
314705,XG REGULATOR; XGR,Percent
314800,XH ANTIGEN,
314850,"KELL BLOOD GROUP PROTEIN, MCLEOD SYNDROME-ASSOCIATED; XK",Asterisk
314900,XM SYSTEM,Percent
314920,REMOVED FROM DATABASE,Caret
314940,REMOVED FROM DATABASE,Caret
314960,REMOVED FROM DATABASE,Caret
314980,"ZINC FINGER PROTEIN, X-LINKED; ZFX",Asterisk
314990,ZINC FINGER PROTEIN 711; ZNF711,Asterisk
314993,ZINC FINGER PROTEIN 182; ZNF182,Asterisk
314995,ZINC FINGER PROTEIN 41; ZNF41,Asterisk
314997,ZINC FINGER PROTEIN 75D; ZNF75D,Asterisk
314998,ZINC FINGER PROTEIN 81; ZNF81,Asterisk
315000,MOVED TO 302200,Caret
400000,REMOVED FROM DATABASE,Caret
400001,MOVED TO 426000,Caret
400002,MOVED TO 314700,Caret
400003,DELETED IN AZOOSPERMIA; DAZ,Asterisk
400004,"RETINITIS PIGMENTOSA, Y-LINKED; RPY",Percent
400005,"UBIQUITIN-SPECIFIC PROTEASE 9, Y CHROMOSOME; USP9Y",Asterisk
400006,"RNA-BINDING MOTIF PROTEIN, Y CHROMOSOME, FAMILY 1, MEMBER A1; RBMY1A1",Asterisk
400007,MOVED TO 400006,Caret
400008,"PROTEIN KINASE, Y-LINKED; PRKY",Asterisk
400009,UBIQUITOUSLY TRANSCRIBED TETRATRICOPEPTIDE REPEAT GENE ON Y CHROMOSOME; UTY,Asterisk
400010,"DEAD/H BOX 3, Y-LINKED; DDX3Y",Asterisk
400011,"ACETYLSEROTONIN METHYLTRANSFERASE-LIKE, Y-LINKED",Asterisk
400012,"VARIABLY CHARGED, Y CHROMOSOME; VCY",Asterisk
400013,"BASIC PROTEIN, Y CHROMOSOME, 2; BPY2",Asterisk
400014,"EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, Y-LINKED; EIF1AY",Asterisk
400015,XK-RELATED PROTEIN ON Y CHROMOSOME,Asterisk
400016,"CHROMODOMAIN PROTEIN, Y CHROMOSOME, 1; CDY1",Asterisk
400017,"THYMOSIN, BETA-4, Y CHROMOSOME; TMSB4Y",Asterisk
400018,"CHROMODOMAIN PROTEIN, Y CHROMOSOME, 2; CDY2",Asterisk
400019,PTPBL-RELATED GENE ON Y; PRY,Asterisk
400020,"SHORT STATURE HOMEOBOX, Y-LINKED; SHOXY",Asterisk
400021,"LYMPHOMA, HODGKIN, Y-LINKED PSEUDOAUTOSOMAL",Percent
400022,"PROTOCADHERIN 11, Y-LINKED; PCDH11Y",Asterisk
400023,"CYTOKINE RECEPTOR-LIKE FACTOR 2, Y-LINKED; CRLF2Y",Asterisk
400024,MOVED TO 415000,Caret
400025,"TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, Y-LINKED; TGIF2LY",Asterisk
400026,DELETED IN AZOOSPERMIA 2; DAZ2,Asterisk
400027,DELETED IN AZOOSPERMIA 3; DAZ3,Asterisk
400028,"NEUROLIGIN 4, Y-LINKED; NLGN4Y",Asterisk
400029,"HEAT-SHOCK TRANSCRIPTION FACTOR, Y-LINKED; HSFY",Asterisk
400030,"RIBOSOMAL PROTEIN S4, Y-LINKED, 2; RPS4Y2",Asterisk
400031,CHROMOSOME Y OPEN READING FRAME 15A; CYORF15A,Asterisk
400032,CHROMOSOME Y OPEN READING FRAME 15B; CYORF15B,Asterisk
400033,"TRANSDUCIN-BETA-LIKE 1, Y-LINKED; TBL1Y",Asterisk
400034,"CHONDROITIN SULFATE PROTEOGLYCAN 4 PSEUDOGENE 1, Y-LINKED; CSPG4P1Y",Asterisk
400035,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 2-LIKE, Y-LINKED; GOLGA2LY",Asterisk
400036,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 3; TTTY3",Asterisk
400037,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 4; TTTY4",Asterisk
400038,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 5; TTTY5",Asterisk
400039,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 6; TTTY6",Asterisk
400040,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 17; TTTY17",Asterisk
400041,"PTPBL-RELATED GENE ON Y, 2; PRY2",Asterisk
400042,"SPERMATOGENIC FAILURE, Y-LINKED, 1; SPGFY1",Number Sign
400043,"DEAFNESS, Y-LINKED 1; DFNY1",Percent
400044,"46,XY SEX REVERSAL 1; SRXY1",Number Sign
400045,"46,XX SEX REVERSAL 1; SRXX1",Number Sign
400046,"PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 1, Y-LINKED",Asterisk
402500,"ACETYLSEROTONIN METHYLTRANSFERASE, Y-CHROMOSOMAL; ASMT",Asterisk
403000,"ADENINE NUCLEOTIDE TRANSLOCATOR 3, Y-CHROMOSOMAL; ANT3Y",Asterisk
410000,"AMELOGENIN, Y-CHROMOSOMAL; AMELY",Asterisk
415000,"SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2",Number Sign
424000,REMOVED FROM DATABASE,Caret
424500,GONADOBLASTOMA; GBY,
425000,"GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, ALPHA SUBUNIT, Y-CHROMOSOMAL; CSF2RY",Asterisk
425500,"HAIRY EARS, Y-LINKED",
426000,LYSINE-SPECIFIC DEMETHYLASE 5D; KDM5D,Asterisk
430000,"INTERLEUKIN 3 RECEPTOR, Y-CHROMOSOMAL; IL3RA",Asterisk
450000,"CD99 ANTIGEN, Y CHROMOSOME",Asterisk
465000,"A-KINASE ANCHOR PROTEIN 17A, Y-CHROMOSOMAL; AKAP17A",Asterisk
470000,"RIBOSOMAL PROTEIN S4, Y-LINKED, 1; RPS4Y1",Asterisk
475000,"GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY",Percent
480000,SEX-DETERMINING REGION Y; SRY,Asterisk
480100,"TESTIS-SPECIFIC PROTEIN, Y-LINKED, 1; TSPY1",Asterisk
488000,MOVED TO 475000,Caret
489000,"UBIQUITIN-ACTIVATING ENZYME, Y-LINKED",
489500,XG REGULATOR; XGR,Asterisk
490000,"ZINC FINGER PROTEIN, Y-LINKED; ZFY",Asterisk
500000,"CARDIOMYOPATHY, INFANTILE HISTIOCYTOID",Number Sign
500001,LEBER OPTIC ATROPHY AND DYSTONIA,Number Sign
500002,MITOCHONDRIAL MYOPATHY WITH DIABETES,Number Sign
500003,"STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL",Number Sign
500004,RETINITIS PIGMENTOSA-DEAFNESS SYNDROME,Number Sign
500005,"HYPOMAGNESEMIA, HYPERTENSION, AND HYPERCHOLESTEROLEMIA, MITOCHONDRIAL",Number Sign
500006,"CARDIOMYOPATHY, INFANTILE HYPERTROPHIC",Number Sign
500007,CYCLIC VOMITING SYNDROME; CVS,Number Sign
500008,"DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL",Number Sign
500009,"MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT",Number Sign
500010,"ATAXIA AND POLYNEUROPATHY, ADULT-ONSET",Number Sign
500011,"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 3; MLASA3",Number Sign
502000,AGING,Number Sign
502500,"ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL",Number Sign
510000,REMOVED FROM DATABASE,Caret
515000,CHLORAMPHENICOL TOXICITY,Number Sign
516000,"COMPLEX I, SUBUNIT ND1; MTND1",Asterisk
516001,"COMPLEX I, SUBUNIT ND2; MTND2",Asterisk
516002,"COMPLEX I, SUBUNIT ND3; MTND3",Asterisk
516003,"COMPLEX I, SUBUNIT ND4; MTND4",Asterisk
516004,"COMPLEX I, SUBUNIT ND4L; MTND4L",Asterisk
516005,"COMPLEX I, SUBUNIT ND5; MTND5",Asterisk
516006,"COMPLEX I, SUBUNIT ND6; MTND6",Asterisk
516020,CYTOCHROME b OF COMPLEX III; MTCYB,Asterisk
516030,"COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT I; MTCO1",Asterisk
516040,"COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT II; MTCO2",Asterisk
516050,CYTOCHROME c OXIDASE III; MTCO3,Asterisk
516060,ATP SYNTHASE 6; MTATP6,Plus
516070,ATP SYNTHASE 8; MTATP8,Plus
520000,"DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD",Number Sign
520100,"DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY",Number Sign
530000,KEARNS-SAYRE SYNDROME; KSS,Number Sign
535000,LEBER OPTIC ATROPHY,Number Sign
540000,"MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS",Number Sign
545000,MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF,Number Sign
550000,MOVED TO 157640,Caret
550500,"MYOGLOBINURIA, RECURRENT",Number Sign
550900,MOVED TO 603041,Caret
551000,"MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM",Number Sign
551200,"NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL",Number Sign
551500,"NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA",Number Sign
553000,ONCOCYTOMA,Number Sign
555000,MOVED TO 607313,Caret
556500,"PARKINSON DISEASE, MITOCHONDRIAL",Number Sign
557000,PEARSON MARROW-PANCREAS SYNDROME,Number Sign
560000,"RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA",Number Sign
561000,"RIBOSOMAL RNA, MITOCHONDRIAL, 12S; MTRNR1",Asterisk
561010,"RIBOSOMAL RNA, MITOCHONDRIAL, 16S; MTRNR2",Asterisk
580000,"DEAFNESS, AMINOGLYCOSIDE-INDUCED",Number Sign
590000,"TRANSFER RNA, MITOCHONDRIAL, ALANINE; MTTA",Asterisk
590005,"TRANSFER RNA, MITOCHONDRIAL, ARGININE; MTTR",Asterisk
590010,"TRANSFER RNA, MITOCHONDRIAL, ASPARAGINE; MTTN",Asterisk
590015,"TRANSFER RNA, MITOCHONDRIAL, ASPARTIC ACID; MTTD",Asterisk
590020,"TRANSFER RNA, MITOCHONDRIAL, CYSTEINE; MTTC",Asterisk
590025,"TRANSFER RNA, MITOCHONDRIAL, GLUTAMIC ACID; MTTE",Asterisk
590030,"TRANSFER RNA, MITOCHONDRIAL, GLUTAMINE; MTTQ",Asterisk
590035,"TRANSFER RNA, MITOCHONDRIAL, GLYCINE; MTTG",Asterisk
590040,"TRANSFER RNA, MITOCHONDRIAL, HISTIDINE; MTTH",Asterisk
590045,"TRANSFER RNA, MITOCHONDRIAL, ISOLEUCINE; MTTI",Asterisk
590050,"TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 1; MTTL1",Asterisk
590055,"TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 2; MTTL2",Asterisk
590060,"TRANSFER RNA, MITOCHONDRIAL, LYSINE; MTTK",Asterisk
590065,"TRANSFER RNA, MITOCHONDRIAL, METHIONINE; MTTM",Asterisk
590070,"TRANSFER RNA, MITOCHONDRIAL, PHENYLALANINE; MTTF",Asterisk
590075,"TRANSFER RNA, MITOCHONDRIAL, PROLINE; MTTP",Asterisk
590080,"TRANSFER RNA, MITOCHONDRIAL, SERINE, 1; MTTS1",Asterisk
590085,"TRANSFER RNA, MITOCHONDRIAL, SERINE, 2; MTTS2",Asterisk
590090,"TRANSFER RNA, MITOCHONDRIAL, THREONINE; MTTT",Asterisk
590095,"TRANSFER RNA, MITOCHONDRIAL, TRYPTOPHAN; MTTW",Asterisk
590100,"TRANSFER RNA, MITOCHONDRIAL, TYROSINE; MTTY",Asterisk
590105,"TRANSFER RNA, MITOCHONDRIAL, VALINE; MTTV",Asterisk
598500,"WOLFRAM SYNDROME, MITOCHONDRIAL FORM",Number Sign
600000,SPONDYLOCAMPTODACTYLY,
600001,"HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA",Number Sign
600002,EIKEN SYNDROME,Number Sign
600003,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-2 SUBUNIT; CACNB2",Asterisk
600004,EPHRIN RECEPTOR EphA5; EPHA5,Asterisk
600005,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, TRANSACTIVATOR; MHC2TA",Asterisk
600006,"REGULATORY FACTOR X, 1; RFX1",Asterisk
600007,FMS-RELATED TYROSINE KINASE 3 LIGAND; FLT3LG,Asterisk
600008,NICOTINAMIDE N-METHYLTRANSFERASE; NNMT,Asterisk
600009,INTERFERON-ALPHA-INDUCIBLE PROTEIN 27; IFI27,Asterisk
600010,INSULINOMA-ASSOCIATED 1; INSM1,Asterisk
600011,EPHRIN RECEPTOR EphB4; EPHB4,Asterisk
600012,UBIQUITIN-CONJUGATING ENZYME E2L 1; UBE2L1,Asterisk
600013,TRANSCRIPTION FACTOR YY1; YY1,Asterisk
600014,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 2; SMARCA2",Asterisk
600015,MOVED TO 106165,Caret
600016,CONTACTIN 1; CNTN1,Asterisk
600017,SYNDECAN 4; SDC4,Asterisk
600018,"OPIOID RECEPTOR, MU-1; OPRM1",Asterisk
600019,CYTOCHROME b561; CYB561,Asterisk
600020,MAX-INTERACTING PROTEIN 1; MXI1,Asterisk
600021,MAX DIMERIZATION PROTEIN 1; MXD1,Asterisk
600022,PROSTAGLANDIN I2 RECEPTOR; PTGIR,Asterisk
600023,CADHERIN 11; CDH11,Asterisk
600024,LAMIN B RECEPTOR; LBR,Asterisk
600025,KINESIN LIGHT CHAIN 1; KLC1,Asterisk
600026,"SYNTROPHIN, BETA-1; SNTB1",Asterisk
600027,"SYNTROPHIN, BETA-2; SNTB2",Asterisk
600028,DISTAL-LESS HOMEOBOX 5; DLX5,Asterisk
600029,DISTAL-LESS HOMEOBOX 1; DLX1,Asterisk
600030,DISTAL-LESS HOMEOBOX 6; DLX6,Asterisk
600031,CHITINASE 1; CHIT1,Asterisk
600032,MOVED TO 182455,Caret
600033,TISSUE FACTOR PATHWAY INHIBITOR 2; TFPI2,Asterisk
600034,"EMPTY SPIRACLES, DROSOPHILA, HOMOLOG OF, 1; EMX1",Asterisk
600035,"EMPTY SPIRACLES, DROSOPHILA, 2, HOMOLOG OF; EMX2",Asterisk
600036,"ORTHODENTICLE, DROSOPHILA, HOMOLOG OF, 1; OTX1",Asterisk
600037,"ORTHODENTICLE, DROSOPHILA, HOMOLOG OF, 2; OTX2",Asterisk
600038,MEGAKARYOCTYE-ASSOCIATED TYROSINE KINASE; MATK,Asterisk
600039,BCL2-LIKE 1; BCL2L1,Asterisk
600040,BCL2-ASSOCIATED X PROTEIN; BAX,Asterisk
600041,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 2; P2RY2",Asterisk
600042,MELANOCORTIN 5 RECEPTOR; MC5R,Asterisk
600043,"SULFOTRANSFERASE FAMILY 1E, ESTROGEN-PREFERRING, MEMBER 1; SULT1E1",Asterisk
600044,THROMBOPOIETIN; THPO,Asterisk
600045,DNA DAMAGE-BINDING PROTEIN 1; DDB1,Asterisk
600046,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1",Plus
600047,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2",Asterisk
600048,MOVED TO 114480,Caret
600049,MDS1 GENE; MDS1,Asterisk
600050,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11; MAP3K11,Asterisk
600051,EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; EPS15,Asterisk
600052,APELIN RECEPTOR; APLNR,Asterisk
600053,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-3; CNGA3",Asterisk
600054,MOVED TO 300338,Caret
600055,MOVED TO 426000,Caret
600056,MOVED TO 314690,Caret
600057,EXSTROPHY OF BLADDER,Percent
600058,PROTEIN TYROSINE KINASE TXK; TXK,Asterisk
600059,RETINITIS PIGMENTOSA 13; RP13,Number Sign
600060,"DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2",Number Sign
600061,"RAD23, YEAST, HOMOLOG OF, A; RAD23A",Asterisk
600062,"RAD23, YEAST, HOMOLOG OF, B; RAD23B",Asterisk
600063,"TROVE DOMAIN FAMILY, MEMBER 2; TROVE2",Asterisk
600064,KERATIN-ASSOCIATED PROTEIN 11-1; KRTAP11-1,Asterisk
600065,"INTEGRIN, BETA-2; ITGB2",Asterisk
600066,EPHRIN RECEPTOR EphA6; EPHA6,Asterisk
600067,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B4; UGT2B4",Asterisk
600068,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B7; UGT2B7",Asterisk
600069,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B15; UGT2B15",Asterisk
600070,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B10; UGT2B10",Asterisk
600071,MOVED TO 600067,Caret
600072,FATAL FAMILIAL INSOMNIA; FFI,Number Sign
600073,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2; LRP2,Asterisk
600074,CD24 ANTIGEN; CD24,Asterisk
600075,TATA BOX-BINDING PROTEIN; TBP,Asterisk
600076,TENSIN 1; TNS1,Asterisk
600077,MOVED TO 224750,Caret
600078,MOVED TO 300012,Caret
600079,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 12; PTPN12",Asterisk
600080,"MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC",
600081,"VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B",Number Sign
600082,"PROSTATIC HYPERPLASIA, BENIGN; BPH",Percent
600083,MOVED TO 300144,Caret
600084,"MACROCYTOSIS, FAMILIAL",
600085,PROTEIN-TYROSINE KINASE SYK; SYK,Asterisk
600086,ALCOHOL DEHYDROGENASE 7; ADH7,Asterisk
600087,TUFTELIN; TUFT1,Asterisk
600088,MOVED TO 113810,Caret
600089,PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS,
600090,MOVED TO 300013,Caret
600091,MOVED TO 158600,Caret
600092,CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME,
600093,SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES,
600094,MOVED TO 300095,Caret
600095,MOVED TO 246560,Caret
600096,PUERTO RICAN INFANT HYPOTONIA SYNDROME,
600097,MOVED TO 300106,Caret
600098,RELATED RAS VIRAL ONCOGENE HOMOLOG 2; RRAS2,Asterisk
600099,MOVED TO 246530,Caret
600100,MOVED TO 601792,Caret
600101,"DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A",Number Sign
600102,MOVED TO 300067,Caret
600103,SYNAPTOTAGMIN 4; SYT4,Asterisk
600104,SYNAPTOTAGMIN 2; SYT2,Asterisk
600105,RETINITIS PIGMENTOSA 12; RP12,Number Sign
600106,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 40-KD; INPP5A",Asterisk
600107,MOVED TO 300014,Caret
600108,MATRIX METALLOPROTEINASE 13; MMP13,Asterisk
600109,MOVED TO 602668,Caret
600110,STARGARDT DISEASE 3; STGD3,Number Sign
600111,"SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 3; SLC1A3",Asterisk
600112,"DYNEIN, CYTOPLASMIC 1, HEAVY CHAIN 1; DYNC1H1",Asterisk
600113,MOVED TO 300005,Caret
600114,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 3; CCT3",Asterisk
600115,MOVED TO 163260,Caret
600116,"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2",Number Sign
600117,"DYSPHASIA, FAMILIAL DEVELOPMENTAL",
600118,WARBURG MICRO SYNDROME 1; WARBM1,Number Sign
600119,"SARCOGLYCAN, ALPHA; SGCA",Asterisk
600120,MOVED TO 186100,Caret
600121,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3",Number Sign
600122,"MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE",
600123,ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL AND RADIAL DEFECTS,
600124,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1; HNRNPA2B1,Asterisk
600125,MOVED TO 126065,Caret
600126,"PHOSPHODIESTERASE 4A, cAMP-SPECIFIC; PDE4A",Asterisk
600127,"PHOSPHODIESTERASE 4B, cAMP-SPECIFIC; PDE4B",Asterisk
600128,"PHOSPHODIESTERASE 4C, cAMP-SPECIFIC; PDE4C",Asterisk
600129,"PHOSPHODIESTERASE 4D, cAMP-SPECIFIC; PDE4D",Asterisk
600130,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE 1; APOBEC1",Asterisk
600131,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1",Percent
600132,RETINITIS PIGMENTOSA 14; RP14,Number Sign
600133,"LAMININ, ALPHA-4; LAMA4",Asterisk
600134,MOVED TO 605158,Caret
600135,CORTEXIN 1; CTXN1,Asterisk
600136,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9; MAP3K9,Asterisk
600137,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 10; MAP3K10,Asterisk
600138,RETINITIS PIGMENTOSA 11; RP11,Number Sign
600139,MOVED TO 137800,Caret
600140,CREB-BINDING PROTEIN; CREBBP,Asterisk
600141,HEAT-SHOCK 10-KD PROTEIN; HSPE1,Asterisk
600142,"CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL",Number Sign
600143,"CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8",Number Sign
600144,"INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 2; ITPR2",Asterisk
600145,SACRAL DEFECT WITH ANTERIOR MENINGOCELE,Number Sign
600146,MOVED TO 270800,Caret
600147,MESENCHYME HOMEOBOX 1; MEOX1,Asterisk
600148,GLYCEROL KINASE 2; GK2,
600149,GLYCEROL KINASE 3 PSEUDOGENE; GK3P,
600150,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, ALPHA MEMBER 1; KCNMA1",Asterisk
600151,BARDET-BIEDL SYNDROME 3; BBS3,Number Sign
600152,SEC13-LIKE PROTEIN 1; SEC13L1,Asterisk
600153,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS F PROTEIN; PIGF,Asterisk
600154,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS H PROTEIN; PIGH,Asterisk
600155,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2",Number Sign
600156,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5; HSCR5",Percent
600157,"ADAPTOR-RELATED PROTEIN COMPLEX 1, BETA-1 SUBUNIT; AP1B1",Asterisk
600158,MOVED TO 251290,Caret
600159,PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES,
600160,CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A,Asterisk
600161,PRADER-WILLI/ANGELMAN REGION RNA 1; PWAR1,Asterisk
600162,PRADER-WILLI/ANGELMAN REGION RNA 5; PWAR5,Asterisk
600163,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A",Asterisk
600164,GTP-BINDING MITOGEN-INDUCED T-CELL PROTEIN; GEM,Asterisk
600165,NANOPHTHALMOS 1; NNO1,Percent
600166,"HYPERPARATHYROIDISM, PRIMARY, CAUSED BY WATER CLEAR CELL HYPERPLASIA",
600167,HISTAMINE RECEPTOR H1; HRH1,Asterisk
600168,MACROPHAGE STIMULATING 1 RECEPTOR; MST1R,Asterisk
600169,MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE A; MICA,Asterisk
600170,AQUAPORIN 3; AQP3,Asterisk
600171,GONADAL AGENESIS,
600172,METAL-REGULATORY TRANSCRIPTION FACTOR 1; MTF1,Asterisk
600173,JANUS KINASE 3; JAK3,Asterisk
600174,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, ALPHA; PITPNA",Asterisk
600175,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; HMN8",Number Sign
600176,"PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS",Percent
600177,MOVED TO 300102,Caret
600178,MICROTUBULE-ASSOCIATED PROTEIN 1A; MAP1A,Asterisk
600179,"GUANYLATE CYCLASE 2D, MEMBRANE; GUCY2D",Asterisk
600180,MOVED TO 108355,Caret
600181,LIPOCALIN 2; LCN2,Asterisk
600182,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 5; SLC7A5",Asterisk
600183,DUAL-SPECIFICITY PHOSPHATASE 3; DUSP3,Asterisk
600184,CARNITINE ACETYLTRANSFERASE; CRAT,Asterisk
600185,BRCA2 GENE; BRCA2,Asterisk
600186,MOVED TO 300016,Caret
600187,EUKARYOTIC TRANSLATION INITIATION FACTOR 5A; EIF5A,Asterisk
600188,AMINO-TERMINAL ENHANCER OF SPLIT; AES,Asterisk
600189,TRANSDUCIN-LIKE ENHANCER OF SPLIT 1; TLE1,Asterisk
600190,TRANSDUCIN-LIKE ENHANCER OF SPLIT 3; TLE3,Asterisk
600191,MOVED TO 300018,Caret
600192,"SYNOVIAL SARCOMA TRANSLOCATION, CHROMOSOME 18; SS18",Asterisk
600193,"WAARDENBURG SYNDROME, TYPE 2B; WS2B",Percent
600194,"KERATIN 2, TYPE II; KRT2",Asterisk
600195,"VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM",Number Sign
600196,MOVED TO 300019,Caret
600197,"V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN K; MAFK",Asterisk
600198,MOVED TO 163260,Caret
600199,MOVED TO 300021,Caret
600200,MOVED TO 133440,Caret
600201,AGOUTI SIGNALING PROTEIN; ASIP,Asterisk
600202,"DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2",Percent
600203,MOVED TO 300030,Caret
600204,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2",Number Sign
600205,MOVED TO 107748,Caret
600206,EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8; EPS8,Asterisk
600207,HIPPOCALCIN-LIKE 1; HPCAL1,Asterisk
600208,MOVED TO 155100,Caret
600209,"EXOSTOSES, MULTIPLE, TYPE III; EXT3",Percent
600210,RUNT-RELATED TRANSCRIPTION FACTOR 3; RUNX3,Asterisk
600211,RUNT-RELATED TRANSCRIPTION FACTOR 2; RUNX2,Asterisk
600212,FATTY ACID SYNTHASE; FASN,Asterisk
600213,MOVED TO 176310,Caret
600214,ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGER,Asterisk
600215,MICROFIBRILLAR-ASSOCIATED PROTEIN 1; MFAP1,Asterisk
600216,MOVED TO 400002,Caret
600217,MOVED TO 601545,Caret
600218,MOVED TO 600068,Caret
600219,MOVED TO 600069,Caret
600220,"PHOSPHOLIPASE C, GAMMA-2; PLCG2",Asterisk
600221,"TEK TYROSINE KINASE, ENDOTHELIAL; TEK",Asterisk
600222,TYROSINE KINASE WITH IMMUNOGLOBULIN AND EGF FACTOR HOMOLOGY DOMAINS 1; TIE1,Asterisk
600223,SPINOCEREBELLAR ATAXIA 4; SCA4,Percent
600224,SPINOCEREBELLAR ATAXIA 5; SCA5,Number Sign
600225,GTP CYCLOHYDROLASE I; GCH1,Asterisk
600226,MOVED TO 300031,Caret
600227,CYCLIN F; CCNF,Asterisk
600228,"SODIUM CHANNEL, NONVOLTAGE-GATED 1, ALPHA SUBUNIT; SCNN1A",Asterisk
600229,"SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4; SLC1A4",Asterisk
600230,"PHOSPHOLIPASE C, BETA-3; PLCB3",Asterisk
600231,"PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB",Number Sign
600232,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-2; GABRB2",Asterisk
600233,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-3; GABRG3",Asterisk
600234,3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2; HMGCS2,Asterisk
600235,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, BETA SUBUNIT; SCN1B",Asterisk
600236,CENTROMERIC PROTEIN F; CENPF,Asterisk
600237,"HISTONE CELL CYCLE REGULATION DEFECTIVE, S. CEREVISIAE, HOMOLOG OF, A; HIRA",Asterisk
600238,TRANSGLUTAMINASE 3; TGM3,Asterisk
600239,G PROTEIN-COUPLED RECEPTOR 1; GPR1,Asterisk
600240,CHEMOKINE (C-C) RECEPTOR 10; CCR10,Asterisk
600241,G PROTEIN-COUPLED RECEPTOR 3; GPR3,Asterisk
600242,"CHEMOKINE, CC MOTIF, RECEPTOR 7; CCR7",Asterisk
600243,DEFENDER AGAINST CELL DEATH 1; DAD1,Asterisk
600244,PROGRAMMED CELL DEATH 1; PDCD1,Asterisk
600245,FIBROMODULIN; FMOD,Asterisk
600246,"ELK4, ETS-DOMAIN PROTEIN; ELK4",Asterisk
600247,"ELK3, ETS-DOMAIN PROTEIN; ELK3",Asterisk
600248,MOVED TO 300009,Caret
600249,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L1; ALDH1L1",Asterisk
600250,"CHEMOKINE, C MOTIF, LIGAND 1; XCL1",Asterisk
600251,"FACIAL CLEFTING, OBLIQUE, 1; OBLFC1",Number Sign
600252,LOWRY-MACLEAN SYNDROME,
600253,ARYL HYDROCARBON RECEPTOR; AHR,Asterisk
600254,MOVED TO 300032,Caret
600255,MOVED TO 400000,Caret
600256,MOVED TO 123155,Caret
600257,CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME,Number Sign
600258,"POSTMEIOTIC SEGREGATION INCREASED, S. CEREVISIAE, 1; PMS1",Asterisk
600259,"POSTMEIOTIC SEGREGATION INCREASED, S. CEREVISIAE, 2; PMS2",Asterisk
600260,MOVED TO 300008,Caret
600261,REMOVED FROM DATABASE,Caret
600262,PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2,Asterisk
600263,"HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO",Number Sign
600264,ARGININE VASOPRESSIN RECEPTOR 1B; AVPR1B,Asterisk
600265,MOVED TO 300033,Caret
600266,"SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 1; SLC11A1",Asterisk
600267,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 13; PTPN13",Asterisk
600268,OCULOECTODERMAL SYNDROME; OES,Percent
600269,SHORT TARSUS WITH ABSENCE OF LOWER EYELASHES; STALE,
600270,PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER; PCOLCE,Asterisk
600271,DESMOCOLLIN 3; DSC3,Asterisk
600272,COILIN; COIL,Asterisk
600273,"POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS; PKDTS",Number Sign
600274,FRONTOTEMPORAL DEMENTIA; FTD,Number Sign
600275,"NOTCH, DROSOPHILA, HOMOLOG OF, 2; NOTCH2",Asterisk
600276,"NOTCH, DROSOPHILA, HOMOLOG OF, 3; NOTCH3",Asterisk
600277,INHIBITOR OF DNA BINDING 3; ID3,Asterisk
600278,"RAP1, GTPase-ACTIVATING PROTEIN 1; RAP1GA1",Asterisk
600279,PEROXISOME BIOGENESIS FACTOR 19; PEX19,Asterisk
600280,NUCLEOTIDE-BINDING PROTEIN 1; NUBP1,Asterisk
600281,HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A,Asterisk
600282,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 4; GRIK4",Asterisk
600283,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 5; GRIK5",Asterisk
600284,ELONGATION FACTOR RNA POLYMERASE II; ELL,Asterisk
600285,EUKARYOTIC TRANSLATION TERMINATION FACTOR 1; ETF1,Asterisk
600286,"PHOSPHATIDYLINOSITOL 4-KINASE, CATALYTIC, ALPHA; PI4KA",Asterisk
600287,GLYCYL-tRNA SYNTHETASE; GARS,Asterisk
600288,FORKHEAD BOX A2; FOXA2,Asterisk
600289,MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14,Asterisk
600290,MOVED TO 600289,Caret
600291,ADENYLATE CYCLASE 3; ADCY3,Asterisk
600292,ADENYLATE CYCLASE 4; ADCY4,Asterisk
600293,ADENYLATE CYCLASE 5; ADCY5,Asterisk
600294,ADENYLATE CYCLASE 6; ADCY6,Asterisk
600295,NATRIURETIC PEPTIDE PRECURSOR B; NPPB,Asterisk
600296,NATRIURETIC PEPTIDE PRECURSOR C; NPPC,Asterisk
600297,CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 2; CDX2,Asterisk
600298,"LIM HOMEOBOX TRANSCRIPTION FACTOR 1, ALPHA; LMX1A",Asterisk
600299,PERICENTRIOLAR MATERIAL 1; PCM1,Asterisk
600300,"SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 2; SLC1A2",Asterisk
600301,"ACYL-CoA DEHYDROGENASE, SHORT/BRANCHED CHAIN; ACADSB",Asterisk
600302,FRYNS MACROCEPHALY,
600303,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RAPGEF1,Asterisk
600304,MOVED TO 170400,Caret
600305,ENOYL-CoA DELTA ISOMERASE 1; ECI1,Asterisk
600306,"PROTEASOME SUBUNIT, BETA-TYPE, 5; PSMB5",Asterisk
600307,"PROTEASOME SUBUNIT, BETA-TYPE, 6; PSMB6",Asterisk
600308,AQUAPORIN 4; AQP4,Asterisk
600309,ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3,Number Sign
600310,CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMP,Asterisk
600311,GRANZYME M; GZMM,Asterisk
600312,NUDIX HYDROLASE 1; NUDT1,Asterisk
600313,MOVED TO 600535,Caret
600314,SH2 DOMAIN-CONTAINING ADAPTOR PROTEIN B; SHB,Asterisk
600315,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 4; TNFRSF4",Asterisk
600316,"DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3",Number Sign
600317,TROPOMYOSIN 4; TPM4,Asterisk
600318,"DIABETES MELLITUS, INSULIN-DEPENDENT, 3; IDDM3",Percent
600319,"DIABETES MELLITUS, INSULIN-DEPENDENT, 4; IDDM4",Percent
600320,"DIABETES MELLITUS, INSULIN-DEPENDENT, 5; IDDM5",Number Sign
600321,"DIABETES MELLITUS, INSULIN-DEPENDENT, 7; IDDM7",Percent
600322,"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25",Asterisk
600323,REGULATOR OF G PROTEIN SIGNALING 1; RGS1,Asterisk
600324,"CHEMOKINE, CXC MOTIF, LIGAND 5; CXCL5",Asterisk
600325,AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA,Percent
600326,DEAD/H BOX 6; DDX6,Asterisk
600327,SYNAPTOTAGMIN 3; SYT3,Asterisk
600328,"MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 6; MLLT6",Asterisk
600329,OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY,
600330,MOVED TO 102500,Caret
600331,PARC SYNDROME,
600332,RIPPLING MUSCLE DISEASE 1; RMD1,Percent
600333,MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA,
600334,"TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD",Number Sign
600335,SUCCINIC ACIDEMIA,
600336,"SOLUTE CARRIER FAMILY 18 (VESICULAR ACETYLCHOLINE), MEMBER 3; SLC18A3",Asterisk
600337,BRADYKININ RECEPTOR B1; BDKRB1,Asterisk
600338,ARYLACETAMIDE DEACETYLASE; AADAC,Asterisk
600339,HEPATOMA-DERIVED GROWTH FACTOR; HDGF,Asterisk
600340,PLASMA MEMBRANE PROTEOLIPID; PLLP,Asterisk
600341,TYRO3 PROTEIN TYROSINE KINASE; TYRO3,Asterisk
600342,"G PROTEIN-COUPLED RECEPTOR, RETINAL; RGR",Asterisk
600343,"PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP",Percent
600344,MOVED TO 300058,Caret
600345,BETACELLULIN; BTC,Asterisk
600346,POLYCOMB GROUP RING FINGER PROTEIN 2; PCGF2,Asterisk
600347,BREVICAN; BCAN,Asterisk
600348,BAND HETEROTOPIA; BH,Number Sign
600349,INHIBITOR OF DNA BINDING 1; ID1,Asterisk
600350,MOVED TO 300034,Caret
600351,"ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY",
600352,MOVED TO 112205,Caret
600353,S100 CALCIUM-BINDING PROTEIN A7; S100A7,Asterisk
600354,SURVIVAL OF MOTOR NEURON 1; SMN1,Asterisk
600355,NEURONAL APOPTOSIS INHIBITORY PROTEIN; NAIP,Asterisk
600356,"PACHYDERMODACTYLY, FAMILIAL",
600357,RIBOSOMAL PROTEIN S8; RPS8,Asterisk
600358,GUANINE MONOPHOSPHATE SYNTHETASE; GMPS,Asterisk
600359,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 1; KCNJ1",Asterisk
600360,"APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE",Percent
600361,HEREDITARY MOTOR AND SENSORY NEUROPATHY V,Percent
600362,"FLIGHTLESS I, DROSOPHILA, HOMOLOG OF; FLII",Asterisk
600363,"SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6",Number Sign
600364,GUANYLATE CYCLASE ACTIVATOR 1A; GUCA1A,Asterisk
600365,ACTIVE BCR-RELATED GENE; ABR,Asterisk
600366,ISL LIM HOMEOBOX 1; ISL1,Asterisk
600367,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 3, 77-KD; CSTF3",Asterisk
600368,MOVED TO 300907,Caret
600369,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 1, 50-KD; CSTF1",Asterisk
600370,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 3; SLC25A3",Asterisk
600371,MOVED TO 142695,Caret
600372,"NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 1; NEDD1",Asterisk
600373,CODAS SYNDROME,Number Sign
600374,BBS4 GENE; BBS4,Asterisk
600375,"X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; XRCC2",Asterisk
600376,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2",Number Sign
600377,GALANIN RECEPTOR 1; GALR1,Asterisk
600378,"INNER MEMBRANE PROTEIN, MITOCHONDRIAL; IMMT",Asterisk
600379,MYELIN TRANSCRIPTION FACTOR 1; MYT1,Asterisk
600380,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2; NR1H2",Asterisk
600381,KINECTIN; KTN1,Asterisk
600382,MYC PROMOTER-BINDING PROTEIN,Asterisk
600383,MESOMELIA-SYNOSTOSES SYNDROME,Number Sign
600384,"APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL IV",Percent
600385,ADENYLATE CYCLASE 7; ADCY7,Asterisk
600386,INHIBITOR OF DNA BINDING 2; ID2,Asterisk
600387,BONE MARROW STROMAL CELL ANTIGEN 1; BST1,Asterisk
600388,"MEPRIN, ALPHA SUBUNIT; MEP1A",Asterisk
600389,"MEPRIN, BETA SUBUNIT; MEP1B",Asterisk
600390,"UPSTREAM TRANSCRIPTION FACTOR 2, FOS-INTERACTING; USF2",Asterisk
600391,"GLUCOSAMINYL (N-ACETYL) TRANSFERASE 1, CORE 2; GCNT1",Asterisk
600392,"RAD52, YEAST, HOMOLOG OF; RAD52",Asterisk
600393,FLAP STRUCTURE-SPECIFIC ENDONUCLEASE 1; FEN1,Asterisk
600394,MOVED TO 300036,Caret
600395,GLYPICAN 1; GPC1,Asterisk
600396,DEAH BOX POLYPEPTIDE 8; DHX8,Asterisk
600397,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 1; KCNB1",Asterisk
600398,ZINC FINGER PROTEIN 160; ZNF160,Asterisk
600399,"PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS",Percent
600400,PROLYL ENDOPEPTIDASE; PREP,Asterisk
600401,MOVED TO 600247,Caret
600402,MOVED TO 300035,Caret
600403,"FIBROBLAST ACTIVATION PROTEIN, ALPHA; FAP",Asterisk
600404,"REPLICATION FACTOR C, SUBUNIT 2; RFC2",Asterisk
600405,"REPLICATION FACTOR C, SUBUNIT 3; RFC3",Asterisk
600406,MOVED TO 102577,Caret
600407,"REPLICATION FACTOR C, SUBUNIT 5; RFC5",Asterisk
600408,"DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1; DDR1",Asterisk
600409,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD,Asterisk
600410,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 6; TNFAIP6,Asterisk
600411,"GUANYLATE-BINDING PROTEIN 1, INTERFERON-INDUCIBLE, 67-KD; GBP1",Asterisk
600412,"GUANYLATE-BINDING PROTEIN 2, INTERFERON-INDUCIBLE; GBP2",Asterisk
600413,GUANYLATE-BINDING PROTEIN 3; GBP3,Asterisk
600414,PEROXISOME BIOGENESIS FACTOR 5; PEX5,Asterisk
600415,"TOCOPHEROL TRANSFER PROTEIN, ALPHA; TTPA",Asterisk
600416,"MUSCULAR DYSTROPHY, SCAPULOHUMERAL",
600417,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC II; NT5C2",Asterisk
600418,AMPHIPHYSIN; AMPH,Asterisk
600419,ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS,
600420,MOVED TO 300039,Caret
600421,"GLYCINE RECEPTOR, ALPHA-3 SUBUNIT; GLRA3",Asterisk
600422,FATTY ACID-BINDING PROTEIN 6; FABP6,Asterisk
600423,ENDOTHELIN-CONVERTING ENZYME 1; ECE1,Asterisk
600424,"SOLUTE CARRIER FAMILY 19 (FOLATE TRANSPORTER), MEMBER 1; SLC19A1",Asterisk
600425,MOVED TO 189902,Caret
600426,E2F TRANSCRIPTION FACTOR 2; E2F2,Asterisk
600427,E2F TRANSCRIPTION FACTOR 3; E2F3,Asterisk
600428,VAV2 ONCOGENE; VAV2,Asterisk
600429,"GLUCOSAMINYL (N-ACETYL) TRANSFERASE 2, I-BRANCHING ENZYME; GCNT2",Asterisk
600430,CHROMOSOME 2q37 DELETION SYNDROME,Number Sign
600431,CYCLIN-DEPENDENT KINASE INHIBITOR 2B; CDKN2B,Asterisk
600432,PRECEREBELLIN 1; CBLN1,Asterisk
600433,PRECEREBELLIN 2; CBLN2,Asterisk
600434,FATTY ACID-BINDING PROTEIN 4; FABP4,Asterisk
600435,CARDIOTROPHIN 1; CTF1,Asterisk
600436,"GLUTATHIONE S-TRANSFERASE, THETA-1; GSTT1",Asterisk
600437,"GLUTATHIONE S-TRANSFERASE, THETA-2; GSTT2",Asterisk
600438,"TRANSCRIPTION FACTOR A, MITOCHONDRIAL; TFAM",Asterisk
600439,SINGLE-STRANDED DNA-BINDING PROTEIN 1; SSBP1,Asterisk
600440,"ENDONUCLEASE G, MITOCHONDRIAL; ENDOG",Asterisk
600441,GROWTH ARREST-SPECIFIC 6; GAS6,Asterisk
600442,AQUAPORIN 5; AQP5,Asterisk
600443,GLUTAREDOXIN; GLRX,Asterisk
600444,"SOLUTE CARRIER FAMILY 5 (INOSITOL TRANSPORTER), MEMBER 3; SLC5A3",Asterisk
600445,ADENOSINE A3 RECEPTOR; ADORA3,Asterisk
600446,ADENOSINE A2B RECEPTOR; ADORA2B,Asterisk
600447,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12; MAP3K12,Asterisk
600448,"PROTEIN KINASE C, THETA; PRKCQ",Asterisk
600449,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER 1; AKR1C1",Asterisk
600450,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER C2; AKR1C2",Asterisk
600451,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER C4; AKR1C4",Asterisk
600452,MOVED TO 600408,Caret
600453,TRIPARTITE MOTIF-CONTAINING PROTEIN 25; TRIM25,Asterisk
600454,RIBOSOMAL PROTEIN S3; RPS3,Asterisk
600455,"RNA, U15A SMALL NUCLEOLAR; RNU15A",Asterisk
600456,"NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2; NTRK2",Asterisk
600457,"HYPERTRICHOSIS, ANTERIOR CERVICAL",
600458,ADENOMYOSIS,
600459,ARTERIAL DISSECTION WITH LENTIGINOSIS,
600460,"CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY",
600461,"HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES",
600462,"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1",Number Sign
600463,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A3; ALDH1A3",Asterisk
600464,ADP-RIBOSYLATION FACTOR 6; ARF6,Asterisk
600465,ANKYRIN 3; ANK3,Asterisk
600466,"ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B1; ALDH3B1",Asterisk
600467,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4",Percent
600468,MOVED TO 300011,Caret
600469,NUCLEAR CAP-BINDING PROTEIN 1; NCBP1,Asterisk
600470,"ZIC FAMILY, MEMBER 1; ZIC1",Asterisk
600471,"DEFENSIN, ALPHA, 6; DEFA6",Asterisk
600472,"DEFENSIN, ALPHA, 5; DEFA5",Asterisk
600473,PURINE-RICH ELEMENT-BINDING PROTEIN A; PURA,Asterisk
600474,CATHELICIDIN ANTIMICROBIAL PEPTIDE; CAMP,Asterisk
600475,"TAF10 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 30-KD; TAF10",Asterisk
600476,MOVED TO 300040,Caret
600477,"SOLUTE CARRIER FAMILY 9, MEMBER 5; SLC9A5",Asterisk
600478,"SUPERKILLER VIRALICIDIC ACTIVITY 2, S. CEREVISIAE, HOMOLOG-LIKE; SKIV2L",Asterisk
600479,MOVED TO 120324,Caret
600480,TRANSCRIPTION FACTOR 12; TCF12,Asterisk
600481,STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 2; SREBF2,Asterisk
600482,MOVED TO 300116,Caret
600483,FIBROBLAST GROWTH FACTOR 8; FGF8,Asterisk
600484,MOVED TO 300002,Caret
600485,MOVED TO 300003,Caret
600486,MOVED TO 300076,Caret
600487,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 4; PCSK4",Asterisk
600488,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 5; PCSK5",Asterisk
600489,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 1; NFATC1",Asterisk
600490,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 2; NFATC2",Asterisk
600491,MICROFIBRILLAR-ASSOCIATED PROTEIN 3; MFAP3,Asterisk
600492,NUCLEAR FACTOR ERYTHROID 2-LIKE 2; NFE2L2,Asterisk
600493,ADHESION G PROTEIN-COUPLED RECEPTOR E1; ADGRE1,Asterisk
600494,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 2; POU3F2",Asterisk
600495,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 1; EIF4G1",Asterisk
600496,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3",Number Sign
600497,"PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-2; PRKAA2",Asterisk
600498,MOVED TO 313470,Caret
600499,REMOVED FROM DATABASE,Caret
600500,MOVED TO 600758,Caret
600501,ABCD SYNDROME; ABCDS,Number Sign
600502,IMMUNOGLOBULIN MU-BINDING PROTEIN 2; IGHMBP2,Asterisk
600503,"SUB1, S. CEREVISIAE, HOMOLOG OF; SUB1",Asterisk
600504,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 4; KCNJ4",Asterisk
600505,"CASEIN KINASE I, ALPHA-1; CSNK1A1",Asterisk
600506,MOVED TO 604286,Caret
600507,MOVED TO 601177,Caret
600508,NCK ADAPTOR PROTEIN 1; NCK1,Asterisk
600509,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 8; ABCC8",Asterisk
600510,GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1,Percent
600511,SCHIZOPHRENIA 3; SCZD3,Percent
600512,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1",Number Sign
600513,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1",Number Sign
600514,REELIN; RELN,Asterisk
600515,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 12; P2RY12",Asterisk
600516,BCL2 ANTAGONIST KILLER 1; BAK1,Asterisk
600517,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 3; SERPINB3",Asterisk
600518,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 4; SERPINB4",Asterisk
600519,"GENERAL TRANSCRIPTION FACTOR IIA, GAMMA SUBUNIT; GTF2A2",Asterisk
600520,"GENERAL TRANSCRIPTION FACTOR IIA, ALPHA/BETA SUBUNITS; GTF2A1",Asterisk
600521,MANNAN-BINDING LECTIN SERINE PROTEASE 1; MASP1,Asterisk
600522,"PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A",Plus
600523,"SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 2; SLC11A2",Asterisk
600524,RYK RECEPTOR-LIKE TYROSINE KINASE; RYK,Asterisk
600525,DISTAL-LESS HOMEOBOX 3; DLX3,Asterisk
600526,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2; MARK2,Asterisk
600527,EPHRIN B2; EFNB2,Asterisk
600528,"CARNITINE PALMITOYLTRANSFERASE I, LIVER; CPT1A",Asterisk
600529,AU-SPECIFIC RNA-BINDING PROTEIN; AUH,Asterisk
600530,"SOLUTE CARRIER FAMILY 9, MEMBER 2; SLC9A2",Asterisk
600531,"SOLUTE CARRIER FAMILY 9, MEMBER 4; SLC9A4",Asterisk
600532,NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 2; NDUFV2,Asterisk
600533,VANG-LIKE 2; VANGL2,Asterisk
600534,BONE MARROW STROMAL CELL ANTIGEN 2; BST2,Asterisk
600535,MESENCHYME HOMEOBOX 2; MEOX2,Asterisk
600536,"INTEGRIN, ALPHA-7; ITGA7",Asterisk
600537,RECQ PROTEIN-LIKE; RECQL,Asterisk
600538,PEROXIREDOXIN 2; PRDX2,Asterisk
600539,"PROTEIN KINASE C, IOTA FORM; PRKCI",Asterisk
600540,TRANSCRIPTION FACTOR Sp4; SP4,Asterisk
600541,ETS VARIANT GENE 1; ETV1,Asterisk
600542,"NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; NR4A3",Asterisk
600543,V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 4; ERBB4,Asterisk
600544,"SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 1; SLC15A1",Asterisk
600545,MOVED TO 300240,Caret
600546,INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY,
600547,CYSTEINE CONJUGATE BETA-LYASE 1; CCBL1,Asterisk
600548,HEAT-SHOCK 70-KD PROTEIN 9; HSPA9,Asterisk
600549,"IK CYTOKINE, DOWNREGULATOR OF HLA II; IK",Asterisk
600550,CATHEPSIN O; CTSO,Asterisk
600551,G PROTEIN-COUPLED RECEPTOR 4; GPR4,Asterisk
600552,"CHEMOKINE, C MOTIF, RECEPTOR 1; XCR1",Asterisk
600553,G PROTEIN-COUPLED RECEPTOR 6; GPR6,Asterisk
600554,INTERLEUKIN 15; IL15,Asterisk
600555,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1,Asterisk
600556,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2; STAT2,Asterisk
600557,MOVED TO 102582,Caret
600558,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4; STAT4,Asterisk
600559,"HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS",
600560,SHC TRANSFORMING PROTEIN 1; SHC1,Asterisk
600561,SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY,
600562,CADHERIN 12; CDH12,Asterisk
600563,PROSTAGLANDIN F RECEPTOR; PTGFR,Asterisk
600564,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 4; ITIH4",Asterisk
600565,NEUREXIN I; NRXN1,Asterisk
600566,NEUREXIN II; NRXN2,Asterisk
600567,NEUREXIN III; NRXN3,Asterisk
600568,NEUROLIGIN 1; NLGN1,Asterisk
600569,MOVED TO 300103,Caret
600570,CHLORIDE CHANNEL 2; CLCN2,Asterisk
600571,RE1-SILENCING TRANSCRIPTION FACTOR; REST,Asterisk
600572,"SPLICING FACTOR, SERINE/ARGININE-RICH, 7; SRSF7",Asterisk
600573,"TAF7 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 55-KD; TAF7",Asterisk
600574,LEUCINE ZIPPER-LIKE TRANSCRIPTIONAL REGULATOR 1; LZTR1,Asterisk
600575,TRANSLIN; TSN,Asterisk
600576,GATA-BINDING PROTEIN 4; GATA4,Asterisk
600577,LIM HOMEOBOX GENE 3; LHX3,Asterisk
600578,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY H, MEMBER 3; OR2H3",Asterisk
600579,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, O; PTPRO",Asterisk
600580,CHLORIDE CHANNEL 3; CLCN3,Asterisk
600581,INHIBITOR OF DNA BINDING 4; ID4,Asterisk
600582,ASPARTATE BETA-HYDROXYLASE; ASPH,Asterisk
600583,TEC PROTEIN TYROSINE KINASE; TEC,Asterisk
600584,NK2 HOMEOBOX 5; NKX2-5,Asterisk
600585,TRANSGLUTAMINASE 4; TGM4,Asterisk
600586,EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOGENE; ECT2,Asterisk
600587,POM121/ZP3 FUSION PROTEIN; POMZP3,Asterisk
600588,MOVED TO 188025,Caret
600589,SERUM RESPONSE FACTOR; SRF,Asterisk
600590,"PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, BETA ISOFORM; PPP1CB",Asterisk
600591,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 1; SNAPC1",Asterisk
600592,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7; MCM7,Asterisk
600593,"CRANIOSYNOSTOSIS, ADELAIDE TYPE; CRSA",Percent
600594,DIGEORGE SYNDROME CRITICAL REGION GENE 2; DGCR2,Asterisk
600595,"INTRAFLAGELLAR TRANSPORT 88, CHLAMYDOMONAS, HOMOLOG OF; IFT88",Asterisk
600596,MICROFIBRILLAR-ASSOCIATED PROTEIN 4; MFAP4,Asterisk
600597,PHOSPHOLIPASE C-LIKE 1; PLCL1,Asterisk
600598,"SETTING-SUN PHENOMENON, FAMILIAL BENIGN",
600599,KRUPPEL-LIKE FACTOR 1; KLF1,Asterisk
600600,EPHRIN RECEPTOR EphB1; EPHB1,Asterisk
600601,MOVED TO 600289,Caret
600602,MOVED TO 300083,Caret
600603,MOVED TO 300071,Caret
600604,MOVED TO 600376,Caret
600605,METAXIN 1; MTX1,Asterisk
600606,REMOVED FROM DATABASE,Caret
600607,"VACUOLAR PROTEIN SORTING 72, YEAST, HOMOLOG OF; VPS72",Asterisk
600608,"PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 2; P4HA2",Asterisk
600609,"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, ALPHA SUBUNIT; GABPA",Asterisk
600610,"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, BETA SUBUNIT; GABPB",Asterisk
600611,FK506-BINDING PROTEIN 4; FKBP4,Asterisk
600612,MOVED TO 300101,Caret
600613,"NEUROBLASTOMA CANDIDATE REGION, SUPPRESSION OF TUMORIGENICITY 1; NBL1",Asterisk
600614,S100 CALCIUM-BINDING PROTEIN P; S100P,Asterisk
600615,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 7; LGALS7",Asterisk
600616,LUMICAN; LUM,Asterisk
600617,STEROIDOGENIC ACUTE REGULATORY PROTEIN; STAR,Asterisk
600618,ETS VARIANT GENE 6; ETV6,Asterisk
600619,MOVED TO 300097,Caret
600620,FK506-BINDING PROTEIN 1B; FKBP1B,Asterisk
600621,STATHMIN-LIKE 2; STMN2,Asterisk
600622,MOVED TO 300069,Caret
600623,CD82 ANTIGEN; CD82,Asterisk
600624,CONE-ROD DYSTROPHY 1; CORD1,Percent
600625,OROFACIAL CLEFT 11; OFC11,Number Sign
600626,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN; LGALS3BP",Asterisk
600627,HYPERTRYPTOPHANEMIA; HYPTRP,Number Sign
600628,LOOSE ANAGEN HAIR SYNDROME,
600629,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DO BETA; HLA-DOB",Asterisk
600630,UV-SENSITIVE SYNDROME 1; UVSS1,Number Sign
600631,"ENURESIS, NOCTURNAL, 1; ENUR1",Percent
600632,OPIOID-BINDING PROTEIN/CELL ADHESION MOLECULE-LIKE; OPCML,Asterisk
600633,TREFOIL FACTOR 3; TFF3,Asterisk
600634,"PITUITARY ADENOMA, PROLACTIN-SECRETING",Number Sign
600635,NK2 HOMEOBOX 1; NKX2-1,Asterisk
600636,"CASPASE 3, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP3",Asterisk
600637,"SOLUTE CARRIER FAMILY 1 (HIGH AFFINITY ASPARTATE/GLUTAMATE TRANSPORTER), MEMBER 6; SLC1A6",Asterisk
600638,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A",Number Sign
600639,"CASPASE 2, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP2",Asterisk
600640,MOVED TO 311770,Caret
600641,"SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 3; SULT1A3",Asterisk
600642,MYOSIN IG; MYO1G,Asterisk
600643,"CAROLI DISEASE, ISOLATED",
600644,NECTIN 1; NECTIN1,Asterisk
600645,MOVED TO 600579,Caret
600646,PROTEIN C RECEPTOR; PROCR,Asterisk
600647,H6 FAMILY HOMEOBOX 2; HMX2,Asterisk
600648,MOVED TO 113800,Caret
600649,"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE",Number Sign
600650,CARNITINE PALMITOYLTRANSFERASE II; CPT2,Asterisk
600651,FRAGILE SITE 11B; FRA11B,Number Sign
600652,"DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A",Number Sign
600653,MOVED TO 600381,Caret
600654,PROTEASOME ACTIVATOR SUBUNIT 1; PSME1,Asterisk
600655,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2; EEF1B2",Asterisk
600656,MOVED TO 600655,Caret
600657,MOVED TO 300140,Caret
600658,"PROTEIN PHOSPHATASE 5, CATALYTIC SUBUNIT; PPP5C",Asterisk
600659,E2F TRANSCRIPTION FACTOR 4; E2F4,Asterisk
600660,"MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE A; MEF2A",Asterisk
600661,"MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE B; MEF2B",Asterisk
600662,"MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE C; MEF2C",Asterisk
600663,"MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE D; MEF2D",Asterisk
600664,CONSERVED HELIX-LOOP-HELIX UBIQUITOUS KINASE; CHUK,Asterisk
600665,MELATONIN RECEPTOR 1A; MTNR1A,Asterisk
600666,POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD3,Number Sign
600667,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 2; FZD2",Asterisk
600668,CHONDROCALCINOSIS 1; CCAL1,Percent
600669,"EPILEPSY, IDIOPATHIC GENERALIZED; EIG",Percent
600670,"VARICELLA, SEVERE RECURRENT",
600671,MOVED TO 600594,Caret
600672,MOVED TO 300025,Caret
600673,UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF,Asterisk
600674,MICROTIA-ANOTIA,Percent
600675,"X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; XRCC3",Asterisk
600676,CATR TUMORIGENIC CONVERSION 1; CATR1,Asterisk
600677,MOVED TO 300192,Caret
600678,"MutS, E. COLI, HOMOLOG OF, 6; MSH6",Asterisk
600679,"DERMOID CYSTS, FAMILIAL FRONTONASAL",
600680,MOVED TO 256730,Caret
600681,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 2; KCNJ2",Asterisk
600682,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 1; SLC16A1",Asterisk
600683,MOVED TO 109190,Caret
600684,T-LYMPHOCYTE SURFACE ANTIGEN LY-9; LY9,Asterisk
600685,KARYOPHERIN ALPHA-2; KPNA2,Asterisk
600686,KARYOPHERIN ALPHA-1; KPNA1,Asterisk
600687,T-CELL LYMPHOMA INVASION AND METASTASIS 1; TIAM1,Asterisk
600688,"CARBOXYPEPTIDASE A2, PANCREATIC; CPA2",Asterisk
600689,MOVED TO 300096,Caret
600690,T-CELL LEUKEMIA TRANSLOCATION-ASSOCIATED GENE; TCTA,Asterisk
600691,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 1; SLC27A1",Asterisk
600692,"TROPONIN T3, FAST SKELETAL; TNNT3",Asterisk
600693,POLYPYRIMIDINE TRACT-BINDING PROTEIN 1; PTBP1,Asterisk
600694,INTERLEUKIN 6 SIGNAL TRANSDUCER; IL6ST,Asterisk
600695,MOVED TO 601434,Caret
600696,"ENOYL-CoA HYDRATASE 1, PEROXISOMAL; ECH1",Asterisk
600697,RETINOBLASTOMA-BINDING PROTEIN 5; RBBP5,Asterisk
600698,HIGH MOBILITY GROUP AT-HOOK 2; HMGA2,Asterisk
600699,MOVED TO 400003,Caret
600700,LIM DOMAIN-CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA; LPP,Asterisk
600701,HIGH MOBILITY GROUP AT-HOOK 1; HMGA1,Asterisk
600702,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A",Asterisk
600703,RIBOSOMAL PROTEIN S1-LIKE; RPS1L,Asterisk
600704,MOVED TO 300047,Caret
600705,SATOYOSHI SYNDROME,
600706,PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA,
600707,"SIGNAL RECOGNITION PARTICLE, 9-KD; SRP9",Asterisk
600708,"SIGNAL RECOGNITION PARTICLE, 14-KD; SRP14",Asterisk
600709,ISOLEUCYL-tRNA SYNTHETASE; IARS,Asterisk
600710,MOVED TO 600564,Caret
600711,ETS VARIANT GENE 4; ETV4,Asterisk
600712,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HNRNPK,Asterisk
600713,"11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE I; HSD11B1",Asterisk
600714,DUAL-SPECIFICITY PHOSPHATASE 1; DUSP1,Asterisk
600715,THROMBOSPONDIN IV; THBS4,Asterisk
600716,"PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22; PTPN22",Asterisk
600717,MOVED TO 120165,Caret
600718,MOVED TO 185535,Caret
600719,NITRIC OXIDE SYNTHASE 2B; NOS2B,Asterisk
600720,NITRIC OXIDE SYNTHASE 2C; NOS2C,Asterisk
600721,D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1,Number Sign
600722,PALMITOYL-PROTEIN THIOESTERASE 1; PPT1,Asterisk
600723,"MEMBRANE PROTEIN, PALMITOYLATED 2; MPP2",Asterisk
600724,"CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-1; CNGB1",Asterisk
600725,SONIC HEDGEHOG; SHH,Asterisk
600726,INDIAN HEDGEHOG; IHH,Asterisk
600727,NUCLEAR FACTOR I/A; NFIA,Asterisk
600728,NUCLEAR FACTOR I/B; NFIB,Asterisk
600729,NUCLEAR FACTOR I/C; NFIC,Asterisk
600730,NEUROPEPTIDES B AND W RECEPTOR 1; NPBWR1,Asterisk
600731,G PROTEIN-COUPLED RECEPTOR 8; GPR8,Asterisk
600732,ADP-RIBOSYLATION FACTOR-LIKE 4D; ARL4D,Asterisk
600733,PANCREAS/DUODENUM HOMEOBOX PROTEIN 1; PDX1,Asterisk
600734,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 5; KCNJ5",Asterisk
600735,INTERFERON-INDUCED PROTEIN 35; IFI35,Asterisk
600736,VELOFACIOSKELETAL SYNDROME,
600737,MOVED TO 605820,Caret
600738,SELECTIN P LIGAND; SELPLG,Asterisk
600739,SHC-LIKE PROTEIN; SHCL1,Asterisk
600740,"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3",Number Sign
600741,MOVED TO 176636,Caret
600742,"TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE III; TGFBR3",Asterisk
600743,TRANSCRIPTION FACTOR AP4; TFAP4,Asterisk
600744,T-CELL TRANSCRIPTION FACTOR EB; TFEB,Asterisk
600745,APOLIPOPROTEIN C-IV; APOC4,Asterisk
600746,CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 1; CDX1,Asterisk
600747,T-BOX 2; TBX2,Asterisk
600748,TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 6; TMBIM6,Asterisk
600749,"CCAAT/ENHANCER-BINDING PROTEIN, EPSILON; CEBPE",Asterisk
600750,"PENTRAXIN II, NEURONAL; NPTX2",Asterisk
600751,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 1; SIGLEC1,Asterisk
600752,G PROTEIN-COUPLED RECEPTOR 12; GPR12,Asterisk
600753,GOLGI APPARATUS PROTEIN 1; GLG1,Asterisk
600754,MATRIX METALLOPROTEINASE 14; MMP14,Asterisk
600755,SYNAPSIN II; SYN2,Asterisk
600756,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-PRIME; PPP2R4",Asterisk
600757,OROFACIAL CLEFT 3; OFC3,Percent
600758,"PROTEIN-TYROSINE KINASE, CYTOPLASMIC; PTK2",Asterisk
600759,PRESENILIN 2; PSEN2,Asterisk
600760,"SODIUM CHANNEL, NONVOLTAGE-GATED 1, BETA SUBUNIT; SCNN1B",Asterisk
600761,"SODIUM CHANNEL, NONVOLTAGE-GATED 1, GAMMA SUBUNIT; SCNN1G",Asterisk
600762,HUMAN PAPILLOMAVIRUS E5 CENTRAL SEQUENCE-LIKE 1; HPVC1,Asterisk
600763,"TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1; TPT1",Asterisk
600764,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I-RELATED; MR1",Asterisk
600765,MOVED TO 600137,Caret
600766,MOVED TO 300104,Caret
600767,GDP-DISSOCIATION INHIBITOR 2; GDI2,Asterisk
600768,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 9; PTPN9",Asterisk
600769,TETRASPANIN 8; TSPAN8,Asterisk
600770,"MUCIN 5, SUBTYPE B, TRACHEOBRONCHIAL; MUC5B",Asterisk
600771,"DWARFISM, FAMILIAL, WITH MUSCLE SPASMS",Percent
600772,"TAF11 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 28-KD; TAF11",Asterisk
600773,"TAF12 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 20-KD; TAF12",Asterisk
600774,"TAF13 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 18-KD; TAF13",Asterisk
600775,CRANIOSYNOSTOSIS 4; CRS4,Number Sign
600776,FRYNS MICROPHTHALMIA SYNDROME,
600777,"TRANSCRIPTION TERMINATION FACTOR, RNA POLYMERASE I; TTF1",Asterisk
600778,CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B,Asterisk
600779,MOVED TO 164874,Caret
600780,MOVED TO 241410,Caret
600781,PEPTIDE YY; PYY,Asterisk
600782,SYNAPTOTAGMIN 5; SYT5,Asterisk
600783,HISTIDYL-tRNA SYNTHETASE 2; HARS2,Asterisk
600784,GRANZYME K; GZMK,Asterisk
600785,"VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR; VDDR2B",Percent
600786,ELONGIN A; ELOA,Asterisk
600787,ELONGIN B; ELOB,Asterisk
600788,ELONGIN C; ELOC,Asterisk
600789,RIBOSOMAL PROTEIN L23-LIKE; RPL23L,Asterisk
600790,"CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL",Percent
600791,"DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4",Number Sign
600792,"DEAFNESS, AUTOSOMAL RECESSIVE 5; DFNB5",Percent
600793,MOVED TO 300081,Caret
600794,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A",Number Sign
600795,"FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3",Number Sign
600796,"SPLICING FACTOR 3A, SUBUNIT 2; SF3A2",Asterisk
600797,INSULIN RECEPTOR SUBSTRATE 2; IRS2,Asterisk
600798,NECTIN 2; NECTIN2,Asterisk
600799,"BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE II; BMPR2",Asterisk
600800,NGFIA-BINDING PROTEIN; NAB1,Asterisk
600801,ISOPROTERENOL-MEDIATED VASODILATATION,
600802,"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE",Number Sign
600803,GALLBLADDER DISEASE 1; GBD1,Number Sign
600804,MELATONIN RECEPTOR 1B; MTNR1B,Asterisk
600805,"LAMININ, ALPHA-3; LAMA3",Asterisk
600806,CALPONIN 1; CNN1,Asterisk
600807,"ASTHMA, SUSCEPTIBILITY TO",Number Sign
600808,"ENURESIS, NOCTURNAL, 2; ENUR2",Percent
600809,MOVED TO 132890,Caret
600810,"PHOSPHOLIPASE C, BETA-4; PLCB4",Asterisk
600811,DNA DAMAGE-BINDING PROTEIN 2; DDB2,Asterisk
600812,"SPLICING FACTOR, SERINE/ARGININE-RICH, 1; SRSF1",Asterisk
600813,"SPLICING FACTOR, SERINE/ARGININE-RICH, 2; SRSF2",Asterisk
600814,"MEIOTIC RECOMBINATION 11, S. CEREVISIAE, HOMOLOG OF, A; MRE11A",Asterisk
600815,"POLYMERASE (DNA-DIRECTED), DELTA 2, REGULATORY SUBUNIT; POLD2",Asterisk
600816,HEAT-SHOCK 70-KD PROTEIN 8; HSPA8,Asterisk
600817,VISININ-LIKE 1; VSNL1,Asterisk
600818,TRANSGELIN; TAGLN,Asterisk
600819,FMR1 AUTOSOMAL HOMOLOG 1; FXR1,Asterisk
600820,ARCHAIN 1; ARCN1,Asterisk
600821,ARGININE VASOPRESSIN RECEPTOR 1A; AVPR1A,Asterisk
600822,"TAF9 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 32-KD; TAF9",Asterisk
600823,"PROTEASE, SERINE, 8; PRSS8",Asterisk
600824,CYSTEINE- AND GLYCINE-RICH PROTEIN 3; CSRP3,Asterisk
600825,RAR-RELATED ORPHAN RECEPTOR A; RORA,Asterisk
600826,CHONDROITIN SULFATE PROTEOGLYCAN 3; CSPG3,Asterisk
600827,"PHOSPHODIESTERASE 6C, cGMP-SPECIFIC, CONE, ALPHA-PRIME; PDE6C",Asterisk
600828,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, O SUBUNIT; ATP5O",Asterisk
600829,INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE 1; INPPL1,Asterisk
600830,TRIPARTITE MOTIF-CONTAINING PROTEIN 26; TRIM26,Asterisk
600831,DEATH-ASSOCIATED PROTEIN KINASE 1; DAPK1,Asterisk
600832,"ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A; ANP32A",Asterisk
600833,SUPPRESSOR OF TUMORIGENICITY 7; ST7,Asterisk
600834,ZINC FINGER PROTEIN 165; ZNF165,Asterisk
600835,"CHEMOKINE, CXC MOTIF, LIGAND 12; CXCL12",Asterisk
600836,"CRYSTALLIN, BETA-A2; CRYBA2",Asterisk
600837,GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GDNF,Asterisk
600838,FORKHEAD BOX N1; FOXN1,Asterisk
600839,"SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 1; SLC12A1",Asterisk
600840,"SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 2; SLC12A2",Asterisk
600841,EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA-1-LIKE 14; EEF1A1L14,
600842,GLUCOKINASE REGULATORY PROTEIN; GCKR,Asterisk
600843,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 3; P2RX3",Asterisk
600844,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 2; P2RX2",Asterisk
600845,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 1; P2RX1",Asterisk
600846,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 4; P2RX4",Asterisk
600847,MOVED TO 600695,Caret
600848,NUCLEAR RECEPTOR COREPRESSOR 2; NCOR2,Asterisk
600849,NUCLEAR RECEPTOR COREPRESSOR 1; NCOR1,Asterisk
600850,SCHIZOPHRENIA 4; SCZD4,Number Sign
600851,MITOCHONDRIAL IMPORT-STIMULATING FACTOR,
600852,RETINITIS PIGMENTOSA 17; RP17,Number Sign
600853,N-DEACETYLASE/N-SULFOTRANSFERASE 1; NDST1,Asterisk
600854,MOVED TO 600877,Caret
600855,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A,Asterisk
600856,CYCLIN-DEPENDENT KINASE INHIBITOR 1C; CDKN1C,Asterisk
600857,"SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT A, FLAVOPROTEIN; SDHA",Asterisk
600858,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6",Number Sign
600859,AMINOACYL tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 2; AIMP2,Asterisk
600860,GENERAL TRANSCRIPTION FACTOR IIIA; GTF3A,Asterisk
600861,REGULATOR OF G PROTEIN SIGNALING 2; RGS2,Asterisk
600862,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN WITH FG REPEATS 1; AGFG1,Asterisk
600863,"CASEIN KINASE I, EPSILON; CSNK1E",Asterisk
600864,"CASEIN KINASE I, DELTA; CSNK1D",Asterisk
600865,RETICULON 1; RTN1,Asterisk
600866,PROGRAMMED CELL DEATH 2; PDCD2,Asterisk
600867,"SIGNAL SEQUENCE RECEPTOR, BETA; SSR2",Asterisk
600868,"SIGNAL SEQUENCE RECEPTOR, ALPHA; SSR1",Asterisk
600869,G PROTEIN-COUPLED RECEPTOR KINASE 6; GRK6,Asterisk
600870,G PROTEIN-COUPLED RECEPTOR KINASE 5; GRK5,Asterisk
600871,GROWTH FACTOR-INDEPENDENT 1; GFI1,Asterisk
600872,MOVED TO 300113,Caret
600873,"CHITOBIASE, DI-N-ACETYL-; CTBS",Asterisk
600874,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-5; GNG5",Asterisk
600875,"ACYLPHOSPHATASE, ERYTHROCYTE; ACYP1",Asterisk
600876,SYNTAXIN 3; STX3,Asterisk
600877,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 6; KCNJ6",Asterisk
600878,MOVED TO 601296,Caret
600879,NUCLEAR RESPIRATORY FACTOR 1; NRF1,Asterisk
600880,BUDD-CHIARI SYNDROME; BDCHS,Number Sign
600881,"CATARACT 10, MULTIPLE TYPES; CTRCT10",Number Sign
600882,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B",Number Sign
600883,"DIABETES MELLITUS, INSULIN-DEPENDENT, 8; IDDM8",Percent
600884,"CARDIOMYOPATHY, DILATED, 1B; CMD1B",Percent
600885,MOVED TO 251260,Caret
600886,HYPERFERRITINEMIA WITH OR WITHOUT CATARACT; HRFTC,Number Sign
600887,"MutS, E. COLI, HOMOLOG OF, 3; MSH3",Asterisk
600888,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; ARHGEF5,Asterisk
600889,COMPLEMENT FACTOR H-RELATED 2; CFHR2,Asterisk
600890,"HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, ALPHA SUBUNIT; HADHA",Asterisk
600891,MOVED TO 300098,Caret
600892,"SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 2; SIM2",Asterisk
600893,MOVED TO 300099,Caret
600894,MOVED TO 300574,Caret
600895,PROLACTIN-RELEASING HORMONE RECEPTOR; PRLHR,Asterisk
600896,G PROTEIN-COUPLED RECEPTOR 14; GPR14,Asterisk
600897,"GAP JUNCTION PROTEIN, ALPHA-8; GJA8",Asterisk
600898,SRY-BOX 11; SOX11,Asterisk
600899,"PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT; PRKDC",Asterisk
600900,"SARCOGLYCAN, BETA; SGCB",Asterisk
600901,"FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE",Number Sign
600902,SELENOPHOSPHATE SYNTHETASE 1; SEPHS1,Asterisk
600903,"WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM",
600904,ASTROTACTIN 1; ASTN1,Asterisk
600905,MOVED TO 600600,Caret
600906,ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY,
600907,"ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS",
600908,KENNERKNECHT SYNDROME,
600909,LANOSTEROL SYNTHASE; LSS,Asterisk
600910,INSULIN-LIKE 4; INSL4,Asterisk
600911,METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 2; MPPED2,Asterisk
600912,TRANSCRIPTION FACTOR 19; TCF19,Asterisk
600913,MOVED TO 602055,Caret
600914,"SPLICING FACTOR, SERINE/ARGININE-RICH, 5; SRSF5",Asterisk
600915,NESTIN; NES,Asterisk
600916,"INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE I, 107-KD; INPP4A",Asterisk
600917,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3A; PPP1R3A",Asterisk
600918,MOVED TO 220100,Caret
600919,"CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED",Number Sign
600920,VAN DEN ENDE-GUPTA SYNDROME; VDEGS,Number Sign
600921,FIBROBLAST GROWTH FACTOR 9; FGF9,Asterisk
600922,MYOSIN LIGHT CHAIN KINASE; MYLK,Asterisk
600923,PROTOPORPHYRINOGEN OXIDASE; PPOX,Asterisk
600924,"GROWTH FACTOR, ERV1-LIKE; GFER",Asterisk
600925,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, J; PTPRJ",Asterisk
600926,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON; PTPRE",Asterisk
600927,CYCLIN-DEPENDENT KINASE INHIBITOR 2D; CDKN2D,Asterisk
600928,NITROGEN PERMEASE REGULATOR-LIKE 3; NPRL3,Asterisk
600929,"CRYSTALLIN, BETA-B1; CRYBB1",Asterisk
600930,SPERM ADHESION MOLECULE 1; SPAM1,Asterisk
600931,PROTOCADHERIN 3,
600932,"POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 9; KCNJ9",Asterisk
600933,COAGULATION FACTOR II RECEPTOR-LIKE 1; F2RL1,Asterisk
600934,FOLATE HYDROLASE 1; FOLH1,Asterisk
600935,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 8; KCNJ8",Asterisk
600936,HYALURONAN-MEDIATED MOTILITY RECEPTOR; HMMR,Asterisk
600937,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 11; KCNJ11",Asterisk
600938,RETINOBLASTOMA-BINDING PROTEIN 6; RBBP6,Asterisk
600939,"INTERLEUKIN 11 RECEPTOR, ALPHA; IL11RA",Asterisk
600940,"LIGASE III, DNA, ATP-DEPENDENT; LIG3",Asterisk
600941,BILIVERDIN REDUCTASE B; BLVRB,Asterisk
600942,MOVED TO 600943,Caret
600943,"SERPIN PEPTIDASE INHIBITOR, CLADE H, MEMBER 1; SERPINH1",Asterisk
600944,DEOXYHYPUSINE SYNTHASE; DHPS,Asterisk
600945,UROCORTIN; UCN,Asterisk
600946,GROWTH HORMONE RECEPTOR; GHR,Asterisk
600947,HUNTINGTIN-ASSOCIATED PROTEIN 1; HAP1,Asterisk
600948,MYELIN-ASSOCIATED OLIGODENDROCYTE BASIC PROTEIN; MOBP,Asterisk
600949,IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION-2,Asterisk
600950,ARYLALKYLAMINE N-ACETYLTRANSFERASE; AANAT,Asterisk
600951,TELOMERIC REPEAT-BINDING FACTOR 1; TERF1,Asterisk
600952,TRANSSEXUALITY,
600953,INTERLEUKIN 18; IL18,Asterisk
600954,DEATH-ASSOCIATED PROTEIN; DAP,Asterisk
600955,PROPROTEIN CONVERTASE 1/3 DEFICIENCY,Number Sign
600956,ANTI-MULLERIAN HORMONE TYPE II RECEPTOR; AMHR2,Asterisk
600957,ANTI-MULLERIAN HORMONE; AMH,Asterisk
600958,"MYOSIN-BINDING PROTEIN C, CARDIAC; MYBPC3",Asterisk
600959,"COATOMER PROTEIN COMPLEX, SUBUNIT BETA 1; COPB1",Asterisk
600960,SET NUCLEAR PROTOONCOGENE; SET,Asterisk
600961,MOVED TO 601498,Caret
600962,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK",Number Sign
600963,"SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 5; SIX5",Asterisk
600964,MOVED TO 266500,Caret
600965,"DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6",Number Sign
600966,"LETHAL GIANT LARVAE, DROSOPHILA, HOMOLOG OF, 1; LLGL1",Asterisk
600967,E2F TRANSCRIPTION FACTOR 5; E2F5,Asterisk
600968,"SOLUTE CARRIER FAMILY 12 (SODIUM/CHLORIDE TRANSPORTER), MEMBER 3; SLC12A3",Asterisk
600969,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3",Number Sign
600970,MYOSIN VI; MYO6,Asterisk
600971,"DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6",Number Sign
600972,"ACHONDROGENESIS, TYPE IB; ACG1B",Number Sign
600973,MOVED TO 600308,Caret
600974,"DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7",Number Sign
600975,"GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B",Percent
600976,"FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 1; FAT1",Asterisk
600977,CONE-ROD DYSTROPHY 5; CORD5,Number Sign
600978,LYMPHOTOXIN-BETA; LTB,Asterisk
600979,LYMPHOTOXIN B RECEPTOR; LTBR,Asterisk
600980,DENTIN MATRIX ACIDIC PHOSPHOPROTEIN 1; DMP1,Asterisk
600981,PHOSPHOGLUCOMUTASE 5; PGM5,Asterisk
600982,MITOGEN-ACTIVATED KINASE KINASE KINASE 1; MAP3K1,Asterisk
600983,"NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2; NR3C2",Asterisk
600984,"ACTIVATING TRANSCRIPTION FACTOR 6, BETA; ATF6B",Asterisk
600985,TENASCIN XB; TNXB,Asterisk
600986,TRIPARTITE MOTIF-CONTAINING PROTEIN 46; TRIM46,Asterisk
600987,"CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR",Number Sign
600988,"MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 2; MAN2A2",Asterisk
600989,INFUNDIBULOPELVIC DYSGENESIS,
600990,MOVED TO 119580,Caret
600991,"HYDROCEPHALUS, SPRENGEL ANOMALY, AND COSTOVERTEBRAL DYSPLASIA",
600992,MOVED TO 206900,Caret
600993,"MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 4; SMAD4",Asterisk
600994,"DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5",Number Sign
600995,"NEPHROTIC SYNDROME, TYPE 2; NPHS2",Number Sign
600996,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2",Number Sign
600997,EPHRIN RECEPTOR EphB2; EPHB2,Asterisk
600998,"GUANINE NUCLEOTIDE-BINDING PROTEIN, Q POLYPEPTIDE; GNAQ",Asterisk
600999,MYC-ASSOCIATED ZINC FINGER PROTEIN; MAZ,Asterisk
601000,MOVED TO 109170,Caret
601001,"EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1",Number Sign
601002,GLUTATHIONE SYNTHETASE; GSS,Asterisk
601003,BRODY MYOPATHY,Number Sign
601004,"PORTAL VEIN, CAVERNOUS TRANSFORMATION OF",
601005,TIMOTHY SYNDROME; TS,Number Sign
601006,MOVED TO 138890,Caret
601007,LEPTIN RECEPTOR; LEPR,Asterisk
601008,MOVED TO 148760,Caret
601009,TIGHT JUNCTION PROTEIN 1; TJP1,Asterisk
601010,TRANSCRIPTION FACTOR 15; TCF15,Asterisk
601011,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A",Asterisk
601012,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, N TYPE, ALPHA-1B SUBUNIT; CACNA1B",Asterisk
601013,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1E SUBUNIT; CACNA1E",Asterisk
601014,"DISCS LARGE, DROSOPHILA, HOMOLOG OF, 1; DLG1",Asterisk
601015,NPC2 GENE; NPC2,Asterisk
601016,"MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM",
601017,"SYNTROPHIN, ALPHA-1; SNTA1",Asterisk
601018,MOVED TO 600027,Caret
601019,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 9; SLC6A9",Asterisk
601020,CD86 ANTIGEN; CD86,Asterisk
601021,"NUCLEOPORIN, 98-KD; NUP98",Asterisk
601022,NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR-LIKE 1; NFKBIL1,Asterisk
601023,VALOSIN-CONTAINING PROTEIN; VCP,Asterisk
601024,"ADAPTOR-RELATED PROTEIN COMPLEX 2, MU-1 SUBUNIT; AP2M1",Asterisk
601025,"ADAPTOR-RELATED PROTEIN COMPLEX 2, BETA-1 SUBUNIT; AP2B1",Asterisk
601026,"ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-1 SUBUNIT; AP2A1",Asterisk
601027,"TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES",
601028,CD47 ANTIGEN; CD47,Asterisk
601029,"MESODERM-SPECIFIC TRANSCRIPT, MOUSE, HOMOLOG OF; MEST",Asterisk
601030,"RIBONUCLEASE, RNase A FAMILY, 4; RNASE4",Asterisk
601031,RHOPHILIN 1; RHPN1,Asterisk
601032,PROTEIN KINASE N1; PKN1,Asterisk
601033,"LAMININ, ALPHA-5; LAMA5",Asterisk
601034,MOVED TO 155735,Caret
601035,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; HNRNPH1,Asterisk
601036,MOVED TO 300610,Caret
601037,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; HNRNPF,Asterisk
601038,"DEIODINASE, IODOTHYRONINE, TYPE III; DIO3",Asterisk
601039,ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN,
601040,"SCAVENGER RECEPTOR CLASS B, MEMBER 1; SCARB1",Asterisk
601041,TRANSDUCIN-LIKE ENHANCER OF SPLIT 2; TLE2,Asterisk
601042,DYSTONIA 9; DYT9,Number Sign
601043,MOVED TO 600701,Caret
601044,MOVED TO 600701,Caret
601045,"CATENIN, DELTA-1; CTNND1",Asterisk
601046,MATRIX METALLOPROTEINASE 12; MMP12,Asterisk
601047,CAVEOLIN 1; CAV1,Asterisk
601048,CAVEOLIN 2; CAV2,Asterisk
601049,MOVED TO 300119,Caret
601050,REMOVED FROM DATABASE,Caret
601051,MESOTHELIN; MSLN,Asterisk
601052,"PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1; PIN1",Asterisk
601053,PLEXIN B1; PLXNB1,Asterisk
601054,PLEXIN A2; PLXNA2,Asterisk
601055,PLEXIN A1; PLXNA1,Asterisk
601056,BCL2-RELATED PROTEIN A1; BCL2A1,Asterisk
601057,PROGRAMMED CELL DEATH 6; PDCD6,Asterisk
601058,"H3 HISTONE, FAMILY 3B; H3F3B",Asterisk
601059,MOVED TO 146920,Caret
601060,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 2; ENPP2,Asterisk
601061,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D2; SNRPD2,Asterisk
601062,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D3; SNRPD3,Asterisk
601063,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D1; SNRPD1,Asterisk
601064,ZINC FINGER PROTEIN 36-LIKE 1; ZFP36L1,Asterisk
601065,ALANYL-tRNA SYNTHETASE; AARS,Asterisk
601066,"OXIDASE, CYTOCHROME c, ASSEMBLY 1-LIKE; OXA1L",Asterisk
601067,"USHER SYNDROME, TYPE ID; USH1D",Number Sign
601068,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1",Number Sign
601069,ZINC FINGER PROTEIN 239; ZNF239,Asterisk
601070,"INTERLEUKIN 15 RECEPTOR, ALPHA; IL15RA",Asterisk
601071,"DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9",Number Sign
601072,"DEAFNESS, AUTOSOMAL RECESSIVE 8; DFNB8",Number Sign
601073,MOVED TO 600737,Caret
601074,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 1; CELF1",Asterisk
601075,"APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION",
601076,"MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES; MURCS",Percent
601077,"KERATIN 31, TYPE I; KRT31",Asterisk
601078,"KERATIN 82, TYPE II; KRT82",Asterisk
601079,"ZINC FINGER-, CCCH DOMAIN-, AND RNA-BINDING MOTIF-CONTAINING SERINE/ARGININE-RICH PROTEIN 1; ZRSR1",Asterisk
601080,U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1-LIKE 4; U2AF1L4,Asterisk
601081,"ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2; ABCD2",Asterisk
601082,UBIQUITIN-CONJUGATING ENZYME E2H; UBE2H,Asterisk
601083,CD4/CD8 T-CELL RATIO,
601084,MOVED TO 606634,Caret
601085,MOVED TO 245570,Caret
601086,"LATERALITY DEFECTS, AUTOSOMAL DOMINANT",Percent
601087,MOVED TO 121210,Caret
601088,AYME-GRIPP SYNDROME; AYGRP,Number Sign
601089,FORKHEAD BOX F1; FOXF1,Asterisk
601090,FORKHEAD BOX C1; FOXC1,Asterisk
601091,FORKHEAD BOX D1; FOXD1,Asterisk
601092,FORKHEAD BOX D4; FOXD4,Asterisk
601093,FORKHEAD BOX I1; FOXI1,Asterisk
601094,FORKHEAD BOX E3; FOXE3,Asterisk
601095,HARROD SYNDROME,
601096,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC",
601097,PERIPHERAL MYELIN PROTEIN 22; PMP22,Asterisk
601098,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C",Number Sign
601099,SRC-LIKE ADAPTOR; SLA,Asterisk
601100,HEAT SHOCK 70-KD PROTEIN 13; HSPA13,Asterisk
601101,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 3; HHT3",Percent
601102,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 2; EIF4A2",Asterisk
601103,MICROFIBRILLAR-ASSOCIATED PROTEIN 5; MFAP5,Asterisk
601104,"SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1",Number Sign
601105,CATHEPSIN K; CTSK,Asterisk
601106,REMOVED FROM DATABASE,Caret
601107,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 2; ABCC2",Asterisk
601108,MOVED TO 300283,Caret
601109,5-HYDROXYTRYPTAMINE RECEPTOR 6; HTR6,Asterisk
601110,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D",Number Sign
601111,MOVED TO 600941,Caret
601112,THIOREDOXIN REDUCTASE 1; TXNRD1,Asterisk
601113,HEAT-SHOCK 70-KD PROTEIN 4; HSPA4,Asterisk
601114,"MEMBRANE PROTEIN, PALMITOYLATED 3; MPP3",Asterisk
601115,"GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3",Asterisk
601116,"GLUTAMATE RECEPTOR, METABOTROPIC, 8; GRM8",Asterisk
601117,THIMET OLIGOPEPTIDASE 1; THOP1,Asterisk
601118,CALCIUM-MODULATING CYCLOPHILIN LIGAND; CAMLG,Asterisk
601119,CASEINOLYTIC MITOCHONDRIAL MATRIX PEPTIDASE PROTEOLYTIC SUBUNIT; CLPP,Asterisk
601120,CADHERIN 5; CDH5,Asterisk
601121,PLACENTAL GROWTH FACTOR; PGF,Asterisk
601122,5-HYDROXYTRYPTAMINE RECEPTOR 2B; HTR2B,Asterisk
601123,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 1; ST8SIA1",Asterisk
601124,SEMAPHORIN 3F; SEMA3F,Asterisk
601125,HEXOKINASE 2; HK2,Asterisk
601126,TATA ELEMENT MODULATORY FACTOR 1; TMF1,Asterisk
601127,FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION,
601128,"H3 HISTONE, FAMILY 3A; H3F3A",Asterisk
601129,"CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 8; CYP2C8",Asterisk
601130,"CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9",Asterisk
601131,"CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 18; CYP2C18",Asterisk
601132,KINASE SUPPRESSOR OF RAS 1; KSR1,Asterisk
601133,"CYTOCHROME P450, SUBFAMILY IIG, POLYPEPTIDE 1; CYP2G1",Asterisk
601134,"OLIGOSACCHARYLTRANSFERASE COMPLEX, CATALYTIC SUBUNIT STT3A; STT3A",Asterisk
601135,GASTRULATION BRAIN HOMEOBOX 2; GBX2,Asterisk
601136,TRANSSUPPRESSOR OF EXPRESSION 2,
601137,MOVED TO 601138,Caret
601138,"GUANYLATE CYCLASE 2E, PSEUDOGENE; GUCY2EP",
601139,ZINC FINGER PROTEIN 175; ZNF175,Asterisk
601140,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14B; PPP1R14B",Asterisk
601141,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 1; KCNAB1",Asterisk
601142,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 2; KCNAB2",Asterisk
601143,DYNACTIN 1; DCTN1,Asterisk
601144,BRUGADA SYNDROME 1; BRGDA1,Number Sign
601145,CYSTATIN B; CSTB,Asterisk
601146,GROWTH/DIFFERENTIATION FACTOR 5; GDF5,Asterisk
601147,GROWTH/DIFFERENTIATION FACTOR 6; GDF6,Asterisk
601148,SPERM MITOCHONDRIA-ASSOCIATED CYSTEINE-RICH PROTEIN; SMCP,Asterisk
601149,"ISOCITRATE DEHYDROGENASE 3, ALPHA SUBUNIT; IDH3A",Asterisk
601150,DEAD/H BOX 11; DDX11,Asterisk
601151,DEAD/H BOX 12; DDX12,Asterisk
601152,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA; HMSN6A",Number Sign
601153,FRAGILE HISTIDINE TRIAD GENE; FHIT,Asterisk
601154,"CARDIOMYOPATHY, DILATED, 1E; CMD1E",Number Sign
601155,MINOR HISTOCOMPATIBILITY ANTIGEN HA-1; HMHA1,Asterisk
601156,"CHEMOKINE, CC MOTIF, LIGAND 11; CCL11",Asterisk
601157,"DEFENSIN, ALPHA, 4; DEFA4",Asterisk
601158,MITOGEN-ACTIVATED PROTEIN KINASE 8; MAPK8,Asterisk
601159,"CHEMOKINE, CC MOTIF, RECEPTOR 1; CCR1",Asterisk
601160,LISSENCEPHALY TYPE III AND BONE DYSPLASIA,
601161,TRISOMY 18-LIKE SYNDROME,
601162,"SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A",Number Sign
601163,"DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL",Percent
601164,MOVED TO 241080,Caret
601165,"CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION, AND LETHAL CONGENITAL HEART DISEASE",
601166,G PROTEIN-COUPLED RECEPTOR 15; GPR15,Asterisk
601167,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 1; P2RY1",Asterisk
601168,DIHYDROPYRIMIDINASE-LIKE 3; DPYSL3,Asterisk
601169,REMOVED FROM DATABASE,Caret
601170,"MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS",
601171,MOVED TO 173321,Caret
601172,CHONDROITIN SULFATE PROTEOGLYCAN 4; CSPG4,Asterisk
601173,MOVED TO 253600,Caret
601174,MOVED TO 123280,Caret
601175,ADP-RIBOSYLATION FACTOR-LIKE 2; ARL2,Asterisk
601176,"GLUTAMATE-CYSTEINE LIGASE, MODIFIER SUBUNIT; GCLM",Asterisk
601177,ADP-RIBOSYLATION FACTOR 4; ARF4,Asterisk
601178,CELL CYCLE-ASSOCIATED PROTEIN 1; CAPRIN1,Asterisk
601179,RAS-RELATED NUCLEAR PROTEIN; RAN,Asterisk
601180,RAN-BINDING PROTEIN 1; RANBP1,Asterisk
601181,RAN-BINDING PROTEIN 2; RANBP2,Asterisk
601182,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 2, S. CEREVISIAE, HOMOLOG OF; ORC2",Asterisk
601183,CYSTEINE-RICH INTESTINAL PROTEIN 2; CRIP2,Asterisk
601184,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 3; DNAJC3",Asterisk
601185,STANNIOCALCIN 1; STC1,Asterisk
601186,"MICROPHTHALMIA, SYNDROMIC 9; MCOPS9",Number Sign
601187,GURRIERI SYNDROME,
601188,SUPPRESSION OF TUMORIGENICITY 12; ST12,
601189,"POLYMERASE II, RNA, SUBUNIT L; POLR2L",Asterisk
601190,"PHOSPHODIESTERASE 6H, cGMP-SPECIFIC, CONE, GAMMA; PDE6H",Asterisk
601191,"ENHANCER OF RUDIMENTARY, DROSOPHILA, HOMOLOG OF; ERH",Asterisk
601192,"PHOSPHOLIPASE A2, GROUP V; PLA2G5",Asterisk
601193,CYSTEINE-RICH SECRETORY PROTEIN 1; CRISP1,Asterisk
601194,TOLL-LIKE RECEPTOR 1; TLR1,Asterisk
601195,IRON OVERLOAD IN AFRICA,
601196,PR DOMAIN-CONTAINING PROTEIN 2; PRDM2,Asterisk
601197,"TUBBY, MOUSE, HOMOLOG OF; TUB",Asterisk
601198,"HYPOCALCEMIA, AUTOSOMAL DOMINANT 1; HYPOC1",Number Sign
601199,CALCIUM-SENSING RECEPTOR; CASR,Asterisk
601200,PLEUROPULMONARY BLASTOMA; PPB,Number Sign
601201,METHYLATION MODIFIER FOR CLASS I HLA,Asterisk
601202,CATARACT 24; CTRCT24,Percent
601203,INTERLEUKIN 1 RECEPTOR-LIKE 1; IL1RL1,Asterisk
601204,PROSTAGLANDIN F2 RECEPTOR NEGATIVE REGULATOR; PTGFRN,Asterisk
601205,"SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 1; SIX1",Asterisk
601206,"POU DOMAIN, CLASS 2, ASSOCIATING FACTOR 1; POU2AF1",Asterisk
601207,"DIACYLGLYCEROL KINASE, THETA, 110-KD; DGKQ",Asterisk
601208,"DIABETES MELLITUS, INSULIN-DEPENDENT, 11; IDDM11",Percent
601209,POLY(rC)-BINDING PROTEIN 1; PCBP1,Asterisk
601210,POLY(rC)-BINDING PROTEIN 2; PCBP2,Asterisk
601211,ADHESION G PROTEIN-COUPLED RECEPTOR E5; ADGRE5,Asterisk
601212,"PROTEIN-TYROSINE KINASE 2, BETA; PTK2B",Asterisk
601213,RIBONUCLEASE 4 INHIBITOR; RNS4I,Asterisk
601214,NAXOS DISEASE; NXD,Number Sign
601215,ATR GENE; ATR,Asterisk
601216,DENTAL ANOMALIES AND SHORT STATURE; DASS,Number Sign
601217,ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPIC HYPOGONADISM,
601218,"ADENOSINE DEAMINASE, RNA-SPECIFIC, B1; ADARB1",Asterisk
601219,MOVED TO 182390,Caret
601220,OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH,
601221,TISSUE-SPECIFIC EXTINGUISHER 3,
601222,MOVED TO 185900,Caret
601223,"NEURONAL INTESTINAL DYSPLASIA, TYPE B",
601224,POTOCKI-SHAFFER SYNDROME,Number Sign
601225,DISHEVELLED 1-LIKE 1; DVL1L1,Asterisk
601226,MOVED TO 601227,Caret
601227,MOVED TO 157640,Caret
601228,"POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1",Number Sign
601229,MOVED TO 151430,Caret
601230,"DERMATITIS HERPETIFORMIS, FAMILIAL",
601231,MECHANISTIC TARGET OF RAPAMYCIN; MTOR,Asterisk
601232,"PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, GAMMA; PIK3CG",Asterisk
601233,"INHIBIN, BETA C; INHBC",Asterisk
601234,"NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE; NACA",Asterisk
601235,DEAD/H BOX 10; DDX10,Asterisk
601236,"DISABLED, DROSOPHILA, HOMOLOG OF, 2; DAB2",Asterisk
601237,RING FINGER PROTEIN 112; RNF112,Asterisk
601238,"CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY",Number Sign
601239,"DYSTROBREVIN, ALPHA; DTNA",Asterisk
601240,GUANIDINOACETATE METHYLTRANSFERASE; GAMT,Asterisk
601241,HISTONE DEACETYLASE 1; HDAC1,Asterisk
601242,"MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, ALPHA; MAP1LC3A",Asterisk
601243,"TOPOISOMERASE, DNA, III, ALPHA; TOP3A",Asterisk
601244,"GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-2; GUCY1A2",Asterisk
601245,"CHROMATIN ASSEMBLY FACTOR I, SUBUNIT B; CHAF1B",Asterisk
601246,"CHROMATIN ASSEMBLY FACTOR I, SUBUNIT A; CHAF1A",Asterisk
601247,"SON OF SEVENLESS, DROSOPHILA, HOMOLOG 2; SOS2",Asterisk
601248,BRIDGING INTEGRATOR 1; BIN1,Asterisk
601249,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 1; PRPSAP1,Asterisk
601250,PEPTIDE METHIONINE SULFOXIDE REDUCTASE; MSRA,Asterisk
601251,MOVED TO 601777,Caret
601252,FICOLIN 1; FCN1,Asterisk
601253,CAVEOLIN 3; CAV3,Asterisk
601254,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6; MAP2K6,Asterisk
601255,KINESIN FAMILY MEMBER 1A; KIF1A,Asterisk
601256,MOVED TO 106165,Caret
601257,DEAD/H BOX 1; DDX1,Asterisk
601258,"CYTOCHROME P450, SUBFAMILY IIJ, POLYPEPTIDE 2; CYP2J2",Asterisk
601259,AMELOBLASTIN ENAMEL MATRIX PROTEIN; AMBN,Asterisk
601260,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 1; ZKSCAN1,Asterisk
601261,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 21; ZSCAN21,Asterisk
601262,ZINC FINGER PROTEIN 16; ZNF16,Asterisk
601263,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2; MAP2K2,Asterisk
601264,MOVED TO 601271,Caret
601265,"NODAL, MOUSE, HOMOLOG OF; NODAL",Asterisk
601266,dUTP PYROPHOSPHATASE; DUT,Asterisk
601267,"CHEMOKINE, CC MOTIF, RECEPTOR 2; CCR2",Asterisk
601268,"CHEMOKINE, CC MOTIF, RECEPTOR 3; CCR3",Asterisk
601269,COMPLEMENT COMPONENT C1q-BINDING PROTEIN; C1QBP,Asterisk
601270,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 3; CYP4F3",Asterisk
601271,GUANYLATE CYCLASE ACTIVATOR 2B; GUCA2B,Asterisk
601272,SORTING NEXIN 1; SNX1,Asterisk
601273,"CLATHRIN, HEAVY POLYPEPTIDE-LIKE 1; CLTCL1",Asterisk
601274,PROSTAGLANDIN REDUCTASE 1; PTGR1,Asterisk
601275,GLYCOPROTEIN M6A; GPM6A,Asterisk
601276,ZINC FINGER PROTEIN 177; ZNF177,Asterisk
601277,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A",Number Sign
601278,FSHD REGION GENE 1; FRG1,Asterisk
601279,DIGEORGE SYNDROME CRITICAL REGION GENE 6; DGCR6,Asterisk
601280,"MAB21, C. ELEGANS, HOMOLOG-LIKE 1; MAB21L1",Asterisk
601281,SEMAPHORIN 3B; SEMA3B,Asterisk
601282,PLECTIN; PLEC,Asterisk
601283,"DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1",Number Sign
601284,"ACTIVIN A RECEPTOR, TYPE II-LIKE 1; ACVRL1",Asterisk
601285,PROTEASOME 26S SUBUNIT SEM1; SEM1,Asterisk
601286,MOVED TO 115700,Caret
601287,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6; LGMDR6",Number Sign
601288,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ZETA ISOFORM; YWHAZ",Asterisk
601289,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, BETA ISOFORM; YWHAB",Asterisk
601290,STRATIFIN; SFN,Asterisk
601291,URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 8; UGT8,Asterisk
601292,"SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 2; SULT1A2",Asterisk
601293,RAS HOMOLOG ENRICHED IN BRAIN; RHEB,Asterisk
601294,REMOVED FROM DATABASE,Caret
601295,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2; SLC10A2",Asterisk
601296,"MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE; MUSK",Asterisk
601297,SRY-BOX 15; SOX15,Asterisk
601298,MOVED TO 102576,Caret
601299,"BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IA; BMPR1A",Asterisk
601300,"ACTIVIN A RECEPTOR, TYPE IB; ACVR1B",Asterisk
601301,PEPTIDYL-PROLYL ISOMERASE-LIKE 1; PPIL1,Asterisk
601302,"PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, ALPHA; PPP3R1",Asterisk
601303,CYTOSKELETON-ASSOCIATED PROTEIN 1; CKAP1,Asterisk
601304,"SMALL NUCLEAR RIBONUCLEOPROTEIN (U4/U6.U5), SNU13 HOMOLOG; SNU13",Asterisk
601305,5-HYDROXYTRYPTAMINE RECEPTOR 5A; HTR5A,Asterisk
601306,HEMATOPOIETIC CELL-SPECIFIC LYN SUBSTRATE 1; HCLS1,Asterisk
601307,MOVED TO 600924,Caret
601308,MYELOID TUMOR SUPPRESSOR,Percent
601309,"PATCHED, DROSOPHILA, HOMOLOG OF, 1; PTCH1",Asterisk
601310,"CYTOCHROME P450, SUBFAMILY IVA, POLYPEPTIDE 11; CYP4A11",Asterisk
601311,STEROL O-ACYLTRANSFERASE 2; SOAT2,Asterisk
601312,MOVED TO 600408,Caret
601313,POLYCYSTIN 1; PKD1,Asterisk
601314,HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1; HINT1,Asterisk
601315,"EPITHELIAL BASOLATERAL CHLORIDE CONDUCTANCE REGULATOR, RABBIT, HOMOLOG OF",
601316,"DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10",Number Sign
601317,"DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11",Number Sign
601318,"DIABETES MELLITUS, INSULIN-DEPENDENT, 13; IDDM13",Percent
601319,ODONTOMICRONYCHIAL DYSPLASIA,
601320,MOVED TO 601984,Caret
601321,NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS,Number Sign
601322,"PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS",
601323,NUCLEOBINDIN 1; NUCB1,Asterisk
601324,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HNRNPD,Asterisk
601325,CONTACTIN 3; CNTN3,Asterisk
601326,CLAUDIN 11; CLDN11,Asterisk
601327,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, BETA SUBUNIT; SCN2B",Asterisk
601328,"SODIUM CHANNEL, NONVOLTAGE-GATED 1, DELTA SUBUNIT; SCNN1D",Asterisk
601329,LIM DOMAIN KINASE 1; LIMK1,Asterisk
601330,GUANYLATE CYCLASE 2C; GUCY2C,Asterisk
601331,"RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD",Number Sign
601332,MOHAWK HOMEOBOX; MKX,Asterisk
601333,"SUPPRESSOR OF TY 6, S. CEREVISIAE, HOMOLOG OF; SUPT6H",Asterisk
601334,KINESIN LIGHT CHAIN 3; KLC3,Asterisk
601335,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4; MAP2K4,Asterisk
601336,MANNOSYL-OLIGOSACCHARIDE GLYCOSIDASE; MOGS,Asterisk
601337,"REGULATORY FACTOR X, 3; RFX3",Asterisk
601338,"CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS",Number Sign
601339,MOVED TO 601112,Caret
601340,MELANOMA INHIBITORY ACTIVITY PROTEIN; MIA,Asterisk
601341,"ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL; AMVC",
601342,CHROMOSOME SEGREGATION 1-LIKE; CSE1L,Asterisk
601343,MOVED TO 276821,Caret
601344,"SPINAL DYSPLASIA, ANHALT TYPE",
601345,"ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE",
601346,MARTINEZ-FRIAS SYNDROME,Percent
601347,"MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE, AND PSYCHOMOTOR DELAY",
601348,"ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA",
601349,"MICROPHTHALMIA, SYNDROMIC 8; MCOPS8",Percent
601350,"SHORT STATURE SYNDROME, BRUSSELS TYPE",
601351,"GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION",
601352,"MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE",
601353,"BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION",Percent
601354,MOVED TO 300166,Caret
601355,"MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS, AND HYPOSEGMENTED LUNGS",
601356,"LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE",Percent
601357,"BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH",Percent
601358,NICOLAIDES-BARAITSER SYNDROME; NCBRS,Number Sign
601359,MOVED TO 163200,Caret
601360,"AMELIA, AUTOSOMAL RECESSIVE",
601361,GROWTH/DIFFERENTIATION FACTOR 10; GDF10,Asterisk
601362,DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME COMPLEX 2,Percent
601363,WILMS TUMOR 4; WT4,Percent
601364,CADHERIN 13; CDH13,Asterisk
601365,DISHEVELLED 1; DVL1,Asterisk
601366,"MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 2; SMAD2",Asterisk
601367,"STROKE, ISCHEMIC",Number Sign
601368,DISHEVELLED 3; DVL3,Asterisk
601369,"DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9",Number Sign
601370,"HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS",
601371,"CATARACT, AGE-RELATED NUCLEAR",
601372,"CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT",
601373,"CHEMOKINE, CC MOTIF, RECEPTOR 5; CCR5",Asterisk
601374,APROSENCEPHALY AND CEREBELLAR DYSGENESIS,
601375,"ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE",
601376,"CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY",
601377,MOVED TO 218340,Caret
601378,MOVED TO 272430,Caret
601379,HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME,
601380,EPHRIN A4; EFNA4,Asterisk
601381,EPHRIN A3; EFNA3,Asterisk
601382,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1",Number Sign
601383,AQUAPORIN 6; AQP6,Asterisk
601384,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS E; LY6E",Asterisk
601385,TUMOR SUPPRESSOR CANDIDATE 3; TUSC3,Asterisk
601386,"DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12",Number Sign
601387,TUMOR SUSCEPTIBILITY GENE 101; TSG101,Asterisk
601388,"DIABETES MELLITUS, INSULIN-DEPENDENT, 12; IDDM12",Number Sign
601389,"CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION",
601390,VAN MALDERGEM SYNDROME 1; VMLDS1,Number Sign
601391,"CHEMOKINE, CC MOTIF, LIGAND 13; CCL13",Asterisk
601392,"CHEMOKINE, CC MOTIF, LIGAND 14; CCL14",Asterisk
601393,"CHEMOKINE, CC MOTIF, LIGAND 15; CCL15",Asterisk
601394,"CHEMOKINE, CC MOTIF, LIGAND 16; CCL16",Asterisk
601395,"CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 1; CCL3L1",Asterisk
601396,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8B; WNT8B",Asterisk
601397,"T BRACHYURY, MOUSE, HOMOLOG OF; T",Asterisk
601398,VASCULAR ENDOTHELIAL GROWTH FACTOR B; VEGFB,Asterisk
601399,"PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM",Number Sign
601400,MOVED TO 275355,Caret
601401,MYELOID LEUKEMIA FACTOR 2; MLF2,Asterisk
601402,MYELOID LEUKEMIA FACTOR 1; MLF1,Asterisk
601403,DEDICATOR OF CYTOKINESIS 1; DOCK1,Asterisk
601404,G PROTEIN-COUPLED RECEPTOR 68; GPR68,Asterisk
601405,CHYMOTRYPSIN C; CTRC,Asterisk
601406,B-CELL CLL/LYMPHOMA 7A; BCL7A,Asterisk
601407,"DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2; NIDDM2",Percent
601408,LYSINE ACETYLTRANSFERASE 6A; KAT6A,Asterisk
601409,LYSINE ACETYLTRANSFERASE 5; KAT5,Asterisk
601410,"DIABETES MELLITUS, TRANSIENT NEONATAL, 1",Number Sign
601411,"SARCOGLYCAN, DELTA; SGCD",Asterisk
601412,"DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7",Percent
601413,"DEIODINASE, IODOTHYRONINE, TYPE II; DIO2",Asterisk
601414,RETINITIS PIGMENTOSA 18; RP18,Number Sign
601415,V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 2; MYBL2,Asterisk
601416,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 7; SLC39A7",Asterisk
601417,17-BETA-HYDROXYSTEROID DEHYDROGENASE VIII; HSD17B8,Asterisk
601418,RIBOSOME BINDING PROTEIN 1; RRBP1,Asterisk
601419,"MYOPATHY, MYOFIBRILLAR, 1; MFM1",Number Sign
601420,"MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE",
601421,LYSYL-tRNA SYNTHETASE; KARS,Asterisk
601422,LEUCINE ZIPPER PROTEIN 1; LUZP1,Asterisk
601423,THYMINE-DNA GLYCOSYLASE; TDG,Asterisk
601424,3-OXOACID CoA TRANSFERASE 1; OXCT1,Asterisk
601425,"TRANSCRIPTION ELONGATION FACTOR A, 1; TCEA1",Asterisk
601426,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 2; NR2C2",Asterisk
601427,"ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS",
601428,"RNA, U4ATAC SMALL NUCLEAR; RNU4ATAC",Asterisk
601429,"RNA, U6ATAC SMALL NUCLEAR; RNU6ATAC",Asterisk
601430,"UPF1, YEAST, HOMOLOG OF; UPF1",Asterisk
601431,TRANSFER RNA ALANINE 1; TRNAA1,Asterisk
601432,TRANSFER RNA ARGININE 3; TRNAR3,Asterisk
601433,MOVED TO 180621,Caret
601434,S-PHASE KINASE-ASSOCIATED PROTEIN 1; SKP1,Asterisk
601435,S-PHASE KINASE-ASSOCIATED PROTEIN 1 PSEUDOGENE 2; SKP1P2,Asterisk
601436,S-PHASE KINASE-ASSOCIATED PROTEIN 2; SKP2,Asterisk
601437,"Fc FRAGMENT OF IgG, RECEPTOR TRANSPORTER, ALPHA; FCGRT",Asterisk
601438,"RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE",
601439,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 9; ABCC9",Asterisk
601440,"DIACYLGLYCEROL KINASE, EPSILON, 64-KD; DGKE",Asterisk
601441,"DIACYLGLYCEROL KINASE, ZETA, 104-KD: DGKZ",Asterisk
601442,COFILIN 1; CFL1,Asterisk
601443,COFILIN 2; CFL2,Asterisk
601444,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 1; BLOC1S1",Asterisk
601445,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 9; NDUFB9",Asterisk
601446,MOVED TO 300707,Caret
601447,UBIQUITIN-SPECIFIC PROTEASE 5; USP5,Asterisk
601448,"NUCLEAR PROTEIN, ATAXIA-TELANGIECTASIA LOCUS; NPAT",Asterisk
601449,"DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION",
601450,"DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL DYSMORPHISM",
601451,MOVED TO 225400,Caret
601452,OCULOAURICULOFRONTONASAL SYNDROME; OAFNS,Percent
601453,TRICHODENTAL DYSPLASIA,
601454,"PSORIASIS 3, SUSCEPTIBILITY TO; PSORS3",Percent
601455,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D",Number Sign
601456,MULTIMERIN 1; MMRN1,Asterisk
601457,"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE",Number Sign
601458,INFLAMMATORY BOWEL DISEASE 2; IBD2,Percent
601459,PREPRONOCICEPTIN; PNOC,Asterisk
601460,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2A1; SLCO2A1",Asterisk
601461,"ATONAL, DROSOPHILA, HOMOLOG OF, 1; ATOH1",Asterisk
601462,"MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A",Number Sign
601463,HYALURONAN SYNTHASE 1; HAS1,Asterisk
601464,"AF4/FMR2 FAMILY, MEMBER 3; AFF3",Asterisk
601465,DEOXYGUANOSINE KINASE; DGUOK,Asterisk
601466,PATENT DUCTUS VENOSUS; PDV,
601467,"MITOTIC ARREST-DEFICIENT 2, S. CEREVISIAE, HOMOLOG-LIKE 1; MAD2L1",Asterisk
601468,"METHIONINE ADENOSYLTRANSFERASE II, ALPHA; MAT2A",Asterisk
601469,PARATHYROID HORMONE 2 RECEPTOR; PTH2R,Asterisk
601470,"CHEMOKINE, CX3C MOTIF, RECEPTOR 1; CX3CR1",Asterisk
601471,"FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1",Percent
601472,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D",Number Sign
601473,ZINC FINGER PROTEIN 75A; ZNF75A,Asterisk
601474,MOVED TO 314997,Caret
601475,"PERIODIC TRYPTOPHAN PROTEIN 2, YEAST, HOMOLOG OF; PWP2",Asterisk
601476,"LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 5; LAPTM5",Asterisk
601477,RIBBING DISEASE,
601478,MYOSIN IA; MYO1A,Asterisk
601479,MYOSIN IE; MYO1E,Asterisk
601480,MYOSIN IF; MYO1F,Asterisk
601481,MYOSIN X; MYO10,Asterisk
601482,"DOWNREGULATOR OF TRANSCRIPTION 1, TBP-BINDING; DR1",Asterisk
601483,PATERNALLY EXPRESSED GENE 3; PEG3,Asterisk
601484,SELENOPROTEIN P; SELENOP,Asterisk
601485,SYNTAXIN 1B; STX1B,Asterisk
601486,DELETED IN AZOOSPERMIA-LIKE; DAZL,Asterisk
601487,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG,Asterisk
601488,NEUTROPHIL CYTOSOLIC FACTOR 4; NCF4,Asterisk
601489,"INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT; IGFALS",Asterisk
601490,"NUCLEAR FACTOR ERYTHROID 2, p45 SUBUNIT; NFE2",Asterisk
601491,IMPRINTED IN PRADER-WILLI SYNDROME; IPW,Asterisk
601492,"MUCOPOLYSACCHARIDOSIS, TYPE IX; MPS9",Number Sign
601493,"CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C",Number Sign
601494,"CARDIOMYOPATHY, DILATED, 1D; CMD1D",Number Sign
601495,"AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1",Number Sign
601496,GDNF FAMILY RECEPTOR ALPHA-1; GFRA1,Asterisk
601497,BCL2-ASSOCIATED ATHANOGENE 1; BAG1,Asterisk
601498,PEROXISOME BIOGENESIS FACTOR 6; PEX6,Asterisk
601499,"AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2",Percent
601500,"SMOOTHENED, DROSOPHILA, HOMOLOG OF; SMOH",Asterisk
601501,"VACUOLAR PROTEIN SORTING 35, YEAST, HOMOLOG OF; VPS35",Asterisk
601502,"Fc FRAGMENT OF IgG, HIGH AFFINITY Ib, RECEPTOR FOR; FCGR1B",Asterisk
601503,"Fc FRAGMENT OF IgG, HIGH AFFINITY Ic, RECEPTOR FOR; FCGR1C",Asterisk
601504,SEC14-LIKE 1; SEC14L1,Asterisk
601505,ZINC FINGER PROTEIN 146; ZNF146,Asterisk
601506,SEPTIN 2; SEPT2,Asterisk
601507,"ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-1 SUBUNIT; AP3S1",Asterisk
601508,MOVED TO 168601,Caret
601509,GAMMA-GLUTAMYL HYDROLASE; GGH,Asterisk
601510,SREBP CLEAVAGE-ACTIVATING PROTEIN; SCAP,Asterisk
601511,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5A; STAT5A,Asterisk
601512,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6; STAT6,Asterisk
601513,FIBROBLAST GROWTH FACTOR 12; FGF12,Asterisk
601514,FIBROBLAST GROWTH FACTOR 11; FGF11,Asterisk
601515,FIBROBLAST GROWTH FACTOR 14; FGF14,Asterisk
601516,SPLICING FACTOR 1; SF1,Asterisk
601517,ATAXIN 2; ATXN2,Asterisk
601518,"PROSTATE CANCER, HEREDITARY, 1; HPC1",Number Sign
601519,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT E; ATP5I",Asterisk
601520,"CHEMOKINE, CC MOTIF, LIGAND 17; CCL17",Asterisk
601521,ENDOTHELIAL CELL-SPECIFIC MOLECULE 1; ESM1,Asterisk
601522,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7; GRB7,Asterisk
601523,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 10; GRB10,Asterisk
601524,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 14; GRB14,Asterisk
601525,CHITINASE 3-LIKE 1; CHI3L1,Asterisk
601526,CHITINASE 3-LIKE 2; CHI3L2,Asterisk
601527,ARISTALESS-LIKE HOMEOBOX 1; ALX1,Asterisk
601528,VASCULAR ENDOTHELIAL GROWTH FACTOR C; VEGFC,Asterisk
601529,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1; NR2C1",Asterisk
601530,SEQUESTOSOME 1; SQSTM1,Asterisk
601531,LEUKOTRIENE B4 RECEPTOR; LTB4R,Asterisk
601532,"CASPASE 6, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP6",Asterisk
601533,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 2; ADAM2,Asterisk
601534,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 3; KCNJ3",Asterisk
601535,EPHRIN A5; EFNA5,Asterisk
601536,ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS,Number Sign
601537,"MICROCEPHALY, RETINITIS PIGMENTOSA, AND SUTURAL CATARACT",Percent
601538,PROP PAIRED-LIKE HOMEOBOX 1; PROP1,Asterisk
601539,PEROXISOME BIOGENESIS DISORDER 1B; PBD1B,Number Sign
601540,BROMODOMAIN-CONTAINING PROTEIN 2; BRD2,Asterisk
601541,BROMODOMAIN-CONTAINING PROTEIN 3; BRD3,Asterisk
601542,PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 2; PITX2,Asterisk
601543,"DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12",Number Sign
601544,"DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A",Number Sign
601545,"PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT; PAFAH1B1",Asterisk
601546,PROSPERO-RELATED HOMEOBOX 1; PROX1,Asterisk
601547,"CATARACT 3, MULTIPLE TYPES; CTRCT3",Number Sign
601548,EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 1; EFEMP1,Asterisk
601549,"ALACRIMA, CONGENITAL, AUTOSOMAL RECESSIVE",Percent
601550,BLOOD GROUP--SWANN SYSTEM; SW,Number Sign
601551,BLOOD GROUP--FROESE,Number Sign
601552,"FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB",Number Sign
601553,"HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD",Number Sign
601554,"DYNEIN, LIGHT CHAIN, TCTEX TYPE, 1; DYNLT1",Asterisk
601555,RHO FAMILY GTPase 2; RND2,Asterisk
601556,ATAXIN 1; ATXN1,Asterisk
601557,ACETYL-CoA CARBOXYLASE-BETA; ACACB,Asterisk
601558,RNA-BINDING PROTEIN GENE WITH MULTIPLE SPLICING; RBPMS,Asterisk
601559,STUVE-WIEDEMANN SYNDROME,Number Sign
601560,MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE,
601561,DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA,
601562,"DYNEIN, LIGHT CHAIN, LC8 TYPE, 1; DYNLL1",Asterisk
601563,HORNS IN SHEEP,
601564,"PROTEASE, SERINE, 2; PRSS2",Asterisk
601565,INTERFERON REGULATORY FACTOR 8; IRF8,Asterisk
601566,INHIBITOR OF GROWTH 1; ING1,Asterisk
601567,"LECTIN, MANNOSE-BINDING, 1; LMAN1",Asterisk
601568,ADDUCIN 3; ADD3,Asterisk
601569,UBIQUITIN-CONJUGATING ENZYME E2G 1; UBE2G1,Asterisk
601570,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7A; WNT7A",Asterisk
601571,"CAPPING PROTEIN, ALPHA-2; CAPZA2",Asterisk
601572,"CAPPING PROTEIN, BETA; CAPZB",Asterisk
601573,"ENHANCER OF ZESTE, DROSOPHILA, HOMOLOG 2; EZH2",Asterisk
601574,"TAF15 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 68-KD; TAF15",Asterisk
601575,FOS-LIKE ANTIGEN 2; FOSL2,Asterisk
601576,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, SIGMA; PTPRS",Asterisk
601577,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C POLYPEPTIDE-ASSOCIATED PROTEIN; PTPRCAP",Asterisk
601578,CYCLIN G1; CCNG1,Asterisk
601579,ORNITHINE DECARBOXYLASE ANTIZYME 1; OAZ1,Asterisk
601580,"CAPPING PROTEIN, ALPHA-1; CAPZA1",Asterisk
601581,NEURONAL CELL ADHESION MOLECULE; NRCAM,Asterisk
601582,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 145-KD; INPP5D",Asterisk
601583,WILMS TUMOR 5; WT5,Number Sign
601584,"PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 2; PTP4A2",Asterisk
601585,"PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 1; PTP4A1",Asterisk
601586,"PROSTAGLANDIN E RECEPTOR 4, EP4 SUBTYPE; PTGER4",Asterisk
601587,MOVED TO 300939,Caret
601588,MOVED TO 152445,Caret
601589,RAS p21 PROTEIN ACTIVATOR 2; RASA2,Asterisk
601590,ENVOPLAKIN; EVPL,Asterisk
601591,"PROTEIN KINASE, cGMP-DEPENDENT, TYPE II; PRKG2",Asterisk
601592,"RECEPTOR-ASSOCIATED PROTEIN OF THE SYNAPSE, 43-KD; RAPSN",Asterisk
601593,BRCA1-ASSOCIATED RING DOMAIN 1; BARD1,Asterisk
601594,"JUMONJI, AT-RICH INTERACTIVE DOMAIN 2; JARID2",Asterisk
601595,"MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 1; SMAD1",Asterisk
601596,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C",Number Sign
601597,B-CELL TRANSLOCATION GENE 2; BTG2,Asterisk
601598,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, DELTA; PTPRD",Asterisk
601599,SARCOSPAN; SSPN,Asterisk
601600,ETS VARIANT GENE 5; ETV5,Asterisk
601601,TRANSCRIPTION FACTOR AP2-BETA; TFAP2B,Asterisk
601602,TRANSCRIPTION FACTOR AP2-GAMMA; TFAP2C,Asterisk
601603,LYMPHOCYTE CYTOSOLIC PROTEIN 2; LCP2,Asterisk
601604,"INTERLEUKIN 12 RECEPTOR, BETA-1; IL12RB1",Asterisk
601605,MOVED TO 601448,Caret
601606,"TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1",Number Sign
601607,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY B, MEMBER 1; SMARCB1",Asterisk
601608,SPASTIC PARAPLEGIA AND EVANS SYNDROME,
601609,3-HYDROXYACYL-CoA DEHYDROGENASE; HADH,Asterisk
601610,"BUTYROPHILIN, SUBFAMILY 1, MEMBER A1; BTN1A1",Asterisk
601611,"SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 2; SLC14A2",Asterisk
601612,"LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME; LACHT",Percent
601613,"CHEMOKINE, CXC MOTIF, RECEPTOR 5; CXCR5",Asterisk
601614,NETRIN 1; NTN1,Asterisk
601615,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 3; ABCA3",Asterisk
601616,IRIS PIGMENT EPITHELIUM ANOMALIES,Percent
601617,RETINOL DEHYDROGENASE 5; RDH5,Asterisk
601618,SRY-BOX 18; SOX18,Asterisk
601619,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR; RALGDS,Asterisk
601620,T-BOX 5; TBX5,Asterisk
601621,T-BOX 3; TBX3,Asterisk
601622,"TWIST, DROSOPHILA, HOMOLOG OF, 1; TWIST1",Asterisk
601623,UBIQUITIN-PROTEIN LIGASE E3A; UBE3A,Asterisk
601624,FICOLIN 2; FCN2,Asterisk
601625,ADP-RIBOSYLTRANSFERASE 1; ART1,Asterisk
601626,"LEUKEMIA, ACUTE MYELOID; AML",Number Sign
601627,SURVIVAL OF MOTOR NEURON 2; SMN2,Asterisk
601628,MOVED TO 111730,Caret
601629,PURKINJE CELL PROTEIN 4; PCP4,Asterisk
601630,MOVED TO 600274,Caret
601631,ANTERIOR SEGMENT DYSGENESIS 3; ASGD3,Number Sign
601632,"POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 1; POU4F1",Asterisk
601633,N-ETHYLMALEIMIDE-SENSITIVE FACTOR; NSF,Asterisk
601634,"NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS",Number Sign
601635,MOVED TO 608317,Caret
601636,HYALURONAN SYNTHASE 2; HAS2,Asterisk
601637,"CYTOCHROME P450, FAMILY 51, SUBFAMILY A, POLYPEPTIDE 1; CYP51A1",Asterisk
601638,ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 2; ARFIP2,Asterisk
601639,"PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, ALPHA; PRKACA",Asterisk
601640,MOVED TO 601314,Caret
601641,"ACYL-CoA OXIDASE 2, BRANCHED-CHAIN; ACOX2",Asterisk
601642,"INTERLEUKIN 12 RECEPTOR, BETA-2; IL12RB2",Asterisk
601643,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), ALPHA; PPP2R5A",Asterisk
601644,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), BETA; PPP2R5B",Asterisk
601645,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), GAMMA; PPP2R5C",Asterisk
601646,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), DELTA; PPP2R5D",Asterisk
601647,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), EPSILON; PPP2R5E",Asterisk
601648,"PROTEASOME 26S SUBUNIT, NON-ATPase, 4; PSMD4",Asterisk
601649,MOVED TO 101400,Caret
601650,PARAGANGLIOMAS 2; PGL2,Number Sign
601651,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 4; NAP1L4,Asterisk
601652,MYOCILIN; MYOC,Asterisk
601653,EYES ABSENT 1; EYA1,Asterisk
601654,EYES ABSENT 2; EYA2,Asterisk
601655,EYES ABSENT 3; EYA3,Asterisk
601656,GATA-BINDING PROTEIN 6; GATA6,Asterisk
601657,EPIPHYCAN; EPYC,Asterisk
601658,OTOCONIN 90; OC90,Asterisk
601659,GLUTAMINE AMIDOTRANSFERASE-LIKE CLASS 1 DOMAIN-CONTAINING PROTEIN 3A; GATD3A,Asterisk
601660,MOVED TO 601150,Caret
601661,UBIQUITIN-CONJUGATING ENZYME E2I; UBE2I,Asterisk
601662,ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALCAM,Asterisk
601663,ESTROGEN RECEPTOR 2; ESR2,Asterisk
601664,"SMALL NUCLEAR RIBONUCLEOPROTEIN, 200-KD; SNRNP200",Asterisk
601665,OBESITY,Number Sign
601666,"DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15",Percent
601667,ANGIOPOIETIN 1; ANGPT1,Asterisk
601668,SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD,
601669,MOVED TO 602229,Caret
601670,"D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 1; DPF1",Asterisk
601671,"D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 2; DPF2",Asterisk
601672,"D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 3; DPF3",Asterisk
601673,"EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 2; ELAVL2",Asterisk
601674,"ENHANCER OF ZESTE, DROSOPHILA, HOMOLOG 1; EZH1",Asterisk
601675,"TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1",Number Sign
601676,ACUTE INSULIN RESPONSE,Percent
601677,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 5; NDUFA5",Asterisk
601678,"BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1",Number Sign
601679,GENERAL TRANSCRIPTION FACTOR II-I; GTF2I,Asterisk
601680,"ARTHROGRYPOSIS, DISTAL, TYPE 2B; DA2B",Number Sign
601681,"PROTEASOME 26S SUBUNIT, ATPase, 5; PSMC5",Asterisk
601682,"GLAUCOMA 1, PRIMARY OPEN ANGLE, C; GLC1C",Percent
601683,"COQ7, S. CEREVISIAE, HOMOLOG OF; COQ7",Asterisk
601684,"RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 1; RPS6KA1",Asterisk
601685,"RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 2; RPS6KA2",Asterisk
601686,TELOMERASE-ASSOCIATED PROTEIN 1; TEP1,Asterisk
601687,"KERATIN 12, TYPE I; KRT12",Asterisk
601688,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; HPGD,Asterisk
601689,"TAF4B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 105-KD; TAF4B",Asterisk
601690,"PHOSPHOLIPASE A2, GROUP VII; PLA2G7",Asterisk
601691,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 4; ABCA4",Asterisk
601692,"TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; TGFBI",Asterisk
601693,UNCOUPLING PROTEIN 2; UCP2,Asterisk
601694,"LEPTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; LEPQTL1",Percent
601695,"CASEIN, KAPPA; CSN3",Asterisk
601696,NOVELTY SEEKING PERSONALITY TRAIT,
601697,"SERPIN FAMILY B, MEMBER 8; SERPINB8",Asterisk
601698,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N, POLYPEPTIDE 2; PTPRN2",Asterisk
601699,PROSTAGLANDIN I2 SYNTHASE; PTGIS,Asterisk
601700,"SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE",Percent
601701,ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA,
601702,RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 1; ROCK1,Asterisk
601703,VASODILATOR-STIMULATED PHOSPHOPROTEIN; VASP,Asterisk
601704,"CHEMOKINE, CXC MOTIF, LIGAND 9; CXCL9",Asterisk
601705,"T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY",Number Sign
601706,YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME,
601707,CURRY-JONES SYNDROME; CRJS,Number Sign
601708,"SUPERIOR TRANSVERSE SCAPULAR LIGAMENT, CALCIFICATION OF, FAMILIAL",
601709,QUEBEC PLATELET DISORDER; QPD,Number Sign
601710,EUKARYOTIC TRANSLATION INITIATION FACTOR 5; EIF5,Asterisk
601711,TNF RECEPTOR-ASSOCIATED FACTOR 1; TRAF1,Asterisk
601712,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2; BIRC2,Asterisk
601713,"GLIA MATURATION FACTOR, BETA; GMFB",Asterisk
601714,TEA DOMAIN FAMILY MEMBER 4; TEAD4,Asterisk
601715,MOVED TO 601582,Caret
601716,"STAUFEN, DROSOPHILA, HOMOLOG OF, 1; STAU1",Asterisk
601717,SYNTAXIN-BINDING PROTEIN 2; STXBP2,Asterisk
601718,RETINITIS PIGMENTOSA 19; RP19,Number Sign
601719,T-BOX 4; TBX4,Asterisk
601720,"ANTIGENIC DETERMINANT OF RECOMBINATION PROTEIN A, MOUSE, HOMOLOG OF; KIN",Asterisk
601721,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 3; BIRC3,Asterisk
601722,MOVED TO 601712,Caret
601723,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 5; FZD5",Asterisk
601724,NEUROGENIC DIFFERENTIATION 1; NEUROD1,Asterisk
601725,NEUROGENIC DIFFERENTIATION 2; NEUROD2,Asterisk
601726,NEUROGENIN 1; NEUROG1,Asterisk
601727,MOVED TO 601714,Caret
601728,PHOSPHATASE AND TENSIN HOMOLOG; PTEN,Asterisk
601729,TEA DOMAIN FAMILY MEMBER 2; TEAD2,Asterisk
601730,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS C PROTEIN; PIGC,Asterisk
601731,5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE/IMP CYCLOHYDROLASE; ATIC,Asterisk
601732,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 1; SMARCC1",Asterisk
601733,"GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 2; MGST2",Asterisk
601734,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 2; SMARCC2",Asterisk
601735,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 1; SMARCD1",Asterisk
601736,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 2; SMARCD2",Asterisk
601737,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 3; SMARCD3",Asterisk
601738,EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 1; EXTL1,Asterisk
601739,"MEIS1, MOUSE, HOMOLOG OF, 1; MEIS1",Asterisk
601740,"MEIS1, MOUSE, HOMOLOG OF, 2; MEIS2",Asterisk
601741,CULLIN 5; CUL5,Asterisk
601742,TRIPARTITE MOTIF-CONTAINING PROTEIN 28; TRIM28,Asterisk
601743,ONCOSTATIN M RECEPTOR; OSMR,Asterisk
601744,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1",Number Sign
601745,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 1; KCNK1",Asterisk
601746,HYPOXIA UP-REGULATED 1; HYOU1,Asterisk
601747,TRIPARTITE MOTIF-CONTAINING PROTEIN 23; TRIM23,Asterisk
601748,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 2; GTF2H2",Asterisk
601749,GLOMULIN; GLMN,Asterisk
601750,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 3; GTF2H3",Asterisk
601751,MELANIN-CONCENTRATING HORMONE RECEPTOR 1; MCHR1,Asterisk
601752,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; ENTPD1,Asterisk
601753,PEPTIDYL-PROLYL ISOMERASE D; PPID,Asterisk
601754,UBIQUITIN FUSION DEGRADATION 1-LIKE; UFD1L,Asterisk
601755,"ESS2 SPLICING FACTOR, XENOPUS, HOMOLOG OF; ESS2",Asterisk
601756,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3; GALNT3,Asterisk
601757,PEROXISOME BIOGENESIS FACTOR 7; PEX7,Asterisk
601758,PEROXISOME BIOGENESIS FACTOR 12; PEX12,Asterisk
601759,PREAXIAL HALLUCAL POLYDACTYLY,
601760,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 4; GTF2H4",Asterisk
601761,"CASPASE 7, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP7",Asterisk
601762,"CASPASE 10, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP10",Asterisk
601763,"CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8",Asterisk
601764,"SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1",Percent
601765,MOVED TO 601542,Caret
601766,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 9; FZD9",Asterisk
601767,HUNTINGTIN-INTERACTING PROTEIN 1; HIP1,Asterisk
601768,"SH3 DOMAIN, GRB2-LIKE, 1; SH3GL1",Asterisk
601769,VITAMIN D RECEPTOR; VDR,Asterisk
601770,NEUROPEPTIDE Y RECEPTOR Y6; NPY6R,Asterisk
601771,"CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1B1",Asterisk
601772,"H2A HISTONE FAMILY, MEMBER X; H2AFX",Asterisk
601773,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N; PTPRN",Asterisk
601774,"ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT5",Asterisk
601775,FOLATE LEVEL IN ERYTHROCYTES,
601776,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1",Number Sign
601777,CONE-ROD DYSTROPHY 6; CORD6,Number Sign
601778,"POLYMERASE, RNA, MITOCHONDRIAL; POLRMT",Asterisk
601779,MOVED TO 258450,Caret
601780,"CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6",Number Sign
601781,MOVED TO 194554,Caret
601782,TESTIS-SPECIFIC PROTEIN KINASE 1; TESK1,Asterisk
601783,MICROTUBULE-ASSOCIATED PROTEIN 6; MAP6,Asterisk
601784,"CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 1; ACCN1",Asterisk
601785,PHOSPHOMANNOMUTASE 2; PMM2,Asterisk
601786,PHOSPHOMANNOMUTASE 1; PMM1,Asterisk
601787,"TAF5 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 100-KD; TAF5",Asterisk
601788,MYOSTATIN; MSTN,Asterisk
601789,PEROXISOME BIOGENESIS FACTOR 13; PEX13,Asterisk
601790,PANCREATIC POLYPEPTIDE RECEPTOR 1; PPYR1,Asterisk
601791,PEROXISOME BIOGENESIS FACTOR 14; PEX14,Asterisk
601792,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2; PPP1R2",Asterisk
601793,MOVED TO 600724,Caret
601794,COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME,Percent
601795,MITOGEN-ACTIVATED PROTEIN KINASE 3; MAPK3,Asterisk
601796,"TAF4 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 135-KD; TAF4",Asterisk
601797,ABSENT IN MELANOMA 1; AIM1,Asterisk
601798,GLUCOSAMINE-6-PHOSPHATE DEAMINASE 1; GNPDA1,Asterisk
601799,"PROTEASE INHIBITOR 9, OVALBUMIN TYPE; PI9",Asterisk
601800,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3",Number Sign
601801,TRANSCRIPTION FACTOR Sp2; SP2,Asterisk
601802,HOMEOBOX GENE EXPRESSED IN ES CELLS; HESX1,Asterisk
601803,PALLISTER-KILLIAN SYNDROME; PKS,Number Sign
601804,TRANSCRIPTION FACTOR Sp3; SP3,Asterisk
601805,G PROTEIN-COUPLED ESTROGEN RECEPTOR; GPER,Asterisk
601806,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6; MCM6,Asterisk
601807,MATRIX METALLOPROTEINASE 19; MMP19,Asterisk
601808,CHROMOSOME 18q DELETION SYNDROME,Number Sign
601809,SPONDYLOSPINAL THORACIC DYSOSTOSIS,
601810,"DNA REPLICATION HELICASE 2, YEAST, HOMOLOG OF; DNA2",Asterisk
601811,"PREMATURE AGING SYNDROME, OKAMOTO TYPE",
601812,"PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT",Number Sign
601813,EXUDATIVE VITREORETINOPATHY 4; EVR4,Number Sign
601814,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2; FXYD2,Asterisk
601815,PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD,Number Sign
601816,"BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1",Number Sign
601817,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 3; NME3,Asterisk
601818,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 4; NME4,Asterisk
601819,BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR; BPTF,Asterisk
601820,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2",Number Sign
601821,"RNA, Y1 SMALL CYTOPLASMIC; RNY1",Asterisk
601822,"RNA, Y3 SMALL CYTOPLASMIC; RNY3",Asterisk
601823,"RNA, Y4 SMALL CYTOPLASMIC; RNY4",Asterisk
601824,"RNA, Y5 SMALL CYTOPLASMIC; RNY5",Asterisk
601825,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 7; NDUFS7,Asterisk
601826,"DIACYLGLYCEROL KINASE, DELTA, 130-KD; DGKD",Asterisk
601827,MOVED TO 601659,Caret
601828,"NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2",Asterisk
601829,"ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE",
601830,MOVED TO 601770,Caret
601831,"HISTONE GENE CLUSTER 2, H2B HISTONE FAMILY, MEMBER E; HIST2H2BE",Asterisk
601832,RIBOSOMAL PROTEIN L29; RPL29,Asterisk
601833,ALLOGRAFT INFLAMMATORY FACTOR 1; AIF1,Asterisk
601834,"CHEMOKINE, CC MOTIF, RECEPTOR 8; CCR8",Asterisk
601835,"CHEMOKINE, CC MOTIF, RECEPTOR 6; CCR6",Asterisk
601836,KINESIN-ASSOCIATED PROTEIN 3; KIFAP3,Asterisk
601837,"LIGASE IV, DNA, ATP-DEPENDENT; LIG4",Asterisk
601838,"INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE; ITPK1",Asterisk
601839,EPHRIN RECEPTOR EphB3; EPHB3,Asterisk
601840,MOVED TO 600286,Caret
601841,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 5; SERPINA5",Asterisk
601842,MOVED TO 601543,Caret
601843,"SOLUTE CARRIER FAMILY 5 (SODIUM IODIDE SYMPORTER), MEMBER 5; SLC5A5",Asterisk
601844,"PROTEIN KINASE, LYSINE-DEFICIENT 4; WNK4",Asterisk
601845,GOOSECOID HOMEOBOX 2; GSC2,Asterisk
601846,VACUOLAR NEUROMYOPATHY,Percent
601847,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2",Number Sign
601848,"TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 20, S. CEREVISIAE, HOMOLOG OF; TOMM20",Asterisk
601849,MOVED TO 228930,Caret
601850,MOVED TO 500004,Caret
601851,CIRCADIAN LOCOMOTOR OUTPUT CYCLES KAPUT; CLOCK,Asterisk
601852,INTERCELLULAR ADHESION MOLECULE 5; ICAM5,Asterisk
601853,GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS,Percent
601854,"DIACYLGLYCEROL KINASE, GAMMA, 90-KD; DGKG",Asterisk
601855,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARHGEF1,Asterisk
601856,ZINC FINGER PROTEIN 211; ZNF211,Asterisk
601857,MOVED TO 601056,Caret
601858,CALMEGIN; CLGN,Asterisk
601859,AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS,Number Sign
601860,17-BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4,Asterisk
601861,REGULATORY FACTOR X-ASSOCIATED PROTEIN; RFXAP,Asterisk
601862,MOVED TO 104160,Caret
601863,"REGULATORY FACTOR X, 5; RFX5",Asterisk
601864,MOVED TO 177060,Caret
601865,"PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 2; PLOD2",Asterisk
601866,SEMAPHORIN 4D; SEMA4D,Asterisk
601867,"ATPase, Na+/K+ TRANSPORTING, BETA-3 POLYPEPTIDE; ATP1B3",Asterisk
601868,"DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13",Number Sign
601869,"DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15",Number Sign
601870,METHIONINE AMINOPEPTIDASE 2; METAP2,Asterisk
601871,CYSTEINE- AND GLYCINE-RICH PROTEIN 2; CSRP2,Asterisk
601872,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 2; SLC7A2",Asterisk
601873,"BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 1; B4GALNT1",Asterisk
601874,"ELONGATION FACTOR, RNA POLYMERASE II, 2; ELL2",Asterisk
601875,MOVED TO 601630,Caret
601876,SPERM-SPECIFIC ANTIGEN 1; SSFA1,
601877,LEFT-RIGHT DETERMINATION FACTOR 2; LEFTY2,Asterisk
601878,KRUPPEL-LIKE FACTOR 10; KLF10,Asterisk
601879,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 9; LGALS9",Asterisk
601880,"CHEMOKINE, CX3C MOTIF, LIGAND 1; CX3CL1",Asterisk
601881,RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX GENE; RAX,Asterisk
601882,"DNA FRAGMENTATION FACTOR, 45-KD, ALPHA SUBUNIT; DFFA",Asterisk
601883,"DNA FRAGMENTATION FACTOR, 40-KD, BETA SUBUNIT; DFFB",Asterisk
601884,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1,Number Sign
601885,"CATARACT 14, MULTIPLE TYPES; CTRCT14",Number Sign
601886,"ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 2; ASCL2",Asterisk
601887,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5",Number Sign
601888,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6",Percent
601889,NEUROBEACHIN PSEUDOGENE 1; NBEAP1,Asterisk
601890,PROTEIN-TYROSINE KINASE PTK7; PTK7,Asterisk
601891,CYSTATIN 6; CST6,Asterisk
601892,KARYOPHERIN ALPHA-3; KPNA3,Asterisk
601893,TRIPLE FUNCTIONAL DOMAIN; TRIO,Asterisk
601894,GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2,Number Sign
601895,TNF RECEPTOR-ASSOCIATED FACTOR 2; TRAF2,Asterisk
601896,TNF RECEPTOR-ASSOCIATED FACTOR 3; TRAF3,Asterisk
601897,ZINC FINGER PROTEIN 148; ZNF148,Asterisk
601898,GROWTH HORMONE SECRETAGOGUE RECEPTOR; GHSR,Asterisk
601899,SIGNAL-TRANSDUCING ADAPTOR MOLECULE 1; STAM,Asterisk
601900,INTERFERON REGULATORY FACTOR 4; IRF4,Asterisk
601901,"SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A2; SLC8A2",Asterisk
601902,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; ORC1",Asterisk
601903,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B17; UGT2B17",Asterisk
601904,MOVED TO 300899,Caret
601905,"RAB GERANYLGERANYL TRANSFERASE, ALPHA SUBUNIT; RABGGTA",Asterisk
601906,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10B; WNT10B",Asterisk
601907,NEOGENIN; NEO1,Asterisk
601908,G PROTEIN-COUPLED RECEPTOR 20; GPR20,Asterisk
601909,G PROTEIN-COUPLED RECEPTOR 21; GPR21,Asterisk
601910,G PROTEIN-COUPLED RECEPTOR 22; GPR22,Asterisk
601911,DISTAL-LESS HOMEOBOX 4; DLX4,Asterisk
601912,SMALL UBIQUITIN-LIKE MODIFIER 1; SUMO1,Asterisk
601913,"arsA ARSENITE TRANSPORTER, ATP-BINDING, E. COLI, HOMOLOG OF, 1; ASNA1",Asterisk
601914,PROLINE-ARGININE-RICH END LEUCINE-RICH REPEAT PROTEIN; PRELP,Asterisk
601915,TISSUE INHIBITOR OF METALLOPROTEINASE 4; TIMP4,Asterisk
601916,ARGININE-RICH PROTEIN MUTATED IN EARLY STAGE TUMORS; ARMET,Asterisk
601917,"ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B2; ALDH3B2",Asterisk
601918,GROWTH/DIFFERENTIATION FACTOR 9; GDF9,Asterisk
601919,COAGULATION FACTOR II RECEPTOR-LIKE 2; F2RL2,Asterisk
601920,JAGGED 1; JAG1,Asterisk
601921,MOVED TO 156535,Caret
601922,ANGIOPOIETIN 2; ANGPT2,Asterisk
601923,MOVED TO 601124,Caret
601924,"COATOMER PROTEIN COMPLEX, SUBUNIT ALPHA; COPA",Asterisk
601925,RHO GDP-DISSOCIATION INHIBITOR ALPHA; ARHGDIA,Asterisk
601926,"THYROID HORMONE-RESPONSIVE SPOT14, RAT, HOMOLOG OF; THRSP",Asterisk
601927,"LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES",Percent
601928,"KERATIN 86, TYPE II; KRT86",Asterisk
601929,"ATPase, Ca(2+)-TRANSPORTING, UBIQUITOUS; ATP2A3",Asterisk
601930,BASONUCLIN 1; BNC1,Asterisk
601931,BCL2-LIKE 2; BCL2L2,Asterisk
601932,"MUCIN 8, TRACHEOBRONCHIAL; MUC8",Asterisk
601933,CRYPTOCHROME 1; CRY1,Asterisk
601934,G PROTEIN PATHWAY SUPPRESSOR 1; GPS1,Asterisk
601935,G PROTEIN PATHWAY SUPPRESSOR 2; GPS2,Asterisk
601936,"PRKC, APOPTOSIS, WT1, REGULATOR; PAWR",Asterisk
601937,NUCLEAR RECEPTOR COACTIVATOR 3; NCOA3,Asterisk
601938,MOVED TO 600523,Caret
601939,"PROTEIN KINASE, SERINE/ARGININE-SPECIFIC, 1; SRPK1",Asterisk
601940,"SPLICING FACTOR, SERINE/ARGININE-RICH, 4; SRSF4",Asterisk
601941,"DIABETES MELLITUS, INSULIN-DEPENDENT, 6; IDDM6",Percent
601942,"DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10",Number Sign
601943,"SPLICING FACTOR, SERINE/ARGININE-RICH, 9; SRSF9",Asterisk
601944,"SPLICING FACTOR, SERINE/ARGININE-RICH, 6; SRSF6",Asterisk
601945,"SPLICING FACTOR, SUPPRESSOR-OF-WHITE-APRICOT FAMILY; SFSWAP",Asterisk
601946,MOVED TO 601531,Caret
601947,SRY-BOX 12; SOX12,Asterisk
601948,MOVED TO 601784,Caret
601949,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-4 SUBUNIT; CACNB4",Asterisk
601950,"ZINC FINGER PROTEIN, MULTITYPE 1; ZFPM1",Asterisk
601951,CDC-LIKE KINASE 1; CLK1,Asterisk
601952,KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA; KLICK,Number Sign
601953,CYCLIN H; CCNH,Asterisk
601954,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7; LGMDR7",Number Sign
601955,CYCLIN-DEPENDENT KINASE 7; CDK7,Asterisk
601956,GDNF FAMILY RECEPTOR ALPHA-2; GFRA2,Asterisk
601957,ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME,
601958,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-3 SUBUNIT; CACNB3",Asterisk
601959,NEVER IN MITOSIS GENE A-RELATED KINASE 4; NEK4,Asterisk
601960,"CHEMOKINE, CC MOTIF, LIGAND 20; CCL20",Asterisk
601961,PROTEIN ARGININE METHYLTRANSFERASE 2; PRMT2,Asterisk
601962,TAP-BINDING PROTEIN; TAPBP,Asterisk
601963,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1; TTC1,Asterisk
601964,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 7; DNAJC7",Asterisk
601965,SPHINGOSINE-1-PHOSPHATE RECEPTOR 3; S1PR3,Asterisk
601966,"REGULATORY SOLUTE CARRIER PROTEIN, FAMILY 1, MEMBER 1; RSC1A1",Asterisk
601967,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7B; WNT7B",Asterisk
601968,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2B; WNT2B",Asterisk
601969,DELETED IN MALIGNANT BRAIN TUMORS 1; DMBT1,Asterisk
601970,VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 2; VIPR2,Asterisk
601971,MOVED TO 600825,Caret
601972,RAR-RELATED ORPHAN RECEPTOR B; RORB,Asterisk
601973,RETINOIC ACID RECEPTOR RESPONDER 2; RARRES2,Asterisk
601974,SPHINGOSINE-1-PHOSPHATE RECEPTOR 1; S1PR1,Asterisk
601975,PLAKOPHILIN 1; PKP1,Asterisk
601976,OTOFACIOOSSEOUS-GONADAL SYNDROME,
601977,THROMBOCYTHEMIA 2; THCYT2,Number Sign
601978,SIGMA NONOPIOID INTRACELLULAR RECEPTOR 1; SIGMAR1,Asterisk
601979,HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION,
601980,"LIPASE, GASTRIC; LIPF",Asterisk
601981,"RIBONUCLEASE, RNase A FAMILY, 6; RNASE6",Asterisk
601982,8-OXOGUANINE DNA GLYCOSYLASE; OGG1,Asterisk
601983,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1; MAP4K1,Asterisk
601984,NUCLEAR RECEPTOR COACTIVATOR 4; NCOA4,Asterisk
601985,COILED-COIL DOMAIN-CONTAINING PROTEIN 6; CCDC6,Asterisk
601986,MOVED TO 601698,Caret
601987,"CARNITINE PALMITOYLTRANSFERASE I, MUSCLE; CPT1B",Asterisk
601988,LIM DOMAIN KINASE 2; LIMK2,Asterisk
601989,S100 CALCIUM-BINDING PROTEIN A13; S100A13,Asterisk
601990,TUMOR PROTEIN p73; TP73,Asterisk
601991,NEUROONCOLOGIC VENTRAL ANTIGEN 2; NOVA2,Asterisk
601992,FRIEDREICH ATAXIA 2; FRDA2,Percent
601993,NUCLEAR RECEPTOR COACTIVATOR 2; NCOA2,Asterisk
601994,TRANSFER RNA ARGININE,Asterisk
601995,TENASCIN R; TNR,Asterisk
601996,MOVED TO 602026,Caret
601997,BH3-INTERACTING DOMAIN DEATH AGONIST; BID,Asterisk
601998,"ESTROGEN-RELATED RECEPTOR, ALPHA; ESRRA",Asterisk
601999,LIM HOMEOBOX GENE 1; LHX1,Asterisk
602000,"POLYMERASE I, RNA, SUBUNIT B; POLR1B",Asterisk
602001,NEUROPEPTIDE Y RECEPTOR Y5; NPY5R,Asterisk
602002,ZYXIN; ZYX,Asterisk
602003,LYMPHOID-RESTRICTED MEMBRANE PROTEIN; LRMP,Asterisk
602004,PROTEIN-TYROSINE KINASE 6; PTK6,Asterisk
602005,SORTILIN-RELATED RECEPTOR; SORL1,Asterisk
602006,MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2; MAPKAPK2,Asterisk
602007,V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG-LIKE; CRKL,Asterisk
602008,IMPORTIN 5; IPO5,Asterisk
602009,"CYTOCHROME c OXIDASE, SUBUNIT 6A2; COX6A2",Asterisk
602010,"SPLICING FACTOR, SERINE/ARGININE-RICH, 11; SRSF11",Asterisk
602011,SUPPRESSOR OF TUMORIGENICITY 11; ST11,Asterisk
602012,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; ENTPD2,Asterisk
602013,"POLYMERASE II, RNA, SUBUNIT G; POLR2G",Asterisk
602014,"HYPOMAGNESEMIA 1, INTESTINAL; HOMG1",Number Sign
602015,OUTER DENSE FIBER OF SPERM TAILS 2; ODF2,Asterisk
602016,KRUPPEL-LIKE FACTOR 2; KLF2,Asterisk
602017,"PROTEASOME SUBUNIT, BETA-TYPE, 1; PSMB1",Asterisk
602018,NEURTURIN; NRTN,Asterisk
602019,SQUALENE EPOXIDASE; SQLE,Asterisk
602020,"V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN G; MAFG",Asterisk
602021,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12A; PPP1R12A",Asterisk
602022,MAL-LIKE; MALL,Asterisk
602023,"CHLORIDE CHANNEL, KIDNEY, B; CLCNKB",Asterisk
602024,"CHLORIDE CHANNEL, KIDNEY, A; CLCNKA",Asterisk
602025,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9,Number Sign
602026,PHYTANOYL-CoA HYDROXYLASE; PHYH,Asterisk
602027,TELOMERIC REPEAT-BINDING FACTOR 2; TERF2,Asterisk
602028,MOVED TO 601900,Caret
602029,REMOVED FROM DATABASE,Caret
602030,FUCOSYLTRANSFERASE 7; FUT7,Asterisk
602031,"PROTEIN GERANYLGERANYLTRANSFERASE TYPE I, BETA SUBUNIT; PGGT1B",Asterisk
602032,"ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4",Number Sign
602033,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1; EML1,Asterisk
602034,CORTICOTROPIN-RELEASING HORMONE RECEPTOR 2; CRHR2,Asterisk
602035,"PROTEIN PHOSPHATASE 4, CATALYTIC SUBUNIT; PPP4C",Asterisk
602036,MOVED TO 133200,Caret
602037,"RAS HOMOLOG GENE FAMILY, MEMBER H; RHOH",Asterisk
602038,DUAL-SPECIFICITY PHOSPHATASE 8; DUSP8,Asterisk
602039,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT A; EIF3A",Asterisk
602040,"CELL ADHESION MOLECULE, NEURAL, 2; NCAM2",Asterisk
602041,NK3 HOMEOBOX 1; NKX3-1,Asterisk
602042,G PROTEIN-COUPLED RECEPTOR 18; GPR18,Asterisk
602043,G PROTEIN-COUPLED RECEPTOR 31; GPR31,Asterisk
602044,UNCOUPLING PROTEIN 3; UCP3,Asterisk
602045,RING FINGER PROTEIN 1; RING1,Asterisk
602046,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 3; PDIA3",Asterisk
602047,"PHOSPHODIESTERASE 3B, cGMP-INHIBITED; PDE3B",Asterisk
602048,RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1; RAC1,Asterisk
602049,RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 2; RAC2,Asterisk
602050,RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 3; RAC3,Asterisk
602051,"PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1-LIKE; PIN1L",Asterisk
602052,CYCLIN G-ASSOCIATED KINASE; GAK,Asterisk
602053,KRUPPEL-LIKE FACTOR 6; KLF6,Asterisk
602054,T-BOX 1; TBX1,Asterisk
602055,INSULIN-INDUCED GENE 1; INSIG1,Asterisk
602056,"DEFENSIN, BETA, 1; DEFB1",Asterisk
602057,MOVED TO 300256,Caret
602058,PROTEASE INHIBITOR 10; PI10,Asterisk
602059,IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT; ISLR,Asterisk
602060,"TRANSMEMBRANE PROTEASE, SERINE 2; TMPRSS2",Asterisk
602061,EPIREGULIN; EREG,Asterisk
602062,NERVE INJURY-INDUCED PROTEIN 1; NINJ1,Asterisk
602063,TRANSALDOLASE 1; TALDO1,Asterisk
602064,MYOINOSITOL MONOPHOSPHATASE 1; IMPA1,Asterisk
602065,"ADENOSINE DEAMINASE, RNA-SPECIFIC, B2; ADARB2",Asterisk
602066,"CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA",Number Sign
602067,MOVED TO 601419,Caret
602068,"LEISHMANIASIS, TEGUMENTARY, SUSCEPTIBILITY TO",
602069,NEUROPILIN 1; NRP1,Asterisk
602070,NEUROPILIN 2; NRP2,Asterisk
602071,"BROAD TERMINAL PHALANGES, FAMILIAL",Percent
602072,"CYTOCHROME c OXIDASE, SUBUNIT 6A1; COX6A1",Asterisk
602073,MOVED TO 601533,Caret
602074,DEATH-ASSOCIATED PROTEIN 3; DAP3,Asterisk
602075,SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 1; SATB1,Asterisk
602076,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 1; TRPV1",Asterisk
602077,MOVED TO 604292,Caret
602078,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2",Number Sign
602079,TRIMETHYLAMINURIA; TMAU,Number Sign
602080,"PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2",Number Sign
602081,SPEECH-LANGUAGE DISORDER 1; SPCH1,Number Sign
602082,"CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB",Number Sign
602083,"USHER SYNDROME, TYPE IF; USH1F",Number Sign
602084,MOVED TO 601728,Caret
602085,"POLYDACTYLY, POSTAXIAL, TYPE A2; PAPA2",Percent
602086,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3; ARVD3",Percent
602087,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4; ARVD4",Percent
602088,NEPHRONOPHTHISIS 2; NPHP2,Number Sign
602089,"HEMANGIOMA, CAPILLARY INFANTILE",Number Sign
602090,LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 3; LTBP3,Asterisk
602091,LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 2; LTBP2,Asterisk
602092,"DEAFNESS, AUTOSOMAL RECESSIVE 18A; DFNB18A",Number Sign
602093,CONE DYSTROPHY 3; COD3,Number Sign
602094,MOVED TO 151660,Caret
602095,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 4; SLC30A4",Asterisk
602096,ALZHEIMER DISEASE 5,Percent
602097,"USHER SYNDROME, TYPE IE; USH1E",Percent
602098,POLO-LIKE KINASE 1; PLK1,Asterisk
602099,"AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5",Number Sign
602100,PBX/KNOTTED 1 HOMEOBOX 1; PKNOX1,Asterisk
602101,CLAUDIN 5; CLDN5,Asterisk
602102,"SUPPRESSOR OF TY 5, S. CEREVISIAE, HOMOLOG OF; SUPT5H",Asterisk
602103,TRANSMEMBRANE PROTEIN 1; TMEM1,Asterisk
602104,SH3 DOMAIN-BINDING PROTEIN 2; SH3BP2,Asterisk
602105,"MutS, E. COLI, HOMOLOG OF, 4; MSH4",Asterisk
602106,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 15; KCNJ15",Asterisk
602107,"NEUROPATHY, HEREDITARY THERMOSENSITIVE",
602108,MATRILIN 2; MATN2,Asterisk
602109,MATRILIN 3; MATN3,Asterisk
602110,"SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 2; SLC29A2",Asterisk
602111,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE",Number Sign
602112,METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; MPPED1,Asterisk
602113,LYSINE-SPECIFIC METHYLTRANSFERASE 2D; KMT2D,Asterisk
602114,"NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVER DISEASE",
602115,FIBROBLAST GROWTH FACTOR 10; FGF10,Asterisk
602116,YEATS DOMAIN-CONTAINING PROTEIN 4; YEATS4,Asterisk
602117,NECDIN; NDN,Asterisk
602118,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1; CHD1,Asterisk
602119,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 2; CHD2,Asterisk
602120,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 3; CHD3,Asterisk
602121,"DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 1; DIAPH1",Asterisk
602122,"SIGNAL RECOGNITION PARTICLE, 72-KD; SRP72",Asterisk
602123,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-GAMMA; CAMK2G,Asterisk
602124,"DYSTONIA 7, TORSION; DYT7",Percent
602125,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX10; COX10,Asterisk
602126,"ZINC FINGER PROTEIN 161, MOUSE, HOMOLOG OF; ZFP161",Asterisk
602127,SMOOTHELIN; SMTN,Asterisk
602128,GROWTH ARREST-SPECIFIC 2-LIKE 1; GAS2L1,Asterisk
602129,MYOSIN IXB; MYO9B,Asterisk
602130,MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3; MAPKAPK3,Asterisk
602131,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 2; PHLDA2",Asterisk
602132,CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 5; CTAGE5,Asterisk
602133,PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE; PFAS,Asterisk
602134,"TREMOR, HEREDITARY ESSENTIAL, 2; ETM2",Percent
602135,"DYNEIN, AXONEMAL, LIGHT INTERMEDIATE POLYPEPTIDE 1; DNALI1",Asterisk
602136,PEROXISOME BIOGENESIS FACTOR 1; PEX1,Asterisk
602137,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 2; NDUFA2",Asterisk
602138,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 6; NDUFA6",Asterisk
602139,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 7; NDUFA7",Asterisk
602140,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 8; NDUFB8",Asterisk
602141,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 8; NDUFS8,Asterisk
602142,"PHOSPHOLIPASE C, DELTA-1; PLCD1",Asterisk
602143,TUMOR PROTEIN p53-BINDING PROTEIN 2; TP53BP2,Asterisk
602144,"BROMODOMAIN, TESTIS-SPECIFIC; BRDT",Asterisk
602145,"PROLIFERATION-ASSOCIATED 2G4, 38-KD; PA2G4",Asterisk
602146,LIM HOMEOBOX GENE 4; LHX4,Asterisk
602147,REMOVED FROM DATABASE,Caret
602148,SRY-BOX 1; SOX1,Asterisk
602149,PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PITX1,Asterisk
602150,"SNAIL, DROSOPHILA, HOMOLOG OF, 2; SNAI2",Asterisk
602151,DISHEVELLED 2; DVL2,Asterisk
602152,RHYNS SYNDROME,
602153,"KERATIN 81, TYPE II; KRT81",Asterisk
602154,NONCODING TRANSCRIPT IN T CELLS,Asterisk
602155,UBX DOMAIN PROTEIN 8; UBXN8,Asterisk
602156,MOVED TO 601134,Caret
602157,NEUROONCOLOGIC VENTRAL ANTIGEN 1; NOVA1,Asterisk
602158,"CHLORIDE CHANNEL, NUCLEOTIDE SENSITIVE, 1A; CLNS1A",Asterisk
602159,CORONIN 2A; CORO2A,Asterisk
602160,TRANSCRIPTION FACTOR DP2; TFDP2,Asterisk
602161,PROTEASOME ACTIVATOR SUBUNIT 2; PSME2,Asterisk
602162,SYNAPTONEMAL COMPLEX PROTEIN 1; SYCP1,Asterisk
602163,UBIQUITIN-CONJUGATING ENZYME E2E 2; UBE2E2,Asterisk
602164,5-HYDROXYTRYPTAMINE RECEPTOR 4; HTR4,Asterisk
602165,TRIPARTITE MOTIF-CONTAINING PROTEIN 27; TRIM27,Asterisk
602166,"ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-2 SUBUNIT; AP3B2",Asterisk
602167,"ESTROGEN-RELATED RECEPTOR, BETA; ESRRB",Asterisk
602168,VACCINIA-RELATED KINASE 1; VRK1,Asterisk
602169,VACCINIA-RELATED KINASE 2; VRK2,Asterisk
602170,MYELOID DIFFERENTIATION PRIMARY RESPONSE GENE 88; MYD88,Asterisk
602171,GLYCOPROTEIN A33; GPA33,Asterisk
602172,"CYTOCHROME P450, SUBFAMILY VIIIB, POLYPEPTIDE 1; CYP8B1",Asterisk
602173,"SEC62, S. CEREVISIAE, HOMOLOG OF; SEC62",Asterisk
602174,G PROTEIN-COUPLED RECEPTOR 25; GPR25,Asterisk
602175,"PROTEASOME SUBUNIT, BETA-TYPE, 2; PSMB2",Asterisk
602176,"PROTEASOME SUBUNIT, BETA-TYPE, 3; PSMB3",Asterisk
602177,"PROTEASOME SUBUNIT, BETA-TYPE, 4; PSMB4",Asterisk
602178,CHONDROADHERIN; CHAD,Asterisk
602179,HEAT-SHOCK 27-KD PROTEIN 2; HSPB2,Asterisk
602180,SIGNAL-INDUCED PROLIFERATION-ASSOCIATED GENE 1; SIPA1,Asterisk
602181,STAPHYLOCOCCAL NUCLEASE DOMAIN- AND TUDOR DOMAIN-CONTAINING PROTEIN 1; SND1,Asterisk
602182,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 3; ENPP3,Asterisk
602183,NK3 HOMEOBOX 2; NKX3-2,Asterisk
602184,NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 3; NDUFV3,Asterisk
602185,MOVED TO 600004,Caret
602186,"VGF, NERVE GROWTH FACTOR-INDUCIBLE; VGF",Asterisk
602187,ZINC FINGER PROTEIN 195; ZNF195,Asterisk
602188,EPHRIN RECEPTOR EphA4; EPHA4,Asterisk
602189,REGULATOR OF G PROTEIN SIGNALING 3; RGS3,Asterisk
602190,EPHRIN RECEPTOR EphA7; EPHA7,Asterisk
602191,E74-LIKE FACTOR 3; ELF3,Asterisk
602192,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 10; ADAM10,Asterisk
602193,"SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 1; SLC29A1",Asterisk
602194,HTRA SERINE PEPTIDASE 1; HTRA1,Asterisk
602195,HEAT-SHOCK 27-KD PROTEIN 1; HSPB1,Asterisk
602196,PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES,Percent
602197,CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3,
602198,CDK2-ASSOCIATED PROTEIN 1; CDK2AP1,Asterisk
602199,MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY,Percent
602200,VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY,Percent
602201,EXTRACELLULAR MATRIX PROTEIN 1; ECM1,Asterisk
602202,DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE-PROTEIN GLYCOSYLTRANSFERASE; DDOST,Asterisk
602203,SARCOLIPIN; SLN,Asterisk
602204,"BICAUDAL D, DROSOPHILA, HOMOLOG OF, 1; BICD1",Asterisk
602205,MOVED TO 601805,Caret
602206,RAS-ASSOCIATED PROTEIN RAB17; RAB17,Asterisk
602207,RAS-ASSOCIATED PROTEIN RAB18; RAB18,Asterisk
602208,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 10; KCNJ10",Asterisk
602209,RAS-RESPONSIVE ELEMENT BINDING PROTEIN 1; RREB1,Asterisk
602210,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT E; EIF3E",Asterisk
602211,"FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 17; FKHL17",Asterisk
602212,"SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 1; SIAH1",Asterisk
602213,"SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 2; SIAH2",Asterisk
602214,"CASEIN KINASE I, GAMMA-2; CSNK1G2",Asterisk
602215,"DEFENSIN, BETA, 4A; DEFB4A",Asterisk
602216,SERINE/THREONINE PROTEIN KINASE 11; STK11,Asterisk
602217,SYNDECAN-BINDING PROTEIN; SDCBP,Asterisk
602218,SAL-LIKE 1; SALL1,Asterisk
602219,SAL-LIKE 2; SALL2,Asterisk
602220,"RAS-LIKE, FAMILY 10, MEMBER A; RASL10A",Asterisk
602221,"ZINC FINGER, MYM-TYPE 2; ZMYM2",Asterisk
602222,MOVED TO 602022,Caret
602223,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 1; EIF4EBP1,Asterisk
602224,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 2; EIF4EBP2,Asterisk
602225,CONE-ROD HOMEOBOX-CONTAINING GENE; CRX,Asterisk
602226,CD180 MOLECULE; CD180,Asterisk
602227,"CHEMOKINE, CC MOTIF, LIGAND 19; CCL19",Asterisk
602228,TRANSCRIPTION FACTOR 7-LIKE 2; TCF7L2,Asterisk
602229,SRY-BOX 10; SOX10,Asterisk
602230,SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN; SH3BGR,Asterisk
602231,SMALL UBIQUITIN-LIKE MODIFIER 3; SUMO3,Asterisk
602232,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 3; KCNQ3",Asterisk
602233,APOPTOTIC PROTEASE ACTIVATING FACTOR 1; APAF1,Asterisk
602234,"CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP9",Asterisk
602235,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 2; KCNQ2",Asterisk
602236,MOVED TO 601880,Caret
602237,MOVED TO 601470,Caret
602238,EXOSOME COMPONENT 2; EXOSC2,Asterisk
602239,"CYTOCHROME P450, SUBFAMILY XXVIA, POLYPEPTIDE 1; CYP26A1",Asterisk
602240,ZINC FINGER PROTEIN 192; ZNF192,Asterisk
602241,MITOCHONDRIAL INTERMEDIATE PEPTIDASE; MIPEP,Asterisk
602242,"ADAPTOR-RELATED PROTEIN COMPLEX 2, SIGMA-1 SUBUNIT; AP2S1",Asterisk
602243,CD151 ANTIGEN; CD151,Asterisk
602244,DEOXYRIBONUCLEASE I-LIKE 3; DNASE1L3,Asterisk
602245,GTP-BINDING PROTEIN 1; GTPBP1,Asterisk
602246,ZINC FINGER PROTEIN 193; ZNF193,Asterisk
602247,"XANTHOMATOSIS, SUSCEPTIBILITY TO",Percent
602248,MALIGNANT ATROPHIC PAPULOSIS,Percent
602249,PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES,
602250,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 9; TNFRSF9",Asterisk
602251,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 10, YEAST, HOMOLOG OF; TIMM10",Asterisk
602252,"MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TIM12, YEAST, HOMOLOG OF",
602253,KRUPPEL-LIKE FACTOR 4; KLF4,Asterisk
602254,SRR1 DOMAIN-CONTAINING PROTEIN; SRRD,Asterisk
602255,SERINE/THREONINE PROTEIN KINASE 25; STK25,Asterisk
602256,"PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 2; PPEF2",Asterisk
602257,"SCAVENGER RECEPTOR CLASS B, MEMBER 2; SCARB2",Asterisk
602258,MOVED TO 601040,Caret
602259,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3; TTC3,Asterisk
602260,"PERIOD, DROSOPHILA, HOMOLOG OF; PER1",Asterisk
602261,MATRIX METALLOPROTEINASE 15; MMP15,Asterisk
602262,MATRIX METALLOPROTEINASE 16; MMP16,Asterisk
602263,MOVED TO 601807,Caret
602264,"SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN; SPOCK1",Asterisk
602265,"NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 9; NEDD9",Asterisk
602266,MOVED TO 300135,Caret
602267,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 8; ADAM8,Asterisk
602268,"AMINE OXIDASE, COPPER-CONTAINING, 2; AOC2",Asterisk
602269,ARMADILLO REPEAT GENE DELETED IN VCFS; ARVCF,Asterisk
602270,ANTIOXIDANT PROTEIN 1; ATOX1,Asterisk
602271,"SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX",Number Sign
602272,TRANSCRIPTION FACTOR 4; TCF4,Asterisk
602273,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 1; GALNT1,Asterisk
602274,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2; GALNT2,Asterisk
602275,GUANYLATE CYCLASE ACTIVATOR 1B; GUCA1B,Asterisk
602276,TRANSCRIPTIONAL ADAPTOR 2A; TADA2A,Asterisk
602277,ZINC FINGER PROTEIN 184; ZNF184,Asterisk
602278,"NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 4; NEDD4",Asterisk
602279,"POLYADENYLATE-BINDING PROTEIN, NUCLEAR, 1; PABPN1",Asterisk
602280,TUBBY-LIKE PROTEIN 1; TULP1,Asterisk
602281,MILK FAT GLOBULE-EGF FACTOR 8; MFGE8,Asterisk
602282,LYSOPHOSPHATIDIC ACID RECEPTOR 1; LPAR1,Asterisk
602283,"CHEMOKINE, CC MOTIF, LIGAND 8; CCL8",Asterisk
602284,BONE MORPHOGENETIC PROTEIN 8B; BMP8B,Asterisk
602285,MATRIX METALLOPROTEINASE 17; MMP17,Asterisk
602286,STEROL C5-DESATURASE-LIKE; SC5DL,Asterisk
602287,"ENDOPLASMIC RETICULUM PROTEIN, 29-KD; ERP29",Asterisk
602288,RHOTEKIN; RTKN,Asterisk
602289,DR1-ASSOCIATED PROTEIN 1; DRAP1,Asterisk
602290,TRIPARTITE MOTIF-CONTAINING PROTEIN 32; TRIM32,Asterisk
602291,FORKHEAD BOX J1; FOXJ1,Asterisk
602292,"ENOYL-CoA HYDRATASE, SHORT-CHAIN, 1, MITOCHONDRIAL; ECHS1",Asterisk
602293,CALCIUM- AND INTEGRIN-BINDING PROTEIN 1; CIB1,Asterisk
602294,FORKHEAD BOX A1; FOXA1,Asterisk
602295,FORKHEAD BOX A3; FOXA3,Asterisk
602296,"ADAPTOR-RELATED PROTEIN COMPLEX 4, MU-1 SUBUNIT; AP4M1",Asterisk
602297,EPHRIN B3; EFNB3,Asterisk
602298,RAS-ASSOCIATED PROTEIN RAB7; RAB7,Asterisk
602299,MOVED TO 300284,Caret
602300,GALACTOSE-3-O-SULFOTRANSFERASE 1; GAL3ST1,Asterisk
602301,LYSINE ACETYLTRANSFERASE 2A; KAT2A,Asterisk
602302,"HAIRLESS, MOUSE, HOMOLOG OF; HR",Asterisk
602303,LYSINE ACETYLTRANSFERASE 2B; KAT2B,Asterisk
602304,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 2; NR1D2",Asterisk
602305,MOVED TO 602162,Caret
602306,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 2; RGL2,Asterisk
602307,WW DOMAIN-CONTAINING PROTEIN 1; WWP1,Asterisk
602308,WW DOMAIN-CONTAINING PROTEIN 2; WWP2,Asterisk
602309,TUBBY-LIKE PROTEIN 2; TULP2,Asterisk
602310,"RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 1; RBMS1",Asterisk
602311,"AGOUTI-RELATED PROTEIN, MOUSE, HOMOLOG OF; AGRP",Asterisk
602312,MOVED TO 142711,Caret
602313,OVO-LIKE 1; OVOL1,Asterisk
602314,LADININ 1; LAD1,Asterisk
602315,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 3; MAP2K3,Asterisk
602316,PEROXIREDOXIN 6; PRDX6,Asterisk
602317,SH3 AND CYSTEINE-RICH DOMAINS 1; STAC1,Asterisk
602318,"TRANSCRIPTION TERMINATION FACTOR 1, MITOCHONDRIAL; MTERF1",Asterisk
602319,NEL-LIKE 1; NELL1,Asterisk
602320,NEL-LIKE 2; NELL2,Asterisk
602321,"GLUTATHIONE S-TRANSFERASE, KAPPA-1; GSTK1",Asterisk
602322,TELOMERASE RNA COMPONENT; TERC,Asterisk
602323,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 12; KCNJ12",Asterisk
602324,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H3; HNRNPH3,Asterisk
602325,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 2; EIF4G2",Asterisk
602326,RIBOSOMAL PROTEIN L23A; RPL23A,Asterisk
602327,PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN; PSD,Asterisk
602328,MOVED TO 300118,Caret
602329,SUPPRESSOR OF LIN12-LIKE; SEL1L,Asterisk
602330,"ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 1; ABLIM1",Asterisk
602331,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 5, S. CEREVISIAE, HOMOLOG OF; ORC5",Asterisk
602332,NON-SMC CONDENSIN I COMPLEX SUBUNIT H; NCAPH,Asterisk
602333,EPITHELIAL MEMBRANE PROTEIN 1; EMP1,Asterisk
602334,EPITHELIAL MEMBRANE PROTEIN 2; EMP2,Asterisk
602335,EPITHELIAL MEMBRANE PROTEIN 3; EMP3,Asterisk
602336,RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1; ROR1,Asterisk
602337,RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 2; ROR2,Asterisk
602338,"PRECURSOR mRNA-PROCESSING FACTOR 4, S. POMBE, HOMOLOG OF, B; PRPF4B",Asterisk
602339,"SOLUTE CARRIER FAMILY 15 (H+/PEPTIDE TRANSPORTER), MEMBER 2; SLC15A2",Asterisk
602340,"SENSORINEURAL HEARING LOSS, RETINAL PIGMENT EPITHELIUM LESIONS, DISCOLORED TEETH",
602341,FORKHEAD BOX M1; FOXM1,Asterisk
602342,PIERPONT SYNDROME; PRPTS,Number Sign
602343,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1; TRPC1",Asterisk
602344,PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 2; PAFAH2,Asterisk
602345,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 3; TRPC3",Asterisk
602346,CONTACTIN-ASSOCIATED PROTEIN 1; CNTNAP1,Asterisk
602347,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3",Number Sign
602348,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 3; SNAPC3",Asterisk
602349,NETRIN 3; NTN3,Asterisk
602350,NEUROGRANIN; NRGN,Asterisk
602351,CHEMOKINE-LIKE RECEPTOR 1; CMKLR1,Asterisk
602352,GONADOTROPIN-RELEASING HORMONE 2; GNRH2,Asterisk
602353,"TRANSFORMING GROWTH FACTOR, BETA-1-INDUCED 1; TGFB1I1",Asterisk
602354,LINKER FOR ACTIVATION OF T CELLS; LAT,Asterisk
602355,TNF RECEPTOR-ASSOCIATED FACTOR 6; TRAF6,Asterisk
602356,TNF RECEPTOR-ASSOCIATED FACTOR 5; TRAF5,Asterisk
602357,"WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 1; WIPF1",Asterisk
602358,HYPOCRETIN; HCRT,Asterisk
602359,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1; FXYD1,Asterisk
602360,L-ARGININE:GLYCINE AMIDINOTRANSFERASE; GATM,Asterisk
602361,GRACILE BONE DYSPLASIA; GCLEB,Number Sign
602362,"GTPase-ACTIVATING PROTEIN, RAN, 1; RANGAP1",Asterisk
602363,MOVED TO 225500,Caret
602364,CATHEPSIN W; CTSW,Asterisk
602365,CATHEPSIN C; CTSC,Asterisk
602366,INTEGRIN-LINKED KINASE; ILK,Asterisk
602367,"PENTRAXIN I, NEURONAL; NPTX1",Asterisk
602368,"GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 2; GRID2",Asterisk
602369,"CYSTEINE-RICH, ANGIOGENIC INDUCER, 61; CYR61",Asterisk
602370,GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED MOLECULE-LIKE PROTEIN; GML,Asterisk
602371,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3; ACSL3",Asterisk
602372,ZONADHESIN; ZAN,Asterisk
602373,CALPONIN 2; CNN2,Asterisk
602374,CALPONIN 3; CNN3,Asterisk
602375,MITOCHONDRIAL RIBOSOMAL PROTEIN L12; MRPL12,Asterisk
602376,"INTERFERON-ALPHA, -BETA, AND -OMEGA RECEPTOR 2; IFNAR2",Asterisk
602377,DYNAMIN 1; DNM1,Asterisk
602378,DYNAMIN 2; DNM2,Asterisk
602379,MOVED TO 300141,Caret
602380,UROPLAKIN 1B; UPK1B,Asterisk
602381,NGFIA-BINDING PROTEIN 2; NAB2,Asterisk
602382,"PHOSPHOLIPASE D1, PHOSPHATIDYLCHOLINE-SPECIFIC; PLD1",Asterisk
602383,OSTEOGLYCIN; OGN,Asterisk
602384,PHOSPHOLIPASE D2; PLD2,Asterisk
602385,"SULFOTRANSFERASE FAMILY 1C, MEMBER 2; SULT1C2",Asterisk
602386,ZINC FINGER PROTEIN 212; ZNF212,Asterisk
602387,"RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 2; RBMS2",Asterisk
602388,SYMPLEKIN; SYMPK,Asterisk
602389,"Tu TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TUFM",Asterisk
602390,"HEMOCHROMATOSIS, TYPE 2A; HFE2A",Number Sign
602391,PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PEMT,Asterisk
602392,HYPOCRETIN RECEPTOR 1; HCRTR1,Asterisk
602393,HYPOCRETIN RECEPTOR 2; HCRTR2,Asterisk
602394,NUCLEOLAR AND COILED-BODY PHOSPHOPROTEIN 1; NOLC1,Asterisk
602395,"GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE, MITOCHONDRIAL; GPAM",Asterisk
602396,ANNEXIN A8; ANXA8,Asterisk
602397,"ATPase, CLASS I, TYPE 8B, MEMBER 1; ATP8B1",Asterisk
602398,DESMOSTEROLOSIS,Number Sign
602399,MITOGEN-ACTIVATED PROTEIN KINASE 12; MAPK12,Asterisk
602400,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11",Number Sign
602401,"ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE; ECTD8",Percent
602402,FORKHEAD BOX C2; FOXC2,Asterisk
602403,BLEOMYCIN HYDROLASE; BLMH,Asterisk
602404,"PARKINSON DISEASE 3, AUTOSOMAL DOMINANT; PARK3",Percent
602405,MOVED TO 600910,Caret
602406,HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 1; HAND1,Asterisk
602407,HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 2; HAND2,Asterisk
602408,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; NR1D1",Asterisk
602409,"MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 10; MLLT10",Asterisk
602410,BROMODOMAIN- AND PHD FINGER-CONTAINING PROTEIN; BRPF1,Asterisk
602411,EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 2; EXTL2,Asterisk
602412,RIBOSOMAL PROTEIN S24; RPS24,Asterisk
602413,"SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT C, INTEGRAL MEMBRANE PROTEIN, 15-KD; SDHC",Asterisk
602414,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 1; APBA1",Asterisk
602415,"DYSTROBREVIN, BETA; DTNB",Asterisk
602416,"ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-2 SUBUNIT; AP3S2",Asterisk
602417,MOVED TO 602974,Caret
602418,WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME,
602419,EARLY GROWTH RESPONSE 3; EGR3,Asterisk
602420,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 10; KCNA10",Asterisk
602421,CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR,Asterisk
602422,STEM-LOOP BINDING PROTEIN; SLBP,Asterisk
602423,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 3; NR1H3",Asterisk
602424,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 1; DMRT1,Asterisk
602425,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4; MAP3K4,Asterisk
602426,NUCLEAR VALOSIN-CONTAINING PROTEIN-LIKE; NVL,Asterisk
602427,T-BOX 6; TBX6,Asterisk
602428,HYALURONAN SYNTHASE 3; HAS3,Asterisk
602429,"GLAUCOMA 1, OPEN ANGLE, D; GLC1D",Percent
602430,"ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 1; ROBO1",Asterisk
602431,"ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 2; ROBO2",Asterisk
602432,OPTINEURIN; OPTN,Asterisk
602433,"AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4",Number Sign
602434,ANCIENT UBIQUITOUS PROTEIN 1; AUP1,Asterisk
602435,PEPTIDYL-PROLYL ISOMERASE E; PPIE,Asterisk
602436,MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE B; MICB,Asterisk
602437,GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN; GCHFR,Asterisk
602438,HEAT-SHOCK TRANSCRIPTION FACTOR 4; HSF4,Asterisk
602439,MOVED TO 601626,Caret
602440,"AMYOTROPHY, MONOMELIC",Percent
602441,CYTOKINE-INDUCIBLE SH2-CONTAINING PROTEIN; CISH,Asterisk
602442,INTERSECTIN 1; ITSN1,Asterisk
602443,X-PROLYL AMINOPEPTIDASE 1; XPNPEP1,Asterisk
602444,TRANSCRIPTION FACTOR 17; TCF17,Asterisk
602445,"SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1",Asterisk
602446,GLYPICAN 5; GPC5,Asterisk
602447,PARAOXONASE 2; PON2,Asterisk
602448,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5; MAP3K5,Asterisk
602449,A-KINASE ANCHOR PROTEIN 1; AKAP1,Asterisk
602450,SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION,Number Sign
602451,"PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 6; P2RY6",Asterisk
602452,"BUDDING UNINHIBITED BY BENZIMIDAZOLES 1, S. CEREVISIAE, HOMOLOG OF; BUB1",Asterisk
602453,"INTEGRIN, ALPHA-D; ITGAD",Asterisk
602454,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, U; PTPRU",Asterisk
602455,MOVED TO 605271,Caret
602456,REMOVED FROM DATABASE,Caret
602457,FAS-ASSOCIATED VIA DEATH DOMAIN; FADD,Asterisk
602458,SORTILIN; SORT1,Asterisk
602459,"DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15",Number Sign
602460,"POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 3; POU4F3",Asterisk
602461,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, SUBSTRATE 1; PTPNS1",Asterisk
602462,COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; CRMP1,Asterisk
602463,DIHYDROPYRIMIDINASE-LIKE 2; DPYSL2,Asterisk
602464,TNF RECEPTOR-ASSOCIATED FACTOR 4; TRAF4,Asterisk
602465,"SPROUTY, DROSOPHILA, HOMOLOG OF, 1; SPRY1",Asterisk
602466,"SPROUTY, DROSOPHILA, HOMOLOG OF, 2; SPRY2",Asterisk
602467,MOVED TO 300531,Caret
602468,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9A; PPP1R9A",Asterisk
602469,FOLATE RECEPTOR 3; FOLR3,Asterisk
602470,PROSTATE STEM CELL ANTIGEN; PSCA,Asterisk
602471,"SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES; SAMS",Number Sign
602472,"CREASES, INFRA-AURICULAR CUTANEOUS, WITH TALL STATURE AND ADVANCED BONE AGE",
602473,"ENCEPHALOPATHY, ETHYLMALONIC; EE",Number Sign
602474,"PROTEIN KINASE, MEMBRANE-ASSOCIATED TYROSINE/THREONINE, 1; PKMYT1",Asterisk
602475,OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL,Percent
602476,MOVED TO 121210,Caret
602477,"FEBRILE SEIZURES, FAMILIAL, 2; FEB2",Percent
602478,tRNA ASPARTIC ACID METHYLTRANSFERASE 1; TRDMT1,Asterisk
602479,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 1; POU3F1",Asterisk
602480,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 3; POU3F3",Asterisk
602481,"MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2",Number Sign
602482,"AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3",Number Sign
602483,AURICULOCONDYLAR SYNDROME 1; ARCND1,Number Sign
602484,PELVIC HYPOPLASIA WITH LOWER-LIMB ARTHROGRYPOSIS,
602485,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3",Number Sign
602486,"PROCESSING OF PRECURSOR 1, S. CEREVISIAE, HOMOLOG OF; POP1",Asterisk
602487,HEAT-RESPONSIVE PROTEIN 12; HRSP12,Asterisk
602488,CYTOHESIN 2; CYTH2,Asterisk
602489,"KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 1; KHDRBS1",Asterisk
602490,NUCLEAR RECEPTOR-INTERACTING PROTEIN 1; NRIP1,Asterisk
602491,"HYPERLIPIDEMIA, COMBINED, 1",Number Sign
602492,"PENTRAXIN 3, LONG; PTX3",Asterisk
602493,UV RADIATION RESISTANCE-ASSOCIATED GENE; UVRAG,Asterisk
602494,"CHEMOKINE, CC MOTIF, LIGAND 23; CCL23",Asterisk
602495,"CHEMOKINE, CC MOTIF, LIGAND 24; CCL24",Asterisk
602496,MERCAPTOPYRUVATE SULFURTRANSFERASE; MPST,Asterisk
602497,"CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC, AUTOSOMAL",
602498,TRK-FUSED GENE; TFG,Asterisk
602499,"MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM",Number Sign
602500,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY B, 1; GOLGB1",Asterisk
602501,MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP,Number Sign
602502,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 1; GOLGA1",Asterisk
602503,FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS; FRAT1,Asterisk
602504,SHORT STATURE HOMEOBOX 2; SHOX2,Asterisk
602505,PAXILLIN; PXN,Asterisk
602506,MOVED TO 143055,Caret
602507,"ZINC FINGER PROTEIN 103, MOUSE, HOMOLOG OF; ZFP103",Asterisk
602508,"PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, BETA SUBUNIT; PAFAH1B2",Asterisk
602509,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 4; GOLGA4",Asterisk
602510,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, H; PTPRH",Asterisk
602511,PSEUDOACROMEGALY WITH SEVERE INSULIN RESISTANCE,
602512,REGULATOR OF G PROTEIN SIGNALING 12; RGS12,Asterisk
602513,REGULATOR OF G PROTEIN SIGNALING 14; RGS14,Asterisk
602514,REGULATOR OF G PROTEIN SIGNALING 16; RGS16,Asterisk
602515,"PHOSPHOLIPASE D1, GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC; GPLD1",Asterisk
602516,REGULATOR OF G PROTEIN SIGNALING 4; RGS4,Asterisk
602517,REGULATOR OF G PROTEIN SIGNALING 7; RGS7,Asterisk
602518,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 4; LGALS4",Asterisk
602519,UBIQUITIN-SPECIFIC PROTEASE 7; USP7,Asterisk
602520,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5; MAP2K5,Asterisk
602521,MITOGEN-ACTIVATED PROTEIN KINASE 7; MAPK7,Asterisk
602522,"BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4A",Number Sign
602523,DOWN SYNDROME CELL ADHESION MOLECULE; DSCAM,Asterisk
602524,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 1; PDK1",Asterisk
602525,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 2; PDK2",Asterisk
602526,MOVED TO 300906,Caret
602527,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 4; PDK4",Asterisk
602528,"TUBULIN, ALPHA-3C; TUBA3C",Asterisk
602529,"TUBULIN, ALPHA-1A; TUBA1A",Asterisk
602530,"TUBULIN, ALPHA-1B; TUBA1B",Asterisk
602531,GRANGE SYNDROME; GRNG,Number Sign
602532,SIX-TWELVE LEUKEMIA GENE,Asterisk
602533,ONCOGENE DJ1; DJ1,Asterisk
602534,"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 23-KD; SNAP23",Asterisk
602535,MARSHALL-SMITH SYNDROME; MRSHSS,Number Sign
602536,"RAB3 GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT; RAB3GAP1",Asterisk
602537,CALPAIN 5; CAPN5,Asterisk
602538,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 2; CELF2",Asterisk
602539,MITOGEN-ACTIVATED KINASE KINASE KINASE 3; MAP3K3,Asterisk
602540,"ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS",Number Sign
602541,"MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC",Number Sign
602542,BASIC TRANSCRIPTION FACTOR 3; BTF3,Asterisk
602543,BASIC TRANSCRIPTION FACTOR 3-LIKE 1; BTF3L1,Asterisk
602544,PARKIN; PARK2,Asterisk
602545,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, KAPPA; PTPRK",Asterisk
602546,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 2; ST8SIA2",Asterisk
602547,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 4; ST8SIA4",Asterisk
602548,OPIOID RECEPTOR-LIKE 1; OPRL1,Asterisk
602549,PROTEIN KINASE N2; PKN2,Asterisk
602550,ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR-LIKE PROTEIN; ARNTL,Asterisk
602551,JEJUNAL ATRESIA WITH RENAL ADYSPLASIA,
602552,"NUCLEOPORIN, 88-KD; NUP88",Asterisk
602553,"ANAL ATRESIA, HYPOSPADIAS, AND PENOSCROTAL INVERSION",
602554,TORSION DYSTONIA WITH ONSET IN INFANCY,
602555,"MICROCEPHALY, MACROTIA, AND MENTAL RETARDATION",
602556,"FACIAL DYSMORPHISM, CLEFT PALATE, HEARING LOSS, AND CAMPTODACTYLY",
602557,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH",Number Sign
602558,CRANIOMICROMELIC SYNDROME,
602559,EXPORTIN 1; XPO1,Asterisk
602560,TRACHEAL ANTIMICROBIAL PEPTIDE,Asterisk
602561,"BRACHYDACTYLY, INTRAVENTRICULAR SEPTAL DEFECT, AND DEAFNESS",
602562,MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA,
602563,"NK6, DROSOPHILA, HOMOLOG OF, 1; NKX6-1",Asterisk
602564,"EMPHYSEMA, CONGENITAL, WITH DEAFNESS, PENOSCROTAL WEB, AND MENTAL RETARDATION",
602565,"CHEMOKINE, CC MOTIF, LIGAND 25; CCL25",Asterisk
602566,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 7; P2RX7",Asterisk
602567,LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 1; LIMS1,Asterisk
602568,METHIONINE SYNTHASE REDUCTASE; MTRR,Asterisk
602569,"SYNUCLEIN, BETA; SNCB",Asterisk
602570,JAGGED 2; JAG2,Asterisk
602571,RNA-BINDING MOTIF PROTEIN 4; RBM4,Asterisk
602572,ANNEXIN A11; ANXA11,Asterisk
602573,ANNEXIN A13; ANXA13,Asterisk
602574,"TECTORIN, ALPHA; TECTA",Asterisk
602575,"LIM HOMEOBOX TRANSCRIPTION FACTOR 1, BETA; LMX1B",Asterisk
602576,LUNATIC FRINGE; LFNG,Asterisk
602577,MANIC FRINGE; MFNG,Asterisk
602578,RADICAL FRINGE; RFNG,Asterisk
602579,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B",Number Sign
602580,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 2; GOLGA2",Asterisk
602581,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 3; GOLGA3",Asterisk
602582,"DELTEX, DROSOPHILA, HOMOLOG OF, 1; DTX1",Asterisk
602583,G PROTEIN-COUPLED RECEPTOR 37; GPR37,Asterisk
602584,RETICULOCALBIN 2; RCN2,Asterisk
602585,MOVED TO 164280,Caret
602586,MOVED TO 602857,Caret
602587,ACYL-CoA THIOESTERASE 7; ACOT7,Asterisk
602588,BRANCHIOOTIC SYNDROME 1; BOS1,Number Sign
602589,FUCOSYLTRANSFERASE 8; FUT8,Asterisk
602590,p21 PROTEIN-ACTIVATED KINASE 1; PAK1,Asterisk
602591,KINESIN HEAVY CHAIN MEMBER 2A; KIF2A,Asterisk
602592,LYMPHOCYTE ANTIGEN CD5-LIKE; CD5L,Asterisk
602593,CORNEODESMOSIN; CDSN,Asterisk
602594,RETINITIS PIGMENTOSA 22; RP22,Percent
602595,GEM-ASSOCIATED PROTEIN 2; GEMIN2,Asterisk
602596,"PANCREATIC LYMPHOMA, FAMILIAL",
602597,B-CELL CLL/LYMPHOMA 9; BCL9,Asterisk
602598,"PROSTAGLANDIN D2 SYNTHASE, HEMATOPOIETIC; HPGDS",Asterisk
602599,MOVED TO 602631,Caret
602600,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 8; LRP8,Asterisk
602601,"LOW DENSITY LIPOPROTEIN, OXIDIZED, RECEPTOR 1; OLR1",Asterisk
602602,SECRETED AND TRANSMEMBRANE 1; SECTM1,Asterisk
602603,"MAGO NASHI, DROSOPHILA, HOMOLOG OF; MAGOH",Asterisk
602604,MOVED TO 602323,Caret
602605,MOVED TO 602221,Caret
602606,CART PREPROPEPTIDE; CARTPT,Asterisk
602607,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 1; SLC22A1",Asterisk
602608,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 2; SLC22A2",Asterisk
602609,"PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 3; PIK3C3",Asterisk
602610,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 4; PIK3R4",Asterisk
602611,"SPONDYLOEPIPHYSEAL DYSPLASIA WITH CORONAL CRANIOSYNOSTOSIS, CATARACTS, CLEFT PALATE, AND MENTAL RETARDATION",
602612,"CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF EYE",
602613,"SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL",
602614,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7; MAP3K7,Asterisk
602615,TAK1-BINDING PROTEIN 1; TAB1,Asterisk
602616,"ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT2",Asterisk
602617,FORKHEAD BOX E1; FOXE1,Asterisk
602618,C-TERMINAL-BINDING PROTEIN 1; CTBP1,Asterisk
602619,C-TERMINAL-BINDING PROTEIN 2; CTBP2,Asterisk
602620,LEGUMAIN; LGMN,Asterisk
602621,COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR; CXADR,Asterisk
602622,DEOXYRIBONUCLEASE I-LIKE 2; DNASE1L2,Asterisk
602623,FK506-BINDING PROTEIN 5; FKBP5,Asterisk
602624,MOVED TO 602570,Caret
602625,"MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 1; MAGI1",Asterisk
602626,INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; IL1RAP,Asterisk
602627,"CELL DIVISION CYCLE 6, S. CEREVISIAE, HOMOLOG OF; CDC6",Asterisk
602628,FORKHEAD BOX N3; FOXN3,Asterisk
602629,"DYSTONIA 6, TORSION; DYT6",Number Sign
602630,TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR; TGIF,Asterisk
602631,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18; SLC22A18",Asterisk
602632,PODOCALYXIN-LIKE; PODXL,Asterisk
602633,FOUR-AND-A-HALF LIM DOMAINS 2; FHL2,Asterisk
602634,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 9; DNAJB9",Asterisk
602635,DEFORMED EPIDERMAL AUTOREGULATORY FACTOR 1 HOMOLOG; DEAF1,Asterisk
602636,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 8; PPP1R8",Asterisk
602637,SECRETED PHOSPHOPROTEIN 2; SPP2,Asterisk
602638,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 4; MCM4,Asterisk
602639,"TOOTH AGENESIS, SELECTIVE, 2; STHAG2",Percent
602640,N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 1; NAALADL1,Asterisk
602641,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 1; EIF4A1",Asterisk
602642,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 11; TNFSF11",Asterisk
602643,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11B; TNFRSF11B",Asterisk
602644,TETRASPANIN 4; TSPAN4,Asterisk
602645,SEMAPHORIN 3C; SEMA3C,Asterisk
602646,G PROTEIN-COUPLED RECEPTOR 35; GPR35,Asterisk
602647,NUCLEAR RNA EXPORT FACTOR 1; NXF1,Asterisk
602648,ATYPICAL CHEMOKINE RECEPTOR 2; ACKR2,Asterisk
602649,COLD-INDUCIBLE RNA-BINDING PROTEIN; CIRBP,Asterisk
602650,SPECKLE-TYPE POZ PROTEIN; SPOP,Asterisk
602651,NARDILYSIN; NRD1,Asterisk
602652,KALLIKREIN-RELATED PEPTIDASE 6; KLK6,Asterisk
602653,"TECTORIN, BETA; TECTB",Asterisk
602654,"FERM, ARHGEF, AND PLECKSTRIN DOMAINS-CONTAINING PROTEIN 1; FARP1",Asterisk
602655,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1, ADAPTOR PROTEIN; SLC4A1AP",Asterisk
602656,ENDONUCLEASE III-LIKE 1; NTHL1,Asterisk
602657,MOVED TO 300572,Caret
602658,"PHOSPHODIESTERASE 2A, cGMP-STIMULATED; PDE2A",Asterisk
602659,MENAGE A TROIS 1; MNAT1,Asterisk
602660,"TUBULIN, BETA-4B; TUBB4B",Asterisk
602661,"TUBULIN, BETA-3; TUBB3",Asterisk
602662,"TUBULIN, BETA-4A; TUBB4A",Asterisk
602663,PROLACTIN-RELEASING HORMONE; PRLH,Asterisk
602664,"CASPASE 4, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP4",Asterisk
602665,"CASPASE 5, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP5",Asterisk
602666,MYOSIN XVA; MYO15A,Asterisk
602667,NIBRIN; NBN,Asterisk
602668,MYOTONIC DYSTROPHY 2; DM2,Number Sign
602669,PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 3; PITX3,Asterisk
602670,"POLYMERASE, DNA, EPSILON-2; POLE2",Asterisk
602671,"SOLUTE CARRIER FAMILY 37 (GLUCOSE-6-PHOSPHATE TRANSPORTER), MEMBER 4; SLC37A4",Asterisk
602672,RAS-ASSOCIATED PROTEIN RAB13; RAB13,Asterisk
602673,KALLIKREIN-RELATED PEPTIDASE 10; KLK10,Asterisk
602674,MOVED TO 601802,Caret
602675,ARGINYL AMINOPEPTIDASE; RNPEP,Asterisk
602676,"PHOSPHODIESTERASE 6D, cGMP-SPECIFIC, ROD, DELTA; PDE6D",Asterisk
602677,RING FINGER PROTEIN 5; RNF5,Asterisk
602678,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3; MARK3,Asterisk
602679,"PHOSPHATE CYTIDYLYLTRANSFERASE 2, ETHANOLAMINE; PCYT2",Asterisk
602680,RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5,Asterisk
602681,FORKHEAD BOX O3A; FOXO3A,Asterisk
602682,ADHESION G PROTEIN-COUPLED RECEPTOR B1; ADGRB1,Asterisk
602683,ADHESION G PROTEIN-COUPLED RECEPTOR B2; ADGRB2,Asterisk
602684,ADHESION G PROTEIN-COUPLED RECEPTOR B3; ADGRB3,Asterisk
602685,"MENTAL RETARDATION, SEVERE, WITH SPASTICITY AND PIGMENTARY TAPETORETINAL DEGENERATION",Percent
602686,"MITOTIC ARREST-DEFICIENT 1, YEAST, HOMOLOG-LIKE 1; MAD1L1",Asterisk
602687,MOVED TO 603072,Caret
602688,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A/B; HNRNPAB,Asterisk
602689,FASCIN ACTIN-BUNDLING PROTEIN 1; FSCN1,Asterisk
602690,"SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN; SDHD",Asterisk
602691,NUCLEAR RECEPTOR COACTIVATOR 1; NCOA1,Asterisk
602692,GLIOMA PATHOGENESIS-RELATED PROTEIN 1; GLIPR1,Asterisk
602693,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 3; MCM3,Asterisk
602694,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 4; NDUFS4,Asterisk
602695,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12",Asterisk
602696,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 5; MCM5,Asterisk
602697,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 11; P2RY11",Asterisk
602698,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 3; NFATC3",Asterisk
602699,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4; NFATC4",Asterisk
602700,"E1A-BINDING PROTEIN, 300-KD; EP300",Asterisk
602701,SARCOLEMMAL-ASSOCIATED PROTEIN; SLMAP,Asterisk
602702,PERILIPIN 3; PLIN3,Asterisk
602703,"KATANIN, p80 SUBUNIT, B1; KATNB1",Asterisk
602704,MOUSE DOUBLE MINUTE 4 HOMOLOG; MDM4,Asterisk
602705,SYNAPSIN III; SYN3,Asterisk
602706,"PROTEASOME 26S SUBUNIT, ATPase, 1; PSMC1",Asterisk
602707,"PROTEASOME 26S SUBUNIT, ATPase, 4; PSMC4",Asterisk
602708,"PROTEASOME 26S SUBUNIT, ATPase, 6; PSMC6",Asterisk
602709,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 1; APBB1",Asterisk
602710,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 2; APBB2",Asterisk
602711,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 3; APBB3",Asterisk
602712,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2; APBA2",Asterisk
602713,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 9; ADAM9,Asterisk
602714,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 12; ADAM12,Asterisk
602715,LEIOMODIN 1; LMOD1,Asterisk
602716,NEPHRIN; NPHS1,Asterisk
602717,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2D; GRIN2D",Asterisk
602718,"TRANSFORMER 2, DROSOPHILA, HOMOLOG OF, ALPHA; TRA2A",Asterisk
602719,"TRANSFORMER 2, DROSOPHILA, HOMOLOG OF, BETA; TRA2B",Asterisk
602720,PARAOXONASE 3; PON3,Asterisk
602721,"DISRUPTED MEIOTIC cDNA 1, YEAST, HOMOLOG OF; DMC1",Asterisk
602722,"RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR",Number Sign
602723,PSORIASIS 2; PSORS2,Number Sign
602724,SEPTIN 5; SEPT5,Asterisk
602725,INTERFERON-RELATED DEVELOPMENTAL REGULATOR 2; IFRD2,Asterisk
602726,CHLORIDE CHANNEL 6; CLCN6,Asterisk
602727,CHLORIDE CHANNEL 7; CLCN7,Asterisk
602728,"SCAVENGER RECEPTOR CLASS A, MEMBER 3; SCARA3",Asterisk
602729,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, PI; GABRP",Asterisk
602730,"ACTIVIN A RECEPTOR, TYPE IIB; ACVR2B",Asterisk
602731,FYN-BINDING PROTEIN; FYB,Asterisk
602732,RHO GTPase-ACTIVATING PROTEIN 1; ARHGAP1,Asterisk
602733,"ALDEHYDE DEHYDROGENASE, FAMILY 9, SUBFAMILY A, MEMBER 1; ALDH9A1",Asterisk
602734,PLASTIN 1; PLS1,Asterisk
602735,RETICULOCALBIN 1; RCN1,Asterisk
602736,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 3; ATP5G3",Asterisk
602737,"CHEMOKINE, CC MOTIF, LIGAND 21; CCL21",Asterisk
602738,KARYOPHERIN BETA-1; KPNB1,Asterisk
602739,"PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-1; PRKAA1",Asterisk
602740,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-1; PRKAB1",Asterisk
602741,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-2; PRKAB2",Asterisk
602742,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-1; PRKAG1",Asterisk
602743,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-2; PRKAG2",Asterisk
602744,GLYCERONEPHOSPHATE O-ACYLTRANSFERASE; GNPAT,Asterisk
602745,"PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, BETA; PIP5K1B",Asterisk
602746,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14; TNFRSF14",Asterisk
602747,DUAL-SPECIFICITY PHOSPHATASE 4; DUSP4,Asterisk
602748,DUAL-SPECIFICITY PHOSPHATASE 6; DUSP6,Asterisk
602749,DUAL-SPECIFICITY PHOSPHATASE 7; DUSP7,Asterisk
602750,D-DOPACHROME TAUTOMERASE; DDT,Asterisk
602751,BTB AND CNC HOMOLOGY 1; BACH1,Asterisk
602752,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 8; RGPD8,Asterisk
602753,"ARISTALESS HOMEOBOX, DROSOPHILA, HOMOLOG OF; ARIX",Asterisk
602754,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 4; KCNN4",Asterisk
602755,CYCLIN B2; CCNB2,Asterisk
602756,EPHRIN A2; EFNA2,Asterisk
602757,EPHRIN RECEPTOR EphB6; EPHB6,Asterisk
602758,"PHOSPHATIDYLINOSITOL 4-KINASE, CATALYTIC, BETA; PIK4CB",Asterisk
602759,"PROSTATE CANCER, HEREDITARY, 8",Percent
602760,"KERATIN 32, TYPE I; KRT32",Asterisk
602761,"KERATIN 33A, TYPE I; KRT33A",Asterisk
602762,"KERATIN 33B, TYPE I; KRT33B",Asterisk
602763,"KERATIN 34, TYPE I; KRT34",Asterisk
602764,"KERATIN 35, TYPE I; KRT35",Asterisk
602765,"KERATIN 83, TYPE II; KRT83",Asterisk
602766,"KERATIN 84, TYPE II; KRT84",Asterisk
602767,"KERATIN 85, TYPE II; KRT85",Asterisk
602768,DELTA-LIKE 3; DLL3,Asterisk
602769,DNA METHYLTRANSFERASE 3A; DNMT3A,Asterisk
602770,"CHROMOBOX HOMOLOG 2, DROSOPHILA POLYCOMB CLASS; CBX2",Asterisk
602771,RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1,Number Sign
602772,RETINITIS PIGMENTOSA 25; RP25,Number Sign
602773,DISRUPTED IN RENAL CARCINOMA 2; DIRC2,Asterisk
602774,"RAD51, S. CEREVISIAE, HOMOLOG OF, C; RAD51C",Asterisk
602775,"SUPPRESSOR OF CLEAR, C. ELEGANS, HOMOLOG OF; SHOC2",Asterisk
602776,"REV3, S. CEREVISIAE, HOMOLOG OF; REV3L",Asterisk
602777,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 4; SNAPC4",Asterisk
602778,"NUCLEAR RECEPTOR SUBFAMILY 6, GROUP A, MEMBER 1; NR6A1",Asterisk
602779,COAGULATION FACTOR II RECEPTOR-LIKE 3; F2RL3,Asterisk
602780,HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1; HCN1,Asterisk
602781,HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 2; HCN2,Asterisk
602782,HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME,Number Sign
602783,SPG7 GENE; SPG7,Asterisk
602784,CORTISTATIN; CORT,Asterisk
602785,"H1 HISTONE FAMILY, MEMBER X; H1FX",Asterisk
602786,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER E; HIST1H2AE",Asterisk
602787,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER I; HIST1H2AI",Asterisk
602788,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER K; HIST1H2AK",Asterisk
602789,MOVED TO 300163,Caret
602790,FOUR-AND-A-HALF LIM DOMAINS 3; FHL3,Asterisk
602791,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER J; HIST1H2AJ",Asterisk
602792,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER D; HIST1H2AD",Asterisk
602793,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER L; HIST1H2AL",Asterisk
602794,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER C; HIST1H2AC",Asterisk
602795,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER B; HIST1H2AB",Asterisk
602796,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER M; HIST1H2AM",Asterisk
602797,"HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER C; HIST2H2AC",Asterisk
602798,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER G; HIST1H2BG",Asterisk
602799,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER D; HIST1H2BD",Asterisk
602800,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER L; HIST1H2BL",Asterisk
602801,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER N; HIST1H2BN",Asterisk
602802,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER M; HIST1H2BM",Asterisk
602803,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER B; HIST1H2BB",Asterisk
602804,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER F; HIST1H2BF",Asterisk
602805,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER E; HIST1H2BE",Asterisk
602806,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER H; HIST1H2BH",Asterisk
602807,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER I; HIST1H2BI",Asterisk
602808,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER O; HIST1H2BO",Asterisk
602809,KINESIN FAMILY MEMBER 5B; KIF5B,Asterisk
602810,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER A; HIST1H3A",Asterisk
602811,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER D; HIST1H3D",Asterisk
602812,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER C; HIST1H3C",Asterisk
602813,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER E; HIST1H3E",Asterisk
602814,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER I; HIST1H3I",Asterisk
602815,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER G; HIST1H3G",Asterisk
602816,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER F; HIST1H3F",Asterisk
602817,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER J; HIST1H3J",Asterisk
602818,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER H; HIST1H3H",Asterisk
602819,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER B; HIST1H3B",Asterisk
602820,"HISTONE GENE CLUSTER 3, H3 HISTONE; HIST3H3",Asterisk
602821,KINESIN FAMILY MEMBER 5A; KIF5A,Asterisk
602822,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER A; HIST1H4A",Asterisk
602823,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER D; HIST1H4D",Asterisk
602824,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER F; HIST1H4F",Asterisk
602825,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER K; HIST1H4K",Asterisk
602826,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER J; HIST1H4J",Asterisk
602827,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER C; HIST1H4C",Asterisk
602828,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER H; HIST1H4H",Asterisk
602829,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER B; HIST1H4B",Asterisk
602830,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER E; HIST1H4E",Asterisk
602831,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER L; HIST1H4L",Asterisk
602832,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER G; HIST1H4G",Asterisk
602833,"HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER I; HIST1H4I",Asterisk
602834,MOVED TO 600279,Caret
602835,GROWTH ARREST-SPECIFIC 2; GAS2,Asterisk
602836,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 5; P2RX5",Asterisk
602837,"DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 1; DNAJA1",Asterisk
602838,"PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, BETA; PIK3C2B",Asterisk
602839,"PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, DELTA; PIK3CD",Asterisk
602840,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 7; TNFSF7",Asterisk
602841,ALDEHYDE OXIDASE 1; AOX1,Asterisk
602842,GEMININ; GMNN,Asterisk
602843,RHO GDP-DISSOCIATION INHIBITOR BETA; ARHGDIB,Asterisk
602844,RHO GDP-DISSOCIATION INHIBITOR GAMMA; ARHGDIG,Asterisk
602845,KINESIN FAMILY MEMBER 3C; KIF3C,Asterisk
602846,UBIQUITIN-CONJUGATING ENZYME E2K; UBE2K,Asterisk
602847,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER C; HIST1H2BC",Asterisk
602848,BROMODOMAIN-CONTAINING PROTEIN 8; BRD8,Asterisk
602849,MUENKE SYNDROME; MNKES,Number Sign
602850,RING FINGER PROTEIN 4; RNF4,Asterisk
602851,ADHESION G PROTEIN-COUPLED RECEPTOR V1; ADGRV1,Asterisk
602852,NUDIX HYDROLASE 2; NUDT2,Asterisk
602853,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, R; PTPRR",Asterisk
602854,"PROTEASOME SUBUNIT, ALPHA-TYPE, 1; PSMA1",Asterisk
602855,"PROTEASOME SUBUNIT, ALPHA-TYPE, 6; PSMA6",Asterisk
602856,REGULATOR OF G PROTEIN SIGNALING 10; RGS10,Asterisk
602857,CHIMERIN 2; CHN2,Asterisk
602858,7-DEHYDROCHOLESTEROL REDUCTASE; DHCR7,Asterisk
602859,PEROXISOME BIOGENESIS FACTOR 10; PEX10,Asterisk
602860,"BUDDING UNINHIBITED BY BENZIMIDAZOLES 1, S. CEREVISIAE, HOMOLOG OF, BETA; BUB1B",Asterisk
602861,PLAKOPHILIN 2; PKP2,Asterisk
602862,UDP-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE 1; UAP1,Asterisk
602863,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9A; WNT9A",Asterisk
602864,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9B; WNT9B",Asterisk
602865,BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 1; BRINP1,Asterisk
602866,"CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 2; ACCN2",Asterisk
602867,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7; IGFBP7,Asterisk
602868,"CELL DIVISION CYCLE 5, S. POMBE, HOMOLOG OF; CDC5L",Asterisk
602869,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; HNRNPU,Asterisk
602870,INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 1; IMPG1,Asterisk
602871,PERIPLAKIN; PPL,Asterisk
602872,CHLORIDE INTRACELLULAR CHANNEL 1; CLIC1,Asterisk
602873,NEBULIN-RELATED ANCHORING PROTEIN; NRAP,Asterisk
602874,UDP-GLUCOSE CERAMIDE GLUCOSYLTRANSFERASE; UGCG,Asterisk
602875,"ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM",Number Sign
602876,OCCLUDIN; OCLN,Asterisk
602877,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 7; PPP1R7",Asterisk
602878,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 3; SLC30A3",Asterisk
602879,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 1; EPB41L1,Asterisk
602880,GROWTH/DIFFERENTIATION FACTOR 1; GDF1,Asterisk
602881,PHD FINGER PROTEIN 1; PHF1,Asterisk
602882,LEUKOCYTE CELL-DERIVED CHEMOTAXIN 2; LECT2,Asterisk
602883,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1A2; SLCO1A2",Asterisk
602884,"GDP-MANNOSE 4,6-DEHYDRATASE; GMDS",Asterisk
602885,MOTILIN RECEPTOR; MLNR,Asterisk
602886,G PROTEIN-COUPLED RECEPTOR 39; GPR39,Asterisk
602887,"DISCS LARGE, DROSOPHILA, HOMOLOG OF, 4; DLG4",Asterisk
602888,BETAINE-HOMOCYSTEINE METHYLTRANSFERASE; BHMT,Asterisk
602889,MOVED TO 601533,Caret
602890,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1; KLRB1",Asterisk
602891,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 2; KLRC2",Asterisk
602892,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 3; KLRC3",Asterisk
602893,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4; KLRC4",Asterisk
602894,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY D, MEMBER 1; KLRD1",Asterisk
602895,SCAFFOLD ATTACHMENT FACTOR B; SAFB,Asterisk
602896,MITOGEN-ACTIVATED PROTEIN KINASE 9; MAPK9,Asterisk
602897,MITOGEN-ACTIVATED PROTEIN KINASE 10; MAPK10,Asterisk
602898,MITOGEN-ACTIVATED PROTEIN KINASE 11; MAPK11,Asterisk
602899,MITOGEN-ACTIVATED PROTEIN KINASE 13; MAPK13,Asterisk
602900,DNA METHYLTRANSFERASE 3B; DNMT3B,Asterisk
602901,TRANSPORTIN 1; TNPO1,Asterisk
602902,KRUPPEL-LIKE FACTOR 9; KLF9,Asterisk
602903,KRUPPEL-LIKE FACTOR 5; KLF5,Asterisk
602904,MITOGEN-ACTIVATED PROTEIN KINASE 6; MAPK6,Asterisk
602905,"POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 1; KCNS1",Asterisk
602906,"POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 2; KCNS2",Asterisk
602907,CENTRIN 3; CETN3,Asterisk
602908,RETINOBLASTOMA-BINDING PROTEIN 9; RBBP9,Asterisk
602909,CLAUDIN 4; CLDN4,Asterisk
602910,CLAUDIN 3; CLDN3,Asterisk
602911,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-2 SUBUNIT; CACNG2",Asterisk
602912,EUKARYOTIC TRANSLATION INITIATION FACTOR 6; EIF6,Asterisk
602913,POLO-LIKE KINASE 3; PLK3,Asterisk
602914,AQUAPORIN 9; AQP9,Asterisk
602915,TRYPTOPHAN-RICH BASIC PROTEIN; WRB,Asterisk
602916,UBIQUITIN-CONJUGATING ENZYME E2E 1; UBE2E1,Asterisk
602917,REGULATOR OF CALCINEURIN 1; RCAN1,Asterisk
602918,"PHENYLALANINE-tRNA SYNTHETASE, ALPHA SUBUNIT; FARSA",Asterisk
602919,DOCKING PROTEIN 1; DOK1,Asterisk
602920,LIM AND SH3 PROTEIN 1; LASP1,Asterisk
602921,PERSEPHIN; PSPN,Asterisk
602922,MOVED TO 300825,Caret
602923,RETINOBLASTOMA-BINDING PROTEIN 4; RBBP4,Asterisk
602924,RHO FAMILY GTPase 3; RND3,Asterisk
602925,"PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, BETA; PIK3CB",Asterisk
602926,SYNTAXIN-BINDING PROTEIN 1; STXBP1,Asterisk
602927,G PROTEIN-COUPLED RECEPTOR 19; GPR19,Asterisk
602928,TROPOMODULIN 2; TMOD2,Asterisk
602929,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 5A; VWA5A,Asterisk
602930,"RNA EXONUCLEASE 4, S. CEREVISIAE, HOMOLOG OF; REXO4",Asterisk
602931,"MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 6; SMAD6",Asterisk
602932,"MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 7; SMAD7",Asterisk
602933,THYROID HORMONE RECEPTOR INTERACTOR 6; TRIP6,Asterisk
602934,STROMAL CELL-DERIVED FACTOR 2; SDF2,Asterisk
602935,FATTY ACID AMIDE HYDROLASE; FAAH,Asterisk
602936,MOVED TO 300149,Caret
602937,"CBP/p300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 2; CITED2",Asterisk
602938,BILE ACID CoA:AMINO ACID N-ACYLTRANSFERASE; BAAT,Asterisk
602939,FORKHEAD BOX S1; FOXS1,Asterisk
602940,MARCKS-LIKE PROTEIN 1; MARCKSL1,Asterisk
602941,BREAST CANCER ANTIESTROGEN RESISTANCE 1; BCAR1,Asterisk
602942,ECOTROPIC VIRAL INTEGRATION SITE 5; EVI5,Asterisk
602943,RAR-RELATED ORPHAN RECEPTOR C; RORC,Asterisk
602944,E2F TRANSCRIPTION FACTOR 6; E2F6,Asterisk
602945,TRANSCRIPTIONAL ADAPTOR 3; TADA3,Asterisk
602946,TAF6-LIKE RNA POLYMERASE II; TAF6L,Asterisk
602947,"SUPPRESSOR OF TY 3, S. CEREVISIAE, HOMOLOG OF; SUPT3H",Asterisk
602948,"RAD51, S. CEREVISIAE, HOMOLOG OF, B; RAD51L1",Asterisk
602949,"SIN3-ASSOCIATED POLYPEPTIDE, 18-KD; SAP18",Asterisk
602950,PROTEIN ARGININE METHYLTRANSFERASE 1; PRMT1,Asterisk
602951,"ZINC FINGER PROTEIN 37, MOUSE, HOMOLOG OF; ZFP37",Asterisk
602952,NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 2; NSD2,Asterisk
602953,HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF 1; HEY1,Asterisk
602954,"RAD51, S. CEREVISIAE, HOMOLOG OF, D; RAD51D",Asterisk
602955,"TAF6 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 80-KD; TAF6",Asterisk
602956,FANCG GENE; FANCG,Asterisk
602957,"CHEMOKINE, CC MOTIF, LIGAND 22; CCL22",Asterisk
602958,SERUM/GLUCOCORTICOID-REGULATED KINASE 1; SGK1,Asterisk
602959,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-2; EEF1A2",Asterisk
602960,MOVED TO 300506,Caret
602961,UBIQUITIN-CONJUGATING ENZYME E2D 1; UBE2D1,Asterisk
602962,UBIQUITIN-CONJUGATING ENZYME E2D 2; UBE2D2,Asterisk
602963,UBIQUITIN-CONJUGATING ENZYME E2D 3; UBE2D3,Asterisk
602964,TRANSLIN-ASSOCIATED FACTOR X; TSNAX,Asterisk
602965,FATTY ACID-BINDING PROTEIN 7; FABP7,Asterisk
602966,OROFACIAL CLEFT 2; OFC2,Percent
602967,ZINC FINGER PROTEIN 217; ZNF217,Asterisk
602968,BREAST CARCINOMA AMPLIFIED SEQUENCE 1; BCAS1,Asterisk
602969,"ESTROGEN-RELATED RECEPTOR, GAMMA; ESRRG",Asterisk
602970,KARYOPHERIN ALPHA-4; KPNA4,Asterisk
602971,TUBULIN-SPECIFIC CHAPERONE C; TBCC,Asterisk
602972,PHOSPHODIESTERASE 8A; PDE8A,Asterisk
602973,PHOSPHODIESTERASE 9A; PDE9A,Asterisk
602974,AQUAPORIN 7; AQP7,Asterisk
602975,MOVED TO 608833,Caret
602976,MAX-LIKE PROTEIN X; MLX,Asterisk
602977,"GLYCOPROTEIN 2, ZYMOGEN GRANULE MEMBRANE; GP2",Asterisk
602978,POLYHOMEOTIC-LIKE 1; PHC1,Asterisk
602979,POLYHOMEOTIC-LIKE 2; PHC2,Asterisk
602980,"PROTEIN KINASE, SERINE/ARGININE-SPECIFIC, 2; SRPK2",Asterisk
602981,AE-BINDING PROTEIN 1; AEBP1,Asterisk
602982,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 1; KCNN1",Asterisk
602983,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 3; KCNN3",Asterisk
602984,MEDIATOR COMPLEX SUBUNIT 6; MED6,Asterisk
602985,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 2; NDUFS2,Asterisk
602986,DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 2; DRG2,Asterisk
602987,PHOSPHODIESTERASE 1C; PDE1C,Asterisk
602988,PROTOCADHERIN 7; PCDH7,Asterisk
602989,CDC-LIKE KINASE 2; CLK2,Asterisk
602990,CDC-LIKE KINASE 3; CLK3,Asterisk
602991,"NOGGIN, MOUSE, HOMOLOG OF; NOG",Asterisk
602992,LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1; LAIR1,Asterisk
602993,LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 2; LAIR2,Asterisk
602994,LEUKOREGULIN,
602995,UBIQUITIN-CONJUGATING ENZYME E2 VARIANT 1; UBE2V1,Asterisk
602996,IMMEDIATE-EARLY RESPONSE 3; IER3,Asterisk
602997,CUBILIN; CUBN,Asterisk
602998,"SYNUCLEIN, GAMMA; SNCG",Asterisk
602999,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3C; PPP1R3C",Asterisk
603000,IMMATURE COLON CARCINOMA TRANSCRIPT 1; ICT1,Asterisk
603001,UBIQUITIN-CONJUGATING ENZYME E2 VARIANT 2; UBE2V2,Asterisk
603002,TRANSPORTIN 2; TNPO2,Asterisk
603003,BILE DUCT CYSTS,Percent
603004,GLIOBLASTOMA AMPLIFIED SEQUENCE; GBAS,Asterisk
603005,3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2,Asterisk
603006,CADHERIN 4; CDH4,Asterisk
603007,CADHERIN 6; CDH6,Asterisk
603008,CADHERIN 8; CDH8,Asterisk
603009,DYSFERLIN; DYSF,Asterisk
603010,"DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17",Percent
603011,SMALL EDRK-RICH FACTOR 1A; SERF1A,Asterisk
603012,HEAT-SHOCK 70-KD PROTEIN 1B; HSPA1B,Asterisk
603013,SCHIZOPHRENIA 6; SCZD6,Percent
603014,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7; MAP2K7,Asterisk
603015,TRANSFORMATION/TRANSCRIPTION DOMAIN-ASSOCIATED PROTEIN; TRRAP,Asterisk
603016,CADHERIN 19; CDH19,Asterisk
603017,CADHERIN 17; CDH17,Asterisk
603018,BETA-3-GALACTOSYLTRANSFERASE 2; B3GALT2,Asterisk
603019,CADHERIN 18; CDH18,Asterisk
603020,ATPase FAMILY GENE 3-LIKE 1; AFG3L1,Asterisk
603021,MITOCHONDRIAL RIBOSOMAL PROTEIN S12; MRPS12,Asterisk
603022,E4F TRANSCRIPTION FACTOR 1; E4F1,Asterisk
603023,IKAROS FAMILY ZINC FINGER 1; IKZF1,Asterisk
603024,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1A; ARID1A,Asterisk
603025,PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN; PICALM,Asterisk
603026,PLEOMORPHIC ADENOMA GENE 1; PLAG1,Asterisk
603027,"FRUCTOSE-1,6-BISPHOSPHATASE 2; FBP2",Asterisk
603028,TOLL-LIKE RECEPTOR 2; TLR2,Asterisk
603029,TOLL-LIKE RECEPTOR 3; TLR3,Asterisk
603030,TOLL-LIKE RECEPTOR 4; TLR4,Asterisk
603031,TOLL-LIKE RECEPTOR 5; TLR5,Asterisk
603032,STANNIN; SNN,Asterisk
603033,COLLAGENIC TAIL OF ENDPLATE ACETYLCHOLINESTERASE; COLQ,Asterisk
603034,"MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5",Number Sign
603035,INTERLEUKIN 16; IL16,Asterisk
603036,MOVED TO 601877,Caret
603037,LEFT-RIGHT DETERMINATION FACTOR 1; LEFTY1,Asterisk
603038,SPERM-ASSOCIATED ANTIGEN 4; SPAG4,Asterisk
603039,MAX-BINDING PROTEIN; MNT,Asterisk
603040,TUMOR SUPPRESSOR GENE ON CHROMOSOME 11,Percent
603041,MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1,Number Sign
603042,SMALL UBIQUITIN-LIKE MODIFIER 2; SUMO2,Asterisk
603043,NEUTRAL SPHINGOMYELINASE ACTIVATION-ASSOCIATED FACTOR; NSMAF,Asterisk
603044,PLEOMORPHIC ADENOMA GENE-LIKE 1; PLAGL1,Asterisk
603045,MOVED TO 603499,Caret
603046,RING FINGER PROTEIN 139; RNF139,Asterisk
603047,ASTIGMATISM,Percent
603048,GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR ATTACHMENT PROTEIN 1; GPAA1,Asterisk
603049,THIOREDOXIN-LIKE 1; TXNL1,Asterisk
603050,ABL INTERACTOR 1; ABI1,Asterisk
603051,ALKYLGLYCERONE-PHOSPHATE SYNTHASE; AGPS,Asterisk
603052,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 4; CPSF4,Asterisk
603053,HISTONE ACETYLTRANSFERASE 1; HAT1,Asterisk
603054,"GREMLIN 1 HOMOLOG, CYSTINE KNOT SUPERFAMILY; GREM1",Asterisk
603055,SKI-INTERACTING PROTEIN; SKIIP,Asterisk
603056,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 4, S. CEREVISIAE, HOMOLOG OF; ORC4",Asterisk
603057,"DACHSOUS, DROSOPHILA, HOMOLOG OF, 1; DCHS1",Asterisk
603058,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 4; PCDHGB4",Asterisk
603059,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 12; PCDHGA12",Asterisk
603060,KINESIN FAMILY MEMBER 1C; KIF1C,Asterisk
603061,"ENDOSULFINE, ALPHA; ENSA",Asterisk
603062,TRANS-GOLGI NETWORK PROTEIN 2; TGOLN2,Asterisk
603063,3-HYDROXYBUTYRATE DEHYDROGENASE 1; BDH1,Asterisk
603064,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B11; UGT2B11",Asterisk
603065,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 2; NR1I2",Asterisk
603066,"PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 3; PLOD3",Asterisk
603067,MOVED TO 602413,Caret
603068,DUAL-SPECIFICITY PHOSPHATASE 2; DUSP2,Asterisk
603069,DUAL-SPECIFICITY PHOSPHATASE 5; DUSP5,Asterisk
603070,RAD51-ASSOCIATED PROTEIN 1; RAD51AP1,Asterisk
603071,G PROTEIN-COUPLED RECEPTOR 17; GPR17,Asterisk
603072,AURORA KINASE A; AURKA,Asterisk
603073,"ZIC FAMILY, MEMBER 2; ZIC2",Asterisk
603074,"PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, GAMMA SUBUNIT; PAFAH1B3",Asterisk
603075,"MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1",Number Sign
603076,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 1; ABCG1",Asterisk
603077,MOVED TO 300157,Caret
603078,"CHECKPOINT, S. POMBE, HOMOLOG OF, 1; CHEK1",Asterisk
603079,"CHROMOBOX HOMOLOG 4, DROSOPHILA POLYCOMB CLASS; CBX4",Asterisk
603080,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, BETAINE/GABA), MEMBER 12; SLC6A12",Asterisk
603081,ADP-RIBOSYLARGININE HYDROLASE; ADPRH,Asterisk
603082,MOVED TO 188855,Caret
603083,HETEROGENEOUS NUCLEAR RIBOPROTEIN L; HNRNPL,Asterisk
603084,ASPARTYL-tRNA SYNTHETASE; DARS,Asterisk
603085,"SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 1; SLC31A1",Asterisk
603086,ADP-RIBOSYLTRANSFERASE 3; ART3,Asterisk
603087,MOVED TO 110600,Caret
603088,"SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 2; SLC31A2",Asterisk
603089,BRCA1-ASSOCIATED PROTEIN 1; BAP1,Asterisk
603090,UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3; UCHL3,Asterisk
603091,UBIQUITIN-SPECIFIC PROTEASE 12; USP12,Asterisk
603092,DUAL-SPECIFICITY PHOSPHATASE 11; DUSP11,Asterisk
603093,BETA-3-GALACTOSYLTRANSFERASE 1; B3GALT1,Asterisk
603094,"BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 1; B3GALNT1",Asterisk
603095,"UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4; B3GALT4",Asterisk
603096,MOVED TO 262300,Caret
603097,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 42-KD, V1 SUBUNIT C, ISOFORM 1; ATP6V1C1",Asterisk
603098,"DEAFNESS, AUTOSOMAL RECESSIVE 13; DFNB13",Percent
603099,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1; AGPAT1,Asterisk
603100,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 2; AGPAT2,Asterisk
603101,"CARBOXYPEPTIDASE B2, PLASMA; CPB2",Asterisk
603102,CARBOXYPEPTIDASE D; CPD,Asterisk
603103,"CARBOXYPEPTIDASE N, POLYPEPTIDE 1, 50-KD; CPN1",Asterisk
603104,"CARBOXYPEPTIDASE N, POLYPEPTIDE 2, 83-KD; CPN2",Asterisk
603105,CARBOXYPEPTIDASE Z; CPZ,Asterisk
603106,NEURONATIN; NNAT,Asterisk
603107,TRANSCRIPTION FACTOR 20; TCF20,Asterisk
603108,"MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 1; MAPRE1",Asterisk
603109,"MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 3; SMAD3",Asterisk
603110,"MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 5; SMAD5",Asterisk
603111,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY E, MEMBER 1; SMARCE1",Asterisk
603112,S100 CALCIUM-BINDING PROTEIN A12; S100A12,Asterisk
603113,"PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, BETA; PPP2R1B",Asterisk
603114,S100 CALCIUM-BINDING PROTEIN A11; S100A11,Asterisk
603115,DEAH BOX POLYPEPTIDE 9; DHX9,Asterisk
603116,CDAGS SYNDROME,Percent
603117,"SPASTIC PARAPLEGIA, OPTIC ATROPHY, MICROCEPHALY, AND XY SEX REVERSAL",
603118,CADHERIN 16; CDH16,Asterisk
603119,APRAXIA OF EYELID OPENING,
603120,QUIESCIN Q6 SULFHYDRYL OXIDASE 1; QSOX1,Asterisk
603121,MOVED TO 300768,Caret
603122,DEDICATOR OF CYTOKINESIS 2; DOCK2,Asterisk
603123,DEDICATOR OF CYTOKINESIS 3; DOCK3,Asterisk
603124,UBIQUITIN-CONJUGATING ENZYME E2G 2; UBE2G2,Asterisk
603125,TYROSYLPROTEIN SULFOTRANSFERASE 1; TPST1,Asterisk
603126,TYROSYLPROTEIN SULFOTRANSFERASE 2; TPST2,Asterisk
603127,GROWTH ARREST-SPECIFIC 7; GAS7,Asterisk
603128,"SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 1; SIM1",Asterisk
603129,LIM DOMAIN ONLY 4; LMO4,Asterisk
603130,ATTRACTIN; ATRN,Asterisk
603131,"PEPTIDASE, MITOCHONDRIAL PROCESSING, BETA; PMPCB",Asterisk
603132,ZINC FINGER PROTEIN 189; ZNF189,Asterisk
603133,"DISLOCATED ELBOWS, BOWED TIBIAS, SCOLIOSIS, DEAFNESS, CATARACT, MICROCEPHALY, AND MENTAL RETARDATION",
603134,CULLIN 1; CUL1,Asterisk
603135,CULLIN 2; CUL2,Asterisk
603136,CULLIN 3; CUL3,Asterisk
603137,CULLIN 4A; CUL4A,Asterisk
603138,MOVED TO 300304,Caret
603139,"RAD17, S. POMBE, HOMOLOG OF; RAD17",Asterisk
603140,"PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, ALPHA; PIP4K2A",Asterisk
603141,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN-BINDING PROTEIN 1; PPFIBP1",Asterisk
603142,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN-BINDING PROTEIN 2; PPFIBP2",Asterisk
603143,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA-2; PPFIA2",Asterisk
603144,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA 3; PPFIA3",Asterisk
603145,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA 4; PPFIA4",Asterisk
603146,"PROTEASOME 26S SUBUNIT, NON-ATPase, 9; PSMD9",Asterisk
603147,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C",Number Sign
603148,ACTIVATING TRANSCRIPTION FACTOR 3; ATF3,Asterisk
603149,INTERLEUKIN 17A; IL17A,Asterisk
603150,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, DELTA SUBUNIT; ATP5F1D",Asterisk
603151,SEPTIN 7; SEPT7,Asterisk
603152,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT F6; ATP5J",Asterisk
603153,"RAD1, S. POMBE, HOMOLOG OF; RAD1",Asterisk
603154,PININ; PNN,Asterisk
603155,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 14; PTPN14",Asterisk
603156,BIPHENYL HYDROLASE-LIKE; BPHL,Asterisk
603157,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 2; PIK3R2",Asterisk
603158,UBIQUITIN-SPECIFIC PROTEASE 8; USP8,Asterisk
603159,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 3; LRP3,Asterisk
603160,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 6; ENTPD6,Asterisk
603161,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; ENTPD3,Asterisk
603162,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 5; ENTPD5,Asterisk
603163,STIMULATOR OF CHONDROGENESIS 1; SCRG1,Asterisk
603164,PEROXISOME BIOGENESIS FACTOR 3; PEX3,Asterisk
603165,"DERMATITIS, ATOPIC",Percent
603166,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 2; MAP4K2,Asterisk
603167,BCL2-ASSOCIATED AGONIST OF CELL DEATH; BAD,Asterisk
603168,UNC51-LIKE KINASE 1; ULK1,Asterisk
603169,CATHEPSIN Z; CTSZ,Asterisk
603170,TEA DOMAIN FAMILY MEMBER 3; TEAD3,Asterisk
603171,"NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8; NEDD8",Asterisk
603172,UBIQUITIN-ACTIVATING ENZYME E1C; UBE1C,Asterisk
603173,UBIQUITIN-CONJUGATING ENZYME E2M; UBE2M,Asterisk
603174,HOMOCYSTEINEMIA,
603175,SCHIZOPHRENIA 5; SCZD5,Percent
603176,SCHIZOPHRENIA 7; SCZD7,Percent
603177,VESICLE-ASSOCIATED MEMBRANE PROTEIN 8; VAMP8,Asterisk
603178,"ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1; ALDH6A1",Asterisk
603179,CARBONIC ANHYDRASE IX; CA9,Asterisk
603180,"EXPORTIN, tRNA; XPOT",Asterisk
603181,INTERLEUKIN ENHANCER-BINDING FACTOR 2; ILF2,Asterisk
603182,INTERLEUKIN ENHANCER-BINDING FACTOR 3; ILF3,Asterisk
603183,RETICULON 2; RTN2,Asterisk
603184,CYCLIN-DEPENDENT KINASE 8; CDK8,Asterisk
603185,NUCLEAR AUTOANTIGENIC SPERM PROTEIN; NASP,Asterisk
603186,DEATH-ASSOCIATED PROTEIN 6; DAXX,Asterisk
603187,CENTRIN 1; CETN1,Asterisk
603188,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8; BMIQ8,Percent
603189,SYNTAXIN 5; STX5,Asterisk
603190,PROTEIN ARGININE N-METHYLTRANSFERASE 3; PRMT3,Asterisk
603191,CILIA AND FLAGELLA-ASSOCIATED PROTEIN 410; CFAP410,Asterisk
603192,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 1; ATP5G1",Asterisk
603193,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 2; ATP5G2",Asterisk
603194,"MECKEL SYNDROME, TYPE 2; MKS2",Number Sign
603195,G PROTEIN-COUPLED RECEPTOR 32; GPR32,Asterisk
603196,COCHLIN; COCH,Asterisk
603197,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 6; PNPLA6,Asterisk
603198,CAVEOLAE-ASSOCIATED PROTEIN 1; CAVIN1,Asterisk
603199,PALS1-ASSOCIATED TIGHT JUNCTION PROTEIN; PATJ,Asterisk
603200,"REGULATORY FACTOR X, ANKYRIN REPEAT-CONTAINING; RFXANK",Asterisk
603201,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 11; ABCB11",Asterisk
603202,LACTASE; LCT,Asterisk
603203,CYCLIN G2; CCNG2,Asterisk
603204,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2",Percent
603205,MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 1; MORC1,Asterisk
603206,SCHIZOPHRENIA 8; SCZD8,Percent
603207,"VTI1, S. CEREVISIAE, HOMOLOG OF, B; VTI1B",Asterisk
603208,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 13; KCNJ13",Asterisk
603209,"CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLASE, PSEUDOGENE; CMAHP",
603210,"JERKY, MOUSE, HOMOLOG OF; JRK",Asterisk
603211,"JERKY, MOUSE, HOMOLOG-LIKE; JRKL",Asterisk
603212,BEADED FILAMENT STRUCTURAL PROTEIN 2; BFSP2,Asterisk
603213,KINESIN FAMILY MEMBER 22; KIF22,Asterisk
603214,"ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 4; ABCD4",Asterisk
603215,"N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA; NAPA",Asterisk
603216,"N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, GAMMA; NAPG",Asterisk
603217,SYNTAXIN 7; STX7,Asterisk
603218,HUNTINGTON DISEASE-LIKE 1; HDL1,Number Sign
603219,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 2; KCNK2",Asterisk
603220,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3; KCNK3",Asterisk
603221,"MYOPIA 3, AUTOSOMAL DOMINANT; MYP3",Percent
603222,U22 HOST GENE,Asterisk
603223,"RNA, U22 SMALL NUCLEOLAR; RNU22",Asterisk
603224,"RNA, U25 SMALL NUCLEOLAR; RNU25",Asterisk
603225,"RNA, U26 SMALL NUCLEOLAR; RNU26",Asterisk
603226,"RNA, U27 SMALL NUCLEOLAR; RNU27",Asterisk
603227,"RNA, U28 SMALL NUCLEOLAR; RNU28",Asterisk
603228,"RNA, U29 SMALL NUCLEOLAR; RNU29",Asterisk
603229,"RNA, U30 SMALL NUCLEOLAR; RNU30",Asterisk
603230,"RNA, U31 SMALL NUCLEOLAR; RNU31",Asterisk
603231,ZINC FINGER PROTEIN 200; ZNF200,Asterisk
603232,"OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY F, MEMBER 1; OR1F1",Asterisk
603233,"PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B",Number Sign
603234,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 6; ABCC6",Asterisk
603235,SELENOPROTEIN W; SELENOW,Asterisk
603236,MEVALONATE PYROPHOSPHATE DECARBOXYLASE; MVD,Asterisk
603237,ERYTHROCYTE MEMBRANE PROTEIN 4.1-LIKE 2; EPB41L2,Asterisk
603238,"RNA, U17D SMALL NUCLEOLAR; RNU17D",Asterisk
603239,"SMALL NUCLEOLAR RNA, H/ACA BOX, 73B; SNORA73B",Asterisk
603240,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18, ANTISENSE; SLC22A18AS",Asterisk
603241,LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN; LSAMP,Asterisk
603242,"C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER B; CLEC2B",Asterisk
603243,AUTOCRINE MOTILITY FACTOR RECEPTOR; AMFR,Asterisk
603244,HEPARAN SULFATE (GLUCOSAMINE) 3-O-SULFOTRANSFERASE 1; HS3ST1,Asterisk
603245,NK2 HOMEOBOX 8; NKX2-8,Asterisk
603246,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 1; GTF3C1",Asterisk
603247,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 2; SLC27A2",Asterisk
603248,"BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IB; BMPR1B",Asterisk
603249,"NIPSNAP, C. ELEGANS, HOMOLOG OF, 1; NIPSNAP1",Asterisk
603250,FORKHEAD BOX F2; FOXF2,Asterisk
603251,CYCLIN-DEPENDENT KINASE 9; CDK9,Asterisk
603252,FORKHEAD BOX L1; FOXL1,Asterisk
603253,CYSTATIN 7; CST7,Asterisk
603254,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4; SMARCA4",Asterisk
603255,"NUCLEAR TRANSCRIPTION FACTOR, X BOX-BINDING, 1; NFX1",Asterisk
603256,LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 1; LRRFIP1,Asterisk
603257,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 3; SMARCA3",Asterisk
603258,"INHIBITOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS, KINASE OF, BETA; IKBKB",Asterisk
603259,MOVED TO 191195,Caret
603260,BarH-LIKE HOMEOBOX GENE 1; BARX1,Asterisk
603261,"PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, BETA; PIP4K2B",Asterisk
603262,3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 1; PAPSS1,Asterisk
603263,CARBONIC ANHYDRASE XII; CA12,Asterisk
603264,RHOMBOID-LIKE 1; RHBDL1,Asterisk
603265,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3A; ARID3A,Asterisk
603266,"DIABETES MELLITUS, INSULIN-DEPENDENT, 17; IDDM17",Percent
603267,"SMALL OPTIC LOBES, DROSOPHILA, HOMOLOG OF; SOLH",Asterisk
603268,N-DEACETYLASE/N-SULFOTRANSFERASE 2; NDST2,Asterisk
603269,"SPLICING FACTOR, SERINE/ARGININE-RICH, 8; SRSF8",Asterisk
603270,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT B, ISOFORM 1; ATP5F1",Asterisk
603271,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 21; PTPN21",Asterisk
603272,CONNECTOR ENHANCER OF KINASE SUPPRESSOR OF RAS 1; CNKSR1,Asterisk
603273,TUMOR PROTEIN p63; TP63,Asterisk
603274,MOVED TO 602961,Caret
603275,"PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, ALPHA; PIP5K1A",Asterisk
603276,REGULATOR OF G PROTEIN SIGNALING 5; RGS5,Asterisk
603277,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 4; CHD4,Asterisk
603278,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1,Number Sign
603279,"EXPANDED REPEAT DOMAIN, CAG/CTG, 1; ERDA1",Asterisk
603280,MOVED TO 157640,Caret
603281,"2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE-LIKE; OASL",Asterisk
603282,ZINC FINGER PROTEIN 204; ZNF204,
603283,TRIADIN; TRDN,Asterisk
603284,CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2,Number Sign
603285,CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3,Number Sign
603286,KISS1 METASTASIS SUPPRESSOR; KISS1,Asterisk
603287,PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE; PNPO,Asterisk
603288,KERATOCAN; KERA,Asterisk
603289,DEATH-ASSOCIATED PROTEIN KINASE 3; DAPK3,Asterisk
603290,SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 2; SHANK2,Asterisk
603291,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 1; BNIP1,Asterisk
603292,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2; BNIP2,Asterisk
603293,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3; BNIP3,Asterisk
603294,MINICHROMOSOME MAINTENANCE 3-ASSOCIATED PROTEIN; MCM3AP,Asterisk
603295,"MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 9; SMAD9",Asterisk
603296,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 3; LAMTOR3",Asterisk
603297,"DYNEIN, CYTOPLASMIC 2, HEAVY CHAIN 1; DYNC2H1",Asterisk
603298,PALMITOYL-PROTEIN THIOESTERASE 2; PPT2,Asterisk
603299,MOVED TO 603339,Caret
603300,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 2; TNFAIP2,Asterisk
603301,KRUPPEL-LIKE FACTOR 11; KLF11,Asterisk
603302,ADENYLATE CYCLASE 9; ADCY9,Asterisk
603303,"TRF1-INTERACTING, ANKYRIN-RELATED ADP-RIBOSE POLYMERASE; TNKS",Asterisk
603304,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 2; IRAK2,Asterisk
603305,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 1; KCNH1",Asterisk
603306,TRANSCRIPTION FACTOR 21; TCF21,Asterisk
603307,BEADED FILAMENT STRUCTURAL PROTEIN 1; BFSP1,Asterisk
603308,CATHEPSIN L2; CTSL2,Asterisk
603309,CYCLIN-DEPENDENT KINASE 13; CDK13,Asterisk
603310,PHOSPHODIESTERASE 5A; PDE5A,Asterisk
603311,"CELL DIVISION CYCLE 7, S. CEREVISIAE, HOMOLOG-LIKE 1; CDC7L1",Asterisk
603312,"BUTYROBETAINE-GAMMA,2-OXOGLUTARATE DIOXYGENASE 1; BBOX1",Asterisk
603313,"ALG10, S. CEREVISIAE, HOMOLOG OF; ALG10",Asterisk
603314,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 5; SLC27A5",Asterisk
603315,"FREQUENIN, DROSOPHILA, HOMOLOG OF; FREQ",Asterisk
603316,CYTIDINE 5-PRIME-MONOPHOSPHATE N-ACETYLNEURAMINIC ACID SYNTHETASE; CMAS,Asterisk
603317,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, Q; PTPRQ",Asterisk
603318,MOVED TO 603345,Caret
603319,ANNEXIN A9; ANXA9,Asterisk
603320,MATRIX METALLOPROTEINASE 23A; MMP23A,Asterisk
603321,MATRIX METALLOPROTEINASE 23B; MMP23B,Asterisk
603322,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 6; NDUFB6",Asterisk
603323,"MUSCULAR DYSTROPHY, CONGENITAL, WITH CEREBELLAR ATROPHY",
603324,"GAP JUNCTION PROTEIN, BETA-3; GJB3",Plus
603325,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9B; PPP1R9B",Asterisk
603326,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3D; PPP1R3D",Asterisk
603327,RAN-BINDING PROTEIN 3; RANBP3,Asterisk
603328,"MUSASHI, DROSOPHILA, HOMOLOG OF, 1; MSI1",Asterisk
603329,MOVED TO 300931,Caret
603330,"DYNEIN, AXONEMAL, HEAVY CHAIN 9; DNAH9",Asterisk
603331,"DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 2; DYNC1I2",Asterisk
603332,"DYNEIN, AXONEMAL, HEAVY CHAIN 1; DNAH1",Asterisk
603333,"DYNEIN, AXONEMAL, HEAVY CHAIN 2; DNAH2",Asterisk
603334,"DYNEIN, AXONEMAL, HEAVY CHAIN 3; DNAH3",Asterisk
603335,"DYNEIN, AXONEMAL, HEAVY CHAIN 5; DNAH5",Asterisk
603336,"DYNEIN, AXONEMAL, HEAVY CHAIN 6; DNAH6",Asterisk
603337,"DYNEIN, AXONEMAL, HEAVY CHAIN 8; DNAH8",Asterisk
603338,MOVED TO 603330,Caret
603339,"DYNEIN, AXONEMAL, HEAVY CHAIN 11; DNAH11",Asterisk
603340,"DYNEIN, AXONEMAL, HEAVY CHAIN 12; DNAH12",Asterisk
603341,"DYNEIN, AXONEMAL, HEAVY CHAIN 14; DNAH14",Asterisk
603342,SCHIZOPHRENIA 2; SCZD2,Percent
603343,"RNA EXPORT 1, S. POMBE, HOMOLOG OF; RAE1",Asterisk
603344,"USO1 VESICLE DOCKING PROTEIN, S. CEREVISIAE, HOMOLOG OF; USO1",Asterisk
603345,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 4; SLC4A4",Asterisk
603346,NEURONAL PAS DOMAIN PROTEIN 1; NPAS1,Asterisk
603347,NEURONAL PAS DOMAIN PROTEIN 2; NPAS2,Asterisk
603348,"HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A",Asterisk
603349,ENDOTHELIAL PAS DOMAIN PROTEIN 1; EPAS1,Asterisk
603350,"2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 2; OAS2",Asterisk
603351,"2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 3; OAS3",Asterisk
603352,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5; BIRC5,Asterisk
603353,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 7; SLC4A7",Asterisk
603354,GASTRULATION BRAIN HOMEOBOX 1; GBX1,Asterisk
603355,"MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 1; MBTPS1",Asterisk
603356,CD164 ANTIGEN; CD164,Asterisk
603357,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 7; SERPINB7",Asterisk
603358,GRACILE SYNDROME,Number Sign
603359,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 8; NDUFA8",Asterisk
603360,PEROXISOME BIOGENESIS FACTOR 16; PEX16,Asterisk
603361,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 6B; TNFRSF6B",Asterisk
603362,"SH3 DOMAIN, GRB2-LIKE, 3; SH3GL3",Asterisk
603363,CGG-BINDING PROTEIN 1; CGGBP1,Asterisk
603364,"SPLICING FACTOR, SERINE/ARGININE-RICH, 3; SRSF3",Asterisk
603365,HIRA-INTERACTING PROTEIN 3; HIRIP3,Asterisk
603366,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 25; TNFRSF25",Asterisk
603367,MOVED TO 300255,Caret
603368,CYCLIN-DEPENDENT KINASE 6; CDK6,Asterisk
603369,CYCLIN-DEPENDENT KINASE INHIBITOR 2C; CDKN2C,Asterisk
603370,UDP-GLUCOSE DEHYDROGENASE; UGDH,Asterisk
603371,"GLE1, RNA EXPORT MEDIATOR; GLE1",Asterisk
603372,THYROID-STIMULATING HORMONE RECEPTOR; TSHR,Plus
603373,"HYPERTHYROIDISM, FAMILIAL GESTATIONAL",Number Sign
603374,MOVED TO 300186,Caret
603375,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 5; SMARCA5",Asterisk
603376,"LONG CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF",
603377,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5",Asterisk
603378,"SIN3-ASSOCIATED POLYPEPTIDE, 30-KD; SAP30",Asterisk
603379,IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 1; IQGAP1,Asterisk
603380,"LIN7, C. ELEGANS, HOMOLOG OF, A; LIN7A",Asterisk
603381,FILAMIN B; FLNB,Asterisk
603382,"MutS, E. COLI, HOMOLOG OF, 5; MSH5",Asterisk
603383,"GLAUCOMA 1, OPEN ANGLE, F; GLC1F",Number Sign
603384,SYNAPTIC RAS-GTPase-ACTIVATING PROTEIN 1; SYNGAP1,Asterisk
603385,"NEDD8-ACTIVATING ENZYME E1, SUBUNIT 1; NAE1",Asterisk
603386,"THYROID CARCINOMA, NONMEDULLARY, WITH OR WITHOUT CELL OXYPHILIA",Percent
603387,MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1,Number Sign
603388,"GRAVES DISEASE, SUSCEPTIBILITY TO, 2",Percent
603389,OSEBOLD SKELETAL DYSPLASIA/OSTEOLYSIS SYNDROME,
603390,PHOSPHODIESTERASE 8B; PDE8B,Asterisk
603391,MOVED TO 139210,Caret
603392,BCL2-INTERACTING KILLER; BIK,Asterisk
603393,"OSTEOSCLEROTIC CHONDRODYSPLASIA, LETHAL, WITH INTRACELLULAR INCLUSIONS",
603394,"MICROCEPHALY, SEVERE, WITH SKELETAL ANOMALIES INCLUDING POSTERIOR RIB-GAP DEFECTS",
603395,SPERM-ASSOCIATED ANTIGEN 1; SPAG1,Asterisk
603396,TONOKI SYNDROME,
603397,ZINC FINGER PROTEIN 282; ZNF282,Asterisk
603398,WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 1; WISP1,Asterisk
603399,WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 2; WISP2,Asterisk
603400,WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 3; WISP3,Asterisk
603401,"ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1",Asterisk
603402,"ACYL-CoA OXIDASE 3, PRISTANOYL; ACOX3",Asterisk
603403,DEAH BOX POLYPEPTIDE 15; DHX15,Asterisk
603404,ZINC FINGER PROTEIN 169; ZNF169,Asterisk
603405,DEAH BOX POLYPEPTIDE 16; DHX16,Asterisk
603406,TRIPARTITE MOTIF-CONTAINING PROTEIN 24; TRIM24,Asterisk
603407,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 4; PABPC4",Asterisk
603408,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 1; FZD1",Asterisk
603409,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 6; FZD6",Asterisk
603410,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 7; FZD7",Asterisk
603411,EFFECTOR CELL PROTEASE RECEPTOR 1; EPR1,Asterisk
603412,"CDC42-BINDING PROTEIN KINASE, ALPHA; CDC42BPA",Asterisk
603413,TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN-LIKE 1; TIAL1,Asterisk
603414,"TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 2; TM7SF2",Asterisk
603415,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT; SCN9A",Asterisk
603416,RIBOSOMAL PROTEIN L21 PSEUDOGENE 1; RPL21P1,
603417,RAB-INTERACTING FACTOR; RABIF,Asterisk
603418,"ALDO-KETO REDUCTASE FAMILY 7, MEMBER A2; AKR7A2",Asterisk
603419,"SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT-CONTAINING PROTEIN, ALPHA; SGTA",Asterisk
603420,CALUMENIN; CALU,Asterisk
603421,TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 1; TMEFF1,Asterisk
603422,PDZ AND LIM DOMAIN PROTEIN 4; PDLIM4,Asterisk
603423,PR DOMAIN-CONTAINING PROTEIN 1; PRDM1,Asterisk
603424,"PROTEIN KINASE, INTERFERON-INDUCIBLE DOUBLE-STRANDED RNA-DEPENDENT ACTIVATOR; PRKRA",Asterisk
603425,ADP-RIBOSYLATION FACTOR-LIKE 1; ARL1,Asterisk
603426,"PERIOD, DROSOPHILA, HOMOLOG OF, 2; PER2",Asterisk
603427,"PERIOD, DROSOPHILA, HOMOLOG OF, 3; PER3",Asterisk
603428,ZINC FINGER PROTEIN 207; ZNF207,Asterisk
603429,"ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 1; ABCF1",Asterisk
603430,ZINC FINGER PROTEIN 202; ZNF202,Asterisk
603431,EUKARYOTIC TRANSLATION INITIATION FACTOR 4H; EIF4H,Asterisk
603432,CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 2; CLIP2,Asterisk
603433,ZINC FINGER PROTEIN 143; ZNF143,Asterisk
603434,"PHOSPHOPROTEIN ENRICHED IN ASTROCYTES, 15-KD; PEA15",Asterisk
603435,GLUTATHIONE PEROXIDASE 5; GPX5,Asterisk
603436,ZINC FINGER PROTEIN 205; ZNF205,Asterisk
603437,COLD-SHOCK DOMAIN PROTEIN A; CSDA,Asterisk
603438,"RADIOULNAR SYNOSTOSIS WITH MICROCEPHALY, SHORT STATURE, SCOLIOSIS, AND MENTAL RETARDATION",
603439,EXPANSILE BONE LESIONS,
603440,CYCLIN-DEPENDENT KINASE 17; CDK17,Asterisk
603441,CYCLIN-DEPENDENT KINASE-LIKE 1; CDKL1,Asterisk
603442,CYCLIN-DEPENDENT KINASE-LIKE 2; CDKL2,Asterisk
603443,"VACUOLAR PROTEIN SORTING 52, S. CEREVISIAE, HOMOLOG OF; VPS52",Asterisk
603444,FAR UPSTREAM ELEMENT-BINDING PROTEIN 1; FUBP1,Asterisk
603445,KH-TYPE SPLICING REGULATORY PROTEIN; KHSRP,Asterisk
603446,"OROACRAL SYNDROME, VERLOES-KOULISCHER TYPE",
603447,HARAKIRI; HRK,Asterisk
603448,"DISABLED, DROSOPHILA, HOMOLOG OF, 1; DAB1",Asterisk
603449,"RUVB, E. COLI, HOMOLOG-LIKE 1; RUVBL1",Asterisk
603450,LIM DOMAIN-BINDING 2; LDB2,Asterisk
603451,LIM DOMAIN-BINDING 1; LDB1,Asterisk
603452,MOVED TO 602712,Caret
603453,RECEPTOR-INTERACTING SERINE/THREONINE KINASE 1; RIPK1,Asterisk
603454,CASP2 AND RIPK1 DOMAIN-CONTAINING ADAPTOR WITH DEATH DOMAIN; CRADD,Asterisk
603455,RECEPTOR-INTERACTING SERINE/THREONINE KINASE 2; RIPK2,Asterisk
603456,"DPH2, S. CEREVISIAE, HOMOLOG OF; DPH2",Asterisk
603457,BOSMA ARHINIA MICROPHTHALMIA SYNDROME; BAMS,Number Sign
603458,"EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 3; ELAVL3",Asterisk
603459,MOVED TO 160980,Caret
603460,"CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 1; CDK5R1",Asterisk
603461,"CELL DIVISION CYCLE 16, S. CEREVISIAE, HOMOLOG OF; CDC16",Asterisk
603462,CELL DIVISION CYCLE 23; CDC23,Asterisk
603463,MOVED TO 211380,Caret
603464,CYCLIN-DEPENDENT KINASE 10; CDK10,Asterisk
603465,CELL DIVISION CYCLE 45; CDC45,Asterisk
603466,"EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 1; ELAVL1",Asterisk
603467,"FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF",Number Sign
603468,MOVED TO 227650,Caret
603469,MOVED TO 603240,Caret
603470,ARGININOSUCCINATE SYNTHETASE 1; ASS1,Asterisk
603471,"CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2",Number Sign
603472,NEURONAL INTRANUCLEAR INCLUSION DISEASE,
603473,"LARGE TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 1; LATS1",Asterisk
603474,RIBOSOMAL PROTEIN S19; RPS19,Asterisk
603475,CHORDIN; CHRD,Asterisk
603476,cAMP RESPONSE ELEMENT-BINDING PROTEIN-LIKE 2; CREBL2,Asterisk
603477,"BUD31, S. CEREVISIAE, HOMOLOG OF; BUD31",Asterisk
603478,UBIQUITIN-SPECIFIC PROTEASE 1; USP1,Asterisk
603479,EXTRACELLULAR MATRIX PROTEIN 2; ECM2,Asterisk
603480,MOVED TO 300880,Caret
603481,"PROTEASOME 26S SUBUNIT, NON-ATPase, 13; PSMD13",Asterisk
603482,BETA-TRANSDUCIN REPEAT-CONTAINING PROTEIN; BTRC,Asterisk
603483,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 3; EIF4EBP3,Asterisk
603484,PROTEIN REGULATING CYTOKINESIS 1; PRC1,Asterisk
603485,NITROGEN FIXATION GENE 1; NFS1,Asterisk
603486,UBIQUITIN-SPECIFIC PROTEASE 4; USP4,Asterisk
603487,"MYOSIN, SKELETAL MUSCLE, HEAVY CHAIN 13; MYH13",Asterisk
603488,ANGIO-ASSOCIATED MIGRATORY CELL PROTEIN; AAMP,Asterisk
603489,CARTILAGE INTERMEDIATE LAYER PROTEIN; CILP,Asterisk
603490,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4; WNT4",Asterisk
603491,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 3; IGSF3",Asterisk
603492,"SLAM FAMILY, MEMBER 1; SLAMF1",Asterisk
603493,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 5; KCNK5",Asterisk
603494,PREFOLDIN-LIKE CHAPERONE URI1; URI1,Asterisk
603495,AURORA KINASE C; AURKC,Asterisk
603496,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 2; DYRK2,Asterisk
603497,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 3; DYRK3,Asterisk
603498,"SPHINGOMYELIN PHOSPHODIESTERASE 2, NEUTRAL MEMBRANE; SMPD2",Asterisk
603499,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11A; TNFRSF11A",Asterisk
603500,TUMOR NECROSIS FACTOR RECEPTOR 1-ASSOCIATED DEATH DOMAIN PROTEIN; TRADD,Asterisk
603501,POLY(ADP-RIBOSE) GLYCOHYDROLASE; PARG,Asterisk
603502,INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1; IFRD1,Asterisk
603503,"DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 1, CATALYTIC SUBUNIT; DPM1",Asterisk
603504,"CELL DIVISION CYCLE 14, S. CEREVISIAE, HOMOLOG A; CDC14A",Asterisk
603505,"CELL DIVISION CYCLE 14, S. CEREVISIAE, HOMOLOG B; CDC14B",Asterisk
603506,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 5; LRP5,Asterisk
603507,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6; LRP6,Asterisk
603508,MYOMESIN 1; MYOM1,Asterisk
603509,MYOMESIN 2; MYOM2,Asterisk
603510,MOVED TO 300904,Caret
603511,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1; LGMDD1",Number Sign
603512,RNA GUANYLYLTRANSFERASE AND 5-PRIME-PHOSPHATASE; RNGTT,Asterisk
603513,"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1",Number Sign
603514,RNA GUANINE-7-METHYLTRANSFERASE; RNMT,Asterisk
603515,CHORIONIC SOMATOMAMMOTROPIN HORMONE-LIKE 1; CSHL1,Asterisk
603516,SPINOCEREBELLAR ATAXIA 10; SCA10,Number Sign
603517,B-CELL CLL/LYMPHOMA 10; BCL10,Asterisk
603518,TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN; TIA1,Asterisk
603519,SURVIVAL MOTOR NEURON DOMAIN-CONTAINING PROTEIN 1; SMNDC1,Asterisk
603520,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE B-DOUBLE PRIME; SNRPB2,Asterisk
603521,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A-PRIME; SNRPA1,Asterisk
603522,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE C; SNRPC,Asterisk
603523,"CHYLOTHORAX, CONGENITAL",
603524,RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 2; RCBTB2,Asterisk
603525,NMYC INTERACTOR; NMI,Asterisk
603526,METASTASIS-ASSOCIATED GENE 1; MTA1,Asterisk
603527,"DPH1, S. CEREVISIAE, HOMOLOG OF; DPH1",Asterisk
603528,MOVED TO 194380,Caret
603529,"DYSERYTHROPOIESIS, CONGENITAL, WITH ULTRASTRUCTURALLY NORMAL ERYTHROBLAST HETEROCHROMATIN",
603530,LIGHT FIXATION SEIZURE SYNDROME,
603531,"ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-1 SUBUNIT; AP1S1",Asterisk
603532,MOVED TO 300629,Caret
603533,"ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-1 SUBUNIT; AP1G1",Asterisk
603534,"ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-2 SUBUNIT; AP1G2",Asterisk
603535,"ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-1 SUBUNIT; AP1M1",Asterisk
603536,FAR UPSTREAM ELEMENT-BINDING PROTEIN 3; FUBP3,Asterisk
603537,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 4; KCNQ4",Asterisk
603538,KYNURENINE 3-MONOOXYGENASE; KMO,Asterisk
603539,CATHEPSIN F; CTSF,Asterisk
603540,GAMMA-AMINOBUTYRIC ACID B RECEPTOR 1; GABBR1,Asterisk
603541,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE F; SNRPF,Asterisk
603542,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE G; SNRPG,Asterisk
603543,LIMB-MAMMARY SYNDROME; LMS,Number Sign
603544,CYCLIN K; CCNK,Asterisk
603545,MOVED TO 600791,Caret
603546,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2; SEMDJL2",Number Sign
603547,METHYL-CpG-BINDING DOMAIN PROTEIN 2; MBD2,Asterisk
603548,CDP-DIACYLGLYCEROL SYNTHASE 1; CDS1,Asterisk
603549,CDP-DIACYLGLYCEROL SYNTHASE 2; CDS2,Asterisk
603550,EYES ABSENT 4; EYA4,Asterisk
603551,HYALURONOGLUCOSAMINIDASE 2; HYAL2,Asterisk
603552,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4",Number Sign
603553,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2",Number Sign
603554,OMENN SYNDROME,Number Sign
603555,"SUPPRESSOR OF TY 4, S. CEREVISIAE, HOMOLOG OF, 1; SUPT4H1",Asterisk
603556,MOVED TO 300171,Caret
603557,MYOTUBULARIN-RELATED PROTEIN 2; MTMR2,Asterisk
603558,MYOTUBULARIN-RELATED PROTEIN 3; MTMR3,Asterisk
603559,MYOTUBULARIN-RELATED PROTEIN 4; MTMR4,Asterisk
603560,SET-BINDING FACTOR 1; SBF1,Asterisk
603561,MYOTUBULARIN-RELATED PROTEIN 6; MTMR6,Asterisk
603562,MYOTUBULARIN-RELATED PROTEIN 7; MTMR7,Asterisk
603563,"SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8",Number Sign
603564,"DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 2, REGULATORY SUBUNIT; DPM2",Asterisk
603565,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 4; GALNT4,Asterisk
603566,PROTEIN INHIBITOR OF ACTIVATED STAT1; PIAS1,Asterisk
603567,PROTEIN INHIBITOR OF ACTIVATED STAT2; PIAS2,Asterisk
603568,"RNA, U73 SMALL NUCLEOLAR; RNU73",Asterisk
603569,"TRACHEOBRONCHIAL STENOSIS, CONGENITAL",
603570,VANIN 1; VNN1,Plus
603571,VANIN 2; VNN2,Asterisk
603572,"MICROCEPHALY, FACIAL ABNORMALITIES, MICROMELIA, AND MENTAL RETARDATION",
603573,METHYL-CpG-BINDING DOMAIN PROTEIN 3; MBD3,Asterisk
603574,METHYL-CpG-BINDING DOMAIN PROTEIN 4; MBD4,Asterisk
603575,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 5; NME5,Asterisk
603576,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 1; TRPM1",Asterisk
603577,NUCLEOLAR PROTEIN 4; NOL4,Asterisk
603578,OVIDUCTAL GLYCOPROTEIN 1; OVGP1,Asterisk
603579,RIO KINASE 3; RIOK3,Asterisk
603580,PROTOCADHERIN 8; PCDH8,Asterisk
603581,PROTOCADHERIN 9; PCDH9,Asterisk
603582,"TOPOISOMERASE, DNA, III, BETA; TOP3B",Asterisk
603583,"DISCS LARGE, DROSOPHILA, HOMOLOG OF, 2; DLG2",Asterisk
603584,MAP KINASE-ACTIVATING DEATH DOMAIN; MADD,Asterisk
603585,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F",Number Sign
603586,MOVED TO 603147,Caret
603587,"FOLLICULAR ATROPHODERMA, PERIORAL PIGMENTED, WITH MILIA AND EPIDERMOID CYSTS",
603588,"PAROTITIS, JUVENILE RECURRENT",
603589,"FACIAL DYSMORPHISM, SELECTIVE TOOTH AGENESIS, AND CHOROID CALCIFICATION",
603590,ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN; LARGE1,Asterisk
603591,UBIQUITIN-SPECIFIC PROTEASE 13; USP13,Asterisk
603592,"XANTHINURIA, TYPE II; XAN2",Number Sign
603593,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 7; SLC7A7",Asterisk
603594,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 4; TNFSF4",Asterisk
603595,CRANIOSYNOSTOSIS WITH ECTOPIA LENTIS,
603596,POLYDACTYLY,Number Sign
603597,SUPPRESSOR OF CYTOKINE SIGNALING 1; SOCS1,Asterisk
603598,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 10; TNFSF10",Asterisk
603599,CASP8- AND FADD-LIKE APOPTOSIS REGULATOR; CFLAR,Asterisk
603600,"OSTEOMA OF CRANIAL VAULT, FAMILIAL",
603601,"PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, ALPHA; PIK3C2A",Asterisk
603602,"PHOSPHOLIPASE A2, GROUP IVC; PLA2G4C",Asterisk
603603,"PHOSPHOLIPASE A2, GROUP X; PLA2G10",Asterisk
603604,"PHOSPHOLIPASE A2, GROUP VI; PLA2G6",Asterisk
603605,AMINOACYL-tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 1; AIMP1,Asterisk
603606,"RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 4; RPS6KA4",Asterisk
603607,"RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 5; RPS6KA5",Asterisk
603608,CARBONYL REDUCTASE 3; CBR3,Asterisk
603609,FUCOSE-1-PHOSPHATE GUANYLYLTRANSFERASE; FPGT,Asterisk
603610,"UNC5, C. ELEGANS, HOMOLOG OF, C; UNC5C",Asterisk
603611,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10A; TNFRSF10A",Asterisk
603612,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10B; TNFRSF10B",Asterisk
603613,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10C; TNFRSF10C",Asterisk
603614,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10D; TNFRSF10D",Asterisk
603615,"RAD54, S. CEREVISIAE, HOMOLOG-LIKE; RAD54L",Asterisk
603616,"RABAPTIN, RAB GTPase-BINDING EFFECTOR PROTEIN 1; RABEP1",Asterisk
603617,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 1; SLC24A1",Asterisk
603618,"CELL DIVISION CYCLE 20, S. CEREVISIAE, HOMOLOG OF; CDC20",Asterisk
603619,"FIZZY-RELATED PROTEIN, DROSOPHILA, HOMOLOG OF, 1; FZR1",Asterisk
603620,PC4- AND SFRS1-INTERACTING PROTEIN 1; PSIP1,Asterisk
603621,FORKHEAD BOX H1; FOXH1,Asterisk
603622,"DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17",Number Sign
603623,TYROSYL-tRNA SYNTHETASE; YARS,Asterisk
603624,RIBOSOMAL PROTEIN S2; RPS2,Asterisk
603625,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS H; LY6H",Asterisk
603626,PROTOCADHERIN 1; PCDH1,Asterisk
603627,"PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 3; PCDHGC3",Asterisk
603628,MUSCULIN; MSC,Asterisk
603629,"DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21",Number Sign
603630,RIBOSOMAL PROTEIN S5; RPS5,Asterisk
603631,RIBOSOMAL PROTEIN S9; RPS9,Asterisk
603632,RIBOSOMAL PROTEIN S10; RPS10,Asterisk
603633,RIBOSOMAL PROTEIN S29; RPS29,Asterisk
603634,RIBOSOMAL PROTEIN L5; RPL5,Asterisk
603635,"RNA, U21 SMALL NUCLEOLAR; RNU21",Asterisk
603636,RIBOSOMAL PROTEIN L21; RPL21,Asterisk
603637,RIBOSOMAL PROTEIN L27a; RPL27A,Asterisk
603638,RIBOSOMAL PROTEIN L28; RPL28,Asterisk
603639,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17; ADAM17,Asterisk
603640,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 19; ADAM19,Asterisk
603641,"NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA",
603642,"ATRIAL SEPTAL DEFECT, SECUNDUM, WITH VARIOUS CARDIAC AND NONCARDIAC DEFECTS",
603643,SITUS INVERSUS TOTALIS WITH CYSTIC DYSPLASIA OF KIDNEYS AND PANCREAS,
603644,SCO1 CYTOCHROME c OXIDASE ASSEMBLY PROTEIN; SCO1,Asterisk
603645,"GLUTAMYL-tRNA AMIDOTRANSFERASE, SUBUNIT B; GATB",Asterisk
603646,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX15; COX15,Asterisk
603647,"BCS1, S. CEREVISIAE, HOMOLOG-LIKE; BCS1L",Asterisk
603648,CYTOCHROME c OXIDASE COPPER CHAPERONE COX11; COX11,Asterisk
603649,CONE-ROD DYSTROPHY 7; CORD7,Number Sign
603650,BBS5 GENE; BBS5,Asterisk
603651,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 4; TRPC4",Asterisk
603652,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 6; TRPC6",Asterisk
603653,REMOVED FROM DATABASE,Caret
603654,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 7; SLC16A7",Asterisk
603655,MOVED TO 139391,Caret
603656,"EXOSTOSIS, DUPUYTREN SUBUNGUAL",
603657,VESICLE-ASSOCIATED MEMBRANE PROTEIN 3; VAMP3,Asterisk
603658,RIBOSOMAL PROTEIN S7; RPS7,Asterisk
603659,GLUCAGON-LIKE PEPTIDE 2 RECEPTOR; GLP2R,Asterisk
603660,RIBOSOMAL PROTEIN S12; RPS12,Asterisk
603661,RIBOSOMAL PROTEIN L17; RPL17,Asterisk
603662,RIBOSOMAL PROTEIN L23; RPL23,Asterisk
603663,MENTAL HEALTH WELLNESS 1,Percent
603664,MENTAL HEALTH WELLNESS 2,
603665,STANNIOCALCIN 2; STC2,Asterisk
603666,SYNTAXIN 16; STX16,Asterisk
603667,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12; SLC25A12",Asterisk
603668,SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 11; SCAF11,Asterisk
603669,ECCRINE SYRINGOFIBROADENOMATOSIS WITH EYELID ABNORMALITIES,
603670,"BLUE NEVI, FAMILIAL MULTIPLE",
603671,ACROMELIC FRONTONASAL DYSOSTOSIS; AFND,Number Sign
603672,"CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2, TRANSLOCATED TO, 2; CBFA2T2",Asterisk
603673,"PATCHED, DROSOPHILA, HOMOLOG OF, 2; PTCH2",Asterisk
603674,RIBOSOMAL PROTEIN S15a; RPS15A,Asterisk
603675,RIBOSOMAL PROTEIN S16; RPS16,Asterisk
603676,MOVED TO 181350,Caret
603677,MYELIN TRANSCRIPTION FACTOR 2; MYT2,Asterisk
603678,"DEAFNESS, AUTOSOMAL RECESSIVE 14; DFNB14",Percent
603679,UBIQUITIN-CONJUGATING ENZYME E2N; UBE2N,Asterisk
603680,ATAXIN 8 OPPOSITE STRAND; ATXN8OS,Asterisk
603681,OTOFERLIN; OTOF,Asterisk
603682,RIBOSOMAL PROTEIN S20; RPS20,Asterisk
603683,RIBOSOMAL PROTEIN S23; RPS23,Asterisk
603684,"LIPASE, ENDOTHELIAL; LIPG",Asterisk
603685,RIBOSOMAL PROTEIN S28; RPS28,Asterisk
603686,RIBOSOMAL PROTEIN L9; RPL9,Asterisk
603687,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A2; ALDH1A2",Asterisk
603688,PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY,Number Sign
603689,HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF,Number Sign
603690,"SOLUTE CARRIER FAMILY 33 (ACETYL-CoA TRANSPORTER), MEMBER 1; SLC33A1",Asterisk
603691,GALANIN RECEPTOR 2; GALR2,Asterisk
603692,GALANIN RECEPTOR 3; GALR3,Asterisk
603693,"ZINC FINGER PROTEIN, MULTITYPE 2; ZFPM2",Asterisk
603694,"DIABETES MELLITUS, NONINSULIN-DEPENDENT, 3",Percent
603695,"GUANYLATE CYCLASE 1, SOLUBLE, BETA-2; GUCY1B2",Asterisk
603696,SEPTIN 4; SEPT4,Asterisk
603697,"ARACHIDONATE 15-LIPOXYGENASE, SECOND TYPE; ALOX15B",Asterisk
603698,GOLGI-SPECIFIC BREFELDIN-A RESISTANCE FACTOR 1; GBF1,Asterisk
603699,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 11; WNT11",Asterisk
603700,ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN; ALOX5AP,Asterisk
603701,RIBOSOMAL PROTEIN S26; RPS26,Asterisk
603702,RIBOSOMAL PROTEIN S27; RPS27,Asterisk
603703,RIBOSOMAL PROTEIN L6; RPL6,Asterisk
603704,RIBOSOMAL PROTEIN L26; RPL26,Asterisk
603705,ANGIOPOIETIN 4; ANGPT4,Asterisk
603706,SEMAPHORIN 4F; SEMA4F,Asterisk
603707,MOLYBDENUM COFACTOR SYNTHESIS GENE 1; MOCS1,Asterisk
603708,MOLYBDENUM COFACTOR SYNTHESIS GENE 2; MOCS2,Asterisk
603709,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 22; ADAM22,Asterisk
603710,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 23; ADAM23,Asterisk
603711,"CYTOCHROME P450, FAMILY 7, SUBFAMILY B, POLYPEPTIDE 1; CYP7B1",Asterisk
603712,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 20; ADAM20,Asterisk
603713,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 21; ADAM21,Asterisk
603714,"SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 3; SIX3",Asterisk
603715,"GLIAL CELLS MISSING, DROSOPHILA, HOMOLOG OF, 1; GCM1",Asterisk
603716,"GLIAL CELLS MISSING, DROSOPHILA, HOMOLOG OF, 2; GCM2",Asterisk
603717,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 21-KD, V0 SUBUNIT C-PRIME, PRIME; ATP6V0B",Asterisk
603718,CLAUDIN 1; CLDN1,Asterisk
603719,"BUDDING UNINHIBITED BY BENZIMIDAZOLES 3, S. CEREVISIAE, HOMOLOG OF; BUB3",Asterisk
603720,"DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16",Number Sign
603721,UBIQUITIN-CONJUGATING ENZYME E2L 3; UBE2L3,Asterisk
603722,"INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE COMPLEX-ASSOCIATED PROTEIN; IKBKAP",Asterisk
603723,MOVED TO 300248,Caret
603724,MOVED TO 300827,Caret
603725,FIBROBLAST GROWTH FACTOR 17; FGF17,Asterisk
603726,FIBROBLAST GROWTH FACTOR 18; FGF18,Asterisk
603727,GLUTAMINYL-tRNA SYNTHETASE; QARS,Asterisk
603728,"NUMB, DROSOPHILA, HOMOLOG OF; NUMB",Asterisk
603729,SPHINGOSINE-1-PHOSPHATE LYASE 1; SGPL1,Asterisk
603730,SPHINGOSINE KINASE 1; SPHK1,Asterisk
603731,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 8; CNOT8",Asterisk
603732,CRYPTOCHROME 2; CRY2,Asterisk
603733,"SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 1; SLC43A1",Asterisk
603734,INTERFERON REGULATORY FACTOR 3; IRF3,Asterisk
603735,"AMINE OXIDASE, COPPER-CONTAINING, 3; AOC3",Asterisk
603736,"OHDO SYNDROME, SBBYS VARIANT; SBBYSS",Number Sign
603737,OVARIAN GERM CELL CANCER,
603738,BASIC TRANSCRIPTION FACTOR 3-LIKE 2; BTF3L2,Asterisk
603739,BASIC TRANSCRIPTION FACTOR 3-LIKE 3; BTF3L3,Asterisk
603740,"ACRODYSPLASIA WITH OSSIFICATION ABNORMALITIES, SHORT STATURE, AND FIBULAR HYPOPLASIA",
603741,"ARACHIDONATE 12-LIPOXYGENASE, R TYPE; ALOX12B",Asterisk
603742,"SLIT, DROSOPHILA, HOMOLOG OF, 1; SLIT1",Asterisk
603743,APOLIPOPROTEIN L-I; APOL1,Asterisk
603744,PAPILLARY THYROID MICROCARCINOMA,
603745,"SLIT, DROSOPHILA, HOMOLOG OF, 3; SLIT3",Asterisk
603746,"SLIT, DROSOPHILA, HOMOLOG OF, 2; SLIT2",Asterisk
603747,TUMOR PROTEIN D52-LIKE 2; TPD52L2,Asterisk
603748,MOVED TO 300297,Caret
603749,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 2; TRPM2",Asterisk
603750,AQUAPORIN 8; AQP8,Asterisk
603751,SPHINGOSINE-1-PHOSPHATE RECEPTOR 4; S1PR4,Asterisk
603752,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 4; SLC7A4",Asterisk
603753,UBIQUITINATION FACTOR E4A; UBE4A,Asterisk
603754,KINESIN FAMILY MEMBER 3B; KIF3B,Asterisk
603755,ZINC FINGER FYVE TYPE-CONTAINING PROTEIN 9; ZFYVE9,Asterisk
603756,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 2; ABCG2",Asterisk
603757,"CHEMOKINE, CC MOTIF, LIGAND 18; CCL18",Asterisk
603758,"GLUTATHIONE S-TRANSFERASE, ZETA-1; GSTZ1",Asterisk
603759,LIM HOMEOBOX GENE 2; LHX2,Asterisk
603760,"HYDROXYUREA-SENSITIVE 1, S. POMBE, HOMOLOG OF; HUS1",Asterisk
603761,"RAD9, S. POMBE, HOMOLOG OF, A; RAD9A",Asterisk
603762,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 2; PRPSAP2,Asterisk
603763,KINESIN FAMILY MEMBER C1; KIFC1,Asterisk
603764,"CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 2; CDK5R2",Asterisk
603765,SYNTAXIN 10; STX10,Asterisk
603766,MITOCHONDRIAL TRANSLATIONAL INITIATION FACTOR 2; MTIF2,Asterisk
603767,KALLIKREIN-RELATED PEPTIDASE 4; KLK4,Asterisk
603768,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12B; PPP1R12B",Asterisk
603769,T-CELL LYMPHOMA/LEUKEMIA 1B; TCL1B,Asterisk
603770,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1B; PPM1B",Asterisk
603771,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10; PPP1R10",Asterisk
603772,"DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 1; DYNC1I1",Asterisk
603773,"CYTOCHROME c OXIDASE, SUBUNIT 5A; COX5A",Asterisk
603774,"CYTOCHROME c OXIDASE, SUBUNIT 7C; COX7C",Asterisk
603775,CYCLIN E2; CCNE2,Asterisk
603776,"HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3",Number Sign
603777,"CERBERUS 1 HOMOLOG, CYSTINE KNOT SUPERFAMILY; CER1",Asterisk
603778,CHROMODOMAIN PROTEIN ON Y CHROMOSOME-LIKE; CDYL,Asterisk
603779,SYNUCLEIN-ALPHA-INTERACTING PROTEIN; SNCAIP,Asterisk
603780,RECQ PROTEIN-LIKE 4; RECQL4,Asterisk
603781,RECQ PROTEIN-LIKE 5; RECQL5,Asterisk
603782,"CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 1; CCL4L1",Asterisk
603783,INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1,Percent
603784,PITUITARY TUMOR-TRANSFORMING GENE 1 PROTEIN-INTERACTING PROTEIN; PTTG1IP,Asterisk
603785,MULTIPLE PDZ DOMAIN PROTEIN; MPDZ,Asterisk
603786,STARGARDT DISEASE 4; STGD4,Number Sign
603787,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY F, MEMBER 1; KCNF1",Asterisk
603788,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 1; KCNG1",Asterisk
603789,MOVED TO 300237,Caret
603790,"SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 1; SLC23A1",Asterisk
603791,"SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 2; SLC23A2",Asterisk
603792,MOVED TO 300885,Caret
603793,REMOVED FROM DATABASE,Caret
603794,"HYDROA VACCINIFORME, FAMILIAL",
603795,LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR-ALPHA FACTOR; LITAF,Asterisk
603796,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 2; KCNE2",Asterisk
603797,CARBOHYDRATE SULFOTRANSFERASE 1; CHST1,Asterisk
603798,CARBOHYDRATE SULFOTRANSFERASE 2; CHST2,Asterisk
603799,CARBOHYDRATE SULFOTRANSFERASE 3; CHST3,Asterisk
603800,MEDIATOR COMPLEX SUBUNIT 21; MED21,Asterisk
603801,N-MYRISTOYLTRANSFERASE 2; NMT2,Asterisk
603802,MICROCEPHALY WITH SIMPLIFIED GYRAL PATTERN,Percent
603803,"DACHSHUND, DROSOPHILA, HOMOLOG OF, 1; DACH1",Asterisk
603804,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 1; NEURL1,Asterisk
603805,TRANSGLUTAMINASE 5; TGM5,Asterisk
603806,"URINARY TRACT INFECTIONS, RECURRENT, SUSCEPTIBILITY TO",
603807,MOVED TO 107250,Caret
603808,MEDIATOR COMPLEX SUBUNIT 13; MED13,Asterisk
603809,THYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN 3; THRAP3,Asterisk
603810,MEDIATOR COMPLEX SUBUNIT 17; MED17,Asterisk
603811,BARRIER-TO-AUTOINTEGRATION FACTOR 1; BANF1,Asterisk
603812,DDB1- AND CUL4-ASSOCIATED FACTOR 5; DCAF5,Asterisk
603813,"HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH",Number Sign
603814,RING-BOX 1; RBX1,Asterisk
603815,KINESIN FAMILY MEMBER 25; KIF25,Asterisk
603816,AXIS INHIBITOR 1; AXIN1,Asterisk
603817,DEVELOPMENT- AND DIFFERENTIATION-ENHANCING FACTOR 2; DDEF2,Asterisk
603818,NEUREGULIN 2; NRG2,Asterisk
603819,STEROID RECEPTOR RNA ACTIVATOR 1; SRA1,Asterisk
603820,FREE FATTY ACID RECEPTOR 1; FFAR1,Asterisk
603821,FREE FATTY ACID RECEPTOR 3; FFAR3,Asterisk
603822,G PROTEIN-COUPLED RECEPTOR 42; GPR42,Asterisk
603823,FREE FATTY ACID RECEPTOR 2; FFAR2,Asterisk
603824,UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; GNE,Asterisk
603825,HYPERMETHYLATED IN CANCER 1; HIC1,Asterisk
603826,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 4; NR1H4",Asterisk
603827,BCL2-LIKE 11; BCL2L11,Asterisk
603828,BRITTLE BONE DISORDER,
603829,"VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1",Number Sign
603830,LONG QT SYNDROME 3; LQT3,Number Sign
603831,PDZ DOMAIN-CONTAINING 1; PDZK1,Asterisk
603832,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 3; NDUFA3",Asterisk
603833,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 4; NDUFA4",Asterisk
603834,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 9; NDUFA9",Asterisk
603835,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 10; NDUFA10",Asterisk
603836,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA/BETA SUBCOMPLEX, 1; NDUFAB1",Asterisk
603837,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 1; NDUFB1",Asterisk
603838,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 2; NDUFB2",Asterisk
603839,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 3; NDUFB3",Asterisk
603840,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 4; NDUFB4",Asterisk
603841,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 5; NDUFB5",Asterisk
603842,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 7; NDUFB7",Asterisk
603843,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 10; NDUFB10",Asterisk
603844,"NADH-UBIQUINONE OXIDOREDUCTASE 1, SUBUNIT C1; NDUFC1",Asterisk
603845,"NADH-UBIQUINONE OXIDOREDUCTASE 1, SUBUNIT C2; NDUFC2",Asterisk
603846,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 3; NDUFS3,Asterisk
603847,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 5; NDUFS5,Asterisk
603848,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 6; NDUFS6,Asterisk
603849,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 1; NR2E1",Asterisk
603850,DYNAMIN 1-LIKE; DNM1L,Asterisk
603851,PAIRED-LIKE HOMEOBOX 2B; PHOX2B,Asterisk
603852,TUMOR-SUPPRESSING SUBCHROMOSOMAL TRANSFERABLE FRAGMENT CANDIDATE GENE 4; TSSC4,Asterisk
603853,TETRASPANIN 32; TSPAN32,Asterisk
603854,RAN-BINDING PROTEIN 9; RANBP9,Asterisk
603855,"CYSTIC FIBROSIS, MODIFIER OF, 1; CFM1",Percent
603856,MAKORIN 3; MKRN3,Asterisk
603857,MKRN3 ANTISENSE RNA; MKRN3AS,Asterisk
603858,MOVED TO 256370,Caret
603859,"SOLUTE CARRIER FAMILY 25 (CITRIN), MEMBER 13; SLC25A13",Asterisk
603860,MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2,Number Sign
603861,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 15; SLC25A15",Asterisk
603862,CYCLIN T2; CCNT2,Asterisk
603863,RING FINGER PROTEIN 7; RNF7,Asterisk
603864,COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE; CCS,Asterisk
603865,GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 2; GFPT2,Asterisk
603866,PEROXISOME BIOGENESIS FACTOR 11A; PEX11A,Asterisk
603867,PEROXISOME BIOGENESIS FACTOR 11B; PEX11B,Asterisk
603868,RAS-ASSOCIATED PROTEIN RAB27A; RAB27A,Asterisk
603869,RAS-ASSOCIATED PROTEIN RAB27B; RAB27B,Asterisk
603870,"CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 3; CBFA2T3",Asterisk
603871,"BY THE RIBOSOMAL PROTEIN S6 GENE, DROSOPHILA, HOMOLOG-LIKE; BYSL",Asterisk
603872,TROPHININ-ASSOCIATED PROTEIN; TROAP,Asterisk
603873,PHOSPHOLIPASE A2-ACTIVATING PROTEIN; PLAA,Asterisk
603874,ANGIOPOIETIN-LIKE 1; ANGPTL1,Asterisk
603875,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 8; TNFSF8",Asterisk
603876,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 4; ADAMTS4",Asterisk
603877,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 3; SLC16A3",Asterisk
603878,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 4; SLC16A4",Asterisk
603879,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 5; SLC16A5",Asterisk
603880,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 6; SLC16A6",Asterisk
603881,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 3; NR1I3",Asterisk
603882,BCL2-ASSOCIATED ATHANOGENE 2; BAG2,Asterisk
603883,BCL2-ASSOCIATED ATHANOGENE 3; BAG3,Asterisk
603884,BCL2-ASSOCIATED ATHANOGENE 4; BAG4,Asterisk
603885,BCL2-ASSOCIATED ATHANOGENE 5; BAG5,Asterisk
603886,ARTEMIN; ARTN,Asterisk
603887,"TIMELESS, DROSOPHILA, HOMOLOG OF; TIMELESS",Asterisk
603888,"POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 3; KCNS3",Asterisk
603889,"SIGNAL REGULATORY PROTEIN, BETA-1; SIRPB1",Asterisk
603890,UBIQUITIN-CONJUGATING ENZYME E2L 6; UBE2L6,Asterisk
603891,FIBROBLAST GROWTH FACTOR 19; FGF19,Asterisk
603892,ELONGATION FACTOR Tu GTP-BINDING DOMAIN-CONTAINING 2; EFTUD2,Asterisk
603893,TRAF FAMILY MEMBER-ASSOCIATED NF-KAPPA-B ACTIVATOR; TANK,Asterisk
603894,REGULATOR OF G PROTEIN SIGNALING 6; RGS6,Asterisk
603895,REGULATOR OF G PROTEIN SIGNALING 11; RGS11,Asterisk
603896,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM,Number Sign
603897,MATRILIN 4; MATN4,Asterisk
603898,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 18; TNFSF18",Asterisk
603899,ZINC FINGER PROTEIN 85; ZNF85,Asterisk
603900,ZINC FINGER PROTEIN 174; ZNF174,Asterisk
603901,ZPR1 ZINC FINGER; ZPR1,Asterisk
603902,"BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE",Number Sign
603903,SICKLE CELL ANEMIA,Number Sign
603904,INTEGRAL MEMBRANE PROTEIN 2B; ITM2B,Asterisk
603905,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 18; TNFRSF18",Asterisk
603906,CHLORIDE CHANNEL ACCESSORY 1; CLCA1,Asterisk
603907,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 1; EIF2S1",Asterisk
603908,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 2; EIF2S2",Asterisk
603909,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A",Number Sign
603910,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT J; EIF3J",Asterisk
603911,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT I; EIF3I",Asterisk
603912,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT H; EIF3H",Asterisk
603913,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT G; EIF3G",Asterisk
603914,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT F; EIF3F",Asterisk
603915,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT D; EIF3D",Asterisk
603916,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT C; EIF3C",Asterisk
603917,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT B; EIF3B",Asterisk
603918,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1",Percent
603919,SERINE/THREONINE PROTEIN KINASE 10; STK10,Asterisk
603920,"CRYSTALLIN, ZETA-LIKE 1; CRYZL1",Asterisk
603921,"SUCCINATE-CoA LIGASE, ADP-FORMING, BETA SUBUNIT; SUCLA2",Asterisk
603922,"SUCCINATE-CoA LIGASE, GDP-FORMING, BETA SUBUNIT; SUCLG2",Asterisk
603923,MOVED TO 139260,Caret
603924,HYALURONAN-BINDING PROTEIN 2; HABP2,Asterisk
603925,SYNAPTOGYRIN 1; SYNGR1,Asterisk
603926,SYNAPTOGYRIN 2; SYNGR2,Asterisk
603927,SYNAPTOGYRIN 3; SYNGR3,Asterisk
603928,EUKARYOTIC TRANSLATION INITIATION FACTOR 4B; EIF4B,Asterisk
603929,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 3; EIF4G3",Asterisk
603930,GEPHYRIN; GPHN,Asterisk
603931,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E1; ATP6V0E1",Asterisk
603932,INTERVERTEBRAL DISC DISEASE; IDD,Number Sign
603933,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1",Number Sign
603934,COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; CARM1,Asterisk
603935,"PSORIASIS 4, SUSCEPTIBILITY TO; PSORS4",Percent
603936,GROWTH/DIFFERENTIATION FACTOR 11; GDF11,Asterisk
603937,RP1 GENE; RP1,Asterisk
603938,MOVED TO 300205,Caret
603939,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 6; KCNK6",Asterisk
603940,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 7; KCNK7",Asterisk
603941,"SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2; SLC19A2",Asterisk
603942,GLYCOGENIN 1; GYG1,Asterisk
603943,CYSTEINE DIOXYGENASE; CDO,Asterisk
603944,SYNTAXIN 6; STX6,Asterisk
603945,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5",Asterisk
603946,"HELICASE, LYMPHOID-SPECIFIC; HELLS",Asterisk
603947,METASTASIS-ASSOCIATED PROTEIN 2; MTA2,Asterisk
603948,"NUCLEOPORIN, 153-KD; NUP153",Asterisk
603949,RAB7-LIKE 1; RAB7L1,Asterisk
603950,N-DEACETYLASE/N-SULFOTRANSFERASE 3; NDST3,Asterisk
603951,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 1; KCNMB1",Asterisk
603952,DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 1; DRG1,Asterisk
603953,"POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 14; KCNJ14",Asterisk
603954,"ZESTE-WHITE 10, DROSOPHILA, HOMOLOG OF; ZW10",Asterisk
603955,FLAVIN-CONTAINING MONOOXYGENASE 2; FMO2,Asterisk
603956,CERVICAL CANCER,Number Sign
603957,FLAVIN-CONTAINING MONOOXYGENASE 5; FMO5,Asterisk
603958,"REGULATORY FACTOR X, 4; RFX4",Asterisk
603959,CLAUDIN 16; CLDN16,Asterisk
603960,CALICIN; CCIN,Asterisk
603961,SEMAPHORIN 3A; SEMA3A,Asterisk
603962,RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 1; RASGRP1,Asterisk
603963,"INTEGRIN, ALPHA-9; ITGA9",Asterisk
603964,"DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16",Percent
603965,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2,Number Sign
603966,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER C3; AKR1C3",Asterisk
603967,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, ALPHA SUBUNIT; SCN4A",Asterisk
603968,"POLYMERASE, DNA, ETA; POLH",Asterisk
603969,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B; TNFSF13B",Asterisk
603970,PARANEOPLASTIC MA ANTIGEN 2; PNMA2,Asterisk
603971,ZINC FINGER PROTEIN 91; ZNF91,Asterisk
603972,ZINC FINGER PROTEIN 43; ZNF43,Asterisk
603973,ZINC FINGER PROTEIN 90; ZNF90,Asterisk
603974,ZINC FINGER PROTEIN 92; ZNF92,Asterisk
603975,ZINC FINGER PROTEIN 93; ZNF93,Asterisk
603976,ZINC FINGER PROTEIN 94; ZNF94,Asterisk
603977,ZINC FINGER PROTEIN 208; ZNF208,Asterisk
603978,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 12; ZSCAN12,Asterisk
603979,ZINC FINGER PROTEIN 97; ZNF97,Asterisk
603980,ZINC FINGER PROTEIN 98; ZNF98,Asterisk
603981,ZINC FINGER PROTEIN 99; ZNF99,Asterisk
603982,ZINC FINGER PROTEIN 100; ZNF100,Asterisk
603983,ZINC FINGER PROTEIN 101; ZNF101,Asterisk
603984,ZINC FINGER PROTEIN 737; ZNF737,Asterisk
603985,ZINC FINGER PROTEIN 103; ZNF103,Asterisk
603986,REMOVED FROM DATABASE,Caret
603987,ZINC FINGER PROTEIN 105; ZNF105,Asterisk
603988,ZINC FINGER PROTEIN 106; ZNF106,Asterisk
603989,ZINC FINGER PROTEIN 107; ZNF107,Asterisk
603990,REMOVED FROM DATABASE,Caret
603991,ZINC FINGER PROTEIN 109; ZNF109,Asterisk
603992,ZINC FINGER PROTEIN 110; ZNF110,Asterisk
603993,ZINC FINGER PROTEIN 111; ZNF111,Asterisk
603994,ZINC FINGER PROTEIN 112; ZNF112,Asterisk
603995,ZINC FINGER PROTEIN 113; ZNF113,Asterisk
603996,ZINC FINGER PROTEIN 114; ZNF114,Asterisk
603997,ZINC FINGER PROTEIN 118; ZNF118,Asterisk
603998,ZINC FINGER PROTEIN 119; ZNF119,Asterisk
603999,ZINC FINGER PROTEIN 120; ZNF120,Asterisk
604000,ZINC FINGER PROTEIN 122; ZNF122,Asterisk
604001,A-KINASE ANCHOR PROTEIN 9; AKAP9,Asterisk
604002,RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 2; ROCK2,Asterisk
604003,CHLORIDE CHANNEL ACCESSORY 2; CLCA2,Asterisk
604004,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1,Number Sign
604005,MOVED TO 157640,Caret
604006,REMOVED FROM DATABASE,Caret
604007,REMOVED FROM DATABASE,Caret
604008,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-2; PTPRZ2",Asterisk
604009,BAI1-ASSOCIATED PROTEIN 3; BAIAP3,Asterisk
604010,PARANEOPLASTIC MA ANTIGEN 1; PNMA1,Asterisk
604011,"UNC119, C. ELEGANS, HOMOLOG OF; UNC119",Plus
604012,"RNA, U20 SMALL NUCLEOLAR; RNU20",Asterisk
604013,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 2; B4GALT2",Asterisk
604014,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 3; B4GALT3",Asterisk
604015,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4; B4GALT4",Asterisk
604016,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5; B4GALT5",Asterisk
604017,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 6; B4GALT6",Asterisk
604018,"NUMB, DROSOPHILA, HOMOLOG-LIKE; NUMBL",Asterisk
604019,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN WITH FG REPEATS 2; AGFG2,Asterisk
604020,"BASSOON, MOUSE, HOMOLOG OF; BSN",Asterisk
604021,MOVED TO 162662,Caret
604022,MOVED TO 162662,Caret
604023,MOVED TO 162662,Caret
604024,"SOLUTE CARRIER FAMILY 5 (SODIUM-DEPENDENT VITAMIN TRANSPORTER), MEMBER 6; SLC5A6",Asterisk
604025,AXIS INHIBITOR 2; AXIN2,Asterisk
604026,GOLGI SNAP RECEPTOR COMPLEX MEMBER 1; GOSR1,Asterisk
604027,GOLGI SNAP RECEPTOR COMPLEX MEMBER 2; GOSR2,Asterisk
604028,"SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG OF, C; SEC22C",Asterisk
604029,"SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG-LIKE 1; SEC22L1",Asterisk
604030,"PROTEASOME SUBUNIT, BETA-TYPE, 7; PSMB7",Asterisk
604031,STEAROYL-CoA DESATURASE; SCD,Asterisk
604032,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3; EIF2AK3,Asterisk
604033,ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 1; ERN1,Asterisk
604034,ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 2; ERN2,Asterisk
604035,CYLICIN 2; CYLC2,Asterisk
604036,CYCLIN A1; CCNA1,Asterisk
604037,RAS-ASSOCIATED PROTEIN RAB5C; RAB5C,Asterisk
604038,HYALURONOGLUCOSAMINIDASE 3; HYAL3,Asterisk
604039,MENINGIOMA-EXPRESSED ANTIGEN 5; MGEA5,Asterisk
604040,"RAD50, S. CEREVISIAE, HOMOLOG OF; RAD50",Asterisk
604041,MANNOSE-P-DOLICHOL UTILIZATION DEFECT 1; MPDU1,Asterisk
604042,"INTEGRIN, ALPHA-10; ITGA10",Asterisk
604043,NEVER IN MITOSIS GENE A-RELATED KINASE 2; NEK2,Asterisk
604044,NEVER IN MITOSIS GENE A-RELATED KINASE 3; NEK3,Asterisk
604045,PROTEIN ARGININE METHYLTRANSFERASE 5; PRMT5,Asterisk
604046,OXIDATIVE STRESS-RESPONSIVE 1; OXSR1,Asterisk
604047,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/URATE TRANSPORTER), MEMBER 13; SLC22A13",Asterisk
604048,"SOLUTE CARRIER FAMILY 22, MEMBER 14; SLC22A14",Asterisk
604049,"XYLULOKINASE, H. INFLUENZAE, HOMOLOG OF; XYLB",Asterisk
604050,DELETED IN LUNG AND ESOPHAGEAL CANCER 1; DLEC1,Asterisk
604051,"ENDO/EXONUCLEASE, ENDOG-LIKE; EXOG",Asterisk
604052,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 15; TNFSF15",Asterisk
604053,"3-PRIME(2-PRIME),5-PRIME-BISPHOSPHATE NUCLEOTIDASE 1; BPNT1",Asterisk
604054,ACETYL-CoA ACYLTRANSFERASE 1; ACAA1,Asterisk
604055,ISOPENTENYL-DIPHOSPHATE DELTA ISOMERASE 1; IDI1,Asterisk
604056,HEPARAN SULFATE (GLUCOSAMINE) 3-O-SULFOTRANSFERASE 2; HS3ST2,Asterisk
604057,HEPARAN SULFATE (GLUCOSAMINE) 3-O-SULFOTRANSFERASE 3A1; HS3ST3A1,Asterisk
604058,HEPARAN SULFATE (GLUCOSAMINE) 3-O-SULFOTRANSFERASE 3B1; HS3ST3B1,Asterisk
604059,HEPARAN SULFATE (GLUCOSAMINE) 3-O-SULFOTRANSFERASE 4; HS3ST4,Asterisk
604060,"DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20",Percent
604061,SEPTIN 9; SEPT9,Asterisk
604062,MEDIATOR COMPLEX SUBUNIT 16; MED16,Asterisk
604063,"INTEGRIN, ALPHA-8; ITGA8",Asterisk
604064,ACTIVATING TRANSCRIPTION FACTOR 4; ATF4,Asterisk
604065,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT; CACNA1G",Asterisk
604066,"UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5; B3GALT5",Asterisk
604067,REGULATOR OF G PROTEIN SIGNALING 9; RGS9,Asterisk
604068,TUMOR PROTEIN D52; TPD52,Asterisk
604069,TUMOR PROTEIN D52-LIKE 1; TPD52L1,Asterisk
604070,"DIACYLGLYCEROL KINASE, BETA, 90-KD; DGKB",Asterisk
604071,"DIACYLGLYCEROL KINASE, ETA, 130-KD; DGKH",Asterisk
604072,"DIACYLGLYCEROL KINASE, IOTA, 130-KD; DGKI",Asterisk
604073,ZINC FINGER PROTEIN 131; ZNF131,Asterisk
604074,ZINC FINGER PROTEIN 132; ZNF132,Asterisk
604075,ZINC FINGER PROTEIN 133; ZNF133,Asterisk
604076,ZINC FINGER PROTEIN 134; ZNF134,Asterisk
604077,ZINC FINGER PROTEIN 135; ZNF135,Asterisk
604078,ZINC FINGER PROTEIN 136; ZNF136,Asterisk
604079,ZINC FINGER PROTEIN 137; ZNF137,Asterisk
604080,ZINC FINGER PROTEIN 138; ZNF138,Asterisk
604081,MOVED TO 601260,Caret
604082,ZINC FINGER PROTEIN 140; ZNF140,Asterisk
604083,ZINC FINGER PROTEIN 142; ZNF142,Asterisk
604084,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 17; ZBTB17,Asterisk
604085,ZINC FINGER PROTEIN 154; ZNF154,Asterisk
604086,ZINC FINGER PROTEIN 155; ZNF155,Asterisk
604087,"CYTOCHROME P450, FAMILY 46, SUBFAMILY A, POLYPEPTIDE 1; CYP46A1",Asterisk
604088,PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 17; PP1R17,Asterisk
604089,HEMATOPOIETIC CELL SIGNAL TRANSDUCER; HCST,Asterisk
604090,"DISCS LARGE, DROSOPHILA, HOMOLOG OF, 5; DLG5",Asterisk
604091,"HYPOALPHALIPOPROTEINEMIA, PRIMARY",Number Sign
604092,TTK PROTEIN KINASE; TTK,Asterisk
604093,KERATOSIS PILARIS ATROPHICANS; KPA,Number Sign
604094,"MITOTIC ARREST-DEFICIENT 2, S. CEREVISIAE, HOMOLOG-LIKE 2; MAD2L2",Asterisk
604095,ECTODYSPLASIN A RECEPTOR; EDAR,Asterisk
604096,"GLUTAMATE RECEPTOR, METABOTROPIC, 6; GRM6",Asterisk
604097,UROTENSIN II; UTS2,Asterisk
604098,"SUPPRESSOR OF G2 ALLELE OF SKP1, S. CEREVISIAE, HOMOLOG OF; SUGT1",Asterisk
604099,"GLUTAMATE RECEPTOR, METABOTROPIC, 2; GRM2",Asterisk
604100,"GLUTAMATE RECEPTOR, METABOTROPIC, 4; GRM4",Asterisk
604101,"GLUTAMATE RECEPTOR, METABOTROPIC, 7; GRM7",Asterisk
604102,"GLUTAMATE RECEPTOR, METABOTROPIC, 5; GRM5",Asterisk
604103,MYOTILIN; MYOT,Asterisk
604104,"GLIA MATURATION FACTOR, GAMMA; GMFG",Asterisk
604105,SYNAPTONEMAL COMPLEX PROTEIN 2; SYCP2,Asterisk
604106,G PROTEIN-COUPLED RECEPTOR 52; GPR52,Asterisk
604107,G PROTEIN-COUPLED RECEPTOR 55; GPR55,Asterisk
604108,MICROTUBULE-ASSOCIATED PROTEIN 7; MAP7,Asterisk
604109,HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 1; HHLA1,Asterisk
604110,ADHESION G PROTEIN-COUPLED RECEPTOR G1; ADGRG1,Asterisk
604111,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 3; KCNAB3",Asterisk
604112,SCIELLIN; SCEL,Asterisk
604113,INTERLEUKIN 18-BINDING PROTEIN; IL18BP,Asterisk
604114,"PHOSPHOLIPASE C, BETA-2; PLCB2",Asterisk
604115,KCNQ1-OVERLAPPING TRANSCRIPT 1; KCNQ1OT1,Asterisk
604116,CONE-ROD DYSTROPHY 3; CORD3,Number Sign
604117,"VOHWINKEL SYNDROME, VARIANT FORM",Number Sign
604118,RAS PROTEIN ACTIVATOR-LIKE 1; RASAL1,Asterisk
604119,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 4; SLC12A4",Asterisk
604120,MOVED TO 600894,Caret
604121,"CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN",Number Sign
604122,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS B PROTEIN; PIGB,Asterisk
604123,RIBONUCLEASE H1; RNASEH1,Asterisk
604124,RETINOBLASTOMA-BINDING PROTEIN 8; RBBP8,Asterisk
604125,"SULFOTRANSFERASE FAMILY 2B, MEMBER 1; SULT2B1",Asterisk
604126,SUPERVILLIN; SVIL,Asterisk
604127,T-BOX 15; TBX15,Asterisk
604128,"TRANSCRIPTION ELONGATION FACTOR A, 3; TCEA3",Asterisk
604129,EPIDERMOLYSIS BULLOSA PRURIGINOSA,Number Sign
604130,UNDIFFERENTIATED EMBRYONIC CELL TRANSCRIPTION FACTOR 1; UTF1,Asterisk
604131,ALPHA-THALASSEMIA,Number Sign
604132,MOVED TO 300601,Caret
604133,MOVED TO 300288,Caret
604134,"A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 13; ADAMTS13",Asterisk
604135,NUCLEAR FACTOR ERYTHROID 2-LIKE 3; NFE2L3,Asterisk
604136,INTERLEUKIN 24; IL24,Asterisk
604137,MOVED TO 192150,Caret
604138,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER A; GPRC5A",Asterisk
604139,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 2; DNAJB2",Asterisk
604140,DEATH INDUCER-OBLITERATOR 1; DIDO1,Asterisk
604141,ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARFGEF1,Asterisk
604142,TYRO PROTEIN TYROSINE KINASE-BINDING PROTEIN; TYROBP,Asterisk
604143,EXTRA SPINDLE POLES-LIKE 1; ESPL1,Asterisk
604144,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 9; SLC7A9",Asterisk
604145,"CARDIOMYOPATHY, DILATED, 1G; CMD1G",Number Sign
604146,SYNAPTOTAGMIN 7; SYT7,Asterisk
604147,PITUITARY TUMOR-TRANSFORMING GENE 1; PTTG1,Asterisk
604148,"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 2; SLC13A2",Asterisk
604149,"SARCOGLYCAN, EPSILON; SGCE",Asterisk
604150,"POLYMERASE II, RNA, SUBUNIT J; POLR2J",Asterisk
604151,UBIQUITIN-CONJUGATING ENZYME E2E 3; UBE2E3,Asterisk
604152,ORNITHINE DECARBOXYLASE ANTIZYME 2; OAZ2,Asterisk
604153,NEUROMEDIN U RECEPTOR 1; NMUR1,Asterisk
604154,ALZHEIMER DISEASE WITHOUT NEUROFIBRILLARY TANGLES,
604155,LanC-LIKE 1; LANCL1,Asterisk
604156,SECRETED FRIZZLED-RELATED PROTEIN 1; SFRP1,Asterisk
604157,SECRETED FRIZZLED-RELATED PROTEIN 2; SFRP2,Asterisk
604158,SECRETED FRIZZLED-RELATED PROTEIN 5; SFRP5,Asterisk
604159,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 5; SLC6A5",Asterisk
604160,"INTEGRIN, BETA-8; ITGB8",Asterisk
604161,KISS1 RECEPTOR; KISS1R,Asterisk
604162,MOVED TO 600816,Caret
604163,RIBOSOMAL PROTEIN L3; RPL3,Asterisk
604164,ONE CUT HOMEOBOX 1; ONECUT1,Asterisk
604165,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, OXOGLUTARATE CARRIER), MEMBER 11; SLC25A11",Asterisk
604166,RIBOSOMAL PROTEIN L7; RPL7,Asterisk
604167,CCCTC-BINDING FACTOR; CTCF,Asterisk
604168,"CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN",Number Sign
604169,LEFT VENTRICULAR NONCOMPACTION 1; LVNC1,Number Sign
604170,PHOSPHOLIPID SCRAMBLASE 1; PLSCR1,Asterisk
604171,ALY/REF EXPORT FACTOR; ALYREF,Asterisk
604172,CARONTE,
604173,POIKILODERMA WITH NEUTROPENIA; PN,Number Sign
604174,RIBOSOMAL PROTEIN L15; RPL15,Asterisk
604175,RIBOSOMAL PROTEIN L11; RPL11,Asterisk
604176,SUPPRESSOR OF CYTOKINE SIGNALING 3; SOCS3,Asterisk
604177,RIBOSOMAL PROTEIN L8; RPL8,Asterisk
604178,RIBOSOMAL PROTEIN L18A; RPL18A,Asterisk
604179,RIBOSOMAL PROTEIN L18; RPL18,Asterisk
604180,RIBOSOMAL PROTEIN L24; RPL24,Asterisk
604181,RIBOSOMAL PROTEIN L37; RPL37,Asterisk
604182,RIBOSOMAL PROTEIN L38; RPL38,Asterisk
604183,"CHOLESTEATOMA, CONGENITAL",
604184,PUTATIVE NEURONAL CELL ADHESION MOLECULE; PUNC,Asterisk
604185,"FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2",Percent
604186,"CHEMOKINE, CXC MOTIF, LIGAND 14; CXCL14",Asterisk
604187,"SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10",Number Sign
604188,SELENIUM-BINDING PROTEIN 1; SELENBP1,Asterisk
604189,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 4; DNAJC4",Asterisk
604190,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 4; SLC22A4",Asterisk
604191,ZINC FINGER PROTEIN 263; ZNF263,Asterisk
604192,MOVED TO 603247,Caret
604193,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 3; SLC27A3",Asterisk
604194,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 4; SLC27A4",Asterisk
604195,MOVED TO 603314,Caret
604196,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 6; SLC27A6",Asterisk
604197,"5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE; MTHFS",Asterisk
604198,RAS-ASSOCIATED PROTEIN RAB11B; RAB11B,Asterisk
604199,RAS-ASSOCIATED PROTEIN RAB35; RAB35,Asterisk
604200,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 5; SIGLEC5,Asterisk
604201,"HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION",Percent
604202,"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 29-KD; SNAP29",Asterisk
604203,SYNTAXIN 8; STX8,Asterisk
604204,SYNTAXIN 17; STX17,Asterisk
604205,COPINE I; CPNE1,Asterisk
604206,COPINE II; CPNE2,Asterisk
604207,COPINE III; CPNE3,Asterisk
604208,COPINE IV; CPNE4,Asterisk
604209,COPINE V; CPNE5,Asterisk
604210,"CRUMBS, DROSOPHILA, HOMOLOG OF, 1; CRB1",Asterisk
604211,"HIRSCHSPRUNG DISEASE WITH HEART DEFECTS, LARYNGEAL ANOMALIES, AND PREAXIAL POLYDACTYLY",
604212,POLYADENYLATE-SPECIFIC RIBONUCLEASE; PARN,Asterisk
604213,CHUDLEY-MCCULLOUGH SYNDROME; CMCS,Number Sign
604214,KREV INTERACTION TRAPPED 1; KRIT1,Asterisk
604215,INHIBITOR OF GROWTH 2; ING2,Asterisk
604216,"SOLUTE CARRIER FAMILY 17, MEMBER 4; SLC17A4",Asterisk
604217,"SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 2; SLC34A2",Asterisk
604218,"ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB",Number Sign
604219,"CATARACT 9, MULTIPLE TYPES; CTRCT9",Number Sign
604220,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1A; ARPC1A",Asterisk
604221,ACTIN-RELATED PROTEIN 2; ACTR2,Asterisk
604222,ACTIN-RELATED PROTEIN 3; ACTR3,Asterisk
604223,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1B; ARPC1B",Asterisk
604224,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 2; ARPC2",Asterisk
604225,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 3; ARPC3",Asterisk
604226,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 4; ARPC4",Asterisk
604227,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5; ARPC5",Asterisk
604228,MOVED TO 607624,Caret
604229,ANTERIOR SEGMENT DYSGENESIS 5; ASGD5,Number Sign
604230,"ADENOSINE DEAMINASE, tRNA-SPECIFIC, 1; ADAT1",Asterisk
604231,PITUITARY TUMOR-TRANSFORMING GENE 2; PTTG2,Asterisk
604232,LEBER CONGENITAL AMAUROSIS 3; LCA3,Number Sign
604233,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1",Number Sign
604234,"INTEGRIN, BETA-LIKE 1; ITGBL1",Asterisk
604235,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 8; SLC7A8",Asterisk
604236,MOVED TO 604233,Caret
604237,CYTOKINE RECEPTOR-LIKE FACTOR 1; CRLF1,Asterisk
604238,"SNAIL, DROSOPHILA, HOMOLOG OF, 1; SNAI1",Asterisk
604239,PHOSPHOSERINE PHOSPHATASE-LIKE; PSPHL,Asterisk
604240,"T-CELL LEUKEMIA, HOMEOBOX 2; TLX2",Asterisk
604241,CD2-ASSOCIATED PROTEIN; CD2AP,Asterisk
604242,RING FINGER PROTEIN 6; RNF6,Asterisk
604243,MOVED TO 300594,Caret
604244,MOVED TO 300595,Caret
604245,MOVED TO 300596,Caret
604246,MOVED TO 300597,Caret
604247,MOVED TO 300598,Caret
604248,MOVED TO 300599,Caret
604249,RETICULON 3; RTN3,Asterisk
604250,"HEMOCHROMATOSIS, TYPE 3; HFE3",Number Sign
604251,CALCINEURIN-BINDING PROTEIN 1,Asterisk
604252,BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 1; BACE1,Asterisk
604253,"CASEIN KINASE I, GAMMA-3; CSNK1G3",Asterisk
604254,"DYSLEXIA, SUSCEPTIBILITY TO, 3; DYX3",Percent
604255,"LADY BIRD LATE, DROSOPHILA, HOMOLOG OF, 1",Asterisk
604256,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E40; BHLHE40",Asterisk
604257,CAMERA-MARUGO-COHEN SYNDROME,
604258,DELETED IN LIVER CANCER 1; DLC1,Asterisk
604259,PLEXIN C1; PLXNC1,Asterisk
604260,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B; STAT5B,Asterisk
604261,"AUTOPHAGY 5, S. CEREVISIAE, HOMOLOG OF; ATG5",Asterisk
604262,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 3; APBA3",Asterisk
604263,"PRION GENE COMPLEX, DOWNSTREAM; PRND",Asterisk
604264,CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 3; CELSR3,Asterisk
604265,CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 2; CELSR2,Asterisk
604266,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 6; MEGF6,Asterisk
604267,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 8; MEGF8,Asterisk
604268,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 9; MEGF9,Asterisk
604269,"FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 2; FAT2",Asterisk
604270,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 4; LRP4,Asterisk
604271,"GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP",Number Sign
604272,SCO2 CYTOCHROME c OXIDASE ASSEMBLY PROTEIN; SCO2,Asterisk
604273,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1",Number Sign
604274,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 1; KLRA1",Asterisk
604275,"CATENIN, DELTA-2; CTNND2",Asterisk
604276,PLAKOPHILIN 4; PKP4,Asterisk
604277,SPASTIN; SPAST,Asterisk
604278,"RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION",Number Sign
604279,JUNCTION-MEDIATING AND REGULATORY PROTEIN; JMY,Asterisk
604280,PLEXIN A4; PLXNA4,Asterisk
604281,"DBF4, S. CEREVISIAE, HOMOLOG OF; DBF4",Asterisk
604282,PLEXIN D1; PLXND1,Asterisk
604283,PROTEOGLYCAN 4; PRG4,Asterisk
604284,MOVED TO 137920,Caret
604285,ALANINE-GLYOXYLATE AMINOTRANSFERASE; AGXT,Asterisk
604286,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4; LGMDR4",Number Sign
604287,CARNEY TRIAD,
604288,"CARDIOMYOPATHY, DILATED, 1H; CMD1H",Percent
604289,"RAD54, S. CEREVISIAE, HOMOLOG OF, B",Asterisk
604290,ACERULOPLASMINEMIA,Number Sign
604291,"ASCARIS LUMBRICOIDES INFECTION, SUSCEPTIBILITY TO",
604292,"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3",Number Sign
604293,PLEXIN B2; PLXNB2,Asterisk
604294,VENTRAL ANTERIOR HOMEOBOX 1; VAX1,Asterisk
604295,VENTRAL ANTERIOR HOMEOBOX 2; VAX2,Asterisk
604296,GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE; GRHPR,Asterisk
604297,SYNAPTOJANIN 1; SYNJ1,Asterisk
604298,SIGNAL TRANSDUCING ADAPTOR FAMILY MEMBER 1; STAP1,Asterisk
604299,"ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 1; APPL1",Asterisk
604300,2-HYDROXYACYL-CoA LYASE 1; HACL1,Asterisk
604301,OCULOMEDIN; OCLM,Asterisk
604302,"RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE",Number Sign
604303,ACTIN-LIKE 7A; ACTL7A,Asterisk
604304,ACTIN-LIKE 7B; ACTL7B,Asterisk
604305,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-1; HLA-DQB1",Asterisk
604306,FAS APOPTOTIC INHIBITORY MOLECULE 2; FAIM2,Asterisk
604307,"CATARACT 2, MULTIPLE TYPES; CTRCT2",Number Sign
604308,MASS SYNDROME,Number Sign
604309,"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 4; SLC13A4",Asterisk
604310,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 6; BLOC1S6",Asterisk
604311,MEDIATOR COMPLEX SUBUNIT 1; MED1,Asterisk
604312,CYSTATIN 3; CST3,Asterisk
604313,GALACTOKINASE 1; GALK1,Asterisk
604314,BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION,Percent
604315,"ANEMIA, CONGENITAL HYPOPLASTIC, WITH MULTIPLE CONGENITAL ANOMALIES/MENTAL RETARDATION SYNDROME",
604316,"PSORIASIS 5, SUSCEPTIBILITY TO; PSORS5",Percent
604317,"MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2",Number Sign
604318,GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 1; GTF2IRD1,Asterisk
604319,TRF1-INTERACTING NUCLEAR FACTOR 2; TINF2,Asterisk
604320,"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1",Number Sign
604321,"MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4",Number Sign
604322,"SOLUTE CARRIER FAMILY 17 (ACIDIC SUGAR TRANSPORTER), MEMBER 5; SLC17A5",Asterisk
604323,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 3; ABCC3",Asterisk
604324,"ACNE, ADULT",
604325,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, BETA; PPP2R2B",Asterisk
604326,SPINOCEREBELLAR ATAXIA 12; SCA12,Number Sign
604327,"BETA-1,4-GALACTOSYLTRANSFERASE 7; B4GALT7",Asterisk
604328,STRUCTURE-SPECIFIC RECOGNITION PROTEIN 1; SSRP1,Asterisk
604329,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2",Percent
604330,GRB2-RELATED ADAPTOR PROTEIN; GRAP,Asterisk
604331,INTEGRATOR COMPLEX SUBUNIT 6; INTS6,Asterisk
604332,CYSTEINE-RICH HYDROPHOBIC DOMAIN PROTEIN 2; CHIC2,Asterisk
604333,WD40 REPEAT-CONTAINING PROTEIN CIAO1; CIAO1,Asterisk
604334,UBIQUITIN-SPECIFIC PROTEASE 6; USP6,Asterisk
604335,REFLEX SYMPATHETIC DYSTROPHY,
604336,TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY; TPTE,Asterisk
604337,"CHLORIDE CHANNEL ACCESSORY 3, PSEUDOGENE; CLCA3P",Asterisk
604338,REMOVED FROM DATABASE,Caret
604339,REMOVED FROM DATABASE,Caret
604340,REMOVED FROM DATABASE,Caret
604341,REMOVED FROM DATABASE,Caret
604342,REMOVED FROM DATABASE,Caret
604343,REMOVED FROM DATABASE,Caret
604344,"MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 1; MAN1A1",Asterisk
604345,"MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 2; MAN1A2",Asterisk
604346,"MANNOSIDASE, ALPHA, CLASS 1B, MEMBER 1; MAN1B1",Asterisk
604347,ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 2; ZRANB2,Asterisk
604348,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1",Number Sign
604349,"LAMININ, GAMMA-3; LAMC3",Asterisk
604350,RAS-ASSOCIATED PROTEIN RAB3D; RAB3D,Asterisk
604351,PHD FINGER PROTEIN 2; PHF2,Asterisk
604352,"FEBRILE SEIZURES, FAMILIAL, 4; FEB4",Number Sign
604353,CYSTEINE- AND HISTIDINE-RICH DOMAIN-CONTAINING PROTEIN 1; CHORDC1,Asterisk
604354,NUCLEAR FMRP-INTERACTING PROTEIN 1; NUFIP1,Asterisk
604355,"COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2; COPG2",Asterisk
604356,DUANE RETRACTION SYNDROME 2; DURS2,Number Sign
604357,"MAB21, C. ELEGANS, HOMOLOG-LIKE 2; MAB21L2",Asterisk
604358,STROMAL ANTIGEN 1; STAG1,Asterisk
604359,MOVED TO 300826,Caret
604360,"SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11",Number Sign
604361,MOVED TO 600638,Caret
604362,LIM DOMAIN ONLY 7; LMO7,Asterisk
604363,"MYOCLONIC EPILEPSY, CONGENITAL DEAFNESS, MACULAR DYSTROPHY, AND PSYCHIATRIC DISORDERS",
604364,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1",Number Sign
604365,PROMININ 1; PROM1,Asterisk
604366,"DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 1; DNAI1",Asterisk
604367,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3",Number Sign
604368,GLYCOPROTEIN NMB; GPNMB,Asterisk
604369,SALLA DISEASE; SD,Number Sign
604370,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1",Number Sign
604371,HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 2; HHLA2,Asterisk
604372,HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 3; HHLA3,Asterisk
604373,"CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2",Plus
604374,"METALLOTHIONEIN-LIKE 5, TESTIS-SPECIFIC; MTL5",Asterisk
604375,HUMAN GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE; HGS,Asterisk
604376,MYELIN PROTEIN ZERO-LIKE 1; MPZL1,Asterisk
604377,"CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1",Number Sign
604378,BECLIN 1; BECN1,Asterisk
604379,HYPOTRICHOSIS 7; HYPT7,Number Sign
604380,ULNAR RAY DYSGENESIS WITH POSTAXIAL POLYDACTYLY AND RENAL CYSTIC DYSPLASIA,
604381,PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES,
604382,"LISSENCEPHALY, FAMILIAL, WITH CLEFT PALATE AND CEREBELLAR HYPOPLASIA",
604383,GROWTH FACTOR-INDEPENDENT 1B; GFI1B,Asterisk
604384,"ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 1; ATP2C1",Asterisk
604385,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE XI, ALPHA SUBUNIT; SCN11A",Asterisk
604386,ZINC FINGER TRANSCRIPTION FACTOR TRPS1; TRPS1,Asterisk
604387,NEPHRONOPHTHISIS 3; NPHP3,Number Sign
604388,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-4; GNG4",Asterisk
604389,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-10; GNG10",Asterisk
604390,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-11; GNG11",Asterisk
604391,ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1,Number Sign
604392,ARYLHYDROCARBON-INTERACTING RECEPTOR PROTEIN-LIKE 1; AIPL1,Asterisk
604393,LEBER CONGENITAL AMAUROSIS 4; LCA4,Number Sign
604394,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-12; GNA12",Asterisk
604395,"MutL, E. COLI, HOMOLOG OF, 3; MLH3",Asterisk
604396,"SET DOMAIN PROTEIN, BIFURCATED, 1; SETDB1",Asterisk
604397,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-14; GNA14",Asterisk
604398,"SECRETOGLOBIN, FAMILY 2A, MEMBER 1; SCGB2A1",Asterisk
604399,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1B; PPP1R1B",Asterisk
604400,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5",Number Sign
604401,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6; ARVD6",Percent
604402,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 5; ST3GAL5",Asterisk
604403,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2",Number Sign
604404,GLYPICAN 6; GPC6,Asterisk
604405,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 6; SIGLEC6,Asterisk
604406,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-13; GNA13",Asterisk
604407,LEUCINE ZIPPER/EF-HAND-CONTAINING TRANSMEMBRANE PROTEIN 1; LETM1,Asterisk
604408,MOVED TO 600610,Caret
604409,GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 1; GMEB1,Asterisk
604410,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 7; SIGLEC7,Asterisk
604411,INNER CENTROMERE PROTEIN; INCENP,Asterisk
604412,T-CELL LEUKEMIA/LYMPHOMA 6; TCL6,Asterisk
604413,MOVED TO 604412,Caret
604414,"POLYMERASE II, RNA, SUBUNIT F; POLR2F",Asterisk
604415,SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE; STEAP,Asterisk
604416,"PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE",Number Sign
604417,"AF4/FMR2 FAMILY, MEMBER 4; AFF4",Asterisk
604418,"GAP JUNCTION PROTEIN, BETA-6; GJB6",Asterisk
604419,"POLYMERASE, DNA, THETA; POLQ",Asterisk
604420,HEMATOPOIETICALLY EXPRESSED HOMEOBOX; HHEX,Asterisk
604421,PHOSDUCIN-LIKE; PDCL,Asterisk
604422,PANCREATIC LIPASE-RELATED PROTEIN 1; PNLIPRP1,Asterisk
604423,PANCREATIC LIPASE-RELATED PROTEIN 2; PNLIPRP2,Asterisk
604424,HOMEODOMAIN-INTERACTING PROTEIN KINASE 3; HIPK3,Asterisk
604425,LIM HOMEOBOX GENE 8; LHX8,Asterisk
604426,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 2; CYP4F2",Asterisk
604427,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE X, ALPHA SUBUNIT; SCN10A",Asterisk
604428,MOVED TO 300935,Caret
604429,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 2; PRRG2,Asterisk
604430,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-7; GNG7",Asterisk
604431,"POLYNEUROPATHY, LETHAL NEONATAL, AXONAL SENSORIMOTOR, AUTOSOMAL RECESSIVE",Percent
604432,SPINOCEREBELLAR ATAXIA 11; SCA11,Number Sign
604433,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 3; KCNE3",Asterisk
604434,KALLIKREIN-RELATED PEPTIDASE 11; KLK11,Asterisk
604435,MOVED TO 164010,Caret
604436,"PROLINE SYNTHETASE COTRANSCRIBED, BACTERIA, HOMOLOG OF; PROSC",Asterisk
604437,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 3; SLC38A3",Asterisk
604438,KALLIKREIN-RELATED PEPTIDASE 7; KLK7,Asterisk
604439,GRB2-ASSOCIATED BINDING PROTEIN 1; GAB1,Asterisk
604440,CELL DEATH-INDUCING DFFA-LIKE EFFECTOR A; CIDEA,Asterisk
604441,CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B; CIDEB,Asterisk
604442,MOVED TO 144700,Caret
604443,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 6; ACSL6",Asterisk
604444,"BMP AND ACTIVIN MEMBRANE-BOUND INHIBITOR, XENOPUS, HOMOLOG OF; BAMBI",Asterisk
604445,PROTEASE INHIBITOR 13; PI13,Asterisk
604446,PHOSPHOTRIESTERASE-RELATED PROTEIN; PTER,Asterisk
604447,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-5; GNB5",Asterisk
604448,CYTOHESIN 1-INTERACTING PROTEIN; CYTIP,Asterisk
604449,"PROTEASOME 26S SUBUNIT, NON-ATPase, 11; PSMD11",Asterisk
604450,"PROTEASOME 26S SUBUNIT, NON-ATPase, 12; PSMD12",Asterisk
604451,"BASAL CELL CARCINOMA, INFUNDIBULOCYSTIC",
604452,"PROTEASOME 26S SUBUNIT, NON-ATPase, 5; PSMD5",Asterisk
604453,"NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 2; NR5A2",Asterisk
604454,WELANDER DISTAL MYOPATHY; WDM,Number Sign
604455,SARCOSINE DEHYDROGENASE; SARDH,Asterisk
604456,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 1; IFITM1,Asterisk
604457,NUCLEAR BODY PROTEIN SP110; SP110,Asterisk
604458,MOVED TO 604457,Caret
604459,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 3; IRAK3,Asterisk
604460,FAS-ASSOCIATED FACTOR 1; FAF1,Asterisk
604461,HUMAN PAPILLOMAVIRUS TYPE 6A INTEGRATION SITE 1; HPV6AI1,Asterisk
604462,SEMAPHORIN 4C; SEMA4C,Asterisk
604463,CD160 ANTIGEN; CD160,Asterisk
604464,INTERSECTIN 2; ITSN2,Asterisk
604465,"SH3 DOMAIN, GRB2-LIKE, 2; SH3GL2",Asterisk
604466,METHYLTRANSFERASE-LIKE 1; METTL1,Asterisk
604467,MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN; MMD,Asterisk
604468,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 6; MAP3K6,Asterisk
604469,EXOCYST COMPLEX COMPONENT 5; EXOC5,Asterisk
604470,CD2 ANTIGEN-BINDING PROTEIN 2; CD2BP2,Asterisk
604471,"SOLUTE CARRIER FAMILY 1 (GLUTAMATE TRANSPORTER), MEMBER 7; SLC1A7",Asterisk
604472,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13; TNFSF13",Asterisk
604473,"GLUTAMATE RECEPTOR, METABOTROPIC, 1; GRM1",Asterisk
604474,"HUMAN HERPESVIRUS TYPE 6, INTEGRATED",
604475,RETICULON 4; RTN4,Asterisk
604476,MOVED TO 604350,Caret
604477,CHROMOBOX HOMOLOG 3; CBX3,Asterisk
604478,CHROMOBOX HOMOLOG 5; CBX5,Asterisk
604479,SIRTUIN 1; SIRT1,Asterisk
604480,SIRTUIN 2; SIRT2,Asterisk
604481,SIRTUIN 3; SIRT3,Asterisk
604482,SIRTUIN 4; SIRT4,Asterisk
604483,SIRTUIN 5; SIRT5,Asterisk
604484,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO",Number Sign
604485,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 3; NR2E3",Asterisk
604486,"PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, MITOCHONDRIAL; PPIF",Asterisk
604487,OTOGELIN; OTOG,Asterisk
604488,TITIN-CAP; TCAP,Asterisk
604489,ALPHA-METHYLACYL-CoA RACEMASE; AMACR,Asterisk
604490,SACSIN; SACS,Asterisk
604491,CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE B; CBLB,Asterisk
604492,VOLTAGE-DEPENDENT ANION CHANNEL 1; VDAC1,Asterisk
604493,"GAP JUNCTION PROTEIN, BETA-5; GJB5",Asterisk
604494,INTERLEUKIN 18 RECEPTOR 1; IL18R1,Asterisk
604495,"NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, BETA; NFKBIB",Asterisk
604496,NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 1; NKIRAS1,Asterisk
604497,NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 2; NKIRAS2,Asterisk
604498,"AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT",Number Sign
604499,"HYPERLIPIDEMIA, COMBINED, 2",Percent
604500,ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 3; ZNHIT3,Asterisk
604501,THYROID HORMONE RECEPTOR INTERACTOR 4; TRIP4,Asterisk
604502,HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 3; HMGN3,Asterisk
604503,JUMONJI DOMAIN-CONTAINING PROTEIN 1C; JMJD1C,Asterisk
604504,THYROID HORMONE RECEPTOR INTERACTOR 10; TRIP10,Asterisk
604505,THYROID HORMONE RECEPTOR INTERACTOR 11; TRIP11,Asterisk
604506,THYROID HORMONE RECEPTOR INTERACTOR 12; TRIP12,Asterisk
604507,THYROID HORMONE RECEPTOR INTERACTOR 13; TRIP13,Asterisk
604508,"COP9 SIGNALOSOME, SUBUNIT 2; COPS2",Asterisk
604509,INTERLEUKIN 18 RECEPTOR ACCESSORY PROTEIN; IL18RAP,Asterisk
604510,HYALURONOGLUCOSAMINIDASE 4; HYAL4,Asterisk
604511,CHROMOBOX HOMOLOG 1; CBX1,Asterisk
604512,INTERLEUKIN 1 RECEPTOR-LIKE 2; IL1RL2,Asterisk
604513,CD84 ANTIGEN; CD84,Asterisk
604514,SH2 DOMAIN PROTEIN 2A; SH2D2A,Asterisk
604515,B-CELL LINKER PROTEIN; BLNK,Asterisk
604516,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 2; IGSF2",Asterisk
604517,"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, ALPHA; PPARGC1A",Asterisk
604518,GRB2-RELATED ADAPTOR PROTEIN 2; GRAP2,Asterisk
604519,INFLAMMATORY BOWEL DISEASE 3; IBD3,Percent
604520,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14; TNFSF14",Asterisk
604521,"3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE; HAAO",Asterisk
604522,"DEFENSIN, ALPHA, 3; DEFA3",Asterisk
604523,CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 1; CELSR1,Asterisk
604524,LYMPHOCYTE ANTIGEN 75; LY75,Asterisk
604525,HISTAMINE RECEPTOR H3; HRH3,Asterisk
604526,"ISOCITRATE DEHYDROGENASE 3, BETA SUBUNIT; IDH3B",Asterisk
604527,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 3; KCNH3",Asterisk
604528,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 4; KCNH4",Asterisk
604529,"ORTHOPEDIA, DROSOPHILA, HOMOLOG OF; OTP",Asterisk
604530,NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1,Asterisk
604531,NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NCR2,Asterisk
604532,POLYCYSTIN 2-LIKE 1; PKD2L1,Asterisk
604533,"INTERFERON-STIMULATED GENE, 20-KD; ISG20",Asterisk
604534,CD83 ANTIGEN; CD83,Asterisk
604535,KINESIN FAMILY MEMBER C3; KIFC3,Asterisk
604536,ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME,Number Sign
604537,LEBER CONGENITAL AMAUROSIS 5; LCA5,Number Sign
604538,KINESIN FAMILY MEMBER 2C; KIF2C,Asterisk
604539,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 2; ADAMTS2",Asterisk
604540,"KERATIN 36, TYPE I; KRT36",Asterisk
604541,"KERATIN 37, TYPE I; KRT37",Asterisk
604542,"KERATIN 38, TYPE I; KRT38",Asterisk
604543,LIM DOMAIN-CONTAINING PROTEIN 1; LIMD1,Asterisk
604544,LEUCYL-tRNA SYNTHETASE 2; LARS2,Asterisk
604545,KARYOPHERIN ALPHA-5; KPNA5,Asterisk
604546,TONSOKU-LIKE DNA REPAIR PROTEIN; TONSL,Asterisk
604547,"VAN DER WOUDE SYNDROME 1, MODIFIER OF",Percent
604548,"NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, EPSILON; NFKBIE",Asterisk
604549,MOVED TO 172471,Caret
604550,DENSITY-REGULATED PROTEIN; DENR,Asterisk
604551,CHOLESTEROL 25-HYDROXYLASE; CH25H,Asterisk
604552,HEPATOCYTE GROWTH FACTOR ACTIVATOR; HGFAC,Asterisk
604553,HEAT-SHOCK FACTOR-BINDING PROTEIN 1; HSBP1,Asterisk
604554,HEAT-SHOCK TRANSCRIPTION FACTOR 2-BINDING PROTEIN; HSF2BP,Asterisk
604555,CADHERIN 10; CDH10,Asterisk
604556,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1B; DYRK1B,Asterisk
604557,ZINC FINGER PROTEIN 423; ZNF423,Asterisk
604558,INDUCIBLE T-CELL COSTIMULATOR; ICOS,Asterisk
604559,"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B",Number Sign
604560,MOVED TO 604453,Caret
604561,"ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B; MGAT4B",Asterisk
604562,APOPTOTIC CHROMATIN CONDENSATION INDUCER 1; ACIN1,Asterisk
604563,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2",Number Sign
604564,"GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 3; MGST3",Asterisk
604565,"ALG5, S. CEREVISIAE, HOMOLOG OF; ALG5",Asterisk
604566,"ALG6, S. CEREVISIAE, HOMOLOG OF; ALG6",Asterisk
604567,"DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, ALPHA; DOC2A",Asterisk
604568,"DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, BETA; DOC2B",Asterisk
604569,CONTACTIN-ASSOCIATED PROTEIN-LIKE 2; CNTNAP2,Asterisk
604570,SHROOM FAMILY MEMBER 3; SHROOM3,Asterisk
604571,"BARE LYMPHOCYTE SYNDROME, TYPE I",Number Sign
604572,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 1; DNAJB1",Asterisk
604573,CHROMOSOME 14 OPEN READING FRAME 2; C14ORF2,Asterisk
604574,FERRIC CHELATE REDUCTASE 1-LIKE; FRRS1L,Asterisk
604575,ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 2; ZNHIT2,Asterisk
604576,ERGOSTEROL BIOSYNTHESIS 28 HOMOLOG; ERG28,Asterisk
604577,BLOOD VESSEL EPICARDIAL SUBSTANCE; BVES,Asterisk
604578,ABSENT IN MELANOMA 2; AIM2,Asterisk
604579,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 4; FZD4",Asterisk
604580,FIBULIN 5; FBLN5,Asterisk
604581,ATPase FAMILY GENE 3-LIKE 2; AFG3L2,Asterisk
604582,A-KINASE ANCHOR PROTEIN 2; AKAP2,Asterisk
604583,PROGRAMMED CELL DEATH 5; PDCD5,Asterisk
604584,PLATELET-DERIVED GROWTH FACTOR RECEPTOR-LIKE; PDGFRL,Asterisk
604585,NUCLEAR BODY PROTEIN SP100; SP100,Asterisk
604586,SYNTAXIN-BINDING PROTEIN 5; STXBP5,Asterisk
604587,CALCIUM BINDING AND COILED-COIL DOMAIN PROTEIN 2; CALCOCO2,Asterisk
604588,NEVER IN MITOSIS GENE A-RELATED KINASE 1; NEK1,Asterisk
604589,BROMODOMAIN-CONTAINING PROTEIN 1; BRD1,Asterisk
604590,"Fc FRAGMENT OF IgG, LOW AFFINITY IIb, RECEPTOR FOR; FCGR2B",Asterisk
604591,PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 1; PEBP1,Asterisk
604592,T CELL IMMUNE REGULATOR 1; TCIRG1,Asterisk
604593,KINESIN FAMILY MEMBER 5C; KIF5C,Asterisk
604594,CYSTEINE-RICH PDZ DOMAIN-BINDING PROTEIN; CRIPT,Asterisk
604595,CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1,Percent
604596,CMT1A DUPLICATED REGION TRANSCRIPT 1; CDRT1,Asterisk
604597,GLUTAMATE RECEPTOR-INTERACTING PROTEIN 1; GRIP1,Asterisk
604598,OXIDATIVE STRESS-INDUCED GROWTH INHIBITOR FAMILY MEMBER 2; OSGIN2,Asterisk
604599,EUCHROMATIC HISTONE-LYSINE N-METHYLTRANSFERASE 2; EHMT2,Asterisk
604600,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 5; TRPM5",Asterisk
604601,"TRANSLATIONAL RELEASE FACTOR, MITOCHONDRIAL, 1; MTRF1",Asterisk
604602,"RIBOSOME-RECYCLING FACTOR, MITOCHONDRIAL; MRRF",Asterisk
604603,"FER-1, C. ELEGANS, HOMOLOG-LIKE 3; FER1L3",Asterisk
604604,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 9; SLC30A9",Asterisk
604605,KALIRIN; KALRN,Asterisk
604606,ODORANT-BINDING PROTEIN 2B; OBP2B,Asterisk
604607,HOMEOBOX B13; HOXB13,Asterisk
604608,MOVED TO 604609,Caret
604609,MUCIN 12; MUC12,Asterisk
604610,RECQ PROTEIN-LIKE 3; RECQL3,Asterisk
604611,RECQ PROTEIN-LIKE 2; RECQL2,Asterisk
604612,NK2 HOMEOBOX 2; NKX2-2,Asterisk
604613,T-BOX 18; TBX18,Asterisk
604614,T-BOX 19; TBX19,Asterisk
604615,"EOMESODERMIN, XENOPUS, HOMOLOG OF; EOMES",Asterisk
604616,"T-BOX, BRAIN, 1; TBR1",Asterisk
604617,NEURAMINIDASE 3; NEU3,Asterisk
604618,NITRILASE 1; NIT1,Asterisk
604619,"LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 1; LGI1",Asterisk
604620,G PROTEIN-COUPLED RECEPTOR 65; GPR65,Asterisk
604621,"BETA-1,4-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT3",Asterisk
604622,MOVED TO 606519,Caret
604623,"ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME A; MGAT4A",Asterisk
604624,HEAT-SHOCK 27-KD PROTEIN 3; HSPB3,Asterisk
604625,"TOOTH AGENESIS, SELECTIVE, 3; STHAG3",Number Sign
604626,MALIC ENZYME 3; ME3,Asterisk
604627,INTERLEUKIN 17B; IL17B,Asterisk
604628,INTERLEUKIN 17C; IL17C,Asterisk
604629,MATRIX METALLOPROTEINASE 20; MMP20,Asterisk
604630,"NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; NR0B2",Asterisk
604631,VESICLE AMINE TRANSPORT PROTEIN 1; VAT1,Asterisk
604632,"VAC14, S. CEREVISIAE, HOMOLOG OF; VAC14",Asterisk
604633,EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 2; EFEMP2,Asterisk
604634,TRANSGELIN 2; TAGLN2,Asterisk
604635,NEUREXOPHILIN 2; NXPH2,Asterisk
604636,NEUREXOPHILIN 3; NXPH3,Asterisk
604637,NEUREXOPHILIN 4; NXPH4,Asterisk
604638,"ACTININ, ALPHA-4; ACTN4",Asterisk
604639,NEUREXOPHILIN 1; NXPH1,Asterisk
604640,T-CELL LEUKEMIA HOMEOBOX 3; TLX3,Asterisk
604641,MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 1; MAPK8IP1,Asterisk
604642,CARBONIC ANHYDRASE X; CA10,Asterisk
604643,NEUROPEPTIDE FF-AMIDE PEPTIDE; NPFF,Asterisk
604644,CARBONIC ANHYDRASE XI; CA11,Asterisk
604645,"PHOSPHODIESTERASE 7B, cAMP-SPECIFIC, HIGH AFFINITY; PDE7B",Asterisk
604646,"NUCLEOPORIN, 50-KD; NUP50",Asterisk
604647,CALCYON; CALY,Asterisk
604648,T-BOX 10; TBX10,Asterisk
604649,TUBULIN-SPECIFIC CHAPERONE D; TBCD,Asterisk
604650,INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 3; IFIT3,Asterisk
604651,GROWTH/DIFFERENTIATION FACTOR 7; GDF7,Asterisk
604652,TRANSCRIPTION FACTOR 7-LIKE 1; TCF7L1,Asterisk
604653,"SOLUTE CARRIER FAMILY 40 (IRON-REGULATED TRANSPORTER), MEMBER 1; SLC40A1",Asterisk
604654,5-HYDROXYTRYPTAMINE RECEPTOR 3B; HTR3B,Asterisk
604655,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; MAP3K14,Asterisk
604656,FORMIN-LIKE 1; FMNL1,Asterisk
604657,"TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 5; TM4SF5",Asterisk
604658,"TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 1; TM7SF1",Asterisk
604659,"ENDOGENOUS RETROVIRAL FAMILY W, MEMBER 1; ERVW1",Asterisk
604660,POTASSIUM CHANNEL-INTERACTING PROTEIN 1; KCNIP1,Asterisk
604661,POTASSIUM CHANNEL-INTERACTING PROTEIN 2; KCNIP2,Asterisk
604662,POTASSIUM CHANNEL-INTERACTING PROTEIN 3; KCNIP3,Asterisk
604663,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 6; WNT6",Asterisk
604664,INTERFERON-GAMMA-INDUCIBLE PROTEIN 30; IFI30,Asterisk
604665,"COP9 SIGNALOSOME, SUBUNIT 3; COPS3",Asterisk
604666,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; MAP4K4,Asterisk
604667,CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION; CADPS,Asterisk
604668,ZINC FINGER PROTEIN 264; ZNF264,Asterisk
604669,POLYCYSTIN 2-LIKE 2; PKD2L2,Asterisk
604670,POLYCYSTIN AND SEA URCHIN REJ HOMOLOG-LIKE; PKDREJ,Asterisk
604671,JUMPING TRANSLOCATION BREAKPOINT; JTB,Asterisk
604672,CD209 ANTIGEN; CD209,Asterisk
604673,"MURINE RETROVIRUS INTEGRATION SITE 1, HOMOLOG OF; MRVI1",Asterisk
604674,HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF 2; HEY2,Asterisk
604675,PAIRED-RELATED HOMEOBOX GENE 2; PRRX2,Asterisk
604676,HLA COMPLEX P5 GENE; HCP5,Asterisk
604677,COL4A3-BINDING PROTEIN; COL4A3BP,Asterisk
604678,"TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 2; TM9SF2",Asterisk
604679,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 1; PABPC1",Asterisk
604680,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 3; PABPC3",Asterisk
604681,MOVED TO 604680,Caret
604682,"INTEGRIN, ALPHA-E; ITGAE",Asterisk
604683,KINESIN FAMILY MEMBER 3A; KIF3A,Asterisk
604684,"MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA, TRANSLOCATED TO, 11; MLLT11",Asterisk
604685,HOMEOBOX A2; HOXA2,Asterisk
604686,A-KINASE ANCHOR PROTEIN 13; AKAP13,Asterisk
604687,PROSTAGLANDIN D2 RECEPTOR; PTGDR,Asterisk
604688,A-KINASE ANCHOR PROTEIN 5; AKAP5,Asterisk
604689,A-KINASE ANCHOR PROTEIN 3; AKAP3,Asterisk
604690,"GROWTH AND DEVELOPMENTAL RETARDATION, OCULAR PTOSIS, CARDIAC DEFECT, AND ANAL ATRESIA",
604691,A-KINASE ANCHOR PROTEIN 6; AKAP6,Asterisk
604692,A-KINASE ANCHOR PROTEIN 8; AKAP8,Asterisk
604693,A-KINASE ANCHOR PROTEIN 7; AKAP7,Asterisk
604694,A-KINASE ANCHOR PROTEIN 10; AKAP10,Asterisk
604695,ADP-RIBOSYLATION FACTOR-LIKE 3; ARL3,Asterisk
604696,A-KINASE ANCHOR PROTEIN 11; AKAP11,Asterisk
604697,"CHEMOKINE, CC MOTIF, LIGAND 26; CCL26",Asterisk
604698,A-KINASE ANCHOR PROTEIN 12; AKAP12,Asterisk
604699,ADP-RIBOSYLATION FACTOR-RELATED PROTEIN 1; ARFRP1,Asterisk
604700,"TARGET OF MYB1, CHICKEN, HOMOLOG OF; TOM1",Asterisk
604701,TOM1-LIKE 1; TOM1L1,Asterisk
604702,HMG BOX DOMAIN-CONTAINING 4; HMGXB4,Asterisk
604703,MOVED TO 604702,Caret
604704,BREAST CANCER ANTIESTROGEN RESISTANCE 3; BCAR3,Asterisk
604705,MER TYROSINE KINASE PROTOONCOGENE; MERTK,Asterisk
604706,MOVED TO 164015,Caret
604707,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER B10; AKR1B10",Asterisk
604708,NUCLEAR FACTOR OF ACTIVATED T CELLS 5; NFAT5,Asterisk
604709,T-CELL LYMPHOMA INVASION AND METASTASIS 2; TIAM2,Asterisk
604710,LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4; LTBP4,Asterisk
604711,UBIQUITIN-LIKE 3; UBL3,Asterisk
604712,"RIBONUCLEOTIDE REDUCTASE, M2 B; RRM2B",Asterisk
604713,"C-TYPE LECTIN DOMAIN FAMILY 11, MEMBER A; CLEC11A",Asterisk
604714,TSPY-LIKE 1; TSPYL1,Asterisk
604715,ORTHOSTATIC INTOLERANCE,Number Sign
604716,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER A1; UGT2A1",Asterisk
604717,"DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20",Number Sign
604718,"TRANSCRIPTION TERMINATION FACTOR, RNA POLYMERASE II; TTF2",Asterisk
604719,SERINE/THREONINE PROTEIN KINASE 16; STK16,Asterisk
604720,TRANSFERRIN RECEPTOR 2; TFR2,Asterisk
604721,SH2 DOMAIN-CONTAINING PROTEIN 3A; SH2D3A,Asterisk
604722,SH2 DOMAIN-CONTAINING PROTEIN 3C; SH2D3C,Asterisk
604723,"Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TSFM",Asterisk
604724,HEPARANASE; HPSE,Asterisk
604725,UBIQUITIN-SPECIFIC PROTEASE 2; USP2,Asterisk
604726,SERINE/THREONINE PROTEIN KINASE 17A; STK17A,Asterisk
604727,SERINE/THREONINE PROTEIN KINASE 17B; STK17B,Asterisk
604728,UBIQUITIN-SPECIFIC PROTEASE 3; USP3,Asterisk
604729,UBIQUITIN-SPECIFIC PROTEASE 21; USP21,Asterisk
604730,TUBBY-LIKE PROTEIN 3; TULP3,Asterisk
604731,UBIQUITIN-SPECIFIC PROTEASE 15; USP15,Asterisk
604732,TRANSCRIPTION FACTOR EC; TFEC,Asterisk
604733,TRYPTOPHANYL-tRNA SYNTHETASE 2; WARS2,Asterisk
604734,WD REPEAT-CONTAINING PROTEIN 1; WDR1,Asterisk
604735,UBIQUITIN-SPECIFIC PROTEASE 16; USP16,Asterisk
604736,UBIQUITIN-SPECIFIC PROTEASE 25; USP25,Asterisk
604737,WD REPEAT-CONTAINING PROTEIN 3; WDR3,Asterisk
604738,"CHEMOKINE, CC MOTIF, RECEPTOR 9; CCR9",Asterisk
604739,RNA BINDING MOTIF PROTEIN 39; RBM39,Asterisk
604740,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 1; SLC39A1",Asterisk
604741,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER D1; AKR1D1",Asterisk
604742,DOUBLECORTIN-LIKE KINASE 1; DCLK1,Asterisk
604743,DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1; DDAH1,Asterisk
604744,DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 2; DDAH2,Asterisk
604745,TRANSCRIPTION FACTOR-LIKE 5; TCFL5,Asterisk
604746,TESTIS-SPECIFIC PROTEIN KINASE 2; TESK2,Asterisk
604747,SRY-BOX 14; SOX14,Asterisk
604748,SRY-BOX 13; SOX13,Asterisk
604749,"ZINC FINGER PROTEIN 93, MOUSE, HOMOLOG OF; ZFP93",Asterisk
604750,ZINC FINGER PROTEIN 234; ZNF234,Asterisk
604751,ZINC FINGER PROTEIN 266; ZNF266,Asterisk
604752,ZINC FINGER PROTEIN 267; ZNF267,Asterisk
604753,ZINC FINGER PROTEIN 268; ZNF268,Asterisk
604754,ZINC FINGER PROTEIN 271; ZNF271,Asterisk
604755,ZINC FINGER PROTEIN 272; ZNF272,Asterisk
604756,ZINC FINGER PROTEIN 273; ZNF273,Asterisk
604757,CRANIOSYNOSTOSIS 2; CRS2,Number Sign
604758,V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG B; RELB,Asterisk
604759,SYNAPTONEMAL COMPLEX PROTEIN 3; SYCP3,Asterisk
604760,ZINC FINGER PROTEIN 236; ZNF236,Asterisk
604761,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 5; ZFAND5,Asterisk
604762,SWITCH-ASSOCIATED PROTEIN 70,Asterisk
604763,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 12; ARHGEF12,Asterisk
604764,ZINC FINGER AND HOMEODOMAIN PROTEIN 1; ZHX1,Asterisk
604765,"CARDIOMYOPATHY, DILATED, 1I; CMD1I",Number Sign
604766,PODOCIN; NPHS2,Asterisk
604767,DELETED IN ESOPHAGEAL CANCER 1; DEC1,Asterisk
604768,ZINC FINGER PROTEIN 254; ZNF254,Asterisk
604769,PEROXIREDOXIN 3; PRDX3,Asterisk
604770,ACETYL-CoA ACYLTRANSFERASE 2; ACAA2,Asterisk
604771,POLYCYSTIC BONE DISEASE,
604772,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1",Number Sign
604773,"ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8; ACAD8",Asterisk
604774,ANGIOPOIETIN-LIKE 3; ANGPTL3,Asterisk
604775,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY A, MEMBER 1; TRPA1",Asterisk
604776,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-5; HLA-DRB5",Asterisk
604777,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5",Number Sign
604778,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 29; ADAM29,Asterisk
604779,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 30; ADAM30,Asterisk
604780,ABHYDROLASE DOMAIN-CONTAINING 5; ABHD5,Asterisk
604781,MOVED TO 604777,Caret
604782,ASH2-LIKE; ASH2L,Asterisk
604783,CLEFT LIP AND PALATE-ASSOCIATED TRANSMEMBRANE PROTEIN 1; CLPTM1,Asterisk
604784,"TRANSCRIPTION ELONGATION FACTOR A, 2; TCEA2",Asterisk
604785,"CATENIN, ALPHA-LIKE, 1; CTNNAL1",Asterisk
604786,ADP-RIBOSYLATION FACTOR-LIKE 4A; ARL4A,Asterisk
604787,ADP-RIBOSYLATION FACTOR-LIKE 4C; ARL4C,Asterisk
604788,"RUVB, E. COLI, HOMOLOG-LIKE 2; RUVBL2",Asterisk
604789,"INTEGRIN, ALPHA-11; ITGA11",Asterisk
604790,"TASTE RECEPTOR, TYPE 2, MEMBER 14; TAS2R14",Asterisk
604791,"TASTE RECEPTOR, TYPE 2, MEMBER 10; TAS2R10",Asterisk
604792,"TASTE RECEPTOR, TYPE 2, MEMBER 13; TAS2R13",Asterisk
604793,"TASTE RECEPTOR, TYPE 2, MEMBER 7; TAS2R7",Asterisk
604794,"TASTE RECEPTOR, TYPE 2, MEMBER 8; TAS2R8",Asterisk
604795,"TASTE RECEPTOR, TYPE 2, MEMBER 9; TAS2R9",Asterisk
604796,"TASTE RECEPTOR, TYPE 2, MEMBER 1; TAS2R1",Asterisk
604797,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 2; APOBEC2",Asterisk
604798,"HOMER, DROSOPHILA, HOMOLOG OF, 1; HOMER1",Asterisk
604799,"HOMER, DROSOPHILA, HOMOLOG OF, 2; HOMER2",Asterisk
604800,"HOMER, DROSOPHILA, HOMOLOG OF, 3; HOMER3",Asterisk
604801,"MUSCULAR DYSTROPHY, CONGENITAL, 1B; MDC1B",Percent
604802,HUNTINGTON DISEASE-LIKE 3; HDL3,Percent
604803,DOPEY FAMILY MEMBER 2; DOPEY2,Asterisk
604804,"MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3",Number Sign
604805,"SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12",Number Sign
604806,FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 1; FLRT1,Asterisk
604807,FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 2; FLRT2,Asterisk
604808,FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 3; FLRT3,Asterisk
604809,"PANBRONCHIOLITIS, DIFFUSE",Percent
604810,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 1; LILRA1",Asterisk
604811,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1; LILRB1",Asterisk
604812,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 2; LILRA2",Asterisk
604813,CYTOCHROME c OXIDASE COPPER CHAPERONE COX17; COX17,Asterisk
604814,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 5; LILRB5",Asterisk
604815,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 2; LILRB2",Asterisk
604816,MOVED TO 604213,Caret
604817,CARBOHYDRATE SULFOTRANSFERASE 5; CHST5,Asterisk
604818,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 3; LILRA3",Asterisk
604819,"POLY-U-BINDING SPLICING FACTOR, 60-KD; PUF60",Asterisk
604820,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 3; LILRB3",Asterisk
604821,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 4; LILRB4",Asterisk
604822,CALPAIN 11; CAPN11,Asterisk
604823,BarH-LIKE HOMEOBOX GENE 2; BARX2,Asterisk
604824,KLOTHO; KL,Asterisk
604825,FASCICULATION AND ELONGATION PROTEIN ZETA 1; FEZ1,Asterisk
604826,FASCICULATION AND ELONGATION PROTEIN ZETA 2; FEZ2,Asterisk
604827,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7; EIG7",Percent
604828,"CHEMOKINE, C MOTIF, LIGAND 2; XCL2",Asterisk
604829,DOWN SYNDROME CRITICAL REGION GENE 4; DSCR4,Asterisk
604830,"MANDIBULOFACIAL DYSOSTOSIS SYNDROME, BAURU TYPE",
604831,EVC GENE; EVC,Asterisk
604832,CARBONIC ANHYDRASE XIV; CA14,Asterisk
604833,"CHEMOKINE, CC MOTIF, LIGAND 27; CCL27",Asterisk
604834,TANK-BINDING KINASE 1; TBK1,Asterisk
604835,DUAL-SPECIFICITY PHOSPHATASE 12; DUSP12,Asterisk
604836,"CHEMOKINE, CC MOTIF, RECEPTOR 4; CCR4",Asterisk
604837,PROSTAGLANDIN D2 RECEPTOR 2; PTGDR2,Asterisk
604838,G PROTEIN-COUPLED RECEPTOR 45; GPR45,Asterisk
604839,FK506-BINDING PROTEIN 6; FKBP6,Asterisk
604840,FK506-BINDING PROTEIN 8; FKBP8,Asterisk
604841,"STICKLER SYNDROME, TYPE II; STL2",Number Sign
604842,"SOLUTE CARRIER FAMILY 22 (EXTRANEURONAL MONOAMINE TRANSPORTER), MEMBER 3; SLC22A3",Asterisk
604843,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B1; SLCO1B1",Asterisk
604844,HEPARAN SULFATE 2-O-SULFOTRANSFERASE 1; HS2ST1,Asterisk
604845,PROSTATE CANCER ANTIGEN 3; PCA3,Asterisk
604846,HEPARAN SULFATE 6-O-SULFOTRANSFERASE 1; HS6ST1,Asterisk
604847,G PROTEIN-COUPLED RECEPTOR 26; GPR26,Asterisk
604848,MOVED TO 604849,Caret
604849,TRACE AMINE-ASSOCIATED RECEPTOR 2; TAAR2,Asterisk
604850,"COP9 SIGNALOSOME, SUBUNIT 5; COPS5",Asterisk
604851,G-RICH RNA SEQUENCE-BINDING FACTOR 1; GRSF1,Asterisk
604852,"CHEMOKINE, CXC MOTIF, LIGAND 11; CXCL11",Asterisk
604853,MITOCHONDRIAL RIBOSOMAL PROTEIN L28; MRPL28,Asterisk
604854,INDOLETHYLAMINE N-METHYLTRANSFERASE; INMT,Asterisk
604855,"HYALURONAN METABOLISM, DEFECT IN",
604856,LANGERHANS CELL HISTIOCYTOSIS,
604857,"SIGNAL RECOGNITION PARTICLE, 54-KD; SRP54",Asterisk
604858,"SIGNAL RECOGNITION PARTICLE, 68-KD; SRP68",Asterisk
604859,LIM AND CYSTEINE-RICH DOMAINS 1; LMCD1,Asterisk
604860,MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION GENE 1; MALT1,Asterisk
604861,"LARGE TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 2; LATS2",Asterisk
604862,CD207 ANTIGEN; CD207,Asterisk
604863,LECITHIN RETINOL ACYLTRANSFERASE; LRAT,Asterisk
604864,OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA; OSCDP,Number Sign
604865,KRUPPEL-LIKE FACTOR 7; KLF7,Asterisk
604866,PLEOMORPHIC ADENOMA GENE-LIKE 2; PLAGL2,Asterisk
604867,"TASTE RECEPTOR, TYPE 2, MEMBER 16; TAS2R16",Asterisk
604868,"TASTE RECEPTOR, TYPE 2, MEMBER 3; TAS2R3",Asterisk
604869,"TASTE RECEPTOR, TYPE 2, MEMBER 4; TAS2R4",Asterisk
604870,MACROPHAGE RECEPTOR WITH COLLAGENOUS STRUCTURE; MARCO,Asterisk
604871,MATRIX METALLOPROTEINASE 24; MMP24,Asterisk
604872,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 7; PCSK7",Asterisk
604873,MYELIN PROTEIN ZERO-LIKE 2; MPZL2,Asterisk
604874,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY G, MEMBER 1; KLRG1",Asterisk
604875,MYOSIN IXA; MYO9A,Asterisk
604876,REGULATOR OF CALCINEURIN 2; RCAN2,Asterisk
604877,"V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN F; MAFF",Asterisk
604878,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 6; SLC12A6",Asterisk
604879,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 7; SLC12A7",Asterisk
604880,MOVED TO 300609,Caret
604881,RABPHILIN 3A-LIKE; RPH3AL,Asterisk
604882,NEUROGENIN 3; NEUROG3,Asterisk
604883,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 2; GTF3C2",Asterisk
604884,NEVER IN MITOSIS GENE A-RELATED KINASE 6; NEK6,Asterisk
604885,MYB-BINDING PROTEIN 1A; MYBBP1A,Asterisk
604886,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 8; EMC8",Asterisk
604887,METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2; MTHFD2,Asterisk
604888,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 3; GTF3C3",Asterisk
604889,NEUROBEACHIN; NBEA,Asterisk
604890,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 5; GTF3C5",Asterisk
604891,NCK-ASSOCIATED PROTEIN 1; NCKAP1,Asterisk
604892,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 4; GTF3C4",Asterisk
604893,"ANTISENSE IGF2R RNA, NONCODING; AIRN",Asterisk
604894,ONE CUT HOMEOBOX 2; ONECUT2,Asterisk
604895,T-BOX 21; TBX21,Asterisk
604896,MKKS GENE; MKKS,Asterisk
604897,PREFOLDIN 1; PFDN1,Asterisk
604898,PREFOLDIN 4; PFDN4,Asterisk
604899,PREFOLDIN 5; PFDN5,Asterisk
604900,DIACYLGLYCEROL O-ACYLTRANSFERASE 1; DGAT1,Asterisk
604901,NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC,Percent
604902,BRF1 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR; BRF1,Asterisk
604903,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1A; TAF1A,Asterisk
604904,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1B; TAF1B,Asterisk
604905,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1C; TAF1C,Asterisk
604906,SCHIZOPHRENIA 9; SCZD9,Number Sign
604907,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13B; TNFRSF13B",Asterisk
604908,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 1; PPP4R1",Asterisk
604909,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 2; CNOT2",Asterisk
604910,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 3; CNOT3",Asterisk
604911,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 4; CNOT4",Asterisk
604912,"TAF2 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 150-KD; TAF2",Asterisk
604913,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 7; CNOT7",Asterisk
604914,JUMONJI DOMAIN-CONTAINING PROTEIN 6; JMJD6,Asterisk
604915,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 13; MAP3K13,Asterisk
604916,"HYDRONEPHROSIS, CONGENITAL, WITH CLEFT PALATE, CHARACTERISTIC FACIES, HYPOTONIA, AND MENTAL RETARDATION",
604917,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 1; CNOT1",Asterisk
604918,"PICCOLO, MOUSE, HOMOLOG OF; PCLO",Asterisk
604919,BECKER NEVUS SYNDROME,
604920,MOVED TO 603218,Caret
604921,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3; MAP4K3,Asterisk
604922,"CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA",
604923,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 5; MAP4K5,Asterisk
604924,PHOSPHORYLATED ADAPTOR FOR RNA EXPORT; PHAX,Asterisk
604925,RAB ACCEPTOR 1; RABAC1,Asterisk
604926,MOVED TO 300948,Caret
604927,"C-TERMINAL DOMAIN OF RNA POLYMERASE II SUBUNIT A, PHOSPHATASE OF, SUBUNIT 1; CTDP1",Asterisk
604928,WOLFRAM SYNDROME 2; WFS2,Number Sign
604929,MOVED TO 181350,Caret
604930,NCK ADAPTOR PROTEIN 2; NCK2,Asterisk
604931,CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1,Number Sign
604932,"PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR GAMMA; PKIG",Asterisk
604933,"MutY, E. COLI, HOMOLOG OF; MUTYH",Asterisk
604934,TUBULIN-SPECIFIC CHAPERONE E; TBCE,Asterisk
604935,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 2; DMRT2,Asterisk
604936,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 1; KIR2DL1",Asterisk
604937,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 2; KIR2DL2",Asterisk
604938,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 3; KIR2DL3",Asterisk
604939,PHOSPHOLIPASE A2 RECEPTOR 1; PLA2R1,Asterisk
604940,MOVED TO 601228,Caret
604941,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, ALPHA; PPP2R2A",Asterisk
604942,SYNTAPHILIN; SNPH,Asterisk
604943,"SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5",Asterisk
604944,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, ALPHA; PPP2R3A",Asterisk
604945,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 4; KIR2DL4",Asterisk
604946,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 1; KIR3DL1",Asterisk
604947,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 2; KIR3DL2",Asterisk
604948,"GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, BETA; GADD45B",Asterisk
604949,"GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, GAMMA; GADD45G",Asterisk
604950,PUTATIVE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PHTF1,Asterisk
604951,6-PHOSPHOGLUCONOLACTONASE; PGLS,Asterisk
604952,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 1; KIR2DS1",Asterisk
604953,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 2; KIR2DS2",Asterisk
604954,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 3; KIR2DS3",Asterisk
604955,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 4; KIR2DS4",Asterisk
604956,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 5; KIR2DS5",Asterisk
604957,MOVED TO 604946,Caret
604958,ACTIN-LIKE 6A; ACTL6A,Asterisk
604959,PHORBOL-12-MYRISTATE-13-ACETATE-INDUCED PROTEIN 1; PMAIP1,Asterisk
604960,PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 2; PACSIN2,Asterisk
604961,PHOSPHODIESTERASE 11A; PDE11A,Asterisk
604962,T-CELL RECEPTOR-ASSOCIATED TRANSMEMBRANE ADAPTOR 1; TRAT1,Asterisk
604963,PEPTIDOGLYCAN RECOGNITION PROTEIN 1; PGLYRP1,Asterisk
604964,SHP2-INTERACTING TRANSMEMBRANE ADAPTOR PROTEIN 1; SIT1,Asterisk
604965,SERINE/THREONINE PROTEIN KINASE 4; STK4,Asterisk
604966,PROTOCADHERIN-ALPHA GENE CLUSTER; PCDHA@,Number Sign
604967,PROTOCADHERIN-BETA GENE CLUSTER; PCDHB@,Number Sign
604968,PROTOCADHERIN-GAMMA GENE CLUSTER; PCDHG@,Number Sign
604969,SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 1; SKAP1,Asterisk
604970,AURORA KINASE B; AURKB,Asterisk
604971,MYOD FAMILY INHIBITOR; MDFI,Asterisk
604972,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 3, S. CEREVISIAE, HOMOLOG OF; ORC3",Asterisk
604973,FICOLIN 3; FCN3,Asterisk
604974,SRY-BOX 21; SOX21,Asterisk
604975,SRY-BOX 5; SOX5,Asterisk
604976,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-3; PRKAG3",Plus
604977,SERINE/THREONINE PROTEIN KINASE 19; STK19,Asterisk
604978,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 5; CPSF5,Asterisk
604979,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 6; CPSF6,Asterisk
604980,"GTPase-ACTIVATING PROTEIN, RAC, 1; RACGAP1",Asterisk
604981,WW DOMAIN-CONTAINING BINDING PROTEIN 4; WBP4,Asterisk
604982,HPS1 GENE; HPS1,Asterisk
604983,"POLYMERASE, DNA, GAMMA-2; POLG2",Asterisk
604984,SERINE/THREONINE PROTEIN KINASE 24; STK24,Asterisk
604985,"SPECTRIN, BETA, NONERYTHROCYTIC, 2; SPTBN2",Asterisk
604986,BRCA1-ASSOCIATED PROTEIN; BRAP,Asterisk
604987,"C-TYPE LECTIN DOMAIN FAMILY 5, MEMBER A; CLEC5A",Asterisk
604988,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2B1; SLCO2B1",Asterisk
604989,SPONDIN 1; SPON1,Asterisk
604990,"SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 1; SLC9A3R1",Asterisk
604991,PROSTATE ANDROGEN-REGULATED TRANSCRIPT 1; PART1,Asterisk
604992,SARCALUMENIN; SRL,Asterisk
604993,"PRECURSOR mRNA-PROCESSING FACTOR 18, S. CEREVISIAE, HOMOLOG OF; PRPF18",Asterisk
604994,"SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 2; SIX2",Asterisk
604995,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 7; SLC22A7",Asterisk
604996,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3; FXYD3,Asterisk
604997,DOCKING PROTEIN 2; DOK2,Asterisk
604998,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I; CAMK1,Asterisk
604999,SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1; SHANK1,Asterisk
605000,CORONIN 1A; CORO1A,Asterisk
605001,ANGIOPOIETIN-LIKE 2; ANGPTL2,Asterisk
605002,CORONIN 2B; CORO2B,Asterisk
605003,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 6; SENP6",Asterisk
605004,GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B,Asterisk
605005,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7; GALNT7,Asterisk
605006,FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS 2; FRAT2,Asterisk
605007,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 5; ADAMTS5",Asterisk
605008,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 6; ADAMTS6",Asterisk
605009,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 7; ADAMTS7",Asterisk
605010,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 5; SPINK5",Asterisk
605011,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 3; ADAMTS3",Asterisk
605012,"SUPPRESSOR OF TY 16, S. CEREVISIAE, HOMOLOG OF; SUPT16H",Asterisk
605013,MICROHYDRANENCEPHALY; MHAC,Number Sign
605014,SYNTAXIN 11; STX11,Asterisk
605015,ZINC FINGER PROTEIN 214; ZNF214,Asterisk
605016,ZINC FINGER PROTEIN 215; ZNF215,Asterisk
605017,PRE-B-LYMPHOCYTE GENE 3; VPREB3,Asterisk
605018,CYLD GENE; CYLD,Asterisk
605019,"HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2",Number Sign
605020,"VISUAL SYSTEM HOMEOBOX GENE 1, ZEBRAFISH, HOMOLOG OF; VSX1",Asterisk
605021,"MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME",Number Sign
605022,p21 PROTEIN-ACTIVATED KINASE 2; PAK2,Asterisk
605023,HYDROXYACID OXIDASE 1; HAO1,Asterisk
605024,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 8; SLC4A8",Asterisk
605025,"INTEGRIN, ALPHA-3; ITGA3",Asterisk
605026,"DIABETES MELLITUS, CONGENITAL AUTOIMMUNE",
605027,"LYMPHOMA, NON-HODGKIN, FAMILIAL",Number Sign
605028,"LOW DENSITY LIPOPROTEIN CHOLESTEROL, MILD ELEVATION OF",
605029,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY F, MEMBER 1; KLRF1",Asterisk
605030,SERINE/THREONINE PROTEIN KINASE 3; STK3,Asterisk
605031,POLO-LIKE KINASE 4; PLK4,Asterisk
605032,COMPLEXIN 1; CPLX1,Asterisk
605033,COMPLEXIN 2; CPLX2,Asterisk
605034,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 23, YEAST, HOMOLOG OF; TIMM23",Asterisk
605035,"WAS PROTEIN FAMILY, MEMBER 1; WASF1",Asterisk
605036,ZINC FINGER PROTEIN 219; ZNF219,Asterisk
605037,KINESIN FAMILY MEMBER 17; KIF17,Asterisk
605038,POSTMEIOTIC SEGREGATION INCREASED 2-LIKE 1; PMS2L1,Asterisk
605039,BOHRING-OPITZ SYNDROME; BOPS,Number Sign
605040,"CLAVICULAR HYPOPLASIA, ZYGOMATIC ARCH HYPOPLASIA, AND MICROGNATHIA",
605041,BROOKE-SPIEGLER SYNDROME; BRSS,Number Sign
605042,MEDIATOR COMPLEX SUBUNIT 23; MED23,Asterisk
605043,MEDIATOR COMPLEX SUBUNIT 26; MED26,Asterisk
605044,MEDIATOR COMPLEX SUBUNIT 27; MED27,Asterisk
605045,MEDIATOR COMPLEX SUBUNIT 7; MED7,Asterisk
605046,UBIQUILIN 1; UBQLN1,Asterisk
605047,INTERFERON REGULATORY FACTOR 7; IRF7,Asterisk
605048,"INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE OF, EPSILON; IKBKE",Asterisk
605049,TWISTED GASTRULATION HOMOLOG 1; TWSG1,Asterisk
605050,MOVED TO 142750,Caret
605051,CANNABINOID RECEPTOR 2; CNR2,Asterisk
605052,TAR RNA-BINDING PROTEIN 1; TARBP1,Asterisk
605053,TAR RNA-BINDING PROTEIN 2; TARBP2,Asterisk
605054,SMALL EDRK-RICH FACTOR 2; SERF2,Asterisk
605055,"ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY",Percent
605056,WAS GENE-LIKE; WASL,Asterisk
605057,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17, YEAST, HOMOLOG OF, A; TIMM17A",Asterisk
605058,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 44, YEAST, HOMOLOG OF; TIMM44",Asterisk
605059,MOVED TO 123930,Caret
605060,SEDOHEPTULOKINASE; SHPK,Asterisk
605061,TERF2-INTERACTING PROTEIN; TERF2IP,Asterisk
605062,"TASTE RECEPTOR, TYPE 2, MEMBER 5; TAS2R5",Asterisk
605063,STRESS-INDUCED PHOSPHOPROTEIN 1; STIP1,Asterisk
605064,KINESIN FAMILY MEMBER 23; KIF23,Asterisk
605065,"CELL DIVISION CYCLE 37, S. CEREVISIAE, HOMOLOG OF; CDC37",Asterisk
605066,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, EPSILON ISOFORM; YWHAE",Asterisk
605067,TRICUSPID ATRESIA,
605068,"WAS PROTEIN FAMILY, MEMBER 3; WASF3",Asterisk
605069,MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 2; MKNK2,Asterisk
605070,EARLY ENDOSOME ANTIGEN 1; EEA1,Asterisk
605071,REGULATOR OF G PROTEIN SIGNALING 19; RGS19,Asterisk
605072,"GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 1; GIPC1",Asterisk
605073,TRIPARTITE MOTIF-CONTAINING PROTEIN 37; TRIM37,Asterisk
605074,"RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1",Number Sign
605075,MOVED TO 605074,Caret
605076,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 2; SNAPC2",Asterisk
605077,DNMT1-ASSOCIATED PROTEIN 1; DNMAP1,Asterisk
605078,TAR DNA-BINDING PROTEIN; TARDBP,Asterisk
605079,SAL-LIKE 3; SALL3,Asterisk
605080,"CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-3; CNGB3",Asterisk
605081,CYTOHESIN 3; CYTH3,Asterisk
605082,RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1; RASSF1,Asterisk
605083,FRIZZLED-RELATED PROTEIN; FRZB,Asterisk
605084,MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 1; MICU1,Asterisk
605085,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TREM1,Asterisk
605086,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TREM2,Asterisk
605087,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS K PROTEIN; PIGK,Asterisk
605088,"MAJOR VAULT PROTEIN, RAT, HOMOLOG OF; MVP",Asterisk
605089,MITOCHONDRIAL RIBOSOMAL PROTEIN L40; MRPL40,Asterisk
605090,RETINOIC ACID RECEPTOR RESPONDER 1; RARRES1,Asterisk
605091,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 2; FGD2",Asterisk
605092,RETINOIC ACID RECEPTOR RESPONDER 3; RARRES3,Asterisk
605093,SH2B ADAPTOR PROTEIN 3; SH2B3,Asterisk
605094,SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 2; STEAP2,Asterisk
605095,PROSTATE CANCER-ASSOCIATED PROTEIN 2; PCANAP2,Asterisk
605096,ANOCTAMIN 7; ANO7,Asterisk
605097,"SOLUTE CARRIER FAMILY 45, MEMBER 3; SLC45A3",Asterisk
605098,MOVED TO 604146,Caret
605099,PROSTATE CANCER-ASSOCIATED PROTEIN 8; PCANAP8,Asterisk
605100,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1D; PPM1D",Asterisk
605101,TAK1-BINDING PROTEIN 2; TAB2,Asterisk
605102,MANNAN-BINDING LECTIN SERINE PROTEASE 2; MASP2,Asterisk
605103,NEUROMEDIN U; NMU,Asterisk
605104,"RNA-BINDING PROTEIN FOX1, C. ELEGANS, HOMOLOG OF, 1; RBFOX1",Asterisk
605105,EARLY RESPONSE TO NEURAL INDUCTION GENE,
605106,LYSOPHOSPHATIDIC ACID RECEPTOR 3; LPAR3,Asterisk
605107,ENDOTHELIAL DIFFERENTIATION-RELATED FACTOR 1; EDF1,Asterisk
605108,NEUROMEDIN U RECEPTOR 2; NMUR2,Asterisk
605109,HECT DOMAIN AND RCC1-LIKE DOMAIN 1; HERC1,Asterisk
605110,LYSOPHOSPHATIDIC ACID RECEPTOR 2; LPAR2,Asterisk
605111,SPHINGOSINE-1-PHOSPHATE RECEPTOR 2; S1PR2,Asterisk
605112,TROPOMODULIN 3; TMOD3,Asterisk
605113,ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE; AASS,Asterisk
605114,"SPO11, S. CEREVISIAE, HOMOLOG OF; SPO11",Asterisk
605115,"HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY",Number Sign
605116,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 9; CHRNA9",Asterisk
605117,SUPPRESSOR OF CYTOKINE SIGNALING 2; SOCS2,Asterisk
605118,SUPPRESSOR OF CYTOKINE SIGNALING 6; SOCS6,Asterisk
605119,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1G; PPM1G",Asterisk
605120,GROWTH/DIFFERENTIATION FACTOR 2; GDF2,Asterisk
605121,"RRN3, S. CEREVISIAE, HOMOLOG OF; RRN3",Asterisk
605122,SUV3-LIKE 1; SUPV3L1,Asterisk
605123,"SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 1; SPINT1",Asterisk
605124,"SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 2; SPINT2",Asterisk
605125,GABA-A RECEPTOR-ASSOCIATED PROTEIN; GABARAP,Asterisk
605126,FOUR-AND-A-HALF LIM DOMAINS 5; FHL5,Asterisk
605127,OPTICIN; OPTC,Asterisk
605128,GUANYLATE CYCLASE ACTIVATOR 1C; GUCA1C,Asterisk
605129,PROTEASOME ACTIVATOR SUBUNIT 3; PSME3,Asterisk
605130,WIEDEMANN-STEINER SYNDROME; WDSTS,Number Sign
605131,WW DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX,Asterisk
605132,TRANSDUCIN-LIKE ENHANCER OF SPLIT 4; TLE4,Asterisk
605133,NUCLEAR CAP-BINDING PROTEIN 2; NCBP2,Asterisk
605134,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, CYTOPLASMIC, 1; PITPNC1",Asterisk
605135,MOVED TO 172100,Caret
605136,MOVED TO 604974,Caret
605137,MOVED TO 601297,Caret
605138,ORNITHINE DECARBOXYLASE ANTIZYME 3; OAZ3,Asterisk
605139,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 2; CCT2",Asterisk
605140,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 7; CCT7",Asterisk
605141,PRE-B-LYMPHOCYTE GENE 1; VPREB1,Asterisk
605142,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 4; CCT4",Asterisk
605143,ACTIN-RELATED PROTEIN 1A; ACTR1A,Asterisk
605144,ACTIN-RELATED PROTEIN 1B; ACTR1B,Asterisk
605145,"ANK, MOUSE, HOMOLOG OF; ANKH",Asterisk
605146,SPHINGOSINE-1-PHOSPHATE RECEPTOR 5; S1PR5,Asterisk
605147,LEUKOCYTE CELL-DERIVED CHEMOTAXIN 1; LECT1,Asterisk
605148,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 6; GALNT6,Asterisk
605149,"CHEMOKINE, CXC MOTIF, LIGAND 13; CXCL13",Asterisk
605150,MOVED TO 601297,Caret
605151,MOVED TO 604747,Caret
605152,COILED-COIL DOMAIN-CONTAINING PROTEIN 19; CCDC19,Asterisk
605153,RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RAMP1,Asterisk
605154,RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RAMP2,Asterisk
605155,RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RAMP3,Asterisk
605156,MOVED TO 259600,Caret
605157,p53-RESPONSIVE GENE 1,Asterisk
605158,"PEROXIDASIN, DROSOPHILA, HOMOLOG OF; PXDN",Asterisk
605159,"APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 2; AIFM2",Asterisk
605160,p53-RESPONSIVE GENE 4,Asterisk
605161,WAP 4-DISULFIDE CORE DOMAIN 5; WFDC5,Asterisk
605162,GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GADD45G-INTERACTING PROTEIN; GADD45GIP1,Asterisk
605163,"CHEMOKINE, CXC MOTIF, RECEPTOR 6; CXCR6",Asterisk
605164,HISTONE DEACETYLASE 2; HDAC2,Asterisk
605165,ZINC FINGER PROTEIN 278; ZNF278,Asterisk
605166,HISTONE DEACETYLASE 3; HDAC3,Asterisk
605167,B MELANOMA ANTIGEN; BAGE,Asterisk
605168,FATTY ACID-BINDING PROTEIN 5; FABP5,Asterisk
605169,E74-LIKE FACTOR 5; ELF5,Asterisk
605170,ETOPOSIDE-INDUCED 1.4 mRNA; EI24,Asterisk
605171,TUMOR PROTEIN p53-INDUCIBLE PROTEIN 3; TP53I3,Asterisk
605172,PROSTAGLANDIN E SYNTHASE; PTGES,Asterisk
605173,ECTODERMAL-NEURAL CORTEX 1; ENC1,Asterisk
605174,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 1; ADAMTS1",Asterisk
605175,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 8; ADAMTS8",Asterisk
605176,HYDROXYACID OXIDASE 2; HAO2,Asterisk
605177,REMOVED FROM DATABASE,Caret
605178,GROWTH ARREST-SPECIFIC 8; GAS8,Asterisk
605179,"GAS8 ANTISENSE RNA 1, NONCODING; GAS8AS1",Asterisk
605180,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 2; SLC38A2",Asterisk
605181,"TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 3; TM7SF3",Asterisk
605182,RAS p21 PROTEIN ACTIVATOR 3; RASA3,Asterisk
605183,CALMODULIN-LIKE 5; CALML5,Asterisk
605184,POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 1; PAIP1,Asterisk
605185,DELTA-LIKE 4; DLL4,Asterisk
605186,WNT INHIBITORY FACTOR 1; WIF1,Asterisk
605187,G PROTEIN-COUPLED RECEPTOR 27; GPR27,Asterisk
605188,G PROTEIN-COUPLED RECEPTOR 85; GPR85,Asterisk
605189,"DICKKOPF, XENOPUS, HOMOLOG OF, 1; DKK1",Asterisk
605190,TRANSLOCATION-ASSOCIATING MEMBRANE PROTEIN 1; TRAM1,Asterisk
605191,"BTAF1 RNA POLYMERASE II, B-TFIID TRANSCRIPTION FACTOR-ASSOCIATED, 170-KD;  BTAF1",Asterisk
605192,"DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23",Number Sign
605193,"DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 3; DIRAS3",Asterisk
605194,CRYPTIC PROTEIN; CFC1,Asterisk
605195,MESODERM POSTERIOR BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR 2; MESP2,Asterisk
605196,"COQ3, S. CEREVISIAE, HOMOLOG OF; COQ3",Asterisk
605197,KYNURENINASE; KYNU,Asterisk
605198,TERMINAL NUCLEOTIDYLTRANSFERASE 4A; TENT4A,Asterisk
605199,"SPLICING FACTOR, PROLINE- AND GLUTAMINE-RICH; SFPQ",Asterisk
605200,HECT DOMAIN AND RCC1-LIKE DOMAIN 3; HERC3,Asterisk
605201,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 14; HDLCQ14,Percent
605202,N-ACETYLNEURAMINIC ACID PHOSPHATE SYNTHASE; NANS,Asterisk
605203,MOVED TO 263650,Caret
605204,TORSIN 1A; TOR1A,Asterisk
605205,ADENYLATE CYCLASE 10; ADCY10,Asterisk
605206,HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 4; HCN4,Asterisk
605207,"CYTOCHROME P450, SUBFAMILY XXVIB, POLYPEPTIDE 1; CYP26B1",Asterisk
605208,"SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 7; SLC17A7",Asterisk
605209,CHECKPOINT PROTEIN WITH FHA AND RING FINGER DOMAINS; CHFR,Asterisk
605210,DISRUPTED IN SCHIZOPHRENIA 1; DISC1,Asterisk
605211,BARH-LIKE 1; BARHL1,Asterisk
605212,BARH-LIKE 2; BARHL2,Asterisk
605213,3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1; PDPK1,Asterisk
605214,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 2; KCNMB2",Asterisk
605215,SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 2; SKAP2,Asterisk
605216,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4; ARHGEF4,Asterisk
605217,SHC TRANSFORMING PROTEIN 2; SHC2,Asterisk
605218,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2",Number Sign
605219,DIRECT IAP-BINDING PROTEIN WITH LOW pI; DIABLO,Asterisk
605220,APOLIPOPROTEIN B RECEPTOR; APOBR,Asterisk
605221,"SPLICING FACTOR, SERINE/ARGININE-RICH, 10; SRSF10",Asterisk
605222,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 3; KCNMB3",Asterisk
605223,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 4; KCNMB4",Asterisk
605224,"RHODOPSIN HOMOLOG, RETINAL PIGMENT EPITHELIUM-DERIVED; RRH",Asterisk
605225,INFLAMMATORY BOWEL DISEASE 7; IBD7,Percent
605226,RE REPEATS-ENCODING GENE; RERE,Asterisk
605227,REVERSION-INDUCING CYSTEINE-RICH PROTEIN WITH KAZAL MOTIFS; RECK,Asterisk
605228,"COREPRESSOR INTERACTING WITH RBPJ, 1; CIR1",Asterisk
605229,"SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE; SPG14",Percent
605230,TUMOR PROTEIN p53-BINDING PROTEIN 1; TP53BP1,Asterisk
605231,BARDET-BIEDL SYNDROME 6; BBS6,Number Sign
605232,"PROTEIN KINASE, LYSINE-DEFICIENT 1; WNK1",Asterisk
605233,DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE,Percent
605234,VOMERONASAL 1 RECEPTOR 1; VN1R1,Asterisk
605235,NUCLEOLAR PROTEIN 3; NOL3,Asterisk
605236,"CORIN, SERINE PEPTIDASE; CORIN",Asterisk
605237,XENOTROPIC AND POLYTROPIC RETROVIRUS RECEPTOR; XPR1,Asterisk
605238,HISTAMINE N-METHYLTRANSFERASE; HNMT,Asterisk
605239,"ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 4; ATP6V0A4",Asterisk
605240,"CHEMOKINE, CC MOTIF, LIGAND 28; CCL28",Asterisk
605241,LYMPHOCYTE ANTIGEN 86; LY86,Asterisk
605242,USH1C GENE; USH1C,Asterisk
605243,LYMPHOCYTE ANTIGEN 96; LY96,Asterisk
605244,"CARNEY COMPLEX, TYPE 2; CNC2",Percent
605245,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 8; SLC2A8",Asterisk
605246,COMPLEMENT COMPONENT 3a RECEPTOR 1; C3AR1,Asterisk
605247,LEUCINE-RICH REPEATS- AND DEATH DOMAIN-CONTAINING PROTEIN; LRDD,Asterisk
605248,MUCOLIPIN 1; MCOLN1,Asterisk
605249,MOVED TO 155100,Caret
605250,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 4; ABCC4",Asterisk
605251,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 5; ABCC5",Asterisk
605252,"POLYMERASE, DNA, IOTA; POLI",Asterisk
605253,"NEUROPATHY, CONGENITAL HYPOMYELINATING OR AMYELINATING, AUTOSOMAL RECESSIVE; CHN",Number Sign
605254,NICASTRIN; NCSTN,Asterisk
605255,ETS VARIANT GENE 7; ETV7,Asterisk
605256,"RAD18, S. CEREVISIAE, HOMOLOG OF; RAD18",Asterisk
605257,ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA,Asterisk
605258,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2",Number Sign
605259,SPINOCEREBELLAR ATAXIA 13; SCA13,Number Sign
605260,MOVED TO 145900,Caret
605261,NADPH OXIDASE 4; NOX4,Asterisk
605262,NMYC DOWNSTREAM-REGULATED GENE 1; NDRG1,Asterisk
605263,SHC TRANSFORMING PROTEIN 3; SHC3,Asterisk
605264,SORBIN AND SH3-DOMAINS CONTAINING PROTEIN 1; SORBS1,Asterisk
605265,APOPTOSIS AND CASPASE ACTIVATION INHIBITOR; AVEN,Asterisk
605266,JUNCTOPHILIN 1; JPH1,Asterisk
605267,JUNCTOPHILIN 2; JPH2,Asterisk
605268,JUNCTOPHILIN 3; JPH3,Asterisk
605269,CORONIN 1C; CORO1C,Asterisk
605270,N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH,Asterisk
605271,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 10; SERPINA10",Asterisk
605272,NMYC DOWNSTREAM-REGULATED GENE 2; NDRG2,Asterisk
605273,NMYC DOWNSTREAM-REGULATED GENE 3; NDRG3,Asterisk
605274,"MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE",
605275,NOONAN SYNDROME 2; NS2,
605276,APOPTOSIS-ASSOCIATED TYROSINE KINASE; AATK,Asterisk
605277,GLUCOCORTICOID RECEPTOR DNA-BINDING FACTOR 1; GRLF1,Asterisk
605278,CARBOXYLESTERASE 2; CES2,Asterisk
605279,CARBOXYLESTERASE 3; CES3,Asterisk
605280,"SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13",Number Sign
605281,DEAD/H BOX 4; DDX4,Asterisk
605282,TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS,Number Sign
605283,MAGE-LIKE 2; MAGEL2,Asterisk
605284,TSC1 GENE; TSC1,Asterisk
605285,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR",Number Sign
605286,CALPAIN 10; CAPN10,Asterisk
605287,ARGINYL AMINOPEPTIDASE-LIKE 1; RNPEPL1,Asterisk
605288,MOVED TO 273300,Caret
605289,SPLIT-HAND/FOOT MALFORMATION 4; SHFM4,Number Sign
605290,OPA1 GENE; OPA1,Asterisk
605291,MOVED TO 191720,Caret
605292,"5-PRIME-NUCLEOTIDASE, MITOCHONDRIAL; NT5M",Asterisk
605293,OPTIC ATROPHY 4; OPA4,Percent
605294,CARBOHYDRATE SULFOTRANSFERASE 6; CHST6,Asterisk
605295,FIDGETIN; FIGN,Asterisk
605296,PROTEASOME ASSEMBLY CHAPERONE 1; PSMG1,Asterisk
605297,TH1-LIKE; TH1L,Asterisk
605298,DOWN SYNDROME CRITICAL REGION GENE 3; DSCR3,Asterisk
605299,NUCLEAR RECEPTOR COACTIVATOR 6; NCOA6,Asterisk
605300,SH2B ADAPTOR PROTEIN 2; SH2B2,Asterisk
605301,"TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 1; TACC1",Asterisk
605302,"TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 2; TACC2",Asterisk
605303,"TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 3; TACC3",Asterisk
605304,NEUROGLOBIN; NGB,Asterisk
605305,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 5A; KIR2DL5A",Asterisk
605306,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER A; CLEC4A",Asterisk
605307,ADRENOMEDULLIN RECEPTOR; ADMR,Asterisk
605308,ZINC FINGER PROTEIN 346; ZNF346,Asterisk
605309,MACROCEPHALY/AUTISM SYNDROME,Number Sign
605310,COILED-COIL ALPHA-HELICAL ROD PROTEIN 1; CCHCR1,Asterisk
605311,MOVED TO 601776,Caret
605312,GROWTH/DIFFERENTIATION FACTOR 15; GDF15,Asterisk
605313,RNA-BINDING MOTIF PROTEIN 8A; RBM8A,Asterisk
605314,HISTONE DEACETYLASE 4; HDAC4,Asterisk
605315,HISTONE DEACETYLASE 5; HDAC5,Asterisk
605316,MOVED TO 601072,Caret
605317,FORKHEAD BOX P2; FOXP2,Asterisk
605318,MOVED TO 600833,Caret
605319,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3; PFKFB3",Asterisk
605320,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 4; PFKFB4",Asterisk
605321,FRONTOOCULAR SYNDROME,
605322,WAP 4-DISULFIDE CORE DOMAIN 1; WFDC1,Asterisk
605323,"C-TERMINAL DOMAIN OF RNA POLYMERASE II POLYPEPTIDE A, SMALL PHOSPHATASE OF, 1; CTDSP1",Asterisk
605324,AMYLOID BETA PRECURSOR PROTEIN-BINDING PROTEIN 2; APPBP2,Asterisk
605325,"CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 5; CYP3A5",Asterisk
605326,TAX1-BINDING PROTEIN 1; TAX1BP1,Asterisk
605327,"NUCLEAR FACTOR, INTERLEUKIN 3-REGULATED; NFIL3",Asterisk
605328,KRUPPEL-LIKE FACTOR 13; KLF13,Asterisk
605329,MOVED TO 605205,Caret
605330,INTERLEUKIN 22; IL22,Asterisk
605331,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 3; EPB41L3,Asterisk
605332,KELCH-LIKE 1; KLHL1,Asterisk
605333,"PDS5, REGULATOR OF COHESION MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, B; PDS5B",Asterisk
605334,MOVED TO 300290,Caret
605335,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 1; PHLDA1",Asterisk
605336,COMPLEMENT FACTOR H-RELATED 3; CFHR3,Asterisk
605337,COMPLEMENT FACTOR H-RELATED 4; CFHR4,Asterisk
605338,"INTERNEXIN, ALPHA; INA",Asterisk
605339,FMR1 AUTOSOMAL HOMOLOG 2; FXR2,Asterisk
605340,"CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 7; CYP3A7",Asterisk
605341,"PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, ALPHA; PILRA",Asterisk
605342,"PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, BETA; PILRB",Asterisk
605343,FOLLISTATIN-LIKE 3; FSTL3,Asterisk
605344,"NUCLEAR TRANSCRIPTION FACTOR Y, GAMMA; NFYC",Asterisk
605345,"AlkB, E. COLI, HOMOLOG OF, 1; ALKBH1",Asterisk
605346,MOVED TO 176730,Caret
605347,"PEPTIDYLARGININE DEIMINASE, TYPE IV; PADI4",Asterisk
605348,TRANSMEMBRANE PROTEIN 50A; TMEM50A,Asterisk
605349,NUCLEAR PRELAMIN A RECOGNITION FACTOR; NARF,Asterisk
605350,"INTERLEUKIN 27 RECEPTOR, ALPHA; IL27RA",Asterisk
605351,FIBRINOGEN-LIKE 2; FGL2,Asterisk
605352,MALIGNANT FIBROUS HISTIOCYTOMA-AMPLIFIED SEQUENCE 1; MFHAS1,Asterisk
605353,GHRELIN; GHRL,Asterisk
605354,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 18; CARD18,Asterisk
605355,NEMALINE MYOPATHY 5; NEM5,Number Sign
605356,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, GAMMA ISOFORM; YWHAG",Asterisk
605357,STONIN 1; STON1,Asterisk
605358,"GENERAL TRANSCRIPTION FACTOR IIA, 1-LIKE; GTF2A1L",Asterisk
605359,PROLINE-RICH 4; PROL4,Asterisk
605360,COILED-COIL DOMAIN-CONTAINING PROTEIN 85B; CCDC85B,Asterisk
605361,SPINOCEREBELLAR ATAXIA 14; SCA14,Number Sign
605362,"CARDIOMYOPATHY, DILATED, 1J; CMD1J",Number Sign
605363,GLUTAMATE DECARBOXYLASE 1; GAD1,Asterisk
605364,"PSORIASIS 6, SUSCEPTIBILITY TO; PSORS6",Percent
605365,MOVED TO 114480,Caret
605366,OLFACTOMEDIN 1; OLFM1,Asterisk
605367,"ELAC, E. COLI, HOMOLOG OF, 2; ELAC2",Asterisk
605368,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3-LIKE; BNIP3L,Asterisk
605369,"TRANSMEMBRANE PROTEASE, SERINE 11D; TMPRSS11D",Asterisk
605370,RHO GTPase-ACTIVATING PROTEIN 26; ARHGAP26,Asterisk
605371,ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARFGEF2,Asterisk
605372,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HNRNPA3,Asterisk
605373,PARAGANGLIOMAS 3; PGL3,Number Sign
605374,"MYCN, OPPOSITE STRAND; MYCNOS",Asterisk
605375,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3",Number Sign
605376,"HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2",Number Sign
605377,DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK,Asterisk
605378,AAAS GENE; AAAS,Asterisk
605379,GIGAXONIN; GAN,Asterisk
605380,FIBROBLAST GROWTH FACTOR 23; FGF23,Asterisk
605381,"RHESUS BLOOD GROUP, C GLYCOPROTEIN; RHCG",Asterisk
605382,MOVED TO 167320,Caret
605383,INTERLEUKIN 21 RECEPTOR; IL21R,Asterisk
605384,INTERLEUKIN 21; IL21,Asterisk
605385,PRENYL PROTEIN PROTEASE RCE1; RCE1,Asterisk
605386,MICRO RNA LET7A1; MIRLET7A1,Asterisk
605387,"CATARACT 31, MULTIPLE TYPES; CTRCT31",Number Sign
605388,"CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE",Percent
605389,HYPOTRICHOSIS 1; HYPT1,Number Sign
605390,LEUPAXIN; LPXN,Asterisk
605391,MULTIPLE INOSITOL POLYPHOSPHATE PHOSPHATASE 1; MINPP1,Asterisk
605392,FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER; FGFR1OP,Asterisk
605393,LYSINE-SPECIFIC DEMETHYLASE 5B; KDM5B,Asterisk
605394,BTB AND CNC HOMOLOGY 2; BACH2,Asterisk
605395,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 1; TMED1,Asterisk
605396,MOVED TO 604686,Caret
605397,CD226 ANTIGEN; CD226,Asterisk
605398,"CHEMOKINE, CXC MOTIF, LIGAND 16; CXCL16",Asterisk
605399,NIDOGEN 2; NID2,Asterisk
605400,"FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS AND MENTAL RETARDATION",
605401,IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 2; IQGAP2,Asterisk
605402,CD274 MOLECULE; CD274,Asterisk
605403,TOLL-LIKE RECEPTOR 6; TLR6,Asterisk
605404,BCL2-RELATED OVARIAN KILLER; BOK,Asterisk
605405,USP6 N-TERMINAL-LIKE; USP6NL,Asterisk
605406,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 10; TMED10,Asterisk
605407,"SEGAWA SYNDROME, AUTOSOMAL RECESSIVE",Number Sign
605408,MOVED TO 159900,Caret
605409,TRANSCRIPTION ELONGATION REGULATOR 1; TCERG1,Asterisk
605410,"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2; KCND2",Asterisk
605411,"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 3; KCND3",Asterisk
605412,RAB-LIKE 2A; RABL2A,Asterisk
605413,RAB-LIKE 2B; RABL2B,Asterisk
605414,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 7; ABCA7",Asterisk
605415,"DICKKOPF, XENOPUS, HOMOLOG OF, 2; DKK2",Asterisk
605416,"DICKKOPF, XENOPUS, HOMOLOG OF, 3; DKK3",Asterisk
605417,"DICKKOPF, XENOPUS, HOMOLOG OF, 4; DKK4",Asterisk
605418,DICKKOPF-LIKE 1; DKKL1,Asterisk
605419,SCHIZOPHRENIA 10; SCZD10,Percent
605420,"ARISTALESS-LIKE 4, MOUSE, HOMOLOG OF; ALX4",Asterisk
605421,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9; ADAMTS9",Asterisk
605422,ZINC FINGER PROTEIN 350; ZNF350,Asterisk
605423,DESERT HEDGEHOG; DHH,Asterisk
605424,MASTERMIND-LIKE 1; MAML1,Asterisk
605425,"GAP JUNCTION PROTEIN, BETA-4; GJB4",Asterisk
605426,TUMOR PROTEIN p53-REGULATED APOPTOSIS-INDUCING PROTEIN 1; TP53AIP1,Asterisk
605427,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4; TRPV4",Asterisk
605428,"DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26",Number Sign
605429,"DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF; DFNB26M",Number Sign
605430,SPERM-ASSOCIATED ANTIGEN 9; SPAG9,Asterisk
605431,MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 3; MAPK8IP3,Asterisk
605432,RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1; RUSAT1,Number Sign
605433,KINESIN FAMILY MEMBER 13A; KIF13A,Asterisk
605434,"CLASPIN, XENOPUS, HOMOLOG OF; CLSPN",Asterisk
605435,PROTEIN KINASE D1; PRKD1,Asterisk
605436,"SMALL NUCLEOLAR RNA, C/D BOX, 116-1; SNORD116-1",Asterisk
605437,"PROTEIN KINASE C, ETA; PRKCH",Asterisk
605438,DISCS LARGE-ASSOCIATED PROTEIN 2; DLGAP2,Asterisk
605439,ETS HOMOLOGOUS FACTOR; EHF,Asterisk
605440,UBIQUILIN 4; UBQLN4,Asterisk
605441,"ADIPOCYTE-, C1q-, AND COLLAGEN DOMAIN-CONTAINING; ADIPOQ",Asterisk
605442,WT1-ASSOCIATED PROTEIN; WTAP,Asterisk
605443,PROSTATE-SPECIFIC GENE PCGEM1; PCGEM1,Asterisk
605444,"RNA-BINDING MOTIF PROTEIN, X CHROMOSOME, LIKE 2; RBMXL2",Asterisk
605445,DISCS LARGE-ASSOCIATED PROTEIN 1; DLGAP1,Asterisk
605446,RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1,Asterisk
605447,CHROMOSOME 6 OPEN READING FRAME 48; C6ORF48,Asterisk
605448,RUN DOMAIN-CONTAINING PROTEIN 3A; RUNDC3A,Asterisk
605449,"GLUTATHIONE S-TRANSFERASE, ALPHA-3; GSTA3",Asterisk
605450,"GLUTATHIONE S-TRANSFERASE, ALPHA-4; GSTA4",Asterisk
605451,p21 PROTEIN-ACTIVATED KINASE 4; PAK4,Asterisk
605452,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 6; ABCB6",Asterisk
605453,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 9; ABCB9",Asterisk
605454,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 10; ABCB10",Asterisk
605455,RAS-ASSOCIATED PROTEIN RAB26; RAB26,Asterisk
605456,BET1 GOLGI VESICULAR MEMBRANE-TRAFFICKING PROTEIN; BET1,Asterisk
605457,"INTERLEUKIN 22 RECEPTOR, ALPHA-1; IL22RA1",Asterisk
605458,INTERLEUKIN 17 RECEPTOR B; IL17RB,Asterisk
605459,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 5; ABCG5",Asterisk
605460,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 8; ABCG8",Asterisk
605461,INTERLEUKIN 17 RECEPTOR A; IL17RA,Asterisk
605462,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1",Percent
605463,"RADIATION SENSITIVITY/CHROMOSOME INSTABILITY SYNDROME, AUTOSOMAL DOMINANT",
605464,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 8; ABCB8",Asterisk
605465,ZINC FINGER PROTEIN 277; ZNF277,Asterisk
605466,"SIGNAL REGULATORY PROTEIN, GAMMA; SIRPG",Asterisk
605467,ZINC FINGER PROTEIN 274; ZNF274,Asterisk
605468,CDC42 EFFECTOR PROTEIN 4; CDC42EP4,Asterisk
605469,LYSINE-SPECIFIC DEMETHYLASE 4C; KDM4C,Asterisk
605470,MATRIX METALLOPROTEINASE 26; MMP26,Asterisk
605471,ZINC FINGER FYVE TYPE-CONTAINING PROTEIN 1; ZFYVE1,Asterisk
605472,"USHER SYNDROME, TYPE IIC; USH2C",Number Sign
605473,UBIQUILIN 3; UBQLN3,Asterisk
605474,TOLL-LIKE RECEPTOR 9; TLR9,Asterisk
605475,BAI1-ASSOCIATED PROTEIN 2; BAIAP2,Asterisk
605476,"ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 2; AGAP2",Asterisk
605477,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 7; ARHGEF7,Asterisk
605478,SINGLE IMMUNOGLOBULIN DOMAIN-CONTAINING IL1R-RELATED PROTEIN; SIGIRR,Asterisk
605479,"CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2",Number Sign
605480,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3; SLEB3",Percent
605481,"ABNORMAL SPINDLE-LIKE, MICROCEPHALY-ASSOCIATED; ASPM",Asterisk
605482,"GLUTATHIONE S-TRANSFERASE, OMEGA-1; GSTO1",Asterisk
605483,"DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 2; DNAI2",Asterisk
605484,"Fc FRAGMENT OF IgA AND IgM, RECEPTOR FOR; FCAMR",Asterisk
605485,"VACUOLAR PROTEIN SORTING 41, YEAST, HOMOLOG OF; VPS41",Asterisk
605486,MOVED TO 605313,Caret
605487,"CYCLIC AMP-REGULATED PHOSPHOPROTEIN, 19-KD; ARPP19",Asterisk
605488,"CYCLIC AMP-REGULATED PHOSPHOPROTEIN, 21-KD; ARPP21",Asterisk
605489,"INTRAFLAGELLAR TRANSPORT 81, CHLAMYDOMONAS, HOMOLOG OF; IFT81",Asterisk
605490,"LON PEPTIDASE 1, MITOCHONDRIAL; LONP1",Asterisk
605491,NEBULETTE; NEBL,Asterisk
605492,"LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 2; LRRN2",Asterisk
605493,TRIPARTITE MOTIF-CONTAINING PROTEIN 3; TRIM3,Asterisk
605494,"INTEGRIN, BETA-3, BINDING PROTEIN OF; ITGB3BP",Asterisk
605495,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B3; SLCO1B3",Asterisk
605496,CENTROSOMAL PROTEIN 1; CEP1,Asterisk
605497,CARTILAGE-ASSOCIATED PROTEIN; CRTAP,Asterisk
605498,M-PHASE PHOSPHOPROTEIN 1; MPHOSPH1,Asterisk
605499,"ZW10 INTERACTOR, ANTISENSE; ZWINTAS",Asterisk
605500,M-PHASE PHOSPHOPROTEIN 6; MPHOSPH6,Asterisk
605501,M-PHASE PHOSPHOPROTEIN 9; MPHOSPH9,Asterisk
605502,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 2; DNAJC2",Asterisk
605503,M-PHASE PHOSPHOPROTEIN 10; MPHOSPH10,Asterisk
605504,KALLIKREIN-RELATED PEPTIDASE 9; KLK9,Asterisk
605505,KALLIKREIN-RELATED PEPTIDASE 13; KLK13,Asterisk
605506,"VACUOLAR PROTEIN SORTING 26, YEAST, HOMOLOG OF, A; VPS26A",Asterisk
605507,INTERLEUKIN 36 RECEPTOR ANTAGONIST; IL36RN,Asterisk
605508,"INTERLEUKIN 36, BETA; IL36B",Asterisk
605509,"INTERLEUKIN 36, ALPHA; IL36A",Asterisk
605510,INTERLEUKIN 37; IL37,Asterisk
605511,"TRANSMEMBRANE PROTEASE, SERINE 3; TMPRSS3",Asterisk
605512,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 4; ELOVL4,Asterisk
605513,MELAN A; MLANA,Asterisk
605514,PROTOCADHERIN 15; PCDH15,Asterisk
605515,FORKHEAD BOX P1; FOXP1,Asterisk
605516,CADHERIN 23; CDH23,Asterisk
605517,"BETA-1,4-GLUCURONYLTRANSFERASE 1; B4GAT1",Asterisk
605518,LIPIN 1; LPIN1,Asterisk
605519,LIPIN 2; LPIN2,Asterisk
605520,LIPIN 3; LPIN3,Asterisk
605521,TATA BOX-BINDING PROTEIN-LIKE PROTEIN 1; TBPL1,Asterisk
605522,"LIMB REGION 1, MOUSE, HOMOLOG OF; LMBR1",Asterisk
605523,"TRANSDUCER OF ERBB2, 1; TOB1",Asterisk
605524,MOVED TO 164874,Caret
605525,CHROMATIN LICENSING AND DNA REPLICATION FACTOR 1; CDT1,Asterisk
605526,ALZHEIMER DISEASE 6,Percent
605527,"METHIONINE ADENOSYLTRANSFERASE II, BETA; MAT2B",Asterisk
605528,NEURAMINIDASE 2; NEU2,Asterisk
605529,"UPF2, YEAST, HOMOLOG OF; UPF2",Asterisk
605530,"UPF3, YEAST, HOMOLOG OF, A; UPF3A",Asterisk
605531,MOVED TO 300298,Caret
605532,SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 2; SMURF2,Asterisk
605533,NEUREGULIN 3; NRG3,Asterisk
605534,HIGH MOBILITY GROUP PROTEIN 20A; HMG20A,Asterisk
605535,HIGH MOBILITY GROUP PROTEIN 20B; HMG20B,Asterisk
605536,RAB11 FAMILY-INTERACTING PROTEIN 5; RAB11FIP5,Asterisk
605537,ACTIVATING TRANSCRIPTION FACTOR 6; ATF6,Asterisk
605538,NEUROTENSIN RECEPTOR 2; NTSR2,Asterisk
605539,KALLIKREIN-RELATED PEPTIDASE 12; KLK12,Asterisk
605540,TERMINAL NUCLEOTIDYLTRANSFERASE 4B; TENT4B,Asterisk
605541,VAV3 ONCOGENE; VAV3,Asterisk
605542,"INTERLEUKIN 36, GAMMA; IL36G",Asterisk
605543,"PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4",Number Sign
605544,"FIBROMATOSIS, GINGIVAL, 2; GINGF2",Percent
605545,CD163 ANTIGEN; CD163,Asterisk
605546,"GLYCOPROTEIN VI, PLATELET; GP6",Asterisk
605547,FOLLISTATIN-LIKE 1; FSTL1,Asterisk
605548,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 15; ADAM15,Asterisk
605549,CONE-ROD DYSTROPHY 8; CORD8,Percent
605550,"RAS PROTEIN, DEXAMETHASONE-INDUCED, 1; RASD1",Asterisk
605551,NITRIC OXIDE SYNTHASE 1 (NEURONAL) ADAPTOR PROTEIN; NOS1AP,Asterisk
605552,ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1,Percent
605553,"POLY(A) POLYMERASE, ALPHA; PAPOLA",Asterisk
605554,CD244 ANTIGEN; CD244,Asterisk
605555,ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; AIP,Asterisk
605556,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE TRANSPORTER-LIKE), MEMBER 10; SLC4A10",Asterisk
605557,PR DOMAIN-CONTAINING PROTEIN 16; PRDM16,Asterisk
605558,FIBROBLAST GROWTH FACTOR 20; FGF20,Asterisk
605559,HOMEOBOX C11; HOXC11,Asterisk
605560,HOMEOBOX C10; HOXC10,Asterisk
605561,PLAKOPHILIN 3; PKP3,Asterisk
605562,"SECRETOGLOBIN, FAMILY 2A, MEMBER 2; SCGB2A2",Asterisk
605563,CALCIUM-BINDING PROTEIN 1; CABP1,Asterisk
605564,CALCIUM- AND INTEGRIN-BINDING PROTEIN 2; CIB2,Asterisk
605565,RESISTIN; RETN,Asterisk
605566,RETICULON 4 RECEPTOR; RTN4R,Asterisk
605567,SIVA APOPTOSIS-INDUCING FACTOR 1; SIVA1,Asterisk
605568,SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 1; SMURF1,Asterisk
605569,G PROTEIN-COUPLED RECEPTOR 83; GPR83,Asterisk
605570,RAS-ASSOCIATED PROTEIN RAB11A; RAB11A,Asterisk
605571,PIWI-LIKE 1; PIWIL1,Asterisk
605572,ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2,Percent
605573,17-BETA HYDROXYSTEROID DEHYDROGENASE III; HSD17B3,Asterisk
605574,UBIQUITIN-CONJUGATING ENZYME E2C; UBE2C,Asterisk
605575,STRUCTURAL MAINTENANCE OF CHROMOSOMES 4; SMC4,Asterisk
605576,STRUCTURAL MAINTENANCE OF CHROMOSOMES 2; SMC2,Asterisk
605577,RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 2; RASGRP2,Asterisk
605578,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 2; IFITM2,Asterisk
605579,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 3; IFITM3,Asterisk
605580,INTERLEUKIN 23-ALPHA; IL23A,Asterisk
605581,"BETA-1,3-N-ACETYLGLUCOSYAMINYLTRANSFERASE 2; B3GNT2",Asterisk
605582,"CARDIOMYOPATHY, DILATED, 1K; CMD1K",Percent
605583,"DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25",Number Sign
605584,DEAH BOX POLYPEPTIDE 38; DHX38,Asterisk
605585,"CELL DIVISION CYCLE 40, S. CEREVISIAE, HOMOLOG OF; CDC40",Asterisk
605586,IMPORTIN 7; IPO7,Asterisk
605587,PROTEASE INHIBITOR 14; PI14,Asterisk
605588,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1",Number Sign
605589,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2",Number Sign
605590,"SPLICING FACTOR 3B, SUBUNIT 1; SF3B1",Asterisk
605591,"SPLICING FACTOR 3B, SUBUNIT 2; SF3B2",Asterisk
605592,"SPLICING FACTOR 3B, SUBUNIT 3; SF3B3",Asterisk
605593,"SPLICING FACTOR 3B, SUBUNIT 4; SF3B4",Asterisk
605594,"DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1",Number Sign
605595,"SPLICING FACTOR 3A, SUBUNIT 1; SF3A1",Asterisk
605596,"SPLICING FACTOR 3A, SUBUNIT 3; SF3A3",Asterisk
605597,FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2,Asterisk
605598,"DIABETES MELLITUS, INSULIN-DEPENDENT, 18; IDDM18",Percent
605599,LYSOPHOSPHOLIPASE I; LYPLA1,Asterisk
605600,IMPORTIN 8; IPO8,Asterisk
605601,PROTEOGLYCAN 2; PRG2,Asterisk
605602,MYOZENIN 2; MYOZ2,Asterisk
605603,MYOZENIN 1; MYOZ1,Asterisk
605604,POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2; PAIP2,Asterisk
605605,MOVED TO 605535,Caret
605606,"PSORIASIS 7, SUSCEPTIBILITY TO; PSORS7",Percent
605607,CENTROMERIC PROTEIN H; CENPH,Asterisk
605608,CLAUDIN 14; CLDN14,Asterisk
605609,OXIDATION RESISTANCE 1; OXR1,Asterisk
605610,POLYNUCLEOTIDE KINASE 3-PRIME PHOSPHATASE; PNKP,Asterisk
605611,SH3 DOMAIN-BINDING PROTEIN 4; SH3BP4,Asterisk
605612,SH3 DOMAIN-BINDING PROTEIN 5; SH3BP5,Asterisk
605613,HUNTINGTIN-INTERACTING PROTEIN 1-RELATED PROTEIN; HIP1R,Asterisk
605614,"GENERAL CONTROL OF AMINO ACID SYNTHESIS 1, YEAST, HOMOLOG-LIKE 1; GCN1L1",Asterisk
605615,"ARIADNE, DROSOPHILA, HOMOLOG OF, 2; ARIH2",Asterisk
605616,"SOLUTE CARRIER FAMILY 6 (PROLINE IMINO TRANSPORTER), MEMBER 20; SLC6A20",Asterisk
605617,MOVED TO 220600,Caret
605618,"TETRALOGY OF FALLOT SYNDROME, AUTOSOMAL RECESSIVE",
605619,INTERLEUKIN 20; IL20,Asterisk
605620,"INTERLEUKIN 20 RECEPTOR, ALPHA; IL20RA",Asterisk
605621,"INTERLEUKIN 20 RECEPTOR, BETA; IL20RB",Asterisk
605622,PROTOCADHERIN 12; PCDH12,Asterisk
605623,MUSKELIN 1; MKLN1,Asterisk
605624,"ARIADNE, DROSOPHILA, HOMOLOG OF, 1; ARIH1",Asterisk
605625,MYELOMA OVEREXPRESSED GENE; MYEOV,Asterisk
605626,"ENDOGENOUS RETROVIRUS GROUP K, MEMBER 6; ERVK-6",Asterisk
605627,CEREBROOCULONASAL SYNDROME,Percent
605628,"HIV-1 TAT-INTERACTING PROTEIN 2, 30-KD; HTATIP2",Asterisk
605629,CITRON RHO-INTERACTING SERINE/THREONINE KINASE; CIT,Asterisk
605630,"PHOSPHOLIPASE A2, GROUP IID; PLA2G2D",Asterisk
605631,NAPSIN A; NAPSA,Asterisk
605632,"SOLUTE CARRIER FAMILY 35 (UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER 3; SLC35A3",Asterisk
605633,"MUCIN 3B, INTESTINAL; MUC3B",Asterisk
605634,"SOLUTE CARRIER FAMILY 35 (CMP-SIALIC ACID TRANSPORTER), MEMBER 1; SLC35A1",Asterisk
605635,"HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2",Number Sign
605636,MATERNALLY EXPRESSED GENE 3; MEG3,Asterisk
605637,"MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA",Number Sign
605638,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 6; BIRC6,Asterisk
605639,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 8; SIGLEC8,Asterisk
605640,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 9; SIGLEC9,Asterisk
605641,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 6; SLC7A6",Asterisk
605642,"THYROID CARCINOMA, PAPILLARY, WITH PAPILLARY RENAL NEOPLASIA",Percent
605643,KALLIKREIN-RELATED PEPTIDASE 5; KLK5,Asterisk
605644,KALLIKREIN-RELATED PEPTIDASE 8; KLK8,Asterisk
605645,"RESISTIN-LIKE PROTEIN, BETA; RETNLB",Asterisk
605646,"SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4",Asterisk
605647,F-BOX ONLY PROTEIN 6; FBXO6,Asterisk
605648,F-BOX ONLY PROTEIN 7; FBXO7,Asterisk
605649,F-BOX ONLY PROTEIN 8; FBXO8,Asterisk
605650,"POLYMERASE, DNA, KAPPA; POLK",Asterisk
605651,F-BOX AND WD40 DOMAIN PROTEIN 11; FBXW11,Asterisk
605652,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 2; FBXL2,Asterisk
605653,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 3; FBXL3,Asterisk
605654,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 4; FBXL4,Asterisk
605655,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 5; FBXL5,Asterisk
605656,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 7; FBXL7,Asterisk
605657,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 11; FBXL11,Asterisk
605658,INTERLEUKIN 25; IL25,Asterisk
605659,"C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER D; CLEC2D",Asterisk
605660,PREFOLDIN 6; PFDN6,Asterisk
605661,TRIPARTITE MOTIF-CONTAINING PROTEIN 13; TRIM13,Asterisk
605662,RAS-ASSOCIATED PROTEIN RAB36; RAB36,Asterisk
605663,"RADIAL SPOKE HEAD 14, CHLAMYDOMONAS, HOMOLOG OF; RSPH14",Asterisk
605664,KINESIN FAMILY MEMBER 20A; KIF20A,Asterisk
605665,MOVED TO 600582,Caret
605666,CYSTEINYL LEUKOTRIENE RECEPTOR 2; CYSLTR2,Asterisk
605667,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 1; RGL1,Asterisk
605668,BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 2; BACE2,Asterisk
605669,PROSTATE AND BREAST CANCER OVEREXPRESSED 1; PBOV1,Asterisk
605670,LATE-ONSET RETINAL DEGENERATION; LORD,Number Sign
605671,DMX-LIKE 1; DMXL1,Asterisk
605672,CEREBELLAR ATAXIA AND HYPERGONADOTROPIC HYPOGONADISM,
605673,B-CELL TRANSLOCATION GENE 4; BTG4,Asterisk
605674,B-CELL TRANSLOCATION GENE 3; BTG3,Asterisk
605675,RING FINGER PROTEIN 14; RNF14,Asterisk
605676,"CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK",Number Sign
605677,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 5; ACSL5",Asterisk
605678,MLX-INTERACTING PROTEIN-LIKE; MLXIPL,Asterisk
605679,INTERLEUKIN 26; IL26,Asterisk
605680,"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1A; BAZ1A",Asterisk
605681,"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1B; BAZ1B",Asterisk
605682,"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2A; BAZ2A",Asterisk
605683,"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2B; BAZ2B",Asterisk
605684,TRIPARTITE MOTIF-CONTAINING PROTEIN 34; TRIM34,Asterisk
605685,MOVED TO 216550,Caret
605686,CELL ADHESION MOLECULE 1; CADM1,Asterisk
605687,INTERLEUKIN 19; IL19,Asterisk
605688,COPINE VI; CPNE6,Asterisk
605689,COPINE VII; CPNE7,Asterisk
605690,GLIOMA TUMOR SUPPRESSOR CANDIDATE REGION GENE 1; GLTSCR1,Asterisk
605691,RIBOSOME BIOGENESIS FACTOR NOP53; NOP53,Asterisk
605692,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 7; TRPM7",Asterisk
605693,RAS-ASSOCIATED PROTEIN RAB30; RAB30,Asterisk
605694,RAS-ASSOCIATED PROTEIN RAB31; RAB31,Asterisk
605695,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 4; BLOC1S4",Asterisk
605696,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 2; KCNG2",Asterisk
605697,UL16-BINDING PROTEIN 1; ULBP1,Asterisk
605698,UL16-BINDING PROTEIN 2; ULBP2,Asterisk
605699,UL16-BINDING PROTEIN 3; ULBP3,Asterisk
605700,TRIPARTITE MOTIF-CONTAINING PROTEIN 39; TRIM39,Asterisk
605701,TRIPARTITE MOTIF-CONTAINING PROTEIN 10; TRIM10,Asterisk
605702,LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1,Asterisk
605703,VESICLE-ASSOCIATED MEMBRANE PROTEIN-ASSOCIATED PROTEIN A; VAPA,Asterisk
605704,VESICLE-ASSOCIATED MEMBRANE PROTEIN-ASSOCIATED PROTEIN B; VAPB,Asterisk
605705,SALT-INDUCIBLE KINASE 1; SIK1,Asterisk
605706,RECEPTOR-INTERACTING SERINE-THREONINE KINASE 4; RIPK4,Asterisk
605707,MOVED TO 604985,Caret
605708,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 11; ARHGEF11,Asterisk
605709,ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 5; ARL6IP5,Asterisk
605710,GDNF FAMILY RECEPTOR ALPHA-3; GFRA3,Asterisk
605711,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1,Number Sign
605712,"SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 1; SPTLC1",Asterisk
605713,"SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 2; SPTLC2",Asterisk
605714,"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED",Number Sign
605715,CD276 ANTIGEN; CD276,Asterisk
605716,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 5; KCNH5",Asterisk
605717,INDUCIBLE T-CELL COSTIMULATOR LIGAND; ICOSLG,Asterisk
605718,MEDIATOR COMPLEX SUBUNIT 4; MED4,Asterisk
605719,"LINKER FOR ACTIVATION OF T CELLS FAMILY, MEMBER 2; LAT2",Asterisk
605720,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 4; KCNK4",Asterisk
605721,JUNCTION ADHESION MOLECULE 1; JAM1,Asterisk
605722,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 16; KCNJ16",Asterisk
605723,PROGRAMMED CELL DEATH 1 LIGAND 2; PDCD1LG2,Asterisk
605724,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1",Number Sign
605725,PERIAXIN; PRX,Asterisk
605726,"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2",Number Sign
605727,OTOSCLEROSIS 2; OTSC2,Percent
605728,CATARACT 25; CTRCT25,Percent
605729,AT-HOOK TRANSCRIPTION FACTOR AKNA; AKNA,Asterisk
605730,SPERM-ASSOCIATED ANTIGEN 6; SPAG6,Asterisk
605731,SPERM-ASSOCIATED ANTIGEN 8; SPAG8,Asterisk
605732,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 21; TNFRSF21",Asterisk
605733,PRELI DOMAIN-CONTAINING PROTEIN 1; PRELID1,Asterisk
605734,TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 2; TMEFF2,Asterisk
605735,"BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12",Percent
605736,UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN A; UBASH3A,Asterisk
605737,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; BIRC7,Asterisk
605738,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 2; MCOPCB2",Percent
605739,KYPHOSCOLIOSIS PEPTIDASE; KY,Asterisk
605740,SCLEROSTIN; SOST,Asterisk
605741,G PROTEIN-COUPLED RECEPTOR 183; GPR183,Asterisk
605742,"TUBULIN, ALPHA-8; TUBA8",Asterisk
605743,HEDGEHOG ACYLTRANSFERASE; HHAT,Asterisk
605744,EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 3; EXTL3,Asterisk
605745,CYTOCHROME b REDUCTASE 1; CYBRD1,Asterisk
605746,ANISOMASTIA,Percent
605747,LOW DENSITY LIPOPROTEIN RECEPTOR ADAPTOR PROTEIN 1; LDLRAP1,Asterisk
605748,BETA-CAROTENE OXYGENASE 1; BCO1,Asterisk
605749,"CATARACT 26, MULTIPLE TYPES; CTRCT26",Percent
605750,EXUDATIVE VITREORETINOPATHY 3; EVR3,Percent
605751,"SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2",Number Sign
605752,HID1 DOMAIN-CONTAINING PROTEIN 1; HID1,Asterisk
605753,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 2; SPINK2",Asterisk
605754,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Q PROTEIN; PIGQ,Asterisk
605755,DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 2; DCDC2,Asterisk
605756,"OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH SHORT STATURE AND RECURRENT METABOLIC ACIDOSIS",
605757,"PELOTA, DROSOPHILA, HOMOLOG OF; PELO",Asterisk
605758,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; ASB1,Asterisk
605759,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 2; ASB2,Asterisk
605760,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 3; ASB3,Asterisk
605761,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 4; ASB4,Asterisk
605762,RENAL TUMOR ANTIGEN; RAGE,Asterisk
605763,"SOLUTE CARRIER FAMILY 45, MEMBER 1; SLC45A1",Asterisk
605764,TYROSYL-DNA PHOSPHODIESTERASE 2; TDP2,Asterisk
605765,"DELETED IN LYMPHOCYTIC LEUKEMIA, 1; DLEU1",Asterisk
605766,"DELETED IN LYMPHOCYTIC LEUKEMIA, 2; DLEU2",Asterisk
605767,PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID-ENRICHED MICRODOMAINS 1; PAG1,Asterisk
605768,DUAL ADAPTOR OF PHOSPHOTYROSINE AND 3-PHOSPHOINOSITIDES 1,Asterisk
605769,TRIPARTITE MOTIF-CONTAINING PROTEIN 33; TRIM33,Asterisk
605770,ILVB-LIKE; ILVBL,Asterisk
605771,COX7A2-LIKE PROTEIN; COX7A2L,Asterisk
605772,"ESTROGEN RECEPTOR-BINDING SITE-ASSOCIATED ANTIGEN, 9; EBAG9",Asterisk
605773,LEUKOTRIENE B4 RECEPTOR 2; LTB4R2,Asterisk
605774,KELCH-LIKE 2; KLHL2,Asterisk
605775,KELCH-LIKE 3; KLHL3,Asterisk
605776,FIBRINOGEN-LIKE 1; FGL1,Asterisk
605777,"SPHINGOMYELIN PHOSPHODIESTERASE 3, NEUTRAL MEMBRANE; SMPD3",Asterisk
605778,NIF3-LIKE 1; NIF3L1,Asterisk
605779,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7; NDNC7",Percent
605780,PR DOMAIN-CONTAINING PROTEIN 4; PRDM4,Asterisk
605781,"RAS HOMOLOG GENE FAMILY, MEMBER D; RHOD",Asterisk
605782,EUKARYOTIC TRANSLATION INITIATION FACTOR 5A2; EIF5A2,Asterisk
605783,BREAST CARCINOMA AMPLIFIED SEQUENCE 2; BCAS2,Asterisk
605784,"TWEETY, DROSOPHILA, HOMOLOG OF, 1; TTYH1",Asterisk
605785,"TUBULIN, GAMMA-2; TUBG2",Asterisk
605786,"RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 3; RBMS3",Asterisk
605787,"ANKYRIN REPEAT-CONTAINING PROTEIN, FAMILY A, MEMBER 2; ANKRA2",Asterisk
605788,"MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 3; MAPRE3",Asterisk
605789,"MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 2; MAPRE2",Asterisk
605790,SERINE/THREONINE KINASE 31; STK31,Asterisk
605791,TESTIS-EXPRESSED GENE 12; TEX12,Asterisk
605792,TESTIS-EXPRESSED GENE 14; TEX14,Asterisk
605793,RING FINGER PROTEIN 17; RNF17,Asterisk
605794,MOV10-LIKE 1; MOV10L1,Asterisk
605795,TESTIS-EXPRESSED GENE 15; TEX15,Asterisk
605796,TUDOR DOMAIN-CONTAINING PROTEIN 1; TDRD1,Asterisk
605797,"ANKYRIN REPEAT, SAM, AND BASIC LEUCINE ZIPPER DOMAIN-CONTAINING 1; ASZ1",Asterisk
605798,"NEURAL PROLIFERATION, DIFFERENTIATION, AND CONTROL PROTEIN 1; NPDC1",Asterisk
605799,"AMNIONLESS, MOUSE, HOMOLOG OF; AMN",Asterisk
605800,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U-LIKE 1; HNRNPUL1,Asterisk
605801,RALA-BINDING PROTEIN 1; RALBP1,Asterisk
605802,ZINC FINGER E BOX-BINDING HOMEOBOX 2; ZEB2,Asterisk
605803,"DERMATITIS, ATOPIC, 2; ATOD2",Number Sign
605804,"DERMATITIS, ATOPIC, 3; ATOD3",Percent
605805,"DERMATITIS, ATOPIC, 4; ATOD4",Percent
605806,CADHERIN 7; CDH7,Asterisk
605807,CADHERIN 20; CDH20,Asterisk
605808,BIRDSHOT CHORIORETINOPATHY,
605809,"MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A",Number Sign
605810,MITOCHONDRIAL RIBOSOMAL PROTEIN S22; MRPS22,Asterisk
605811,NTF2-LIKE EXPORT FACTOR 1; NXT1,Asterisk
605812,DEAD/H BOX 19; DDX19,Asterisk
605813,NUCLEAR TRANSPORT FACTOR 2,Asterisk
605814,"CITRULLINEMIA, TYPE II, NEONATAL-ONSET",Number Sign
605815,"NUCLEOPORIN, 62-KD; NUP62",Asterisk
605816,EPSTEIN-BARR VIRUS-INDUCED GENE 3; EBI3,Asterisk
605817,RECEPTOR-INTERACTING SERINE/THREONINE KINASE 3; RIPK3,Asterisk
605818,"DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27",Percent
605819,"PESCADILLO, ZEBRAFISH, HOMOLOG OF, 1; PES1",Asterisk
605820,NONAKA MYOPATHY; NM,Number Sign
605821,ERYTHROID-ASSOCIATED FACTOR; ERAF,Asterisk
605822,SPONDYLOOCULAR SYNDROME; SOS,Number Sign
605823,POPEYE DOMAIN-CONTAINING PROTEIN 2; POPDC2,Asterisk
605824,POPEYE DOMAIN-CONTAINING PROTEIN 3; POPDC3,Asterisk
605825,HEME-BINDING PROTEIN 2; HEBP2,Asterisk
605826,HEME-BINDING PROTEIN 1; HEBP1,Asterisk
605827,"BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS",Percent
605828,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 6; TMC6,Asterisk
605829,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 8; TMC8,Asterisk
605830,FIBROBLAST GROWTH FACTOR RECEPTOR-LIKE 1; FGFRL1,Asterisk
605831,FIBROBLAST GROWTH FACTOR 22; FGF22,Asterisk
605832,"ACETYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 2; ACSS2",Asterisk
605833,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 2; BMND2,Percent
605834,TROPOMODULIN 4; TMOD4,Asterisk
605835,TRANSMEMBRANE PROTEIN 2; TMEM2,Asterisk
605836,"UNC13, C. ELEGANS, HOMOLOG OF, B; UNC13B",Asterisk
605837,HECT DOMAIN AND RCC1-LIKE DOMAIN 2; HERC2,Asterisk
605838,BABY RATTLE PELVIS DYSPLASIA,
605839,MOVED TO 150800,Caret
605840,RING FINGER PROTEIN 111; RNF111,Asterisk
605841,"NARCOLEPSY 2, SUSCEPTIBILITY TO; NRCLP2",Percent
605842,TRANSDUCIN-BETA-LIKE 2; TBL2,Asterisk
605843,PEROXISOMAL TRANS-2-ENOYL-CoA REDUCTASE; PECR,Asterisk
605844,"DERMATITIS, ATOPIC, 5; ATOD5",Percent
605845,"DERMATITIS, ATOPIC, 6; ATOD6",Percent
605846,B-CELL CLL/LYMPHOMA 7B; BCL7B,Asterisk
605847,B-CELL CLL/LYMPHOMA 7C; BCL7C,Asterisk
605848,"CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP14",Asterisk
605849,DIMETHYLGLYCINE DEHYDROGENASE; DMGDH,Asterisk
605850,DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD,Number Sign
605851,ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE; ICMT,Asterisk
605852,CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 1; CLASP1,Asterisk
605853,CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 2; CLASP2,Asterisk
605854,BCL2-BINDING COMPONENT 3; BBC3,Asterisk
605855,"ATPase, CLASS V, TYPE 10A; ATP10A",Asterisk
605856,"SHORT STATURE, MENTAL RETARDATION, CALLOSAL AGENESIS, HEMINASAL HYPOPLASIA, MICROPHTHALMIA, AND ATYPICAL CLEFTING",Percent
605857,"RAS HOMOLOG GENE FAMILY, MEMBER Q; RHOQ",Asterisk
605858,"SCRATCH, MOUSE, HOMOLOG OF; SCRT1",Asterisk
605859,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 32; ZBTB32,Asterisk
605860,RCAN FAMILY MEMBER 3; RCAN3,Asterisk
605861,CANOPY FGF SIGNALING REGULATOR 2; CNPY2,Asterisk
605862,RIBITOL XYLOSYLTRANSFERASE 1; RXYLT1,Asterisk
605863,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 3; B3GNT3",Asterisk
605864,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 4; B3GNT4",Asterisk
605865,"TASTE RECEPTOR TYPE 1, MEMBER 3; TAS1R3",Asterisk
605866,"ATPase, CLASS I, TYPE 8B, MEMBER 3; ATP8B3",Asterisk
605867,"ATPase, CLASS I, TYPE 8B, MEMBER 2; ATP8B2",Asterisk
605868,"ATPase, CLASS VI, TYPE 11A; ATP11A",Asterisk
605869,"ATPase, CLASS VI, TYPE 11B; ATP11B",Asterisk
605870,"ATPase, CLASS I, TYPE 8A, MEMBER 2; ATP8A2",Asterisk
605871,MOVED TO 193090,Caret
605872,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER M; CLEC4M",Asterisk
605873,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 10; KCNK10",Asterisk
605874,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 9; KCNK9",Asterisk
605875,"WASP PROTEIN FAMILY, MEMBER 2; WASF2",Asterisk
605876,Fc RECEPTOR-LIKE PROTEIN 4; FCRL4,Asterisk
605877,Fc RECEPTOR-LIKE PROTEIN 5; FCRL5,Asterisk
605878,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7A; ZBTB7A,Asterisk
605879,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 2; KCNN2",Asterisk
605880,LYSINE ACETYLTRANSFERASE 6B; KAT6B,Asterisk
605881,"SOLUTE CARRIER FAMILY 35, MEMBER C1; SLC35C1",Asterisk
605882,BRCA1-INTERACTING PROTEIN 1; BRIP1,Asterisk
605883,LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 3; LAMP3,Asterisk
605884,"DYNEIN, AXONEMAL, HEAVY CHAIN 10; DNAH10",Asterisk
605885,SEMAPHORIN 6A; SEMA6A,Asterisk
605886,COMPLEMENT COMPONENT RECEPTOR 1-LIKE; CR1L,Asterisk
605887,MOVED TO 300357,Caret
605888,EH DOMAIN-CONTAINING 1; EHD1,Asterisk
605889,PDZ AND LIM DOMAIN PROTEIN 3; PDLIM3,Asterisk
605890,EH DOMAIN-CONTAINING 2; EHD2,Asterisk
605891,EH DOMAIN-CONTAINING 3; EHD3,Asterisk
605892,EH DOMAIN-CONTAINING 4; EHD4,Asterisk
605893,CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE; CDIPT,Asterisk
605894,EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 1; EID1,Asterisk
605895,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 2; EIF4E2",Asterisk
605896,ENDOTHELIN-CONVERTING ENZYME-LIKE 1; ECEL1,Asterisk
605897,UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 1; UGGT1,Asterisk
605898,UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 2; UGGT2,Asterisk
605899,GLYCINE ENCEPHALOPATHY; GCE,Number Sign
605900,PDZ AND LIM DOMAIN PROTEIN 1; PDLIM1,Asterisk
605901,UROCORTIN III; UCN3,Asterisk
605902,UROCORTIN II; UCN2,Asterisk
605903,PDZ AND LIM DOMAIN PROTEIN 7; PDLIM7,Asterisk
605904,PDZ AND LIM DOMAIN PROTEIN 5; PDLIM5,Asterisk
605905,DCN1 DOMAIN-CONTAINING PROTEIN 1; DCUN1D1,Asterisk
605906,LIM DOMAIN-BINDING 3; LDB3,Asterisk
605907,"ALG1, YEAST, HOMOLOG OF; ALG1",Asterisk
605908,MLC1 GENE; MLC1,Asterisk
605909,"PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6",Number Sign
605910,ANGIOPOIETIN-LIKE 4; ANGPTL4,Asterisk
605911,3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY; HMGCS2D,Number Sign
605912,"MATRIX, EXTRACELLULAR, PHOSPHOGLYCOPROTEIN; MEPE",Asterisk
605913,"BLEEDING DISORDER, EAST TEXAS TYPE",Percent
605914,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 12A; TNFRSF12A",Asterisk
605915,TRANSDUCIN-BETA-LIKE 3; TBL3,Asterisk
605916,"SPECTRIN, BETA, NONERYTHROCYTIC, 5; SPTBN5",Asterisk
605917,"TPX2, XENOPUS, HOMOLOG OF; TPX2",Asterisk
605918,SPONDIN 2; SPON2,Asterisk
605919,MOVED TO 300361,Caret
605920,"STAUFEN, DROSOPHILA, HOMOLOG OF, 2; STAU2",Asterisk
605921,STROMAL INTERACTION MOLECULE 1; STIM1,Asterisk
605922,MYOINOSITOL MONOPHOSPHATASE 2; IMPA2,Asterisk
605923,SRY-BOX 8; SOX8,Asterisk
605924,WD REPEAT-CONTAINING PROTEIN 4; WDR4,Asterisk
605925,PERICENTRIN; PCNT,Asterisk
605926,PROTEIN INTERACTING WITH C KINASE 1; PICK1,Asterisk
605927,"MOUSE DOUBLE MINUTE 2 HOMOLOG, BINDING PROTEIN OF; MTBP",Asterisk
605928,ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 1; ARFIP1,Asterisk
605929,SORTING NEXIN 2; SNX2,Asterisk
605930,SORTING NEXIN 3; SNX3,Asterisk
605931,SORTING NEXIN 4; SNX4,Asterisk
605932,BETAINE-HOMOCYSTEINE METHYLTRANSFERASE 2; BHMT2,Asterisk
605933,"TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 4; TM7SF4",Asterisk
605934,HOLOPROSENCEPHALY 6; HPE6,Percent
605935,"ARTHROPATHY, EROSIVE",
605936,BRIDGING INTEGRATOR 2; BIN2,Asterisk
605937,SORTING NEXIN 5; SNX5,Asterisk
605938,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS P PROTEIN; PIGP,Asterisk
605939,"PHOSPHOLIPASE C, DELTA-4; PLCD4",Asterisk
605940,"BRAIN-ABUNDANT SIGNAL PROTEIN, MEMBRANE-ATTACHED, 1; BASP1",Asterisk
605941,SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 1; SART1,Asterisk
605942,DERMATAN SULFATE EPIMERASE; DSE,Asterisk
605943,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE 1; GDE1,Asterisk
605944,LIVER FIBROCYSTIC DISEASE AND POLYDACTYLY,
605945,CRUMPLED HELICES AND SMALL MOUTH,
605946,"METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE",Percent
605947,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS L PROTEIN; PIGL,Asterisk
605948,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER B; GPRC5B",Asterisk
605949,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER C; GPRC5C",Asterisk
605950,RAS-ASSOCIATED PROTEIN RAB33B; RAB33B,Asterisk
605951,DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 3; DPM3,Asterisk
605952,SORTING NEXIN 9; SNX9,Asterisk
605953,"ARF GTPase-ACTIVATING PROTEIN WITH SH3 DOMAIN, ANKYRIN REPEAT, AND PH DOMAIN 1; ASAP1",Asterisk
605954,FETUIN B; FETUB,Asterisk
605955,"NK6, DROSOPHILA, HOMOLOG OF, 2; NKX6-2",Asterisk
605956,NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 2; NOD2,Asterisk
605957,MOVED TO 600965,Caret
605958,TRAF-INTERACTING PROTEIN; TRAIP,Asterisk
605959,HR44 ANTIGEN,Asterisk
605960,EXOSOME COMPONENT 10; EXOSC10,Asterisk
605961,PLEIOTROPIC REGULATOR 1; PLRG1,Asterisk
605962,RAB9 EFFECTOR PROTEIN WITH KELCH MOTIFS; RABEPK,Asterisk
605963,SORTING NEXIN 17; SNX17,Asterisk
605964,SORTING NEXIN 15; SNX15,Asterisk
605965,RAS AND RAB INTERACTOR 1; RIN1,Asterisk
605966,HEPATOCYTE NUCLEAR FACTOR 4-GAMMA; HNF4G,Asterisk
605967,ACROPECTORAL SYNDROME; ACRPS,Percent
605968,RET FINGER PROTEIN-LIKE 1; RFPL1,Asterisk
605969,RET FINGER PROTEIN-LIKE 2; RFPL2,Asterisk
605970,RET FINGER PROTEIN-LIKE 3; RFPL3,Asterisk
605971,"RET FINGER PROTEIN-LIKE 3, ANTISENSE; RFPL3S",Asterisk
605972,"RET FINGER PROTEIN-LIKE 1, ANTISENSE; RFPL1S",Asterisk
605973,DDB1- AND CUL4-ASSOCIATED FACTOR 7; DCAF7,Asterisk
605974,"SLU7 SPLICING FACTOR, S. CEREVISIAE, HOMOLOG OF; SLU7",Asterisk
605975,SERINE/ARGININE REPETITIVE MATRIX PROTEIN 1; SRRM1,Asterisk
605976,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 6; ZBTB6,Asterisk
605977,"INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 2, S. CEREVISIAE, HOMOLOG OF; IMMP2L",Asterisk
605978,"VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, A; VPS13A",Asterisk
605979,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 5; SNAPC5",Asterisk
605980,NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 1; NOD1,Asterisk
605981,UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 1; UBR1,Asterisk
605982,MOVED TO 194070,Caret
605983,"PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, ALPHA; PPP2R1A",Asterisk
605984,"EMBRYONIC ECTODERM DEVELOPMENT PROTEIN, MOUSE, HOMOLOG OF; EED",Asterisk
605985,MOVED TO 300408,Caret
605986,SERINE/THREONINE KINASE RECEPTOR-ASSOCIATED PROTEIN; STRAP,Asterisk
605987,PROTEIN INHIBITOR OF ACTIVATED STAT3,Asterisk
605988,DNA CROSS-LINK REPAIR PROTEIN 1C; DCLRE1C,Asterisk
605989,PROTEIN INHIBITOR OF ACTIVATED STAT4; PIAS4,Asterisk
605990,"NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO",Number Sign
605991,NEURONAL GUANINE NUCLEOTIDE EXCHANGE FACTOR; NGEF,Asterisk
605992,LIM HOMEOBOX PROTEIN 5; LHX5,Asterisk
605993,PYRUVATE DEHYDROGENASE PHOSPHATASE CATALYTIC SUBUNIT 1; PDP1,Asterisk
605994,"CYTOCHROME P450, FAMILY 39, SUBFAMILY A, POLYPEPTIDE 1; CYP39A1",Asterisk
605995,KINESIN FAMILY MEMBER 1B; KIF1B,Asterisk
605996,"DOM3, C. ELEGANS, HOMOLOG OF, Z; DOM3Z",Asterisk
605997,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, GAMMA ISOFORM; PPP2R2C",Asterisk
605998,HCLS1-ASSOCIATED PROTEIN X1; HAX1,Asterisk
605999,"C-TYPE LECTIN DOMAIN FAMILY 10, MEMBER A; CLEC10A",Asterisk
606000,BUTYROPHILIN-LIKE PROTEIN 2; BTNL2,Asterisk
606001,INTERLEUKIN 32; IL32,Asterisk
606002,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1",Number Sign
606003,TRANSALDOLASE DEFICIENCY,Number Sign
606004,"GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 1; GGA1",Asterisk
606005,"GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 2; GGA2",Asterisk
606006,"GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 3; GGA3",Asterisk
606007,"POLYMERASE III, RNA, SUBUNIT K; POLR3K",Asterisk
606008,NATURAL KILLER CELL GROUP 7 SEQUENCE; NKG7,Asterisk
606009,DOUBLE HOMEOBOX PROTEIN 4; DUX4,Asterisk
606010,NUCLEAR RECEPTOR-BINDING PROTEIN 1; NRBP1,Asterisk
606011,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; VSIG2,Asterisk
606012,"DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18",Percent
606013,F-BOX ONLY PROTEIN 5; FBXO5,Asterisk
606014,ARISTALESS-LIKE HOMEOBOX 3; ALX3,Asterisk
606015,FAS APOPTOTIC INHIBITORY MOLECULE 3; FAIM3,Asterisk
606016,KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; KEAP1,Asterisk
606017,"POLYMERASE II, RNA, SUBUNIT D; POLR2D",Asterisk
606018,EGF-LIKE REPEATS- AND DISCOIDIN I-LIKE DOMAINS-CONTAINING PROTEIN 3; EDIL3,Asterisk
606019,EXOSOME COMPONENT 8; EXOSC8,Asterisk
606020,OPA-INTERACTING PROTEIN 5; OIP5,Asterisk
606021,PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA; PRAME,Asterisk
606022,NUDIX HYDROLASE 9; NUDT9,Asterisk
606023,"POLYMERASE II, RNA, SUBUNIT H; POLR2H",Asterisk
606024,MOVED TO 604753,Caret
606025,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 20; ZBTB20,Asterisk
606026,WHS CANDIDATE 2 GENE; WHSC2,Asterisk
606027,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 1; CPSF1,Asterisk
606028,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 2; CPSF2,Asterisk
606029,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 3; CPSF3,Asterisk
606030,ENHANCER OF mRNA DECAPPING 4; EDC4,Asterisk
606031,WD REPEAT-CONTAINING PROTEIN 6; WDR6,Asterisk
606032,SERINE/ARGININE REPETITIVE MATRIX PROTEIN 2; SRRM2,Asterisk
606033,"POLYMERASE II, RNA, SUBUNIT K; POLR2K",Asterisk
606034,"RIBONUCLEASE H2, SUBUNIT A; RNASEH2A",Asterisk
606035,FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1; FIQTL1,Percent
606036,ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR 2; ARNT2,Asterisk
606037,CD96 ANTIGEN; CD96,Asterisk
606038,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6D; LY6G6D",Asterisk
606039,HYDROXYCARBOXYLIC ACID RECEPTOR 3; HCAR3,Asterisk
606040,WD REPEAT-CONTAINING PROTEIN 8; WDR8,Asterisk
606041,SPARC-LIKE PROTEIN 1; SPARCL1,Asterisk
606042,MYONEURIN; MYNN,Asterisk
606043,ZINC FINGER PROTEIN 331; ZNF331,Asterisk
606044,SJOGREN SYNDROME/SCLERODERMA AUTOANTIGEN 1; SSSCA1,Asterisk
606045,"INTRAFLAGELLAR TRANSPORT 122, CHLAMYDOMONAS, HOMOLOG OF; IFT122",Asterisk
606046,SYNTAXIN 18; STX18,Asterisk
606047,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 5; LILRA5",Asterisk
606048,MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 7; MBOAT7,Asterisk
606049,"ACROMEGALOID FEATURES, OVERGROWTH, CLEFT PALATE, AND HERNIA",Percent
606050,UBIQUITIN D; UBD,Asterisk
606051,SECRETION-REGULATING GUANINE NUCLEOTIDE EXCHANGE FACTOR; SERGEF,Asterisk
606052,MOVED TO 607745,Caret
606053,"AUTISM, SUSCEPTIBILITY TO, 5; AUTS5",Percent
606054,PROPIONIC ACIDEMIA,Number Sign
606055,PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; PCTP,Asterisk
606056,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B",Number Sign
606057,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; RAPGEF3,Asterisk
606058,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF4,Asterisk
606059,"PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR ALPHA; PKIA",Asterisk
606060,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 12; DNAJC12",Asterisk
606061,T-BOX 20; TBX20,Asterisk
606062,STRUCTURAL MAINTENANCE OF CHROMOSOMES 3; SMC3,Asterisk
606063,"EXONUCLEASE 1, S. CEREVISIAE, HOMOLOG OF; EXO1",Asterisk
606064,CD248 ANTIGEN; CD248,Asterisk
606065,ATYPICAL CHEMOKINE RECEPTOR 4; ACKR4,Asterisk
606066,LIM HOMEOBOX GENE 9; LHX9,Asterisk
606067,OTORAPLIN; OTOR,Asterisk
606068,RETINITIS PIGMENTOSA 28; RP28,Number Sign
606069,"HEMOCHROMATOSIS, TYPE 4; HFE4",Number Sign
606070,AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21,Number Sign
606071,"HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C",Number Sign
606072,RIPPLING MUSCLE DISEASE 2; RMD2,Number Sign
606073,NADPH-DEPENDENT DIFLAVIN OXIDOREDUCTASE 1; NDOR1,Asterisk
606074,"GLOBOSIDE ALPHA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE; GBGT1",Asterisk
606075,TWINKLE mtDNA HELICASE; TWNK,Asterisk
606076,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 3; PIK3R3",Asterisk
606077,RNA-BINDING MOTIF PROTEIN 15; RBM15,Asterisk
606078,MEGAKARYOBLASTIC LEUKEMIA 1 GENE; MKL1,Asterisk
606079,CD163 ANTIGEN-LIKE 1; CD163L1,Asterisk
606080,"CHITINASE, ACIDIC; CHIA",Asterisk
606081,"TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 70, YEAST, HOMOLOG OF, A; TOMM70A",Asterisk
606082,"GOITER, MULTINODULAR 3; MNG3",Percent
606083,"POLYBROMO 1, CHICKEN, HOMOLOG OF; PBRM1",Asterisk
606084,CDC42 EFFECTOR PROTEIN 1; CDC42EP1,Asterisk
606085,TESTIS-DERIVED TRANSCRIPT; TES,Asterisk
606086,EUKARYOTIC TRANSLATION INITIATION FACTOR 5B; EIF5B,Asterisk
606087,DESMUSLIN; DMN,Asterisk
606088,"PHOSPHOLIPASE A2, GROUP IVB; PLA2G4B",Asterisk
606089,BRAIN CYTOPLASMIC RNA 1; BCYRN1,Asterisk
606090,CARNITINE OCTANOYLTRANSFERASE; CROT,Asterisk
606091,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 10; SIGLEC10,Asterisk
606092,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 14; DNAJC14",Asterisk
606093,PEPTIDYL-PROLYL ISOMERASE G; PPIG,Asterisk
606094,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 12; SIGLEC12,Asterisk
606095,PEPTIDYL-PROLYL ISOMERASE H; PPIH,Asterisk
606096,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 12",Asterisk
606097,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS N PROTEIN; PIGN,Asterisk
606098,SORTING NEXIN 6; SNX6,Asterisk
606099,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 8; LGALS8",Asterisk
606100,ADHESION G PROTEIN-COUPLED RECEPTOR E2; ADGRE2,Asterisk
606101,ADHESION G PROTEIN-COUPLED RECEPTOR E3; ADGRE3,Asterisk
606102,"PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, GAMMA; PIP5K1C",Asterisk
606103,SESTRIN 1; SESN1,Asterisk
606104,MOVED TO 124000,Caret
606105,"SOLUTE CARRIER FAMILY 44, MEMBER 1; SLC44A1",Asterisk
606106,"SOLUTE CARRIER FAMILY 44, MEMBER 2; SLC44A2",Asterisk
606107,"SOLUTE CARRIER FAMILY 44, MEMBER 4; SLC44A4",Asterisk
606108,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1A; PPM1A",Asterisk
606109,NUDC DOMAIN-CONTAINING PROTEIN 1; NUDCD1,Asterisk
606110,LY6/NEUROTOXIN 1; LYNX1,Asterisk
606111,MELANIN-CONCENTRATING HORMONE RECEPTOR 2; MCHR2,Asterisk
606112,"RIBONUCLEASE P, 14-KD SUBUNIT; RPP14",Asterisk
606113,"PROCESSING OF PRECURSOR 7, S. CEREVISIAE, HOMOLOG OF; POP7",Asterisk
606114,"PROCESSING OF PRECURSOR 4, S. CEREVISIAE, HOMOLOG OF; POP4",Asterisk
606115,"RIBONUCLEASE P/MRP, 30-KD SUBUNIT; RPP30",Asterisk
606116,"RIBONUCLEASE P/MRP, 38-KD SUBUNIT; RPP38",Asterisk
606117,"RIBONUCLEASE P, 40-KD SUBUNIT; RPP40",Asterisk
606118,HPS3 GENE; HPS3,Asterisk
606119,SECRETED LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; SLURP1,Asterisk
606120,MOVED TO 561010,Caret
606121,CALCITONIN GENE-RELATED PEPTIDE RECEPTOR COMPONENT PROTEIN,Asterisk
606122,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 19; TNFRSF19",Asterisk
606123,RING FINGER PROTEIN 16; RNF16,Asterisk
606124,RING FINGER PROTEIN 18; RNF18,Asterisk
606125,TRIPARTITE MOTIF-CONTAINING PROTEIN 8; TRIM8,Asterisk
606126,APOPTOSIS REGULATOR BCLG,Asterisk
606127,MYOCARDIN; MYOCD,Asterisk
606128,MOVED TO 606078,Caret
606129,DIAMOND-BLACKFAN ANEMIA 2; DBA2,Percent
606130,RING FINGER PROTEIN 26; RNF26,Asterisk
606131,TRIPARTITE MOTIF-CONTAINING PROTEIN 63; TRIM63,Asterisk
606132,CDC42 EFFECTOR PROTEIN 2; CDC42EP2,Asterisk
606133,CDC42 EFFECTOR PROTEIN 3; CDC42EP3,Asterisk
606134,"REV1, S. CEREVISIAE, HOMOLOG OF; REV1L",Asterisk
606135,KALLIKREIN-RELATED PEPTIDASE 14; KLK14,Asterisk
606136,RAS PROTEIN ACTIVATOR-LIKE 2; RASAL2,Asterisk
606137,CELL GROWTH REGULATOR WITH EF-HAND DOMAIN 1; CGREF1,Asterisk
606138,CELL GROWTH REGULATOR WITH RING FINGER DOMAIN 1; CGRRF1,Asterisk
606139,KRUPPEL-LIKE FACTOR 16; KLF16,Asterisk
606140,EXPORTIN 7; XPO7,Asterisk
606141,RAN-BINDING PROTEIN 17; RANBP17,Asterisk
606142,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 9; SLC2A9",Asterisk
606143,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 3; FZD3",Asterisk
606144,RAS-ASSOCIATED PROTEIN RAB23; RAB23,Asterisk
606145,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 10; SLC2A10",Asterisk
606146,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 8; FZD8",Asterisk
606147,"FRIZZLED, DROSOPHILA, HOMOLOG OF, 10; FZD10",Asterisk
606148,FATTY ACID DESATURASE 1; FADS1,Asterisk
606149,FATTY ACID DESATURASE 2; FADS2,Asterisk
606150,FATTY ACID DESATURASE 3; FADS3,Asterisk
606151,BBS2 GENE; BBS2,Asterisk
606152,"SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 3; SLC19A3",Asterisk
606153,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, EPSILON SUBUNIT; ATP5F1E",Asterisk
606154,MUCIN 16; MUC16,Asterisk
606155,MOVED TO 243310,Caret
606156,SENER SYNDROME,
606157,PANTOTHENATE KINASE 2; PANK2,Asterisk
606158,BSCL2 GENE; BSCL2,Asterisk
606159,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3,Number Sign
606160,PANTOTHENATE KINASE 1; PANK1,Asterisk
606161,PANTOTHENATE KINASE 3; PANK3,Asterisk
606162,PANTOTHENATE KINASE 4; PANK4,Asterisk
606163,MOVED TO 300829,Caret
606164,DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15,Number Sign
606165,BOL-LIKE; BOLL,Asterisk
606166,MOVED TO 603100,Caret
606167,G PROTEIN-COUPLED RECEPTOR 132; GPR132,Asterisk
606168,DEAD/H BOX 20; DDX20,Asterisk
606169,MOVED TO 277410,Caret
606170,GENITOPATELLAR SYNDROME; GTPTS,Number Sign
606171,TRANSFER RNA SERINE 1; TRNAS1,Asterisk
606172,TRANSFER RNA SERINE (TGA) 4-1; TRS-TGA4-1,Asterisk
606173,"GrpE, E. COLI, HOMOLOG OF, 1; GRPEL1",Asterisk
606174,"BACULUM, CONGENITAL ABSENCE OF",
606175,CARNITINE ACETYLTRANSFERASE DEFICIENCY,
606176,"DIABETES MELLITUS, PERMANENT NEONATAL; PNDM",Number Sign
606177,PARS PLANITIS,
606178,HEDGEHOG-INTERACTING PROTEIN; HHIP,Asterisk
606179,ANEURYSMAL BONE CYSTS,
606180,EXOSOME COMPONENT 9; EXOSC9,Asterisk
606181,DEAD/H BOX 24; DDX24,Asterisk
606182,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 9; TNFSF9",Asterisk
606183,LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY,
606184,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 12; ADAMTS12",Asterisk
606185,TUMOR PROTEIN p53-INDUCIBLE NUCLEAR PROTEIN 1; TP53INP1,Asterisk
606186,CALCYCLIN-BINDING PROTEIN; CACYBP,Asterisk
606187,ALZHEIMER DISEASE 7,Percent
606188,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 28; ADAM28,Asterisk
606189,CYSTEINE-RICH MOTOR NEURON PROTEIN 1; CRIM1,Asterisk
606190,"MENINGIOMA, RADIATION-INDUCED",
606191,FORMIN-BINDING PROTEIN 1; FNBP1,Asterisk
606192,BUTYROPHILIN-LIKE PROTEIN 3; BTNL3,Asterisk
606193,"SOLUTE CARRIER FAMILY 13 (SODIUM/SULFATE SYMPORTER), MEMBER 1; SLC13A1",Asterisk
606194,"KERATIN 23, TYPE I; KRT23",Asterisk
606195,IROQUOIS HOMEOBOX PROTEIN 5; IRX5,Asterisk
606196,IROQUOIS HOMEOBOX PROTEIN 6; IRX6,Asterisk
606197,IROQUOIS HOMEOBOX PROTEIN 1; IRX1,Asterisk
606198,IROQUOIS HOMEOBOX PROTEIN 2; IRX2,Asterisk
606199,IROQUOIS HOMEOBOX PROTEIN 4; IRX4,Asterisk
606200,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E41; BHLHE41",Asterisk
606201,WOLFRAMIN ER TRANSMEMBRANE GLYCOPROTEIN; WFS1,Asterisk
606202,"SOLUTE CARRIER FAMILY 45, MEMBER 2; SLC45A2",Asterisk
606203,GRB2-ASSOCIATED BINDING PROTEIN 2; GAB2,Asterisk
606204,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS D; LY6D",Asterisk
606205,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, L-PROLINE), MEMBER 7; SLC6A7",Asterisk
606206,METALLOTHIONEIN 4; MT4,Asterisk
606207,"SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 1; SLC28A1",Asterisk
606208,"SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 2; SLC28A2",Asterisk
606209,"YKT6, S. CEREVISIAE, HOMOLOG OF; YKT6",Asterisk
606210,SELENOPROTEIN N; SELENON,Asterisk
606211,SIRTUIN 6; SIRT6,Asterisk
606212,SIRTUIN 7; SIRT7,Asterisk
606213,"SIGNAL SEQUENCE RECEPTOR, GAMMA; SSR3",Asterisk
606214,"SPECTRIN, BETA, NONERYTHROCYTIC, 4; SPTBN4",Asterisk
606215,ATRIOVENTRICULAR SEPTAL DEFECT; AVSD,Percent
606216,METHIONINE SULFOXIDE REDUCTASE B1; MSRB1,Asterisk
606217,"ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2",Number Sign
606218,SELENOPHOSPHATE SYNTHETASE 2; SEPHS2,Asterisk
606219,TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PROTEIN 1; TRAP1,Asterisk
606220,"MENTAL RETARDATION, SHORT STATURE, FACIAL ANOMALIES, AND JOINT DISLOCATIONS",
606221,IKAROS FAMILY ZINC FINGER 3; IKZF3,Asterisk
606222,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 6; IGSF6",Asterisk
606223,"PROTEASOME 26S SUBUNIT, NON-ATPASE, 2; PSMD2",Asterisk
606224,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC IIIA; NT5C3A",Asterisk
606225,"TASTE RECEPTOR TYPE 1, MEMBER 1; TAS1R1",Asterisk
606226,"TASTE RECEPTOR TYPE 1, MEMBER 2; TAS1R2",Asterisk
606227,MEMBRANE-TYPE FRIZZLED-RELATED PROTEIN; MFRP,Asterisk
606228,"ARGONAUTE 1, RISC CATALYTIC COMPONENT; AGO1",Asterisk
606229,"ARGONAUTE 2, RISC CATALYTIC COMPONENT; AGO2",Asterisk
606230,SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3; SHANK3,Asterisk
606231,"ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 2; APPL2",Asterisk
606232,PHELAN-MCDERMID SYNDROME; PHMDS,Number Sign
606233,PROKINETICIN 1; PROK1,Asterisk
606234,IKAROS FAMILY ZINC FINGER 2; IKZF2,Asterisk
606235,THIOREDOXIN REDUCTASE 3; TXNRD3,Asterisk
606236,"ALVEOLAR SOFT PART SARCOMA CHROMOSOME REGION, CANDIDATE 1; ASPSCR1",Asterisk
606237,TRANSFORMING GROWTH FACTOR-BETA RECEPTOR-ASSOCIATED PROTEIN 1; TGFBRAP1,Asterisk
606238,IKAROS FAMILY ZINC FINGER 5; IKZF5,Asterisk
606239,IKAROS FAMILY ZINC FINGER 4; IKZF4,Asterisk
606240,"THYROID CANCER, NONMEDULLARY, 3; NMTC3",Percent
606241,"DICER, DROSOPHILA, HOMOLOG OF, 1; DICER1",Asterisk
606242,"MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES, AND FACIAL DYSMORPHISM",Percent
606243,ALVEOLAR SOFT PART SARCOMA; ASPS,Number Sign
606244,SIGNAL-TRANSDUCING ADAPTOR MOLECULE 2; STAM2,Asterisk
606245,"SUPPRESSOR OF ZESTE 12, DROSOPHILA, HOMOLOG OF; SUZ12",Asterisk
606246,JUXTAPOSED WITH ANOTHER ZINC FINGER GENE 1; JAZF1,Asterisk
606247,STAM-BINDING PROTEIN; STAMBP,Asterisk
606248,QUINOLINATE PHOSPHORIBOSYLTRANSFERASE; QPRT,Asterisk
606249,"PROTEIN KINASE, LYSINE-DEFICIENT 2; WNK2",Asterisk
606250,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 8; GALNT8,Asterisk
606251,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 9; GALNT9,Asterisk
606252,TIR DOMAIN-CONTAINING ADAPTOR PROTEIN; TIRAP,Asterisk
606253,MOVED TO 191343,Caret
606254,SELENOPROTEIN F; SELENOF,Asterisk
606255,STATURE AS A QUANTITATIVE TRAIT,Percent
606256,STATURE QUANTITATIVE TRAIT LOCUS 2; STQTL2,Percent
606257,STATURE QUANTITATIVE TRAIT LOCUS 3; STQTL3,Percent
606258,STATURE QUANTITATIVE TRAIT LOCUS 4; STQTL4,Percent
606259,BREAST CANCER METASTASIS SUPPRESSOR 1; BRMS1,Asterisk
606260,MYOTUBULARIN-RELATED PROTEIN 9; MTMR9,Asterisk
606261,NUDIX HYDROLASE 6; NUDT6,Asterisk
606262,MOVED TO 602080,Caret
606263,PAGET DISEASE OF BONE 4; PDB4,Percent
606264,"C-TYPE LECTIN DOMAIN FAMILY 7, MEMBER A; CLEC7A",Asterisk
606265,"E1A-BINDING PROTEIN, 400-KD; EP400",Asterisk
606266,BCL2-MODIFYING FACTOR; BMF,Asterisk
606267,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 16; WNT16",Asterisk
606268,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10A; WNT10A",Asterisk
606269,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13C; TNFRSF13C",Asterisk
606270,TOLL-LIKE RECEPTOR 10; TLR10,Asterisk
606271,DISRUPTED IN SCHIZOPHRENIA 2; DISC2,Asterisk
606272,CYSTINOSIN; CTNS,Asterisk
606273,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 3; EIF2B3",Asterisk
606274,"CASEIN KINASE I, GAMMA-1; CSNK1G1",Asterisk
606275,MOVED TO 601172,Caret
606276,CARTILAGE ACIDIC PROTEIN 1; CRTAC1,Asterisk
606277,TOLL-INTERACTING PROTEIN; TOLLIP,Asterisk
606278,F-BOX AND WD40 DOMAIN PROTEIN 7; FBXW7,Asterisk
606279,ABI FAMILY MEMBER 3 BINDING PROTEIN; ABI3BP,Asterisk
606280,NON-SMC CONDENSIN I COMPLEX SUBUNIT G; NCAPG,Asterisk
606281,RAS-ASSOCIATED PROTEIN RAB38; RAB38,Asterisk
606282,"DEAFNESS, AUTOSOMAL DOMINANT 24; DFNA24",Percent
606283,SORCS RECEPTOR 1; SORCS1,Asterisk
606284,SORCS RECEPTOR 2; SORCS2,Asterisk
606285,SORCS RECEPTOR 3; SORCS3,Asterisk
606286,DEAD/H BOX 43; DDX43,Asterisk
606287,MOVED TO 605743,Caret
606288,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 1; PCDHGA1",Asterisk
606289,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 2; PCDHGA2",Asterisk
606290,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 3; PCDHGA3",Asterisk
606291,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 4; PCDHGA4",Asterisk
606292,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 5; PCDHGA5",Asterisk
606293,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 6; PCDHGA6",Asterisk
606294,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 7; PCDHGA7",Asterisk
606295,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 8; PCDHGA8",Asterisk
606296,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 9; PCDHGA9",Asterisk
606297,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 10; PCDHGA10",Asterisk
606298,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 11; PCDHGA11",Asterisk
606299,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 1; PCDHGB1",Asterisk
606300,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 2; PCDHGB2",Asterisk
606301,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 3; PCDHGB3",Asterisk
606302,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 5; PCDHGB5",Asterisk
606303,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 6; PCDHGB6",Asterisk
606304,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 7; PCDHGB7",Asterisk
606305,"PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 4; PCDHGC4",Asterisk
606306,"PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 5; PCDHGC5",Asterisk
606307,PROTOCADHERIN-ALPHA 1; PCDHA1,Asterisk
606308,PROTOCADHERIN-ALPHA 2; PCDHA2,Asterisk
606309,PROTOCADHERIN-ALPHA 3; PCDHA3,Asterisk
606310,PROTOCADHERIN-ALPHA 4; PCDHA4,Asterisk
606311,PROTOCADHERIN-ALPHA 5; PCDHA5,Asterisk
606312,PROTOCADHERIN-ALPHA 6; PCDHA6,Asterisk
606313,PROTOCADHERIN-ALPHA 7; PCDHA7,Asterisk
606314,PROTOCADHERIN-ALPHA 8; PCDHA8,Asterisk
606315,PROTOCADHERIN-ALPHA 9; PCDHA9,Asterisk
606316,PROTOCADHERIN-ALPHA 10; PCDHA10,Asterisk
606317,PROTOCADHERIN-ALPHA 11; PCDHA11,Asterisk
606318,PROTOCADHERIN-ALPHA 12; PCDHA12,Asterisk
606319,PROTOCADHERIN-ALPHA 13; PCDHA13,Asterisk
606320,"PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 1; PCDHAC1",Asterisk
606321,"PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 2; PCDHAC2",Asterisk
606322,CYTOPLASMIC FMRP-INTERACTING PROTEIN 1; CYFIP1,Asterisk
606323,CYTOPLASMIC FMRP-INTERACTING PROTEIN 2; CYFIP2,Asterisk
606324,"PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7",Number Sign
606325,"HETEROTAXY, VISCERAL, 3, AUTOSOMAL; HTX3",Percent
606326,"SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 6; SIX6",Asterisk
606327,PROTOCADHERIN-BETA 1; PCDHB1,Asterisk
606328,PROTOCADHERIN-BETA 2; PCDHB2,Asterisk
606329,PROTOCADHERIN-BETA 3; PCDHB3,Asterisk
606330,PROTOCADHERIN-BETA 4; PCDHB4,Asterisk
606331,PROTOCADHERIN-BETA 5; PCDHB5,Asterisk
606332,PROTOCADHERIN-BETA 6; PCDHB6,Asterisk
606333,PROTOCADHERIN-BETA 7; PCDHB7,Asterisk
606334,PROTOCADHERIN-BETA 8; PCDHB8,Asterisk
606335,PROTOCADHERIN-BETA 9; PCDHB9,Asterisk
606336,PROTOCADHERIN-BETA 10; PCDHB10,Asterisk
606337,PROTOCADHERIN-BETA 11; PCDHB11,Asterisk
606338,PROTOCADHERIN-BETA 12; PCDHB12,Asterisk
606339,PROTOCADHERIN-BETA 13; PCDHB13,Asterisk
606340,PROTOCADHERIN-BETA 14; PCDHB14,Asterisk
606341,PROTOCADHERIN-BETA 15; PCDHB15,Asterisk
606342,"SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 4; SIX4",Asterisk
606343,"POLYMERASE, DNA, LAMBDA; POLL",Asterisk
606344,"POLYMERASE, DNA, MU; POLM",Asterisk
606345,PROTOCADHERIN-BETA 16; PCDHB16,Asterisk
606346,"DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22",Number Sign
606347,PROLINE/SERINE/THREONINE PHOSPHATASE-INTERACTING PROTEIN 1; PSTPIP1,Asterisk
606348,INFLAMMATORY BOWEL DISEASE 5; IBD5,Percent
606349,"GAMBLING, PATHOLOGIC",
606350,APRATAXIN; APTX,Asterisk
606351,"ESPIN, MOUSE, HOMOLOG OF; ESPN",Asterisk
606352,ALSIN,Asterisk
606353,"PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ",Number Sign
606354,MOVED TO 605317,Caret
606355,DEAD BOX POLYPEPTIDE 18; DDX18,Asterisk
606356,TRANSMEMBRANE PROTEIN 123; TMEM123,Asterisk
606357,DEAD/H BOX 21; DDX21,Asterisk
606358,"ANTERIOR GRADIENT 2, XENOPUS, HOMOLOG OF; AGR2",Asterisk
606359,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A",Asterisk
606360,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8A; WNT8A",Asterisk
606361,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5B; WNT5B",Asterisk
606362,"ACID PHOSPHATASE, TESTICULAR; ACPT",Asterisk
606363,ABI FAMILY MEMBER 3; ABI3,Asterisk
606364,MOVED TO 606658,Caret
606365,"GLUTAMINASE, LIVER; GLS2",Asterisk
606366,"RAS HOMOLOG GENE FAMILY, MEMBER U; RHOU",Asterisk
606367,IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41,Number Sign
606368,APOLIPOPROTEIN A-V; APOA5,Asterisk
606369,MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY,
606370,THIAMINE PYROPHOSPHOKINASE; TPK1,Asterisk
606371,ACTIVATING TRANSCRIPTION FACTOR 7; ATF7,Asterisk
606372,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 10; CHRNA10",Asterisk
606373,FORMIN 2; FMN2,Asterisk
606374,"BETA-1,3-GLUCURONYLTRANSFERASE 3; B3GAT3",Asterisk
606375,MOVED TO 151290,Caret
606376,CARBOHYDRATE SULFOTRANSFERASE 10; CHST10,Asterisk
606377,DIMERIC DIHYDRODIOL DEHYDROGENASE; DHDH,Asterisk
606378,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 4; ST6GALNAC4",Asterisk
606379,G PROTEIN-COUPLED RECEPTOR 87; GPR87,Asterisk
606380,G PROTEIN-COUPLED RECEPTOR 86; GPR86,Asterisk
606381,SUCCINATE RECEPTOR 1; SUCNR1,Asterisk
606382,"MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 2; MAGI2",Asterisk
606383,G PROTEIN-COUPLED RECEPTOR 84; GPR84,Asterisk
606384,UBIQUITIN PROTEIN LIGASE NEDD4-LIKE; NEDD4L,Asterisk
606385,OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 1; OLIG1,Asterisk
606386,OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; OLIG2,Asterisk
606387,"TOPOISOMERASE I, MITOCHONDRIAL; TOP1MT",Asterisk
606388,THIOESTERASE SUPERFAMILY MEMBER 4; THEM4,Asterisk
606389,"CATION CHANNEL, SPERM-ASSOCIATED, 1; CATSPER1",Asterisk
606390,MOVED TO 142560,Caret
606391,MATURITY-ONSET DIABETES OF THE YOUNG; MODY,Number Sign
606392,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4",Number Sign
606393,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN-LIKE PROTEIN DECYSIN 1; ADAMDEC1,Asterisk
606394,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6",Number Sign
606395,PROLACTIN REGULATORY ELEMENT-BINDING PROTEIN; PREB,Asterisk
606396,BRIDGING INTEGRATOR 3; BIN3,Asterisk
606397,CLARIN 1; CLRN1,Asterisk
606398,ACTIVATING TRANSCRIPTION FACTOR 5; ATF5,Asterisk
606399,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 3; CACNA2D3",Asterisk
606400,CALPAIN 7; CAPN7,Asterisk
606401,CALPAIN 9; CAPN9,Asterisk
606402,GASTROKINE 1; GKN1,Asterisk
606403,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-3 SUBUNIT; CACNG3",Asterisk
606404,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-4 SUBUNIT; CACNG4",Asterisk
606405,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-5 SUBUNIT; CACNG5",Asterisk
606406,NUCLEAR PORE COMPLEX-INTERACTING PROTEIN; NPIP,Asterisk
606407,HYPOTONIA-CYSTINURIA SYNDROME,Number Sign
606408,"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL",Number Sign
606409,"ITCHY E3 UBIQUITIN PROTEIN LIGASE, MOUSE, HOMOLOG OF; ITCH",Asterisk
606410,ANTHRAX TOXIN RECEPTOR 1; ANTXR1,Asterisk
606411,"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 3; SLC13A3",Asterisk
606412,BSND GENE; BSND,Asterisk
606413,INSULIN-LIKE 5; INSL5,Asterisk
606414,INSULIN-LIKE 6; INSL6,Asterisk
606415,MOVED TO 114580,Caret
606416,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 3; NLRP3",Asterisk
606417,WD REPEAT-CONTAINING PROTEIN 11; WDR11,Asterisk
606418,24-DEHYDROCHOLESTEROL REDUCTASE; DHCR24,Asterisk
606419,"PRECURSOR mRNA-PROCESSING FACTOR 31, S. CEREVISIAE, HOMOLOG OF; PRPF31",Asterisk
606420,ENGULFMENT AND CELL MOTILITY GENE 1; ELMO1,Asterisk
606421,ENGULFMENT AND CELL MOTILITY GENE 2; ELMO2,Asterisk
606422,ENGULFMENT AND CELL MOTILITY GENE 3; ELMO3,Asterisk
606423,DISRUPTED IN RENAL CARCINOMA 1; DIRC1,Asterisk
606424,"EGL9, C. ELEGANS, HOMOLOG OF, 2; EGLN2",Asterisk
606425,"EGL9, C. ELEGANS, HOMOLOG OF, 1; EGLN1",Asterisk
606426,"EGL9, C. ELEGANS, HOMOLOG OF, 3; EGLN3",Asterisk
606427,ZINC FINGER PROTEIN 320; ZNF320,Asterisk
606428,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A3; UGT1A3",Asterisk
606429,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A4; UGT1A4",Asterisk
606430,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A5; UGT1A5",Asterisk
606431,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A6; UGT1A6",Asterisk
606432,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A7; UGT1A7",Asterisk
606433,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A8; UGT1A8",Asterisk
606434,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A9; UGT1A9",Asterisk
606435,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A10; UGT1A10",Asterisk
606436,SYNAPTOTAGMIN 12; SYT12,Asterisk
606437,MOVED TO 121200,Caret
606438,HUNTINGTON DISEASE-LIKE 2; HDL2,Number Sign
606439,ATLASTIN GTPase 1; ATL1,Asterisk
606440,STEREOCILIN; STRC,Asterisk
606441,HTRA SERINE PEPTIDASE 2; HTRA2,Asterisk
606442,ABL INTERACTOR 2; ABI2,Asterisk
606443,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3; CREB3,Asterisk
606444,CREB/ATF BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CREBZF,Asterisk
606445,PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL,
606446,"SLAM FAMILY, MEMBER 6; SLAMF6",Asterisk
606447,RNA-BINDING PROTEIN S1; RNPS1,Asterisk
606448,THIOREDOXIN REDUCTASE 2; TXNRD2,Asterisk
606449,"PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 3; PTP4A3",Asterisk
606450,NEUROEPITHELIAL CELL TRANSFORMING GENE 1; NET1,Asterisk
606451,"DEAFNESS, AUTOSOMAL DOMINANT 30; DFNA30",Percent
606452,WILDTYPE p53-INDUCED GENE,Asterisk
606453,"LIPOPOLYSACCHARIDE-RESPONSIVE, BEIGE-LIKE ANCHOR PROTEIN; LRBA",Asterisk
606454,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2; EIF2B2",Asterisk
606455,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13B; PPP1R13B",Asterisk
606456,"NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 3; NPM3",Asterisk
606457,INHIBITOR OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; IBTK,Asterisk
606458,AXIN1 UPREGULATED; AXUD1,Asterisk
606459,OPIOID GROWTH FACTOR RECEPTOR; OGFR,Asterisk
606460,LONGEVITY 2,Percent
606461,"TRIMETHYLGUANOSINE SYNTHASE, S. CEREVISIAE, HOMOLOG OF; TGS1",Asterisk
606462,"RAD21, S. POMBE, HOMOLOG OF; RAD21",Asterisk
606463,"GLUCOSIDASE, BETA, ACID; GBA",Asterisk
606464,HEPCIDIN ANTIMICROBIAL PEPTIDE; HAMP,Asterisk
606465,KRUPPEL-LIKE FACTOR 15; KLF15,Asterisk
606466,PML-RARA TARGET GENE ENCODING AN ADAPTOR MOLECULE 1; PRAM1,Asterisk
606467,"ALDEHYDE DEHYDROGENASE 8 FAMILY, MEMBER A1; ALDH8A1",Asterisk
606468,"NUCLEOLAR PROTEIN FAMILY A, MEMBER 1; NOLA1",Asterisk
606469,RING FINGER PROTEIN 29; RNF29,Asterisk
606470,"NUCLEOLAR PROTEIN FAMILY A, MEMBER 2; NOLA2",Asterisk
606471,"NUCLEOLAR PROTEIN FAMILY A, MEMBER 3; NOLA3",Asterisk
606472,SS18-LIKE GENE 1; SS18L1,Asterisk
606473,SS18-LIKE GENE 2; SS18L2,Asterisk
606474,RING FINGER PROTEIN 30; RNF30,Asterisk
606475,CD320 ANTIGEN; CD320,Asterisk
606476,"INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C; ITPKC",Asterisk
606477,SERINE RACEMASE; SRR,Asterisk
606478,PROTECTION OF TELOMERES 1; POT1,Asterisk
606479,NEUROLIGIN 2; NLGN2,Asterisk
606480,ZINC METALLOPROTEINASE STE24; ZMPSTE24,Asterisk
606481,"PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 5-PHOSPHATASE, A; PIB5PA",Asterisk
606482,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB",Number Sign
606483,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA",Percent
606484,MYOTROPHIN; MTPN,Asterisk
606485,"POLYMERASE II, RNA, SUBUNIT M; POLR2M",Asterisk
606486,"CHMP FAMILY, MEMBER 1B; CHMP1B",Asterisk
606487,HRAS-LIKE SUPPRESSOR; HRASLS,Asterisk
606488,EXOSOME COMPONENT 7; EXOSC7,Asterisk
606489,EXOSOME COMPONENT 3; EXOSC3,Asterisk
606490,EXOSOME COMPONENT 6; EXOSC6,Asterisk
606491,EXOSOME COMPONENT 4; EXOSC4,Asterisk
606492,EXOSOME COMPONENT 5; EXOSC5,Asterisk
606493,EXOSOME COMPONENT 1; EXOSC1,Asterisk
606494,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 3; ST3GAL3",Asterisk
606495,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4; MARK4,Asterisk
606496,INTERLEUKIN 17F; IL17F,Asterisk
606497,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B28; UGT2B28",Asterisk
606498,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 3; MS4A3",Asterisk
606499,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 5; MS4A5",Asterisk
606500,"SECRETOGLOBIN, FAMILY 3A, MEMBER 1; SCGB3A1",Asterisk
606501,MYOTUBULARIN-RELATED PROTEIN 12; MTMR12,Asterisk
606502,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 7; MS4A7",Asterisk
606503,"SUPPRESSOR OF VARIEGATION 3-9, DROSOPHILA, HOMOLOG OF, 2; SUV39H2",Asterisk
606504,CANCER SUSCEPTIBILITY CANDIDATE 3; CASC3,Asterisk
606505,PIN2-INTERACTING PROTEIN 1; PINX1,Asterisk
606506,MOVED TO 300927,Caret
606507,MOVED TO 602488,Caret
606508,Fc RECEPTOR-LIKE PROTEIN 1; FCRL1,Asterisk
606509,Fc RECEPTOR-LIKE PROTEIN 2; FCRL2,Asterisk
606510,Fc RECEPTOR-LIKE PROTEIN 3; FCRL3,Asterisk
606511,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 1; MARK1,Asterisk
606512,PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 1; PACSIN1,Asterisk
606513,PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 3; PACSIN3,Asterisk
606514,CYTOHESIN 4; CYTH4,Asterisk
606515,"RNA, 7SK, SMALL NUCLEAR; RN7SK",Asterisk
606516,MUSCLEBLIND-LIKE SPLICING REGULATOR 1; MBNL1,Asterisk
606517,ARYLHYDROCARBON RECEPTOR REPRESSOR; AHRR,Asterisk
606518,HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HAVCR1,Asterisk
606519,PHACE ASSOCIATION,
606520,MEGAKARYOCYTE AND PLATELET INHIBITORY RECEPTOR G6B; MPIG6B,Asterisk
606521,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL THIAMINE PYROPHOSPHATE CARRIER), MEMBER 19; SLC25A19",Asterisk
606522,GROWTH/DIFFERENTIATION FACTOR 3; GDF3,Asterisk
606523,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 1; SRGAP1,Asterisk
606524,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2; SRGAP2,Asterisk
606525,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 3; SRGAP3,Asterisk
606526,MELANOPHILIN; MLPH,Asterisk
606527,MEGARBANE SYNDROME,
606528,HOMOZYGOUS 11p15-p14 DELETION SYNDROME,Number Sign
606529,"CRANIOSYNOSTOSIS SYNDROME, AUTOSOMAL RECESSIVE",
606530,"CYTOCHROME P450, SUBFAMILY XXVIIA, POLYPEPTIDE 1; CYP27A1",Asterisk
606531,"SECRETOGLOBIN, FAMILY 3A, MEMBER 2; SCGB3A2",Asterisk
606532,HORMONALLY UPREGULATED NEU-ASSOCIATED KINASE; HUNK,Asterisk
606533,CHLORIDE INTRACELLULAR CHANNEL 3; CLIC3,Asterisk
606534,"CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 43; CYP3A43",Asterisk
606535,MYC-BINDING PROTEIN; MYCBP,Asterisk
606536,CHLORIDE INTRACELLULAR CHANNEL 4; CLIC4,Asterisk
606537,MYOSIN IB; MYO1B,Asterisk
606538,MYOSIN IC; MYO1C,Asterisk
606539,MYOSIN ID; MYO1D,Asterisk
606540,MYOSIN VB; MYO5B,Asterisk
606541,MYOSIN VIIB; MYO7B,Asterisk
606542,HISTONE DEACETYLASE 7A; HDAC7A,Asterisk
606543,HISTONE DEACETYLASE 9; HDAC9,Asterisk
606544,MITOCHONDRIAL ELONGATION FACTOR G2; GFM2,Asterisk
606545,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3; ARCI3",Number Sign
606546,HYDATIDIFORM MOLE-ASSOCIATED AND IMPRINTED TRANSCRIPT; HYMAI,Asterisk
606547,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4A; MS4A4A",Asterisk
606548,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6A; MS4A6A",Asterisk
606549,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 8B; MS4A8B",Asterisk
606550,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 12",Asterisk
606551,"LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 1; LZTS1",Asterisk
606552,"EPISODIC ATAXIA, TYPE 4; EA4",Percent
606553,"SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 2; SLC9A3R2",Asterisk
606554,"EPISODIC ATAXIA, TYPE 3; EA3",Percent
606555,TRIPARTITE MOTIF-CONTAINING PROTEIN 9; TRIM9,Asterisk
606556,TRIPARTITE MOTIF-CONTAINING PROTEIN 14; TRIM14,Asterisk
606557,B-CELL CLL/LYMPHOMA 11A; BCL11A,Asterisk
606558,B-CELL CLL/LYMPHOMA 11B; BCL11B,Asterisk
606559,TRIPARTITE MOTIF-CONTAINING PROTEIN 22; TRIM22,Asterisk
606560,SPERM-ASSOCIATED ANTIGEN 11; SPAG11,Asterisk
606561,"SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 1; SLC36A1",Asterisk
606562,"TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 1; TM6SF1",Asterisk
606563,"TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 2; TM6SF2",Asterisk
606564,"PROSTATE TRANSMEMBRANE PROTEIN, ANDROGEN-INDUCED; PMEPA1",Asterisk
606565,"TRANSMEMBRANE PROTEASE, SERINE 4; TMPRSS4",Asterisk
606566,MYOSIN LIGHT CHAIN KINASE 2; MYLK2,Asterisk
606567,"TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 4; TM4SF4",Asterisk
606568,LEUCINE ZIPPER TRANSCRIPTION FACTOR-LIKE 1; LZTFL1,Asterisk
606569,SUPPRESSOR OF ACTIN MUTATIONS 1-LIKE; SACM1L,Asterisk
606570,SECRETED FRIZZLED-RELATED PROTEIN 4; SFRP4,Asterisk
606571,LOW DENSITY LIPOPROTEIN RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 4; LDLRAD4,Asterisk
606572,NADPH OXIDASE 5; NOX5,Asterisk
606573,FYN-RELATED KINASE; FRK,Asterisk
606574,"ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4",Number Sign
606575,"MEMBRANE PROTEIN, PALMITOYLATED 4; MPP4",Asterisk
606576,"TAF3 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 140-KD; TAF3",Asterisk
606577,SRC-LIKE ADAPTOR 2; SLA2,Asterisk
606578,AQUAPORIN 10; AQP10,Asterisk
606579,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1,Number Sign
606580,OPA3 GENE; OPA3,Asterisk
606581,"POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB",Number Sign
606582,DELTA-LIKE 1; DLL1,Asterisk
606583,PEROXIREDOXIN 5; PRDX5,Asterisk
606584,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 23; PTPN23",Asterisk
606585,ENAMELIN; ENAM,Asterisk
606586,RETINOIC ACID-INDUCED 14; RAI14,Asterisk
606587,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 18; PTPN18",Asterisk
606588,DNA METHYLTRANSFERASE 3-LIKE PROTEIN; DNMT3L,Asterisk
606589,SORTING NEXIN 13; SNX13,Asterisk
606590,"NUCLEAR PROTEIN LOCALIZATION 4, S. CEREVISIAE, HOMOLOG OF; NPLOC4",Asterisk
606591,"MUS81, S. CEREVISIAE, HOMOLOG OF; MUS81",Asterisk
606592,VANIN 3; VNN3,Asterisk
606593,LIG4 SYNDROME,Number Sign
606594,SET DOMAIN-CONTAINING PROTEIN 7; SETD7,Asterisk
606595,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F",Number Sign
606596,FUKUTIN-RELATED PROTEIN; FKRP,Asterisk
606597,PAIRED BOX GENE 3; PAX3,Asterisk
606598,GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1,Asterisk
606599,THIOREDOXIN-INTERACTING PROTEIN; TXNIP,Asterisk
606600,RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 1; RASGRF1,Asterisk
606601,"ENDOGENOUS RETROVIRAL SEQUENCE E, 1; ERVE1",Asterisk
606602,"BRAIN AND ACUTE LEUKEMIA GENE, CYTOPLASMIC; BAALC",Asterisk
606603,EDAR-ASSOCIATED DEATH DOMAIN; EDARADD,Asterisk
606604,F-BOX ONLY PROTEIN 32; FBXO32,Asterisk
606605,ATR-INTERACTING PROTEIN; ATRIP,Asterisk
606606,MOVED TO 262700,Caret
606607,"PROTEASOME SUBUNIT, ALPHA-TYPE, 7; PSMA7",Asterisk
606608,"YES-ASSOCIATED PROTEIN 1, 65-KD; YAP1",Asterisk
606609,3-PRIME REPAIR EXONUCLEASE 1; TREX1,Asterisk
606610,NSFL1 COFACTOR; NSFL1C,Asterisk
606611,"DEFENSIN, BETA, 103A; DEFB103A",Asterisk
606612,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5; MDDGB5",Number Sign
606613,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1; HDLCQ1,Percent
606614,RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 2; RASGRF2,Asterisk
606615,HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR; HIF1AN,Asterisk
606616,"DYSLEXIA, SUSCEPTIBILITY TO, 6; DYX6",Percent
606617,MOVED TO 604169,Caret
606618,DUAL-SPECIFICITY PHOSPHATASE 14; DUSP14,Asterisk
606619,"GLUCOSIDASE, BETA, ACID 3; GBA3",Asterisk
606620,"SLAM FAMILY, MEMBER 8; SLAMF8",Asterisk
606621,"INTRAFLAGELLAR TRANSPORT 57, CHLAMYDOMONAS, HOMOLOG OF; IFT57",Asterisk
606622,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A-LIKE PROTEIN 1; SMARCAL1",Asterisk
606623,17-BETA-HYDROXYSTEROID DEHYDROGENASE VI; HSD17B6,Asterisk
606624,NEUROGENIN 2; NEUROG2,Asterisk
606625,"SLAM FAMILY, MEMBER 7; SLAMF7",Asterisk
606626,DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 1; DAAM1,Asterisk
606627,DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 2; DAAM2,Asterisk
606628,GLYCINE N-METHYLTRANSFERASE; GNMT,Asterisk
606629,PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 1; RIMS1,Asterisk
606630,PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 2; RIMS2,Asterisk
606631,"CAMURATI-ENGELMANN DISEASE, TYPE 2",Percent
606632,"ODOR, MALE, WOMEN'S CHOICE OF",
606633,TRANSCRIPTION FACTOR Sp7; SP7,Asterisk
606634,DERMCIDIN; DCD,Asterisk
606635,"PROTEASE, SERINE, 7; PRSS7",Asterisk
606636,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 1; NLRP1",Asterisk
606637,"PEPTIDE YY, 2; PYY2",Asterisk
606638,PANCREATIC POLYPEPTIDE 2; PPY2,Asterisk
606639,MITOCHONDRIAL ELONGATION FACTOR G1; GFM1,Asterisk
606640,AMYOTROPHIC LATERAL SCLEROSIS 3; ALS3,Percent
606641,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1; BMIQ1,Percent
606642,MOVED TO 606641,Caret
606643,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 2; BMIQ2,Percent
606644,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 8; IGSF8",Asterisk
606645,"CENTAURIN, DELTA-1; CENTD1",Asterisk
606646,"CENTAURIN, DELTA-2; CENTD2",Asterisk
606647,"CENTAURIN, DELTA-3; CENTD3",Asterisk
606648,"INTERLEUKIN 22 RECEPTOR, ALPHA-2; IL22RA2",Asterisk
606649,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 3; HIVEP3,Asterisk
606650,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A",Asterisk
606651,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B; GRIN3B",Asterisk
606652,HEPATITIS A VIRUS CELLULAR RECEPTOR 2; HAVCR2,Asterisk
606653,LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 6; LGR6,Asterisk
606654,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 1; RXFP1,Asterisk
606655,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 2; RXFP2,Asterisk
606656,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2; IBGC2",Percent
606657,"GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO",Number Sign
606658,SPINOCEREBELLAR ATAXIA 15; SCA15,Number Sign
606659,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8, YEAST, HOMOLOG OF, B; TIMM8B",Asterisk
606660,"MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1",Percent
606661,"MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2",Percent
606662,"WAARDENBURG SYNDROME, TYPE 2C; WS2C",Percent
606663,LYSYL OXIDASE-LIKE 2; LOXL2,Asterisk
606664,GLYCINE N-METHYLTRANSFERASE DEFICIENCY,Number Sign
606665,OPSIN 4; OPN4,Asterisk
606666,G PROTEIN-COUPLED RECEPTOR 48; GPR48,Asterisk
606667,LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 5; LGR5,Asterisk
606668,INFLAMMATORY BOWEL DISEASE 8; IBD8,Percent
606669,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 5; FXYD5,Asterisk
606670,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 11; PPP1R11",Asterisk
606671,NCK-INTERACTING PROTEIN WITH SH3 DOMAIN; NCKIPSD,Asterisk
606672,"GLYCOPROTEIN Ib, PLATELET, ALPHA POLYPEPTIDE; GP1BA",Asterisk
606673,BETA-UREIDOPROPIONASE; UPB1,Asterisk
606674,INFLAMMATORY BOWEL DISEASE 6; IBD6,Percent
606675,INFLAMMATORY BOWEL DISEASE 4; IBD4,Percent
606676,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 2; TRPV2",Asterisk
606677,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER C; CLEC4C",Asterisk
606678,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8; TRPM8",Asterisk
606679,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5; TRPV5",Asterisk
606680,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 6; TRPV6",Asterisk
606681,NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 1; NSD1,Asterisk
606682,HPS4 GENE; HPS4,Asterisk
606683,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6,Asterisk
606684,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7; FXYD7,Asterisk
606685,"CARDIOMYOPATHY, DILATED, 1L; CMD1L",Number Sign
606686,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1; EIF2B1",Asterisk
606687,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4; EIF2B4",Asterisk
606688,SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES,Number Sign
606689,"GLAUCOMA 1, OPEN ANGLE, B; GLC1B",Percent
606690,LYMPHANGIOLEIOMYOMATOSIS; LAM,Number Sign
606691,CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 19; CEACAM19,Asterisk
606692,TNF RECEPTOR-ASSOCIATED FACTOR 7; TRAF7,Asterisk
606693,KUFOR-RAKEB SYNDROME; KRS,Number Sign
606694,"NUCLEOPORIN, 155-KD; NUP155",Asterisk
606695,OPSIN 3; OPN3,Asterisk
606696,"KATANIN, p60 SUBUNIT, A1; KATNA1",Asterisk
606697,ZINC FINGER PROTEIN ZK1,Asterisk
606698,SRY-BOX 30,Asterisk
606699,HELICASE WITH ZINC FINGER DOMAIN; HELZ,Asterisk
606700,"MIDNOLIN, MOUSE, HOMOLOG OF; MIDN",Asterisk
606701,DORSAL ROOT GANGLIA HOMEOBOX; DRGX,Asterisk
606702,PKHD1 GENE; PKHD1,Asterisk
606703,"DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM",Number Sign
606704,G PROTEIN-COUPLED RECEPTOR 75; GPR75,Asterisk
606705,"DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36",Number Sign
606706,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 1; TMC1,Asterisk
606707,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 2; TMC2,Asterisk
606708,SPLIT-HAND/FOOT MALFORMATION 5; SHFM5,Percent
606709,"PROTEASE, SERINE, 12; PRSS12",Asterisk
606710,LIPOMA HMGIC FUSION PARTNER; LHFP,Asterisk
606711,SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1,Percent
606712,SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2,Percent
606713,VAN DER WOUDE SYNDROME 2; VWS2,Number Sign
606714,PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 1; PNRC1,Asterisk
606715,"CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 4; ACCN4",Asterisk
606716,N-ACETYLTRANSFERASE 8; NAT8,Asterisk
606717,XIAP-ASSOCIATED FACTOR 1; XAF1,Asterisk
606718,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2; SLC26A2",Asterisk
606719,MELANOMA-PANCREATIC CANCER SYNDROME,Number Sign
606720,"ENDONUCLEASE, POLY(U)-SPECIFIC; ENDOU",Asterisk
606721,"PARTIAL LIPODYSTROPHY, CONGENITAL CATARACTS, AND NEURODEGENERATION SYNDROME; LCCNS",Number Sign
606722,"NEUROCALCIN, DELTA; NCALD",Asterisk
606723,MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5,Asterisk
606724,MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 1; MKNK1,Asterisk
606725,CLN6 GENE; CLN6,Asterisk
606726,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 5; SLC12A5",Asterisk
606727,NK2 HOMEOBOX 3; NKX2-3,Asterisk
606728,CAVEOLAE-ASSOCIATED PROTEIN 2; CAVIN2,Asterisk
606729,OXYSTEROL-BINDING PROTEIN 2; OSBP2,Asterisk
606730,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A; OSBPL1A,Asterisk
606731,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 2; OSBPL2,Asterisk
606732,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 3; OSBPL3,Asterisk
606733,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 5; OSBPL5,Asterisk
606734,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 6; OSBPL6,Asterisk
606735,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 7; OSBPL7,Asterisk
606736,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 8; OSBPL8,Asterisk
606737,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 9; OSBPL9,Asterisk
606738,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 10; OSBPL10,Asterisk
606739,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 11; OSBPL11,Asterisk
606740,ZINC FINGER PROTEIN 180; ZNF180,Asterisk
606741,ZINC FINGER PROTEIN 181; ZNF181,Asterisk
606742,TOLLOID-LIKE 1; TLL1,Asterisk
606743,TOLLOID-LIKE 2; TLL2,Asterisk
606744,SECKEL SYNDROME 2; SCKL2,Number Sign
606745,"PARTITIONING-DEFECTIVE PROTEIN 3, C. ELEGANS, HOMOLOG OF; PARD3",Asterisk
606746,CHROMOSOME 19 OPEN READING FRAME 10; C19ORF10,Asterisk
606747,VASCULAR ENDOTHELIAL ZINC FINGER 1; VEZF1,Asterisk
606748,COACTOSIN-LIKE PROTEIN 1; COTL1,Asterisk
606749,TUBULOINTERSTITIAL NEPHRITIS ANTIGEN; TINAG,Asterisk
606750,Z-DNA BINDING PROTEIN 1; ZBP1,Asterisk
606751,"TRANSMEMBRANE PROTEASE, SERINE 5; TMPRSS5",Asterisk
606752,ACUTE HEMORRHAGIC LEUKOENCEPHALITIS,
606753,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 4; TTC4,Asterisk
606754,SAM DOMAIN- AND HD DOMAIN-CONTAINING PROTEIN 1; SAMHD1,Asterisk
606755,"PEPTIDYLARGININE DEIMINASE, TYPE III; PADI3",Asterisk
606756,17-BETA-HYDROXYSTEROID DEHYDROGENASE VII; HSD17B7,Asterisk
606757,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 5; SLC4A5",Asterisk
606758,DUAL OXIDASE 1; DUOX1,Asterisk
606759,DUAL OXIDASE 2; DUOX2,Asterisk
606760,MOVED TO 603977,Caret
606761,MALONYL-CoA DECARBOXYLASE; MLYCD,Asterisk
606762,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6",Number Sign
606763,"CILIARY DYSKINESIA, PRIMARY, 2; CILD2",Number Sign
606764,GASTROINTESTINAL STROMAL TUMOR; GIST,Number Sign
606765,THYROID PEROXIDASE; TPO,Asterisk
606766,SPERMATOGENIC FAILURE 3; SPGF3,Number Sign
606767,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 3; KCNG3",Asterisk
606768,"MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT",Number Sign
606769,"HELICASE, POLQ-LIKE; HELQ",Asterisk
606770,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2; ADIPQTL2",Percent
606771,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3; ADIPQTL3",Percent
606772,"MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN ANOMALIES",Percent
606773,HEMIFACIAL MYOHYPERPLASIA; HMH,
606774,MYOINOSITOL OXYGENASE; MIOX,Asterisk
606775,CHONDROITIN SULFATE PROTEOGLYCAN 5; CSPG5,Asterisk
606776,TRANSGLUTAMINASE 7; TGM7,Asterisk
606777,GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1,Number Sign
606778,"SLINGSHOT, DROSOPHILA, HOMOLOG OF, 1; SSH1",Asterisk
606779,"SLINGSHOT, DROSOPHILA, HOMOLOG OF, 2; SSH2",Asterisk
606780,"SLINGSHOT, DROSOPHILA, HOMOLOG OF, 3; SSH3",Asterisk
606781,TRANSKETOLASE; TKT,Asterisk
606782,"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER A; CLEC1A",Asterisk
606783,"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER B; CLEC1B",Asterisk
606784,GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A,Asterisk
606785,"CRIGLER-NAJJAR SYNDROME, TYPE II",Number Sign
606786,CD300C ANTIGEN; CD300C,Asterisk
606787,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1,Percent
606788,"ANOREXIA NERVOSA, SUSCEPTIBILITY TO; ANON",Percent
606789,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 4; HBFQTL4,Percent
606790,CD300A ANTIGEN; CD300A,Asterisk
606791,TRANSMEMBRANE PHOSPHOINOSITIDE 3-PHOSPHATASE AND TENSIN HOMOLOG 2; TPTE2,Asterisk
606792,HISTAMINE RECEPTOR H4; HRH4,Asterisk
606793,"AMINOPEPTIDASE, PUROMYCIN-SENSITIVE; NPEPPS",Asterisk
606794,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 10; SLC25A10",Asterisk
606795,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 17; SLC25A17",Asterisk
606796,SUPPRESSION OF TUMORIGENICITY 13; ST13,Asterisk
606797,SUPPRESSION OF TUMORIGENICITY 14; ST14,Asterisk
606798,"BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO",Number Sign
606799,"STROKE, SUSCEPTIBILITY TO, 1",Percent
606800,"GLUCOSIDASE, ALPHA, ACID; GAA",Asterisk
606801,MACROPHAGE ERYTHROBLAST ATTACHER; MAEA,Asterisk
606802,SPIB TRANSCRIPTION FACTOR; SPIB,Asterisk
606803,ACYL-CoA THIOESTERASE 11; ACOT11,Asterisk
606804,GOLGI MEMBRANE PROTEIN 1; GOLM1,Asterisk
606805,GOLGI INTEGRAL MEMBRANE PROTEIN 4; GOLIM4,Asterisk
606806,FORMIMINOTRANSFERASE CYCLODEAMINASE; FTCD,Asterisk
606807,INTERLEUKIN 17 RECEPTOR D; IL17RD,Asterisk
606808,MYOSIN IIIA; MYO3A,Asterisk
606809,ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 3; ACBD3,Asterisk
606810,PROLINE DEHYDROGENASE 1; PRODH,Asterisk
606811,"ALDEHYDE DEHYDROGENASE, FAMILY 4, SUBFAMILY A, MEMBER 1; ALDH4A1",Asterisk
606812,FUMARASE DEFICIENCY; FMRD,Number Sign
606813,"SOLUTE CARRIER FAMILY 2i (FACILITATED GLUCOSE TRANSPORTER), MEMBER 6; SLC2A6",Asterisk
606814,PROTEOGLYCAN 3; PRG3,Asterisk
606815,"CBP/P300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH CARBOXY TERMINAL DOMAIN, 4; CITED4",Asterisk
606816,"SID1 TRANSMEMBRANE FAMILY, MEMBER 1; SIDT1",Asterisk
606817,"PRE-T-CELL RECEPTOR, ALPHA-CHAIN PRECURSOR; PTCRA",Asterisk
606818,DIPEPTIDYL PEPTIDASE III; DPP3,Asterisk
606819,DIPEPTIDYL PEPTIDASE VIII; DPP8,Asterisk
606820,GLUTAREDOXIN 2; GLRX2,Asterisk
606821,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 5; COG5,Asterisk
606822,"PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; POMGNT1",Asterisk
606823,ADHESION G PROTEIN-COUPLED RECEPTOR A2; ADGRA2,Asterisk
606824,GLUCOSE/GALACTOSE MALABSORPTION; GGM,Number Sign
606825,TENSIN 3; TNS3,Asterisk
606826,PLEXIN DOMAIN-CONTAINING PROTEIN 1; PLXDC1,Asterisk
606827,PLEXIN DOMAIN-CONTAINING PROTEIN 2; PLXDC2,Asterisk
606828,N-ACETYLGLUCOSAMINE KINASE; NAGK,Asterisk
606829,FRATAXIN; FXN,Asterisk
606830,ATP/GTP-BINDING PROTEIN 1; AGTPBP1,Asterisk
606831,"NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 4; NLRC4",Asterisk
606832,ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; ERAP1,Asterisk
606833,LYSINE-SPECIFIC METHYLTRANSFERASE 2C; KMT2C,Asterisk
606834,LYSINE-SPECIFIC METHYLTRANSFERASE 2B; KMT2B,Asterisk
606835,"DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB",Number Sign
606836,"GLUCOSAMINYL (N-ACETYL) TRANSFERASE 3, MUCIN-TYPE; GCNT3",Asterisk
606837,RB1-INDUCIBLE COILED-COIL 1; RB1CC1,Asterisk
606838,PYD AND CARD DOMAIN-CONTAINING PROTEIN; PYCARD,Asterisk
606839,"CADHERIN-RELATED FAMILY, MEMBER 5; CDHR5",Asterisk
606840,"PARASOMNIA, SLEEP BRUXISM TYPE; PSMNSB",Percent
606841,DEATH EFFECTOR DOMAIN-CONTAINING PROTEIN; DEDD,Asterisk
606842,CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS,Percent
606843,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3",Number Sign
606844,ALMS1 GENE; ALMS1,Asterisk
606845,GOLGI-ASSOCIATED PDZ AND COILED-COIL DOMAINS-CONTAINING PROTEIN; GOPC,Asterisk
606846,SET AND MYND DOMAIN-CONTAINING PROTEIN 1; SMYD1,Asterisk
606847,TCOF1 GENE; TCOF1,Asterisk
606848,NEVER IN MITOSIS GENE A-RELATED KINASE 7; NEK7,Asterisk
606849,UBIQUITIN-LIKE 5; UBL5,Asterisk
606850,MIPOL1 GENE; MIPOL1,Asterisk
606851,CREE MENTAL RETARDATION SYNDROME,
606852,PARKINSON DISEASE 10; PARK10,Percent
606853,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 2; ATP6V1G2",Asterisk
606854,"POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP",Number Sign
606855,RELAXIN 3; RLN3,Asterisk
606856,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 1",Number Sign
606857,"GLUTAMATE-CYSTEINE LIGASE, CATALYTIC SUBUNIT; GCLC",Asterisk
606858,MOVED TO 251200,Caret
606859,MOVED TO 270700,Caret
606860,COMPLEMENT COMPONENT 1 INHIBITOR; C1NH,Asterisk
606861,PROSTATE- AND TESTIS-EXPRESSED GENE; PATE,Asterisk
606862,OSTEOCLAST-ASSOCIATED RECEPTOR; OSCAR,Asterisk
606863,THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX; TOX,Asterisk
606864,PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,Number Sign
606865,FUCOSYLTRANSFERASE 9; FUT9,Asterisk
606866,MITOCHONDRIAL RIBOSOMAL PROTEIN L49; MRPL49,Asterisk
606867,GOLGI REASSEMBLY STACKING PROTEIN 1; GORASP1,Asterisk
606868,HOMEODOMAIN-INTERACTING PROTEIN KINASE 2; HIPK2,Asterisk
606869,HEXOSAMINIDASE A; HEXA,Asterisk
606870,JUNCTIONAL ADHESION MOLECULE 2; JAM2,Asterisk
606871,JUNCTIONAL ADHESION MOLECULE 3; JAM3,Asterisk
606872,CAS-BR-M MURINE ECTOPIC RETROVIRAL TRANSFORMING SEQUENCE LIKE-1; CBLL1,Asterisk
606873,HEXOSAMINIDASE B; HEXB,Asterisk
606874,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 6; HSCR6",Percent
606875,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 7; HSCR7",Percent
606876,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, BETA; PITPNB",Asterisk
606877,"ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER C; ANP32C",Asterisk
606878,"ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER D; ANP32D",Asterisk
606879,PHOSPHOGLYCERATE DEHYDROGENASE; PHGDH,Asterisk
606880,CASPASE 8-ASSOCIATED PROTEIN 2; CASP8AP2,Asterisk
606881,FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 1; FHOD1,Asterisk
606882,"ATPase, Cu(2+)-TRANSPORTING, BETA POLYPEPTIDE; ATP7B",Asterisk
606883,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 4; IRAK4,Asterisk
606884,RNA-BINDING MOTIF PROTEIN 5; RBM5,Asterisk
606885,"ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS",Asterisk
606886,RNA-BINDING MOTIF PROTEIN 6; RBM6,Asterisk
606887,SULFITE OXIDASE; SUOX,Asterisk
606888,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 6; CHRNA6",Asterisk
606889,ALZHEIMER DISEASE 4,Number Sign
606890,GALACTOSYLCERAMIDASE; GALC,Asterisk
606891,Fc RECEPTOR-LIKE PROTEIN A; FCRLA,Asterisk
606892,SYNTAXIN 12; STX12,Asterisk
606893,"VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS",Number Sign
606894,"DUODENOJEJUNAL ATRESIA WITH VOLVULUS, ABSENT DORSAL MESENTERY, AND ABSENT SUPERIOR MESENTERIC ARTERY",
606895,"SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWED ZYGOMATIC ARCH",
606896,"DYSLEXIA, SUSCEPTIBILITY TO, 5; DYX5",Percent
606897,LYSOSOMAL TRAFFICKING REGULATOR; LYST,Asterisk
606898,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-6 SUBUNIT; CACNG6",Asterisk
606899,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-7 SUBUNIT; CACNG7",Asterisk
606900,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-8 SUBUNIT; CACNG8",Asterisk
606901,MOVED TO 604754,Caret
606902,"PYGOPUS, DROSOPHILA, HOMOLOG OF, 1",Asterisk
606903,"PYGOPUS, DROSOPHILA, HOMOLOG OF, 2",Asterisk
606904,MOVED TO 254770,Caret
606905,"PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 1; PREX1",Asterisk
606906,"FTSJ, E. COLI, HOMOLOG OF, 2; FTSJ2",Asterisk
606907,APOLIPOPROTEIN M; APOM,Asterisk
606908,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2; ARFGAP2,Asterisk
606909,VESICLE-ASSOCIATED MEMBRANE PROTEIN 4; VAMP4,Asterisk
606910,BCL2-LIKE 10; BCL2L10,Asterisk
606911,SECRETORY CARRIER MEMBRANE PROTEIN 1; SCAMP1,Asterisk
606912,SECRETORY CARRIER MEMBRANE PROTEIN 2; SCAMP2,Asterisk
606913,SECRETORY CARRIER MEMBRANE PROTEIN 3; SCAMP3,Asterisk
606914,"PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR BETA; PKIB",Asterisk
606915,G PROTEIN-COUPLED RECEPTOR 63; GPR63,Asterisk
606916,G PROTEIN-COUPLED RECEPTOR 61; GPR61,Asterisk
606917,G PROTEIN-COUPLED RECEPTOR 62; GPR62,Asterisk
606918,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 5; GOLGA5",Asterisk
606919,CERAMIDE SYNTHASE 1; CERS1,Asterisk
606920,CERAMIDE SYNTHASE 2; CERS2,Asterisk
606921,G PROTEIN-COUPLED RECEPTOR 78; GPR78,Asterisk
606922,G PROTEIN-COUPLED RECEPTOR 80; GPR80,Asterisk
606923,HYDROXYCARBOXYLIC ACID RECEPTOR 1; HCAR1,Asterisk
606924,MOVED TO 300748,Caret
606925,PYROGLUTAMYLATED RF-AMIDE PEPTIDE RECEPTOR; QRFPR,Asterisk
606926,LYSOPHOSPHATIDIC ACID RECEPTOR 5; LPAR5,Asterisk
606927,TRACE AMINE-ASSOCIATED RECEPTOR 8; TAAR8,Asterisk
606928,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3; BMND3,Percent
606929,"THO COMPLEX, SUBUNIT 3; THOC3",Asterisk
606930,"THO COMPLEX, SUBUNIT 1; THOC1",Asterisk
606931,MOVED TO 601501,Caret
606932,"VACUOLAR PROTEIN SORTING 29, YEAST, HOMOLOG OF; VPS29",Asterisk
606933,TYROSINASE; TYR,Asterisk
606934,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 1; NDUFAF1",Asterisk
606935,RNA-BINDING MOTIF PROTEIN 17; RBM17,Asterisk
606936,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 4; TRPM4",Asterisk
606937,MOVED TO 251300,Caret
606938,UROPORPHYRINOGEN III SYNTHASE; UROS,Asterisk
606939,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 2; ATP6V1B2",Asterisk
606940,ZINC FINGER HOMEOBOX 4; ZFHX4,Asterisk
606941,"ALG9, S. CEREVISIAE, HOMOLOG OF; ALG9",Asterisk
606942,"COATOMER PROTEIN COMPLEX, SUBUNIT EPSILON; COPE",Asterisk
606943,"USHER SYNDROME, TYPE IG; USH1G",Number Sign
606944,ERBB2 INTERACTING PROTEIN; ERBB2IP,Asterisk
606945,LOW DENSITY LIPOPROTEIN RECEPTOR; LDLR,Asterisk
606946,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 2; ANAPC2",Asterisk
606947,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 4; ANAPC4",Asterisk
606948,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 5; ANAPC5",Asterisk
606949,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 7; ANAPC7",Asterisk
606950,THYROTROPIN-RELEASING HORMONE-DEGRADING ECTOENZYME; TRHDE,Asterisk
606951,INTERFERON-INDUCED HELICASE C DOMAIN-CONTAINING PROTEIN 1; IFIH1,Asterisk
606952,"ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B",Number Sign
606953,UDP-GALACTOSE-4-EPIMERASE; GALE,Asterisk
606954,ZINC FINGER PROTEIN 253; ZNF253,Asterisk
606955,MOVED TO 194555,Caret
606956,ZINC FINGER PROTEIN 256; ZNF256,Asterisk
606957,ZINC FINGER PROTEIN 257; ZNF257,Asterisk
606958,"MEMBRANE PROTEIN, PALMITOYLATED 5; MPP5",Asterisk
606959,"MEMBRANE PROTEIN, PALMITOYLATED 6; MPP6",Asterisk
606960,INSULINOMA TUMOR SUPPRESSOR GENE LOCUS,Percent
606961,WW DOMAIN-BINDING PROTEIN 1; WBP1,Asterisk
606962,WW DOMAIN-BINDING PROTEIN 2; WBP2,Asterisk
606963,"PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD",Percent
606964,SERINE/THREONINE PROTEIN KINASE 38; STK38,Asterisk
606965,FAS-ACTIVATED SERINE/THREONINE KINASE; FASTK,Asterisk
606966,NEPHRONOPHTHISIS 4; NPHP4,Number Sign
606967,LECITHIN:CHOLESTEROL ACYLTRANSFERASE; LCAT,Asterisk
606968,EUKARYOTIC ELONGATION FACTOR 2 KINASE; EEF2K,Asterisk
606969,GEM-ASSOCIATED PROTEIN 4; GEMIN4,Asterisk
606970,MOVED TO 600669,Caret
606971,MOVED TO 607631,Caret
606972,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2; EIG2",Percent
606973,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 1; COG1,Asterisk
606974,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 2; COG2,Asterisk
606975,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 3; COG3,Asterisk
606976,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 4; COG4,Asterisk
606977,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 6; COG6,Asterisk
606978,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 7; COG7,Asterisk
606979,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 8; COG8,Asterisk
606980,COENZYME Q8A; COQ8A,Asterisk
606981,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-2; GNG2",Asterisk
606982,GERANYLGERANYL DIPHOSPHATE SYNTHASE 1; GGPS1,Asterisk
606983,DIACYLGLYCEROL O-ACYLTRANSFERASE 2; DGAT2,Asterisk
606984,"HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 2",Percent
606985,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 4; ELP4",Asterisk
606986,MOVED TO 600716,Caret
606987,G PROTEIN-COUPLED RECEPTOR KINASE 7; GRK7,Asterisk
606988,CALCINEURIN B HOMOLOGOUS PROTEIN,Asterisk
606989,MYELOPEROXIDASE; MPO,Asterisk
606990,"COATOMER PROTEIN COMPLEX, SUBUNIT BETA-2; COPB2",Asterisk
606991,INOSITOL HEXAPHOSPHATE KINASE 1; IHPK1,Asterisk
606992,INOSITOL HEXAPHOSPHATE KINASE 2; IHPK2,Asterisk
606993,INOSITOL HEXAPHOSPHATE KINASE 3; IHPK3,Asterisk
606994,"TYROSINE KINASE, NONRECEPTOR, 2; TNK2",Asterisk
606995,SENIOR-LOKEN SYNDROME 3; SLSN3,Percent
606996,SENIOR-LOKEN SYNDROME 4; SLSN4,Number Sign
606997,C1D NUCLEAR RECEPTOR COREPRESSOR; C1D,Asterisk
606998,FLOTILLIN 1; FLOT1,Asterisk
606999,GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT,Asterisk
607000,MEDIATOR COMPLEX SUBUNIT 24; MED24,Asterisk
607001,EUCHROMATIC HISTONE METHYLTRANSFERASE 1; EHMT1,Asterisk
607002,PROKINETICIN 2; PROK2,Asterisk
607003,THYMIC STROMAL LYMPHOPOIETIN; TSLP,Asterisk
607004,"BRACHYDACTYLY, TYPE A1, B; BDA1B",Percent
607005,GEM-ASSOCIATED PROTEIN 5,Asterisk
607006,GEM-ASSOCIATED PROTEIN 6; GEMIN6,Asterisk
607007,SNAP-ASSOCIATED PROTEIN; SNAPIN,Asterisk
607008,"ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN; ACADM",Asterisk
607009,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 6; TRPM6",Asterisk
607010,"DECAPPING ENZYME 1, S. CEREVISIAE, HOMOLOG OF, A; DCP1A",Asterisk
607011,UBIQUITIN-SPECIFIC PROTEASE 17; USP17,Asterisk
607012,"B-DOUBLE PRIME 1, SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR IIIB; BDP1",Asterisk
607013,BRF2 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR; BRF2,Asterisk
607014,HURLER SYNDROME,Number Sign
607015,HURLER-SCHEIE SYNDROME,Number Sign
607016,SCHEIE SYNDROME,Number Sign
607017,"DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21",Percent
607018,ADHESION G PROTEIN-COUPLED RECEPTOR L2; ADGRL2,Asterisk
607019,RAS ASSOCIATION DOMAIN FAMILY PROTEIN 3; RASSF3,Asterisk
607020,RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; RASSF5,Asterisk
607021,SEZ6-LIKE PROTEIN; SEZ6L,Asterisk
607022,CCCTC-BINDING FACTOR-LIKE PROTEIN; CTCFL,Asterisk
607023,POLO-LIKE KINASE 2; PLK2,Asterisk
607024,"DEBRANCHING ENZYME 1, S. CEREVISIAE, HOMOLOG OF; DBR1",Asterisk
607025,MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; MELK,Asterisk
607026,NEURON NAVIGATOR 2; NAV2,Asterisk
607027,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 70-KD, VI SUBUNIT A; ATP6V1A",Asterisk
607028,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 1; ATP6V0D1",Asterisk
607029,VESICLE-ASSOCIATED MEMBRANE PROTEIN 5; VAMP5,Asterisk
607030,GRANCALCIN; GCA,Asterisk
607031,LIPOIC ACID SYNTHASE; LIAS,Asterisk
607032,"SMG1, C. ELEGANS, HOMOLOG OF; SMG1",Asterisk
607033,"TRANSCRIPTION FACTOR B1, MITOCHONDRIAL; TFB1M",Asterisk
607034,MOVED TO 135700,Caret
607035,"SUPPRESSOR OF FUSED, DROSOPHILA, HOMOLOG OF; SUFU",Asterisk
607036,ISOVALERYL-CoA DEHYDROGENASE; IVD,Asterisk
607037,ENOYL-CoA HYDRATASE/3-HYDROXYACYL CoA DEHYDROGENASE; EHHADH,Asterisk
607038,OTOANCORIN; OTOA,Asterisk
607039,"DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22",Number Sign
607040,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 11; ABCC11",Asterisk
607041,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 12; ABCC12",Asterisk
607042,CLN3 GENE; CLN3,Asterisk
607043,TRAF3-INTERACTING PROTEIN 2; TRAF3IP2,Asterisk
607044,T-BOX 24,
607045,RHABDOMYOSARCOMA 2-ASSOCIATED TRANSCRIPT; RMST,Asterisk
607046,"TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 22, YEAST, HOMOLOG OF; TOMM22",Asterisk
607047,ATAXIN 3; ATXN3,Asterisk
607048,START DOMAIN-CONTAINING PROTEIN 3; STARD3,Asterisk
607049,START DOMAIN-CONTAINING PROTEIN 4; STARD4,Asterisk
607050,START DOMAIN-CONTAINING PROTEIN 5; STARD5,Asterisk
607051,START DOMAIN-CONTAINING PROTEIN 6; STARD6,Asterisk
607052,TUMOR SUPPRESSOR CANDIDATE 2; TUSC2,Asterisk
607053,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2; HDLCQ2,Percent
607054,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 3; PHLDA3",Asterisk
607055,"TRANSCRIPTION FACTOR B2, MITOCHONDRIAL; TFB2M",Asterisk
607056,INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 2; IMPG2,Asterisk
607057,UBIQUITIN-SPECIFIC PROTEASE 18; USP18,Asterisk
607058,"GAP JUNCTION PROTEIN, DELTA-2; GJD2",Asterisk
607059,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 4; SLC39A4",Asterisk
607060,"PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8",Number Sign
607061,PROSTAGLANDIN E SYNTHASE 3; PTGES3,Asterisk
607062,FK506-BINDING PROTEIN 7; FKBP7,Asterisk
607063,FK506-BINDING PROTEIN 10; FKBP10,Asterisk
607064,PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER 2; PCOLCE2,Asterisk
607065,GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE; QPCT,Asterisk
607066,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 3; TRPV3",Asterisk
607067,SAITOHIN,Asterisk
607068,CYTOCHROME b561 DOMAIN-CONTAINING PROTEIN 2; CYB561D2,Asterisk
607069,PL6 GENE,Asterisk
607070,ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 10; ZMYND10,Asterisk
607071,HYALURONOGLUCOSAMINIDASE 1; HYAL1,Asterisk
607072,"NPR2-LIKE PROTEIN, GATOR1 COMPLEX SUBUNIT; NPRL2",Asterisk
607073,FUS2 GENE,Asterisk
607074,PROTEIN KINASE D2; PRKD2,Asterisk
607075,PDGFA-ASSOCIATED PROTEIN 1; PDAP1,Asterisk
607076,PROTEASE INHIBITOR 15; PI15,Asterisk
607077,"PROTEIN KINASE C, NU; PRKCN",Asterisk
607078,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5",Number Sign
607079,"RHESUS BLOOD GROUP, B GLYCOPROTEIN; RHBG",Asterisk
607080,"46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY",Number Sign
607081,TAP-BINDING PROTEIN-LIKE; TAPBPL,Asterisk
607082,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 2; CACNA2D2",Asterisk
607083,NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 3; NSD3,Asterisk
607084,"DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31",Number Sign
607085,MYASTHENIA GRAVIS WITH THYMUS HYPERPLASIA,Percent
607086,"AORTIC ANEURYSM, FAMILIAL THORACIC 1; AAT1",Percent
607087,"AORTIC ANEURYSM, FAMILIAL THORACIC 2; AAT2",Percent
607088,"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3; DSMA3",Percent
607089,CYCLIN D-TYPE-BINDING PROTEIN 1; CCNDBP1,Asterisk
607090,"SYF2, S. CEREVISIAE, HOMOLOG OF; SYF2",Asterisk
607091,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D",Number Sign
607092,SPHINGOSINE KINASE 2; SPHK2,Asterisk
607093,"5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR",Asterisk
607094,SUPPRESSOR OF CYTOKINE SIGNALING 5; SOCS5,Asterisk
607095,ANAUXETIC DYSPLASIA 1; ANXD1,Number Sign
607096,"SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12; SLC22A12",Asterisk
607097,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 11",Asterisk
607098,"ENOLASE ALPHA, LUNG-SPECIFIC; ENO1B",Asterisk
607099,MBD2-INTERACTING ZINC FINGER PROTEIN; MIZF,Asterisk
607100,NEPHROCYSTIN 1; NPHP1,Asterisk
607101,"DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30",Number Sign
607102,WT1 GENE; WT1,Asterisk
607103,ARGINYLTRANSFERASE 1; ATE1,Asterisk
607104,TANKYRASE 1-BINDING PROTEIN 1; TNKS1BP1,Asterisk
607105,NADPH OXIDASE 3; NOX3,Asterisk
607106,MINOR HISTOCOMPATIBILITY 13; HM13,Asterisk
607107,NASOPHARYNGEAL CARCINOMA,Percent
607108,PAIRED BOX GENE 6; PAX6,Asterisk
607109,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3A; APOBEC3A",Asterisk
607110,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3B; APOBEC3B",Asterisk
607111,SPARTIN; SPART,Asterisk
607112,F-BOX ONLY PROTEIN 2; FBXO2,Asterisk
607113,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3G; APOBEC3G",Asterisk
607114,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33; ADAM33,Asterisk
607115,CINCA SYNDROME; CINCA,Number Sign
607116,ALZHEIMER DISEASE 8,Percent
607117,MCPH1 GENE; MCPH1,Asterisk
607118,MITOCHONDRIAL RIBOSOMAL PROTEIN L3; MRPL3,Asterisk
607119,DOUBLE RING FINGER PROTEIN,Asterisk
607120,"PHOSPHOLIPASE C, BETA-1; PLCB1",Asterisk
607121,MOVED TO 605569,Caret
607122,PROKINETICIN RECEPTOR 1; PROKR1,Asterisk
607123,PROKINETICIN RECEPTOR 2; PROKR2,Asterisk
607124,PHOSPHOLIPID PHOSPHATASE 1; PLPP1,Asterisk
607125,PHOSPHOLIPID PHOSPHATASE 3; PLPP3,Asterisk
607126,PHOSPHOLIPID PHOSPHATASE 2; PLPP2,Asterisk
607127,"ELKS/RAB6-INTERACTING/CAST FAMILY, MEMBER 1; ERC1",Asterisk
607128,TRF1-INTERACTING ANKYRIN-RELATED ADP-RIBOSE POLYMERASE 2; TNKS2,Asterisk
607129,"MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 1; MICAL1",Asterisk
607130,REGULATORY ASSOCIATED PROTEIN OF MTOR; RPTOR,Asterisk
607131,AL-GAZALI-BAKALINOVA SYNDROME; AGBK,Number Sign
607132,"LARYNGEAL ATRESIA, ENCEPHALOCELE, AND LIMB DEFORMITIES",
607133,MOVED TO 601547,Caret
607134,SPECIFIC LANGUAGE IMPAIRMENT 3; SLI3,Percent
607135,CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS,Percent
607136,SPINOCEREBELLAR ATAXIA 17; SCA17,Number Sign
607137,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D-LIKE PROTEIN; HNRNPDL,Asterisk
607138,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 4; CREB3L4,Asterisk
607139,FANCA GENE; FANCA,Asterisk
607140,ANGIOID STREAKS,Number Sign
607141,GLIOMA PATHOGENESIS-RELATED PROTEIN 2; GLIPR2,Asterisk
607142,MOVED TO 602617,Caret
607143,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G",Number Sign
607144,"ALG12, S. CEREVISIAE, HOMOLOG OF; ALG12",Asterisk
607145,DYSTROBREVIN-BINDING PROTEIN 1; DTNBP1,Asterisk
607146,PDZ DOMAIN-CONTAINING 3; PDZD3,Asterisk
607147,NECTIN 3; NECTIN3,Asterisk
607148,MOVED TO 300417,Caret
607149,"RNA EXONUCLEASE 2, S. CEREVISIAE, HOMOLOG OF; REXO2",Asterisk
607150,FIFTH EWING SARCOMA VARIANT; FEV,Asterisk
607151,MOYAMOYA DISEASE 2; MYMY2,Number Sign
607152,"SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT; SPG19",Percent
607153,"INTEGRIN, BETA-1, BINDING PROTEIN OF, 1; ITGB1BP1",Asterisk
607154,ALLERGIC RHINITIS,Number Sign
607155,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5",Number Sign
607156,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 6; ST3GAL6",Asterisk
607157,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 11; SIGLEC11,Asterisk
607158,VENT HOMEOBOX; VENTX,Asterisk
607159,ZINC FINGER MIZ-DOMAIN CONTAINING 1; ZMIZ1,Asterisk
607160,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 14-KD, V1 SUBUNIT F; ATP6V1F",Asterisk
607161,MULTIPLE CONGENITAL ANOMALIES SYNDROME WITH CLOVERLEAF SKULL,
607162,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 5; ST8SIA5",Asterisk
607163,LYSYL OXIDASE-LIKE 3; LOXL3,Asterisk
607164,LADY BIRD-LIKE HOMEOBOX 2; LBX2,Asterisk
607165,SERINE INCORPORATOR 3; SERINC3,Asterisk
607166,TESTIS-SPECIFIC PROTEIN 10; TSGA10,Asterisk
607167,"DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 1; DYNLRB1",Asterisk
607168,"DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 2; DYNLRB2",Asterisk
607169,"PROTEASE, SERINE, 16; PRSS16",Asterisk
607170,CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 1; CRELD1,Asterisk
607171,CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 2,Asterisk
607172,SERINE/THREONINE KINASE 11-INTERACTING PROTEIN; STK11IP,Asterisk
607173,"PROTEASOME 26S SUBUNIT, NON-ATPase, 14; PSMD14",Asterisk
607174,"MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO",Number Sign
607175,DUAL-SPECIFICITY PHOSPHATASE 16; DUSP16,Asterisk
607176,CALNEURON 1; CALN1,Asterisk
607177,IMMEDIATE-EARLY RESPONSE GENE 5; IER5,Asterisk
607178,PDZK1-INTERACTING PROTEIN 1; PDZK1IP1,Asterisk
607179,RNA-BINDING MOTIF PROTEIN 12; RBM12,Asterisk
607180,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 2; LRRC2,Asterisk
607181,RECEPTOR-TRANSPORTING PROTEIN 3; RTP3,Asterisk
607182,FYVE AND COILED-COIL DOMAIN CONTAINING 1; FYCO1,Asterisk
607183,"SEC24-RELATED GENE FAMILY, MEMBER A; SEC24A",Asterisk
607184,"SEC24-RELATED GENE FAMILY, MEMBER B; SEC24B",Asterisk
607185,"SEC24-RELATED GENE FAMILY, MEMBER C; SEC24C",Asterisk
607186,"SEC24-RELATED GENE FAMILY, MEMBER D; SEC24D",Asterisk
607187,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 1; ST3GAL1",Asterisk
607188,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 2; ST3GAL2",Asterisk
607189,REGULATOR OF G PROTEIN SIGNALING 8; RGS8,Asterisk
607190,REGULATOR OF G PROTEIN SIGNALING 13; RGS13,Asterisk
607191,REGULATOR OF G PROTEIN SIGNALING 17; RGS17,Asterisk
607192,REGULATOR OF G PROTEIN SIGNALING 18; RGS18,Asterisk
607193,REGULATOR OF G PROTEIN SIGNALING 20; RGS20,Asterisk
607194,"PANCREAS TRANSCRIPTION FACTOR 1, ALPHA SUBUNIT; PTF1A",Asterisk
607195,MOVED TO 128230,Caret
607196,"MICROCEPHALY, AMISH TYPE; MCPHA",Number Sign
607197,"DEAFNESS, AUTOSOMAL RECESSIVE",
607198,TYROSYL-DNA PHOSPHODIESTERASE 1; TDP1,Asterisk
607199,INTERFERON REGULATORY FACTOR 6; IRF6,Asterisk
607200,THYROID DYSHORMONOGENESIS 6; TDH6,Number Sign
607201,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN R; HNRNPR,Asterisk
607202,"CELIAC DISEASE, SUSCEPTIBILITY TO, 5; CELIAC5",Percent
607203,"SALVADOR, DROSOPHILA, HOMOLOG OF; SAV1",Asterisk
607204,"PUMILIO, DROSOPHILA, HOMOLOG OF, 1; PUM1",Asterisk
607205,"PUMILIO, DROSOPHILA, HOMOLOG OF, 2; PUM2",Asterisk
607206,ARACHIDONATE LIPOXYGENASE 3; ALOXE3,Asterisk
607207,STIP1 HOMOLOGOUS AND U BOX-CONTAINING PROTEIN 1; STUB1,Asterisk
607208,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6",Number Sign
607209,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 10; CARD10,Asterisk
607210,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 11; CARD11,Asterisk
607211,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 14; CARD14,Asterisk
607212,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 9; CARD9,Asterisk
607213,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 6, S. CEREVISIAE, HOMOLOG OF; ORC6",Asterisk
607214,"ANONYCHIA, TOTAL, WITH MICROCEPHALY",
607215,NEPHROCYSTIN 4; NPHP4,Asterisk
607216,"SIDEKICK, DROSOPHILA, HOMOLOG OF, 1; SDK1",Asterisk
607217,"SIDEKICK, DROSOPHILA, HOMOLOG OF, 2; SDK2",Asterisk
607218,INTERFERON REGULATORY FACTOR 5; IRF5,Asterisk
607219,CONTACTIN 5; CNTN5,Asterisk
607220,CONTACTIN 6; CNTN6,Asterisk
607221,"EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES; PEPS",Percent
607222,F-BOX ONLY PROTEIN 18; FBXO18,Asterisk
607223,SPARC-RELATED MODULAR CALCIUM-BINDING PROTEIN 2; SMOC2,Asterisk
607224,ORAL CANCER OVEREXPRESSED GENE 1; ORAOV1,Asterisk
607225,"SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP",Number Sign
607226,HISTONE DEACETYLASE 11; HDAC11,Asterisk
607227,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X1; MRGPRX1",Asterisk
607228,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X2; MRGPRX2",Asterisk
607229,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X3; MRGPRX3",Asterisk
607230,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X4; MRGPRX4",Asterisk
607231,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER D; MRGPRD",Asterisk
607232,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER E; MRGPRE",Asterisk
607233,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER F; MRGPRF",Asterisk
607234,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER G; MRGPRG",Asterisk
607235,MAS1 ONCOGENE-LIKE; MAS1L,Asterisk
607236,"HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION",Number Sign
607237,TRANSMEMBRANE INNER EAR-EXPRESSED GENE; TMIE,Asterisk
607238,COMM DOMAIN-CONTAINING PROTEIN 1; COMMD1,Asterisk
607239,"DEAFNESS, AUTOSOMAL RECESSIVE 33; DFNB33",Percent
607240,SET DOMAIN-CONTAINING PROTEIN 8; SETD8,Asterisk
607241,CHROMOSOME 4 OPEN READING FRAME 7; C4ORF7,Asterisk
607242,"ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-2 SUBUNIT; AP2A2",Asterisk
607243,"ADAPTOR-RELATED PROTEIN COMPLEX 4, SIGMA-1 SUBUNIT; AP4S1",Asterisk
607244,"ADAPTOR-RELATED PROTEIN COMPLEX 4, EPSILON-1 SUBUNIT; AP4E1",Asterisk
607245,"ADAPTOR-RELATED PROTEIN COMPLEX 4, BETA-1 SUBUNIT; AP4B1",Asterisk
607246,"ADAPTOR-RELATED PROTEIN COMPLEX 3, DELTA-1 SUBUNIT; AP3D1",Asterisk
607247,CHONDROLECTIN; CHODL,Asterisk
607248,GLIOMA SUSCEPTIBILITY 4; GLM4,Percent
607249,"CATION CHANNEL, SPERM-ASSOCIATED, 2; CATSPER2",Asterisk
607250,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY; SCAN1",Number Sign
607251,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 22, YEAST, HOMOLOG OF; TIMM22",Asterisk
607252,APOLIPOPROTEIN L-II; APOL2,Asterisk
607253,APOLIPOPROTEIN L-III; APOL3,Asterisk
607254,APOLIPOPROTEIN L-IV; APOL4,Asterisk
607255,APOLIPOPROTEIN L-V; APOL5,Asterisk
607256,APOLIPOPROTEIN L-VI; APOL6,Asterisk
607257,SRY-BOX 6; SOX6,Asterisk
607258,"HYPERCALCIURIA, ABSORPTIVE, 1",Percent
607259,"SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7",Number Sign
607260,PLACENTAL PROTEIN 13-LIKE PROTEIN,Asterisk
607261,EVC2 GENE; EVC2,Asterisk
607262,EPSIN 1; EPN1,Asterisk
607263,EPSIN 2; EPN2,Asterisk
607264,EPSIN 3; EPN3,Asterisk
607265,CLATHRIN INTERACTOR 1; CLINT1,Asterisk
607266,MOVED TO 608048,Caret
607267,"POLYMERASE, DNA, EPSILON-3; POLE3",Asterisk
607268,"CHROMATIN ACCESSIBILITY COMPLEX, SUBUNIT 1; CHRAC1",Asterisk
607269,"POLYMERASE, DNA, EPSILON-4; POLE4",Asterisk
607270,KIAA0442 GENE; KIAA0442,Asterisk
607271,CASPASE 8 DEFICIENCY,Number Sign
607272,"NDC80, S. CEREVISIAE, HOMOLOG OF; NDC80",Asterisk
607273,FOLLICULIN; FLCN,Asterisk
607274,UBIQUITIN-SPECIFIC PROTEASE 14; USP14,Asterisk
607275,HOP HOMEOBOX; HOPX,Asterisk
607276,"RESTING HEART RATE, VARIATION IN",Number Sign
607277,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1",Number Sign
607278,"OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD",Number Sign
607279,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1; SLEH1",Percent
607280,CONTACTIN 4; CNTN4,Asterisk
607281,LSM1 PROTEIN; LSM1,Asterisk
607282,LSM2 PROTEIN; LSM2,Asterisk
607283,LSM3 PROTEIN; LSM3,Asterisk
607284,LSM4 PROTEIN; LSM4,Asterisk
607285,LSM5 PROTEIN; LSM5,Asterisk
607286,LSM6 PROTEIN; LSM6,Asterisk
607287,LSM7 PROTEIN; LSM7,Asterisk
607288,LSM8 PROTEIN; LSM8,Asterisk
607289,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 5; BLOC1S5",Asterisk
607290,"SHISA FAMILY, MEMBER 5; SHISA5",Asterisk
607291,ADAPTOR-RELATED PROTEIN COMPLEX 1 GAMMA SUBUNIT-BINDING PROTEIN 1; AP1GBP1,Asterisk
607292,SEMAPHORIN 4A; SEMA4A,Asterisk
607293,CHLORIDE INTRACELLULAR CHANNEL 5; CLIC5,Asterisk
607294,TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2; TGIF2,Asterisk
607295,MYOSIN XVIIIB; MYO18B,Asterisk
607296,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 1; ATP6V1G1",Asterisk
607297,NERVE INJURY-INDUCED PROTEIN 2; NINJ2,Asterisk
607298,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-13; GNG13",Asterisk
607299,DELTA- AND NOTCH-LIKE EPIDERMAL GROWTH FACTOR-RELATED RECEPTOR; DNER,Asterisk
607300,"PRECURSOR mRNA-PROCESSING FACTOR 8, S. CEREVISIAE, HOMOLOG OF; PRPF8",Asterisk
607301,"PRECURSOR mRNA-PROCESSING FACTOR 3, S. CEREVISIAE, HOMOLOG OF; PRPF3",Asterisk
607302,MOVED TO 116960,Caret
607303,MORTALITY FACTOR 4-LIKE PROTEIN 1; MORF4L1,Asterisk
607304,CATARACT 27; CTRCT27,Percent
607305,MDS2 GENE,Asterisk
607306,STEROID 5-ALPHA-REDUCTASE 2; SRD5A2,Asterisk
607307,FILAMIN A-INTERACTING PROTEIN 1; FILIP1,Asterisk
607308,MAMMOGRAPHIC DENSITY,Percent
607309,"ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-2 SUBUNIT; AP1M2",Asterisk
607310,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 7; ADAM7,Asterisk
607311,PROGESTERONE RECEPTOR; PGR,Asterisk
607312,ZINC FINGER CCCH DOMAIN-CONTAINING ANTIVIRAL PROTEIN 1; ZC3HAV1,Asterisk
607313,"GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1",Number Sign
607314,CALCIUM-BINDING PROTEIN 2; CABP2,Asterisk
607315,CALCIUM-BINDING PROTEIN 5; CABP5,Asterisk
607316,MOVED TO 607315,Caret
607317,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4",Number Sign
607318,LYSYL OXIDASE-LIKE 4; LOXL4,Asterisk
607319,SCM-LIKE PROTEIN WITH 4 MBT DOMAINS 1; SFMBT1,Asterisk
607320,RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 4; RASGRP4,Asterisk
607321,"ATPase, Na+/K+ TRANSPORTING, ALPHA-4 POLYPEPTIDE; ATP1A4",Asterisk
607322,MOVED TO 143470,Caret
607323,DUANE-RADIAL RAY SYNDROME; DRRS,Number Sign
607324,"POLYDACTYLY, POSTAXIAL, TYPE A3; PAPA3",Percent
607325,DEDICATOR OF CYTOKINESIS 9; DOCK9,Asterisk
607326,SMITH-MCCORT DYSPLASIA 1; SMC1,Number Sign
607327,MUSCLEBLIND-LIKE SPLICING REGULATOR 2; MBNL2,Asterisk
607328,HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 1; HEXIM1,Asterisk
607329,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3",Percent
607330,LATHOSTEROLOSIS,Number Sign
607331,RP9 GENE; RP9,Asterisk
607332,CHROMOSOME 5 OPEN READING FRAME 13; C5ORF13,Asterisk
607333,STE20-RELATED KINASE ADAPTOR BETA; STRADB,Asterisk
607334,"TRAFFICKING PROTEIN, KINESIN-BINDING 2; TRAK2",Asterisk
607335,BESTROPHIN 2; BEST2,Asterisk
607336,BESTROPHIN 4; BEST4,Asterisk
607337,BESTROPHIN 3; BEST3,Asterisk
607338,LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT-LIKE 1; LEPROTL1,Asterisk
607339,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1",Percent
607340,GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2,Asterisk
607341,"FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2",Number Sign
607342,CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 1; CPEB1,Asterisk
607343,SAL-LIKE 4; SALL4,Asterisk
607344,"TUBULIN, DELTA-1; TUBD1",Asterisk
607345,"TUBULIN, EPSILON-1; TUBE1",Asterisk
607346,SPINOCEREBELLAR ATAXIA 19; SCA19,Number Sign
607347,ALPHA KINASE 1; ALPK1,Asterisk
607348,"HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 5; HES5",Asterisk
607349,TALIN 2; TLN2,Asterisk
607350,KINESIN FAMILY MEMBER 13B; KIF13B,Asterisk
607351,RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 1; RHOBTB1,Asterisk
607352,RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 2; RHOBTB2,Asterisk
607353,RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 3; RHOBTB3,Asterisk
607354,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 2; IS2",Percent
607355,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 3; EIF2C3",Asterisk
607356,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 4; EIF2C4",Asterisk
607357,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 5; KCNQ5",Asterisk
607358,AUTOIMMUNE REGULATOR; AIRE,Asterisk
607359,CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 2; CCAR2,Asterisk
607360,LACRITIN; LACRT,Asterisk
607361,"MECKEL SYNDROME, TYPE 3; MKS3",Number Sign
607362,"RGM DOMAIN FAMILY, MEMBER A; RGMA",Asterisk
607363,KINETOCHORE-ASSOCIATED PROTEIN 1; KNTC1,Asterisk
607364,"BARTTER SYNDROME, TYPE 3; BARTS3",Number Sign
607365,LIPASE H; LIPH,Asterisk
607366,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 12; KCNK12",Asterisk
607367,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 13; KCNK13",Asterisk
607368,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 15; KCNK15",Asterisk
607369,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 16; KCNK16",Asterisk
607370,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 17; KCNK17",Asterisk
607371,"DYSTONIA, JUVENILE-ONSET; DJO",Number Sign
607372,MEDIATOR COMPLEX SUBUNIT 15; MED15,Asterisk
607373,"AUTISM, SUSCEPTIBILITY TO, 8; AUTS8",Percent
607374,"PRKR INHIBITOR, REPRESSOR OF; PRKRIR",Asterisk
607375,DOT1-LIKE; DOT1L,Asterisk
607376,DYNACTIN 2; DCTN2,Asterisk
607377,LENS EPITHELIAL PROTEIN; LENEP,Asterisk
607378,SERPINE1 mRNA-BINDING PROTEIN 1; SERBP1,Asterisk
607379,NEUROFIBROMIN 2; NF2,Asterisk
607380,TNF RECEPTOR-ASSOCIATED FACTOR 3-INTERACTING PROTEIN 1; TRAF3IP1,Asterisk
607381,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 50, YEAST, HOMOLOG OF; TIMM50",Asterisk
607382,CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 3; CLIP3,Asterisk
607383,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 13, YEAST, HOMOLOG OF; TIMM13",Asterisk
607384,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 9, YEAST, HOMOLOG OF; TIMM9",Asterisk
607385,"UDP-N-ACETYLGLUCOSAMINE:ALPHA-1,3-D-MANNOSIDE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE IV",Asterisk
607386,"INTRAFLAGELLAR TRANSPORT 172, CHLAMYDOMONAS, HOMOLOG OF; IFT172",Asterisk
607387,DYNACTIN 3; DCTN3,Asterisk
607388,"FRACTURE CALLUS 1, RAT, HOMOLOG OF; FXC1",Asterisk
607389,SINGLE-STRANDED DNA-BINDING PROTEIN 2; SSBP2,Asterisk
607390,SINGLE-STRANDED DNA-BINDING PROTEIN 3; SSBP3,Asterisk
607391,SINGLE-STRANDED DNA-BINDING PROTEIN 4; SSBP4,Asterisk
607392,WW DOMAIN-CONTAINING TRANSCRIPTION REGULATOR 1; WWTR1,Asterisk
607393,"CELL DIVISION CYCLE PROTEIN 73, S. CEREVISIAE, HOMOLOG OF; CDC73",Asterisk
607394,"POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 3; POU2F3",Asterisk
607395,"STREPTOCOCCUS, GROUP A, SEVERITY OF INFECTION BY",
607396,"TRANSDUCER OF ERBB2, 2; TOB2",Asterisk
607397,MELANOCORTIN 2 RECEPTOR; MC2R,Asterisk
607398,GLUCOCORTICOID DEFICIENCY 2; GCCD2,Number Sign
607399,MUCOLIPIN 2; MCOLN2,Asterisk
607400,MUCOLIPIN 3; MCOLN3,Asterisk
607401,"INTERFERON, LAMBDA-2; IFNL2",Asterisk
607402,"INTERFERON, LAMBDA-3; IFNL3",Asterisk
607403,"INTERFERON, LAMBDA-1; IFNL1",Asterisk
607404,INTERFERON-LAMBDA RECEPTOR 1; IFNLR1,Asterisk
607405,TRACE AMINE-ASSOCIATED RECEPTOR 5; TAAR5,Asterisk
607406,STARCH-BINDING DOMAIN-CONTAINING PROTEIN 1; STBD1,Asterisk
607407,EARLY B-CELL FACTOR 3; EBF3,Asterisk
607408,D-AMINO ACID OXIDASE ACTIVATOR; DAOA,Asterisk
607409,NEURITIN 1; NRN1,Asterisk
607410,DIENCEPHALON/MESENCEPHALON HOMEOBOX 1; DMBX1,Asterisk
607411,PATENT DUCTUS ARTERIOSUS 1; PDA1,Percent
607412,"BPI FOLD-CONTAINING PROTEIN, FAMILY A, MEMBER 1; BPIFA1",Asterisk
607413,ALZHEIMER DISEASE NEURONAL THREAD PROTEIN,
607414,FEZ FAMILY ZINC FINGER PROTEIN 2; FEZF2,Asterisk
607415,DAOA ANTISENSE RNA; DAOAAS,Asterisk
607416,"CHL1, MOUSE, HOMOLOG OF; CHL1",Asterisk
607417,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2",Number Sign
607418,GRIP AND COILED-COIL DOMAINS-CONTAINING PROTEIN 1; GCC1,Asterisk
607419,GEM-ASSOCIATED PROTEIN 7; GEMIN7,Asterisk
607420,GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 1; GABARAPL1,Asterisk
607421,NME/NM23 FAMILY MEMBER 8; NME8,Asterisk
607422,GLYCINE C-ACETYLTRANSFERASE; GCAT,Asterisk
607423,PROTEIN O-MANNOSYLTRANSFERASE 1; POMT1,Asterisk
607424,GLYCINE N-ACYLTRANSFERASE; GLYAT,Asterisk
607425,"GAP JUNCTION PROTEIN, DELTA-3; GJD3",Asterisk
607426,"COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1",Number Sign
607427,ENOLASE SUPERFAMILY MEMBER 1; ENOSF1,Asterisk
607428,KIN OF IRRE-LIKE; KIRREL,Asterisk
607429,"PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 1; PDSS1",Asterisk
607430,DAZ-ASSOCIATED PROTEIN 1; DAZAP1,Asterisk
607431,DAZ-ASSOCIATED PROTEIN 2; DAZAP2,Asterisk
607432,LISSENCEPHALY 1; LIS1,Number Sign
607433,"TWINFILIN, DROSOPHILA, HOMOLOG OF, 2; TWF2",Asterisk
607434,GTP-BINDING PROTEIN 2; GTPBP2,Asterisk
607435,ERA G-PROTEIN-LIKE 1; ERAL1,Asterisk
607436,"POLY(A) POLYMERASE, BETA; PAPOLB",Asterisk
607437,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER D; GPRC5D",Asterisk
607438,MOVED TO 138210,Caret
607439,PROTEIN O-MANNOSYLTRANSFERASE 2; POMT2,Asterisk
607440,FUKUTIN; FKTN,Asterisk
607441,EPITHELIAL STROMAL INTERACTION 1; EPSTI1,Asterisk
607442,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 4; EML4,Asterisk
607443,EPIDIDYMAL SPERM BINDING PROTEIN 1; ELSPBP1,Asterisk
607444,SBDS GENE; SBDS,Asterisk
607445,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E NUCLEAR IMPORT FACTOR 1; EIF4ENIF1,Asterisk
607446,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 3; BMIQ3,Percent
607447,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4,Number Sign
607448,G PROTEIN-COUPLED RECEPTOR 147; GPR147,Asterisk
607449,G PROTEIN-COUPLED RECEPTOR 74; GPR74,Asterisk
607450,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8",Number Sign
607451,GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 2; GMEB2,Asterisk
607452,GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 2; GABARAPL2,Asterisk
607453,"DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44",Number Sign
607454,SPINOCEREBELLAR ATAXIA 21; SCA21,Number Sign
607455,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 3; ZFAND3,Asterisk
607456,"UTP4, S. CEREVISIAE, HOMOLOG OF; UTP4",Asterisk
607457,GIL BLOOD GROUP,Number Sign
607458,SPINOCEREBELLAR ATAXIA 18; SCA18,Percent
607459,"SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO",Number Sign
607460,PHOSPHATIDYLSERINE-SPECIFIC PHOSPHOLIPASE A1-ALPHA; PLA1A,Asterisk
607461,DYMECLIN; DYM,Asterisk
607462,ATROPHIN 1; ATN1,Asterisk
607463,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13-LIKE; PPP1R13L",Asterisk
607464,"THYROID CARCINOMA, HURTHLE CELL",Number Sign
607465,CODANIN 1; CDAN1,Asterisk
607466,RAS-ASSOCIATED PROTEIN RAB2B; RAB2B,Asterisk
607467,C-TYPE LECTIN-LIKE 1; CLECL1,Asterisk
607468,G PROTEIN-COUPLED RECEPTOR 88; GPR88,Asterisk
607469,N-ACYLETHANOLAMINE ACID AMIDASE; NAAA,Asterisk
607470,BREAST CARCINOMA AMPLIFIED SEQUENCE 3; BCAS3,Asterisk
607471,BREAST CARCINOMA AMPLIFIED SEQUENCE 4; BCAS4,Asterisk
607472,MITOCHONDRIAL ESCAPE 1-LIKE 1; YME1L1,Asterisk
607473,"VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2",Number Sign
607474,"HOMOGENTISATE 1,2-DIOXYGENASE; HGD",Asterisk
607475,BOTHNIA RETINAL DYSTROPHY,Number Sign
607476,NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD,Number Sign
607477,G2- AND S-PHASE EXPRESSED GENE 1; GTSE1,Asterisk
607478,TRYPTOPHAN HYDROXYLASE 2; TPH2,Asterisk
607479,"APC, DOWNREGULATED BY, 1; APCDD1",Asterisk
607480,MOVED TO 300424,Caret
607481,MMAA GENE; MMAA,Asterisk
607482,"CARDIOMYOPATHY, DILATED, 1M; CMD1M",Number Sign
607483,THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2,Number Sign
607484,"PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, ALPHA; PARD6A",Asterisk
607485,"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED",Number Sign
607486,KNOPS BLOOD GROUP SYSTEM; KN,Number Sign
607487,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25",Number Sign
607488,"DYSTONIA 15, MYOCLONIC; DYT15",Percent
607489,CULLIN 9; CUL9,Asterisk
607490,LACTATE DEHYDROGENASE D; LDHD,Asterisk
607491,PROTEIN O-FUCOSYLTRANSFERASE 1; POFUT1,Asterisk
607492,PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1; PACS1,Asterisk
607493,INHIBITOR OF GROWTH 3; ING3,Asterisk
607494,"INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE II, 105-KD; INPP4B",Asterisk
607495,MOVED TO 607138,Caret
607496,NITRIC OXIDE SYNTHASE TRAFFICKER; NOSTRIN,Asterisk
607497,"BETA-1,3-GLUCURONYLTRANSFERASE 2; B3GAT2",Asterisk
607498,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3",Percent
607499,"BULIMIA NERVOSA, SUSCEPTIBILITY TO; BULN",Percent
607500,MOVED TO 146390,Caret
607501,"MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4",Percent
607502,"DISPATCHED, DROSOPHILA, HOMOLOG OF, 1; DISP1",Asterisk
607503,"DISPATCHED, DROSOPHILA, HOMOLOG OF, 2; DISP2",Asterisk
607504,HEADACHE ASSOCIATED WITH SEXUAL ACTIVITY; HSA,
607505,PAS DOMAIN-CONTAINING SERINE/THREONINE KINASE; PASK,Asterisk
607506,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 14; ADAMTS14",Asterisk
607507,"PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO",Number Sign
607508,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5",Percent
607509,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 15; ADAMTS15",Asterisk
607510,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 16; ADAMTS16",Asterisk
607511,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 17; ADAMTS17",Asterisk
607512,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 18; ADAMTS18",Asterisk
607513,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 19; ADAMTS19",Asterisk
607514,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10,Number Sign
607515,PLACENTA-SPECIFIC GENE 8; PLAC8,Asterisk
607516,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6",Percent
607517,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 4; LILRA4",Asterisk
607518,MONOCYTE AND PLASMACYTOID ACTIVATED MOLECULE,Asterisk
607519,POLY(ADP-RIBOSE) POLYMERASE 4; PARP4,Asterisk
607520,ZYGOTE ARREST 1; ZAR1,Asterisk
607521,HPS5 GENE; HPS5,Asterisk
607522,HPS6 GENE; HPS6,Asterisk
607523,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8",Number Sign
607524,RING FINGER PROTEIN 39; RNF39,Asterisk
607525,ZINC RIBBON DOMAIN-CONTAINING PROTEIN 1; ZNRD1,Asterisk
607526,RIBOSOMAL PROTEIN L27; RPL27,Asterisk
607527,REGULATOR OF DIFFERENTIATION 1; ROD1,Asterisk
607528,"ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 4; ROBO4",Asterisk
607529,SERYL-tRNA SYNTHETASE; SARS,Asterisk
607530,"HOMEOBOX A11, ANTISENSE; HOXA11AS",Asterisk
607531,KRUPPEL-LIKE FACTOR 12; KLF12,Asterisk
607532,PROGESTERONE-INDUCED BLOCKING FACTOR 1; PIBF1,Asterisk
607533,"DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG OF; DIS3",Asterisk
607534,YY1-ASSOCIATED FACTOR 2; YAF2,Asterisk
607535,RING1- AND YY1-BINDING PROTEIN; RYBP,Asterisk
607536,CREB-REGULATED TRANSCRIPTION COACTIVATOR 1; CRTC1,Asterisk
607537,MASTERMIND-LIKE 2; MAML2,Asterisk
607538,NUDE NEURODEVELOPMENT PROTEIN 1-LIKE 1; NDEL1,Asterisk
607539,"CAMPTOSYNPOLYDACTYLY, COMPLEX; CCSPD",Number Sign
607540,"SECRETORY DIARRHEA, MYOPATHY, AND DEAFNESS",
607541,"CORNEAL DYSTROPHY, AVELLINO TYPE; CDA",Number Sign
607542,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1",Asterisk
607543,SPONDYLOMETAPHYSEAL DYSPLASIA WITH BOWED FOREARMS AND FACIAL DYSMORPHISM,
607544,LEUCINE-RICH PPR MOTIF-CONTAINING PROTEIN; LRPPRC,Asterisk
607545,METHYLSTEROL MONOOXYGENASE 1; MSMO1,Asterisk
607546,CD200 RECEPTOR 1; CD200R1,Asterisk
607547,RIBOSOMAL PROTEIN L39-LIKE; RPL39L,Asterisk
607548,RADIAL SPOKEHEAD-LIKE 1; RSHL1,Asterisk
607549,"POTE ANKYRIN DOMAIN FAMILY, MEMBER D; POTED",Asterisk
607550,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 10; SLC16A10",Asterisk
607551,STROMAL CELL-DERIVED FACTOR 2-LIKE 1; SDF2L1,Asterisk
607552,MOVED TO 255320,Caret
607553,EPIPLAKIN 1; EPPK1,Asterisk
607554,"ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3",Number Sign
607555,TORSIN 3A; TOR3A,Asterisk
607556,"TWIST, DROSOPHILA, HOMOLOG OF, 2; TWIST2",Asterisk
607557,"SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 8; SLC17A8",Asterisk
607558,SEC14-LIKE 2; SEC14L2,Asterisk
607559,"MAHOGUNIN, RING FINGER 1; MGRN1",Asterisk
607560,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARHGEF2,Asterisk
607561,MOVED TO 210720,Caret
607562,INTERLEUKIN 23 RECEPTOR; IL23R,Asterisk
607563,"SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 6; SLC17A6",Asterisk
607564,TRIPARTITE MOTIF-CONTAINING PROTEIN 6; TRIM6,Asterisk
607565,"SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION",
607566,EPM2A GENE; EPM2A,Asterisk
607567,OLFACTOMEDIN 3; OLFM3,Asterisk
607568,MMAB GENE; MMAB,Asterisk
607569,"MYOPATHY, DISTAL, WITH EARLY RESPIRATORY FAILURE, AUTOSOMAL DOMINANT",
607570,DEAH BOX POLYPEPTIDE 40; DHX40,Asterisk
607571,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL OXODICARBOXYLATE CARRIER), MEMBER 21; SLC25A21",Asterisk
607572,"LEPROSY, SUSCEPTIBILITY TO, 2; LPRS2",Percent
607573,MICROTUBULE-ASSOCIATED PROTEIN 1S; MAP1S,Asterisk
607574,ARYLSULFATASE A; ARSA,Asterisk
607575,"CAT EYE SYNDROME CHROMOSOME REGION, CANDIDATE 1; CECR1",Asterisk
607576,"CAT EYE SYNDROME CHROMOSOME REGION, CANDIDATE 2; CECR2",Asterisk
607577,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 4; ENTPD4,Asterisk
607578,BREATH-HOLDING SPELLS,
607579,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 9; SLC22A9",Asterisk
607580,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 10; SLC22A10",Asterisk
607581,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 8; SLC22A8",Asterisk
607582,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 6; SLC22A6",Asterisk
607583,PEROXISOME BIOGENESIS FACTOR 11G; PEX11G,Asterisk
607584,"SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE; SPG24",Percent
607585,ATAXIA-TELANGIECTASIA MUTATED GENE; ATM,Asterisk
607586,CALCIUM RESPONSE FACTOR; CARF,Asterisk
607587,INTERLEUKIN 17D; IL17D,Asterisk
607588,PEPTIDYL-PROLYL ISOMERASE-LIKE 2; PPIL2,Asterisk
607589,SERUM/GLUCOCORTICOID-REGULATED KINASE 2; SGK2,Asterisk
607590,BBS7 GENE; BBS7,Asterisk
607591,SERUM/GLUCOCORTICOID-REGULATED KINASE 3; SGK3,Asterisk
607592,PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19,Percent
607593,MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1; MDC1,Asterisk
607594,"IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1",Number Sign
607595,BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES; BSVD,Number Sign
607596,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A",Number Sign
607597,"MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES",
607598,LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2,Number Sign
607599,RETINOL DEHYDROGENASE 10; RDH10,Asterisk
607600,EPIDERMOLYSIS BULLOSA SIMPLEX SUPERFICIALIS; EBSS,Percent
607601,TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 1; TICAM1,Asterisk
607602,"ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS",Number Sign
607603,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 4; KCNG4",Asterisk
607604,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 2; KCNV2",Asterisk
607605,"GLUTATHIONE S-TRANSFERASE, ALPHA-5; GSTA5",Asterisk
607606,"KERATIN 9, TYPE I; KRT9",Asterisk
607607,"NUCLEOPORIN, 54-KD; NUP54",Asterisk
607608,"SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL; SMPD1",Asterisk
607609,PEPTIDYL-PROLYL ISOMERASE-LIKE 4; PPIL4,Asterisk
607610,PHOSPHOLIPID SCRAMBLASE 2; PLSCR2,Asterisk
607611,PHOSPHOLIPID SCRAMBLASE 3; PLSCR3,Asterisk
607612,PHOSPHOLIPID SCRAMBLASE 4; PLSCR4,Asterisk
607613,"NUCLEOPORIN, 133-KD; NUP133",Asterisk
607614,"NUCLEOPORIN, 160-KD; NUP160",Asterisk
607615,"NUCLEOPORIN, 58-KD; NUP58",Asterisk
607616,"NIEMANN-PICK DISEASE, TYPE B",Number Sign
607617,"NUCLEOPORIN, 107-KD; NUP107",Asterisk
607618,DEAD/H BOX 28; DDX28,Asterisk
607619,FERM DOMAIN-CONTAINING PROTEIN 3; FRMD3,Asterisk
607620,COLLECTIN 10; COLEC10,Asterisk
607621,COLLECTIN 12; COLEC12,Asterisk
607622,PHOSPHOMEVALONATE KINASE; PMVK,Asterisk
607623,NPC1 GENE; NPC1,Asterisk
607624,"GRISCELLI SYNDROME, TYPE 2; GS2",Number Sign
607625,"NIEMANN-PICK DISEASE, TYPE C2; NPC2",Number Sign
607626,"ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC",Number Sign
607627,BREAST CANCER- AND SALIVARY GLAND-EXPRESSED GENE,Asterisk
607628,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11",Number Sign
607629,"ANTERIOR PHARYNX DEFECTIVE 1, C. ELEGANS, HOMOLOG OF, A; APH1A",Asterisk
607630,"ANTERIOR PHARYNX DEFECTIVE 1, C. ELEGANS, HOMOLOG OF, B; APH1B",Asterisk
607631,"EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1",Number Sign
607632,"PRESENILIN ENHANCER 2, C. ELEGANS, HOMOLOG OF; PSENEN",Asterisk
607633,XANTHINE DEHYDROGENASE; XDH,Asterisk
607634,"OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1",Number Sign
607635,CARBOXYPEPTIDASE A4; CPA4,Asterisk
607636,"VAN BUCHEM DISEASE, TYPE 2",Number Sign
607637,EMX2 OPPOSITE STRAND; EMX2OS,Asterisk
607638,DEOXYCYTIDYLATE DEAMINASE; DCTD,Asterisk
607639,PROTEIN WITH 4 GROUP B SCAVENGER RECEPTOR CYSTEINE-RICH DOMAINS; SRCRB4D,Asterisk
607640,ATAXIN 7; ATXN7,Asterisk
607641,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B",Number Sign
607642,RETINOIC ACID-INDUCED GENE 1; RAI1,Asterisk
607643,"FASCIN ACTIN-BUNDLING PROTEIN 2, RETINAL; FSCN2",Asterisk
607644,"CANDIDIASIS, FAMILIAL, 3; CANDF3",Percent
607645,D4S234E GENE; D4S234E,Asterisk
607646,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7B; ZBTB7B,Asterisk
607647,PLASMALEMMA VESICLE-ASSOCIATED PROTEIN; PLVAP,Asterisk
607648,SERINE/THREONINE PROTEIN KINASE 39; STK39,Asterisk
607649,OSTEOPETROSIS-ASSOCIATED TRANSMEMBRANE PROTEIN 1; OSTM1,Asterisk
607650,"DEFENSIN, BETA, 118; DEFB118",Asterisk
607651,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY B, MEMBER 1; PLEKHB1",Asterisk
607652,SERINE/THREONINE PROTEIN KINASE 36; STK36,Asterisk
607653,"RAS HOMOLOG GENE FAMILY, MEMBER J; RHOJ",Asterisk
607654,KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3,Number Sign
607655,SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS,Number Sign
607656,CURLY HAIR-ACRAL KERATODERMA-CARIES SYNDROME,Percent
607657,CYSTATHIONINE GAMMA-LYASE; CTH,Asterisk
607658,HYPOTRICHOSIS-OSTEOLYSIS-PERIODONTITIS-PALMOPLANTAR KERATODERMA SYNDROME,Percent
607659,ELL-ASSOCIATED FACTOR 2; EAF2,Asterisk
607660,TESTIS-SPECIFIC SERINE/THREONINE KINASE 3; TSSK3,Asterisk
607661,SPERM-ASSOCIATED ANTIGEN 10; SPAG10,Asterisk
607662,SPERMATOGENESIS-ASSOCIATED PROTEIN 2; SPATA2,Asterisk
607663,DEAD BOX POLYPEPTIDE 25; DDX25,Asterisk
607664,N-ACETYLGLUCOSAMINE-6-SULFATASE; GNS,Asterisk
607665,TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU,
607666,ANGIOPOIETIN-LIKE 5; ANGPTL5,Asterisk
607667,"CATENIN, ALPHA-3; CTNNA3",Asterisk
607668,ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 4; ARL6IP4,Asterisk
607669,ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 1; ARL6IP1,Asterisk
607670,SERINE/THREONINE PROTEIN KINASE 33; STK33,Asterisk
607671,"DYSTONIA 13, TORSION, AUTOSOMAL DOMINANT; DYT13",Percent
607672,CARDIOTROPHIN-LIKE CYTOKINE FACTOR 1; CLCF1,Asterisk
607673,ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 1; EDEM1,Asterisk
607674,"CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY",Percent
607675,REST COREPRESSOR; RCOR,Asterisk
607676,IRAK4 DEFICIENCY,Number Sign
607677,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I",Number Sign
607678,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D",Number Sign
607679,DEDICATOR OF CYTOKINESIS 4; DOCK4,Asterisk
607680,ZINC FINGER PROTEIN 363; ZNF363,Asterisk
607681,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; ECA2",Number Sign
607682,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9",Number Sign
607683,"DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52",Percent
607684,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E",Number Sign
607685,"HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES",Number Sign
607686,FIP1-LIKE 1; FIP1L1,Asterisk
607687,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3,Percent
607688,"PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK11",Number Sign
607689,MOVED TO 246700,Caret
607690,"SAR1, S. CEREVISIAE, HOMOLOG B; SAR1B",Asterisk
607691,"SAR1, S. CEREVISIAE, HOMOLOG OF, A; SAR1A",Asterisk
607692,MOVED TO 248800 AND 246700,Caret
607693,SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2; SECISBP2,Asterisk
607694,"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7",Number Sign
607695,"EUKARYOTIC ELONGATION FACTOR, SELENOCYSTEINE-tRNA-SPECIFIC; EEFSEC",Asterisk
607696,USH1G GENE; USH1G,Asterisk
607697,SET-BINDING FACTOR 2; SBF2,Asterisk
607698,LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR; LCOR,Asterisk
607699,RING FINGER PROTEIN 20; RNF20,Asterisk
607700,RING FINGER PROTEIN 40; RNF40,Asterisk
607701,KELCH-LIKE 41; KLHL41,Asterisk
607702,TRANSCRIPTIONAL AND IMMUNE RESPONSE REGULATOR; TCIM,Asterisk
607703,"NUCLEOPORIN, 210-KD; NUP210",Asterisk
607704,KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1; KANK1,Asterisk
607705,PROTEASOME ACTIVATOR SUBUNIT 4; PSME4,Asterisk
607706,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE",Number Sign
607707,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-BETA; CAMK2B,Asterisk
607708,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-DELTA; CAMK2D,Asterisk
607709,TIGHT JUNCTION PROTEIN 2; TJP2,Asterisk
607710,"FAMILY WITH SEQUENCE SIMILARITY 189, MEMBER A2; FAM189A2",Asterisk
607711,"DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, A; DIP2A",Asterisk
607712,HYPERMETHYLATED IN CANCER 2; HIC2,Asterisk
607713,"KILLER-SPECIFIC SECRETORY PROTEIN, 37-KD",Asterisk
607714,TNFAIP3-INTERACTING PROTEIN 1; TNIP1,Asterisk
607715,"TSC22 DOMAIN FAMILY, MEMBER 1; TSC22D1",Asterisk
607716,SYNAPTOTAGMIN 13; SYT13,Asterisk
607717,TENSIN 2; TNS2,Asterisk
607718,SYNAPTOTAGMIN 6; SYT6,Asterisk
607719,SYNAPTOTAGMIN 8; SYT8,Asterisk
607720,TRANSLIN-ASSOCIATED FACTOR X-INTERACTING PROTEIN 1; TSNAXIP1,Asterisk
607721,NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1,Number Sign
607722,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 2; EMC2",Asterisk
607723,SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 1; SUN1,Asterisk
607724,CALCYPHOSINE 2; CAPS2,Asterisk
607725,POLY(ADP-RIBOSE) POLYMERASE 2; PARP2,Asterisk
607726,POLY(ADP-RIBOSE) POLYMERASE 3; PARP3,Asterisk
607727,CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED PROTEIN 1; CAND1,Asterisk
607728,"POROKERATOSIS 4, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK4",Percent
607729,DNA DAMAGE-INDUCIBLE TRANSCRIPT 4; DDIT4,Asterisk
607730,DNA DAMAGE-INDUCIBLE TRANSCRIPT 4-LIKE; DDIT4L,Asterisk
607731,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H",Percent
607732,STERILE ALPHA AND TIR MOTIFS-CONTAINING PROTEIN 1; SARM1,Asterisk
607733,"SCRIBBLE, DROSOPHILA, HOMOLOG OF; SCRIB",Asterisk
607734,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F",Number Sign
607735,PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2; PGRMC2,Asterisk
607736,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J",Number Sign
607737,FIBROBLAST GROWTH FACTOR-BINDING PROTEIN 1; FGFBP1,Asterisk
607738,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 2; KCNB2",Asterisk
607739,MOVED TO 604563,Caret
607740,UBIQUITIN-SPECIFIC PROTEASE 32; USP32,Asterisk
607741,"TBC1 DOMAIN FAMILY, MEMBER 3; TBC1D3",Asterisk
607742,"KERATIN 24, TYPE I; KRT24",Asterisk
607743,FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2; FRS2,Asterisk
607744,FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 3; FRS3,Asterisk
607745,"SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3",Number Sign
607746,FERMITIN FAMILY (DROSOPHILA) HOMOLOG 2; FERMT2,Asterisk
607747,FILAMIN-BINDING LIM PROTEIN 1; FBLP1,Asterisk
607748,"HYPERCHOLANEMIA, FAMILIAL; FHCA",Number Sign
607749,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 3; CDCA3,Asterisk
607750,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3C; APOBEC3C",Asterisk
607751,"TASTE RECEPTOR, TYPE 2, MEMBER 38; TAS2R38",Asterisk
607752,CYCLIN O; CCNO,Asterisk
607753,SINGLE-STRAND-SELECTIVE MONOFUNCTIONAL URACIL-DNA GLYCOSYLASE 1,Asterisk
607754,MAKORIN 1; MKRN1,Asterisk
607755,MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 2; MAPK8IP2,Asterisk
607756,ALPHA-AMINOADIPATE SEMIALDEHYDE DEHYDROGENASE-PHOSPHOPANTETHEINYL TRANSFERASE; AASDHPPT,Asterisk
607757,CHIBBY; CBY,Asterisk
607758,"CATENIN, BETA-INTERACTING PROTEIN 1; CTNNBIP1",Asterisk
607759,"INTEGRIN, ALPHA-2B; ITGA2B",Asterisk
607760,DNA TOPOISOMERASE II-BINDING PROTEIN 1; TOPBP1,Asterisk
607761,KIN OF IRRE-LIKE 3; KIRREL3,Asterisk
607762,KIN OF IRRE-LIKE 2; KIRREL2,Asterisk
607763,"CENTAURIN, BETA-1; CENTB1",Asterisk
607764,3-BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE; HSD3B7,Asterisk
607765,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1",Number Sign
607766,"CENTAURIN, BETA-2; CENTB2",Asterisk
607767,SESTRIN 2; SESN2,Asterisk
607768,SESTRIN 3; SESN3,Asterisk
607769,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 4; PLEKHA4",Asterisk
607770,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 5; PLEKHA5",Asterisk
607771,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 6; PLEKHA6",Asterisk
607772,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 1; PLEKHA1",Asterisk
607773,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 2; PLEKHA2",Asterisk
607774,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 3; PLEKHA3",Asterisk
607775,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 4; KCNE4",Asterisk
607776,"SIN3, YEAST, HOMOLOG OF, A; SIN3A",Asterisk
607777,"SIN3, YEAST, HOMOLOG OF, B; SIN3B",Asterisk
607778,ACROCAPITOFEMORAL DYSPLASIA; ACFD,Number Sign
607779,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 7; PAQR7",Asterisk
607780,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 8; PAQR8",Asterisk
607781,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 5; PAQR5",Asterisk
607782,"LUC7, S. CEREVISIAE, HOMOLOG OF; LUC7L",Asterisk
607783,MESODERM DEVELOPMENT CANDIDATE GENE 2; MESDC2,Asterisk
607784,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 4; ABCG4",Asterisk
607785,JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML,Number Sign
607786,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 9; PCSK9",Asterisk
607787,G PROTEIN-COUPLED RECEPTOR 180; GPR180,Asterisk
607788,MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2; MCFD2,Asterisk
607789,PHD FINGER PROTEIN 3; PHF3,Asterisk
607790,"TET ONCOGENE FAMILY, MEMBER 1; TET1",Asterisk
607791,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID",Number Sign
607792,"GERMINAL CENTER-ASSOCIATED, SIGNALING AND MOTILITY; GCSAM",Asterisk
607793,"PETER PAN, DROSOPHILA, HOMOLOG OF; PPAN",Asterisk
607794,MEST INTRONIC TRANSCRIPT 1; MESTIT1,Asterisk
607795,"PRECURSOR mRNA-PROCESSING FACTOR 4, S. CEREVISIAE, HOMOLOG OF; PRPF4",Asterisk
607796,PHD FINGER PROTEIN 11; PHF11,Asterisk
607797,"SMALL NUCLEAR RIBONUCLEOPROTEIN, 40-KD; SNRNP40",Asterisk
607798,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1-LIKE; TAF1L,Asterisk
607799,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 17; ZDHHC17,Asterisk
607800,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 12; ABCA12",Asterisk
607801,MOVED TO 606072,Caret
607802,CYCLIN M1; CNNM1,Asterisk
607803,CYCLIN M2; CNNM2,Asterisk
607804,CYCLIN M3; CNNM3,Asterisk
607805,CYCLIN M4; CNNM4,Asterisk
607806,OTOPETRIN 1; OTOP1,Asterisk
607807,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 13; ABCA13",Asterisk
607808,NK2 HOMEOBOX 4; NKX2-4,Asterisk
607809,ACETYL-CoA ACETYLTRANSFERASE 1; ACAT1,Asterisk
607810,RADICAL S-ADENOSYL METHIONINE DOMAIN-CONTAINING PROTEIN 2; RSAD2,Asterisk
607811,p21-ACTIVATED KINASE- AND PHOSPHOLIPASE C-INTERACTING PROTEIN 1; PAK1IP1,Asterisk
607812,CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD,Number Sign
607813,PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 4; PLPPR4,Asterisk
607814,REGULATOR OF G PROTEIN SIGNALING 9-BINDING PROTEIN; RGS9BP,Asterisk
607815,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1B; ANKS1B,Asterisk
607816,POLYCOMB GROUP RING FINGER PROTEIN 6; PCGF6,Asterisk
607817,"VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, B; VPS13B",Asterisk
607818,ZINC FINGER PROTEIN 365; ZNF365,Asterisk
607819,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 5; SLC30A5",Asterisk
607820,"HOOK, DROSOPHILA, HOMOLOG OF, 1; HOOK1",Asterisk
607821,"DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37",Number Sign
607822,ALZHEIMER DISEASE 3; AD,Number Sign
607823,HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS,Number Sign
607824,"HOOK, DROSOPHILA, HOMOLOG OF, 2; HOOK2",Asterisk
607825,"HOOK, DROSOPHILA, HOMOLOG OF, 3; HOOK3",Asterisk
607826,ADENOSYLHOMOCYSTEINASE-LIKE 2; AHCYL1,Asterisk
607827,OTOPETRIN 2; OTOP2,Asterisk
607828,OTOPETRIN 3; OTOP3,Asterisk
607829,MITRAL VALVE PROLAPSE 2; MVP2,Number Sign
607830,FRAS1 GENE; FRAS1,Asterisk
607831,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K",Number Sign
607832,"FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3",Number Sign
607833,TACHYKININ 4; TAC4,Asterisk
607834,ANXIETY,Percent
607835,"SPLICING FACTOR 3B, 14-KD SUBUNIT",Asterisk
607836,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1",Number Sign
607837,CLN8 GENE; CLN8,Asterisk
607838,"N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, GAMMA SUBUNIT; GNPTG",Asterisk
607839,GLYCOGEN BRANCHING ENZYME; GBE1,Asterisk
607840,"N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS; GNPTAB",Asterisk
607841,"DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48",Percent
607842,"AURAL ATRESIA, CONGENITAL; CAA",Number Sign
607843,PKHD1-LIKE 1; PKHD1L1,Asterisk
607844,LEM DOMAIN-CONTAINING PROTEIN 3; LEMD3,Asterisk
607845,EXPORTIN 5; XPO5,Asterisk
607846,METHYLTRANSFERASE-LIKE 2; METTL2,Asterisk
607847,"NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS",Number Sign
607848,RAB-INTERACTING LYSOSOMAL PROTEIN; RILP,Asterisk
607849,RETINOL DEHYDROGENASE 11; RDH11,Asterisk
607850,OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3,Number Sign
607851,"NAKED CUTICLE, DROSOPHILA, HOMOLOG OF, 1; NKD1",Asterisk
607852,"NAKED CUTICLE, DROSOPHILA, HOMOLOG OF, 2; NKD2",Asterisk
607853,PANIC DISORDER 2,Percent
607854,BESTROPHIN 1; BEST1,Asterisk
607855,"MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A",Number Sign
607856,CINGULIN-LIKE 1; CGNL1,Asterisk
607857,"PSORIASIS 9, SUSCEPTIBILITY TO; PSORS9",Percent
607858,PRESENILIN-ASSOCIATED RHOMBOID-LIKE PROTEIN; PARL,Asterisk
607859,"ANGIOMA, TUFTED",
607860,YY1 ASSOCIATED PROTEIN 1; YY1AP1,Asterisk
607861,"DAPPER, ANTAGONIST OF BETA-CATENIN, 1; DACT1",Asterisk
607862,"DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 1; DIRAS1",Asterisk
607863,"DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 2; DIRAS2",Asterisk
607864,CAUDAL DUPLICATION ANOMALY,Number Sign
607865,"SET DOMAIN PROTEIN, BIFURCATED, 2; SETDB2",Asterisk
607866,SPRY DOMAIN-CONTAINING PROTEIN 7; SPRYD7,Asterisk
607867,RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 1; RCBTB1,Asterisk
607868,TRIPARTITE MOTIF-CONTAINING PROTEIN 11; TRIM11,Asterisk
607869,"UNC5, C. ELEGANS, HOMOLOG OF, A; UNC5A",Asterisk
607870,"UNC5, C. ELEGANS, HOMOLOG OF, B; UNC5B",Asterisk
607871,F-BOX ONLY PROTEIN 11; FBXO11,Asterisk
607872,CHROMOSOME 1p36 DELETION SYNDROME,Number Sign
607873,"SCAVENGER RECEPTOR CLASS F, MEMBER 1; SCARF1",Asterisk
607874,ZINC FINGER PROTEIN 444; ZNF444,Asterisk
607875,INOSITOL POLYPHOSPHATE-5-PHOSPHATASE K; INPP5K,Asterisk
607876,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2",Number Sign
607877,OTOSPIRALIN,Asterisk
607878,NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; NNT,Asterisk
607879,EXOCYST COMPLEX COMPONENT 1; EXOC1,Asterisk
607880,EXOCYST COMPLEX COMPONENT 6B; EXOC6B,Asterisk
607881,SIGNAL-TRANSDUCING ADAPTOR PROTEIN 2,Asterisk
607882,"SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 2; SLC52A2",Asterisk
607883,"SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 1; SLC52A1",Asterisk
607884,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 1; CMTM1,Asterisk
607885,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 2; CMTM2,Asterisk
607886,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 3; CMTM3,Asterisk
607887,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 4; CMTM4,Asterisk
607888,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 5; CMTM5,Asterisk
607889,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 6; CMTM6,Asterisk
607890,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 7; CMTM7,Asterisk
607891,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 8; CMTM8,Asterisk
607892,DESMOGLEIN 4; DSG4,Asterisk
607893,"OVARIAN CANCER, SUSCEPTIBILITY TO, 1; OVCAS1",Percent
607894,POLYCYSTIN 1-LIKE 2; PKD1L2,Asterisk
607895,POLYCYSTIN 1-LIKE 3; PKD1L3,Asterisk
607896,OVARIAN CANCER-ASSOCIATED GENE 2,Asterisk
607897,"MUSASHI, DROSOPHILA, HOMOLOG OF, 2; MSI2",Asterisk
607898,"TRIBBLES, DROSOPHILA, HOMOLOG OF, 3; TRIB3",Asterisk
607899,WT1 ANTISENSE RNA; WT1AS,Asterisk
607900,FERMITIN FAMILY (DROSOPHILA) HOMOLOG 1; FERMT1,Asterisk
607901,FERMITIN FAMILY (DROSOPHILA) HOMOLOG 3; FERMT3,Asterisk
607902,SNURPORTIN 1; SNUPN,Asterisk
607903,HYPOTRICHOSIS 6; HYPT6,Number Sign
607904,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1H SUBUNIT; CACNA1H",Asterisk
607905,"ALG2, S. CEREVISIAE, HOMOLOG OF; ALG2",Asterisk
607906,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I",Number Sign
607907,DERMATOFIBROSARCOMA PROTUBERANS; DFSP,Number Sign
607908,LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 2; LIMS2,Asterisk
607909,ANTIZYME INHIBITOR 1; AZIN1,Asterisk
607910,KINESIN FAMILY MEMBER 9; KIF9,Asterisk
607911,EPM2A-INTERACTING PROTEIN 1; EPM2AIP1,Asterisk
607912,SELENOPROTEIN T; SELENOT,Asterisk
607913,GLUTATHIONE PEROXIDASE 6; GPX6,Asterisk
607914,SELENOPROTEIN H; SELENOH,Asterisk
607915,SELENOPROTEIN I; SELENOI,Asterisk
607916,SELENOPROTEIN K; SELENOK,Asterisk
607917,SELENOPROTEIN O; SELENOO,Asterisk
607918,SELENOPROTEIN S; SELENOS,Asterisk
607919,SELENOPROTEIN V; SELENOV,Asterisk
607920,MOVED TO 159001,Caret
607921,RETINITIS PIGMENTOSA 30; RP30,Number Sign
607922,"ALPHA-1,4-GALACTOSYLTRANSFERASE; A4GALT",Asterisk
607923,"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 91-KD; SNAP91",Asterisk
607924,METASTASIS-ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MALAT1,Asterisk
607925,B- AND T-LYMPHOCYTE ATTENUATOR; BTLA,Asterisk
607926,HOST CELL FACTOR C2; HCFC2,Asterisk
607927,ANKYRIN REPEATS- AND FYVE DOMAIN-CONTAINING PROTEIN 1; ANKFY1,Asterisk
607928,WHIRLIN; WHRN,Asterisk
607929,CCM2 GENE; CCM2,Asterisk
607930,CYTOKINE-LIKE PROTEIN 1; CYTL1,Asterisk
607931,ATAXIN 2-LIKE; ATXN2L,Asterisk
607932,"MICROPHTHALMIA, SYNDROMIC 6; MCOPS6",Number Sign
607933,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 11; SLC7A11",Asterisk
607934,"PEPTIDYLARGININE DEIMINASE, TYPE I; PADI1",Asterisk
607935,"PEPTIDYLARGININE DEIMINASE, TYPE II; PADI2",Asterisk
607936,PEELING SKIN SYNDROME 4; PSS4,Number Sign
607937,HOMEOBOX TRANSCRIPTION FACTOR NANOG; NANOG,Asterisk
607938,NEUROTRIMIN; NTM,Asterisk
607939,SULFATASE-MODIFYING FACTOR 1; SUMF1,Asterisk
607940,SULFATASE-MODIFYING FACTOR 2; SUMF2,Asterisk
607941,ATRIAL SEPTAL DEFECT 2; ASD2,Number Sign
607942,PHOSPHOINOSITIDE 3-KINASE ADAPTOR PROTEIN 1; PIK3AP1,Asterisk
607943,RAS p21 PROTEIN ACTIVATOR 4; RASA4,Asterisk
607944,SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI,Number Sign
607945,ADIPONECTIN RECEPTOR 1; ADIPOR1,Asterisk
607946,ADIPONECTIN RECEPTOR 2; ADIPOR2,Asterisk
607947,POTASSIUM CHANNEL REGULATOR; KCNRG,Asterisk
607948,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",Number Sign
607949,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1",Percent
607950,TESTIS-SPECIFIC PROTEASE 50,Asterisk
607951,"CENTROSOMAL PROTEIN, 57-KD; CEP57",Asterisk
607952,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 11; SLC6A11",Asterisk
607953,"NEURONAL PROTEIN, 25-KD, RAT, HOMOLOG OF",Asterisk
607954,RAN GUANINE NUCLEOTIDE RELEASE FACTOR,Asterisk
607955,STERILE ALPHA MOTIFS- AND SH3 DOMAIN-CONTAINING PROTEIN 1; SASH1,Asterisk
607956,MEDIATOR COMPLEX SUBUNIT 8; MED8,Asterisk
607957,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I-DELTA; CAMK1D,Asterisk
607958,SYNTAXIN-BINDING PROTEIN 6; STXBP6,Asterisk
607959,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 10; SLC7A10",Asterisk
607960,DEAH BOX POLYPEPTIDE 32; DHX32,Asterisk
607961,SEMAPHORIN 7A; SEMA7A,Asterisk
607962,MICRO RNA 23A; MIR23A,Asterisk
607963,METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 1; MBD3L1,Asterisk
607964,METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 2; MBD3L2,Asterisk
607965,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1; SLEN1",Percent
607966,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2; SLEN2",Percent
607967,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3; SLEN3",Percent
607968,PARATHYROID HORMONE-RESPONSIVE B1 GENE,Asterisk
607969,CDC-LIKE KINASE 4; CLK4,Asterisk
607970,G PROTEIN-COUPLED RECEPTOR 135; GPR135,Asterisk
607971,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 15; SLC6A15",Asterisk
607972,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 16; SLC6A16",Asterisk
607973,NEUROPILIN- AND TOLLOID-LIKE 1; NETO1,Asterisk
607974,NEUROPILIN- AND TOLLOID-LIKE 2; NETO2,Asterisk
607975,OXIDATIVE STRESS-INDUCED GROWTH INHIBITOR 1; OSGIN1,Asterisk
607976,"CYTOCHROME c OXIDASE, SUBUNIT 4I2; COX4I2",Asterisk
607977,"HEADCASE, DROSOPHILA, HOMOLOG OF; HECA",Asterisk
607978,"SAM DOMAIN, SH3 DOMAIN, AND NUCLEAR LOCALIZATION SIGNALS 1; SAMSN1",Asterisk
607979,SERINE HYDROLASE-LIKE; SERHL,Asterisk
607980,"TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 7, YEAST, HOMOLOG OF; TOMM7",Asterisk
607981,NEGATIVE REGULATOR OF UBIQUITIN-LIKE PROTEINS 1; NUB1,Asterisk
607982,SCY1-LIKE 1; SCYL1,Asterisk
607983,"GOLGIN, RAB6-INTERACTING; GORAB",Asterisk
607984,"SPROUTY, DROSOPHILA, HOMOLOG OF, 4; SPRY4",Asterisk
607985,N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N-ACETYLGLUCOSAMINIDASE; NAGPA,Asterisk
607986,S100 CALCIUM-BINDING PROTEIN A14; S100A14,Asterisk
607987,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 10; DNAJC10",Asterisk
607988,"SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 2; SPOCK2",Asterisk
607989,"SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 3; SPOCK3",Asterisk
607990,UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 1; UHRF1,Asterisk
607991,"SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A3; SLC8A3",Asterisk
607992,SURP AND G-PATCH DOMAINS-CONTAINING PROTEIN 1; SUGP1,Asterisk
607993,SURP AND G-PATCH DOMAINS-CONTAINING PROTEIN 2; SUGP2,Asterisk
607994,"5-PRIME,3-PRIME-EXORIBONUCLEASE 1; XRN1",Asterisk
607995,"UNC93, C. ELEGANS, HOMOLOG OF, A; UNC93A",Asterisk
607996,PREPRONEUROPEPTIDE B,Asterisk
607997,NEUROPEPTIDE W; NPW,Asterisk
607998,TRIPEPTIDYL PEPTIDASE I; TPP1,Asterisk
607999,ASH1-LIKE; ASH1L,Asterisk
608000,"N-ALPHA-ACETYLTRANSFERASE 15, NatA AUXILIARY SUBUNIT; NAA15",Asterisk
608001,MELANOMA INHIBITORY ACTIVITY PROTEIN 2; MIA2,Asterisk
608002,NEPHROCYSTIN 3; NPHP3,Asterisk
608003,HOMEODOMAIN-INTERACTING PROTEIN KINASE 1; HIPK1,Asterisk
608004,"NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, ZETA; NFKBIZ",Asterisk
608005,"SIL1, S. CEREVISIAE, HOMOLOG OF; SIL1",Asterisk
608006,LEIOMODIN 2; LMOD2,Asterisk
608007,PLECKSTRIN 2; PLEK2,Asterisk
608008,ANNEXIN A10; ANXA10,Asterisk
608009,ADENYLATE KINASE 5; AK5,Asterisk
608010,NPC1-LIKE 1; NPC1L1,Asterisk
608011,GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3; GNL3,Asterisk
608012,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 2; PDIA2",Asterisk
608013,"GAUCHER DISEASE, PERINATAL LETHAL",Number Sign
608014,HEAT-SHOCK 22-KD PROTEIN 8; HSPB8,Asterisk
608015,TSUKUSHIN; TSKU,Asterisk
608016,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 8; CHCHD8,Asterisk
608017,"FAMILY WITH SEQUENCE SIMILARITY 162, MEMBER A; FAM162A",Asterisk
608018,PANCREASIN,Asterisk
608019,TNFAIP3-INTERACTING PROTEIN 3; TNIP3,Asterisk
608020,NUCLEOBINDIN 2; NUCB2,Asterisk
608021,"WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 1; WFIKKN1",Asterisk
608022,DIAPHANOSPONDYLODYSOSTOSIS,Number Sign
608023,DEAD/H BOX 56; DDX56,Asterisk
608024,"PEROXISOMAL D3,D2-ENOYL-CoA ISOMERASE; PECI",Asterisk
608025,NEUROBLASTOMA-AMPLIFIED SEQUENCE; NBAS,Asterisk
608026,HYPERTENSIVE NEPHROPATHY; HNP1,Percent
608027,"PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3",Number Sign
608028,THAI SYMPHALANGISM SYNDROME,
608029,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6; SCAR6",Percent
608030,AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6,Number Sign
608031,AMYOTROPHIC LATERAL SCLEROSIS 7; ALS7,Percent
608032,MOVED TO 127500,Caret
608033,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3",Number Sign
608034,ASPARTOACYLASE; ASPA,Asterisk
608035,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4; CMM4",Percent
608036,"DIABETES MELLITUS, NONINSULIN-DEPENDENT, 4",Percent
608037,CHONDROITIN POLYMERIZING FACTOR 2; CHPF2,Asterisk
608038,p21 PROTEIN-ACTIVATED KINASE 7; PAK7,Asterisk
608039,NYD-SP16,Asterisk
608040,"INTRAFLAGELLAR TRANSPORT 74, CHLAMYDOMONAS, HOMOLOG OF; IFT74",Asterisk
608041,ANTHRAX TOXIN RECEPTOR 2; ANTXR2,Asterisk
608042,SYNAPTOTAGMIN-LIKE 1; SYTL1,Asterisk
608043,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 10; GALNT10,Asterisk
608044,"SOLUTE CARRIER FAMILY 5 (IODIDE TRANSPORTER), MEMBER 8; SLC5A8",Asterisk
608045,REPRESSOR OF TELOMERASE EXPRESSION 1,Percent
608046,SYNOVIAL APOPTOSIS INHIBITOR 1; SYVN1,Asterisk
608047,UBIQUITIN-PROTEIN LIGASE E3B; UBE3B,Asterisk
608048,"SNF2, LINKER HISTONE, PHD FINGER, RING FINGER, AND HELICASE DOMAINS-CONTAINING PROTEIN; SHPRH",Asterisk
608049,"AUTISM, SUSCEPTIBILITY TO, 3; AUTS3",Percent
608050,TORSIN 1B; TOR1B,Asterisk
608051,"MACULAR DYSTROPHY, RETINAL, 2; MCDR2",Number Sign
608052,TORSIN 2A; TOR2A,Asterisk
608053,"ELECTRON TRANSFER FLAVOPROTEIN, ALPHA POLYPEPTIDE; ETFA",Asterisk
608054,"CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 7; CYP2A7",Asterisk
608055,"CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 13; CYP2A13",Asterisk
608056,MOVED TO 151660,Caret
608057,DEOXYRIBONUCLEASE II BETA; DNASE2B,Asterisk
608058,"GLUCOSE-6-PHOSPHATASE, CATALYTIC, 2; G6PC2",Asterisk
608059,"HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 7; HES7",Asterisk
608060,"HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 4",Asterisk
608061,"TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40, YEAST, HOMOLOG OF; TOMM40",Asterisk
608062,DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 1; DCDC1,Asterisk
608063,"BILE AND PANCREATIC DUCTS, COMPLETE ABSENCE OF",
608064,KELCH-LIKE 5; KLHL5,Asterisk
608065,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 4; SLC38A4",Asterisk
608066,SCAFFOLD ATTACHMENT FACTOR B2; SAFB2,Asterisk
608067,RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 2; RFWD2,Asterisk
608068,"NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE",Percent
608069,ERBB RECEPTOR FEEDBACK INHIBITOR 1; ERRFI1,Asterisk
608070,"HOMOCYSTEINE- AND ENDOPLASMIC RETICULUM STRESS-INDUCIBLE PROTEIN, UBIQUITIN-LIKE DOMAIN-CONTAINING, 1; HERPUD1",Asterisk
608071,F-BOX AND WD40 DOMAIN PROTEIN 4; FBXW4,Asterisk
608072,NHL REPEAT-CONTAINING 1 GENE; NHLRC1,Asterisk
608073,"NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 2; NPM2",Asterisk
608074,PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN; PDCD6IP,Asterisk
608075,"PHOSPHOLIPASE C, ZETA-1; PLCZ1",Asterisk
608076,"TYROSINE KINASE, NONRECEPTOR, 1; TNK1",Asterisk
608077,PURINERGIC RECEPTOR P2X-LIKE 1; P2RXL1,Asterisk
608078,SCHIZOPHRENIA 11,Percent
608079,"ELAC, E. COLI, HOMOLOG OF, 1; ELAC1",Asterisk
608080,MAESTRO; MRO,Asterisk
608081,SYNAPTOTAGMIN 15; SYT15,Asterisk
608082,YIPPEE-LIKE 1; YPEL1,Asterisk
608083,APOLIPOPROTEIN C-II; APOC2,Asterisk
608084,"GTPase, IMAP FAMILY, MEMBER 1; GIMAP1",Asterisk
608085,"GTPase, IMAP FAMILY, MEMBER 2; GIMAP2",Asterisk
608086,"GTPase, IMAP FAMILY, MEMBER 5; GIMAP5",Asterisk
608087,"GTPase, IMAP FAMILY, MEMBER 4; GIMAP4",Asterisk
608088,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX",Percent
608089,ENDOMETRIAL CANCER,Number Sign
608090,MLX-INTERACTING PROTEIN; MLXIP,Asterisk
608091,JOUBERT SYNDROME 2; JBTS2,Number Sign
608092,"PALLADIN, MOUSE, HOMOLOG OF; PALLD",Asterisk
608093,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J",Number Sign
608094,"SOLUTE CARRIER FAMILY 37 (SUGAR-PHOSPHATE TRANSPORTER), MEMBER 1; SLC37A1",Asterisk
608095,SODIUM CHANNEL MODIFIER 1; SCNM1,Asterisk
608096,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2",Percent
608097,"PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM",Number Sign
608098,"HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5p ANOMALIES",Percent
608099,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3; LGMDR3",Number Sign
608100,"NFU1, S. CEREVISIAE, HOMOLOG OF; NFU1",Asterisk
608101,SPERMATID-SPECIFIC LINKER HISTONE H1-LIKE PROTEIN,Asterisk
608102,CLN5 GENE; CLN5,Asterisk
608103,"ALG8, S. CEREVISIAE, HOMOLOG OF; ALG8",Asterisk
608104,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H",Number Sign
608105,"EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC",Percent
608106,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5",Number Sign
608107,FAMILIAL MEDITERRANEAN FEVER GENE; MEFV,Asterisk
608108,CRANIOFACIAL DEVELOPMENT PROTEIN 1; CFDP1,Asterisk
608109,PSEUDOURIDINE SYNTHASE 1; PUS1,Asterisk
608110,p21 PROTEIN-ACTIVATED KINASE 6; PAK6,Asterisk
608111,FANCL GENE; FANCL,Asterisk
608112,"TRAFFICKING PROTEIN, KINESIN-BINDING 1; TRAK1",Asterisk
608113,"SARCOGLYCAN, ZETA; SGCZ",Asterisk
608114,"CENTAURIN, ALPHA-1; CENTA1",Asterisk
608115,OVARIAN HYPERSTIMULATION SYNDROME; OHSS,Number Sign
608116,HEDGEHOG ACYLTRANSFERASE-LIKE PROTEIN; HHATL,Asterisk
608117,PHOSPHODIESTERASE 4D-INTERACTING PROTEIN; PDE4DIP,Asterisk
608118,"ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD",Number Sign
608119,HOMEODOMAIN LEUCINE ZIPPER-CONTAINING FACTOR,Asterisk
608120,"PARVIN, ALPHA; PARVA",Asterisk
608121,"PARVIN, BETA; PARVB",Asterisk
608122,"PARVIN, GAMMA; PARVG",Asterisk
608123,ACYL-CoA THIOESTERASE 8; ACOT8,Asterisk
608124,XYLOSYLTRANSFERASE 1; XYLT1,Asterisk
608125,XYLOSYLTRANSFERASE 2; XYLT2,Asterisk
608126,"ACIDIC NUCLEOPLASMIC DNA-BINDING PROTEIN 1, XENOPUS, HOMOLOG OF",Asterisk
608127,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 4; PBX4,Asterisk
608128,MOVED TO 604605,Caret
608129,UBIQUITIN-ASSOCIATED DOMAIN-CONTAINING PROTEIN 1; UBAC1,Asterisk
608130,"NUAK FAMILY, SNF1-LIKE KINASE, 1; NUAK1",Asterisk
608131,"NUAK FAMILY, SNF1-LIKE KINASE, 2; NUAK2",Asterisk
608132,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 8; TTC8,Asterisk
608133,RETINITIS PIGMENTOSA 7; RP7,Number Sign
608134,PARALEMMIN; PALM,Asterisk
608135,ASPORIN; ASPN,Asterisk
608136,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10; ARHGEF10,Asterisk
608137,NMDA RECEPTOR SYNAPTONUCLEAR SIGNALING AND NEURONAL MIGRATION FACTOR; NSMF,Asterisk
608138,PROGRAMMED CELL DEATH 7; PDCD7,Asterisk
608139,CENTROMERE PROTEIN V; CENPV,Asterisk
608140,"NUCLEOPORIN, 35-KD; NUP35",Asterisk
608141,"NUCLEOPORIN, 43-KD; NUP43",Asterisk
608142,"HSC20, E. COLI, HOMOLOG OF",Asterisk
608143,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 6; AGPAT6,Asterisk
608144,SAM POINTED DOMAIN-CONTAINING ETS TRANSCRIPTION FACTOR; SPDEF,Asterisk
608145,NONIMPRINTED GENE IN PRADER-WILLI SYNDROME/ANGELMAN SYNDROME CHROMOSOME REGION 1; NIPA1,Asterisk
608146,NONIMPRINTED GENE IN PRADER-WILLI SYNDROME/ANGELMAN SYNDROME CHROMOSOME REGION 2; NIPA2,Asterisk
608147,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 5; TUBGCP5,Asterisk
608148,SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2; SATB2,Asterisk
608149,KAGAMI-OGATA SYNDROME,Number Sign
608150,PERIPHILIN 1; PPHLN1,Asterisk
608151,WD REPEAT-CONTAINING PROTEIN 19; WDR19,Asterisk
608152,PROSTAGLANDIN E SYNTHASE 2; PTGES2,Asterisk
608153,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14A; PPP1R14A",Asterisk
608154,"LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES",Percent
608155,SYNAPTOPODIN; SYNPO,Asterisk
608156,NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS,Number Sign
608157,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 2; SLC25A2",Asterisk
608158,CoQ-RESPONSIVE OXPHOS DEFICIENCY,Percent
608159,"PROTEASE, SERINE, 21; PRSS21",Asterisk
608160,SRY-BOX 9; SOX9,Asterisk
608161,"MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3",Number Sign
608162,V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1; VTCN1,Asterisk
608163,EXOCYST COMPLEX COMPONENT 7; EXOC7,Asterisk
608164,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 1; KCNV1",Asterisk
608165,PTB DOMAIN-CONTAINING ENGULFMENT ADAPTOR PROTEIN 1; GULP1,Asterisk
608166,SEMAPHORIN 3E; SEMA3E,Asterisk
608167,"POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 1; KCNT1",Asterisk
608168,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 6; KCNH6",Asterisk
608169,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 7; KCNH7",Asterisk
608170,DEAD/H BOX 41; DDX41,Asterisk
608171,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 4; CACNA2D4",Asterisk
608172,DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; DHDDS,Asterisk
608173,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1",Percent
608174,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2",Percent
608175,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3",Number Sign
608176,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4",Percent
608177,EXOSTOSIN GLYCOSYLTRANSFERASE 1; EXT1,Asterisk
608178,LEUCINE ZIPPER PROTEIN 2; LUZP2,Asterisk
608179,CAYTAXIN; ATCAY,Asterisk
608180,SYNPOLYDACTYLY 2; SPD2,Number Sign
608181,"ACIDIC CLUSTER PROTEIN, 33-KD; ACP33",Asterisk
608182,POTASSIUM CHANNEL-INTERACTING PROTEIN 4,Asterisk
608183,CHONDROITIN SULFATE SYNTHASE 1; CHSY1,Asterisk
608184,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 4; HIGM4",
608185,EXOCYST COMPLEX COMPONENT 4; EXOC4,Asterisk
608186,EXOCYST COMPLEX COMPONENT 3; EXOC3,Asterisk
608187,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 8; MCM8,Asterisk
608188,CARDIOLIPIN SYNTHASE 1; CRLS1,Asterisk
608189,TROPICAL CALCIFIC PANCREATITIS,Number Sign
608190,N-ACETYLTRANSFERASE 8B; NAT8B,Asterisk
608191,RB-ASSOCIATED KRAB REPRESSOR,Asterisk
608192,SCY1-LIKE PROTEIN 3; SCYL3,Asterisk
608193,"REC8, S. POMBE, HOMOLOG OF; REC8L1",Asterisk
608194,CONE-ROD DYSTROPHY 13; CORD13,Number Sign
608195,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 1; LRRC1,Asterisk
608196,WERNER HELICASE-INTERACTING PROTEIN 1; WRNIP1,Asterisk
608197,PEPTIDOGLYCAN RECOGNITION PROTEIN 3; PGLYRP3,Asterisk
608198,PEPTIDOGLYCAN RECOGNITION PROTEIN 4; PGLYRP4,Asterisk
608199,PEPTIDOGLYCAN RECOGNITION PROTEIN 2; PGLYRP2,Asterisk
608200,CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1; CDK5RAP1,Asterisk
608201,CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 2; CDK5RAP2,Asterisk
608202,CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 3; CDK5RAP3,Asterisk
608203,NEUTROPHIL IMMUNODEFICIENCY SYNDROME,Number Sign
608204,"UNC93, C. ELEGANS, HOMOLOG OF, B1; UNC93B1",Asterisk
608205,MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE; MECR,Asterisk
608206,SH3 DOMAIN AND TETRATRICOPEPTIDE REPEAT DOMAIN 2; SH3TC2,Asterisk
608207,"KALA-AZAR, SUSCEPTIBILITY TO, 1; KAZA1",Percent
608208,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 4; MARCH4,Asterisk
608209,DIPEPTIDYL PEPTIDASE X; DPP10,Asterisk
608210,EXOSTOSIN GLYCOSYLTRANSFERASE 2; EXT2,Asterisk
608211,KIDNEY-ASSOCIATED ANTIGEN 1; KAAG1,Asterisk
608212,"IMMUNITY-RELATED GTPase FAMILY, M; IRGM",Asterisk
608213,CELL CYCLE EXIT AND NEURONAL DIFFERENTIATION 1; CEND1,Asterisk
608214,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, BETA SUBUNIT; SCN3B",Asterisk
608215,LIM HOMEOBOX GENE 6; LHX6,Asterisk
608216,COMM DOMAIN-CONTAINING PROTEIN 5; COMMD5,Asterisk
608217,"SEIZURES, BENIGN FAMILIAL NEONATAL, 3; BFNS3",Percent
608218,"KERATIN 20, TYPE I; KRT20",Asterisk
608219,"DEAFNESS, AUTOSOMAL RECESSIVE 38; DFNB38",Percent
608220,"SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE; SPG25",Percent
608221,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE-LIKE; MASTL,Asterisk
608222,ADENYLOSUCCINATE LYASE; ADSL,Asterisk
608223,ASPIRIN RESISTANCE,
608224,"DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41",Number Sign
608225,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14; GALNT14,Asterisk
608226,"NANOS, DROSOPHILA, HOMOLOG OF, 1; NANOS1",Asterisk
608227,"CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL NEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION",
608228,"NANOS, DROSOPHILA, HOMOLOG OF, 2; NANOS2",Asterisk
608229,"NANOS, DROSOPHILA, HOMOLOG OF, 3; NANOS3",Asterisk
608230,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1I SUBUNIT; CACNA1I",Asterisk
608231,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 8; RASSF8",Asterisk
608232,"LEUKEMIA, CHRONIC MYELOID; CML",Number Sign
608233,HERMANSKY-PUDLAK SYNDROME 2; HPS2,Number Sign
608234,GALACTOSE-3-O-SULFOTRANSFERASE 3; GAL3ST3,Asterisk
608235,GALACTOSE-3-O-SULFOTRANSFERASE 4; GAL3ST4,Asterisk
608236,"SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV",Number Sign
608237,GALACTOSE-3-O-SULFOTRANSFERASE 2; GAL3ST2,Asterisk
608238,SIGNAL PEPTIDE PEPTIDASE-LIKE 2A; SPPL2A,Asterisk
608239,SIGNAL PEPTIDE PEPTIDASE-LIKE 2B,Asterisk
608240,SIGNAL PEPTIDE PEPTIDASE-LIKE 3,Asterisk
608241,SMAD NUCLEAR INTERACTING PROTEIN 1; SNIP1,Asterisk
608242,HECT DOMAIN AND RCC1-LIKE DOMAIN 5; HERC5,Asterisk
608243,NONSTRUCTURAL MAINTENANCE OF CHROMOSOMES ELEMENT 3 HOMOLOG; NSMCE3,Asterisk
608244,OTOSCLEROSIS 3; OTSC3,Percent
608245,"KERATIN 71, TYPE II; KRT71",Asterisk
608246,"KERATIN 72, TYPE II; KRT72",Asterisk
608247,"KERATIN 73, TYPE II; KRT73",Asterisk
608248,"KERATIN 74, TYPE II; KRT74",Asterisk
608249,CYCLIN B1 INTERACTING PROTEIN 1; CCNB1IP1,Asterisk
608250,"SDS3, YEAST, HOMOLOG OF",Asterisk
608251,"PHOBIA, SPECIFIC",Percent
608252,ACTIN FILAMENT-ASSOCIATED PROTEIN 1; AFAP1,Asterisk
608253,TESTIS-SPECIFIC KINASE SUBSTRATE,Asterisk
608254,PAX TRANSCRIPTION ACTIVATION DOMAIN-INTERACTING PROTEIN 1; PAXIP1,Asterisk
608255,TRAF3-INTERACTING PROTEIN 3; TRAF3IP3,Asterisk
608256,"SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, BETA SUBUNIT; SCN4B",Asterisk
608257,"MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT",
608258,DIPEPTIDYL PEPTIDASE IX; DPP9,Asterisk
608259,INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 3; IGF2BP3,Asterisk
608260,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 8; KCNH8",Asterisk
608261,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 2; SENP2",Asterisk
608262,DISRUPTED IN RENAL CARCINOMA 3; DIRC3,Asterisk
608263,HEAT-SHOCK 27-KD PROTEIN-ASSOCIATED PROTEIN 1; HSPBAP1,Asterisk
608264,"DEAFNESS, AUTOSOMAL RECESSIVE 40; DFNB40",Percent
608265,"DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39",Number Sign
608266,PARATHYROID CARCINOMA,Number Sign
608267,RAS-RELATED GTP-BINDING PROTEIN C; RRAGC,Asterisk
608268,RAS-RELATED GTP-BINDING PROTEIN D; RRAGD,Asterisk
608269,"SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 3; SLC28A3",Asterisk
608270,THREONINE ASPARTASE 1; TASP1,Asterisk
608271,MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1; MACF1,Asterisk
608272,NEURAMINIDASE 1; NEU1,Asterisk
608273,INTERLEUKIN 27; IL27,Asterisk
608274,PROTEIN ARGININE N-METHYLTRANSFERASE 6; PRMT6,Asterisk
608275,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 15; SLC22A15",Asterisk
608276,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 16; SLC22A16",Asterisk
608277,CARBOHYDRATE SULFOTRANSFERASE 15; CHST15,Asterisk
608278,"GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGE JOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLAR ATROPHY",
608279,CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS,
608280,GROWTH ARREST-SPECIFIC 5; GAS5,Asterisk
608281,"SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL AND CENTRAL NERVOUS SYSTEM ABNORMALITIES",
608282,TRACE AMINE-ASSOCIATED RECEPTOR 9; TAAR9,Asterisk
608283,KINESIN FAMILY MEMBER 21A; KIF21A,Asterisk
608284,INTRAMEMBRANE PROTEASE 5,Asterisk
608285,NAD SYNTHETASE 1; NADSYN1,Asterisk
608286,PROTOCADHERIN 10; PCDH10,Asterisk
608287,PROTOCADHERIN 18; PCDH18,Asterisk
608288,INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 1; IGF2BP1,Asterisk
608289,INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 2; IGF2BP2,Asterisk
608290,LELIS SYNDROME,Percent
608291,TUBULIN-TYROSINE LIGASE; TTL,Asterisk
608292,STOMATIN-LIKE PROTEIN 2; STOML2,Asterisk
608293,RHO GTPase-ACTIVATING PROTEIN 17; ARHGAP17,Asterisk
608294,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 6; NME6,Asterisk
608295,"FAMILY WITH SEQUENCE SIMILARITY 107, MEMBER A; FAM107A",Asterisk
608296,"FIBROBLAST GROWTH FACTOR, ACIDIC, INTRACELLULAR BINDING PROTEIN; FIBP",Asterisk
608297,REMOVED FROM DATABASE,Caret
608298,"URB, MOUSE, HOMOLOG OF",Asterisk
608299,RING FINGER PROTEIN 34; RNF34,Asterisk
608300,N-ACETYLGLUTAMATE SYNTHASE; NAGS,Asterisk
608301,"LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 2; LGI2",Asterisk
608302,"LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 3; LGI3",Asterisk
608303,"LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 4; LGI4",Asterisk
608304,CANCER/TESTIS ANTIGEN 3; CTAG3,Asterisk
608305,"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT CITRATE TRANSPORTER), MEMBER 5; SLC13A5",Asterisk
608306,TRANSCRIPTION FACTOR Sp8; SP8,Asterisk
608307,CARBAMOYL PHOSPHATE SYNTHETASE I; CPS1,Plus
608308,ANKYRIN REPEAT AND BTB/POZ DOMAIN CONTAINING 1; ABTB1,Asterisk
608309,PTEN-INDUCED PUTATIVE KINASE 1; PINK1,Asterisk
608310,ARGININOSUCCINATE LYASE; ASL,Asterisk
608311,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL D-ASPARTATE-LIKE 1B; GRINL1B",Asterisk
608312,TWIST NEIGHBOR; TWISTNB,Asterisk
608313,ARGINASE 1; ARG1,Asterisk
608314,SEPTIN 3; SEPT3,Asterisk
608315,ELL-ASSOCIATED FACTOR 1; EAF1,Asterisk
608316,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2",Percent
608317,GRAINYHEAD-LIKE 3; GRHL3,Asterisk
608318,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4",Percent
608319,MOVED TO 605097,Caret
608320,"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1",Number Sign
608321,TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 2; TICAM2,Asterisk
608322,KINESIN FAMILY MEMBER 21B; KIF21B,Asterisk
608323,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC",Number Sign
608324,SMALL INTEGRAL MEMBRANE PROTEIN 3; SMIM3,Asterisk
608325,PHD FINGER PROTEIN 21A; PHF21A,Asterisk
608326,STOMATIN-LIKE PROTEIN 1; STOML1,Asterisk
608327,STOMATIN-LIKE PROTEIN 3; STOML3,Asterisk
608328,WEILL-MARCHESANI SYNDROME 2; WMS2,Number Sign
608329,MYELIN REGULATORY FACTOR; MYRF,Asterisk
608330,"PRECURSOR mRNA-PROCESSING FACTOR 19, S. CEREVISIAE, HOMOLOG OF; PRPF19",Asterisk
608331,"SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 2; SLC36A2",Asterisk
608332,"SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 3; SLC36A3",Asterisk
608333,DOCKING PROTEIN 4; DOK4,Asterisk
608334,DOCKING PROTEIN 5; DOK5,Asterisk
608335,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY O, MEMBER 1; PLEKHO1",Asterisk
608336,"TRANSMEMBRANE DOMAIN PROTEIN REGULATED IN ADIPOCYTES, 40-KD",Asterisk
608337,OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 1; OTUB1,Asterisk
608338,OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 2; OTUB2,Asterisk
608339,SYNTAXIN-BINDING PROTEIN 3; STXBP3,Asterisk
608340,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA",Number Sign
608341,CYTOCHROME b5 REDUCTASE 1; CYB5R1,Asterisk
608342,CYTOCHROME b5 REDUCTASE 2; CYB5R2,Asterisk
608343,CYTOCHROME b5 REDUCTASE 4; CYB5R4,Asterisk
608344,HEAT-SHOCK 27-KD PROTEIN 9,Asterisk
608345,"NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3",Percent
608346,MOVED TO 236670,Caret
608347,DICARBONYL/L-XYLULOSE REDUCTASE; DCXR,Asterisk
608348,"BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, ALPHA POLYPEPTIDE; BCKDHA",Asterisk
608349,HEMATOPOIETIC SH2 DOMAIN-CONTAINING PROTEIN; HSH2D,Asterisk
608350,ENDOMUCIN; EMCN,Asterisk
608351,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 11; IGSF11",Asterisk
608352,ACROSIN-BINDING PROTEIN; ACRBP,Asterisk
608353,ANTIZYME INHIBITOR 2; AZIN2,Asterisk
608354,CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM,Number Sign
608355,PARKES WEBER SYNDROME; PKWS,Number Sign
608356,OUTER DENSE FIBER OF SPERM TAILS 3; ODF3,Asterisk
608357,"SULFOTRANSFERASE FAMILY 1C, MEMBER 4; SULT1C4",Asterisk
608358,"MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA",Number Sign
608359,"SULFOTRANSFERASE FAMILY 4A, MEMBER 1; SULT4A1",Asterisk
608360,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8A; LRRC8A,Asterisk
608361,"SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE; SEDK",Number Sign
608362,STATHMIN-LIKE 3; STMN3,Asterisk
608363,CHROMOSOME 22q11.2 DUPLICATION SYNDROME,Number Sign
608364,LIM DOMAIN AND ACTIN-BINDING PROTEIN 1; LIMA1,Asterisk
608365,T-COMPLEX PROTEIN 10-LIKE; TCP10L,Asterisk
608366,KIAA1199 GENE; KIAA1199,Asterisk
608367,"MYOPIA 17, AUTOSOMAL DOMINANT; MYP17",Percent
608368,"RAD9, S. POMBE, HOMOLOG OF, B; RAD9B",Asterisk
608369,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 13; GALNT13,Asterisk
608370,STEAROYL-CoA DESATURASE 5; SCD5,Asterisk
608371,OROFACIAL CLEFT 4; OFC4,Percent
608372,"DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49",Percent
608373,SYNAPTOGYRIN 4; SYNGR4,Asterisk
608374,HEMOJUVELIN; HJV,Asterisk
608375,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 6; DNAJC6",Asterisk
608376,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 12; DNAJB12",Asterisk
608377,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 1; ARFGAP1,Asterisk
608378,NUCLEAR EXPORT MEDIATOR FACTOR; NEMF,Asterisk
608379,"CHEMOKINE, CC MOTIF, RECEPTOR-LIKE PROTEIN 2; CCRL2",Asterisk
608380,RETINITIS PIGMENTOSA 26; RP26,Number Sign
608381,CERAMIDE KINASE-LIKE; CERKL,Asterisk
608382,"DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 3; DNAJA3",Asterisk
608383,DIHYDROPYRIMIDINASE-LIKE 5; DPYSL5,Asterisk
608384,GASDERMIN C; GSDMC,Asterisk
608385,TENSIN 4; TNS4,Asterisk
608386,TUBEROINFUNDIBULAR PEPTIDE OF 39 AMINO ACIDS,Asterisk
608387,ZINC FINGER PROTEIN 213; ZNF213,Asterisk
608388,EVOLUTIONARILY-CONSERVED SIGNALING INTERMEDIATE IN TOLL PATHWAY; ECSIT,Asterisk
608389,BRANCHIOOTIC SYNDROME 3; BOS3,Number Sign
608390,"MYOTONIA, POTASSIUM-AGGRAVATED",Number Sign
608391,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2; AIS2",Percent
608392,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3; AIS3",Percent
608393,"MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6",Number Sign
608394,"DEAFNESS, AUTOSOMAL DOMINANT 43; DFNA43",Percent
608395,MOVED TO 610217,Caret
608396,"SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 9; SLC9A9",Asterisk
608397,CUB AND SUSHI MULTIPLE DOMAINS 1; CSMD1,Asterisk
608398,CUB AND SUSHI MULTIPLE DOMAINS 2; CSMD2,Asterisk
608399,CUB AND SUSHI MULTIPLE DOMAINS 3; CSMD3,Asterisk
608400,USH2A GENE; USH2A,Asterisk
608401,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4E; MS4A4E",Asterisk
608402,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6E; MS4A6E",Asterisk
608403,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 10; MS4A10",Asterisk
608404,PLATELET GLYCOPROTEIN IV DEFICIENCY,Number Sign
608405,1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; ACCS,Asterisk
608406,"VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY",
608407,DIHYDROPYRIMIDINASE-LIKE 4; DPYSL4,Asterisk
608408,DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 3; DPPA3,Asterisk
608409,NORMAL MUCOSA OF ESOPHAGUS-SPECIFIC GENE 1,Asterisk
608410,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7; BMIQ7,Percent
608411,EXPORTIN 6; XPO6,Asterisk
608412,GC-RICH PROMOTER-BINDING PROTEIN 1; GPBP1,Asterisk
608413,UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 5; UBR5,Asterisk
608414,"PHOSPHOLIPASE C, EPSILON-1; PLCE1",Asterisk
608415,PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS,Number Sign
608416,MATRIX METALLOPROTEINASE 21; MMP21,Asterisk
608417,MATRIX METALLOPROTEINASE 28; MMP28,Asterisk
608418,SEPTIN 8; SEPT8,Asterisk
608419,METHYLMALONYL-CoA EPIMERASE; MCEE,Asterisk
608420,PANNEXIN 1; PANX1,Asterisk
608421,PANNEXIN 2; PANX2,Asterisk
608422,PANNEXIN 3; PANX3,Asterisk
608423,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2",Number Sign
608424,MUCIN 17; MUC17,Asterisk
608425,FRUCTOSAMINE 3-KINASE,Asterisk
608426,MAKORIN 2; MKRN2,Asterisk
608427,PARKIN COREGULATED GENE; PACRG,Asterisk
608428,"CYTOCHROME P450, SUBFAMILY XXVIC, POLYPEPTIDE 1; CYP26C1",Asterisk
608429,CARBOHYDRATE SULFOTRANSFERASE 14; CHST14,Asterisk
608430,TRPC4-ASSOCIATED PROTEIN; TRPC4AP,Asterisk
608431,GTPase-ACTIVATING PROTEIN SH3 DOMAIN-BINDING PROTEIN 1; G3BP1,Asterisk
608432,"CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM",
608433,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 18; ZBTB18,Asterisk
608434,G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN 1; GIT1,Asterisk
608435,MUSCLE RAS VIRAL ONCOGENE HOMOLOG; MRAS,Asterisk
608436,"SULFOTRANSFERASE FAMILY 1B, MEMBER 1; SULT1B1",Asterisk
608437,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4; SLEB4",Percent
608438,TOUSLED-LIKE KINASE 1; TLK1,Asterisk
608439,TOUSLED-LIKE KINASE 2; TLK2,Asterisk
608440,"LACTAMASE, BETA; LACTB",Asterisk
608441,SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 1; SYNE1,Asterisk
608442,SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 2; SYNE2,Asterisk
608443,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3",Number Sign
608444,LYSINE-SPECIFIC METHYLTRANSFERASE 2E; KMT2E,Asterisk
608445,SPEECH-SOUND DISORDER,Percent
608446,"MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO",Number Sign
608447,CAROTID INTIMAL MEDIAL THICKNESS 2,Percent
608448,INFLAMMATORY BOWEL DISEASE 9; IBD9,Percent
608449,POLYPYRIMIDINE TRACT-BINDING PROTEIN 2; PTBP2,Asterisk
608450,B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-EXPRESSED GENE; BLACE,Asterisk
608451,ETHE1 GENE; ETHE1,Asterisk
608452,PLATELET-DERIVED GROWTH FACTOR C; PDGFC,Asterisk
608453,CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE C; CBLC,Asterisk
608454,MOVED TO 267750,Caret
608455,"GLYCOGEN PHOSPHORYLASE, MUSCLE; PYGM",Asterisk
608456,FAMILIAL ADENOMATOUS POLYPOSIS 2; FAP2,Number Sign
608457,CHROMOBOX HOMOLOG 7; CBX7,Asterisk
608458,NEUROCHONDRIN; NCDN,Asterisk
608459,CYCLIN-DEPENDENT KINASE-LIKE 3; CDKL3,Asterisk
608460,ZINC FINGER PROTEIN 276; ZFP276,Asterisk
608461,"COLLAGEN, TYPE XXVII, ALPHA-1; COL27A1",Asterisk
608462,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 8; HSCR8",Percent
608463,APOPTOSIS-ANTAGONIZING TRANSCRIPTION FACTOR; AATF,Asterisk
608464,ANGIOGENIC FACTOR WITH G-PATCH AND FHA DOMAINS 1; AGGF1,Asterisk
608465,SENATAXIN; SETX,Asterisk
608466,ACTIVATOR OF HEAT-SHOCK 90-KD PROTEIN ATPase 1; AHSA1,Asterisk
608467,STONIN 2; STON2,Asterisk
608468,CARBON CATABOLITE REPRESSION 4-LIKE; CCRN4L,Asterisk
608469,DEAD/H BOX 17; DDX17,Asterisk
608470,"CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB",Number Sign
608471,"CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A",Number Sign
608472,"ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 2; ST6GAL2",Asterisk
608473,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 1; ANAPC1",Asterisk
608474,"MYOPIA 5, AUTOSOMAL DOMINANT; MYP5",Percent
608475,3-HYDROXYISOBUTYRATE DEHYDROGENASE; HIBADH,Asterisk
608476,TBK1-BINDING PROTEIN 1; TBKBP1,Asterisk
608477,"ALDO-KETO REDUCTASE FAMILY 7, MEMBER A3; AKR7A3",Asterisk
608478,"ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4",Asterisk
608479,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 7; SLC26A7",Asterisk
608480,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 8; SLC26A8",Asterisk
608481,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 9; SLC26A9",Asterisk
608482,MATRIX METALLOPROTEINASE 25; MMP25,Asterisk
608483,AKT-INTERACTING PROTEIN; AKTIP,Asterisk
608484,"CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA",
608485,TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2; TRAM2,Asterisk
608486,METASTASIS SUPPRESSOR 1; MTSS1,Asterisk
608487,TRIPARTITE MOTIF-CONTAINING PROTEIN 5; TRIM5,Asterisk
608488,SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1,Asterisk
608489,STROMAL ANTIGEN 3; STAG3,Asterisk
608490,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 1; SLC38A1",Asterisk
608491,CYCLIN D-BINDING MYB-LIKE TRANSCRIPTION FACTOR 1; DMTF1,Asterisk
608492,"OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY F, MEMBER 1; OR5F1",Asterisk
608493,"OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY A, MEMBER 1; OR10A1",Asterisk
608494,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY D, MEMBER 2; OR2D2",Asterisk
608495,"OLFACTORY RECEPTOR, FAMILY 6, SUBFAMILY A, MEMBER 2; OR6A2",Asterisk
608496,"OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY I, MEMBER 1; OR5I1",Asterisk
608497,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY F, MEMBER 1; OR2F1",Asterisk
608498,ZONA PELLUCIDA-BINDING PROTEIN; ZPBP,Asterisk
608499,ZONA PELLUCIDA-BINDING PROTEIN 2; ZPBP2,Asterisk
608500,"PRICKLE, DROSOPHILA, HOMOLOG OF, 1; PRICKLE1",Asterisk
608501,"PRICKLE, DROSOPHILA, HOMOLOG OF, 2; PRICKLE2",Asterisk
608502,POLY(rC)-BINDING PROTEIN 3; PCBP3,Asterisk
608503,POLY(rC)-BINDING PROTEIN 4; PCBP4,Asterisk
608504,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 15; ARHGEF15,Asterisk
608505,MOVED TO 225750,Caret
608506,MITOFUSIN 1; MFN1,Asterisk
608507,MITOFUSIN 2; MFN2,Asterisk
608508,"CYTOCHROME b(-245), ALPHA SUBUNIT; CYBA",Asterisk
608509,"ALOPECIA UNIVERSALIS CONGENITA, XY GONADAL DYSGENESIS, AND LARYNGOMALACIA",
608510,SH2 DOMAIN-CONTAINING 1B; SH2D1B,Asterisk
608511,PHYTANOYL-CoA HYDROXYLASE-INTERACTING PROTEIN; PHYHIP,Asterisk
608512,NEUTROPHIL CYTOSOLIC FACTOR 1; NCF1,Asterisk
608513,"RIBONUCLEASE P, RNA COMPONENT H1; RPPH1",Asterisk
608514,ANDROGEN-INDUCED GENE 1; AIG1,Asterisk
608515,NEUTROPHIL CYTOSOLIC FACTOR 2; NCF2,Asterisk
608516,MAJOR DEPRESSIVE DISORDER; MDD,Number Sign
608517,MYOPALLADIN; MYPN,Asterisk
608518,OROFACIODIGITAL SYNDROME VII; OFD7,
608519,F-BOX ONLY PROTEIN 16; FBXO16,Asterisk
608520,MAJOR DEPRESSIVE DISORDER 1,Percent
608521,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 5; LAMTOR5",Asterisk
608522,HEPATITIS B VIRUS X-ASSOCIATED PROTEIN; HBXAP,Asterisk
608523,"DIO3, OPPOSITE STRAND; DIO3OS",Asterisk
608524,INHIBITOR OF GROWTH 4; ING4,Asterisk
608525,INHIBITOR OF GROWTH 5; ING5,Asterisk
608526,"PERIODONTITIS, AGGRESSIVE, 2",Percent
608527,NEURAMINIDASE 4; NEU4,Asterisk
608528,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS U PROTEIN; PIGU,Asterisk
608529,FIBRILLIN 3; FBN3,Asterisk
608530,BTB/POZ DOMAIN-CONTAINING PROTEIN 1; BTBD1,Asterisk
608531,BTB/POZ DOMAIN-CONTAINING PROTEIN 2; BTBD2,Asterisk
608532,NON-SMC CONDENSIN II COMPLEX SUBUNIT G2; NCAPG2,Asterisk
608533,F-BOX ONLY PROTEIN 38; FBXO38,Asterisk
608534,ACTIN-RELATED PROTEIN M1,Asterisk
608535,ACTIN-RELATED PROTEIN T2; ACTRT2,Asterisk
608536,GTP-BINDING PROTEIN 3; GTPBP3,Asterisk
608537,VHL GENE; VHL,Asterisk
608538,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5B; ARID5B,Asterisk
608539,GLIS FAMILY ZINC FINGER PROTEIN 2; GLIS2,Asterisk
608540,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K",Number Sign
608541,"RHO GTPase INVOLVED IN BETA-CATENIN, N-CADHERIN, AND NMDA RECEPTOR SIGNALING",Asterisk
608542,"ANEURYSM, INTRACRANIAL BERRY, 2; ANIB2",Percent
608543,SCHIZOPHRENIA 12,Percent
608544,HISTONE DEACETYLASE 10; HDAC10,Asterisk
608545,LARSEN-LIKE SYNDROME,Percent
608546,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 3; EIF4A3",Asterisk
608547,"VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1; VKORC1",Asterisk
608548,HEMICENTIN; HMCN1,Asterisk
608549,"VACUOLAR PROTEIN SORTING 11, YEAST, HOMOLOG OF; VPS11",Asterisk
608550,"VACUOLAR PROTEIN SORTING 16, YEAST, HOMOLOG OF; VPS16",Asterisk
608551,"VACUOLAR PROTEIN SORTING 18, YEAST, HOMOLOG OF; VPS18",Asterisk
608552,"VACUOLAR PROTEIN SORTING 33, YEAST, HOMOLOG OF, B; VPS33B",Asterisk
608553,LEBER CONGENITAL AMAUROSIS 9; LCA9,Number Sign
608554,NEURONAL PAS DOMAIN PROTEIN 4; NPAS4,Asterisk
608555,METAXIN 2; MTX2,Asterisk
608556,"LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO",Number Sign
608557,"MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2",Percent
608558,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5; BMIQ5,Percent
608559,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6; BMIQ6,Percent
608560,STABILIN 1; STAB1,Asterisk
608561,STABILIN 2; STAB2,Asterisk
608562,"POLYDACTYLY, POSTAXIAL, TYPE A4",Percent
608563,MOVED TO 204650,Caret
608564,G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN 2; GIT2,Asterisk
608565,"DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35",Number Sign
608566,"MUCIN 15, TRANSMEMBRANE; MUC15",Asterisk
608567,SICK SINUS SYNDROME 1; SSS1,Number Sign
608568,"MYOSIN, HEAVY CHAIN 14, NONMUSCLE; MYH14",Asterisk
608569,"CARDIOMYOPATHY, DILATED, 1O; CMD1O",Number Sign
608570,AHNAK NUCLEOPROTEIN 2; AHNAK2,Asterisk
608571,ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY,
608572,BURN-MCKEOWN SYNDROME; BMKS,Number Sign
608573,MOVED TO 605096,Caret
608574,EMSY GENE; EMSY,Asterisk
608575,RETINOL DEHYDROGENASE 8; RDH8,Asterisk
608576,GRAINYHEAD-LIKE 2; GRHL2,Asterisk
608577,CHURCHILL DOMAIN-CONTAINING 1; CHURC1,Asterisk
608578,MOVED TO 243310,Caret
608579,"SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO",Number Sign
608580,"MYOSIN, HEAVY CHAIN 16, SKELETAL MUSCLE, PSEUDOGENE; MYH16",
608581,RP1-LIKE PROTEIN 1; RP1L1,Asterisk
608582,EPIDERMAL GROWTH FACTOR-LIKE 7; EGFL7,Asterisk
608583,"ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1",Percent
608584,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2",Number Sign
608585,"BRACHIAL PALSY, FAMILIAL CONGENITAL",Percent
608586,KERATOCONUS 3; KTCN3,Percent
608587,"LGP1, MOUSE, HOMOLOG OF",Asterisk
608588,DEXH BOX POLYPEPTIDE 58; DHX58,Asterisk
608589,"SLAM FAMILY, MEMBER 9; SLAMF9",Asterisk
608590,MOVED TO 608358,Caret
608591,MOVED TO 614436,Caret
608592,CTD SMALL PHOSPHATASE-LIKE; CTDSPL,Asterisk
608593,COMPLEMENT FACTOR H-RELATED 5; CFHR5,Asterisk
608594,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1",Number Sign
608595,NEUROPEPTIDE S RECEPTOR 1; NPSR1,Asterisk
608596,ASTHMA-ASSOCIATED ALTERNATIVELY SPLICED GENE 1,Asterisk
608597,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 2; NEURL2,Asterisk
608598,CANCER SUSCEPTIBILITY CANDIDATE 2; CASC2,Asterisk
608599,RAB11 FAMILY-INTERACTING PROTEIN 2; RAB11FIP2,Asterisk
608600,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1; FPLD1",Percent
608601,FIBROSIN 1; FBS1,Asterisk
608602,NUCLEAR BODY PROTEIN SP140; SP140,Asterisk
608603,GLIOMEDIN; GLDN,Asterisk
608604,RETINOL-BINDING PROTEIN 7; RBP7,Asterisk
608605,"OLIGOSACCHARYLTRANSFERASE COMPLEX, CATALYTIC SUBUNIT STT3B; STT3B",Asterisk
608606,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER A15; BHLHA15",Asterisk
608607,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 12; NBPF12",Asterisk
608608,PEPTIDYL-PROLYL ISOMERASE A-LIKE PROTEIN 4E; PPIAL4E,Asterisk
608609,CHROMOSOME 1 OPEN READING FRAME 152; C1ORF152,Asterisk
608610,PROGRAMMED CELL DEATH 4; PDCD4,Asterisk
608611,RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY,Number Sign
608612,MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB,Number Sign
608613,TRANSCRIPTION FACTOR Sp6; SP6,Asterisk
608614,"CYTOCHROME P450, FAMILY 4, SUBFAMILY V, POLYPEPTIDE 2; CYP4V2",Asterisk
608615,OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS,Number Sign
608616,OBSCURIN; OBSCN,Asterisk
608617,"FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER B; FAM3B",Asterisk
608618,"FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER C; FAM3C",Asterisk
608619,"FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER D; FAM3D",Asterisk
608620,MOVED TO 605232,Caret
608621,SPERM AUTOANTIGENIC PROTEIN 17; SPA17,Asterisk
608622,"HYPERTENSION, DIASTOLIC, RESISTANCE TO",Number Sign
608623,MOVED TO 276300,Caret
608624,"MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA",
608625,PEPTIDYL-tRNA HYDROLASE 2; PTRH2,Asterisk
608626,STE20-RELATED KINASE ADAPTOR ALPHA; STRADA,Asterisk
608627,AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8,Number Sign
608628,TRANSDUCIN-BETA-LIKE 1 RECEPTOR 1; TBL1XR1,Asterisk
608629,JOUBERT SYNDROME 3; JBTS3,Number Sign
608630,"ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 3; ROBO3",Asterisk
608631,"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2",Percent
608632,MICRO RNA 196A1; MIR196A1,Asterisk
608633,"CASPASE 12, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP12",Asterisk
608634,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B",Number Sign
608635,ARFGAP WITH DUAL PLECKSTRIN HOMOLOGY DOMAINS 2; ADAP2,Asterisk
608636,CHROMOSOME 15q11-q13 DUPLICATION SYNDROME,Number Sign
608637,MOVED TO 143095,Caret
608638,"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1",Percent
608639,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 8; PLEKHA8",Asterisk
608640,ZINC FINGER PROTEIN 461; ZNF461,Asterisk
608641,"DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28",Number Sign
608642,ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 1; ZADH1,Asterisk
608643,AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY,Number Sign
608644,"CILIARY DYSKINESIA, PRIMARY, 3; CILD3",Number Sign
608645,"DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31",Percent
608646,"CILIARY DYSKINESIA, PRIMARY, 4; CILD4",Percent
608647,"CILIARY DYSKINESIA, PRIMARY, 5; CILD5",Number Sign
608648,"SEC63, S. CEREVISIAE, HOMOLOG OF; SEC63",Asterisk
608649,ICHTHYOSIS PREMATURITY SYNDROME; IPS,Number Sign
608650,UNC51-LIKE KINASE 2; ULK2,Asterisk
608651,"ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 1; AGAP1",Asterisk
608652,"DEAFNESS, AUTOSOMAL DOMINANT 47; DFNA47",Percent
608653,"DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32",Number Sign
608654,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5",Number Sign
608655,"GAP JUNCTION PROTEIN, GAMMA-1; GJC1",Asterisk
608656,"PROSTATE CANCER, HEREDITARY, 3",Percent
608657,JUN DIMERIZATION PROTEIN 2; JDP2,Asterisk
608658,"PROSTATE CANCER, HEREDITARY, 4",Percent
608659,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 8; SENP8",Asterisk
608660,INSULIN-INDUCED GENE 2; INSIG2,Asterisk
608661,PODOCAN; PODN,Asterisk
608662,ANOCTAMIN 5; ANO5,Asterisk
608663,ANOCTAMIN 6; ANO6,Asterisk
608664,MOVED TO 210600,Caret
608665,PSMC3-INTERACTING PROTEIN; PSMC3IP,Asterisk
608666,PEROXISOME BIOGENESIS FACTOR 26; PEX26,Asterisk
608667,NIPPED-B-LIKE; NIPBL,Asterisk
608668,ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11; ZMYND11,Asterisk
608669,BASONUCLIN 2; BNC2,Asterisk
608670,ROBIN SEQUENCE WITH DISTINCTIVE FACIAL APPEARANCE AND BRACHYDACTYLY,
608671,DAZ-INTERACTING ZINC FINGER PROTEIN 1; DZIP1,Asterisk
608672,DAZ-INTERACTING ZINC FINGER PROTEIN 3; DZIP3,Asterisk
608673,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L",Number Sign
608674,SH3 DOMAIN PROTEIN 19,Asterisk
608675,FUCOKINASE; FUK,Asterisk
608676,"TAXILIN, ALPHA; TXLNA",Asterisk
608677,"MINDBOMB, DROSOPHILA, HOMOLOG OF, 1; MIB1",Asterisk
608678,INTERLEUKIN 33; IL33,Asterisk
608679,TP53-REGULATING KINASE; TP53RK,Asterisk
608680,TP53RK-BINDING PROTEIN; TPRKB,Asterisk
608681,"SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2",Number Sign
608682,ADRENOMEDULLIN 2; ADM2,Asterisk
608683,CYSTATIN 8; CST8,Asterisk
608684,NINEIN; NIN,Asterisk
608685,STRUCTURAL MAINTENANCE OF CHROMOSOMES 1B; SMC1B,Asterisk
608686,RAB3A-INTERACTING PROTEIN; RAB3IP,Asterisk
608687,SPINOCEREBELLAR ATAXIA 20; SCA20,Number Sign
608688,AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY,Number Sign
608689,MESODERM POSTERIOR BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR 1; MESP1,Asterisk
608690,SSX2-INTERACTING PROTEIN; SSX2IP,Asterisk
608691,MAJOR DEPRESSIVE DISORDER 2,Percent
608692,BASIC LEUCINE ZIPPER NUCLEAR FACTOR 1; BLZF1,Asterisk
608693,GOLGI REASSEMBLY STACKING PROTEIN 2; GORASP2,Asterisk
608694,ZINC FINGER PROTEIN 622; ZNF622,Asterisk
608695,"GLAUCOMA 1, OPEN ANGLE, J; GLC1J",Percent
608696,"GLAUCOMA 1, OPEN ANGLE, K; GLC1K",Percent
608697,"FACTOR IN GERMLINE ALPHA, MOUSE, HOMOLOG OF; FIGLA",Asterisk
608698,"DISCOIDIN, CUB, AND LCCL DOMAIN-CONTAINING PROTEIN 2; DCBLD2",Asterisk
608699,BONE MORPHOGENETIC PROTEIN-BINDING ENDOTHELIAL REGULATOR PROTEIN; BMPER,Asterisk
608700,NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1; NMNAT1,Asterisk
608701,NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; NMNAT2,Asterisk
608702,NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 3; NMNAT3,Asterisk
608703,SPINOCEREBELLAR ATAXIA 25; SCA25,Percent
608704,NICOTINAMIDE RIBOSIDE KINASE 1; NMRK1,Asterisk
608705,"INTEGRIN, BETA-1, BINDING PROTEIN OF, 3; ITGB1BP3",Asterisk
608706,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 4; DNAAF4",Asterisk
608707,CELL ADHESION MOLECULE-RELATED/DOWNREGULATED BY ONCOGENES; CDON,Asterisk
608708,BROTHER OF CDON; BOC,Asterisk
608709,"LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD",Number Sign
608710,GRANULOMATOSIS WITH POLYANGIITIS; GPA,Percent
608711,CTD SMALL PHOSPHATASE 2; CTDSP2,Asterisk
608712,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, T; PTPRT",Asterisk
608713,"CYTOCHROME P450, SUBFAMILY IIR, POLYPEPTIDE 1; CYP2R1",Asterisk
608714,"SYNTROPHIN, GAMMA-1; SNTG1",Asterisk
608715,"SYNTROPHIN, GAMMA-2; SNTG2",Asterisk
608716,"MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5",Number Sign
608717,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 13; LGALS13",Asterisk
608718,KERATIN-ASSOCIATED PROTEIN 13-1; KRTAP13-1,Asterisk
608719,"TR4-ASSOCIATED PROTEIN, 16-KD",Asterisk
608720,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA",
608721,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 2; CAMK2N2,Asterisk
608722,"CAPPING PROTEIN, ALPHA-3; CAPZA3",Asterisk
608723,PHOSPHATASE AND ACTIN REGULATOR 1; PHACTR1,Asterisk
608724,PHOSPHATASE AND ACTIN REGULATOR 2; PHACTR2,Asterisk
608725,PHOSPHATASE AND ACTIN REGULATOR 3; PHACTR3,Asterisk
608726,PHOSPHATASE AND ACTIN REGULATOR 4; PHACTR4,Asterisk
608727,"DE-ETIOLATED 1, ARABIDOPSIS, HOMOLOG OF; DET1",Asterisk
608728,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED",Number Sign
608729,ANGIOTENSIN II RECEPTOR-ASSOCIATED PROTEIN; AGTRAP,Asterisk
608730,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 5; SLC39A5",Asterisk
608731,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 6; SLC39A6",Asterisk
608732,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 8; SLC39A8",Asterisk
608733,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 10; SLC39A10",Asterisk
608734,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 12; SLC39A12",Asterisk
608735,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 13; SLC39A13",Asterisk
608736,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 14; SLC39A14",Asterisk
608737,RAB11 FAMILY-INTERACTING PROTEIN 1; RAB11FIP1,Asterisk
608738,RAB11 FAMILY-INTERACTING PROTEIN 3; RAB11FIP3,Asterisk
608739,EXORIBONUCLEASE 1; ERI1,Asterisk
608740,NFAT ACTIVATING PROTEIN WITH ITAM MOTIF 1; NFAM1,Asterisk
608741,SYNAPTOTAGMIN 11; SYT11,Asterisk
608742,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4",Percent
608743,"JP45, MOUSE, HOMOLOG OF",Asterisk
608744,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 24; SLC25A24",Asterisk
608745,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 25; SLC25A25",Asterisk
608746,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 23; SLC25A23",Asterisk
608747,INSULIN-LIKE GROWTH FACTOR I DEFICIENCY,Number Sign
608748,BONE MORPHOGENETIC PROTEIN 10; BMP10,Asterisk
608749,BROMODOMAIN-CONTAINING PROTEIN 4; BRD4,Asterisk
608750,"ALG3, S. CEREVISIAE, HOMOLOG OF; ALG3",Asterisk
608751,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8",Number Sign
608752,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 5; C1QTNF5,Asterisk
608753,"tRNA SPLICING ENDONUCLEASE 2, S. CEREVISIAE, HOMOLOG OF; TSEN2",Asterisk
608754,"tRNA SPLICING ENDONUCLEASE 34, S. CEREVISIAE, HOMOLOG OF; TSEN34",Asterisk
608755,"tRNA SPLICING ENDONUCLEASE 54, S. CEREVISIAE, HOMOLOG OF; TSEN54",Asterisk
608756,"tRNA SPLICING ENDONUCLEASE 15, S. CEREVISIAE, HOMOLOG OF; TSEN15",Asterisk
608757,"CLEAVAGE AND POLYADENYLATION FACTOR I SUBUNIT 1, YEAST, HOMOLOG OF; CLP1",Asterisk
608758,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10",Number Sign
608759,CYTOGLOBIN; CYGB,Asterisk
608760,"AUTOPHAGY 7, S. CEREVISIAE, HOMOLOG OF; ATG7",Asterisk
608761,"SOLUTE CARRIER FAMILY 5 (CHOLINE TRANSPORTER), MEMBER 7; SLC5A7",Asterisk
608762,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3",Percent
608763,"EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE",
608764,NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NAMPT,Asterisk
608765,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3; IS3",Percent
608766,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1B; LRP1B,Asterisk
608767,"FEM1, C. ELEGANS, HOMOLOG OF, C; FEM1C",Asterisk
608768,SPINOCEREBELLAR ATAXIA 8; SCA8,Number Sign
608769,"PYRUVATE DEHYDROGENASE COMPLEX, COMPONENT X; PDHX",Asterisk
608770,DIHYDROLIPOAMIDE S-ACETYLTRANSFERASE; DLAT,Asterisk
608771,MEDIATOR COMPLEX SUBUNIT 13-LIKE; MED13L,Asterisk
608772,"INVASION INHIBITORY PROTEIN, 45-KD",Asterisk
608773,TUBULIN POLYMERIZATION-PROMOTING PROTEIN; TPPP,Asterisk
608774,ANKYRIN REPEAT- AND KINASE DOMAIN-CONTAINING PROTEIN 1; ANKK1,Asterisk
608775,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 1; HAUS1",Asterisk
608776,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L",Number Sign
608777,PERIOSTIN; POSTN,Asterisk
608778,KELCH-LIKE 10; KLHL10,Asterisk
608779,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E",Number Sign
608780,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 5; GTF2H5",Asterisk
608781,"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 3; ASPG3",Percent
608782,PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD,Number Sign
608783,SET AND MYND DOMAIN-CONTAINING PROTEIN 3; SMYD3,Asterisk
608784,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 8; ZDHHC8,Asterisk
608785,HTRA SERINE PEPTIDASE 3; HTRA3,Asterisk
608786,PYRUVATE CARBOXYLASE; PC,Asterisk
608787,OTOSCLEROSIS 5; OTSC5,Percent
608788,SUPPRESSOR OF CYTOKINE SIGNALING 7; SOCS7,Asterisk
608789,NCK-ASSOCIATED PROTEIN 5; NCKAP5,Asterisk
608790,TRANSCRIPTIONAL ADAPTOR 2B; TADA2B,Asterisk
608791,NUCLEOREDOXIN-LIKE PROTEIN 1; NXNL1,Asterisk
608792,"GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 3; GIPC3",Asterisk
608793,SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1; SPECC1,Asterisk
608794,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 1; PITPNM1",Asterisk
608795,"PHOSPHOLIPASE C, DELTA-3; PLCD3",Asterisk
608796,MOYAMOYA DISEASE 3; MYMY3,Percent
608797,"MEI1, MOUSE, HOMOLOG OF; MEI1",Asterisk
608798,GASDERMIN E; GSDME,Asterisk
608799,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E",Number Sign
608800,SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT,Number Sign
608801,GLUTARYL-CoA DEHYDROGENASE; GCDH,Asterisk
608802,L3MBT-LIKE; L3MBTL,Asterisk
608803,"GAP JUNCTION PROTEIN, GAMMA-2; GJC2",Asterisk
608804,"LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2",Number Sign
608805,"AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1; ANFH1",Number Sign
608806,N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 2,Asterisk
608807,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10",Number Sign
608808,"TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1; DTGA1",Number Sign
608809,"LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA; LACH",
608810,"MYOPATHY, MYOFIBRILLAR, 2; MFM2",Number Sign
608811,"METAPHYSEAL UNDERMODELING, SPONDYLAR DYSPLASIA, AND OVERGROWTH",
608812,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1",Number Sign
608813,"DER1-LIKE DOMAIN FAMILY, MEMBER 1; DERL1",Asterisk
608814,"LATERAL SEMICIRCULAR CANAL MALFORMATION, FAMILIAL, WITH EXTERNAL AND MIDDLE EAR ABNORMALITIES",
608815,EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 1; EFHC1,Asterisk
608816,"MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3; EJM3",Percent
608817,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4C; LRRC4C,Asterisk
608818,NETRIN G1; NTNG1,Asterisk
608819,KERATIN-ASSOCIATED PROTEIN 1-1; KRTAP1-1,Asterisk
608820,KERATIN-ASSOCIATED PROTEIN 1-3; KRTAP1-3,Asterisk
608821,KERATIN-ASSOCIATED PROTEIN 1-4; KRTAP1-4,Asterisk
608822,KERATIN-ASSOCIATED PROTEIN 1-5; KRTAP1-5,Asterisk
608823,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 1; CGB1",Asterisk
608824,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 2; CGB2",Asterisk
608825,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 5; CGB5",Asterisk
608826,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 7; CGB7",Asterisk
608827,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 8; CGB8",Asterisk
608828,"RIBONUCLEASE III, NUCLEAR; RNASEN",Asterisk
608829,SMALL UBIQUITIN-LIKE MODIFIER 4; SUMO4,Asterisk
608830,RETINOL DEHYDROGENASE 12; RDH12,Asterisk
608831,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2; RLS2",Percent
608832,"GREMLIN 2 HOMOLOG, CYSTINE KNOT SUPERFAMILY; GREM2",Asterisk
608833,REGULATOR OF TELOMERE ELONGATION HELICASE 1; RTEL1,Asterisk
608834,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 2; CREB3L2,Asterisk
608835,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 13; ABCC13",Asterisk
608836,"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL",Number Sign
608837,CARNEY COMPLEX VARIANT,Number Sign
608838,"VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1-LIKE 1; VKORC1L1",Asterisk
608839,CALPAIN 12; CAPN12,Asterisk
608840,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6; MDDGB6",Number Sign
608841,COMPLEMENT COMPONENT 3- AND PREGNANCY ZONE PROTEIN-LIKE ALPHA-2-MACROGLOBULIN DOMAIN-CONTAINING PROTEIN 8; CPAMD8,Asterisk
608842,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 1; CHCHD1,Asterisk
608843,VASORIN,Asterisk
608844,ENDONUCLEASE VIII-LIKE 1; NEIL1,Asterisk
608845,ADP-RIBOSYLATION FACTOR-LIKE 6; ARL6,Asterisk
608846,CARNITINE PALMITOYLTRANSFERASE IC; CPT1C,Asterisk
608847,"FERRITIN, MITOCHONDRIAL; FTMT",Asterisk
608848,FORMIN-BINDING PROTEIN 1-LIKE; FNBP1L,Asterisk
608849,U2AF HOMOLOGY MOTIF KINASE 1; UHMK1,Asterisk
608850,"MACULAR DYSTROPHY, RETINAL, 3; MCDR3",Percent
608851,"5-PRIME,3-PRIME-EXORIBONUCLEASE 2; XRN2",Asterisk
608852,PULMONARY FUNCTION,Percent
608853,BH3-LIKE MOTIF-CONTAINING CELL DEATH INDUCER; BLID,Asterisk
608854,OXIDORED-NITRO DOMAIN-CONTAINING PROTEIN 1,Asterisk
608855,"TWEETY, DROSOPHILA, HOMOLOG OF, 2; TTYH2",Asterisk
608856,CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 1; CTAGE1,Asterisk
608857,CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 3; CTAGE3,Asterisk
608858,FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER 2; FGFR1OP2,Asterisk
608859,CD109 ANTIGEN; CD109,Asterisk
608860,ASTACIN-LIKE METALLOENDOPEPTIDASE; ASTL,Asterisk
608861,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 50/57-KD, V1 SUBUNIT H; ATP6V1H",Asterisk
608862,NAD(P)HX EPIMERASE; NAXE,Asterisk
608863,PODOPLANIN; PDPN,Asterisk
608864,"OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6",Number Sign
608865,"URB1 RIBOSOME BIOGENESIS 1, S. CEREVISIAE, HOMOLOG OF; URB1",Asterisk
608866,"FRAGILE SITE, FOLIC ACID-TYPE, RARE, FRA(10)(q23.3), CANDIDATE GENE 1; FRA10AC1",Asterisk
608867,DUAL-SPECIFICITY PHOSPHATASE 10; DUSP10,Asterisk
608868,LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 1; LRIG1,Asterisk
608869,LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 2; LRIG2,Asterisk
608870,LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 3; LRIG3,Asterisk
608871,"NIPSNAP, C. ELEGANS, HOMOLOG OF, 3A; NIPSNAP3A",Asterisk
608872,"NIPSNAP, C. ELEGANS, HOMOLOG OF, 3B; NIPSNAP3B",Asterisk
608873,SEMAPHORIN 6B; SEMA6B,Asterisk
608874,OROFACIAL CLEFT 5; OFC5,Number Sign
608875,"GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14",Percent
608876,"PCF11, YEAST, HOMOLOG OF",Asterisk
608877,"VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, D; VPS13D",Asterisk
608878,"GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 20",Percent
608879,"VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, C; VPS13C",Asterisk
608880,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 16; ZFYVE16,Asterisk
608881,"MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 2; MICAL2",Asterisk
608882,"MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 3; MICAL3",Asterisk
608883,MOVED TO 137030,Caret
608884,"RAL GTPase-ACTIVATING PROTEIN, ALPHA SUBUNIT 1; RALGAPA1",Asterisk
608885,STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN,Number Sign
608886,"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, BETA; PPARGC1B",Asterisk
608887,PURINE-RICH ELEMENT-BINDING PROTEIN B; PURB,Asterisk
608888,DEVELOPMENTALLY REGULATED RNA-BINDING PROTEIN 1,Asterisk
608889,AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE; ACMSD,Asterisk
608890,"WAARDENBURG SYNDROME, TYPE 2D; WS2D",Number Sign
608891,ODD-SKIPPED-RELATED 1; OSR1,Asterisk
608892,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 7; CHD7,Asterisk
608893,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 19; SLC6A19",Asterisk
608894,ABELSON HELPER INTEGRATION SITE 1; AHI1,Asterisk
608895,"NEUROPATHY, HEREDITARY, WITH OR WITHOUT AGE-RELATED MACULAR DEGENERATION; HNARMD",Number Sign
608896,"SARCOGLYCAN, GAMMA; SGCG",Asterisk
608897,"UNC13, C. ELEGANS, HOMOLOG OF, D; UNC13D",Asterisk
608898,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3",Number Sign
608899,"GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, ALPHA",Asterisk
608900,"GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, BETA",Asterisk
608901,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5",Number Sign
608902,"DRUG METABOLISM, POOR, CYP2D6-RELATED",Number Sign
608903,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1",Percent
608904,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 2",Percent
608905,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 3",Percent
608906,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 4",Percent
608907,"ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9",Number Sign
608908,MYOPIA 6; MYP6,Number Sign
608909,ADP-RIBOSYLATION FACTOR-LIKE 5B; ARL5B,Asterisk
608910,CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 4; CTAGE4,Asterisk
608911,"CHOANAL ATRESIA, POSTERIOR; PCA",Percent
608912,"POTE ANKYRIN DOMAIN FAMILY, MEMBER B; POTEB",Asterisk
608913,"POTE ANKYRIN DOMAIN FAMILY, MEMBER H; POTEH",Asterisk
608914,"POTE ANKYRIN DOMAIN FAMILY, MEMBER E; POTEE",Asterisk
608915,"POTE ANKYRIN DOMAIN FAMILY, MEMBER A; POTEA",Asterisk
608916,"POTE ANKYRIN DOMAIN FAMILY, MEMBER G; POTEG",Asterisk
608917,"ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 1; ATPAF1",Asterisk
608918,"ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 2; ATPAF2",Asterisk
608919,"TWEETY, DROSOPHILA, HOMOLOG OF, 3; TTYH3",Asterisk
608920,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 2; PITPNM2",Asterisk
608921,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 3; PITPNM3",Asterisk
608922,ADP-RIBOSYLATION FACTOR-LIKE 13B; ARL13B,Asterisk
608923,TRACE AMINE-ASSOCIATED RECEPTOR 6; TAAR6,Asterisk
608924,FORKHEAD BOX P4; FOXP4,Asterisk
608925,MULTIMERIN 2; MMRN2,Asterisk
608926,EMI DOMAIN-CONTAINING PROTEIN 1; EMID1,Asterisk
608927,EMI DOMAIN-CONTAINING PROTEIN 2; EMID2,Asterisk
608928,ELASTIN MICROFIBRIL INTERFACER 2; EMILIN2,Asterisk
608929,ELASTIN MICROFIBRIL INTERFACER 3; EMILIN3,Asterisk
608930,"MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B",Number Sign
608931,"MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C",Number Sign
608932,KERATOCONUS 2; KTCN2,Percent
608933,ENDONUCLEASE VIII-LIKE 2; NEIL2,Asterisk
608934,ENDONUCLEASE VIII-LIKE 3; NEIL3,Asterisk
608935,LUNG CANCER SUSCEPTIBILITY 1; LNCR1,Percent
608936,PROLINE-RICH LACRIMAL PROTEIN 1; PROL1,Asterisk
608937,SH2B ADAPTOR PROTEIN 1; SH2B1,Asterisk
608938,"RIBOSOMAL PROTEIN S6 KINASE, 70-KD, 1; RPS6KB1",Asterisk
608939,"RIBOSOMAL PROTEIN S6 KINASE, 70-KD, 2; RPS6KB2",Asterisk
608940,SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD,Number Sign
608941,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-3; GNG3",Asterisk
608942,"DYNEIN, LIGHT CHAIN, LC8 TYPE, 2; DYNLL2",Asterisk
608943,CYTOKINE-INDUCED APOPTOSIS INHIBITOR 1; CIAPIN1,Asterisk
608944,FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 1; FREM1,Asterisk
608945,FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 2; FREM2,Asterisk
608946,FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 3,Asterisk
608947,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 13; KCTD13,Asterisk
608948,"ZIC FAMILY, MEMBER 4; ZIC4",Asterisk
608949,GLYCOLIPID TRANSFER PROTEIN; GLTP,Asterisk
608950,MAGI2 INTRONIC TRANSCRIPT; MAGI2IT,Asterisk
608951,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6; CNOT6",Asterisk
608952,REPLICATION TIMING REGULATORY FACTOR 1; RIF1,Asterisk
608953,TEKTIN 2; TEKT2,Asterisk
608954,"MON1, S. CEREVISIAE, HOMOLOG OF, B; MON1B",Asterisk
608955,"TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 1; TTLL1",Asterisk
608956,"SOLUTE CARRIER FAMILY 46, MEMBER 2; SLC46A2",Asterisk
608957,"CD8 DEFICIENCY, FAMILIAL",Number Sign
608958,ADENOSINE DEAMINASE; ADA,Asterisk
608959,"DPH3, S. CEREVISIAE, HOMOLOG OF; DPH3",Asterisk
608960,ADP-RIBOSYLATION FACTOR-LIKE 5A; ARL5A,Asterisk
608961,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 3; TRPM3",Asterisk
608962,RHOMBOID-LIKE 2; RHBDL2,Asterisk
608963,NUCLEAR PROTEIN IN TESTIS,Asterisk
608964,TATA BOX-BINDING PROTEIN-LIKE PROTEIN 2; TBPL2,Asterisk
608965,CALCIUM-BINDING PROTEIN 4; CABP4,Asterisk
608966,"DAPPER, ANTAGONIST OF BETA-CATENIN, 2; DACT2",Asterisk
608967,MOVED TO 609192,Caret
608968,"V-MAF MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN B; MAFB",Asterisk
608969,"UTP14, S. CEREVISIAE, HOMOLOG OF, B",Asterisk
608970,"MACULAR DYSTROPHY, PATTERNED, 2; MDPT2",Number Sign
608971,"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE",Number Sign
608972,CREB-REGULATED TRANSCRIPTION COACTIVATOR 2; CRTC2,Asterisk
608973,SALT-INDUCIBLE KINASE 2; SIK2,Asterisk
608974,COMPLEMENT COMPONENT C1r-LIKE PROTEIN; C1RL,Asterisk
608975,"PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, BETA; PARD6B",Asterisk
608976,"PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, GAMMA; PARD6G",Asterisk
608977,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 19; DNAJC19",Asterisk
608978,MEACHAM SYNDROME,Number Sign
608979,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1M; PPM1M",Asterisk
608980,BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR,Number Sign
608981,"ACTIVIN A RECEPTOR, TYPE IC; ACVR1C",Asterisk
608982,STATURE QUANTITATIVE TRAIT LOCUS 5; STQTL5,Percent
608983,MOVED TO 115700,Caret
608984,"ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1",Number Sign
608985,RING FINGER PROTEIN 2; RNF2,Asterisk
608986,CREB-REGULATED TRANSCRIPTION COACTIVATOR 3; CRTC3,Asterisk
608987,"PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 3; P4HA3",Asterisk
608988,"ATRIAL FIBRILLATION, FAMILIAL, 2; ATFB2",Percent
608989,"RETINAL DEHYDROGENASE, EPIDERMAL, 2",Asterisk
608990,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 10; ADAMTS10",Asterisk
608991,MASTERMIND-LIKE 3; MAML3,Asterisk
608992,B-CELL LYMPHOMA 6B; BCL6B,Asterisk
608993,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3F; APOBEC3F",Asterisk
608994,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1A; ANKS1A,Asterisk
608995,"DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8",Percent
608996,PREMATURE OVARIAN FAILURE 3; POF3,Number Sign
608997,MOVED TO 300512,Caret
608998,EARP COMPLEX AND GARP COMPLEX INTERACTING PROTEIN 1; EIPR1,Asterisk
608999,TUMOR-SUPPRESSING SUBTRANSFERABLE FRAGMENT CANDIDATE GENE 2; TSSC2,Asterisk
609000,"MONOOXYGENASE, DBH-LIKE, 1; MOXD1",Asterisk
609001,"PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, GAMMA; PIK3C2G",Asterisk
609002,TEKTIN 1; TEKT1,Asterisk
609003,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 11; TTC11,Asterisk
609004,B-CELL CLL/LYMPHOMA 9-LIKE; BCL9L,Asterisk
609005,WD REPEAT-CONTAINING PROTEIN 17; WDR17,Asterisk
609006,"DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36",Number Sign
609007,LEUCINE-RICH REPEAT KINASE 2; LRRK2,Asterisk
609008,MARFANOID HABITUS WITH SITUS INVERSUS,
609009,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, THETA ISOFORM; YWHAQ",Asterisk
609010,3-METHYLCROTONYL-CoA CARBOXYLASE 1; MCCC1,Asterisk
609011,VASOHIBIN 1; VASH1,Asterisk
609012,WD REPEAT-CONTAINING PROTEIN 5; WDR5,Asterisk
609013,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4C1; SLCO4C1",Asterisk
609014,3-METHYLCROTONYL-CoA CARBOXYLASE 2; MCCC2,Asterisk
609015,MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD,Number Sign
609016,LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY,Number Sign
609017,ERYTHROBLAST MEMBRANE-ASSOCIATED PROTEIN; ERMAP,Asterisk
609018,HOLOCARBOXYLASE SYNTHETASE; HLCS,Asterisk
609019,BIOTINIDASE; BTD,Asterisk
609020,FOLATE HYDROLASE 1B; FOLH1B,Asterisk
609021,PERIPHERAL CONE DYSTROPHY,Percent
609022,RAPAMYCIN-INSENSITIVE COMPANION OF MTOR; RICTOR,Asterisk
609023,MYOFIBRILLOGENESIS REGULATOR 1,Asterisk
609024,KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 2; KDELR2,Asterisk
609025,"KERATIN 75, TYPE II; KRT75",Asterisk
609026,CATARACT 28; CTRCT28,Percent
609027,"BLOOD GROUP, INDIAN SYSTEM; IN",Number Sign
609028,TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN; TIFA,Asterisk
609029,EMANUEL SYNDROME,Number Sign
609030,DIGEORGE SYNDROME CRITICAL REGION GENE 8; DGCR8,Asterisk
609031,SERINE PROTEASE INHIBITOR-LIKE PROTEIN WITH KUNITZ AND WAP DOMAINS 1; SPINLW1,Asterisk
609032,FSHD REGION GENE 2; FRG2,Asterisk
609033,POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1,Number Sign
609034,HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF-LIKE PROTEIN; HEYL,Asterisk
609035,RAS ASSOCIATION AND PLECKSTRIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1; RAPH1,Asterisk
609036,APBB1-INTERACTING PROTEIN; APBB1IP,Asterisk
609037,"MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE",
609038,RHO FAMILY GTPase 1; RND1,Asterisk
609039,NARCOLEPSY 3; NRCLP3,Percent
609040,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9",Number Sign
609041,"SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE; SPG27",Percent
609042,OPSIN 5; OPN5,Asterisk
609043,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 4; RXFP4,Asterisk
609044,FREE FATTY ACID RECEPTOR 4; FFAR4,Asterisk
609045,G PROTEIN-COUPLED RECEPTOR 141; GPR141,Asterisk
609046,G PROTEIN-COUPLED RECEPTOR 142; GPR142,Asterisk
609047,"SKELETAL DYSPLASIA, RHIZOMELIC, WITH RETINITIS PIGMENTOSA",
609048,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3",Number Sign
609049,PIERSON SYNDROME,Number Sign
609050,METASTASIS-ASSOCIATED GENE 3; MTA3,Asterisk
609051,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 8; CARD8,Asterisk
609052,"SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4",Percent
609053,"FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI",Number Sign
609054,"FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ",Number Sign
609055,"CEROID LIPOFUSCINOSIS, NEURONAL, 9; CLN9",Percent
609056,SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS,Number Sign
609057,NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS,Number Sign
609058,METHYLMALONYL-CoA MUTASE; MUT,Asterisk
609059,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 2; PNPLA2,Asterisk
609060,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1,Number Sign
609061,"ENABLED, DROSOPHILA, HOMOLOG OF; ENAH",Asterisk
609062,"POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 2; POU6F2",Asterisk
609063,THIOREDOXIN 2; TXN2,Asterisk
609064,CARNOSINE DIPEPTIDASE 1; CNDP1,Asterisk
609065,MOVED TO 605714,Caret
609066,"AJUBA, MOUSE, HOMOLOG OF; JUB",Asterisk
609067,"SCLERAXIS, MOUSE, HOMOLOG OF, A; SCXA",Asterisk
609068,"DAN DOMAIN FAMILY, MEMBER 5; DAND5",Asterisk
609069,PANCREATIC AND CEREBELLAR AGENESIS; PACA,Number Sign
609070,"HEMOGLOBIN, HIGH ALTITUDE ADAPTATION; HALAH",Number Sign
609071,F-BOX AND WD40 DOMAIN PROTEIN 2; FBXW2,Asterisk
609072,F-BOX AND WD40 DOMAIN PROTEIN 5; FBXW5,Asterisk
609073,F-BOX AND WD40 DOMAIN PROTEIN 8; FBXW8,Asterisk
609074,F-BOX AND WD40 DOMAIN PROTEIN 9; FBXW9,Asterisk
609075,F-BOX AND WD40 DOMAIN PROTEIN 12; FBXW12,Asterisk
609076,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 6; FBXL6,Asterisk
609077,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 8; FBXL8,Asterisk
609078,LYSINE-SPECIFIC DEMETHYLASE 2B; KDM2B,Asterisk
609079,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 12; FBXL12,Asterisk
609080,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 13; FBXL13,Asterisk
609081,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14; FBXL14,Asterisk
609082,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 16; FBXL16,Asterisk
609083,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 17; FBXL17,Asterisk
609084,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 18; FBXL18,Asterisk
609085,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 19; FBXL19,Asterisk
609086,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20; FBXL20,Asterisk
609087,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 21; FBXL21,Asterisk
609088,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 22; FBXL22,Asterisk
609089,F-BOX ONLY PROTEIN 3; FBXO3,Asterisk
609090,F-BOX ONLY PROTEIN 4; FBXO4,Asterisk
609091,F-BOX ONLY PROTEIN 9; FBXO9,Asterisk
609092,F-BOX ONLY PROTEIN 10; FBXO10,Asterisk
609093,F-BOX ONLY PROTEIN 15; FBXO15,Asterisk
609094,F-BOX ONLY PROTEIN 17; FBXO17,Asterisk
609095,F-BOX ONLY PROTEIN 21; FBXO21,Asterisk
609096,F-BOX ONLY PROTEIN 22; FBXO22,Asterisk
609097,F-BOX ONLY PROTEIN 24; FBXO24,Asterisk
609098,F-BOX ONLY PROTEIN 25; FBXO25,Asterisk
609099,F-BOX ONLY PROTEIN 27; FBXO27,Asterisk
609100,F-BOX ONLY PROTEIN 28; FBXO28,Asterisk
609101,F-BOX ONLY PROTEIN 30; FBXO30,Asterisk
609102,F-BOX ONLY PROTEIN 31; FBXO31,Asterisk
609103,F-BOX ONLY PROTEIN 33; FBXO33,Asterisk
609104,F-BOX ONLY PROTEIN 34; FBXO34,Asterisk
609105,F-BOX ONLY PROTEIN 36; FBXO36,Asterisk
609106,F-BOX ONLY PROTEIN 39; FBXO39,Asterisk
609107,F-BOX ONLY PROTEIN 40; FBXO40,Asterisk
609108,F-BOX ONLY PROTEIN 41; FBXO41,Asterisk
609109,F-BOX ONLY PROTEIN 42; FBXO42,Asterisk
609110,F-BOX ONLY PROTEIN 43; FBXO43,Asterisk
609111,F-BOX ONLY PROTEIN 44; FBXO44,Asterisk
609112,F-BOX ONLY PROTEIN 45; FBXO45,Asterisk
609113,"TELOMERE LENGTH, MEAN LEUKOCYTE; LTL",Percent
609114,DESTRIN; DSTN,Asterisk
609115,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3; LGMDD3",Number Sign
609116,RESPIRATORY RHYTHMICITY IN SLEEP,Percent
609117,F-BOX ONLY PROTEIN 46; FBXO46,Asterisk
609118,PROGRAMMED CELL DEATH 10; PDCD10,Asterisk
609119,THAP DOMAIN-CONTAINING PROTEIN 11; THAP11,Asterisk
609120,"CATION CHANNEL, SPERM-ASSOCIATED, 3; CATSPER3",Asterisk
609121,"CATION CHANNEL, SPERM-ASSOCIATED, 4; CATSPER4",Asterisk
609122,"ANEURYSM, INTRACRANIAL BERRY, 3; ANIB3",Percent
609123,"ATPase, CLASS I, TYPE 8B, MEMBER 4; ATP8B4",Asterisk
609124,ZINC FINGER PROTEIN 385A; ZNF385A,Asterisk
609125,MOTILE SPERM DOMAIN-CONTAINING PROTEIN 3; MOSPD3,Asterisk
609126,"ATPase, CLASS II, TYPE 9A; ATP9A",Asterisk
609127,MOVED TO 300516,Caret
609128,"ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4",Percent
609129,"AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1",Number Sign
609130,"APOPTOSIS-INDUCING, TAF9-LIKE DOMAIN 1; APITD1",Asterisk
609131,CLAUDIN 7; CLDN7,Asterisk
609132,LYSINE-SPECIFIC DEMETHYLASE 1A; KDM1A,Asterisk
609133,FLT3-INTERACTING ZINC FINGER PROTEIN 1; FIZ1,Asterisk
609134,UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 2; UBR2,Asterisk
609135,APLASTIC ANEMIA,Number Sign
609136,"PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH",Number Sign
609137,RECEPTOR-TRANSPORTING PROTEIN 1; RTP1,Asterisk
609138,RECEPTOR-TRANSPORTING PROTEIN 2; RTP2,Asterisk
609139,RECEPTOR EXPRESSION-ENHANCING PROTEIN 1; REEP1,Asterisk
609140,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2",Number Sign
609141,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3",Number Sign
609142,CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 3; CEACAM3,Asterisk
609143,MOVED TO 607278,Caret
609144,FELINE LEUKEMIA VIRUS SUBGROUP C RECEPTOR 1; FLVCR1,Asterisk
609145,NEUROFASCIN; NFASC,Asterisk
609146,"RIC8, C. ELEGANS, HOMOLOG OF, A; RIC8A",Asterisk
609147,"RIC8, C. ELEGANS, HOMOLOG OF, B; RIC8B",Asterisk
609148,"MALARIA, MILD, SUSCEPTIBILITY TO",Number Sign
609149,"SOLUTE CARRIER FAMILY 29 (MONOAMINE TRANSPORTER), MEMBER 4; SLC29A4",Asterisk
609150,CXXC FINGER PROTEIN 1; CXXC1,Asterisk
609151,UBX DOMAIN PROTEIN 11; UBXN11,Asterisk
609152,"HYPERTHYROIDISM, NONAUTOIMMUNE",Number Sign
609153,"PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK; PSHK2",Number Sign
609154,"ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 3; ASCL3",Asterisk
609155,"ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 4; ASCL4",Asterisk
609156,"NICALIN, ZEBRAFISH, HOMOLOG OF; NCLN",Asterisk
609157,NODAL MODULATOR 1; NOMO1,Asterisk
609158,NODAL MODULATOR 2; NOMO2,Asterisk
609159,NODAL MODULATOR 3; NOMO3,Asterisk
609160,MOVED TO 601419,Caret
609161,"STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1; ADSD1",Number Sign
609162,CZECH DYSPLASIA,Number Sign
609163,HYDROXYCARBOXYLIC ACID RECEPTOR 2; HCAR2,Asterisk
609164,"UMBILICUS, FAMILIAL FLAT",Percent
609165,"ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE",Number Sign
609166,BRANCHIOGENIC-DEAFNESS SYNDROME,Percent
609167,MOVED TO 604379,Caret
609168,SHUGOSHIN-LIKE 1; SGOL1,Asterisk
609169,"GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, SPERMATOGENIC; GAPDHS",Asterisk
609170,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 4; TXNDC4,Asterisk
609171,CDC42 EFFECTOR PROTEIN 5; CDC42EP5,Asterisk
609172,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16A; PPP1R16A",Asterisk
609173,KINETOCHORE SCAFFOLD 1; KNL1,Asterisk
609174,"NSL1, MIS12 KINETOCHORE COMPLEX COMPONENT; NSL1",Asterisk
609175,"DSN1, MIS12 KINETOCHORE COMPLEX COMPONENT; DSN1",Asterisk
609176,POLYAMINE-MODULATED FACTOR 1; PMF1,Asterisk
609177,ZW10 INTERACTOR; ZWINT,Asterisk
609178,"MIS12, S. POMBE, HOMOLOG OF; MIS12",Asterisk
609179,"MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7",Percent
609180,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F",Number Sign
609181,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 4; DYRK4,Asterisk
609182,"SOLUTE CARRIER FAMILY 35, MEMBER D2; SLC35D2",Asterisk
609183,AURORA KINASE A-INTERACTING PROTEIN,Asterisk
609184,KINESIN FAMILY MEMBER 4B; KIF4B,Asterisk
609185,ZINC FINGER AND HOMEODOMAIN PROTEIN 2; ZHX2,Asterisk
609186,D-2-HYDROXYGLUTARATE DEHYDROGENASE; D2HGDH,Asterisk
609187,SUCCINYL-CoA:GLUTARATE-CoA TRANSFERASE; SUGCT,Asterisk
609188,M-PHASE-SPECIFIC PLK1-INTERACTING PROTEIN; MPLKIP,Asterisk
609189,"ANTI-SILENCING FUNCTION 1, S. CEREVISIAE, HOMOLOG OF, A; ASF1A",Asterisk
609190,"ANTI-SILENCING FUNCTION 1, S. CEREVISIAE, HOMOLOG OF, B; ASF1B",Asterisk
609191,PROTEIN KINASE A-INTERACTING PROTEIN 1; AKIP1,Asterisk
609192,LOEYS-DIETZ SYNDROME 1; LDS1,Number Sign
609193,PEPTIDYL-PROLYL ISOMERASE-LIKE 5; PPIL5,Asterisk
609194,CDK5 AND ABL ENZYME SUBSTRATE 1; CABLES1,Asterisk
609195,"SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26",Number Sign
609196,MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; MRAP,Asterisk
609197,GLUCOCORTICOID DEFICIENCY 3; GCCD3,Percent
609198,ADAMTS-LIKE PROTEIN 1; ADAMTSL1,Asterisk
609199,ADAMTS-LIKE PROTEIN 3; ADAMTSL3,Asterisk
609200,"MYOPATHY, MYOFIBRILLAR, 3; MFM3",Number Sign
609201,UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN B; UBASH3B,Asterisk
609202,SECRETAGOGIN; SCGN,Asterisk
609203,CLAUDIN 23; CLDN23,Asterisk
609204,MITOCHONDRIAL RIBOSOMAL PROTEIN S16: MRPS16,Asterisk
609205,DAB2-INTERACTING PROTEIN; DAB2IP,Asterisk
609206,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, EPSILON-1; EEF1E1",Asterisk
609207,MELANOREGULIN; MREG,Asterisk
609208,KAZAL-TYPE PROTEASE INHIBITOR DOMAIN-CONTAINING PROTEIN 1; KAZALD1,Asterisk
609209,INFLUENZA VIRUS NS1A PROTEIN-BINDING PROTEIN; IVNS1ABP,Asterisk
609210,CLAUDIN 18; CLDN18,Asterisk
609211,"MYOSIN, LIGHT CHAIN 12B, REGULATORY; MYL12B",Asterisk
609212,ASPARAGINASE-LIKE PROTEIN 1; ASRGL1,Asterisk
609213,"SEC61 COMPLEX, ALPHA-1 SUBUNIT; SEC61A1",Asterisk
609214,"SEC61 COMPLEX, BETA SUBUNIT; SEC61B",Asterisk
609215,"SEC61 COMPLEX, GAMMA SUBUNIT; SEC61G",Asterisk
609216,"SPIRE, DROSOPHILA, HOMOLOG OF, 1; SPIRE1",Asterisk
609217,"SPIRE, DROSOPHILA, HOMOLOG OF, 2; SPIRE2",Asterisk
609218,FOVEAL HYPOPLASIA 2; FVH2,Number Sign
609219,NUDIX HYDROLASE 14; NUDT14,Asterisk
609220,BRUCK SYNDROME 2; BRKS2,Number Sign
609221,N-ACETYLTRANSFERASE 10; NAT10,Asterisk
609222,"DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT; ADDWOC",Percent
609223,"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGER TYPE",Percent
609224,WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 1; WIPI1,Asterisk
609225,WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 2; WIPI2,Asterisk
609226,WD REPEAT-CONTAINING PROTEIN 45B; WDR45B,Asterisk
609227,"GRISCELLI SYNDROME, TYPE 3; GS3",Number Sign
609228,NUDIX HYDROLASE 3; NUDT3,Asterisk
609229,NUDIX HYDROLASE 4; NUDT4,Asterisk
609230,NUDIX HYDROLASE 5; NUDT5,Asterisk
609231,NUDIX HYDROLASE 7; NUDT7,Asterisk
609232,NUDIX HYDROLASE 12; NUDT12,Asterisk
609233,NUDIX HYDROLASE 13; NUDT13,Asterisk
609234,EUKARYOTIC TRANSLATION INITIATION FACTOR 2A; EIF2A,Asterisk
609235,BR SERINE/THREONINE KINASE 1; BRSK1,Asterisk
609236,BR SERINE/THREONINE KINASE 2; BRSK2,Asterisk
609237,IQ MOTIF-CONTAINING PROTEIN B1; IQCB1,Asterisk
609238,RAB GTPase-ACTIVATING PROTEIN 1-LIKE; RABGAP1L,Asterisk
609239,LYSOPHOSPHATIDIC ACID RECEPTOR 6; LPAR6,Asterisk
609240,GERM CELL-SPECIFIC GENE 2; GSG2,Asterisk
609241,"SCHINDLER DISEASE, TYPE I",Number Sign
609242,KANZAKI DISEASE,Number Sign
609243,RETINOIC ACID EARLY TRANSCRIPT 1E; RAET1E,Asterisk
609244,RETINOIC ACID EARLY TRANSCRIPT 1G; RAET1G,Asterisk
609245,G PROTEIN SIGNALING MODULATOR 2; GPSM2,Asterisk
609246,PYRIDOXAL PHOSPHATASE; PDXP,Asterisk
609247,RING FINGER PROTEIN 13; RNF13,Asterisk
609248,HECT DOMAIN AND RCC1-LIKE DOMAIN 4; HERC4,Asterisk
609249,HECT DOMAIN AND RCC1-LIKE DOMAIN 6; HERC6,Asterisk
609250,"HYPOTRICHOSIS, PROGRESSIVE PATTERNED SCALP, WITH WIRY HAIR, ONYCHOLYSIS, AND CLEFT LIP/PALATE",
609251,Fc RECEPTOR-LIKE PROTEIN B; FCRLB,Asterisk
609252,LIPASE I; LIPI,Asterisk
609253,"FEBRILE SEIZURES, FAMILIAL, 6; FEB6",Percent
609254,SENIOR-LOKEN SYNDROME 5; SLSN5,Number Sign
609255,"FEBRILE SEIZURES, FAMILIAL, 5; FEB5",Percent
609256,MYOPIA 7; MYP7,Percent
609257,MYOPIA 8; MYP8,Percent
609258,MYOPIA 9; MYP9,Percent
609259,MYOPIA 10; MYP10,Percent
609260,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A",Number Sign
609261,"STUTTERING, FAMILIAL PERSISTENT, 2; STUT2",Percent
609262,CEREBLON; CRBN,Asterisk
609263,SEH1-LIKE PROTEIN; SEH1L,Asterisk
609264,"NUCLEOPORIN, 37-KD; NUP37",Asterisk
609265,LI-FRAUMENI SYNDROME 2; LFS2,Number Sign
609266,MOVED TO 151623,Caret
609267,"MELANOMA ANTIGEN, FAMILY F, 1; MAGEF1",Asterisk
609268,"SPLICING REGULATORY PROTEIN, GLUTAMINE/LYSINE-RICH, 1; SREK1",Asterisk
609269,KIAA0319 GENE; KIAA0319,Asterisk
609270,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7",Number Sign
609271,KERATOCONUS 4; KTCN4,Percent
609272,"TRYPTASE, DELTA-1; TPSD1",Asterisk
609273,NEMALINE MYOPATHY 6; NEM6,Number Sign
609274,"NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE, 2",Asterisk
609275,"RAB3 GTPase-ACTIVATING PROTEIN, NONCATALYTIC SUBUNIT; RAB3GAP2",Asterisk
609276,NON-SMC CONDENSIN II COMPLEX SUBUNIT D3; NCAPD3,Asterisk
609277,MOLYBDENUM COFACTOR SYNTHESIS 3; MOCS3,Asterisk
609278,IZUMO SPERM-EGG FUSION PROTEIN 1; IZUMO1,Asterisk
609279,CENTROMERIC PROTEIN J; CENPJ,Asterisk
609280,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4; EIF2AK4,Asterisk
609281,MOB1-LIKE PROTEIN 1B; MOBKL1B,Asterisk
609282,MOB1-LIKE PROTEIN 1A; MOBKL1A,Asterisk
609283,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2",Number Sign
609284,NEMALINE MYOPATHY 1; NEM1,Number Sign
609285,NEMALINE MYOPATHY 4; NEM4,Number Sign
609286,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3",Number Sign
609287,"SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B1; SH3GLB1",Asterisk
609288,"SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B2; SH3GLB2",Asterisk
609289,"SYNCOPE, FAMILIAL VASOVAGAL; VVS",Percent
609290,ADENYLATE KINASE 3; AK3,Asterisk
609291,SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 1; SPRED1,Asterisk
609292,SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 2; SPRED2,Asterisk
609293,SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 3; SPRED3,Asterisk
609294,SEMAPHORIN 6C; SEMA6C,Asterisk
609295,SEMAPHORIN 6D; SEMA6D,Asterisk
609296,"B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS",Percent
609297,SEMAPHORIN 5A; SEMA5A,Asterisk
609298,SEMAPHORIN 5B; SEMA5B,Asterisk
609299,"PROSTATE CANCER, HEREDITARY, 5",Percent
609300,"CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1; CYP17A1",Asterisk
609301,p53 EFFECTOR RELATED TO PMP22; PERP,Asterisk
609302,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 22; SLC25A22",Asterisk
609303,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 18; SLC25A18",Asterisk
609304,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3",Number Sign
609305,LATEXIN; LXN,Asterisk
609306,SPINOCEREBELLAR ATAXIA 26; SCA26,Number Sign
609307,SPINOCEREBELLAR ATAXIA 27; SCA27,Number Sign
609308,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1",Number Sign
609309,"MutS, E. COLI, HOMOLOG OF, 2; MSH2",Asterisk
609310,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2",Number Sign
609311,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H",Number Sign
609312,"DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH",Asterisk
609313,"MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA; MEDNIK",Number Sign
609314,"RADIAL SPOKE HEAD 1, CHLAMYDOMONAS, HOMOLOG OF; RSPH1",Asterisk
609315,TRIPARTITE MOTIF-CONTAINING PROTEIN 7; TRIM7,Asterisk
609316,TRIPARTITE MOTIF-CONTAINING PROTEIN 31; TRIM31,Asterisk
609317,TRIPARTITE MOTIF-CONTAINING PROTEIN 36; TRIM36,Asterisk
609318,TRIPARTITE MOTIF-CONTAINING PROTEIN 45; TRIM45,Asterisk
609319,HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HCHGQ1,Percent
609320,HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HCHGQ2,Percent
609321,SAS6 CENTRIOLAR ASSEMBLY PROTEIN; SASS6,Asterisk
609322,RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1,Number Sign
609323,OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 3; OLIG3,Asterisk
609324,"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA",Percent
609325,"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES",Percent
609326,MICRO RNA 1-1; MIR1-1,Asterisk
609327,MICRO RNA 124-1; MIR124-1,Asterisk
609328,URIDINE/CYTIDINE KINASE 1; UCK1,Asterisk
609329,URIDINE/CYTIDINE KINASE 2; UCK2,Asterisk
609330,"ONCOPROTEIN-INDUCED TRANSCRIPT 3, MOUSE, HOMOLOG OF; OIT3",Asterisk
609331,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E23; BHLHE23",Asterisk
609332,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 7A; TTC7A,Asterisk
609333,TRACE AMINE-ASSOCIATED RECEPTOR 1; TAAR1,Asterisk
609334,CHROMOSOME 18 PERICENTRIC INVERSION,Number Sign
609335,"ODORANT RESPONSE ABNORMAL 4, C. ELEGANS, HOMOLOG OF; ODR4",Asterisk
609336,ANGIOPOIETIN-LIKE 6; ANGPTL6,Asterisk
609337,MICRO RNA 155; MIR155,Asterisk
609338,CAROTID INTIMAL MEDIAL THICKNESS 1,Number Sign
609339,MOVED TO 265000,Caret
609340,"SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28",Number Sign
609341,"TRYPTASE, GAMMA-1; TPSG1",Asterisk
609342,GASTRIC INTRINSIC FACTOR; GIF,Asterisk
609343,"PROTEASE, SERINE, 22; PRSS22",Asterisk
609344,KIELIN/CHORDIN-LIKE PROTEIN,Asterisk
609345,CEREBRORENODIGITAL SYNDROME WITH LIMB MALFORMATIONS AND TRIRADIATE ACETABULA,
609346,RECEPTOR EXPRESSION-ENHANCING PROTEIN 6; REEP6,Asterisk
609347,RECEPTOR EXPRESSION-ENHANCING PROTEIN 2; REEP2,Asterisk
609348,RECEPTOR EXPRESSION-ENHANCING PROTEIN 3; REEP3,Asterisk
609349,RECEPTOR EXPRESSION-ENHANCING PROTEIN 4; REEP4,Asterisk
609350,RECEPTOR-TRANSPORTING PROTEIN 4; RTP4,Asterisk
609351,ADP-RIBOSYLATION FACTOR-LIKE 11; ARL11,Asterisk
609352,EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA,Number Sign
609353,"ESTABLISHMENT OF COHESION 1, S. CEREVISIAE, HOMOLOG OF, 2; ESCO2",Asterisk
609354,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 5; BMND5,Percent
609355,MICRO RNA 32; MIR32,Asterisk
609356,NUCLEAR FMRP-INTERACTING PROTEIN 2; NUFIP2,Asterisk
609357,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 10; MCM10,Asterisk
609358,ETS VARIANT GENE 2; ETV2,Asterisk
609359,HS1-BINDING PROTEIN 3; HS1BP3,Asterisk
609360,RENALASE; RNLS,Asterisk
609361,"MOB FAMILY, MEMBER 4; MOB4",Asterisk
609362,LYSOPHOSPHOLIPASE 3; LYPLA3,Asterisk
609363,COLLOID CYSTS OF THIRD VENTRICLE,
609364,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 2; NLRP2",Asterisk
609365,GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 2; GNL2,Asterisk
609366,SH2 DOMAIN-BINDING PROTEIN 1; SH2BP1,Asterisk
609367,KIAA1279 GENE; KIAA1279,Asterisk
609368,ATLASTIN GTPase 2; ATL2,Asterisk
609369,ATLASTIN GTPase 3; ATL3,Asterisk
609370,SERINE/THREONINE KINASE 35; STK35,Asterisk
609371,CHROMOSOME 5 OPEN READING FRAME 5; C5ORF5,Asterisk
609372,"FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER C; FAM53C",Asterisk
609373,LYSINE-SPECIFIC DEMETHYLASE 3B; KDM3B,Asterisk
609374,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 5; CDCA5,Asterisk
609375,"LIN9, C. ELEGANS, HOMOLOG OF; LIN9",Asterisk
609376,CATARACT 35; CTRCT35,Percent
609377,"ACD, MOUSE, HOMOLOG OF; ACD",Asterisk
609378,"AUTISM, SUSCEPTIBILITY TO, 6; AUTS6",Percent
609379,LIPOCALIN 6; LCN6,Asterisk
609380,LEISHMANOLYSIN-LIKE; LMLN,Asterisk
609381,SYNTAXIN-BINDING PROTEIN 5-LIKE; STXBP5L,Asterisk
609382,IMMEDIATE-EARLY RESPONSE 3-INTERACTING PROTEIN 1; IER3IP1,Asterisk
609383,NIPA-LIKE DOMAIN-CONTAINING 4; NIPAL4,Asterisk
609384,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3C; CFEOM3C",Percent
609385,"DEAD END, ZEBRAFISH, HOMOLOG OF, 1; DND1",Asterisk
609386,STRUCTURAL MAINTENANCE OF CHROMOSOMES 5; SMC5,Asterisk
609387,STRUCTURAL MAINTENANCE OF CHROMOSOMES 6; SMC6,Asterisk
609388,METHYLTRANSFERASE-LIKE 9; METTL9,Asterisk
609389,INOSITOL POLYPHOSPHATE 5-PHOSPHATASE F; INPP5F,Asterisk
609390,"FIG4, S. CEREVISIAE, HOMOLOG OF; FIG4",Asterisk
609391,TRANSCRIPTION FACTOR Sp5; SP5,Asterisk
609392,KRUPPEL-LIKE FACTOR 3; KLF3,Asterisk
609393,KRUPPEL-LIKE FACTOR 14; KLF14,Asterisk
609394,"SPC24, NDC80 KINETOCHORE COMPLEX COMPONENT; SPC24",Asterisk
609395,"SPC25, NDC80 KINETOCHORE COMPLEX COMPONENT; SPC25",Asterisk
609396,PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE 1; PHLPP1,Asterisk
609397,STORKHEAD BOX 1; STOX1,Asterisk
609398,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 34-KD, V1 SUBUNIT D; ATP6V1D",Asterisk
609399,SPERM EQUATORIAL SEGMENT PROTEIN 1; SPESP1,Asterisk
609400,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4; AIS4",Percent
609401,HEPARAN SULFATE 6-O-SULFOTRANSFERASE 3; HS6ST3,Asterisk
609402,PREECLAMPSIA/ECLAMPSIA 2; PEE2,Percent
609403,PREECLAMPSIA/ECLAMPSIA 3; PEE3,Percent
609404,PREECLAMPSIA/ECLAMPSIA 4; PEE4,Number Sign
609405,RHO GTPase-ACTIVATING PROTEIN 8; ARHGAP8,Asterisk
609406,PROLINE-RICH PROTEIN 5; PRR5,Asterisk
609407,HEPARAN SULFATE (GLUCOSAMINE) 3-O-SULFOTRANSFERASE 5; HS3ST5,Asterisk
609408,HOLOPROSENCEPHALY 8; HPE8,Percent
609409,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A0; HNRNPA0,Asterisk
609410,SYNAPTOJANIN 2; SYNJ2,Asterisk
609411,SYNAPTOJANIN 2-BINDING PROTEIN; SYNJ2BP,Asterisk
609412,"EXCISION REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8",Asterisk
609413,"EXCISION REPAIR CROSS-COMPLEMENTING, GROUP 6; ERCC6",Asterisk
609414,"PHOSPHOINOSITIDE KINASE, FYVE FINGER-CONTAINING; PIKFYVE",Asterisk
609415,MICRO RNA 17 HOST GENE; MIR17HG,Asterisk
609416,MICRO RNA 17; MIR17,Asterisk
609417,MICRO RNA 18A; MIR18A,Asterisk
609418,MICRO RNA 19A; MIR19A,Asterisk
609419,MICRO RNA 19B1; MIR19B1,Asterisk
609420,MICRO RNA 20A; MIR20A,Asterisk
609421,MOVED TO 609416,Caret
609422,MICRO RNA 92A1; MIR92A1,Asterisk
609423,"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO",Number Sign
609424,RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING 1; RC3H1,Asterisk
609425,CHROMOSOME 3q29 DELETION SYNDROME,Number Sign
609426,MISSHAPEN/NIK-RELATED KINASE 1; MINK1,Asterisk
609427,LHFP-LIKE PROTEIN 5; LHFPL5,Asterisk
609428,TUKEL SYNDROME,Percent
609429,FORKHEAD BOX N4; FOXN4,Asterisk
609430,NEURONAL PAS DOMAIN PROTEIN 3; NPAS3,Asterisk
609431,MAP3K12-BINDING INHIBITORY PROTEIN; MBIP,Asterisk
609432,"SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD",Number Sign
609433,UBIQUITIN INTERACTION MOTIF-CONTAINING PROTEIN 1; UIMC1,Asterisk
609434,"LUC7, S. CEREVISIAE, HOMOLOG OF, 3; LUC7L3",Asterisk
609435,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 13; NDUFA13",Asterisk
609436,FIBROBLAST GROWTH FACTOR 21; FGF21,Asterisk
609437,SERINE/THREONINE PROTEIN KINASE 40; STK40,Asterisk
609438,"MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIAL BLOCK",
609439,"DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48",Number Sign
609440,UTP11-LIKE PROTEIN; UTP11L,Asterisk
609441,"ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD",Number Sign
609442,"VALPROATE EMBRYOPATHY, SUSCEPTIBILITY TO",
609443,"CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2A; CELA2A",Asterisk
609444,"CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2B; CELA2B",Asterisk
609445,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 3; RXFP3,Asterisk
609446,"PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3",Number Sign
609447,MARGINAL ZONE B AND B1 CELL-SPECIFIC PROTEIN; MZB1,Asterisk
609448,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 12; TXNDC12,Asterisk
609449,NUDE NEURODEVELOPMENT PROTEIN 1; NDE1,Asterisk
609450,MAX DIMERIZATION PROTEIN 3; MXD3,Asterisk
609451,"ZINC FINGER PROTEIN 90, MOUSE, HOMOLOG OF; ZFP90",Asterisk
609452,"MYOPATHY, MYOFIBRILLAR, 4; MFM4",Number Sign
609453,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 7; GOLGA7",Asterisk
609454,"SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2",Percent
609455,"PROLINE-, GLUTAMIC ACID-, AND LEUCINE-RICH PROTEIN 1; PELP1",Asterisk
609456,"MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE",Percent
609457,HISTIDINE AMMONIA-LYASE; HAL,Asterisk
609458,"MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 1; MAN2B1",Asterisk
609459,DIGEORGE SYNDROME CRITICAL REGION GENE 6-LIKE; DGCR6L,Asterisk
609460,GOLDBERG-SHPRINTZEN SYNDROME; GOSHS,Number Sign
609461,"TRIBBLES, DROSOPHILA, HOMOLOG OF, 1; TRIB1",Asterisk
609462,"TRIBBLES, DROSOPHILA, HOMOLOG OF, 2; TRIB2",Asterisk
609463,MKL/MYOCARDIN-LIKE 2; MKL2,Asterisk
609464,MOVED TO 186580,Caret
609465,AL-GAZALI SYNDROME,
609466,"CLEFT PALATE, MIDFACIAL HYPOPLASIA, TRIANGULAR FACIES, AND SENSORINEURAL HEARING LOSS",
609467,"CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 2; CCL3L2",Asterisk
609468,"CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 3; CCL3L3",Asterisk
609469,"NEPHROPATHY, PROGRESSIVE, WITH DEAFNESS",Percent
609470,LEFT VENTRICULAR NONCOMPACTION 2; LVNC2,Percent
609471,"GLUCOSIDASE, BETA, ACID 2; GBA2",Asterisk
609472,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-4; CNGA4",Asterisk
609473,"CINGULIN, XENOPUS, HOMOLOG OF; CGN",Asterisk
609474,NEURONAL PENTRAXIN RECEPTOR; NPTXR,Asterisk
609475,A-KINASE ANCHOR PROTEIN 8-LIKE PROTEIN; AKAP8L,Asterisk
609476,NEMO-LIKE KINASE; NLK,Asterisk
609477,SINGLE-PASS MEMBRANE PROTEIN WITH COILED-COIL DOMAINS 4; SMCO4,Asterisk
609478,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 3; ST8SIA3",Asterisk
609479,LEUCINE ZIPPER- AND STERILE ALPHA MOTIF-CONTAINING KINASE; ZAK,Asterisk
609480,MOVED TO 194521,Caret
609481,"ISL2 TRANSCRIPTION FACTOR, LIM/HOMEODOMAIN; ISL2",Asterisk
609482,"ANTERIOR GRADIENT 3, XENOPUS, HOMOLOG OF; AGR3",Asterisk
609483,"FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER B; FAM84B",Asterisk
609484,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 3; LYPD3,Asterisk
609485,MODULATOR OF APOPTOSIS 1; MOAP1,Asterisk
609486,E2F-ASSOCIATED PHOSPHOPROTEIN; EAPP,Asterisk
609487,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2; MAP3K2,Asterisk
609488,CANCER/TESTIS ANTIGEN KM-HN-1,Asterisk
609489,"MANNOSIDASE, BETA A, LYSOSOMAL; MANBA",Asterisk
609490,INHIBITORY CASPASE RECRUITMENT DOMAIN PROTEIN,Asterisk
609491,G PROTEIN SIGNALING MODULATOR 1; GPSM1,Asterisk
609492,RAS ASSOCIATION DOMAIN FAMILY PROTEIN 2; RASSF2,Asterisk
609493,SLC2A4 REGULATOR; SLC2A4RG,Asterisk
609494,ZINC FINGER PROTEIN 395; ZNF395,Asterisk
609495,GAMETOGENETIN-BINDING PROTEIN 1; GGNBP1,Asterisk
609496,MOVED TO 609814,Caret
609497,ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2; ERAP2,Asterisk
609498,F-BOX ONLY PROTEIN 47,Asterisk
609499,MCF2-LIKE PROTEIN; MCF2L,Asterisk
609500,"MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET",Percent
609501,TUDOR AND KH DOMAINS-CONTAINING PROTEIN; TDRKH,Asterisk
609502,"CADHERIN-RELATED FAMILY, MEMBER 1; CDHR1",Asterisk
609503,"TESTICULAR HAPLOID EXPRESSED GENE, MOUSE, HOMOLOG OF; THEG",Asterisk
609504,MICROSPHERULE PROTEIN 1; MCRS1,Asterisk
609505,TRIPARTITE MOTIF-CONTAINING PROTEIN 16; TRIM16,Asterisk
609506,"CYTOCHROME P450, SUBFAMILY XXVIIB, POLYPEPTIDE 1; CYP27B1",Asterisk
609507,TOPOISOMERASE I-BINDING ARGININE/SERINE-RICH PROTEIN; TOPORS,Asterisk
609508,"STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR",Number Sign
609509,INTERLEUKIN 31; IL31,Asterisk
609510,INTERLEUKIN 31 RECEPTOR A; IL31RA,Asterisk
609511,"RABENOSYN, RAB EFFECTOR; RBSN",Asterisk
609512,"CHMP FAMILY, MEMBER 2B; CHMP2B",Asterisk
609513,NEUROPEPTIDE S,Asterisk
609514,"TAUBE NUSS, MOUSE, HOMOLOG OF; TBN",Asterisk
609515,IRIDOGONIODYSGENESIS AND SKELETAL ANOMALIES,
609516,ZINC FINGER PROTEIN 382; ZNF382,Asterisk
609517,TGFB1-INDUCED ANTIAPOPTOTIC FACTOR 1; TIAF1,Asterisk
609518,THAP DOMAIN-CONTAINING PROTEIN 7; THAP7,Asterisk
609519,TCF3 FUSION PARTNER; TFPT,Asterisk
609520,THAP DOMAIN-CONTAINING PROTEIN 1; THAP1,Asterisk
609521,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 1; SLC30A1",Asterisk
609522,ELONGIN A2; ELOA2,Asterisk
609523,"ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 2; ALDH3A2",Asterisk
609524,"MYOPATHY, MYOFIBRILLAR, 5; MFM5",Number Sign
609525,TENSION-INDUCED/INHIBITED PROTEIN,Asterisk
609526,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G4; PLEKHG4,Asterisk
609527,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; RAPGEF5,Asterisk
609528,"CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME",Number Sign
609529,IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2,Number Sign
609530,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; RAPGEF2,Asterisk
609531,RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 3; RASGRP3,Asterisk
609532,"HEPATITIS C VIRUS, SUSCEPTIBILITY TO",Number Sign
609533,"DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23",Number Sign
609534,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 5; ATAD5",Asterisk
609535,"DRUG METABOLISM, POOR, CYP2C19-RELATED",Number Sign
609536,COMPLEMENT COMPONENT 5 DEFICIENCY; C5D,Number Sign
609537,LIPOMYELOMENINGOCELE,
609538,"PROTEIN-TYROSINE PHOSPHATASE, MITOCHONDRIAL, 1; PTPMT1",Asterisk
609539,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 2; ARID2,Asterisk
609540,WD REPEAT-CONTAINING PROTEIN 61; WDR61,Asterisk
609541,"SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN",Number Sign
609542,"ATPase, CLASS I, TYPE 8A, MEMBER 1; ATP8A1",Asterisk
609543,BEYLA GENE,Asterisk
609544,"CENTRIOLAR COILED-COIL PROTEIN, 110-KD; CCP110",Asterisk
609545,"OMPHALOCELE, DIAPHRAGMATIC HERNIA, AND RADIAL RAY DEFECTS",
609546,UBIQUITIN-SPECIFIC PROTEASE 29; USP29,Asterisk
609547,MOVED TO 131200,Caret
609548,LMAN1-LIKE PROTEIN; LMAN1L,Asterisk
609549,NANOPHTHALMOS 2; NNO2,Number Sign
609550,ZINC FINGER PROTEIN 330; ZNF330,Asterisk
609551,"LECTIN, MANNOSE-BINDING, 2; LMAN2",Asterisk
609552,LMAN2-LIKE PROTEIN; LMAN2L,Asterisk
609553,RETBINDIN,Asterisk
609554,INTEGRAL MEMBRANE PROTEIN 2C; ITM2C,Asterisk
609555,"CARBOXYPEPTIDASE X, M14 FAMILY, MEMBER 1; CPXM1",Asterisk
609556,"ATPase, TYPE 13A4; ATP13A4",Asterisk
609557,PROLYL ENDOPEPTIDASE-LIKE; PREPL,Asterisk
609558,"PROSTATE CANCER, HEREDITARY, 6",Percent
609559,CALMODULIN LYSINE N-METHYLTRANSFERASE; CAMKMT,Asterisk
609560,MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2,Number Sign
609561,CARBOXYPEPTIDASE A5; CPA5,Asterisk
609562,CARBOXYPEPTIDASE A6; CPA6,Asterisk
609563,CARBOXYPEPTIDASE O; CPO,Asterisk
609564,POLY(ADP-RIBOSE) POLYMERASE 10; PARP10,Asterisk
609565,MAST CELL-EXPRESSED MEMBRANE PROTEIN 1,Asterisk
609566,PARIETAL FORAMINA 3; PFM3,Percent
609567,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3; PNPLA3,Asterisk
609568,RHO GTPase-ACTIVATING PROTEIN 20; ARHGAP20,Asterisk
609569,MOVED TO 132100,Caret
609570,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8",Percent
609571,ZINC FINGER PROTEIN 699; ZNF699,Asterisk
609572,PHOTOPAROXYSMAL RESPONSE 2; PPR2,Percent
609573,PHOTOPAROXYSMAL RESPONSE 3; PPR3,Percent
609574,17-BETA-HYDROXYSTEROID DEHYDROGENASE XII; HSD17B12,Asterisk
609575,"ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN; ACADVL",Asterisk
609576,"ACYL-CoA DEHYDROGENASE, LONG-CHAIN; ACADL",Asterisk
609577,CULLIN 7; CUL7,Asterisk
609578,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 2; RCM2",Percent
609579,"SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION",Number Sign
609580,NINEIN-LIKE PROTEIN; NINL,Asterisk
609581,MOVED TO 130720,Caret
609582,MICRO RNA 122A; MIR122A,Asterisk
609583,JOUBERT SYNDROME 4; JBTS4,Number Sign
609584,L-2-HYDROXYGLUTARATE DEHYDROGENASE; L2HGDH,Asterisk
609585,COMPLEXIN 3; CPLX3,Asterisk
609586,COMPLEXIN 4; CPLX4,Asterisk
609587,REGULATOR OF CHROMOSOME CONDENSATION 2; RCC2,Asterisk
609588,GLUTAREDOXIN 5; GLRX5,Asterisk
609589,MITOCHONDRIAL TUMOR SUPPRESSOR GENE 1; MTUS1,Asterisk
609590,"QUAKING, MOUSE, HOMOLOG OF; QKI",Asterisk
609591,RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 1; RIT1,Asterisk
609592,RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 2; RIT2,Asterisk
609593,CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 1; CARMIL1,Asterisk
609594,"VENTRICULAR ZONE-EXPRESSED PH DOMAIN-CONTAINING PROTEIN, ZEBRAFISH, HOMOLOG OF, 1; VEPH1",Asterisk
609595,"R-SPONDIN FAMILY, MEMBER 1; RSPO1",Asterisk
609596,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT K; EIF3K",Asterisk
609597,PARIETAL FORAMINA 2; PFM2,Number Sign
609598,ZINC FINGER AND HOMEODOMAIN PROTEIN 3; ZHX3,Asterisk
609599,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1; ANKRD1,Asterisk
609600,ZINC FINGER PROTEIN 396; ZNF396,Asterisk
609601,ZINC FINGER PROTEIN 397; ZNF397,Asterisk
609602,ZINC FINGER PROTEIN 393; ZNF393,Asterisk
609603,"CRYSTALLIN, GAMMA-N; CRYGN",Asterisk
609604,"MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, BETA; MAP1LC3B",Asterisk
609605,"MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, GAMMA; MAP1LC3C",Asterisk
609606,"AUTOPHAGY 3, S. CEREVISIAE, HOMOLOG OF; ATG3",Asterisk
609607,NECTIN 4; NECTIN4,Asterisk
609608,"AUTOPHAGY 12, S. CEREVISIAE, HOMOLOG OF; ATG12",Asterisk
609609,MOVED TO 231530,Caret
609610,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 4; TUBGCP4,Asterisk
609611,"ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER E; ANP32E",Asterisk
609612,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE",
609613,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 2; PLEKHM2",Asterisk
609614,"RNA EXONUCLEASE 1, S. CEREVISIAE, HOMOLOG OF; REXO1",Asterisk
609615,QUEUINE tRNA-RIBOSYLTRANSFERASE 1; QTRT1,Asterisk
609616,"SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATE CALCIFICATIONS, AND DEAFNESS",
609617,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 2; SLC30A2",Asterisk
609618,NONCODING REPRESSOR OF NFAT; NRON,Asterisk
609619,"GOLGIN A8 FAMILY, MEMBER B; GOLGA8B",Asterisk
609620,SHORT QT SYNDROME 1; SQT1,Number Sign
609621,SHORT QT SYNDROME 2; SQT2,Number Sign
609622,SHORT QT SYNDROME 3; SQT3,Number Sign
609623,RAS-INTERACTING PROTEIN 1; RASIP1,Asterisk
609624,MITOCHONDRIAL COILED-COIL DOMAIN 1; MCCD1,Asterisk
609625,CHROMOSOME 10q26 DELETION SYNDROME,Number Sign
609626,MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 1; MDGA1,Asterisk
609627,"TASTE RECEPTOR, TYPE 2, MEMBER 50; TAS2R50",Asterisk
609628,MAJEED SYNDROME; MJDS,Number Sign
609629,"VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL DOMINANT",Percent
609630,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1",Percent
609631,DEAD BOX POLYPEPTIDE 58; DDX58,Asterisk
609632,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 5; GDPD5,Asterisk
609633,MAJOR AFFECTIVE DISORDER 3; MAFD3,Percent
609634,"MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3",Number Sign
609635,TRANSCRIPTION FACTOR 23; TCF23,Asterisk
609636,ALZHEIMER DISEASE 10,Percent
609637,HOLOPROSENCEPHALY 5; HPE5,Number Sign
609638,"EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA",Number Sign
609639,HEMOGLOBIN MU,Asterisk
609640,FRIAS SYNDROME,Number Sign
609641,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT M; EIF3M",Asterisk
609642,"T-CELL ANTIGEN RECEPTOR, GAMMA SUBUNIT, ALTERNATE READING FRAME PROTEIN",Asterisk
609643,NGUYEN SYNDROME,Percent
609644,FANCM GENE; FANCM,Asterisk
609645,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 4; NLRP4",Asterisk
609646,"DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42",Number Sign
609647,"DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46",Percent
609648,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 12; NLRP12",Asterisk
609649,TRICHILEMMAL CYST 1; TRICY1,Percent
609650,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 6; NLRP6",Asterisk
609651,"GLYCOPROTEIN HORMONE, ALPHA-2; GPHA2",Asterisk
609652,"GLYCOPROTEIN HORMONE, BETA-5; GPHB5",Asterisk
609653,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 2; NDUFAF2",Asterisk
609654,SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS,
609655,"TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS",
609656,BONE SIZE QUANTITATIVE TRAIT LOCUS 1,Percent
609657,BONE SIZE QUANTITATIVE TRAIT LOCUS 2,Percent
609658,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 5; NLRP5",Asterisk
609659,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 8; NLRP8",Asterisk
609660,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 13; NLRP13",Asterisk
609661,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 7; NLRP7",Asterisk
609662,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 10; NLRP10",Asterisk
609663,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 9; NLRP9",Asterisk
609664,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 11; NLRP11",Asterisk
609665,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 14; NLRP14",Asterisk
609666,TWO-PORE SEGMENT CHANNEL 1; TPCN1,Asterisk
609667,T-CELL ACTIVATION GTPase-ACTIVATING PROTEIN; TAGAP,Asterisk
609668,"PTC7 PROTEIN PHOSPHATASE, S. CEREVISIAE, HOMOLOG OF; PPTC7",Asterisk
609669,WD REPEAT-CONTAINING PROTEIN 36; WDR36,Asterisk
609670,"MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9",Percent
609671,SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 3; STEAP3,Asterisk
609672,EXOCYST COMPLEX COMPONENT 6; EXOC6,Asterisk
609673,PLATELET-DERIVED GROWTH FACTOR D; PDGFD,Asterisk
609674,"ESTABLISHMENT OF COHESION 1, S. CEREVISIAE, HOMOLOG OF, 1; ESCO1",Asterisk
609675,SCLEROSTIN DOMAIN-CONTAINING PROTEIN 1; SOSTDC1,Asterisk
609676,MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MAVS,Asterisk
609677,OSTEOSARCOMA-AMPLIFIED GENE 9; OS9,Asterisk
609678,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 1; SLITRK1",Asterisk
609679,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 3; SLITRK3",Asterisk
609680,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 5; SLITRK5",Asterisk
609681,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 6; SLITRK6",Asterisk
609682,DNA CROSS-LINK REPAIR PROTEIN 1A; DCLRE1A,Asterisk
609683,DNA CROSS-LINK REPAIR PROTEIN 1B; DCLRE1B,Asterisk
609684,MAL PROTEOLIPID PROTEIN 2; MAL2,Asterisk
609685,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE; CDCA7L,Asterisk
609686,CITRATE LYASE BETA-LIKE; CLYBL,Asterisk
609687,MICRO RNA 196A2; MIR196A2,Asterisk
609688,MICRO RNA 196B; MIR196B,Asterisk
609689,CENTROSOMAL PROTEIN 2; CEP2,Asterisk
609690,"PHENYLALANINE-tRNA SYNTHETASE, BETA SUBUNIT; FARSB",Asterisk
609691,FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 3; FHOD3,Asterisk
609692,"WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 2; WIPF2",Asterisk
609693,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 7; VWA7,Asterisk
609694,GEM-INTERACTING PROTEIN; GMIP,Asterisk
609695,4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; HPD,Asterisk
609696,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4B; ARID4B,Asterisk
609697,"SIN3A-ASSOCIATED PROTEIN, 130-KD; SAP130",Asterisk
609698,"THYROID HORMONE METABOLISM, ABNORMAL",Number Sign
609699,MONOGLYCERIDE LIPASE; MGLL,Asterisk
609700,RAB GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RABGEF1,Asterisk
609701,"N-ACETYLGLUCOSAMINIDASE, ALPHA-; NAGLU",Asterisk
609702,PROTEASOME ASSEMBLY CHAPERONE 2; PSMG2,Asterisk
609703,MICRO RNA 15A; MIR15A,Asterisk
609704,MICRO RNA 16-1; MIR16-1,Asterisk
609705,MICRO RNA 24-1; MIR24-1,Asterisk
609706,"DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53",Number Sign
609707,DIHYDROURIDINE SYNTHASE 2-LIKE; DUS2L,Asterisk
609708,LIPOPROTEIN LIPASE; LPL,Plus
609709,GLYCOSYLTRANSFERASE-LIKE 1B; GYLTL1B,Asterisk
609710,DENDRITIC CELL-ASSOCIATED NUCLEAR PROTEIN 1; DCANP1,Asterisk
609711,"UBIQUINOL-CYTOCHROME c REDUCTASE, 6.4-KD SUBUNIT; UQCR",Asterisk
609712,"PYRUVATE KINASE, LIVER AND RED BLOOD CELL; PKLR",Asterisk
609713,"HYDROXYUREA-SENSITIVE 1, S. POMBE, HOMOLOG OF, B; HUS1B",Asterisk
609714,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 1; TREML1,Asterisk
609715,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 2; TREML2,Asterisk
609716,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 3; TREML3,Asterisk
609717,PROSTATE CANCER-ASSOCIATED TRANSCRIPT 4; PCAT4,Asterisk
609718,LHFP-LIKE PROTEIN 2; LHFPL2,Asterisk
609719,LHFP-LIKE PROTEIN 3; LHFPL3,Asterisk
609720,"CRUMBS, DROSOPHILA, HOMOLOG OF, 2; CRB2",Asterisk
609721,POLYCYSTIN 1-LIKE 1; PKD1L1,Asterisk
609722,PDZ AND LIM DOMAIN PROTEIN 2; PDLIM2,Asterisk
609723,YIPPEE-LIKE 2; YPEL2,Asterisk
609724,YIPPEE-LIKE 3; YPEL3,Asterisk
609725,YIPPEE-LIKE 4; YPEL4,Asterisk
609726,YIPPEE-LIKE 5; YPEL5,Asterisk
609727,"SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT; SPG29",Percent
609728,METHIONYL-tRNA SYNTHETASE 2; MARS2,Asterisk
609729,PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 3; PDZRN3,Asterisk
609730,PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 4; PDZRN4,Asterisk
609731,CYSTATIN 11; CST11,Asterisk
609732,LIGAND OF NUMB PROTEIN X1; LNX1,Asterisk
609733,LIGAND OF NUMB PROTEIN X2; LNX2,Asterisk
609734,"OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH",Number Sign
609735,RING FINGER AND FYVE-LIKE DOMAIN CONTAINING 1; RFFL,Asterisk
609736,COILED-COIL DOMAIN-CONTAINING PROTEIN 88A; CCDC88A,Asterisk
609737,"CRUMBS, DROSOPHILA, HOMOLOG OF, 3; CRB3",Asterisk
609738,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9; IGSF9",Asterisk
609739,IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 1; ILDR1,Asterisk
609740,PHD FINGER PROTEIN 19; PHF19,Asterisk
609741,"CATARACT 22, MULTIPLE TYPES; CTRCT22",Number Sign
609742,INTERLEUKIN 4-INDUCED GENE 1; IL4I1,Asterisk
609743,CELL ADHESION MOLECULE 3; CADM3,Asterisk
609744,CELL ADHESION MOLECULE 4; CADM4,Asterisk
609745,"GLAUCOMA 1, OPEN ANGLE, I; GLC1I",Percent
609746,RHO GTPase-ACTIVATING PROTEIN 10; ARHGAP10,Asterisk
609747,ACTIN-BINDING RHO-ACTIVATING PROTEIN; ABRA,Asterisk
609748,UBIQUITIN-LIKE 7; UBL7,Asterisk
609749,UDP-GLUCURONATE DECARBOXYLASE 1; UXS1,Asterisk
609750,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4; EIG4",Percent
609751,"ACYL-CoA OXIDASE 1, PALMITOYL; ACOX1",Asterisk
609752,NUCLEAR RECEPTOR COACTIVATOR 7; NCOA7,Asterisk
609753,"CELIAC DISEASE, SUSCEPTIBILITY TO, 4; CELIAC4",Number Sign
609754,"CELIAC DISEASE, SUSCEPTIBILITY TO, 2; CELIAC2",Percent
609755,"CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3",Number Sign
609756,CHRNA7/FAM7A FUSION GENE; CHRFAM7A,Asterisk
609757,WILLIAMS-BEUREN REGION DUPLICATION SYNDROME,Number Sign
609758,Na+/K+ TRANSPORTING ATPase-INTERACTING 2; NKAIN2,Asterisk
609759,PR DOMAIN-CONTAINING PROTEIN 7; PRDM7,Asterisk
609760,PR DOMAIN-CONTAINING PROTEIN 9; PRDM9,Asterisk
609761,TRIO- AND F-ACTIN-BINDING PROTEIN; TRIOBP,Asterisk
609762,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 3; BLOC1S3",Asterisk
609763,"PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, ALPHA; PI4K2A",Asterisk
609764,LYSINE-SPECIFIC DEMETHYLASE 4A; KDM4A,Asterisk
609765,LYSINE-SPECIFIC DEMETHYLASE 4B; KDM4B,Asterisk
609766,LYSINE-SPECIFIC DEMETHYLASE 4D; KDM4D,Asterisk
609767,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 28; SLC25A28",Asterisk
609768,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 2; BLOC1S2",Asterisk
609769,"SHORT CHAIN DEHYDROGENASE/REDUCTASE FAMILY 9C, MEMBER 7; SDR9C7",Asterisk
609770,"ADHESION MOLECULE, INTERACTS WITH CXADR ANTIGEN 1; AMICA1",Asterisk
609771,UBINUCLEIN 1; UBN1,Asterisk
609772,CORTACTIN-BINDING PROTEIN 2; CTTNBP2,Asterisk
609773,EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 2; EID2,Asterisk
609774,APOPTOSIS INHIBITOR 5; API5,Asterisk
609775,"YIP1 DOMAIN FAMILY, MEMBER 3; YIPF3",Asterisk
609776,PROLINE-RICH ACIDIC PROTEIN 1; PRAP1,Asterisk
609777,CARDIOMYOPATHY-ASSOCIATED PROTEIN 1; CMYA1,Asterisk
609778,CARDIOMYOPATHY-ASSOCIATED PROTEIN 3; CMYA3,Asterisk
609779,NEVER IN MITOSIS GENE A-RELATED KINASE 11; NEK11,Asterisk
609780,"CARBOXYPEPTIDASE, VITELLOGENIC-LIKE; CPVL",Asterisk
609781,MOVED TO 100070,Caret
609782,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2; AAA2",Percent
609783,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 5; ITIH5",Asterisk
609784,UPSTREAM BINDING PROTEIN 1; UBP1,Asterisk
609785,TRANSCRIPTION FACTOR CP2-LIKE 1; TFCP2L1,Asterisk
609786,GRAINYHEAD-LIKE 1; GRHL1,Asterisk
609787,UBIQUITIN-ASSOCIATED PROTEIN 1; UBAP1,Asterisk
609788,X-RAY RADIATION RESISTANCE-ASSOCIATED 1; XRRA1,Asterisk
609789,AQUAPORIN 12A; AQP12A,Asterisk
609790,ALZHEIMER DISEASE 11,Percent
609791,LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 1; LINGO1,Asterisk
609792,LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 3; LINGO3,Asterisk
609793,LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 2; LINGO2,Asterisk
609794,LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 4; LINGO4,Asterisk
609795,PYROGLUTAMYLATED RF-AMIDE PEPTIDE PRECURSOR PROTEIN; QRFP,Asterisk
609796,PEELING SKIN SYNDROME 2; PSS2,Number Sign
609797,"BICAUDAL D, DROSOPHILA, HOMOLOG OF, 2; BICD2",Asterisk
609798,NEVER IN MITOSIS GENE A-RELATED KINASE 9; NEK9,Asterisk
609799,NEVER IN MITOSIS GENE A-RELATED KINASE 8; NEK8,Asterisk
609800,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4",Percent
609801,CD300E ANTIGEN; CD300E,Asterisk
609802,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 5; SLC24A5",Asterisk
609803,ANKYRIN AND ARMADILLO REPEATS-CONTAINING PROTEIN; ANKAR,Asterisk
609804,WD REPEAT-CONTAINING PROTEIN 16; WDR16,Asterisk
609805,SPERMATOGENESIS-ASSOCIATED PROTEIN 19; SPATA19,Asterisk
609806,HYDROXYMETHYLBILANE SYNTHASE; HMBS,Asterisk
609807,"CD300 ANTIGEN-LIKE FAMILY, MEMBER F; CD300LF",Asterisk
609808,"HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS",
609809,LCK-INTERACTING TRANSMEMBRANE ADAPTOR 1; LIME1,Asterisk
609810,PATERNALLY EXPRESSED GENE 10; PEG10,Asterisk
609811,"CYTOCHROME C OXIDASE, SUBUNIT 7B2; COX7B2",Asterisk
609812,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8",Number Sign
609813,"SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3",Number Sign
609814,COMPLEMENT FACTOR H DEFICIENCY; CFHD,Number Sign
609815,ZYGODACTYLY 1,Percent
609816,NEUROBEACHIN-LIKE 1; NBEAL1,Asterisk
609817,"VASCULITIS, LYMPHOCYTIC, CUTANEOUS SMALL VESSEL",Percent
609818,UBIQUITIN-SPECIFIC PROTEIN 10; USP10,Asterisk
609819,"PROSTATE, RECTUM, AND COLON GENE 1; PRAC1",Asterisk
609820,"ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3",Number Sign
609821,"BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8",Number Sign
609822,STATURE QUANTITATIVE TRAIT LOCUS 7; STQTL7,Percent
609823,"DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28",Number Sign
609824,HORMA DOMAIN-CONTAINING 1; HORMAD1,Asterisk
609825,"COQ2, S. CEREVISIAE, HOMOLOG OF; COQ2",Asterisk
609826,"SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 3; SLC34A3",Asterisk
609827,"PELLINO, DROSOPHILA, HOMOLOG OF, 3; PELI3",Asterisk
609828,FIBRONECTIN TYPE III AND SPRY DOMAINS-CONTAINING PROTEIN 1; FSD1,Asterisk
609829,FSD1 N-TERMINUS-LIKE PROTEIN; FSD1NL,Asterisk
609830,REMOVED FROM DATABASE,Caret
609831,MMACHC GENE; MMACHC,Asterisk
609832,"SOLUTE CARRIER FAMILY 47, MEMBER 1; SLC47A1",Asterisk
609833,"SOLUTE CARRIER FAMILY 47, MEMBER 2; SLC47A2",Asterisk
609834,SET AND MARINER TRANSPOSASE DOMAINS-CONTAINING PROTEIN; SETMAR,Asterisk
609835,MYCBP-ASSOCIATED PROTEIN; MYCBPAP,Asterisk
609836,PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 2; PCBD2,Asterisk
609837,"SMALL NUCLEOLAR RNA, C/D BOX, 115-1; SNORD115-1",Asterisk
609838,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 2; SLC24A2",Asterisk
609839,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 3; SLC24A3",Asterisk
609840,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 4; SLC24A4",Asterisk
609841,"SOLUTE CARRIER FAMILY 8 (SODIUM/LITHIUM/CALCIUM EXCHANGER), MEMBER B1; SLC8B1",Asterisk
609842,"ENHANCER OF mRNA DECAPPING 3, S. CEREVISIAE, HOMOLOG OF; EDC3",Asterisk
609843,"DECAPPING ENZYME 1, S. CEREVISIAE, HOMOLOG OF, B; DCP1B",Asterisk
609844,"DECAPPING ENZYME 2, S. CEREVISIAE, HOMOLOG OF; DCP2",Asterisk
609845,SUCRASE-ISOMALTASE; SI,Asterisk
609846,"REGENERATING ISLET-DERIVED FAMILY, MEMBER 4; REG4",Asterisk
609847,"NOTUM, DROSOPHILA, HOMOLOG OF; NOTUM",Asterisk
609848,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 11; KCTD11,Asterisk
609849,CORONIN 1B; CORO1B,Asterisk
609850,"TBC1 DOMAIN FAMILY, MEMBER 1; TBC1D1",Asterisk
609851,INOSITOL POLYPHOSPHATE MULTIKINASE; IPMK,Asterisk
609852,MIX1 HOMEOBOX-LIKE PROTEIN 1; MIXL1,Asterisk
609853,PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE; PPCS,Asterisk
609854,PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE; PPCDC,Asterisk
609855,COENZYME A SYNTHASE; COASY,Asterisk
609856,SPERMATOGENESIS-ASSOCIATED PROTEIN 16; SPATA16,Asterisk
609857,DYSTROPHIA MYOTONICA WD REPEAT-CONTAINING PROTEIN; DMWD,Asterisk
609858,ETHANOLAMINE KINASE 1; ETNK1,Asterisk
609859,ETHANOLAMINE KINASE 2; ETNK2,Asterisk
609860,DAD1-RELATED GENE,Asterisk
609861,I-KAPPA-B KINASE-INTERACTING PROTEIN; IKBIP,Asterisk
609862,"TRANSMEMBRANE PROTEASE, SERINE 6; TMPRSS6",Asterisk
609863,"TECTONIC FAMILY, MEMBER 1; TCTN1",Asterisk
609864,TRANSMEMBRANE PROTEIN 55A; TMEM55A,Asterisk
609865,TRANSMEMBRANE PROTEIN 55B; TMEM55B,Asterisk
609866,START DOMAIN-CONTAINING PROTEIN 13; STARD13,Asterisk
609867,UBIQUITIN-LIKE DOMAIN-CONTAINING CTD PHOSPHATASE 1; UBLCP1,Asterisk
609868,SPERMATOGENESIS-ASSOCIATED PROTEIN 7; SPATA7,Asterisk
609869,SPERMATOGENESIS-ASSOCIATED PROTEIN 12; SPATA12,Asterisk
609870,RHO GTPase-ACTIVATING PROTEIN 21; ARHGAP21,Asterisk
609871,"TBC1 DOMAIN FAMILY, MEMBER 2; TBC1D2",Asterisk
609872,WAP 4-DISULFIDE CORE DOMAIN 12; WFDC12,Asterisk
609873,INTELECTIN 1; ITLN1,Asterisk
609874,INTELECTIN 2; ITLN2,Asterisk
609875,"ATONAL, DROSOPHILA, HOMOLOG OF, 7; ATOH7",Asterisk
609876,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 6; BMND6,Percent
609877,"CRYSTALLIN, LAMBDA-1; CRYL1",Asterisk
609878,MEDIATOR COMPLEX SUBUNIT 9; MED9,Asterisk
609879,SPERMATOGENESIS-ASSOCIATED PROTEIN 4; SPATA4,Asterisk
609880,LYSINE ACETYLTRANSFERASE 7; KAT7,Asterisk
609881,RNA POLYMERASE II POLYPEPTIDE J-RELATED GENE,Asterisk
609882,METAL-REGULATORY TRANSCRIPTION FACTOR 2; MTF2,Asterisk
609883,MKS1 GENE; MKS1,Asterisk
609884,TRANSMEMBRANE PROTEIN 67; TMEM67,Asterisk
609885,"ELONGATION FACTOR, RNA POLYMERASE II, 3; ELL3",Asterisk
609886,GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA,Number Sign
609887,"GLAUCOMA 1, OPEN ANGLE, G; GLC1G",Number Sign
609888,"LEPROSY, SUSCEPTIBILITY TO, 1; LPRS1",Percent
609889,"ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY",Number Sign
609890,UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 4; UBR4,Asterisk
609891,RIPPLY TRANSCRIPTIONAL REPRESSOR 2; RIPPLY2,Asterisk
609892,DOWN SYNDROME CRITICAL REGION GENE 6; DSCR6,Asterisk
609893,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3; CHNG3",Percent
609894,"UNC13, C. ELEGANS, HOMOLOG OF, A; UNC13A",Asterisk
609895,CASTOR ZINC FINGER PROTEIN 1; CASZ1,Asterisk
609896,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 3; EIF4E3",Asterisk
609897,EPIDERMAL GROWTH FACTOR-LIKE 8; EGFL8,Asterisk
609898,KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 1; KREMEN1,Asterisk
609899,KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 2; KREMEN2,Asterisk
609900,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3D; APOBEC3D",Asterisk
609901,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 4B; ANKS4B,Asterisk
609902,MOVED TO 603317,Caret
609903,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5; SLEB5",Percent
609904,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER A; HIST1H2BA",Asterisk
609905,"MYOSIN LIGHT CHAIN 9, REGULATORY; MYL9",Asterisk
609906,EMBRYONAL FYN-ASSOCIATED SUBSTRATE; EFS,Asterisk
609907,SEMAPHORIN 3D; SEMA3D,Asterisk
609908,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 4; APOBEC4",Asterisk
609909,"CARDIOMYOPATHY, DILATED, 1P; CMD1P",Number Sign
609910,MYCBP-ASSOCIATED TESTIS-EXPRESSED PROTEIN 1; MAATS1,Asterisk
609911,HEPATOCELLULAR CARCINOMA-DOWNREGULATED MITOCHONDRIAL CARRIER PROTEIN,Asterisk
609912,LYSINE ACETYLTRANSFERASE 8; KAT8,Asterisk
609913,RETINITIS PIGMENTOSA 32; RP32,Percent
609914,AQUAPORIN 11; AQP11,Asterisk
609915,"CARDIOMYOPATHY, DILATED, 1Q; CMD1Q",Percent
609916,"5-AZACYTIDINE-INDUCED GENE 2, MOUSE, HOMOLOG OF; AZI2",Asterisk
609917,PRION PROTEIN-INTERACTING PROTEIN; PRNPIP,Asterisk
609918,GALLBLADDER DISEASE 2; GBD2,Percent
609919,GALLBLADDER DISEASE 3; GBD3,Percent
609920,CADHERIN 22; CDH22,Asterisk
609921,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 10; LRP10,Asterisk
609922,EH DOMAIN-BINDING PROTEIN 1; EHBP1,Asterisk
609923,RETINITIS PIGMENTOSA 31; RP31,Number Sign
609924,AMINOACYLASE 1 DEFICIENCY; ACY1D,Number Sign
609925,DIPEPTIDASE 2; DPEP2,Asterisk
609926,DIPEPTIDASE 3; DPEP3,Asterisk
609927,"VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, A; VPS37A",Asterisk
609928,"MYOSIN, HEAVY CHAIN 7B, CARDIAC MUSCLE, BETA; MYH7B",Asterisk
609929,"MYOSIN, HEAVY CHAIN 15; MYH15",Asterisk
609930,"MYOSIN, LIGHT CHAIN 6B, ALKALI, SMOOTH MUSCLE AND NONMUSCLE, SLOW; MYL6B",Asterisk
609931,"MYOSIN LIGHT CHAIN 6, ALKALI, SMOOTH MUSCLE AND NONMUSCLE; MYL6",Asterisk
609932,SPERM ACROSOME-ASSOCIATED PROTEIN 4; SPACA4,Asterisk
609933,REGENERATING ISLET-DERIVED 3-GAMMA; REG3G,Asterisk
609934,EARLY B-CELL FACTOR 2; EBF2,Asterisk
609935,EARLY B-CELL FACTOR 4; EBF4,Asterisk
609936,SPINDLIN 1; SPIN1,Asterisk
609937,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7; CDCA7,Asterisk
609938,CELL ADHESION MOLECULE 2; CADM2,Asterisk
609939,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6",Percent
609940,MOVED TO 112250,Caret
609941,"DEAFNESS, AUTOSOMAL RECESSIVE 51; DFNB51",Percent
609942,NOONAN SYNDROME 3; NS3,Number Sign
609943,"HYPERTRICHOSIS, HYPERKERATOSIS, MENTAL RETARDATION, AND DISTINCTIVE FACIAL FEATURES",
609944,"ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES",
609945,"BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA",
609946,"DEAFNESS, AUTOSOMAL RECESSIVE 47; DFNB47",Percent
609947,KIAA0391 GENE; KIAA0391,Asterisk
609948,RING FINGER PROTEIN 216; RNF216,Asterisk
609949,COMPLEMENT COMPONENT 5a RECEPTOR 2; C5AR2,Asterisk
609950,"RAVER1, MOUSE, HOMOLOG OF",Asterisk
609951,ZINC FINGER PROTEIN 384; ZNF384,Asterisk
609952,"DEAFNESS, AUTOSOMAL RECESSIVE 55; DFNB55",Percent
609953,"RAVER2, MOUSE, HOMOLOG OF",Asterisk
609954,"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 4; ASPG4",Percent
609955,"FIBROMATOSIS, GINGIVAL, 3; GINGF3",Percent
609956,RAS-ASSOCIATED PROTEIN RAB37; RAB37,Asterisk
609957,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1J; PPM1J",Asterisk
609958,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3",Percent
609959,MYELOID-ASSOCIATED DIFFERENTIATION MARKER; MYADM,Asterisk
609960,KIAA0020 GENE; KIAA0020,Asterisk
609961,MINOR HISTOCOMPATIBILITY ANTIGEN HB-1,Asterisk
609962,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER E; CLEC4E",Asterisk
609963,CHONDROITIN SULFATE SYNTHASE 3; CHSY3,Asterisk
609964,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER D; CLEC4D",Asterisk
609965,"DEAFNESS, AUTOSOMAL DOMINANT 53; DFNA53",Percent
609966,"GAMETOGENETIN, MOUSE, HOMOLOG OF; GGN",Asterisk
609967,B-CELL NOVEL PROTEIN 1,Asterisk
609968,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5",Number Sign
609969,SUPRABASIN,Asterisk
609970,"HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 2; HES2",Asterisk
609971,"HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 3; HES3",Asterisk
609972,ACYL-CoA THIOESTERASE 2; ACOT2,Asterisk
609973,HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 3; HCN3,Asterisk
609974,CADHERIN 9; CDH9,Asterisk
609975,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4",Number Sign
609976,"HYPOXIA-INDUCIBLE FACTOR 3, ALPHA SUBUNIT; HIF3A",Asterisk
609977,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 8; CDCA8,Asterisk
609978,CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 2; CADPS2,Asterisk
609979,VESTIGIAL-LIKE 2; VGLL2,Asterisk
609980,VESTIGIAL-LIKE 3; VGLL3,Asterisk
609981,IMMUNODEFICIENCY 54; IMD54,Number Sign
609982,"VACUOLAR PROTEIN SORTING 4, YEAST, HOMOLOG OF, A; VPS4A",Asterisk
609983,"VACUOLAR PROTEIN SORTING 4, S. CEREVISIAE, HOMOLOG OF, B; VPS4B",Asterisk
609984,"ZWILCH, DROSOPHILA, HOMOLOG OF; ZWILCH",Asterisk
609985,PANIC DISORDER 3,Percent
609986,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 6; CARD6,Asterisk
609987,STIMULATED BY RETINOIC ACID 8; STRA8,Asterisk
609988,"PYROPHOSPHATASE, INORGANIC, 2; PPA2",Asterisk
609989,"METAPHYSEAL CHONDRODYSPLASIA WITH CONE-SHAPED EPIPHYSES, NORMAL HAIR, AND NORMAL HANDS",Percent
609990,TRICHOSCYPHODYSPLASIA,Percent
609991,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; FNDC1,Asterisk
609992,"PROCESSING OF PRECURSOR 5, S. CEREVISIAE, HOMOLOG OF; POP5",Asterisk
609993,OSTEOSCLEROSIS WITH ICHTHYOSIS AND PREMATURE OVARIAN FAILURE,Percent
609994,"MYOPIA 11, AUTOSOMAL DOMINANT; MYP11",Percent
609995,"MYOPIA 12, AUTOSOMAL DOMINANT; MYP12",Percent
609996,"COLLAGEN, TYPE XXVIII, ALPHA-1; COL28A1",Asterisk
609997,HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2; HINT2,Asterisk
609998,HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 3; HINT3,Asterisk
609999,SYNAPSE DIFFERENTIATION-INDUCED GENE 1-LIKE; SYNDIG1L,Asterisk
610000,"CENTROSOMAL PROTEIN, 55-KD; CEP55",Asterisk
610001,"ARTHROGRYPOSIS MULTIPLEX WITH DEAFNESS, INGUINAL HERNIAS, AND EARLY DEATH",
610002,"COLLAGEN, TYPE XXI, ALPHA-1; COL21A1",Asterisk
610003,"CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT",Number Sign
610004,"COLLAGEN, TYPE XXV, ALPHA-1; COL25A1",Asterisk
610005,TRAF2- AND NCK-INTERACTING KINASE; TNIK,Asterisk
610006,2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY,Number Sign
610007,LIMB REGION 1 HOMOLOG-LIKE; LMBR1L,Asterisk
610008,ARYLSULFATASE G; ARSG,Asterisk
610009,ARYLSULFATASE I; ARSI,Asterisk
610010,ARYLSULFATASE J; ARSJ,Asterisk
610011,ARYLSULFATASE K; ARSK,Asterisk
610012,SULFATASE 1; SULF1,Asterisk
610013,SULFATASE 2; SULF2,Asterisk
610014,TM2 DOMAIN-CONTAINING PROTEIN 3; TM2D3,Asterisk
610015,"GLUTAMINE DEFICIENCY, CONGENITAL",Number Sign
610016,MICRO RNA 132; MIR132,Asterisk
610017,MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2,Number Sign
610018,SOLO GENE,Asterisk
610019,CATARACT 18; CTRCT18,Number Sign
610020,"TBC1 DOMAIN FAMILY, MEMBER 10A; TBC1D10A",Asterisk
610021,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7",Number Sign
610022,MYOSIN VC; MYO5C,Asterisk
610023,"BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS",
610024,RETINAL CONE DYSTROPHY 3A; RCD3A,Number Sign
610025,"COLLAGEN, TYPE XXIV, ALPHA-1; COL24A1",Asterisk
610026,"COLLAGEN, TYPE XXII, ALPHA-1; COL22A1",Asterisk
610027,"VACUOLAR PROTEIN SORTING 26, YEAST, HOMOLOG OF, B; VPS26B",Asterisk
610028,POLY(ADP-RIBOSE) POLYMERASE 14; PARP14,Asterisk
610029,VOLTAGE-DEPENDENT ANION CHANNEL 3; VDAC3,Asterisk
610030,VOLTAGE-DEPENDENT ANION CHANNEL 4; VDAC4,Asterisk
610031,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7",Number Sign
610032,TRANSPORTIN 3; TNPO3,Asterisk
610033,PENTA-EF-HAND DOMAIN-CONTAINING PROTEIN 1; PEF1,Asterisk
610034,"VACUOLAR PROTEIN SORTING 33, YEAST, HOMOLOG OF, A; VPS33A",Asterisk
610035,"VACUOLAR PROTEIN SORTING 45, YEAST, HOMOLOG OF; VPS45",Asterisk
610036,CLAUDIN 19; CLDN19,Asterisk
610037,"VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, B; VPS37B",Asterisk
610038,"VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, C; VPS37C",Asterisk
610039,"VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, D; VPS37D",Asterisk
610040,MYOSIN IIIB; MYO3B,Asterisk
610041,NEDD4 FAMILY-INTERACTING PROTEIN 2; NDFIP2,Asterisk
610042,PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1,Number Sign
610043,"COLLAGEN, TYPE XXIII, ALPHA-1; COL23A1",Asterisk
610044,"POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 2; KCNT2",Asterisk
610045,"ALDEHYDE DEHYDROGENASE 5 FAMILY, MEMBER A1; ALDH5A1",Asterisk
610046,LAEVERIN,Asterisk
610047,CANOPY FGF SIGNALING REGULATOR 4; CNPY4,Asterisk
610048,"CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD",Number Sign
610049,SAP DOMAIN-CONTAINING RIBONUCLEOPROTEIN; SARNP,Asterisk
610050,"TRANSMEMBRANE PROTEIN, SERINE 13; TMPRSS13",Asterisk
610051,"CHMP FAMILY, MEMBER 4A; CHMP4A",Asterisk
610052,"VACUOLAR PROTEIN SORTING 24, YEAST, HOMOLOG OF; VPS24",Asterisk
610053,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 6; TUBGCP6,Asterisk
610054,"H2A HISTONE FAMILY, MEMBER Y; H2AFY",Asterisk
610055,COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 1A; CC2D1A,Asterisk
610056,SPERM-ASSOCIATED ANTIGEN 7; SPAG7,Asterisk
610057,"TRANS-2,3-ENOYL-CoA REDUCTASE; TECR",Asterisk
610058,TUBULIN-SPECIFIC CHAPERONE A; TBCA,Asterisk
610059,MITOCHONDRIAL RIBOSOMAL PROTEIN L33; MRPL33,Asterisk
610060,"POLYMERASE I, RNA, SUBUNIT C; POLR1C",Asterisk
610061,"DYNEIN, AXONEMAL, HEAVY CHAIN 7; DNAH7",Asterisk
610062,"DYNEIN, AXONEMAL, LIGHT CHAIN 1; DNAL1",Asterisk
610063,"DYNEIN, AXONEMAL, HEAVY CHAIN 17; DNAH17",Asterisk
610064,"OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1",Percent
610065,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7; SLEB7",Percent
610066,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8; SLEB8",Percent
610067,MYOSIN XVIIIA; MYO18A,Asterisk
610068,"SOLUTE CARRIER FAMILY 26 (ANION TRANSPORTER), MEMBER 6: SLC26A6",Asterisk
610069,"POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2",Number Sign
610070,ASTER-ASSOCIATED PROTEIN,Asterisk
610071,HYPERPARATHYROIDISM 3; HRPT3,Percent
610072,ERMIN; ERMN,Asterisk
610073,ORM1-LIKE PROTEIN 1; ORMDL1,Asterisk
610074,ORM1-LIKE PROTEIN 2; ORMDL2,Asterisk
610075,ORM1-LIKE PROTEIN 3; ORMDL3,Asterisk
610076,CYCLIN-DEPENDENT KINASE 20; CDK20,Asterisk
610077,REGULATOR OF CELL CYCLE; RGCC,Asterisk
610078,MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 3; MORC3,Asterisk
610079,SIALIC ACID ACETYLESTERASE; SIAE,Asterisk
610080,TM2 DOMAIN-CONTAINING PROTEIN 1; TM2D1,Asterisk
610081,TM2 DOMAIN-CONTAINING PROTEIN 2; TM2D2,Asterisk
610082,MYOSIN REGULATORY LIGHT CHAIN-INTERACTING PROTEIN; MYLIP,Asterisk
610083,TENEURIN TRANSMEMBRANE PROTEIN 3; TENM3,Asterisk
610084,TENEURIN TRANSMEMBRANE PROTEIN 4; TENM4,Asterisk
610085,"FAMILY WITH SEQUENCE SIMILARITY 167, MEMBER A; FAM167A",Asterisk
610086,PROTEIN ARGININE METHYLTRANSFERASE 8; PRMT8,Asterisk
610087,PROTEIN ARGININE N-METHYLTRANSFERASE 7; PRMT7,Asterisk
610088,OLFACTOMEDIN-LIKE 3; OLFML3,Asterisk
610089,RAD50-INTERACTING PROTEIN 1; RINT1,Asterisk
610090,PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD,Number Sign
610091,WD REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; WSB1,Asterisk
610092,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3",Number Sign
610093,"MICROPHTHALMIA, ISOLATED 2; MCOP2",Number Sign
610094,"DEF6, MOUSE, HOMOLOG OF; DEF6",Asterisk
610095,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 3; KIR3DL3",Asterisk
610096,T-CELL IMMUNOGLOBULIN AND MUCIN DOMAINS-CONTAINING PROTEIN 4; TIMD4,Asterisk
610097,OUTER DENSE FIBER OF SPERM TAILS 4; ODF4,Asterisk
610098,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 9; MCM9,Asterisk
610099,"MYOPATHY, DISTAL, 3; MPD3",Percent
610100,"GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2",Number Sign
610101,"CUTC COPPER TRANSPORTER, E. COLI, HOMOLOG OF; CUTC",Asterisk
610102,COMPLEMENT COMPONENT 7 DEFICIENCY; C7D,Number Sign
610103,"S100 CALCIUM-BINDING PROTEIN, ZETA; S100Z",Asterisk
610104,MICRO RNA 125B1; MIR125B1,Asterisk
610105,MICRO RNA 125B2; MIR125B2,Asterisk
610106,DREBRIN-LIKE; DBNL,Asterisk
610107,O-SIALOGLYCOPROTEIN ENDOPEPTIDASE; OSGEP,Asterisk
610108,"ANOCTAMIN 1, CALCIUM-ACTIVATED CHLORIDE CHANNEL; ANO1",Asterisk
610109,ANOCTAMIN 2; ANO2,Asterisk
610110,ANOCTAMIN 3; ANO3,Asterisk
610111,ANOCTAMIN 4; ANO4,Asterisk
610112,C-MAF-INDUCING PROTEIN,Asterisk
610113,ADAMTS-LIKE 4; ADAMTSL4,Asterisk
610114,STATURE QUANTITATIVE TRAIT LOCUS 8; STQTL8,Percent
610115,TRANSMEMBRANE PROTEIN 48; TMEM48,Asterisk
610116,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 14; P2RY14",Asterisk
610117,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 11; SLC26A11",Asterisk
610118,G PROTEIN-COUPLED RECEPTOR 33; GPR33,Asterisk
610119,TENEURIN TRANSMEMBRANE PROTEIN 2; TENM2,Asterisk
610120,TETRASPANIN 33; TSPAN33,Asterisk
610121,5-HYDROXYTRYPTAMINE RECEPTOR 3C; HTR3C,Asterisk
610122,5-HYDROXYTRYPTAMINE RECEPTOR 3D; HTR3D,Asterisk
610123,5-HYDROXYTRYPTAMINE RECEPTOR 3E; HTR3E,Asterisk
610124,CARBOHYDRATE SULFOTRANSFERASE 13; CHST13,Asterisk
610125,"MICROPHTHALMIA, SYNDROMIC 5; MCOPS5",Number Sign
610126,MOVED TO 607932,Caret
610127,"CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10",Number Sign
610128,CARBOHYDRATE SULFOTRANSFERASE 11; CHST11,Asterisk
610129,CARBOHYDRATE SULFOTRANSFERASE 12; CHST12,Asterisk
610130,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 1; SLC26A1",Asterisk
610131,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4",Number Sign
610132,VANG-LIKE 1; VANGL1,Asterisk
610133,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 3; ST6GALNAC3",Asterisk
610134,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 5; ST6GALNAC5",Asterisk
610135,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 6; ST6GALNAC6",Asterisk
610136,DEVRIENDT SYNDROME,
610137,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 2; ST6GALNAC2",Asterisk
610138,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 1; ST6GALNAC1",Asterisk
610139,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 6; ST8SIA6",Asterisk
610140,"HEART-HAND SYNDROME, SLOVENIAN TYPE",Number Sign
610141,"QT INTERVAL, VARIATION IN",Percent
610142,"CENTROSOMAL PROTEIN, 290-KD; CEP290",Asterisk
610143,"DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62",Percent
610144,"TBC1 DOMAIN FAMILY, MEMBER 3B; TBC1D3B",Asterisk
610145,ENDOTHELIN-CONVERTING ENZYME 2; ECE2,Asterisk
610146,"INSULIN-LIKE GROWTH FACTOR II, ANTISENSE; IGF2AS",Asterisk
610147,G PROTEIN-COUPLED BILE ACID RECEPTOR 1; GPBAR1,Asterisk
610148,BBS10 GENE; BBS10,Asterisk
610149,"MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7",Number Sign
610150,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 5; CCT5",Asterisk
610151,METHIONYL AMINOPEPTIDASE 1; METAP1,Asterisk
610152,CENTROMERIC PROTEIN M; CENPM,Asterisk
610153,"DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49",Number Sign
610154,"DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44",Number Sign
610155,"DIABETES MELLITUS, INSULIN-DEPENDENT, 19; IDDM19",Percent
610156,"MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS",Number Sign
610157,HEAT-SHOCK RNA 1,
610158,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2",Percent
610159,ZINC FINGER PROTEIN 366; ZNF366,Asterisk
610160,ZINC FINGER PROTEIN 367; ZNF367,Asterisk
610161,TRANSCRIPTION FACTOR AP2-DELTA; TFAP2D,Asterisk
610162,COILED-COIL DOMAIN-CONTAINING PROTEIN 28B; CCDC28B,Asterisk
610163,IMMUNODEFICIENCY 25; IMD25,Number Sign
610164,MICRO RNA 134; MIRN134,Asterisk
610165,GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING PROTEIN 1; GTDC1,Asterisk
610166,IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 1; IQSEC1,Asterisk
610167,PHOSPHOHISTIDINE PHOSPHATASE 1; PHPT1,Asterisk
610168,LOEYS-DIETZ SYNDROME 2; LDS2,Number Sign
610169,INO80 COMPLEX SUBUNIT; INO80,Asterisk
610170,KYPHOSCOLIOSIS 1; KYPSC1,Percent
610171,CALMODULIN-LIKE 6; CALML6,Asterisk
610172,SPERM FLAGELLAR PROTEIN 2; SPEF2,Asterisk
610173,MICRO RNA 10A; MIR10A,Asterisk
610174,UBIQUITIN DOMAIN-CONTAINING PROTEIN 2; UBTD2,Asterisk
610175,MICRO RNA 130A; MIR130A,Asterisk
610176,"SECRETOGLOBIN, FAMILY 1C, MEMBER 1; SCGB1C1",Asterisk
610177,APOPTOSIS-ENHANCING NUCLEASE; AEN,Asterisk
610178,KIAA0586 GENE; KIAA0586,Asterisk
610179,PHOSPHOLIPASE B1; PLB1,Asterisk
610180,OSTEOCLAST-STIMULATING FACTOR 1; OSTF1,Asterisk
610181,AICARDI-GOUTIERES SYNDROME 2; AGS2,Number Sign
610182,PALMDELPHIN; PALMD,Asterisk
610183,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 6; ZFAND6,Asterisk
610184,MONOACYLGLYCEROL O-ACYLTRANSFERASE 3; MOGAT3,Asterisk
610185,"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2",Number Sign
610186,UBIQUITIN-SPECIFIC PEPTIDASE 17-LIKE FAMILY MEMBER 2; USP17L2,Asterisk
610187,DIAPHRAGMATIC HERNIA 3; DIH3,Number Sign
610188,JOUBERT SYNDROME 5; JBTS5,Number Sign
610189,SENIOR-LOKEN SYNDROME 6; SLSN6,Number Sign
610190,CARBOHYDRATE SULFOTRANSFERASE 8; CHST8,Asterisk
610191,CARBOHYDRATE SULFOTRANSFERASE 9; CHST9,Asterisk
610192,GLIS FAMILY ZINC FINGER PROTEIN 3; GLIS3,Asterisk
610193,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10",Number Sign
610194,"BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 2; B3GALNT2",Asterisk
610195,PROSTATE TUMOR OVEREXPRESSED GENE 1; PTOV1,Asterisk
610196,ELMO/CED12 DOMAIN-CONTAINING PROTEIN 2; ELMOD2,Asterisk
610197,MEDIATOR COMPLEX SUBUNIT 25; MED25,Asterisk
610198,"3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5",Number Sign
610199,"DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH",Number Sign
610200,MITOCHONDRIAL RIBOSOMAL PROTEIN L13; MRPL13,Asterisk
610201,"CENTROSOMAL PROTEIN, 162-KD; CEP162",Asterisk
610202,"CATARACT 21, MULTIPLE TYPES; CTRCT21",Number Sign
610203,CYSTEINE-RICH INHIBITOR OF PAK1; CRIPAK,Asterisk
610204,"PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5",Number Sign
610205,ALAGILLE SYNDROME 2; ALGS2,Number Sign
610206,"SOLUTE CARRIER FAMILY 4 (SODIUM BORATE COTRANSPORTER), MEMBER 11; SLC4A11",Asterisk
610207,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 9; SLC4A9",Asterisk
610208,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10",Percent
610209,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11",Percent
610210,"MAF1, S. CEREVISIAE, HOMOLOG OF; MAF1",Asterisk
610211,SRA STEM LOOP-INTERACTING RNA-BINDING PROTEIN; SLIRP,Asterisk
610212,"DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66",Number Sign
610213,"ANEURYSM, INTRACRANIAL BERRY, 4; ANIB4",Percent
610214,ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 3; EDEM3,Asterisk
610215,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 25; ARHGEF25,Asterisk
610216,ANOCTAMIN 8; ANO8,Asterisk
610217,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B,Number Sign
610218,SAP30-BINDING PROTEIN; SAP30BP,Asterisk
610219,DFNB59 GENE,Asterisk
610220,"DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59",Number Sign
610221,"AKT1 SUBSTRATE 1, PROLINE-RICH; AKT1S1",Asterisk
610222,RAS AND RAB INTERACTOR 2; RIN2,Asterisk
610223,RAS AND RAB INTERACTOR 3; RIN3,Asterisk
610224,SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 1; SOHLH1,Asterisk
610225,RIBOSOMAL PROTEIN S19 BINDING PROTEIN 1; RPS19BP1,Asterisk
610226,ZINC FINGER PROTEIN 750; ZNF750,Asterisk
610227,SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS,Number Sign
610228,CALPAIN 13; CAPN13,Asterisk
610229,CALPAIN 14; CAPN14,Asterisk
610230,tRNA 5-METHYLAMINOMETHYL-2-THIOURIDYLATE METHYLTRANSFERASE; TRMU,Asterisk
610231,POLYCOMB GROUP RING FINGER PROTEIN 1; PCGF1,Asterisk
610232,"ATPase, TYPE 13A3; ATP13A3",Asterisk
610233,MOVED TO 211900,Caret
610234,SYNPOLYDACTYLY 3; SPD3,Percent
610235,"MITOCHONDRIAL PROTEIN, 18-KD",Asterisk
610236,LUNAPARK; LNPK,Asterisk
610237,MEDIATOR COMPLEX SUBUNIT 30; MED30,Asterisk
610238,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 11; SLC5A11",Asterisk
610239,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4,Percent
610240,LHFP-LIKE PROTEIN 4; LHFPL4,Asterisk
610241,RING FINGER PROTEIN 32; RNF32,Asterisk
610242,CHROMOSOME 7 OPEN READING FRAME 13; C7ORF13,Asterisk
610243,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 27; ZFYVE27,Asterisk
610244,"SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33",Number Sign
610245,SPINOCEREBELLAR ATAXIA 23; SCA23,Number Sign
610246,SPINOCEREBELLAR ATAXIA 28; SCA28,Number Sign
610247,"ESOPHAGITIS, EOSINOPHILIC, 1; EOE1",Percent
610248,"DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65",Percent
610249,PROTEIN O-FUCOSYLTRANSFERASE 2; POFUT2,Asterisk
610250,"SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31",Number Sign
610251,"ALCOHOL SENSITIVITY, ACUTE",Number Sign
610252,MICRO RNA 1-2; MIR1-2,Asterisk
610253,KLEEFSTRA SYNDROME 1; KLEFS1,Number Sign
610254,MICRO RNA 133A1; MIR133A1,Asterisk
610255,MICRO RNA 133A2; MIR133A2,Asterisk
610256,ANTERIOR SEGMENT DYSGENESIS 2; ASGD2,Number Sign
610257,"SEC31, YEAST, HOMOLOG OF, A; SEC31A",Asterisk
610258,"SEC31, YEAST, HOMOLOG OF, B; SEC31B",Asterisk
610259,LONG INTERGENIC NONCODING RNA 163; LINC00163,Asterisk
610260,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2; IHPS2",Percent
610261,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5",Percent
610262,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6",Percent
610263,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 13; DNAJB13",Asterisk
610264,TESTIS-PROSTATE-PLACENTA-EXPRESSED PROTEIN; TEPP,Asterisk
610265,"DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67",Number Sign
610266,TAO KINASE 1; TAOK1,Asterisk
610267,METHIONINE AMINOPEPTIDASE 1D; METAP1D,Asterisk
610268,MONOACYLGLYCEROL O-ACYLTRANSFERASE 1; MOGAT1,Asterisk
610269,MOVED TO 607499 AND 606788,Caret
610270,MONOACYLGLYCEROL O-ACYLTRANSFERASE 2; MOGAT2,Asterisk
610271,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS S PROTEIN; PIGS,Asterisk
610272,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS T PROTEIN; PIGT,Asterisk
610273,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS M PROTEIN; PIGM,Asterisk
610274,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS V PROTEIN; PIGV,Asterisk
610275,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS W PROTEIN; PIGW,Asterisk
610276,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS X PROTEIN; PIGX,Asterisk
610277,ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 1; ORAI1,Asterisk
610278,PLATELET ENDOTHELIAL AGGREGATION RECEPTOR 1,Asterisk
610279,"PACHYGYRIA, FRONTOTEMPORAL",Percent
610280,OSTEOCRIN; OSTN,Asterisk
610281,ZINC FINGER PROTEIN 62; ZFP62,Asterisk
610282,RETINITIS PIGMENTOSA 35; RP35,Number Sign
610283,CONE-ROD DYSTROPHY 10; CORD10,Number Sign
610284,LIPOYLTRANSFERASE 1; LIPT1,Asterisk
610285,DOWNSTREAM OF TYROSINE KINASE 7; DOK7,Asterisk
610286,LEUCINE CARBOXYL METHYLTRANSFERASE 1; LCMT1,Asterisk
610287,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 15; FBXL15,Asterisk
610288,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 6; GOLGA6",Asterisk
610289,3-OXOACID CoA TRANSFERASE 2; OXCT2,Asterisk
610290,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 12; GALNT12,Asterisk
610291,SYNAPTIC VESICLE GLYCOPROTEIN 2C; SV2C,Asterisk
610292,B-CELL SCAFFOLD PROTEIN WITH ANKYRIN REPEATS 1; BANK1,Asterisk
610293,GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; GPID,Number Sign
610294,INTELLIGENCE QUANTITATIVE TRAIT LOCUS 2,Percent
610295,INTELLIGENCE QUANTITATIVE TRAIT LOCUS 3,Percent
610296,NUDC DOMAIN-CONTAINING PROTEIN 3; NUDCD3,Asterisk
610297,"PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13",Number Sign
610298,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 2; PHLDB2",Asterisk
610299,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 17; SLC6A17",Asterisk
610300,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 18; SLC6A18",Asterisk
610301,TRANSMEMBRANE PROTEIN 57; TMEM57,Asterisk
610302,ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 2; EDEM2,Asterisk
610303,V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE HOMOLOG A; MAFA,Asterisk
610304,"DER1-LIKE DOMAIN FAMILY, MEMBER 2; DERL2",Asterisk
610305,"DER1-LIKE DOMAIN FAMILY, MEMBER 3; DERL3",Asterisk
610306,NEPHRONECTIN; NPNT,Asterisk
610307,CERAMIDE KINASE; CERK,Asterisk
610308,BETA-3-GLUCOSYLTRANSFERASE; B3GLCT,Asterisk
610309,UBIQUITIN-CONJUGATING ENZYME E2S; UBE2S,Asterisk
610310,LOC152586 GENE,Asterisk
610311,MEDIATOR COMPLEX SUBUNIT 28; MED28,Asterisk
610312,PIWI-LIKE 2: PIWIL2,Asterisk
610313,CRISPONI/COLD-INDUCED SWEATING SYNDROME 2; CISS2,Number Sign
610314,PIWI-LIKE 3: PIWIL3,Asterisk
610315,PIWI-LIKE 4; PIWIL4,Asterisk
610316,POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE 1; PNPT1,Asterisk
610317,"CORDON-BLEU, MOUSE, HOMOLOG OF; COBL",Asterisk
610318,COBL-LIKE PROTEIN 1: COBLL1,Asterisk
610319,"RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA",
610320,MYOPIA 14; MYP14,Percent
610321,"PROSTATE CANCER, HEREDITARY, 7; HPC7",Percent
610322,TRANSCRIPTIONAL REGULATING FACTOR 1; TRERF1,Asterisk
610323,METADHERIN; MTDH,Asterisk
610324,"3-OXOACYL-ACP SYNTHASE, MITOCHONDRIAL; OXSM",Asterisk
610325,"NUCLEAR DISTRIBUTION GENE C, A. NIDULANS, HOMOLOG OF; NUDC",Asterisk
610326,"RIBONUCLEASE H2, SUBUNIT B; RNASEH2B",Asterisk
610327,RUN AND FYVE DOMAINS-CONTAINING PROTEIN 1; RUFY1,Asterisk
610328,RUN AND FYVE DOMAINS-CONTAINING PROTEIN 2; RUFY2,Asterisk
610329,AICARDI-GOUTIERES SYNDROME 3; AGS3,Number Sign
610330,"RIBONUCLEASE H2, SUBUNIT C; RNASEH2C",Asterisk
610331,"HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 6; HES6",Asterisk
610332,MOVED TO 608572,Caret
610333,AICARDI-GOUTIERES SYNDROME 4; AGS4,Number Sign
610334,HEPATOCELLULAR CARCINOMA-ASSOCIATED ANTIGEN 112,Asterisk
610335,PHD FINGER PROTEIN 20; PHF20,Asterisk
610336,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4C; C2CD4C,Asterisk
610337,UPREGULATOR OF CELL PROLIFERATION; URGCP,Asterisk
610338,"RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL",
610339,PROLYL 3-HYDROXYLASE 1; P3H1,Asterisk
610340,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4B; EPB41L4B,Asterisk
610341,PROLYL 3-HYDROXYLASE 2; P3H2,Asterisk
610342,PROLYL 3-HYDROXYLASE 3; P3H3,Asterisk
610343,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4A; C2CD4A,Asterisk
610344,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4B; C2CD4B,Asterisk
610345,ACYLGLYCEROL KINASE; AGK,Asterisk
610346,CDC37-LIKE 1; CDC37L1,Asterisk
610347,REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1A; RPRD1A,Asterisk
610348,"FAMILY WITH SEQUENCE SIMILARITY 178, MEMBER A; FAM178A",Asterisk
610349,MEF2-ACTIVATING SAP TRANSCRIPTIONAL REGULATOR; MAMSTR,Asterisk
610350,"LINES, DROSOPHILA, HOMOLOG OF; LINS",Asterisk
610351,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 3, ALPHA; PPP4R3A",Asterisk
610352,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 3, BETA; PPP4R3B",Asterisk
610353,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4",Number Sign
610354,"CONNEXIN 43-INTERACTING PROTEIN, 150-KD",Asterisk
610355,PARTNER AND LOCALIZER OF BRCA2; PALB2,Asterisk
610356,RETINAL CONE DYSTROPHY 3B; RCD3B,Number Sign
610357,"SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30",Number Sign
610358,"SIGNAL PEPTIDASE COMPLEX, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; SPCS1",Asterisk
610359,RETINITIS PIGMENTOSA 33; RP33,Number Sign
610360,"MUCIN 20, CELL SURFACE-ASSOCIATED; MUC20",Asterisk
610361,OROFACIAL CLEFT 9; OFC9,Percent
610362,RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX 2; RAX2,Asterisk
610363,"PEPTIDYLARGININE DEIMINASE, TYPE VI; PADI6",Asterisk
610364,TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 1; TMBIM1,Asterisk
610365,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 1; C1QTNF1,Asterisk
610366,"ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT; AP3M1",Asterisk
610367,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 11; SLC2A11",Asterisk
610368,LEUCINE-RICH REPEATS AND CALPONIN HOMOLOGY DOMAIN-CONTAINING 1; LRCH1,Asterisk
610369,HEAT-SHOCK 70-KD PROTEIN 14; HSPA14,Asterisk
610370,"DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4",Number Sign
610371,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 7; SLC2A7",Asterisk
610372,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 12; SLC2A12",Asterisk
610373,DEAD/H BOX 50; DDX50,Asterisk
610374,"DIABETES MELLITUS, TRANSIENT NEONATAL, 2",Number Sign
610375,"CAPRIN FAMILY, MEMBER 2; CAPRIN2",Asterisk
610376,ATYPICAL CHEMOKINE RECEPTOR 3; ACKR3,Asterisk
610377,MEVALONIC ACIDURIA; MEVA,Number Sign
610378,GLIS FAMILY ZINC FINGER PROTEIN 1; GLIS1,Asterisk
610379,"WEST NILE VIRUS, SUSCEPTIBILITY TO",Number Sign
610380,MOVED TO 610168,Caret
610381,CONE-ROD DYSTROPHY 11; CORD11,Number Sign
610382,"PROSOPAGNOSIA, HEREDITARY",Percent
610383,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 9; RASSF9",Asterisk
610384,"HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 1; HECW1",Asterisk
610385,LR8 PROTEIN; LR8,Asterisk
610386,BTB/POZ DOMAIN-CONTAINING PROTEIN 7; BTBD7,Asterisk
610387,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL IRON CARRIER), MEMBER 37; SLC25A37",Asterisk
610388,RRAD- AND GEM-LIKE GTPase 1; REM1,Asterisk
610389,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MAPK AND MTOR ACTIVATOR 2; LAMTOR2",Asterisk
610390,MACROPHAGE EXPRESSED GENE 1,Asterisk
610391,PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 3; PLPPR3,Asterisk
610392,MYC-BINDING PROTEIN 2; MYCBP2,Asterisk
610393,GON4-LIKE PROTEIN; GON4L,Asterisk
610394,GLIPR1-LIKE PROTEIN 2; GLIPR1L2,Asterisk
610395,GLIPR1-LIKE PROTEIN 1; GLIPR1L1,Asterisk
610396,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6A; TRAPPC6A",Asterisk
610397,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6B; TRAPPC6B",Asterisk
610398,SAP30-LIKE PROTEIN; SAP30L,Asterisk
610399,"TRANSMEMBRANE PROTEASE, SERINE 11E; TMPRSS11E",Asterisk
610400,MACRO DOMAIN-CONTAINING 1; MACROD1,Asterisk
610401,NETRIN 4; NTN4,Asterisk
610402,MOVED TO 609122 AND 300870,Caret
610403,CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED 2; CAND2,Asterisk
610404,RECQ-MEDIATED GENOME INSTABILITY 1; RMI1,Asterisk
610405,CHONDROITIN POLYMERIZING FACTOR; CHPF,Asterisk
610406,TRANSFER RNA ARGININE 1; TRNAR1,Asterisk
610407,TRANSFER RNA GLYCINE 2; TRNAG2,Asterisk
610408,"SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 3; SLC15A3",Asterisk
610409,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 8; SLC16A8",Asterisk
610410,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 1; DHRS1",Asterisk
610411,IMPORTIN 13; IPO13,Asterisk
610412,"SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, B; SPTSSB",Asterisk
610413,INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-LIKE 1; IGFBPL1,Asterisk
610414,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15",Asterisk
610415,SYNTAXIN-BINDING PROTEIN 4; STXBP4,Asterisk
610416,SCAN DOMAIN-CONTAINING 1; SCAND1,Asterisk
610417,SCAN DOMAIN-CONTAINING 2; SCAND2,Asterisk
610418,WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 2; WDFY2,Asterisk
610419,"DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68",Number Sign
610420,"PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1",Percent
610421,"KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 3; KHDRBS3",Asterisk
610422,ALOPECIA-MENTAL RETARDATION SYNDROME 2; APMR2,Percent
610423,PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2; PACS2,Asterisk
610424,"HEPATITIS B VIRUS, SUSCEPTIBILITY TO",Number Sign
610425,"CATARACT 23, MULTIPLE TYPES; CTRCT23",Number Sign
610426,MOVED TO 610425,Caret
610427,"CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD",Number Sign
610428,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX18; COX18,Asterisk
610429,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX19; COX19,Asterisk
610430,"MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2; WM2",Percent
610431,RING FINGER PROTEIN 167; RNF167,Asterisk
610432,RING FINGER PROTEIN 125; RNF125,Asterisk
610433,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5B; LY6G5B",Asterisk
610434,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5C; LY6G5C",Asterisk
610435,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6C; LY6G6C",Asterisk
610436,ROTATIN; RTTN,Asterisk
610437,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6E; LY6G6E",Asterisk
610438,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3; RLS3",Percent
610439,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4; RLS4",Percent
610440,SMALL G PROTEIN SIGNALING MODULATOR 3; SGSM3,Asterisk
610441,TESTICULAR MICROLITHIASIS,Percent
610442,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG",Number Sign
610443,KOOLEN-DE VRIES SYNDROME; KDVS,Number Sign
610444,"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3",Number Sign
610445,"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1",Number Sign
610446,"BURULI ULCER, SUSCEPTIBILITY TO",Number Sign
610447,SHADOW OF PRION PROTEIN; SPRN,Asterisk
610448,CHILBLAIN LUPUS 1; CHBL1,Number Sign
610449,MITOCHONDRIAL CARRIER HOMOLOG 1; MTCH1,Asterisk
610450,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; LYPD1,Asterisk
610451,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 35; LRRC35,Asterisk
610452,MUTAGEN SENSITIVITY,Percent
610453,HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE; HGSNAT,Asterisk
610454,"LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 2; LZTS2",Asterisk
610455,"TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC",Number Sign
610456,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9; SAMD9,Asterisk
610457,"SPHINGOMYELIN PHOSPHODIESTERASE 4, NEUTRAL MEMBRANE; SMPD4",Asterisk
610458,LEUCINE ZIPPER AND CTNNBIP1 DOMAINS-CONTAINING PROTEIN; LZIC,Asterisk
610459,PROLINE-RICH PROTEIN 13; PRR13,Asterisk
610460,"THIOPURINES, POOR METABOLISM OF, 1; THPM1",Number Sign
610461,RETICULON 4 RECEPTOR-LIKE 1; RTN4RL1,Asterisk
610462,RETICULON 4 RECEPTOR-LIKE 2; RTN4RL2,Asterisk
610463,"NUCLEAR UNDECAPRENYL PYROPHOSPHATE SYNTHASE 1, S. CEREVISIAE, HOMOLOG OF; NUS1",Asterisk
610464,G PROTEIN-COUPLED RECEPTOR 156; GPR156,Asterisk
610465,"ACYL-CoA SYNTHETASE FAMILY, MEMBER 2; ACSF2",Asterisk
610466,"LIMB EXPRESSION 1, MOUSE, HOMOLOG OF; LIX1",Asterisk
610467,3-HYDROXYACYL-CoA DEHYDRATASE 1; HACD1,Asterisk
610468,INTERFERON-INDUCED PROTEIN 44; IFI44,Asterisk
610469,"ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2",Asterisk
610470,TRANSFER RNA PHOSPHOTRANSFERASE 1; TRPT1,Asterisk
610471,VASOHIBIN 2; VASH2,Asterisk
610472,ACYLTRANSFERASE-LIKE 2; AYTL2,Asterisk
610473,LYSOPHOSPHATIDYLGLYCEROL ACYLTRANSFERASE 1; LPGAT1,Asterisk
610474,"CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS",Number Sign
610475,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2",Number Sign
610476,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11",Number Sign
610477,"TRANSMEMBRANE PROTEASE, SERINE 9; TMPRSS9",Asterisk
610478,RETINAL CONE DYSTROPHY 4; RCD4,Number Sign
610479,SERUM RESPONSE FACTOR BINDING PROTEIN 1; SRFBP1,Asterisk
610480,LEM DOMAIN-CONTAINING PROTEIN 1; LEMD1,Asterisk
610481,SH2 DOMAIN-CONTAINING PROTEIN D; SHD,Asterisk
610482,SH2 DOMAIN-CONTAINING PROTEIN E; SHE,Asterisk
610483,"AGAMMAGLOBULINEMIA, MICROCEPHALY, AND SEVERE DERMATITIS",Percent
610484,PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN-INTERACTING PROTEIN 1,Asterisk
610485,"LOSS OF HETEROZYGOSITY, CHROMOSOME 3, REGION 2, GENE A; LOH3CR2A",Asterisk
610486,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4; LRRC4,Asterisk
610487,"KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 2; KHDRBS2",Asterisk
610488,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 9; TTC9,Asterisk
610489,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1",Number Sign
610490,"PURPLE ACID PHOSPHATASE, LONG FORM",Asterisk
610491,"SLAIN MOTIF FAMILY, MEMBER 1; SLAIN1",Asterisk
610492,"SLAIN MOTIF FAMILY, MEMBER 2; SLAIN2",Asterisk
610493,DIX DOMAIN-CONTAINING PROTEIN 1; DIXDC1,Asterisk
610494,DDB1- AND CUL4-ASSOCIATED FACTOR 6; DCAF6,Asterisk
610495,HOM-TES-103 GENE,Asterisk
610496,RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29,Asterisk
610497,BRAIN AND REPRODUCTIVE ORGAN-EXPRESSED PROTEIN; BRE,Asterisk
610498,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2,Number Sign
610499,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6,Asterisk
610500,ANKYRIN REPEAT AND KH DOMAIN-CONTAINING PROTEIN 1; ANKHD1,Asterisk
610501,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 1; NBPF1",Asterisk
610502,RETICULON 4-INTERACTING PROTEIN 1; RTN4IP1,Asterisk
610503,CELL DEATH-INDUCING p53 TARGET 1; CDIP1,Asterisk
610504,PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM,Number Sign
610505,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3,Number Sign
610506,"PAF1 RNA POLYMERASE II-ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF; PAF1",Asterisk
610507,"LEO1 RNA POLYMERASE II ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF; LEO1",Asterisk
610508,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7",Number Sign
610509,"RESISTANCE TO INHIBITORS OF CHOLINESTERASE 3, C. ELEGANS, HOMOLOG OF; RIC3",Asterisk
610510,AURORA BOREALIS; BORA,Asterisk
610511,"SEC23, S. CEREVISIAE, HOMOLOG OF, A; SEC23A",Asterisk
610512,"SEC23, S. CEREVISIAE, HOMOLOG OF, B; SEC23B",Asterisk
610513,"ATPase, TYPE 13A2; ATP13A2",Asterisk
610514,PHD FINGER PROTEIN 17; PHF17,Asterisk
610515,PHD FINGER PROTEIN 15; PHF15,Asterisk
610516,GLYCERATE KINASE; GLYCTK,Asterisk
610517,CONTACTIN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3,Asterisk
610518,CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4,Asterisk
610519,CONTACTIN-ASSOCIATED PROTEIN-LIKE 5; CNTNAP5,Asterisk
610520,"CD300 ANTIGEN-LIKE FAMILY, MEMBER G; CD300LG",Asterisk
610521,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 12; KCTD12,Asterisk
610522,COORDINATED EXPRESSION TO IRXA2,Asterisk
610523,"CENTROSOMAL PROTEIN, 41-KD; CEP41",Asterisk
610524,"ENDOGENOUS RETROVIRUS GROUP FRD, MEMBER 1; ERVFRD1",Asterisk
610525,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC, IA; NT5C1A",Asterisk
610526,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC, IB; NT5C1B",Asterisk
610527,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 1; TXNDC1,Asterisk
610528,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 8; CHD8,Asterisk
610529,TUMOR SUPPRESSOR CANDIDATE 1; TUSC1,Asterisk
610530,TRIPARTITE MOTIF-CONTAINING PROTEIN 41; TRIM41,Asterisk
610531,"FAMILY WITH SEQUENCE SIMILARITY 126, MEMBER A; FAM126A",Asterisk
610532,"LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5",Number Sign
610533,"WW, C2, AND COILED-COIL DOMAIN-CONTAINING 1; WWC1",Asterisk
610534,"DECAPPING ENZYME, SCAVENGER; DCPS",Asterisk
610535,"GLAUCOMA 1, OPEN ANGLE, M; GLC1M",Percent
610536,"MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA",Number Sign
610537,DIPEPTIDYL PEPTIDASE VII; DPP7,Asterisk
610538,UBIQUITIN-CONJUGATING ENZYME E2T; UBE2T,Asterisk
610539,"GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY",Number Sign
610540,"GNAS COMPLEX LOCUS, ANTISENSE TRANSCRIPT 1; GNASAS1",Asterisk
610541,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3B; PPP1R3B",Asterisk
610542,"MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12",Number Sign
610543,"CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL",Number Sign
610544,IGF-LIKE FAMILY MEMBER 1; IGFL1,Asterisk
610545,IGF-LIKE FAMILY MEMBER 2; IGFL2,Asterisk
610546,IGF-LIKE FAMILY MEMBER 3; IGFL3,Asterisk
610547,IGF-LIKE FAMILY MEMBER 4; IGFL4,Asterisk
610548,"AQUARIUS, MOUSE, HOMOLOG OF; AQR",Asterisk
610549,"DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS",Number Sign
610550,"METHIONINE ADENOSYLTRANSFERASE I, ALPHA; MAT1A",Asterisk
610551,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 1; IIAE1",Number Sign
610552,UBIQUITIN-LIKE MODIFIER ACTIVATING ENZYME 5; UBA5,Asterisk
610553,UBIQUITIN-FOLD MODIFIER 1; UFM1,Asterisk
610554,UBIQUITIN-FOLD MODIFIER-CONJUGATING ENZYME 1; UFC1,Asterisk
610555,"CORE 1 SYNTHASE, GLYCOPROTEIN-N-ACETYLGALACTOSAMINE 3-BETA-GALACTOSYLTRANSFERASE, 1; C1GALT1",Asterisk
610556,HIGHLY ACCELERATED REGION GENE 1A; HAR1A,Asterisk
610557,HIGHLY ACCELERATED REGION GENE 1B; HAR1B,Asterisk
610558,MITOGEN-ACTIVATED PROTEIN KINASE-ASSOCIATED PROTEIN 1; MAPKAP1,Asterisk
610559,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 4; RASSF4",Asterisk
610560,"PROTEASE, SERINE, 36; PRSS36",Asterisk
610561,POLYSERASE 3,Asterisk
610562,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12A; ZC3H12A,Asterisk
610563,KARYOPHERIN ALPHA-6; KPNA6,Asterisk
610564,"PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2; PDSS2",Asterisk
610565,"DYNEIN, AXONEMAL, LIGHT CHAIN 4; DNAL4",Asterisk
610566,MICRO RNA 146A; MIR146A,Asterisk
610567,MICRO RNA 146B; MIR146B,Asterisk
610568,ZINC FINGER PROTEIN 687; ZNF687,Asterisk
610569,UBIQUITIN-SPECIFIC PROTEASE 24; USP24,Asterisk
610570,UBIQUITIN-SPECIFIC PROTEASE 40; USP40,Asterisk
610571,FK506-BINDING PROTEIN 11; FKBP11,Asterisk
610572,MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2,Asterisk
610573,"R-SPONDIN FAMILY, MEMBER 4; RSPO4",Asterisk
610574,"R-SPONDIN FAMILY, MEMBER 3; RSPO3",Asterisk
610575,"R-SPONDIN FAMILY, MEMBER 2; RSPO2",Asterisk
610576,RHO GTPase-ACTIVATING PROTEIN 9; ARHGAP9,Asterisk
610577,RHO GTPase-ACTIVATING PROTEIN 12; ARHGAP12,Asterisk
610578,RHO GTPase-ACTIVATING PROTEIN 15; ARHGAP15,Asterisk
610579,RCSD DOMAIN-CONTAINING PROTEIN 1; RCSD1,Asterisk
610580,ONCOGENE PIM3; PIM3,Asterisk
610581,"COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2, INTRONIC TRANSCRIPT 1; COPG2IT1",Asterisk
610582,"DIABETES MELLITUS, TRANSIENT NEONATAL, 3",Number Sign
610583,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 6; ANKRD6,Asterisk
610584,TRIPARTITE MOTIF-CONTAINING PROTEIN 67; TRIM67,Asterisk
610585,RHO GTPase-ACTIVATING PROTEIN 22; ARHGAP22,Asterisk
610586,RHO GTPase-ACTIVATING PROTEIN 24; ARHGAP24,Asterisk
610587,RHO GTPase-ACTIVATING PROTEIN 25; ARHGAP25,Asterisk
610588,DENDRIN; DDN,Asterisk
610589,RHO GTPase-ACTIVATING PROTEIN 11A; ARHGAP11A,Asterisk
610590,RHO GTPase-ACTIVATING PROTEIN 23; ARHGAP23,Asterisk
610591,RHO GTPase-ACTIVATING PROTEIN 27; ARHGAP27,Asterisk
610592,RHO GTPase-ACTIVATING PROTEIN 28; ARHGAP28,Asterisk
610593,MAP6 DOMAIN-CONTAINING PROTEIN 1; MAP6D1,Asterisk
610594,FOLLICULIN-INTERACTING PROTEIN 1; FNIP1,Asterisk
610595,"FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE, S. CEREVISIAE, HOMOLOG OF; FLAD1",Asterisk
610596,BLOCK OF PROLIFERATION 1; BOP1,Asterisk
610597,GLUTAMATE-RICH WD REPEAT-CONTAINING PROTEIN 1; GRWD1,Asterisk
610598,"PRCD, DOG, HOMOLOG OF; PRCD",Asterisk
610599,RETINITIS PIGMENTOSA 36; RP36,Number Sign
610600,CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY,Number Sign
610601,KALLIKREIN-RELATED PEPTIDASE 15; KLK15,Asterisk
610602,"AlkB, E. COLI, HOMOLOG OF, 2; ALKBH2",Asterisk
610603,"AlkB, E. COLI, HOMOLOG OF, 3; ALKBH3",Asterisk
610604,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, PSEUDOGENE 1; KIR3DP1",Asterisk
610605,CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 2; CPEB2,Asterisk
610606,CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 3; CPEB3,Asterisk
610607,CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 4; CPEB4,Asterisk
610608,GINS COMPLEX SUBUNIT 1; GINS1,Asterisk
610609,GINS COMPLEX SUBUNIT 2; GINS2,Asterisk
610610,GINS COMPLEX SUBUNIT 3; GINS3,Asterisk
610611,GINS COMPLEX SUBUNIT 4; GINS4,Asterisk
610612,LEBER CONGENITAL AMAUROSIS 12; LCA12,Number Sign
610613,"CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 1; CYP11B1",Asterisk
610614,TRANSFORMING GROWTH FACTOR-BETA REGULATOR 1; TBRG1,Asterisk
610615,RAB-LIKE PROTEIN 6; RABL6,Asterisk
610616,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 12; ANKRD12,Asterisk
610617,"DENTICLELESS, DROSOPHILA, HOMOLOG OF; DTL",Asterisk
610618,"ANGIOEDEMA, HEREDITARY, TYPE III; HAE3",Number Sign
610619,COAGULATION FACTOR XII; F12,Asterisk
610620,ADP-RIBOSYLHYDROLASE-LIKE 1; ADPRHL1,Asterisk
610621,"INTURNED, DROSOPHILA, HOMOLOG OF; INTU",Asterisk
610622,"FUZZY, DROSOPHILA, HOMOLOG OF; FUZ",Asterisk
610623,"CATARACT 11, MULTIPLE TYPES; CTRCT11",Number Sign
610624,ADP-RIBOSYLHYDROLASE-LIKE 2; ADPRHL2,Asterisk
610625,ADP-RIBOSYLTRANSFERASE 5; ART5,Asterisk
610626,PHOSPHOLIPID PHOSPHATASE 5; PLPP5,Asterisk
610627,ALPHA-2-MACROGLOBULIN-LIKE 1; A2ML1,Asterisk
610628,HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4,Number Sign
610629,DIAMOND-BLACKFAN ANEMIA 3; DBA3,Number Sign
610630,"PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20A; PTPN20A",Asterisk
610631,"PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20B; PTPN20B",Asterisk
610632,MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 2; MICU2,Asterisk
610633,MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 3; MICU3,Asterisk
610634,MOVED TO 115650,Caret
610635,COLLAGEN TRIPLE-HELIX REPEAT-CONTAINING PROTEIN 1; CTHRC1,Asterisk
610636,MICRO RNA 27B; MIR27B,Asterisk
610637,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 5; MARCH5,Asterisk
610638,JUNCTIONAL ADHESION MOLECULE 4,Asterisk
610639,GRID2-INTERACTING PROTEIN 1; GRID2IP1,Asterisk
610640,YTH N6-METHYLADENOSINE RNA-BINDING PROTEIN 2; YTHDF2,Asterisk
610641,"TERMINAL URIDYLYL TRANSFERASE 1, U6 snRNA-SPECIFIC; TUT1",Asterisk
610642,"ENDOPLASMIC RETICULUM PROTEIN, 27-KD; ERP27",Asterisk
610643,CELL PROLIFERATION-REGULATING INHIBITOR OF PROTEIN PHOSPHATASE 2A; CIP2A,Asterisk
610644,"PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL",Number Sign
610645,CALCIUM- AND INTEGRIN-BINDING PROTEIN 3; CIB3,Asterisk
610646,CALCIUM- AND INTEGRIN-BINDING PROTEIN 4; CIB4,Asterisk
610647,N-ACETYLTRANSFERASE 8-LIKE; NAT8L,Asterisk
610648,CUT-LIKE 2; CUTL2,Asterisk
610649,BONE SIZE QUANTITATIVE TRAIT LOCUS 3,Percent
610650,ADHESION-REGULATING MOLECULE 1; ADRM1,Asterisk
610651,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB",Number Sign
610652,PHOSPHODIESTERASE 10A; PDE10A,Asterisk
610653,"RIBOSOMAL RNA-PROCESSING 1, S. CEREVISIAE, HOMOLOG OF; RRP1",Asterisk
610654,"RIBOSOMAL RNA-PROCESSING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF, B; RRP1B",Asterisk
610655,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4",Percent
610656,CYSTEINE CONJUGATE BETA-LYASE 2; CCBL2,Asterisk
610657,"WASH COMPLEX, SUBUNIT 5; WASHC5",Asterisk
610658,TRIPARTITE MOTIF-CONTAINING PROTEIN 29; TRIM29,Asterisk
610659,"GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 1; GRID1",Asterisk
610660,GLYOXYLATE REDUCTASE 1 HOMOLOG; GLYR1,Asterisk
610661,N-GLYCANASE 1; NGLY1,Asterisk
610662,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Y PROTEIN; PIGY,Asterisk
610663,SET AND MYND DOMAIN-CONTAINING PROTEIN 2; SMYD2,Asterisk
610664,BREAST CANCER-OVEREXPRESSED GENE 1,Asterisk
610665,"Fc FRAGMENT OF IgG, LOW AFFINITY IIIb, RECEPTOR FOR; FCGR3B",Asterisk
610666,NEURENSIN 2; NRSN2,Asterisk
610667,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L5; UCHL5,Asterisk
610668,"INSCUTEABLE, DROSOPHILA, HOMOLOG OF; INSC",Asterisk
610669,TNFAIP3-INTERACTING PROTEIN 2; TNIP2,Asterisk
610670,"CYTOCHROME P450, FAMILY 2, SUBFAMILY U, POLYPEPTIDE 1; CYP2U1",Asterisk
610671,ZINC FINGER PROTEIN 628; ZNF628,Asterisk
610672,"NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN 1, BEN AND BTB/POZ DOMAINS-CONTAINING; NACC1",Asterisk
610673,NUCLEAR APOPTOSIS-INDUCING FACTOR 1; NAIF1,Asterisk
610674,SPERM FLAGELLAR PROTEIN 1; SPEF1,Asterisk
610675,"UNCONVENTIONAL SNARE IN THE ER 1, S. CEREVISIAE, HOMOLOG OF; USE1",Asterisk
610676,"AUTISM, SUSCEPTIBILITY TO, 7; AUTS7",Percent
610677,LSM14A PROTEIN; LSM14A,Asterisk
610678,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4,Number Sign
610679,CYCLIN-DEPENDENT KINASE 14; CDK14,Asterisk
610680,"HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS",
610681,"PHOSPHOFRUCTOKINASE, MUSCLE TYPE; PFKM",Asterisk
610682,"OSTEOGENESIS IMPERFECTA, TYPE VII; OI7",Number Sign
610683,BBS12 GENE; BBS12,Asterisk
610684,C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1; CTDNEP1,Asterisk
610685,SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 2; SHFLD2,Percent
610686,UBX DOMAIN PROTEIN 2B; UBXN2B,Asterisk
610687,NEMALINE MYOPATHY 7; NEM7,Number Sign
610688,JOUBERT SYNDROME 6; JBTS6,Number Sign
610689,"DIPLA1, ANTISENSE",Asterisk
610690,3-HYDROXYISOBUTYRYL-CoA HYDROLASE; HIBCH,Asterisk
610691,"PRUNE, DROSOPHILA, HOMOLOG OF, 2; PRUNE2",Asterisk
610692,HEAT-SHOCK 27-KD PROTEIN 7; HSPB7,Asterisk
610693,HYLS1 GENE; HYLS1,Asterisk
610694,PYROGLUTAMYL PEPTIDASE I; PGPEP1,Asterisk
610695,HEAT-SHOCK 27-KD PROTEIN 6; HSPB6,Asterisk
610696,"PCNA-ASSOCIATED FACTOR, 15-KD",Asterisk
610697,PDZ DOMAIN-CONTAINING 2; PDZD2,Asterisk
610698,"MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4",Number Sign
610699,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2A; ZFAND2A,Asterisk
610700,HTRA SERINE PEPTIDASE 4; HTRA4,Asterisk
610701,HEAT-SHOCK 70-KD PROTEIN 12A; HSPA12A,Asterisk
610702,HEAT-SHOCK 70-KD PROTEIN 12B; HSPA12B,Asterisk
610703,HEAT-SHOCK 105/110-KD PROTEIN 1; HSPH1,Asterisk
610704,PROHIBITIN 2; PHB2,Asterisk
610705,"CD300 ANTIGEN-LIKE FAMILY, MEMBER B; CD300LB",Asterisk
610706,"DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA",Number Sign
610707,"PSORIASIS 8, SUSCEPTIBILITY TO; PSORS8",Percent
610708,OPTIC ATROPHY 5; OPA5,Number Sign
610709,TESTIS-SPECIFIC SERINE/THREONINE KINASE 1; TSSK1,Asterisk
610710,TESTIS-SPECIFIC SERINE/THREONINE KINASE 2; TSSK2,Asterisk
610711,TESTIS-SPECIFIC SERINE/THREONINE KINASE 4; TSSK4,Asterisk
610712,TESTIS-SPECIFIC SERINE/THREONINE KINASE 6; TSSK6,Asterisk
610713,BRACHYDACTYLY-SYNDACTYLY SYNDROME; BDSD,Number Sign
610714,PROTEIN KINASE N3; PKN3,Asterisk
610715,HEMOGEN; HEMGN,Asterisk
610716,TIMELESS-INTERACTING PROTEIN; TIPIN,Asterisk
610717,NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM,Number Sign
610718,MICRO RNA 195; MIR195,Asterisk
610719,MICRO RNA 199A1; MIR199A1,Asterisk
610720,MICRO RNA 199A2; MIR199A2,Asterisk
610721,MICRO RNA 214; MIR214,Asterisk
610722,MOVED TO 607962,Caret
610723,MICRO RNA 23B; MIR23B,Asterisk
610724,MICRO RNA 24-2; MIR24-2,Asterisk
610725,"NEPHROTIC SYNDROME, TYPE 3; NPHS3",Number Sign
610726,"TRUB PSEUDOURIDINE SYNTHASE, E. COLI, HOMOLOG OF, 1; TRUB1",Asterisk
610727,"TRUB PSEUDOURIDINE SYNTHASE, E. COLI, HOMOLOG OF, 2; TRUB2",Asterisk
610728,"SPHINGOMYELIN PHOSPHODIESTERASE, ACID-LIKE, 3A; SMPDL3A",Asterisk
610729,WD REPEAT-CONTAINING PROTEIN 92; WDR92,Asterisk
610730,"CHAPERONIN-CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6B; CCT6B",Asterisk
610731,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 7; ANKRD7,Asterisk
610732,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 12; TTC12,Asterisk
610733,NOONAN SYNDROME 4; NS4,Number Sign
610734,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2; ANKRD2,Asterisk
610735,MYOZENIN 3; MYOZ3,Asterisk
610736,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 23; ANKRD23,Asterisk
610737,KINASE SUPPRESSOR OF RAS 2; KSR2,Asterisk
610738,"NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3",Number Sign
610739,TRINUCLEOTIDE REPEAT-CONTAINING GENE 6A; TNRC6A,Asterisk
610740,TRINUCLEOTIDE REPEAT-CONTAINING GENE 6B; TNRC6B,Asterisk
610741,TRINUCLEOTIDE REPEAT-CONTAINING GENE 6C; TNRC6C,Asterisk
610742,"MOLONEY LEUKEMIA VIRUS 10, MOUSE, HOMOLOG OF; MOV10",Asterisk
610743,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8",Number Sign
610744,IRIS PATTERN,Percent
610745,STIMULATED BY RETINOIC ACID 6; STRA6,Asterisk
610746,DOLICHOL KINASE; DOLK,Asterisk
610747,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4A; SAMD4A,Asterisk
610748,UBIQUITIN-SPECIFIC PROTEASE 28; USP28,Asterisk
610749,KELCH-LIKE 31; KLHL31,Asterisk
610750,ZINC FINGER CCHC DOMAIN- AND RNA-BINDING MOTIF-CONTAINING PROTEIN 1; ZCRB1,Asterisk
610751,PHOSPHORIBOSYL TRANSFERASE DOMAIN-CONTAINING PROTEIN 1; PRTFDC1,Asterisk
610752,URONYL 2-SULFOTRANSFERASE; UST,Asterisk
610753,ALOPECIA AREATA 2; AA2,Percent
610754,"WINGS APART-LIKE PROTEIN, DROSOPHILA, HOMOLOG OF; WAPL",Asterisk
610755,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4",Number Sign
610756,CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2,Number Sign
610757,"CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 2; CCL4L2",Asterisk
610758,CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4,Number Sign
610759,CORNELIA DE LANGE SYNDROME 3; CDLS3,Number Sign
610760,CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2,Percent
610761,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5,Percent
610762,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6,Number Sign
610763,N-ACETYLNEURAMINIC ACID PHOSPHATASE; NANP,Asterisk
610764,BENZODIAZAPINE RECEPTOR (PERIPHERAL)-ASSOCIATED PROTEIN 1; BZRAP1,Asterisk
610765,MOVED TO 602400,Caret
610766,MEIOSIS-SPECIFIC NUCLEAR STRUCTURAL PROTEIN 1; MNS1,Asterisk
610767,AUTOPHAGY 16-LIKE 1; ATG16L1,Asterisk
610768,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M",Number Sign
610769,"NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; NOC3L",Asterisk
610770,"NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 2, S. CEREVISIAE, HOMOLOG OF; NOC2L",Asterisk
610771,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 5; CHD5,Asterisk
610772,NK6 HOMEOBOX 3; NKX6-3,Asterisk
610773,MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY,Number Sign
610774,CANOPY FGF SIGNALING REGULATOR 3; CNPY3,Asterisk
610775,TP53-INDUCED GLYCOLYSIS AND APOPTOSIS REGULATOR; TIGAR,Asterisk
610776,DAMAGE-REGULATED AUTOPHAGY MODULATOR 1; DRAM1,Asterisk
610777,NEUROGUIDIN; NGDN,Asterisk
610778,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1-LIKE; GNB1L",Asterisk
610779,NUCLEOTIDE-BINDING PROTEIN 2; NUBP2,Asterisk
610780,"LARGE SUBUNIT GTPase 1, S. CEREVISIAE, HOMOLOG OF; LSG1",Asterisk
610781,GUANOSINE MONOPHOSPHATE REDUCTASE 2; GMPR2,Asterisk
610782,MICRO RNA 29A; MIR29A,Asterisk
610783,MICRO RNA 29B1; MIR29B1,Asterisk
610784,MICRO RNA 29C; MIR29C,Asterisk
610785,PDLIM1-INTERACTING KINASE 1-LIKE; PDIK1L,Asterisk
610786,SRC KINASE SIGNALING INHIBITOR 1; SRCIN1,Asterisk
610787,PRAC2 SMALL NUCLEAR PROTEIN; PRAC2,Asterisk
610788,"SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B2; SLC35B2",Asterisk
610789,p53 AND DNA DAMAGE-REGULATED 1; PDRG1,Asterisk
610790,"SOLUTE CARRIER FAMILY 35, MEMBER B1; SLC35B1",Asterisk
610791,"SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 2; SLC43A2",Asterisk
610792,"SOLUTE CARRIER FAMILY 22, MEMBER 25; SLC22A25",Asterisk
610793,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, KIDNEY), MEMBER 30; SLC25A30",Asterisk
610794,ZINC FINGER PROTEIN 323; ZNF323,Asterisk
610795,SORBIN AND SH3 DOMAINS-CONTAINING PROTEIN 3; SORBS3,Asterisk
610796,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 31; SLC25A31",Asterisk
610797,"EPIPHYSEAL DYSPLASIA, BAUMANN TYPE",
610798,IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN,Number Sign
610799,"INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1",Number Sign
610800,"AUTOPHAGY 10, S. CEREVISIAE, HOMOLOG OF; ATG10",Asterisk
610801,"SOLUTE CARRIER FAMILY 41, MEMBER 1; SLC41A1",Asterisk
610802,"SOLUTE CARRIER FAMILY 41, MEMBER 2; SLC41A2",Asterisk
610803,"SOLUTE CARRIER FAMILY 41, MEMBER 3; SLC41A3",Asterisk
610804,"SOLUTE CARRIER FAMILY 35 (UDP-GLUCURONIC ACID/UDP-N-ACETYLGALACTOSAMINE DUAL TRANSPORTER), MEMBER D1; SLC35D1",Asterisk
610805,CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1; CAKUT1,Number Sign
610806,"TBC1 DOMAIN FAMILY, MEMBER 3C; TBC1D3C",Asterisk
610807,"TBC1 DOMAIN FAMILY, MEMBER 3D; TBC1D3D",Asterisk
610808,"TBC1 DOMAIN FAMILY, MEMBER 3E; TBC1D3E",Asterisk
610809,"TBC1 DOMAIN FAMILY, MEMBER 3F; TBC1D3F",Asterisk
610810,"TBC1 DOMAIN FAMILY, MEMBER 3G; TBC1D3G",Asterisk
610811,"TBC1 DOMAIN FAMILY, MEMBER 3H; TBC1D3H",Asterisk
610812,"HYDROCEPHALUS-INDUCING, MOUSE, HOMOLOG OF; HYDIN",Asterisk
610813,"HYDROCEPHALUS-INDUCING, MOUSE, HOMOLOG OF, 2; HYDIN2",Asterisk
610814,MOVED TO 601186,Caret
610815,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, FOLATE), MEMBER 32; SLC25A32",Asterisk
610816,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PYRIMIDINE NUCLEOTIDE TRANSPORTER), MEMBER 33; SLC25A33",Asterisk
610817,"SOLUTE CARRIER FAMILY 25, MEMBER 34; SLC25A34",Asterisk
610818,"SOLUTE CARRIER FAMILY 25, MEMBER 35; SLC25A35",Asterisk
610819,"SOLUTE CARRIER FAMILY 25, MEMBER 38; SLC25A38",Asterisk
610820,"SOLUTE CARRIER FAMILY 25, MEMBER 39; SLC25A39",Asterisk
610821,"SOLUTE CARRIER FAMILY 25, MEMBER 40; SLC25A40",Asterisk
610822,"SOLUTE CARRIER FAMILY 25, MEMBER 41; SLC25A41",Asterisk
610823,"SOLUTE CARRIER FAMILY 25, MEMBER 42; SLC25A42",Asterisk
610824,"SOLUTE CARRIER FAMILY 25, MEMBER 44; SLC25A44",Asterisk
610825,"SOLUTE CARRIER FAMILY 25, MEMBER 45; SLC25A45",Asterisk
610826,"SOLUTE CARRIER FAMILY 25, MEMBER 46; SLC25A46",Asterisk
610827,ZINC FINGER PROTEIN 335; ZNF335,Asterisk
610828,HOLOPROSENCEPHALY 7; HPE7,Number Sign
610829,HOLOPROSENCEPHALY 9; HPE9,Number Sign
610830,POLYOSTEOLYSIS-HYPEROSTOSIS SYNDROME,
610831,"TBC1 DOMAIN FAMILY, MEMBER 10C; TBC1D10C",Asterisk
610832,"FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN",Number Sign
610833,N-ACETYLTRANSFERASE 5; NAT5,Asterisk
610834,N-ACETYLTRANSFERASE 13; NAT13,Asterisk
610835,NMDA RECEPTOR-REGULATED 2; NARG2,Asterisk
610836,"AUTISM, SUSCEPTIBILITY TO, 11; AUTS11",Percent
610837,BCL2-LIKE 12; BCL2L12,Asterisk
610838,"AUTISM, SUSCEPTIBILITY TO, 12; AUTS12",Percent
610839,OSTEOARTHRITIS SUSCEPTIBILITY 4; OS4,Percent
610840,MITRAL VALVE PROLAPSE 3; MVP3,Percent
610841,STROMAL INTERACTION MOLECULE 2; STIM2,Asterisk
610842,PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY,Number Sign
610843,"UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX, 7.2-KD SUBUNIT",Asterisk
610844,SPG11 GENE; SPG11,Asterisk
610845,"SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B3; SLC35B3",Asterisk
610846,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 10; LRRC10,Asterisk
610847,ZINC FINGER PROTEIN 322A; ZNF322A,Asterisk
610848,RAB15 EFFECTOR PROTEIN; REP15,Asterisk
610849,"TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 6; TTLL6",Asterisk
610850,XPA-BINDING PROTEIN 2; XAB2,Asterisk
610851,CHROMOSOME 4 OPEN READING FRAME 16; C4ORF16,Asterisk
610852,"CILIARY DYSKINESIA, PRIMARY, 6; CILD6",Number Sign
610853,AT HOOK-CONTAINING TRANSCRIPTION FACTOR 1; AHCTF1,Asterisk
610854,MOVED TO 610682,Caret
610855,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 26; ANKRD26,Asterisk
610856,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30A; ANKRD30A,Asterisk
610857,SMALL BREAST EPITHELIAL MUCIN,Asterisk
610858,"RNA TRANSCRIPTION, TRANSLATION, AND TRANSPORT FACTOR; RTRAF",Asterisk
610859,CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 2; CARMIL2,Asterisk
610860,"AMYLO-1,6-GLUCOSIDASE, 4-ALPHA-GLUCANOTRANSFERASE; AGL",Asterisk
610861,SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 3; SYNE3,Asterisk
610862,"DELTA(4)-DESATURASE, SPHINGOLIPID, 2; DEGS2",Asterisk
610863,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-4; GNB4",Asterisk
610864,LQK1 PROTEIN,Asterisk
610865,FELINE LEUKEMIA VIRUS SUBGROUP C RECEPTOR 2; FLVCR2,Asterisk
610866,URIDINE/CYTIDINE KINASE-LIKE 1; UCKL1,Asterisk
610867,LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 1: LRRTM1,Asterisk
610868,LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 2; LRRTM2,Asterisk
610869,LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 3; LRRTM3,Asterisk
610870,LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 4; LRRTM4,Asterisk
610871,SAKODA COMPLEX,
610872,IBR DOMAIN-CONTAINING PROTEIN 3; IBRDC3,Asterisk
610873,"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENAQ1",Percent
610874,SPERMATOGENESIS AND CENTRIOLE-ASSOCIATED 1; SPATC1,Asterisk
610875,"SAPS DOMAIN FAMILY, MEMBER 1; SAPS1",Asterisk
610876,HECT DOMAIN- AND ANKYRIN REPEAT-CONTAINING E3 UBIQUITIN PROTEIN LIGASE 1; HACE1,Asterisk
610877,"SAPS DOMAIN FAMILY, MEMBER 2; SAPS2",Asterisk
610878,VESICOURETERAL REFLUX 2; VUR2,Number Sign
610879,"SAPS DOMAIN FAMILY, MEMBER 3; SAPS3",Asterisk
610880,CHROMOSOME 11 OPEN READING FRAME 24; C11ORF24,Asterisk
610881,LYSINE-SPECIFIC METHYLTRANSFERASE 5B; KMT5B,Asterisk
610882,SJOGREN SYNDROME NUCLEAR AUTOANTIGEN 1; SSNA1,Asterisk
610883,POTOCKI-LUPSKI SYNDROME; PTLS,Number Sign
610884,CHROMOSOME 19 OPEN READING FRAME 40; C19ORF40,Asterisk
610885,"ESSENTIAL MEIOTIC ENDONUCLEASE 1, S. POMBE, HOMOLOG OF, 1; EME1",Asterisk
610886,"ESSENTIAL MEIOTIC ENDONUCLEASE 1, S. POMBE, HOMOLOG OF, 2; EME2",Asterisk
610887,"POLYMERASE, DNA, NU; POLN",Asterisk
610888,GASTRIC CANCER-RELATED GENE 224,Asterisk
610889,IMPORTIN 11; IPO11,Asterisk
610890,REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN; RGS7BP,Asterisk
610891,"FAMILY WITH SEQUENCE SIMILARITY 102, MEMBER A; FAM102A",Asterisk
610892,SYNAPTOTAGMIN 14-LIKE PROTEIN; SYT14L,Asterisk
610893,"CHMP FAMILY, MEMBER 2A; CHMP2A",Asterisk
610894,NEUREGULIN 4; NRG4,Asterisk
610895,"WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 2; WFIKKN2",Asterisk
610896,BRANCHIOOTORENAL SYNDROME 2; BOR2,Number Sign
610897,"CHMP FAMILY, MEMBER 4B; CHMP4B",Asterisk
610898,"SUPRANUCLEAR PALSY, PROGRESSIVE, 3; PSNP3",Percent
610899,"CHMP FAMILY, MEMBER 4C; CHMP4C",Asterisk
610900,"CHMP FAMILY, MEMBER 5; CHMP5",Asterisk
610901,"CHMP FAMILY, MEMBER 6; CHMP6",Asterisk
610902,CHROMOSOME 6 OPEN READING FRAME 55; C6ORF55,Asterisk
610903,"VACUOLAR PROTEIN SORTING 36, S. CEREVISIAE, HOMOLOG OF; VPS36",Asterisk
610904,"SNF8, S. CEREVISIAE, HOMOLOG OF; SNF8",Asterisk
610905,MOVED TO 225750,Caret
610906,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4",Percent
610907,"VACUOLAR PROTEIN SORTING 25, S. CEREVISIAE, HOMOLOG OF; VPS25",Asterisk
610908,"AUTISM, SUSCEPTIBILITY TO, 13; AUTS13",Percent
610909,MINICHROMOSOME MAINTENANCE COMPLEX-BINDING PROTEIN; MCMBP,Asterisk
610910,"PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED",Percent
610911,RHO GTPase-ACTIVATING PROTEIN 31; ARHGAP31,Asterisk
610912,AMELOTIN; AMTN,Asterisk
610913,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2",Number Sign
610914,ECTO-NOX DISULFIDE-THIOL EXCHANGER 1; ENOX1,Asterisk
610915,"OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8",Number Sign
610916,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 2; NSUN2",Asterisk
610917,RAS-ASSOCIATED PROTEIN 34; RAB34,Asterisk
610918,SELENOPROTEIN M; SELENOM,Asterisk
610919,GTP-BINDING PROTEIN 5; GTPBP5,Asterisk
610920,GTP-BINDING PROTEIN 10; GTPBP10,Asterisk
610921,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3",Number Sign
610922,NUCLEAR PORE ASSOCIATED PROTEIN 1; NPAP1,Asterisk
610923,"SOLUTE CARRIER FAMILY 35 (UDP-XYLOSE/UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER B4; SLC35B4",Asterisk
610924,RANBP-TYPE AND C3HC4-TYPE ZINC FINGER-CONTAINING 1; RBCK1,Asterisk
610925,INTERLEUKIN 17 RECEPTOR C; IL17RC,Asterisk
610926,"TOOTH AGENESIS, SELECTIVE, 5; STHAG5",Percent
610927,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9",Number Sign
610928,SRY-BOX 17; SOX17,Asterisk
610929,ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 2; ORAI2,Asterisk
610930,ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 3; ORAI3,Asterisk
610931,ZINC FINGER GENE IN AUTOIMMUNE THYROID DISEASE 1; ZFAT1,Asterisk
610932,"TWINFILIN, DROSOPHILA, HOMOLOG OF, 1; TWF1",Asterisk
610933,LEUCINE-RICH REPEAT- AND STERILE ALPHA MOTIF-CONTAINING 1; LRSAM1,Asterisk
610934,"NEWBORN OVARY HOMEOBOX, MOUSE, HOMOLOG OF; NOBOX",Asterisk
610935,"LIGAND-GATED ION CHANNEL, ZINC-ACTIVATED, 1; LGICZ1",Asterisk
610936,PHOSPHOSERINE AMINOTRANSFERASE 1; PSAT1,Asterisk
610937,RPGRIP1-LIKE; RPGRIP1L,Asterisk
610938,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7",Number Sign
610939,MICRO RNA 192; MIR192,Asterisk
610940,MICRO RNA 194-1; MIR194-1,Asterisk
610941,MICRO RNA 194-2; MIR194-2,Asterisk
610942,MICRO RNA 204; MIR204,Asterisk
610943,MICRO RNA 215; MIR215,Asterisk
610944,MICRO RNA 216; MIR216,Asterisk
610945,MICRO RNA 296; MIR296,Asterisk
610946,MICRO RNA 133B; MIR133B,Asterisk
610947,"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2",Number Sign
610948,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7",Percent
610949,SYNAPTOTAGMIN 14; SYT14,Asterisk
610950,SYNAPTOTAGMIN 16; SYT16,Asterisk
610951,"CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7",Number Sign
610952,CROOKED NECK PRE-mRNA SPLICING FACTOR-LIKE 1; CRNKL1,Asterisk
610953,"PIF1, S. CEREVISIAE, HOMOLOG OF; PIF1",Asterisk
610954,PITT-HOPKINS SYNDROME; PTHS,Number Sign
610955,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 3; TRAPPC3",Asterisk
610956,ASPARTYL-tRNA SYNTHETASE 2; DARS2,Asterisk
610957,TYROSYL-tRNA SYNTHETASE 2; YARS2,Asterisk
610958,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 9; AGPAT9,Asterisk
610959,MICRO RNA 376A1; MIR376A1,Asterisk
610960,MICRO RNA 376A2; MIR376A2,Asterisk
610961,MICRO RNA 376B; MIR376B,Asterisk
610962,"SMG5, C. ELEGANS, HOMOLOG OF; SMG5",Asterisk
610963,"SMG6, C. ELEGANS, HOMOLOG OF; SMG6",Asterisk
610964,"SMG7, C. ELEGANS, HOMOLOG OF; SMG7",Asterisk
610965,XFE PROGEROID SYNDROME; XFEPS,Number Sign
610966,FAT MASS- AND OBESITY-ASSOCIATED GENE; FTO,Asterisk
610967,"OSTEOGENESIS IMPERFECTA, TYPE V; OI5",Number Sign
610968,"OSTEOGENESIS IMPERFECTA, TYPE XI; OI11",Number Sign
610969,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 1; TRAPPC1",Asterisk
610970,TRAFFICKING PROTEIN PARTICLE COMPLEX 2-LIKE; TRAPPC2L,Asterisk
610971,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 4; TRAPPC4",Asterisk
610972,ADHERENS JUNCTION-ASSOCIATED PROTEIN 1; AJAP1,Asterisk
610973,"MEMBRANE PROTEIN, PALMITOYLATED 7; MPP7",Asterisk
610974,ZINC FINGER PROTEIN 521; ZNF521,Asterisk
610975,"SKIN-, EMBRYO-, BRAIN-, AND OOCYTE-SPECIFIC HOMEOBOX",Asterisk
610976,"APOLIPOPROTEIN B mRNA EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3H; APOBEC3H",Asterisk
610977,TETRACYCLINE TRANSPORTER-LIKE PROTEIN,Asterisk
610978,CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP,Number Sign
610979,DIPHOSPHOINOSITOL PENTAKISPHOSPHATE KINASE 1; PPIP5K1,Asterisk
610980,KCNQ1 DOWNSTREAM NEIGHBOR; KCNQ1DN,Asterisk
610981,WWBP2 N-TERMINAL-LIKE PROTEIN; WBP2NL,Asterisk
610982,INVERTED FORMIN 2; INF2,Asterisk
610983,MICRO RNA 376C; MIR376C,Asterisk
610984,COMPLEMENT FACTOR I DEFICIENCY; CFID,Number Sign
610985,UBIQUITIN E2 VARIANT AND LACTATE/MALATE DEHYDROGENASE DOMAINS-CONTAINING PROTEIN; UEVLD,Asterisk
610986,LEUCINE-RICH REPEAT KINASE 1; LRRK1,Asterisk
610987,N-ACYLSPHINGOSINE AMIDOHYDROLASE 2C; ASAH2C,Asterisk
610988,"LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4",Number Sign
610989,LEMUR TYROSINE KINASE 2; LMTK2,Asterisk
610990,PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 18; PPP1R18,Asterisk
610991,OBSCURIN-LIKE 1; OBSL1,Asterisk
610992,PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD,Number Sign
610993,UBIQUITIN-SPECIFIC PROTEASE 44; USP44,Asterisk
610994,TRANSMEMBRANE PROTEIN 189; TMEM189,Asterisk
610995,PRENYLCYSTEINE OXIDASE 1; PCYOX1,Asterisk
610996,"D-TYROSYL-tRNA DEACYLASE 1, S. CEREVISIAE, HOMOLOG OF; DTD1",Asterisk
610997,"PROSTATE CANCER, HEREDITARY, 9",Percent
610998,METEORIN; METRN,Asterisk
610999,"ENHANCER OF POLYCOMB, DROSOPHILA, HOMOLOG OF, 1; EPC1",Asterisk
611000,"ENHANCER OF POLYCOMB, DROSOPHILA, HOMOLOG OF, 2; EPC2",Asterisk
611001,MYST/ESA1-ASSOCIATED FACTOR 6; MEAF6,Asterisk
611002,TRANSMEMBRANE PROTEIN 204; TMEM204,Asterisk
611003,SMOKING AS A QUANTITATIVE TRAIT LOCUS 1; SQTL1,Percent
611004,SMOKING AS A QUANTITATIVE TRAIT LOCUS 2; SQTL2,Percent
611005,"MEX3, C. ELEGANS, HOMOLOG OF, C; MEX3C",Asterisk
611006,"IRON-SULFUR CLUSTER ASSEMBLY 1, S. CEREVISIAE, HOMOLOG OF; ISCA1",Asterisk
611007,"MEX3, C. ELEGANS, HOMOLOG OF, A; MEX3A",Asterisk
611008,"MEX3, C. ELEGANS, HOMOLOG OF, B; MEX3B",Asterisk
611009,"MEX3, C. ELEGANS, HOMOLOG OF, D; MEX3D",Asterisk
611010,"FIBROMATOSIS, GINGIVAL, 4; GINGF4",Percent
611011,TRANSMEMBRANE PROTEIN 259; TMEM259,Asterisk
611012,REGULATOR OF G PROTEIN SIGNALING-LIKE 1; RGSL1,Asterisk
611013,REGULATOR OF G PROTEIN SIGNALING-LIKE 2; RGSL2,Asterisk
611014,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8; HYT8",Percent
611015,"AUTISM, SUSCEPTIBILITY TO, 9; AUTS9",Percent
611016,"AUTISM, SUSCEPTIBILITY TO, 10; AUTS10",Percent
611017,TRYPSIN DOMAIN-CONTAINING PROTEIN 1; TYSND1,Asterisk
611018,POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2B; PAIP2B,Asterisk
611019,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E2; ATP6V0E2",Asterisk
611020,MICRO RNA 21; MIR21,Asterisk
611021,"NMD3, S. CEREVISIAE, HOMOLOG OF; NMD3",Asterisk
611022,"DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24",Number Sign
611023,"tRNA METHYLTRANSFERASE 5, S. CEREVISIAE, HOMOLOG OF; TRMT5",Asterisk
611024,ZINC FINGER PROTEIN 667; ZNF667,Asterisk
611025,"ENKURIN, TRPC CHANNEL-INTERACTING PROTEIN; ENKUR",Asterisk
611026,FATTY ACID 2-HYDROXYLASE; FA2H,Asterisk
611027,SHC SH2 DOMAIN-BINDING PROTEIN 1; SHCBP1,Asterisk
611028,TRANSMEMBRANE PROTEIN 30A; TMEM30A,Asterisk
611029,TRANSMEMBRANE PROTEIN 30B; TMEM30B,Asterisk
611030,TRANSMEMBRANE PROTEIN 30C; TMEM30C,Asterisk
611031,EPISODIC KINESIGENIC DYSKINESIA 2; EKD2,Percent
611032,SPERMATOGENESIS-ASSOCIATED PROTEIN 17; SPATA17,Asterisk
611033,CHROMOSOME 11 OPEN READING FRAME 21; C11ORF21,Asterisk
611034,"SOLUTE CARRIER FAMILY 17 (ORGANIC ANION TRANSPORTER), MEMBER 3; SLC17A3",Asterisk
611035,APRATAXIN- AND PNKP-LIKE FACTOR; APLF,Asterisk
611036,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 13; SLC2A13",Asterisk
611037,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 26; SLC25A26",Asterisk
611038,"MICROPHTHALMIA, ISOLATED 3; MCOP3",Number Sign
611039,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 14; SLC2A14",Asterisk
611040,"MICROPHTHALMIA, ISOLATED 5; MCOP5",Number Sign
611041,TRIPARTITE MOTIF-CONTAINING PROTEIN 47; TRIM47,Asterisk
611042,LATE CORNIFIED ENVELOPE-LIKE PROLINE-RICH 1; LELP1,Asterisk
611043,"LIN28, C. ELEGANS, HOMOLOG OF, A; LIN28A",Asterisk
611044,"LIN28, C. ELEGANS, HOMOLOG OF, B; LIN28B",Asterisk
611045,"GLUCOSE-6-PHOSPHATASE, CATALYTIC, 3; G6PC3",Asterisk
611046,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2",Percent
611047,RETINOIC ACID EARLY TRANSCRIPT 1L; RAET1L,Asterisk
611048,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15A; PPP1R15A",Asterisk
611049,"SOLUTE CARRIER FAMILY 17, MEMBER 2; SLC17A2",Asterisk
611050,LEUCINE ZIPPER PROTEIN 6; LUZP6,Asterisk
611051,COILED-COIL DOMAIN-CONTAINING PROTEIN 50; CCDC50,Asterisk
611052,SET DOMAIN-CONTAINING PROTEIN 1A; SETD1A,Asterisk
611053,RUN DOMAIN AND SH3 DOMAIN-CONTAINING PROTEIN 2; RUSC2,Asterisk
611054,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA-1; PPFIA1",Asterisk
611055,SET DOMAIN-CONTAINING PROTEIN 1B; SETD1B,Asterisk
611056,SELENOCYSTEINE LYASE; SCLY,Asterisk
611057,MOVED TO 603989,Caret
611058,PEROXISOME BIOGENESIS FACTOR 5-LIKE; PEX5L,Asterisk
611059,WD REPEAT-CONTAINING PROTEIN 82; WDR82,Asterisk
611060,SET-BINDING PROTEIN 1; SETBP1,Asterisk
611061,"FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER C; FAM20C",Asterisk
611062,"FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER A; FAM20A",Asterisk
611063,"FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER B; FAM20B",Asterisk
611064,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5",Number Sign
611065,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1K; PPM1K",Asterisk
611066,PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE-LIKE; PHLPPL,Asterisk
611067,"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4",Number Sign
611068,"SMALL NUCLEOLAR RNA, C/D BOX, 43; SNORD43",Asterisk
611069,"RNA, U86 SMALL NUCLEOLAR",Asterisk
611070,"SMALL NUCLEOLAR RNA, C/D BOX, 83A; SNORD83A",Asterisk
611071,"SMALL NUCLEOLAR RNA, C/D BOX, 83B; SNORD83B",Asterisk
611072,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 24; DNAJC24",Asterisk
611073,ALZHEIMER DISEASE 12,Percent
611074,"BRAIN-SPECIFIC HOMEOBOX, MOUSE, HOMOLOG OF; BSX",Asterisk
611075,"DPH5, S. CEREVISIAE, HOMOLOG OF; DPH5",Asterisk
611076,5-PRIME-NUCLEOTIDASE DOMAIN-CONTAINING PROTEIN 3; NT5DC3,Asterisk
611077,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 4; CHCHD4,Asterisk
611078,COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 1; CBWD1,Asterisk
611079,COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 2; CBWD2,Asterisk
611080,COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 3; CBWD3,Asterisk
611081,INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10; IBD10,Number Sign
611082,MIAT GENE; MIAT,Asterisk
611083,"ALCOHOL DEHYDROGENASE, IRON-CONTAINING, 1; ADHFE1",Asterisk
611084,FORKHEAD BOX D4-LIKE 1; FOXD4L1,Asterisk
611085,FORKHEAD BOX D4-LIKE 4; FOXD4L4,Asterisk
611086,FORKHEAD BOX D4-LIKE 3; FOXD4L3,Asterisk
611087,"POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE",Number Sign
611088,COILED-COIL DOMAIN-CONTAINING PROTEIN 65; CCDC65,Asterisk
611089,MYOTUBULARIN-RELATED PROTEIN 14; MTMR14,Asterisk
611090,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12",Number Sign
611091,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5",Number Sign
611092,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6",Number Sign
611093,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7",Number Sign
611094,MOVED TO 614300,Caret
611095,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9",Percent
611096,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10; MRT10",Percent
611097,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11; MRT11",Percent
611098,SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 4; STEAP4,Asterisk
611099,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 6; PDIA6",Asterisk
611100,"PROSTATE CANCER, HEREDITARY, 10; HPC10",Percent
611101,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G5; PLEKHG5,Asterisk
611102,DEAFNESS-INFERTILITY SYNDROME; DIS,Number Sign
611103,"ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9; ACAD9",Asterisk
611104,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 4; FGD4",Asterisk
611105,LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL,Number Sign
611106,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12D; ZC3H12D,Asterisk
611107,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4; MRT4",Percent
611108,VON WILLEBRAND FACTOR C DOMAIN-CONTAINING PROTEIN 2; VWC2,Asterisk
611109,"CINNAMON ODOR, PLEASANTNESS OF",Percent
611110,MAP3K7 C-TERMINAL-LIKE PROTEIN; MAP3K7CL,Asterisk
611111,DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 5; DPPA5,Asterisk
611112,"DAPPER, ANTAGONIST OF BETA-CATENIN, 3; DACT3",Asterisk
611113,CEMENTUM PROTEIN 1; CEMP1,Asterisk
611114,MICRO RNA 150; MIR150,Asterisk
611115,VON WILLEBRAND FACTOR C AND EGF DOMAIN-CONTAINING PROTEIN; VWCE,Asterisk
611116,MICRO RNA 208A; MIR208A,Asterisk
611117,PROTEIN PHOSPHATASE METHYLESTERASE 1; PPME1,Asterisk
611118,NUCLEAR PRELAMIN A RECOGNITION FACTOR-LIKE; NARFL,Asterisk
611119,KELCH-LIKE 7; KLHL7,Asterisk
611120,"SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 3; SPTLC3",Asterisk
611121,CALMIN; CLMN,Asterisk
611122,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28; ANKRD28,Asterisk
611123,EPHRIN RECEPTOR EphA10; EPHA10,Asterisk
611124,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 8; MFSD8,Asterisk
611125,DERMATAN SULFATE EPIMERASE-LIKE; DSEL,Asterisk
611126,MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY,Number Sign
611127,UBIQUITIN-LIKE 4B; UBL4B,Asterisk
611128,MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 2; MDGA2,Asterisk
611129,WW DOMAIN-BINDING PROTEIN 1-LIKE; WBP1L,Asterisk
611130,"CHMP FAMILY, MEMBER 7; CHMP7",Asterisk
611131,RETINITIS PIGMENTOSA 37; RP37,Number Sign
611132,RIBOKINASE; RBKS,Asterisk
611133,"SMALL NUCLEOLAR RNA, C/D BOX, 82; SNORD82",Asterisk
611134,"MECKEL SYNDROME, TYPE 4; MKS4",Number Sign
611135,"KLOTHO, BETA; KLB",Asterisk
611136,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13",Number Sign
611137,"PROTEASOME SUBUNIT, BETA-TYPE, 11; PSMB11",Asterisk
611138,SPERMATID PERINUCLEAR RNA-BINDING PROTEIN; STRBP,Asterisk
611139,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8; CHDS8",Percent
611140,"TELOMERE MAINTENANCE 2, S. CEREVISIAE, HOMOLOG OF; TELO2",Asterisk
611141,"MINDBOMB, DROSOPHILA, HOMOLOG OF, 2; MIB2",Asterisk
611142,CYTOSKELETON-ASSOCIATED PROTEIN 5; CKAP5,Asterisk
611143,"FAMILY WITH SEQUENCE SIMILARITY 175, MEMBER A; FAM175A",Asterisk
611144,"FAMILY WITH SEQUENCE SIMILARITY 175, MEMBER B; FAM175B",Asterisk
611145,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 8; SLC30A8",Asterisk
611146,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 10; SLC30A10",Asterisk
611147,PAROXYSMAL NONKINESIGENIC DYSKINESIA 2; PNKD2,Percent
611148,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 6; SLC30A6",Asterisk
611149,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 7; SLC30A7",Asterisk
611150,ATAXIN 10; ATXN10,Asterisk
611151,"tRNA METHYLTRANSFERASE 2, S. CEREVISIAE, HOMOLOG OF, A; TRMT2A",Asterisk
611152,ALZHEIMER DISEASE 13; AD13,Percent
611153,XPA GENE; XPA,Asterisk
611154,ALZHEIMER DISEASE 14; AD14,Percent
611155,ALZHEIMER DISEASE 15; AD15,Percent
611156,ENDOPLASMIC RETICULUM METALLOPEPTIDASE 1; ERMP1,Asterisk
611157,MRG/MORF4L-BINDING PROTEIN; MRGBP,Asterisk
611158,"KERATIN 77, TYPE II; KRT77",Asterisk
611159,"KERATIN 78, TYPE II; KRT78",Asterisk
611160,"KERATIN 79, TYPE II; KRT79",Asterisk
611161,"KERATIN 80, TYPE II; KRT80",Asterisk
611162,"MALARIA, SUSCEPTIBILITY TO",Number Sign
611163,TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2,Asterisk
611164,ARGININE-FIFTY HOMEOBOX; ARGFX,Asterisk
611165,DIVERGENT-PAIRED RELATED HOMEOBOX; DPRX,Asterisk
611166,TETRAPEPTIDE REPEAT HOMEOBOX 1; TPRX1,Asterisk
611167,TETRAPEPTIDE REPEAT HOMEOBOX-LIKE; TPRXL,Asterisk
611168,DOUBLE HOMEOBOX A; DUXA,Asterisk
611169,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT BETA; CATSPERB",Asterisk
611170,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9-LIKE; SAMD9L,Asterisk
611171,SHOOTIN1; SHTN1,Asterisk
611172,MICRO RNA 34A; MIR34A,Asterisk
611173,MICRO RNA 375; MIR375,Asterisk
611174,HAMAMY SYNDROME; HMMS,Number Sign
611175,OBG-LIKE ATPase 1; OLA1,Asterisk
611176,JNK/MAPK8-ASSOCIATED MEMBRANE PROTEIN; JKAMP,Asterisk
611177,"INTRAFLAGELLAR TRANSPORT 80, CHLAMYDOMONAS, HOMOLOG OF; IFT80",Asterisk
611178,GALANIN-LIKE PEPTIDE; GALP,Asterisk
611179,SHROOM FAMILY MEMBER 1; SHROOM1,Asterisk
611180,COFACTOR OF BRCA1; COBRA1,Asterisk
611181,"ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 10; ACAD10",Asterisk
611182,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H",Number Sign
611183,"BRICK1, SCAR/WAVE ACTIN-NUCLEATING COMPLEX SUBUNIT; BRK1",Asterisk
611184,PIEZO-TYPE MECHANOSENSITIVE ION CHANNEL COMPONENT 1; PIEZO1,Asterisk
611185,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6; RLS6",Percent
611186,MICRO RNA 9-1; MIR9-1,Asterisk
611187,MICRO RNA 9-2; MIR9-2,Asterisk
611188,MICRO RNA 9-3; MIR9-3,Asterisk
611189,MICRO RNA 197; MIR197,Asterisk
611190,MICRO RNA 346; MIR346,Asterisk
611191,MICRO RNA 125A; MIR125A,Asterisk
611192,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 11; ANKRD11,Asterisk
611193,"RIBOSOMAL RNA-PROCESSING 15, S. CEREVISIAE, HOMOLOG OF; RRP15",Asterisk
611194,RUN AND FYVE DOMAINS-CONTAINING PROTEIN 3; RUFY3,Asterisk
611195,JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 1; JAKMIP1,Asterisk
611196,ZINC FINGER MIZ-DOMAIN CONTAINING 2; ZMIZ2,Asterisk
611197,JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 2; JAKMIP2,Asterisk
611198,JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 3; JAKMIP3,Asterisk
611199,DNTT-INTERACTING PROTEIN 2; DNTTIP2,Asterisk
611200,TUDOR DOMAIN-CONTAINING PROTEIN 6; TDRD6,Asterisk
611201,KELCH-LIKE 9; KLHL9,Asterisk
611202,N-ACYLSPHINGOSINE AMIDOHYDROLASE 2; ASAH2,Asterisk
611203,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5; DNAJC5",Asterisk
611204,COILED-COIL DOMAIN-CONTAINING PROTEIN 88C; CCDC88C,Asterisk
611205,COILED-COIL DOMAIN-CONTAINING PROTEIN 88B; CCDC88B,Asterisk
611206,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9; DNAJC9",Asterisk
611207,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 1; DNAJC1",Asterisk
611208,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L-LIKE; HNRNPLL,Asterisk
611209,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G",Number Sign
611210,PDZ-BINDING KINASE; PBK,Asterisk
611211,RECEPTOR EXPRESSED IN LYMPHOID TISSUES; RELT,Asterisk
611212,RELT-LIKE 1; RELL1,Asterisk
611213,RELT-LIKE 2; RELL2,Asterisk
611214,"TSR1, 20S rRNA ACCUMULATION, S. CEREVISIAE, HOMOLOG OF; TSR1",Asterisk
611215,PRADER-WILLI REGION NONCODING RNA 1; PWRN1,Asterisk
611216,UBX DOMAIN PROTEIN 4; UBXN4,Asterisk
611217,PRADER-WILLI REGION NONCODING RNA 2; PWRN2,Asterisk
611218,GASDERMIN A; GSDMA,Asterisk
611219,"UNC45, C. ELEGANS, HOMOLOG OF, A; UNC45A",Asterisk
611220,"UNC45, C. ELEGANS, HOMOLOG OF, B; UNC45B",Asterisk
611221,GASDERMIN B; GSDMB,Asterisk
611222,"MICROPHTHALMIA, SYNDROMIC 10; MCOPS10",Percent
611223,V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 3; AKT3,Asterisk
611224,"SUCCINATE-CoA LIGASE, ALPHA SUBUNIT; SUCLG1",Asterisk
611225,"SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18",Number Sign
611226,ARMADILLO REPEAT-CONTAINING PROTEIN 3; ARMC3,Asterisk
611227,HYDROGEN VOLTAGE-GATED CHANNEL 1; HVCN1,Asterisk
611228,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J",Number Sign
611229,ENDOPLASMIC RETICULUM LECTIN 1; ERLEC1,Asterisk
611230,NON-SMC CONDENSIN II COMPLEX SUBUNIT H2; NCAPH2,Asterisk
611231,CLAUDIN 8; CLDN8,Asterisk
611232,CLAUDIN 12; CLDN12,Asterisk
611233,ARGININE-RICH PROTEIN MUTATED IN EARLY STAGE TUMORS-LIKE 1; ARMETL1,Asterisk
611234,"FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER A; FAM84A",Asterisk
611235,TRANSMEMBRANE PROTEIN 38A; TMEM38A,Asterisk
611236,TRANSMEMBRANE PROTEIN 38B; TMEM38B,Asterisk
611237,BTB/POZ DOMAIN-CONTAINING PROTEIN 9; BTBD9,Asterisk
611238,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 7; CHCHD7,Asterisk
611239,G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 1; GPRIN1,Asterisk
611240,G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 2; GPRIN2,Asterisk
611241,G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 3; GPRIN3,Asterisk
611242,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5; RLS5",Percent
611243,"tRNA-WYBUTOSINE-SYNTHESIZING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF; TYW1",Asterisk
611244,"tRNA METHYLTRANSFERASE 12, S. CEREVISIAE, HOMOLOG OF; TRMT12",Asterisk
611245,"tRNA-WYBUTOSINE-SYNTHESIZING PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; TYW3",Asterisk
611246,LEUCINE CARBOXYL METHYLTRANSFERASE 2; LCMT2,Asterisk
611247,MAJOR AFFECTIVE DISORDER 4; MAFD4,Percent
611248,KELCH DOMAIN-CONTAINING PROTEIN 3; KLHDC3,Asterisk
611249,MICRO RNA LET7B; MIRLET7B,Asterisk
611250,MICRO RNA LET7E; MIRLET7E,Asterisk
611251,PATCHED DOMAIN-CONTAINING PROTEIN 2; PTCHD2,Asterisk
611252,"SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32",Percent
611253,KINESIN FAMILY MEMBER 27; KIF27,Asterisk
611254,KINESIN FAMILY MEMBER 7; KIF7,Asterisk
611255,NADPH OXIDASE ACTIVATOR 1; NOXA1,Asterisk
611256,NADPH OXIDASE ORGANIZER 1; NOXO1,Asterisk
611257,TRANSMEMBRANE PROTEIN 132D; TMEM132D,Asterisk
611258,TUDOR DOMAIN-CONTAINING PROTEIN 7; TDRD7,Asterisk
611259,CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1; CDKAL1,Asterisk
611260,THREONINE SYNTHASE-LIKE 1; THNSL1,Asterisk
611261,THREONINE SYNTHASE-LIKE 2; THNSL2,Asterisk
611262,DEOXYHYPUSINE HYDROXYLASE; DOHH,Asterisk
611263,SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2,Number Sign
611264,CENTROMERIC PROTEIN W; CENPW,Asterisk
611265,"PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-INTERACTING COFACTOR COMPLEX, 285-KD SUBUNIT",Asterisk
611266,"POTE ANKYRIN DOMAIN FAMILY, MEMBER K, PSEUDOGENE; POTEKP",Asterisk
611267,"OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 1; OR51E1",Asterisk
611268,"OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 2; OR51E2",Asterisk
611269,NUCLEOLAR PROTEIN WITH MIF4G DOMAIN 1; NOM1,Asterisk
611270,"N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, BETA; NAPB",Asterisk
611271,KINESIN FAMILY MEMBER 18A; KIF18A,Asterisk
611272,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 5; ZKSCAN5,Asterisk
611273,"LBX1 COREPRESSOR 1, MOUSE, HOMOLOG OF; LBXCOR1",Asterisk
611274,"GLAUCOMA 1, OPEN ANGLE, N; GLC1N",Percent
611275,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2-LIKE; BNIPL,Asterisk
611276,"GLAUCOMA 1, OPEN ANGLE, H; GLC1H",Percent
611277,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3; GEFSP3",Number Sign
611278,KINESIN FAMILY MEMBER 12; KIF12,Asterisk
611279,KINESIN FAMILY MEMBER 14; KIF14,Asterisk
611280,KELCH DOMAIN-CONTAINING PROTEIN 2; KLHDC2,Asterisk
611281,KELCH DOMAIN-CONTAINING PROTEIN 1; KLHDC1,Asterisk
611282,DYNAMIN-BINDING PROTEIN; DNMBP,Asterisk
611283,ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY,Number Sign
611284,"DYSTONIA, FOCAL, TASK-SPECIFIC; FTSD",Percent
611285,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 5; KCTD5,Asterisk
611286,RNA TERMINAL PHOSPHATE CYCLASE DOMAIN-CONTAINING PROTEIN 1; RTCD1,Asterisk
611287,"CORNICHON, DROSOPHILA, HOMOLOG OF; CNIH",Asterisk
611288,"CORNICHON, DROSOPHILA, HOMOLOG OF, 2; CNIH2",Asterisk
611289,LEUCINE-RICH ALPHA-2-GLYCOPROTEIN 1; LRG1,Asterisk
611290,NONHOMOLOGOUS END-JOINING FACTOR 1; NHEJ1,Asterisk
611291,"SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION",Number Sign
611292,CLAVESIN 1; CLVS1,Asterisk
611293,COILED-COIL DOMAIN-CONTAINING PROTEIN 86; CCDC86,Asterisk
611294,ONE CUT HOMEOBOX 3; ONECUT3,Asterisk
611295,KELCH-LIKE 24; KLHL24,Asterisk
611296,ANNEXIN A2 RECEPTOR; ANXA2R,Asterisk
611297,ODD-SKIPPED-RELATED 2; OSR2,Asterisk
611298,KIAA1324,Asterisk
611299,G2/M PHASE-SPECIFIC E3 UBIQUITIN LIGASE; G2E3,Asterisk
611300,"La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 6; LARP6",Asterisk
611301,CHROMOSOME 17 OPEN READING FRAME 70; C17ORF70,Asterisk
611302,"SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2",Number Sign
611303,"C-TYPE LECTIN DOMAIN FAMILY 16, MEMBER A; CLEC16A",Asterisk
611304,TRANSMEMBRANE PROTEIN 159; TMEM159,Asterisk
611305,"ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 3; ABLIM3",Asterisk
611306,"SCAVENGER RECEPTOR CLASS A, MEMBER 5; SCARA5",Asterisk
611307,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12",Number Sign
611308,"PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL DOMINANT; PHPVAD",Percent
611309,CHROMOSOME 10 OPEN READING FRAME 10; C10ORF10,Asterisk
611310,PHOSPHOSERYL-tRNA KINASE; PSTK,Asterisk
611311,MOVED TO 221900,Caret
611312,CORNULIN; CRNN,Asterisk
611313,ARMS2 GENE; ARMS2,Asterisk
611314,HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 2 PSEUDOGENE 46; HMGN2P46,Asterisk
611315,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 20; ZSCAN20,Asterisk
611316,"SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 8; SLC12A8",Asterisk
611317,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 5; PIK3R5",Asterisk
611318,MEDIATOR COMPLEX SUBUNIT 12-LIKE; MED12L,Asterisk
611319,INTERFERON-ALPHA-INDUCIBLE PROTEIN 27-LIKE 2; IFI27L2,Asterisk
611320,"FAMILY WITH SEQUENCE SIMILARITY 14, MEMBER B; FAM14B",Asterisk
611321,CALSYNTENIN 1; CLSTN1,Asterisk
611322,"DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 2; DNAJA2",Asterisk
611323,CALSYNTENIN 2; CLSTN2,Asterisk
611324,CALSYNTENIN 3; CLSTN3,Asterisk
611325,TRANSFORMING GROWTH FACTOR-BETA REGULATOR 4; TBRG4,Asterisk
611326,CELL CYCLE PROGRESSION 1; CCPG1,Asterisk
611327,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 4; DNAJB4",Asterisk
611328,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 5; DNAJB5",Asterisk
611329,SMALL CAJAL BODY-SPECIFIC RNA 18; SCARNA18,Asterisk
611330,"SMALL NUCLEOLAR RNA, H/ACA BOX, 12; SNORA12",Asterisk
611331,"SMALL NUCLEOLAR RNA, H/ACA BOX, 74B; SNORA74B",Asterisk
611332,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 6; DNAJB6",Asterisk
611333,"SMALL NUCLEOLAR RNA, H/ACA BOX, 3B; SNORA3B",Asterisk
611334,"SMALL NUCLEOLAR RNA, H/ACA BOX, 81; SNORA81",Asterisk
611335,"SMALL NUCLEOLAR RNA, H/ACA BOX, 5C; SNORA5C",Asterisk
611336,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 7; DNAJB7",Asterisk
611337,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 8; DNAJB8",Asterisk
611338,"AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, B; ATG4B",Asterisk
611339,"AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, C; ATG4C",Asterisk
611340,"AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, D; ATG4D",Asterisk
611341,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 11; DNAJB11",Asterisk
611342,CHROMOSOME 9 OPEN READING FRAME 64; C9ORF64,Asterisk
611343,CHROMOSOME 9 OPEN READING FRAME 103; C9ORF103,Asterisk
611344,RAS AND EF-HAND DOMAINS-CONTAINING PROTEIN; RASEF,Asterisk
611345,INTEGRATOR COMPLEX SUBUNIT 1; INTS1,Asterisk
611346,INTEGRATOR COMPLEX SUBUNIT 2; INTS2,Asterisk
611347,INTEGRATOR COMPLEX SUBUNIT 3; INTS3,Asterisk
611348,INTEGRATOR COMPLEX SUBUNIT 4; INTS4,Asterisk
611349,INTEGRATOR COMPLEX SUBUNIT 5; INTS5,Asterisk
611350,INTEGRATOR COMPLEX SUBUNIT 7; INTS7,Asterisk
611351,INTEGRATOR COMPLEX SUBUNIT 8; INTS8,Asterisk
611352,INTEGRATOR COMPLEX SUBUNIT 9; INTS9,Asterisk
611353,INTEGRATOR COMPLEX SUBUNIT 10; INTS10,Asterisk
611354,CLEAVAGE AND POLYADENYLATION-SPECIFIC FACTOR 3-LIKE; CPSF3L,Asterisk
611355,INTEGRATOR COMPLEX SUBUNIT 12; INTS12,Asterisk
611356,G KINASE-ANCHORING PROTEIN 1; GKAP1,Asterisk
611357,TERMINAL NUCLEOTIDYLTRANSFERASE 5A; TENT5A,Asterisk
611358,RING FINGER PROTEIN 135; RNF135,Asterisk
611359,ACTIVATING MOLECULE IN BECLIN 1-REGULATED AUTOPHAGY; AMBRA1,Asterisk
611360,FANCI GENE; FANCI,Asterisk
611361,UBIQUITIN-ACTIVATING ENZYME E1-LIKE 2; UBE1L2,Asterisk
611362,UBIQUITIN-CONJUGATING ENZYME E2Z; UBE2Z,Asterisk
611363,ATRIAL SEPTAL DEFECT 4; ASD4,Number Sign
611364,"MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4",Percent
611365,TRANSMEMBRANE PROTEIN 183B; TMEM183B,Asterisk
611366,CHROMOSOME 12 OPEN READING FRAME 10; C12ORF10,Asterisk
611367,ASPARTYL AMINOPEPTIDASE; DNPEP,Asterisk
611368,"MAELSTROM, DROSOPHILA, HOMOLOG OF; MAEL",Asterisk
611369,LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3,Number Sign
611370,FGGY CARBOHYDRATE KINASE DOMAIN-CONTAINING PROTEIN; FGGY,Asterisk
611371,ZINC FINGER PROTEIN 653; ZNF653,Asterisk
611372,SMALL ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 1; SMAP1,Asterisk
611373,LIVER-EXPRESSED ANTIMICROBIAL PEPTIDE 2; LEAP2,Asterisk
611374,MICRO RNA 34B; MIR34B,Asterisk
611375,MICRO RNA 34C; MIR34C,Asterisk
611376,MUNGAN SYNDROME; MGS,Number Sign
611377,"BRACHYDACTYLY, TYPE B2; BDB2",Number Sign
611378,"MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9",Number Sign
611379,"DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, B; DIP2B",Asterisk
611380,"DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, C; DIP2C",Asterisk
611381,"KALA-AZAR, SUSCEPTIBILITY TO, 2; KAZA2",Percent
611382,"KALA-AZAR, SUSCEPTIBILITY TO, 3; KAZA3",Percent
611383,"USHER SYNDROME, TYPE IID; USH2D",Number Sign
611384,PLASMODIUM FALCIPARUM FEVER EPISODES QUANTITATIVE TRAIT LOCUS 1,Percent
611385,MOVED TO 176846,Caret
611386,ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX; ADNP,Asterisk
611387,CXC CHEMOKINE LIGAND 17; CXCL17,Asterisk
611388,"DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL, INTERACTING PROTEIN 1; DNTTIP1",Asterisk
611389,"PRICKLE, DROSOPHILA, HOMOLOG OF, 4; PRICKLE4",Asterisk
611390,"SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3",Number Sign
611391,"CATARACT 33, MULTIPLE TYPES; CTRCT33",Number Sign
611392,2-AMINOETHANETHIOL DIOXYGENASE; ADO,Asterisk
611393,"FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER A; FAM110A",Asterisk
611394,"FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER B; FAM110B",Asterisk
611395,"FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER C; FAM110C",Asterisk
611396,ADIPOGENIN; ADIG,Asterisk
611397,"TETRATRICOPEPTIDE REPEAT-, ANKYRIN REPEAT-, AND COILED-COIL-CONTAINING PROTEIN 1; TANC1",Asterisk
611398,GROWTH ARREST-SPECIFIC 2-LIKE 2; GAS2L2,Asterisk
611399,SODIUM CHANNEL AND CLATHRIN LINKER 1; SCLT1,Asterisk
611400,"HOX TRANSCRIPT ANTISENSE RNA, NONCODING; HOTAIR",Asterisk
611401,CHROMOSOME 6 OPEN READING FRAME 15; C6ORF15,Asterisk
611402,DOCKING PROTEIN 6; DOK6,Asterisk
611403,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6",Percent
611404,CHROMOSOME 6 OPEN READING FRAME 21; C6ORF21,Asterisk
611405,RNA TERMINAL PHOSPHATE CYCLASE-LIKE 1; RCL1,Asterisk
611406,"DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 2; DYNC1LI2",Asterisk
611407,"CARDIOMYOPATHY, DILATED, 1W; CMD1W",Number Sign
611408,LCA5 GENE; LCA5,Asterisk
611409,OCA2 MELANOSOMAL TRANSMEMBRANE PROTEIN; OCA2,Asterisk
611410,"FAMILY WITH SEQUENCE SIMILARITY 65, MEMBER B; FAM65B",Asterisk
611411,"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1, ALPHA; CAMKK1",Asterisk
611412,N-ACETYLNEURAMINATE PYRUVATE LYASE; NPL,Asterisk
611413,DISCS LARGE-ASSOCIATED PROTEIN 3; DLGAP3,Asterisk
611414,CALRETICULIN 3; CALR3,Asterisk
611415,"POLYMERASE (DNA-DIRECTED), DELTA 3, ACCESSORY SUBUNIT; POLD3",Asterisk
611416,TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TOX3,Asterisk
611417,SMALL G PROTEIN SIGNALING MODULATOR 1; SGSM1,Asterisk
611418,SMALL G PROTEIN SIGNALING MODULATOR 2; SGSM2,Asterisk
611419,CHROMOSOME 6 OPEN READING FRAME 1; C6ORF1,Asterisk
611420,CDKN1A-INTERACTING ZINC FINGER PROTEIN 1; CIZ1,Asterisk
611421,SNF2-RELATED CBP ACTIVATOR PROTEIN; SRCAP,Asterisk
611422,"MEIOTIC NUCLEAR DIVISION 1, S. CEREVISIAE, HOMOLOG OF; MND1",Asterisk
611423,"CENTROSOMAL PROTEIN, 135-KD; CEP135",Asterisk
611424,ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 19; ZMYND19,Asterisk
611425,CENTROSOMAL BRCA2-INTERACTING PROTEIN; CNTROB,Asterisk
611426,TENTED EYEBROWS,
611427,"METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1-LIKE, NADP(+)-DEPENDENT; MTHFD1L",Asterisk
611428,DOWNSTREAM NEIGHBOR OF SON; DONSON,Asterisk
611429,CHROMOSOME 3 OPEN READING FRAME 35; C3ORF35,Asterisk
611430,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 21A; TTC21A,Asterisk
611431,LEGIUS SYNDROME,Number Sign
611432,DEDICATOR OF CYTOKINESIS 8; DOCK8,Asterisk
611433,SERINE/THREONINE/TYROSINE KINASE 1; STYK1,Asterisk
611434,CYTOKINE-DEPENDENT HEMATOPOIETIC CELL LINKER; CLNK,Asterisk
611435,DOCKING PROTEIN 3; DOK3,Asterisk
611436,CARBONIC ANHYDRASE XIII; CA13,Asterisk
611437,DUAL-SPECIFICITY PHOSPHATASE 19; DUSP19,Asterisk
611438,"TAXILIN, BETA; TXLNB",Asterisk
611439,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 22; ZBTB22,Asterisk
611440,WD REPEAT-CONTAINING PROTEIN 46; WDR46,Asterisk
611441,DOUBLE HOMEOBOX PROTEIN 1; DUX1,Asterisk
611442,DOUBLE HOMEOBOX PROTEIN 2; DUX2,Asterisk
611443,DOUBLE HOMEOBOX PROTEIN 3; DUX3,Asterisk
611444,DOUBLE HOMEOBOX PROTEIN 5; DUX5,Asterisk
611445,DYNAMIN 3; DNM3,Asterisk
611446,DUAL-SPECIFICITY PHOSPHATASE 18; DUSP18,Asterisk
611447,Y BOX-BINDING PROTEIN 2; YBX2,Asterisk
611448,"BMS1, RIBOSOME ASSEMBLY PROTEIN, S. CEREVISIAE, HOMOLOG OF; BMS1",Asterisk
611449,EXPORTIN 4; XPO4,Asterisk
611450,PXK DOMAIN-CONTAINING SERINE/THREONINE KINASE; PXK,Asterisk
611451,"DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63",Number Sign
611452,MOVED TO 278150,Caret
611453,DYSBINDIN DOMAIN-CONTAINING 2; DBNDD2,Asterisk
611454,MOVED TO 105550,Caret
611455,KINOCILIN; KNCN,Asterisk
611456,"TREMOR, HEREDITARY ESSENTIAL, 3; ETM3",Percent
611457,FORKHEAD BOX O6,Asterisk
611458,"GALACTOSIDASE, BETA-1; GLB1",Asterisk
611459,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 7; SLC10A7",Asterisk
611460,TUMOR PROTEIN p63-REGULATED PROTEIN 1-LIKE; TPRG1L,Asterisk
611461,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 17; SLC22A17",Asterisk
611462,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 6; PIK3R6",Asterisk
611463,SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE 2; SAT2,Asterisk
611464,"MON1, S. CEREVISIAE, HOMOLOG OF, A; MON1A",Asterisk
611465,GALLBLADDER DISEASE 4; GBD4,Number Sign
611466,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 1; PLEKHM1",Asterisk
611467,GUANYLATE-BINDING PROTEIN 5: GBP5,Asterisk
611468,BDNF ANTISENSE RNA; BDNFAS,Asterisk
611469,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 2; CRCS2",Percent
611470,GLUTAMATE-AMMONIA LIGASE (GLUTAMINE SYNTHETASE) DOMAIN-CONTAINING 1; GLULD1,Asterisk
611471,"ACID PHOSPHATASE 6, LYSOPHOSPHATIDE; ACP6",Asterisk
611472,METHYL-CpG-BINDING DOMAIN PROTEIN 5; MBD5,Asterisk
611473,EMBRYONIC STEM CELL-RELATED PROTEIN,Asterisk
611474,"HRAS-LIKE SUPPRESSOR FAMILY, MEMBER 5; HRASLS5",Asterisk
611475,RNA POLYMERASE II-ASSOCIATED PROTEIN 1; RPAP1,Asterisk
611476,RNA POLYMERASE II-ASSOCIATED PROTEIN 2; RPAP2,Asterisk
611477,RNA POLYMERASE II-ASSOCIATED PROTEIN 3; RPAP3,Asterisk
611478,METHYLPHOSPHATE CAPPING ENZYME; MEPCE,Asterisk
611479,XPA-BINDING PROTEIN 1; XAB1,Asterisk
611480,PIH1 DOMAIN-CONTAINING PROTEIN 1; PIH1D1,Asterisk
611481,UFM1-SPECIFIC PEPTIDASE 1; UFSP1,Asterisk
611482,UFM1-SPECIFIC PEPTIDASE 2; UFSP2,Asterisk
611483,"YIP1 DOMAIN FAMILY, MEMBER 5; YIPF5",Asterisk
611484,"YIP1-INTERACTING FACTOR, S. CEREVISIAE, HOMOLOG OF, A; YIF1A",Asterisk
611485,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 12; CYP4F12",Asterisk
611486,SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 1; SYCE1,Asterisk
611487,SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 2; SYCE2,Asterisk
611488,"MACULAR DEGENERATION, AGE-RELATED, 10; ARMD10",Percent
611489,CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY,Number Sign
611490,"OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4",Number Sign
611491,RAS ASSOCIATION AND DILUTE DOMAINS PROTEIN; RADIL,Asterisk
611492,CARBONIC ANHYDRASE II; CA2,Asterisk
611493,"ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4",Number Sign
611494,"ATRIAL FIBRILLATION, FAMILIAL, 5; ATFB5",Percent
611495,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 22; CYP4F22",Asterisk
611496,GATA-BINDING PROTEIN 5; GATA5,Asterisk
611497,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6",Number Sign
611498,NEPHRONOPHTHISIS 7; NPHP7,Number Sign
611499,BETA-GLUCURONIDASE; GUSB,Asterisk
611500,MICRO RNA 219-1; MIR219-1,Asterisk
611501,CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 1; CAMTA1,Asterisk
611502,CENTROMERIC PROTEIN K; CENPK,Asterisk
611503,CENTROMERIC PROTEIN L; CENPL,Asterisk
611504,CENTROMERIC PROTEIN O; CENPO,Asterisk
611505,CENTROMERIC PROTEIN P; CENPP,Asterisk
611506,CENTROMERIC PROTEIN Q; CENPQ,Asterisk
611507,CDGSH IRON SULFUR DOMAIN PROTEIN 2; CISD2,Asterisk
611508,CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 2; CAMTA2,Asterisk
611509,CENTROMERIC PROTEIN N; CENPN,Asterisk
611510,CENTROMERIC PROTEIN T; CENPT,Asterisk
611511,MLF1-INTERACTING PROTEIN; MLF1IP,Asterisk
611512,LYSINE-SPECIFIC DEMETHYLASE 3A; KDM3A,Asterisk
611513,NEUROGENIC DIFFERENTIATION 6; NEUROD6,Asterisk
611514,"WNTLESS, DROSOPHILA, HOMOLOG OF; WLS",Asterisk
611515,"FEBRILE SEIZURES, FAMILIAL, 7; FEB7",Percent
611516,NICOLIN 1; NICN1,Asterisk
611517,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 11; CYP4F11",Asterisk
611518,DEDICATOR OF CYTOKINESIS 10; DOCK10,Asterisk
611519,POLYMERASE DELTA-INTERACTING PROTEIN 2; POLDIP2,Asterisk
611520,POLYMERASE DELTA-INTERACTING PROTEIN 3; POLDIP3,Asterisk
611521,IMMUNODEFICIENCY 35; IMD35,Number Sign
611522,INTRAOCULAR PRESSURE QUANTITATIVE TRAIT LOCUS; IOPQTL,Percent
611523,"PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6",Number Sign
611524,ARGINYL-tRNA SYNTHETASE 2; RARS2,Asterisk
611525,"POLYMERASE (DNA-DIRECTED), DELTA 4; POLD4",Asterisk
611526,"NOP14, S. CEREVISIAE, HOMOLOG OF; NOP14",Asterisk
611527,Na+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 1; NHEDC1,Asterisk
611528,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12",Number Sign
611529,"CYTOCHROME P450, FAMILY 2, SUBFAMILY S, POLYPEPTIDE 1; CYP2S1",Asterisk
611530,NEUROLYSIN; NLN,Asterisk
611531,"ESSENTIAL FOR MITOTIC GROWTH 1, S. CEREVISIAE, HOMOLOG OF; EMG1",Asterisk
611532,NUCLEOLAR PROTEIN 6; NOL6,Asterisk
611533,NUCLEOLAR PROTEIN 7; NOL7,Asterisk
611534,NUCLEOLAR PROTEIN 8; NOL8,Asterisk
611535,MAJOR AFFECTIVE DISORDER 5; MAFD5,Percent
611536,MAJOR AFFECTIVE DISORDER 6; MAFD6,Percent
611537,"CATENIN, BETA-LIKE, 1; CTNNBL1",Asterisk
611538,"OLFACTORY RECEPTOR, FAMILY 7, SUBFAMILY D, MEMBER 4; OR7D4",Asterisk
611539,FORKHEAD BOX D3; FOXD3,Asterisk
611540,SH3-DOMAIN GRB2-LIKE (ENDOPHILIN)-INTERACTING PROTEIN 1; SGIP1,Asterisk
611541,SORTING NEXIN 27; SNX27,Asterisk
611542,ARYLSULFATASE B; ARSB,Asterisk
611543,CAVITARY OPTIC DISC ANOMALIES; CODA,Number Sign
611544,"CATARACT 17, MULTIPLE TYPES; CTRCT17",Number Sign
611545,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 8; CYP4F8",Asterisk
611546,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 6; ELOVL6,Asterisk
611547,STATURE QUANTITATIVE TRAIT LOCUS 9; STQTL9,Percent
611548,PREMATURE OVARIAN FAILURE 5; POF5,Number Sign
611549,"SODIUM LEAK CHANNEL, NONSELECTIVE; NALCN",Asterisk
611550,NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NCR3,Asterisk
611551,FIBULIN 7; FBLN7,Asterisk
611552,NICOTINATE PHOSPHORIBOSYLTRANSFERASE DOMAIN-CONTAINING 1; NAPRT1,Asterisk
611553,NOONAN SYNDROME 5; NS5,Number Sign
611554,LEOPARD SYNDROME 2; LPRD2,Number Sign
611555,"RENAL TUBULAR ACIDOSIS, DISTAL, WITH NEPHROCALCINOSIS, SHORT STATURE, MENTAL RETARDATION, AND DISTINCTIVE FACIES",
611556,"GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B",Number Sign
611557,UROPLAKIN 1A; UPK1A,Asterisk
611558,UROPLAKIN 2; UPK2,Asterisk
611559,UROPLAKIN 3A; UPK3A,Asterisk
611560,JOUBERT SYNDROME 7; JBTS7,Number Sign
611561,"MECKEL SYNDROME, TYPE 5; MKS5",Number Sign
611562,SEPTIN 12; SEPT12,Asterisk
611563,SEPTIN 13; SEPT13,Asterisk
611564,BTG3-ASSOCIATED NUCLEAR PROTEIN; BANP,Asterisk
611565,KIAA1109 GENE; KIAA1109,Asterisk
611566,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE 1-LIKE 1; PRPS1L1,Asterisk
611567,MACRO DOMAIN-CONTAINING 2; MACROD2,Asterisk
611568,SYNTABULIN; SYBU,Asterisk
611569,CYTOSKELETON-ASSOCIATED PROTEIN 2; CKAP2,Asterisk
611570,"FRUCTOSE-1,6-BISPHOSPHATASE 1; FBP1",Asterisk
611571,OTOSCLEROSIS 4; OTSC4,Percent
611572,OTOSCLEROSIS 7; OTSC7,Percent
611573,SPHINGOMYELIN SYNTHASE 1; SGMS1,Asterisk
611574,SPHINGOMYELIN SYNTHASE 2; SGMS2,Asterisk
611575,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 8; SAMD8,Asterisk
611576,MICRO RNA 10B; MIR10B,Asterisk
611577,LYSINE-SPECIFIC DEMETHYLASE 6B; KDM6B,Asterisk
611578,FERRIC CHELATE REDUCTASE 1; FRRS1,Asterisk
611579,TRANSMEMBRANE PROTEIN 114; TMEM114,Asterisk
611580,EPIDIDYMAL PROTEIN 3A; EDDM3A,Asterisk
611581,MOVED TO 601067,Caret
611582,"FAMILY WITH SEQUENCE SIMILARITY 12, MEMBER B; FAM12B",Asterisk
611583,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5A; ARID5A,Asterisk
611584,"WAARDENBURG SYNDROME, TYPE 2E; WS2E",Number Sign
611585,"TESCALCIN, MOUSE, HOMOLOG OF; TESC",Asterisk
611586,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 1; C1QL1",Asterisk
611587,RHO GTPase-ACTIVATING PROTEIN 19; ARHGAP19,Asterisk
611588,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4",Number Sign
611589,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 5; PNPLA5,Asterisk
611590,"RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA",Number Sign
611591,PRO-PLATELET BASIC PROTEIN PSEUDOGENE 2; PPBPP2,Asterisk
611592,"PHENYLALANYL-tRNA SYNTHETASE 2, MITOCHONDRIAL; FARS2",Asterisk
611593,"SUBMAXILLARY GLAND ANDROGEN-REGULATED PROTEIN 3, MOUSE, HOMOLOG OF, B; SMR3B",Asterisk
611594,UBIQUITIN-SPECIFIC PROTEASE 39; USP39,Asterisk
611595,THIOREDOXIN-LIKE 4A; TXNL4A,Asterisk
611596,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4; DHRS4",Asterisk
611597,"CATARACT 12, MULTIPLE TYPES; CTRCT12",Number Sign
611598,"CELIAC DISEASE, SUSCEPTIBILITY TO, 6; CELIAC6",Percent
611599,MICRO RNA 206; MIR206,Asterisk
611600,PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 3; RIMS3,Asterisk
611601,PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 4; RIMS4,Asterisk
611602,RIMS-BINDING PROTEIN 2; RIMBP2,Asterisk
611603,LISSENCEPHALY 3; LIS3,Number Sign
611604,ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 1; ERLIN1,Asterisk
611605,ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 2; ERLIN2,Asterisk
611606,MICRO RNA 96; MIR96,Asterisk
611607,MICRO RNA 182; MIR182,Asterisk
611608,MICRO RNA 183; MIR183,Asterisk
611609,SIPA1-LIKE PROTEIN 2; SIPA1L2,Asterisk
611610,PHOSPHOGLUCOMUTASE 2-LIKE 1; PGM2L1,Asterisk
611611,S-PHASE CYCLIN A-ASSOCIATED PROTEIN IN THE ENDOPLASMIC RETICULUM; SCAPER,Asterisk
611612,THIAMINE TRIPHOSPHATASE; THTPA,Asterisk
611613,KDEL MOTIF-CONTAINING 1; KDELC1,Asterisk
611614,"UTP3, S. CEREVISIAE, HOMOLOG OF; UTP3",Asterisk
611615,"CARDIOMYOPATHY, DILATED, 1X; CMD1X",Number Sign
611616,NAD KINASE; NADK,Asterisk
611617,"EF-HAND DOMAIN FAMILY, MEMBER D1; EFHD1",Asterisk
611618,MOVED TO 248370,Caret
611619,MICRO RNA 877; MIR877,Asterisk
611620,MICRO RNA 1224; MIR1224,Asterisk
611621,MICRO RNA 1225; MIR1225,Asterisk
611622,IQ MOTIF-CONTAINING PROTEIN J; IQCJ,Asterisk
611623,NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 1; NECAP1,Asterisk
611624,NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 2; NECAP2,Asterisk
611625,"GID COMPLEX, SUBUNIT 8; GID8",Asterisk
611626,M-PHASE PHOSPHOPROTEIN 8; MPHOSPH8,Asterisk
611627,"FAMILY WITH SEQUENCE SIMILARITY 57, MEMBER A; FAM57A",Asterisk
611628,NEURON NAVIGATOR 1; NAV1,Asterisk
611629,NEURON NAVIGATOR 3; NAV3,Asterisk
611630,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3",Percent
611631,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 4; ETL4",Percent
611632,UbiA PRENYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; UBIAD1,Asterisk
611633,"RTF1, S. CEREVISIAE, HOMOLOG OF; RTF1",Asterisk
611634,"FEBRILE SEIZURES, FAMILIAL, 9; FEB9",Percent
611635,NEUROGENIC DIFFERENTIATION 4; NEUROD4,Asterisk
611636,N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE 2; NAALAD2,Asterisk
611637,"PRIMARY LATERAL SCLEROSIS, ADULT, 1; PLSA1",Percent
611638,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5",Number Sign
611639,ZINC FINGER GATA-LIKE PROTEIN 1; ZGLP1,Asterisk
611640,FIBRONECTIN TYPE III AND ANKYRIN REPEAT DOMAINS 1; FANK1,Asterisk
611641,CANCER SUSCEPTIBILITY GENE HEPN1; HEPN1,Asterisk
611642,HEPATOCYTE CELL ADHESION MOLECULE; HEPACAM,Asterisk
611643,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 4; ZKSCAN4,Asterisk
611644,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 9; HSCR9",Percent
611645,CXXC FINGER PROTEIN 4; CXXC4,Asterisk
611646,SPHK1-INTERACTING PROTEIN; SPHKAP,Asterisk
611647,"ARV1, S. CEREVISIAE, HOMOLOG OF; ARV1",Asterisk
611648,HISTIDINE ACID PHOSPHATASE DOMAIN-CONTAINING PROTEIN 1; HISPPD1,Asterisk
611649,MINDY LYSINE-48 DEUBIQUITINASE 3; MINDY3,Asterisk
611650,"PERIPAPILLARY ATROPHY, BETA TYPE; PPAB",
611651,"PHOSPHOLIPASE A2, GROUP III; PLA2G3",Asterisk
611652,"PHOSPHOLIPASE A2, GROUP XIIA; PLA2G12A",Asterisk
611653,"PHOSPHOLIPASE A2, GROUP XIIB; PLA2G12B",Asterisk
611654,CENTROSOME SPINDLE POLE-ASSOCIATED PROTEIN 1; CSPP1,Asterisk
611655,POST-GPI ATTACHMENT TO PROTEINS 1; PGAP1,Asterisk
611656,SUPPRESSOR OF IKBKE 1; SIKE1,Asterisk
611657,SPRY DOMAIN- AND SOCS BOX-CONTAINING 1; SPSB1,Asterisk
611658,SPRY DOMAIN- AND SOCS BOX-CONTAINING 2; SPSB2,Asterisk
611659,SPRY DOMAIN- AND SOCS BOX-CONTAINING 3; SPSB3,Asterisk
611660,SPRY DOMAIN- AND SOCS BOX-CONTAINING 4; SPSB4,Asterisk
611661,"DBF4, S. CEREVISIAE, HOMOLOG OF, B; DBF4B",Asterisk
611662,EOSINOPHIL GRANULE ONTOGENY,Asterisk
611663,"TBC1 DOMAIN FAMILY, MEMBER 20; TBC1D20",Asterisk
611664,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7",Number Sign
611665,DEAD/H BOX 54; DDX54,Asterisk
611666,PHOSPHOLIPID PHOSPHATASE 6; PLPP6,Asterisk
611667,SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2; SPATS2,Asterisk
611668,CORONIN 7; CORO7,Asterisk
611669,"tRNA METHYLTRANSFERASE 1, S. CEREVISIAE, HOMOLOG OF; TRMT1",Asterisk
611670,INOSITOL-3-PHOSPHATE SYNTHASE 1; ISYNA1,Asterisk
611671,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Z PROTEIN; PIGZ,Asterisk
611672,"SOLUTE CARRIER FAMILY 46 (FOLATE TRANSPORTER), MEMBER 1; SLC46A1",Asterisk
611673,tRNA METHYLTRANSFERASE 1-LIKE; TRMT1L,Asterisk
611674,"X KELL BLOOD GROUP PRECURSOR-RELATED FAMILY, MEMBER 3; XKR3",Asterisk
611675,KIAA0513 GENE; KIAA0513,Asterisk
611676,PHOSDUCIN-LIKE 2; PDCL2,Asterisk
611677,"OLFACTORY RECEPTOR, FAMILY 13, SUBFAMILY G, MEMBER 1; OR13G1",Asterisk
611678,PHOSDUCIN-LIKE 3; PDCL3,Asterisk
611679,F-BOX AND WD40 DOMAIN PROTEIN 10; FBXW10,Asterisk
611680,SPECIFICALLY ANDROGEN-REGULATED GENE,Asterisk
611681,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 20; ADAMTS20",Asterisk
611682,LIPOPROTEIN(a)-LIKE 2; LPAL2,Asterisk
611683,FRUCTOSAMINE 3-KINASE-RELATED PROTEIN,Asterisk
611684,SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 3; SART3,Asterisk
611685,RING FINGER PROTEIN 8; RNF8,Asterisk
611686,CAS1 DOMAIN-CONTAINING PROTEIN 1; CASD1,Asterisk
611687,"KHDC3-LIKE PROTEIN, SUBCORTICAL MATERNAL COMPLEX MEMBER; KHDC3L",Asterisk
611688,KH HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; KHDC1,Asterisk
611689,"OOCYTE-EXPRESSED PROTEIN, DOG, HOMOLOG OF; OOEP",Asterisk
611690,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 4; PRRG4,Asterisk
611691,"SUSHI, VON WILLEBRAND FACTOR TYPE A, EGF, AND PENTRAXIN DOMAINS-CONTAINING 1; SVEP1",Asterisk
611692,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 34; ZBTB34,Asterisk
611693,COXSACKIEVIRUS- AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN; CLMP,Asterisk
611694,DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA,Percent
611695,TAU TUBULIN KINASE 2; TTBK2,Asterisk
611696,"SOLUTE CARRIER FAMILY 22, MEMBER 20; SLC22A20",Asterisk
611697,CHROMOSOME 6 OPEN READING FRAME 85; C6ORF85,Asterisk
611698,"SOLUTE CARRIER FAMILY 22, MEMBER 24; SLC22A24",Asterisk
611699,SV2-RELATED PROTEIN; SVOP,Asterisk
611700,SV2-RELATED PROTEIN-LIKE; SVOPL,Asterisk
611701,"SPINSTER, DROSOPHILA, HOMOLOG OF, 3; SPNS3",Asterisk
611702,"SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE",
611703,ZINC FINGER PROTEIN 436; ZNF436,Asterisk
611704,"TRANSMEMBRANE PROTEASE, SERINE 11A; TMPRSS11A",Asterisk
611705,SALIH MYOPATHY; SALMY,Number Sign
611706,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12",Percent
611707,MYELIN PROTEIN ZERO-LIKE 3; MPZL3,Asterisk
611708,MICRO RNA 431; MIR431,Asterisk
611709,MICRO RNA 127; MIR127,Asterisk
611710,MICRO RNA 136; MIR136,Asterisk
611711,MICRO RNA 433; MIR433,Asterisk
611712,HOMEODOMAIN-INTERACTING PROTEIN KINASE 4; HIPK4,Asterisk
611713,TCTEX1 DOMAIN-CONTAINING PROTEIN 4; TCTEX1D4,Asterisk
611714,GTPase-ACTIVATING PROTEIN AND VPS9 DOMAINS 1; GAPVD1,Asterisk
611715,STEROID 5-ALPHA-REDUCTASE 3; SRD5A3,Asterisk
611716,"ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A2; ATP6V0A2",Asterisk
611717,SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH,Percent
611718,"HYPOMAGNESEMIA 4, RENAL; HOMG4",Number Sign
611719,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5,Number Sign
611720,INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN LIKE; IRF2BPL,Asterisk
611721,COMBINED SAPOSIN DEFICIENCY,Number Sign
611722,"KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY",Number Sign
611723,CHROMOSOME 21 OPEN READING FRAME 24; C21ORF24,Asterisk
611724,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8; SHEP8",Number Sign
611725,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 7; KCTD7,Asterisk
611726,"EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3",Number Sign
611727,CHROMOSOME 1 OPEN READING FRAME 76; C1ORF76,Asterisk
611728,PROLINE-RICH PROTEIN 5-LIKE; PRR5L,Asterisk
611729,KINESIN LIGHT CHAIN 2; KLC2,Asterisk
611730,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 5; EPB41L5,Asterisk
611731,APC GENE; APC,Asterisk
611732,MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; MBOAT1,Asterisk
611733,DAUWERSE-PETERS SYNDROME,
611734,WD REPEAT-CONTAINING PROTEIN 77; WDR77,Asterisk
611735,CUB DOMAIN-CONTAINING PROTEIN 1; CDCP1,Asterisk
611736,GREB1 PROTEIN,Asterisk
611737,SEPTIN 10; SEPT10,Asterisk
611738,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7; BMND7,Percent
611739,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8; BMND8,Percent
611740,BETA-CAROTENE OXYGENASE 2; BCO2,Asterisk
611741,"CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL 3; ACCN3",Asterisk
611742,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9; SHEP9",Number Sign
611743,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G6; PLEKHG6,Asterisk
611744,OTU DOMAIN-CONTAINING PROTEIN 4; OTUD4,Asterisk
611745,VCP/p47 COMPLEX-INTERACTING PROTEIN 1;   VCPIP1,Asterisk
611746,"SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 1; SCUBE1",Asterisk
611747,"SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 2; SCUBE2",Asterisk
611748,OTU DOMAIN-CONTAINING PROTEIN 7B; OTUD7B,Asterisk
611749,ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 1; ZRANB1,Asterisk
611750,SYNCOILIN 1; SYNC1,Asterisk
611751,THUMP DOMAIN-CONTAINING PROTEIN 2; THUMPD2,Asterisk
611752,CHROMOSOME 2 OPEN READING FRAME 40; C2ORF40,Asterisk
611753,VACUOLE MEMBRANE PROTEIN 1; VMP1,Asterisk
611754,ALPHA-AMINOADIPATE AMINOTRANSFERASE; AADAT,Asterisk
611755,LEBER CONGENITAL AMAUROSIS 10; LCA10,Number Sign
611756,RHOPHILIN ASSOCIATED TAIL PROTEIN 1-LIKE; ROPN1L,Asterisk
611757,RHOPHILIN-ASSOCIATED TAIL PROTEIN 1; ROPN1,Asterisk
611758,OTU DOMAIN-CONTAINING PROTEIN 3; OTUD3,Asterisk
611759,STARD3 N-TERMINAL-LIKE; STARD3NL,Asterisk
611760,PROTOCADHERIN 17; PCDH17,Asterisk
611761,LIPASE MATURATION FACTOR 1; LMF1,Asterisk
611762,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2,Number Sign
611763,"LIMB BUD AND HEART DEVELOPMENT, MOUSE, HOMOLOG OF; LBH",Asterisk
611764,CORNIFELIN; CNFN,Asterisk
611765,"ASPARTIC PEPTIDASE, RETROVIRAL-LIKE 1; ASPRV1",Asterisk
611766,MITOCHONDRIAL METHIONYL-tRNA FORMYLTRANSFERASE; MTFMT,Asterisk
611767,MICRO RNA 126; MIR126,Asterisk
611768,MICRO RNA 335; MIR335,Asterisk
611769,MICRO RNA 128-2; MIR128-2,Asterisk
611770,"NK2, DROSOPHILA, HOMOLOG OF, 6; NKX2-6",Asterisk
611771,LIPOPROTEIN GLOMERULOPATHY; LPG,Number Sign
611772,"NUF2, S. CEREVISIAE, HOMOLOG OF; NUF2",Asterisk
611773,"ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC",Number Sign
611774,MICRO RNA 128-1; MIR128-1,Asterisk
611775,KAWASAKI DISEASE,Number Sign
611776,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 4; NDUFAF4",Asterisk
611777,BRUGADA SYNDROME 2; BRGDA2,Number Sign
611778,GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1-LIKE; GPD1L,Asterisk
611779,FIBROUS SHEATH CABYR-BINDING PROTEIN; FSCB,Asterisk
611780,PHD AND RING FINGER DOMAIN-CONTAINING PROTEIN 1; PHRF1,Asterisk
611781,PR DOMAIN-CONTAINING PROTEIN 14; PRDM14,Asterisk
611782,DOWN SYNDROME CELL ADHESION MOLECULE-LIKE 1; DSCAML1,Asterisk
611783,"ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4",Number Sign
611784,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 6; GTF3C6",Asterisk
611785,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 5; ABCB5",Asterisk
611786,MEDIATOR OF CELL MOTILITY 1; MEMO1,Asterisk
611787,"CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 2, MITOCHONDRIAL; CMPK2",Asterisk
611788,"AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6",Number Sign
611789,NA+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 2; NHEDC2,Asterisk
611790,MYOSIN VIIA- AND RAB-INTERACTING PROTEIN; MYRIP,Asterisk
611791,PATCHED DOMAIN-CONTAINING PROTEIN 3; PTCHD3,Asterisk
611792,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 4; ZCCHC4,Asterisk
611793,"LSM12, S. CEREVISIAE, HOMOLOG OF; LSM12",Asterisk
611794,MICRO RNA 369; MIR369,Asterisk
611795,MICRO RNA 145; MIR145,Asterisk
611796,SECRETOGRANIN III; SCG3,Asterisk
611797,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CHAPERONE 1; UQCC1,Asterisk
611798,"EFR3, S. CEREVISIAE, HOMOLOG OF, A; EFR3A",Asterisk
611799,LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR-LIKE PROTEIN; LCORL,Asterisk
611800,THYROID ADENOMA-ASSOCIATED GENE; THADA,Asterisk
611801,POST-GPI ATTACHMENT TO PROTEINS 3; PGAP3,Asterisk
611802,MIGRATION AND INVASION ENHANCER 1; MIEN1,Asterisk
611803,INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 1; ITFG1,Asterisk
611804,ELLIPTOCYTOSIS 1; EL1,Number Sign
611805,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 5; ELOVL5,Asterisk
611806,ARSENIC (+3 OXIDATION STATE) METHYLTRANSFERASE; AS3MT,Asterisk
611807,TIP41-LIKE PROTEIN; TIPRL,Asterisk
611808,"TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS; ETINPH",
611809,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB",Number Sign
611810,USH1C-BINDING PROTEIN 1; USHBP1,Asterisk
611811,ZINC FINGER PROTEIN 333; ZNF333,Asterisk
611812,"46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL",Number Sign
611813,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 1; ELOVL1,Asterisk
611814,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 2; ELOVL2,Asterisk
611815,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 3; ELOVL3,Asterisk
611816,TEMPLE-BARAITSER SYNDROME; TMBTS,Number Sign
611817,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY K, MEMBER 1; KLRK1",Asterisk
611818,LONG QT SYNDROME 9; LQT9,Number Sign
611819,LONG QT SYNDROME 10; LQT10,Number Sign
611820,LONG QT SYNDROME 11; LQT11,Number Sign
611821,MITOCHONDRIAL RIBOSOMAL PROTEIN L1; MRPL1,Asterisk
611822,MITOCHONDRIAL RIBOSOMAL PROTEIN L2; MRPL2,Asterisk
611823,MITOCHONDRIAL RIBOSOMAL PROTEIN L4; MRPL4,Asterisk
611824,MITOCHONDRIAL RIBOSOMAL PROTEIN L9; MRPL9,Asterisk
611825,MITOCHONDRIAL RIBOSOMAL PROTEIN L10; MRPL10,Asterisk
611826,MITOCHONDRIAL RIBOSOMAL PROTEIN L11; MRPL11,Asterisk
611827,MITOCHONDRIAL RIBOSOMAL PROTEIN L14; MRPL14,Asterisk
611828,MITOCHONDRIAL RIBOSOMAL PROTEIN L15; MRPL15,Asterisk
611829,MITOCHONDRIAL RIBOSOMAL PROTEIN L16; MRPL16,Asterisk
611830,MITOCHONDRIAL RIBOSOMAL PROTEIN L17; MRPL17,Asterisk
611831,MITOCHONDRIAL RIBOSOMAL PROTEIN L18; MRPL18,Asterisk
611832,MITOCHONDRIAL RIBOSOMAL PROTEIN L19; MRPL19,Asterisk
611833,MITOCHONDRIAL RIBOSOMAL PROTEIN L20; MRPL20,Asterisk
611834,MITOCHONDRIAL RIBOSOMAL PROTEIN L21; MRPL21,Asterisk
611835,MITOCHONDRIAL RIBOSOMAL PROTEIN L22; MRPL22,Asterisk
611836,MITOCHONDRIAL RIBOSOMAL PROTEIN L24; MRPL24,Asterisk
611837,MITOCHONDRIAL RIBOSOMAL PROTEIN L27; MRPL27,Asterisk
611838,MITOCHONDRIAL RIBOSOMAL PROTEIN L30; MRPL30,Asterisk
611839,MITOCHONDRIAL RIBOSOMAL PROTEIN L32; MRPL32,Asterisk
611840,MITOCHONDRIAL RIBOSOMAL PROTEIN L34; MRPL34,Asterisk
611841,MITOCHONDRIAL RIBOSOMAL PROTEIN L35; MRPL35,Asterisk
611842,MITOCHONDRIAL RIBOSOMAL PROTEIN L36; MRPL36,Asterisk
611843,MITOCHONDRIAL RIBOSOMAL PROTEIN L37; MRPL37,Asterisk
611844,MITOCHONDRIAL RIBOSOMAL PROTEIN L38; MRPL38,Asterisk
611845,MITOCHONDRIAL RIBOSOMAL PROTEIN L39; MRPL39,Asterisk
611846,MITOCHONDRIAL RIBOSOMAL PROTEIN L41; MRPL41,Asterisk
611847,MITOCHONDRIAL RIBOSOMAL PROTEIN L42; MRPL42,Asterisk
611848,MITOCHONDRIAL RIBOSOMAL PROTEIN L43; MRPL43,Asterisk
611849,MITOCHONDRIAL RIBOSOMAL PROTEIN L44; MRPL44,Asterisk
611850,MITOCHONDRIAL RIBOSOMAL PROTEIN L45; MRPL45,Asterisk
611851,MITOCHONDRIAL RIBOSOMAL PROTEIN L46; MRPL46,Asterisk
611852,MITOCHONDRIAL RIBOSOMAL PROTEIN L47; MRPL47,Asterisk
611853,MITOCHONDRIAL RIBOSOMAL PROTEIN L48; MRPL48,Asterisk
611854,MITOCHONDRIAL RIBOSOMAL PROTEIN L50; MRPL50,Asterisk
611855,MITOCHONDRIAL RIBOSOMAL PROTEIN L51; MRPL51,Asterisk
611856,MITOCHONDRIAL RIBOSOMAL PROTEIN L52; MRPL52,Asterisk
611857,MITOCHONDRIAL RIBOSOMAL PROTEIN L53; MRPL53,Asterisk
611858,MITOCHONDRIAL RIBOSOMAL PROTEIN L54; MRPL54,Asterisk
611859,MITOCHONDRIAL RIBOSOMAL PROTEIN L55; MRPL55,Asterisk
611860,MOVED TO 210720,Caret
611861,ADP-DEPENDENT GLUCOKINASE; ADPGK,Asterisk
611862,WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1; WBCQ1,Number Sign
611863,MICROTIA WITH NASOLACRIMAL DUCT IMPERFORATION AND EYE COLOBOMA,Percent
611864,ARMADILLO REPEAT-CONTAINING 10; ARMC10,Asterisk
611865,L3MBT-LIKE 2; L3MBTL2,Asterisk
611866,RETINOL-BINDING PROTEIN 5; RBP5,Asterisk
611867,"CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL",Number Sign
611868,"PROSTATE CANCER, HEREDITARY, 12; HPC12",Number Sign
611869,"RABAPTIN, RAB GTPase-BINDING EFFECTOR PROTEIN 2; RABEP2",Asterisk
611870,CENTLEIN; CNTLN,Asterisk
611871,"FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER B; FAM82B",Asterisk
611872,"FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER A1; FAM82A1",Asterisk
611873,"FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER A2; FAM82A2",Asterisk
611874,NEURON-DERIVED NEUROTROPHIC FACTOR; NENF,Asterisk
611875,BRUGADA SYNDROME 3; BRGDA3,Number Sign
611876,BRUGADA SYNDROME 4; BRGDA4,Number Sign
611877,BAI1-ASSOCIATED PROTEIN 2-LIKE 1; BAIAP2L1,Asterisk
611878,"CARDIOMYOPATHY, DILATED, 1Y; CMD1Y",Number Sign
611879,"CARDIOMYOPATHY, DILATED, 1Z; CMD1Z",Number Sign
611880,"CARDIOMYOPATHY, DILATED, 2A; CMD2A",Number Sign
611881,GLYCOGEN STORAGE DISEASE XII; GSD12,Number Sign
611882,PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 2; PNRC2,Asterisk
611883,BRCA2- AND CDKN1A-INTERACTING PROTEIN; BCCIP,Asterisk
611884,"CILIARY DYSKINESIA, PRIMARY, 7; CILD7",Number Sign
611885,SHANK-ASSOCIATED RH DOMAIN INTERACTOR; SHARPIN,Asterisk
611886,"MESOMELIC DYSPLASIA, CAMERA TYPE",
611887,UROPLAKIN 3B; UPK3B,Asterisk
611888,ETS2 REPRESSOR FACTOR; ERF,Asterisk
611889,S100P-BINDING PROTEIN; S100PBP,Asterisk
611890,LETHAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; LAAHD,Number Sign
611891,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3; AAA3",Percent
611892,"ANEURYSM, INTRACRANIAL BERRY, 6; ANIB6",Percent
611893,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G2; PLEKHG2,Asterisk
611894,MICRO RNA 140; MIR140,Asterisk
611895,AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9,Number Sign
611896,RETROTRANSPOSON-LIKE GENE 1; RTL1,Asterisk
611897,NANOPHTHALMOS 3; NNO3,Percent
611898,ENDO-BETA-N-ACETYLGLUCOSAMINIDASE; ENGASE,Asterisk
611899,MICRO RNA 203; MIR203,Asterisk
611900,METALLOPHOSPHOESTERASE 1; MPPE1,Asterisk
611901,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 1; VWA1,Asterisk
611902,COILED-COIL DOMAIN-CONTAINING PROTEIN 136; CCDC136,Asterisk
611903,ZINC FINGER PROTEIN 649; ZNF649,Asterisk
611904,"PLACENTA-EXPRESSED TRANSCRIPT 1, MOUSE, HOMOLOG OF; PLET1",Asterisk
611905,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4; FNDC4,Asterisk
611906,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5; FNDC5,Asterisk
611907,"EPISODIC ATAXIA, TYPE 7; EA7",Percent
611908,"RFT1, S. CEREVISIAE, HOMOLOG OF; RFT1",Asterisk
611909,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3B; FNDC3B,Asterisk
611910,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 12; SLC16A12",Asterisk
611911,"IRON-SULFUR CLUSTER SCAFFOLD, E. COLI, HOMOLOG OF; ISCU",Asterisk
611912,NUCLEAR CASEIN KINASE AND CYCLIN-DEPENDENT KINASE SUBSTRATE 1; NUCKS1,Asterisk
611913,"CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB",Number Sign
611914,"TSC22 DOMAIN FAMILY, MEMBER 4; TSC22D4",Asterisk
611915,"VESICULAR, OVEREXPRESSED IN CANCER, PROSURVIVAL PROTEIN 1; VOPP1",Asterisk
611916,"COLLAGEN, TYPE VI, ALPHA-5; COL6A5",Asterisk
611917,LYSINE-SPECIFIC DEMETHYLASE 8; KDM8,Asterisk
611918,MOVED TO 601869,Caret
611919,RIBOSOMAL OXYGENASE 1; RIOX1,Asterisk
611920,"C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; CRPQTL1",Percent
611921,"GAP JUNCTION PROTEIN, BETA-7; GJB7",Asterisk
611922,"GAP JUNCTION PROTEIN, DELTA-4; GJD4",Asterisk
611923,"GAP JUNCTION PROTEIN, ALPHA-9; GJA9",Asterisk
611924,"GAP JUNCTION PROTEIN, ALPHA-10; GJA10",Asterisk
611925,"GAP JUNCTION PROTEIN, GAMMA-3; GJC3",Asterisk
611926,"IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS",Percent
611927,"FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER H; FAM83H",Asterisk
611928,"PROSTATE CANCER, HEREDITARY, 13; HPC13",Number Sign
611929,"CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III",Percent
611930,INTERFERON-STIMULATED EXONUCLEASE GENE 20-KD-LIKE 2; ISG20L2,Asterisk
611931,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1L; PPM1L",Asterisk
611932,CDGSH IRON SULFUR DOMAIN PROTEIN 1; CISD1,Asterisk
611933,CDGSH IRON SULFUR DOMAIN PROTEIN 3; CISD3,Asterisk
611934,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5; EIG5",Percent
611935,MMADHC GENE; MMADHC,Asterisk
611936,CHROMOSOME 3q29 DUPLICATION SYNDROME,Number Sign
611937,IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE 3-3; IGHD3-3,Asterisk
611938,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2",Number Sign
611939,IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE 3-23; IGHV3-23,Asterisk
611940,MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 4; MBOAT4,Asterisk
611941,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 2; ATAD2",Asterisk
611942,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6",Number Sign
611943,RIDDLE SYNDROME,Number Sign
611944,"LYMPHEDEMA, HEREDITARY, IB; LMPH1B",Percent
611945,"SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37",Percent
611946,UBX DOMAIN PROTEIN 6; UBXN6,Asterisk
611947,NLR FAMILY MEMBER X1; NLRX1,Asterisk
611948,MOVED TO 267750,Caret
611949,MEMBRANE-BOUND O-ACYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 2; MBOAT2,Asterisk
611950,LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 3; LPCAT3,Asterisk
611951,B9 DOMAIN-CONTAINING PROTEIN 2; B9D2,Asterisk
611952,"VACUOLAR PROTEIN SORTING 28, YEAST, HOMOLOG OF; VPS28",Asterisk
611953,"MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11",Number Sign
611954,MICRO RNA 373; MIR373,Asterisk
611955,"PROSTATE CANCER, HEREDITARY, 11; HPC11",Percent
611956,CHROMOSOME 3 OPEN READING FRAME 52; C3ORF52,Asterisk
611957,MICRO RNA 378; MIRN378,Asterisk
611958,"PROSTATE CANCER, HEREDITARY, 14; HPC14",Percent
611959,"PROSTATE CANCER, HEREDITARY, 15; HPC15",Percent
611960,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7",Number Sign
611961,STEVENSON-CAREY SYNDROME,
611962,HUNTER-MACDONALD SYNDROME,Percent
611963,ACYL-CoA THIOESTERASE 7-LIKE,Asterisk
611964,"CYTOCHROME b5, TYPE B (OUTER MITOCHONDRIAL MEMBRANE); CYB5B",Asterisk
611965,"THO COMPLEX, SUBUNIT 7; THOC7",Asterisk
611966,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 9; TRAPPC9",Asterisk
611967,KELCH-LIKE 8; KLHL8,Asterisk
611968,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD, TAU VARIANT; CSTF2T",Asterisk
611969,HCCA2 GENE; HCCA2,Asterisk
611970,NUCLEOLAR PROTEIN INTERACTING WITH THE FHA DOMAIN OF MKI67; NIFK,Asterisk
611971,MITOCHONDRIAL RIBOSOMAL PROTEIN S2; MRPS2,Asterisk
611972,MITOCHONDRIAL RIBOSOMAL PROTEIN S5; MRPS5,Asterisk
611973,MITOCHONDRIAL RIBOSOMAL PROTEIN S6; MRPS6,Asterisk
611974,MITOCHONDRIAL RIBOSOMAL PROTEIN S7; MRPS7,Asterisk
611975,MITOCHONDRIAL RIBOSOMAL PROTEIN S9; MRPS9,Asterisk
611976,MITOCHONDRIAL RIBOSOMAL PROTEIN S10; MRPS10,Asterisk
611977,MITOCHONDRIAL RIBOSOMAL PROTEIN S11; MRPS11,Asterisk
611978,MITOCHONDRIAL RIBOSOMAL PROTEIN S14; MRPS14,Asterisk
611979,MITOCHONDRIAL RIBOSOMAL PROTEIN S15; MRPS15,Asterisk
611980,MITOCHONDRIAL RIBOSOMAL PROTEIN S17; MRPS17,Asterisk
611981,MITOCHONDRIAL RIBOSOMAL PROTEIN S18A; MRPS18A,Asterisk
611982,MITOCHONDRIAL RIBOSOMAL PROTEIN S18B; MRPS18B,Asterisk
611983,MITOCHONDRIAL RIBOSOMAL PROTEIN S18C; MRPS18C,Asterisk
611984,MITOCHONDRIAL RIBOSOMAL PROTEIN S21; MRPS21,Asterisk
611985,MITOCHONDRIAL RIBOSOMAL PROTEIN S23; MRPS23,Asterisk
611986,MITOCHONDRIAL RIBOSOMAL PROTEIN S24; MRPS24,Asterisk
611987,MITOCHONDRIAL RIBOSOMAL PROTEIN S25; MRPS25,Asterisk
611988,MITOCHONDRIAL RIBOSOMAL PROTEIN S26; MRPS26,Asterisk
611989,MITOCHONDRIAL RIBOSOMAL PROTEIN S27; MRPS27,Asterisk
611990,MITOCHONDRIAL RIBOSOMAL PROTEIN S28; MRPS28,Asterisk
611991,MITOCHONDRIAL RIBOSOMAL PROTEIN S30; MRPS30,Asterisk
611992,MITOCHONDRIAL RIBOSOMAL PROTEIN S31; MRPS31,Asterisk
611993,MITOCHONDRIAL RIBOSOMAL PROTEIN S33; MRPS33,Asterisk
611994,MITOCHONDRIAL RIBOSOMAL PROTEIN S34; MRPS34,Asterisk
611995,MITOCHONDRIAL RIBOSOMAL PROTEIN S35; MRPS35,Asterisk
611996,MITOCHONDRIAL RIBOSOMAL PROTEIN S36; MRPS36,Asterisk
611997,MITOCHONDRIAL RIBOSOMAL PROTEIN 63; MRP63,Asterisk
611998,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 3; CREB3L3,Asterisk
611999,RAB11 FAMILY-INTERACTING PROTEIN 4; RAB11FIP4,Asterisk
612000,TRIPARTITE MOTIF-CONTAINING PROTEIN 66; TRIM66,Asterisk
612001,CHROMOSOME 15q13.3 DELETION SYNDROME,Number Sign
612002,DEP DOMAIN-CONTAINING PROTEIN 1; DEPDC1,Asterisk
612003,GRB10-INTERACTING GYF PROTEIN 2; GIGYF2,Asterisk
612004,THROMBOCYTOPENIA 4; THC4,Number Sign
612005,"CELIAC DISEASE, SUSCEPTIBILITY TO, 7; CELIAC7",Percent
612006,"CELIAC DISEASE, SUSCEPTIBILITY TO, 8; CELIAC8",Percent
612007,"CELIAC DISEASE, SUSCEPTIBILITY TO, 9; CELIAC9",Percent
612008,"CELIAC DISEASE, SUSCEPTIBILITY TO, 10; CELIAC10",Percent
612009,"CELIAC DISEASE, SUSCEPTIBILITY TO, 11; CELIAC11",Percent
612010,"CELIAC DISEASE, SUSCEPTIBILITY TO, 12; CELIAC12",Percent
612011,"CELIAC DISEASE, SUSCEPTIBILITY TO, 13; CELIAC13",Percent
612012,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 26; ZFYVE26,Asterisk
612013,COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 2A; CC2D2A,Asterisk
612014,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 21B; TTC21B,Asterisk
612015,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N",Number Sign
612016,"COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4",Number Sign
612017,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 3; IHPS3",Percent
612018,CATARACT 47; CTRCT47,Number Sign
612019,INTESTINE-SPECIFIC HOMEOBOX; ISX,Asterisk
612020,"SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39",Number Sign
612021,OTU DOMAIN-CONTAINING PROTEIN 6B; OTUD6B,Asterisk
612022,OTU DOMAIN-CONTAINING PROTEIN 1; OTUD1,Asterisk
612023,"YOD1 OTU DEUBIQUITINATING ENZYME 1, S. CEREVISIAE, HOMOLOG OF; YOD1",Asterisk
612024,OTU DOMAIN-CONTAINING PROTEIN 7A; OTUD7A,Asterisk
612025,IODOTYROSINE DEIODINASE; IYD,Asterisk
612026,"La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 7; LARP7",Asterisk
612027,GRP1-ASSOCIATED SCAFFOLD PROTEIN; GRASP,Asterisk
612028,FAT STORAGE-INDUCING TRANSMEMBRANE PROTEIN 1; FITM1,Asterisk
612029,FAT STORAGE-INDUCING TRANSMEMBRANE PROTEIN 2; FITM2,Asterisk
612030,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9; CHDS9",Percent
612031,"INHIBIN, BETA E; INHBE",Asterisk
612032,"DPY30, C. ELEGANS, HOMOLOG OF: DPY30",Asterisk
612033,PAXIP1-ASSOCIATED GLUTAMATE-RICH PROTEIN 1; PAGR1,Asterisk
612034,APC2 GENE; APC2,Asterisk
612035,ALANYL-tRNA SYNTHETASE 2; AARS2,Asterisk
612036,PROLYL-tRNA SYNTHETASE 2; PARS2,Asterisk
612037,MITOCHONDRIAL UBIQUITIN LIGASE ACTIVATOR OF NFKB 1; MUL1,Asterisk
612038,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 4; TMED4,Asterisk
612039,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 7; AGPAT7,Asterisk
612040,LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 2; LPCAT2,Asterisk
612041,RING FINGER PROTEIN 212; RNF212,Asterisk
612042,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1,Number Sign
612043,MICRO RNA 371A; MIR371A,Asterisk
612044,MICRO RNA 372; MIRN372,Asterisk
612045,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 3; C1QTNF3,Asterisk
612046,E2F TRANSCRIPTION FACTOR 7; E2F7,Asterisk
612047,E2F TRANSCRIPTION FACTOR 8; E2F8,Asterisk
612048,TRANSMEMBRANE PROTEIN 43; TMEM43,Asterisk
612049,MYC-INDUCED NUCLEAR ANTIGEN; MINA,Asterisk
612050,NEDD4 FAMILY-INTERACTING PROTEIN 1; NDFIP1,Asterisk
612051,"BRAIN-EXPRESSED, ASSOCIATED WITH NEDD4; BEAN",Asterisk
612052,SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3,Number Sign
612053,ZINC FINGER PROTEIN 36-LIKE 2; ZFP36L2,Asterisk
612054,"REQUIRED FOR CELL DIFFERENTIATION 1, S. POMBE, HOMOLOG OF; RQCD1",Asterisk
612055,RIBOSOMAL PROTEIN S27-LIKE; RPS27L,Asterisk
612056,"GOLGI TO ER TRAFFIC PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; GET4",Asterisk
612057,SUPPRESSOR APC DOMAIN-CONTAINING PROTEIN 2; SAPCD2,Asterisk
612058,"SORTING AND ASSEMBLY MACHINERY COMPONENT 50, S. CEREVISIAE, HOMOLOG OF; SAMM50",Asterisk
612059,"La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 1; LARP1",Asterisk
612060,ZINC FINGER AND RING FINGER PROTEIN 1; ZNRF1,Asterisk
612061,ZINC FINGER AND RING FINGER PROTEIN 2; ZNRF2,Asterisk
612062,ZINC FINGER AND RING FINGER PROTEIN 3; ZNRF3,Asterisk
612063,ZINC FINGER AND RING FINGER PROTEIN 4; ZNRF4,Asterisk
612064,GRB10-INTERACTING GYF PROTEIN 1; GIGYF1,Asterisk
612065,POLY(ADP-RIBOSE) POLYMERASE 9; PARP9,Asterisk
612066,POLY(ADP-RIBOSE) POLYMERASE 15; PARP15,Asterisk
612067,DYSTONIA 16; DYT16,Number Sign
612068,PHOSPHOINOSITIDE-INTERACTING REGULATOR OF TRANSIENT RECEPTOR POTENTIAL CHANNELS; PIRT,Asterisk
612069,AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10,Number Sign
612070,MICRO RNA 144; MIRN144,Asterisk
612071,MICRO RNA 451; MIRN451,Asterisk
612072,MIF4G DOMAIN-CONTAINING PROTEIN; MIF4GD,Asterisk
612073,MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5,Number Sign
612074,RNA-BINDING MOTIF PROTEIN 28; RBM28,Asterisk
612075,MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A,Number Sign
612076,"HYPOURICEMIA, RENAL, 2; RHUC2",Number Sign
612077,MICRO RNA 22; MIR22,Asterisk
612078,ZINC FINGER PROTEIN 469; ZNF469,Asterisk
612079,"ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES",Number Sign
612080,"UBIQUINOL-CYTOCHROME c REDUCTASE, COMPLEX III SUBUNIT VII, 9.5-KD; UQCRQ",Asterisk
612081,INTERLEUKIN 34; IL34,Asterisk
612082,"CAPICUA, DROSOPHILA, HOMOLOG OF; CIC",Asterisk
612083,MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1,Percent
612084,"ORGANIC SOLUTE TRANSPORTER, ALPHA",Asterisk
612085,"ORGANIC SOLUTE TRANSPORTER, BETA",Asterisk
612086,"MINOR HISTOCOMPATIBILITY ANTIGEN, SERPIN DOMAIN-CONTAINING; HMSD",Asterisk
612087,"C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER A; CLEC2A",Asterisk
612088,"C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER A; CLEC12A",Asterisk
612089,HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM,Percent
612090,MICRO RNA 200A; MIR200A,Asterisk
612091,MICRO RNA 200B; MIRN200B,Asterisk
612092,MICRO RNA 200C; MIR200C,Asterisk
612093,MICRO RNA 141; MIR141,Asterisk
612094,MICRO RNA 429; MIRN429,Asterisk
612095,RETINITIS PIGMENTOSA 41; RP41,Number Sign
612096,OTOSCLEROSIS 8; OTSC8,Percent
612097,"DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS",Percent
612098,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11",Number Sign
612099,"TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 2",Percent
612100,"AUTISM, SUSCEPTIBILITY TO, 15; AUTS15",Number Sign
612101,"PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, BETA; PI4K2B",Asterisk
612102,MICRO RNA LET7G; MIRNLET7G,Asterisk
612103,OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 2A; OBFC2A,Asterisk
612104,OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 2B; OBFC2B,Asterisk
612105,KILLIN; KLLN,Asterisk
612106,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 40; ZBTB40,Asterisk
612107,"SOLUTE CARRIER FAMILY 17 (VESICULAR NUCLEOTIDE TRANSPORTER), MEMBER 9; SLC17A9",Asterisk
612108,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1; FGQTL1,Percent
612109,OCULOAURICULAR SYNDROME; OCACS,Number Sign
612110,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9; BMND9,Percent
612111,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8; TNFAIP8,Asterisk
612112,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 2; TNFAIP8L2,Asterisk
612113,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10; BMND10,Percent
612114,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11; BMND11,Percent
612115,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; ARHGEF3,Asterisk
612116,UBIQUITIN-SPECIFIC PROTEASE 22; USP22,Asterisk
612117,MICRO RNA 143; MIR143,Asterisk
612118,IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 3; IQSEC3,Asterisk
612119,TREHALASE DEFICIENCY,Number Sign
612120,CELL DEATH-INDUCING DFFA-LIKE EFFECTOR C; CIDEC,Asterisk
612121,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 1; PNPLA1,Asterisk
612122,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 7; PNPLA7,Asterisk
612123,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 8; PNPLA8,Asterisk
612124,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12",Number Sign
612125,SERTA DOMAIN-CONTAINING PROTEIN 3; SERTAD3,Asterisk
612126,GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2,Number Sign
612127,17-BETA-HYDROXYSTEROID DEHYDROGENASE XIII; HSD17B13,Asterisk
612128,"RAS-LIKE, FAMILY 10, MEMBER B; RASL10B",Asterisk
612129,"INDOLEAMINE 2,3-DIOXYGENASE 2; IDO2",Asterisk
612130,GENE AMPLIFIED IN ESOPHAGEAL CANCER 1; GAEC1,Asterisk
612131,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 9; DHRS9",Asterisk
612132,"ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT",Number Sign
612133,TRANSCRIPTION FACTOR NFE4; NFE4,Asterisk
612134,GLUCURONIC ACID EPIMERASE; GLCE,Asterisk
612135,CALCIUM-BINDING TYROSINE PHOSPHORYLATION-REGULATED PROTEIN; CABYR,Asterisk
612136,ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 1; ECHDC1,Asterisk
612137,RING FINGER PROTEIN 146; RNF146,Asterisk
612138,EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA; EBSPA,Number Sign
612139,"PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 2; PREX2",Asterisk
612140,SEPTIN 14; SEPT14,Asterisk
612141,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4A; EPB41L4A,Asterisk
612142,MICRO RNA LET7A2; MIRLET7A2,Asterisk
612143,MICRO RNA LET7A3; MIRNLET7A3,Asterisk
612144,MICRO RNA LET7C; MIRLET7C,Asterisk
612145,MICRO RNA LET7D; MIRNLET7D,Asterisk
612146,MICRO RNA LET7F1; MIRLET7F1,Asterisk
612147,MYOSIN LIGHT CHAIN KINASE 3; MYLK3,Asterisk
612148,MICRO RNA LET7I; MIRNLET7I,Asterisk
612149,"RNA-BINDING PROTEIN FOX1, C. ELEGANS, HOMOLOG OF, 2; RBFOX2",Asterisk
612150,MICRO RNA 25; MIR25,Asterisk
612151,MICRO RNA 26A1; MIR26A1,Asterisk
612152,MICRO RNA 26B; MIR26B,Asterisk
612153,MICRO RNA 27A; MIR27A,Asterisk
612154,MICRO RNA 28; MIR28,Asterisk
612155,MICRO RNA 31; MIR31,Asterisk
612156,MICRO RNA 33A; MIR33A,Asterisk
612157,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 1; SENP1",Asterisk
612158,"CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA",Number Sign
612159,RABPHILIN 3A; RPH3A,Asterisk
612160,"HISTIOCYTOMA, ANGIOMATOID FIBROUS",Number Sign
612161,"ANEURYSM, INTRACRANIAL BERRY, 7; ANIB7",Percent
612162,"ANEURYSM, INTRACRANIAL BERRY, 8; ANIB8",Percent
612163,TWO-PORE SEGMENT CHANNEL 2; TPCN2,Asterisk
612164,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4",Number Sign
612165,RETINITIS PIGMENTOSA 29; RP29,Percent
612166,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 2; SLC39A2",Asterisk
612167,WD REPEAT-CONTAINING PROTEIN 48; WDR48,Asterisk
612168,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 3; SLC39A3",Asterisk
612169,"Fc FRAGMENT OF IgG, LOW AFFINITY IIc, RECEPTOR FOR; FCGR2C",Asterisk
612170,"MUCIN 19, OLIGOMERIC; MUC19",Asterisk
612171,REPRIMO; RPRM,Asterisk
612172,DEAD BOX POLYPEPTIDE 23; DDX23,Asterisk
612173,SPERM-ASSOCIATED ANTIGEN 16; SPAG16,Asterisk
612174,CALCIUM-BINDING PROTEIN 39; CAB39,Asterisk
612175,CALCIUM-BINDING PROTEIN 39-LIKE PROTEIN; CAB39L,Asterisk
612176,"MYB-LIKE, SWIRM, AND MPN DOMAINS-CONTAINING PROTEIN 1; MYSM1",Asterisk
612177,"RNA, 7SL, CYTOPLASMIC 1; RN7SL1",Asterisk
612178,"HEN1 METHYLTRANSFERASE, ARABIDOPSIS, HOMOLOG OF; HENMT1",Asterisk
612179,"RNA, 7SL, CYTOPLASMIC 2; RN7SL2",Asterisk
612180,"RNA, 7SL, CYTOPLASMIC 3; RN7SL3",Asterisk
612181,"MUCIN 13, CELL SURFACE-ASSOCIATED; MUC13",Asterisk
612182,N-ACETYLTRANSFERASE 2; NAT2,Asterisk
612183,G PROTEIN-COUPLED RECEPTOR 176; GPR176,Asterisk
612184,CASK-INTERACTING PROTEIN 1; CASKIN1,Asterisk
612185,CASK-INTERACTING PROTEIN 2; CASKIN2,Asterisk
612186,DMX-LIKE 2; DMXL2,Asterisk
612187,HEME-RESPONSIVE GENE 1,Asterisk
612188,"VACUOLAR PROTEIN SORTING 39, YEAST, HOMOLOG OF; VPS39",Asterisk
612189,PHENAZINE BIOSYNTHESIS-LIKE PROTEIN DOMAIN-CONTAINING PROTEIN; PBLD,Asterisk
612190,MTOR-ASSOCIATED PROTEIN LST8; MLST8,Asterisk
612191,"MICROSEMINOPROTEIN, PROSTATE-ASSOCIATED; MSMP",Asterisk
612192,"ZINC FINGER PROTEIN 57, MOUSE, HOMOLOG OF; ZFP57",Asterisk
612193,CARDIOMYOPATHY-ASSOCIATED PROTEIN 5; CMYA5,Asterisk
612194,RAS-RELATED GTP-BINDING PROTEIN A; RRAGA,Asterisk
612195,ABHYDROLASE DOMAIN-CONTAINING 1; ABHD1,Asterisk
612196,ABHYDROLASE DOMAIN-CONTAINING 2; ABHD2,Asterisk
612197,ABHYDROLASE DOMAIN-CONTAINING 3; ABHD3,Asterisk
612198,DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA,Percent
612199,CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1; CRMCC1,Number Sign
612200,CHROMOSOME 3 OPEN READING FRAME 58; C3ORF58,Asterisk
612201,"ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6",Number Sign
612202,SRY-BOX 7; SOX7,Asterisk
612203,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 5; NAP1L5,Asterisk
612204,"AUTOPHAGY 9, S. CEREVISIAE, HOMOLOG OF, A; ATG9A",Asterisk
612205,"AUTOPHAGY 9, S. CEREVISIAE, HOMOLOG OF, B; ATG9B",Asterisk
612206,"FOUR-JOINTED BOX, DROSOPHILA, HOMOLOG OF, 1; FJX1",Asterisk
612207,GOLGI PHOSPHOPROTEIN 3; GOLPH3,Asterisk
612208,GOLGI PHOSPHOPROTEIN 3-LIKE; GOLPH3L,Asterisk
612209,MESOGENIN 1; MSGN1,Asterisk
612210,HIGHLY UPREGULATED IN LIVER CANCER; HULC,Asterisk
612211,TUMOR SUPPRESSOR CANDIDATE 5; TUSC5,Asterisk
612212,PLASMINOGEN-LIKE A; PLGLA,Asterisk
612213,"SEMINAL PLASMA PROTEIN, BOVINE, HOMOLOG OF, 1; BSPH1",Asterisk
612214,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 4; RGL4,Asterisk
612215,SMALL NUCLEOLAR RNA HOST GENE 6; SNHG6,Asterisk
612216,"SMALL NUCLEOLAR RNA, C/D BOX, 87; SNORD87",Asterisk
612217,CHROMOSOME 6 OPEN READING FRAME 106; C6ORF106,Asterisk
612218,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 38; ZBTB38,Asterisk
612219,EWING SARCOMA; ES,Number Sign
612220,"BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 3; B4GALNT3",Asterisk
612221,STATURE QUANTITATIVE TRAIT LOCUS 10; STQTL10,Percent
612222,GALACTOSAMINE-6-SULFATE SULFATASE; GALNS,Asterisk
612223,STATURE QUANTITATIVE TRAIT LOCUS 11; STQTL11,Percent
612224,STATURE QUANTITATIVE TRAIT LOCUS 12; STQTL12,Percent
612225,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9",Number Sign
612226,STATURE QUANTITATIVE TRAIT LOCUS 13; STQTL13,Percent
612227,"DIABETES MELLITUS, KETOSIS-PRONE; KPD",Number Sign
612228,STATURE QUANTITATIVE TRAIT LOCUS 14; STQTL14,Percent
612229,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3",Number Sign
612230,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 5; CRCS5",Percent
612231,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 6; CRCS6",Percent
612232,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 7; CRCS7",Percent
612233,"LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4",Number Sign
612234,CALCIUM HOMEOSTASIS MODULATOR 1; CALHM1,Asterisk
612235,CALCIUM HOMEOSTASIS MODULATOR 2; CALHM2,Asterisk
612236,ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 2; ERGIC2,Asterisk
612237,"CHONDROSARCOMA, EXTRASKELETAL MYXOID",Number Sign
612238,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 4; IS4",Percent
612239,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 5; IS5",Percent
612240,"ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7",Number Sign
612241,INFLAMMATORY BOWEL DISEASE 12; IBD12,Percent
612242,CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME,Number Sign
612243,ADHESION G PROTEIN-COUPLED RECEPTOR G6; ADGRG6,Asterisk
612244,INFLAMMATORY BOWEL DISEASE 13; IBD13,Number Sign
612245,INFLAMMATORY BOWEL DISEASE 14; IBD14,Number Sign
612246,CD302 ANTIGEN; CD302,Asterisk
612247,CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN,Number Sign
612248,ZINC FINGER PROTEIN 627; ZNF627,Asterisk
612249,THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 7A; THSD7A,Asterisk
612250,G PROTEIN-COUPLED RECEPTOR 161: GPR161,Asterisk
612251,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10",Number Sign
612252,"C-TYPE LECTIN DOMAIN FAMILY 9, MEMBER A; CLEC9A",Asterisk
612253,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11",Number Sign
612254,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12; SLEB12",Percent
612255,INFLAMMATORY BOWEL DISEASE 15; IBD15,Percent
612256,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 1; MAST1,Asterisk
612257,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 2; MAST2,Asterisk
612258,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 3; MAST3,Asterisk
612259,INFLAMMATORY BOWEL DISEASE 16; IBD16,Percent
612260,MYD88 DEFICIENCY; MYD88D,Number Sign
612261,INFLAMMATORY BOWEL DISEASE 17; IBD17,Number Sign
612262,INFLAMMATORY BOWEL DISEASE 18; IBD18,Percent
612263,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7; CMM7",Percent
612264,"MANNOSE RECEPTOR, C-TYPE, 2; MRC2",Asterisk
612265,"FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER A; FAM120A",Asterisk
612266,"FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER B; FAM120B",Asterisk
612267,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10; SHEP10",Number Sign
612268,"TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 5; TTLL5",Asterisk
612269,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5",Number Sign
612270,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 4; CDCA4,Asterisk
612271,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11",Number Sign
612272,MOVED TO 608644,Caret
612273,MOVED TO 611884,Caret
612274,"CILIARY DYSKINESIA, PRIMARY, 8; CILD8",Percent
612275,GAMETOGENETIN-BINDING PROTEIN 2; GGNBP2,Asterisk
612276,YRDC DOMAIN-CONTAINING PROTEIN; YRDC,Asterisk
612277,ADAMTS-LIKE PROTEIN 2; ADAMTSL2,Asterisk
612278,INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 19; IBD19,Number Sign
612279,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 6; GEFSP6",Percent
612280,"FUCOSIDASE, ALPHA-L, 1; FUCA1",Asterisk
612281,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6; ARCI6",Number Sign
612282,ZINC FINGER PROTEIN 804A; ZNF804A,Asterisk
612283,PROTEIN C; PROC,Asterisk
612284,"MECKEL SYNDROME, TYPE 6; MKS6",Number Sign
612285,JOUBERT SYNDROME 9; JBTS9,Number Sign
612286,"NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1",Number Sign
612287,"NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2",Number Sign
612288,INFLAMMATORY BOWEL DISEASE 20; IBD20,Percent
612289,FONTAINE PROGEROID SYNDROME; FPS,Number Sign
612290,"MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE",Number Sign
612291,JOUBERT SYNDROME 8; JBTS8,Number Sign
612292,BIRK-BAREL SYNDROME,Number Sign
612293,"POROKERATOSIS 5, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK5",Percent
612294,DEP DOMAIN-CONTAINING PROTEIN 7; DEPDC7,Asterisk
612295,ADP RIBOSYLATION FACTOR-LIKE GTPase 14 EFFECTOR PROTEIN; ARL14EP,Asterisk
612296,LOC283267 GENE,Asterisk
612297,CHROMOSOME 11 OPEN READING FRAME 41; C11ORF41,Asterisk
612298,TRIPARTITE MOTIF-CONTAINING PROTEIN 44; TRIM44,Asterisk
612299,COMM DOMAIN-CONTAINING PROTEIN 9; COMMD9,Asterisk
612300,"HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59",Number Sign
612301,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7",Number Sign
612302,ADHESION G PROTEIN-COUPLED RECEPTOR A1; ADGRA1,Asterisk
612303,ADHESION G PROTEIN-COUPLED RECEPTOR A3; ADGRA3,Asterisk
612304,"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4",Number Sign
612305,"ADHESION G PROTEIN-COUPLED RECEPTOR E4, PSEUDOGENE; ADGRE4P",Asterisk
612306,THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1; TSHQTL1,Percent
612307,ADHESION G PROTEIN-COUPLED RECEPTOR G7; ADGRG7,Asterisk
612308,ZINC FINGER AND BTB DOMAIN-CONTAINING 4; ZBTB4,Asterisk
612309,COAGULATION FACTOR V; F5,Asterisk
612310,PREMATURE OVARIAN FAILURE 6; POF6,Number Sign
612311,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 5",Percent
612312,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 6",Percent
612313,GLASS SYNDROME; GLASS,Number Sign
612314,"GLUTATHIONE S-TRANSFERASE, OMEGA-2; GSTO2",Asterisk
612315,"KERATIN 6C, TYPE II; KRT6C",Asterisk
612316,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3A; ATAD3A",Asterisk
612317,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3B; ATAD3B",Asterisk
612318,PSEUDOFOLLICULITIS BARBAE,Number Sign
612319,"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35",Number Sign
612320,CUB DOMAIN-CONTAINING PROTEIN 2; CDCP2,Asterisk
612321,DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 5; DCDC5,Asterisk
612322,FAST KINASE DOMAINS 2; FASTKD2,Asterisk
612323,"INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; IMMP1L",Asterisk
612324,COILED-COIL DOMAIN-CONTAINING PROTEIN 34; CCDC34,Asterisk
612325,INTESTINAL CELL KINASE; ICK,Asterisk
612326,TRANSCRIPTION FACTOR 25; TCF25,Asterisk
612327,"MANNOSIDASE, ENDO-ALPHA; MANEA",Asterisk
612328,COILED-COIL DOMAIN-CONTAINING PROTEIN 73: CCDC73,Asterisk
612329,MICRO RNA 30A; MIR30A,Asterisk
612330,MICRO RNA 610; MIRN610,Asterisk
612331,"LIN7, C. ELEGANS, HOMOLOG OF, B; LIN7B",Asterisk
612332,"LIN7, C. ELEGANS, HOMOLOG OF, C; LIN7C",Asterisk
612333,PROGRAMMED CELL DEATH 11; PDCD11,Asterisk
612334,N-ACYL PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D; NAPEPLD,Asterisk
612335,"SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38",Percent
612336,"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5",Number Sign
612337,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22",Number Sign
612338,"GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 1; GGTLC1",Asterisk
612339,"GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 2; GGTLC2",Asterisk
612340,"GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 3; GGTLC3",Asterisk
612341,GAMMA-GLUTAMYLTRANSFERASE 6; GGT6,Asterisk
612342,GAMMA-GLUTAMYLTRANSFERASE 7; GGT7,Asterisk
612343,MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS,Percent
612344,ZINC FINGER PROTEIN 385B; ZNF385B,Asterisk
612345,CHROMOSOME 2q31.2 DELETION SYNDROME,Number Sign
612346,GAMMA-GLUTAMYLTRANSFERASE 1; GGT1,Asterisk
612347,JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2,Number Sign
612348,"THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR; THPH9",Percent
612349,PHENYLALANINE HYDROXYLASE; PAH,Asterisk
612350,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3; EDSSPD3",Number Sign
612351,FORKHEAD BOX I3; FOXI3,Asterisk
612352,STAM-BINDING PROTEIN-LIKE 1; STAMBPL1,Asterisk
612353,"POROKERATOSIS 6, MULTIPLE TYPES; POROK6",Percent
612354,INFLAMMATORY BOWEL DISEASE 21; IBD21,Percent
612355,MICAL C TERMINUS-LIKE PROTEIN; MICALCL,Asterisk
612356,HEPARIN COFACTOR II DEFICIENCY,Number Sign
612357,MAJOR AFFECTIVE DISORDER 8; MAFD8,Percent
612358,KININOGEN 1; KNG1,Asterisk
612359,MOVED TO 158350,Caret
612360,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 5; NDUFAF5",Asterisk
612361,SCHIZOPHRENIA 14,Percent
612362,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12,Number Sign
612363,"ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",Percent
612364,"ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",Percent
612365,"GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",Percent
612366,"GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",Percent
612367,"ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",Percent
612368,"ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3",Percent
612369,"ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4",Percent
612370,HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5,Number Sign
612371,MAJOR AFFECTIVE DISORDER 7; MAFD7,Number Sign
612372,MAJOR AFFECTIVE DISORDER 9; MAFD9,Percent
612373,"SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 3: SLC29A3",Asterisk
612374,TRANSMEMBRANE PROTEIN 173; TMEM173,Asterisk
612375,"AXIN INTERACTOR, DORSALIZATION-ASSOCIATED; AIDA",Asterisk
612376,ACUTE PROMYELOCYTIC LEUKEMIA; APL,Number Sign
612377,COMM DOMAIN-CONTAINING PROTEIN 6; COMMD6,Asterisk
612378,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13",Percent
612379,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q",Number Sign
612380,INFLAMMATORY BOWEL DISEASE 22; IBD22,Percent
612381,INFLAMMATORY BOWEL DISEASE 23; IBD23,Percent
612382,MEDIATOR COMPLEX SUBUNIT 10; MED10,Asterisk
612383,MEDIATOR COMPLEX SUBUNIT 11; MED11,Asterisk
612384,MEDIATOR COMPLEX SUBUNIT 18; MED18,Asterisk
612385,MEDIATOR COMPLEX SUBUNIT 19; MED19,Asterisk
612386,FERROCHELATASE; FECH,Asterisk
612387,"SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2",Number Sign
612388,"SARCOIDOSIS, SUSCEPTIBILITY TO, 3; SS3",Percent
612389,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B",Number Sign
612390,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C",Number Sign
612391,MOVED TO 602782,Caret
612392,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 6; NDUFAF6",Asterisk
612393,"WAS PROTEIN HOMOLOG ASSOCIATED WITH ACTIN, GOLGI MEMBRANES, AND MICROTUBULES; WHAMM",Asterisk
612394,"BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS",Number Sign
612395,"CHOLINE KINASE, BETA; CHKB",Asterisk
612396,ALLANTOICASE; ALLC,
612397,"COLLAGEN, TYPE VI, ALPHA-4, PSEUDOGENE 1; COL6A4P1",Asterisk
612398,RAB-ASSOCIATED PROTEIN RAB21; RAB21,Asterisk
612399,TRANSDUCIN-LIKE ENHANCER OF SPLIT 6; TLE6,Asterisk
612400,OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5,Number Sign
612401,OSTEOARTHRITIS SUSCEPTIBILITY 6; OS6,Percent
612402,ALS2 C-TERMINAL-LIKE PROTEIN; ALS2CL,Asterisk
612403,"RAS-LIKE, FAMILY 11, MEMBER A; RASL11A",Asterisk
612404,"RAS-LIKE, FAMILY 11, MEMBER B; RASL11B",Asterisk
612405,ADP-RIBOSYLATION FACTOR-LIKE 9; ARL9,Asterisk
612406,"DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17",Percent
612407,REGULATOR OF G PROTEIN SIGNALING 21; RGS21,Asterisk
612408,PARASPECKLE COMPONENT 1; PSPC1,Asterisk
612409,RNA-BINDING MOTIF PROTEIN 14; RBM14,Asterisk
612410,"PSORIASIS 10, SUSCEPTIBILITY TO; PSORS10",Percent
612411,"FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 4; FAT4",Asterisk
612412,SPERMATOGENESIS AND CENTRIOLE-ASSOCIATED PROTEIN 1-LIKE; SPATC1L,Asterisk
612413,RNA-BINDING MOTIF PROTEIN 7; RBM7,Asterisk
612414,LEUCINE-RICH TRANSMEMBRANE O-METHYLTRANSFERASE; LRTOMT,Asterisk
612415,RAS-ASSOCIATED PROTEIN 24; RAB24,Asterisk
612416,FACTOR XI DEFICIENCY,Number Sign
612417,"NARCOLEPSY 4, SUSCEPTIBILITY TO; NRCLP4",Percent
612418,TRANSMEMBRANE PROTEIN 70; TMEM70,Asterisk
612419,CARTILAGE INTERMEDIATE LAYER PROTEIN 2; CILP2,Asterisk
612420,ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE PROTEIN 2; AFAP1L2,Asterisk
612421,"ALOPECIA, ANDROGENETIC, 3; AGA3",Percent
612422,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3",Number Sign
612423,PREKALLIKREIN DEFICIENCY,Number Sign
612424,"EYES SHUT, DROSOPHILA, HOMOLOG OF; EYS",Asterisk
612425,SHUGOSHIN-LIKE 2; SGOL2,Asterisk
612426,RECQ-MEDIATED GENOME INSTABILITY 2; RMI2,Asterisk
612427,RNA-BINDING MOTIF PROTEIN 25; RBM25,Asterisk
612428,RNA-BINDING MOTIF PROTEIN 38; RBM38,Asterisk
612429,ZINC FINGER PROTEIN 300; ZNF300,Asterisk
612430,RNA-BINDING MOTIF PROTEIN 22; RBM22,Asterisk
612431,"DEAFNESS, AUTOSOMAL DOMINANT 27; DFNA27",Percent
612432,"WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 3; WIPF3",Asterisk
612433,"DEAFNESS, AUTOSOMAL RECESSIVE 45; DFNB45",Percent
612434,"CYSTEINE-RICH SECRETORY PROTEIN, LCCL DOMAIN-CONTAINING, 2; CRISPLD2",Asterisk
612435,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 3A1; SLCO3A1",Asterisk
612436,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4A1; SLCO4A1",Asterisk
612437,"EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B",Number Sign
612438,"LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6",Number Sign
612439,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 3; ARFGAP3,Asterisk
612440,MOVED TO 607694,Caret
612441,"ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B; MGAT5B",Asterisk
612442,"SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG OF, A; SEC22A",Asterisk
612443,MOVED TO 612319,Caret
612444,"CILIARY DYSKINESIA, PRIMARY, 9; CILD9",Number Sign
612445,"SCOLIOSIS, ARACHNODACTYLY, AND BLINDNESS",
612446,COMPLEMENT COMPONENT 6 DEFICIENCY; C6D,Number Sign
612447,"SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION",Number Sign
612448,AGE-RELATED HEARING IMPAIRMENT 1; ARHI1,Percent
612449,"GEN1, DROSOPHILA, HOMOLOG OF; GEN1",Asterisk
612450,HBS1-LIKE PROTEIN; HBS1L,Asterisk
612451,RING FINGER PROTEIN 114; RNF114,Asterisk
612452,"KAT8 REGULATORY NSL COMPLEX, SUBUNIT 1; KANSL1",Asterisk
612453,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 10; MEGF10,Asterisk
612454,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 11; MEGF11,Asterisk
612455,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 12; SLC5A12",Asterisk
612456,APOLIPOPROTEIN L DOMAIN-CONTAINING 1; APOLD1,Asterisk
612457,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3B; ARID3B,Asterisk
612458,ACTIN-LIKE 6B; ACTL6B,Asterisk
612459,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13; BMIQ13,Percent
612460,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14,Number Sign
612461,ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN; ARC,Asterisk
612462,"PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C",Number Sign
612463,PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP,Number Sign
612464,ARRESTIN DOMAIN-CONTAINING 3; ARRDC3,Asterisk
612465,"TBC1 DOMAIN FAMILY, MEMBER 4; TBC1D4",Asterisk
612466,GUANYLATE-BINDING PROTEIN 4; GBP4,Asterisk
612467,GUANYLATE-BINDING PROTEIN 6; GBP6,Asterisk
612468,GUANYLATE-BINDING PROTEIN 7; GBP7,Asterisk
612469,"WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, MENTAL RETARDATION, AND OBESITY SYNDROME; WAGRO",Number Sign
612470,"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE 3; BATF3",Asterisk
612471,ALANINE-GLYOXYLATE AMINOTRANSFERASE 2; AGXT2,Asterisk
612472,METHYLTRANSFERASE-LIKE 3; METTL3,Asterisk
612473,PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 4,Asterisk
612474,"CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB",Number Sign
612475,CHROMOSOME 1q21.1 DUPLICATION SYNDROME,Number Sign
612476,"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE; BATF",Asterisk
612477,IQ MOTIF-CONTAINING PROTEIN G; IQCG,Asterisk
612478,N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 3; NECAB3,Asterisk
612479,MOVED TO 603075 AND 603029,Caret
612480,TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE; TIPARP,Asterisk
612481,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 12; PARP12",Asterisk
612482,RING FINGER PROTEIN 43; RNF43,Asterisk
612483,"FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 3; FAT3",Asterisk
612484,"RIBONUCLEASE, RNase A FAMILY, 7; RNASE7",Asterisk
612485,"RIBONUCLEASE, RNase A FAMILY, 8; RNASE8",Asterisk
612486,"DACHSOUS, DROSOPHILA, HOMOLOG OF, 2; DCHS2",Asterisk
612487,RING FINGER PROTEIN 31; RNF31,Asterisk
612488,RING FINGER PROTEIN 38; RNF38,Asterisk
612489,RING FINGER PROTEIN 24; RNF24,Asterisk
612490,RING FINGER PROTEIN 181; RNF181,Asterisk
612491,APAF1-INTERACTING PROTEIN; APIP,Asterisk
612492,UBIQUITIN-SPECIFIC PROTEASE 30; USP30,Asterisk
612493,CANOPY FGF SIGNALING REGULATOR 1; CNPY1,Asterisk
612494,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10-LIKE PROTEIN; ARHGEF10L,Asterisk
612495,UBIQUITIN-CONJUGATING ENZYME E2C-BINDING PROTEIN; UBE2CBP,Asterisk
612496,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 19; ARHGEF19,Asterisk
612497,TRANSFORMING GROWTH FACTOR-BETA-INDUCIBLE NUCLEAR PROTEIN 1,Asterisk
612498,ADENYLOSUCCINATE SYNTHASE-LIKE 1; ADSSL1,Asterisk
612499,DIMETHYLADENOSINE TRANSFERASE 1-LIKE; DIMT1L,Asterisk
612500,DEAD BOX POLYPEPTIDE 52; DDX52,Asterisk
612501,UBIQUITIN-CONJUGATING ENZYME E2Q 2; UBE2Q2,Asterisk
612502,COLLECTIN 11; COLEC11,Asterisk
612503,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 5; ABCA5",Asterisk
612504,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 6; ABCA6",Asterisk
612505,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 8; ABCA8",Asterisk
612506,UBIQUITIN-CONJUGATING ENZYME E2R 2; UBE2R2,Asterisk
612507,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 9; ABCA9",Asterisk
612508,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 10; ABCA10",Asterisk
612509,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 10; ABCC10",Asterisk
612510,"ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 2; ABCF2",Asterisk
612511,MICRO RNA 101-1; MIRN101-1,Asterisk
612512,MICRO RNA 101-2; MIRN101-2,Asterisk
612513,CHROMOSOME 2p16.1-p15 DELETION SYNDROME,Number Sign
612514,SPECIFIC LANGUAGE IMPAIRMENT 4; SLI4,Percent
612515,DDB1- AND CUL4-ASSOCIATED FACTOR 17; DCAF17,Asterisk
612516,UVEAL AUTOANTIGEN WITH COILED-COIL DOMAINS AND ANKYRIN REPEATS; UACA,Asterisk
612517,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 2; DNAAF2",Asterisk
612518,"CILIARY DYSKINESIA, PRIMARY, 10; CILD10",Number Sign
612519,"SOLUTE CARRIER FAMILY 35, MEMBER D3; SLC35D3",Asterisk
612520,"DIABETES MELLITUS, INSULIN-DEPENDENT, 20; IDDM20",Number Sign
612521,"DIABETES MELLITUS, INSULIN-DEPENDENT, 21; IDDM21",Percent
612522,"DIABETES MELLITUS, INSULIN-DEPENDENT, 22; IDDM22",Number Sign
612523,IQ MOTIF-CONTAINING PROTEIN H: IQCH,Asterisk
612524,"RIBONUCLEASE P/MRP, 21-KD SUBUNIT; RPP21",Asterisk
612525,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 5; IHPS5",Percent
612526,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3",Number Sign
612527,DIAMOND-BLACKFAN ANEMIA 4; DBA4,Number Sign
612528,DIAMOND-BLACKFAN ANEMIA 5; DBA5,Number Sign
612529,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2",Number Sign
612530,CHROMOSOME 1q41-q42 DELETION SYNDROME,Number Sign
612531,THAP DOMAIN-CONTAINING PROTEIN 2; THAP2,Asterisk
612532,THAP DOMAIN-CONTAINING PROTEIN 3; THAP3,Asterisk
612533,THAP DOMAIN-CONTAINING PROTEIN 4; THAP4,Asterisk
612534,THAP DOMAIN-CONTAINING PROTEIN 5; THAP5,Asterisk
612535,THAP DOMAIN-CONTAINING PROTEIN 6; THAP6,Asterisk
612536,THAP DOMAIN-CONTAINING PROTEIN 8; THAP8,Asterisk
612537,THAP DOMAIN-CONTAINING PROTEIN 9; THAP9,Asterisk
612538,THAP DOMAIN-CONTAINING PROTEIN 10; THAP10,Asterisk
612539,"SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42",Number Sign
612540,"MYOPATHY, CONGENITAL, COMPTON-NORTH; MYPCN",Number Sign
612541,"NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4",Number Sign
612542,VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1,Number Sign
612543,UBIQUITIN-SPECIFIC PROTEASE 36; USP36,Asterisk
612544,"ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 2; ABLIM2",Asterisk
612545,WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 26; WBSCR26,Asterisk
612546,WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 27; WBSCR27,Asterisk
612547,WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 28; WBSCR28,Asterisk
612548,TRIPARTITE MOTIF-CONTAINING PROTEIN 50; TRIM50,Asterisk
612549,TRIPARTITE MOTIF-CONTAINING PROTEIN 73; TRIM73,Asterisk
612550,TRIPARTITE MOTIF-CONTAINING PROTEIN 74; TRIM74,Asterisk
612551,"FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4",Number Sign
612552,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 4; ZBED4,Asterisk
612553,MICRO RNA 370; MIR370,Asterisk
612554,"MYOPIA 16, AUTOSOMAL DOMINANT; MYP16",Percent
612555,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2",Number Sign
612556,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1",Number Sign
612557,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3",Percent
612558,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 4",Percent
612559,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 5",Percent
612560,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12,Number Sign
612561,DIAMOND-BLACKFAN ANEMIA 6; DBA6,Number Sign
612562,DIAMOND-BLACKFAN ANEMIA 7; DBA7,Number Sign
612563,DIAMOND-BLACKFAN ANEMIA 8; DBA8,Number Sign
612564,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 9; TXNDC9,Asterisk
612565,RAS-ASSOCIATED PROTEIN RAB1B; RAB1B,Asterisk
612566,INFLAMMATORY BOWEL DISEASE 24; IBD24,Percent
612567,"INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25",Number Sign
612568,SPIC TRANSCRIPTION FACTOR; SPIC,Asterisk
612569,CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 1; CCAR1,Asterisk
612570,FIBRILLIN 2; FBN2,Asterisk
612571,LUNG CANCER SUSCEPTIBILITY 3; LNCR3,Percent
612572,RETINITIS PIGMENTOSA 46; RP46,Number Sign
612573,MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 1; MPVQTL1,Percent
612574,MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 2; MPVQTL2,Percent
612575,MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 3; MPVQTL3,Percent
612576,"CHROMOSOME 17p13.3, TELOMERIC, DUPLICATION SYNDROME",Number Sign
612577,AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11,Number Sign
612578,STATURE QUANTITATIVE TRAIT LOCUS 15; STQTL15,Percent
612579,STATURE QUANTITATIVE TRAIT LOCUS 16; STQTL16,Percent
612580,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3",Number Sign
612581,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4",Percent
612582,CHROMOSOME 6pter-p24 DELETION SYNDROME,Number Sign
612583,"SPINSTER, DROSOPHILA, HOMOLOG OF, 1; SPNS1",Asterisk
612584,"SPINSTER, DROSOPHILA, HOMOLOG OF, 2; SPNS2",Asterisk
612585,CLPTM1-LIKE PROTEIN; CLPTM1L,Asterisk
612586,"ANEURYSM, INTRACRANIAL BERRY, 9; ANIB9",Percent
612587,"ANEURYSM, INTRACRANIAL BERRY, 10; ANIB10",Percent
612588,BCL2-ASSOCIATED TRANSCRIPTION FACTOR 1; BCLAF1,Asterisk
612589,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 8; CRCS8",Percent
612590,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 9; CRCS9",Percent
612591,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10",Number Sign
612592,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 11; CRCS11",Percent
612593,LUNG CANCER SUSCEPTIBILITY 4; LNCR4,Percent
612594,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2; MS2",Percent
612595,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3",Percent
612596,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4; MS4",Percent
612597,CYTOTOXIC AND REGULATORY T-CELL MOLECULE; CRTAM,Asterisk
612598,RING FINGER PROTEIN 11; RNF11,Asterisk
612599,"PSORIASIS 11, SUSCEPTIBILITY TO; PSORS11",Percent
612600,RNA METHYLTRANSFERASE-LIKE 1; RNMTL1,Asterisk
612601,RET FINGER PROTEIN-LIKE 4A; RFPL4A,Asterisk
612602,RNA-BINDING MOTIF PROTEIN 15B; RBM15B,Asterisk
612603,LATE CORNIFIED ENVELOPE PROTEIN 1A; LCE1A,Asterisk
612604,LATE CORNIFIED ENVELOPE PROTEIN 1B; LCE1B,Asterisk
612605,LATE CORNIFIED ENVELOPE 1C; LCE1C,Asterisk
612606,LATE CORNIFIED ENVELOPE PROTEIN 1D; LCE1D,Asterisk
612607,LATE CORNIFIED ENVELOPE PROTEIN 1E; LCE1E,Asterisk
612608,LATE CORNIFIED ENVELOPE PROTEIN 1F; LCE1F,Asterisk
612609,LATE CORNIFIED ENVELOPE PROTEIN 2A; LCE2A,Asterisk
612610,LATE CORNIFIED ENVELOPE PROTEIN 2B; LCE2B,Asterisk
612611,LATE CORNIFIED ENVELOPE PROTEIN 2C; LCE2C,Asterisk
612612,LATE CORNIFIED ENVELOPE PROTEIN 2D; LCE2D,Asterisk
612613,LATE CORNIFIED ENVELOPE PROTEIN 3A; LCE3A,Asterisk
612614,LATE CORNIFIED ENVELOPE PROTEIN 3B; LCE3B,Asterisk
612615,LATE CORNIFIED ENVELOPE PROTEIN 3C; LCE3C,Asterisk
612616,LATE CORNIFIED ENVELOPE PROTEIN 3D; LCE3D,Asterisk
612617,LATE CORNIFIED ENVELOPE PROTEIN 3E; LCE3E,Asterisk
612618,LATE CORNIFIED ENVELOPE PROTEIN 4A; LCE4A,Asterisk
612619,LATE CORNIFIED ENVELOPE PROTEIN 5A; LCE5A,Asterisk
612620,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 6; RASSF6",Asterisk
612621,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5",Number Sign
612622,"DIABETES MELLITUS, INSULIN-DEPENDENT, 23; IDDM23",Percent
612623,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2",Number Sign
612624,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3",Number Sign
612625,LMBR1 DOMAIN-CONTAINING PROTEIN 1: LMBRD1,Asterisk
612626,CHROMOSOME 15q26-qter DELETION SYNDROME,Number Sign
612627,"SEIZURES, BENIGN FAMILIAL INFANTILE, 4; BFIS4",Percent
612628,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4",Number Sign
612629,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 4; ADIPQTL4",Percent
612630,HAIR MORPHOLOGY 1; HRM1,Number Sign
612631,"ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO",Number Sign
612632,"USHER SYNDROME, TYPE IH; USH1H",Percent
612633,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5",Number Sign
612634,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6",Number Sign
612635,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7",Number Sign
612636,"UNC80, C. ELEGANS, HOMOLOG OF; UNC80",Asterisk
612637,"FEBRILE SEIZURES, FAMILIAL, 10; FEB10",Percent
612638,"NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, 11; NDUFA11",Asterisk
612639,INFLAMMATORY BOWEL DISEASE 26; IBD26,Percent
612640,"THYMUS, BRAIN, AND TESTES ASSOCIATED; TBATA",Asterisk
612641,ANKYRIN 1; ANK1,Asterisk
612642,"DEAFNESS, AUTOSOMAL DOMINANT 59; DFNA59",Percent
612643,"DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B",Number Sign
612644,"DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B",Number Sign
612645,"DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B",Number Sign
612646,METASTASIS-ASSOCIATED GENE IN COLON CANCER 1; MACC1,Asterisk
612647,"RADIAL SPOKE HEAD 4, CHLAMYDOMONAS, HOMOLOG OF, A; RSPH4A",Asterisk
612648,"RADIAL SPOKE HEAD 9, CHLAMYDOMONAS, HOMOLOG OF; RSPH9",Asterisk
612649,"CILIARY DYSKINESIA, PRIMARY, 11; CILD11",Number Sign
612650,"CILIARY DYSKINESIA, PRIMARY, 12; CILD12",Number Sign
612651,ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO,Number Sign
612652,MOVED TO 219150,Caret
612653,"SPHEROCYTOSIS, TYPE 4; SPH4",Number Sign
612654,TRICHOPLEIN; TCHP,Asterisk
612655,"TBC1 DOMAIN FAMILY, MEMBER 7; TBC1D7",Asterisk
612656,"EPISODIC ATAXIA, TYPE 6; EA6",Number Sign
612657,CONE-ROD DYSTROPHY 12; CORD12,Number Sign
612658,TIGHT JUNCTION-ASSOCIATED PROTEIN 1; TJAP1,Asterisk
612659,"REGULATORY FACTOR X, 6; RFX6",Asterisk
612660,"REGULATORY FACTOR X, 7; RFX7",Asterisk
612661,WD REPEAT-CONTAINING PROTEIN ANTISENSE TO TP53; WRAP53,Asterisk
612662,"TBC1 DOMAIN FAMILY, MEMBER 15; TBC1D15",Asterisk
612663,"TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN, FAMILY MEMBER B; TIFAB",Asterisk
612664,RAS-LIKE AND ESTROGEN-REGULATED GROWTH INHIBITOR; RERG,Asterisk
612665,TESTIS-EXPRESSED GENE 101; TEX101,Asterisk
612666,DUAL SERINE/THREONINE AND TYROSINE PROTEIN KINASE; DSTYK,Asterisk
612667,HOLLIDAY JUNCTION RECOGNITION PROTEIN; HJURP,Asterisk
612668,"TASTE RECEPTOR, TYPE 2, MEMBER 43; TAS2R43",Asterisk
612669,"TASTE RECEPTOR, TYPE 2, MEMBER 31; TAS2R31",Asterisk
612670,MOVED TO 138900,Caret
612671,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4",Number Sign
612672,RAS-ASSOCIATED PROTEIN RAB10; RAB10,Asterisk
612673,RAS-ASSOCIATED PROTEIN RAB14; RAB14,Asterisk
612674,"POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC",Number Sign
612675,SMALL CAJAL BODY-SPECIFIC RNA 15; SCARNA15,Asterisk
612676,QUINOID DIHYDROPTERIDINE REDUCTASE; QDPR,Asterisk
612677,"PYRIN AND HIN DOMAIN FAMILY, MEMBER 1; PYHIN1",Asterisk
612678,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 3; CELF3",Asterisk
612679,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 4; CELF4",Asterisk
612680,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 5; CELF5",Asterisk
612681,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 6; CELF6",Asterisk
612682,DORSAL REPULSIVE AXON GUIDANCE PROTEIN,Asterisk
612683,TEKTIN 3; TEKT3,Asterisk
612684,"ISTHMIN 2, ZEBRAFISH, HOMOLOG OF; ISM2",Asterisk
612685,CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 3; CAMSAP3,Asterisk
612686,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 7; PLEKHA7",Asterisk
612687,"RGM DOMAIN FAMILY, MEMBER B; RGMB",Asterisk
612688,RING FINGER PROTEIN 168; RNF168,Asterisk
612689,TIGHT JUNCTION PROTEIN 3; TJP3,Asterisk
612690,"SPHEROCYTOSIS, TYPE 5; SPH5",Number Sign
612691,"POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP",Number Sign
612692,"AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6",Number Sign
612693,"UBIQUITIN-RELATED MODIFIER 1, S. CEREVISIAE, HOMOLOG OF; URM1",Asterisk
612694,"CYTOSOLIC THIOURIDYLASE, SUBUNIT 1; CTU1",Asterisk
612695,VAULT RNA 1-1; VTRNA1-1,Asterisk
612696,VAULT RNA 1-2; VTRNA1-2,Asterisk
612697,VAULT RNA 1-3; VTRNA1-3,Asterisk
612698,MICRO RNA 187; MIR187,Asterisk
612699,RIMS-BINDING PROTEIN 3; RIMBP3,Asterisk
612700,RIMS-BINDING PROTEIN 3B; RIMBP3B,Asterisk
612701,RIMS-BINDING PROTEIN 3C; RIMBP3C,Asterisk
612702,HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6,Number Sign
612703,"MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7",Number Sign
612704,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 1; RGPD1,Asterisk
612705,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 2; RGPD2,Asterisk
612706,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 3; RGPD3,Asterisk
612707,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 4; RGPD4,Asterisk
612708,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 5; RGPD5,Asterisk
612709,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 6; RGPD6,Asterisk
612710,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 7; RGPD7,Asterisk
612711,GRIP AND COILED-COIL DOMAIN-CONTAINING PROTEIN 2; GCC2,Asterisk
612712,LEBER CONGENITAL AMAUROSIS 13; LCA13,Number Sign
612713,KAHRIZI SYNDROME; KHRZ,Number Sign
612714,"EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS",Number Sign
612715,DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2; DUH2,Percent
612716,"DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY",Number Sign
612717,"MYOPIA 15, AUTOSOMAL DOMINANT; MYP15",Percent
612718,CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3,Number Sign
612719,6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE; PTS,Asterisk
612720,DEAH BOX POLYPEPTIDE 29; DHX29,Asterisk
612721,REGULATED ENDOCRINE-SPECIFIC PROTEIN 18,Asterisk
612722,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 3; ELP3",Asterisk
612723,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY H, MEMBER 2; PLEKHH2",Asterisk
612724,"ALDOLASE B, FRUCTOSE-BISPHOSPHATE; ALDOB",Asterisk
612725,"PROTEIN PHOSPHATASE 6, CATALYTIC SUBUNIT; PPP6C",Asterisk
612726,HARDIKAR SYNDROME,Percent
612727,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13,Percent
612728,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14; BMND14,Percent
612729,LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1,Percent
612730,"SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 8; SLC9A8",Asterisk
612731,FACIOCARDIOMELIC SYNDROME,Percent
612732,COPROPORPHYRINOGEN OXIDASE; CPOX,Asterisk
612733,"THO COMPLEX, SUBUNIT 5; THOC5",Asterisk
612734,TLX1 DIVERGENT GENE,Asterisk
612735,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-3; HLA-DRB3",Asterisk
612736,CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2,Number Sign
612737,STATURE QUANTITATIVE TRAIT LOCUS 17; STQTL17,Percent
612738,"SOLUTE CARRIER FAMILY 9, MEMBER 10; SLC9A10",Asterisk
612739,SPERM ACROSOME-ASSOCIATED PROTEIN 1; SPACA1,Asterisk
612740,"PORPHYRIA, ACUTE HEPATIC",Number Sign
612741,"SNAIL, DROSOPHILA, HOMOLOG OF, 3; SNAI3",Asterisk
612742,MICRO RNA 181A1; MIR181A1,Asterisk
612743,MICRO RNA 181A2; MIR181A2,Asterisk
612744,MICRO RNA 181B1; MIR181B1,Asterisk
612745,MICRO RNA 181B2; MIR181B2,Asterisk
612746,MICRO RNA 181C; MIR181C,Asterisk
612747,TUFTELIN-INTERACTING PROTEIN 11; TFIP11,Asterisk
612748,LYSOZYME-LIKE 2; LYZL2,Asterisk
612749,SPERM ACROSOME-ASSOCIATED PROTEIN 3; SPACA3,Asterisk
612750,LYSOZYME-LIKE 4; LYZL4,Asterisk
612751,LYSOZYME-LIKE 6; LYZL6,Asterisk
612752,CXXC FINGER PROTEIN 5; CXXC5,Asterisk
612753,COLLAGEN AND CALCIUM-BINDING EGF DOMAIN-CONTAINING PROTEIN 1; CCBE1,Asterisk
612754,GLUTAREDOXIN 3; GLRX3,Asterisk
612755,"MITOCHONDRIAL DISTRIBUTION AND MORPHOLOGY 20, YEAST, HOMOLOG OF",Asterisk
612756,TESTICULAR CELL ADHESION MOLECULE 1; TCAM1,Asterisk
612757,GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN 1; GPIHBP1,Asterisk
612758,TRANSMEMBRANE ANTERIOR POSTERIOR TRANSFORMATION 1; TAPT1,Asterisk
612759,SYNESTHESIA,Percent
612760,SNF-RELATED KINASE; SNRK,Asterisk
612761,"SWI/SNF-RELATED, MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, DEAD/H BOX-CONTAINING, 1; SMARCAD1",Asterisk
612762,SUPPRESSOR OF TY 7-LIKE; SUPT7L,Asterisk
612763,TRANSCRIPTIONAL ADAPTOR 1-LIKE; TADA1L,Asterisk
612764,"ISY1 SPLICING FACTOR, S. CEREVISIAE, HOMOLOG OF; ISY1",Asterisk
612765,"SFI1, YEAST, HOMOLOG OF; SFI1",Asterisk
612766,"BRISC AND BRCA1 A COMPLEX, MEMBER 1; BABAM1",Asterisk
612767,DEAH BOX POLYPEPTIDE 36; DHX36,Asterisk
612768,FOLLICULIN-INTERACTING PROTEIN 2; FNIP2,Asterisk
612769,NONCODING NUCLEAR-ENRICHED ABUNDANT TRANSCRIPT 1; NEAT1,Asterisk
612770,PHOSPHATIDYLSERINE DECARBOXYLASE; PISD,Asterisk
612771,DUAL OXIDASE MATURATION FACTOR 1; DUOXA1,Asterisk
612772,DUAL OXIDASE MATURATION FACTOR 2; DUOXA2,Asterisk
612773,BASAL CELL ADHESION MOLECULE; BCAM,Asterisk
612774,"TASTE RECEPTOR, TYPE 2, MEMBER 46; TAS2R46",Asterisk
612775,CONE-ROD DYSTROPHY 9; CORD9,Number Sign
612776,HYPOGLOSSIA WITH SITUS INVERSUS,Percent
612777,"HYPOTONIA, SEIZURES, AND PRECOCIOUS PUBERTY",
612778,SET DOMAIN-CONTAINING PROTEIN 2; SETD2,Asterisk
612779,DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD,Asterisk
612780,"SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES",Number Sign
612781,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B",Number Sign
612782,IMMUNODEFICIENCY 9; IMD9,Number Sign
612783,IMMUNODEFICIENCY 10; IMD10,Number Sign
612784,HUNTINGTIN-INTERACTING PROTEIN K,Asterisk
612785,MEGARBANE-JALKH SYNDROME,
612786,CYCLIN Y; CCNY,Asterisk
612787,PSEUDOURIDYLATE SYNTHASE 10; PUS10,Asterisk
612788,FORKHEAD BOX Q1; FOXQ1,Asterisk
612789,"DEAFNESS, AUTOSOMAL RECESSIVE 71; DFNB71",Percent
612790,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 28; ARHGEF28,Asterisk
612791,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 3; ZKSCAN3,Asterisk
612792,PHOSPHATIDYLSERINE SYNTHASE 1; PTDSS1,Asterisk
612793,PHOSPHATIDYLSERINE SYNTHASE 2; PTDSS2,Asterisk
612794,ATRIAL SEPTAL DEFECT 5; ASD5,Number Sign
612795,POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; PUFAQTL1,Percent
612796,INFLAMMATORY BOWEL DISEASE 27; IBD27,Percent
612797,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12,Number Sign
612798,"QUESTION MARK EARS, ISOLATED; QME",Number Sign
612799,GLUTAMYL-tRNA SYNTHETASE 2; EARS2,Asterisk
612800,CYSTEINYL-tRNA SYNTHETASE 2; CARS2,Asterisk
612801,ISOLEUCYL-tRNA SYNTHETASE 2; IARS2,Asterisk
612802,VALYL-tRNA SYNTHETASE 2; VARS2,Asterisk
612803,ASPARAGINYL-tRNA SYNTHETASE 2; NARS2,Asterisk
612804,SERYL-tRNA SYNTHETASE 2; SARS2,Asterisk
612805,THREONYL-tRNA SYNTHETASE 2; TARS2,Asterisk
612806,G PROTEIN-COUPLED RECEPTOR 89B; GPR89B,Asterisk
612807,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; LRFN1,Asterisk
612808,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 2; LRFN2,Asterisk
612809,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3; LRFN3,Asterisk
612810,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4; LRFN4,Asterisk
612811,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5; LRFN5,Asterisk
612812,PROFILIN 3; PFN3,Asterisk
612813,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG",Number Sign
612814,SPERMATOGENESIS-ASSOCIATED PROTEIN 18; SPATA18,Asterisk
612815,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 13; ZDHHC13,Asterisk
612816,"UTP18, S. CEREVISIAE, HOMOLOG OF; UTP18",Asterisk
612817,"KRR1, YEAST, HOMOLOG OF; KRR1",Asterisk
612818,NUCLEOLAR AND SPINDLE-ASSOCIATED PROTEIN 1; NUSAP1,Asterisk
612819,"NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; NOC4L",Asterisk
612820,NEUROPLASTIN; NPTN,Asterisk
612821,G PROTEIN-COUPLED RECEPTOR 89A; GPR89A,Asterisk
612822,"UTP20, S. CEREVISIAE, HOMOLOG OF; UTP20",Asterisk
612823,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1D; TAF1D,Asterisk
612824,SEC14-LIKE 3; SEC14L3,Asterisk
612825,SEC14-LIKE 4; SEC14L4,Asterisk
612826,SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 1; SGPP1,Asterisk
612827,SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 2; SGPP2,Asterisk
612828,"CCAAT/ENHANCER-BINDING PROTEIN, ZETA; CEBPZ",Asterisk
612829,RAS-ASSOCIATED PROTEIN RAB3C; RAB3C,Asterisk
612830,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 3; DHRS3",Asterisk
612831,17-BETA-HYDROXYSTEROID DEHYDROGENASE XI; HSD17B11,Asterisk
612832,17-BETA-HYDROXYSTEROID DEHYDROGENASE XIV; HSD17B14,Asterisk
612833,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7; DHRS7",Asterisk
612834,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 1; PHLDB1",Asterisk
612835,"PHOSPHOLIPASE C, ETA-1; PLCH1",Asterisk
612836,"PHOSPHOLIPASE C, ETA-2; PLCH2",Asterisk
612837,COENZYME 9; COQ9,Asterisk
612838,BRUGADA SYNDROME 5; BRGDA5,Number Sign
612839,"TET ONCOGENE FAMILY, MEMBER 2; TET2",Asterisk
612840,"LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3",Number Sign
612841,HYPOTRICHOSIS 5; HYPT5,Percent
612842,"RASD FAMILY, MEMBER 2; RASD2",Asterisk
612843,"KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD",Percent
612844,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 3; SENP3",Asterisk
612845,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 5; SENP5",Asterisk
612846,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 7; SENP7",Asterisk
612847,BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4,Number Sign
612848,SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 1; SDHAF1,Asterisk
612849,UBIQUITIN-SPECIFIC PEPTIDASE 46; USP46,Asterisk
612850,"TUBULIN, BETA-2B; TUBB2B",Asterisk
612851,"NARCOLEPSY 5, SUSCEPTIBILITY TO; NRCLP5",Percent
612852,"OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP",Number Sign
612853,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7; RLS7",Percent
612854,"SEC16, S. CEREVISIAE, HOMOLOG OF, A; SEC16A",Asterisk
612855,"SEC16, S. CEREVISIAE, HOMOLOG OF, B; SEC16B",Asterisk
612856,ASTROTACTIN 2; ASTN2,Asterisk
612857,PLACENTA-SPECIFIC GENE 9; PLAC9,Asterisk
612858,OROFACIAL CLEFT 12; OFC12,Percent
612859,T-CELL IMMUNORECEPTOR WITH IMMUNOGLOBULIN AND ITIM DOMAINS; TIGIT,Asterisk
612860,QUIESCIN Q6 SULFHYDRYL OXIDASE 2; QSOX2,Asterisk
612861,"NOP16, S. CEREVISIAE, HOMOLOG OF; NOP16",Asterisk
612862,"PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO",Percent
612863,CHROMOSOME 6q24-q25 DELETION SYNDROME,Number Sign
612864,"PHOSPHOLIPASE A2, GROUP IVD; PLA2G4D",Asterisk
612865,PHOSPHATIDYLINOSITOL 4-PHOSPHATE-5-KINASE-LIKE 1; PIP5KL1,Asterisk
612866,"ALG14, S. CEREVISIAE, HOMOLOG OF; ALG14",Asterisk
612867,"CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD",
612868,"CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS; PACD",Number Sign
612869,ATTRACTIN-LIKE 1; ATRNL1,Asterisk
612870,PLECKSTRIN HOMOLOGY DOMAIN-INTERACTING PROTEIN; PHIP,Asterisk
612871,Na+/K+ TRANSPORTING ATPase-INTERACTING 1; NKAIN1,Asterisk
612872,Na+/K+ TRANSPORTING ATPase-INTERACTING 3; NKAIN3,Asterisk
612873,Na+/K+ TRANSPORTING ATPase-INTERACTING 4; NKAIN4,Asterisk
612874,ERYTHROCYTE AMP DEAMINASE DEFICIENCY,Number Sign
612875,GONADOTROPIN-RELEASING HORMONE RECEPTOR 2; GNRHR2,
612876,SPINOCEREBELLAR ATAXIA 9; SCA9,Percent
612877,"CARDIOMYOPATHY, DILATED, 1BB; CMD1BB",Number Sign
612878,EXOPHILIN 5; EXPH5,Asterisk
612879,MAM DOMAIN-CONTAINING PROTEIN 2; MAMDC2,Asterisk
612880,SYNAPTOTAGMIN-LIKE 2; SYTL2,Asterisk
612881,"CHROMOSOME 5q14.3 DELETION SYNDROME, DISTAL",Number Sign
612882,"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENAQ2",Percent
612883,"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENAQ3",Percent
612884,"MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENOQ2",Percent
612885,PREMATURE OVARIAN FAILURE 10; POF10,Number Sign
612886,"MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4; MENOQ4",Percent
612887,SEPTIN 11; SEPT11,Asterisk
612888,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8B; LRRC8B,Asterisk
612889,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8C; LRRC8C,Asterisk
612890,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8D; LRRC8D,Asterisk
612891,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8E; LRRC8E,Asterisk
612892,STATURE QUANTITATIVE TRAIT LOCUS 18; STQTL18,Percent
612893,STATURE QUANTITATIVE TRAIT LOCUS 19; STQTL19,Percent
612894,STATURE QUANTITATIVE TRAIT LOCUS 20; STQTL20,Percent
612895,NUCLEOREDOXIN; NXN,Asterisk
612896,RAD52 MOTIF-CONTAINING PROTEIN 1; RDM1,Asterisk
612897,SEPTIN 1; SEPT1,Asterisk
612898,"COENZYME Q4, S. CEREVISIAE, HOMOLOG OF; COQ4",Asterisk
612899,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8",Number Sign
612900,"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2",Number Sign
612901,"TUBULIN, BETA-1; TUBB1",Asterisk
612902,LIPOCALIN 8; LCN8,Asterisk
612903,LIPOCALIN 9; LCN9,Asterisk
612904,LIPOCALIN 10; LCN10,Asterisk
612905,LIPOCALIN 12; LCN12,Asterisk
612906,RAS-ASSOCIATED PROTEIN RAB32; RAB32,Asterisk
612907,"tRNA NUCLEOTIDYLTRANSFERASE, CCA-ADDING, 1; TRNT1",Asterisk
612908,KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2,Number Sign
612909,RAS-ASSOCIATED PROTEIN RAB6C; RAB6C,Asterisk
612910,PHD FINGER PROTEIN 23; PHF23,Asterisk
612911,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 3; NDUFAF3",Asterisk
612912,TRANSMEMBRANE PROTEIN 97; TMEM97,Asterisk
612913,OROFACIODIGITAL SYNDROME XI; OFD11,Percent
612914,MEDIATOR COMPLEX SUBUNIT 29; MED29,Asterisk
612915,MEDIATOR COMPLEX SUBUNIT 20; MED20,Asterisk
612916,ZECHI-CEIDE SYNDROME,
612917,GIACHETI SYNDROME,
612918,"CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI",Number Sign
612919,LanC-LIKE 2; LANCL2,Asterisk
612920,THROMBOSPONDIN-TYPE LAMININ G DOMAIN AND EAR REPEATS; TSPEAR,Asterisk
612921,THREE M SYNDROME 2; 3M2,Number Sign
612922,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2",Number Sign
612923,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3",Number Sign
612924,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4",Number Sign
612925,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5",Number Sign
612926,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6",Number Sign
612927,"AVL9, S. CEREVISIAE, HOMOLOG OF; AVL9",Asterisk
612928,ISOCHORISMATASE DOMAIN-CONTAINING 2; ISOC2,Asterisk
612929,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3",Percent
612930,PHOSPHOTYROSINE INTERACTION DOMAIN-CONTAINING 1; PID1,Asterisk
612931,PHOSPHOGLYCERATE MUTASE 2; PGAM2,Asterisk
612932,GLYCOGEN STORAGE DISEASE XIII; GSD13,Number Sign
612933,GLYCOGEN STORAGE DISEASE XI; GSD11,Number Sign
612934,MOVED TO 614921,Caret
612935,MYOSIN PHOSPHATASE RHO-INTERACTING PROTEIN; MPRIP,Asterisk
612936,"SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50",Number Sign
612937,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io; CDG1O",Number Sign
612938,"GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD",Number Sign
612939,HEAT-SHOCK 70-KD PROTEIN-BINDING PROTEIN 1; HSPBP1,Asterisk
612940,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B",Number Sign
612941,"PRECURSOR mRNA-PROCESSING FACTOR 40, S. CEREVISIAE, HOMOLOG OF, A; PRPF40A",Asterisk
612942,RAS-ASSOCIATED PROTEIN RAB25; RAB25,Asterisk
612943,RETINITIS PIGMENTOSA 42; RP42,Number Sign
612944,RIBONUCLEASE T2; RNASET2,Asterisk
612945,RAS-ASSOCIATED PROTEIN RAB4B; RAB4B,Asterisk
612946,HADZISELIMOVIC SYNDROME,Percent
612947,"MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE",
612948,"STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, MENTAL RETARDATION, AND DYSMORPHIC FEATURES",
612949,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39; EIEE39",Number Sign
612950,"PSORIASIS 12, SUSCEPTIBILITY TO; PSORS12",Percent
612951,"LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY",Number Sign
612952,AICARDI-GOUTIERES SYNDROME 5; AGS5,Number Sign
612953,"PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14",Number Sign
612954,"MYOPATHY, MYOFIBRILLAR, 6; MFM6",Number Sign
612955,LONG QT SYNDROME 12; LQT12,Number Sign
612956,"VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2",Number Sign
612957,VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B6QTL1,Percent
612958,TRANSLATIONAL ACTIVATOR OF MITOCHONDRIALLY ENCODED CYTOCHROME c OXIDASE SUBUNIT I; TACO1,Asterisk
612959,EPITHELIAL SPLICING REGULATORY PROTEIN 1; ESRP1,Asterisk
612960,EPITHELIAL SPLICING REGULATORY PROTEIN 2; ESRP2,Asterisk
612961,MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3,Number Sign
612962,DYNACTIN 5; DCTN5,Asterisk
612963,DYNACTIN 6; DCTN6,Asterisk
612964,PREMATURE OVARIAN FAILURE 7; POF7,Number Sign
612965,"46,XY SEX REVERSAL 3; SRXY3",Number Sign
612966,RAS-ASSOCIATED PROTEIN RAB22A; RAB22A,Asterisk
612967,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15; BMIQ15,Percent
612968,"CATARACT 34, MULTIPLE TYPES; CTRCT34",Number Sign
612969,TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 7; TIGD7,Asterisk
612970,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 17, PSEUDOGENE; NBPF17P",
612971,PDZ DOMAIN-CONTAINING 7; PDZD7,Asterisk
612972,TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 1; TIGD1,Asterisk
612973,TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 2; TIGD2,Asterisk
612974,DEP DOMAIN-CONTAINING PROTEIN 6; DEPDC6,Asterisk
612975,SHORT SLEEPER,Number Sign
612976,AGE-RELATED HEARING IMPAIRMENT 2; ARHI2,Percent
612977,DCN1 DOMAIN-CONTAINING PROTEIN 4; DCUN1D4,Asterisk
612978,PRECEREBELLIN 3; CBLN3,Asterisk
612979,"SYS1 GOLGI-LOCALIZED INTEGRAL MEMBRANE PROTEIN, S. CEREVISIAE, HOMOLOG OF; SYS1",Asterisk
612980,"IMP3, S. CEREVISIAE, HOMOLOG OF; IMP3",Asterisk
612981,"IMP4, S. CEREVISIAE, HOMOLOG OF; IMP4",Asterisk
612982,MICRO RNA 210; MIR210,Asterisk
612983,MICRO RNA 106B; MIR106B,Asterisk
612984,MICRO RNA 93; MIR93,Asterisk
612985,IROQUOIS HOMEOBOX PROTEIN 3; IRX3,Asterisk
612986,EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 3; EID3,Asterisk
612987,"NON-SMC ELEMENT 4, S. CEREVISIAE, HOMOLOG OF, A; NSMCE4A",Asterisk
612988,TRANSMEMBRANE PROTEIN 126A; TMEM126A,Asterisk
612989,OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7,Number Sign
612990,ADDITIONAL SEX COMBS-LIKE 1; ASXL1,Asterisk
612991,ADDITIONAL SEX COMBS-LIKE 2; ASXL2,Asterisk
612992,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 3; NBPF3",Asterisk
612993,FILAMIN A-INTERACTING PROTEIN 1-LIKE; FILIP1L,Asterisk
612994,RAS-ASSOCIATED PROTEIN 28; RAB28,Asterisk
612995,TRANSFER RNA VALINE (CAC) 1-2; TRV-CAC1-2,Asterisk
612996,TRANSFER RNA LYSINE (CTT) 2-4; TRK-CTT2-4,Asterisk
612997,SPERMATOGENIC FAILURE 7; SPGF7,Number Sign
612998,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4",Number Sign
612999,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5",Number Sign
613000,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1; FNEPPK1",Number Sign
613001,ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL,Number Sign
613002,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2",Number Sign
613003,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7",Number Sign
613004,HUNTINGTIN; HTT,Asterisk
613005,SANTOS SYNDROME,
613006,"DIABETES MELLITUS, INSULIN-DEPENDENT, 24; IDDM24",Percent
613007,"BILIARY CIRRHOSIS, PRIMARY, 2; PBC2",Percent
613008,"BILIARY CIRRHOSIS, PRIMARY, 3; PBC3",Percent
613009,O-PHOSPHOSERINE tRNA-SELENOCYSTEINE tRNA SYNTHASE; SEPSECS,Asterisk
613010,RIBOFLAVIN KINASE; RFK,Asterisk
613011,LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1,Number Sign
613012,UROCANASE DOMAIN-CONTAINING PROTEIN 1; UROC1,Asterisk
613013,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2",Number Sign
613014,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3",Number Sign
613015,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 4; NBLST4",Percent
613016,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 5; NBLST5",Percent
613017,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 6; NBLST6",Percent
613018,TYROSINE AMINOTRANSFERASE; TAT,Asterisk
613019,SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 2; SDHAF2,Asterisk
613020,MOVED TO 116600,Caret
613021,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2,Number Sign
613022,OXOGLUTARATE DEHYDROGENASE; OGDH,Asterisk
613023,"CENTROSOMAL PROTEIN, 170-KD; CEP170",Asterisk
613024,"FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1; FL1",Percent
613025,SCHIZOPHRENIA 13; SCZD13,Percent
613026,"CHROMOSOME 19q13.11 DELETION SYNDROME, DISTAL",Number Sign
613027,GLYCOGEN STORAGE DISEASE IXc; GSD9C,Number Sign
613028,GLIOMA SUSCEPTIBILITY 2; GLM2,Number Sign
613029,GLIOMA SUSCEPTIBILITY 3; GLM3,Number Sign
613030,GLIOMA SUSCEPTIBILITY 5; GLM5,Percent
613031,GLIOMA SUSCEPTIBILITY 6; GLM6,Percent
613032,GLIOMA SUSCEPTIBILITY 7; GLM7,Percent
613033,GLIOMA SUSCEPTIBILITY 8; GLM8,Percent
613034,MOVED TO 612541,Caret
613035,"HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO; NIHL",Percent
613036,"PEPTIDASE, MITOCHONDRIAL PROCESSING, ALPHA; PMPCA",Asterisk
613037,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 72-KD; INPP5E",Asterisk
613038,"PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1",Number Sign
613039,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1-LIKE; CHD1L,Asterisk
613040,COILED-COIL DOMAIN-CONTAINING PROTEIN 26; CCDC26,Asterisk
613041,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A1; FAM90A1",Asterisk
613042,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A3; FAM90A3",Asterisk
613043,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A5; FAM90A5",Asterisk
613044,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A7; FAM90A7",Asterisk
613045,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A8; FAM90A8",Asterisk
613046,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A9; FAM90A9",Asterisk
613047,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A10; FAM90A10",Asterisk
613048,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A12; FAM90A12",Asterisk
613049,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A13; FAM90A13",Asterisk
613050,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A14; FAM90A14",Asterisk
613051,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A15; FAM90A15",Asterisk
613052,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A18; FAM90A18",Asterisk
613053,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A19; FAM90A19",Asterisk
613054,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A20; FAM90A20",Asterisk
613055,"ATRIAL FIBRILLATION, FAMILIAL, 8; ATFB8",Percent
613056,"LUC7, S. CEREVISIAE, HOMOLOG OF, 2; LUC7L2",Asterisk
613057,MICRO RNA 26A2; MIR26A2,Asterisk
613058,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2; BCC2",Percent
613059,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3; BCC3",Percent
613060,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10",Number Sign
613061,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4; BCC4",Percent
613062,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5; BCC5",Percent
613063,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6; BCC6",Percent
613064,"DERMATITIS, ATOPIC, 7; ATOD7",Percent
613065,"LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL",Percent
613066,PBX/KNOTTED 1 HOMEOBOX 2; PKNOX2,Asterisk
613067,"LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2; ALL2",Percent
613068,NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY,Number Sign
613069,PHD FINGER PROTEIN 10; PHF10,Asterisk
613070,"LIVER FAILURE, INFANTILE, TRANSIENT; LFIT",Number Sign
613071,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3,Number Sign
613072,LIPOXYGENASE HOMOLOGY DOMAIN-CONTAINING 1; LOXHD1,Asterisk
613073,METAPHYSEAL ANADYSPLASIA 2; MANDP2,Number Sign
613074,"DEAFNESS, AUTOSOMAL DOMINANT 50; DFNA50",Number Sign
613075,MACS SYNDROME,Number Sign
613076,"MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING LOSS, AND DEVELOPMENTAL DELAY",Number Sign
613077,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5",Number Sign
613078,NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD,Number Sign
613079,"DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77",Number Sign
613080,"46,XY SEX REVERSAL 5; SRXY5",Number Sign
613081,LYSINE-SPECIFIC DEMETHYLASE 1B; KDM1B,Asterisk
613082,"ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 2; ATP2C2",Asterisk
613083,LISTERIN E3 UBIQUITIN PROTEIN LIGASE 1; LTN1,Asterisk
613084,MYELIN TRANSCRIPTION FACTOR 1-LIKE; MYT1L,Asterisk
613085,"GLAUCOMA 3, PRIMARY CONGENITAL, C; GLC3C",Percent
613086,"GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D",Number Sign
613087,ATRIAL SEPTAL DEFECT 6; ASD6,Number Sign
613088,"PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2",Percent
613089,"CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH",
613090,"BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B",Number Sign
613091,SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3,Number Sign
613092,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2",Number Sign
613093,CONE DYSTROPHY 4; COD4,Number Sign
613094,"MICROPHTHALMIA, ISOLATED 4; MCOP4",Number Sign
613095,POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD2,Number Sign
613096,"SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36",Percent
613097,MOVED TO 601216,Caret
613098,"INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC",Number Sign
613099,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5",Number Sign
613100,"GLAUCOMA 1, OPEN ANGLE, O; GLC1O",Number Sign
613101,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5",Number Sign
613102,HYPOTRICHOSIS AND RECURRENT SKIN VESICLES,Number Sign
613103,SERINE/ARGININE REPETITIVE MATRIX PROTEIN 4; SRRM4,Asterisk
613104,CALCIUM CHANNEL FLOWER-DOMAIN CONTAINING PROTEIN 1; CACFD1,Asterisk
613105,"CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2",Number Sign
613106,"VERTIGO, BENIGN RECURRENT, 2; BRV2",Percent
613107,"NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2",Number Sign
613108,"CANDIDIASIS, FAMILIAL, 4; CANDF4",Number Sign
613109,GM2 ACTIVATOR; GM2A,Asterisk
613110,BLADDER CANCER-ASSOCIATED PROTEIN; BLCAP,Asterisk
613111,CATHEPSIN A; CTSA,Asterisk
613112,"MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED",Number Sign
613113,NEUROFIBROMIN 1; NF1,Asterisk
613114,"FAMILY WITH SEQUENCE SIMILARITY 134, MEMBER B; FAM134B",Asterisk
613115,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B",Number Sign
613116,THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11,Number Sign
613117,"SMALL NUCLEOLAR RNA, C/D BOX, 50A; SNORD50A",Asterisk
613118,ANTITHROMBIN III DEFICIENCY; AT3D,Number Sign
613119,BRUGADA SYNDROME 6; BRGDA6,Number Sign
613120,BRUGADA SYNDROME 7; BRGDA7,Number Sign
613121,NEXILIN F-ACTIN-BINDING PROTEIN; NEXN,Asterisk
613122,"CARDIOMYOPATHY, DILATED, 1CC; CMD1CC",Number Sign
613123,BRUGADA SYNDROME 8; BRGDA8,Number Sign
613124,"HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES",
613125,NUCLEAR RECEPTOR-INTERACTING PROTEIN 3; NRIP3,Asterisk
613126,PROLINE/SERINE-RICH COILED-COIL PROTEIN 1; PSRC1,Asterisk
613127,CHORDIN-LIKE 2; CHRDL2,Asterisk
613128,"STN1, CST COMPLEX SUBUNIT; STN1",Asterisk
613129,CONSERVED TELOMERE MAINTENANCE COMPONENT 1; CTC1,Asterisk
613130,"TEN1, CST COMPLEX SUBUNIT; TEN1",Asterisk
613131,MICRO RNA 449A; MIR449A,Asterisk
613132,MICRO RNA 449B; MIR449B,Asterisk
613133,TETRASPANIN 2; TSPAN2,Asterisk
613134,TETRASPANIN 3; TSPAN3,Asterisk
613135,"PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1",Number Sign
613136,TETRASPANIN 5; TSPAN5,Asterisk
613137,TETRASPANIN 9; TSPAN9,Asterisk
613138,TETRASPANIN 12; TSPAN12,Asterisk
613139,TETRASPANIN 13; TSPAN13,Asterisk
613140,TETRASPANIN 15; TSPAN15,Asterisk
613141,"DELTEX, DROSOPHILA, HOMOLOG OF, 2; DTX2",Asterisk
613142,"DELTEX, DROSOPHILA, HOMOLOG OF, 3; DTX3",Asterisk
613143,DTX3-LIKE; DTX3L,Asterisk
613144,"CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 3; CACD3",Percent
613145,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14; SLEB14",Percent
613146,MICRO RNA 184; MIR184,Asterisk
613147,MICRO RNA 205; MIR205,Asterisk
613148,"INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28",Number Sign
613149,CDKN2B ANTISENSE RNA; CDKN2BAS,Asterisk
613150,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2",Number Sign
613151,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3; MDDGB3",Number Sign
613152,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4; MDDGB4",Number Sign
613153,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5",Number Sign
613154,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6",Number Sign
613155,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1",Number Sign
613156,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2; MDDGB2",Number Sign
613157,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3",Number Sign
613158,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2",Number Sign
613159,NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1,Number Sign
613160,VON WILLEBRAND FACTOR; VWF,Asterisk
613161,BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D,Number Sign
613162,"SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45",Number Sign
613163,GABA-TRANSAMINASE DEFICIENCY,Number Sign
613164,PARKINSON DISEASE 16; PARK16,Percent
613165,CALCIUM-ACTIVATED NUCLEOTIDASE 1; CANT1,Asterisk
613166,DOUBLECORTIN-LIKE KINASE 2; DCLK2,Asterisk
613167,DOUBLECORTIN-LIKE KINASE 3; DCLK3,Asterisk
613168,"SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 2; SERPINF2",Asterisk
613169,KELCH DOMAIN-CONTAINING PROTEIN 8B; KLHDC8B,Asterisk
613170,TETRASPANIN 1; TSPAN1,Asterisk
613171,RNA-BINDING MOTIF PROTEIN 20; RBM20,Asterisk
613172,"CARDIOMYOPATHY, DILATED, 1DD; CMD1DD",Number Sign
613173,NEURONAL GROWTH REGULATOR 1; NEGR1,Asterisk
613174,CHROMOSOME 5p13 DUPLICATION SYNDROME,Number Sign
613175,SMG8 NONSENSE MEDIATED mRNA DECAY FACTOR; SMG8,Asterisk
613176,SMG9 NONSENSE-MEDIATED mRNA DECAY FACTOR; SMG9,Asterisk
613177,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C",Number Sign
613178,KIAA0427 GENE; KIAA0427,Asterisk
613179,PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY,Number Sign
613180,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 8; CDCBM8",Number Sign
613181,"BolA, E. COLI, HOMOLOG OF, 1; BOLA1",Asterisk
613182,"BolA, E. COLI, HOMOLOG OF, 2; BOLA2",Asterisk
613183,"BolA, E. COLI, HOMOLOG OF, 3; BOLA3",Asterisk
613184,TRIPARTITE MOTIF-CONTAINING PROTEIN 68; TRIM68,Asterisk
613185,MICRO RNA 95; MIR95,Asterisk
613186,MICRO RNA 100; MIR100,Asterisk
613187,MICRO RNA 103-1; MIR103-1,Asterisk
613188,MICRO RNA 103-2; MIR103-2,Asterisk
613189,MICRO RNA 107; MIR107,Asterisk
613190,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 1; DNAAF1",Asterisk
613191,DUAL-SPECIFICITY PHOSPHATASE 13; DUSP13,Asterisk
613192,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13",Number Sign
613193,"CILIARY DYSKINESIA, PRIMARY, 13; CILD13",Number Sign
613194,RETINITIS PIGMENTOSA 50; RP50,Number Sign
613195,WEILL-MARCHESANI SYNDROME 4; WMS4,Number Sign
613196,EWING TUMOR-ASSOCIATED ANTIGEN 1; ETAA1,Asterisk
613197,TRAF-TYPE ZINC FINGER DOMAIN-CONTAINING 1; TRAFD1,Asterisk
613198,"SUPPRESSOR OF VARIEGATION 4-20, DROSOPHILA, HOMOLOG OF, 2; SUV420H2",Asterisk
613199,TAO KINASE 2; TAOK2,Asterisk
613200,"PDS5, REGULATOR OF COHESION MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, A; PDS5A",Asterisk
613201,"CHROMOSOME TRANSMISSION FIDELITY FACTOR 18, S. CEREVISIAE, HOMOLOG OF; CHTF18",Asterisk
613202,"CHROMOSOME TRANSMISSION FIDELITY FACTOR 8, S. CEREVISIAE, HOMOLOG OF; CHTF8",Asterisk
613203,"DEFECTIVE IN SISTER CHROMATID COHESION 1, S. CEREVISIAE, HOMOLOG OF; DSCC1",Asterisk
613204,"MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY",Number Sign
613205,"MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED",Number Sign
613206,"SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44",Number Sign
613207,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8; ASRT8",Percent
613208,XPC GENE; XPC,Asterisk
613209,TRANSMEMBRANE PROTEIN 181; TMEM181,Asterisk
613210,WD REPEAT-CONTAINING PROTEIN 85; WDR85,Asterisk
613211,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3",Number Sign
613212,ALANYL-tRNA SYNTHETASE DOMAIN-CONTAINING 1; AARSD1,Asterisk
613213,CYTOCHROME b5 REDUCTASE 3; CYB5R3,Asterisk
613214,WD REPEAT-CONTAINING PROTEIN 72; WDR72,Asterisk
613215,"CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME",Number Sign
613216,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C",Number Sign
613217,"DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5",Number Sign
613218,"CYTOCHROME b5, TYPE A (MICROSOMAL); CYB5A",Asterisk
613219,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2; FGQTL2,Percent
613220,TRANSMEMBRANE PROTEIN 18; TMEM18,Asterisk
613221,MITOCHONDRIAL CARRIER HOMOLOG 2; MTCH2,Asterisk
613222,GLUCOSAMINE-6-PHOSPHATE DEAMINASE 2; GNPDA2,Asterisk
613223,"LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5",Number Sign
613224,NOONAN SYNDROME 6; NS6,Number Sign
613225,"FACTOR XIII, A SUBUNIT, DEFICIENCY OF",Number Sign
613226,ZINC FINGER PROTEIN 296; ZNF296,Asterisk
613227,"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3",Number Sign
613228,ASPARTYLGLUCOSAMINIDASE; AGA,Asterisk
613229,TRICHOTILLOMANIA; TTM,Number Sign
613230,PEPTIDASE D; PEPD,Asterisk
613231,KINESIN FAMILY MEMBER 26A; KIF26A,Asterisk
613232,RNA-BINDING MOTIF PROTEIN 42; RBM42,Asterisk
613233,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3; FGQTL3,Percent
613234,NEUTRAL CHOLESTEROL ESTER HYDROLASE 1; NCEH1,Asterisk
613235,"FACTOR XIII, B SUBUNIT, DEFICIENCY OF",Number Sign
613236,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 18; KCNJ18",Asterisk
613237,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5,Number Sign
613238,"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3; SPDA3",Percent
613239,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2",Number Sign
613240,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1C; PPP1R1C",Asterisk
613241,PSEUDOPILI ANNULATI,
613242,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14C; PPP1R14C",Asterisk
613243,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13",Number Sign
613244,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8",Number Sign
613245,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12C; PPP1R12C",Asterisk
613246,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1A; PPP1R1A",Asterisk
613247,PERILIPIN 4; PLIN4,Asterisk
613248,PERILIPIN 5; PLIN5,Asterisk
613249,ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 1; EBLN1,Asterisk
613250,ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 2; EBLN2,Asterisk
613251,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14",Number Sign
613252,"CARDIOMYOPATHY, DILATED, 1EE; CMD1EE",Number Sign
613253,MOVED TO 603046,Caret
613254,TUBEROUS SCLEROSIS 2; TSC2,Number Sign
613255,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15",Number Sign
613256,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14D; PPP1R14D",Asterisk
613257,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15B; PPP1R15B",Asterisk
613258,CHROMOSOME 18 OPEN READING FRAME 54; C18ORF54,Asterisk
613259,REPETIN; RPTN,Asterisk
613260,KERATINOCYTE PROLINE-RICH PROTEIN; KPRP,Asterisk
613261,"PROTOGENIN, CHICKEN, HOMOLOG OF; PRTG",Asterisk
613262,RIBOSOMAL PROTEIN L24 DOMAIN-CONTAINING PROTEIN 1; RSL24D1,Asterisk
613263,SMALL NUCLEOLAR RNA HOST GENE 5; SNHG5,Asterisk
613264,"SMALL NUCLEOLAR RNA, C/D BOX; SNORD50B",Asterisk
613265,"WAARDENBURG SYNDROME, TYPE 4B; WS4B",Number Sign
613266,"WAARDENBURG SYNDROME, TYPE 4C; WS4C",Number Sign
613267,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3",Number Sign
613268,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4",Number Sign
613269,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5; FECD5",Percent
613270,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6",Number Sign
613271,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7; FECD7",Percent
613272,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 3; KCTD3,Asterisk
613273,INST3- AND NABP-INTERACTING PROTEIN; INIP,Asterisk
613274,MOLYBDENUM COFACTOR SULFURASE; MOCOS,Asterisk
613275,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16B; PPP1R16B",Asterisk
613276,U6 SMALL NUCLEAR RNA BIOGENESIS PHOSPHODIESTERASE 1; USB1,Asterisk
613277,TRANSMEMBRANE PROTEIN 216; TMEM216,Asterisk
613278,"SLX4, S. CEREVISIAE, HOMOLOG OF; SLX4",Asterisk
613279,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 14: ZC3H14,Asterisk
613280,HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1,Number Sign
613281,SORTING NEXIN 20; SNX20,Asterisk
613282,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1",Percent
613283,"GLUTAREDOXIN, CYSTEINE-RICH, 1; GRXCR1",Asterisk
613284,HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3,Percent
613285,"DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25",Number Sign
613286,"CARDIOMYOPATHY, DILATED, 1FF; CMD1FF",Number Sign
613287,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N",Number Sign
613288,TRIPARTITE MOTIF-CONTAINING PROTEIN 72; TRIM72,Asterisk
613289,ATAXIN 8; ATXN8,Asterisk
613290,"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO; CIHL",Percent
613291,"BILE ACID MALABSORPTION, PRIMARY; PBAM",Number Sign
613292,DENN/MADD DOMAIN-CONTAINING PROTEIN 1B; DENND1B,Asterisk
613293,SH3 AND PX DOMAINS-CONTAINING PROTEIN 2B; SH3PXD2B,Asterisk
613294,"SUMO1-ACTIVATING ENZYME, SUBUNIT 1; SAE1",Asterisk
613295,UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 2; UBA2,Asterisk
613296,"LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 4, BETA; LAPTM4B",Asterisk
613297,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 6; MARCH6,Asterisk
613298,TOPBP1-INTERACTING CHECKPOINT AND REPLICATION REGULATOR; TICRR,Asterisk
613299,"FAMILY WITH SEQUENCE SIMILARITY 13, MEMBER A; FAM13A",Asterisk
613300,FAM13A OPPOSITE STRAND; FAM13AOS,Asterisk
613301,FEZ FAMILY ZINC FINGER PROTEIN 1; FEZF1,Asterisk
613302,"AlkB, E. COLI, HOMOLOG OF, 4; ALKBH4",Asterisk
613303,"AlkB, E. COLI, HOMOLOG OF, 5; ALKBH5",Asterisk
613304,"AlkB, E. COLI, HOMOLOG OF, 6; ALKBH6",Asterisk
613305,"AlkB, E. COLI, HOMOLOG OF, 7; ALKBH7",Asterisk
613306,"AlkB, E. COLI, HOMOLOG OF, 8; ALKBH8",Asterisk
613307,"DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79",Number Sign
613308,DIAMOND-BLACKFAN ANEMIA 9; DBA9,Number Sign
613309,DIAMOND-BLACKFAN ANEMIA 10; DBA10,Number Sign
613310,EXUDATIVE VITREORETINOPATHY 5; EVR5,Number Sign
613311,LYR MOTIF-CONTAINING PROTEIN 4; LYRM4,Asterisk
613312,"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2",Number Sign
613313,"HEMOCHROMATOSIS, TYPE 2B; HFE2B",Number Sign
613314,RIBOSOMAL PROTEIN L37A; RPL37A,Asterisk
613315,RIBOSOMAL PROTEIN L41; RPL41,Asterisk
613316,WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 4; WDFY4,Asterisk
613317,DDB1- AND CUL4-ASSOCIATED FACTOR 11; DCAF11,Asterisk
613318,MIYOSHI MUSCULAR DYSTROPHY 2; MMD2,Percent
613319,MIYOSHI MUSCULAR DYSTROPHY 3; MMD3,Number Sign
613320,"SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM",Number Sign
613321,GLUCOSIDE XYLOSYLTRANSFERASE 1; GXYLT1,Asterisk
613322,GLUCOSIDE XYLOSYLTRANSFERASE 2; GXYLT2,Asterisk
613323,FERM AND PDZ DOMAINS-CONTAINING PROTEIN 2; FRMPD2,Asterisk
613324,SPERMATOGENESIS-ASSOCIATED PROTEIN 13; SPATA13,Asterisk
613325,RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2,Number Sign
613326,DIHYDROPYRIMIDINASE; DPYS,Asterisk
613327,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4",Number Sign
613328,ROIFMAN-CHITAYAT SYNDROME,
613329,PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY,Number Sign
613330,SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD,Number Sign
613331,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 1; MARCH1,Asterisk
613332,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 2; MARCH2,Asterisk
613333,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 3; MARCH3,Asterisk
613334,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 7; MARCH7,Asterisk
613335,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 8; MARCH8,Asterisk
613336,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 9; MARCH9,Asterisk
613337,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 10; MARCH10,Asterisk
613338,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 11; MARCH11,Asterisk
613339,"EPILEPSY, HOT WATER, 1; HWE1",Percent
613340,"EPILEPSY, HOT WATER, 2; HWE2",Percent
613341,LEBER CONGENITAL AMAUROSIS 14; LCA14,Number Sign
613342,MSELENI JOINT DISEASE,
613343,HANDIGODU JOINT DISEASE,Percent
613344,KIAA1549 GENE; KIAA1549,Asterisk
613345,"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2",Number Sign
613346,"SHISA FAMILY, MEMBER 9; SHISA9",Asterisk
613347,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 2",Number Sign
613348,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 3",Number Sign
613349,ORNITHINE AMINOTRANSFERASE; OAT,Asterisk
613350,"SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 3; SLC52A3",Asterisk
613351,RHO GTPase-ACTIVATING PROTEIN 18; ARHGAP18,Asterisk
613352,ARGININE/SERINE-RICH COILED-COIL PROTEIN 1; RSRC1,Asterisk
613353,"MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN",Number Sign
613354,TAPERIN; TPRN,Asterisk
613355,CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME,Number Sign
613356,TLR4 INTERACTOR WITH LEUCINE-RICH REPEATS; TRIL,Asterisk
613357,FIBRINOGEN C DOMAIN-CONTAINING PROTEIN 1; FIBCD1,Asterisk
613358,"ALDEHYDE DEHYDROGENASE 16 FAMILY, MEMBER A1; ALDH16A1",Asterisk
613359,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 6; LYPD6,Asterisk
613360,DAMAGE-REGULATED AUTOPHAGY MODULATOR 2; DRAM2,Asterisk
613361,"SOLUTE CARRIER FAMILY 18, MEMBER B1; SLC18B1",Asterisk
613362,CDK2-INTERACTING PROTEIN; CINP,Asterisk
613363,WD REPEAT-CONTAINING PROTEIN 34; WDR34,Asterisk
613364,"SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41",Percent
613365,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 6A1; SLCO6A1",Asterisk
613366,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 6; SLC10A6",Asterisk
613367,"LIN54, C. ELEGANS, HOMOLOG OF; LIN54",Asterisk
613368,CARNOSINE SYNTHASE 1; CARNS1,Asterisk
613369,DEAD BOX HELICASE 42; DDX42,Asterisk
613370,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10",Number Sign
613371,SPINOCEREBELLAR ATAXIA 30; SCA30,Percent
613372,UFM1-SPECIFIC LIGASE 1; UFL1,Asterisk
613373,YEATS DOMAIN-CONTAINING PROTEIN 2; YEATS2,Asterisk
613374,COILED-COIL DOMAIN-CONTAINING PROTEIN 101; CCDC101,Asterisk
613375,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11",Number Sign
613376,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C",Number Sign
613377,SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 2; SH3RF2,Asterisk
613378,AIG2-LIKE DOMAIN-CONTAINING PROTEIN 1; A2LD1,Asterisk
613379,CARBOXYMETHYLENEBUTENOLIDASE-LIKE PROTEIN; CMBL,Asterisk
613380,H6 FAMILY HOMEOBOX 3; HMX3,Asterisk
613381,CYSTATHIONINE BETA-SYNTHASE; CBS,Asterisk
613382,"BRACHYDACTYLY, TYPE E2; BDE2",Number Sign
613383,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 54; ANKRD54,Asterisk
613384,CYCLIN L1; CCNL1,Asterisk
613385,"AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD",Number Sign
613386,PROTEASOME MATURATION PROTEIN; POMP,Asterisk
613387,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2",Percent
613388,FANCONI RENOTUBULAR SYNDROME 2; FRTS2,Number Sign
613389,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1C1; SLCO1C1",Asterisk
613390,"FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO",Number Sign
613391,"DEAFNESS, AUTOSOMAL RECESSIVE 84A; DFNB84A",Number Sign
613392,"DEAFNESS, AUTOSOMAL RECESSIVE 85; DFNB85",Percent
613393,BIRBECK GRANULE DEFICIENCY,Number Sign
613394,MICRO RNA 138-1; MIR138-1,Asterisk
613395,MICRO RNA 138-2; MIR138-2,Asterisk
613396,DOWN SYNDROME CRITICAL REGION GENE 8; DSCR8,Asterisk
613397,ADVILLIN; AVIL,Asterisk
613398,WARSAW BREAKAGE SYNDROME; WABS,Number Sign
613399,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3",Number Sign
613400,ACIREDUCTONE DIOXYGENASE 1; ADI1,Asterisk
613401,"VPS33B-INTERACTING PROTEIN, APICAL-BASOLATERAL POLARITY REGULATOR, SPE39 HOMOLOG; VIPAS39",Asterisk
613402,"MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ",Number Sign
613403,TRANSMEMBRANE PROTEIN 127; TMEM127,Asterisk
613404,"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2",Number Sign
613405,MICRO RNA 2861; MIR2861,Asterisk
613406,WITTEVEEN-KOLK SYNDROME; WITKOS,Number Sign
613407,"LEPROSY, SUSCEPTIBILITY TO, 6; LPRS6",Percent
613408,COILED-COIL DOMAIN-CONTAINING PROTEIN 122; CCDC122,Asterisk
613409,LACCASE (MULTICOPPER REDUCTASE) DOMAIN-CONTAINING PROTEIN 1; LACC1,Asterisk
613410,"AUTISM, SUSCEPTIBILITY TO, 16; AUTS16",Number Sign
613411,OGUCHI DISEASE 2,Number Sign
613412,"ESOPHAGITIS, EOSINOPHILIC, 2; EOE2",Percent
613413,TRANSMEMBRANE PROTEIN 106B; TMEM106B,Asterisk
613414,INTERLEUKIN 17 RECEPTOR E-LIKE; IL17REL,Asterisk
613415,"CREATINE KINASE, MITOCHONDRIAL 1A; CKMT1A",Asterisk
613416,SCINDERIN; SCIN,Asterisk
613417,"FAMILY WITH SEQUENCE SIMILARITY 48, MEMBER A; FAM48A",Asterisk
613418,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15,Number Sign
613419,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 4; ZSCAN4,Asterisk
613420,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 1; KCTD1,Asterisk
613421,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 10; KCTD10,Asterisk
613422,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 2; KCTD2,Asterisk
613423,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 16; KCTD16,Asterisk
613424,"CARDIOMYOPATHY, DILATED, 1R; CMD1R",Number Sign
613425,CHROMOSOME 2 OPEN READING FRAME 71; C2ORF71,Asterisk
613426,"CARDIOMYOPATHY, DILATED, 1S; CMD1S",Number Sign
613427,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 16; ANAPC16",Asterisk
613428,RETINITIS PIGMENTOSA 54; RP54,Number Sign
613429,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 2; HAUS2",Asterisk
613430,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 3; HAUS3",Asterisk
613431,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 4; HAUS4",Asterisk
613432,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 5; HAUS5",Asterisk
613433,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 6; HAUS6",Asterisk
613434,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 8; HAUS8",Asterisk
613435,AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12,Number Sign
613436,"AUTISM, SUSCEPTIBILITY TO, 17; AUTS17",Number Sign
613437,FCH DOMAIN ONLY PROTEIN 1; FCHO1,Asterisk
613438,FCH DOMAIN ONLY PROTEIN 2; FCHO2,Asterisk
613439,CONSORTIN; CNST,Asterisk
613440,STATURE QUANTITATIVE TRAIT LOCUS 21; STQTL21,Percent
613441,TRANSCOBALAMIN II; TCN2,Asterisk
613442,"PENTRAXIN 4, LONG; PTX4",Asterisk
613443,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; MRD20",Number Sign
613444,"CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB",Number Sign
613445,MOVED TO 600642,Caret
613446,"CENTROSOMAL PROTEIN, 120-KD; CEP120",Asterisk
613447,SPINDLE- AND CENTRIOLE-ASSOCIATED PROTEIN 1; SPICE1,Asterisk
613448,MITOTIC SPINDLE ORGANIZING PROTEIN 1; MZT1,Asterisk
613449,"FAMILY WITH SEQUENCE SIMILARITY 128, MEMBER A; FAM128A",Asterisk
613450,"FAMILY WITH SEQUENCE SIMILARITY 128, MEMBER B; FAM128B",Asterisk
613451,FRONTONASAL DYSPLASIA 2; FND2,Number Sign
613452,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT GAMMA; CATSPERG",Asterisk
613453,"DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91",Number Sign
613454,"RETT SYNDROME, CONGENITAL VARIANT",Number Sign
613455,"MELANOMA INHIBITORY ACTIVITY FAMILY, MEMBER 3; MIA3",Asterisk
613456,FRONTONASAL DYSPLASIA 3; FND3,Number Sign
613457,CHROMOSOME 14q11-q22 DELETION SYNDROME,Number Sign
613458,CHROMOSOME 16p13.3 DUPLICATION SYNDROME,Number Sign
613459,BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 2; BWQTL2,Percent
613460,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 6; FGQTL6,Percent
613461,LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT; LEPROT,Asterisk
613462,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 4; FGQTL4,Percent
613463,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5,Number Sign
613464,RETINITIS PIGMENTOSA 51; RP51,Number Sign
613465,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 7; NME7,Asterisk
613466,PREFOLDIN 2; PFDN2,Asterisk
613467,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 6; ZCCHC6,Asterisk
613468,N-ACYLSPHINGOSINE AMIDOHYDROLASE 1; ASAH1,Asterisk
613469,HEPARANASE 2; HPSE2,Asterisk
613470,"HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY",Number Sign
613471,REYNOLDS SYNDROME,Number Sign
613472,UNC51-LIKE KINASE 3; ULK3,Asterisk
613473,WD REPEAT-CONTAINING PROTEIN 7; WDR7,Asterisk
613474,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2B; ZFAND2B,Asterisk
613475,"RIBOSOMAL RNA-PROCESSING FACTOR, 36-KD, S. CEREVISIAE, HOMOLOG OF; RRP36",Asterisk
613476,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 6; MFSD6,Asterisk
613477,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5",Number Sign
613478,COILED-COIL DOMAIN-CONTAINING PROTEIN 106; CCDC106,Asterisk
613479,"5-AZACYTIDINE-INDUCED GENE 1, MOUSE, HOMOLOG OF; AZI1",Asterisk
613480,"LYMPHEDEMA, HEREDITARY, IC; LMPH1C",Number Sign
613481,COILED-COIL DOMAIN-CONTAINING PROTEIN 62: CCDC62,Asterisk
613482,CYCLIN L2; CCNL2,Asterisk
613483,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E22; BHLHE22",Asterisk
613484,"SPEN, DROSOPHILA, HOMOLOG OF; SPEN",Asterisk
613485,LONG QT SYNDROME 13; LQT13,Number Sign
613486,MICRO RNA 33B; MIR33B,Asterisk
613487,MICRO RNA 212; MIR212,Asterisk
613488,MYXOID LIPOSARCOMA,Number Sign
613489,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J",Number Sign
613490,ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD,Number Sign
613491,ALKALINE CERAMIDASE 1; ACER1,Asterisk
613492,ALKALINE CERAMIDASE 2; ACER2,Asterisk
613493,"IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3",Number Sign
613494,"IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4",Number Sign
613495,"IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5",Number Sign
613496,"IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6",Number Sign
613497,"LIPASE A, LYSOSOMAL ACID; LIPA",Asterisk
613498,SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS; SXGQTL1,Percent
613499,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER A; HIST1H2AA",Asterisk
613500,"AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2",Number Sign
613501,"AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3",Number Sign
613502,"AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4",Number Sign
613503,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-2; HLA-DQA2",Asterisk
613504,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 21; ZFYVE21,Asterisk
613505,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 26; LRRC26,Asterisk
613506,"AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5",Number Sign
613507,GLYCOGEN STORAGE DISEASE XV; GSD15,Number Sign
613508,SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1,Number Sign
613509,CHROMOSOME 4q21 DELETION SYNDROME,Number Sign
613510,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 1; LAMTOR1",Asterisk
613511,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 9; SPINK9",Asterisk
613512,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 6; ZBED6,Asterisk
613513,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 11A; ZC3H11A,Asterisk
613514,ZONA PELLUCIDA GLYCOPROTEIN 4; ZP4,Asterisk
613515,"AUTOPHAGY 14, S. CEREVISIAE, HOMOLOG OF; ATG14",Asterisk
613516,RUN DOMAIN- AND CYSTEINE-RICH DOMAIN-CONTAINING BECLIN-1-INTERACTING PROTEIN; RUBCN,Asterisk
613517,"MICROPHTHALMIA, ISOLATED 6; MCOP6",Number Sign
613518,"DERMATITIS, ATOPIC, 8; ATOD8",Percent
613519,"DERMATITIS, ATOPIC, 9; ATOD9",Percent
613520,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 6; FGD6",Asterisk
613521,UROPORPHYRINOGEN DECARBOXYLASE; UROD,Asterisk
613522,"OPSIN 1, SHORT-WAVE-SENSITIVE; OPN1SW",Asterisk
613523,CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME,Number Sign
613524,SEROLOGICALLY DEFINED COLON CANCER ANTIGEN 8; SDCCAG8,Asterisk
613525,SEEK1 GENE,Asterisk
613526,SPR1 GENE,Asterisk
613527,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 27; DNAJC27",Asterisk
613528,SYNAPTOTAGMIN 9; SYT9,Asterisk
613529,"CENTROSOMAL PROTEIN, 152-KD; CEP152",Asterisk
613530,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H",Percent
613531,PHOSPHATASE AND TENSIN HOMOLOG PSEUDOGENE; PTENP1,Asterisk
613532,RAS-ASSOCIATED PROTEIN RAB8B; RAB8B,Asterisk
613533,CHROMOSOME 17q21.31 DUPLICATION SYNDROME,Number Sign
613534,FANCD2/FANCI-ASSOCIATED NUCLEASE 1; FAN1,Asterisk
613535,KIAA0319-LIKE; KIAA0319L,Asterisk
613536,"LEUCINE-, GLUTAMATE-, AND LYSINE-RICH PROTEIN 1; LEKR1",Asterisk
613537,"NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 5; NLRC5",Asterisk
613538,"FEM1, C. ELEGANS, HOMOLOG OF, A; FEM1A",Asterisk
613539,"FEM1, C. ELEGANS, HOMOLOG OF, B; FEM1B",Asterisk
613540,"SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, A; SPTSSA",Asterisk
613541,CHROMOSOME 12 OPEN READING FRAME 65; C12ORF65,Asterisk
613542,MITOCHONDRIAL TRANSLATIONAL RELEASE FACTOR 1-LIKE; MTRF1L,Asterisk
613543,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 5A1; SLCO5A1",Asterisk
613544,CHROMOSOME 6q11-q14 DELETION SYNDROME,Number Sign
613545,"MACROSTOMIA, ISOLATED",Percent
613546,AROMATASE DEFICIENCY,Number Sign
613547,STATURE QUANTITATIVE TRAIT LOCUS 22; STQTL22,Percent
613548,STATURE QUANTITATIVE TRAIT LOCUS 23; STQTL23,Percent
613549,STATURE QUANTITATIVE TRAIT LOCUS 24; STQTL24,Percent
613550,NEPHRONOPHTHISIS 11; NPHP11,Number Sign
613551,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6",Number Sign
613552,GAMMA-SECRETASE-ACTIVATING PROTEIN; GSAP,Asterisk
613553,X-PROLYL AMINOPEPTIDASE 3; XPNPEP3,Asterisk
613554,"VON WILLEBRAND DISEASE, TYPE 2; VWD2",Number Sign
613555,"TET ONCOGENE FAMILY, MEMBER 3; TET3",Asterisk
613556,MICRO RNA 659; MIR659,Asterisk
613557,MOVED TO 604213,Caret
613558,"DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51",Number Sign
613559,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7,Number Sign
613560,N-TERMINAL X-PRO-LYS N-METHYLTRANSFERASE 1; NTMT1,Asterisk
613561,"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2",Number Sign
613562,Fc RECEPTOR-LIKE PROTEIN 6; FCRL6,Asterisk
613563,NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL,Number Sign
613564,CHROMOSOME 2p12-p11.2 DELETION SYNDROME,Number Sign
613565,UBIQUITINATION FACTOR E4B; UBE4B,Asterisk
613566,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6,Number Sign
613567,"ZINC FINGER, MYM-TYPE 6; ZMYM6",Asterisk
613568,"ZINC FINGER, MYM-TYPE 4; ZMYM4",Asterisk
613569,SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 2; SUN2,Asterisk
613570,LIPID DROPLET ASSOCIATED HYDROLASE; LDAH,Asterisk
613571,DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY,Number Sign
613572,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 6, MEMBER A; GPRC6A",Asterisk
613573,ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1,Number Sign
613574,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 39B; TTC39B,Asterisk
613575,RETINITIS PIGMENTOSA 55; RP55,Number Sign
613576,ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2,Percent
613577,"TBC1 DOMAIN FAMILY, MEMBER 24; TBC1D24",Asterisk
613578,"PROTEASE, SERINE, 3; PRSS3",Asterisk
613579,"C-TYPE LECTIN DOMAIN FAMILY 6, MEMBER A; CLEC6A",Asterisk
613580,WD REPEAT-CONTAINING PLANAR CELL POLARITY EFFECTOR; WDPCP,Asterisk
613581,RETINITIS PIGMENTOSA 56; RP56,Number Sign
613582,RETINITIS PIGMENTOSA 57; RP57,Number Sign
613583,WD REPEAT-CONTAINING PROTEIN 62; WDR62,Asterisk
613584,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L2; ALDH1L2",Asterisk
613585,TRANSMEMBRANE PROTEIN 147; TMEM147,Asterisk
613586,"NIN1/RPN12-BINDING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF; NOB1",Asterisk
613587,OCCULT MACULAR DYSTROPHY; OCMD,Number Sign
613588,"C-TYPE LECTIN DOMAIN FAMILY 3, MEMBER A; CLEC3A",Asterisk
613589,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; LDLCQ6,Number Sign
613590,"BUTYROPHILIN, SUBFAMILY 2, MEMBER A1; BTN2A1",Asterisk
613591,"BUTYROPHILIN, SUBFAMILY 2, MEMBER A2; BTN2A2",Asterisk
613592,"BUTYROPHILIN, SUBFAMILY 2, MEMBER A3; BTN2A3",Asterisk
613593,"BUTYROPHILIN, SUBFAMILY 3, MEMBER A1; BTN3A1",Asterisk
613594,"BUTYROPHILIN, SUBFAMILY 3, MEMBER A2; BTN3A2",Asterisk
613595,"BUTYROPHILIN, SUBFAMILY 3, MEMBER A3; BTN3A3",Asterisk
613596,"FAMILY WITH SEQUENCE SIMILARITY 161, MEMBER A; FAM161A",Asterisk
613597,4-HYDROXY-2-OXOGLUTARATE ALDOLASE 1; HOGA1,Asterisk
613598,ZINC FINGER PROTEIN 513; ZNF513,Asterisk
613599,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 12; ABHD12,Asterisk
613600,"TORSADE DE POINTES, SHORT-COUPLED VARIANT",
613601,EARLY REPOLARIZATION ASSOCIATED WITH VENTRICULAR FIBRILLATION,
613602,WD REPEAT-CONTAINING PROTEIN 35; WDR35,Asterisk
613603,CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME,Number Sign
613604,"CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB",Number Sign
613605,BBS PROTEIN COMPLEX-INTERACTING PROTEIN 1; BBIP1,Asterisk
613606,FORSYTHE-WAKELING SYNDROME; FWS,Percent
613607,THYMOCYTE SELECTION-ASSOCIATED PROTEIN; THEMIS,Asterisk
613608,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3",Percent
613609,HFE GENE; HFE,Asterisk
613610,CRANIOECTODERMAL DYSPLASIA 2; CED2,Number Sign
613611,CHOANAL ATRESIA AND LYMPHEDEMA; CATLPH,Number Sign
613612,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I",Number Sign
613613,MICRO RNA 208B; MIR208B,Asterisk
613614,MICRO RNA 499; MIR499,Asterisk
613615,SENIOR-LOKEN SYNDROME 7; SLSN7,Number Sign
613616,"HYPEROXALURIA, PRIMARY, TYPE III; HP3",Number Sign
613617,RETINITIS PIGMENTOSA 58; RP58,Number Sign
613618,CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME,Number Sign
613619,"SCAVENGER RECEPTOR CLASS F, MEMBER 2; SCARF2",Asterisk
613620,"TBC1 DOMAIN FAMILY, MEMBER 10B; TBC1D10B",Asterisk
613621,NUCLEOTIDE-BINDING PROTEIN-LIKE PROTEIN; NUBPL,Asterisk
613622,FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1; FOXRED1,Asterisk
613623,AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA,
613624,ZINC FINGER PROTEIN 592; ZNF592,Asterisk
613625,"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2",Number Sign
613626,MOVED TO 255500,Caret
613627,"BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY, PTOSIS, HEARING LOSS, AND MENTAL RETARDATION",
613628,ODONTOID HYPOPLASIA,Percent
613629,PIEZO-TYPE MECHANOSENSITIVE ION CHANNEL COMPONENT 2; PIEZO2,Asterisk
613630,COCOON SYNDROME,Number Sign
613631,"WASH COMPLEX, SUBUNIT 2C; WASHC2C",Asterisk
613632,"WASH COMPLEX, SUBUNIT 1; WASHC1",Asterisk
613633,DENN/MADD DOMAIN-CONTAINING PROTEIN 1A; DENND1A,Asterisk
613634,DENN/MADD DOMAIN-CONTAINING PROTEIN 1C; DENND1C,Asterisk
613635,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 1; EIF2AK1,Asterisk
613636,"TUBERCULIN SKIN TEST REACTIVITY, ABSENCE OF",Percent
613637,TUBERCULIN SKIN TEST REACTIVITY QUANTITATIVE TRAIT LOCUS,Percent
613638,CHROMOSOME 19p13.13 DELETION SYNDROME,Number Sign
613639,ADHESION G PROTEIN-COUPLED RECEPTOR D1; ADGRD1,Asterisk
613640,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C",Number Sign
613641,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB",Number Sign
613642,"CARDIOMYOPATHY, DILATED, 1GG; CMD1GG",Number Sign
613643,"PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK5",Number Sign
613644,ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN; ATF7IP,Asterisk
613645,ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN 2; ATF7IP2,Asterisk
613646,"METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT",Number Sign
613647,"SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48",Number Sign
613648,MATERNALLY EXPRESSED GENE 8; MEG8,Asterisk
613649,"SMALL NUCLEOLAR RNA, C/D BOX, 112; SNORD112",Asterisk
613650,"SMALL NUCLEOLAR RNA, C/D BOX, 113-1; SNORD113-1",Asterisk
613651,"SMALL NUCLEOLAR RNA, C/D BOX, 114-1; SNORD114-1",Asterisk
613652,C1q DEFICIENCY; C1QD,Number Sign
613653,"ADAPTOR-RELATED PROTEIN COMPLEX 5, ZETA-1 SUBUNIT; AP5Z1",Asterisk
613654,MICRO RNA 380; MIR380,Asterisk
613655,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 18; KCNK18",Asterisk
613656,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13",Number Sign
613657,D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2,Number Sign
613658,RAJAB SYNDROME,Percent
613659,GASTRIC CANCER,Number Sign
613660,CONE-ROD DYSTROPHY 15; CORD15,Number Sign
613661,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P",Number Sign
613662,MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B,Number Sign
613663,"SHQ1, S. CEREVISIAE, HOMOLOG OF; SHQ1",Asterisk
613664,SMOOTHELIN-LIKE 1; SMTNL1,Asterisk
613665,ATYPICAL CHEMOKINE RECEPTOR 1; ACKR1,Asterisk
613666,"ALG11, S. CEREVISIAE, HOMOLOG OF; ALG11",Asterisk
613667,"SINE OCULIS-BINDING PROTEIN, DROSOPHILA, HOMOLOG OF; SOBP",Asterisk
613668,"MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY",Number Sign
613669,MITOCHONDRIAL POLY(A) POLYMERASE; MTPAP,Asterisk
613670,MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES,Number Sign
613671,"MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS",Number Sign
613672,"SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4",Number Sign
613673,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV; CDAN4",Number Sign
613674,VESICOURETERAL REFLUX 3; VUR3,Number Sign
613675,"CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB",Number Sign
613676,SECKEL SYNDROME 4; SCKL4,Number Sign
613677,"HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3",Number Sign
613678,BRACHYOLMIA TYPE 2; BCYM2,Percent
613679,"PROTHROMBIN DEFICIENCY, CONGENITAL",Number Sign
613680,BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS,Number Sign
613681,CHROMOSOME 2q31.1 DUPLICATION SYNDROME,Number Sign
613682,MICRO RNA 130B; MIR130B,Asterisk
613683,"SOLUTE CARRIER FAMILY 50 (SUGAR TRANSPORTER), MEMBER 1; SLC50A1",Asterisk
613684,RUBINSTEIN-TAYBI SYNDROME 2; RSTS2,Number Sign
613685,"DEAFNESS, AUTOSOMAL RECESSIVE 83; DFNB83",Percent
613686,"SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4",Number Sign
613687,PARP1-BINDING PROTEIN; PARPBP,Asterisk
613688,LONG QT SYNDROME 2; LQT2,Number Sign
613689,MAMMARY-DIGITAL-NAIL SYNDROME; MDNS,Percent
613690,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7",Number Sign
613691,GRAM DOMAIN-CONTAINING PROTEIN 4; GRAMD4,Asterisk
613692,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 11; ZCCHC11,Asterisk
613693,LONG QT SYNDROME 6; LQT6,Number Sign
613694,"CARDIOMYOPATHY, DILATED, 1U; CMD1U",Number Sign
613695,LONG QT SYNDROME 5; LQT5,Number Sign
613696,UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I)-LIKE 1; UBTFL1,Asterisk
613697,"CARDIOMYOPATHY, DILATED, 1V; CMD1V",Number Sign
613698,"SOLUTE CARRIER FAMILY 25 (CARNITINE/ACYLCARNITINE TRANSLOCASE), MEMBER 20; SLC25A20",Asterisk
613699,GLYCOSYLTRANSFERASE 6 DOMAIN-CONTAINING 1; GLT6D1,Asterisk
613700,SUPERNUMERARY DER(22)t(8;22) SYNDROME,Number Sign
613701,MICRO RNA 328; MIR328,Asterisk
613702,"KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3",Number Sign
613703,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6",Number Sign
613704,"MICROPHTHALMIA, ISOLATED 7; MCOP7",Number Sign
613705,OROFACIAL CLEFT 10; OFC10,Number Sign
613706,NOONAN SYNDROME 7; NS7,Number Sign
613707,LEOPARD SYNDROME 3; LPRD3,Number Sign
613708,"NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D",Number Sign
613709,EUKARYOTIC TRANSLATION INITIATION FACTOR 2D; EIF2D,Asterisk
613710,THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4,Number Sign
613711,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3",Number Sign
613712,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4",Number Sign
613713,PCI DOMAIN-CONTAINING PROTEIN 2; PCID2,Asterisk
613714,B7 HOMOLOG 6,Asterisk
613715,"POLYMERASE I, RNA, SUBUNIT D; POLR1D",Asterisk
613716,MICRO RNA 661; MIR661,Asterisk
613717,TREACHER COLLINS SYNDROME 2; TCS2,Number Sign
613718,"DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74",Number Sign
613719,METHIONINE SULFOXIDE REDUCTASE B3; MSRB3,Asterisk
613720,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7",Number Sign
613721,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11",Number Sign
613722,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12",Number Sign
613723,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17; LGMD17",Number Sign
613724,LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY; LKDMN,Number Sign
613725,"SOLUTE CARRIER FAMILY 25, MEMBER 17; SLC25A27",Asterisk
613726,ANOCTAMIN 10; ANO10,Asterisk
613727,KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 13; KBTBD13,Asterisk
613728,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10",Number Sign
613729,"CHROMOSOME 7q11.23 DELETION SYNDROME, DISTAL, 1.2-MB",Number Sign
613730,"HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS; HDBSCC",Number Sign
613731,RETINITIS PIGMENTOSA 4; RP4,Number Sign
613732,MOVED TO 256040,Caret
613733,MEN1 GENE; MEN1,Asterisk
613734,COILED-COIL DOMAIN-CONTAINING PROTEIN 115; CCDC115,Asterisk
613735,BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD,Number Sign
613736,"ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2",Number Sign
613737,"ACNE INVERSA, FAMILIAL, 3; ACNINV3",Number Sign
613738,ALKYLGLYCEROL MONOOXYGENASE; AGMO,Asterisk
613739,THYMOCYTE NUCLEAR PROTEIN 1; THYN1,Asterisk
613740,MOVED TO 115200,Caret
613741,"GLYCOGEN PHOSPHORYLASE, LIVER; PYGL",Asterisk
613742,"GLUCOSE-6-PHOSPHATASE, CATALYTIC; G6PC",Asterisk
613743,"ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE",Number Sign
613744,"SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51",Number Sign
613745,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 10; ANAPC10",Asterisk
613746,BREAST CANCER ANTIESTROGEN RESISTANCE 4; BCAR4,Asterisk
613747,KINESIN FAMILY MEMBER 24; KIF24,Asterisk
613748,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 3; CHCHD3,Asterisk
613749,ZINC FINGER PROTEIN 260; ZNF260,Asterisk
613750,RETINITIS PIGMENTOSA 27; RP27,Number Sign
613751,"HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4",Number Sign
613752,HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY,Number Sign
613753,MICRO RNA 211; MIR211,Asterisk
613754,RING FINGER PROTEIN 187; RNF187,Asterisk
613755,MICRO RNA 326; MIR326,Asterisk
613756,RETINITIS PIGMENTOSA 49; RP49,Number Sign
613757,"MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6",Number Sign
613758,RETINITIS PIGMENTOSA 47; RP47,Number Sign
613759,"INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS",Number Sign
613760,"SOLUTE CARRIER FAMILY 36, MEMBER 4; SLC36A4",Asterisk
613761,"MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5",Number Sign
613762,"46,XY SEX REVERSAL 6; SRXY6",Number Sign
613763,"CATARACT 16, MULTIPLE TYPES; CTRCT16",Number Sign
613764,SECRETORY CARRIER MEMBRANE PROTEIN 4; SCAMP4,Asterisk
613765,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9",Number Sign
613766,SECRETORY CARRIER MEMBRANE PROTEIN 5; SCAMP5,Asterisk
613767,RETINITIS PIGMENTOSA 45; RP45,Number Sign
613768,RING FINGER PROTEIN 213; RNF213,Asterisk
613769,RETINITIS PIGMENTOSA 44; RP44,Number Sign
613770,PLACENTA-SPECIFIC GENE 4; PLAC4,Asterisk
613771,TRANSMEMBRANE PROTEIN 205; TMEM205,Asterisk
613772,KELCH-LIKE 14; KLHL14,Asterisk
613773,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9B; IGSF9B",Asterisk
613774,CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 1; CAMSAP1,Asterisk
613775,CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 2; CAMSAP2,Asterisk
613776,CHROMOSOME 17p13.1 DELETION SYNDROME,Number Sign
613777,FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2; FOXRED2,Asterisk
613778,"MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8",Number Sign
613779,"COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D",Number Sign
613780,"AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7",Number Sign
613781,COILED-COIL DOMAIN-CONTAINING PROTEIN 125; CCDC125,Asterisk
613782,METHIONINE SULFOXIDE REDUCTASE B2; MSRB2,Asterisk
613783,COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD,Number Sign
613784,"MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12",Number Sign
613785,"COMPLEMENT COMPONENT 1, r SUBCOMPONENT; C1R",Asterisk
613786,MICRO RNA 148A; MIR148A,Asterisk
613787,MICRO RNA 148B; MIR148B,Asterisk
613788,MICRO RNA 152; MIR152,Asterisk
613789,"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2",Number Sign
613790,"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1",Number Sign
613791,MASP2 DEFICIENCY,Number Sign
613792,CHROMOSOME 3pter-p25 DELETION SYNDROME,Number Sign
613793,"BLOOD GROUP, CROMER SYSTEM; CROM",Number Sign
613794,RETINITIS PIGMENTOSA 20; RP20,Number Sign
613795,LOEYS-DIETZ SYNDROME 3; LDS3,Number Sign
613796,IMMUNODEFICIENCY 31B; IMD31B,Number Sign
613797,"PROTEASE, SERINE, 33; PRSS33",Asterisk
613798,COILED-COIL DOMAIN-CONTAINING PROTEIN 39; CCDC39,Asterisk
613799,COILED-COIL DOMAIN-CONTAINING PROTEIN 40; CCDC40,Asterisk
613800,MEIER-GORLIN SYNDROME 2; MGORS2,Number Sign
613801,RETINITIS PIGMENTOSA 40; RP40,Number Sign
613802,MALECTIN; MLEC,Asterisk
613803,MEIER-GORLIN SYNDROME 3; MGORS3,Number Sign
613804,MEIER-GORLIN SYNDROME 4; MGORS4,Number Sign
613805,MEIER-GORLIN SYNDROME 5; MGORS5,Number Sign
613806,"CHOLANGITIS, PRIMARY SCLEROSING; PSC",Percent
613807,"CILIARY DYSKINESIA, PRIMARY, 14; CILD14",Number Sign
613808,"CILIARY DYSKINESIA, PRIMARY, 15; CILD15",Number Sign
613809,RETINITIS PIGMENTOSA 39; RP39,Number Sign
613810,RETINITIS PIGMENTOSA 43; RP43,Number Sign
613811,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D",Number Sign
613812,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3",Number Sign
613813,MOUSE DOUBLE MINUTE 1 HOMOLOG; MDM1,Asterisk
613814,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 19; TTC19,Asterisk
613815,"CYTOCHROME P450, FAMILY 21, SUBFAMILY A, POLYPEPTIDE 2; CYP21A2",Asterisk
613816,UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 7; UBR7,Asterisk
613817,SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2-LIKE; SPATS2L,Asterisk
613818,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9",Number Sign
613819,SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4,Number Sign
613820,NEPHRONOPHTHISIS 12; NPHP12,Number Sign
613821,"PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, BETA; PPP3R2",Asterisk
613822,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 2; PPP4R2",Asterisk
613823,SECKEL SYNDROME 5; SCKL5,Number Sign
613824,NEPHRONOPHTHISIS 9; NPHP9,Number Sign
613825,COMPLEMENT COMPONENT 9 DEFICIENCY; C9D,Number Sign
613826,LEBER CONGENITAL AMAUROSIS 6; LCA6,Number Sign
613827,RETINITIS PIGMENTOSA 48; RP48,Number Sign
613828,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8; GEFSP8",Percent
613829,LEBER CONGENITAL AMAUROSIS 7; LCA7,Number Sign
613830,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D",Number Sign
613831,UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 3; UBR3,Asterisk
613832,MOVED TO {607459},Caret
613833,KAT8 REGULATORY NSL COMPLEX SUBUNIT 1-LIKE PROTEIN; KANSL1L,Asterisk
613834,MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME,Number Sign
613835,LEBER CONGENITAL AMAUROSIS 8; LCA8,Number Sign
613836,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 5; ADIPQTL5",Percent
613837,LEBER CONGENITAL AMAUROSIS 11; LCA11,Number Sign
613838,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16",Number Sign
613839,MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY,Number Sign
613840,ZINC FINGER PROTEIN 304; ZNF304,Asterisk
613841,UBINUCLEIN 2; UBN2,Asterisk
613842,GDNF-INDUCIBLE ZINC FINGER PROTEIN 1; GZF1,Asterisk
613843,LEBER CONGENITAL AMAUROSIS 15; LCA15,Number Sign
613844,UBIQUINOL-CYTOCHROME C REDUCTASE HINGE PROTEIN; UQCRH,Asterisk
613845,"HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS",Number Sign
613846,"TECTONIC FAMILY, MEMBER 2; TCTN2",Asterisk
613847,"TECTONIC FAMILY, MEMBER 3; TCTN3",Asterisk
613848,"OSTEOGENESIS IMPERFECTA, TYPE X; OI10",Number Sign
613849,"OSTEOGENESIS IMPERFECTA, TYPE XII; OI12",Number Sign
613850,INOSINE TRIPHOSPHATASE DEFICIENCY,Number Sign
613851,PROLINE-RICH MEMBRANE ANCHOR 1; PRIMA1,Asterisk
613852,FUCOSYLTRANSFERASE 6 DEFICIENCY,Number Sign
613853,MOVED TO 605376,Caret
613854,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6",Number Sign
613855,"EPISODIC ATAXIA, TYPE 5; EA5",Number Sign
613856,ACHROMATOPSIA 4; ACHM4,Number Sign
613857,OROFACIAL CLEFT 13; OFC13,Percent
613858,"PROTEASE, SERINE, 56; PRSS56",Asterisk
613859,UROMODULIN-LIKE 1; UMODL1,Asterisk
613860,FICOLIN 3 DEFICIENCY,Number Sign
613861,RETINITIS PIGMENTOSA 59; RP59,Number Sign
613862,RETINITIS PIGMENTOSA 38; RP38,Number Sign
613863,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7",Number Sign
613864,ZINC FINGER PROTEIN 317; ZNF317,Asterisk
613865,"DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61",Number Sign
613866,HRAS-LIKE SUPPRESSOR 2; HRASLS2,Asterisk
613867,"PHOSPHOLIPASE A2, GROUP XVI; PLA2G16",Asterisk
613868,"SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 1; SLC14A1",Asterisk
613869,"MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED",Number Sign
613870,"HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD",Number Sign
613871,FUMARYLACETOACETATE HYDROLASE; FAH,Asterisk
613872,COAGULATION FACTOR X; F10,Asterisk
613873,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17",Number Sign
613874,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18",Number Sign
613875,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19; CMH19",Number Sign
613876,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20",Number Sign
613877,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4",Number Sign
613878,COAGULATION FACTOR VII; F7,Asterisk
613879,THYROTROPIN-RELEASING HORMONE; TRH,Asterisk
613880,BROMO-ADJACENT HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; BAHD1,Asterisk
613881,"CARDIOMYOPATHY, DILATED, 1HH; CMD1HH",Number Sign
613882,"HYPOMAGNESEMIA 6, RENAL; HOMG6",Number Sign
613883,KELL BLOOD GROUP METALLOENDOPEPTIDASE; KEL,Asterisk
613884,CHROMOSOME 13q14 DELETION SYNDROME,Number Sign
613885,"MECKEL SYNDROME, TYPE 8; MKS8",Number Sign
613886,"OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD",Number Sign
613887,CATARACT 36; CTRCT36,Number Sign
613888,"RAS HOMOLOG GENE FAMILY, MEMBER T1; RHOT1",Asterisk
613889,"RAS HOMOLOG GENE FAMILY, MEMBER T2; RHOT2",Asterisk
613890,3-BETA-HYDROXYSTEROID DEHYDROGENASE 2; HSD3B2,Asterisk
613891,URIDINE MONOPHOSPHATE SYNTHETASE; UMPS,Asterisk
613892,DPY19-LIKE 1; DPY19L1,Asterisk
613893,DPY19-LIKE 2; DPY19L2,Asterisk
613894,DPY19-LIKE 3; DPY19L3,Asterisk
613895,DPY19-LIKE 4; DPY19L4,Asterisk
613896,BISPHOSPHOGLYCERATE MUTASE; BPGM,Asterisk
613897,FANCF GENE; FANCF,Asterisk
613898,3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE; HMGCL,Asterisk
613899,FANCC GENE; FANCC,Asterisk
613900,TRANSGLUTAMINASE 6; TGM6,Asterisk
613901,"RNA 2-PRIME,3-PRIME CYCLIC PHOSPHATE AND 5-PRIME-OH LIGASE; RTCB",Asterisk
613902,ZINC FINGER PROTEIN 503; ZNF503,Asterisk
613903,ZINC FINGER PROTEIN 540; ZNF540,Asterisk
613904,ZINC FINGER PROTEIN 569; ZNF569,Asterisk
613905,ZINC FINGER PROTEIN 606; ZNF606,Asterisk
613906,ZINC FINGER PROTEIN 641; ZNF641,Asterisk
613907,ZINC FINGER PROTEIN 652; ZNF652,Asterisk
613908,SPINOCEREBELLAR ATAXIA 35; SCA35,Number Sign
613909,SPINOCEREBELLAR ATAXIA 32; SCA32,Percent
613910,ZINC FINGER PROTEIN 480; ZNF480,Asterisk
613911,ZINC FINGER PROTEIN 496; ZNF496,Asterisk
613912,COMPLEMENT FACTOR D DEFICIENCY; CFDD,Number Sign
613913,"LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3",Percent
613914,ZINC FINGER PROTEIN 746; ZNF746,Asterisk
613915,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 42: ZBTB42,Asterisk
613916,"DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89",Number Sign
613917,MUCIN 22; MUC22,Asterisk
613918,HLA COMPLEX GROUP 22; HCG22,Asterisk
613919,KINESIN FAMILY MEMBER 6; KIF6,Asterisk
613920,CYTOCHROME C OXIDASE ASSEMBLY FACTOR 5; COA5,Asterisk
613921,"LIPASE FAMILY, MEMBER J; LIPJ",Asterisk
613922,"LIPASE FAMILY, MEMBER K; LIPK",Asterisk
613923,"LIPASE FAMILY, MEMBER M; LIPM",Asterisk
613924,"LIPASE FAMILY, MEMBER N; LIPN",Asterisk
613925,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A,Number Sign
613926,"MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B",Number Sign
613927,COMPLEMENT COMPONENT 2; C2,Asterisk
613928,DIFFUSE PANBRONCHIOLITIS CRITICAL REGION GENE 1; DPCR1,Asterisk
613929,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 4; SPINK4",Asterisk
613930,ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3,Percent
613931,TARGET OF EGR1; TOE1,Asterisk
613932,TNNI3-INTERACTING KINASE; TNNI3K,Asterisk
613933,ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD,Percent
613934,TRANSMEMBRANE PROTEIN 25; TMEM25,Asterisk
613935,TRANSMEMBRANE PROTEIN 74; TMEM74,Asterisk
613936,TRANSMEMBRANE PROTEIN 102; TMEM102,Asterisk
613937,TRANSMEMBRANE PROTEIN 184C; TMEM184C,Asterisk
613938,"PARASOMNIA, SLEEPWALKING TYPE; PSMNSW",Percent
613939,SPERMATOGENESIS-ASSOCIATED PROTEIN 20; SPATA20,Asterisk
613940,SPERMATOGENESIS-ASSOCIATED PROTEIN 5; SPATA5,Asterisk
613941,"SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 3; SPINT3",Asterisk
613942,SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 5; SUN5,Asterisk
613943,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8",Number Sign
613944,"IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2",Percent
613945,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, BETA; DNAJC5B",Asterisk
613946,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, GAMMA; DNAJC5G",Asterisk
613947,SPERMATOGENESIS-ASSOCIATED PROTEIN 6; SPATA6,Asterisk
613948,SPERMATOGENESIS-ASSOCIATED PROTEIN 8; SPATA8,Asterisk
613949,OKT4 EPITOPE DEFICIENCY,Number Sign
613950,SCHIZOPHRENIA 15; SCZD15,Number Sign
613951,"FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP",Number Sign
613952,TERMINAL NUCLEOTIDYLTRANSFERASE 5C; TENT5C,Asterisk
613953,IMMUNODEFICIENCY 51; IMD51,Number Sign
613954,AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS14,Number Sign
613955,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2",Number Sign
613956,"CANDIDIASIS, FAMILIAL, 6; CANDF6",Number Sign
613957,SPERMATOGENIC FAILURE 8; SPGF8,Number Sign
613958,SPERMATOGENIC FAILURE 9; SPGF9,Number Sign
613959,SCHIZOPHRENIA 16; SCZD16,Number Sign
613960,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III; CDG3",Number Sign
613961,"TASTE RECEPTOR, TYPE 2, MEMBER 19; TAS2R19",Asterisk
613962,"TASTE RECEPTOR, TYPE 2, MEMBER 20; TAS2R20",Asterisk
613963,"TASTE RECEPTOR, TYPE 2, MEMBER 30; TAS2R30",Asterisk
613964,"TASTE RECEPTOR, TYPE 2, MEMBER 40; TAS2R40",Asterisk
613965,"TASTE RECEPTOR, TYPE 2, MEMBER 41; TAS2R41",Asterisk
613966,"TASTE RECEPTOR, TYPE 2, MEMBER 42; TAS2R42",Asterisk
613967,"TASTE RECEPTOR, TYPE 2, MEMBER 45; TAS2R45",Asterisk
613968,"TASTE RECEPTOR, TYPE 2, MEMBER 60; TAS2R60",Asterisk
613969,"MYOPIA 19, AUTOSOMAL DOMINANT; MYP19",Percent
613970,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6",Number Sign
613971,MOVED TO 245570,Caret
613972,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6",Number Sign
613973,CYCLIC GMP-AMP SYNTHASE; CGAS,Asterisk
613974,DEAD BOX POLYPEPTIDE 60; DDX60,Asterisk
613975,INTERFERON-INDUCED PROTEIN 44-LIKE; IFI44L,Asterisk
613976,FANCE GENE; FANCE,Asterisk
613977,"CYANOSIS, TRANSIENT NEONATAL; TNCY",Number Sign
613978,HEMOGLOBIN H DISEASE; HBH,Number Sign
613979,"PRECURSOR mRNA-PROCESSING FACTOR 6, S. CEREVISIAE, HOMOLOG OF; PRPF6",Asterisk
613980,"ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9",Number Sign
613981,HYPOTRICHOSIS 3; HYPT3,Number Sign
613982,"OSTEOGENESIS IMPERFECTA, TYPE VI; OI6",Number Sign
613983,RETINITIS PIGMENTOSA 60; RP60,Number Sign
613984,FANCD2 GENE; FANCD2,Asterisk
613985,BETA-THALASSEMIA,Number Sign
613986,"PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6",Number Sign
613987,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2",Number Sign
613988,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3; DKCB3",Number Sign
613989,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2",Number Sign
613990,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3",Number Sign
613991,"CDC42-BINDING PROTEIN KINASE, GAMMA; CDC42BPG",Asterisk
613992,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, DELTA; PPP2R2D",Asterisk
613993,"MYOSIN, LIGHT CHAIN 7, REGULATORY; MYL7",Asterisk
613994,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 4; NBPF4",Asterisk
613995,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 5; NBPF5",Asterisk
613996,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 6; NBPF6",Asterisk
613997,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 7; NBPF7",Asterisk
613998,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 8; NBPF8",Asterisk
613999,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 9; NBPF9",Asterisk
614000,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 10; NBPF10",Asterisk
614001,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 11; NBPF11",Asterisk
614002,MOVED TO 608607,Caret
614003,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 14; NBPF14",Asterisk
614004,MOVED TO 610414,Caret
614005,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 16; NBPF16",Asterisk
614006,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 19; NBPF19",Asterisk
614007,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 20; NBPF20",Asterisk
614008,NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS,Number Sign
614009,"BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13",Number Sign
614010,INOSITOL MONOPHOSPHATASE DOMAIN-CONTAINING PROTEIN 1; IMPAD1,Asterisk
614011,"ENDOGENOUS RETROVIRUS GROUP K, MEMBER 4; ERVK-4",Asterisk
614012,"ENDOGENOUS RETROVIRUS GROUP K, MEMBER 5; ERVK-5",Asterisk
614013,"ENDOGENOUS RETROVIRUS GROUP K, MEMBER 7; ERVK-7",Asterisk
614014,"RIBONUCLEASE, RNase A FAMILY, 9; RNASE9",Asterisk
614015,"DIACYLGLYCEROL LIPASE, ALPHA; DAGLA",Asterisk
614016,"DIACYLGLYCEROL LIPASE, BETA; DAGLB",Asterisk
614017,"CILIARY DYSKINESIA, PRIMARY, 16; CILD16",Number Sign
614018,"EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6",Number Sign
614019,LISSENCEPHALY 4; LIS4,Number Sign
614020,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14",Number Sign
614021,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3",Number Sign
614022,"ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10",Number Sign
614023,PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD,Number Sign
614024,PROTEIN Z DEFICIENCY,Number Sign
614025,HEPATIC LIPASE DEFICIENCY,Number Sign
614026,KINESIN FAMILY MEMBER 26B; KIF26B,Asterisk
614027,INSULINOMA-ASSOCIATED 2; INSM2,Asterisk
614028,APOLIPOPROTEIN C-III DEFICIENCY,Number Sign
614029,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER A; SPDYA",Asterisk
614030,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER C; SPDYC",Asterisk
614031,RAN-BINDING PROTEIN 10; RANBP10,Asterisk
614032,TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 4; TOX4,Asterisk
614033,HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY,
614034,HEME OXYGENASE 1 DEFICIENCY; HMOX1D,Number Sign
614035,"DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29",Number Sign
614036,ALPHA-2-MACROGLOBULIN DEFICIENCY; A2MD,
614037,LEUKOTRIENE C4 SYNTHASE DEFICIENCY,
614038,"LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA",Number Sign
614039,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1",Number Sign
614040,ZINC FINGER PROTEIN 467; ZNF467,Asterisk
614041,RB1 GENE; RB1,Asterisk
614042,MOYAMOYA DISEASE 5; MYMY5,Number Sign
614043,LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 2; LRRFIP2,Asterisk
614044,TRYPSINOGEN DEFICIENCY,
614045,"FAMILY WITH SEQUENCE SIMILARITY 129, MEMBER B; FAM129B",Asterisk
614046,ARGININE- AND GLUTAMATE-RICH PROTEIN 1; ARGLU1,Asterisk
614047,"METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2-LIKE, NADP(+)-DEPENDENT; MTHFD2L",Asterisk
614048,KIAA1324-LIKE; KIAA1324L,Asterisk
614049,"ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11",Number Sign
614050,"ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12",Number Sign
614051,MOVED TO 212066,Caret
614052,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2",Number Sign
614053,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3",Number Sign
614054,"RIBOSOMAL MODIFICATION PROTEIN RimK-LIKE FAMILY, MEMBER B; RIMKLB",Asterisk
614055,ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY; ACAT2D,
614056,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 26; PPP1R26",Asterisk
614057,MICRO RNA 409; MIR409,Asterisk
614058,KETOHEXOKINASE; KHK,Asterisk
614059,MICRO RNA 338; MIR338,Asterisk
614060,HOXA DISTAL TRANSCRIPT ANTISENSE RNA; HOTTIP,Asterisk
614061,OLFACTOMEDIN 4; OLFM4,Asterisk
614062,"CDC42-BINDING PROTEIN KINASE, BETA; CDC42BPB",Asterisk
614063,N-ACETYLASPARTATE DEFICIENCY; NACED,Number Sign
614064,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 24; ZBTB24,Asterisk
614065,"MYOPATHY, DISTAL, 4; MPD4",Number Sign
614066,"SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47",Number Sign
614067,"SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52",Number Sign
614068,"INTRAFLAGELLAR TRANSPORT 43, CHLAMYDOMONAS, HOMOLOG OF; IFT43",Asterisk
614069,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2,Number Sign
614070,"PSORIASIS 13, SUSCEPTIBILITY TO; PSORS13",Number Sign
614071,MYOCARDIAL ZONULA ADHERENS PROTEIN; MYZAP,Asterisk
614072,HERMANSKY-PUDLAK SYNDROME 3; HPS3,Number Sign
614073,HERMANSKY-PUDLAK SYNDROME 4; HPS4,Number Sign
614074,HERMANSKY-PUDLAK SYNDROME 5; HPS5,Number Sign
614075,HERMANSKY-PUDLAK SYNDROME 6; HPS6,Number Sign
614076,HERMANSKY-PUDLAK SYNDROME 7; HPS7,Number Sign
614077,HERMANSKY-PUDLAK SYNDROME 8; HPS8,Number Sign
614078,"CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE",Number Sign
614079,"ASPERGILLOSIS, SUSCEPTIBILITY TO",Number Sign
614080,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1,Number Sign
614081,ANHAPTOGLOBINEMIA; AHP,Number Sign
614082,"FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG",Number Sign
614083,"FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL",Number Sign
614084,"WEE1, S. POMBE, HOMOLOG OF, 2; WEE2",Asterisk
614085,"RAD9-, RAD1-, AND HUS1-INTERACTING NUCLEAR ORPHAN 1; RHNO1",Asterisk
614086,MULTICILIATE DIFFERENTIATION AND DNA SYNTHESIS-ASSOCIATED CELL CYCLE PROTEIN; MCIDAS,Asterisk
614087,MOVED TO 227650 AND 609644,Caret
614088,INTRACELLULAR ADHESION MOLECULE 4; ICAM4,Asterisk
614089,ATRIAL SEPTAL DEFECT 3; ASD3,Number Sign
614090,"SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3",Number Sign
614091,SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7,Number Sign
614092,RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 1; RILPL1,Asterisk
614093,RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 2; RILPL2,Asterisk
614094,MARVEL DOMAIN-CONTAINING PROTEIN 3; MARVELD3,Asterisk
614095,"PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL; PCK2",Asterisk
614096,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8,Number Sign
614097,ACATALASEMIA,Number Sign
614098,KEPPEN-LUBINSKY SYNDROME; KPLBS,Number Sign
614099,CRANIOECTODERMAL DYSPLASIA 3; CED3,Number Sign
614100,"CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE",Percent
614101,PLASMA FIBRONECTIN DEFICIENCY,Percent
614102,IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD,Number Sign
614103,LIPEDEMA,Percent
614104,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7",Number Sign
614105,METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD,Number Sign
614106,MUSCULAR LMNA-INTERACTING PROTEIN; MLIP,Asterisk
614107,KARYOPHERIN ALPHA-7; KPNA7,Asterisk
614108,"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 2; BPIFB2",Asterisk
614109,"BPI FOLD-CONTAINING PROTEIN, FAMILY C; BPIFC",Asterisk
614110,"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 6; BPIFB6",Asterisk
614111,PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD,Number Sign
614112,MICRO RNA 320A; MIR320A,Asterisk
614113,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2",Number Sign
614114,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2,Number Sign
614115,"CORTICAL MALFORMATIONS, OCCIPITAL; OCCM",Number Sign
614116,"NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E",Number Sign
614117,EXOCYST COMPLEX COMPONENT 3-LIKE 1; EXOC3L1,Asterisk
614118,TEASHIRT ZINC FINGER HOMEOBOX 2; TSHZ2,Asterisk
614119,TEASHIRT ZINC FINGER HOMEOBOX 3; TSHZ3,Asterisk
614120,HYDROLETHALUS SYNDROME 2; HLS2,Number Sign
614121,TERMINAL NUCLEOTIDYLTRANSFERASE 2; TENT2,Asterisk
614122,CHITOTRIOSIDASE DEFICIENCY; CHITD,Number Sign
614123,TRANSMEMBRANE AND COILED-COIL DOMAINS PROTEIN 1; TMCO1,Asterisk
614124,"GLYCEROPHOSPHOCHOLINE PHOSPHODIESTERASE GDE1, S. CEREVISIAE, HOMOLOG OF; GPCPD1",Asterisk
614125,DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 4; DPPA4,Asterisk
614126,MOLYBDENUM COFACTOR SULFURASE C-TERMINAL DOMAIN-CONTAINING PROTEIN 1; MOSC1,Asterisk
614127,MOLYBDENUM COFACTOR SULFURASE C-TERMINAL DOMAIN-CONTAINING PROTEIN 2; MOSC2,Asterisk
614128,LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD,Number Sign
614129,PERRAULT SYNDROME 3; PRLTS3,Number Sign
614130,"ADENOSINE DEAMINASE DOMAIN-CONTAINING PROTEIN 1, TESTIS-SPECIFIC; ADAD1",Asterisk
614131,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6,Number Sign
614132,MOVED TO 213980,Caret
614133,HEPACAM FAMILY MEMBER 2; HEPACAM2,Asterisk
614134,"STICKLER SYNDROME, TYPE IV; STL4",Number Sign
614135,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6",Number Sign
614136,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 8; TRAPPC8",Asterisk
614137,"BET3, S. CEREVISIAE, HOMOLOG-LIKE; BET3L",Asterisk
614138,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 11; TRAPPC11",Asterisk
614139,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 12; TRAPPC12",Asterisk
614140,SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1-LIKE; SPECC1L,Asterisk
614141,TRIPARTITE MOTIF-CONTAINING PROTEIN 2; TRIM2,Asterisk
614142,CUE DOMAIN-CONTAINING PROTEIN 2; CUEDC2,Asterisk
614143,IGF-LIKE FAMILY RECEPTOR 1; IGFLR1,Asterisk
614144,B9 DOMAIN-CONTAINING PROTEIN 1; B9D1,Asterisk
614145,COILED-COIL DOMAIN-CONTAINING PROTEIN 8; CCDC8,Asterisk
614146,CHROMOSOME 20 OPEN READING FRAME 194; C20ORF194,Asterisk
614147,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 8; C1QTNF8,Asterisk
614148,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9B; C1QTNF9B,Asterisk
614149,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9",Percent
614150,"PROTEIN KINASE DOMAIN-CONTAINING PROTEIN, CYTOPLASMIC, MOUSE, HOMOLOG OF; PKDCC",Asterisk
614151,RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 3; RFWD3,Asterisk
614152,"DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64",Number Sign
614153,SPINOCEREBELLAR ATAXIA 36; SCA36,Number Sign
614154,"NOP56, S. CEREVISIAE, HOMOLOG OF; NOP56",Asterisk
614155,MICRO RNA 1292; MIR1292,Asterisk
614156,HYPERBILIVERDINEMIA; HBLVD,Number Sign
614157,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10; NDNC10",Number Sign
614158,"BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14",
614159,ZINC FINGER PROTEIN 644; ZNF644,Asterisk
614160,MUSCLE HYPERTROPHY; MSLHP,Number Sign
614161,PR DOMAIN-CONTAINING PROTEIN 5; PRDM5,Asterisk
614162,IMMUNODEFICIENCY 31C; IMD31C,Number Sign
614163,"DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD",Number Sign
614164,GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD,Percent
614165,PARAGANGLIOMAS 5; PGL5,Number Sign
614166,"MYOPIA 20, AUTOSOMAL DOMINANT; MYP20",Percent
614167,"MYOPIA 21, AUTOSOMAL DOMINANT; MYP21",Number Sign
614168,"PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE; PCK1",Asterisk
614169,NEUROBEACHIN-LIKE 2; NBEAL2,Asterisk
614170,BRITTLE CORNEA SYNDROME 2; BCS2,Number Sign
614171,HERMANSKY-PUDLAK SYNDROME 9; HPS9,Number Sign
614172,IMMUNODEFICIENCY 21; IMD21,Number Sign
614173,JOUBERT SYNDROME 13; JBTS13,Number Sign
614174,"MEIOSIS-EXPRESSED GENE 1, MOUSE, HOMOLOG OF; MEIG1",Asterisk
614175,"MECKEL SYNDROME, TYPE 10; MKS10",Number Sign
614176,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 28; ZFYVE28,Asterisk
614177,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 4A; EFCAB4A,Asterisk
614178,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 4B; EFCAB4B,Asterisk
614179,IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT 2; ISLR2,Asterisk
614180,RETINITIS PIGMENTOSA 61; RP61,Number Sign
614181,RETINITIS PIGMENTOSA 62; RP62,Number Sign
614182,"HEART OF GLASS, ZEBRAFISH, HOMOLOG OF, 1; HEG1",Asterisk
614183,"DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG-LIKE; DIS3L",Asterisk
614184,"DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG-LIKE 2; DIS3L2",Asterisk
614185,GELEOPHYSIC DYSPLASIA 2; GPHYSD2,Number Sign
614186,LEBER CONGENITAL AMAUROSIS 16; LCA16,Number Sign
614187,"HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD",Percent
614188,CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA,Number Sign
614189,"GOLGIN A7 FAMILY, MEMBER B; GOLGA7B",Asterisk
614190,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3",Number Sign
614191,DEP DOMAIN-CONTAINING PROTEIN 5; DEPDC5,Asterisk
614192,"MACROCEPHALY, MACROSOMIA, AND FACIAL DYSMORPHISM SYNDROME; MMFD",Number Sign
614193,TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2,Number Sign
614194,DEDICATOR OF CYTOKINESIS 6; DOCK6,Asterisk
614195,CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS,Number Sign
614196,"NEPHROTIC SYNDROME, TYPE 6; NPHS6",Number Sign
614197,MITOCHONDRIAL CALCIUM UNIPORTER; MCU,Asterisk
614198,"MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16",Number Sign
614199,"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5",Number Sign
614200,"BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9",Percent
614201,"BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11",Number Sign
614202,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15",Number Sign
614203,PARKINSON DISEASE 17; PARK17,Number Sign
614204,"PSORIASIS 14, PUSTULAR; PSORS14",Number Sign
614205,THREE M SYNDROME 3; 3M3,Number Sign
614206,CHROMATIN TARGET OF PRMT1; CHTOP,Asterisk
614207,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3,Number Sign
614208,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16; MRT16",Percent
614209,"MECKEL SYNDROME, TYPE 9; MKS9",Number Sign
614210,LUNG CANCER SUSCEPTIBILITY 5; LNCR5,Percent
614211,"DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33",Percent
614212,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4",Number Sign
614213,"NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C",Number Sign
614214,KELCH-LIKE 6; KLHL6,Asterisk
614215,"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 1; ASCC1",Asterisk
614216,"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 2; ASCC2",Asterisk
614217,"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 3; ASCC3",Asterisk
614218,WD REPEAT-CONTAINING PROTEIN 81; WDR81,Asterisk
614219,ADAMS-OLIVER SYNDROME 2; AOS2,Number Sign
614220,"BILIARY CIRRHOSIS, PRIMARY, 4; PBC4",Percent
614221,"BILIARY CIRRHOSIS, PRIMARY, 5; PBC5",Percent
614222,WARBURG MICRO SYNDROME 3; WARBM3,Number Sign
614223,"NARCOLEPSY 6, SUSCEPTIBILITY TO; NRCLP6",Percent
614224,RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS; RAMSVPS,Number Sign
614225,WARBURG MICRO SYNDROME 2; WARBM2,Number Sign
614226,HOLOPROSENCEPHALY 11; HPE11,Number Sign
614227,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3",Percent
614228,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O",Number Sign
614229,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11",Number Sign
614230,CHROMOSOME 8q21.11 DELETION SYNDROME,Number Sign
614231,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS",Number Sign
614232,"11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II; HSD11B2",Asterisk
614233,"HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1; FPH1",Percent
614234,"PITCHFORK, MOUSE, HOMOLOG OF; PIFO",Asterisk
614235,PDZ DOMAIN-CONTAINING PROTEIN 8; PDZD8,Asterisk
614236,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 7; SLC38A7",Asterisk
614237,HYPOTRICHOSIS 9; HYPT9,Percent
614238,HYPOTRICHOSIS 10; HYPT10,Percent
614239,"FAMILY WITH SEQUENCE SIMILARITY 109, MEMBER A; FAM109A",Asterisk
614240,"FAMILY WITH SEQUENCE SIMILARITY 109, MEMBER B; FAM109B",Asterisk
614241,LYSOCARDIOLIPIN ACYLTRANSFERASE 1; LCLAT1,Asterisk
614242,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 9; SLC16A9",Asterisk
614243,5-OXOPROLINASE (ATP-HYDROLYZING); OPLAH,Asterisk
614244,PYRIDOXAL-DEPENDENT DECARBOXYLASE DOMAIN-CONTAINING PROTEIN 1; PDXDC1,Asterisk
614245,"ACYL-CoA SYNTHETASE FAMILY, MEMBER 3; ACSF3",Asterisk
614246,"N-ALPHA-ACETYLTRANSFERASE 60, NatF CATALYTIC SUBUNIT; NAA60",Asterisk
614247,MICRO RNA 519D; MIR519D,Asterisk
614248,PSEUDOPODIUM-ENRICHED ATYPICAL KINASE 1,Asterisk
614249,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18",Number Sign
614250,NARCOLEPSY 7; NRCLP7,Number Sign
614251,"PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18",Number Sign
614252,"ANEURYSM, INTRACRANIAL BERRY, 11; ANIB11",Percent
614253,MOVED TO 204690,Caret
614254,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD",Number Sign
614255,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9",Number Sign
614256,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10",Number Sign
614257,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11",Number Sign
614258,"POLYMERASE III, RNA, SUBUNIT A; POLR3A",Asterisk
614259,WD REPEAT-CONTAINING PROTEIN 65; WDR65,Asterisk
614260,CHROMOSOME 9 OPEN READING FRAME 72; C9ORF72,Asterisk
614261,MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP,Number Sign
614262,"ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG",Number Sign
614263,BACE1 ANTISENSE RNA: BACE1AS,Asterisk
614264,RHO GTPase-ACTIVATING PROTEIN 30; ARHGAP30,Asterisk
614265,COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA,Number Sign
614266,BARRETT ESOPHAGUS,Number Sign
614267,ACYL-CoA THIOESTERASE 6; ACOT6,Asterisk
614268,ADHESION G PROTEIN-COUPLED RECEPTOR F4; ADGRF4,Asterisk
614269,G PROTEIN-COUPLED RECEPTOR 153; GPR153,Asterisk
614270,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 65; CFAP65,Asterisk
614271,COILED-COIL DOMAIN-CONTAINING PROTEIN 137; CCDC137,Asterisk
614272,FAST KINASE DOMAINS 5; FASTKD5,Asterisk
614273,"OLFACTORY RECEPTOR, FAMILY 4, SUBFAMILY C, MEMBER 46; OR4C46",Asterisk
614274,"STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 1; SBNO1",Asterisk
614275,ZINC FINGER PROTEIN 565; ZNF565,Asterisk
614276,PHOSPHOLIPASE C-LIKE 2; PLCL2,Asterisk
614277,UBIQUITIN-CONJUGATING ENZYME 2W; UBE2W,Asterisk
614278,PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD,Number Sign
614279,"46,XY SEX REVERSAL 8; SRXY8",Number Sign
614280,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9",Percent
614281,ENDOTHELIAL CELL ADHESION MOLECULE; ESAM,Asterisk
614282,STROMAL CELL-DERIVED FACTOR 4; SDF4,Asterisk
614283,GLUCOCORTICOID-INDUCED TRANSCRIPT 1; GLCCI1,Asterisk
614284,"STICKLER SYNDROME, TYPE V; STL5",Number Sign
614285,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9; C1QTNF9,Asterisk
614286,MYELODYSPLASTIC SYNDROME; MDS,Number Sign
614287,OFC1 CANDIDATE GENE 1; OFCC1,Asterisk
614288,"ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 11; ACAD11",Asterisk
614289,SUPPRESSOR OF LIN12-LIKE 2; SEL1L2,Asterisk
614290,TETRASOMY 18p,Number Sign
614291,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4",Number Sign
614292,"MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD",Number Sign
614293,"HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2",Number Sign
614294,CHROMOSOME 15q25 DELETION SYNDROME,Number Sign
614295,"BICAUDAL C, DROSOPHILA, HOMOLOG OF, 1; BICC1",Asterisk
614296,"WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL",Number Sign
614297,CHROMOSOME 19 OPEN READING FRAME 12; C19ORF12,Asterisk
614298,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4,Number Sign
614299,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2,Number Sign
614300,HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY,Number Sign
614301,ATAXIN 1-LIKE; ATXN1L,Asterisk
614302,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7",Number Sign
614303,EDICT SYNDROME; EDICT,Number Sign
614304,MICRO RNA 137; MIR137,Asterisk
614305,SCLEROSTEOSIS 2; SOST2,Number Sign
614306,COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT,Number Sign
614307,ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD,Number Sign
614308,FORMIMINOTRANSFERASE CYCLODEAMINASE N-TERMINAL-LIKE PROTEIN 1; FTCDNL1,Asterisk
614309,"tRNA METHYLTRANSFERASE 44, S. CEREVISIAE, HOMOLOG OF; TRMT44",Asterisk
614310,"CENTROSOMAL PROTEIN, 70-KD; CEP70",Asterisk
614311,SYNAPSE DIFFERENTIATION-INDUCED GENE 1; SYNDIG1,Asterisk
614312,ZINC FINGER MYND-CONTAINING PROTEIN 15; ZMYND15,Asterisk
614313,ACYL-CoA THIOESTERASE 1; ACOT1,Asterisk
614314,ACYL-CoA THIOESTERASE 4; ACOT4,Asterisk
614315,ACYL-CoA THIOESTERASE 12; ACOT12,Asterisk
614316,"VTI1, S. CEREVISIAE, HOMOLOG OF, A; VTI1A",Asterisk
614317,VESICOURETERAL REFLUX 4; VUR4,Percent
614318,VESICOURETERAL REFLUX 5; VUR5,Percent
614319,VESICOURETERAL REFLUX 6; VUR6,Percent
614320,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4",Number Sign
614321,"MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT",Number Sign
614322,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12",Number Sign
614323,"NEVOID HYPERMELANOSIS, LINEAR AND WHORLED; LWNH",Percent
614324,OVARIAN DYSGENESIS 3; ODG3,Number Sign
614325,PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2,Number Sign
614326,FEINGOLD SYNDROME 2; FGLDS2,Number Sign
614327,TUMOR PREDISPOSITION SYNDROME; TPDS,Number Sign
614328,"INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1",Number Sign
614329,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31",Percent
614330,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 2; C1QL2",Asterisk
614331,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6",Number Sign
614332,CHROMOSOME 2p16.3 DELETION SYNDROME,Number Sign
614333,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29; MRT29",Percent
614334,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 13; DNAJC13",Asterisk
614335,"ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B",Number Sign
614336,"PRESEQUENCE TRANSLOCASE-ASSOCIATED MOTOR 16, S. CEREVISIAE, HOMOLOG OF; PAM16",Asterisk
614337,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4",Number Sign
614338,PANCREATIC LIPASE DEFICIENCY; PNLIPD,Number Sign
614339,MOVED TO 607596,Caret
614340,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27",Number Sign
614341,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33; MRT33",Percent
614342,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30; MRT30",Percent
614343,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19; MRT19",Percent
614344,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23; MRT23",Percent
614345,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24; MRT24",Percent
614346,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25; MRT25",Percent
614347,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28; MRT28",Percent
614348,CHROMOSOME 6 OPEN READING FRAME 105; C6ORF105,Asterisk
614349,ZINC FINGER PROTEIN 638; ZNF638,Asterisk
614350,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5",Number Sign
614351,"NUCLEOPORIN, 93-KD; NUP93",Asterisk
614352,"NUCLEOPORIN, 205-KD; NUP205",Asterisk
614353,HAS2 ANTISENSE RNA 1; HAS2AS1,Asterisk
614354,PRO2268 GENE,Asterisk
614355,"ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 1; ACSS1",Asterisk
614356,"ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 3; ACSS3",Asterisk
614357,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 1; ACSM1",Asterisk
614358,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2A; ACSM2A",Asterisk
614359,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2B; ACSM2B",Asterisk
614360,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 4; ACSM4",Asterisk
614361,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 5; ACSM5",Asterisk
614362,"ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 1; ACSBG1",Asterisk
614363,"ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 2; ACSBG2",Asterisk
614364,ACETOACETYL-CoA SYNTHETASE; AACS,Asterisk
614365,AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE; AASDH,Asterisk
614366,"POLYMERASE III, RNA, SUBUNIT B; POLR3B",Asterisk
614367,"ADAPTOR-RELATED PROTEIN COMPLEX 5, BETA-1 SUBUNIT; AP5B1",Asterisk
614368,"ADAPTOR-RELATED PROTEIN COMPLEX 5, MU-1 SUBUNIT; AP5M1",Asterisk
614369,"PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH",Number Sign
614370,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5",Number Sign
614371,"DENGUE VIRUS, SUSCEPTIBILITY TO",Number Sign
614372,MANNOSE-BINDING LECTIN DEFICIENCY; MBLD,Number Sign
614373,"AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16",Number Sign
614374,"BLOOD GROUP, CHIDO/RODGERS SYSTEM",Number Sign
614375,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 4; AAA4",Percent
614376,SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5,Number Sign
614377,NEPHRONOPHTHISIS 13; NPHP13,Number Sign
614378,CRANIOECTODERMAL DYSPLASIA 4; CED4,Number Sign
614379,COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD,Number Sign
614380,COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD,Number Sign
614381,"LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8",Number Sign
614382,"BACTEREMIA, SUSCEPTIBILITY TO, 1; BACTS1",Number Sign
614383,"BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2",Number Sign
614384,MICRO RNA 492; MIR492,Asterisk
614385,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7",Number Sign
614386,PROLINE-RICH TRANSMEMBRANE PROTEIN 2; PRRT2,Asterisk
614387,ZINC FINGER PROTEIN 526; ZNF526,Asterisk
614388,ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1,Number Sign
614389,"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1",Number Sign
614390,"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2",Number Sign
614391,"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3",Number Sign
614392,TUDOR DOMAIN-CONTAINING PROTEIN 3; TDRD3,Asterisk
614393,O-ACYL-ADP-RIBOSE DEACYLASE 1; OARD1,Asterisk
614394,"INTRAFLAGELLAR TRANSPORT 20, CHLAMYDOMONAS, HOMOLOG OF: IFT20",Asterisk
614395,"GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO; GVHDS",Number Sign
614396,G-PATCH DOMAIN-CONTAINING PROTEIN 8; GPATCH8,Asterisk
614397,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 2A; MFSD2A,Asterisk
614398,KIAA1462 GENE; KIAA1462,Asterisk
614399,"MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD",Number Sign
614400,"GLUCOCORTICOID THERAPY, RESPONSE TO; GCTR",Number Sign
614401,"ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO; ACTFS",Number Sign
614402,"MICROPHTHALMIA, SYNDROMIC 11; MCOPS11",Number Sign
614403,"RHOMBOID 5, DROSOPHILA, HOMOLOG OF, 1; RHBDF1",Asterisk
614404,"RHOMBOID 5, DROSOPHILA, HOMOLOG OF, 2; RHBDF2",Asterisk
614405,DEAH BOX POLYPEPTIDE 33; DHX33,Asterisk
614406,SLP ADAPTOR- AND CSK-INTERACTING MEMBRANE PROTEIN; SCIMP,Asterisk
614407,"MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD",Percent
614408,"MYOPATHY, CENTRONUCLEAR, 3; CNM3",Number Sign
614409,"SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46",Number Sign
614410,ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE 1; AFAP1L1,Asterisk
614411,GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL,Number Sign
614412,TESTIS- AND OVARY-SPECIFIC PAZ DOMAIN-CONTAINING PROTEIN 1; TOPAZ1,Asterisk
614413,AMINOACYLASE 3; ACY3,Asterisk
614414,"DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96",Percent
614415,CHILBLAIN LUPUS 2; CHBL2,Number Sign
614416,RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA,Number Sign
614417,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5",Number Sign
614418,"FEBRILE SEIZURES, FAMILIAL, 11; FEB11",Number Sign
614419,"ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",Number Sign
614420,SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16,Number Sign
614421,MOVED TO 277590,Caret
614422,CATARACT 37; CTRCT37,Percent
614423,TRANSMEMBRANE PROTEIN 237; TMEM237,Asterisk
614424,JOUBERT SYNDROME 14; JBTS14,Number Sign
614425,TELO2-INTERACTING PROTEIN 1; TTI1,Asterisk
614426,TELO2-INTERACTING PROTEIN 2; TTI2,Asterisk
614427,TEASHIRT ZINC FINGER HOMEOBOX 1; TSHZ1,Asterisk
614428,TRANSCRIPTION FACTOR AP2-EPSILON; TFAP2E,Asterisk
614429,VENTRICULAR SEPTAL DEFECT 1; VSD1,Number Sign
614430,ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4,Number Sign
614431,VENTRICULAR SEPTAL DEFECT 2; VSD2,Number Sign
614432,VENTRICULAR SEPTAL DEFECT 3; VSD3,Number Sign
614433,ATRIAL SEPTAL DEFECT 8; ASD8,Number Sign
614434,"CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2",Number Sign
614435,HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2,Number Sign
614436,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P",Number Sign
614437,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B",Number Sign
614438,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B",Number Sign
614439,ADP-RIBOSYLATION FACTOR-LIKE 14; ARL14,Asterisk
614440,PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 3; PSD3,Asterisk
614441,"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2",Number Sign
614442,PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 4; PSD4,Asterisk
614443,EBNA1-BINDING PROTEIN 2; EBNA1BP2,Asterisk
614444,RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 1; RALGPS1,Asterisk
614445,DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 2; DPPA2,Asterisk
614446,"ATPase, CLASS II, TYPE 9B; ATP9B",Asterisk
614447,G0/G1 SWITCH GENE 2; G0S2,Asterisk
614448,GEMININ COILED-COIL DOMAIN-CONTAINING PROTEIN; GMNC,Asterisk
614449,PROTOCADHERIN 20; PCDH20,Asterisk
614450,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6",Number Sign
614451,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 7; ELOVL7,Asterisk
614452,"ATPASE FAMILY, AAA DOMAIN-CONTAINING, MEMBER 1; ATAD1",Asterisk
614453,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 7; LRRC7,Asterisk
614454,UBIQUITIN PROTEIN LIGASE E3C; UBE3C,Asterisk
614455,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE",Number Sign
614456,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8",Number Sign
614457,"ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR",Number Sign
614458,THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5,Number Sign
614459,TRANSMEMBRANE PROTEIN 138; TMEM138,Asterisk
614460,UBIQUITIN-SPECIFIC PROTEASE 47; USP47,Asterisk
614461,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 2; UQCC2,Asterisk
614462,"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS",Number Sign
614463,NMYC DOWNSTREAM-REGULATED GENE 4; NDRG4,Asterisk
614464,JOUBERT SYNDROME 15; JBTS15,Number Sign
614465,JOUBERT SYNDROME 16; JBTS16,Number Sign
614466,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6",Number Sign
614467,MOVED TO 212350,Caret
614468,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3,Number Sign
614469,"SERRATE RNA EFFECTOR MOLECULE, ARABIDOPSIS, HOMOLOG OF; SRRT",Asterisk
614470,RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD,Number Sign
614471,UBIQUITIN-SPECIFIC PROTEASE 19; USP19,Asterisk
614472,RING FINGER PROTEIN 123; RNF123,Asterisk
614473,"ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2",Number Sign
614474,ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5,Number Sign
614475,ATRIAL SEPTAL DEFECT 9; ASD9,Number Sign
614476,THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 4; THSD4,Asterisk
614477,CHROMOSOME 8 OPEN READING FRAME 37; C8ORF37,Asterisk
614478,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX14; COX14,Asterisk
614479,"MALONYL CoA:ACP ACYLTRANSFERASE, MITOCHONDRIAL; MCAT",Asterisk
614480,"HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI",Number Sign
614481,ATXN7 ANTISENSE RNA 1; ATXN7AS1,Asterisk
614482,"CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND",Number Sign
614483,PORENCEPHALY 2; POREN2,Number Sign
614484,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 13; ANAPC13",Asterisk
614485,TRIGONOCEPHALY 2; TRIGNO2,Number Sign
614486,THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12,Number Sign
614487,"SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5",Number Sign
614488,MICRO RNA 1258; MIR1258,Asterisk
614489,MICRO RNA 616; MIR616,Asterisk
614490,"BLOOD GROUP, JUNIOR SYSTEM; JR",Number Sign
614491,"PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B",Number Sign
614492,"PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C",Number Sign
614493,WISKOTT-ALDRICH SYNDROME 2; WAS2,Number Sign
614494,RETINITIS PIGMENTOSA 63; RP63,Percent
614495,"PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D",Number Sign
614496,"PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E",Number Sign
614497,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7",Number Sign
614498,"RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL",Number Sign
614499,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34",Number Sign
614500,CONE-ROD DYSTROPHY 16; CORD16,Number Sign
614501,"PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; PMRED",Number Sign
614502,CHROMOSOME 9 OPEN READING FRAME 116; C9ORF116,Asterisk
614503,KELCH DOMAIN-CONTAINING PROTEIN 8A; KLHDC8A,Asterisk
614504,"USHER SYNDROME, TYPE IIIB; USH3B",Number Sign
614505,FK506-BINDING PROTEIN 14; FKBP14,Asterisk
614506,BRCA1-ASSOCIATED ATM ACTIVATOR 1; BRAT1,Asterisk
614507,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R",Number Sign
614508,MIRROR MOVEMENTS 2; MRMV2,Number Sign
614509,MICRO RNA 99A; MIR99A,Asterisk
614510,MICRO RNA 99B; MIR99B,Asterisk
614511,MYOD FAMILY INHIBITOR DOMAIN-CONTAINING PROTEIN; MDFIC,Asterisk
614512,TORSIN A-INTERACTING PROTEIN 1; TOR1AIP1,Asterisk
614513,TORSIN A-INTERACTING PROTEIN 2; TOR1AIP2,Asterisk
614514,"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6",Number Sign
614515,G PROTEIN-COUPLED RECEPTOR 179; GPR179,Asterisk
614516,DOLICHYL PYROPHOSPHATE PHOSPHATASE 1; DOLPP1,Asterisk
614517,ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR-LIKE PROTEIN 2; ARNTL2,Asterisk
614518,GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 1; GATAD1,Asterisk
614519,"HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH",Number Sign
614520,"ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY",
614521,THROMBOCYTHEMIA 3; THCYT3,Number Sign
614522,KELCH-LIKE 12; KLHL12,Asterisk
614523,MICRO RNA 489; MIR489,Asterisk
614524,FIBROCHONDROGENESIS 2; FBCG2,Number Sign
614525,NFATC2-INTERACTING PROTEIN; NFATC2IP,Asterisk
614526,CHROMOSOME 17q12 DUPLICATION SYNDROME,Number Sign
614527,CHROMOSOME 17q12 DELETION SYNDROME,Number Sign
614528,HIF1A ANTISENSE RNA 1; HIF1AAS1,Asterisk
614529,HIF1A ANTISENSE RNA 2; HIF1AAS2,Asterisk
614530,"NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 12; NDUFA12",Asterisk
614531,"RASGEF DOMAIN FAMILY, MEMBER 1A; RASGEF1A",Asterisk
614532,"RASGEF DOMAIN FAMILY, MEMBER 1B; RASGEF1B",Asterisk
614533,"CELL DIVISION CYCLE 26, S. CEREVISIAE, HOMOLOG OF; CDC26",Asterisk
614534,ANAPHASE-PROMOTING COMPLEX SUBUNIT 11; ANAPC11,Asterisk
614535,ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 7; ZSWIM7,Asterisk
614536,SWIM-TYPE ZINC FINGER DOMAIN-CONTAINING PROTEIN 7-ASSOCIATED PROTEIN 1; SWSAP1,Asterisk
614537,LEUCINE-RICH MELANOCYTE DIFFERENTIATION-ASSOCIATED PROTEIN; LRMDA,Asterisk
614538,MICRO RNA 570; MIR570,Asterisk
614539,"HELICASE, DNA, B; HELB",Asterisk
614540,MOVED TO 213600,Caret
614541,CHROMOSOME 16q22 DELETION SYNDROME,Number Sign
614542,"FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER A; FAM69A",Asterisk
614543,"FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER B; FAM69B",Asterisk
614544,"FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER C; FAM69C",Asterisk
614545,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 10; EMC10",Asterisk
614546,"EFAVIRENZ, POOR METABOLISM OF",Number Sign
614547,"FAMILY WITH SEQUENCE SIMILARITY 103, MEMBER A1; FAM103A1",Asterisk
614548,SERINE INCORPORATOR 1; SERINC1,Asterisk
614549,SERINE INCORPORATOR 2; SERINC2,Asterisk
614550,SERINE INCORPORATOR 4; SERINC4,Asterisk
614551,SERINE INCORPORATOR 5; SERINC5,Asterisk
614552,XYLOSIDE XYLOSYLTRANSFERASE 1; XXYLT1,Asterisk
614553,"N6 ADENINE-SPECIFIC DNA METHYLTRANSFERASE 1, PUTATIVE; N6AMT1",Asterisk
614554,"FAMILY WITH SEQUENCE SIMILARITY 32, MEMBER A; FAM32A",Asterisk
614555,FERM DOMAIN-CONTAINING PROTEIN 6; FRMD6,Asterisk
614556,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1B; ARID1B,Asterisk
614557,"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2",Number Sign
614558,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13",Number Sign
614559,INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD,Number Sign
614560,"MAU2 CHROMATID COHESION FACTOR, C. ELEGANS, HOMOLOG OF; MAU2",Asterisk
614561,"LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC",Number Sign
614562,MOVED TO 135900,Caret
614563,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13",Number Sign
614564,"CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS",Number Sign
614565,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E",Number Sign
614566,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 3; DNAAF3",Asterisk
614567,"DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 3; DIAPH3",Asterisk
614568,"UNC13, C. ELEGANS, HOMOLOG OF, C; UNC13C",Asterisk
614569,"MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE",Percent
614570,KINESIN FAMILY MEMBER 18B; KIF18B,Asterisk
614571,CILIOGENESIS AND PLANAR POLARITY EFFECTOR 1; CPLANE1,Asterisk
614572,ZINC FINGER PROTEIN 42; ZFP42,Asterisk
614573,G PROTEIN-COUPLED RECEPTOR 158; GPR158,Asterisk
614574,"ROGDI, DROSOPHILA, HOMOLOG OF; ROGDI",Asterisk
614575,"CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS",Percent
614576,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L",Number Sign
614577,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 3; PAQR3",Asterisk
614578,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 4; PAQR4",Asterisk
614579,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 6; PAQR6",Asterisk
614580,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 9; PAQR9",Asterisk
614581,MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN 2; MMD2,Asterisk
614582,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9,Number Sign
614583,BARAITSER-WINTER SYNDROME 2; BRWS2,Number Sign
614584,"PROLYL 4-HYDROXYLASE, TRANSMEMBRANE; P4HTM",Asterisk
614585,FERREDOXIN 1-LIKE PROTEIN; FDX1L,Asterisk
614586,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 5; ZDHHC5,Asterisk
614587,"ChaC, E. COLI, HOMOLOG OF, 1; CHAC1",Asterisk
614588,DYSTONIA 21; DYT21,Percent
614589,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 37; TTC37,Asterisk
614590,"PODOCONIOSIS, SUSCEPTIBILITY TO; PDCOS",Percent
614591,CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 16; CEACAM16,Asterisk
614592,BENT BONE DYSPLASIA SYNDROME; BBDS,Number Sign
614593,MEIOSIS REGULATOR AND mRNA STABILITY FACTOR 1; MARF1,Asterisk
614594,"PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES",Number Sign
614595,PREECLAMPSIA/ECLAMPSIA 5; PEE5,Number Sign
614596,MICRO RNA 302A; MIR302A,Asterisk
614597,MICRO RNA 302B; MIR302B,Asterisk
614598,MICRO RNA 302C; MIR302C,Asterisk
614599,MICRO RNA 302D; MIR302D,Asterisk
614600,MICRO RNA 367; MIR367,Asterisk
614601,ZINC FINGER PROTEIN 326; ZNF326,Asterisk
614602,TRICHOHEPATOENTERIC SYNDROME 2; THES2,Number Sign
614603,DDHD DOMAIN-CONTAINING PROTEIN 1; DDHD1,Asterisk
614604,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 7; ZDHHC7,Asterisk
614605,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 21; ZDHHC21,Asterisk
614606,FOCADHESIN; FOCAD,Asterisk
614607,COFFIN-SIRIS SYNDROME 2; CSS2,Number Sign
614608,COFFIN-SIRIS SYNDROME 3; CSS3,Number Sign
614609,COFFIN-SIRIS SYNDROME 4; CSS4,Number Sign
614610,KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2; KANK2,Asterisk
614611,KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 3; KANK3,Asterisk
614612,KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 4; KANK4,Asterisk
614613,ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2,Number Sign
614614,"DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B",Number Sign
614615,JOUBERT SYNDROME 17; JBTS17,Number Sign
614616,DIARRHEA 6; DIAR6,Number Sign
614617,"DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86",Number Sign
614618,HYPEREKPLEXIA 3; HKPX3,Number Sign
614619,HYPEREKPLEXIA 2; HKPX2,Number Sign
614620,"INTRAFLAGELLAR TRANSPORT 140, CHLAMYDOMONAS, HOMOLOG OF; IFT140",Asterisk
614621,UV-SENSITIVE SYNDROME 2; UVSS2,Number Sign
614622,KERATOCONUS 5; KTCN5,Percent
614623,KERATOCONUS 6; KTCN6,Percent
614624,MITOCHONDRIAL ASSEMBLY OF RIBOSOMAL LARGE SUBUNIT 1; MALSU1,Asterisk
614625,DIFFERENTIATION-ANTAGONIZING NONCODING RNA; DANCR,Asterisk
614626,"SMALL NUCLEOLAR RNA, H/ACA BOX, 26; SNORA26",Asterisk
614627,MICRO RNA 4449; MIR4449,Asterisk
614628,KERATOCONUS 8; KTCN8,Percent
614629,KERATOCONUS 7; KTCN7,Percent
614630,ANDROGLOBIN; ADGB,Asterisk
614631,ISOPRENOID SYNTHASE DOMAIN-CONTAINING PROTEIN; ISPD,Asterisk
614632,UV-STIMULATED SCAFFOLD PROTEIN A; UVSSA,Asterisk
614633,"VACUOLAR PROTEIN SORTING 54, S. CEREVISIAE, HOMOLOG OF; VPS54",Asterisk
614634,CENTROSOMAL PROTEIN 126; CEP126,Asterisk
614635,LONG INTERGENIC NONCODING RNA 538; LINC00538,Asterisk
614636,MYOSIN IH; MYO1H,Asterisk
614637,DESUMOYLATING ISOPEPTIDASE 1; DESI1,Asterisk
614638,DESUMOYLATING ISOPEPTIDASE 2; DESI2,Asterisk
614639,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 46; ZBTB46,Asterisk
614640,UV-SENSITIVE SYNDROME 3; UVSS3,Number Sign
614641,LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 5; LAMP5,Asterisk
614642,START DOMAIN-CONTAINING PROTEIN 9; STARD9,Asterisk
614643,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7",Number Sign
614644,MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 4; MPVQTL4,Percent
614645,MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 5; MPVQTL5,Percent
614646,MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 6; MPVQTL6,Percent
614647,"COQ6, S. CEREVISIAE, HOMOLOG OF; COQ6",Asterisk
614648,RALY-LIKE PROTEIN; RALYL,Asterisk
614649,RING FINGER PROTEIN 170; RNF170,Asterisk
614650,"COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6",Number Sign
614651,"COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2",Number Sign
614652,"COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3",Number Sign
614653,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6",Number Sign
614654,"COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5",Number Sign
614655,"STUTTERING, FAMILIAL PERSISTENT, 3; STUT3",Percent
614656,PALADIN1; PALD1,Asterisk
614657,ANGIOMOTIN-LIKE 1; AMOTL1,Asterisk
614658,ANGIOMOTIN-LIKE 2; AMOTL2,Asterisk
614659,"FAMILY WITH SEQUENCE SIMILARITY 123, MEMBER A; FAM123A",Asterisk
614660,"PROTEIN ASSOCIATED WITH TOPOISOMERASE II, S. CEREVISIAE, HOMOLOG OF, 1; PATL1",Asterisk
614661,"PROTEIN ASSOCIATED WITH TOPOISOMERASE II, S. CEREVISIAE, HOMOLOG OF, 2; PATL2",Asterisk
614662,CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2,Number Sign
614663,"HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN ASSOCIATED WITH LETHAL YELLOW, MOUSE, HOMOLOG OF; RALY",Asterisk
614664,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 4; TREML4,Asterisk
614665,MECONIUM ILEUS,Number Sign
614666,COILED-COIL DOMAIN-CONTAINING PROTEIN 78; CCDC78,Asterisk
614667,"MITOCHONDRIAL TRANSLATION OPTIMIZATION 1, S. CEREVISIAE, HOMOLOG OF; MTO1",Asterisk
614668,"STUTTERING, FAMILIAL PERSISTENT, 4; STUT4",Percent
614669,AURICULOCONDYLAR SYNDROME 2; ARCND2,Number Sign
614670,"PERIPARTUM CARDIOMYOPATHY, SUSCEPTIBILITY TO",Percent
614671,CHROMOSOME 16p11.2 DUPLICATION SYNDROME,Number Sign
614672,"CARDIOMYOPATHY, DILATED, 2B; CMD2B",Number Sign
614673,"MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8",Number Sign
614674,"PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT",Number Sign
614675,BONE MARROW FAILURE SYNDROME 1; BMFS1,Number Sign
614676,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 21; CMH21",Percent
614677,COILED-COIL DOMAIN-CONTAINING PROTEIN 103; CCDC103,Asterisk
614678,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B",Number Sign
614679,"CILIARY DYSKINESIA, PRIMARY, 17; CILD17",Number Sign
614680,"INFLUENZA, SEVERE, SUSCEPTIBILITY TO",Number Sign
614681,AMINOGLYCOSIDE PHOSPHOTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; AGPHD1,Asterisk
614682,ALANINE-GLYOXYLATE AMINOTRANSFERASE 2-LIKE 1; AGXT2L1,Asterisk
614683,5-PHOSPHOHYDROXY-L-LYSINE PHOSPHO-LYASE; PHYKPL,Asterisk
614684,"HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES",Percent
614685,ZINC FINGER PROTEIN 597; ZNF597,Asterisk
614686,"FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER B; FAM50B",Asterisk
614687,"ALAR CLEFT, ISOLATED",
614688,PONTINE TEGMENTAL CAP DYSPLASIA; PTCD,
614689,"SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS",Number Sign
614690,CHROMOSOME 4 OPEN READING FRAME 48; C4ORF48,Asterisk
614691,CATARACT 38; CTRCT38,Number Sign
614692,"MEMBRANOUS NEPHROPATHY, SUSCEPTIBILITY TO; MBNP",Percent
614693,ATM INTERACTOR; ATMIN,Asterisk
614694,REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1B; RPRD1B,Asterisk
614695,REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING 2; RPRD2,Asterisk
614696,AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17,Number Sign
614697,"KATANIN, p60 SUBUNIT, A-LIKE PROTEIN 2; KATNAL2",Asterisk
614698,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX20; COX20,Asterisk
614699,"IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7",Number Sign
614700,"IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8",Number Sign
614701,CORNELIA DE LANGE SYNDROME 4; CDLS4,Number Sign
614702,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10,Number Sign
614703,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2B; SRGAP2B,Asterisk
614704,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2C; SRGAP2C,Asterisk
614705,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2D; SRGAP2D,Asterisk
614706,"CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11",Number Sign
614707,BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2,Number Sign
614708,"SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 3; SCUBE3",Asterisk
614709,LYR MOTIF-CONTAINING PROTEIN 1; LYRM1,Asterisk
614710,"FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER A; FAM72A",Asterisk
614711,"FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER B; FAM72B",Asterisk
614712,"FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER D; FAM72D",Asterisk
614713,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 10; RASSF10",Asterisk
614714,"POROKERATOSIS 7, MULTIPLE TYPES; POROK7",Number Sign
614715,TRANSMEMBRANE AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; TMIGD2,Asterisk
614716,CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 3; CARMIL3,Asterisk
614717,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 15; ANAPC15",Asterisk
614718,KINETOCHORE-LOCALIZED ASTRIN/SPAG5-BINDING PROTEIN; KNSTRN,Asterisk
614719,POTASSIUM CHANNEL MODULATORY FACTOR 1; KCMF1,Asterisk
614720,CYCLIN-DEPENDENT KINASE 19; CDK19,Asterisk
614721,TSPY-LIKE 5; TSPYL5,Asterisk
614722,MICRO RNA 3120; MIR3120,Asterisk
614723,ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD,Number Sign
614724,"CENTROSOMAL PROTEIN, 63-KD; CEP63",Asterisk
614725,SERINE ACTIVE SITE-CONTAINING PROTEIN 1; SERAC1,Asterisk
614726,TRANSMEMBRANE PROTEIN 165; TMEM165,Asterisk
614727,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K",Number Sign
614728,SECKEL SYNDROME 6; SCKL6,Number Sign
614729,"COP9 SIGNALOSOME, SUBUNIT 6; COPS6",Asterisk
614730,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS O PROTEIN; PIGO,Asterisk
614731,"PROSTATE CANCER, HEREDITARY, 2; HPC2",Number Sign
614732,"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES",Number Sign
614733,MICRO RNA 193A; MIR193A,Asterisk
614734,MICRO RNA 193B; MIR193B,Asterisk
614735,MICRO RNA 365A; MIR365A,Asterisk
614736,GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4,Number Sign
614737,BRAIN PROTEIN 44; BRP44,Asterisk
614738,BRAIN PROTEIN 44-LIKE; BRP44L,Asterisk
614739,"3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL",Number Sign
614740,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7",Number Sign
614741,MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD,Number Sign
614742,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1",Number Sign
614743,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2",Number Sign
614744,"FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3",Number Sign
614745,"BLOOD GROUP, JOHN MILTON HAGEN SYSTEM; JMH",Number Sign
614746,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 5; UAQTL5",Percent
614747,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 6; UAQTL6",Percent
614748,"INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB",Number Sign
614749,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2,Number Sign
614750,"MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13",Number Sign
614751,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B",Number Sign
614752,"INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS",Number Sign
614753,SOTOS SYNDROME 2; SOTOS2,Number Sign
614754,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 3; DMRT3,Asterisk
614755,MICRO RNA 520H; MIR520H,Asterisk
614756,"CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR",Number Sign
614757,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 5; IFITM5,Asterisk
614758,DYNACTIN 4; DCTN4,Asterisk
614759,COILED-COIL DOMAIN-CONTAINING PROTEIN 11; CCDC11,Asterisk
614760,PQ LOOP REPEAT-CONTAINING PROTEIN 2; PQLC2,Asterisk
614761,GLYCINE N-ACYLTRANSFERASE-LIKE 1; GLYATL1,Asterisk
614762,GLYCINE N-ACYLTRANSFERASE-LIKE 2; GLYATL2,Asterisk
614763,GLYCINE N-ACYLTRANSFERASE-LIKE 3; GLYATL3,Asterisk
614764,"KATANIN, p60 SUBUNIT, A-LIKE 1; KATNAL1",Asterisk
614765,"STRIATIN, CALMODULIN-BINDING PROTEIN; STRN",Asterisk
614766,"STRIATIN, CALMODULIN-BINDING PROTEIN 3; STRN3",Asterisk
614767,"STRIATIN, CALMODULIN-BINDING PROTEIN 4; STRN4",Asterisk
614768,TRANSMEMBRANE PROTEIN 66; TMEM66,Asterisk
614769,"CYTOCHROME C OXIDASE ASSEMBLY FACTOR 1, S. CEREVISIAE, HOMOLOG OF; COA1",Asterisk
614770,"PET100, S. CEREVISIAE, HOMOLOG OF; PET100",Asterisk
614771,"PET117, S. CEREVISIAE, HOMOLOG OF; PET117",Asterisk
614772,CYTOCHROME c OXIDASE ASSEMBLY FACTOR 6; COA6,Asterisk
614773,"MSS51 MITOCHONDRIAL TRANSLATIONAL ACTIVATOR, S. CEREVISIAE, HOMOLOG OF; MSS51",Asterisk
614774,PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1; PTCD1,Asterisk
614775,CYTOCHROME C OXIDASE ASSEMBLY FACTOR 3; COA3,Asterisk
614776,SIK FAMILY KINASE 3; SIK3,Asterisk
614777,"MMS19 NUCLEOTIDE EXCISION REPAIR, S. CEREVISIAE, HOMOLOG OF; MMS19",Asterisk
614778,"FAMILY WITH SEQUENCE SIMILARITY 96, MEMBER B; FAM96B",Asterisk
614779,"HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6",Number Sign
614780,SORTING NEXIN 10; SNX10,Asterisk
614781,TECTONIN BETA-PROPELLER REPEAT-CONTAINING 1; TECPR1,Asterisk
614782,"TREMOR, HEREDITARY ESSENTIAL, 4; ETM4",Number Sign
614783,"POC1 CENTRIOLAR PROTEIN, CHLAMYDOMONAS, HOMOLOG OF, A; POC1A",Asterisk
614784,"POC1 CENTRIOLAR PROTEIN, CHLAMYDOMONAS, HOMOLOG OF, B; POC1B",Asterisk
614785,MITOCHONDRIAL FISSION FACTOR; MFF,Asterisk
614786,TRANSMEMBRANE PROTEIN 207; TMEM207,Asterisk
614787,POGO TRANSPOSABLE ELEMENT WITH ZNF DOMAIN; POGZ,Asterisk
614788,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 5; FGD5",Asterisk
614789,EGF DOMAIN-SPECIFIC O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; EOGT,Asterisk
614790,WT1-INTERACTING PROTEIN; WTIP,Asterisk
614791,MICRO RNA 199B; MIR199B,Asterisk
614792,TRANSMEMBRANE AND UBIQUITIN-LIKE DOMAIN-CONTAINING PROTEIN 1; TMUB1,Asterisk
614793,MIXED-LINEAGE KINASE 4,Asterisk
614794,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 3; AGPAT3,Asterisk
614795,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 4; AGPAT4,Asterisk
614796,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 5; AGPAT5,Asterisk
614797,"PELLINO, DROSOPHILA, HOMOLOG OF, 1; PELI1",Asterisk
614798,"PELLINO, DROSOPHILA, HOMOLOG OF, 2; PELI2",Asterisk
614799,CHROMOSOME 1 OPEN READING FRAME 109; C1ORF109,Asterisk
614800,"SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH",Number Sign
614801,"MALE-SPECIFIC LETHAL 1, DROSOPHILA, HOMOLOG OF; MSL1",Asterisk
614802,"MALE-SPECIFIC LETHAL 2, DROSOPHILA, HOMOLOG OF; MSL2",Asterisk
614803,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A1; DMRTA1,Asterisk
614804,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A2; DMRTA2,Asterisk
614805,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR B1; DMRTB1,Asterisk
614806,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C2; DMRTC2,Asterisk
614807,"MYOPATHY, CENTRONUCLEAR, 4; CNM4",Number Sign
614808,AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18,Number Sign
614809,CFHR5 DEFICIENCY,Number Sign
614810,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5",Number Sign
614811,"L-3-HYDROXYPROLINE DEHYDRATASE, TRANS; L3HYPDH",Asterisk
614812,"NUCLEAR PROTEIN, TRANSCRIPTIONAL REGULATOR, 1; NUPR1",Asterisk
614813,"SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT",Number Sign
614814,ADAMS-OLIVER SYNDROME 3; AOS3,Number Sign
614815,JOUBERT SYNDROME 18; JBTS18,Number Sign
614816,LOEYS-DIETZ SYNDROME 4; LDS4,Number Sign
614817,"INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN",Number Sign
614818,"FURRY, DROSOPHILA, HOMOLOG OF; FRY",Asterisk
614819,WEILL-MARCHESANI SYNDROME 3; WMS3,Number Sign
614820,ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2,Number Sign
614821,PTCSC3 GENE; PTCSC3,Asterisk
614822,SPERMATOGENIC FAILURE 10; SPGF10,Number Sign
614823,AORTIC VALVE DISEASE 2; AOVD2,Number Sign
614824,"ADAPTOR-RELATED PROTEIN COMPLEX 5, SIGMA-1 SUBUNIT; AP5S1",Asterisk
614825,RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 1; REPS1,Asterisk
614826,"NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7",Percent
614827,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 11; DNAJC11",Asterisk
614828,"PROTEIN O-MANNOSE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE 2; POMGNT2",Asterisk
614829,ODONTOGENESIS-ASSOCIATED PHOSPHOPROTEIN; ODAPH,Asterisk
614830,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8",Number Sign
614831,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13",Number Sign
614832,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4",Number Sign
614833,"MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP",Number Sign
614834,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 3; TTPP3",Percent
614835,"ACTIN, BETA-LIKE, 2; ACTBL2",Asterisk
614836,"HUMAN HERPESVIRUS 8, SUSCEPTIBILITY TO; HHV8S",Percent
614837,HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8,Number Sign
614838,HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9,Number Sign
614839,HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10,Number Sign
614840,HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11,Number Sign
614841,HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12,Number Sign
614842,HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13,Number Sign
614843,ODONTOGENIC AMELOBLAST-ASSOCIATED PROTEIN; ODAM,Asterisk
614844,NEPHRONOPHTHISIS 14; NPHP14,Number Sign
614845,NEPHRONOPHTHISIS 15; NPHP15,Number Sign
614846,TETRASOMY 15q26,Number Sign
614847,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12",Number Sign
614848,"CENTROSOMAL PROTEIN, 164-KD; CEP164",Asterisk
614849,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 5; IIAE5",Number Sign
614850,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6; IIAE6",Number Sign
614851,SECKEL SYNDROME 7; SCKL7,Number Sign
614852,"MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9",Number Sign
614853,CYTOKINE RECEPTOR-LIKE FACTOR 3; CRLF3,Asterisk
614854,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 59; LRRC59,Asterisk
614855,"TBC1 DOMAIN FAMILY, MEMBER 14; TBC1D14",Asterisk
614856,"OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13",Number Sign
614857,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ",Number Sign
614858,HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14,Number Sign
614859,PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A,Number Sign
614860,DYSTONIA 23; DYT23,Number Sign
614861,"DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98",Number Sign
614862,PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A,Number Sign
614863,PEROXISOME BIOGENESIS DISORDER 4B; PBD4B,Number Sign
614864,DYNEIN AXONEMAL ASSEMBLY FACTOR 5; DNAAF5,Asterisk
614865,"D4Z4 BINDING ELEMENT TRANSCRIPT, NONCODING; DBET",Asterisk
614866,PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A,Number Sign
614867,PEROXISOME BIOGENESIS DISORDER 5B; PBD5B,Number Sign
614868,"T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS; TIIAC",Number Sign
614869,"USHER SYNDROME, TYPE IJ; USH1J",Number Sign
614870,PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A,Number Sign
614871,PEROXISOME BIOGENESIS DISORDER 6B; PBD6B,Number Sign
614872,PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A,Number Sign
614873,PEROXISOME BIOGENESIS DISORDER 7B; PBD7B,Number Sign
614874,"CILIARY DYSKINESIA, PRIMARY, 18; CILD18",Number Sign
614875,METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA,Percent
614876,PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A,Number Sign
614877,PEROXISOME BIOGENESIS DISORDER 8B; PBD8B,Number Sign
614878,"AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; APLAID",Number Sign
614879,PEROXISOME BIOGENESIS DISORDER 9B; PBD9B,Number Sign
614880,HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15,Number Sign
614881,"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5",Number Sign
614882,PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A,Number Sign
614883,PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A,Number Sign
614884,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 3B; VWA3B,Asterisk
614885,PEROXISOME BIOGENESIS DISORDER 11B; PBD11B,Number Sign
614886,PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A,Number Sign
614887,PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A,Number Sign
614888,ALPHA- AND GAMMA-ADAPTIN-BINDING PROTEIN; AAGAB,Asterisk
614889,IMMUNODEFICIENCY 28; IMD28,Number Sign
614890,IMMUNODEFICIENCY 29; IMD29,Number Sign
614891,IMMUNODEFICIENCY 30; IMD30,Number Sign
614892,IMMUNODEFICIENCY 31A; IMD31A,Number Sign
614893,IMMUNODEFICIENCY 32A; IMD32A,Number Sign
614894,MOVED TO 226990,Caret
614895,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F",Number Sign
614896,SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD,Number Sign
614897,HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16,Number Sign
614898,"SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53",Number Sign
614899,"DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93",Number Sign
614900,DIAMOND-BLACKFAN ANEMIA 11; DBA11,Number Sign
614901,BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE KINASE; BCKDK,Asterisk
614902,RHO GTPase-ACTIVATING PROTEIN 33; ARHGAP33,Asterisk
614903,SORTING NEXIN 16; SNX16,Asterisk
614904,SORTING NEXIN 7; SNX7,Asterisk
614905,SORTING NEXIN 8; SNX8,Asterisk
614906,SORTING NEXIN 11; SNX11,Asterisk
614907,"PRECURSOR mRNA-PROCESSING FACTOR 39, S. CEREVISIAE, HOMOLOG OF; PRPF39",Asterisk
614908,HEAT SHOCK PROTEIN NUCLEAR IMPORT FACTOR HIKESHI; HIKESHI,Asterisk
614909,TRANSMEMBRANE PROTEIN 174; TMEM174,Asterisk
614910,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 6; C1QTNF6,Asterisk
614911,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 4; C1QTNF4,Asterisk
614912,TRAB DOMAIN-CONTAINING PROTEIN 2A; TRABD2A,Asterisk
614913,TRAB DOMAIN-CONTAINING PROTEIN 2B; TRABD2B,Asterisk
614914,MICRO RNA 298; MIR298,Asterisk
614915,LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4,Number Sign
614916,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4",Number Sign
614917,"REQUIRED FOR MEIOTIC NUCLEAR DIVISION 1, S. CEREVISIAE, HOMOLOG OF; RMND1",Asterisk
614918,PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3; PTCD3,Asterisk
614919,NITRIC OXIDE-ASSOCIATED PROTEIN 1; NOA1,Asterisk
614920,PEROXISOME BIOGENESIS DISORDER 14B; PEX14B,Number Sign
614921,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T",Number Sign
614922,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11,Number Sign
614923,BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD,Number Sign
614924,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12,Number Sign
614925,OTOGELIN-LIKE PROTEIN; OTOGL,Asterisk
614926,PERRAULT SYNDROME 2; PRLTS2,Number Sign
614927,"ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE; ECTD5",Percent
614928,"ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6",Percent
614929,"ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7",Number Sign
614930,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 6; LRRC6,Asterisk
614931,"ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE; ECTD9",Number Sign
614932,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13,Number Sign
614933,"LONG INTERGENIC NONCODING RNA, MUSCLE DIFFERENTIATION 1; LINCMD1",Asterisk
614934,"DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70",Number Sign
614935,"CILIARY DYSKINESIA, PRIMARY, 19; CILD19",Number Sign
614936,"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IB; PPKP1B",Percent
614937,"MYOCLONUS, FAMILIAL CORTICAL; FCM",Number Sign
614938,VAULT RNA 2-1; VTRNA2-1,Asterisk
614939,"PHOSPHOGLYCERATE MUTASE FAMILY, MEMBER 5; PGAM5",Asterisk
614940,"ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A",Number Sign
614941,"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B",Number Sign
614942,PHOSPHATIDYLGLYCEROPHOSPHATE SYNTHASE 1; PGS1,Asterisk
614943,TP53-REGULATED INHIBITOR OF APOPTOSIS 1; TRIAP1,Asterisk
614944,"DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B",Number Sign
614945,"DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B",Number Sign
614946,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14,Number Sign
614947,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15,Number Sign
614948,"TRANSLOCATOR ASSEMBLY AND MAINTENANCE, MITOCHONDRIAL, S. CEREVISIAE, HOMOLOG OF; TAMM41",Asterisk
614949,TRANSMEMBRANE PROTEIN 231; TMEM231,Asterisk
614950,TRANSMEMBRANE PROTEIN 17; TMEM17,Asterisk
614951,HEAT REPEAT-CONTAINING PROTEIN 3; HEATR3,Asterisk
614952,"SCHLAFEN FAMILY, MEMBER 5; SLFN5",Asterisk
614953,"SCHLAFEN FAMILY, MEMBER 11; SLFN11",Asterisk
614954,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3",Percent
614955,"SCHLAFEN FAMILY, MEMBER 12; SLFN12",Asterisk
614956,"SCHLAFEN FAMILY, MEMBER 12-LIKE; SLFN12L",Asterisk
614957,"SCHLAFEN FAMILY, MEMBER 13; SLFN13",Asterisk
614958,"SCHLAFEN FAMILY, MEMBER 14; SLFN14",Asterisk
614959,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14",Number Sign
614960,"PHOSPHOLIPASE D FAMILY, MEMBER 6; PLD6",Asterisk
614961,"PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8",Number Sign
614962,LEPTIN DEFICIENCY OR DYSFUNCTION; LEPD,Number Sign
614963,LEPTIN RECEPTOR DEFICIENCY,Number Sign
614964,EXTRACELLULAR LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; ELFN1,Asterisk
614965,SECERNIN 1; SCRN1,Asterisk
614966,SECERNIN 2; SCRN2,Asterisk
614967,SECERNIN 3; SCRN3,Asterisk
614968,SH2 DOMAIN-CONTAINING PROTEIN 4A; SH2D4A,Asterisk
614969,"PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7",Number Sign
614970,JOUBERT SYNDROME 20; JBTS20,Number Sign
614971,"TAURINE-UPREGULATED GENE 1, NONCODING; TUG1",Asterisk
614972,"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3",Number Sign
614973,"FOCAL FACIAL DERMAL DYSPLASIA 2, BRAUER-SETLEIS TYPE; FFDD2",Percent
614974,FOCAL FACIAL DERMAL DYSPLASIA 4; FFDD4,Number Sign
614975,FOXF1 ADJACENT NONCODING DEVELOPMENTAL REGULATORY RNA; FENDRR,Asterisk
614976,CARPENTER SYNDROME 2; CRPT2,Number Sign
614977,LONG INTERGENIC NONCODING RNA 1081; LINC01081,Asterisk
614978,LONG INTERGENIC NONCODING RNA 1082; LINC01082,Asterisk
614979,"SPLENOMEGALY, CYTOPENIA, AND VISION LOSS",Percent
614980,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2",Number Sign
614981,ATPase INHIBITORY FACTOR 1; ATPIF1,Asterisk
614982,STRUCTURAL MAINTENANCE OF CHROMOSOMES FLEXIBLE HINGE DOMAIN-CONTAINING PROTEIN 1; SMCHD1,Asterisk
614983,"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE 2; BATF2",Asterisk
614984,DEHYDROGENASE E1 AND TRANSKETOLASE DOMAINS-CONTAINING PROTEIN 1; DHTKD1,Asterisk
614985,HELLP SYNDROME-ASSOCIATED LONG NONCODING RNA; HELLPAR,Asterisk
614986,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 1; CAMK2N1,Asterisk
614987,EPS8-LIKE PROTEIN 1; EPS8L1,Asterisk
614988,EPS8-LIKE PROTEIN 2; EPS8L2,Asterisk
614989,EPS8-LIKE PROTEIN 3; EPS8L3,Asterisk
614990,"USHER SYNDROME, TYPE IK; USH1K",Percent
614991,"UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1, ANTISENSE; UCH1LAS",Asterisk
614992,LONG INTERGENIC NONCODING RNA 237; LINC00237,Asterisk
614993,CAM KINASE-LIKE VESICLE-ASSOCIATED; CAMKV,Asterisk
614994,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IG; CAMK1G,Asterisk
614995,INTERLEUKIN 17 RECEPTOR E; IL17RE,Asterisk
614996,MYELINATING SCHWANN CELL ELEMENT; MSE,Asterisk
614997,GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 2A; GATAD2A,Asterisk
614998,GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 2B; GATAD2B,Asterisk
614999,"CYTOCHROME P450, FAMILY 4, SUBFAMILY X, POLYPEPTIDE 1; CYP4X1",Asterisk
615000,TECTONIN BETA-PROPELLER REPEAT-CONTAINING PROTEIN 2; TECPR2,Asterisk
615001,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12C; ZC3H12C,Asterisk
615002,"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA; CAMKK2",Asterisk
615003,DDHD DOMAIN-CONTAINING PROTEIN 2; DDHD2,Asterisk
615004,"LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 3; LRIT3",Asterisk
615005,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5",Number Sign
615006,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15",Number Sign
615007,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4",Number Sign
615008,"NEPHROTIC SYNDROME, TYPE 7; NPHS7",Number Sign
615009,SCHUURS-HOEIJMAKERS SYNDROME; SHMS,Number Sign
615010,AICARDI-GOUTIERES SYNDROME 6; AGS6,Number Sign
615011,PHOSPHOHYDROXYLYSINURIA; PHLU,Number Sign
615012,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER G; HIST1H2AG",Asterisk
615013,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER H; HIST1H2AH",Asterisk
615014,"HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER B; HIST2H2AB",Asterisk
615015,"HISTONE GENE CLUSTER 3, H2A HISTONE; HIST3H2A",Asterisk
615016,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY J, MEMBER 3; OR2J3",Asterisk
615017,MICRO RNA 139; MIR139,Asterisk
615019,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 5; ELP5",Asterisk
615020,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 6; ELP6",Asterisk
615021,"BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB",Number Sign
615022,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 7; ARCI7",Percent
615023,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9; ARCI9",Number Sign
615024,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10",Number Sign
615025,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q",Number Sign
615026,RIBOFLAVIN DEFICIENCY; RBFVD,Number Sign
615027,SIN3-HDAC COMPLEX ASSOCIATED FACTOR; SINHCAF,Asterisk
615028,"EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE; EBNS",Number Sign
615029,PRECEREBELLIN 4; CBLN4,Asterisk
615030,"SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56",Number Sign
615031,"SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49",Number Sign
615032,"AUTISM, SUSCEPTIBILITY TO, 18; AUTS18",Number Sign
615033,"SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54",Number Sign
615034,DYSTONIA 24; DYT24,Number Sign
615035,"SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55",Number Sign
615036,MICRO RNA 410; MIR410,Asterisk
615037,MICRO RNA 487B; MIR487B,Asterisk
615038,COILED-COIL DOMAIN-CONTAINING PROTEIN 114: CCDC114,Asterisk
615039,N-DEACETYLASE/N-SULFOTRANSFERASE 4; NDST4,Asterisk
615040,"EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1",Number Sign
615041,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10; MDDGA10",Number Sign
615042,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U",Number Sign
615043,"SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43",Number Sign
615044,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER J; HIST1H2BJ",Asterisk
615045,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER K; HIST1H2BK",Asterisk
615046,"HISTONE GENE CLUSTER 3, H2B HISTONE FAMILY, MEMBER B; HIST3H2BB",Asterisk
615047,"TETRATRICOPEPTIDE REPEAT-, ANKYRIN REPEAT-, AND COILED-COIL-CONTAINING PROTEIN 2; TANC2",Asterisk
615048,"SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ",Number Sign
615049,WW DOMAIN-CONTAINING ADAPTOR WITH COILED-COIL REGION; WAC,Asterisk
615050,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 5; ASB5,Asterisk
615051,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 6; ASB6,Asterisk
615052,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 7; ASB7,Asterisk
615053,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 8; ASB8,Asterisk
615054,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 10; ASB10,Asterisk
615055,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 13; ASB13,Asterisk
615056,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 16; ASB16,Asterisk
615057,MOVED TO 244450,Caret
615058,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F",Number Sign
615059,HYPOTRICHOSIS 11; HYPT11,Number Sign
615060,"SECRETOGLOBIN, FAMILY 1D, MEMBER 1; SCGB1D1",Asterisk
615061,"SECRETOGLOBIN, FAMILY 1D, MEMBER 2; SCGB1D2",Asterisk
615062,"SECRETOGLOBIN, FAMILY 1D, MEMBER 4; SCGB1D4",Asterisk
615063,"SECRETOGLOBIN, FAMILY 2B, MEMBER 2; SCGB2B2",Asterisk
615064,"SOLUTE CARRIER FAMILY 25 (CARNITINE/ACYLCARNITINE TRANSLOCASE), MEMBER 29; SLC25A29",Asterisk
615065,"ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D",Number Sign
615066,"OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14",Number Sign
615067,"CILIARY DYSKINESIA, PRIMARY, 20; CILD20",Number Sign
615068,"ECTOPIC P-GRANULES AUTOPHAGY PROTEIN 5, C. ELEGANS, HOMOLOG OF; EPG5",Asterisk
615069,"HISTONE GENE CLUSTER 4, H4 HISTONE; HIST4H4",Asterisk
615070,MICRO RNA 590; MIR590,Asterisk
615071,ALAZAMI SYNDROME; ALAZS,Number Sign
615072,"BRACHYDACTYLY, TYPE A1, C; BDA1C",Number Sign
615073,DYSTONIA 25; DYT25,Number Sign
615074,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18",Number Sign
615075,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 19; MRD19",Number Sign
615076,MITOCHONDRIAL GENOME MAINTENANCE EXONUCLEASE 1; MGME1,Asterisk
615077,"TBC1 DOMAIN FAMILY, MEMBER 30; TBC1D30",Asterisk
615078,GOLGI TRANSPORT 1B; GOLT1B,Asterisk
615079,"ASUNDER, SPERMATOGENESIS REGULATOR; ASUN",Asterisk
615080,ALZHEIMER DISEASE 17; AD17,Percent
615081,SPERMATOGENIC FAILURE 11; SPGF11,Number Sign
615082,"C3HEX, ABILITY TO SMELL",Number Sign
615083,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12",Number Sign
615084,MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11,Number Sign
615085,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8",Number Sign
615086,HARBINGER TRANSPOSASE-DERIVED GENE 1; HARBI1,Asterisk
615087,MOVED TO 613091,Caret
615088,"AUTOPHAGY 13, S. CEREVISIAE, HOMOLOG OF; ATG13",Asterisk
615089,AUTOPHAGY-RELATED PROTEIN 101; ATG101,Asterisk
615090,"INTERFERON, LAMBDA-4; IFNL4",Asterisk
615091,"AUTISM, SUSCEPTIBILITY TO, 19; AUTS19",Number Sign
615092,LEFT VENTRICULAR NONCOMPACTION 7; LVNC7,Number Sign
615093,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS K; LY6K",Asterisk
615094,PROSPERO-RELATED HOMEOBOX 2; PROX2,Asterisk
615095,"MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10",Number Sign
615096,MICRO RNA 217; MIR217,Asterisk
615097,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 13; SLC6A13",Asterisk
615098,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 28; TTC28,Asterisk
615099,ERYTHROFERRONE; ERFE,Asterisk
615100,CTTNBP2 N TERMINUS-LIKE PROTEIN; CTTNBP2NL,Asterisk
615101,"TUBULIN, BETA-2A; TUBB2A",Asterisk
615102,TYSHCHENKO SYNDROME,Percent
615103,"TUBULIN, BETA-6; TUBB6",Asterisk
615104,NCK-ASSOCIATED PROTEIN 5-LIKE; NCKAP5L,Asterisk
615105,"METHYLTHIORIBOSE-1-PHOSPHATE ISOMERASE, S. CEREVISIAE, HOMOLOG OF; MRI1",Asterisk
615106,MOVED TO 158350,Caret
615107,COWDEN SYNDROME 4; CWS4,Number Sign
615108,COWDEN SYNDROME 5; CWS5,Number Sign
615109,COWDEN SYNDROME 6; CWS6,Number Sign
615110,WD REPEAT-CONTAINING PROTEIN 53; WDR53,Asterisk
615111,DENN/MADD DOMAIN-CONTAINING PROTEIN 2D; DENND2D,Asterisk
615112,UROFACIAL SYNDROME 2; UFS2,Number Sign
615113,"MICROPHTHALMIA, ISOLATED 8; MCOP8",Number Sign
615114,ZINC FINGER PROTEIN 516; ZNF516,Asterisk
615115,ADDITIONAL SEX COMBS-LIKE 3; ASXL3,Asterisk
615116,SPERMATID MATURATION PROTEIN 1; SPEM1,Asterisk
615117,CHROMOSOME 2 OPEN READING FRAME 88; C2ORF88,Asterisk
615118,MOVED TO 269300,Caret
615119,"CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2",Number Sign
615120,"MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8",Number Sign
615121,"STOMATIN-LIKE PROTEIN-2, HYPERPHOSPHORYLATION OF",Percent
615122,LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2,Number Sign
615123,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13A; ANKRD13A,Asterisk
615124,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13B; ANKRD13B,Asterisk
615125,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13C; ANKRD13C,Asterisk
615126,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13D; ANKRD13D,Asterisk
615127,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4",Percent
615128,STIMULATED BY RETINOIC ACID 13; STRA13,Asterisk
615129,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 5; GALNT5,Asterisk
615130,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 11; GALNT11,Asterisk
615131,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 15; GALNT15,Asterisk
615132,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 16; GALNT16,Asterisk
615133,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE-LIKE 5; GALNTL5,Asterisk
615134,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9",Number Sign
615135,"MAPLE SYRUP URINE DISEASE, MILD VARIANT; MSUDMV",Number Sign
615136,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 18; GALNT18,Asterisk
615137,WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 17; WBSCR17,Asterisk
615138,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE-LIKE 6; GALNTL6,Asterisk
615139,"FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS",Number Sign
615140,CHROMOSOME 12 OPEN READING FRAME 57; C12ORF57,Asterisk
615141,MOVED TO 177700,Caret
615142,KINESIN FAMILY MEMBER 2B; KIF2B,Asterisk
615143,UBIQUITIN-SPECIFIC PROTEASE 20; USP20,Asterisk
615144,"PROTEASE, SERINE, 55; PRSS55",Asterisk
615145,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9",Number Sign
615146,UBIQUITIN-SPECIFIC PROTEASE 33; USP33,Asterisk
615147,"RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS",Number Sign
615148,MICRO RNA 551A; MIR551A,Asterisk
615149,MICRO RNA 495; MIR495,Asterisk
615150,MICRO RNA 191; MIR191,Asterisk
615151,MICRO RNA 30C-1; MIR30C1,Asterisk
615152,KELCH DOMAIN-CONTAINING PROTEIN 10; KLHDC10,Asterisk
615153,MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN; MLKL,Asterisk
615154,DPY30 DOMAIN-CONTAINING PROTEIN 1; DYDC1,Asterisk
615155,STEEL SYNDROME; STLS,Number Sign
615156,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6; PEOA6",Number Sign
615157,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2",Number Sign
615158,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3",Number Sign
615159,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4",Number Sign
615160,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5",Number Sign
615161,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-2; HLA-DQB2",Asterisk
615162,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35; MRT35",Percent
615163,CONE-ROD DYSTROPHY 17; CORD17,Percent
615164,AKIRIN 1; AKIRIN1,Asterisk
615165,AKIRIN 2; AKIRIN2,Asterisk
615166,"COX ASSEMBLY MITOCHONDRIAL PROTEIN 1, S. CEREVISIAE, HOMOLOG OF; CMC1",Asterisk
615167,LEUCINE-RICH REPEATS- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; LRWD1,Asterisk
615168,ARCHAELYSIN FAMILY METALLOPEPTIDASE 1; AMZ1,Asterisk
615169,ARCHAELYSIN FAMILY METALLOPEPTIDASE 2; AMZ2,Asterisk
615170,WAHAB SYNDROME,Percent
615171,LOC100134040 GENE,Asterisk
615172,"RING FINGER PROTEIN, TRANSMEMBRANE 1; RNFT1",Asterisk
615173,"LONG INTERGENIC NONCODING RNA, REGULATOR OF REPROGRAMMING; LINC-ROR",Asterisk
615174,"L-THREONINE DEHYDROGENASE, PSEUDOGENE; TDH",
615175,"FAMILY WITH SEQUENCE SIMILARITY 57, MEMBER B; FAM57B",Asterisk
615176,"NPTN INTRONIC TRANSCRIPT 1, NONCODING; NPTNIT1",Asterisk
615177,RING FINGER PROTEIN 126; RNF126,Asterisk
615178,KXDL MOTIF-CONTAINING PROTEIN 1; KXD1,Asterisk
615179,"ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7",Number Sign
615180,"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 21, YEAST, HOMOLOG OF; TIMM21",Asterisk
615181,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11",Number Sign
615182,COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD,Number Sign
615183,CHROMOSOME 1 OPEN READING FRAME 86; C1ORF86,Asterisk
615184,"CARDIOMYOPATHY, DILATED, 1II; CMD1II",Number Sign
615185,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF",Number Sign
615186,"CWC22 SPLICEOSOME-ASSOCIATED PROTEIN, S. CEREVISIAE, HOMOLOG OF; CWC22",Asterisk
615187,POST-GPI ATTACHMENT TO PROTEINS 2; PGAP2,Asterisk
615188,"CATARACT 39, MULTIPLE TYPES; CTRCT39",Number Sign
615189,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 55; ANKRD55,Asterisk
615190,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5",Number Sign
615191,LISSENCEPHALY 5; LIS5,Number Sign
615192,BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 4; BWQTL4,Percent
615193,"BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15",Number Sign
615194,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 2; DHRS2",Asterisk
615195,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4-LIKE 1; DHRS4L1",Asterisk
615196,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4-LIKE 2; DHRS4L2",Asterisk
615197,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 8; RLS8",Percent
615198,OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA; OSMD,Percent
615199,"SOLUTE CARRIER FAMILY 35, MEMBER G5; SLC35G5",Asterisk
615200,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY F, MEMBER 1; PLEKHF1",Asterisk
615201,MICRO RNA 1909; MIR1909,Asterisk
615202,MICRO RNA 1915; MIR1915,Asterisk
615203,RHOMBOID DOMAIN-CONTAINING PROTEIN 2; RHBDD2,Asterisk
615204,"UPREGULATED DURING SKELETAL MUSCLE GROWTH 5, MOUSE, HOMOLOG OF; USMG5",Asterisk
615205,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 13; SPINK13",Asterisk
615206,IMMUNODEFICIENCY 11; IMD11A,Number Sign
615207,IMMUNODEFICIENCY 56; IMD56,Number Sign
615208,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY F, MEMBER 2; PLEKHF2",Asterisk
615209,MICRO RNA 149; MIR149,Asterisk
615210,PEST-CONTAINING NUCLEAR PROTEIN; PCNP,Asterisk
615211,"UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 2, E3 UBIQUITIN PROTEIN LIGASE; UHRF2",Asterisk
615212,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 38; LRRC38,Asterisk
615213,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 55; LRRC55,Asterisk
615214,"AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7",Number Sign
615215,"POTASSIUM CHANNEL, SUBFAMILY U, MEMBER 1; KCNU1",Asterisk
615216,KINESIN FAMILY MEMBER C2; KIFC2,Asterisk
615217,ATAXIA-OCULOMOTOR APRAXIA 3; AOA3,Number Sign
615218,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 52; LRRC52,Asterisk
615219,"HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2",Number Sign
615220,"OSTEOGENESIS IMPERFECTA, TYPE XV; OI15",Number Sign
615221,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16,Number Sign
615222,SMITH-MCCORT DYSPLASIA 2; SMC2,Number Sign
615223,"INTERFERON, EPSILON; IFNE",Asterisk
615224,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2",Number Sign
615225,"PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC",Number Sign
615226,"POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6",Number Sign
615227,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 3; C1QL3",Asterisk
615228,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4",Number Sign
615229,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 4; C1QL4",Asterisk
615230,LONG INTERGENIC NONCODING RNA 1080; LINC01080,Asterisk
615231,RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING PROTEIN 2; RC3H2,Asterisk
615232,SCHIZOPHRENIA 18; SCZD18,Number Sign
615233,RETINITIS PIGMENTOSA 66; RP66,Number Sign
615234,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2",Number Sign
615235,"CARDIOMYOPATHY, DILATED, 1JJ; CMD1JJ",Number Sign
615236,WOODS SYNDROME,
615237,CONGENITAL SHORT BOWEL SYNDROME; CSBS,Number Sign
615238,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5",Number Sign
615239,MICRO RNA 7-1; MIR7-1,Asterisk
615240,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 15; KCTD15,Asterisk
615241,TERMINAL DIFFERENTIATION-INDUCED NONCODING RNA; TINCR,Asterisk
615242,SMALL INTEGRAL MEMBRANE PROTEIN 1; SMIM1,Asterisk
615243,"DEFENSIN, BETA, 114; DEFB114",Asterisk
615244,"NEPHROTIC SYNDROME, TYPE 8; NPHS8",Number Sign
615245,MICRO RNA 671; MIR671,Asterisk
615246,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 2; ZBED2,Asterisk
615247,PROTEIN-O-MANNOSE KINASE; POMK,Asterisk
615248,"CARDIOMYOPATHY, DILATED, 1KK; CMD1KK",Number Sign
615249,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12",Number Sign
615250,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 3; ZBED3,Asterisk
615251,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 5; ZBED5,Asterisk
615252,ZBED6 C TERMINUS-LIKE PROTEIN; ZBED6CL,Asterisk
615253,CHROMOSOME 5 OPEN READING FRAME 54; C5ORF54,Asterisk
615254,SCAN DOMAIN-CONTAINING PROTEIN 3; SCAND3,Asterisk
615255,METHYLTRANSFERASE-LIKE 18; METTL18,Asterisk
615256,ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT LYSINE METHYLTRANSFERASE; ETFBKMT,Asterisk
615257,METHYLTRANSFERASE-LIKE 21A; METTL21A,Asterisk
615258,EEF1A LYSINE METHYLTRANSFERASE 3; EEF1AKMT3,Asterisk
615259,METHYLTRANSFERASE-LIKE 21C; METTL21C,Asterisk
615260,VALOSIN-CONTAINING PROTEIN LYSINE METHYLTRANSFERASE; VCPKMT,Asterisk
615261,METHYLTRANSFERASE-LIKE 22; METTL22,Asterisk
615262,METHYLTRANSFERASE-LIKE 23; METTL23,Asterisk
615263,EUKARYOTIC ELONGATION FACTOR 2 LYSINE METHYLTRANSFERASE; EEF2KMT,Asterisk
615264,"BLOOD GROUP, VEL SYSTEM; VEL",Number Sign
615265,FORMIN-BINDING PROTEIN 4; FNBP4,Asterisk
615266,HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17,Number Sign
615267,HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18,Number Sign
615268,"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4",Number Sign
615269,HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19,Number Sign
615270,HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20,Number Sign
615271,HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21,Number Sign
615272,"FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ",Number Sign
615273,CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG,Number Sign
615274,"CATARACT 15, MULTIPLE TYPES; CTRCT15",Number Sign
615275,ACONITATE DECARBOXYLASE 1; ACOD1,Asterisk
615276,CERAMIDE SYNTHASE 3; CERS3,Asterisk
615277,"CATARACT 19, MULTIPLE TYPES; CTRCT19",Number Sign
615278,CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2,Number Sign
615279,CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3,Number Sign
615280,CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4,Number Sign
615281,HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL,Number Sign
615282,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2",Number Sign
615283,EXOCYST COMPLEX COMPONENT 8; EXOC8,Asterisk
615284,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3",Number Sign
615285,"NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5",Number Sign
615286,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36",Number Sign
615287,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13",Number Sign
615288,"DYNEIN REGULATORY COMPLEX, SUBUNIT 1, CHLAMYDOMONAS, HOMOLOG OF; DRC1",Asterisk
615289,MITOTIC SPINDLE-POSITIONING PROTEIN; MISP,Asterisk
615290,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMAL DOMINANT; SMALED2",Number Sign
615291,"BETA-1,3-GALACTOSYLTRANSFERASE 6; B3GALT6",Asterisk
615292,"FAMILY WITH SEQUENCE SIMILARITY 111, MEMBER A; FAM111A",Asterisk
615293,"MYOFIBROMATOSIS, INFANTILE, 2; IMF2",Number Sign
615294,"CILIARY DYSKINESIA, PRIMARY, 21; CILD21",Number Sign
615295,UBIQUITIN-SPECIFIC PROTEASE 34; USP34,Asterisk
615296,"INTERLEUKIN 1 FAMILY, MEMBER 10; IL1F10",Asterisk
615297,ADAMS-OLIVER SYNDROME 4; AOS4,Number Sign
615298,"SYMPHALANGISM, PROXIMAL, 1B; SYM1B",Number Sign
615299,NUCLEOREDOXIN-LIKE PROTEIN 2; NXNL2,Asterisk
615300,PERRAULT SYNDROME 4; PRLTS4,Number Sign
615301,TRANSMEMBRANE PROTEIN 214; TMEM214,Asterisk
615302,"ADENOSINE DEAMINASE, tRNA-SPECIFIC, 3; ADAT3",Asterisk
615303,TRANSFER RNA GLYCINE 3; TRNAG3,Asterisk
615304,TRANSFER RNA VALINE 32; TRNAV32,Asterisk
615305,TRANSFER RNA ARGININE 2; TRNAR2,Asterisk
615306,TRANSFER RNA VALINE 21; TRNAV21,Asterisk
615307,TRANSFER RNA VALINE 12; TRNAV12,Asterisk
615308,TRANSFER RNA VALINE 17; TRNAV17,Asterisk
615309,TRANSFER RNA THREONINE 15; TRNAT15,Asterisk
615310,TRANSFER RNA VALINE (AAC) 1-1; TRV-AAC1-1,Asterisk
615311,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17; BMND17,Number Sign
615312,"ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5",Percent
615313,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 7; B3GNT7",Asterisk
615314,CRANIOSYNOSTOSIS 3; CRS3,Number Sign
615315,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 6; B3GNT6",Asterisk
615316,"IBA57, S. CEREVISIAE, HOMOLOG OF; IBA57",Asterisk
615317,"IRON-SULFUR CLUSTER ASSEMBLY 2, S. CEREVISIAE, HOMOLOG OF; ISCA2",Asterisk
615318,TRANSMEMBRANE PROTEIN 14C; TMEM14C,Asterisk
615319,IMPACT RWD DOMAIN PROTEIN; IMPACT,Asterisk
615320,GDP-MANNOSE PYROPHOSPHORYLASE B; GMPPB,Asterisk
615321,CHLORIDE INTRACELLULAR CHANNEL 6; CLIC6,Asterisk
615322,NEGATIVE REGULATOR OF REACTIVE OXYGEN SPECIES; NRROS,Asterisk
615323,JOSEPHIN DOMAIN-CONTAINING PROTEIN 1; JOSD1,Asterisk
615324,JOSEPHIN DOMAIN-CONTAINING PROTEIN 2; JOSD2,Asterisk
615325,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R",Number Sign
615326,"INTERFERON, KAPPA; IFNK",Asterisk
615327,DOWLING-DEGOS DISEASE 2; DDD2,Number Sign
615328,SHAHEEN SYNDROME; SHNS,Number Sign
615329,EXOCYST COMPLEX COMPONENT 2; EXOC2,Asterisk
615330,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3,Number Sign
615331,INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN 1; IRF2BP1,Asterisk
615332,INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN 2; IRF2BP2,Asterisk
615333,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 5; B3GNT5",Asterisk
615334,CERAMIDE SYNTHASE 4; CERS4,Asterisk
615335,CERAMIDE SYNTHASE 5; CERS5,Asterisk
615336,CERAMIDE SYNTHASE 6; CERS6,Asterisk
615337,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE-LIKE 1; B3GNTL1",Asterisk
615338,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16",Number Sign
615339,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 15; DNAJC15",Asterisk
615340,KELCH-LIKE 40: KLHL40,Asterisk
615341,"CYTOCHROME P450, FAMILY 4, SUBFAMILY A, POLYPEPTIDE 22; CYP4A22",Asterisk
615342,"PULMONARY HYPERTENSION, PRIMARY, 2; PPH2",Number Sign
615343,"PULMONARY HYPERTENSION, PRIMARY, 3; PPH3",Number Sign
615344,"PULMONARY HYPERTENSION, PRIMARY, 4; PPH4",Number Sign
615345,MYOMAKER; MYMK,Asterisk
615346,"PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2",Number Sign
615347,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 2B; ATAD2B",Asterisk
615348,NEMALINE MYOPATHY 8; NEM8,Number Sign
615349,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2",Number Sign
615350,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14",Number Sign
615351,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14",Number Sign
615352,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14",Number Sign
615353,COILED-COIL DOMAIN-CONTAINING PROTEIN 28A; CCDC28A,Asterisk
615354,LIGAND-DEPENDENT NUCLEAR RECEPTOR-INTERACTING FACTOR 1; LRIF1,Asterisk
615355,NOONAN SYNDROME 8; NS8,Number Sign
615356,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18",Number Sign
615357,"BETA-1,3-GALACTOSYLTRANSFERASE 8; B3GNT8",Asterisk
615358,ADENYLATE KINASE 9; AK9,Asterisk
615359,"MISSING OOCYTE/MEIOSIS REGULATOR, DROSOPHILA, HOMOLOG OF; MIOS",Asterisk
615360,LEBER CONGENITAL AMAUROSIS 17; LCA17,Number Sign
615361,"HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2",Number Sign
615362,"CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13",Number Sign
615363,ESTROGEN RESISTANCE; ESTRR,Number Sign
615364,ADENYLATE KINASE 7; AK7,Asterisk
615365,ADENYLATE KINASE 8; AK8,Asterisk
615366,NUCLEOLAR PROTEIN 11; NOL11,Asterisk
615367,N-TERMINAL ASPARAGINE AMIDASE; NTAN1,Asterisk
615368,LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5,Number Sign
615369,"EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC",Number Sign
615370,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 6; ANKS6,Asterisk
615371,"PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO; PHN",Number Sign
615372,MICRO RNA 1260B; MIR1260B,Asterisk
615373,LEFT VENTRICULAR NONCOMPACTION 8; LVNC8,Number Sign
615374,CONE-ROD DYSTROPHY 18; CORD18,Number Sign
615375,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1-BINDING PROTEIN 1; IRAK1BP1,Asterisk
615376,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC",Number Sign
615377,"ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13",Number Sign
615378,"ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14",Number Sign
615379,MICRO RNA 650; MIR650,Asterisk
615380,APOPTOSIS-RESISTANT E3 UBIQUITIN PROTEIN LIGASE 1; AREL1,Asterisk
615381,"MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL",Number Sign
615382,NEPHRONOPHTHISIS 16; NPHP16,Number Sign
615383,FIDGETIN-LIKE PROTEIN 1; FIGNL1,Asterisk
615384,SCAFFOLDING PROTEIN INVOLVED IN DNA REPAIR; SPIDR,Asterisk
615385,MICRO RNA 485; MIR485,Asterisk
615386,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14",Number Sign
615387,T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY,Number Sign
615388,"ADENOSINE DEAMINASE, tRNA-SPECIFIC, 2; ADAT2",Asterisk
615389,ISOPENTENYL-DIPHOSPHATE DELTA ISOMERASE 2; IDI2,Asterisk
615390,VESICOURETERAL REFLUX 7; VUR7,Percent
615391,"IDI2 ANTISENSE RNA 1, NONCODING; IDI2AS1",Asterisk
615392,SCM-LIKE PROTEIN WITH 4 MBT DOMAINS 2; SFMBT2,Asterisk
615393,MITOCHONDRIAL TRANSCRIPTION TERMINATION FACTOR 4; MTERF4,Asterisk
615394,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 4; NSUN4",Asterisk
615395,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16,Number Sign
615396,LEFT VENTRICULAR NONCOMPACTION 10; LVNC10,Number Sign
615397,"MECKEL SYNDROME, TYPE 11; MKS11",Number Sign
615398,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3,Number Sign
615399,PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2,Number Sign
615400,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5",Number Sign
615401,IMMUNODEFICIENCY 8; IMD8,Number Sign
615402,DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3,Number Sign
615403,"THO COMPLEX, SUBUNIT 6; THOC6",Asterisk
615404,"TRANSMEMBRANE 4 L6 FAMILY, MEMBER 20; TM4SF20",Asterisk
615405,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-12; GNG12",Asterisk
615406,"GNG12 ANTISENSE RNA 1, NONCODING; GNG12AS1",Asterisk
615407,ADP RIBOSYLATION FACTOR-LIKE 2-BINDING PROTEIN; ARL2BP,Asterisk
615408,ARMADILLO REPEAT-CONTAINING PROTEIN 4; ARMC4,Asterisk
615409,SPERMATOGENESIS-ASSOCIATED PROTEIN 33; SPATA33,Asterisk
615410,MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN 2; MRAP2,Asterisk
615411,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3",Number Sign
615412,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4",Number Sign
615413,SPERMATOGENIC FAILURE 12; SPGF12,Number Sign
615414,"MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11",Number Sign
615415,RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2,Number Sign
615416,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER A9; BHLHA9",Asterisk
615417,BET1-LIKE PROTEIN; BET1L,Asterisk
615418,"MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE; MTDPS12B",Number Sign
615419,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1",Number Sign
615420,"MYOPIA 22, AUTOSOMAL DOMINANT; MYP22",Number Sign
615421,COILED-COIL DOMAIN CONTAINING 111; CCDC111,Asterisk
615422,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2,Number Sign
615423,"tRNA METHYLTRANSFERASE 10, S. CEREVISIAE, HOMOLOG OF, C; TRMT10C",Asterisk
615424,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3,Number Sign
615425,"EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2; EBSB2",Number Sign
615426,AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20,Number Sign
615427,ELMO/CED12 DOMAIN-CONTAINING PROTEIN 3; ELMOD3,Asterisk
615428,DEAD BOX POLYPEPTIDE 47; DDX47,Asterisk
615429,"DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88",Number Sign
615430,TRANSMEMBRANE PROTEIN 241; TMEM241,Asterisk
615431,"MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23",Number Sign
615432,SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5,Number Sign
615433,CHROMOSOME 3q13.31 DELETION SYNDROME,Number Sign
615434,RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS; RP82,Number Sign
615435,ENDOPLASMIC RETICULUM OXIDOREDUCTIN 1-LIKE; ERO1L,Asterisk
615436,"AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8",Number Sign
615437,"ENDOPLASMIC RETICULUM OXIDOREDUCTIN 1-LIKE, BETA; ERO1LB",Asterisk
615438,INFANTILE LIVER FAILURE SYNDROME 1; ILFS1,Number Sign
615439,"MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13",Number Sign
615440,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17,Number Sign
615441,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5",Number Sign
615442,T-CELL RECEPTOR ALPHA CHAIN VARIABLE GENE CLUSTER; TRAV@,Asterisk
615443,T-CELL RECEPTOR ALPHA CHAIN JOINING GENE CLUSTER; TRAJ@,Asterisk
615444,"CILIARY DYSKINESIA, PRIMARY, 22; CILD22",Number Sign
615445,T-CELL RECEPTOR BETA CHAIN CONSTANT REGION 2; TRBC2,Asterisk
615446,T-CELL RECEPTOR BETA CHAIN VARIABLE GENE CLUSTER; TRBV@,Asterisk
615447,T-CELL RECEPTOR BETA CHAIN DIVERSITY GENE 1; TRBD1,Asterisk
615448,T-CELL RECEPTOR BETA CHAIN DIVERSITY GENE 2; TRBD2,Asterisk
615449,T-CELL RECEPTOR BETA CHAIN JOINING GENE CLUSTER; TRBJ@,Asterisk
615450,T-CELL RECEPTOR GAMMA CHAIN CONSTANT REGION 2; TRGC2,Asterisk
615451,"CILIARY DYSKINESIA, PRIMARY, 23; CILD23",Number Sign
615452,PROSTATE CANCER-ASSOCIATED NONCODING RNA 1; PRNCR1,Asterisk
615453,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6",Number Sign
615454,T-CELL RECEPTOR GAMMA CHAIN VARIABLE GENE CLUSTER; TRGV@,Asterisk
615455,T-CELL RECEPTOR GAMMA CHAIN JOINING GENE CLUSTER; TRGJ@,Asterisk
615456,ELMO/CED12 DOMAIN-CONTAINING PROTEIN 1; ELMOD1,Asterisk
615457,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18,Number Sign
615458,"MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT",Number Sign
615459,T-CELL RECEPTOR DELTA CHAIN VARIABLE GENE CLUSTER; TRDV@,Asterisk
615460,T-CELL RECEPTOR DELTA CHAIN DIVERSITY GENE CLUSTER; TRDD@,Asterisk
615461,T-CELL RECEPTOR DELTA CHAIN JOINING GENE CLUSTER; TRDJ@,Asterisk
615462,WD REPEAT-CONTAINING PROTEIN 60; WDR60,Asterisk
615463,"SEIZURE THRESHOLD 2, MOUSE, HOMOLOG OF; SZT2",Asterisk
615464,DEAD BOX POLYPEPTIDE 59; DDX59,Asterisk
615465,HARTSFIELD SYNDROME; HRTFDS,Number Sign
615466,MESODERM DEVELOPMENT CANDIDATE 1; MESDC1,Asterisk
615467,GLYCOLIPID TRANSFER PROTEIN DOMAIN-CONTAINING PROTEIN 1; GLTPD1,Asterisk
615468,IMMUNODEFICIENCY 12; IMD12,Number Sign
615469,MICRO RNA 574; MIR574,Asterisk
615470,"CENTROSOMAL PROTEIN, 89-KD; CEP89",Asterisk
615471,MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13,Number Sign
615472,"COATOMER PROTEIN COMPLEX, SUBUNIT ZETA-1; COPZ1",Asterisk
615473,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17",Number Sign
615474,"PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA",Number Sign
615475,DEAH BOX POLYPEPTIDE 34; DHX34,Asterisk
615476,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18; EIEE18",Number Sign
615477,NEURONAL TYROSINE-PHOSPHORYLATED PHOSPHOINOSITIDE 3-KINASE ADAPTOR 1; NYAP1,Asterisk
615478,NEURONAL TYROSINE-PHOSPHORYLATED PHOSPHOINOSITIDE 3-KINASE ADAPTOR 2; NYAP2,Asterisk
615479,MYOSIN XVI; MYO16,Asterisk
615480,"BLADDER CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING; BLACAT1",Asterisk
615481,"CILIARY DYSKINESIA, PRIMARY, 24; CILD24",Number Sign
615482,"CILIARY DYSKINESIA, PRIMARY, 25; CILD25",Number Sign
615483,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5",Number Sign
615484,PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 2; PTCD2,Asterisk
615485,BAINBRIDGE-ROPERS SYNDROME; BRPS,Number Sign
615486,INTERSTITIAL LUNG AND LIVER DISEASE; ILLD,Number Sign
615487,"SMALL NUCLEOLAR RNA, H/ACA BOX, 2C; SNORA2C",Asterisk
615488,"KAT8 REGULATORY NSL COMPLEX, SUBUNIT 2; KANSL2",Asterisk
615489,"MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14",Number Sign
615490,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R",Number Sign
615491,"SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79",Number Sign
615492,LONG INTERGENIC NONCODING RNA COX2,Asterisk
615493,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37; MRT37",Number Sign
615494,CHROMOSOME 21 OPEN READING FRAME 59; C21ORF59,Asterisk
615495,GDP-MANNOSE PYROPHOSPHORYLASE A; GMPPA,Asterisk
615496,ATP/GTP-BINDING PROTEIN-LIKE 1; AGBL1,Asterisk
615497,MITOCHONDRIAL ELONGATION FACTOR 1; MIEF1,Asterisk
615498,MITOCHONDRIAL ELONGATION FACTOR 2; MIEF2,Asterisk
615499,PYRUVATE DEHYDROGENASE PHOSPHATASE CATALYTIC SUBUNIT 2; PDP2,Asterisk
615500,"CILIARY DYSKINESIA, PRIMARY, 26; CILD26",Number Sign
615501,"MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC",Number Sign
615502,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21",Number Sign
615503,SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8,Number Sign
615504,"CILIARY DYSKINESIA, PRIMARY, 27; CILD27",Number Sign
615505,"CILIARY DYSKINESIA, PRIMARY, 28; CILD28",Number Sign
615506,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5",Number Sign
615507,NISCHARIN; NISCH,Asterisk
615508,"ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE",Number Sign
615509,MICRO RNA 675; MIR675,Asterisk
615510,"ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR",Number Sign
615511,MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD,Number Sign
615512,TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID,Number Sign
615513,IMMUNODEFICIENCY 14; IMD14,Number Sign
615514,CYCLIN-DEPENDENT KINASE 12; CDK12,Asterisk
615515,AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19,Number Sign
615516,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38",Number Sign
615517,"HEMOCHROMATOSIS, TYPE 5; HFE5",Number Sign
615518,IMMUNODEFICIENCY 13; IMD13,Number Sign
615519,TOM1-LIKE 2; TOM1L2,Asterisk
615520,MICRO RNA 297; MIR297,Asterisk
615521,SH3 AND CYSTEINE-RICH DOMAINS 3; STAC3,Asterisk
615522,COLE DISEASE; COLED,Number Sign
615523,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8",Number Sign
615524,"MICROPHTHALMIA, SYNDROMIC 12; MCOPS12",Number Sign
615525,"COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-1; COPG1",Asterisk
615526,"COATOMER PROTEIN COMPLEX, SUBUNIT ZETA-2; COPZ2",Asterisk
615527,"CANDIDIASIS, FAMILIAL, 8; CANDF8",Number Sign
615528,"PARKINSON DISEASE 19A, JUVENILE-ONSET; PARK19A",Number Sign
615529,"CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5",Number Sign
615530,"PARKINSON DISEASE 20, EARLY-ONSET; PARK20",Number Sign
615531,TRANSMEMBRANE PROTEIN 79; TMEM79,Asterisk
615532,ENDOPLASMIC RETICULUM MEMBRANE-ASSOCIATED RNA DEGRADATION PROTEIN; ERMARD,Asterisk
615533,TRANSMEMBRANE PROTEIN 126B; TMEM126B,Asterisk
615534,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE DOMAIN-CONTAINING PROTEIN 1; TIMMDC1,Asterisk
615535,SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 4; SYNE4,Asterisk
615536,CHROMOSOME 2 OPEN READING FRAME 80; C2ORF80,Asterisk
615537,RETICULATE ACROPIGMENTATION OF KITAMURA; RAK,Number Sign
615538,CHROMOSOME 22q13 DUPLICATION SYNDROME,Number Sign
615539,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2",Number Sign
615540,"DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76",Number Sign
615541,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39",Number Sign
615542,TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD,Number Sign
615543,ACTIN-RELATED PROTEIN 2/3 COMPLEX INHIBITOR; ARPIN,Asterisk
615544,PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6,Number Sign
615545,"LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3; ALL3",Number Sign
615546,VAN MALDERGEM SYNDROME 2; VMLDS2,Number Sign
615547,SCHAAF-YANG SYNDROME; SHFYNG,Number Sign
615548,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7",Number Sign
615549,ARMADILLO REPEAT-CONTAINING PROTEIN 5; ARMC5,Asterisk
615550,DIAMOND-BLACKFAN ANEMIA 12; DBA12,Number Sign
615551,"EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2",Number Sign
615552,"EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3",Number Sign
615553,"ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES; AMRS",Number Sign
615554,MULTIPLE FIBROADENOMAS OF THE BREAST; MFAB,Number Sign
615555,HYPERPROLACTINEMIA; HPRL,Number Sign
615556,ALPHA-TUBULIN ACETYLTRANSFERASE 1; ATAT1,Asterisk
615557,"MELIOIDOSIS, SUSCEPTIBILITY TO",Number Sign
615558,"HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1",Number Sign
615559,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3",Number Sign
615560,OTOFACIOCERVICAL SYNDROME 2; OTFCS2,Number Sign
615561,COMPLEMENT FACTOR B DEFICIENCY; CFBD,Number Sign
615562,SPERM-ASSOCIATED ANTIGEN 5; SPAG5,Asterisk
615563,NUCLEAR RECEPTOR-BINDING PROTEIN 2; NRBP2,Asterisk
615564,SIDEROFLEXIN 4; SFXN4,Asterisk
615565,RETINITIS PIGMENTOSA 67; RP67,Number Sign
615566,BTB/POZ DOMAIN-CONTAINING PROTEIN 3; BTBD3,Asterisk
615567,COENZYME Q8B; COQ8B,Asterisk
615568,"SWI/SNF COMPLEX ANTAGONIST ASSOCIATED WITH PROSTATE CANCER 1, NONCODING; SCHLAP1",Asterisk
615569,SIDEROFLEXIN 1; SFXN1,Asterisk
615570,SIDEROFLEXIN 2; SFXN2,Asterisk
615571,SIDEROFLEXIN 3; SFXN3,Asterisk
615572,SIDEROFLEXIN 5; SFXN5,Asterisk
615573,"NEPHROTIC SYNDROME, TYPE 9; NPHS9",Number Sign
615574,ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD,Number Sign
615575,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D",Number Sign
615576,MICRO RNA 185; MIR185,Asterisk
615577,"IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10",Number Sign
615578,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18; COXPD18,Number Sign
615579,ATAXIN 7-LIKE 3B; ATXN7L3B,Asterisk
615580,ZINC FINGER PROTEIN 528; ZNF528,Asterisk
615581,DOUBLE HOMEOBOX 4-LIKE 9; DUX4L9,Asterisk
615582,LOEYS-DIETZ SYNDROME 5; LDS5,Number Sign
615583,VERHEIJ SYNDROME; VRJS,Number Sign
615584,"FAMILY WITH SEQUENCE SIMILARITY 111, MEMBER B; FAM111B",Asterisk
615585,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 8; SLC38A8",Asterisk
615586,"CENTROSOMAL PROTEIN, 19-KD; CEP19",Asterisk
615587,"NUCLEOPORIN, 188-KD; NUP188",Asterisk
615588,SINGLE-PASS MEMBRANE PROTEIN WITH ASPARTATE-RICH TAIL 1; SMDT1,Asterisk
615589,OTOSCLEROSIS 10; OTSC10,Percent
615590,ALZHEIMER DISEASE 18; AD18,Number Sign
615591,"MACULAR DEGENERATION, AGE-RELATED, 15; ARMD15",Number Sign
615592,IMMUNODEFICIENCY 15; IMD15,Number Sign
615593,IMMUNODEFICIENCY 16; IMD16,Number Sign
615594,APELIN RECEPTOR EARLY ENDOGENOUS LIGAND; APELA,Asterisk
615595,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19,Number Sign
615596,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W",Number Sign
615597,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X",Number Sign
615598,"PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN",Number Sign
615599,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40",Number Sign
615600,ZINC FINGER PROTEIN 582; ZNF582,Asterisk
615601,GLUTAMATE DECARBOXYLASE-LIKE 1; GADL1,Asterisk
615602,MEMORY QUANTITATIVE TRAIT LOCUS; MEMRYQTL,Number Sign
615603,CALCINEURIN-LIKE PHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; CPPED1,Asterisk
615604,L-FERRITIN DEFICIENCY; LFTD,Number Sign
615605,FANCONI RENOTUBULAR SYNDROME 3; FRTS3,Number Sign
615606,BUTYROPHILIN-LIKE PROTEIN 8; BTNL8,Asterisk
615607,IMMUNODEFICIENCY 17; IMD17,Number Sign
615608,V-SET IMMUNOREGULATORY RECEPTOR; VSIR,Asterisk
615609,"SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 3; SIAH3",Asterisk
615610,"CADHERIN-RELATED FAMILY, MEMBER 3; CDHR3",Asterisk
615611,CASEINOLYTIC MITOCHONDRIAL MATRIX PEPTIDASE CHAPERONE SUBUNIT; CLPX,Asterisk
615612,DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2,Percent
615613,HEPATOCELLULAR CARCINOMA-ASSOCIATED TRANSCRIPT 5; HCCAT5,Asterisk
615614,MMS22-LIKE PROTEIN; MMS22L,Asterisk
615615,IMMUNODEFICIENCY 18; IMD18,Number Sign
615616,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13",Number Sign
615617,IMMUNODEFICIENCY 19; IMD19,Number Sign
615618,PROTEIN O-GLUCOSYLTRANSFERASE 1; POGLUT1,Asterisk
615619,"CHOLANGIOCARCINOMA, SUSCEPTIBILITY TO",
615620,KAPTIN; KPTN,Asterisk
615622,TNF- AND HNRNPL-RELATED IMMUNOREGULATORY LONG NONCODING RNA; THRIL,Asterisk
615623,CYTOCHROME C OXIDASE ASSEMBLY FACTOR 7; COA7,Asterisk
615624,"COLORECTAL NEOPLASIA DIFFERENTIALLY EXPRESSED GENE, NONCODING; CRNDE",Asterisk
615625,"SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72",Number Sign
615626,CHROMOSOME 15 OPEN READING FRAME 41; C15ORF41,Asterisk
615627,BRI3-BINDING PROTEIN; BRI3BP,Asterisk
615628,BRAIN PROTEIN I3; BRI3,Asterisk
615629,"DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56",Number Sign
615630,SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10,Number Sign
615631,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B",Number Sign
615632,"NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F",Number Sign
615633,SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11,Number Sign
615634,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 6; CHCHD6,Asterisk
615635,ZINC FINGER RNA-BINDING PROTEIN; ZFR,Asterisk
615636,JOUBERT SYNDROME 21; JBTS21,Number Sign
615637,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41",Number Sign
615638,NON-SMC CONDENSIN I COMPLEX SUBUNIT D2; NCAPD2,Asterisk
615639,SMALL CAJAL BODY-SPECIFIC RNA 10; SCARNA10,Asterisk
615640,SMALL CAJAL BODY-SPECIFIC RNA 5; SCARNA5,Asterisk
615641,SMALL CAJAL BODY-SPECIFIC RNA 6; SCARNA6,Asterisk
615642,SMALL CAJAL BODY-SPECIFIC RNA 12; SCARNA12,Asterisk
615643,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6,Number Sign
615644,SMALL CAJAL BODY-SPECIFIC RNA 7; SCARNA7,Asterisk
615645,SMALL CAJAL BODY-SPECIFIC RNA 17; SCARNA17,Asterisk
615646,SMALL CAJAL BODY-SPECIFIC RNA 8; SCARNA8,Asterisk
615647,TESTIS-EXPRESSED GENE 19; TEX19,Asterisk
615648,"NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 3; NLRC3",Asterisk
615649,"DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54",Percent
615650,REGULATOR OF G PROTEIN SIGNALING 22; RGS22,Asterisk
615651,LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT,Number Sign
615652,ACYL-CoA THIOESTERASE 13; ACOT13,Asterisk
615653,THIOESTERASE SUPERFAMILY MEMBER 5; THEM5,Asterisk
615654,"DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58",Percent
615655,ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 3; ZRANB3,Asterisk
615656,CHROMOSOME 15q11.2 DELETION SYNDROME,Number Sign
615657,MICRO RNA 142; MIR142,Asterisk
615658,"SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57",Number Sign
615659,TRANSMEMBRANE PROTEIN 131; TMEM131,Asterisk
615660,RIBOSOMAL PROTEIN L10A; RPL10A,Asterisk
615661,PROGRAMMED CELL DEATH 2-LIKE PROTEIN; PDCD2L,Asterisk
615662,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 12; SERPINB12",Asterisk
615663,WARBURG MICRO SYNDROME 4; WARBM4,Number Sign
615664,THYMOCYTE-EXPRESSED POSITIVE SELECTION-ASSOCIATED PROTEIN 1; TESPA1,Asterisk
615665,JOUBERT SYNDROME 22; JBTS22,Number Sign
615666,KIAA1456 GENE; KIAA1456,Asterisk
615667,ERCC6-LIKE 2; ERCC6L2,Asterisk
615668,CHROMOSOME 5q12 DELETION SYNDROME,Number Sign
615669,EMBIGIN; EMB,Asterisk
615670,SCHWANNOMATOSIS 2; SWNTS2,Number Sign
615671,SET DOMAIN-CONTAINING PROTEIN 3; SETD3,Asterisk
615672,MICRO RNA 497; MIR497,Asterisk
615673,MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS,Number Sign
615674,DOWLING-DEGOS DISEASE 3; DDD3,Percent
615675,MICRO RNA 301A; MIR301A,Asterisk
615676,"TESTIS DEVELOPMENT-RELATED GENE 1, NONCODING; TDRG1",Asterisk
615677,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 9; SERPINA9",Asterisk
615678,SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN 2; SH3BGRL2,Asterisk
615679,SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN 3; SH3BGRL3,Asterisk
615680,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 16; CARD16,Asterisk
615681,"SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE; SPG62",Number Sign
615682,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 11; SERPINB11",Asterisk
615683,"SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64",Number Sign
615684,"HFM1, ATP-DEPENDENT DNA HELICASE, S. CEREVISIAE, HOMOLOG OF; HFM1",Asterisk
615685,"SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61",Number Sign
615686,"SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63",Number Sign
615687,BECLIN 2; BECN2,Asterisk
615688,"POLYARTERITIS NODOSA, CHILDHOOD-ONSET; PAN",Number Sign
615689,ADHESION MOLECULE WITH Ig-LIKE DOMAIN 1; AMIGO1,Asterisk
615690,ADHESION MOLECULE WITH Ig-LIKE DOMAIN 2; AMIGO2,Asterisk
615691,ADHESION MOLECULE WITH Ig-LIKE DOMAIN 3; AMIGO3,Asterisk
615692,CHITINASE DOMAIN-CONTAINING PROTEIN 1; CHID1,Asterisk
615693,COLCA1 GENE; COLCA1,Asterisk
615694,COLCA2 GENE; COLCA2,Asterisk
615695,HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 2; HEXIM2,Asterisk
615696,DOWLING-DEGOS DISEASE 4; DDD4,Number Sign
615697,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6",Percent
615698,"PHOSPHOLIPASE D FAMILY, MEMBER 3; PLD3",Asterisk
615699,CHROMOSOME 11 OPEN READING FRAME 95; C11ORF95,Asterisk
615700,PYRIN DOMAIN-CONTAINING PROTEIN 1; PYDC1,Asterisk
615701,PYRIN DOMAIN-CONTAINING PROTEIN 2; PYDC2,Asterisk
615702,"OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY AN, MEMBER 1; OR5AN1",Asterisk
615703,MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF,Number Sign
615704,"POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP",Number Sign
615705,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15",Number Sign
615706,AURICULOCONDYLAR SYNDROME 3; ARCND3,Number Sign
615707,IMMUNODEFICIENCY 20; IMD20,Number Sign
615708,ZINC FINGER PROTEIN 451; ZNF451,Asterisk
615709,SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA,Number Sign
615710,MITCHELL-RILEY SYNDROME; MTCHRS,Number Sign
615711,ALZHEIMER DISEASE 19; AD19,
615712,OTU DEUBIQUITINASE WITH LINEAR LINKAGE SPECIFICITY; OTULIN,Asterisk
615713,ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 8; ZMYND8,Asterisk
615714,ZNRD1 ANTISENSE RNA 1; ZNRD1AS1,Asterisk
615715,BONE MARROW FAILURE SYNDROME 2; BMFS2,Number Sign
615716,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4,Number Sign
615717,"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 3; BPIFB3",Asterisk
615718,"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 4; BPIFB4",Asterisk
615719,TCL1 UPSTREAM NEURAL DIFFERENTIATION-ASSOCIATED RNA; TUNAR,Asterisk
615720,"SOLUTE CARRIER FAMILY 7, MEMBER 14; SLC7A14",Asterisk
615721,RENAL HYPODYSPLASIA/APLASIA 2; RHDA2,Number Sign
615722,BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS,Number Sign
615723,PREMATURE OVARIAN FAILURE 8; POF8,Number Sign
615724,PREMATURE OVARIAN FAILURE 9; POF9,Number Sign
615725,RETINITIS PIGMENTOSA 68; RP68,Number Sign
615726,PACHYONYCHIA CONGENITA 3; PC3,Number Sign
615727,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 5B; KIR2DL5B",Asterisk
615728,PACHYONYCHIA CONGENITA 4; PC4,Number Sign
615729,"STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 2; SBNO2",Asterisk
615730,DEDICATOR OF CYTOKINESIS 7; DOCK7,Asterisk
615731,NEMALINE MYOPATHY 9; NEM9,Number Sign
615732,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 5; NSUN5",Asterisk
615733,rRNA METHYLTRANSFERASE AND RIBOSOME MATURATION FACTOR BUD23; BUD23,Asterisk
615734,WD REPEAT-CONTAINING PROTEIN 47; WDR47,Asterisk
615735,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE; PPKNEFD",Number Sign
615736,ENDOTHELIAL CELL SURFACE-EXPRESSED CHEMOTAXIS AND APOPTOSIS REGULATOR; ECSCR,Asterisk
615737,FOLATE RECEPTOR 4; FOLR4,Asterisk
615738,"VACUOLAR PROTEIN SORTING 51, S. CEREVISIAE, HOMOLOG OF; VPS51",Asterisk
615739,"POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1B; POU5F1B",Asterisk
615740,"TBC1 DOMAIN FAMILY, MEMBER 5; TBC1D5",Asterisk
615741,KIAA0141 GENE; KIAA0141,Asterisk
615742,"RGP1 RETROGRADE GOLGI TRANSPORT, S. CEREVISIAE, HOMOLOG OF; RGP1",Asterisk
615743,SET DOMAIN-CONTAINING PROTEIN 5; SETD5,Asterisk
615744,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19",Number Sign
615745,ATRIAL STANDSTILL 2; ATRST2,Number Sign
615746,ZXD FAMILY ZINC FINGER PROTEIN C; ZXDC,Asterisk
615747,CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 8; CEACAM8,Asterisk
615748,"WASH COMPLEX, SUBUNIT 4; WASHC4",Asterisk
615749,"ECULIZUMAB, POOR RESPONSE TO",Number Sign
615750,MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA; MYMY6,Number Sign
615751,"CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD",Number Sign
615752,"POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR",Number Sign
615753,POM121 TRANSMEMBRANE NUCLEOPORIN; POM121,Asterisk
615754,POM121 TRANSMEMBRANE NUCLEOPORIN C; POM121C,Asterisk
615755,FORKHEAD BOX R1; FOXR1,Asterisk
615756,SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2-LIKE; SECISBP2L,Asterisk
615757,KIZUNA CENTROSOMAL PROTEIN; KIZ,Asterisk
615758,IMMUNODEFICIENCY 22; IMD22,Number Sign
615759,"KINASE D-INTERACTING SUBSTRATE, 220-KD; KIDINS220",Asterisk
615760,"MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA",Number Sign
615761,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23",Number Sign
615762,"GLUTAREDOXIN, CYSTEINE-RICH, 2; GRXCR2",Asterisk
615763,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5",Number Sign
615764,LONG STRESS-INDUCED NONCODING TRANSCRIPT 5; LSINCT5,Asterisk
615765,"SOLUTE CARRIER FAMILY 16, MEMBER 11; SLC16A11",Asterisk
615766,MICROTUBULE CROSSLINKING FACTOR 1; MTCL1,Asterisk
615767,"IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11",Number Sign
615768,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16",Number Sign
615769,"FAMILY WITH SEQUENCE SIMILARITY 169, MEMBER A; FAM169A",Asterisk
615770,"ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15",Number Sign
615771,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6",Number Sign
615772,"LONG NONCODING RNA, DENDRITIC CELL",Asterisk
615773,"ACN9, S. CEREVISIAE, HOMOLOG OF; ACN9",Asterisk
615774,OOCYTE MATURATION DEFECT 1; OOMD1,Number Sign
615775,SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 3; SYCE3,Asterisk
615776,CILIARY ROOTLET COILED-COIL PROTEIN; CROCC,Asterisk
615777,DESBUQUOIS DYSPLASIA 2; DBQD2,Number Sign
615778,CLAUDIN 15; CLDN15,Asterisk
615779,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4",Number Sign
615780,RETINITIS PIGMENTOSA 69; RP69,Number Sign
615781,"ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-3 SUBUNIT; AP1S3",Asterisk
615782,CIRCADIAN-ASSOCIATED REPRESSOR OF TRANSCRIPTION; CIART,Asterisk
615783,N-ACETYLTRANSFERASE 16; NAT16,Asterisk
615784,GLUTATHIONE PEROXIDASE 7; GPX7,Asterisk
615785,WHITE SPONGE NEVUS 2; WSN2,Number Sign
615786,"NACC FAMILY, MEMBER 2, BEN AND BTB/POZ DOMAINS-CONTAINING; NACC2",Asterisk
615787,"NAD KINASE 2, MITOCHONDRIAL; NADK2",Asterisk
615788,NEDD4-BINDING PROTEIN 2-LIKE 2; N4BP2L2,Asterisk
615789,SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES,Number Sign
615790,AT-HOOK DNA-BINDING MOTIF-CONTAINING PROTEIN 1; AHDC1,Asterisk
615791,NUDIX HYDROLASE 18; NUDT18,Asterisk
615792,NUDIX HYDROLASE 15; NUDT15,Asterisk
615793,"ISTHMIN 1, ANGIOGENESIS INHIBITOR; ISM1",Asterisk
615794,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3A;; FNDC3A,Asterisk
615795,FIBROUS SHEATH-INTERACTING PROTEIN 1; FSIP1,Asterisk
615796,FIBROUS SHEATH-INTERACTING PROTEIN 2; FSIP2,Asterisk
615797,"HLA COMPLEX GROUP 9, NONCODING; HCG9",Asterisk
615798,CLAUDIN 6; CLDN6,Asterisk
615799,CLAUDIN 9; CLDN9,Asterisk
615800,"FASCIN ACTIN-BUNDLING PROTEIN 3, TESTICULAR; FSCN3",Asterisk
615801,HLA COMPLEX GROUP 8; HCG8,Asterisk
615802,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42",Number Sign
615803,"PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10",Number Sign
615804,UREIDOIMIDAZOLINE (2-OXO-4-HYDROXY-4-CARBOXY-5-) DECARBOXYLASE; URAD,Asterisk
615805,"URATE (HYDROXYISO-) HYDROLASE, PSEUDOGENE; URAHP",Asterisk
615806,"SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 4; SLC15A4",Asterisk
615807,SECKEL SYNDROME 8; SCKL8,Number Sign
615808,"TRANSLATION MACHINERY-ASSOCIATED 7, S. CEREVISIAE, HOMOLOG OF; TMA7",Asterisk
615809,"PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9",Number Sign
615810,CHROMOSOME 11 OPEN READING FRAME 54; C11ORF54,Asterisk
615811,PEPTIDYL-PROLYL ISOMERASE-LIKE 3; PPIL3,Asterisk
615812,ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3,Number Sign
615813,"FAMILY WITH SEQUENCE SIMILARITY 193, MEMBER B; FAM193B",Asterisk
615814,SERINE/THREONINE/TYROSINE-INTERACTING PROTEIN; STYX,Asterisk
615815,SMOOTH MUSCLE- AND ENDOTHELIAL CELL-ENRICHED MIGRATION/DIFFERENTIATION-ASSOCIATED LONG NONCODING RNA; SENCR,Asterisk
615816,IMMUNODEFICIENCY 23; IMD23,Number Sign
615817,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43",Number Sign
615818,"RIBOSOMAL RNA PROCESSING PROTEIN 8, METHYLTRANSFERASE, S. CEREVISIAE, HOMOLOG OF; RRP8",Asterisk
615819,"SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 4; SULT1A4",Asterisk
615820,DDB1- AND CUL4-ASSOCIATED FACTOR 8; DCAF8,Asterisk
615821,"CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA",Number Sign
615822,"SLX1 STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT, S. CEREVISIAE, HOMOLOG OF, A; SLX1A",Asterisk
615823,"SLX1 STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT, S. CEREVISIAE, HOMOLOG OF, B; SLX1B",Asterisk
615824,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7",Number Sign
615825,SUSHI DOMAIN-CONTAINING PROTEIN 2; SUSD2,Asterisk
615826,SPERM-TAIL PG-RICH REPEAT-CONTAINING PROTEIN 1; STPG1,Asterisk
615827,SUSHI DOMAIN-CONTAINING PROTEIN 4; SUSD4,Asterisk
615828,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24",Number Sign
615829,XIA-GIBBS SYNDROME,Number Sign
615830,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4",Number Sign
615831,LYR MOTIF-CONTAINING PROTEIN 7; LYRM7,Asterisk
615832,UBIQUITIN-CONJUGATING ENZYME E2Q FAMILY-LIKE PROTEIN 1; UBE2QL1,Asterisk
615833,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21",Number Sign
615834,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26",Number Sign
615835,"CHROMOSOME 16 INVERSION, 0.45-MB",Number Sign
615836,SERINE/THREONINE PROTEIN KINASE 38-LIKE PROTEIN; STK38L,Asterisk
615837,"DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101",Number Sign
615838,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8",Number Sign
615839,"2,4-DIENOYL-CoA REDUCTASE 2, PEROXISOMAL; DECR2",Asterisk
615840,dCTP PYROPHOSPHATASE 1; DCTPP1,Asterisk
615841,SPERMATOGENIC FAILURE 13; SPGF13,Number Sign
615842,SPERMATOGENIC FAILURE 14; SPGF14,Number Sign
615843,"DELTA(4)-DESATURASE, SPHINGOLIPID, 1; DEGS1",Asterisk
615844,"DIHYDROXYACETONE KINASE 2, S. CEREVISIAE, HOMOLOG OF; DAK",Asterisk
615845,MICRO RNA 190A; MIR190A,Asterisk
615846,AICARDI-GOUTIERES SYNDROME 7; AGS7,Number Sign
615847,"CENTROSOMAL PROTEIN, 83-KD; CEP83",Asterisk
615848,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10",Number Sign
615849,CULLER-JONES SYNDROME; CJS,Number Sign
615850,"VACUOLAR PROTEIN SORTING 53, S. CEREVISIAE, HOMOLOG OF; VPS53",Asterisk
615851,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E",Number Sign
615852,RAS-ASSOCIATED PROTEIN RAB6B; RAB6B,Asterisk
615853,POLYAMINE OXIDASE; PAOX,Asterisk
615854,SPERMINE OXIDASE; SMOX,Asterisk
615855,TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 1; TMTC1,Asterisk
615856,TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 2; TMTC2,Asterisk
615857,2-OXOGLUTARATE- AND IRON-DEPENDENT OXYGENASE DOMAIN-CONTAINING PROTEIN 1; OGFOD1,Asterisk
615858,ROUND SPERMATID BASIC PROTEIN 1; RSBN1,Asterisk
615859,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23",Number Sign
615860,CONE-ROD DYSTROPHY 19; CORD19,Number Sign
615861,"NEPHROTIC SYNDROME, TYPE 10; NPHS10",Number Sign
615862,NEPHRONOPHTHISIS 18; NPHP18,Number Sign
615863,DIARRHEA 7; DIAR7,Number Sign
615864,"CENTROSOMAL PROTEIN, 97-KD; CEP97",Asterisk
615865,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 4; NEURL4,Asterisk
615866,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 27; MRD27",Number Sign
615867,"TBC1 DOMAIN FAMILY, MEMBER 32; TBC1D32",Asterisk
615868,"SERINE PEPTIDASE INHIBITOR, KAZAL-TYPE, 6; SPINK6",Asterisk
615869,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 1; TNFAIP8L1,Asterisk
615870,"INTRAFLAGELLAR TRANSPORT 27, CHLAMYDOMONAS, HOMOLOG OF; IFT27",Asterisk
615871,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24",Number Sign
615872,"CILIARY DYSKINESIA, PRIMARY, 29; CILD29",Number Sign
615873,HELSMOORTEL-VAN DER AA SYNDROME; HVDAS,Number Sign
615874,RIBOSOMAL L1 DOMAIN-CONTAINING PROTEIN 1; RSL1D1,Asterisk
615875,RWD DOMAIN-CONTAINING PROTEIN 3; RWDD3,Asterisk
615876,"RADIAL SPOKE HEAD 3, CHLAMYDOMONAS, HOMOLOG OF; RSPH3",Asterisk
615877,MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS,Number Sign
615878,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4",Number Sign
615879,TATTON-BROWN-RAHMAN SYNDROME; TBRS,Number Sign
615880,RHO GTPase-ACTIVATING PROTEIN 39; ARHGAP39,Asterisk
615881,PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS; TGQTL,Number Sign
615882,RAB GTPase-ACTIVATING PROTEIN 1; RABGAP1,Asterisk
615883,"MYOPATHY, TUBULAR AGGREGATE, 2; TAM2",Number Sign
615884,ADIPOCYTE PLASMA MEMBRANE-ASSOCIATED PROTEIN; APMAP,Asterisk
615885,HYPOTRICHOSIS 12; HYPT12,Number Sign
615886,"FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER G; FAM83G",Asterisk
615887,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5",Number Sign
615888,"BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18",Number Sign
615889,"LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP",Number Sign
615890,"DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 1; DYNC1LI1",Asterisk
615891,"ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 8, OPPOSITE STRAND; ZBTB8OS",Asterisk
615892,OROFACIAL CLEFT 14; OFC14,Percent
615893,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 1B; NEURL1B,Asterisk
615894,ZINC FINGER PROTEIN 407; ZNF407,Asterisk
615895,POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1,Number Sign
615896,HYPOTRICHOSIS 13; HYPT13,Number Sign
615897,IMMUNODEFICIENCY 24; IMD24,Number Sign
615898,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 7; NDUFAF7",Asterisk
615899,OLFACTOMEDIN-LIKE 2A; OLFML2A,Asterisk
615900,AATP/GTP-BINDING PROTEIN-LIKE 5; AGBL5,Asterisk
615901,"NONSPECIFIC CYTOTOXIC CELL RECEPTOR PROTEIN 1, ZEBRAFISH, HOMOLOG OF; NCCRP1",Asterisk
615902,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, GAMMA; PPP2R3C",Asterisk
615903,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 10; CHCHD10,Asterisk
615904,"PEROXIDASIN, DROSOPHILA, HOMOLOG-LIKE; PXDNL",Asterisk
615905,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25; EIEE25",Number Sign
615906,RING FINGER PROTEIN 219; RNF219,Asterisk
615907,"LYMPHEDEMA, HEREDITARY, ID; LMPH1D",Number Sign
615908,MICRO RNA 520C; MIR520C,Asterisk
615909,DIAMOND-BLACKFAN ANEMIA 13; DBA13,Number Sign
615910,NAD(P)HX DEHYDRATASE; NAXD,Asterisk
615911,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2,Number Sign
615912,GLUTATHIONE S-TRANSFERASE C-TERMINAL DOMAIN-CONTAINING PROTEIN; GSTCD,Asterisk
615913,PEPTIDASE M20 DOMAIN-CONTAINING PROTEIN 2; PM20D2,Asterisk
615914,CYCLIN-DEPENDENT KINASE INHIBITOR 2A-INTERACTING PROTEIN; CDKN2AIP,Asterisk
615915,ZONA PELLUCIDA-LIKE DOMAIN-CONTAINING PROTEIN 1; ZPLD1,Asterisk
615916,"CARDIOMYOPATHY, DILATED, 1NN; CMD1NN",Number Sign
615917,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20,Number Sign
615918,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21,Number Sign
615919,ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2,Number Sign
615920,PROLINE-RICH PROTEIN 11; PRR11,Asterisk
615921,"PPARGC1- AND ESRR-INDUCED REGULATOR, MUSCLE, 1; PERM1",Asterisk
615922,RETINITIS PIGMENTOSA 70; RP70,Number Sign
615923,"EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM",Number Sign
615924,"ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD",Number Sign
615925,"GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP",Number Sign
615926,WEBB-DATTANI SYNDROME; WEDAS,Number Sign
615927,"FAMILY WITH SEQUENCE SIMILARITY 101, MEMBER A; FAM101A",Asterisk
615928,"FAMILY WITH SEQUENCE SIMILARITY 101, MEMBER B; FAM101B",Asterisk
615929,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 17; ANKRD17,Asterisk
615930,"COLORECTAL ADENOCARCINOMA HYPERMETHYLATED GENE, NONCODING; CAHM",Asterisk
615931,PROLINE-RICH PROTEIN 16; PRR16,Asterisk
615932,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 20; KCTD20,Asterisk
615933,BTB/POZ DOMAIN-CONTAINING PROTEIN 10; BTBD10,Asterisk
615934,"STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI",Number Sign
615935,PANCREATIC AGENESIS 2; PAGEN2,Number Sign
615936,RHO GTPase-ACTIVATING PROTEIN 42; ARHGAP42,Asterisk
615937,MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2,Number Sign
615938,MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3,Number Sign
615939,"PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE), MEMBER B; PTPLB",Asterisk
615940,PROTEIN TYROSINE PHOSPHATASE-LIKE A DOMAIN-CONTAINING PROTEIN 1; PTPLAD1,Asterisk
615941,PROTEIN TYROSINE PHOSPHATASE-LIKE A DOMAIN-CONTAINING PROTEIN 2; PTPLAD2,Asterisk
615942,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44; MRT44",Number Sign
615943,"MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 3; MAGI3",Asterisk
615944,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 3; C2CD3,Asterisk
615945,SPINOCEREBELLAR ATAXIA 37; SCA37,Number Sign
615946,"MYOPIA 24, AUTOSOMAL DOMINANT; MYP24",Number Sign
615947,"HYPERLIPOPROTEINEMIA, TYPE ID",Number Sign
615948,OROFACIODIGITAL SYNDROME XIV; OFD14,Number Sign
615949,TRANSMEMBRANE PROTEIN 98; TMEM98,Asterisk
615950,SPEG COMPLEX LOCUS; SPEG,Asterisk
615951,ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 6; ZSWIM6,Asterisk
615952,"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1",Number Sign
615953,"KALLIKREIN, DECREASED URINARY ACTIVITY OF",Number Sign
615954,ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2,Number Sign
615955,COILED-COIL DOMAIN-CONTAINING PROTEIN 183; CCDC183,Asterisk
615956,COILED-COIL DOMAIN-CONTAINING PROTEIN 151; CCDC151,Asterisk
615957,SPINOCEREBELLAR ATAXIA 38; SCA38,Number Sign
615958,SLX4-INTERACTING PROTEIN; SLX4IP,Asterisk
615959,"MYOPATHY, CENTRONUCLEAR, 5; CNM5",Number Sign
615960,PORETTI-BOLTSHAUSER SYNDROME; PTBHS,Number Sign
615961,ACID-LABILE SUBUNIT DEFICIENCY; ACLSD,Number Sign
615962,"GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR",Number Sign
615963,VESICOURETERAL REFLUX 8; VUR8,Number Sign
615964,"MIR99A-LET7C CLUSTER HOST GENE, NONCODING; MIR99AHG",Asterisk
615965,"MIR100-LET7A2 CLUSTER HOST GENE, NONCODING; MIR100HG",Asterisk
615966,IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26,Number Sign
615967,"CYTOCHROME P450, FAMILY 2, SUBFAMILY W, POLYPEPTIDE 1; CYP2W1",Asterisk
615968,"MYCN UPSTREAM TRANSCRIPT, NONCODING; MYCNUT",Asterisk
615969,ALPHA-FETOPROTEIN DEFICIENCY; AFPD,Number Sign
615970,"ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF; HPAFP",Number Sign
615971,REMOVED FROM DATABASE,Caret
615972,NANOPHTHALMOS 4; NNO4,Number Sign
615973,CONE-ROD DYSTROPHY 20; CORD20,Number Sign
615974,"DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102",Number Sign
615975,TRANSMEMBRANE PROTEIN 129; TMEM129,Asterisk
615976,"FOXC1 UPSTREAM TRANSCRIPT, NONCODING; FOXCUT",Asterisk
615977,MICRO RNA 339; MIR339,Asterisk
615978,IMMUNODEFICIENCY 27B; IMD27B,Number Sign
615979,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45",Number Sign
615980,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6",Number Sign
615981,BARDET-BIEDL SYNDROME 2; BBS2,Number Sign
615982,BARDET-BIEDL SYNDROME 4; BBS4,Number Sign
615983,BARDET-BIEDL SYNDROME 5; BBS5,Number Sign
615984,BARDET-BIEDL SYNDROME 7; BBS7,Number Sign
615985,BARDET-BIEDL SYNDROME 8; BBS8,Number Sign
615986,BARDET-BIEDL SYNDROME 9; BBS9,Number Sign
615987,BARDET-BIEDL SYNDROME 10; BBS10,Number Sign
615988,BARDET-BIEDL SYNDROME 11; BBS11,Number Sign
615989,BARDET-BIEDL SYNDROME 12; BBS12,Number Sign
615990,BARDET-BIEDL SYNDROME 13; BBS13,Number Sign
615991,BARDET-BIEDL SYNDROME 14; BBS14,Number Sign
615992,BARDET-BIEDL SYNDROME 15; BBS15,Number Sign
615993,BARDET-BIEDL SYNDROME 16; BBS16,Number Sign
615994,BARDET-BIEDL SYNDROME 17; BBS17,Number Sign
615995,BARDET-BIEDL SYNDROME 18; BBS18,Number Sign
615996,BARDET-BIEDL SYNDROME 19; BBS19,Number Sign
615997,"DEFENSIN, BETA, 119; DEFB119",Asterisk
615998,RING FINGER PROTEIN 10; RNF10,Asterisk
615999,"HYPERTHYROXINEMIA, FAMILIAL DYSALBUMINEMIC; FDAH",Number Sign
616000,ANALBUMINEMIA; ANALBA,Number Sign
616001,"BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2",Number Sign
616002,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7,Number Sign
616003,"APOPTOGENIC PROTEIN 1, MITOCHONDRIAL; APOPT1",Asterisk
616004,"DYSFIBRINOGENEMIA, CONGENITAL",Number Sign
616005,IMMUNODEFICIENCY 36; IMD36,Number Sign
616006,HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2,Number Sign
616007,"CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS",Number Sign
616008,"COP9 SIGNALOSOME, SUBUNIT 4; COPS4",Asterisk
616009,"COP9 SIGNALOSOME, SUBUNIT 7A; COPS7A",Asterisk
616010,"COP9 SIGNALOSOME, SUBUNIT 7B; COPS7B",Asterisk
616011,"COP9 SIGNALOSOME, SUBUNIT 8; COPS8",Asterisk
616012,"JAGUNAL, DROSOPHILA, HOMOLOG OF, 1; JAGN1",Asterisk
616013,"tRNA METHYLTRANSFERASE 10, S. CEREVISIAE, HOMOLOG OF, A; TRMT10A",Asterisk
616014,RING FINGER PROTEIN 25; RNF25,Asterisk
616015,RING FINGER PROTEIN 180; RNF180,Asterisk
616016,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1H; PPM1H",Asterisk
616017,TRIPARTITE MOTIF-CONTAINING PROTEIN 69; TRIM69,Asterisk
616018,REMOVED FROM DATABASE,Caret
616019,REST COREPRESSOR 2; RCOR2,Asterisk
616020,CYSTEINE/TYROSINE-RICH PROTEIN 1; CYYR1,Asterisk
616021,CYYR1 ANTISENSE RNA 1; CYYR1AS1,Asterisk
616022,"NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6",Number Sign
616023,SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 4; SCAF4,Asterisk
616024,SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 8; SCAF8,Asterisk
616025,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11,Number Sign
616026,FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4,Number Sign
616027,ACTIN-BINDING PROTEIN ANILLIN; ANLN,Asterisk
616028,ADAMS-OLIVER SYNDROME 5; AOS5,Number Sign
616029,ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME; ECTDS,Number Sign
616030,HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22,Number Sign
616031,COILED-COIL DOMAIN-CONTAINING PROTEIN 141; CCDC141,Asterisk
616032,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8,Number Sign
616033,"MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1",Number Sign
616034,"2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD",Number Sign
616035,FORKHEAD BOX J3; FOXJ3,Asterisk
616036,MICRO RNA 494; MIR494,Asterisk
616037,"CILIARY DYSKINESIA, PRIMARY, 30; CILD30",Number Sign
616038,NEU-LAXOVA SYNDROME 2; NLS2,Number Sign
616039,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID",Number Sign
616040,"MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7",Number Sign
616041,THIOSULFATE SULFURTRANSFERASE (RHODANESE)-LIKE DOMAIN-CONTAINING PROTEIN 1; TSTD1,Asterisk
616042,"DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103",Number Sign
616043,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING; PCAT1",Asterisk
616044,"DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65",Number Sign
616045,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22; COXPD22,Number Sign
616046,PROLINE/SERINE/THREONINE PHOSPHATASE-INTERACTING PROTEIN 2; PSTPIP2,Asterisk
616047,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 97; CFAP97,Asterisk
616048,"ALU-MEDIATED CDKN1A/p21 TRANSCRIPTIONAL REGULATOR, NONCODING; APTR",Asterisk
616049,"TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 34, YEAST, HOMOLOG OF; TOMM34",Asterisk
616050,AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC,Number Sign
616051,"MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13",Number Sign
616052,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7",Number Sign
616053,SPINOCEREBELLAR ATAXIA 40; SCA40,Number Sign
616054,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 2; ELP2",Asterisk
616055,"EPISODIC ATAXIA, TYPE 8; EA8",Percent
616056,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26",Number Sign
616057,"TUMOR SUPPRESSOR CANDIDATE 7, NONCODING; TUSC7",Asterisk
616058,TCF21 ANTISENSE RNA INDUCING PROMOTER DEMETHYLATION; TARID,Asterisk
616059,MIRROR MOVEMENTS 3; MRMV3,Number Sign
616060,"BLOOD GROUP, DOMBROCK SYSTEM; DO",Number Sign
616061,MAX DIMERIZATION PROTEIN MGA; MGA,Asterisk
616062,ANKYRIN REPEAT- AND LEM DOMAIN-CONTAINING PROTEIN 2; ANKLE2,Asterisk
616063,"POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8",Number Sign
616064,TUBULOINTERSTITIAL NEPHRITIS ANTIGEN-LIKE PROTEIN 1; TINAGL1,Asterisk
616065,PILR-ALPHA-ASSOCIATED NEURAL PROTEIN; PIANP,Asterisk
616066,SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 2; SOHLH2,Asterisk
616067,"46,XY SEX REVERSAL 9; SRXY9",Number Sign
616068,HOXA CLUSTER ANTISENSE RNA 2; HOXAAS2,Asterisk
616069,"INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2",Number Sign
616070,COILED-COIL DOMAIN-CONTAINING PROTEIN 113; CCDC113,Asterisk
616071,CHROMOSOME 7 OPEN READING FRAME 31; C7ORF31,Asterisk
616072,HETEROCHROMATIN PROTEIN 1-BINDING PROTEIN 3; HP1BP3,Asterisk
616073,DEP DOMAIN-CONTAINING PROTEIN 1B; DEPDC1B,Asterisk
616074,CHEMOKINE-LIKE FACTOR; CKLF,Asterisk
616075,"DEFENSIN, BETA, 121; DEFB121",Asterisk
616076,"DEFENSIN, BETA, 123; DEFB123",Asterisk
616077,"DEFENSIN, BETA, 122, PSEUDOGENE; DEFB122",Asterisk
616078,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29",Number Sign
616079,RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA,Number Sign
616080,"MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12",Number Sign
616081,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C",Number Sign
616082,CHROMOSOME 12 OPEN READING FRAME 4; C12ORF4,Asterisk
616083,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30",Number Sign
616084,"SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD",Number Sign
616085,ZINC FINGER PROTEIN 37A; ZNF37A,Asterisk
616086,SprT-LIKE N-TERMINAL DOMAIN PROTEIN; SPRTN,Asterisk
616087,"DIABETES MELLITUS, NONINSULIN-DEPENDENT, 5; NIDDM5",Number Sign
616088,CHROMOSOME 1 OPEN READING FRAME 186; C1ORF186,Asterisk
616089,"BLOOD GROUP, GERBICH SYSTEM; GE",Number Sign
616090,MICRO RNA 802; MIR802,Asterisk
616091,METHYLTRANSFERASE-LIKE 17; METTL17,Asterisk
616092,FOCALLY AMPLIFIED LONG NONCODING RNA IN EPITHELIAL CANCER; FALEC,Asterisk
616093,"BLOOD GROUP, ABO SYSTEM",Number Sign
616094,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12",Number Sign
616095,MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D,Number Sign
616096,"MYOSIN HEAVY CHAIN-ASSOCIATED RNA TRANSCRIPT, NONCODING; MHRT",Asterisk
616097,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 3; UQCC3,Asterisk
616098,IMMUNODEFICIENCY 37; IMD37,Number Sign
616099,PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH,Number Sign
616100,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5",Number Sign
616101,TRANSMEMBRANE PROTEIN 240; TMEM240,Asterisk
616102,THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 3; TMX3,Asterisk
616103,"LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 1; LRIT1",Asterisk
616104,RBPJ-LIKE PROTEIN; RBPJL,Asterisk
616105,SORTING NEXIN 14; SNX14,Asterisk
616106,"PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15",Number Sign
616107,FATTY ACYL CoA REDUCTASE 1; FAR1,Asterisk
616108,"RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS",Number Sign
616109,CHROMOSOME 11 OPEN READING FRAME 80; C11ORF80,Asterisk
616110,"DELTEX, DROSOPHILA, HOMOLOG OF, 4; DTX4",Asterisk
616111,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9; MC3DN9",Number Sign
616112,LEIOMODIN 3; LMOD3,Asterisk
616113,POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS,Number Sign
616114,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 6; CHD6,Asterisk
616115,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4,Number Sign
616116,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46; MRT46",Number Sign
616117,CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY; CCDD,Number Sign
616118,"MACULAR DEGENERATION, EARLY-ONSET; EOMD",Number Sign
616119,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 126; CFAP126,Asterisk
616120,CWF19-LIKE PROTEIN 1; CWF19L1,Asterisk
616121,"GTPase, VERY LARGE INTERFERON-INDUCIBLE, PSEUDOGENE 1; GVINP1",
616122,"FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER B1; FAM86B1",Asterisk
616123,"FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER B2; FAM86B2",Asterisk
616124,"FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER C1; FAM86C1",Asterisk
616125,PROTEIN ARGININE METHYLTRANSFERASE 9; PRMT9,Asterisk
616126,IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38,Number Sign
616127,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17",Number Sign
616128,"FAMILY WITH SEQUENCE SIMILARITY 89, MEMBER B; FAM89B",Asterisk
616129,LEUCINE-RICH ADAPTOR PROTEIN 1; LURAP1,Asterisk
616130,LEUCINE-RICH ADAPTOR PROTEIN 1-LIKE; LURAP1L,Asterisk
616131,"GASTRIC CANCER-ASSOCIATED TRANSCRIPT 2, NONCODING; GACAT2",Asterisk
616132,"GASTRIC CANCER-ASSOCIATED TRANSCRIPT 3, NONCODING; GACAT3",Asterisk
616133,MPV17-LIKE PROTEIN 2; MPV17L2,Asterisk
616134,"H3 HISTONE, FAMILY 3C; H3F3C",Asterisk
616135,INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 5; IFIT5,Asterisk
616136,RING FINGER PROTEIN 220; RNF220,Asterisk
616137,MICRO RNA 873; MIR873,Asterisk
616138,PERRAULT SYNDROME 5; PRLTS5,Number Sign
616139,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27",Number Sign
616140,"LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9",Number Sign
616141,"H2A HISTONE FAMILY, MEMBER Y2; H2AFY2",Asterisk
616142,"FAMILY WITH SEQUENCE SIMILARITY 98, MEMBER B; FAM98B",Asterisk
616143,LYSOPHOSPHOLIPASE II; LYPLA2,Asterisk
616144,WD REPEAT-CONTAINING PROTEIN 73; WDR73,Asterisk
616145,CATEL-MANZKE SYNDROME; CATMANS,Number Sign
616146,"TDP-GLUCOSE 4,6-DEHYDRATASE; TGDS",Asterisk
616147,CYCLIN-DEPENDENT KINASE 15; CDK15,Asterisk
616148,TRIPARTITE MOTIF-CONTAINING PROTEIN 59; TRIM59,Asterisk
616149,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PYRIMIDINE NUCLEOTIDE TRANSPORTER), MEMBER 36; SLC25A36",Asterisk
616150,"SOLUTE CARRIER FAMILY 25, MEMBER 48; SLC25A48",Asterisk
616151,"MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4",Number Sign
616152,"MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5",Number Sign
616153,"SOLUTE CARRIER FAMILY 25, MEMBER 52; SLC25A52",Asterisk
616154,PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD,Number Sign
616155,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S",Number Sign
616156,FATTY ACYL CoA REDUCTASE 2; FAR2,Asterisk
616157,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 13; DHRS13",Asterisk
616158,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31",Number Sign
616159,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 11; DHRS11",Asterisk
616160,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7B; DHRS7B",Asterisk
616161,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7C; DHRS7C",Asterisk
616162,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY 39U, MEMBER 1; SDR39U1",Asterisk
616163,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 12; DHRS12",Asterisk
616164,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY 42E, MEMBER 1; SDR42E1",Asterisk
616165,NEMALINE MYOPATHY 10; NEM10,Number Sign
616166,"AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9",Number Sign
616167,DCN1 DOMAIN-CONTAINING PROTEIN 3; DCUN1D3,Asterisk
616168,"TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 6, YEAST, HOMOLOG OF; TOMM6",Asterisk
616169,"TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 5, YEAST, HOMOLOG OF; TOMM5",Asterisk
616170,MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD,Number Sign
616171,"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2",Number Sign
616172,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9",Number Sign
616173,NUCLEAR SPECKLE SPLICING REGULATORY PROTEIN 1; NSRP1,Asterisk
616174,CYTOSKELETON-ASSOCIATED PROTEIN 2-LIKE; CKAP2L,Asterisk
616175,UBIQUITIN-CONJUGATING ENZYME E2J 1; UBE2J1,Asterisk
616176,"BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19",Number Sign
616177,DDRGK DOMAIN-CONTAINING PROTEIN 1; DDRGK1,Asterisk
616178,TRANSMEMBRANE PROTEIN 132E; TMEM132E,Asterisk
616179,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 16; TXNDC16,Asterisk
616180,"GOLGIN A8 FAMILY, MEMBER A; GOLGA8A",Asterisk
616181,ZINC FINGER PROTEIN 713; ZNF713,Asterisk
616182,"CHRONIC MOUNTAIN SICKNESS, SUSCEPTIBILITY TO",Percent
616183,TRANSMEMBRANE PROTEIN 107; TMEM107,Asterisk
616184,"CLUSTERED MITOCHONDRIA, D. DISCOIDEUM, HOMOLOG OF; CLUH",Asterisk
616185,OVARIAN DYSGENESIS 4; ODG4,Number Sign
616186,H19/IGF2-IMPRINTING CONTROL REGION,Asterisk
616187,"EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7",Number Sign
616188,RETINAL DYSTROPHY AND OBESITY; RDOB,Number Sign
616189,CAP METHYLTRANSFERASE 1; CMTR1,Asterisk
616190,CAP METHYLTRANSFERASE 2; CMTR2,Asterisk
616191,DISCS LARGE-ASSOCIATED PROTEIN 4; DLGAP4,Asterisk
616192,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD",Number Sign
616193,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47; MRT47",Number Sign
616194,"UTP15, U3 SMALL NUCLEOLAR RIBONUCLEOPROTEIN, S. CEREVISIAE, HOMOLOG OF; UTP15",Asterisk
616195,WD REPEAT-CONTAINING PROTEIN 43; WDR43,Asterisk
616196,DDB1- AND CUL4-ASSOCIATED FACTOR 13; DCAF13,Asterisk
616197,NUCLEOLAR PROTEIN 10; NOL10,Asterisk
616198,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23,Number Sign
616199,POLYGLUCOSAN BODY MYOPATHY 2; PGBM2,Number Sign
616200,RUIJS-AALFS SYNDROME; RJALS,Number Sign
616201,CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID,Number Sign
616202,CEREBELLOFACIODENTAL SYNDROME; CFDS,Number Sign
616203,"SOLUTE CARRIER FAMILY 38, MEMBER 9; SLC38A9",Asterisk
616204,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18",Number Sign
616205,MICRO RNA 648; MIR648,Asterisk
616206,"NEUROBLASTOMA-ASSOCIATED TRANSCRIPT 1, NONCODING; NBAT1",Asterisk
616207,"NEGATIVE REGULATOR OF ANTIVIRAL RESPONSE, NONCODING; NRAV",Asterisk
616208,AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22,Number Sign
616209,"MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD",Number Sign
616210,CHROMOSOME 4 OPEN READING FRAME 46; C4ORF46,Asterisk
616211,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28",Number Sign
616212,LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6,Number Sign
616213,ZINC FINGER PROTEIN 292; ZNF292,Asterisk
616214,HYPERPROINSULINEMIA,Number Sign
616215,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 1; CREB3L1,Asterisk
616216,THROMBOCYTOPENIA 5; THC5,Number Sign
616217,NEPHRONOPHTHISIS 19; NPHP19,Number Sign
616218,"TBC1 DOMAIN FAMILY, MEMBER 13; TBC1D13",Asterisk
616219,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5",Number Sign
616220,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9,Number Sign
616221,"AMELOGENESIS IMPERFECTA, TYPE IH; AI1H",Number Sign
616222,TEMPLE SYNDROME,Number Sign
616223,CHROMOSOME 19 OPEN READING FRAME 80; C19ORF80,Asterisk
616224,"MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22",Number Sign
616225,"AUTOPHAGY 2, S. CEREVISIAE, HOMOLOG OF, A; ATG2A",Asterisk
616226,"AUTOPHAGY 2, S. CEREVISIAE, HOMOLOG OF, B; ATG2B",Asterisk
616227,"MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15",Number Sign
616228,"MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14",Number Sign
616229,"OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16",Number Sign
616230,"EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8",Number Sign
616231,"MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA",Number Sign
616232,MEIOTIC KINETOCHORE FACTOR; MEIKIN,Asterisk
616233,MOVED TO 614881,Caret
616234,WD REPEAT- AND COILED-COIL-CONTAINING PROTEIN; WDCP,Asterisk
616235,"KATANIN, p80 SUBUNIT, B-LIKE 1; KATNBL1",Asterisk
616236,CHONDROADHERIN-LIKE; CHADL,Asterisk
616237,KINASE NONCATALYTIC C-LOBE DOMAIN-CONTAINING PROTEIN 1; KNDC1,Asterisk
616238,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 49; ZBTB49,Asterisk
616239,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24,Number Sign
616240,OLIGODENDROCYTE MATURATION-ASSOCIATED LONG INTERGENIC NONCODING RNA; OLMALINC,Asterisk
616241,METEORIN-LIKE PROTEIN; METRNL,Asterisk
616242,"TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 1; TMCC1",Asterisk
616243,KIAA0922 GENE; KIAA0922,Asterisk
616244,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 2; CHCHD2,Asterisk
616245,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 4; EMC4",Asterisk
616246,MYOREGULIN; MRLN,Asterisk
616247,LONG QT SYNDROME 14; LQT14,Number Sign
616248,LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6,Number Sign
616249,LONG QT SYNDROME 15; LQT15,Number Sign
616250,NACHT DOMAIN- AND WD REPEAT-CONTAINING PROTEIN 1; NWD1,Asterisk
616251,TRPM8 CHANNEL-ASSOCIATED FACTOR 1; TCAF1,Asterisk
616252,TRPM8 CHANNEL-ASSOCIATED FACTOR 2; TCAF2,Asterisk
616253,GS HOMEOBOX 2; GSX2,Asterisk
616254,CASEINOLYTIC PEPTIDASE B; CLPB,Asterisk
616255,SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK,Number Sign
616256,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER G; CLEC4G",Asterisk
616257,FK506-BINDING PROTEIN 9; FKBP9,Asterisk
616258,MECKEL SYNDROME 12; MKS12,Number Sign
616259,SMALL NUCLEOLAR RNA HOST GENE 14; SNHG14,Asterisk
616260,TENORIO SYNDROME; TNORS,Number Sign
616261,"PSEUDOURIDYLATE SYNTHASE 7, PUTATIVE; PUS7",Asterisk
616262,KELCH-LIKE 21; KLHL21,Asterisk
616263,"NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD",Number Sign
616264,"MAF TRANSCRIPTIONAL REGULATOR RNA, NONCODING; MAFTRR",Asterisk
616265,PEELING SKIN SYNDROME 3; PSS3,Number Sign
616266,"CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD",Number Sign
616267,ATAXIA-OCULOMOTOR APRAXIA 4; AOA4,Number Sign
616268,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32",Number Sign
616269,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48",Number Sign
616270,"AMELOGENESIS IMPERFECTA, TYPE IF; AI1F",Number Sign
616271,"3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN",Number Sign
616272,MICRO RNA 520G; MIR520G,Asterisk
616273,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 29, NONCODING; PCAT29",Asterisk
616274,MICRO RNA 4276; MIR4276,Asterisk
616275,"FAMILY WITH SEQUENCE SIMILARITY 136, MEMBER A; FAM136A",Asterisk
616276,"COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7",Number Sign
616277,MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D,Number Sign
616278,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5",Number Sign
616279,CATARACT 43; CTRCT43,Number Sign
616280,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U",Number Sign
616281,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49",Number Sign
616282,"SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73",Number Sign
616283,PSEUDOURIDYLATE SYNTHASE 3; PUS3,Asterisk
616284,FILAGGRIN FAMILY MEMBER 2; FLG2,Asterisk
616285,FORMIN-LIKE 2; FMNL2,Asterisk
616286,LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7,Number Sign
616287,LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8,Number Sign
616288,FORMIN-LIKE 3; FMNL3,Asterisk
616289,OPTIC ATROPHY 9; OPA9,Number Sign
616290,ZINC FINGER PROTEIN 658; ZNF658,Asterisk
616291,LICHTENSTEIN-KNORR SYNDROME; LIKNS,Number Sign
616292,STABILIZER OF AXONEMAL MICROTUBULES 1; SAXO1,Asterisk
616293,HORNERIN; HRNR,Asterisk
616294,COLE-CARPENTER SYNDROME 2; CLCRP2,Number Sign
616295,"PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS; PLACK",Number Sign
616296,MULTIPLE C2 DOMAINS-CONTAINING TRANSMEMBRANE PROTEIN 1; MCTP1,Asterisk
616297,MULTIPLE C2 DOMAINS-CONTAINING TRANSMEMBRANE PROTEIN 2; MCTP2,Asterisk
616298,SINGLETON-MERTEN SYNDROME 2; SGMRT2,Number Sign
616299,LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D,Number Sign
616300,SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13,Number Sign
616301,"CD300 ANTIGEN-LIKE FAMILY, MEMBER D; CD300LD",Asterisk
616302,FORKHEAD BOX K1; FOXK1,Asterisk
616303,WD REPEAT-CONTAINING PROTEIN 91; WDR91,Asterisk
616304,"MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17",Number Sign
616305,FERM DOMAIN-CONTAINING PROTEIN 4A; FRMD4A,Asterisk
616306,FIBRINOGEN SILENCER-BINDING PROTEIN; FSBP,Asterisk
616307,SENIOR-LOKEN SYNDROME 8; SLSN8,Number Sign
616308,"BETA-GLOBIN LOCUS TRANSCRIPT 3, NONCODING; BGLT3",Asterisk
616309,FERM DOMAIN-CONTAINING PROTEIN 5; FRMD5,Asterisk
616310,RHO GTPase-ACTIVATING PROTEIN 11B; ARHGAP11B,Asterisk
616311,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33",Number Sign
616312,LEM DOMAIN-CONTAINING PROTEIN 2; LEMD2,Asterisk
616313,"MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A",Number Sign
616314,"MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C",Number Sign
616315,PARALOG OF XRCC4 AND XLF; PAXX,Asterisk
616316,"FAMILY WITH SEQUENCE SIMILARITY 168, MEMBER A; FAM168A",Asterisk
616317,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 1; GDPD1,Asterisk
616318,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 3; GDPD3,Asterisk
616319,RING FINGER PROTEIN 138; RNF138,Asterisk
616320,FUMARYLACETOACETATE HYDROLASE DOMAIN-CONTAINING PROTEIN 1; FAHD1,Asterisk
616321,"MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A",Number Sign
616322,"MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B",Number Sign
616323,"MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C",Number Sign
616324,"MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B",Number Sign
616325,"MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9",Number Sign
616326,"MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11",Number Sign
616327,CHROMOSOME ALIGNMENT-MAINTAINING PHOSPHOPROTEIN 1; CHAMP1,Asterisk
616328,LONG INTERGENIC NONCODING RNA PINKY,Asterisk
616329,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13",Number Sign
616330,"MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18",Number Sign
616331,"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2",Number Sign
616332,ACIDIC RESIDUE METHYLTRANSFERASE 1; ARMT1,Asterisk
616333,WNT SIGNALING PATHWAY ACTIVATING NONCODING RNA; WSPAR,Asterisk
616334,TRANSMEMBRANE PROTEIN 100; TMEM100,Asterisk
616335,"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3",Number Sign
616336,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER B15; AKR1B15",Asterisk
616337,SUPPRESSOR OF CYTOKINE SIGNALING 4; SOCS4,Asterisk
616338,"SOX2 OVERLAPPING TRANSCRIPT, NONCODING; SOX2OT",Asterisk
616339,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29",Number Sign
616340,"DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67",Number Sign
616341,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30",Number Sign
616342,LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7,Number Sign
616343,"TUMOR PROTEIN p53 PATHWAY COREPRESSOR 1, NONCODING; TP53COR1",Asterisk
616344,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 23-LIKE; TTC23L,Asterisk
616345,IMMUNODEFICIENCY 39; IMD39,Number Sign
616346,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31",Number Sign
616347,PR DOMAIN-CONTAINING PROTEIN 11; PRDM11,Asterisk
616348,ZINC FINGER PROTEIN 695; ZNF695,Asterisk
616349,SORBIN AND SH3 DOMAINS-CONTAINING PROTEIN 2; SORBS2,Asterisk
616350,PROMOTER OF MAT2A ANTISENSE RADIATION-INDUCED CIRCULATING LONG NONCODING RNA; PARTICL,Asterisk
616351,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34",Number Sign
616352,ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 6; ACBD6,Asterisk
616353,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6; DKCB6",Number Sign
616354,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20",Number Sign
616355,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35",Number Sign
616356,"MICRO RNA 31 HOST GENE, NONCODING; MIR31HG",Asterisk
616357,"DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40",Number Sign
616358,MICRO RNA 379; MIR379,Asterisk
616359,"COQ5, S. CEREVISIAE, HOMOLOG OF; COQ5",Asterisk
616360,TRANSMEMBRANE PROTEIN 135; TMEM135,Asterisk
616361,PARKINSON DISEASE 21; PARK21,Percent
616362,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36",Number Sign
616363,SMALL PROLINE-RICH PROTEIN 4; SPRR4,Asterisk
616364,WHITE-SUTTON SYNDROME; WHSUS,Number Sign
616365,SCY1-LIKE PROTEIN 2; SCYL2,Asterisk
616366,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32",Number Sign
616367,MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA,Number Sign
616368,CHOPS SYNDROME; CHOPS,Number Sign
616369,MOVED TO 243605,Caret
616370,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4,Number Sign
616371,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4",Number Sign
616372,DDB1- AND CUL4-ASSOCIATED FACTOR 4; DCAF4,Asterisk
616373,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3",Number Sign
616374,BEN DOMAIN-CONTAINING PROTEIN 3; BEND3,Asterisk
616375,UNKEMPT FAMILY ZINC FINGER PROTEIN; UNK,Asterisk
616376,MICRO RNA 656; MIR656,Asterisk
616377,PROLINE DEHYDROGENASE (OXIDASE) 2; PRODH2,Asterisk
616378,UBX DOMAIN PROTEIN 1; UBXN1,Asterisk
616379,UBX DOMAIN PROTEIN 7; UBXN7,Asterisk
616380,"LAMININ, BETA-4; LAMB4",Asterisk
616381,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 8; ZCCHC8,Asterisk
616382,"URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2 FAMILY, MEMBER A3; UGT2A3",Asterisk
616383,"URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 3 FAMILY, MEMBER A1; UGT3A1",Asterisk
616384,"URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 3 FAMILY, MEMBER A2; UGT3A2",Asterisk
616385,LONG INTERGENIC NONCODING RNA 1018; LINC01018,Asterisk
616386,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 17; KCTD17,Asterisk
616387,"DOWNREGULATED RNA IN ANDROGEN-INDEPENDENT CELLS, NONCODING; DRAIC",Asterisk
616388,UBIQUITIN DOMAIN-CONTAINING PROTEIN 1; UBTD1,Asterisk
616389,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G",Number Sign
616390,"TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE; TTD2",Number Sign
616391,RAN-BINDING PROTEIN 3-LIKE; RANBP3L,Asterisk
616392,SKINT1-LIKE PSEUDOGENE; SKINTL,
616393,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38",Number Sign
616394,RETINITIS PIGMENTOSA 71; RP71,Number Sign
616395,"TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3",Number Sign
616396,"SEX COMB ON MIDLEG, DROSOPHILA, HOMOLOG OF, 1; SCMH1",Asterisk
616397,PEROXISOMAL MEMBRANE PROTEIN 4; PXMP4,Asterisk
616398,"DYSTONIA 26, MYOCLONIC; DYT26",Number Sign
616399,BRUGADA SYNDROME 9; BRGDA9,Number Sign
616400,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2; FNEPPK2",Number Sign
616401,SPINDLE APPARATUS COILED-COIL PROTEIN 1; SPDL1,Asterisk
616402,"MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14",Number Sign
616403,TP53 TARGET GENE 1; TP53TG1,Asterisk
616404,"POLYMERASE I, RNA, SUBUNIT A; POLR1A",Asterisk
616405,ADAPTOR PROTEIN 2-ASSOCIATED KINASE 1; AAK1,Asterisk
616406,PYRROLINE-5-CARBOXYLATE REDUCTASE 2; PYCR2,Asterisk
616407,BROWN SYNDROME; BRWNS,Percent
616408,PYRROLINE-5-CARBOXYLATE REDUCTASE-LIKE; PYCRL,Asterisk
616409,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33",Number Sign
616410,SPINOCEREBELLAR ATAXIA 41; SCA41,Number Sign
616411,DYSTONIA 27; DYT27,Number Sign
616412,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 5; TXNDC5,Asterisk
616413,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6",Number Sign
616414,"AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK",Number Sign
616415,FAMILIAL ADENOMATOUS POLYPOSIS 3; FAP3,Number Sign
616416,ADHESION G PROTEIN-COUPLED RECEPTOR L1; ADGRL1,Asterisk
616417,ADHESION G PROTEIN-COUPLED RECEPTOR L3; ADGRL3,Asterisk
616418,"HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR",Number Sign
616419,ADHESION G PROTEIN-COUPLED RECEPTOR L4; ADGRL4,Asterisk
616420,"LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10",Number Sign
616421,MYOCLONIC-ATONIC EPILEPSY; MAE,Number Sign
616422,"TRANSCRIPTION ELONGATION FACTOR, MITOCHONDRIAL; TEFM",Asterisk
616423,DEAH BOX POLYPEPTIDE 30; DHX30,Asterisk
616424,SET DOMAIN-CONTAINING PROTEIN 6; SETD6,Asterisk
616425,"46,XY SEX REVERSAL 10; SRXY10",Number Sign
616426,"CENTROSOMAL PROTEIN, 192-KD; CEP192",Asterisk
616427,A-KINASE ANCHOR INHIBITOR 1; AKAIN1,Asterisk
616428,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10; MCOPCB10",Number Sign
616429,SUSHI DOMAIN-CONTAINING PROTEIN 3; SUSD3,Asterisk
616430,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25,Number Sign
616431,"GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE 2, MITOCHONDRIAL; GPAT2",Asterisk
616432,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 18; ARHGEF18,Asterisk
616433,IMMUNODEFICIENCY 40; IMD40,Number Sign
616434,"INCREASED SODIUM TOLERANCE 1, YEAST, HOMOLOG OF; IST1",Asterisk
616435,"FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT",Number Sign
616436,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7",Number Sign
616437,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3,Number Sign
616438,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 3; TNFAIP8L3,Asterisk
616439,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4,Number Sign
616440,"SOLUTE CARRIER FAMILY 32 (GABA VESICULAR TRANSPORTER), MEMBER 1; SLC32A1",Asterisk
616441,OVO-LIKE 2; OVOL2,Asterisk
616442,OVO-LIKE 3; OVOL3,Asterisk
616443,"ZINC FINGER, MYM-TYPE 5; ZMYM5",Asterisk
616444,RNA-BINDING MOTIF PROTEIN 19; RBM19,Asterisk
616445,"CANDIDIASIS, FAMILIAL, 9; CANDF9",Number Sign
616446,CHROMOSOME 1 OPEN READING FRAME 177; C1ORF177,Asterisk
616447,KIAA1429 GENE; KIAA1429,Asterisk
616448,RAS-ASSOCIATED PROTEIN RAB12; RAB12,Asterisk
616449,BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS,Number Sign
616450,"EF-HAND DOMAIN FAMILY, MEMBER D2; EFHD2",Asterisk
616451,"SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74",Number Sign
616452,B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA,Number Sign
616453,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 13; ZC3H13,Asterisk
616454,ZINC FINGER PROTEIN 408; ZNF408,Asterisk
616455,ZIMMERMANN-LABAND SYNDROME 2; ZLS2,Number Sign
616456,"INO80 COMPLEX, SUBUNIT B; INO80B",Asterisk
616457,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50",Number Sign
616458,PR DOMAIN-CONTAINING PROTEIN 12; PRDM12,Asterisk
616459,AL-RAQAD SYNDROME; ARS,Number Sign
616460,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50",Number Sign
616461,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8",Number Sign
616462,"ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN",Number Sign
616463,ZINC FINGER PROTEIN 232; ZNF232,Asterisk
616464,"ECDYSONELESS, DROSOPHILA, HOMOLOG OF; ECD",Asterisk
616465,"VPS50, EARP/GARPII COMPLEX SUBUNIT; VPS50",Asterisk
616466,"UNC5, C. ELEGANS, HOMOLOG OF, D; UNC5D",Asterisk
616467,"DELETED IN PRIMARY CILIARY DYSKINESIA, MOUSE, HOMOLOG OF; DPCD",Asterisk
616468,EXUDATIVE VITREORETINOPATHY 6; EVR6,Number Sign
616469,RETINITIS PIGMENTOSA 72; RP72,Number Sign
616470,ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2,Number Sign
616471,BETHLEM MYOPATHY 2; BTHLM2,Number Sign
616472,UBIQUITIN-ASSOCIATED PROTEIN 2-LIKE; UBAP2L,Asterisk
616473,MICRO RNA 558; MIR558,Asterisk
616474,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 26; ZSCAN26,Asterisk
616475,"CENTROSOMAL PROTEIN, 72-KD; CEP72",Asterisk
616476,ATP/GTP-BINDING PROTEIN-LIKE 4; AGBL4,Asterisk
616477,NUCLEAR RECEPTOR-BINDING FACTOR 2; NRBF2,Asterisk
616478,LEUCINE-RICH REPEATS- AND GUANYLATE KINASE DOMAIN-CONTAINING PROTEIN; LRGUK,Asterisk
616479,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2",Number Sign
616480,KIAA1328 GENE; KIAA1328,Asterisk
616481,"CILIARY DYSKINESIA, PRIMARY, 32; CILD32",Number Sign
616482,"ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN",Number Sign
616483,INFANTILE LIVER FAILURE SYNDROME 2; ILFS2,Number Sign
616484,TAX1-BINDING PROTEIN 3; TAX1BP3,Asterisk
616485,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 21; ZBTB21,Asterisk
616486,"MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE; MCPH15",Number Sign
616487,EPIDERMOLYSIS BULLOSA SIMPLEX WITH NAIL DYSTROPHY; EBSND,Number Sign
616488,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8",Number Sign
616489,"GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF",Number Sign
616490,JOUBERT SYNDROME 23; JBTS23,Number Sign
616491,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V",Number Sign
616492,"EWING SARCOMA-ASSOCIATED TRANSCRIPT 1, NONCODING; EWSAT1",Asterisk
616493,"FAMILY WITH SEQUENCE SIMILARITY 208, MEMBER A; FAM208A",Asterisk
616494,"LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11",Number Sign
616495,ADP-RIBOSYLATION FACTOR-LIKE 6-INTERACTING PROTEIN 6; ARL6IP6,Asterisk
616496,NUCLEAR ENVELOPE INTEGRAL MEMBRANE PROTEIN 1; NEMP1,Asterisk
616497,NUCLEAR ENVELOPE INTEGRAL MEMBRANE PROTEIN 2; NEMP2,Asterisk
616498,"FAMILY WITH SEQUENCE SIMILARITY 134, MEMBER C; FAM134C",Asterisk
616499,TRANSMEMBRANE PROTEIN 203; TMEM203,Asterisk
616500,"CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3; CEMCOX3",Number Sign
616501,"CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4",Number Sign
616502,CONE-ROD DYSTROPHY 21; CORD21,Number Sign
616503,LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9,Number Sign
616504,METHYLTRANSFERASE-LIKE 14; METTL14,Asterisk
616505,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B",Number Sign
616506,NEURON-DERIVED NEUROTROPHIC FACTOR; NDNF,Asterisk
616507,"OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17",Number Sign
616508,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 11; SLC39A11",Asterisk
616509,CATARACT 44; CTRCT44,Number Sign
616510,GLUCOSAMINE-PHOSPHATE N-ACETYLTRANSFERASE 1; GNPNAT1,Asterisk
616511,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14",Number Sign
616512,RING FINGER PROTEIN 152; RNF152,Asterisk
616513,"La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 4B; LARP4B",Asterisk
616514,"FAMILY WITH SEQUENCE SIMILARITY 195, MEMBER B; FAM195B",Asterisk
616515,"DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104",Number Sign
616516,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3",Number Sign
616517,ACHROMATOPSIA 7; ACHM7,Number Sign
616518,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 6; SLC38A6",Asterisk
616519,PHOSPHODIESTERASE 12; PDE12,Asterisk
616520,ADENOSYLHOMOCYSTEINASE-LIKE 2; AHCYL2,Asterisk
616521,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 39; MRD39",Number Sign
616522,DCN1 DOMAIN-CONTAINING PROTEIN 5; DCUN1D5,Asterisk
616523,MICROFIBRILLAR-ASSOCIATED PROTEIN 3-LIKE; MFAP3L,Asterisk
616524,TRANSMEMBRANE PROTEIN 139; TMEM139,Asterisk
616525,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 10; SLC38A10",Asterisk
616526,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 11; SLC38A11",Asterisk
616527,SWI5-DEPENDENT HOMOLOGOUS RECOMBINATION REPAIR PROTEIN 1; SFR1,Asterisk
616528,SWI5 HOMOLOGOUS RECOMBINATION REPAIR PROTEIN; SWI5,Asterisk
616529,YTH N6-METHYLADENOSINE RNA-BINDING PROTEIN 1; YTHDF1,Asterisk
616530,YTH DOMAIN-CONTAINING PROTEIN 2; YTHDC2,Asterisk
616531,"POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA",Number Sign
616532,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7",Number Sign
616533,DEAD BOX POLYPEPTIDE 31; DDX31,Asterisk
616534,"THYROID CANCER, NONMEDULLARY, 4; NMTC4",Number Sign
616535,"THYROID CANCER, NONMEDULLARY, 5; NMTC5",Number Sign
616536,CYSTATIN 9-LIKE; CST9L,Asterisk
616537,V-SET AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 2-LIKE; VSTM2L,Asterisk
616538,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9",Number Sign
616539,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26,Number Sign
616540,"EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9",Number Sign
616541,"SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED",Number Sign
616542,GS HOMEOBOX 1; GSX1,Asterisk
616543,CYSTATIN 9; CST9,Asterisk
616544,RETINITIS PIGMENTOSA 73; RP73,Number Sign
616545,PRELI DOMAIN-CONTAINING PROTEIN 3A; PRELID3A,Asterisk
616546,SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY; SRTD14,Number Sign
616547,LYSOZYME G-LIKE 2; LYG2,Asterisk
616548,LYSOPHOSPHOLIPASE-LIKE 1; LYPLAL1,Asterisk
616549,"KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4",Number Sign
616550,TRANSMEMBRANE PROTEIN 120A; TMEM120A,Asterisk
616551,TRANSMEMBRANE PROTEIN 120B; TMEM120B,Asterisk
616552,CARNOSINE N-METHYLTRANSFERASE 1; CARNMT1,Asterisk
616553,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6",Number Sign
616554,SPERM-ASSOCIATED ANTIGEN 17; SPAG17,Asterisk
616555,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A; LRRC37A,Asterisk
616556,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A2; LRRC37A2,Asterisk
616557,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A3; LRRC37A3,Asterisk
616558,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37B; LRRC37B,Asterisk
616559,NOONAN SYNDROME 9; NS9,Number Sign
616560,CD300H ANTIGEN,Asterisk
616561,RAS PROTEIN ACTIVATOR-LIKE 3; RASAL3,Asterisk
616562,RETINITIS PIGMENTOSA 74; RP74,Number Sign
616563,STE20-LIKE PROTEIN KINASE; SLK,Asterisk
616564,NOONAN SYNDROME 10; NS10,Number Sign
616565,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30B; ANKRD30B,Asterisk
616566,"SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6",Number Sign
616567,DEATH-ASSOCIATED PROTEIN KINASE 2; DAPK2,Asterisk
616568,GLIOMA SUSCEPTIBILITY 9; GLM9,Number Sign
616569,CYSTEINE SULFINIC ACID DECARBOXYLASE; CSAD,Asterisk
616570,CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3,Number Sign
616571,"C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER A; CLEC18A",Asterisk
616572,"C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER B; CLEC18B",Asterisk
616573,"C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER C; CLEC18C",Asterisk
616574,MITOCHONDRIAL INNER MEMBRANE ORGANIZING SYSTEM PROTEIN 1; MINOS1,Asterisk
616575,LEUKOCYTE RECEPTOR CLUSTER GENE 8; LENG8,Asterisk
616576,"IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12",Number Sign
616577,"EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS",Number Sign
616578,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 1; ZBTB1,Asterisk
616579,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40",Number Sign
616580,AU-KLINE SYNDROME; AUKS,Number Sign
616581,LYSINE-SPECIFIC DEMETHYLASE 4E; KDM4E,Asterisk
616582,LIPOLYSIS-STIMULATED LIPOPROTEIN RECEPTOR; LSR,Asterisk
616583,"SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE; SEDSTN",Number Sign
616584,"SPERMATOGENESIS-ASSOCIATED PROTEIN 31, SUBFAMILY A, MEMBER 7; SPATA31A7",Asterisk
616585,RING FINGER- AND SPRY DOMAIN-CONTAINING PROTEIN 1; RSPRY1,Asterisk
616586,"SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B",Number Sign
616587,"FAMILY WITH SEQUENCE SIMILARITY 118, MEMBER B; FAM118B",Asterisk
616588,DIHYDROFOLATE REDUCTASE-LIKE 1; DHFRL1,Asterisk
616589,ADAMS-OLIVER SYNDROME 6; AOS6,Number Sign
616590,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 5; ZBTB5,Asterisk
616591,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7C; ZBTB7C,Asterisk
616592,KOSAKI OVERGROWTH SYNDROME; KOGS,Number Sign
616593,"FAMILY WITH SEQUENCE SIMILARITY 132, MEMBER A; FAM132A",Asterisk
616594,"ARF GTPase-ACTIVATING PROTEIN WITH SH3 DOMAIN, ANKYRIN REPEAT, AND PH DOMAIN 3; ASAP3",Asterisk
616595,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 2; ZBTB2,Asterisk
616596,ADP-RIBOSYLATION FACTOR-LIKE 8B; ARL8B,Asterisk
616597,ADP-RIBOSYLATION FACTOR-LIKE 8A; ARL8A,Asterisk
616598,"BLOC1-RELATED COMPLEX, SUBUNIT 5; BORCS5",Asterisk
616599,"BLOC1-RELATED COMPLEX, SUBUNIT 6; BORCS6",Asterisk
616600,"BLOC1-RELATED COMPLEX, SUBUNIT 7; BORCS7",Asterisk
616601,"BLOC1-RELATED COMPLEX, SUBUNIT 8; BORCS8",Asterisk
616602,CRANIOSYNOSTOSIS 6; CRS6,Number Sign
616603,"CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3",Number Sign
616604,"CHROMOSOME 14q32 DUPLICATION SYNDROME, 700-KB",Number Sign
616605,GSK3B-INTERACTING PROTEIN; GSKIP,Asterisk
616606,RING CHROMOSOME 14 SYNDROME,Number Sign
616607,KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 8; KBTBD8,Asterisk
616608,CHROMOSOME 5 OPEN READING FRAME 30; C5ORF30,Asterisk
616609,TRANSMEMBRANE PROTEIN 65; TMEM65,Asterisk
616610,"CANCER SUSCEPTIBILITY CANDIDATE 15, NONCODING; CASC15",Asterisk
616611,LONG INTERGENIC NONCODING RNA 461; LINC00461,Asterisk
616612,"COLLAGEN, TYPE VI, ALPHA-4, PSEUDOGENE 2; COL6A4P2",Asterisk
616613,"COLLAGEN, TYPE VI, ALPHA-6; COL6A6",Asterisk
616614,HISTONE PARYLATION FACTOR 1; HPF1,Asterisk
616615,CHONDROITIN SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE 1; CSGALNACT1,Asterisk
616616,CHONDROITIN SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE 2; CSGALNACT2,Asterisk
616617,HEIMLER SYNDROME 2; HMLR2,Number Sign
616618,ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 5; ACBD5,Asterisk
616619,"DPPA2 UPSTREAM-BINDING RNA, NONCODING; DUBR",Asterisk
616620,WD REPEAT-CONTAINING PROTEIN 12; WDR12,Asterisk
616621,DEAD BOX POLYPEPTIDE 27; DDX27,Asterisk
616622,IMMUNODEFICIENCY 42; IMD42,Number Sign
616623,"FAMILY WITH SEQUENCE SIMILARITY 30, MEMBER A; FAM30A",Asterisk
616624,NUCLEAR CAP-BINDING PROTEIN 3; NCBP3,Asterisk
616625,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W; CMT2W",Number Sign
616626,CEREBRAL ENDOTHELIAL CELL ADHESION MOLECULE; CERCAM,Asterisk
616627,PODOCALYXIN-LIKE 2; PODXL2,Asterisk
616628,"FAMILY WITH SEQUENCE SIMILARITY 220, MEMBER A; FAM220A",Asterisk
616629,SENIOR-LOKEN SYNDROME 9; SLSN9,Number Sign
616630,NEURENSIN 1; NRSN1,Asterisk
616631,"POROKERATOSIS 9, MULTIPLE TYPES; POROK9",Number Sign
616632,"SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS",Number Sign
616633,PROLINE-RICH PROTEIN 12; PRR12,Asterisk
616634,"SUSHI, NIDOGEN, AND EGF-LIKE DOMAINS PROTEIN 1; SNED1",Asterisk
616635,CYSTEINE- AND HISTIDINE-RICH PROTEIN 1; CYHR1,Asterisk
616636,IMMUNODEFICIENCY 44; IMD44,Number Sign
616637,"TBC1 DOMAIN FAMILY, MEMBER 16; TBC1D16",Asterisk
616638,SMITH-KINGSMORE SYNDROME; SKS,Number Sign
616639,PR DOMAIN-CONTAINING PROTEIN 8; PRDM8,Asterisk
616640,"EPILEPSY, PROGRESSIVE MYOCLONIC, 10; EPM10",Number Sign
616641,RING FINGER PROTEIN 141; RNF141,Asterisk
616642,C6ORF89 GENE; C6ORF89,Asterisk
616643,HEPATOMA-DERIVED GROWTH FACTOR-RELATED PROTEIN 3,Asterisk
616644,CUB AND ZONA PELLUCIDA-LIKE DOMAINS 1; CUZD1,Asterisk
616645,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34",Number Sign
616646,"KERATIN 25, TYPE I; KRT25",Asterisk
616647,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35; EIEE35",Number Sign
616648,OPTIC ATROPHY 8; OPA8,Percent
616649,"SPHEROCYTOSIS, TYPE 2; SPH2",Number Sign
616650,KIAA0556 GENE; KIAA0556,Asterisk
616651,ROIFMAN SYNDROME; RFMN,Number Sign
616652,YUAN-HAREL-LUPSKI SYNDROME; YUHAL,Number Sign
616653,PNN-INTERACTING SERINE/ARGININE-RICH PROTEIN; PNISR,Asterisk
616654,JOUBERT SYNDROME 24; JBTS24,Number Sign
616655,SIPA1-LIKE PROTEIN 3; SIPA1L3,Asterisk
616656,COMM DOMAIN-CONTAINING PROTEIN 8; COMMD8,Asterisk
616657,"SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM",Number Sign
616658,CHROMOSOME 19 OPEN READING FRAME 70; C19ORF70,Asterisk
616659,"TBC1 DOMAIN FAMILY, MEMBER 17; TBC1D17",Asterisk
616660,TRANSMEMBRANE PROTEIN 175: TMEM175,Asterisk
616661,MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 2; MORC2,Asterisk
616662,THUMP DOMAIN-CONTAINING PROTEIN 1; THUMPD1,Asterisk
616663,"SMALL NUCLEOLAR RNA, C/D BOX, 118; SNORD118",Asterisk
616664,"SMALL NUCLEOLAR RNA, C/D BOX, 13; SNORD13",Asterisk
616665,SYNAPTOPHYSIN-LIKE 1; SYPL1,Asterisk
616666,"SEIZURE-RELATED 6, MOUSE, HOMOLOG OF; SEZ6",Asterisk
616667,SEZ6-LIKE PROTEIN 2; SEZ6L2,Asterisk
616668,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X",Number Sign
616669,IMMUNODEFICIENCY 45; IMD45,Number Sign
616670,EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 1; ESYT1,Asterisk
616671,"KERATIN 76, TYPE II; KRT76",Asterisk
616672,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27,Number Sign
616673,"SPINDLE- AND KINETOCHORE-ASSOCIATED COMPLEX, SUBUNIT 1; SKA1",Asterisk
616674,"SPINDLE- AND KINETOCHORE-ASSOCIATED COMPLEX, SUBUNIT 2; SKA2",Asterisk
616675,"KERATIN 26, TYPE I; KRT26",Asterisk
616676,"KERATIN 27, TYPE I; KRT27",Asterisk
616677,"KERATIN 28, TYPE I; KRT28",Asterisk
616678,"KERATIN 39, TYPE I; KRT39",Asterisk
616679,"KERATIN 40, TYPE I; KRT40",Asterisk
616680,"SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75",Number Sign
616681,"MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16",Number Sign
616682,"SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME; SSMS",Number Sign
616683,"LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12",Number Sign
616684,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K",Number Sign
616685,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14",Number Sign
616686,SYNAPTOTAGMIN-BINDING CYTOPLASMIC RNA-INTERACTING PROTEIN; SYNCRIP,Asterisk
616687,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y",Number Sign
616688,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z",Number Sign
616689,DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2,Number Sign
616690,"CENTROSOMAL PROTEIN, 104-KD; CEP104",Asterisk
616691,EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 2; ESYT2,Asterisk
616692,EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 3; ESYT3,Asterisk
616693,ACID-SENSING ION CHANNEL FAMILY MEMBER 5; ASIC5,Asterisk
616694,KIAA0368 GENE; KIAA0368,Asterisk
616695,SERINE/THREONINE/TYROSINE-INTERACTING PROTEIN-LIKE 1; STYXL1,Asterisk
616696,KIAA0040 GENE; KIAA0040,Asterisk
616697,"DEAFNESS, AUTOSOMAL DOMINANT 69; DFNA69",Number Sign
616698,ZINC FINGER PROTEIN 593; ZNF593,Asterisk
616699,COMM DOMAIN-CONTAINING PROTEIN 2; COMMD2,Asterisk
616700,COMM DOMAIN-CONTAINING PROTEIN 3; COMMD3,Asterisk
616701,COMM DOMAIN-CONTAINING PROTEIN 4; COMMD4,Asterisk
616702,ZINC FINGER PROTEIN 589; ZNF589,Asterisk
616703,COMM DOMAIN-CONTAINING PROTEIN 7; COMMD7,Asterisk
616704,COMM DOMAIN-CONTAINING PROTEIN 10; COMMD10,Asterisk
616705,"DEAFNESS, AUTOSOMAL RECESSIVE 97; DFNB97",Number Sign
616706,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 11; PARP11",Asterisk
616707,"DEAFNESS, AUTOSOMAL DOMINANT 68; DFNA68",Number Sign
616708,DESANTO-SHINAWI SYNDROME; DESSH,Number Sign
616709,"ALPHA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; A4GNT",Asterisk
616710,"PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22",Number Sign
616711,TAO KINASE 3; TAOK3,Asterisk
616712,START DOMAIN-CONTAINING PROTEIN 7; STARD7,Asterisk
616713,PIPECOLIC ACID OXIDASE; PIPOX,Asterisk
616714,HMG-BOX TRANSCRIPTION FACTOR 1; HBP1,Asterisk
616715,THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 2; TMX2,Asterisk
616716,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5",Number Sign
616717,TESTIS-EXPRESSED GENE 10; TEX10,Asterisk
616718,NEURITE OUTGROWTH-ASSOCIATED PROTEIN; NGRN,Asterisk
616719,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21",Number Sign
616720,"MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19",Number Sign
616721,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N",Number Sign
616722,RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT; RDICC,Number Sign
616723,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA",Number Sign
616724,"TOOTH AGENESIS, SELECTIVE, 7; STHAG7",Number Sign
616725,DEAD BOX POLYPEPTIDE 60-LIKE; DDX60L,Asterisk
616726,"CILIARY DYSKINESIA, PRIMARY, 33; CILD33",Number Sign
616727,PHD FINGER PROTEIN 21B; PHF21B,Asterisk
616728,"CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES; CPRF",Number Sign
616729,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY W, MEMBER 3; OR2W3",Asterisk
616730,"NEPHROTIC SYNDROME, TYPE 11; NPHS11",Number Sign
616731,NEVER IN MITOSIS GENE A-RELATED KINASE 5; NEK5,Asterisk
616732,"OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA10",Number Sign
616733,"COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8",Number Sign
616734,"SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2",Number Sign
616735,COILED-COIL DOMAIN-CONTAINING PROTEIN 174: CCDC174,Asterisk
616736,"TREMOR, HEREDITARY ESSENTIAL, 5; ETM5",Number Sign
616737,TAKENOUCHI-KOSAKI SYNDROME; TKS,Number Sign
616738,RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2,Number Sign
616739,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51; MRT51",Number Sign
616740,IMMUNODEFICIENCY 46; IMD46,Number Sign
616741,PR DOMAIN-CONTAINING PROTEIN 13; PRDM13,Asterisk
616742,"NOP58, S. CEREVISIAE, HOMOLOG OF; NOP58",Asterisk
616743,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 3; RGL3,Asterisk
616744,"AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE; AISBL",Number Sign
616745,BIORIENTATION OF CHROMOSOMES IN CELL DIVISION 1; BOD1,Asterisk
616746,BOD1-LIKE PROTEIN 1; BOD1L1,Asterisk
616747,CHOLINE PHOSPHOTRANSFERASE 1; CHPT1,Asterisk
616748,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 8; ENTPD8,Asterisk
616749,"HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7",Number Sign
616750,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 16; ZDHHC16,Asterisk
616751,CHOLINE/ETHANOLAMINE PHOSPHOTRANSFERASE 1; CEPT1,Asterisk
616752,"HYPOTHALAMUS GOLGI APPARATUS-EXPRESSED PROTEIN, 19-KD",Asterisk
616753,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 7; ENTPD7,Asterisk
616754,BOMBAY PHENOTYPE,Number Sign
616755,TRIPARTITE MOTIF-CONTAINING PROTEIN 62; TRIM62,Asterisk
616756,SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES; SPPRS,Number Sign
616757,TRANSMEMBRANE PROTEIN 150A; TMEM150A,Asterisk
616758,KERATINOCYTE DIFFERENTIATION FACTOR 1; KDF1,Asterisk
616759,NITRIC OXIDE SYNTHASE-INTERACTING PROTEIN; NOSIP,Asterisk
616760,"WOOLLY HAIR, AUTOSOMAL RECESSIVE 3; ARWH3",Number Sign
616761,SUSHI DOMAIN-CONTAINING PROTEIN 6; SUSD6,Asterisk
616762,"CENTRIOLE-, CILIA-, AND SPINDLE-ASSOCIATED PROTEIN; CCSAP",Asterisk
616763,LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD,Number Sign
616764,"SOLUTE CARRIER FAMILY 46, MEMBER 3; SLC46A3",Asterisk
616765,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 11; SAMD11,Asterisk
616766,THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 4; TMX4,Asterisk
616767,"CALPAIN, SMALL SUBUNIT 2; CAPNS2",Asterisk
616768,"TUBULIN, BETA-8; TUBB8",Asterisk
616769,NITRILASE FAMILY MEMBER 2; NIT2,Asterisk
616770,MICRO RNA 218-1; MIR218-1,Asterisk
616771,MICRO RNA 218-2; MIR218-2,Asterisk
616772,"MANNOSIDASE, ALPHA, CLASS 1C, MEMBER 1; MAN1C1",Asterisk
616773,"FAMILY WITH SEQUENCE SIMILARITY 73, MEMBER A; FAM73A",Asterisk
616774,"FAMILY WITH SEQUENCE SIMILARITY 73, MEMBER B; FAM73B",Asterisk
616775,ZINC FINGER PROTEIN 683; ZNF683,Asterisk
616776,DUAL-SPECIFICITY PHOSPHATASE 15; DUSP15,Asterisk
616777,SECKEL SYNDROME 9; SCKL9,Number Sign
616778,DUAL-SPECIFICITY PHOSPHATASE 22; DUSP22,Asterisk
616779,"CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2",Number Sign
616780,OOCYTE MATURATION DEFECT 2; OOMD2,Number Sign
616781,JOUBERT SYNDROME 25; JBTS25,Number Sign
616782,"GLUCOSAMINYL (N-ACETYL) TRANSFERASE 4, CORE 2; GCNT4",Asterisk
616783,UBX DOMAIN PROTEIN 10; UBXN10,Asterisk
616784,JOUBERT SYNDROME 26; JBTS26,Number Sign
616785,PUTATIVE HOMEODOMAIN TRANSCRIPTION FACTOR 2; PHTF2,Asterisk
616786,MITOGEN-ACTIVATED PROTEIN KINASE-BINDING PROTEIN 1; MAPKBP1,Asterisk
616787,CLUSTERIN-ASSOCIATED PROTEIN 1; CLUAP1,Asterisk
616788,OROFACIAL CLEFT 15; OFC15,Number Sign
616789,MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD,Number Sign
616790,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 4; PPP4R4",Asterisk
616791,PIGGYBAC TRANSPOSABLE ELEMENT-DERIVED GENE 5; PGBD5,Asterisk
616792,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 7; NBLST7",Percent
616793,"PHOSPHOLIPASE A2, GROUP IIF; PLA2G2F",Asterisk
616794,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28,Number Sign
616795,SPINOCEREBELLAR ATAXIA 42; SCA42,Number Sign
616796,RETINOL DEHYDROGENASE 14; RDH14,Asterisk
616797,"EFR3, S. CEREVISIAE, HOMOLOG OF, B; EFR3B",Asterisk
616798,ZINC FINGER PROTEIN 28; ZFP28,Asterisk
616799,SYNAPTONEMAL COMPLEX PROTEIN 2-LIKE; SYCP2L,Asterisk
616800,"LOXL1 ANTISENSE RNA 1, NONCODING; LOXL1AS1",Asterisk
616801,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2",Number Sign
616802,T CELL-INTERACTING ACTIVATING RECEPTOR ON MYELOID CELLS 1; TARM1,Asterisk
616803,LAMB-SHAFFER SYNDROME; LAMSHF,Number Sign
616804,V-SET AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 1; VSTM1,Asterisk
616805,MYC TARGET IN MYELOID CELLS 1; MYCT1,Asterisk
616806,WILMS TUMOR 6; WT6,Number Sign
616807,FAS-BINDING FACTOR 1; FBF1,Asterisk
616808,CHROMOSOME 19 OPEN READING FRAME 66; C19ORF66,Asterisk
616809,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6; HPMRS6,Number Sign
616810,"IMMUNOGLOBULIN SUPERFAMILY, DCC SUBCLASS, MEMBER 4; IGDCC4",Asterisk
616811,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29,Number Sign
616812,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2X; LGMD2X",Number Sign
616813,"ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 3; AGAP3",Asterisk
616814,PREIMPLANTATION EMBRYONIC LETHALITY 1; PREMBL1,Number Sign
616815,TRANSMEMBRANE PROTEIN 199; TMEM199,Asterisk
616816,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR",Number Sign
616817,"MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2; MSSGM2",Number Sign
616818,"IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3; IGAN3",Number Sign
616819,"CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA",Number Sign
616820,METHENYLTETRAHYDROFOLATE SYNTHETASE DOMAIN-CONTAINING PROTEIN; MTHFSD,Asterisk
616821,THROMBOSPONDIN TYPE 1 DOMAIN-CONTAINING PROTEIN 1; THSD1,Asterisk
616822,"MON2, S. CEREVISIAE, HOMOLOG OF; MON2",Asterisk
616823,DOPEY FAMILY MEMBER 1; DOPEY1,Asterisk
616824,TMF1-REGULATED NUCLEAR PROTEIN 1; TRNP1,Asterisk
616825,NUCLEAR RECEPTOR COACTIVATOR 5; NCOA5,Asterisk
616826,EPS15-LIKE PROTEIN 1; EPS15L1,Asterisk
616827,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W",Number Sign
616828,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O",Number Sign
616829,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp; CDG2P",Number Sign
616830,"TRANSPORT AND GOLGI ORGANIZATION 2, DROSOPHILA, HOMOLOG OF; TANGO2",Asterisk
616831,LUSCAN-LUMISH SYNDROME; LLS,Number Sign
616832,MYOMESIN 3; MYOM3,Asterisk
616833,PAGET DISEASE OF BONE 6; PDB6,Number Sign
616834,"MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD",Number Sign
616835,MEIER-GORLIN SYNDROME 6; MGORS6,Number Sign
616836,G-PATCH DOMAIN-CONTAINING PROTEIN 2; GPATCH2,Asterisk
616837,"HUMAN PLURIPOTENCY-ASSOCIATED TRANSCRIPT 5, NONCODING",Asterisk
616838,"C-TYPE LECTIN DOMAIN FAMILY 17, MEMBER A; CLEC17A",Asterisk
616839,"EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE; RREI",Number Sign
616840,"PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23",Number Sign
616841,ZINC FINGER PROTEIN 468; ZNF468,Asterisk
616842,"DNase1 HYPERSENSITIVITY, CHROMOSOME 6, SITE 1; DHS6S1",Asterisk
616843,"LYMPHEDEMA, HEREDITARY, III; LMPH3",Number Sign
616844,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 17; DNAJC17",Asterisk
616845,"C-TYPE LECTIN DOMAIN FAMILY 14, MEMBER A; CLEC14A",Asterisk
616846,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 1; EMC1",Asterisk
616847,ZINC FINGER PROTEIN 543; ZNF543,Asterisk
616848,MESODERM INDUCTION-EARLY RESPONSE PROTEIN 1; MIER1,Asterisk
616849,"BRACHYDACTYLY, TYPE A1, D; BDA1D",Number Sign
616850,WD REPEAT-CONTAINING PROTEIN 83; WDR83,Asterisk
616851,CATARACT 45; CTRCT45,Number Sign
616852,"MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM",Number Sign
616853,"FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER C: FAM72C",Asterisk
616854,EVEN-PLUS SYNDROME; EVPLS,Number Sign
616855,"CYTOCHROME c OXIDASE, SUBUNIT 8C; COX8C",Asterisk
616856,BROMODOMAIN- AND PHD FINGER-CONTAINING PROTEIN 3; BRPF3,Asterisk
616857,CHLORIDE CHANNEL ACCESSORY 4; CLCA4,Asterisk
616858,COWDEN SYNDROME 7; CWS7,Number Sign
616859,"SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA; SPAHGC",Number Sign
616860,"ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3",Number Sign
616861,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 9; SLC12A9",Asterisk
616862,RIBOSOMAL PROTEIN L34; RPL34,Asterisk
616863,CHROMOSOME 16p13.2 DELETION SYNDROME,Number Sign
616864,"HEXOSAMINIDASE (GLYCOSYL HYDROLASE FAMILY 20, CATALYTIC DOMAIN)-CONTAINING PROTEIN; HEXDC",Asterisk
616865,"POLY(A) POLYMERASE, GAMMA; PAPOLG",Asterisk
616866,SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1,Number Sign
616867,SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2,Number Sign
616868,"DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8",Number Sign
616869,C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1 REGULATORY SUBUNIT 1; CNEP1R1,Asterisk
616870,TRANSMEMBRANE PROTEIN 14A; TMEM14A,Asterisk
616871,"MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF",Number Sign
616872,"TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 3; TM9SF3",Asterisk
616873,"IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13",Number Sign
616874,TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 4; TMBIM4,Asterisk
616875,"CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR",Number Sign
616876,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 5; TMED5,Asterisk
616877,TRANSMEMBRANE PROTEIN 9; TMEM9,Asterisk
616878,"METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN",Number Sign
616879,"TBC1 DOMAIN FAMILY, MEMBER 22A; TBC1D22A",Asterisk
616880,"TBC1 DOMAIN FAMILY, MEMBER 22B; TBC1D22B",Asterisk
616881,"LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13",Number Sign
616882,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3",Number Sign
616883,"SIGNAL RECOGNITION PARTICLE RECEPTOR, BETA SUBUNIT; SRPRB",Asterisk
616884,"UNC79, C. ELEGANS, HOMOLOG OF; UNC79",Asterisk
616885,CALCIUM-REGULATED HEAT-STABLE PROTEIN 1; CARHSP1,Asterisk
616886,GSE1 COILED-COIL PROTEIN; GSE1,Asterisk
616887,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52; MRT52",Number Sign
616888,TRANSMEMBRANE PROTEIN 8B; TMEM8B,Asterisk
616889,"CENTROSOMAL PROTEIN, 68-KD; CEP68",Asterisk
616890,SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP,Number Sign
616891,DWARF OPEN READING FRAME,Asterisk
616892,"NEPHROTIC SYNDROME, TYPE 12; NPHS12",Number Sign
616893,"NEPHROTIC SYNDROME, TYPE 13; NPHS13",Number Sign
616894,"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3",Number Sign
616895,SURVIVAL-ASSOCIATED MITOCHONDRIAL MELANOMA-SPECIFIC ONCOGENIC NONCODING RNA; SAMMSON,Asterisk
616896,MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14,Number Sign
616897,"OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG",Number Sign
616898,CHROMOSOME 15q14 DELETION SYNDROME,Number Sign
616899,TBC1 DOMAIN-CONTAINING KINASE; TBCK,Asterisk
616900,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3",Number Sign
616901,"DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR; DEDSSH",Number Sign
616902,"CHROMOSOME 11p13 DELETION SYNDROME, DISTAL",Number Sign
616903,"THIOPURINES, POOR METABOLISM OF, 2; THPM2",Number Sign
616904,DEDICATOR OF CYTOKINESIS 5; DOCK5,Asterisk
616905,MORF4 FAMILY-ASSOCIATED PROTEIN 1; MRFAP1,Asterisk
616906,CANCER SUSCEPTIBILITY CANDIDATE 1; CASC1,Asterisk
616907,"SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE; SPG76",Number Sign
616908,PATCHED DOMAIN-CONTAINING PROTEIN 4; PTCHD4,Asterisk
616909,COILED-COIL DOMAIN-CONTAINING PROTEIN 68; CCDC68,Asterisk
616910,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3,Number Sign
616911,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4,Number Sign
616912,ENAH/VASP-LIKE PROTEIN; EVL,Asterisk
616913,"BLEEDING DISORDER, PLATELET-TYPE, 20; BDPLT20",Number Sign
616914,MARFAN LIPODYSTROPHY SYNDROME; MFLS,Number Sign
616915,"ZEB1 ANTISENSE RNA 1, NONCODING; ZEB1AS1",Asterisk
616916,SMALL ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2; SMAP2,Asterisk
616917,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53",Number Sign
616918,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS G PROTEIN; PIGG,Asterisk
616919,FERM AND PDZ DOMAINS-CONTAINING PROTEIN 1; FRMPD1,Asterisk
616920,HEART AND BRAIN MALFORMATION SYNDROME; HBMS,Number Sign
616921,"DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD",Number Sign
616922,"STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2; ADSD2",Number Sign
616923,RING FINGER PROTEIN 207; RNF207,Asterisk
616924,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC",Number Sign
616925,"DDHRS4 ANTISENSE RNA 1, NONCODING; DHRS4AS1",Asterisk
616926,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 4; FXYD4,Asterisk
616927,EXOCYST COMPLEX COMPONENT 3-LIKE 2; EXOC3L2,Asterisk
616928,TRANSMEMBRANE PROTEIN 45A; TMEM45A,Asterisk
616929,"TRANSCRIPTION TERMINATION FACTOR 2, MITOCHONDRIAL; MTERF2",Asterisk
616930,"TRANSCRIPTION TERMINATION FACTOR 3, MITOCHONDRIAL; MTERF3",Asterisk
616931,FUCOSYLTRANSFERASE 10; FUT10,Asterisk
616932,FUCOSYLTRANSFERASE 11; FUT11,Asterisk
616933,FORTY-TWO-THREE DOMAIN-CONTAINING PROTEIN 1; FYTTD1,Asterisk
616934,MEIOSIS-SPECIFIC PROTEIN WITH COILED-COIL DOMAIN; MEIOC,Asterisk
616935,"FAS-ASSOCIATED FACTOR FAMILY, MEMBER 2; FAF2",Asterisk
616936,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 9; CHD9,Asterisk
616937,THROMBOCYTOPENIA 6; THC6,Number Sign
616938,COFFIN-SIRIS SYNDROME 5; CSS5,Number Sign
616939,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION; COCPMR",Number Sign
616940,EXONUCLEASE 3-PRIME-TO-5-PRIME DOMAIN-CONTAINING PROTEIN 2; EXD2,Asterisk
616941,"AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT; AGM8",Number Sign
616942,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 5; PDIA5",Asterisk
616943,"TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6",Number Sign
616944,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 41; MRD41",Number Sign
616945,CLAVESIN 2; CLVS2,Asterisk
616946,PREMATURE OVARIAN FAILURE 11; POF11,Number Sign
616947,PREMATURE OVARIAN FAILURE 12; POF12,Number Sign
616948,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22; SCAR22",Number Sign
616949,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23",Number Sign
616950,SPERMATOGENIC FAILURE 15; SPGF15,Number Sign
616951,METASTASIS SUPPRESSOR 1-LIKE PROTEIN; MTSS1L,Asterisk
616952,MITOCHONDRIAL CALCIUM UNIPORTER REGULATOR 1; MCUR1,Asterisk
616953,"CutA, E. COLI, HOMOLOG OF; CUTA",Asterisk
616954,YOU-HOOVER-FONG SYNDROME; YHFS,Number Sign
616955,RRAD- AND GEM-LIKE GTPase 2; REM2,Asterisk
616956,"TUBULIN POLYMERIZATION-PROMOTING PROTEIN FAMILY, MEMBER 2; TPPP2",Asterisk
616957,"TUBULIN POLYMERIZATION-PROMOTING PROTEIN FAMILY, MEMBER 3; TPPP3",Asterisk
616958,MOVED TO 608653,Caret
616959,RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM,Number Sign
616960,"GTPase, IMAP FAMILY, MEMBER 6; GIMAP6",Asterisk
616961,"GTPase, IMAP FAMILY, MEMBER 7; GIMAP7",Asterisk
616962,"GTPase, IMAP FAMILY, MEMBER 8; GIMAP8",Asterisk
616963,"HYPERCALCEMIA, INFANTILE, 2; HCINF2",Number Sign
616964,MOVED TO 615225,Caret
616965,ADHESION G PROTEIN-COUPLED RECEPTOR G5; ADGRG5,Asterisk
616966,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 6; ABHD6,Asterisk
616967,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 17; TXNDC17,Asterisk
616968,"DEAFNESS, AUTOSOMAL DOMINANT 70; DFNA70",Number Sign
616969,"DEAFNESS, AUTOSOMAL DOMINANT 66; DFNA66",Number Sign
616970,MARVEL DOMAIN-CONTAINING PROTEIN 1; MARVELD1,Asterisk
616971,ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 3; ERGIC3,Asterisk
616972,MICRO RNA 490; MIR490,Asterisk
616973,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 42; MRD42",Number Sign
616974,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30; COXPD30,Number Sign
616975,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH",Number Sign
616976,TRIPARTITE MOTIF-CONTAINING PROTEIN 40; TRIM40,Asterisk
616977,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43",Number Sign
616978,COILED COIL-HELIX-COILED COIL-HELIX DOMAIN-CONTAINING PROTEIN 5; CHCHD5,Asterisk
616979,DEATH DOMAIN-CONTAINING PROTEIN 1; DTHD1,Asterisk
616980,CELL CYCLE REGULATOR OF NONHOMOLOGOUS END JOINING; CYREN,Asterisk
616981,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37",Number Sign
616982,PR DOMAIN-CONTAINING PROTEIN 6; PRDM6,Asterisk
616983,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 6; ENPP6,Asterisk
616984,NEUROPEPTIDE VF PRECURSOR; NPVF,Asterisk
616985,MTRNR2-LIKE 1; MTRNR2L1,Asterisk
616986,LONG INTERGENIC NONCODING RNA AC011288.2,Asterisk
616987,CHROMOSOME 6 OPEN READING FRAME 120; C6ORF120,Asterisk
616988,CHRONIC LYMPHOCYTIC LEUKEMIA UPREGULATED GENE 1; CLLU1,Asterisk
616989,"CHRONIC LYMPHOCYTIC LEUKEMIA UPREGULATED 1, OPPOSITE STRAND; CLLU1OS",Asterisk
616990,CLUSTERIN-LIKE PROTEIN 1; CLUL1,Asterisk
616991,"MUCIN 21, CELL SURFACE-ASSOCIATED; MUC21",Asterisk
616992,CHROMOSOME 8 OPEN READING FRAME 17; C8ORF17,Asterisk
616993,TRANSMEMBRANE PROTEIN 243; TMEM243,Asterisk
616995,CLOCK-INTERACTING PACEMAKER; CIPC,Asterisk
616996,TRIPARTITE MOTIF-CONTAINING PROTEIN 56; TRIM56,Asterisk
616997,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 7; ENPP7,Asterisk
616998,"LLP, APLYSIA, HOMOLOG OF; LLPH",Asterisk
616999,"RNA-BINDING PROTEIN FOX1, C. ELEGANS, HOMOLOG OF, 3; RBFOX3",Asterisk
617000,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 4; ENPP4,Asterisk
617001,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 5; ENPP5,Asterisk
617002,BICD FAMILY-LIKE CARGO ADAPTOR 1; BICDL1,Asterisk
617003,BICD FAMILY-LIKE CARGO ADAPTOR 2; BICDL2,Asterisk
617004,POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS; PCLD2,Number Sign
617005,CLAUDIN 17; CLDN17,Asterisk
617006,"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2",Number Sign
617007,TRIPARTITE MOTIF-CONTAINING PROTEIN 35; TRIM35,Asterisk
617008,"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3",Number Sign
617009,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 53; ANKRD53,Asterisk
617010,UNC51-LIKE KINASE 4; ULK4,Asterisk
617011,"MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR",Number Sign
617012,POLIOVIRUS RECEPTOR-RELATED IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN; PVRIG,Asterisk
617013,HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2,Number Sign
617014,"NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE; SCN7",Number Sign
617015,"PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 2; PLCXD2",Asterisk
617016,"PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 3; PLCXD3",Asterisk
617017,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T",Number Sign
617018,SPINOCEREBELLAR ATAXIA 43; SCA43,Number Sign
617019,TRANSMEMBRANE PROTEIN 230; TMEM230,Asterisk
617020,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38",Number Sign
617021,"HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA",Number Sign
617022,LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10,Number Sign
617023,RETINITIS PIGMENTOSA 75; RP75,Number Sign
617024,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H",Number Sign
617025,NEVUS COMEDONICUS; NC,Number Sign
617026,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2F; PCH2F",Number Sign
617027,"HYPERALDOSTERONISM, FAMILIAL, TYPE IV; HALD4",Number Sign
617028,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54; MRT54",Number Sign
617029,SEMAPHORIN 4B; SEMA4B,Asterisk
617030,"MYOPATHY, DISTAL, 5; MPD5",Number Sign
617031,"PRECURSOR mRNA-PROCESSING FACTOR 38, S. CEREVISIAE, HOMOLOG OF, A; PRPF38A",Asterisk
617032,PROTEIN-GLUCOSYLGALACTOSYLHYDROXYLYSINE GLUCOSIDASE; PGGHG,Asterisk
617033,GATS PROTEIN-LIKE 2; GATSL2,Asterisk
617034,GATS PROTEIN-LIKE 3; GATSL3,Asterisk
617035,PATENT DUCTUS ARTERIOSUS 2; PDA2,Number Sign
617036,ALKALINE CERAMIDASE 3; ACER3,Asterisk
617037,NONCODING RNA ACTIVATED BY DNA DAMAGE; NORAD,Asterisk
617038,LONG INTERGENIC NONCODING RNA 1370; LINC01370,Asterisk
617039,PATENT DUCTUS ARTERIOSUS 3; PDA3,Number Sign
617040,MICRO RNA 1231; MIR1231,Asterisk
617041,DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3,Number Sign
617042,GASDERMIN D; GSDMD,Asterisk
617043,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 17; ARHGEF17,Asterisk
617044,"SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD",Number Sign
617045,ZINC FINGER PROTEIN 703; ZNF703,Asterisk
617046,"SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; SPG77",Number Sign
617047,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26",Number Sign
617048,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 21; DNAJC21",Asterisk
617049,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5; PFIC5",Number Sign
617050,HERMANSKY-PUDLAK SYNDROME 10; HPS10,Number Sign
617051,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55; MRT55",Number Sign
617052,BONE MARROW FAILURE SYNDROME 3; BMFS3,Number Sign
617053,MIRAGE SYNDROME; MIRAGE,Number Sign
617054,"STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC",Number Sign
617055,CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3,Number Sign
617056,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4",Number Sign
617057,"CYTOSOLIC THIOURIDYLASE, SUBUNIT 2; CTU2",Asterisk
617058,"TSR3, AMINOCARBOXYPROPYL TRANSFERASE RIBOSOME MATURATION FACTOR; TSR3",Asterisk
617059,ZINC FINGER DBF DOMAIN-CONTAINING PROTEIN 2; ZDBF2,Asterisk
617060,LACTASE-LIKE PROTEIN; LCTL,Asterisk
617061,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44",Number Sign
617062,OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS,Number Sign
617063,MEIER-GORLIN SYNDROME 7; MGORS7,Number Sign
617064,"GUF1 GTPase, S. CEREVISIAE, HOMOLOG OF; GUF1",Asterisk
617065,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40; EIEE40",Number Sign
617066,"MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC",Number Sign
617067,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 8; LYPD8,Asterisk
617068,"PORTAL HYPERTENSION, NONCIRRHOTIC; NCPH",Number Sign
617069,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3; PEOB3",Number Sign
617070,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4; PEOB4",Number Sign
617071,LONG NONCODING RNA 13,Asterisk
617072,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y",Number Sign
617073,"TOOTH AGENESIS, SELECTIVE, 8; STHAG8",Number Sign
617074,"SMITH-MAGENIS SYNDROME CHROMOSOME REGION, CANDIDATE GENE 8; SMCR8",Asterisk
617075,"NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3; NPCA3",Number Sign
617076,FK506-BINDING PROTEIN-LIKE; FKBPL,Asterisk
617077,ZINC FINGER PROTEIN 618; ZNF618,Asterisk
617078,DEATH EFFECTOR DOMAIN-CONTAINING PROTEIN 2; DEDD2,Asterisk
617079,LONG INTERGENIC NONCODING RNA 673; LINC00673,Asterisk
617080,"SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5",Number Sign
617081,OMA1 ZINC METALLOPEPTIDASE; OMA1,Asterisk
617082,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa; CDG1AA",Number Sign
617083,"DYNEIN, CYTOPLASMIC 2, LIGHT INTERMEDIATE CHAIN 1; DYNC2LI1",Asterisk
617084,TRANSMEMBRANE PROTEIN 59; TMEM59,Asterisk
617085,"FIN BUD INITIATION FACTOR, ZEBRAFISH, HOMOLOG OF; FIBIN",Asterisk
617086,ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2; EMPF2,Number Sign
617087,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B",Number Sign
617088,SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15,Number Sign
617089,NUCLEOLUS AND NEURAL PROGENITOR PROTEIN; NEPRO,Asterisk
617090,"MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17",Number Sign
617091,"CILIARY DYSKINESIA, PRIMARY, 34; CILD34",Number Sign
617092,"CILIARY DYSKINESIA, PRIMARY, 35; CILD35",Number Sign
617093,"GROWTH RETARDATION, INTELLECTUAL DEVELOPMENTAL DISORDER, HYPOTONIA, AND HEPATOPATHY; GRIDHH",Number Sign
617094,"INTRAFLAGELLAR TRANSPORT 52, CHLAMYDOMONAS, HOMOLOG OF; IFT52",Asterisk
617095,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 25; TTC25,Asterisk
617096,TRANSMEMBRANE PROTEIN 59-LIKE; TMEM59L,Asterisk
617097,LONG INTERGENIC NONCODING RNA 1194; LINC01194,Asterisk
617098,RIBONUCLEASE K; RNASEK,Asterisk
617099,"AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS",Number Sign
617100,FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4,Number Sign
617101,INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN,Number Sign
617102,SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16,Number Sign
617103,ZINC FINGER PROTEIN 668; ZNF668,Asterisk
617104,"PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, GAMMA; PIP4K2C",Asterisk
617105,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41",Number Sign
617106,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42",Number Sign
617107,THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS,Number Sign
617108,SESSILE SERRATED POLYPOSIS CANCER SYNDROME; SSPCS,Number Sign
617109,CREB3 RECRUITMENT FACTOR; CREBRF,Asterisk
617110,"CENTROSOMAL PROTEIN, 78-KD; CEP78",Asterisk
617111,"MACULAR DYSTROPHY, PATTERNED, 3; MDPT3",Number Sign
617112,KIAA0753 GENE; KIAA0753,Asterisk
617113,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43; EIEE43",Number Sign
617114,"MYOPATHY, MYOFIBRILLAR, 7; MFM7",Number Sign
617115,PEELING SKIN SYNDROME 5; PSS5,Number Sign
617116,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2",Number Sign
617117,LONG INTERGENIC NONCODING RNA 663; LINC00663,Asterisk
617118,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3",Number Sign
617119,BARDET-BIEDL SYNDROME 20; BBS20,Number Sign
617120,JOUBERT SYNDROME 27; JBTS27,Number Sign
617121,JOUBERT SYNDROME 28; JBTS28,Number Sign
617122,C1QTNF9B ANTISENSE RNA 1; C1QTNF9BAS1,Asterisk
617123,RETINITIS PIGMENTOSA 76; RP76,Number Sign
617124,PEPTIDASE M20 DOMAIN-CONTAINING PROTEIN 1; PM20D1,Asterisk
617125,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56; MRT56",Number Sign
617126,ALAZAMI-YUAN SYNDROME; ALYUS,Number Sign
617127,OROFACIODIGITAL SYNDROME XV; OFD15,Number Sign
617128,INHIBITORY SYNAPTIC FACTOR 1; INSYN1,Asterisk
617129,"FAMILY WITH SEQUENCE SIMILARITY 196, MEMBER A; FAM196A",Asterisk
617130,MEMBRANE-ANCHORED JUNCTION PROTEIN; MAJIN,Asterisk
617131,TELOMERE REPEAT-BINDING BOUQUET FORMATION PROTEIN 2; TERB2,Asterisk
617132,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44; EIEE44",Number Sign
617133,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24",Number Sign
617134,TRANSMEMBRANE AND COILED-COIL DOMAINS PROTEIN 3; TMCO3,Asterisk
617135,L3MBT-LIKE 4; L3MBTL4,Asterisk
617136,LONG NONCODING RNA HIPSTR,Asterisk
617137,FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2,Number Sign
617138,SKI FAMILY TRANSCRIPTIONAL COREPRESSOR 2; SKOR2,Asterisk
617139,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 7B; LGALS7B",Asterisk
617140,ZTTK SYNDROME; ZTTKS,Number Sign
617141,ANIRIDIA 2; AN2,Number Sign
617142,ANIRIDIA 3; AN3,Number Sign
617143,"MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20",Number Sign
617144,"MICRO RNA 4435-2 HOST GENE, NONCODING; MIR4435-2HG",Asterisk
617145,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET; NADGP",Number Sign
617146,"ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT",Number Sign
617147,COILED-COIL DOMAIN-CONTAINING PROTEIN 14; CCDC14,Asterisk
617148,DEUTEROSOME ASSEMBLY PROTEIN 1; DEUP1,Asterisk
617149,FGFR1OP N-TERMINAL DOMAIN-LIKE PROTEIN; FOPNL,Asterisk
617150,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 3; ZDHHC3,Asterisk
617151,"SULFOTRANSFERASE FAMILY 1C, MEMBER 3; SULT1C3",Asterisk
617152,"SULFOTRANSFERASE FAMILY 6B, MEMBER 1; SULT6B1",Asterisk
617153,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45; EIEE45",Number Sign
617154,MRN COMPLEX-INTERACTING PROTEIN; MRNIP,Asterisk
617155,SUPPRESSION OF TUMORIGENICITY 18; ST18,Asterisk
617156,MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15,Number Sign
617157,"SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS",Number Sign
617158,"MYOPATHY, DISTAL, WITH RIMMED VACUOLES; DMRV",Number Sign
617159,SIFRIM-HITZ-WEISS SYNDROME; SIHIWES,Number Sign
617160,PROMININ 2; PROM2,Asterisk
617161,GSG1-LIKE PROTEIN; GSG1L,Asterisk
617162,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46",Number Sign
617163,RING FINGER PROTEIN 186; RNF186,Asterisk
617164,"SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD",Number Sign
617165,"FAMILY WITH SEQUENCE SIMILARITY 213, MEMBER A; FAM213A",Asterisk
617166,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47; EIEE47",Number Sign
617167,"SOLUTE CARRIER FAMILY 35, MEMBER G1; SLC35G1",Asterisk
617168,"AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10",Number Sign
617169,SOTOS SYNDROME 3; SOTOS3,Number Sign
617170,"CWC27 SPLICEOSOME-ASSOCIATED PROTEIN, S. CEREVISIAE, HOMOLOG OF; CWC27",Asterisk
617171,"DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; DYSEIDD",Number Sign
617172,GLUTATHIONE PEROXIDASE 8; GPX8,Asterisk
617173,INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA,Number Sign
617174,"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2",Number Sign
617175,RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA,Number Sign
617176,MICRO RNA 4271; MIR4271,Asterisk
617177,MYOSIN LIGHT CHAIN 10; MYL10,Asterisk
617178,RING FINGER PROTEIN 166; RNF166,Asterisk
617179,PROMOTER OF CDKN1A ANTISENSE DNA DAMAGE-ACTIVATED RNA; PANDAR,Asterisk
617180,CHITAYAT SYNDROME; CHYTS,Number Sign
617181,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 4; TMC4,Asterisk
617182,LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI,Number Sign
617183,HAREL-YOON SYNDROME; HAYOS,Number Sign
617184,"MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A",Number Sign
617185,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 7; NSUN7",Asterisk
617186,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY; PEBEL",Number Sign
617187,SPERMATOGENIC FAILURE 16; SPGF16,Number Sign
617188,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57",Number Sign
617189,TRANSMEMBRANE PROTEIN 110; TMEM110,Asterisk
617190,SHASHI-PENA SYNDROME; SHAPNS,Number Sign
617191,p38-INHIBITED CUTANEOUS SQUAMOUS CELL CARCINOMA-ASSOCIATED LONG INTERGENIC NONCODING RNA; PICSAR,Asterisk
617192,ENDONUCLEASE/EXONUCLEASE/PHOSPHATASE FAMILY DOMAIN-CONTAINING PROTEIN 1; EEPD1,Asterisk
617193,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT",Number Sign
617194,LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11,Number Sign
617195,MUSCULOSKELETAL EMBRYONIC NUCLEAR PROTEIN 1; MUSTN1,Asterisk
617196,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 3; TMC3,Asterisk
617197,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 5; TMC5,Asterisk
617198,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 7; TMC7,Asterisk
617199,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 6; NSUN6",Asterisk
617200,OLIGODENDROCYTIC MYELIN PARANODAL AND INNER LOOP PROTEIN; OPALIN,Asterisk
617201,PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7,Number Sign
617202,FORKHEAD BOX I2; FOXI2,Asterisk
617203,TRANSMEMBRANE PROTEIN 87B; TMEM87B,Asterisk
617204,VIMENTIN-TYPE INTERMEDIATE FILAMENT-ASSOCIATED COILED-COIL PROTEIN; VMAC,Asterisk
617205,"HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8",Number Sign
617206,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 3; NEURL3,Asterisk
617207,"ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO",Number Sign
617208,MAM DOMAIN-CONTAINING PROTEIN 4; MAMDC4,Asterisk
617209,GLUTAMINYL-tRNA SYNTHASE (GLUTAMINE-HYDROLYZING)-LIKE PROTEIN 1; QRSL1,Asterisk
617210,"GLUTAMYL-tRNA AMIDOTRANSFERASE, SUBUNIT C; GATC",Asterisk
617211,DERMOKINE; DMKN,Asterisk
617212,KERATINOCYTE DIFFERENTIATION-ASSOCIATED PROTEIN; KRTDAP,Asterisk
617213,SEDOHEPTULOKINASE DEFICIENCY; SHPKD,Number Sign
617214,SPERMATOGENIC FAILURE 17; SPGF17,Number Sign
617215,CHROMOSOME 17 OPEN READING FRAME 49; C17ORF49,Asterisk
617216,ZINC FINGER PROTEIN 420; ZNF420,Asterisk
617217,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6; AI2A6",Number Sign
617218,TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 3; TMTC3,Asterisk
617219,"CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL",Number Sign
617220,PYRIDINE NUCLEOTIDE-DISULFIDE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1; PYROXD1,Asterisk
617221,HEXOKINASE DOMAIN-CONTAINING PROTEIN 1; HKDC1,Asterisk
617222,"SUDDEN CARDIAC FAILURE, INFANTILE; SCFI",Number Sign
617223,"SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED; SCFAI",Number Sign
617224,GROWTH ARREST-SPECIFIC 2-LIKE 3; GAS2L3,Asterisk
617225,"SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78",Number Sign
617226,MITOGEN-ACTIVATED PROTEIN KINASE 1-INTERACTING PROTEIN 1-LIKE PROTEIN; MAPK1IP1L,Asterisk
617227,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3C; ATAD3C",Asterisk
617228,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31,Number Sign
617229,"FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER A; FAM53A",Asterisk
617230,"ZINC FINGER PROTEIN 1, MOUSE, HOMOLOG OF; ZFP1",Asterisk
617231,PHOSPHOLYSINE PHOSPHOHISTIDINE INORGANIC PYROPHOSPHATE PHOSPHATASE; LHPP,Asterisk
617232,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21; LGMDR21",Number Sign
617233,WD REPEAT-CONTAINING PROTEIN 70; WDR70,Asterisk
617234,PREIMPLANTATION EMBRYONIC LETHALITY 2; PREMBL2,Number Sign
617235,"MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY",Number Sign
617236,CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL,Number Sign
617237,IMMUNODEFICIENCY 49; IMD49,Number Sign
617238,"MYOPIA 25, AUTOSOMAL DOMINANT; MYP25",Number Sign
617239,"MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21",Number Sign
617240,"HAND2 ANTISENSE RNA 1, NONCODING; HAND2AS1",Asterisk
617241,"LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS",Number Sign
617242,"TRANS-2,3-ENOYL-CoA REDUCTASE-LIKE PROTEIN; TECRL",Asterisk
617243,"FANCONI ANEMIA, COMPLEMENTATION GROUP V; FANCV",Number Sign
617244,"FANCONI ANEMIA, COMPLEMENTATION GROUP R; FANCR",Number Sign
617245,"HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2; HECW2",Asterisk
617246,"NON-SMC ELEMENT 2, S. CEREVISIAE, HOMOLOG OF; NSMCE2",Asterisk
617247,"FANCONI ANEMIA, COMPLEMENTATION GROUP U; FANCU",Number Sign
617248,"3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8",Number Sign
617249,"FAMILY WITH SEQUENCE SIMILARITY 122, MEMBER A; FAM122A",Asterisk
617250,"ELKS/RAB6-INTERACTING/CAST FAMILY, MEMBER 2; ERC2",Asterisk
617251,UNCOMBABLE HAIR SYNDROME 2; UHS2,Number Sign
617252,UNCOMBABLE HAIR SYNDROME 3; UHS3,Number Sign
617253,SECKEL SYNDROME 10; SCKL10,Number Sign
617254,LAMIN TAIL DOMAIN-CONTAINING PROTEIN 1; LMNTD1,Asterisk
617255,LISSENCEPHALY 8; LIS8,Number Sign
617256,"SOLUTE CARRIER FAMILY 7, MEMBER 13; SLC7A13",Asterisk
617257,SPERMATOGENESIS-ASSOCIATED PROTEIN 46; SPATA46,Asterisk
617258,"MYOPATHY, MYOFIBRILLAR, 8; MFM8",Number Sign
617259,DDB1- AND CUL4-ASSOCIATED FACTOR 1; DCAF1,Asterisk
617260,"GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF",Number Sign
617261,TRANSMEMBRANE PROTEIN 261; TMEM261,Asterisk
617262,ATP5S-LIKE PROTEIN; ATP5SL,Asterisk
617263,"NON-SMC ELEMENT 1, S. CEREVISIAE, HOMOLOG OF; NSMCE1",Asterisk
617264,SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 1; SCAF1,Asterisk
617265,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 9; KCTD9,Asterisk
617266,KIAA0825 GENE; KIAA0825,Asterisk
617267,MATRIX AAA PEPTIDASE-INTERACTING PROTEIN 1; MAIP1,Asterisk
617268,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL",Number Sign
617269,"SOCS2 ANTISENSE RNA 1, NONCODING; SOCS2AS1",Asterisk
617270,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58",Number Sign
617271,NEPHRONOPHTHISIS 20; NPHP20,Number Sign
617272,"GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E",Number Sign
617273,"FAMILY WITH SEQUENCE SIMILARITY 92, MEMBER A; FAM92A",Asterisk
617274,"FAMILY WITH SEQUENCE SIMILARITY 92, MEMBER B; FAM92B",Asterisk
617275,"TOOTH AGENESIS, SELECTIVE, 9; STHAG9",Number Sign
617276,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48; EIEE48",Number Sign
617277,DYNEIN HEAVY CHAIN DOMAIN 1; DNHD1,Asterisk
617278,DENN DOMAIN-CONTAINING PROTEIN 5A; DENND5A,Asterisk
617279,DENN DOMAIN-CONTAINING PROTEIN 5B; DENND5B,Asterisk
617280,"ATRIAL FIBRILLATION, FAMILIAL, 18; ATFB18",Number Sign
617281,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49",Number Sign
617282,"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG",Number Sign
617283,YTH DOMAIN-CONTAINING PROTEIN 1; YTHDC1,Asterisk
617284,"DYSTONIA 28, CHILDHOOD-ONSET; DYT28",Number Sign
617285,HIGH MOBILITY GROUP BOX 4; HMGB4,Asterisk
617286,PITX2 ADJACENT NONCODING RNA; PANCR,Asterisk
617287,PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 5; PLPPR5,Asterisk
617288,"SERINE PEPTIDASE INHIBITOR, KAZAL-TYPE, 7; SPINK7",Asterisk
617289,"FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER B; FAM53B",Asterisk
617290,"EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D",Number Sign
617291,TRANSMEMBRANE PROTEIN 150B; TMEM150B,Asterisk
617292,TRANSMEMBRANE PROTEIN 150C; TMEM150C,Asterisk
617293,MATRIX REMODELING-ASSOCIATED PROTEIN 8; MXRA8,Asterisk
617294,"EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS; EBSSH",Number Sign
617295,RUN DOMAIN-CONTAINING PROTEIN 3B; RUNDC3B,Asterisk
617296,"SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO",Number Sign
617297,"AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J",Number Sign
617298,"APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 3; AIFM3",Asterisk
617299,RPA-INTERACTING PROTEIN; RPAIN,Asterisk
617300,"HYDROPS FETALIS, NONIMMUNE, AND/OR ATRIAL SEPTAL DEFECT, SUSCEPTIBILITY TO; HFASD",Number Sign
617301,GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE,Number Sign
617302,OPTIC ATROPHY 11; OPA11,Number Sign
617303,MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS,Number Sign
617304,RETINITIS PIGMENTOSA 77; RP77,Number Sign
617305,"FAMILY WITH SEQUENCE SIMILARITY 26, MEMBER F; FAM26F",Asterisk
617306,"COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD",Number Sign
617307,CHROMOSOME 14 OPEN READING FRAME 39; C14ORF39,Asterisk
617308,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6",Number Sign
617309,IMMUNOGLOBULIN-LIKE AND FIBRONECTIN TYPE III DOMAINS-CONTAINING PROTEIN 1; IGFN1,Asterisk
617310,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 3; ANKS3,Asterisk
617311,"ZYMOGEN GRANULE PROTEIN, 16-KD; ZG16",Asterisk
617312,"FAMILY WITH SEQUENCE SIMILARITY 160, MEMBER B1; FAM160B1",Asterisk
617313,SH2 DOMAIN-CONTAINING ADAPTOR PROTEIN F; SHF,Asterisk
617314,SH3 DOMAIN- AND SYLF DOMAIN-CONTAINING PROTEIN 1; SH3YL1,Asterisk
617315,ANTERIOR SEGMENT DYSGENESIS 6; ASGD6,Number Sign
617316,TP53 TARGET GENE 5; TP53TG5,Asterisk
617317,"ZINC FINGER PROTEIN 30, MOUSE, HOMOLOG OF; ZFP30",Asterisk
617318,RUN DOMAIN- AND SH3 DOMAIN-CONTAINING PROTEIN 1; RUSC1,Asterisk
617319,ANTERIOR SEGMENT DYSGENESIS 8; ASGD8,Number Sign
617320,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12; ARCI12",Number Sign
617321,YAO SYNDROME; YAOS,Number Sign
617322,SH3KBP1-BINDING PROTEIN 1; SHKBP1,Asterisk
617323,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59; MRT59",Number Sign
617324,"SHISA FAMILY, MEMBER 2; SHISA2",Asterisk
617325,"SHISA FAMILY, MEMBER 3; SHISA3",Asterisk
617326,"SHISA FAMILY, MEMBER 4; SHISA4",Asterisk
617327,"SHISA FAMILY, MEMBER 6; SHISA6",Asterisk
617328,"SHISA FAMILY, MEMBER 7; SHISA7",Asterisk
617329,"SHISA FAMILY, MEMBER 8; SHISA8",Asterisk
617330,"HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS",Number Sign
617331,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 4B; MFSD4B,Asterisk
617332,TELOMERE REPEAT-BINDING BOUQUET FORMATION PROTEIN 1; TERB1,Asterisk
617333,INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP,Number Sign
617334,ZINC FINGER DHHC-TYPE CONTAINING 23; ZDHHC23,Asterisk
617335,EMOPAMIL-BINDING PROTEIN-LIKE; EBPL,Asterisk
617336,"NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11",Number Sign
617337,"ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE; ECTD12",Number Sign
617338,NUDIX HYDROLASE 16-LIKE 1; NUDT16L1,Asterisk
617339,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51",Number Sign
617340,URIDINE PHOSPHORYLASE 2; UPP2,Asterisk
617341,CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2; CRMCC2,Number Sign
617342,PEPTIDYL-tRNA HYDROLASE DOMAIN-CONTAINING 1; PTRHD1,Asterisk
617343,HYPERPARATHYROIDISM 4; HRPT4,Number Sign
617344,PEAK1-RELATED KINASE-ACTIVATING PSEUDOKINASE 1; PRAG1,Asterisk
617345,ATP/GTP-BINDING PROTEIN-LIKE 2; AGBL2,Asterisk
617346,ATP/GTP-BINDING PROTEIN-LIKE 3; AGBL3,Asterisk
617347,"HYPERLIPOPROTEINEMIA, TYPE III",Number Sign
617348,"CARBOXYPEPTIDASE X, M14 FAMILY, MEMBER 2; CPXM2",Asterisk
617349,"AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO; AAT11",Number Sign
617350,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52",Number Sign
617351,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 10; IGSF10",Asterisk
617352,MULCHANDANI-BHOJ-CONLIN SYNDROME; MBCS,Number Sign
617353,TCTEX1 DOMAIN-CONTAINING PROTEIN 2; TCTEX1D2,Asterisk
617354,CHROMOBOX HOMOLOG 8; CBX8,Asterisk
617355,EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 2B; EID2B,Asterisk
617356,SUBCOMMISSURAL ORGAN SPONDIN; SSPO,Asterisk
617357,ZINC FINGER PROTEIN 222; ZNF222,Asterisk
617358,SYNDECAN-BINDING PROTEIN 2; SDCBP2,Asterisk
617359,STORKHEAD BOX 2; STOX2,Asterisk
617360,"CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD",Number Sign
617361,TRANSMEMBRANE PROTEIN 108; TMEM108,Asterisk
617362,DEAH BOX POLYPEPTIDE 37; DHX37,Asterisk
617363,TRANSMEMBRANE PROTEIN 132A; TMEM132A,Asterisk
617364,CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA; CHDED,Number Sign
617365,"AAR2 SPLICING FACTOR, S. CEREVISIAE, HOMOLOG OF; AAR2",Asterisk
617366,COILED-COIL DOMAIN-CONTAINING PROTEIN 91; CCDC91,Asterisk
617367,KIAA1217 GENE; KIAA1217,Asterisk
617368,SH3 DOMAIN-BINDING PROTEIN 1; SH3BP1,Asterisk
617369,HYALURONAN-BINDING PROTEIN 4; HABP4,Asterisk
617370,PEROXISOME BIOGENESIS DISORDER 10B; PBD10B,Number Sign
617371,ZINC FINGER PROTEIN 462; ZNF462,Asterisk
617372,SHC TRANSFORMING PROTEIN 4; SHC4,Asterisk
617373,PROLINE-RICH COILED-COIL PROTEIN 2C; PRRC2C,Asterisk
617374,"INHIBITOR OF CDK, CYCLIN A1-INTERACTING PROTEIN 1; INCA1",Asterisk
617375,KELCH DOMAIN-CONTAINING PROTEIN 9; KLHDC9,Asterisk
617376,PROLINE-RICH CYCLIN A1-INTERACTING PROTEIN; PROCA1,Asterisk
617377,"SYNAPSE DEFECTIVE RHO GTPase, C. ELEGANS, HOMOLOG OF, 1; SYDE1",Asterisk
617378,"MYOSIN LIGHT CHAIN, PHOSPHORYLATABLE, FAST SKELETAL MUSCLE; MYLPF",Asterisk
617379,MYOSIN XIX; MYO19,Asterisk
617380,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 29; TIMM29,Asterisk
617381,NUDIX HYDROLASE 16; NUDT16,Asterisk
617382,START DOMAIN-CONTAINING PROTEIN 10; STARD10,Asterisk
617383,"AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2; ANFH2",Number Sign
617384,"HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4",Number Sign
617385,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E, ISOFORM 1; ATP6V1E2",Asterisk
617386,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 5, PSEUDOGENE; NR1H5P",
617387,GLUTAMINE-RICH PROTEIN 1; QRICH1,Asterisk
617388,AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK,Number Sign
617389,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53",Number Sign
617390,KIAA1958 GENE; KIAA1958,Asterisk
617391,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54",Number Sign
617392,"ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13",Number Sign
617393,"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM",Number Sign
617394,"SCLEROSING CHOLANGITIS, NEONATAL; NSC",Number Sign
617395,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q",Number Sign
617396,ANAUXETIC DYSPLASIA 2; ANXD2,Number Sign
617397,PSEUDO-TORCH SYNDROME 2; PTORCH2,Number Sign
617398,FK506-BINDING PROTEIN 15; FKBP15,Asterisk
617399,PEROXISOMAL MEMBRANE PROTEIN 2; PXMP2,Asterisk
617400,EPOXIDE HYDROLASE 3; EPHX3,Asterisk
617401,EPOXIDE HYDROLASE 4; EPHX4,Asterisk
617402,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C",Number Sign
617403,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D",Number Sign
617404,"MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID",Number Sign
617405,SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17,Number Sign
617406,BARDET-BIEDL SYNDROME 21; BBS21,Number Sign
617407,POLYCOMB GROUP RING FINGER PROTEIN 5; PCGF5,Asterisk
617408,DIAMOND-BLACKFAN ANEMIA 16; DBA16,Number Sign
617409,DIAMOND-BLACKFAN ANEMIA 17; DBA17,Number Sign
617410,ZINC FINGER PROTEIN 419; ZNF419,Asterisk
617411,ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; ARFGEF3,Asterisk
617412,"BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD",Number Sign
617413,PRUNE EXOPOLYPHOSPHATASE 1; PRUNE1,Asterisk
617414,RIBOSOMAL PROTEIN L14; RPL14,Asterisk
617415,RIBOSOMAL PROTEIN L31; RPL31,Asterisk
617416,RIBOSOMAL PROTEIN L3-LIKE; RPL3L,Asterisk
617417,RIBOSOMAL PROTEIN L7-LIKE 1; RPL7L1,Asterisk
617418,WD REPEAT-CONTAINING PROTEIN 59; WDR59,Asterisk
617419,PROLYL 3-HYDROXYLASE 4; P3H4,Asterisk
617420,CHROMOSOME 12 OPEN READING FRAME 66; C12ORF66,Asterisk
617421,INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 2; ITFG2,Asterisk
617422,ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX 2; ADNP2,Asterisk
617423,PROLINE-RICH PROTEIN 14; PRR14,Asterisk
617424,WD REPEAT-CONTAINING PROTEIN 26; WDR26,Asterisk
617425,IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA,Number Sign
617426,CYSTEINE-RICH C-TERMINAL 1; CRCT1,Asterisk
617427,S100 CALCIUM-BINDING PROTEIN A7A; S100A7A,Asterisk
617428,CHROMOSOME 1 OPEN READING FRAME 43; C1ORF43,Asterisk
617429,UBIQUITIN-CONJUGATING ENZYME E2Q FAMILY MEMBER 1; UBE2Q1,Asterisk
617430,ADHESION G PROTEIN-COUPLED RECEPTOR F1; ADGRF1,Asterisk
617431,UBIQUITIN-SPECIFIC PEPTIDASE 53; USP53,Asterisk
617432,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60; MRT60",Number Sign
617433,RETINITIS PIGMENTOSA 78; RP78,Number Sign
617434,LONG NONCODING RNA HOST2,Asterisk
617435,LOPES-MACIEL-RODAN SYNDROME; LOMARS,Number Sign
617436,"GON7, S. CEREVISIAE, HOMOLOG OF; GON7",Asterisk
617437,S100 CALCIUM-BINDING PROTEIN A16; S100A16,Asterisk
617438,CHROMOBOX HOMOLOG 6; CBX6,Asterisk
617439,CRANIOSYNOSTOSIS 7; CRS7,Number Sign
617440,PAPILLARY THYROID CARCINOMA SUSCEPTIBILITY CANDIDATE 1 GENE; PTCSC1,Asterisk
617441,"THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY",Number Sign
617442,PREMATURE OVARIAN FAILURE 13; POF13,Number Sign
617443,"BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21",Number Sign
617444,ZINC FINGER PROTEIN 479; ZNF479,Asterisk
617445,UBIQUITIN-SPECIFIC PEPTIDASE 48; USP48,Asterisk
617446,"ChaC, E. COLI, HOMOLOG OF, 2; CHAC2",Asterisk
617447,PABP-DEPENDENT POLY(A) NUCLEASE 2; PAN2,Asterisk
617448,PABP-DEPENDENT POLY(A) NUCLEASE 3; PAN3,Asterisk
617449,TRANSMEMBRANE PROTEIN 260; TMEM260,Asterisk
617450,INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD; IDDGIP,Number Sign
617451,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER E2; AKR1E2",Asterisk
617452,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA",Number Sign
617453,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 26; TTC26,Asterisk
617454,"POLYMERASE III, RNA, SUBUNIT C; POLR3C",Asterisk
617455,"POLYMERASE III, RNA, SUBUNIT F; POLR3F",Asterisk
617456,"POLYMERASE III, RNA, SUBUNIT G; POLR3G",Asterisk
617457,"POLYMERASE III, RNA, SUBUNIT G-LIKE; POLR3GL",Asterisk
617458,"PRKR-INTERACTING PROTEIN 1, IL11-INDUCIBLE; PRKRIP1",Asterisk
617459,"TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 3; TMCC3",Asterisk
617460,RETINITIS PIGMENTOSA 79; RP79,Number Sign
617461,YBEY METALLOPEPTIDASE; YBEY,Asterisk
617462,"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR-RELATED PROTEIN 1; PPRC1",Asterisk
617463,UNKEMPT FAMILY-LIKE ZINC FINGER; UNKL,Asterisk
617464,UNC5 FAMILY C-TERMINAL-LIKE PROTEIN; UNC5CL,Asterisk
617465,SMALL INTEGRAL MEMBRANE PROTEIN 20; SMIM20,Asterisk
617466,TOWNES-BROCKS SYNDROME 2; TBS2,Number Sign
617467,FERM DOMAIN-CONTAINING PROTEIN 4B; FRMD4B,Asterisk
617468,"ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT; AMCNMY",Number Sign
617469,AFG1-LIKE ATPase; AFG1L,Asterisk
617470,UBIQUITIN-SPECIFIC PEPTIDASE-LIKE 1; USPL1,Asterisk
617471,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 12; SERPINA12",Asterisk
617472,TENASCIN N; TNN,Asterisk
617473,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F0 COMPLEX, SUBUNIT G; ATP5L",Asterisk
617474,ZINC FINGER PROTEIN 609; ZNF609,Asterisk
617475,SPECIFIC GRANULE DEFICIENCY 2; SGD2,Number Sign
617476,"CNKSR FAMILY, MEMBER 3; CNKSR3",Asterisk
617477,ZINC FINGER PROTEIN 324; ZNF324,Asterisk
617478,STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME; SHDRA,Number Sign
617479,"SSU2, C. ELEGANS, HOMOLOG OF; SSUH2",Asterisk
617480,"46,XX SEX REVERSAL 4; SRXX4",Number Sign
617481,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA",Number Sign
617482,TP53 TARGET GENE 3; TP53TG3,Asterisk
617483,CORNICHON FAMILY AMPA RECEPTOR AUXILIARY PROTEIN 4; CNIH4,Asterisk
617484,GAMETOCYTE-SPECIFIC FACTOR 1; GTSF1,Asterisk
617485,WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 3; WDFY3,Asterisk
617486,G-PATCH DOMAIN-CONTAINING PROTEIN 3; GPATCH3,Asterisk
617487,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 14; DNAJB14",Asterisk
617488,RNA PSEUDOURIDYLATE SYNTHASE DOMAIN-CONTAINING PROTEIN 4; RPUSD4,Asterisk
617489,LONG INTERGENIC NONCODING RNA 305; LINC00305,Asterisk
617490,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT DELTA; CATSPERD",Asterisk
617491,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 3; NSUN3",Asterisk
617492,OLFACTOMEDIN 2; OLFM2,Asterisk
617493,NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM,Number Sign
617494,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 2; EML2,Asterisk
617495,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A1, CC MOTIF CHEMOKINE-LIKE; FAM19A1",Asterisk
617496,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A2, CC MOTIF CHEMOKINE-LIKE; FAM19A2",Asterisk
617497,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A3, CC MOTIF CHEMOKINE-LIKE; FAM19A3",Asterisk
617498,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A4, CC MOTIF CHEMOKINE-LIKE; FAM19A4",Asterisk
617499,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5, CC MOTIF CHEMOKINE-LIKE; FAM19A5",Asterisk
617500,UROTHELIAL CANCER-ASSOCIATED GENE 1; UCA1,Asterisk
617501,LYSINE ACETYLTRANSFERASE 14; KAT14,Asterisk
617502,WD REPEAT-CONTAINING PROTEIN 41; WDR41,Asterisk
617503,DENN DOMAIN-CONTAINING PROTEIN 3; DENND3,Asterisk
617504,SIPA1-LIKE PROTEIN 1; SIPA1L1,Asterisk
617505,TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 1-LIKE 1; TRAM1L1,Asterisk
617506,NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2,Number Sign
617507,PEHO-LIKE SYNDROME; PEHOL,Number Sign
617508,ZINC FINGER PROTEIN 598; ZNF598,Asterisk
617509,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 8; VWA8,Asterisk
617510,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT EPSILON; CATSPERE",Asterisk
617511,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT ZETA; CATSPERZ",Asterisk
617512,ZINC FINGER PROTEIN 318; ZNF318,Asterisk
617513,OXOGLUTARATE DEHYDROGENASE-LIKE PROTEIN; OGDHL,Asterisk
617514,IMMUNODEFICIENCY 52; IMD52,Number Sign
617515,RHOMBOID DOMAIN-CONTAINING 1; RHBDD1,Asterisk
617516,STANKIEWICZ-ISIDOR SYNDROME; STISS,Number Sign
617517,RIBOSOMAL PROTEIN S6 KINASE C1; RPS6KC1,Asterisk
617518,BSD DOMAIN-CONTAINING PROTEIN 1; BSDC1,Asterisk
617519,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND",Number Sign
617520,"MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18",Number Sign
617521,"YIP1 DOMAIN FAMILY, MEMBER 1; YIPF1",Asterisk
617522,"YIP1 DOMAIN FAMILY, MEMBER 2; YIPF2",Asterisk
617523,NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM,Number Sign
617524,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2,Number Sign
617525,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3; EKVP3,Number Sign
617526,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4,Number Sign
617527,"NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA",Number Sign
617528,PROTEASOME ASSEMBLY CHAPERONE 3; PSMG3,Asterisk
617529,FAST KINASE DOMAINS 1; FASTKD1,Asterisk
617530,FAST KINASE DOMAINS 3; FASTKD3,Asterisk
617531,COLLAGEN BETA(1-O)GALACTOSYLTRANSFERASE 1; COLGALT1,Asterisk
617532,INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF,Number Sign
617533,COLLAGEN BETA(1-O)GALACTOSYLTRANSFERASE 2; COLGALT2,Asterisk
617534,"YIP1 DOMAIN FAMILY, MEMBER 4; YIPF4",Asterisk
617535,FAS APOPTOTIC INHIBITORY MOLECULE; FAIM,Asterisk
617536,BAI1-ASSOCIATED PROTEIN 2-LIKE 2; BAIAP2L2,Asterisk
617537,RAHMAN SYNDROME; RMNS,Number Sign
617538,ELONGATION FACTOR-LIKE GTPase 1; EFL1,Asterisk
617539,CHLORIDE CHANNEL CLIC-LIKE 1; CLCC1,Asterisk
617540,"PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5",Number Sign
617541,ANKYRIN REPEAT- AND ZINC FINGER DOMAIN-CONTAINING 1; ANKZF1,Asterisk
617542,"GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 2; HGPPS2",Number Sign
617543,POLYCOMB GROUP RING FINGER PROTEIN 3; PCGF3,Asterisk
617544,LONG INTERGENIC NONCODING RNA 672; LINC00672,Asterisk
617545,MINICHROMOSOME MAINTENANCE DOMAIN-CONTAINING PROTEIN 2; MCMDC2,Asterisk
617546,HELT BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR; HELT,Asterisk
617547,RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS,Number Sign
617548,WAP 4-DISULFIDE CORE DOMAIN 2; WFDC2,Asterisk
617549,TUMOR PROTEIN p53-INDUCIBLE NUCLEAR PROTEIN 2; TP53INP2,Asterisk
617550,PROTEASOME ASSEMBLY CHAPERONE 4; PSMG4,Asterisk
617551,"SID1 TRANSMEMBRANE FAMILY, MEMBER 2; SIDT2",Asterisk
617552,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 26; ARHGEF26,Asterisk
617553,Fc FRAGMENT OF IgG-BINDING PROTEIN; FCGBP,Asterisk
617554,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 3; FGD3",Asterisk
617555,FCH AND DOUBLE SH3 DOMAINS PROTEIN 1; FCHSD1,Asterisk
617556,FCH AND DOUBLE SH3 DOMAINS PROTEIN 2; FCHSD2,Asterisk
617557,GABRIELE-DE VRIES SYNDROME; GADEVS,Number Sign
617558,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 43; CFAP43,Asterisk
617559,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 44; CFAP44,Asterisk
617560,"SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8",Number Sign
617561,COHEN-GIBSON SYNDROME; COGIS,Number Sign
617562,MECKEL SYNDROME 13; MKS13,Number Sign
617563,OROFACIODIGITAL SYNDROME XVI; OFD16,Number Sign
617564,MEIER-GORLIN SYNDROME 8; MGORS8,Number Sign
617565,PERRAULT SYNDROME 6; PRLTS6,Number Sign
617566,ZINC FINGER PROTEIN 568; ZNF568,Asterisk
617567,TUMOR PROTEIN D52-LIKE 3; TPD52L3,Asterisk
617568,"UPSTREAM TRANSCRIPTION FACTOR FAMILY, MEMBER 3; USF3",Asterisk
617569,"KINESIN FAMILY, MEMBER 15; KIF15",Asterisk
617570,DAZ-INTERACTING ZINC FINGER PROTEIN 1-LIKE; DZIP1L,Asterisk
617571,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14",Number Sign
617572,EXUDATIVE VITREORETINOPATHY 7; EVR7,Number Sign
617573,"C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER B; CLEC12B",Asterisk
617574,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13",Number Sign
617575,"NEPHROTIC SYNDROME, TYPE 14; NPHS14",Number Sign
617576,SPERMATOGENIC FAILURE 18; SPGF18,Number Sign
617577,"CILIARY DYSKINESIA, PRIMARY, 37; CILD37",Number Sign
617578,"FER3, DROSOPHILA, HOMOLOG OF; FERD3L",Asterisk
617579,CLAUDIN 10; CLDN10,Asterisk
617580,TETRASPANIN 16; TSPAN16,Asterisk
617581,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 2; C2CD2,Asterisk
617582,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 2-LIKE; C2CD2L,Asterisk
617583,SULFIREDOXIN 1; SRXN1,Asterisk
617584,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25",Number Sign
617585,IMMUNODEFICIENCY 53; IMD53,Number Sign
617586,"FERM, ARHGEF, AND PLECKSTRIN DOMAINS-CONTAINING PROTEIN 2; FARP2",Asterisk
617587,SMALL PROLINE-RICH PROTEIN 2D; SPRR2D,Asterisk
617588,SMALL PROLINE-RICH PROTEIN 2E; SPRR2E,Asterisk
617589,SMALL PROLINE-RICH PROTEIN 2F; SPRR2F,Asterisk
617590,SMALL PROLINE-RICH PROTEIN 2G; SPRR2G,Asterisk
617591,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3,Number Sign
617592,SPERMATOGENIC FAILURE 19; SPGF19,Number Sign
617593,SPERMATOGENIC FAILURE 20; SPGF20,Number Sign
617594,"JHY, MOUSE, HOMOLOG OF; JHY",Asterisk
617595,BIRK-LANDAU-PEREZ SYNDROME; BILAPES,Number Sign
617596,MALEYLACETOACETATE ISOMERASE DEFICIENCY; MAAID,Number Sign
617597,RETINOL SATURASE; RETSAT,Asterisk
617598,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3,Number Sign
617599,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55",Number Sign
617600,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45",Number Sign
617601,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46",Number Sign
617602,CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM,Number Sign
617603,RNA-BINDING MOTIF PROTEIN 24; RBM24,Asterisk
617604,"MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA",Number Sign
617605,"DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71",Number Sign
617606,"DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72",Number Sign
617607,"AMELOGENESIS IMPERFECTA, TYPE IIIB; AI3B",Number Sign
617608,ALPHA KINASE 3; ALPK3,Asterisk
617609,"NEPHROTIC SYNDROME, TYPE 15; NPHS15",Number Sign
617610,POLYCYSTIC KIDNEY DISEASE 5; PKD5,Number Sign
617611,PICALM-INTERACTING MITOTIC REGULATOR; PIMREG,Asterisk
617612,ARMADILLO REPEAT-CONTAINING PROTEIN 9; ARMC9,Asterisk
617613,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5,Number Sign
617614,SPOUT DOMAIN-CONTAINING METHYLTRANSFERASE 1; SPOUT1,Asterisk
617615,TRANSMEMBRANE PROTEIN 258; TMEM258,Asterisk
617616,SKRABAN-DEARDORFF SYNDROME; SKDEAS,Number Sign
617617,"SPRY4 INTRONIC TRANSCRIPT 1, NONCODING; SPRY4IT1",Asterisk
617618,TOG ARRAY REGULATOR OF AXONEMAL MICROTUBULES 1; TOGARAM1,Asterisk
617619,"MISATO 1, MITOCHONDRIAL DISTRIBUTION AND MORPHOLOGY REGULATOR; MSTO1",Asterisk
617620,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 3; LRRC3,Asterisk
617621,PAX3- AND PAX7-BINDING PROTEIN 1; PAXBP1,Asterisk
617622,JOUBERT SYNDROME 30; JBTS30,Number Sign
617623,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E1; SPDYE1",Asterisk
617624,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E2; SPDYE2",Asterisk
617625,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E3; SPDYE3",Asterisk
617626,"FIBROMATOSIS, GINGIVAL, 5; GINGF5",Number Sign
617627,SMALL REGULATORY POLYPEPTIDE OF AMINO ACID RESPONSE; SPAAR,Asterisk
617628,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E4; SPDYE4",Asterisk
617629,SCHIZOPHRENIA 19; SCZD19,Number Sign
617630,G PROTEIN-COUPLED RECEPTOR 37-LIKE 1; GPR37L1,Asterisk
617631,IQ DOMAIN-CONTAINING PROTEIN E; IQCE,Asterisk
617632,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 7; EFCAB7,Asterisk
617633,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26",Number Sign
617634,COILED-COIL GLUTAMATE-RICH PROTEIN 2; CCER2,Asterisk
617635,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47",Number Sign
617636,GPR1 ANTISENSE RNA; GPR1AS,Asterisk
617637,"DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106",Number Sign
617638,IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B,Number Sign
617639,"DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107",Number Sign
617640,SUPPRESSOR OF TUMORIGENICITY 7-LIKE PROTEIN; ST7L,Asterisk
617641,"CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED",Number Sign
617642,"POLYDACTYLY, POSTAXIAL, TYPE A7; PAPA7",Number Sign
617643,"CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS",Number Sign
617644,SPERMATOGENIC FAILURE 21; SPGF21,Number Sign
617645,KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 4; KBTBD4,Asterisk
617646,BAH DOMAIN- AND COILED-COIL DOMAIN-CONTAINING PROTEIN 1; BAHCC1,Asterisk
617647,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 18, NONCODING; PCAT18",Asterisk
617648,BMP2-INDUCIBLE KINASE; BMP2K,Asterisk
617649,UBIQUITIN-CONJUGATING ENZYME E2O; UBE2O,Asterisk
617650,"PTGS2 ANTISENSE NFKB1 COMPLEX-MEDIATED EXPRESSION REGULATOR RNA, NONCODING; PACERR",Asterisk
617651,"EQTN, MOB3B, IFNK, AND C9ORF72 ENHANCER RNA I, NONCODING",Asterisk
617652,MOB KINASE ACTIVATOR 3B; MOB3B,Asterisk
617653,EQUATORIN; EQTN,Asterisk
617654,"DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108",Number Sign
617655,"PECANEX,  DROSOPHILA, HOMOLOG OF, 1; PCNX1",Asterisk
617656,"PECANEX, DROSOPHILA, HOMOLOG OF, 2; PCNX2",Asterisk
617657,"PECANEX, DROSOPHILA, HOMOLOG OF, 3; PCNX3",Asterisk
617658,SULFIDE QUINONE OXIDOREDUCTASE; SQOR,Asterisk
617659,LIPOYL(OCTANOYL) TRANSFERASE 2; LIPT2,Asterisk
617660,"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1",Number Sign
617661,"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2",Number Sign
617662,"JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM",Number Sign
617663,"DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73",Number Sign
617664,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32,Number Sign
617665,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56",Number Sign
617666,FRASER SYNDROME 2; FRASRS2,Number Sign
617667,FRASER SYNDROME 3; FRASRS3,Number Sign
617668,"ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA",Number Sign
617669,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS",Number Sign
617670,MEIOSIS-SPECIFIC PROTEIN WITH OB DOMAINS; MEIOB,Asterisk
617671,HELIX SYNDROME; HELIX,Number Sign
617672,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA",Number Sign
617673,SPERMATOGENESIS-ASSOCIATED PROTEIN 22; SPATA22,Asterisk
617674,STRESS-ASSOCIATED ENDOPLASMIC RETICULUM PROTEIN 1; SERP1,Asterisk
617675,"MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT",Number Sign
617676,"PROTEASOME 26S SUBUNIT, NON-ATPase, 3; PSMD3",Asterisk
617677,ZO2-ASSOCIATED SPECKLE PROTEIN,Asterisk
617678,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 2, NONCODING; PCAT2",Asterisk
617679,KELCH-LIKE 20; KLHL20,Asterisk
617680,"SSU72, S. CEREVISIAE, HOMOLOG OF; SSU72",Asterisk
617681,BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2,Number Sign
617682,PILAROWSKI-BJORNSSON SYNDROME; PILBOS,Number Sign
617683,"EGF-LIKE, FIBRONECTIN TYPE III, AND LAMININ G DOMAINS-CONTAINING PROTEIN; EGFLAM",Asterisk
617684,"Ly1 ANTIBODY-REACTIVE PROTEIN, MOUSE, HOMOLOG OF; LYAR",Asterisk
617685,CADHERIN 26; CDH26,Asterisk
617686,"PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3",Number Sign
617687,"TBC1 DOMAIN FAMILY, MEMBER 23; TBC1D23",Asterisk
617688,PROSTATE ANDROGEN-REGULATED MUCIN-LIKE PROTEIN 1; PARM1,Asterisk
617689,COLD-SHOCK DOMAIN-CONTAINING PROTEIN C2; CSDC2,Asterisk
617690,OVARIAN DYSGENESIS 5; ODG5,Number Sign
617691,SPINOCEREBELLAR ATAXIA 44; SCA44,Number Sign
617692,PR DOMAIN-CONTAINING PROTEIN 15; PRDM15,Asterisk
617693,VITRIN; VIT,Asterisk
617694,AL KAISSI SYNDROME; ALKAS,Number Sign
617695,"PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11",Number Sign
617696,LONG INTERGENIC NONCODING RNA 1488; LINC01488,Asterisk
617697,"CCND1 UPSTREAM INTERGENIC DNA REPAIR 2, NONCODING",Asterisk
617698,"3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9",Number Sign
617699,"GID COMPLEX, SUBUNIT 4; GID4",Asterisk
617700,UBIQUITIN-CONJUGATING ENZYME E2F; UBE2F,Asterisk
617701,"CANCER SUSCEPTIBILITY CANDIDATE 8, NONCODING; CASC8",Asterisk
617702,"CANCER SUSCEPTIBILITY CANDIDATE 21, NONCODING; CASC21",Asterisk
617703,"CANCER SUSCEPTIBILITY CANDIDATE 19, NONCODING; CASC19",Asterisk
617704,"CANCER SUSCEPTIBILITY CANDIDATE 11, NONCODING; CASC11",Asterisk
617705,"COLON CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING; CCAT1",Asterisk
617706,SPERMATOGENIC FAILURE 22; SPGF22,Number Sign
617707,SPERMATOGENIC FAILURE 23; SPGF23,Number Sign
617708,CELL DIVISION CYCLE 123; CDC123,Asterisk
617709,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS",Number Sign
617710,"NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS",Number Sign
617711,"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1",Number Sign
617712,OOCYTE MATURATION DEFECT 3; OOMD3,Number Sign
617713,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33,Number Sign
617714,CAVEOLAE-ASSOCIATED PROTEIN 4; CAVIN4,Asterisk
617715,MAM AND LDL RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 1; MALRD1,Asterisk
617716,RHO GTPase-ACTIVATING PROTEIN 44; ARHGAP44,Asterisk
617717,AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA,Number Sign
617718,PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID,Number Sign
617719,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7",Number Sign
617720,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 42; PPP1R42",Asterisk
617721,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9",Number Sign
617722,THIOREDOXIN-LIKE 4B; TXNL4B,Asterisk
617723,"RIBOSOMAL RNA-PROCESSING PROTEIN 12, S. CEREVISIAE, HOMOLOG OF; RRP12",Asterisk
617724,"TSC22 DOMAIN FAMILY, MEMBER 2; TSC22D2",Asterisk
617725,FUCOSE MUTAROTASE; FUOM,Asterisk
617726,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 19; CARD19,Asterisk
617727,"TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 4; TM9SF4",Asterisk
617728,"CENTROSOMAL PROTEIN, 295-KD; CEP295",Asterisk
617729,GALLOWAY-MOWAT SYNDROME 3; GAMOS3,Number Sign
617730,GALLOWAY-MOWAT SYNDROME 4; GAMOS4,Number Sign
617731,GALLOWAY-MOWAT SYNDROME 5; GAMOS5,Number Sign
617732,"FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD",Number Sign
617733,ZINC FINGER PROTEIN 518A; ZNF518A,Asterisk
617734,ZINC FINGER PROTEIN 518B; ZNF518B,Asterisk
617735,CHROMOSOME 10 OPEN READING FRAME 90; C10ORF90,Asterisk
617736,MORN REPEAT-CONTAINING PROTEIN 4; MORN4,Asterisk
617737,"SPHINGOMYELIN PHOSPHODIESTERASE, ACID-LIKE, 3B; SMPDL3B",Asterisk
617738,KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 6; KBTBD6,Asterisk
617739,KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 7; KBTBD7,Asterisk
617740,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 10-LIKE; VSIG10L,Asterisk
617741,WD REPEAT-CONTAINING PROTEIN 20; WDR20,Asterisk
617742,"KAT8 REGULATORY NSL COMPLEX, SUBUNIT 3; KANSL3",Asterisk
617743,OOCYTE MATURATION DEFECT 4; OOMD4,Number Sign
617744,"IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH",Number Sign
617745,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 12; MFSD12,Asterisk
617746,SWEENEY-COX SYNDROME; SWCOS,Number Sign
617747,NUCLEAR BODY PROTEIN SP140-LIKE; SP140L,Asterisk
617748,TUDOR DOMAIN-CONTAINING PROTEIN 5; TDRD5,Asterisk
617749,ACTN3 DEFICIENCY,Number Sign
617750,LIM AND CALPONIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1; LIMCH1,Asterisk
617751,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48",Number Sign
617752,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49",Number Sign
617753,RIO KINASE 1; RIOK1,Asterisk
617754,RIO KINASE 2; RIOK2,Asterisk
617755,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL,Number Sign
617756,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5; EKVP5,Number Sign
617757,JOUBERT SYNDROME 32; JBTS32,Number Sign
617758,ZINC FINGER PROTEIN 692; ZNF692,Asterisk
617759,RNA PSEUDOURIDYLATE SYNTHASE DOMAIN-CONTAINING PROTEIN 3; RPUSD3,Asterisk
617760,"MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6",Number Sign
617761,JOUBERT SYNDROME 31; JBTS31,Number Sign
617762,"LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO",Number Sign
617763,"SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF",Number Sign
617764,ZYG11-RELATED CELL CYCLE REGULATOR; ZER1,Asterisk
617765,"IMMUNODEFICIENCY, COMMON VARIABLE, 14; CVID14",Number Sign
617766,"FAMILY WITH SEQUENCE SIMILARITY 192, MEMBER A; FAM192A",Asterisk
617767,JOUBERT SYNDROME 33; JBTS33,Number Sign
617768,KLEEFSTRA SYNDROME 2; KLEFS2,Number Sign
617769,SPINOCEREBELLAR ATAXIA 45; SCA45,Number Sign
617770,SPINOCEREBELLAR ATAXIA 46; SCA46,Number Sign
617771,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57",Number Sign
617772,"DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34",Number Sign
617773,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61",Number Sign
617774,"LON PEPTIDASE 2, PEROXISOMAL; LONP2",Asterisk
617775,CHROMOSOME 10 OPEN READING FRAME 99; C10ORF99,Asterisk
617776,"BAGE FAMILY, MEMBER 2; BAGE2",Asterisk
617777,"BAGE FAMILY, MEMBER 3; BAGE3",Asterisk
617778,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 15; TXNDC15,Asterisk
617779,TRANSMEMBRANE PROTEIN 256; TMEM256,Asterisk
617780,COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH,Number Sign
617781,RETINITIS PIGMENTOSA 80; RP80,Number Sign
617782,GREB1-LIKE PROTEIN; GREB1L,Asterisk
617783,"NEPHROTIC SYNDROME, TYPE 16; NPHS16",Number Sign
617784,"FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW",Number Sign
617785,"PAPILIN, PROTEOGLYCAN-LIKE SULFATED GLYCOPROTEIN; PAPLN",Asterisk
617786,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 8; CCT8",Asterisk
617787,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50",Number Sign
617788,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51",Number Sign
617789,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 8; TXNDC8,Asterisk
617790,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 2; TXNDC2,Asterisk
617791,LEUCINE-RICH REPEAT- AND COILED-COIL DOMAIN-CONTAINING CENTROSOMAL PROTEIN 1; LRRCC1,Asterisk
617792,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 11; TXNDC11,Asterisk
617793,EEF1A LYSINE METHYLTRANSFERASE 1; EEF1AKMT1,Asterisk
617794,EEF1A LYSINE METHYLTRANSFERASE 2; EEF1AKMT2,Asterisk
617795,ELONGIN BC- AND POLYCOMB REPRESSIVE COMPLEX 2-ASSOCIATED PROTEIN; EPOP,Asterisk
617796,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52",Number Sign
617797,SRC-RELATED KINASE LACKING C-TERMINAL REGULATORY TYROSINE AND N-TERMINAL MYRISTYLATION SITES; SRMS,Asterisk
617798,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53",Number Sign
617799,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54",Number Sign
617800,"MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19",Number Sign
617801,CYCLASE-ASSOCIATED ACTIN CYTOSKELETON REGULATORY PROTEIN 1; CAP1,Asterisk
617802,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA",Number Sign
617803,TRANSMEMBRANE PROTEIN 26; TMEM26,Asterisk
617804,NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL,Number Sign
617805,RENAL HYPODYSPLASIA/APLASIA 3; RHDA3,Number Sign
617806,TRANSMEMBRANE PROTEIN 86B; TMEM86B,Asterisk
617807,"NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW",Number Sign
617808,COFFIN-SIRIS SYNDROME 6; CSS6,Number Sign
617809,GELEOPHYSIC DYSPLASIA 3; GPHYSD3,Number Sign
617810,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15,Number Sign
617811,DNA REPLICATION REGULATOR AND SPLICEOSOMAL FACTOR SMU1; SMU1,Asterisk
617812,"SOLUTE CARRIER FAMILY 35, MEMBER G2; SLC35G2",Asterisk
617813,TRANSMEMBRANE PROTEIN 88; TMEM88,Asterisk
617814,TRANSMEMBRANE PROTEIN 95; TMEM95,Asterisk
617815,"POLYMERASE III, RNA, SUBUNIT E; POLR3E",Asterisk
617816,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16,Number Sign
617817,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 2; TUBGCP2,Asterisk
617818,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 3; TUBGCP3,Asterisk
617819,RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 2; RALGPS2,Asterisk
617820,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR",Number Sign
617821,"EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2",Number Sign
617822,ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS,Number Sign
617823,PWWP DOMAIN-CONTAINING PROTEIN 2A; PWWP2A,Asterisk
617824,BROMODOMAIN AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; BRWD1,Asterisk
617825,GLUCOCORTICOID DEFICIENCY 5; GCCD5,Number Sign
617826,"UNC50, INNER NUCLEAR MEMBRANE RNA-BINDING PROTEIN; UNC50",Asterisk
617827,IMMUNODEFICIENCY 55; IMD55,Number Sign
617828,ZINC FINGER HOMEOBOX 2; ZFHX2,Asterisk
617829,"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2",Number Sign
617830,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58",Number Sign
617831,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55",Number Sign
617832,"SENTAN, CILIA APICAL STRUCTURAL PROTEIN; SNTN",Asterisk
617833,"ZFHX2 ANTISENSE RNA 1, NONCODING; ZFHX2AS1",Asterisk
617834,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY J, MEMBER 1; PLEKHJ1",Asterisk
617835,PYRUVATE DEHYDROGENASE PHOSPHATASE REGULATORY SUBUNIT; PDPR,Asterisk
617836,DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM,Number Sign
617837,GDNF FAMILY RECEPTOR ALPHA-LIKE PROTEIN; GFRAL,Asterisk
617838,"FAMILY WITH SEQUENCE SIMILARITY 234, MEMBER B; FAM234B",Asterisk
617839,AMYOTROPHIC LATERAL SCLEROSIS 23; ALS23,Number Sign
617840,tRNA ISOPENTENYLTRANSFERASE 1; TRIT1,Asterisk
617841,"PROTEASOME SUBUNIT, ALPHA-TYPE, 8; PSMA8",Asterisk
617842,"PROTEASOME 26S SUBUNIT, NON-ATPase, 1; PSMD1",Asterisk
617843,RWD DOMAIN-CONTAINING PROTEIN 2B; RWDD2B,Asterisk
617844,"PROTEASOME 26S SUBUNIT, NON-ATPase, 8; PSMD8",Asterisk
617845,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 2B; MFSD2B,Asterisk
617846,PHD FINGER PROTEIN 5A; PHF5A,Asterisk
617847,"SPLICING FACTOR 3B, SUBUNIT 5; SF3B5",Asterisk
617848,DEAD BOX HELICASE 46; DDX46,Asterisk
617849,U2 SMALL NUCLEAR RIBONUCLEOPROTEIN-ASSOCIATED SURP DOMAIN-CONTAINING PROTEIN; U2SURP,Asterisk
617850,SERTA DOMAIN-CONTAINING PROTEIN 1; SERTAD1,Asterisk
617851,SERTA DOMAIN-CONTAINING PROTEIN 2; SERTAD2,Asterisk
617852,SEC23-INTERACTING PROTEIN; SEC23IP,Asterisk
617853,SMALL VASOHIBIN-BINDING PROTEIN; SVBP,Asterisk
617854,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56",Number Sign
617855,"BASE METHYLTRANSFERASE OF 25S rRNA 2, S. CEREVISIAE, HOMOLOG OF; BMT2",Asterisk
617856,"THYMOCYTE SELECTION-ASSOCIATED PROTEIN FAMILY, MEMBER 2; THEMIS2",Asterisk
617857,"PROTEASOME 26S SUBUNIT, NON-ATPase, 6; PSMD6",Asterisk
617858,PROTEASOME INHIBITOR SUBUNIT 1; PSMF1,Asterisk
617859,DISCS LARGE-ASSOCIATED PROTEIN 5; DLGAP5,Asterisk
617860,SURFACTANT-ASSOCIATED PROTEIN 3; SFTA3,Asterisk
617861,"MYB-RELATED TRANSCRIPTION FACTOR, PARTNER OF PROFILIN; MYPOP",Asterisk
617862,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA",Number Sign
617864,NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA,Number Sign
617865,"NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA",Number Sign
617866,SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18,Number Sign
617867,TUMOR PROTEIN p53-INDUCIBLE PROTEIN 11; TP53I11,Asterisk
617868,NUCLEAR ASSEMBLY FACTOR 1 RIBONUCLEOPROTEIN; NAF1,Asterisk
617869,NK1 HOMEOBOX 1; NKX1-1,Asterisk
617870,CENTROSOMAL PROTEIN 350; CEP350,Asterisk
617871,RETINITIS PIGMENTOSA 81; RP81,Number Sign
617872,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34,Number Sign
617873,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35,Number Sign
617874,POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3,Number Sign
617875,POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4,Number Sign
617876,"RNA, U7 SMALL NUCLEAR, 1; RNU7-1",Asterisk
617877,"SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC",Number Sign
617878,"TUBULIN, ALPHA-3D; TUBA3D",Asterisk
617879,LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD,Number Sign
617880,POC5 CENTRIOLAR PROTEIN; POC5,Asterisk
617881,CHROMOSOME 4 OPEN READING FRAME 54; C4ORF54,Asterisk
617882,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG",Number Sign
617883,"FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS",Number Sign
617884,HEPATOMA-DERIVED GROWTH FACTOR-LIKE PROTEIN 2; HDGFL2,Asterisk
617885,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19,Number Sign
617886,ZINC FINGER PROTEIN 512B; ZNF512B,Asterisk
617887,AGMATINASE; AGMAT,Asterisk
617888,ZINC FINGER PROTEIN 580; ZNF580,Asterisk
617889,PYRIDINE NUCLEOTIDE-DISULPHIDE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2; PYROXD2,Asterisk
617890,ZINC FINGER PROTEIN 664; ZNF664,Asterisk
617891,ZINC FINGER PROTEIN 655; ZNF655,Asterisk
617892,"AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24",Number Sign
617893,RIBOSOMAL PROTEIN L36; RPL36,Asterisk
617894,TRANSMEMBRANE PROTEIN 50B; TMEM50B,Asterisk
617895,SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19,Number Sign
617896,"ZIC FAMILY, MEMBER 5; ZIC5",Asterisk
617897,CITRATE SYNTHASE LYSINE METHYLTRANSFERASE; CSKMT,Asterisk
617898,MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4,Number Sign
617899,"LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14",Number Sign
617900,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8",Number Sign
617901,DEXAMETHASONE-INDUCED GENE; DEXI,Asterisk
617902,GALECTIN-LIKE PROTEIN; LGALSL,Asterisk
617903,NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS,Number Sign
617904,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59",Number Sign
617905,HYPOXIA-INDUCIBLE LIPID DROPLET-ASSOCIATED PROTEIN; HILPDA,Asterisk
617906,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 20; CFAP20,Asterisk
617907,"ERYTHROCYTOSIS, FAMILIAL, 5; ECYT5",Number Sign
617908,ZINC FINGER PROTEIN 473; ZNF473,Asterisk
617909,"LSM10, U7 SMALL NUCLEAR RNA-ASSOCIATED PROTEIN; LSM10",Asterisk
617910,"LSM11, U7 SMALL NUCLEAR RNA-ASSOCIATED PROTEIN; LSM11",Asterisk
617911,DIAMOND-BLACKFAN ANEMIA-LIKE; DBAL,Number Sign
617912,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5",Number Sign
617913,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR",Number Sign
617914,"MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20",Number Sign
617915,"HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS",Number Sign
617916,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7,Number Sign
617917,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8,Number Sign
617918,STRIATIN-INTERACTING PROTEIN 1; STRIP1,Asterisk
617919,STRIATIN-INTERACTING PROTEIN 2; STRIP2,Asterisk
617920,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3",Number Sign
617921,"AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25; ALS25",Number Sign
617922,GLYCOPHORIN A; GYPA,Asterisk
617923,GLYCOPHORIN B; GYPB,Asterisk
617924,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10",Number Sign
617925,SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20,Number Sign
617926,OROFACIODIGITAL SYNDROME XVII; OFD17,Number Sign
617927,OROFACIODIGITAL SYNDROME XVIII; OFD18,Number Sign
617928,KERATOCONUS 9; KTCN9,Number Sign
617929,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60",Number Sign
617930,CHROMOSOME 1p35 DELETION SYNDROME,Number Sign
617931,SPINOCEREBELLAR ATAXIA 47; SCA47,Number Sign
617932,RHOPHILIN 2; RHPN2,Asterisk
617933,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61",Number Sign
617934,AE-BINDING PROTEIN 2; AEBP2,Asterisk
617935,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4",Number Sign
617936,BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED,Number Sign
617937,RNA-BINDING MOTIF PROTEIN 11; RBM11,Asterisk
617938,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62",Number Sign
617939,ZINC FINGER PROTEIN 69; ZFP69,Asterisk
617940,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G3; PLEKHG3,Asterisk
617941,SHWACHMAN-DIAMOND SYNDROME 2; SDS2,Number Sign
617942,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17A; ABHD17A,Asterisk
617943,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17B; ABHD17B,Asterisk
617944,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17C; ABHD17C,Asterisk
617945,KIAA1107 GENE; KIAA1107,Asterisk
617946,ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 1; ERGIC1,Asterisk
617947,WD REPEAT-CONTAINING PROTEIN 74; WDR74,Asterisk
617948,ELLIPTOCYTOSIS 3; EL3,Number Sign
617949,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 69; CFAP69,Asterisk
617950,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36,Number Sign
617951,"LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15",Number Sign
617952,"OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18",Number Sign
617953,"HYPERTHYROXINEMIA, EUTHYROID, CAUSED BY GENERALIZED 5-PRIME-DEIODINASE DEFICIENCY",
617954,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6,Number Sign
617955,PHENYTOIN TOXICITY,Percent
617956,BETA-GLUCOPYRANOSIDE TASTING,Number Sign
617957,LEUCINE RICH REPEATS- AND IQ MOTIF-CONTAINING PROTEIN 3; LRRIQ3,Asterisk
617958,INTERACTOR OF LITTLE ELONGATION COMPLEX ELL SUBUNIT 1; ICE1,Asterisk
617959,SPERMATOGENIC FAILURE 24; SPGF24,Number Sign
617960,SPERMATOGENIC FAILURE 25; SPGF25,Number Sign
617961,SPERMATOGENIC FAILURE 26; SPGF26,Number Sign
617962,ZINC FINGER PROTEIN 827; ZNF827,Asterisk
617963,TUDOR DOMAIN-CONTAINING PROTEIN 9; TDRD9,Asterisk
617964,"LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16",Number Sign
617965,SPERMATOGENIC FAILURE 27; SPGF27,Number Sign
617966,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7; LDLCQ7,Number Sign
617967,"HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3",Number Sign
617968,WD REPEAT-CONTAINING PROTEIN 63; WDR63,Asterisk
617969,COILED-COIL DOMAIN-CONTAINING PROTEIN 63; CCDC63,Asterisk
617970,"RH-NULL, AMORPH TYPE; RHNA",Number Sign
617971,"METHEMOGLOBINEMIA, BETA TYPE",Number Sign
617972,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 20; ZDHHC20,Asterisk
617973,"METHEMOGLOBINEMIA, ALPHA TYPE",Number Sign
617974,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR",Number Sign
617975,"FAMILY WITH SEQUENCE SIMILARITY 210, MEMBER A; FAM210A",Asterisk
617976,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63",Number Sign
617977,NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS,Number Sign
617978,"FAMILY WITH SEQUENCE SIMILARITY 49, MEMBER B; FAM49B",Asterisk
617979,LONG NONCODING RNA NEAR ACOD1,Asterisk
617980,"ERYTHROCYTOSIS, FAMILIAL, 6; ECYT6",Number Sign
617981,"ERYTHROCYTOSIS, FAMILIAL, 7; ECYT7",Number Sign
617982,VERVERI-BRADY SYNDROME; VERBRAS,Number Sign
617983,"MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21",Number Sign
617984,"MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22",Number Sign
617985,"MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23",Number Sign
617986,LOW DENSITY LIPOPROTEIN RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 3; LDLRAD3,Asterisk
617987,EEF1A LYSINE AND N-TERMINAL METHYLTRANSFERASE; EEF1AKNMT,Asterisk
617988,JABERI-ELAHI SYNDROME; JABELS,Number Sign
617989,"N-ALPHA-ACETYLTRANSFERASE 30, NatC CATALYTIC SUBUNIT; NAA30",Asterisk
617990,"N-ALPHA-ACETYLTRANSFERASE 38, NatC AUXILIARY SUBUNIT; NAA38",Asterisk
617991,"DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD",Number Sign
617992,"DEAFNESS, CONGENITAL HEART DEFECTS, AND POSTERIOR EMBRYOTOXON; DCHE",Number Sign
617993,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2; HFTC2",Number Sign
617994,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3; HFTC3",Number Sign
617995,"IMPDH2 ENZYME ACTIVITY, VARIATION IN; IMPDH2V",Number Sign
617996,OOCYTE MATURATION DEFECT 5; OOMD5,Number Sign
617997,RCC1 DOMAIN-CONTAINING PROTEIN 1; RCCD1,Asterisk
617998,"GRB2-ASSOCIATED REGULATOR OF MAPK1, SUBTYPE 1; GAREM1",Asterisk
617999,"GRB2-ASSOCIATED REGULATOR OF MAPK1, SUBTYPE 2; GAREM2",Asterisk
618000,"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2",Number Sign
618001,"RAB11 EFFECTOR CONTAINING LIS1 HOMOLOGY DOMAIN, COILED-COIL DOMAINS, AND HEAT REPEATS; RELCH",Asterisk
618002,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 4; MAST4,Asterisk
618003,"DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57",Number Sign
618004,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64",Number Sign
618005,CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION; CDGF,Number Sign
618006,"LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17",Number Sign
618007,"NEURODEVELOPMENTAL DISORDER WITH BRAIN, LIVER, AND LUNG ABNORMALITIES; NEDBLLA",Number Sign
618008,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65",Number Sign
618010,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17,Number Sign
618011,HYPEREKPLEXIA 4; HKPX4,Number Sign
618012,"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3",Number Sign
618013,"DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109",Number Sign
618014,PREMATURE OVARIAN FAILURE 14; POF14,Number Sign
618015,"PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2",Number Sign
618016,RNA-BINDING REGION-CONTAINING PROTEIN 3; RNPC3,Asterisk
618017,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 16; ANKRD16,Asterisk
618018,"DRUG METABOLISM, ALTERED, CYP2C8-RELATED",Number Sign
618019,PELGER-HUET ANOMALY WITH MILD SKELETAL ANOMALIES; PHASK,Number Sign
618020,KELCH-LIKE 22; KLHL22,Asterisk
618021,TETRAAMELIA SYNDROME 2; TETAMS2,Number Sign
618022,HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD,Number Sign
618023,NOTCH2 N-TERMINAL-LIKE PROTEIN A; NOTCH2NLA,Asterisk
618024,NOTCH2 N-TERMINAL-LIKE PROTEIN B; NOTCH2NLB,Asterisk
618025,NOTCH2 N-TERMINAL-LIKE PROTEIN C; NOTCH2NLC,Asterisk
618026,"NOTCH2 N-TERMINAL-LIKE-RELATED, PSEUDOGENE; NOTCH2NLR",
618027,COFFIN-SIRIS SYNDROME 7; CSS7,Number Sign
618028,"SHIELD COMPLEX, SUBUNIT 1; SHLD1",Asterisk
618029,"SHIELD COMPLEX, SUBUNIT 2; SHLD2",Asterisk
618030,"SHIELD COMPLEX, SUBUNIT 3; SHLD3",Asterisk
618031,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4",Number Sign
618032,ZINC FINGER PROTEIN 768; ZNF768,Asterisk
618033,ZINC FINGER PROTEIN 689; ZNF689,Asterisk
618034,"SOLUTE CARRIER FAMILY 43, MEMBER 3; SLC43A3",Asterisk
618035,"TBC1 DOMAIN FAMILY, MEMBER 9; TBC1D9",Asterisk
618036,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD",Number Sign
618037,ZINC FINGER PROTEIN 536; ZNF536,Asterisk
618038,CHROMOSOME 9 OPEN READING FRAME 84; C9ORF84,Asterisk
618039,"TBC1 DOMAIN FAMILY, MEMBER 9B; TBC1D9B",Asterisk
618040,DIGEORGE SYNDROME CRITICAL REGION GENE 5; DGCR5,Asterisk
618041,PURINE-RICH ELEMENT-BINDING PROTEIN G; PURG,Asterisk
618042,PULMONARY ALVEOLAR PROTEINOSIS WITH HYPOGAMMAGLOBULINEMIA; PAPHG,Percent
618043,"POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 1; POU6F1",Asterisk
618044,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 5; C2CD5,Asterisk
618045,DNA DAMAGE-INDUCED APOPTOSIS SUPPRESSOR; DDIAS,Asterisk
618046,"OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY A, MEMBER 1; OR1A1",Asterisk
618047,"OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY A, MEMBER 2; OR1A2",Asterisk
618048,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2,Number Sign
618049,"PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2",Number Sign
618050,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57",Number Sign
618051,INNATE IMMUNITY ACTIVATOR; INAVA,Asterisk
618052,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27",Number Sign
618053,ANDROGEN RECEPTOR-REGULATED LONG NONCODING RNA 1; ARLNC1,Asterisk
618054,KIAA1024 GENE; KIAA1024,Asterisk
618055,CELLULAR REPRESSOR OF E1A-STIMULATED GENES 1; CREG1,Asterisk
618056,NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS,Number Sign
618057,"DRUG METABOLISM, ALTERED, CES1-RELATED",Number Sign
618058,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 300; CFAP300,Asterisk
618059,WD REPEAT-CONTAINING PROTEIN 25; WDR25,Asterisk
618060,INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA,Number Sign
618061,POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6,Number Sign
618062,CYSTEINE-RICH SECRETORY PROTEIN 3; CRISP3,Asterisk
618063,"CILIARY DYSKINESIA, PRIMARY, 38; CILD38",Number Sign
618064,CYTOCHROME c OXIDASE ASSEMBLY FACTOR 16; COX16,Asterisk
618065,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D",Number Sign
618066,"HOMEOBOX B CLUSTER ANTISENSE RNA 1, NONCODING; HOXBAS1",Asterisk
618067,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66",Number Sign
618068,SPERMATOGENIC LEUCINE ZIPPER PROTEIN 1; SPZ1,Asterisk
618069,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6-LIKE; CNOT6L",Asterisk
618070,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 42-KD, V1 SUBUNIT C, ISOFORM 2; ATP6V1C2",Asterisk
618071,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 3; ATP6V1G3",Asterisk
618072,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 2; ATP6V0D2",Asterisk
618073,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 12; SAMD12,Asterisk
618074,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 6; FAME6",Number Sign
618075,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 7; FAME7",Number Sign
618076,NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG,Number Sign
618077,INFLAMMATORY BOWEL DISEASE 29; IBD29,Number Sign
618078,OVARIAN DYSGENESIS 6; ODG6,Number Sign
618079,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8; LDLCQ8,Number Sign
618080,WD REPEAT-AND FYVE DOMAIN-CONTAINING PROTEIN 1; WDFY1,Asterisk
618081,IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 2; ILDR2,Asterisk
618082,WD REPEAT-CONTAINING PROTEIN 33; WDR33,Asterisk
618083,WW-BINDING PROTEIN 11; WBP11,Asterisk
618084,PEELING SKIN SYNDROME 6; PSS6,Number Sign
618085,POLYAMINE-MODULATED FACTOR 1-BINDING PROTEIN 1; PMFBP1,Asterisk
618086,SPERMATOGENIC FAILURE 28; SPGF28,Number Sign
618087,"SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND",Number Sign
618088,"NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS",Number Sign
618089,INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA,Number Sign
618090,NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC,Number Sign
618091,SPERMATOGENIC FAILURE 29; SPGF29,Number Sign
618092,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA",Number Sign
618094,"DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110",Number Sign
618095,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63",Number Sign
618096,PREMATURE OVARIAN FAILURE 15; POF15,Number Sign
618097,"MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2",Number Sign
618098,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5",Number Sign
618099,MITOCHONDRIAL RIBOSOMAL RNA METHYLTRANSFERASE 1; MRM1,Asterisk
618100,MPV17-LIKE PROTEIN; MPV17L,Asterisk
618101,MATRIX METALLOPROTEINASE 27; MMP27,Asterisk
618102,SUMO-INTERACTING MOTIFS-CONTAINING PROTEIN 1; SIMC1,Asterisk
618103,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64",Number Sign
618104,MEMBRANE METALLOENDOPEPTIDASE-LIKE 1; MMEL1,Asterisk
618105,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 15; SIGLEC15,Asterisk
618106,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58",Number Sign
618107,"OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3",Number Sign
618108,IMMUNODEFICIENCY 57; IMD57,Number Sign
618109,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65",Number Sign
618110,SPERMATOGENIC FAILURE 30; SPGF30,Number Sign
618111,ZINC FINGER PROTEIN 64; ZFP64,Asterisk
618112,SPERMATOGENIC FAILURE 31; SPGF31,Number Sign
618113,"ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV",Number Sign
618114,LIDDLE SYNDROME 2; LIDLS2,Number Sign
618115,SPERMATOGENIC FAILURE 32; SPGF32,Number Sign
618116,BONE MARROW FAILURE SYNDROME 4; BMFS4,Number Sign
618117,OVARIAN DYSGENESIS 7; ODG7,Number Sign
618118,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 3; EML3,Asterisk
618119,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 5; EML5,Asterisk
618120,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5",Number Sign
618121,"ATP SYNTHASE, PERIPHERAL STALK, SUBUNIT D; ATP5PD",Asterisk
618122,MTR4 EXOSOME RNA HELICASE; MTREX,Asterisk
618123,"POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8",Number Sign
618124,"PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID",Number Sign
618125,COILED-COIL DOMAIN-CONTAINING PROTEIN 155; CCDC155,Asterisk
618126,LIDDLE SYNDROME 3; LIDLS3,Number Sign
618127,"CYTOCHROME C OXIDASE, SUBUNIT 6B2; COX6B2",Asterisk
618128,GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 2; GDAP2,Asterisk
618129,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4",Number Sign
618130,N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 2; NECAB2,Asterisk
618132,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 14; SIGLEC14,Asterisk
618133,"NEUREXOPHILIN AND PC-ESTERASE DOMAIN FAMILY, MEMBER 4; NXPE4",Asterisk
